Citrus Sinensis ID: 006559
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 640 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M9C5 | 670 | Probable leucine-rich rep | yes | no | 0.929 | 0.888 | 0.397 | 1e-107 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.865 | 0.841 | 0.384 | 6e-97 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.937 | 0.917 | 0.372 | 8e-97 | |
| Q9SUQ3 | 638 | Probable inactive recepto | no | no | 0.879 | 0.882 | 0.364 | 2e-91 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.917 | 0.917 | 0.360 | 1e-90 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.935 | 0.935 | 0.363 | 4e-90 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.870 | 0.850 | 0.361 | 1e-83 | |
| Q84MA9 | 652 | Inactive leucine-rich rep | no | no | 0.929 | 0.912 | 0.359 | 4e-83 | |
| Q9SH71 | 587 | Putative inactive recepto | no | no | 0.878 | 0.957 | 0.342 | 1e-82 | |
| Q9FK10 | 601 | Probable inactive recepto | no | no | 0.926 | 0.986 | 0.335 | 3e-79 |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 390 bits (1002), Expect = e-107, Method: Compositional matrix adjust.
Identities = 263/661 (39%), Positives = 386/661 (58%), Gaps = 66/661 (9%)
Query: 25 SDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPA 84
+D TLL+FK + S+ L+SW +T+PC W GV+CN +RV +LVLED++LTG
Sbjct: 30 TDSETLLNFKLTAD-STGKLNSWNTTTNPC--QWTGVSCN--RNRVTRLVLEDINLTGSI 84
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
L+ LT LR+LSLK+N LS NLS+ LK L+LS+N+F+G FP+ ++SL L R+D
Sbjct: 85 SSLTSLTSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLD 144
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
LS N + G+IP +LLTLRLE NRF+G + ++N S + DFNVS N +GQIP
Sbjct: 145 LSFNNFSGQIPPDLTDLT-HLLTLRLESNRFSGQIPNINLS--DLQDFNVSGNNFNGQIP 201
Query: 205 AWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQP---------PRSRPR--------- 246
+S F S F N +LCG PL C+ + +P +P P ++P
Sbjct: 202 NSLSQFPESVFTQNPSLCGAPL-LKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSI 260
Query: 247 --------SSRVVTV--IVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKEVVM 296
+SR+ T+ I I++ D + + + + +C +++ + + + E ++
Sbjct: 261 HGGDKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIV 320
Query: 297 KRGN-----RKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYK 351
N + + + GD +MV FEG + + DLL++SAE+LGKG G YK
Sbjct: 321 YSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRR--FELEDLLRASAEMLGKGGFGTAYK 378
Query: 352 VVLDGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408
VL+ G+ V VKR+++ K+E ++ + V+G LRH+N+VS++AY ++E LVYDY
Sbjct: 379 AVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDY 438
Query: 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA-HLFHGHLSSSNIV 467
+P+GSL LLHG+RGPGR P+DW RLK+A+ +A+GLAF+HG K L HG + S+N++
Sbjct: 439 MPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVL 498
Query: 468 VDQLGNACISDIGVHQLFHTPFFI--NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVV 525
+D+ GNA +SD G+ +F + ++ Y APEL RK Q+ DVYSFGV+
Sbjct: 499 LDRSGNARVSDFGL-SIFAPSQTVAKSNGYRAPEL-------IDGRKHTQKSDVYSFGVL 550
Query: 526 LLEILTGK------MAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQ 579
LLEILTGK G + + +WVQ + ++E EVFD EL+ K++EEEM LLQ
Sbjct: 551 LLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQ 610
Query: 580 VALLCLAPLPKDRPNMSIVHRMIEDIRTKGSIDGCANSIMNNISSDSSPSQSENTYNFTN 639
+A+ C A RP M V ++IEDIR GS N +N S+ SP SE+T T
Sbjct: 611 IAMACTAVAADHRPKMGHVVKLIEDIRGGGSEASPCNDGIN--SAVDSPCLSEDTCGGTT 668
Query: 640 S 640
S
Sbjct: 669 S 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 355 bits (911), Expect = 6e-97, Method: Compositional matrix adjust.
Identities = 232/603 (38%), Positives = 342/603 (56%), Gaps = 49/603 (8%)
Query: 47 WVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTG--PAEVLSRLTQLRLLSLKNNLLS 104
W S C +W GV CN + + L L L G P+ L RLT+LR+LSL++N LS
Sbjct: 47 WNESDSAC--NWVGVECNSNQSSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLS 104
Query: 105 SS-NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP 163
+ S+ HL+ LYL HN F+G FP+ + L +L R+D+S N + G IP + + L
Sbjct: 105 GQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLDISSNNFTGSIPFS-VNNLT 163
Query: 164 NLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCG 223
+L L L +N F+G L S+ S ++DFNVSNN L+G IP+ +S F SF GN +LCG
Sbjct: 164 HLTGLFLGNNGFSGNLPSI---SLGLVDFNVSNNNLNGSIPSSLSRFSAESFTGNVDLCG 220
Query: 224 RPLPSDCSNRTVEPEQPPRSRPRSSRVV--------TVIVIVIFDAVAILVAVVTVTWCC 275
PL C + V P P S+R+ IV +I + + + ++ +
Sbjct: 221 GPL-KPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFL 279
Query: 276 YKRKRRSLRNG-------GGGVHKEVVMKRG--NRKGDYGGARDG--GDVE--EMVMFEG 322
RKRR G + V + G + K + G G G+ E ++V EG
Sbjct: 280 CLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEG 339
Query: 323 CNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRE-RKKKREVDEWLRVI 381
F ++ DLL++SAE+LGKG VG +YK VL+ G VVVKR+++ K+E + + V+
Sbjct: 340 GVYSF-DLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMASKKEFETQMEVV 398
Query: 382 GGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDS 441
G ++H N++ +RAY KDE LV+D++P GSL +LLHGSRG GR P+DW+ R+++A +
Sbjct: 399 GKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITA 458
Query: 442 AKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIN--DAYNAPE 499
A+GLA LH A L HG++ +SNI++ + C+SD G++QLF N Y+APE
Sbjct: 459 ARGLAHLH--VSAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPE 516
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK----MAKGDGELGIVKWVQMMGQDES 555
+ RK + DVYSFGV+LLE+LTGK + G+ + + +WV + ++E
Sbjct: 517 V-------LETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEW 569
Query: 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI-RTKGSIDGC 614
EVFD EL+ +EEEM LLQ+A+ C++ +P RP M V RMIED+ R++ + DG
Sbjct: 570 TAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSETTDDGL 629
Query: 615 ANS 617
S
Sbjct: 630 RQS 632
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 355 bits (910), Expect = 8e-97, Method: Compositional matrix adjust.
Identities = 242/649 (37%), Positives = 353/649 (54%), Gaps = 49/649 (7%)
Query: 2 LASRIFFFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGV 61
L S +F + FC +++ NS D LL+F ASV +W NST+ SW GV
Sbjct: 27 LVSFLFVTTTFCSYAIADLNS---DRQALLAFAASVPHLRRL--NW-NSTNHICKSWVGV 80
Query: 62 TCNPSTHRVIKLVLEDLDLTGP--AEVLSRLTQLRLLSLKNNLLSSSNL--NLSSWPHLK 117
TC V L L + L GP L +L LR+LSL++NLLS NL ++ S P L
Sbjct: 81 TCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSG-NLPPDIHSLPSLD 139
Query: 118 HLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG 177
++YL HN F+G PS VS R L +DLS N++ G+IP T L L L L++N+ +G
Sbjct: 140 YIYLQHNNFSGEVPSFVS--RQLNILDLSFNSFTGKIPAT-FQNLKQLTGLSLQNNKLSG 196
Query: 178 TLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPL--------PSD 229
+ ++++ S + N+SNN L+G IP+ + F SSF+GN LCG PL P
Sbjct: 197 PVPNLDTVS--LRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPS 254
Query: 230 CSNRTVEPEQPPRSRPRSSR----VVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRN 285
+ P PP S+ V T+I I A +L+ V + CC K+K +
Sbjct: 255 LTPHISTPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDK---R 311
Query: 286 GGGGVHKEVVMKRGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGC 345
V + + ++ K ++G + ++V F GC+ F ++ DLL++SAE+LGKG
Sbjct: 312 EDSIVKVKTLTEKA--KQEFGSGVQEPEKNKLVFFNGCSYNF-DLEDLLRASAEVLGKGS 368
Query: 346 VGATYKVVLDGGDVVVVKRIRERKK-KREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELF 403
G YK VL+ VVVKR++E KRE ++ + +I + H ++V +RAY KDE
Sbjct: 369 YGTAYKAVLEESTTVVVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKL 428
Query: 404 LVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSS 463
+V DY P G+L SLLHG+RG + P+DW+ R+K+ +AKG+A LH HG++ S
Sbjct: 429 MVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKS 488
Query: 464 SNIVVDQLGNACISDIGVHQLFHTPF--FINDAYNAPELKFNNNNNYSQRKFWQRCDVYS 521
SN+++ Q +ACISD G+ L P Y APE+ RK + DVYS
Sbjct: 489 SNVIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAPEV-------METRKHTHKSDVYS 541
Query: 522 FGVVLLEILTGK----MAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRAL 577
FGV++LE+LTGK D + + +WVQ + ++E EVFD EL+ + +EEEM +
Sbjct: 542 FGVLILEMLTGKSPVQSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQM 601
Query: 578 LQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSIDGCANSIMNNISSDS 626
LQ+A+ C+A +P+ RP M V RMIE+IR S +S N+ DS
Sbjct: 602 LQIAMACVAQVPEVRPTMDDVVRMIEEIRVSDSETTRPSSDDNSKPKDS 650
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (864), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 220/603 (36%), Positives = 331/603 (54%), Gaps = 40/603 (6%)
Query: 23 PYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTG 82
P D LL F ++ + SL+ W N T + W GVTCN R+I + L + L G
Sbjct: 26 PLEDKRALLEF-LTIMQPTRSLN-W-NETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLNG 82
Query: 83 --PAEVLSRLTQLRLLSLKNNLLSSS-NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRH 139
P +SRL+ LR+LSL++NL+S + L LYL N +G P S ++
Sbjct: 83 QIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWKN 142
Query: 140 LRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNN-Q 198
L V+LS+N + G IP + L+RL + +L L +N +G + ++ S S+ ++SNN
Sbjct: 143 LTSVNLSNNGFNGTIP-SSLSRLKRIQSLNLANNTLSGDIPDLSVLS-SLQHIDLSNNYD 200
Query: 199 LSGQIPAWMSPFGGSSFAG--------NKNLCGRPLPSDCSNRTVEPEQPPRSRPRSSRV 250
L+G IP W+ F SS+ G N L P PS+ ++ ++P ++R
Sbjct: 201 LAGPIPDWLRRFPFSSYTGIDIIPPGGNYTLVTPPPPSEQTH-----QKPSKARFLGLSE 255
Query: 251 VTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYGGARD 310
++IVI ++ ++ A+ V CY R R LR G G + + K+G + +R
Sbjct: 256 TVFLLIVIAVSIVVITALAFVLTVCYVR--RKLRRGDGVISDNKLQKKGGMSPEKFVSRM 313
Query: 311 GGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRE-RK 369
+ FEGCN F ++ DLL++SAE+LGKG G TYK VL+ V VKR+++
Sbjct: 314 EDVNNRLSFFEGCNYSF-DLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAA 372
Query: 370 KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPV 429
KR+ ++ + +IGG++H N+V ++AY KDE +VYDY GS+ SLLHG+RG R+P+
Sbjct: 373 GKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIPL 432
Query: 430 DWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL---FH 486
DW R+K+A +AKG+A +H N L HG++ SSNI ++ N C+SD+G+ +
Sbjct: 433 DWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLA 492
Query: 487 TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK----MAKGDGELG 542
P Y APE+ RK Q DVYSFGVVLLE+LTGK GD +
Sbjct: 493 PPISRQAGYRAPEVT-------DTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIH 545
Query: 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602
+V+WV + ++E EVFD EL+ +EEEM +LQ+A+ C+ RP MS + R+I
Sbjct: 546 LVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLI 605
Query: 603 EDI 605
E++
Sbjct: 606 ENV 608
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 334 bits (857), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 231/641 (36%), Positives = 341/641 (53%), Gaps = 54/641 (8%)
Query: 7 FFFSFFCLF-SLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNP 65
F F F S CLS SD LL F AS+ S L+ W NST P SW G+TC+
Sbjct: 8 FLFLLVTTFVSRCLSADIESDKQALLEF-ASLVPHSRKLN-W-NSTIPICASWTGITCSK 64
Query: 66 STHRVIKLVLEDLDLTGP--AEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLS 122
+ RV L L L GP + +L LR++SL++N L + + + S P ++ LY
Sbjct: 65 NNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYFH 124
Query: 123 HNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV 182
N F+GT P +S L +DLS N+ G IP T L L L L L++N +G + ++
Sbjct: 125 ENNFSGTIPPVLS--HRLVNLDLSANSLSGNIP-TSLQNLTQLTDLSLQNNSLSGPIPNL 181
Query: 183 NSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQPPR 242
+ + N+S N L+G +P+ + F SSF GN LCG PL + C T P P
Sbjct: 182 PPRLKYL---NLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPL-TPCPENTTAPSPSPT 237
Query: 243 S-----------RPRSSRVVT---VIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGG- 287
+ R + +V++ ++ I + +V + + + +T CC K+ R+GG
Sbjct: 238 TPTEGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKK-----RDGGQ 292
Query: 288 --GGVHKEVVMKRGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGC 345
V K + N+ ++G + ++V FEG + F ++ DLL++SAE+LGKG
Sbjct: 293 DSTAVPKAKPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNF-DLEDLLRASAEVLGKGS 351
Query: 346 VGATYKVVLDGGDVVVVKRIRE-RKKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELF 403
G TYK +L+ G VVVKR++E KRE ++ + +G + H N+ +RAY KDE
Sbjct: 352 YGTTYKAILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKL 411
Query: 404 LVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSS 463
LVYDY G+ LLHG+ GR +DW RL++ ++A+G++ +H + A L HG++ S
Sbjct: 412 LVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKS 471
Query: 464 SNIVVDQLGNACISDIGVHQLFHTPFFIND---AYNAPELKFNNNNNYSQRKFWQRCDVY 520
N+++ Q + C+SD G+ L I Y APE RK Q+ DVY
Sbjct: 472 PNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEA-------IETRKHTQKSDVY 524
Query: 521 SFGVVLLEILTGKMA-KGDGELGIV---KWVQMMGQDESAWEVFDFELIMDKE-MEEEMR 575
SFGV+LLE+LTGK A K G +V KWVQ + ++E EVFD ELI + +EEEM
Sbjct: 525 SFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMV 584
Query: 576 ALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSIDGCAN 616
+LQ+A+ C++ P RP+M V M+E+IR GS G N
Sbjct: 585 QMLQIAMACVSKHPDSRPSMEEVVNMMEEIRPSGSGPGSGN 625
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (853), Expect = 4e-90, Method: Compositional matrix adjust.
Identities = 238/655 (36%), Positives = 349/655 (53%), Gaps = 56/655 (8%)
Query: 7 FFFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPS 66
FFF ++ +S SD LL+F ASV +W + C SW G+TC+ S
Sbjct: 13 FFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKL--NWNKNLSLC-SSWIGITCDES 69
Query: 67 --THRVIKLVLEDLDLTG--PAEVLSRLTQLRLLSLKNN-LLSSSNLNLSSWPHLKHLYL 121
T RV+ + L + L G P L +L L++LSL++N L + ++ S P L++LYL
Sbjct: 70 NPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYL 129
Query: 122 SHNRFTG--TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL 179
HN F+G T S S + L +DLS+N+ G IP + L L + L L++N F G +
Sbjct: 130 QHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIP-SGLRNLSQITVLYLQNNSFDGPI 188
Query: 180 YSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQ 239
S++ S ++ N+S N LSG IP + SF GN LCG PL + CS + P
Sbjct: 189 DSLDLPSVKVV--NLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPL-NACSGGAISPSS 245
Query: 240 P-PRS--------RPRSSRVVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGV 290
PR R R S+ +I IV+ +VA+L + C K+ ++ GG GV
Sbjct: 246 NLPRPLTENLHPVRRRQSKAY-IIAIVVGCSVAVLFLGIVFLVCLVKKTKKE-EGGGEGV 303
Query: 291 HKEVVMKRGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATY 350
++ + D+G + ++ FE CN F ++ DLLK+SAE+LGKG G Y
Sbjct: 304 RTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNF-DLEDLLKASAEVLGKGSFGTAY 362
Query: 351 KVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDY 408
K VL+ VVVKR+RE K+E ++ + ++G + +HSN V + AY KDE LVY Y
Sbjct: 363 KAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKY 422
Query: 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV 468
+ GSL ++HG+RG VDW R+K+A+ ++K +++LH HG + SSNI++
Sbjct: 423 MTKGSLFGIMHGNRG--DRGVDWETRMKIATGTSKAISYLHSLK---FVHGDIKSSNILL 477
Query: 469 DQLGNACISDIGVHQLF----HTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGV 524
+ C+SD + LF HTP I YNAPE+ R+ QR DVYSFGV
Sbjct: 478 TEDLEPCLSDTSLVTLFNLPTHTPRTI--GYNAPEV-------IETRRVSQRSDVYSFGV 528
Query: 525 VLLEILTGKMAKGDGEL-------GIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRAL 577
V+LE+LTGK L + +WV+ + ++E EVFD EL+ + +EEEM +
Sbjct: 529 VILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQM 588
Query: 578 LQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSIDGCANSIMNNISSDSSPSQSE 632
LQ+AL C+A P+ RP M V RMIED+R +D N SS+++ + SE
Sbjct: 589 LQLALACVARNPESRPKMEEVARMIEDVR---RLDQSQQLQQNRTSSEATSNVSE 640
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 229/634 (36%), Positives = 340/634 (53%), Gaps = 77/634 (12%)
Query: 25 SDISTLLSFKASVTGSSDSLSSW-VNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTG- 82
+D + LLS +++V G + W + T PC +W GV C ++RV L L + L+G
Sbjct: 35 ADRTALLSLRSAVGGRT---FRWNIKQTSPC--NWAGVKCE--SNRVTALRLPGVALSGD 87
Query: 83 -PAEVLSRLTQLRLLSLKNNLLSSS-NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHL 140
P + LTQLR LSL+ N LS S +LS+ +L+HLYL NRF+G P + SL HL
Sbjct: 88 IPEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHL 147
Query: 141 RRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
R++L+ N++ GEI + T L L TL LE+N+ +G++ ++ ++ FNVSNN L+
Sbjct: 148 VRLNLASNSFTGEIS-SGFTNLTKLKTLFLENNQLSGSIPDLD---LPLVQFNVSNNSLN 203
Query: 201 GQIPAWMSPFGGSSFAGNKNLCGRPL------------PSDCSNRT---VE-PEQPPRSR 244
G IP + F SF +LCG+PL P+ NRT VE E+ +
Sbjct: 204 GSIPKNLQRFESDSFL-QTSLCGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKKN 262
Query: 245 PRSSRVVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVH---------KEVV 295
S + IVI A++V ++ V C K +RS + KE V
Sbjct: 263 KLSGGAIAGIVIGCVVGFALIVLILMV-LCRKKSNKRSRAVDISTIKQQEPEIPGDKEAV 321
Query: 296 --------------MKRGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELL 341
GN K G +G +++V F K F ++ DLL++SAE+L
Sbjct: 322 DNGNVYSVSAAAAAAMTGNGKASEG---NGPATKKLVFFGNATKVF-DLEDLLRASAEVL 377
Query: 342 GKGCVGATYKVVLDGGDVVVVKRIRE-RKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD 400
GKG G YK VLD VV VKR+++ +E E + ++G + H N+V +RAY +D
Sbjct: 378 GKGTFGTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRD 437
Query: 401 ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGH 460
E LVYD++P GSL +LLHG+RG GR P++W+ R ++A +A+GL +LH + HG+
Sbjct: 438 EKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTST-SHGN 496
Query: 461 LSSSNIVVDQLGNACISDIGVHQLFHTPFFIND---AYNAPELKFNNNNNYSQRKFWQRC 517
+ SSNI++ + +A +SD G+ QL + + Y APE+ ++ Q+
Sbjct: 497 IKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVT-------DPKRVSQKG 549
Query: 518 DVYSFGVVLLEILTGKMAKGD--GELGI--VKWVQMMGQDESAWEVFDFELIMDKEMEEE 573
DVYSFGVVLLE++TGK E G+ +WV+ + +DE EVFD EL+ EEE
Sbjct: 550 DVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEE 609
Query: 574 MRA-LLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
M A ++Q+ L C + P RP MS V R +E++R
Sbjct: 610 MMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q84MA9|Y1063_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630 OS=Arabidopsis thaliana GN=At1g60630 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 4e-83, Method: Compositional matrix adjust.
Identities = 242/674 (35%), Positives = 357/674 (52%), Gaps = 79/674 (11%)
Query: 3 ASRIFFFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVT 62
+S FF F F +S SD+ LLS K+S+ S+ W TDPC +W GV
Sbjct: 4 SSSCMFFLVFAFF--LISPVRSSDVEALLSLKSSIDPSNSI--PW-RGTDPC--NWEGVK 56
Query: 63 -CNPSTHRVIKLVLEDLDLTGP--AEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHL 119
C RV KLVLE+L+L+G + L++L QLR+LS K N LS S NLS +LK L
Sbjct: 57 KCMKG--RVSKLVLENLNLSGSLNGKSLNQLDQLRVLSFKGNSLSGSIPNLSGLVNLKSL 114
Query: 120 YLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL 179
YL+ N F+G FP ++SL L+ V LS N + G+IP + L RL L T ++DN F+G++
Sbjct: 115 YLNDNNFSGEFPESLTSLHRLKTVVLSRNRFSGKIP-SSLLRLSRLYTFYVQDNLFSGSI 173
Query: 180 YSVNSSSRSILDFNVSNNQLSGQIP--AWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEP 237
+N ++ FNVSNNQLSG IP ++ F SSF N LCG + + C++ T
Sbjct: 174 PPLNQATLRF--FNVSNNQLSGHIPPTQALNRFNESSFTDNIALCGDQIQNSCNDTTGIT 231
Query: 238 EQP------PRSRPRS-SRVVTVIVIVIFDAVAILVAVVTVTWCCYKRK--------RRS 282
P P ++ RS ++++ +I I + IL+ + ++RK RRS
Sbjct: 232 STPSAKPAIPVAKTRSRTKLIGIISGSICGGILILLLTFLLICLLWRRKRSKSKREERRS 291
Query: 283 LRNGGGGVHKEVVMKRG-----NRKGDYGGARDGGDVEEMVMFEGCNKGFR-NVGDLLKS 336
R K + G N++ + + G V +V R + DLLK+
Sbjct: 292 KRVAESKEAKTAETEEGTSDQKNKRFSWEKESEEGSVGTLVFLGRDITVVRYTMDDLLKA 351
Query: 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIR 393
SAE LG+G +G+TYK V++ G ++ VKR+++ R +DE+ R ++G L+H N+V +R
Sbjct: 352 SAETLGRGTLGSTYKAVMESGFIITVKRLKDAGFPR-MDEFKRHIEILGRLKHPNLVPLR 410
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSR--GPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
AY K+E LVYDY P+GSL SL+HGS+ G G+ P+ W LK+A D A GL ++H
Sbjct: 411 AYFQAKEECLLVYDYFPNGSLFSLIHGSKVSGSGK-PLHWTSCLKIAEDLAMGLVYIH-- 467
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA------YNAPELKFNNN 505
L HG+L SSN+++ +C++D G+ L H P+ I D Y APE +
Sbjct: 468 QNPGLTHGNLKSSNVLLGPDFESCLTDYGLSDL-HDPYSIEDTSAASLFYKAPECR---- 522
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW-----EVF 560
++ Q DVYSFGV+LLE+LTG+ + D V G D S W E
Sbjct: 523 --DLRKASTQPADVYSFGVLLLELLTGRTSFKD-------LVHKYGSDISTWVRAVREEE 573
Query: 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSIDGCANSIMN 620
EE+++ALL +A C+A P++RP M V +M++D R + ++ +
Sbjct: 574 TEVSEELNASEEKLQALLTIATACVAVKPENRPAMREVLKMVKDARAEA-------ALFS 626
Query: 621 NISSDSSPSQSENT 634
SSD SP + +T
Sbjct: 627 FNSSDHSPGRWSDT 640
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 212/619 (34%), Positives = 322/619 (52%), Gaps = 57/619 (9%)
Query: 6 IFFFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNP 65
+FFFS F L S + D LL F +S S W S+D C SW GVTCN
Sbjct: 5 LFFFSLILCFVLISSQTLEDDKKALLHFLSSFNSSR---LHWNQSSDVC-HSWTGVTCNE 60
Query: 66 STHRVIKLVLEDLDLTG--PAEVLSRLTQLRLLSL-KNNLLSSSNLNLSSWPHLKHLYLS 122
+ R++ + L + G P +SRL+ L+ LSL KN+ + ++ L HLYL
Sbjct: 61 NGDRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQ 120
Query: 123 HNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV 182
HN +G + S L++L+ +DLS+N + G IP T L+ L +L L L +N F+G + ++
Sbjct: 121 HNHLSGPLLAIFSELKNLKVLDLSNNGFNGSIP-TSLSGLTSLQVLNLANNSFSGEIPNL 179
Query: 183 NSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQPPR 242
+ S N+SNN+L G IP + F S+F+GN NL R + R
Sbjct: 180 HLPKLS--QINLSNNKLIGTIPKSLQRFQSSAFSGN-NLTER--------------KKQR 222
Query: 243 SRPRSSRVVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKEVVMKRGNRK 302
P + ++I+ V + + + C+ + R S G ++ GN
Sbjct: 223 KTPFGLSQLAFLLILSAACVLCVSGLSFIMITCFGKTRIS----GKLRKRDSSSPPGNWT 278
Query: 303 GDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVV 362
+GG + + F G N F ++ DLL SSAE+LGKG G TYKV ++ VVV
Sbjct: 279 SRDDNTEEGGKI---IFFGGRNHLF-DLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVV 334
Query: 363 KRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGS 421
KR++E +RE ++ + +IG +RH N+ ++AY KD+ VY Y HGSL +LHG+
Sbjct: 335 KRLKEVVVGRREFEQQMEIIGMIRHENVAELKAYYYSKDDKLAVYSYYNHGSLFEILHGN 394
Query: 422 RGP-GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG 480
RG R+P+DW+ RL++A+ +A+GLA +H + HG++ SSNI +D CI D+G
Sbjct: 395 RGRYHRVPLDWDARLRIATGAARGLAKIH---EGKFIHGNIKSSNIFLDSQCYGCIGDVG 451
Query: 481 VHQLFHT---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537
+ + + + Y+APE+ R+ Q DVYSFGVVLLE+LTGK
Sbjct: 452 LTTIMRSLPQTTCLTSGYHAPEIT-------DTRRSTQFSDVYSFGVVLLELLTGKSPVS 504
Query: 538 DGEL--------GIVKWVQMMGQDESAWEVFDFELIMDK-EMEEEMRALLQVALLCLAPL 588
EL + W++ + E EVFD E++ EEEM +LQ+ L C+A
Sbjct: 505 QAELVPTGGENMDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALK 564
Query: 589 PKDRPNMSIVHRMIEDIRT 607
++RP+++ V ++IEDIR+
Sbjct: 565 QQERPHIAQVLKLIEDIRS 583
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FK10|Y5332_ARATH Probable inactive receptor kinase At5g53320 OS=Arabidopsis thaliana GN=At5g53320 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 215/640 (33%), Positives = 336/640 (52%), Gaps = 47/640 (7%)
Query: 2 LASRIFFFSFFCLFSLCL-SNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRG 60
+ ++ +F++C+ + + D TLL F ++ S SL+ W S C W G
Sbjct: 1 MKCQVVLILIVVIFNVCIEAETIKEDKHTLLQFVNNIN-HSHSLN-WSPSLSIC-TKWTG 57
Query: 61 VTCNPSTHRVIKLVLEDLDLTGPAE--VLSRLTQLRLLSLK-NNLLSSSNLNLSSWPHLK 117
VTCN V L L L G E +++RL+ LR L L NN+ + L + +L
Sbjct: 58 VTCNSDHSSVDALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLT 117
Query: 118 HLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG 177
L L N F+G PS +SS L+ +DLS+N + G IP + + +L L +L L N+F+G
Sbjct: 118 ELKLDFNEFSGPLPSDLSSWERLQVLDLSNNRFNGSIP-SSIGKLTLLHSLNLAYNKFSG 176
Query: 178 TLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEP 237
+ ++ +L N+++N L+G +P + F S+F GNK L P+ S T
Sbjct: 177 EIPDLHIPGLKLL--NLAHNNLTGTVPQSLQRFPLSAFVGNKVLA--PVHSSLRKHT--- 229
Query: 238 EQPPRSRPRSSRVVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKEVVMK 297
+ + V+ + + V F +A+L ++ + + +RRS ++ K
Sbjct: 230 ------KHHNHVVLGIALSVCFAILALLAILLVIIIHNREEQRRSSKD-----------K 272
Query: 298 RGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGG 357
R+ D GD ++V FEG N F ++ DLL++SAE+LGKG G TYKV L+
Sbjct: 273 PSKRRKDSDPNVGEGD-NKIVFFEGKNLVF-DLEDLLRASAEVLGKGPFGTTYKVDLEDS 330
Query: 358 DVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416
+VVKRI+E +RE ++ + IG ++H N+ ++R Y KDE +VYDY HGSL +
Sbjct: 331 ATIVVKRIKEVSVPQREFEQQIENIGSIKHENVATLRGYFYSKDEKLVVYDYYEHGSLST 390
Query: 417 LLHGSRG-PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC 475
LLHG +G R ++W RL + +A+G+A +H + L HG++ SSNI ++ G C
Sbjct: 391 LLHGQKGLRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFLNGKGYGC 450
Query: 476 ISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA 535
IS G+ L H+ Y APE+ RK Q DVYSFG+++ E+LTGK
Sbjct: 451 ISGTGMATLMHSLPRHAVGYRAPEIT-------DTRKGTQPSDVYSFGILIFEVLTGKSE 503
Query: 536 KGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595
+ +V+WV + ++E EVFD EL+ ++EEEM +LQV ++C A LP+ RPNM
Sbjct: 504 VAN----LVRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRPNM 559
Query: 596 SIVHRMIEDIRTKGSIDGCANSIMNNISSDSSPSQSENTY 635
V RM+E+IR + G + + ++ S S + Y
Sbjct: 560 IEVVRMVEEIRPEKLASGYRSEVSTGATTTPIGSLSGSPY 599
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 640 | ||||||
| 224092188 | 651 | predicted protein [Populus trichocarpa] | 0.942 | 0.926 | 0.617 | 0.0 | |
| 255550772 | 655 | serine-threonine protein kinase, plant-t | 0.981 | 0.958 | 0.601 | 0.0 | |
| 359475948 | 608 | PREDICTED: probable leucine-rich repeat | 0.925 | 0.973 | 0.579 | 0.0 | |
| 296081654 | 580 | unnamed protein product [Vitis vinifera] | 0.881 | 0.972 | 0.555 | 1e-169 | |
| 225424043 | 671 | PREDICTED: probable leucine-rich repeat | 0.917 | 0.874 | 0.4 | 1e-113 | |
| 356573813 | 642 | PREDICTED: probable leucine-rich repeat | 0.862 | 0.859 | 0.438 | 1e-111 | |
| 297841559 | 669 | At1g68400/T2E12_5 [Arabidopsis lyrata su | 0.918 | 0.878 | 0.410 | 1e-109 | |
| 356534353 | 672 | PREDICTED: probable leucine-rich repeat | 0.918 | 0.875 | 0.404 | 1e-107 | |
| 224108443 | 677 | predicted protein [Populus trichocarpa] | 0.907 | 0.858 | 0.407 | 1e-107 | |
| 449434600 | 672 | PREDICTED: probable leucine-rich repeat | 0.903 | 0.860 | 0.409 | 1e-107 |
| >gi|224092188|ref|XP_002309500.1| predicted protein [Populus trichocarpa] gi|222855476|gb|EEE93023.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1752), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/635 (61%), Positives = 473/635 (74%), Gaps = 32/635 (5%)
Query: 26 DISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAE 85
D TLLSFK+S+ SS++LS+WVNST+PC DSW GVTC+P+THRV KLVLE+L+LTG +
Sbjct: 26 DFITLLSFKSSLLDSSNALSTWVNSTNPCIDSWLGVTCHPTTHRVTKLVLENLNLTGSID 85
Query: 86 VLSRLTQLRLLSLKNNLLSSS-NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
LS+LTQLRLLSLK N LSS+ +LN SS +LK LYLSHNR +G FPSG+ SLR LRR+D
Sbjct: 86 ALSQLTQLRLLSLKQNHLSSAFDLNFSSLKNLKLLYLSHNRLSGNFPSGIHSLRRLRRLD 145
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNS-SSRSILDFNVSNNQLSGQI 203
LS+N + GEIP EL ++P LLTLRL+ N FTG + + S SIL+FNVSNN LSG+I
Sbjct: 146 LSYNYFYGEIPFPELAQMPRLLTLRLDFNSFTGKIGPFSFFPSGSILEFNVSNNFLSGEI 205
Query: 204 PAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVE--PEQP-----PRSRPRSSRVVTVIVI 256
PA S F SSF+GNKNLCG+PL DC +RTVE P +P + + V +I
Sbjct: 206 PAIFSRFPVSSFSGNKNLCGKPLALDCFHRTVESEPAKPGDVGMKNKKKKGVSDWAVFLI 265
Query: 257 VIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYGGARDGGDV-- 314
+ DAV IL A+VT+T CCY +KRR N G +R RK G+ +
Sbjct: 266 ITVDAVTILAALVTITCCCYFKKRR---NSGA-------QERIKRKVRLAGSLNSMGGFY 315
Query: 315 ---------EEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRI 365
E MV+F+GC KGF +V DLLKSSAELLGKG G TYKVV+DGGD++VVKR+
Sbjct: 316 GAGAGGGRDEVMVVFDGC-KGFGDVDDLLKSSAELLGKGFAGTTYKVVVDGGDMMVVKRV 374
Query: 366 RERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPG 425
RER+K++EVD WLR+IGGLRHSNIVS+RAY + +EL LVYD+LP+GSLHSLLHG+RGPG
Sbjct: 375 RERRKRKEVDSWLRIIGGLRHSNIVSLRAYYDSNEELLLVYDFLPNGSLHSLLHGNRGPG 434
Query: 426 RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485
R P+DW RLKLAS SA GLAFLHGYNKA FHG+L+SSNIVVD LGNAC+SDIG+HQL
Sbjct: 435 RTPLDWTTRLKLASGSALGLAFLHGYNKAKHFHGNLTSSNIVVDHLGNACVSDIGLHQLL 494
Query: 486 HTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVK 545
H N+ Y APEL NN NN SQR+F Q+CDVYSFGV+LLEILTGKM G+GE +VK
Sbjct: 495 HAASISNNGYKAPELMPNNQNNVSQRRFTQKCDVYSFGVILLEILTGKMPNGEGETSLVK 554
Query: 546 WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
WVQ + ++E WEVFDFEL+ KEMEEEM L+QVALLCLAP P+DRP MS+VH MIEDI
Sbjct: 555 WVQRVAREEWTWEVFDFELLRYKEMEEEMVGLMQVALLCLAPFPRDRPKMSMVHMMIEDI 614
Query: 606 RTKGSID-GCANSIMNNISSDSSPSQSENTYNFTN 639
RTKG G +SIMN++SSDSSPS SE+T NFT+
Sbjct: 615 RTKGGRQLGDRSSIMNDLSSDSSPSLSESTLNFTS 649
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550772|ref|XP_002516434.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223544254|gb|EEF45775.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/655 (60%), Positives = 488/655 (74%), Gaps = 27/655 (4%)
Query: 4 SRIFFFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTC 63
S F+F F LF S+S D++ LLSFK S++ S +LSSW+N+++PC DSW GVTC
Sbjct: 9 SFFFYFIVFLLFISGSSSSSNCDLAALLSFKKSLSEPSITLSSWINTSNPCLDSWYGVTC 68
Query: 64 NPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLS 122
NP+THRV +LVLE+L+LTG L++LTQLRLLSLK+N LSS S+LNL++WP +KHLYLS
Sbjct: 69 NPTTHRVTRLVLENLNLTGSITPLTKLTQLRLLSLKHNNLSSFSSLNLAAWPSMKHLYLS 128
Query: 123 HNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV 182
+NR +G FPS +SSL+ L R+DLS+N G IP++E++ LP LLTLRLEDN F G++ SV
Sbjct: 129 YNRLSGPFPSAISSLKRLHRLDLSYNHLSGHIPISEISSLPLLLTLRLEDNSFDGSIDSV 188
Query: 183 NSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQPPR 242
+ S S+L+FNVSNN+LSG+IPAW S F SSFAGN LCG PLP +C N++V QP +
Sbjct: 189 HMLSLSVLEFNVSNNRLSGKIPAWSSRFPASSFAGNGELCGEPLPRECWNQSVH-SQPVQ 247
Query: 243 S------RPRSSRVVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRS---------LRNGG 287
S + V++IV D AI+VA+VT+ CCY R+RR ++ G
Sbjct: 248 SGKDGLTTVKKVNNWVVVMIVGVDTAAIVVAIVTIACCCYYRRRRRRNNRTYGEVIKRKG 307
Query: 288 GGVHKEVVMKRGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVG 347
G H E+ G RDG EEMV+FEGC KGF +V DLLKSSAELLGKG VG
Sbjct: 308 GSHHPEIGAYYYGGGG----VRDG---EEMVVFEGC-KGFTDVDDLLKSSAELLGKGSVG 359
Query: 348 ATYKVVLDGGDVVVVKRIRERKKKREVDE-WLRVIGGLRHSNIVSIRAYCNGKDELFLVY 406
TYKV +D GD VVVKR+RER+++R WLR+IGGLRH+NIVS+RAY N KDEL LV+
Sbjct: 360 TTYKVEMDSGDTVVVKRVRERRRRRSEVGGWLRMIGGLRHTNIVSLRAYYNSKDELLLVH 419
Query: 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNI 466
D+LP+GSLHSLLHG+RGPGR P++W+ RL+LAS SAKGLAF HGY+KA LFHG+L+SSNI
Sbjct: 420 DFLPNGSLHSLLHGNRGPGRTPLEWSTRLQLASGSAKGLAFFHGYHKAKLFHGNLTSSNI 479
Query: 467 VVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVL 526
+VD GNACISDIG+HQL H+P NDAY APEL NNNN KF QRCDVYSFGV+L
Sbjct: 480 LVDSWGNACISDIGIHQLLHSPPLSNDAYKAPELMPNNNNIIIHGKFTQRCDVYSFGVIL 539
Query: 527 LEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLA 586
LEILTGKM G+GE + +WVQ + ++E WEVFDFEL+ KEMEEEM AL+QVALLCLA
Sbjct: 540 LEILTGKMPTGEGETSLGRWVQKVPREEWTWEVFDFELLRSKEMEEEMVALMQVALLCLA 599
Query: 587 PLPKDRPNMSIVHRMIEDIRTK-GSIDGCANSIMNNISSDSSPSQSENTYNFTNS 640
LP+DRP MS+VHRMIEDIRTK + ++SI+N+ISSDSSPS SENT NFT+S
Sbjct: 600 TLPRDRPKMSMVHRMIEDIRTKGSARGSASSSILNDISSDSSPSLSENTINFTSS 654
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475948|ref|XP_002279173.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1676), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/635 (57%), Positives = 451/635 (71%), Gaps = 43/635 (6%)
Query: 11 FFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRV 70
F L L L N D + LL+FK+S + +SLSSW NST PC SW GVTCN +V
Sbjct: 12 IFSLLQLSLCNP---DFTALLAFKSS-SDHFNSLSSWSNSTHPCSGSWLGVTCN--NGQV 65
Query: 71 IKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
LVL+ L+LTG LSRL QLRLLSL +N LSS +NLSSWP+LKHLYLS NRF+G F
Sbjct: 66 THLVLDRLNLTGSTRALSRLPQLRLLSLNHNRLSSV-VNLSSWPNLKHLYLSDNRFSGEF 124
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
P+GVSS+R +RR+ LSHN + GEIPM +LT+L +LLTLRLE+N FTGTL S +SSS SI
Sbjct: 125 PAGVSSIRRIRRLVLSHNNFSGEIPMNKLTQLRHLLTLRLEENSFTGTLSSNSSSS-SIY 183
Query: 191 DFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQPPRSRPRSSRV 250
DFNVS N L+G+IPAW+S F SSFA N LCG+PL CSN P ++ R RV
Sbjct: 184 DFNVSGNNLAGEIPAWLSQFPLSSFARNAKLCGKPLGYSCSN------GPTKTSKRKRRV 237
Query: 251 --VTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYGGA 308
++VI+IFDAVA + ++TV WCCY RS+ GVH+E+ G
Sbjct: 238 SDALILVIIIFDAVAGVGIIMTVGWCCY----RSMSRRRTGVHREM------------GG 281
Query: 309 RDGGDVE--EMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIR 366
DG E EMVMFEGC KGF V DLLK+SAELLGKG VG+TYKVV++GG VV VKR+R
Sbjct: 282 SDGAPRERNEMVMFEGC-KGFSKVDDLLKASAELLGKGSVGSTYKVVMEGGGVVAVKRVR 340
Query: 367 ERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGR 426
E K+RE+D ++ IGGLRH NIVS+RAY +DEL LVYD+LP+GSLHSLLHG+RGPGR
Sbjct: 341 EGLKRREIDGLMKEIGGLRHRNIVSLRAYYFSRDELLLVYDFLPNGSLHSLLHGNRGPGR 400
Query: 427 MPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486
P+DW RLKLAS +A+GLAFLHG NK+ L HGHL+SSNI+VD GNACI+DIG+H
Sbjct: 401 TPLDWTTRLKLASGAARGLAFLHGCNKSKLTHGHLTSSNIIVDTSGNACIADIGLHHFLP 460
Query: 487 TPFFIND-AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVK 545
+D AY PEL N+++ K Q+ DVYSFGVVLLEILTGKM G+GE + K
Sbjct: 461 AQSSSSDNAYTPPELAVNHHHA----KLSQKADVYSFGVVLLEILTGKMVVGEGETSLAK 516
Query: 546 WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
WV+M ++E WEVFDFEL KEME+EM+ALLQ+ALLCLAPLP+DRP MS++H+MIEDI
Sbjct: 517 WVEMRQEEEWTWEVFDFELWRYKEMEQEMKALLQIALLCLAPLPRDRPKMSMMHKMIEDI 576
Query: 606 RTKGSIDGCANSIMNNISSDSSPSQSENTYNFTNS 640
R KG G + ++++ S SQSE+T NFT+S
Sbjct: 577 RMKG---GQKDGVVHSPLSSGYSSQSESTPNFTSS 608
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081654|emb|CBI20659.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 601 bits (1550), Expect = e-169, Method: Compositional matrix adjust.
Identities = 353/635 (55%), Positives = 429/635 (67%), Gaps = 71/635 (11%)
Query: 11 FFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRV 70
F L L L N D + LL+FK+S + +SLSSW NST PC SW GVTCN +V
Sbjct: 12 IFSLLQLSLCNP---DFTALLAFKSS-SDHFNSLSSWSNSTHPCSGSWLGVTCN--NGQV 65
Query: 71 IKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
LVL+ L+LTG LSRL QLRLLSL +N LSS +NLSSWP+LKHLYLS NRF+G F
Sbjct: 66 THLVLDRLNLTGSTRALSRLPQLRLLSLNHNRLSSV-VNLSSWPNLKHLYLSDNRFSGEF 124
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
P+G LRHL LTLRLE+N FTGTL S +SSS SI
Sbjct: 125 PAG---LRHL-------------------------LTLRLEENSFTGTLSSNSSSS-SIY 155
Query: 191 DFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQPPRSRPRSSRV 250
DFNVS N L+G+IPAW+S F SSFA N LCG+PL CSN P ++ R RV
Sbjct: 156 DFNVSGNNLAGEIPAWLSQFPLSSFARNAKLCGKPLGYSCSN------GPTKTSKRKRRV 209
Query: 251 --VTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYGGA 308
++VI+IFDAVA + ++TV WCCY RS+ GVH+E+ G
Sbjct: 210 SDALILVIIIFDAVAGVGIIMTVGWCCY----RSMSRRRTGVHREM------------GG 253
Query: 309 RDGGDVE--EMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIR 366
DG E EMVMFEGC KGF V DLLK+SAELLGKG VG+TYKVV++GG VV VKR+R
Sbjct: 254 SDGAPRERNEMVMFEGC-KGFSKVDDLLKASAELLGKGSVGSTYKVVMEGGGVVAVKRVR 312
Query: 367 ERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGR 426
E K+RE+D ++ IGGLRH NIVS+RAY +DEL LVYD+LP+GSLHSLLHG+RGPGR
Sbjct: 313 EGLKRREIDGLMKEIGGLRHRNIVSLRAYYFSRDELLLVYDFLPNGSLHSLLHGNRGPGR 372
Query: 427 MPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486
P+DW RLKLAS +A+GLAFLHG NK+ L HGHL+SSNI+VD GNACI+DIG+H
Sbjct: 373 TPLDWTTRLKLASGAARGLAFLHGCNKSKLTHGHLTSSNIIVDTSGNACIADIGLHHFLP 432
Query: 487 TPFFIND-AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVK 545
+D AY PEL N+++ K Q+ DVYSFGVVLLEILTGKM G+GE + K
Sbjct: 433 AQSSSSDNAYTPPELAVNHHHA----KLSQKADVYSFGVVLLEILTGKMVVGEGETSLAK 488
Query: 546 WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
WV+M ++E WEVFDFEL KEME+EM+ALLQ+ALLCLAPLP+DRP MS++H+MIEDI
Sbjct: 489 WVEMRQEEEWTWEVFDFELWRYKEMEQEMKALLQIALLCLAPLPRDRPKMSMMHKMIEDI 548
Query: 606 RTKGSIDGCANSIMNNISSDSSPSQSENTYNFTNS 640
R KG G + ++++ S SQSE+T NFT+S
Sbjct: 549 RMKG---GQKDGVVHSPLSSGYSSQSESTPNFTSS 580
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225424043|ref|XP_002279580.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1071), Expect = e-113, Method: Compositional matrix adjust.
Identities = 262/655 (40%), Positives = 381/655 (58%), Gaps = 68/655 (10%)
Query: 2 LASRIFFFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGV 61
L S F F+ F L L S SD+ L++FK + +++ L++W + +PC SW GV
Sbjct: 6 LTSLHFAFALFILHFFLLHASTSSDLEALMAFKETAD-AANKLTTWNVTVNPC--SWYGV 62
Query: 62 TCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYL 121
+C +RV +LVLE LDL G + L+ LTQLR+LSLK N LS NLS+ LK L+L
Sbjct: 63 SC--LQNRVSRLVLEGLDLQGSFQPLASLTQLRVLSLKRNRLSGPIPNLSNLTALKLLFL 120
Query: 122 SHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYS 181
S+N F+G FP+ V+SL L R+DLSHN G+IP T + L ++LTLRLE+NRF+G++
Sbjct: 121 SYNEFSGEFPASVTSLFRLYRLDLSHNNLSGQIPET-VNHLAHILTLRLEENRFSGSITG 179
Query: 182 VNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQP- 240
+N + + DFNVS N+L+G IP +S F S+F N LCG P+P+ C N +P +P
Sbjct: 180 LNLPN--LQDFNVSGNRLAGDIPKTLSAFPVSAFDRNAVLCGSPMPT-CKNVAGDPTKPG 236
Query: 241 -----------------------------PRSRPRSSR------VVTVIVIVIFDAVAIL 265
+P+++R V V +I I ++
Sbjct: 237 SGGAIASPVIPGGNPAIVASSPSSIPISTTPIQPQNTRHGATGKVSPVAMIAIILGDILV 296
Query: 266 VAVVTVTWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYGGARDGGDVEEMVMFEGCNK 325
+A+V++ CY + + + G + + ++ A+ G + MV FEG +
Sbjct: 297 LAIVSLLLYCYFWRNYAGKMRDGKSSQILEGEKIVYSSSPYPAQAGYERGRMVFFEGVKR 356
Query: 326 GFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRERK--KKREVDEWLRVIGG 383
+ DLL++SAE+LGKG G YK VLD G+VV VKR+++ KRE ++ + V+G
Sbjct: 357 --FELEDLLRASAEMLGKGGFGTAYKAVLDDGNVVAVKRLKDAHVGGKREFEQHMEVLGR 414
Query: 384 LRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK 443
LRH N+V++RAY +DE LVYDY+P+GSL LLHG+RGPGR P+DW RLK+A+ +A+
Sbjct: 415 LRHPNVVNLRAYYFARDEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAAR 474
Query: 444 GLAFLHGYNKA-HLFHGHLSSSNIVVDQLGNACISDIGVHQLF-HTPFFINDAYNAPELK 501
GLAF+H K L HG++ S+NI++D+ G+A +SD G+ T ++ Y APE+
Sbjct: 475 GLAFIHNSCKTLKLTHGNIKSTNILLDKCGSARVSDFGLSVFASSTAAPRSNGYRAPEI- 533
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK----------MAKGDGELGIVKWVQMMG 551
RK Q+ DVYSFGV+LLE+LTGK + G + + +WVQ +
Sbjct: 534 ------LDGRKGSQKSDVYSFGVLLLELLTGKCPSVMENGGPGSGYGGVVDLPRWVQSVV 587
Query: 552 QDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
++E EVFD EL+ K++EEEM LLQ+A+ C P P RP MS V +MIE+IR
Sbjct: 588 REEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTTPSPDQRPKMSYVVKMIEEIR 642
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573813|ref|XP_003555050.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1050), Expect = e-111, Method: Compositional matrix adjust.
Identities = 264/602 (43%), Positives = 360/602 (59%), Gaps = 50/602 (8%)
Query: 26 DISTLLSFKASVTGSSDSLSSW-VNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPA 84
D L+SFKAS S+ LS W S++PC +W GV+C HRV LVLEDL+LTG
Sbjct: 33 DFHPLMSFKASSDPSNKFLSQWNSTSSNPC--TWHGVSC--LHHRVSHLVLEDLNLTGSI 88
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
L+ LTQLR+LSLK N +LS+ LK L+LSHN+F+G FP+ V+SL HL R+D
Sbjct: 89 LPLTSLTQLRILSLKRNRFDGPFPSLSNLTALKLLFLSHNKFSGEFPATVTSLPHLYRLD 148
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
+SHN G+IP T + L +LLTLRL+ N G + ++ + S + DFNVS+NQLSGQIP
Sbjct: 149 ISHNNLSGQIPAT-VNHLTHLLTLRLDSNNLRGRIPNMINLSH-LQDFNVSSNQLSGQIP 206
Query: 205 AWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVE-PEQPPRSRPRSSRV------------- 250
+S F GS+F+ N LCG PL C +T P +PR+ V
Sbjct: 207 DSLSGFPGSAFSNNLFLCGVPL-RKCKGQTKAIPALASPLKPRNDTVLNKRKTHGAAPKI 265
Query: 251 -VTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKE--VVMKRGNRKGDYGG 307
V V+VI++ V +L V + +C + R L+ G H + V K G
Sbjct: 266 GVMVLVIIVLGDVLVLALVSFLLYCYFWRL---LKEGKAETHSKSNAVYK--------GC 314
Query: 308 ARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRE 367
A G + + MV EG + + +LL++SAE+LGKG G YK VLD G V VKR++E
Sbjct: 315 AERGVNSDGMVFLEGVMR--FELEELLRASAEMLGKGVFGTAYKAVLDDGTVAAVKRLKE 372
Query: 368 RK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPG 425
KRE + + V+G LRH N+V +RAY KDE LV DY+P+GSL LLHG+RGPG
Sbjct: 373 VSVGGKREFQQRMEVLGRLRHCNVVPLRAYYFAKDEKLLVSDYMPNGSLSWLLHGNRGPG 432
Query: 426 RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485
R P+DW R+KLA+ +A+G+AF+H +K L HG++ S+N++VD +GNAC+SD G+ +F
Sbjct: 433 RTPLDWTTRVKLAAGAARGIAFIHNSDK--LTHGNIKSTNVLVDVVGNACVSDFGLSSIF 490
Query: 486 HTPFFI-NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE-LGI 543
P ++ Y APE + RK DVYSFGV+L+EILTGK E L +
Sbjct: 491 AGPTCARSNGYLAPEASLDG------RKQTHMSDVYSFGVLLMEILTGKCPSAAAEALEL 544
Query: 544 VKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603
+WV+ + ++E EVFD EL+ K++EEEM ALLQ+A+ C P RP MS V +MIE
Sbjct: 545 PRWVRSVVREEWTAEVFDLELMRYKDIEEEMVALLQIAMACTVAAPDQRPRMSHVAKMIE 604
Query: 604 DI 605
D+
Sbjct: 605 DL 606
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297841559|ref|XP_002888661.1| At1g68400/T2E12_5 [Arabidopsis lyrata subsp. lyrata] gi|297334502|gb|EFH64920.1| At1g68400/T2E12_5 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1030), Expect = e-109, Method: Compositional matrix adjust.
Identities = 270/657 (41%), Positives = 383/657 (58%), Gaps = 69/657 (10%)
Query: 31 LSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRL 90
L+FK + S+ L+SW +T+PC W GV+CN +RV +LVLED++LTG L+ L
Sbjct: 34 LNFKLTAD-STGKLNSWNKTTNPC--QWTGVSCN--RNRVTRLVLEDIELTGSISPLTSL 88
Query: 91 TQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAY 150
T LR+LSLK+N LS NLS+ LK L+LSHN+F+G FPS ++SL L R+DLS N +
Sbjct: 89 TSLRVLSLKHNSLSGPIPNLSNLTALKLLFLSHNQFSGNFPSSITSLTRLYRLDLSFNNF 148
Query: 151 EGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPF 210
GEIP +LT L +LLTLRLE NRF+G + ++ S + DFNVS N +GQIP +S F
Sbjct: 149 SGEIP-PDLTNLNHLLTLRLESNRFSGQIPNIIISD--LQDFNVSGNNFNGQIPNSLSQF 205
Query: 211 GGSSFAGNKNLCGRPLPSDCSNRTVEPEQPPR----------------SRPRS------- 247
S F N +LCG PL C+ + +P +P R S P S
Sbjct: 206 PESVFTQNPSLCGAPL-LKCTKLSSDPTKPGRPDGAKASPLNNSETVPSSPTSIHGGDKS 264
Query: 248 -SRVVTV-IVIVIFDAVAILVAVVTVTWCCY-------KRKRRSLRNGGGGVHKEVVMKR 298
+R+ T+ +V +I IL V + + C+ K+K + G V+
Sbjct: 265 TTRISTISLVAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKVLEGEKIVYSSSPYPT 324
Query: 299 GNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGD 358
+ + + + GG+ +MV FEG + + DLL++SAE+LGKG G YK VL+ G+
Sbjct: 325 -SAQNNNNQNQQGGEKGKMVFFEGTRR--FELEDLLRASAEMLGKGGFGTAYKAVLEDGN 381
Query: 359 VVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415
V VKR+++ K+E ++ + V+G LRH+N+VS++AY ++E LVYDY+P+GSL
Sbjct: 382 EVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLF 441
Query: 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA-HLFHGHLSSSNIVVDQLGNA 474
LLHG+RGPGR P+DW RLK+A+ +A+GLAF+HG K L HG + S+N+++D+ GNA
Sbjct: 442 WLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNA 501
Query: 475 CISDIGVHQLFHTPFFI--NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
+SD G+ +F + ++ Y APEL RK Q+ DVYSFGV+LLEILTG
Sbjct: 502 RVSDFGL-SIFAPSQTVAKSNGYRAPELT-------DGRKHTQKSDVYSFGVLLLEILTG 553
Query: 533 KMAK---------GDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALL 583
K G + + +WVQ + ++E EVFD EL+ K++EEEM LLQ+A+
Sbjct: 554 KCPNMVETGHSGGAGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMA 613
Query: 584 CLAPLPKDRPNMSIVHRMIEDIRTKGSIDGCANSIMNNISSDSSPSQSENTYNFTNS 640
C A RP M V ++IEDIR GS N +N S+ SP SE+T T S
Sbjct: 614 CTAVAADHRPKMDHVVKLIEDIRGGGSEASPCNDGIN--SAVDSPCLSEDTCGGTTS 668
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534353|ref|XP_003535720.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1017), Expect = e-107, Method: Compositional matrix adjust.
Identities = 270/667 (40%), Positives = 386/667 (57%), Gaps = 79/667 (11%)
Query: 26 DISTLLSFKASVTGSSDSLSSW-VNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPA 84
D LLSFK + + +S L++W +NST+PC SW+GV+C RV +LVLE+LDL G
Sbjct: 31 DFDALLSFK-TASDTSQKLTTWNINSTNPC--SWKGVSC--IRDRVSRLVLENLDLEGSI 85
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
L+ LTQLR+LSLK N S NLS+ LK L+LS N F+G FP+ V SL L R+D
Sbjct: 86 HPLTSLTQLRVLSLKGNRFSGPVPNLSNLTALKLLFLSRNAFSGEFPATVKSLFRLYRLD 145
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
LS+N + GEIP T ++ L +LLTLRL+ N+F+G + VN + +FNVS N+LSG+IP
Sbjct: 146 LSNNNFSGEIPAT-VSHLTHLLTLRLDGNKFSGHIPDVNLPG--LQEFNVSGNRLSGEIP 202
Query: 205 AWMSPFGGSSFAGNKNLCGRPLPSDCSNRT--------VEPEQPPRSRPR---------- 246
+S F SSF N LCG P+ + + T P PP + P
Sbjct: 203 KSLSNFPESSFGQNPFLCGAPIKNCAPDPTKPGSEGAIASPLVPPNNNPTTTVSSSPSSM 262
Query: 247 ------------------SSRVVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGG 288
S++ V +I I +++A+V++ CY + L+ G G
Sbjct: 263 PKTPASASTKSNKSHGKGGSKISPVALIAIIVCDVLVLAIVSLLLYCYFWRNYKLKEGKG 322
Query: 289 G--VHKEVVMKRGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCV 346
E ++ + GG G MV FEG K F + DLL++SAE+LGKG
Sbjct: 323 SKLFESEKIVYSSSPYPAQGGFERG----RMVFFEG-EKRFE-LEDLLRASAEMLGKGGF 376
Query: 347 GATYKVVLDGGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFL 404
G YK VLD G+VV VKR+++ + KRE ++ + ++G LRH N+VS+RAY ++E L
Sbjct: 377 GTAYKAVLDDGNVVAVKRLKDAQITGKREFEQHMELLGRLRHPNVVSLRAYYFAREEKLL 436
Query: 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA-HLFHGHLSS 463
VYDY+P+ +L LLHG+RGPGR P+DW RLK+A+ +A+G+AF+H K+ L HG++ S
Sbjct: 437 VYDYMPNATLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGVAFIHNSCKSLKLTHGNIKS 496
Query: 464 SNIVVDQLGNACISDIGVHQLFHTPFFI---NDAYNAPELKFNNNNNYSQRKFWQRCDVY 520
+N+++D+ GNA +SD G+ +F P + ++ Y APE RK Q+ DVY
Sbjct: 497 TNVLLDKQGNARVSDFGL-SVFAGPGPVGGRSNGYRAPEAS-------EGRKQTQKSDVY 548
Query: 521 SFGVVLLEILTGKM-----AKGDGELGIV---KWVQMMGQDESAWEVFDFELIMDKEMEE 572
SFGV+LLE+LTGK + G G+V +WVQ + ++E EVFD EL+ K++EE
Sbjct: 549 SFGVLLLELLTGKCPSVVESGGSAYGGVVDLPRWVQSVVREEWTAEVFDLELMRYKDIEE 608
Query: 573 EMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSIDGCANSIMNNISSDSSPSQSE 632
EM LLQ+A+ C AP P RP M+ V +MIE++R + C +S+ S SPS SE
Sbjct: 609 EMVGLLQIAMTCTAPAPDQRPRMTHVLKMIEELRGV-EVSPCHDSL---DSVSESPSLSE 664
Query: 633 NTYNFTN 639
+ T+
Sbjct: 665 DACGTTS 671
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108443|ref|XP_002314848.1| predicted protein [Populus trichocarpa] gi|222863888|gb|EEF01019.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1016), Expect = e-107, Method: Compositional matrix adjust.
Identities = 275/675 (40%), Positives = 386/675 (57%), Gaps = 94/675 (13%)
Query: 2 LASRIFFFSFFCLFSLC------LSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCF 55
LA IF F + F L L S D LL FK +++ + + L W +ST+PC
Sbjct: 1 LAKPIFLFPYMTTFFLISLHFSLLQASSNPDSEPLLQFK-TLSDTDNKLQDWNSSTNPC- 58
Query: 56 DSWRGVTCNPSTHRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLK-NNLLSSSNLNLSSW 113
+W G+ C RV +LVLE+L+L G + + L+ LTQLR+LSLK NNL N+S+
Sbjct: 59 -TWTGIAC--LNDRVSRLVLENLNLQGSSLQTLTSLTQLRVLSLKRNNLSGPIPQNISNL 115
Query: 114 PHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
LK L+LSHN F+GTFP V SL L R+DLSHN + G IP+ + RL +LLTLRLE+N
Sbjct: 116 SALKLLFLSHNHFSGTFPVSVLSLSRLYRLDLSHNNFSGNIPVI-VNRLTHLLTLRLEEN 174
Query: 174 RFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGN--KNLCGRPLPSDCS 231
+FTG++ S+N S + DFNVSNN++SG+IP +S F S+FA + LCG PL + C
Sbjct: 175 QFTGSISSLNLPS--LQDFNVSNNRVSGEIPKSLSGFPESAFAQSLPAGLCGSPLQA-CK 231
Query: 232 NRTVEPEQP-----------PRSRPRS--------------------------SRVVTVI 254
+ +P +P P + P S +++ +
Sbjct: 232 SLASDPTRPGSDGAIASPLLPGTNPTSIVSSTPSSVVAPNKPTNTNHKISKTSTKISPLA 291
Query: 255 VIVIFDAVAILVAVVTVTWCCY--KRKRRSLRNGGGG--VHKEVVMKRGNRKGDYGGARD 310
+I I +++AVV++ CY + +RNG G + E ++ + + G
Sbjct: 292 LIAIILGDILILAVVSLLLYCYFWRNYAAKMRNGKGSKLLETEKIVYSSSPYPNQPGFER 351
Query: 311 GGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRERK- 369
G MV FEG + + DLL++SAE+LGKG G YK VLD G+VV VKR+++
Sbjct: 352 G----RMVFFEGVER--FELEDLLRASAEMLGKGGFGTAYKAVLDDGNVVAVKRLKDANV 405
Query: 370 -KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMP 428
KRE+++ + V+G LRH N+VS ++Y ++E LVYDY+P+GSL LLHG+RGPGR P
Sbjct: 406 GGKRELEQHMEVLGRLRHPNLVSFKSYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTP 465
Query: 429 VDWNKRLKLASDSAKGLAFLHGYNKA-HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487
+DW RLK+A+ +A+GLAF+H KA L HG++ S+NI++D+ GNA +SD G+ LF +
Sbjct: 466 LDWTTRLKIAAGAARGLAFMHNSCKALKLVHGNIKSTNILLDKAGNARVSDFGL-TLFAS 524
Query: 488 PFFINDA-----YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK--------- 533
N A Y APE + RK Q+ DVYSFGV+LLEILTGK
Sbjct: 525 S--TNSAPRSNGYRAPEATSDG------RKQTQKSDVYSFGVLLLEILTGKCPSIVDCGA 576
Query: 534 --MAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKD 591
G + + +WVQ + ++E EVFD EL+ K++EEEM LLQ+AL C P P
Sbjct: 577 GPGNGYGGPVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIALACTTPSPDH 636
Query: 592 RPNMSIVHRMIEDIR 606
RP M V RMIE+IR
Sbjct: 637 RPRMGHVVRMIEEIR 651
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434600|ref|XP_004135084.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1016), Expect = e-107, Method: Compositional matrix adjust.
Identities = 266/650 (40%), Positives = 379/650 (58%), Gaps = 72/650 (11%)
Query: 8 FFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPST 67
F SF L+ C+ S D+ L++FKA+ + + L++W ++++PC +W GV+C
Sbjct: 13 FVSF--LYFTCVYASSNIDLDALVAFKAA-SDKGNKLTTWNSTSNPC--AWDGVSC--LR 65
Query: 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT 127
RV +LVLE+LDLTG L+ LTQLR+LSLK N LS +LS++ LK ++LS+N F+
Sbjct: 66 DRVSRLVLENLDLTGTIGPLTALTQLRVLSLKRNRLSGPIPDLSNFKALKLVFLSYNAFS 125
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
G P+ + SL L R+DLSHN GEIP + + RL +LLTLRLEDNRF+G + +N +
Sbjct: 126 GNLPASLLSLVRLYRLDLSHNNLTGEIPAS-VNRLTHLLTLRLEDNRFSGPILELNLPN- 183
Query: 188 SILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQP------- 240
+ DFN+S N+LSG+IP +S F SSF N LCG PL S C + +P +P
Sbjct: 184 -LQDFNISENRLSGEIPKSLSAFPESSFGQNMGLCGSPLQS-CKSIVSKPTEPGSEGAIA 241
Query: 241 -----PR-----SRPRSSRVVTV-------------------IVIVIFDAVAILVAVVTV 271
PR S P S VT ++ +I V +L V +
Sbjct: 242 SPITPPRNLTVSSSPTSLPEVTAETKPENTHHHGTGKIGSLALIAIILGDVVVLALVSLL 301
Query: 272 TWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVG 331
+C + + G G K + ++ A+ G + MV FEG K +
Sbjct: 302 LYCYFWKNSADKAREGKGSSKLLESEKIVYSSSPYPAQAGTERGRMVFFEGVKK--FELE 359
Query: 332 DLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNI 389
DLL++SAE+LGKG G +YK +LD G+VV VKR+++ + KRE ++ + V+G LRH+NI
Sbjct: 360 DLLRASAEMLGKGGFGTSYKAILDDGNVVAVKRLKDAQVGGKREFEQHMEVLGRLRHANI 419
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
VS+RAY ++E LVYDY+P+GSL LLHG+RGPGR P+DW RLK+A+ +A+GLAF+H
Sbjct: 420 VSLRAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIH 479
Query: 450 GYNKA-HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFI-NDAYNAPELKFNNNNN 507
K+ L HG++ S+N+++DQ GNA +SD G+ LF P + Y APE
Sbjct: 480 NSCKSLKLAHGNVKSTNVLLDQSGNARVSDYGL-SLFTPPSTPRTNGYRAPECG------ 532
Query: 508 YSQRKFWQRCDVYSFGVVLLEILTGK-----------MAKGDGELGIVKWVQMMGQDESA 556
RK Q+ DVYSFGV+LLE+LTGK L + +WVQ + ++E
Sbjct: 533 -DDRKLTQKSDVYSFGVLLLELLTGKCPSVVENGGPGGGGYGSVLDLPRWVQSVVREEWT 591
Query: 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
EVFD EL+ K++EEEM LLQ+AL C A P RP M+ V +MI+++R
Sbjct: 592 AEVFDLELMRYKDIEEEMVGLLQIALACTAASPDQRPKMNHVVKMIDELR 641
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 640 | ||||||
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.451 | 0.431 | 0.389 | 5.9e-78 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.457 | 0.445 | 0.364 | 4.9e-65 | |
| TAIR|locus:2044913 | 672 | AT2G36570 [Arabidopsis thalian | 0.514 | 0.489 | 0.336 | 5.3e-65 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.510 | 0.510 | 0.337 | 1.3e-60 | |
| TAIR|locus:2128414 | 638 | AT4G23740 [Arabidopsis thalian | 0.882 | 0.885 | 0.292 | 2.2e-59 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.495 | 0.495 | 0.330 | 4e-59 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.882 | 0.863 | 0.302 | 3.2e-58 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.471 | 0.461 | 0.331 | 4.7e-55 | |
| TAIR|locus:2036499 | 652 | AT1G60630 [Arabidopsis thalian | 0.420 | 0.412 | 0.335 | 3.2e-54 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.45 | 0.445 | 0.334 | 4.9e-54 |
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 485 (175.8 bits), Expect = 5.9e-78, Sum P(2) = 5.9e-78
Identities = 121/311 (38%), Positives = 169/311 (54%)
Query: 312 GDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKXXXXXXXXXXXXXXXXXXXX 371
GD +MV FEG + F + DLL++SAE+LGKG G YK
Sbjct: 341 GDKGKMVFFEGTRR-FE-LEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTV 398
Query: 372 XXXDEW---LRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPXXXXXXXXXXXXXPGRMP 428
E+ + V+G LRH+N+VS++AY ++E LVYDY+P PGR P
Sbjct: 399 AGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTP 458
Query: 429 VDWNKRLKLASDSAKGLAFLHGYNKA-HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487
+DW RLK+A+ +A+GLAF+HG K L HG + S+N+++D+ GNA +SD G+ +F
Sbjct: 459 LDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGL-SIFAP 517
Query: 488 PFFI--NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK---MAK---GDG 539
+ ++ Y APEL RK Q+ DVYSFGV+LLEILTGK M + G
Sbjct: 518 SQTVAKSNGYRAPEL-------IDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGG 570
Query: 540 ELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRXXXXXXXXXXXXXPKDRPNMSIVH 599
+ + +WVQ + ++E EVFD EL+ K++EEEM RP M V
Sbjct: 571 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVV 630
Query: 600 RMIEDIRTKGS 610
++IEDIR GS
Sbjct: 631 KLIEDIRGGGS 641
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 4.9e-65, Sum P(2) = 4.9e-65
Identities = 114/313 (36%), Positives = 164/313 (52%)
Query: 311 GGDVE--EMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKXXXXXXXXXXXXXXXXX 368
GG+ E ++V EG F ++ DLL++SAE+LGKG VG +YK
Sbjct: 326 GGETERNKLVFTEGGVYSF-DLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDV 384
Query: 369 XXXXXXDEW-LRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPXXXXXXXXXXXXXPGRM 427
E + V+G ++H N++ +RAY KDE LV+D++P GR
Sbjct: 385 MASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRT 444
Query: 428 PVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487
P+DW+ R+++A +A+GLA LH A L HG++ +SNI++ + C+SD G++QLF
Sbjct: 445 PLDWDNRMRIAITAARGLAHLHV--SAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSN 502
Query: 488 PFFIND--AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD--GELGI 543
N Y+APE+ RK + DVYSFGV+LLE+LTGK GE GI
Sbjct: 503 SSPPNRLAGYHAPEV-------LETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGI 555
Query: 544 --VKWVQMMGQDESAWEVFDFELIMDKEMEEEMRXXXXXXXXXXXXXPKDRPNMSIVHRM 601
+WV + ++E EVFD EL+ +EEEM P RP M V RM
Sbjct: 556 DLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRM 615
Query: 602 IEDI-RTKGSIDG 613
IED+ R++ + DG
Sbjct: 616 IEDVNRSETTDDG 628
|
|
| TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 5.3e-65, Sum P(2) = 5.3e-65
Identities = 124/369 (33%), Positives = 181/369 (49%)
Query: 273 WCCYKRKRRSLRNGGGGVHKEVVMK-RGNRKGDYG--GARDGG---DVEEMVMFEGCNKG 326
+CC + R R+ G V V G R+ YG G D D +V FE K
Sbjct: 291 FCCGRLDRNGERSKSGSVETGFVGGGEGKRRSSYGEGGESDATSATDRSRLVFFER-RKQ 349
Query: 327 FRNVGDLLKSSAELLGKGCVGATYKXXXXXXXXXXXXXXXXXXX---XXXXDEWLRVIGG 383
F + DLLK+SAE+LGKG +G YK ++++ +IG
Sbjct: 350 FE-LDDLLKASAEMLGKGSLGTVYKAVLDDGSTTVAVKRLKDANPCPRKEFEQYMEIIGR 408
Query: 384 LRHSNIVSIRAYCNGKDELFLVYDYLPXXXXXXXXXXXXXPGRMPVDWNKRLKLASDSAK 443
L+H N+V +RAY K+E LVY+YLP PGR+P+DW R+ L +A+
Sbjct: 409 LKHQNVVKLRAYYYAKEEKLLVYEYLPNGSLHSLLHGNRGPGRIPLDWTTRISLMLGAAR 468
Query: 444 GLAFLHG-YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIN--DAYNAPEL 500
GLA +H Y+ + + HG++ SSN+++D+ G A I+D G+ L + I Y APE
Sbjct: 469 GLAKIHDEYSISKIPHGNIKSSNVLLDRNGVALIADFGLSLLLNPVHAIARLGGYRAPEQ 528
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK----------------MAKGDGELGIV 544
++ Q+ DVYSFGV+LLE+LTGK +A + E +V
Sbjct: 529 S-------EIKRLSQKADVYSFGVLLLEVLTGKAPSIFPSPSRPRSAASVAVEEEEEAVV 581
Query: 545 ---KWVQMMGQDESAWEVFDFELIMDKEMEEEMRXXXXXXXXXXXXXPKDRPNMSIVHRM 601
KWV+ + ++E EVFD EL+ K +EEEM P+ RP M+ V +M
Sbjct: 582 DLPKWVRSVVKEEWTAEVFDPELLRYKNIEEEMVAMLHIGLACVVPQPEKRPTMAEVVKM 641
Query: 602 IEDIRTKGS 610
+E+IR + S
Sbjct: 642 VEEIRVEQS 650
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 1.3e-60, Sum P(2) = 1.3e-60
Identities = 119/353 (33%), Positives = 171/353 (48%)
Query: 274 CCYKRKRRSLRNGGG---GVHKEVVMKRGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNV 330
CC K+ R+GG V K + N+ ++G + ++V FEG + F ++
Sbjct: 283 CCAKK-----RDGGQDSTAVPKAKPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNF-DL 336
Query: 331 GDLLKSSAELLGKGCVGATYKXXXXXXXXXXXXXXXXXXXXXXX-DEWLRVIGGLR-HSN 388
DLL++SAE+LGKG G TYK ++ + +G + H N
Sbjct: 337 EDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVN 396
Query: 389 IVSIRAYCNGKDELFLVYDYLPXXXXXXXXXXXXXPGRMPVDWNKRLKLASDSAKGLAFL 448
+ +RAY KDE LVYDY GR +DW RL++ ++A+G++ +
Sbjct: 397 VAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHI 456
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF--HTPFFIND-AYNAPELKFNNN 505
H + A L HG++ S N+++ Q + C+SD G+ L HT Y APE
Sbjct: 457 HSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEA----- 511
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIV---KWVQMMGQDESAWEVFD 561
RK Q+ DVYSFGV+LLE+LTGK A K G +V KWVQ + ++E EVFD
Sbjct: 512 --IETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFD 569
Query: 562 FELIMDKE-MEEEMRXXXXXXXXXXXXXPKDRPNMSIVHRMIEDIRTKGSIDG 613
ELI + +EEEM P RP+M V M+E+IR GS G
Sbjct: 570 VELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIRPSGSGPG 622
|
|
| TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 2.2e-59, P = 2.2e-59
Identities = 177/605 (29%), Positives = 260/605 (42%)
Query: 21 NSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDL 80
+ P D LL F ++ + SL+ W N T + W GVTCN R+I + L + L
Sbjct: 24 SDPLEDKRALLEF-LTIMQPTRSLN-W-NETSQVCNIWTGVTCNQDGSRIIAVRLPGVGL 80
Query: 81 TG---PAEVXXXXXXXXXXXXXXXXXXXXXXXXXXWPHLKHLYLSHNRFTGTFPSGVSSL 137
G P + L LYL N +G P S
Sbjct: 81 NGQIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVW 140
Query: 138 RHLRRVDLSHNAYEGEIPMXXXXXXXXXXXXXXXDNRFTGTLYSVNSSSRSILDFNVSNN 197
++L V+LS+N + G IP +N +G + ++ S S+ ++SNN
Sbjct: 141 KNLTSVNLSNNGFNGTIP-SSLSRLKRIQSLNLANNTLSGDIPDLSVLS-SLQHIDLSNN 198
Query: 198 -QLSGQIPAWMSPFGGSSFAG--------NKNLCGRPLPSDCSNRTVEPEQXXXXXXXXX 248
L+G IP W+ F SS+ G N L P PS+ +++ +P +
Sbjct: 199 YDLAGPIPDWLRRFPFSSYTGIDIIPPGGNYTLVTPPPPSEQTHQ--KPSKARFLGLSET 256
Query: 249 XXXXXXXXXXXXXXXXXXXXXXXXWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYGGA 308
CY R R LR G G + + K+G + +
Sbjct: 257 VFLLIVIAVSIVVITALAFVLTV---CYVR--RKLRRGDGVISDNKLQKKGGMSPEKFVS 311
Query: 309 RDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKXXXXXXXXXXXXXXXXX 368
R + FEGCN F ++ DLL++SAE+LGKG G TYK
Sbjct: 312 RMEDVNNRLSFFEGCNYSF-DLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDV 370
Query: 369 XXXXXX-DEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPXXXXXXXXXXXXXPGRM 427
++ + +IGG++H N+V ++AY KDE +VYDY R+
Sbjct: 371 AAGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRI 430
Query: 428 PVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487
P+DW R+K+A +AKG+A +H N L HG++ SSNI ++ N C+SD+G+ +
Sbjct: 431 PLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSP 490
Query: 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM----AKGDGE 540
P Y APE+ RK Q DVYSFGVVLLE+LTGK GD
Sbjct: 491 LAPPISRQAGYRAPEVT-------DTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEI 543
Query: 541 LGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRXXXXXXXXXXXXXPKDRPNMSIVHR 600
+ +V+WV + ++E EVFD EL+ +EEEM RP MS + R
Sbjct: 544 IHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVR 603
Query: 601 MIEDI 605
+IE++
Sbjct: 604 LIENV 608
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 422 (153.6 bits), Expect = 4.0e-59, Sum P(2) = 4.0e-59
Identities = 114/345 (33%), Positives = 167/345 (48%)
Query: 275 CYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLL 334
C +K + GG GV ++ + D+G + ++ FE CN F ++ DLL
Sbjct: 288 CLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNF-DLEDLL 346
Query: 335 KSSAELLGKGCVGATYKXXXXXXXXXXXXXXXXXXXXXXX-DEWLRVIGGL-RHSNIVSI 392
K+SAE+LGKG G YK ++ + ++G + +HSN V +
Sbjct: 347 KASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPL 406
Query: 393 RAYCNGKDELFLVYDYLPXXXXXXXXXXXXXPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
AY KDE LVY Y+ G VDW R+K+A+ ++K +++LH
Sbjct: 407 LAYYYSKDEKLLVYKYMTKGSLFGIMHGNR--GDRGVDWETRMKIATGTSKAISYLHSLK 464
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF----HTPFFINDAYNAPELKFNNNNNY 508
HG + SSNI++ + C+SD + LF HTP I YNAPE+
Sbjct: 465 ---FVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIG--YNAPEV-------I 512
Query: 509 SQRKFWQRCDVYSFGVVLLEILTGKMA---KG-DGELGIV---KWVQMMGQDESAWEVFD 561
R+ QR DVYSFGVV+LE+LTGK G + E ++ +WV+ + ++E EVFD
Sbjct: 513 ETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFD 572
Query: 562 FELIMDKEMEEEMRXXXXXXXXXXXXXPKDRPNMSIVHRMIEDIR 606
EL+ + +EEEM P+ RP M V RMIED+R
Sbjct: 573 VELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVR 617
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
Identities = 184/609 (30%), Positives = 261/609 (42%)
Query: 25 SDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPA 84
SD LL+F ASV +W NST+ SW GVTC V L L + L GP
Sbjct: 47 SDRQALLAFAASVPHLRRL--NW-NSTNHICKSWVGVTCTSDGTSVHALRLPGIGLLGPI 103
Query: 85 EVXXXXXXXXXXXXXXXXXXXXXXX---XXXWPHLKHLYLSHNRFTGTFPSGVSSLRHLR 141
P L ++YL HN F+G PS VS R L
Sbjct: 104 PPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVS--RQLN 161
Query: 142 RVDLSHNAYEGEIPMXXXXXXXXXXXXXXXDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201
+DLS N++ G+IP +N+ +G + N + S+ N+SNN L+G
Sbjct: 162 ILDLSFNSFTGKIP-ATFQNLKQLTGLSLQNNKLSGPV--PNLDTVSLRRLNLSNNHLNG 218
Query: 202 QIPAWMSPFGGSSFAGNKNLCGRPL---------PS---DCSNRTVEPEQXXXXXXXXXX 249
IP+ + F SSF+GN LCG PL PS S + P
Sbjct: 219 SIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPHKEGSKRKLH 278
Query: 250 XXXXXXXXXXXXXXXXXXXXXXXWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYGGAR 309
CC K+K + R K + K K ++G
Sbjct: 279 VSTIIPIAAGGAALLLLITVIILCCCIKKKDK--REDSIVKVKTLTEKA---KQEFGSGV 333
Query: 310 DGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKXXXXXXXXXXXXXXXXXX 369
+ ++V F GC+ F ++ DLL++SAE+LGKG G YK
Sbjct: 334 QEPEKNKLVFFNGCSYNF-DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVA 392
Query: 370 XXXXX-DEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPXXXXXXXXXXXXXPGRM 427
++ + +I + H ++V +RAY KDE +V DY P +
Sbjct: 393 AGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKT 452
Query: 428 PVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487
P+DW+ R+K+ +AKG+A LH HG++ SSN+++ Q +ACISD G+ L
Sbjct: 453 PLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAV 512
Query: 488 PFF-INDA-YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA----KGDGEL 541
P + A Y APE+ RK + DVYSFGV++LE+LTGK D +
Sbjct: 513 PIAPMRGAGYRAPEVM-------ETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMV 565
Query: 542 GIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRXXXXXXXXXXXXXPKDRPNMSIVHRM 601
+ +WVQ + ++E EVFD EL+ + +EEEM P+ RP M V RM
Sbjct: 566 DLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRM 625
Query: 602 IEDIRTKGS 610
IE+IR S
Sbjct: 626 IEEIRVSDS 634
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 384 (140.2 bits), Expect = 4.7e-55, Sum P(2) = 4.7e-55
Identities = 107/323 (33%), Positives = 158/323 (48%)
Query: 299 GNRKGDYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKXXXXXXX 358
GN K G +G +++V F K F ++ DLL++SAE+LGKG G YK
Sbjct: 339 GNGKASEG---NGPATKKLVFFGNATKVF-DLEDLLRASAEVLGKGTFGTAYKAVLDAVT 394
Query: 359 XXXXXXXXXXXXXXXX-DEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPXXXXXXX 417
E + ++G + H N+V +RAY +DE LVYD++P
Sbjct: 395 VVAVKRLKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSAL 454
Query: 418 XXXXXXPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACIS 477
GR P++W+ R ++A +A+GL +LH + HG++ SSNI++ + +A +S
Sbjct: 455 LHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTS-TSHGNIKSSNILLTKSHDAKVS 513
Query: 478 DIGVHQLFHTPFFI-NDA--YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM 534
D G+ QL + N A Y APE+ ++ Q+ DVYSFGVVLLE++TGK
Sbjct: 514 DFGLAQLVGSSATNPNRATGYRAPEVT-------DPKRVSQKGDVYSFGVVLLELITGKA 566
Query: 535 AKGD--GELGI--VKWVQMMGQDESAWEVFDFELIMDKEMEEEMRXXXXXXXXX-XXXXP 589
E G+ +WV+ + +DE EVFD EL+ EEEM P
Sbjct: 567 PSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHP 626
Query: 590 KDRPNMSIVHRMIEDIRTKGSID 612
RP MS V R +E++R D
Sbjct: 627 DQRPEMSEVVRKMENLRPYSGSD 649
|
|
| TAIR|locus:2036499 AT1G60630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 349 (127.9 bits), Expect = 3.2e-54, Sum P(2) = 3.2e-54
Identities = 97/289 (33%), Positives = 145/289 (50%)
Query: 332 DLLKSSAELLGKGCVGATYKXXXXXXXXXXXXXXXXXXXXXXXDEWLR---VIGGLRHSN 388
DLLK+SAE LG+G +G+TYK DE+ R ++G L+H N
Sbjct: 347 DLLKASAETLGRGTLGSTYKAVMESGFIITVKRLKDAGFPRM-DEFKRHIEILGRLKHPN 405
Query: 389 IVSIRAYCNGKDELFLVYDYLPXXXXXXXXXXXXXPGR-MPVDWNKRLKLASDSAKGLAF 447
+V +RAY K+E LVYDY P G P+ W LK+A D A GL +
Sbjct: 406 LVPLRAYFQAKEECLLVYDYFPNGSLFSLIHGSKVSGSGKPLHWTSCLKIAEDLAMGLVY 465
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNN 507
+H L HG+L SSN+++ +C++D G+ L H P+ I D +A L +
Sbjct: 466 IH--QNPGLTHGNLKSSNVLLGPDFESCLTDYGLSDL-HDPYSIEDT-SAASLFYKAPEC 521
Query: 508 YSQRKF-WQRCDVYSFGVVLLEILTGKMAKGD--GELG--IVKWVQMMGQDESAWEVFDF 562
RK Q DVYSFGV+LLE+LTG+ + D + G I WV+ + ++E+ EV +
Sbjct: 522 RDLRKASTQPADVYSFGVLLLELLTGRTSFKDLVHKYGSDISTWVRAVREEET--EVSE- 578
Query: 563 ELIMDKEMEEEMRXXXXXXXXXXXXXPKDRPNMSIVHRMIEDIRTKGSI 611
EL EE+++ P++RP M V +M++D R + ++
Sbjct: 579 EL---NASEEKLQALLTIATACVAVKPENRPAMREVLKMVKDARAEAAL 624
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 369 (135.0 bits), Expect = 4.9e-54, Sum P(2) = 4.9e-54
Identities = 103/308 (33%), Positives = 149/308 (48%)
Query: 314 VEEMVMFEGCNKGFRNVGDLLKSSAELLGKGCVGATYKXXXXXXXXXXXXXXXXXXXXXX 373
++++V F K F ++ DLL++SAE+LGKG G YK
Sbjct: 345 MKKLVFFGNATKVF-DLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADR 403
Query: 374 X-DEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPXXXXXXXXXXXXXPGRMPVDWN 432
E + V+G + H N+V +RAY DE LVYD++P GR P++W
Sbjct: 404 EFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWE 463
Query: 433 KRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFI- 491
R +A +A+GL +LH + HG++ SSNI++ +A +SD G+ QL
Sbjct: 464 VRSGIALGAARGLDYLHSQDPLSS-HGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTP 522
Query: 492 NDA--YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD--GELG--IVK 545
N A Y APE+ R+ Q+ DVYSFGVVLLE+LTGK E G + +
Sbjct: 523 NRATGYRAPEVT-------DPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLAR 575
Query: 546 WVQMMGQDESAWEVFDFELIMDK---EMEEEMRXXXXXXXXXXXXXPKDRPNMSIVHRMI 602
WV + ++E EVFD EL+ + +EEEM P RP M V R I
Sbjct: 576 WVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRI 635
Query: 603 EDIRTKGS 610
+++R G+
Sbjct: 636 QELRQSGA 643
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9M9C5 | Y1680_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3978 | 0.9296 | 0.8880 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00032204001 | SubName- Full=Chromosome chr4 scaffold_6, whole genome shotgun sequence; (608 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 640 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-29 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-25 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-13 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-10 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-08 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-05 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.001 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.001 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.001 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.002 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.002 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.002 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.003 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.004 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 0.004 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.004 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-37
Identities = 146/582 (25%), Positives = 235/582 (40%), Gaps = 107/582 (18%)
Query: 90 LTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149
+ L++LSL N + L++L LS N+F+G P + SL L ++ LS N
Sbjct: 451 MPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 150 YEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS- 208
GEIP EL+ L++L L N+ +G + + S + ++S NQLSG+IP +
Sbjct: 511 LSGEIP-DELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569
Query: 209 ------------------PFGG-------SSFAGNKNLCGRPLPSDCSNRTVEPEQPPRS 243
P G S+ AGN +LCG S PP
Sbjct: 570 VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL---------PPCK 620
Query: 244 RPRSSRVVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKG 303
R R + + A LV + + R R +L + + N G
Sbjct: 621 RVRKTPSWWFYITCTL--GAFLVLALVAFGFVFIRGRNNLE----------LKRVENEDG 668
Query: 304 DYGGARDGGDVEEMVMFEGCNKGFRNVGDLLKSSAE--LLGKGCVGATYKVVLDGGDV-V 360
+ E+ F+ + D+L S E ++ +G GA+YK +
Sbjct: 669 TW----------ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQF 718
Query: 361 VVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHG 420
VVK I + + + +G L+H NIV + C + +L+++Y+ +L +L
Sbjct: 719 VVKEINDVNSIPSSE--IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
Query: 421 SRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG 480
+ W +R K+A AK L FLH + G+LS I++D + +
Sbjct: 777 --------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827
Query: 481 VHQLFHTPF--FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538
+ L T FI+ AY APE + + ++ D+Y FG++L+E+LTGK + D
Sbjct: 828 LPGLLCTDTKCFISSAYVAPETR-------ETKDITEKSDIYGFGLILIELLTGK-SPAD 879
Query: 539 GELG----IVKWVQMMGQDESAWEVFDFELIMDKEM-EEEMRALLQVALLCLAPLPKDRP 593
E G IV+W + D D + D + + E+ ++ +AL C A P RP
Sbjct: 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
Query: 594 NMSIVHRMIEDIRTKGSIDGCANSIMNNISSDSSPSQSENTY 635
CAN ++ + S S S S T
Sbjct: 940 --------------------CANDVLKTLESASRSSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAYC 396
LG+G G Y G V +K I++ ++E LR ++ L H NIV +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
++ L+LV +Y GSL LL + G + ++ L++ +GL +LH +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLH---SNGI 113
Query: 457 FHGHLSSSNIVVDQL-GNACISDIGVHQLFH------TPFFINDAYNAPELKFNNNNNYS 509
H L NI++D G ++D G+ +L AY APE+ YS
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEV-LLGKGYYS 172
Query: 510 QRKFWQRCDVYSFGVVLLEI 529
++ D++S GV+L E+
Sbjct: 173 -----EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 73/272 (26%), Positives = 113/272 (41%), Gaps = 40/272 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEW----LRVIGGLRHSNIVSIR 393
LG G G YK G +V VK +++R +K + D+ +R++ L H NIV +
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
KD L+LV +Y G L L P+ ++ K+A +GL +LH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGV------HQLFHTPFFINDAYNAPELKFNNNNN 507
+ H L NI++D+ G I+D G+ T F Y APE+ N
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV-LLGGNG 175
Query: 508 YSQRKFWQRCDVYSFGVVLLEILTGKM----AKGDGELGIVKWVQMMGQDESAWEVFDFE 563
Y + DV+S GV+L E+LTGK +L +++ + + E +
Sbjct: 176 YG-----PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI-LGPPLEFDEPKWS-- 227
Query: 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595
EE + L++ CL P RP
Sbjct: 228 -----SGSEEAKDLIKK---CLNKDPSKRPTA 251
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 68/293 (23%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDV-VVVKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
+ LG+G G T K +G + V VK ++E + E +E+L ++ L H NIV
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C + L++V +Y+P G L L + L++A AKG+ +L
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE- 119
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN-------------A 497
+K + H L++ N +V + ISD G+ + D Y A
Sbjct: 120 -SK-NFVHRDLAARNCLVTENLVVKISDFGL-----SRDIYEDDYYRKRGGGKLPIKWMA 172
Query: 498 PE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA 556
PE LK KF + DV+SFGV+L EI T LG + M +
Sbjct: 173 PESLKD--------GKFTSKSDVWSFGVLLWEIFT---------LGEQPYPGMSNE---- 211
Query: 557 WEVFDFELIMDKE-ME------EEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602
EV EL+ D + +E+ L+ L C A P+DRP S + +
Sbjct: 212 -EV--LELLEDGYRLPRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/265 (24%), Positives = 110/265 (41%), Gaps = 36/265 (13%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
E LG+G G Y G +V +K I+++K K++ + LR ++ L+H NIV +
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
+D+L+LV +Y G L LL GR+ D + L +LH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEAR--FYLRQILSALEYLHSKGIV 119
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND-----AYNAPELKFNNNNNYS 509
H L NI++D+ G+ ++D G+ + + Y APE+
Sbjct: 120 HR---DLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV-------LL 169
Query: 510 QRKFWQRCDVYSFGVVLLEILTGKM-AKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568
+ + + D++S GV+L E+LTGK GD +L + + +D
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI------ 223
Query: 569 EMEEEMRALLQVALLCLAPLPKDRP 593
E + L++ L P+ R
Sbjct: 224 --SPEAKDLIR---KLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 78/297 (26%), Positives = 119/297 (40%), Gaps = 67/297 (22%)
Query: 339 ELLGKGCVGATYKVVLDGGD----VVVVKRIRERKKKREVDEWL---RVIGGLRHSNIVS 391
+ LG+G G YK L G D V VK ++E + E ++L RV+ L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRG----PGRMPVDWNKRLKLASDSAKGLAF 447
+ C ++ L+LV +Y+ G L L SR P + + L A AKG+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN----------- 496
L H L++ N +V + ISD G+ + +D Y
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGL-----SRDVYDDDYYRKKTGGKLPIR 172
Query: 497 --APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQD 553
APE LK + S DV+SFGV+L EI T LG + +
Sbjct: 173 WMAPESLKDGIFTSKS--------DVWSFGVLLWEIFT---------LGATPYPGL---- 211
Query: 554 ESAWEVFDFELIMD-------KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603
S EV ++ + + +E+ L+ C P+DRP S + +E
Sbjct: 212 -SNEEVLEY--LRKGYRLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 55/286 (19%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDV-VVVKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
+ LG+G G K V V VK ++E +++++E+LR ++ L H N+V
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C ++ L++V +Y+ G L S L +R + + L A A+G+ +L
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLE- 119
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIG---------VHQLFHTPFFINDAYNAPE-L 500
+ H L++ N +V + ISD G ++ I + APE L
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI--RWMAPESL 175
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560
K KF + DV+SFGV+L EI T LG + M + EV
Sbjct: 176 KE--------GKFTSKSDVWSFGVLLWEIFT---------LGEQPYPGMSNE-----EV- 212
Query: 561 DFELIMDKEMEEEMR----ALLQVALLCLAPLPKDRPNMSIVHRMI 602
E + + + L + L C A P+DRP S + ++
Sbjct: 213 -LEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 68/293 (23%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
+ LG+G G T K DG +V V VK ++E +++++E+LR ++ L H NIV
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C ++ L +V +Y+P G L L +R + + L A A+G+ +L
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGMEYLE- 120
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIG----VHQLFHTPFFINDAYN---------- 496
+ H L++ N +V + ISD G ++ +D Y
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY---------DDDYYKVKGGKLPIR 169
Query: 497 --APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQD 553
APE LK KF + DV+SFGV+L EI T LG + M
Sbjct: 170 WMAPESLKE--------GKFTSKSDVWSFGVLLWEIFT---------LGEEPYPGMSNA- 211
Query: 554 ESAWEVFDFELIMDKEMEEEMR----ALLQVALLCLAPLPKDRPNMSIVHRMI 602
EV E + + L ++ L C A P+DRP S + ++
Sbjct: 212 ----EV--LEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 9e-20
Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 6 IFFFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNP 65
F F LF L S ++ LLSFK+S+ LS+W +S D C W+G+TCN
Sbjct: 11 YLIFMLFFLF-LNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNN 67
Query: 66 STHRVIKLVLEDLDLTGP-AEVLSRLTQLRLLSLKNNLLSS---SNLNLSSWPHLKHLYL 121
S+ RV+ + L +++G + + RL ++ ++L NN LS ++ +S L++L L
Sbjct: 68 SS-RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSS-LRYLNL 125
Query: 122 SHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL-- 179
S+N FTG+ P G S+ +L +DLS+N GEIP ++ +L L L N G +
Sbjct: 126 SNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPN-DIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 180 YSVNSSSRSILDFNVSNNQLSGQIPA 205
N +S L +++NQL GQIP
Sbjct: 183 SLTNLTSLEFL--TLASNQLVGQIPR 206
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 84.8 bits (208), Expect = 2e-17
Identities = 58/279 (20%), Positives = 105/279 (37%), Gaps = 35/279 (12%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRER--KKKREVDEWLRVIGGLR----HSNIVSI 392
LG+G G Y +V +K + ++ K +EV+ +LR I L NIV +
Sbjct: 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
+ + L+LV +Y+ GSL LL G + + + L +LH
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL--FILAQILSALEYLH--- 118
Query: 453 KAHLFHGHLSSSNIVVDQLGNAC-ISDIGV------------HQLFHTPFFINDAYNAPE 499
+ H + NI++D+ G + D G+ + Y APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK--MAKGDGELGIVKWVQMMGQDESAW 557
+ + Y+ D++S G+ L E+LTG + ++++ + +
Sbjct: 179 VLLGLSLAYASS----SSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ + + LL+ LA PK+R + S
Sbjct: 235 LASPLSPSNPELISKAASDLLKK---LLAKDPKNRLSSS 270
|
Length = 384 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 81/302 (26%), Positives = 127/302 (42%), Gaps = 61/302 (20%)
Query: 339 ELLGKGCVGATYKVVLD-----GGDVVVVKRIRERKKK--REVDEWLRVIGGLRHSNIVS 391
+ LGKG G+ D G+VV VK+++ + R+ + + ++ L+H NIV
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 392 IRAYC--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+ C G+ L LV +YLP+GSL L R +D K L AS KG+ +L
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYLG 125
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF-------------HTPFFINDAYN 496
H L++ NI+V+ I D G+ ++ +P F +
Sbjct: 126 S---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WY 178
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT--GKMAKGDGELGIVKWVQMMGQDE 554
APE + ++ KF DV+SFGVVL E+ T K E +++MMG D+
Sbjct: 179 APE-------SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-----FMRMMGNDK 226
Query: 555 SAWEVFDFELIMDKEMEEEMRALLQ----------VALLCLAPLPKDRPNMSIVHRMIED 604
+ + LI E+ + L + C P RP+ S + +E
Sbjct: 227 QGQMIV-YHLI---ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282
Query: 605 IR 606
IR
Sbjct: 283 IR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRI--------RERKKKREVDEWLR----VIGGLR 385
EL+GKG G Y + + G+++ VK++ R +++++ + LR + L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL 445
H NIV + ++ L + +Y+P GS+ S L R GR + +GL
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVR--FFTEQVLEGL 121
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-FFINDAYN-------- 496
A+LH + H L + N++VD G ISD G+ + + + ND
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFW 176
Query: 497 -APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE 540
APE+ + + YS + D++S G V+LE+ G+ D E
Sbjct: 177 MAPEVIHSYSQGYS-----AKVDIWSLGCVVLEMFAGRRPWSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 76/298 (25%), Positives = 123/298 (41%), Gaps = 57/298 (19%)
Query: 341 LGKGCVGATYKVVLD-----GGDVVVVKRIRERKKKREVDEWLRVIGGLR---HSNIVSI 392
LG+G G D G+ V VK + +++ ++ R I LR H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 393 RAYC--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C G L L+ +YLP GSL L R ++ + L +S KG+ +L
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDYLG- 126
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-------------PFFINDAYNA 497
H L++ NI+V+ ISD G+ ++ P F + A
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----WYA 180
Query: 498 PELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESA 556
PE KF DV+SFGV L E+ T GD ++++M+G +
Sbjct: 181 PE-------CLRTSKFSSASDVWSFGVTLYELFT----YGDPSQSPPAEFLRMIGIAQGQ 229
Query: 557 WEVFDF-ELIMDKE-------MEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
V EL+ + E +E+ L++ LC P+DRP+ + + +++ +R
Sbjct: 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMK---LCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 37/276 (13%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAY 395
E +GKG G YK VL G V VK R KR+ + ++ H NIV +
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
C K +++V + +P GSL + L + R+ V K L+++ D+A G+ +L N
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK--NRLTV--KKLLQMSLDAAAGMEYLESKN--- 113
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFF--------INDAYNAPELKFNNNNN 507
H L++ N +V + ISD G+ + + I + APE N
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL-----N 168
Query: 508 YSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567
Y ++ DV+S+G++L E + LG + M Q + +
Sbjct: 169 YG--RYTSESDVWSYGILLWETFS---------LGDTPYPGMSNQQTRERIESGYRMPAP 217
Query: 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603
+ EE+ L+ C A P++RP+ S ++ ++
Sbjct: 218 QLCPEEIYRLML---QCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 46/198 (23%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIR--ERKKKREVDEWLRVIGGLRHSNIVSIRAYCNG 398
LG G G ++ + V +K ++ + K+++ + ++ + LRH +++S+ A C+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 399 KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFH 458
+ ++++ + + GSL + L R P + + +A A+G+A+L + + H
Sbjct: 74 GEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127
Query: 459 GHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRC 517
L++ NI+V + C ++D G+ +L +++ P K+ S F +
Sbjct: 128 RDLAARNILVGE-DLVCKVADFGLARLIKEDVYLSSDKKIP-YKWTAPEAASHGTFSTKS 185
Query: 518 DVYSFGVVLLEILT-GKM 534
DV+SFG++L E+ T G++
Sbjct: 186 DVWSFGILLYEMFTYGQV 203
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 38/213 (17%)
Query: 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIR----ERKKKREVDEWLRVIGGLRHSNIVSIR 393
+GKG G +KVV V +K+I R+++ E + RV+ L S I+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVD--WNKRLKLASDSAKGLAFLHGY 451
K +L +V +Y +G LH LL RG +P D W + GLA LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVW----RFFIQILLGLAHLH-- 118
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-----------TPFFINDAYNAPEL 500
+ H + S N+ +D N I D+GV +L TP+ Y +PEL
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY-----YLSPEL 172
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ + ++ DV++ GVVL E TGK
Sbjct: 173 -------CEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERKKKRE--VDEWLRVIGGLRHSNIVSIRAYCNG 398
LG G G + +G V VK ++ E + E +++ LRH +V + A C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQE-AQIMKKLRHDKLVQLYAVCSE 72
Query: 399 KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFH 458
++ +++V +Y+ GSL L G G+ + + + +A+ A+G+A+L + H
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS--GEGKK-LRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 459 GHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQRK 512
L++ NI+V + C I+D G+ +L +D Y A E +K+ + +
Sbjct: 127 RDLAARNILVGE-NLVCKIADFGLARLIE-----DDEYTAREGAKFPIKWTAPEAANYGR 180
Query: 513 FWQRCDVYSFGVVLLEILT 531
F + DV+SFG++L EI+T
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 7e-13
Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 339 ELLGKGCVGATYK-VVLDGGDVVVVKRIRERKKKREVDEWL----RVIGGLRHSNIVSIR 393
ELLG+G G+ Y + D G+++ VK + E E L R++ L+H NIV
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 394 AYC--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
K+ L + +Y+ GSL SLL G PV R K +GLA+LH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPV---IR-KYTRQILEGLAYLH-- 118
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGV-------------HQLFHTPFFINDAYNAP 498
+ H + +NI+VD G ++D G + TP+++ AP
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM-----AP 172
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
E+ Y R D++S G ++E+ TGK
Sbjct: 173 EVI--RGEEYG-RA----ADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 65/273 (23%), Positives = 106/273 (38%), Gaps = 53/273 (19%)
Query: 341 LGKGCVGATYKVVLDG-GDVVVVKRI----RERKKK---REVDEWLRVIGGLRHSNIVSI 392
LG+G G YKV G + +K+I E +K RE+ +V
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC----ESPYVVKC 64
Query: 393 R-AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAKGLAFLH 449
A+ + E+ +V +Y+ GSL LL G + + +A KGL +LH
Sbjct: 65 YGAFYK-EGEISIVLEYMDGGSLADLL-KKVGK------IPEPVLAYIARQILKGLDYLH 116
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND------AYNAPELKFN 503
K H+ H + SN++++ G I+D G+ ++ + Y +PE +
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQ 173
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDF 562
+ YS D++S G+ LLE GK G+ + ++M + D
Sbjct: 174 GES-YSYA-----ADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQA------ICDG 218
Query: 563 ELI--MDKEMEEEMRALLQVALLCLAPLPKDRP 593
+E E R + CL PK RP
Sbjct: 219 PPPSLPAEEFSPEFRDFIS---ACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 50/256 (19%), Positives = 97/256 (37%), Gaps = 26/256 (10%)
Query: 360 VVVKRIRERKKKREVDEWLRVIG---GLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416
VVVK +R E +L+ + L H N++ C LV ++ P G L +
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACI 476
L +RG + ++A + A GL +LH +A H L+ N + + I
Sbjct: 85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKI 141
Query: 477 SDIGV-HQLFHTPFFINDA-------YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLE 528
D G+ + + ++I + APEL + + ++ +++S GV + E
Sbjct: 142 GDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201
Query: 529 ILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRA--LLQVALLCLA 586
+ + + + V + ++ + K + + +V C
Sbjct: 202 LF---------TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL 252
Query: 587 PLPKDRPNMSIVHRMI 602
P+ RP VH ++
Sbjct: 253 D-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 66/281 (23%), Positives = 114/281 (40%), Gaps = 69/281 (24%)
Query: 339 ELLGKGCVGATYKV--VLDGGDVVVVKRIRERKKKREVDEWLRVIGGLR---HSNIVSIR 393
E +GKG G YK G V +K I+ K+++ ++ + I L+ H NIV
Sbjct: 6 EKIGKGGFGEVYKARHKRTG-KEVAIKVIKLESKEKK-EKIINEIQILKKCKHPNIVKY- 62
Query: 394 AYCN--GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSA------KGL 445
Y + KDEL++V ++ GSL LL N+ L + + KGL
Sbjct: 63 -YGSYLKKDELWIVMEFCSGGSLKDLLKS----------TNQTLTESQIAYVCKELLKGL 111
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV----------HQLFHTPFFINDAY 495
+LH H + ++NI++ G + D G+ + + TP+++
Sbjct: 112 EYLHSNGIIH---RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWM---- 164
Query: 496 NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD---GELGIVKWVQMMGQ 552
APE+ N Y + D++S G+ +E +A+G EL +K + +
Sbjct: 165 -APEVI--NGKPYDYK-----ADIWSLGITAIE-----LAEGKPPYSELPPMKALFKIAT 211
Query: 553 DESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP 593
+ L ++ +E + L CL P+ RP
Sbjct: 212 NGP------PGLRNPEKWSDEFKDFL---KKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAYCN 397
LG G G ++ + + V VK ++ + ++L ++ LRH ++ + A C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK--PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPG-RMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
++ +++V + + +GSL L G G ++P + + +A+ A G+A+L N
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLP----QLIDMAAQVASGMAYLEAQN---Y 124
Query: 457 FHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYNA-PELKF------NNNNNY 508
H L++ N++V + N C ++D G+ ++ D Y A KF Y
Sbjct: 125 IHRDLAARNVLVGE-NNICKVADFGLARV-----IKEDIYEAREGAKFPIKWTAPEAALY 178
Query: 509 SQRKFWQRCDVYSFGVVLLEILT-GKM 534
+ +F + DV+SFG++L EI+T G+M
Sbjct: 179 N--RFSIKSDVWSFGILLTEIVTYGRM 203
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 67/280 (23%), Positives = 123/280 (43%), Gaps = 46/280 (16%)
Query: 341 LGKGCVGATYKVVLDG-GDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAYC 396
LG G G Y+ V V VK ++E EV+E+L+ V+ ++H N+V + C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
+ +++ +++ +G+L L R R V+ L +A+ + + +L K +
Sbjct: 72 TREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQR 511
H L++ N +V + ++D G+ +L D Y A +K+ + +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 512 KFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK--- 568
KF + DV++FGV+L EI T M+ G + Q+ E + M++
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQVYELLEKGYR-------MERPEG 229
Query: 569 ---EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
++ E MRA C P DRP+ + +H+ E +
Sbjct: 230 CPPKVYELMRA-------CWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 53/221 (23%), Positives = 85/221 (38%), Gaps = 42/221 (19%)
Query: 339 ELLGKGCVGATYK---VVLDGGDVVVVKRIRERKKKREVDEW------LRVIGGLRHSNI 389
E LG+G G YK + I+ K+ E ++ L+H NI
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLL-----------HGSRGPGRMPVDWNKRLKLA 438
V + C + ++++YL HG LH L + +D + L +A
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 439 SDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAP 498
A G+ +L + H H L++ N +V + ISD G+ + D Y+A
Sbjct: 131 IQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR---------DIYSAD 178
Query: 499 ELKFNNNNNYSQR----------KFWQRCDVYSFGVVLLEI 529
+ + + R KF D++SFGVVL EI
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 329 NVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWL---RVIGGLR 385
N +L +GKG G G V VK +++ +L V+ LR
Sbjct: 4 NSKELKLG--ATIGKGEFGDVMLGDYRG-QKVAVKCLKDDSTA--AQAFLAEASVMTTLR 58
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL 445
H N+V + + L++V +Y+ GSL L R GR + ++L A D +G+
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGM 115
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV---HQLFHTPFFINDAYNAPE-LK 501
+L N H L++ N++V + A +SD G+ + + APE L+
Sbjct: 116 EYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALR 172
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEI 529
KF + DV+SFG++L EI
Sbjct: 173 EK--------KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 359 VVVVKRIRERKKKREVD-----EWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413
+V VK ++E + D E L V L+H +IV C L +V++Y+ HG
Sbjct: 37 LVAVKALKEASESARQDFQREAELLTV---LQHQHIVRFYGVCTEGRPLLMVFEYMRHGD 93
Query: 414 LHSLLHGSRGP-------GRM----PVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLS 462
L+ L S GP G + + L +AS A G+ +L H H L+
Sbjct: 94 LNRFLR-SHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLA 149
Query: 463 SSNIVVDQLGNACISDIGVHQ-LFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYS 521
+ N +V Q I D G+ + ++ T ++ +++ + RKF D++S
Sbjct: 150 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWS 209
Query: 522 FGVVLLEILT 531
FGVVL EI T
Sbjct: 210 FGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 6e-11
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 341 LGKGCVGATYKV-VLDGGDVVVVKRIRERK--KKREVD----EWLRVIGGLRHSNIVSIR 393
LGKG G V D G + +K ++++K K++EV+ E ++ + H IV +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTER-NILSRINHPFIVKLH 59
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
+++L+LV +Y P G L S L GR + + A++ L +LH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKE---GRFSEERARFY--AAEIVLALEYLH---S 111
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDA-----YNAPELKFNNNNN 507
+ + L NI++D G+ ++D G+ +L N Y APE+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 508 YSQRKFWQRCDVYSFGVVLLEILTGK 533
+ D +S GV+L E+LTGK
Sbjct: 172 KA-------VDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 58/265 (21%), Positives = 112/265 (42%), Gaps = 22/265 (8%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRE---RKKKREVDEWLRVIGGLRHSNIVSIRAY 395
ELLGKG G +K L V VK +E ++ K + R++ H NIV +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
C + +++V + +P G S L + + + +K A D+A G+A+L N
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT----KQLVKFALDAAAGMAYLESKN--- 113
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQ 515
H L++ N +V + ISD G+ + + + +K+ + ++
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 516 RCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMR 575
DV+S+G++L E + LG+ + M Q + + ++ +++
Sbjct: 174 ESDVWSYGILLWETFS---------LGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVY 224
Query: 576 ALLQVALLCLAPLPKDRPNMSIVHR 600
++Q C P++RP S + +
Sbjct: 225 KVMQ---RCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 336 SSAELLGKGCVGATYKVVLDGGDVVVVKRIRE-RKKKREVDEWLRVIGGLRHSNIVSIRA 394
+ + LG G G + G V +K IRE + + E +V+ L H N+V +
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL--HGYN 452
C + +F+V +Y+ +G L + L +G L + SD + + +L +G+
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW----LLDMCSDVCEAMEYLESNGF- 121
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNN 507
H L++ N +V + +SD G+ + ++D Y + + +K+
Sbjct: 122 ----IHRDLAARNCLVGEDNVVKVSDFGL-----ARYVLDDQYTSSQGTKFPVKWAPPEV 172
Query: 508 YSQRKFWQRCDVYSFGVVLLEILT-GKM 534
+ +F + DV+SFGV++ E+ + GKM
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKM 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (152), Expect = 1e-10
Identities = 61/286 (21%), Positives = 111/286 (38%), Gaps = 69/286 (24%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-----ERKKKREVDEWLRVIGGLRHSNIVSI 392
+ +GKG G Y V G + V+K I E++++ ++E ++++ L H NI+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNE-VKILKKLNHPNIIKY 64
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGR-MPVD--WNKRLKLASDSAKGLAFLH 449
K +L +V +Y G L + + G+ P + + ++L L +LH
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLH 120
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFH----------TPFFINDAYNAP 498
+ H + NI + G + D G+ L TP+ Y +P
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY-----YLSP 172
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAW 557
EL N Y+ + D++S G VL E+ T K +G+ L +
Sbjct: 173 ELC--QNKPYNYKS-----DIWSLGCVLYELCTLKHPFEGENLLELAL------------ 213
Query: 558 EVFDFELIMDKEME-------EEMRALLQVALLCLAPLPKDRPNMS 596
I+ + E+R L+ L P++RP+++
Sbjct: 214 ------KILKGQYPPIPSQYSSELRNLVS---SLLQKDPEERPSIA 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 24/191 (12%)
Query: 356 GGDVVVVKRIRERKK--KREVDEWLRVIGGLR---HSNIVSIRAY----CNGKDELFLVY 406
V+++ ++ K K +D I LR +NI+ I + + L L+
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNI 466
+Y G L +L + + + +L +A D KGL L+ Y + +L+S +
Sbjct: 102 EYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSF 154
Query: 467 VVDQLGNACISDIGVHQLFHTPFF--IND-AYNAPELKFNNNNNYSQRKFWQRCDVYSFG 523
+V + I G+ ++ +P F +N Y + ++ + + Y+ + D+YS G
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD-----DIYSLG 209
Query: 524 VVLLEILTGKM 534
VVL EI TGK+
Sbjct: 210 VVLWEIFTGKI 220
|
Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 20/161 (12%)
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
G P+ +S LRHL+ ++LS N+ G IP + L + +L L L N F G++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 188 SILDFNVSNNQLSGQIPAWMS--PFGGSSF--AGNKNLCGRPLPSDCSNRTVEPEQPPRS 243
S+ N++ N LSG++PA + +SF N LCG P R P
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-----GLRACGPHLS--- 542
Query: 244 RPRSSRVVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLR 284
V + + F + +V C +KR++ LR
Sbjct: 543 -------VGAKIGIAFGVSVAFLFLVICAMCWWKRRQNILR 576
|
Length = 623 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 51/218 (23%)
Query: 341 LGKGCVGATYKVVL--------DGGDVVVVKRIRERKKKREVDEWLRVIGGLR---HSNI 389
LG+G G KV L G++V VK ++ ++ W + I L+ H NI
Sbjct: 12 LGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 390 VSIRAYCN--GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
V + C+ G L L+ +Y+P GSL L + ++ + L A +G+A+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAY 122
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-------HQLFH------TPFFINDA 494
LH H H L++ N+++D I D G+ H+ + +P F
Sbjct: 123 LHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF---- 175
Query: 495 YNAPE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
+ A E LK N KF DV+SFGV L E+LT
Sbjct: 176 WYAVECLKEN--------KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 35/214 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
E++G G Y + L + V +KRI K + VDE + + H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--Y 64
Query: 395 YCN--GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAKGLAFLH 449
Y + DEL+LV YL GSL ++ S P +A+ + KGL +LH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSS-----YPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----------FFINDAYNAPE 499
H + + NI++ + G+ I+D GV F + APE
Sbjct: 120 SNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ + + D++SFG+ +E+ TG
Sbjct: 177 VM------EQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 40/242 (16%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRERKKK--------REVDEWLRVIGGLRHSNIVS 391
+G+G G Y+ G++V +K++R ++ RE+ ++ LRH NIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI----TLLLNLRHPNIVE 70
Query: 392 IRAYCNGK--DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK-LASDSAKGLAFL 448
++ GK D +FLV +Y L SLL P ++K L +GL +L
Sbjct: 71 LKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSES-----QVKCLMLQLLRGLQYL 124
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------TPFFINDAYNAPELKF 502
H + + H L SN+++ G I+D G+ + + TP + Y APEL
Sbjct: 125 H---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELGIVKW-VQMMGQ-DESAWEV 559
+ D+++ G +L E+L K + G E+ + +Q++G +ES W
Sbjct: 182 GCTTYTTA------IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235
Query: 560 FD 561
F
Sbjct: 236 FS 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 339 ELLGKGCVGATYKVVL--DGGDV---VVVKRIRERKKKR---EVDEWLRVIGGLRHSNIV 390
+LLG G G +K + +G + V +K I++R ++ E+ + + +G L H+ IV
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 391 SIRAYCNGKDELFLVYDYLPHGSL--HSLLH-GSRGPGRMPVDWNKRLKLASDSAKGLAF 447
+ C G L LV P GSL H H S P R+ ++W ++ AKG+ +
Sbjct: 73 RLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRL-LNWCVQI------AKGMYY 124
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---TPFFINDAYNAPELKFNN 504
L + + H +L++ NI++ I+D GV L + +F ++ +K+
Sbjct: 125 LE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP--IKWMA 179
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILT 531
+ ++ + DV+S+GV + E+++
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 19/188 (10%)
Query: 359 VVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416
+V VK +++ +++ ++ L+H +IV C D L +V++Y+ HG L+
Sbjct: 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 96
Query: 417 LLHGSRGPGRM------PVDWNKRLKL------ASDSAKGLAFLHGYNKAHLFHGHLSSS 464
L + GP M P L L AS A G+ +L H H L++
Sbjct: 97 FLR-AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATR 152
Query: 465 NIVVDQLGNACISDIGVHQ-LFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFG 523
N +V I D G+ + ++ T ++ + +++ + RKF DV+SFG
Sbjct: 153 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 212
Query: 524 VVLLEILT 531
V+L EI T
Sbjct: 213 VILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 11/174 (6%)
Query: 357 GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAY-CNGKDELFLVYDYLPHGSLH 415
G+ V VK I+ + V+ LRHSN+V + K L++V +Y+ GSL
Sbjct: 29 GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC 475
L R GR + + LK + D + + +L N H L++ N++V + A
Sbjct: 89 DYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAK 142
Query: 476 ISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEI 529
+SD G+ + + D P +K+ ++KF + DV+SFG++L EI
Sbjct: 143 VSDFGLTKEASS---TQDTGKLP-VKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 332 DLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRE-RKKKREVDEWLRVIGGLRHSNIV 390
L E+ G G G + V +K IRE + + E +V+ L H +V
Sbjct: 4 SELTLVQEI-GSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C + + LV++++ HG L L RG L + D +G+A+L
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLE- 117
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNN 505
+++ H L++ N +V + +SD G+ T F ++D Y + +K+++
Sbjct: 118 --SSNVIHRDLAARNCLVGENQVVKVSDFGM-----TRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILT-GKM 534
+S K+ + DV+SFGV++ E+ + GK
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 50/216 (23%)
Query: 339 ELLGKGCVGATYKVVLDG-GDVVVVKRIRERKKKRE--VDEWLRVIGGLRHSNIVS-IRA 394
E +G+G G YK G V +K++R RK+ +E ++E + ++ +H NIV +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINE-ILIMKDCKHPNIVDYYDS 83
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWN-KRLK------LASDSAKGLAF 447
Y G DEL++V +Y+ GSL + + N R+ + + +GL +
Sbjct: 84 YLVG-DELWVVMEYMDGGSLTDI-----------ITQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFINDAYN 496
LH N H + S NI++ + G+ ++D G + + TP+++
Sbjct: 132 LHSQNVIHR---DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM----- 183
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
APE+ +Y + D++S G++ +E+ G
Sbjct: 184 APEVI--KRKDYGPK-----VDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 4e-10
Identities = 63/268 (23%), Positives = 110/268 (41%), Gaps = 56/268 (20%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIR-ERKK-------KREVDEWLRVIGGLRHSNIVS 391
+G+G G YK G++V +K+IR E +K RE+ +++ LRH NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREI----KLLQKLRHPNIVR 62
Query: 392 IRAYC--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK------ 443
++ GK +++V++Y+ H L LL + +K K
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLD------------SPEVKFTESQIKCYMKQL 109
Query: 444 --GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG-------VHQLFHTPFFINDA 494
GL +LH + H + SNI+++ G ++D G + +T I
Sbjct: 110 LEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWV-QMMG- 551
Y PEL Y D++S G +L E+ GK +G EL ++ + ++ G
Sbjct: 167 YRPPELLLGATR-YGPE-----VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS 220
Query: 552 -QDESAWEVFDFELIMDKEMEEEMRALL 578
DE+ V + + ++ + L
Sbjct: 221 PTDENWPGVSKLPWFENLKPKKPYKRRL 248
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 62/263 (23%), Positives = 113/263 (42%), Gaps = 36/263 (13%)
Query: 359 VVVVKRIRERKK--KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416
+V VK +++ +++ ++ L+H +IV C D L +V++Y+ HG L+
Sbjct: 37 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 96
Query: 417 LLHGSRGP-------GRMPVDW--NKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIV 467
L + GP G P + ++ L +A A G+ +L H H L++ N +
Sbjct: 97 FLR-AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCL 152
Query: 468 VDQLGNACISDIGVHQ-LFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVL 526
V + I D G+ + ++ T ++ + +++ + RKF DV+S GVVL
Sbjct: 153 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212
Query: 527 LEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRA----LLQVAL 582
EI T G W Q+ S EV E I + + R + + L
Sbjct: 213 WEIFT---------YGKQPWYQL-----SNNEV--IECITQGRVLQRPRTCPKEVYDLML 256
Query: 583 LCLAPLPKDRPNMSIVHRMIEDI 605
C P R N+ +H +++++
Sbjct: 257 GCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 43/121 (35%), Positives = 64/121 (52%), Gaps = 4/121 (3%)
Query: 87 LSRLTQLRLLSL-KNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145
+ LT L L L NNL +L + +L++L+L N+ +G P + SL+ L +DL
Sbjct: 232 IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291
Query: 146 SHNAYEGEIPMTELT-RLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
S N+ GEIP EL +L NL L L N FTG + +S + + +N+ SG+IP
Sbjct: 292 SDNSLSGEIP--ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349
Query: 205 A 205
Sbjct: 350 K 350
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 50/218 (22%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKRE----VDEWLRVIGGLRHSNIVSIR 393
+L+G+G G YK + L+ GD V +K+I K K E + + + ++ L+H NIV
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSA-------KGLA 446
D L+++ +Y +GSL ++ G P S A +GLA
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKF---GPFP---------ESLVAVYVYQVLQGLA 113
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFINDAY 495
+LH + H + ++NI+ + G ++D GV + TP+++
Sbjct: 114 YLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWM---- 166
Query: 496 NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
APE+ + S D++S G ++E+LTG
Sbjct: 167 -APEVI--EMSGAS-----TASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 339 ELLGKGCVGATYK-VVLDGGDVVVVKRI-------RERKKKREVDEWLRVIGGLRHSNIV 390
ELLG G G+ Y+ + LD GD VK + ++ +++++ + ++ L+H NIV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+D L++ + +P GSL LL G PV ++ GL +LH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQI----LLGLEYLHD 120
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIG-----VHQLFHTPFFINDAYNAPELKFNNN 505
N H + +NI+VD G ++D G V F F + + APE+
Sbjct: 121 RN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV-IAQQ 176
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y D++S G +LE+ TGK
Sbjct: 177 GGYG----LA-ADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 66/279 (23%), Positives = 123/279 (44%), Gaps = 42/279 (15%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVD-EWLRVIGGLRHSNIVSIRAYCNGK 399
LG+GC G + +G V +K ++ E + +V+ LRH +V + A + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72
Query: 400 DELFLVYDYLPHGSLHSLLHGSRGPG-RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFH 458
+ +++V +Y+ GSL L G G R+P + + +A+ A G+A++ N H
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERMNYVHR-- 126
Query: 459 GHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQRKF 513
L ++NI+V + ++D G+ +L ++ Y A + +K+ +F
Sbjct: 127 -DLRAANILVGENLVCKVADFGLARLIE-----DNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 514 WQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD-----FELIMDK 568
+ DV+SFG++L E+ T G V + M+ + EV D + +
Sbjct: 181 TIKSDVWSFGILLTELTTK---------GRVPYPGMVNR-----EVLDQVERGYRMPCPP 226
Query: 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
E E + L+ C P++RP + +ED T
Sbjct: 227 ECPESLHDLM---CQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 17/136 (12%)
Query: 399 KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFH 458
KD L+LV +YL G SL+ + G +P DW K + ++ G+ LH + H
Sbjct: 69 KDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQRG---IIH 120
Query: 459 GHLSSSNIVVDQLGNACISDIGVHQ--LFHTPFFINDAYNAPELKFNNNNNYSQRKFWQR 516
+ N+++DQ G+ ++D G+ + L + F Y APE ++ +
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDD-------KM 173
Query: 517 CDVYSFGVVLLEILTG 532
D +S G V+ E L G
Sbjct: 174 SDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 66/254 (25%), Positives = 104/254 (40%), Gaps = 32/254 (12%)
Query: 360 VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416
V VK +++ E+LR V+ L H IV + C G + L LV + P G L
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLK 84
Query: 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACI 476
L R +PV + +LA A G+A+L H H L++ N+++ A I
Sbjct: 85 YLKKRR---EIPV--SDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKI 136
Query: 477 SDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
SD G+ + +D Y A LK+ + KF + DV+S+GV L E +
Sbjct: 137 SDFGMSRALGAG---SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
Query: 532 GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKD 591
G G +K +++ ES + + EE + + + L C P+D
Sbjct: 194 ----YGAKPYGEMKGAEVIAMLESGER-------LPRP-EECPQEIYSIMLSCWKYRPED 241
Query: 592 RPNMSIVHRMIEDI 605
RP S +
Sbjct: 242 RPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 341 LGKGCVGATYKVVL--DGGDV---VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSI 392
LG G G YK V +G V V +K +RE + E L V+ + H ++V +
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGP--GRMPVDWNKRLKLASDSAKGLAFLHG 450
C ++ L+ +P G L + + + ++W ++ AKG+++L
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL-- 125
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE----LKFNNNN 506
+ L H L++ N++V + I+D G+ +L Y+A +K+
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD---EKEYHAEGGKVPIKWMALE 181
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILT 531
+ R + + DV+S+GV + E++T
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 47/206 (22%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRA 394
+G+G G YK G++V +K+I+ R K + E ++++ L H NI+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE-IKLLKELNHPNIIKLLD 65
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK-LASDSAKGLAFLHGYNK 453
K +L+LV++++ + RG +P +K +GLAF H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRG---LP---ESLIKSYLYQLLQGLAFCH---S 116
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQLF------HTPFFINDAYNAPELKFNNNNN 507
+ H L N++++ G ++D G+ + F +T + + Y APEL +
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD--- 173
Query: 508 YSQRKFWQRCDVYSFGVVLLEILTGK 533
+ + D++S G + E+L+ +
Sbjct: 174 ---KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 360 VVVKRIRERKKKRE-VDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLL 418
V +K I E E E +V+ L H +V + C + L++V +++ +G L + L
Sbjct: 31 VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL 90
Query: 419 HGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478
+G + L + D +G+ +L + H L++ N +V G +SD
Sbjct: 91 RQRQGKLSKDM----LLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSD 143
Query: 479 IGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-G 532
G+ T + ++D Y + +K++ ++ K+ + DV+SFGV++ E+ T G
Sbjct: 144 FGM-----TRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198
Query: 533 KM 534
KM
Sbjct: 199 KM 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 64/288 (22%), Positives = 124/288 (43%), Gaps = 41/288 (14%)
Query: 339 ELLGKGCVGATYKVVLDGGDV----VVVKRIR-ERKKKREVDEWLR---VIGGLRHSNIV 390
++LG+G G+ + L D V VK ++ + E++E+L + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 391 SIRAYC------NGKDELFLVYDYLPHGSLHSLLHGSR---GPGRMPVDWNKRLKLASDS 441
+ C + ++ ++ HG LHS L SR P ++P+ LK D
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDI 122
Query: 442 AKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDAYNAPEL 500
A G+ +L N H L++ N ++ + C++D G+ +++ ++ +
Sbjct: 123 ALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560
K+ + + R + + DV++FGV + EI T G V+ E++
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-------VENH-------EIY 225
Query: 561 DFELIMD---KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
D+ L K+ E+ + L + C PKDRP + + ++E+I
Sbjct: 226 DY-LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 38/212 (17%)
Query: 339 ELLGKGCVGATYKV-VLDGGDVVVVKRIRER------KKK--REVDEWLRVIGGLRHSNI 389
++G+G G K G++V +K+ +E KK REV +V+ LRH NI
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREV----KVLRQLRHENI 62
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAKGLAF 447
V+++ K L+LV++Y+ +L LL PG +P D + +L + +A+
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYIWQL----LQAIAY 115
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-------TPFFINDAYNAPEL 500
H +N + H + NI+V + G + D G + T + Y APEL
Sbjct: 116 CHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
+ N + + DV++ G ++ E+L G
Sbjct: 173 LVGDTN------YGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 39/214 (18%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIR----ERKKKREVDEWLRVIGGLRHSNIVSIRAY 395
+G G G Y V LD G+++ VK IR + K +E+ + ++V+ L+H N+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRG-PGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
++++++ +Y G+L LL R + + +L +GLA+LH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL------LEGLAYLH---SH 118
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIG---------------VHQLFHTPFFINDAYNAPE 499
+ H + +NI +D G + D G V L TP AY APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP-----AYMAPE 173
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ R D++S G V+LE+ TGK
Sbjct: 174 VITGGKGKGHGRA----ADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 357 GDVVVVKRIRERKKKREVDEWLRVIGGLR---HSNIVSIRAYCN--GKDELFLVYDYLPH 411
G+ V VK ++ + + + I LR H NIV + C G + + L+ ++LP
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL 471
GSL L ++ ++ ++LK A KG+ +L H L++ N++V+
Sbjct: 93 GSLKEYLPRNKNK----INLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 145
Query: 472 GNACISDIGVHQLFHTP---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLE 528
I D G+ + T + + D ++P + Q KF+ DV+SFGV L E
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC-LIQSKFYIASDVWSFGVTLYE 204
Query: 529 ILT 531
+LT
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 38/276 (13%)
Query: 339 ELLGKGCVGATYKVVLDGGDV-VVVKRIRERKKKREVDEWL---RVIGGLRHSNIVSIRA 394
E +G+G G + L + V VK RE ++L R++ H NIV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
C K +++V + + G + L + GP R+ V + +++ ++A G+ +L
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR-TEGP-RLKV--KELIQMVENAAAGMEYLE---SK 113
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFF--------INDAYNAPELKFNNNN 506
H H L++ N +V + ISD G+ + + I + APE N
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NYG 171
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566
YS DV+SFG++L E + LG V + + Q L
Sbjct: 172 RYSSES-----DVWSFGILLWEAFS---------LGAVPYANLSNQQTREAIEQGVRLPC 217
Query: 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602
+ + + L++ C P RP+ S VH+ +
Sbjct: 218 PELCPDAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 68/299 (22%), Positives = 111/299 (37%), Gaps = 64/299 (21%)
Query: 339 ELLGKGCVGATYK----VVLDGGD--VVVVKRIRE---RKKKREVDEWLRVIGGLRHSNI 389
LG+G G + + D +V VK ++E +++ + ++ +H NI
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR----------LKLAS 439
V C D +V++Y+ HG L+ L S GP + L++A
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 440 DSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN--- 496
A G+ +L H H L++ N +V I D G+ + +T D Y
Sbjct: 130 QIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT----TDYYRVGG 182
Query: 497 ---------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKW 546
PE + RKF DV+SFGVVL EI T GK W
Sbjct: 183 HTMLPIRWMPPE-------SIMYRKFTTESDVWSFGVVLWEIFTYGKQP----------W 225
Query: 547 VQMMGQDESAWEVFDF--ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603
+ S EV + + + + + + L C P+ R N+ +H ++
Sbjct: 226 YGL-----SNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 4e-09
Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 44/241 (18%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKK--------REVDEWLRVIGGLRHSNI 389
E LG+G G YK G++V +K+IR ++ RE+ ++ L+H NI
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREI----SLLKELKHPNI 60
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK---LASDSAKGLA 446
V + + + +L+LV++Y L L GP + + K + L +GLA
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQLL-----RGLA 112
Query: 447 FLHGYNKAH-LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF--FINDA----YNAPE 499
+ H +H + H L NI++++ G ++D G+ + F P + ++ Y APE
Sbjct: 113 YCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPE 168
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMGQ-DESA 556
+ + +YS D++S G + E++TGK + GD E+ + K Q++G E +
Sbjct: 169 ILL-GSKHYS-----TAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 557 W 557
W
Sbjct: 223 W 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 8/137 (5%)
Query: 75 LEDLDLTGPAEV------LSRLTQLRLLSLKNN-LLSSSNLNLSSWPHLKHLYLSHNRFT 127
L+ LDL G V L+ LT L L+L +N L+ L LK +YL +N +
Sbjct: 166 LKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
G P + L L +DL +N G IP + L L NL L L N+ +G + S +
Sbjct: 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIP-SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284
Query: 188 SILDFNVSNNQLSGQIP 204
++ ++S+N LSG+IP
Sbjct: 285 KLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 59/278 (21%)
Query: 340 LLGKGCVGATYKVV-LDGGDVVVVKRIRER---KKKRE--VDEWLRVIGGLRHSNIVSIR 393
LGKG G+ YKV L +K + +K+RE V+E +R++ + H NI+S +
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNE-IRILASVNHPNIISYK 65
Query: 394 -AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGR-MPVD--WNKRLKLASDSAKGLAFLH 449
A+ +G ++L +V +Y P G L + + + +P W ++L +GL LH
Sbjct: 66 EAFLDG-NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQALH 120
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---------TPFFINDAYNAPEL 500
+ H L S+NI++ I D+G+ ++ TP Y APE+
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH-----YMAPEV 172
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM---AKGDGELGIVKWVQMMGQDESAW 557
+ R + + D++S G +L E+ T A+ +L ++ G+
Sbjct: 173 -------WKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYKVQRGKYPPIP 222
Query: 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595
++ +L L PK RPN
Sbjct: 223 PIYSQDLQ-------------NFIRSMLQVKPKLRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 339 ELLGKGCVGATYKVVL-----DGGDVVVVKRIRERKKKREVDEW----LRVIGGLRHSNI 389
L+G+G +Y +V+ + G +V +K+ E + + V + +R++ LRH N+
Sbjct: 7 GLVGEG----SYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
V++ K L+LV++++ H L L G +D ++ K +G+ F H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCH 117
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------FFINDAYNAPELKFN 503
+N + H + NI+V Q G + D G + P + Y APEL
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
+ K+ + D+++ G ++ E+LTG
Sbjct: 175 DT------KYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 26/204 (12%)
Query: 341 LGKGCVGATYK-VVLDGGDVVVVKRIRERKKKREV-DEWLRVIGGLR---HSNIVSIRAY 395
+G+G G +K + G+ V +K++ R+ + + ++ LR I L+ H +V +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
LV +Y+P L +L P +P K KG+A++H
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERP--LPEAQVKSYMRML--LKGVAYMHANG--- 119
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLF-------HTPFFINDAYNAPELKFNNNNNY 508
+ H L +N+++ G I+D G+ +LF ++ Y APEL Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL------Y 173
Query: 509 SQRKFWQRCDVYSFGVVLLEILTG 532
RK+ D+++ G + E+L G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 51/228 (22%)
Query: 339 ELLGKGCVGATYKVVLDGGD------VVVVKRIRERKKKREVD------EWLRVIGGLRH 386
+ LG+G G K G D V VK +++ ++++ E +++IG +H
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KH 75
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGR-----MPVDWNKRLKL---- 437
NI+++ C + L++V +Y HG+L L R PG P + L
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 438 --ASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAY 495
A A+G+ FL H L++ N++V + I+D G+ + H D Y
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH----IDYY 188
Query: 496 N------------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
APE F+ R + + DV+SFGV+L EI T
Sbjct: 189 RKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 341 LGKGCVGATYKV--VLDGGDVVVVK---RIRERKKKREVDEWLRVIGGLRHSNIVSIRAY 395
+GKG G V DG V+ K R R++++ ++ +++ L+H NIV+ R
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 396 CNGKD-ELFLVYDYLPHGSLHSLLHGSRG---PGRMPVDWNKRLKLASDSAKGLAFLHGY 451
G+D L++V + G L+ L +G P V+W ++ +A L +LH
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH-- 119
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ-----------LFHTPFFINDAYNAPEL 500
+ H+ H L + N+ + + + D+G+ + L TP+ Y +PEL
Sbjct: 120 -EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-----YMSPEL 173
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA 535
N NY + DV++ G + E+ T K A
Sbjct: 174 FSNKPYNY-------KSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 43/213 (20%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCN 397
E LG+G G+ YK + + G VV +K + + +E+ + + ++ IV
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK------LASDSAKGLAFLHGY 451
+L++V +Y GS+ ++ + NK L + + KGL +LH
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKIT----------NKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVH-QLFH----------TPFFINDAYNAPEL 500
K H + + NI++++ G A ++D GV QL TPF++ APE+
Sbjct: 119 KKIHR---DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWM-----APEV 170
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
N + D++S G+ +E+ GK
Sbjct: 171 IQEIGYNN-------KADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-08
Identities = 22/42 (52%), Positives = 29/42 (69%), Gaps = 4/42 (9%)
Query: 25 SDISTLLSFKASVTG-SSDSLSSWV-NSTDPCFDSWRGVTCN 64
D LL+FK+S+ G S +LSSW +S+DPC SW GVTC+
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 59/271 (21%), Positives = 120/271 (44%), Gaps = 32/271 (11%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVD-EWLRVIGGLRHSNIVSIRAYCNGK 399
LG+GC G + +G V +K ++ E + +++ LRH +V + A + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-E 72
Query: 400 DELFLVYDYLPHGSLHSLLHGSRGPG-RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFH 458
+ +++V +++ GSL L G ++P + + +A+ A G+A++ N H
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLP----QLVDMAAQIADGMAYIERMN---YIH 125
Query: 459 GHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQRKF 513
L ++NI+V I+D G+ +L ++ Y A + +K+ +F
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIE-----DNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 514 WQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEE 573
+ DV+SFG++L E++T G V + M+ ++ + + + E
Sbjct: 181 TIKSDVWSFGILLTELVTK---------GRVPYPGMVNREVLEQVERGYRMPCPQGCPES 231
Query: 574 MRALLQVALLCLAPLPKDRPNMSIVHRMIED 604
+ L++ LC P +RP + +ED
Sbjct: 232 LHELMK---LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 35/208 (16%)
Query: 341 LGKGCVGATYKVVLDG-GDVVVVKRIR----ERKKKREVDEWLRVIGGLRHSNIVSIRAY 395
LG G G KV+ G ++ VK IR E +K+ + E L ++ IV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRE-LDILHKCNSPYIVGFYGA 67
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
++ + +Y+ GSL +L GR+P ++ +A KGL +LH K
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAV--LKGLTYLH--EKHK 121
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVH-QLFHTPFFIND---------AYNAPELKFNNN 505
+ H + SNI+V+ G + D GV QL +N +Y APE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERI--QG 173
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGK 533
N+YS + D++S G+ L+E+ TG+
Sbjct: 174 NDYSVKS-----DIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 341 LGKGCVGATYK-VVLDGGDVVVVKRIR--ERKKKREVDEWLRVIGGLRHSNIVSIRAYCN 397
+G G G YK + G++V +K I+ + + + ++ RH NIV+
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLA---SDSAKGLAFLHGYNKA 454
+D+L++V +Y GSL + +RGP L++A ++ KGLA+LH K
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGP-------LSELQIAYVCRETLKGLAYLHETGK- 122
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVH-QLFHT----PFFINDAY-NAPELKFNNNNNY 508
H + +NI++ + G+ ++D GV QL T FI Y APE+
Sbjct: 123 --IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG- 179
Query: 509 SQRKFWQRCDVYSFGVVLLE 528
+ +CD+++ G+ +E
Sbjct: 180 ---GYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 41/220 (18%)
Query: 340 LLGKGCVGATYKVVL-------DGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNI 389
LG G G Y+ G V VK +R+ +E E+L+ ++ H NI
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSR-----GPGRMPVDWNKRLKLASDSAKG 444
V + C + +++ + + G L S L +R P + L + D AKG
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL---LDICLDVAKG 118
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC-----ISDIGVHQ-LFHTPFF-------I 491
+L + H H L++ N +V + G I D G+ + ++ + ++ +
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 492 NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
+ APE + KF + DV+SFGV++ EILT
Sbjct: 176 PVRWMAPE-------SLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 60/284 (21%), Positives = 126/284 (44%), Gaps = 38/284 (13%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERK----KKREVDEWLRVIGGLR---HSNIVSIR 393
LG+G G+ + L+ D ++ ++ K + E++++L ++ H N++ +
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 394 AYC--NGKDELF----LVYDYLPHGSLHSLLHGSR---GPGRMPVDWNKRLKLASDSAKG 444
C + E + ++ ++ HG LHS L SR P +P +K +D A G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIASG 124
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDAYNAPELKFN 503
+ +L + H L++ N ++++ N C++D G+ ++++ ++ +K+
Sbjct: 125 MEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563
+ + R + + DV+SFGV + EI T +G G + S E++D+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIAT----RGQ--------TPYPGVENS--EIYDYL 227
Query: 564 LIMD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ K+ + + L + C PKDRP+ + +E
Sbjct: 228 RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 63/281 (22%), Positives = 123/281 (43%), Gaps = 48/281 (17%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWL---RVIGGLRHSNIVSIRAY 395
+ LG G G + +G V +K +++ + +L ++ L+H +V + A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
++ ++++ +Y+ +GSL L G ++ + NK + +A+ A+G+AF+ N
Sbjct: 70 VT-QEPIYIITEYMENGSLVDFLKTPEGI-KLTI--NKLIDMAAQIAEGMAFIERKN--- 122
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQ 510
H L ++NI+V + I+D G+ +L ++ Y A E +K+ +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIE-----DNEYTAREGAKFPIKWTAPEAINY 177
Query: 511 RKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEM 570
F + DV+SFG++L EI+T G + + M E+I + E
Sbjct: 178 GTFTIKSDVWSFGILLTEIVT---------YGRIPYPGMTNP----------EVIQNLER 218
Query: 571 EEEM-------RALLQVALLCLAPLPKDRPNMSIVHRMIED 604
M L ++ LC P++RP + ++ED
Sbjct: 219 GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 32/203 (15%)
Query: 339 ELLGKGCVGATYKVVLDG---GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAY 395
E++G+G GA VL G G V VK I+ + E V+ L H N+V +
Sbjct: 12 EIIGEGEFGA----VLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 396 C--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
NG L++V + + G+L + L R GR V + L+ + D A+G+ +L
Sbjct: 68 ILHNG---LYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLE---S 118
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA-----YNAPELKFNNNNNY 508
L H L++ NI+V + G A +SD G+ ++ ++++ + APE +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKWTAPEALKHK---- 172
Query: 509 SQRKFWQRCDVYSFGVVLLEILT 531
KF + DV+S+GV+L E+ +
Sbjct: 173 ---KFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 45/224 (20%)
Query: 341 LGKGCVGATYKVVLDGGD--------VVVVKRIRERKKKREVD------EWLRVIGGLRH 386
LG+GC G G D V VK +++ +++ E +++IG +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG--KH 77
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPG--------RMP---VDWNKRL 435
NI+++ C L+++ +Y G+L L R PG ++P + + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 436 KLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAY 495
A A+G+ +L H L++ N++V + I+D G+ + H +
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 496 N--------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
N APE F+ R + + DV+SFGV+L EI T
Sbjct: 195 NGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 58/244 (23%), Positives = 108/244 (44%), Gaps = 49/244 (20%)
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSL------------HSLLHGSR-----GPGRMP 428
H NIV + C + L+++Y+ +G L SL H + G +P
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 429 VDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHT 487
+ ++L +A A G+A+L ++ H L++ N +V + I+D G+ ++
Sbjct: 127 LSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 488 PFFI---NDA----YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE 540
++ NDA + PE F N ++ DV+++GVVL EI + M G
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYN-------RYTTESDVWAYGVVLWEIFSYGMQPYYG- 235
Query: 541 LGIVKWVQMMGQDESAWEVFDFELIMDKE-MEEEMRALLQVALLCLAPLPKDRPNMSIVH 599
M +E + V D ++ + E+ L++ LC + LP DRP+ + ++
Sbjct: 236 ---------MAHEEVIYYVRDGNVLSCPDNCPLELYNLMR---LCWSKLPSDRPSFASIN 283
Query: 600 RMIE 603
R+++
Sbjct: 284 RILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 45/224 (20%)
Query: 341 LGKGCVGATYKVVLDGGD--------VVVVKRIRERKKKREVD------EWLRVIGGLRH 386
LG+GC G G D V VK +++ ++++ E +++IG +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KH 80
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPG--------RMPVDWNKRLKLA 438
NI+++ C L+++ +Y G+L L R PG R+P + L
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 439 SDS---AKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAY 495
S + A+G+ +L H L++ N++V + I+D G+ + + +
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 496 N--------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
N APE F+ R + + DV+SFGV++ EI T
Sbjct: 198 NGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 46/217 (21%)
Query: 341 LGKGCVGATYKVVL----DGGDVVVVKRIR-ERKKKREVDEWLR---VIGGLRHSNIVSI 392
+G+G G K +L + G V+K I + +E +E + V+ ++H NIV
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRG---PGRMPVDWNKRLKLASDSAKGLAFLH 449
+ L++V DY G L+ ++ RG P +DW ++ LA L +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH 118
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-----------TPFFINDAYNAP 498
+ H + S NI + + G + D G+ ++ + TP+++ +P
Sbjct: 119 ---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL-----SP 170
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA 535
E+ N R + + D+++ G VL E+ T K A
Sbjct: 171 EICEN-------RPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 29/234 (12%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREV-DEWLRVIGGLR---HSNIVSIR 393
E +G+G G YK G+VV +K+IR + V +R I L+ H NIV +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPG-RMPVDWNKRLKLASDSAKGLAFLHGYN 452
+ +++L+LV+++L H L + S G +P+ + +L GLAF H +
Sbjct: 66 DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQ----GLAFCHSH- 119
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------FINDAYNAPELKFNNNN 506
+ H L N++++ G ++D G+ + F P + Y APE+
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC-- 175
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMGQ-DESAW 557
+ + D++S G + E++T + + GD E+ + + + +G DE W
Sbjct: 176 ----KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 56/234 (23%), Positives = 101/234 (43%), Gaps = 55/234 (23%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRERKKK--------REVDEWLRVIGGLRHSNIVS 391
+G+G G YK D G++V +K++R +K RE+ +++ L H NIV+
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREI----KILRQLNHRNIVN 70
Query: 392 IRAYCNGKDE----------LFLVYDYLPH---GSLHSLLHGSRGPGRMPVDWNKR--LK 436
++ K + +LV++Y+ H G L S L V +++
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL----------VHFSEDHIKS 120
Query: 437 LASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-------TPF 489
+GL + H K + H + SNI+++ G ++D G+ +L++ T
Sbjct: 121 FMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG 542
I Y PEL + ++ DV+S G +L E+ T K + + + EL
Sbjct: 178 VITLWYRPPELLL------GEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 3/138 (2%)
Query: 69 RVIKLVLEDLDLTGP-AEVLSRLTQLRLLSL-KNNLLSSSNLNLSSWPHLKHLYLSHNRF 126
++I L L D L+G E++ +L L +L L NN + L+S P L+ L L N+F
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 127 TGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSS 186
+G P + +L +DLS N GEIP L NL L L N G + +
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG-LCSSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 187 RSILDFNVSNNQLSGQIP 204
RS+ + +N SG++P
Sbjct: 404 RSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 33/189 (17%)
Query: 360 VVVKRIRE-RKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLL 418
V +K I+E + E E +V+ L H +V + C + +++V +Y+ +G L + L
Sbjct: 31 VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL 90
Query: 419 HGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478
G P + L++ D +G+A+L H L++ N +VD G +SD
Sbjct: 91 R-EHGKRFQPS---QLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSD 143
Query: 479 IGVHQLFHTPFFINDAY------------NAPELKFNNNNNYSQRKFWQRCDVYSFGVVL 526
G+ + + ++D Y + PE+ YS KF + DV++FGV++
Sbjct: 144 FGL-----SRYVLDDEYTSSVGSKFPVRWSPPEVLL-----YS--KFSSKSDVWAFGVLM 191
Query: 527 LEILT-GKM 534
E+ + GKM
Sbjct: 192 WEVYSLGKM 200
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 45/224 (20%)
Query: 341 LGKGCVGATYKVVLDGGD--------VVVVKRIRERKKKREVD------EWLRVIGGLRH 386
LG+GC G + G D V VK +++ +++ E +++IG +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG--KH 77
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPG-----------RMPVDWNKRL 435
NI+++ C + L+++ +Y G+L L R PG + + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 436 KLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAY 495
A A+G+ +L H L++ N++V + I+D G+ + H +
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 496 N--------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
N APE F+ R + + DV+SFG+++ EI T
Sbjct: 195 NGRLPVKWMAPEALFD-------RVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 47/295 (15%)
Query: 339 ELLGKGCVGATYKVVL--DGGDV-VVVKRIRERKKK---REVDEWLRVIGGL-RHSNIVS 391
+++G+G G K + DG + +KR++E K R+ L V+ L H NI++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMP-----------VDWNKRLKLASD 440
+ C + L+L +Y PHG+L L SR P + + L A+D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 441 SAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPEL 500
A+G+ +L ++ H L++ NI+V + A I+D G+ + ++ +
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 187
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQD--ESAWE 558
++ + + + DV+S+GV+L EI++ LG + M + E +
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LGGTPYCGMTCAELYEKLPQ 238
Query: 559 VFDFE--LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIV----HRMIEDIRT 607
+ E L D E+ + MR C P +RP+ + + +RM+E+ +T
Sbjct: 239 GYRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQILVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 339 ELLGKGCVGATYKVVL--DG----GDVVVVKRIRERKKKREVDEWLRVIGGL-RHSNIVS 391
+++G+G G K + DG + +K + R+ L V+ L H NI++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMP-----------VDWNKRLKLASD 440
+ C + L+L +Y PHG+L L SR P + + L A+D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 441 SAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPEL 500
A+G+ +L ++ H L++ NI+V + A I+D G+ + ++ +
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
++ + + + DV+S+GV+L EI++
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 57/277 (20%), Positives = 120/277 (43%), Gaps = 44/277 (15%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERKKKRE--VDEWLRVIGGLRHSNIVSIRAYCNG 398
LG G G + + V VK ++ E + E V+ L+H +V + A
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAE-ANVMKTLQHDKLVKLHAVVT- 71
Query: 399 KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFH 458
K+ ++++ +++ GSL L G + P+ K + ++ A+G+AF+ + + H
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEG-SKQPLP--KLIDFSAQIAEGMAFIE---QRNYIH 125
Query: 459 GHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQRKF 513
L ++NI+V I+D G+ ++ ++ Y A E +K+ + F
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIE-----DNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 514 WQRCDVYSFGVVLLEILT-GK-----MAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567
+ DV+SFG++L+EI+T G+ M+ + + + +M + E+++
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN------ 234
Query: 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604
+ + C P++RP + +++D
Sbjct: 235 ------------IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 58/289 (20%), Positives = 108/289 (37%), Gaps = 65/289 (22%)
Query: 340 LLGKGCVGATYKVVLDGGD------VVVVKRIRERKK-------KREVDEWLRVIGGLRH 386
LG+G G + G + +V+VK +++ K +RE+D + + L H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK----LSH 67
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRM----PVDWNKRLKLASDSA 442
N+V + C + +++ +Y G L L ++ P+ +++ L + A
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 443 KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKF 502
G+ L A H L++ N +V +S D YN+ K
Sbjct: 128 LGMDHLS---NARFVHRDLAARNCLVSSQREVKVS---------LLSLSKDVYNSEYYKL 175
Query: 503 NN--------------NNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWV 547
N +++S + DV+SFGV++ E+ T G++ L + +
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKS-----DVWSFGVLMWEVFTQGELPFYG--LSDEEVL 228
Query: 548 QMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ + V + + L+ C A PKDRP+ S
Sbjct: 229 NRLQAGKLELPVPE-------GCPSRLYKLMTR---CWAVNPKDRPSFS 267
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 24/200 (12%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERKKKRE--VDEWLRVIGGLRHSNIVSIRAYCNG 398
LG G G + +G V VK ++ E ++E +++ LRH +V + A +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEE-AQIMKKLRHDKLVQLYAVVS- 71
Query: 399 KDELFLVYDYLPHGSLHSLLHGSRGPG-RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457
++ +++V +Y+ GSL L G ++P + +A+ A G+A++ N
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLP----NLVDMAAQVAAGMAYIERMN---YI 124
Query: 458 HGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQR 511
H L S+NI+V G C I+D G+ +L ++ Y A + +K+
Sbjct: 125 HRDLRSANILVGD-GLVCKIADFGLARLIE-----DNEYTARQGAKFPIKWTAPEAALYG 178
Query: 512 KFWQRCDVYSFGVVLLEILT 531
+F + DV+SFG++L E++T
Sbjct: 179 RFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 46/201 (22%)
Query: 357 GDVVVVKRIRERKKKRE--VDEWL--RVIGGLRHSNIVSIRAYCN--GKDELFLVYDYLP 410
GD+ +K I++ R+ VD+ L R I S V ++ Y + GK L+LV +YLP
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV-VKLYYSFQGKKNLYLVMEYLP 76
Query: 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ 470
G L SLL G + D + ++ L +LH + H L NI++D
Sbjct: 77 GGDLASLLENV---GSLDEDVAR--IYIAEIVLALEYLHSNG---IIHRDLKPDNILIDS 128
Query: 471 LGNACISDIGV-------------------HQLFHTPFFINDAYNAPELKFNNNNNYSQR 511
G+ ++D G+ ++ TP +I APE+ ++ +
Sbjct: 129 NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI-----APEVILGQGHSKT-- 181
Query: 512 KFWQRCDVYSFGVVLLEILTG 532
D +S G +L E L G
Sbjct: 182 -----VDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 66/287 (22%), Positives = 110/287 (38%), Gaps = 58/287 (20%)
Query: 340 LLGKGCVGATYKVVLDGGDV-----VVVKRIRERKKKREVD---EWLRVIGGLRHSNIVS 391
+LGKG TY +V D+ + +K I ER R V E + + L+H NIV
Sbjct: 15 VLGKG----TYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQ 69
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ + + +P GSL +LL GP + + + +GL +LH
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLH-- 125
Query: 452 NKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFH-----TPFFIND-AYNAPELKFNN 504
+ H + N++V+ ISD G + T F Y APE+
Sbjct: 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI--- 181
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564
+ R + D++S G ++E+ TGK +G+ ++A F++
Sbjct: 182 --DKGPRGYGAPADIWSLGCTIVEMATGKPP-----------FIELGEPQAAM----FKV 224
Query: 565 IMDK-------EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604
M K + E + + L C P P R H +++D
Sbjct: 225 GMFKIHPEIPESLSAEAKNFI---LRCFEPDPDKRA---SAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 45/224 (20%)
Query: 341 LGKGCVGATYKVVLDGGDV--------VVVKRIRERKKKREVD------EWLRVIGGLRH 386
LG+GC G G D V VK ++ ++++ E +++IG +H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG--KH 83
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPG--------RMPVD---WNKRL 435
NI+++ C L+++ +Y G+L L R PG ++P + + +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 436 KLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAY 495
A A+G+ +L H L++ N++V + I+D G+ + H +
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 496 N--------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
N APE F+ R + + DV+SFGV+L EI T
Sbjct: 201 NGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 67/284 (23%), Positives = 118/284 (41%), Gaps = 35/284 (12%)
Query: 341 LGKGCVGATYK-----VVLDGGDV-VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
LG+G G Y+ ++ + V VK + E RE E+L V+ G ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSR-----GPGRMPVDWNKRLKLASDSAKGLA 446
+ + +V + + HG L S L R PGR P + +++A++ A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDAYNAPELKFNNN 505
+L N H L++ N +V I D G+ ++ T ++ +++
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEI--LTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563
+ F D++SFGVVL EI L + +G ++K+V G
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY----------- 239
Query: 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPN-MSIVHRMIEDIR 606
L E + L++ +C PK RP + IV+ + +D+
Sbjct: 240 LDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLKDDLH 280
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 37/238 (15%)
Query: 339 ELLGKGCVGATYKVVLDG-----GDVVVVKRIRERKKKREVDEWLRVIG---GLRHSNIV 390
E LG+G TY V G G++V +K I ++ +R I L+H NIV
Sbjct: 6 EKLGEG----TYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLL--HGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
+ + +++L LV++Y+ L + HG RG +D N KG+AF
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRG----ALDPNTVKSFTYQLLKGIAFC 116
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF--FINDA----YNAPELKF 502
H + + H L N+++++ G ++D G+ + F P F N+ Y AP++
Sbjct: 117 H---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGK--MAKGDGELGIVKWVQMMGQ-DESAW 557
+ R + D++S G ++ E++TG+ + E ++K ++MG ES W
Sbjct: 174 GS------RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 40/120 (33%), Positives = 58/120 (48%), Gaps = 2/120 (1%)
Query: 90 LTQLRLLSLKNNLLSSSNLNL-SSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148
L +L L L +N LS L +L+ L+L N FTG P ++SL L+ + L N
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208
+ GEIP L + NL L L N TG + SS ++ + +N L G+IP +
Sbjct: 343 KFSGEIP-KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401
|
Length = 968 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 47/201 (23%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 384 LRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK 443
L+H +V + A ++ ++++ +Y+ GSL L G G++ + K + ++ A+
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG-GKVLLP--KLIDFSAQIAE 114
Query: 444 GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE---- 499
G+A++ + + H L ++N++V + I+D G+ ++ ++ Y A E
Sbjct: 115 GMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-----DNEYTAREGAKF 166
Query: 500 -LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GK-----MAKGDGELGIVKWVQMMGQ 552
+K+ + F + DV+SFG++L EI+T GK M+ D + + +M
Sbjct: 167 PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM 226
Query: 553 DESAWEVFDFELIMDKEMEEE 573
+ E++D KE EE
Sbjct: 227 ENCPDELYDIMKTCWKEKAEE 247
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 41/278 (14%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERKKKREV-DEWLRVIGGLRHSN---IVSIRAYC 396
LG G G+ KV V+ K++ K V + LR + + IVS
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
++ + + +++ GSL + + G +PV+ K+A +GL +L YN +
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILG--KIAVAVVEGLTYL--YNVHRI 125
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVH-QLFHT---PFFINDAYNAPELKFNNNNNYSQRK 512
H + SNI+V+ G + D GV +L ++ F Y +PE Y+ +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERI--QGGKYTVKS 183
Query: 513 FWQRCDVYSFGVVLLEILTGK----MAKGD-----GELGIVKWVQMMGQDESAWEVFDFE 563
DV+S G+ ++E+ GK + D +GI+ +Q + Q+
Sbjct: 184 -----DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------R 232
Query: 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601
L E++R + CL P +RP + M
Sbjct: 233 LPSSD-FPEDLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 64/299 (21%), Positives = 118/299 (39%), Gaps = 48/299 (16%)
Query: 341 LGKGCVGATYKVV------LDGGDVVVVKRIRERKKKREVDEWL---RVIGGLRHSNIVS 391
LG+G G K G V VK ++E E+ + L ++ + H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSR-------------------GPGRMPVDWN 432
+ C+ L L+ +Y +GSL S L SR P +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 433 KRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ-LFHTPFFI 491
+ A ++G+ +L + L H L++ N++V + ISD G+ + ++ ++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 492 NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG 551
+ +K+ + + + DV+SFGV+L EI+T G+ GI
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---LGGNPYPGIAP------ 235
Query: 552 QDESAWEVFDFELIMDK--EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608
E + + M++ EEM L+ L C P RP + + + +E + K
Sbjct: 236 --ERLFNLLKTGYRMERPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 339 ELLGKGCVGATYKVVL-----DGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
E LG+ G YK L D +V +K +++ ++ E+ + ++ L H NIV
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLL------------HGSRGPGRMPVDWNKRLKLA 438
+ + + ++++YL G LH L G + +D L +A
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 439 SDSAKGLAFLHGYNKAHLF-HGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDAYN 496
A G+ +L +H F H L++ NI++ + + ISD+G+ +++ ++ +
Sbjct: 131 IQIAAGMEYL----SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
+++ KF D++SFGVVL EI +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 47/211 (22%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 339 ELLGKGCVGATYKVVL--DGGDV-VVVKRIRE---RKKKREVDEWLRVIGGL-RHSNIVS 391
+++G+G G + ++ DG + +K ++E R+ L V+ L H NI++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMP-----------VDWNKRLKLASD 440
+ C + L++ +Y P+G+L L SR P + + L+ ASD
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 441 SAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPEL 500
A G+ +L ++ H L++ N++V + + I+D G+ + ++ +
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPV 182
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
++ + + + + DV+SFGV+L EI++
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 341 LGKGCVGATYK-----VVLDGGDV-VVVKRIRERKKKREVDEWLRVIGGLRHSN---IVS 391
LG+G G Y+ VV D + V +K + E RE E+L ++ N +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSR-----GPGRMPVDWNKRLKLASDSAKGLA 446
+ + ++ + + G L S L R P + P K +++A + A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDAYNAPELKFNNN 505
+L N H L++ N +V + I D G+ ++ T ++ +++ +
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILT 531
+ F DV+SFGVVL EI T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 339 ELLGKGCVGATYK-VVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
EL+G+G GA Y+ + G VV +K I +V + R ++ LR S +I
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 395 Y--CNGKD-ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
Y K L+++ +Y GS+ +L+ P+ + + L ++H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH-- 118
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-----------TPFFINDAYNAPEL 500
K + H + ++NI+V GN + D GV L + TP+++ APE+
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWM-----APEV 172
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
+ + + D++S G+ + E+ TG
Sbjct: 173 ITEG------KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 40/215 (18%)
Query: 349 TYKVV-----LDGGDVVVVKRIRERKKK--------REVDEWLRVIGGLRHSNIVSIRAY 395
TY VV G++V +K+++ K+K RE++ L+ L+H NIV+++
Sbjct: 17 TYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLK----LQHPNIVTVKEV 72
Query: 396 CNGK--DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
G D++++V +Y+ H L SL+ + P L+L S G+A LH
Sbjct: 73 VVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLS----GVAHLH---D 124
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQLF------HTPFFINDAYNAPELKFNNNNN 507
+ H L +SN++++ G I D G+ + + +T + Y APEL
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL----- 179
Query: 508 YSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGEL 541
+++ D++S G + E+LT K + G E+
Sbjct: 180 -GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 49/239 (20%), Positives = 89/239 (37%), Gaps = 70/239 (29%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEW----------------LRVIGG 383
LG+G G K G +V +K+++ + +V + L+++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 384 LRHSNIVSIRA-YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSA 442
++H NI+ + Y D + LV D + L ++ +++++L
Sbjct: 77 IKHENIMGLVDVYVE-GDFINLVMDIM-ASDLKKVV-------------DRKIRLTESQV 121
Query: 443 K--------GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA 494
K GL LH + H LS +NI ++ G I+D G+ + + P + +
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 495 --------------------YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y APEL K+ D++S G + E+LTGK
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAE------KYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 52/223 (23%), Positives = 109/223 (48%), Gaps = 41/223 (18%)
Query: 329 NVGDLLK--SSAELLGKGCVGATYKVV-LDGGDVVVVKRI---RERKKKREVDEWLRVIG 382
++GD K + E +G+G G + + + G V +K+I ++ KK+ ++E L V+
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEIL-VMK 71
Query: 383 GLRHSNIVS-IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDS 441
L++ NIV+ + ++ G DELF+V +YL GSL ++ +D + + +
Sbjct: 72 ELKNPNIVNFLDSFLVG-DELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCREC 124
Query: 442 AKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFF 490
+ L FLH + H + S N+++ G+ ++D G + TP++
Sbjct: 125 LQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 491 INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ APE+ +++ + + D++S G++ +E++ G+
Sbjct: 182 M-----APEV-------VTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 334 LKSSAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSI 392
L + E +GKG G +K + + VV +K I + + E+++ + I L + +
Sbjct: 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 393 RAYCNG--KD-ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
Y KD +L+++ +YL GS LL PG P+D + + + KGL +LH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PG--PLDETQIATILREILKGLDYLH 118
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH------QLFHTPFFINDAYNAPELKFN 503
K H + ++N+++ + G ++D GV Q+ F + APE+
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV--- 172
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Q + + D++S G+ +E+ G+
Sbjct: 173 ----IKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 63/288 (21%), Positives = 130/288 (45%), Gaps = 41/288 (14%)
Query: 340 LLGKGCVGATYKVVL----DGGDVVVVKRIR-ERKKKREVDEWLRVIGGLR---HSNI-- 389
+LGKG G+ + L V VK ++ + +++E+LR ++ H N+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 390 ---VSIRAYCNGKDEL-FLVYDYLPHGSLHSLLHGSR---GPGRMPVDWNKRLKLASDSA 442
VS+R+ G+ + ++ ++ HG LH+ L SR P +P+ ++ D A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL--QTLVRFMIDIA 123
Query: 443 KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDAYNAPELK 501
G+ +L N H L++ N ++++ C++D G+ +++ ++ + +K
Sbjct: 124 SGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561
+ + + + DV++FGV + EI+T G + + E++ E+++
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT---------RGQTPYAGV----ENS-EIYN 226
Query: 562 FELIMDKEMEEEMRALLQVALL---CLAPLPKDRPNMSIVHRMIEDIR 606
+ LI +++ L V L C +P PK RP+ + +E I
Sbjct: 227 Y-LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 39/188 (20%), Positives = 76/188 (40%), Gaps = 35/188 (18%)
Query: 360 VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416
V +K ++ ++ ++L ++G H NI+ + + ++ +Y+ +GSL
Sbjct: 35 VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94
Query: 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL--HGYNKAHLFHGHLSSSNIVVDQLGNA 474
L + G + + + A G+ +L Y H L++ NI+V+
Sbjct: 95 FLRENDGK----FTVGQLVGMLRGIASGMKYLSEMNY-----VHRDLAARNILVNSNLVC 145
Query: 475 CISDIGVHQLFHTPFFINDAYN-----------APELKFNNNNNYSQRKFWQRCDVYSFG 523
+SD G+ + Y APE + RKF DV+SFG
Sbjct: 146 KVSDFGLSRRLEDS---EATYTTKGGKIPIRWTAPE-------AIAYRKFTSASDVWSFG 195
Query: 524 VVLLEILT 531
+V+ E+++
Sbjct: 196 IVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 44/183 (24%), Positives = 87/183 (47%), Gaps = 13/183 (7%)
Query: 359 VVVVKRIRERKKKREVDEWL---RVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415
+V VK +RE K +++L +++ L+ NI+ + A C D L ++ +Y+ +G L+
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 416 SLL--HGSRGPGRMP----VDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD 469
L H + + ++ + +A+ A G+ +L N H L++ N +V
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVG 164
Query: 470 QLGNACISDIGVHQ-LFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLE 528
+ I+D G+ + L+ ++ +++ + + KF DV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 529 ILT 531
ILT
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 41/228 (17%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDE------WLRVIGGLR---HSN 388
E +G+G G YK + G +V +K+ R E+DE LR I L+ S
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTR-----LEMDEEGIPPTALREISLLQMLSESI 61
Query: 389 IVSIRAYC-------NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDS 441
+ +R NGK L+LV++YL + RGPGR P+
Sbjct: 62 YI-VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGR-PLPAKTIKSFMYQL 119
Query: 442 AKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPF------FINDA 494
KG+A H + + H L N++VD+ I+D+G+ + F P +
Sbjct: 120 LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGEL 541
Y APE+ + +YS D++S G + E+ + + GD EL
Sbjct: 177 YRAPEVLL-GSTHYS-----TPVDIWSVGCIFAEMSRKQPLFPGDSEL 218
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 340 LLGKGCVGATYKVVL--DGGDV---VVVKRIRER---KKKREVDEWLRVIGGLRHSNIVS 391
+LG G G YK + DG +V V +K +RE K +E+ + V+ G+ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 392 IRAYCNGKDELFLVYDYLPHGSL--HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+ C + LV +P+G L + + R + ++W ++ AKG+++L
Sbjct: 74 LLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--PFFINDAYNAPELKFNNNNN 507
+ L H L++ N++V + I+D G+ +L + D P +K+ +
Sbjct: 127 ---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP-IKWMALES 182
Query: 508 YSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539
R+F + DV+S+GV + E++T DG
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 4/116 (3%)
Query: 89 RLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148
L +L L S N+L +L + L+ + L N F+G PS + L + +D+S+N
Sbjct: 381 NLFKLILFS--NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438
Query: 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
+G I + +P+L L L N+F G L S R + + ++S NQ SG +P
Sbjct: 439 NLQGRIN-SRKWDMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVP 492
|
Length = 968 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 43/235 (18%), Positives = 84/235 (35%), Gaps = 62/235 (26%)
Query: 339 ELLGKGCVGATYKVVL-DGGDVVVVKR------IRERKKK---REVDEWLRVIGGLRHSN 388
+++G+G + +K I+E+K K E + R+ G H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG---HPG 63
Query: 389 IVSIRAYCNGKDE--LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK--- 443
I I+ Y +DE L+ V +Y P+G L + K L +
Sbjct: 64 I--IKLYYTFQDEENLYFVLEYAPNGELLQYIR-------------KYGSLDEKCTRFYA 108
Query: 444 -----GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAP 498
L +LH + H L NI++D+ + I+D G ++ ++
Sbjct: 109 AEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN-SSPESNKGD 164
Query: 499 ELKFNNNNNYSQRKF----------------WQRC----DVYSFGVVLLEILTGK 533
++ ++R+F + D+++ G ++ ++LTGK
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 339 ELLGKGCVGATYK--VVLDGGDV---VVVKRIRERKKKRE----VDEWLRVIGGLRHSNI 389
++LG G G YK V +G V V +K + E + +DE L ++ + H ++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-IMASMDHPHL 71
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGP--GRMPVDWNKRLKLASDSAKGLAF 447
V + C + LV +PHG L +H + ++ ++W ++ AKG+ +
Sbjct: 72 VRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMY 124
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAP----ELKFN 503
L + L H L++ N++V + I+D G+ +L YNA +K+
Sbjct: 125 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD---EKEYNADGGKMPIKWM 178
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILT 531
RKF + DV+S+GV + E++T
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 70/290 (24%), Positives = 116/290 (40%), Gaps = 57/290 (19%)
Query: 341 LGKGCVGATYKVVLDG---GDV---VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
LG+G G Y+ + G G+ V +K + E RE E+L V+ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSR-----GPGRMPVDWNKRLKLASDSAKGLA 446
+ + +V + + G L S L R PG P K +++A++ A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ-LFHTPFFINDA-------YNAP 498
+L H L++ N +V + I D G+ + ++ T ++ + AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 499 E-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557
E LK F + DV+SFGVVL E+ T L + Q S
Sbjct: 191 ESLK--------DGVFTTKSDVWSFGVVLWEMAT---------LA-----EQPYQGLSNE 228
Query: 558 EVFDFEL---IMDK--EMEEEMRALLQVALLCLAPLPKDRPNMS-IVHRM 601
EV F + +D +++ L++ +C PK RP IV +
Sbjct: 229 EVLKFVIDGGHLDLPENCPDKLLELMR---MCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 50/211 (23%), Positives = 103/211 (48%), Gaps = 39/211 (18%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRI---RERKKKREVDEWLRVIGGLRHSNIVS-IR 393
E +G+G G Y + + G V +K++ ++ KK+ ++E L V+ +H NIV+ +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL-VMRENKHPNIVNYLD 83
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
+Y G DEL++V +YL GSL ++ + +D + + + + L FLH
Sbjct: 84 SYLVG-DELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHS--- 133
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFINDAYNAPELKF 502
+ H + S NI++ G+ ++D G + TP+++ APE+
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM-----APEV-- 186
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+++ + + D++S G++ +E++ G+
Sbjct: 187 -----VTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 43/194 (22%), Positives = 81/194 (41%), Gaps = 21/194 (10%)
Query: 352 VVLDGGDVVVVKRIRE---RKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408
D +V VK +R + + + ++++ L NI + C L ++ +Y
Sbjct: 41 DNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEY 100
Query: 409 LPHGSL------HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLS 462
+ +G L H + ++ L +A+ A G+ +L N H L+
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLA 157
Query: 463 SSNIVVDQLGNACISDIGVHQLFHTPFFINDAY----NAP-ELKFNNNNNYSQRKFWQRC 517
+ N +V + I+D G+ + + +D Y AP +++ + KF +
Sbjct: 158 TRNCLVGKNYTIKIADFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKS 213
Query: 518 DVYSFGVVLLEILT 531
DV++FGV L EILT
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 53/236 (22%), Positives = 101/236 (42%), Gaps = 33/236 (13%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREV-DEWLRVIG---GLRHSNIVSIR 393
E +G+G G YK G++V +K+IR + V +R I L H NIV +
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 394 AYCNGKDELFLVYDYLPHG---SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ +++L+LV+++L + S P + +G+A+ H
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK-------SYLYQLLQGIAYCHS 117
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------FINDAYNAPELKFNN 504
+ + H L N+++D+ G ++D G+ + F P + Y APE+
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL-- 172
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMGQ-DESAW 557
R++ D++S G + E++ + + GD E+ + + + +G DE W
Sbjct: 173 ----GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 8e-06
Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRI-----RERKKKREVDEWLRVIGGLRHSNIVSI 392
E +GKG G KV G ++V K I E++K++ V E + ++ L+H NIV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSE-VNILRELKHPNIV-- 62
Query: 393 RAYCN-----GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
Y + L++V +Y G L L+ + + ++ ++ + L
Sbjct: 63 -RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYE 120
Query: 448 LH--GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-----------TPFFINDA 494
H + H L +NI +D N + D G+ ++ TP+
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY----- 175
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y +PE N+ +Y ++ D++S G ++ E+
Sbjct: 176 YMSPEQL--NHMSYD-----EKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 61/242 (25%), Positives = 109/242 (45%), Gaps = 44/242 (18%)
Query: 339 ELLGKGCVGATYKVVLDGGD-----VVVVKRIRERKKKREV-DEWLRVIGGL---RHSNI 389
E +G+G TY VV D + +K+IR ++ V +R I L +H NI
Sbjct: 8 EKIGEG----TYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS----DSAKGL 445
V ++ + + L+LV++YL L H P D+ K +L +G+
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSP-----DFAKNPRLIKTYLYQILRGI 115
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPF--FINDA----YNAP 498
A+ H + + H L N+++D+ NA ++D G+ + F P F ++ Y AP
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMGQ-DES 555
E+ + R + D++S G + E++ K + GD E+ + K +++G +E
Sbjct: 173 EILLGS------RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
Query: 556 AW 557
W
Sbjct: 227 TW 228
|
Length = 294 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 38/178 (21%), Positives = 73/178 (41%), Gaps = 24/178 (13%)
Query: 363 KRIRERKKKREVDEWLRVIGGLRHSNIVSIR-AYCNGKDELFLVYDYLPHGSLHSLLHGS 421
++ E+ R V R++ L H +V++ ++ + ++ ++LV D L G L H S
Sbjct: 36 QKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN-MYLVVDLLLGGDLR--YHLS 92
Query: 422 RGPGRMPVDWNKRLKL-ASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG 480
+ + + ++K + L +LH + H + NI++D+ G+ I+D
Sbjct: 93 QK-VKFSEE---QVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN 145
Query: 481 VHQLFHTPFFIND-----AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ Y APE+ ++ + D +S GV E L GK
Sbjct: 146 IATKVTPDTLTTSTSGTPGYMAPEV-------LCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 52 DPCFDS---WRGVTC---NPSTHRVIK-LVLEDLDLTG--PAEVLSRLTQLRLLSLKNNL 102
DPC W G C + I L L++ L G P ++ S+L L+ ++L N
Sbjct: 395 DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDI-SKLRHLQSINLSGNS 453
Query: 103 LSSS-NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIP 155
+ + +L S L+ L LS+N F G+ P + L LR ++L+ N+ G +P
Sbjct: 454 IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 48/226 (21%)
Query: 339 ELLGKGCVGATYKVVLDG------GDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNI 389
E LG+ G YK L G V +K ++++ + + E + L+H NI
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLL-----H---GSRGPGRM------PVDWNKRL 435
V + + L +++ Y H LH L H GS + P D+ +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---V 127
Query: 436 KLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAY 495
+ + A G+ FL + H+ H L++ N++V N ISD+G+ + + Y
Sbjct: 128 HIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR---------EVY 175
Query: 496 NAPELKFNNNNNYSQR----------KFWQRCDVYSFGVVLLEILT 531
A K N+ R KF D++S+GVVL E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 53/223 (23%), Positives = 107/223 (47%), Gaps = 41/223 (18%)
Query: 329 NVGDLLK--SSAELLGKGCVGATYKV--VLDGGDVVVVKRIRERKKKRE--VDEWLRVIG 382
+VGD K + E +G+G G Y V G +V + + +++ K+E ++E L V+
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMR 72
Query: 383 GLRHSNIVS-IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDS 441
++ NIV+ + +Y G DEL++V +YL GSL ++ +D + + +
Sbjct: 73 ENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCREC 125
Query: 442 AKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFF 490
+ L FLH + H + S NI++ G+ ++D G + TP++
Sbjct: 126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 491 INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ APE+ +++ + + D++S G++ +E++ G+
Sbjct: 183 M-----APEV-------VTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 46/276 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRE-RKKKREVDEW-------LRVIGGLRHSNI 389
+ LG G + Y+ + G ++ VK++ R E +E +R++ L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+ + L +++ GS+ LL G + V N +L +GL++LH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLL----RGLSYLH 120
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVH----------QLFHTPFFINDAYNAP 498
+ + H + +N+++D G I+D G F A+ AP
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558
E+ S CDV+S G V++E+ T K + + ++ + SA
Sbjct: 178 EVLRGEQYGRS-------CDVWSVGCVIIEMATAKPPWNAEK--HSNHLALIFKIASATT 228
Query: 559 VFDFELIMDKEMEEEMR-ALLQVALLCLAPLPKDRP 593
+ E + L V L CL P+DRP
Sbjct: 229 APS--------IPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 42/213 (19%)
Query: 339 ELLGKGCVGATYK-VVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAY-- 395
E +GKG G YK + VV +K I + + E+++ + I L I Y
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 396 CNGKD-ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAKGLAFLHGY 451
K +L+++ +Y GS LL PG++ +A + GL +LH
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDET-----YIAFILREVLLGLEYLHEE 117
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVH-QLFH----------TPFFINDAYNAPEL 500
K H + ++NI++ + G+ ++D GV QL TPF++ APE+
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWM-----APEV 169
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ + + D++S G+ +E+ G+
Sbjct: 170 IKQSGYDE-------KADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR----ERKKKREVDEW---LRVIGGLRHSNIV 390
+LLG+G G Y +D G + VK++ + K+EV+ ++++ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLL--HGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
+ L + +Y+P GS+ L +G + K +G+ +L
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQILEGVEYL 120
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIG---------VHQLFHTPFFINDAYNAPE 499
H + H + +NI+ D GN + D G + +PE
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ S + ++ DV+S G ++E+LT K
Sbjct: 178 V-------ISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 41/219 (18%)
Query: 340 LLGKGCVGATYKVVLDG--GDVVVVKRI--------RERKKKREVDEWLRVIGGLR---H 386
L+G G G+ Y + ++ G+++ VK++ + +K+ +D R I L+ H
Sbjct: 7 LIGSGSFGSVY-LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLA 446
NIV D L + +Y+P GS+ +LL+ + G + N KGL
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRN----FVRQILKGLN 120
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF-----------HTPFFINDAY 495
+LH N+ + H + +NI+VD G ISD G+ + P +
Sbjct: 121 YLH--NRG-IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 496 -NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
APE+ Q + ++ D++S G +++E+LTGK
Sbjct: 178 WMAPEV-------VKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 36/220 (16%)
Query: 334 LKSSAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSI 392
L + E +GKG G +K + + VV +K I + + E+++ + I L + +
Sbjct: 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 393 RAYCNG---KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
Y +L+++ +YL GS LL P D + + + KGL +LH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLH 118
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFINDAYNAP 498
K H + ++N+++ + G+ ++D GV + TPF++ AP
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM-----AP 170
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538
E+ Q + + D++S G+ +E+ G+ D
Sbjct: 171 EV-------IQQSAYDSKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 37/148 (25%), Positives = 55/148 (37%), Gaps = 21/148 (14%)
Query: 336 SSAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKK----REVDEWLRVIGGLRHSNIV- 390
SS +LL G Y + D V+ K R+K REV L+++ R V
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYVL-KINPSREKGADREREV-AILQLLA--RKGLPVP 56
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ A +L+ +++ G V ++ +A A+ LA LH
Sbjct: 57 KVLASGESDGWSYLLMEWIE------------GETLDEVSEEEKEDIAEQLAELLAKLHQ 104
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISD 478
L HG L NI+VD I D
Sbjct: 105 LPLLVLCHGDLHPGNILVDDGKILGIID 132
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-05
Identities = 23/58 (39%), Positives = 28/58 (48%), Gaps = 1/58 (1%)
Query: 92 QLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148
L+ L L NN L+ + P+LK L LS N T P S L LR +DLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 55/282 (19%), Positives = 119/282 (42%), Gaps = 51/282 (18%)
Query: 341 LGKGCVGATYKV--VLDGGDVVVVKRIR-----ERKKKREVDEWLRVIGGLRHSNIVSIR 393
+G+G Y+ +LDG V +K+++ + K + + + + ++ L H N++
Sbjct: 10 IGRGQFSEVYRATCLLDG-VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVD---WNKRLKLASDSAKGLAFLHG 450
A +EL +V + G L ++ + R+ + W ++L S A H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS------ALEHM 122
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFINDAYNAPE 499
+++ + H + +N+ + G + D+G+ H L TP+ Y +PE
Sbjct: 123 HSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-----YMSPE 176
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559
N N+ + D++S G +L E+ + ++ + + + Q
Sbjct: 177 RIHENGYNF-------KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ------- 222
Query: 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601
D+ + EE+R L+ +C+ P P+ RP+++ V+ +
Sbjct: 223 CDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 33/207 (15%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRERK-----KK---REVDEWLRVIGGLRHSNIVS 391
+G+G G +K + G +V +K+ E + KK RE+ R++ L+H N+V+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREI----RMLKQLKHPNLVN 64
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ K +L LV++Y H L+ L RG V + K+ + + + F H +
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKH 119
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF------HTPFFINDAYNAPELKFNNN 505
N H + NI++ + G + D G ++ +T + Y APEL +
Sbjct: 120 N---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTG 532
++ DV++ G V E+LTG
Sbjct: 177 ------QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 50/227 (22%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERK-KKREVDEWLRVIGGLR----HSNIVSI 392
E++G+G G YK G +V +K + + ++ E+ E + LR H NI +
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNI---LRKYSNHPNIATF 68
Query: 393 ------RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPG-RMPVDWNKRLKLA---SDSA 442
+ D+L+LV + GS+ L+ G R G R+ +W +A ++
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETL 123
Query: 443 KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH-QLFH----------TPFFI 491
+GLA+LH + + H + NI++ + + D GV QL TP+++
Sbjct: 124 RGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 492 NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538
APE+ + + R DV+S G+ +E +A G
Sbjct: 181 -----APEVIACDEQ--PDASYDARSDVWSLGITAIE-----LADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 51/222 (22%), Positives = 106/222 (47%), Gaps = 39/222 (17%)
Query: 329 NVGDLLK--SSAELLGKGCVGATYKVV-LDGGDVVVVKR--IRERKKKREVDEWLRVIGG 383
+VGD K + E +G+G G Y + + G V +K+ ++++ KK + + V+
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 384 LRHSNIVS-IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSA 442
++ NIV+ + +Y G DEL++V +YL GSL ++ +D + + +
Sbjct: 73 NKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECL 125
Query: 443 KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFI 491
+ L FLH + H + S NI++ G+ ++D G + TP+++
Sbjct: 126 QALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 492 NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
APE+ +++ + + D++S G++ +E++ G+
Sbjct: 183 -----APEV-------VTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
AE LG+G + VL V VK +R K +++L+ ++ L++ NI+ +
Sbjct: 30 AEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84
Query: 395 YCNGKDELFLVYDYLPHGSLHSLL----------HGSRGPGRMPVDWNKRLKLASDSAKG 444
C D L ++ +Y+ +G L+ L H + P V L +A A G
Sbjct: 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS---VSIANLLYMAVQIASG 141
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ-LFHTPFFINDAYNAPELKFN 503
+ +L N H L++ N +V I+D G+ + L+ ++ +++
Sbjct: 142 MKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWM 198
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILT 531
+ KF DV++FGV L E+ T
Sbjct: 199 AWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 47/211 (22%), Positives = 85/211 (40%), Gaps = 37/211 (17%)
Query: 340 LLGKGCVGATYKVVLDGGD-VVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAY 395
++G+G G V D +K IR K V++ + ++ ++H NIV+ +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRG---PGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
L++V +Y G L + RG P + W ++ L G+ +H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH--- 117
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF-----FINDAYNAP-----ELKF 502
+ + H + S NI + Q G + D G +L +P ++ Y P + +
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPY 177
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
NN + D++S G +L E+ T K
Sbjct: 178 NN-----------KSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 339 ELLGKGCVGATYK--VVLDGGDV---VVVKRIRER---KKKREVDEWLRVIGGLRHSNIV 390
++LG G G YK + +G V V +K +RE K +E+ + V+ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLL--HGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
+ C + L+ +P G L + H + ++W ++ AKG+ +L
Sbjct: 73 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAP----ELKFNN 504
+ L H L++ N++V + I+D G+ +L Y+A +K+
Sbjct: 126 E---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD---EKEYHAEGGKVPIKWMA 179
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539
+ R + + DV+S+GV + E++T DG
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 60/284 (21%), Positives = 122/284 (42%), Gaps = 50/284 (17%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRI-----RERKKKREVDEWLRVIGGLRHSNIVSIRA 394
+G G GA Y + +VV +K++ + +K +++ + +R + LRH N + R
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAKGLAFLHGY 451
+ +LV +Y GS LL + P + +++A+ + +GLA+LH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEVHKKP-------LQEVEIAAVTHGALQGLAYLHSH 134
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIG-------VHQLFHTPFFINDAYNAPELKFNN 504
N + H + + NI++ + G + D G + TP+++ APE+
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWM-----APEVILAM 186
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564
+ + ++ + DV+S G+ +E+ + + + + + Q+ES
Sbjct: 187 D----EGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQNESP-------A 233
Query: 565 IMDKEMEEEMRALLQVALLCLAPLPKDRP--NMSIVHRMIEDIR 606
+ E R + CL +P+DRP + + HR + R
Sbjct: 234 LQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 5/114 (4%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLS-SWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145
L LT L L L NN ++ + +LK L LS N+ + PS + +L +L+ +DL
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170
Query: 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQL 199
S N ++P L+ L NL L L N+ + L ++ + ++SNN +
Sbjct: 171 SFNDLS-DLP-KLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 45/180 (25%), Positives = 72/180 (40%), Gaps = 42/180 (23%)
Query: 371 KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELF----LVYDYLPHGSLHSLLHGSRGPGR 426
KR + E L+++ +H NI++IR F +V D L LH ++H S P
Sbjct: 49 KRTLRE-LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIH-SDQP-- 103
Query: 427 MPVDWNKRLKLASDSA------KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG 480
L +GL ++H A++ H L SN++V++ I D G
Sbjct: 104 --------LTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFG 152
Query: 481 ----------VHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEIL 530
H+ F T + Y APEL S ++ D++S G + E+L
Sbjct: 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLL------SLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 46/204 (22%), Positives = 90/204 (44%), Gaps = 33/204 (16%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRERKKK--REVDEWLRVIGGLRHSNIVSIRAYCN 397
+G G G YK L G++ VK I+ + + + ++ +H NIV+
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457
+++L++ +Y GSL + H + + + + R ++ +GLA+LH K
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGK---M 128
Query: 458 HGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFINDAYNAPEL-KFNNN 505
H + +NI++ G+ ++D GV TP+++ APE+ N
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWM-----APEVAAVEKN 183
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEI 529
Y+ Q CD+++ G+ +E+
Sbjct: 184 GGYN-----QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 52/235 (22%), Positives = 89/235 (37%), Gaps = 68/235 (28%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRERKKK--------REVDEWLRVIGGLRHSNIVS 391
LG+G G YK + G VV +K+I +K RE+ +++ L+H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREI----KILKKLKHPNVVP 71
Query: 392 I--RAYCNGKDEL------FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK 443
+ A ++V Y+ H L LL N +KL K
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE------------NPSVKLTESQIK 118
Query: 444 --------GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--------- 486
G+ +LH + H+ H + ++NI++D G I+D G+ + +
Sbjct: 119 CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 487 --------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
T + Y PEL +R++ D++ G V E+ T +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLG------ERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 45/220 (20%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIR--------ERKKKREVDEWLRVIGGLRHSNIV 390
E+LGKG G Y + + G ++ VK++ K+ ++ E + ++ L+H NIV
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
C + + + +++P GS+ S+L+ GP PV K G+A+LH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPV----FCKYTKQILDGVAYLHN 120
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIG-----------------VHQLFHTPFFIND 493
+ H + +N+++ G + D G + + TP+++
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM-- 175
Query: 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
APE+ N + Y ++ D++S G + E+ TGK
Sbjct: 176 ---APEVI--NESGYGRKS-----DIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 36/129 (27%), Positives = 63/129 (48%), Gaps = 21/129 (16%)
Query: 409 LPHGS--LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNI 466
LPH S L++ L ++ +P+D + L + +GL +LH + H + + NI
Sbjct: 136 LPHYSSDLYTYL--TKRSRPLPID--QALIIEKQILEGLRYLHAQR---IIHRDVKTENI 188
Query: 467 VVDQLGNACISDIGVHQL-FHTPFFINDA----YNAPELKFNNNNNYSQRKFWQRCDVYS 521
++ + CI D+G Q P F+ A NAPE+ ++ K+ + D++S
Sbjct: 189 FINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEV-------LARDKYNSKADIWS 241
Query: 522 FGVVLLEIL 530
G+VL E+L
Sbjct: 242 AGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 32/205 (15%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGL---RHSNIVS-IRAYC 396
LG G G YK + +I + + + E+++++ I L +H NIV AY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 397 NGKDELFLVYDYLPHGSLHSLL----HGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
+++L+++ ++ G+L S++ G P V + L FLH +
Sbjct: 73 Y-ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV--------CRQMLEALNFLHSHK 123
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVH-------QLFHTPFFINDAY-NAPELKFNN 504
+ H L + NI++ G+ ++D GV Q T FI Y APE+
Sbjct: 124 ---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVV--A 176
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEI 529
+ + + D++S G+ L+E+
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 21/154 (13%)
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL 445
H NIV++ C + ++ +Y +G L + L R + L + AKG+
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGM 154
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDA-------YNA 497
AFL N H L++ N+++ I D G+ + + ++ + A
Sbjct: 155 AFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 498 PELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
PE FN + DV+S+G++L EI +
Sbjct: 212 PESIFNC-------VYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 31/203 (15%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRERKKK--REVDEWLRVIGGLRHSNIVSIRAYCN 397
+G G G YK ++ G++ +K I+ + V + + ++ +HSNIV+
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457
+D+L++ ++ GSL + H + P+ ++ ++ ++ +GL +LH K
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 458 HGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFINDAYNAPELKFNNNN 506
H + +NI++ G+ ++D GV TP+++ A E K N
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN- 187
Query: 507 NYSQRKFWQRCDVYSFGVVLLEI 529
Q CD+++ G+ +E+
Sbjct: 188 --------QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 66/281 (23%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 339 ELLGKGCVGATYKVVL---DGGDV-VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
++GKG G Y L DG + VK + EV+++L+ ++ H N++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 392 IRAYCNGKDELFLV-YDYLPHGSLHSLLHGSRGPGRMPVDWNKRL-KLASDSAKGLAFLH 449
+ C + LV Y+ HG L + R P K L AKG+ +L
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPT--VKDLIGFGLQVAKGMEYL- 114
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDAYNAPEL--KFNNNN 506
H L++ N ++D+ ++D G+ ++ ++ + +L K+
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566
+ +KF + DV+SFGV+L E++T G + D ++++ + L
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT---------RGAPPY-----PDVDSFDITVYLLQG 218
Query: 567 DKEMEEEM--RALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ ++ E L +V L C P P+ RP S + IE I
Sbjct: 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
E LG+G YK G +V +K IR ++++ +R ++ GL+H+NIV +
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
+ K+ L LV++Y+ H L + + PG + + N +L L +GL+++H +
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM--DKHPGGLHPE-NVKLFLFQ-LLRGLSYIH---QR 122
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--FFINDA----YNAPELKFNNNNNY 508
++ H L N+++ G ++D G+ + P + N+ Y P++ +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE-- 180
Query: 509 SQRKFWQRC-DVYSFGVVLLEILTGKMA 535
+ C D++ G + +E++ G A
Sbjct: 181 -----YSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 56/234 (23%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 383 GLRHSNIVSIRAYC-NGKDELFLVYDYLPHGSLHSLLHGSR-GPGRMPVDWNKR--LKLA 438
GL H NI+ I C + F++Y Y+ G+L L R G P + + + +A
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 439 SDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ-LFHTPFF-INDAYN 496
A G+++LH + H +++ N V+D+ I+D + + LF + + D N
Sbjct: 124 IQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA 556
P +K+ + +++ DV+SFGV+L E++T LG Q +
Sbjct: 181 RP-VKWMALESLVNKEYSSASDVWSFGVLLWELMT---------LG-----QTPYVEIDP 225
Query: 557 WEVFDFELIMDKEMEEEMRA---LLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
+E+ + L + + + L V C A P++RP+ S + + + D
Sbjct: 226 FEMAAY-LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 61/281 (21%), Positives = 105/281 (37%), Gaps = 42/281 (14%)
Query: 341 LGKGCVGATYKVVLDGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIR-A 394
LG+G G+ K L ++ + +K+ + E L + + IV A
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRE-LEINKSCKSPYIVKYYGA 67
Query: 395 YCNGKD-ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
+ + + + +Y GSL S+ + G + K+A KGL++LH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG-GRIGEKVLGKIAESVLKGLSYLHSRK- 125
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF---FINDA-YNAPELKFNNNNNYS 509
+ H + SNI++ + G + D GV F + Y APE YS
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERI--QGKPYS 181
Query: 510 QRKFWQRCDVYSFGVVLLEILTGKM---AKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566
DV+S G+ LLE+ + +G+ LG ++ + + + EL
Sbjct: 182 IT-----SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN------PELKD 230
Query: 567 DKEME----EEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603
+ EE + ++ CL P RP M+E
Sbjct: 231 EPGNGIKWSEEFKDFIKQ---CLEKDPTRRPT---PWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 49/221 (22%), Positives = 94/221 (42%), Gaps = 46/221 (20%)
Query: 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIR----ERKKKREVDEW---LRVIGGLRHSNI 389
+LLG+G G Y +D G + K+++ + +EV ++++ L+H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 390 VSIRAYC---NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLA 446
V C + L + +Y+P GS+ L + G + + K +G++
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTR--KYTRQILEGMS 120
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNA--------------CISDIGVHQLFHTPFFIN 492
+LH + H + +NI+ D GN C+S G+ + TP+++
Sbjct: 121 YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM- 176
Query: 493 DAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+PE+ S + ++ DV+S G ++E+LT K
Sbjct: 177 ----SPEV-------ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 48/219 (21%)
Query: 339 ELLGKGCVGATYK-VVLDGGDVVVVKRIRERKKK-----------REVDEWLRVIGGLRH 386
+ LG+G YK + G +V +K+I+ ++K RE+ +++ L+H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREI----KLLQELKH 61
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSA---- 442
NI+ + K + LV++++ L ++ D + L A +
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIK----------DKSIVLTPADIKSYMLM 110
Query: 443 --KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF------HTPFFINDA 494
+GL +LH + H L +N+++ G ++D G+ + F T +
Sbjct: 111 TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW 167
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y APEL F R + D++S G + E+L
Sbjct: 168 YRAPELLF------GARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 21/61 (34%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 115 HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNR 174
+LK L LS+NR T L +L+ +DLS N I + LP+L +L L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 175 F 175
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 48/208 (23%), Positives = 96/208 (46%), Gaps = 37/208 (17%)
Query: 341 LGKGCVG-ATYKVVLDGGDVVVVKRIRERKKKRE--VDEWLRVIGGLRHSNIVSI-RAYC 396
+G+G G V G +V VK++ RK++R + + ++ +H N+V + +Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
G DEL++V ++L G+L ++ +R ++ + + K L+ LH +
Sbjct: 88 VG-DELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQG---V 137
Query: 457 FHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFINDAYNAPELKFNNN 505
H + S +I++ G +SD G L TP+++ APEL
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWM-----APEL----- 187
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGK 533
S+ + D++S G++++E++ G+
Sbjct: 188 --ISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 30/103 (29%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 436 KLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH-QLFHTPFFINDA 494
K+A K L +LH +K + H + SN+++++ G + D G+ L + DA
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 495 ----YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y APE + N N Q+ + + DV+S G+ ++E+ TG+
Sbjct: 165 GCKPYMAPE-RINPELN--QKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 3e-04
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 44/213 (20%)
Query: 339 ELLGKGCVGATYKVVL----DGGDVVVVKRIRERK--KKREVDEWL---RVIGGLRHSNI 389
+ LG G G +V+L G +K + + K K ++V+ L R++ +RH +
Sbjct: 7 KTLGTGSFG---RVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 390 VSIRAYCNGKDE--LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
V Y + +D+ L+LV +Y+P G L S L R GR P + A+ L +
Sbjct: 64 V--NLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARF--YAAQVVLALEY 116
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG--------VHQLFHTPFFINDAYNAPE 499
LH + + L N+++D G I+D G + L TP Y APE
Sbjct: 117 LHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTP-----EYLAPE 168
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
+ + + D ++ G+++ E+L G
Sbjct: 169 IILSKGYGKA-------VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 55/264 (20%), Positives = 112/264 (42%), Gaps = 29/264 (10%)
Query: 359 VVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415
+V VK +R K +++L+ ++ L+ NI+ + C +D L ++ +Y+ +G L+
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 416 SLLH--------GSRGPGRMP------VDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHL 461
L + P + ++ L +A A G+ +L N H L
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDL 164
Query: 462 SSSNIVVDQLGNACISDIGVHQ-LFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVY 520
++ N +V + I+D G+ + L+ ++ +++ KF DV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 521 SFGVVLLEILTGKMAKGDGELGIVKWVQMMGQ--DESAWEVFDFELIMDKEMEEEMRALL 578
+FGV L EIL + GEL + ++ G+ + +V+ F + L
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQ------GLY 278
Query: 579 QVALLCLAPLPKDRPNMSIVHRMI 602
++ L C + ++RP+ S +H +
Sbjct: 279 ELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 23/151 (15%)
Query: 392 IRAYCNGKDE--LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
++ +C +D+ L++V +Y+P G L +L+ P + + + LA D+ +
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG--- 162
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDA------YNAPE-LK 501
L H + N+++D+ G+ ++D G ++ T D Y +PE LK
Sbjct: 163 ------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
+ Y R+ CD +S GV L E+L G
Sbjct: 217 SQGGDGYYGRE----CDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 34/139 (24%), Positives = 61/139 (43%), Gaps = 21/139 (15%)
Query: 402 LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHL 461
L++V +Y+P G L +L+ P + + + LA D+ + F+ H +
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI---------HRDV 168
Query: 462 SSSNIVVDQLGNACISDIGVHQLFHTPFFI-------NDAYNAPE-LKFNNNNNYSQRKF 513
N+++D+ G+ ++D G + + Y +PE LK + Y R+
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE- 227
Query: 514 WQRCDVYSFGVVLLEILTG 532
CD +S GV L E+L G
Sbjct: 228 ---CDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
LS L L L L NN L ++ + +L+ L LS+N+ + S + SL +LR +D
Sbjct: 226 SSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELD 283
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQL 199
LS N+ +P+ L L L L + T + +S +L+ N+ +N
Sbjct: 284 LSGNSLSNALPLIALLLLLLEL---LLNLLLTLKALELKLNS-ILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 50/211 (23%), Positives = 81/211 (38%), Gaps = 38/211 (18%)
Query: 341 LGKGCVGATYKV-VLDGGDVVVVKRIRERKKKREVDEWL----RVIGGLRHSN-IVSIRA 394
LGKG G V G + K++ +++ K+ E + + I S IVS+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 395 YCNGKDELFLVYDYLPHGSLHSLL--HGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
KD+L LV + G L + G G + + A+ GL LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-----FPEARAIFYAAQIICGLEHLHQRR 115
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIG----------VHQLFHTPFFINDAYNAPELKF 502
+ + L N+++D GN ISD+G + TP Y APE+
Sbjct: 116 ---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP-----GYMAPEVLQ 167
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
++S D ++ G L E++ G+
Sbjct: 168 GEVYDFS-------VDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 6e-04
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 31/207 (14%)
Query: 341 LGKGCVGATYK-VVLDGGDVVVVKRIRERKKK-------REVDEWLRVIGGLRHSNIVSI 392
LG G G+ Y + G++V +K+++++ REV + LR + H NIV +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV-KSLRKLN--EHPNIVKL 63
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK-LASDSAKGLAFLHGY 451
+ DEL+ V++Y+ G+L+ L+ R ++ + +GLA +H
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMK-DRKGKPFS---ESVIRSIIYQILQGLAHIH-- 116
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIG-----VHQLFHTPFFINDAYNAPELKFNNNN 506
K FH L N++V I+D G + +T + Y APE+ +
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI-LLRST 174
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILTGK 533
+YS D+++ G ++ E+ T +
Sbjct: 175 SYS-----SPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 360 VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416
V +K ++ +K DE +R ++ L + IV + C + L LV + G L+
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNK 83
Query: 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACI 476
L G + + V + ++L + G+ +L G N H L++ N+++ A I
Sbjct: 84 FLSGKKD--EITV--SNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKI 136
Query: 477 SDIGVHQLFHTPFFINDAYNAPE------LKFNNNNNYSQRKFWQRCDVYSFGVVLLEIL 530
SD G+ + +D+Y LK+ + RKF R DV+S+G+ + E
Sbjct: 137 SDFGLSKALGA----DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192
Query: 531 T 531
+
Sbjct: 193 S 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 57/217 (26%), Positives = 84/217 (38%), Gaps = 46/217 (21%)
Query: 339 ELLGKGCVGATYKVVLD--GGDV--VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
+ LG G G + GG V V VK ++ K +D++L+ ++ L H N+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL-- 58
Query: 392 IRAYCNG---KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
IR Y G L +V + P GSL L G + + A A G+ +L
Sbjct: 59 IRLY--GVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLI--STLCDYAVQIANGMRYL 113
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL-----------FH--TPFFINDAY 495
H L++ NI++ I D G+ + H PF A+
Sbjct: 114 E---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF----AW 166
Query: 496 NAPE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
APE L+ R F DV+ FGV L E+ T
Sbjct: 167 CAPESLRT--------RTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 341 LGKGCVGATYKVVLDG-GDVVVVKRI---RERKKKREVDEWLRVIGGLRHSNIVSIRAYC 396
+G G G YKV+ G + +K I E +R++ + ++ + H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
+ E+ ++ +++ GSL G D +A G+A+LH + H+
Sbjct: 142 DHNGEIQVLLEFMDGGSLE---------GTHIADEQFLADVARQILSGIAYLH---RRHI 189
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVHQ-LFHTPFFIND-----AYNAPELKFNNNNNYSQ 510
H + SN++++ N I+D GV + L T N AY +PE + N + N+
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPE-RINTDLNHGA 248
Query: 511 RKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM 550
+ D++S GV +LE G+ G G G W +M
Sbjct: 249 YDGYAG-DIWSLGVSILEFYLGRFPFGVGRQG--DWASLM 285
|
Length = 353 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 64/283 (22%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 341 LGKGCVGATYKVVLDGGDV------VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
LG G G Y+ + G D V VK + E +++ ++L ++ H NIV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRG-PGR-MPVDWNKRLKLASDSAKGLAFLH 449
+ + F++ + + G L S L +R P R + L A D AKG +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGN---ACISDIGV-HQLFHTPFF-INDAYNAPELKFNN 504
+ H H +++ N ++ G A I+D G+ ++ ++ P +K+
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP-IKWMP 189
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564
+ F + DV+SFGV+L EI + LG + + Q EV +F +
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFS---------LGYMPYPGRTNQ-----EVMEF-V 234
Query: 565 IMDKEMEEEMR---ALLQVALLCLAPLPKDRPNMSIVHRMIED 604
++ + ++ C P+DRPN + + I+
Sbjct: 235 TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 339 ELLGKGCVGATYK-VVLDGGDVVVVKRIRERKKK-------REVDEWLRVIGGLRHSNIV 390
E LG+G YK + G +V +K I + ++ RE ++ GL+H+NIV
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREAS----LLKGLKHANIV 66
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ + K+ L V++Y+ H L + + PG + +N RL +GLA++HG
Sbjct: 67 LLHDIIHTKETLTFVFEYM-HTDLAQYM--IQHPGGLH-PYNVRL-FMFQLLRGLAYIHG 121
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA------YNAPELKFNN 504
H+ H L N+++ LG ++D G+ + P + Y P++
Sbjct: 122 ---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL-G 177
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+YS D++ G + +E+L G+
Sbjct: 178 ATDYS-----SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 19/59 (32%), Positives = 26/59 (44%), Gaps = 7/59 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRF 126
L+ LDL+ P L L++L L N L+S + S P L+ L LS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 58/256 (22%), Positives = 98/256 (38%), Gaps = 32/256 (12%)
Query: 360 VVVKRIRERKKKREVDEWLRVIG---GLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416
VVVK +R +E ++L L+HSN++ C LV ++ P G L
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84
Query: 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH---LFHGHLSSSNIVVDQLGN 473
L R M D ++A + A GL LH N H L ++++ V
Sbjct: 85 YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVK---- 140
Query: 474 ACISDIGV-HQLFHTPFFIND-------AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVV 525
I D G+ H + +++ + APEL + N + +V+S GV
Sbjct: 141 --IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198
Query: 526 LLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRA--LLQVALL 583
+ E+ ELG + + + + V + +L + K + + +V
Sbjct: 199 IWELF---------ELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQF 249
Query: 584 CLAPLPKDRPNMSIVH 599
C P+ RP+ VH
Sbjct: 250 CWLQ-PEQRPSAEEVH 264
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 36/191 (18%)
Query: 357 GDVVVVKRIRE--------RKKKREVDEWLRVIGGLRHSNIVSIR-AYCNGKDELFLVYD 407
G V +K+I + ++ RE L+++ LRH NI+S+ + + ++++ V +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRE----LKLLKHLRHENIISLSDIFISPLEDIYFVTE 90
Query: 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIV 467
L LH LL P++ +GL ++H A + H L SNI+
Sbjct: 91 LLG-TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNIL 140
Query: 468 VDQLGNACISDIGV-----HQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSF 522
+++ + I D G+ Q+ T + Y APE+ + +K+ D++S
Sbjct: 141 INENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPEIML------TWQKYDVEVDIWSA 192
Query: 523 GVVLLEILTGK 533
G + E+L GK
Sbjct: 193 GCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 338 AELLGKGCVGATYKVV-LDGGDVVVVKRI----RERKKKREVDEW---LRVIGGLRHSNI 389
+LLG+G G Y D G + VK++ ++ +EV+ ++++ LRH I
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 390 VSIRAYCNGKDE--LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
V +E L + +Y+P GS+ L + G + + +R +G+++
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRY--TRQILQGVSY 121
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNA--------------CISDIGVHQLFHTPFFIND 493
LH + H + +NI+ D GN C+S G+ + TP+++
Sbjct: 122 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM-- 176
Query: 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+PE+ S + ++ DV+S ++E+LT K
Sbjct: 177 ---SPEV-------ISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 40/223 (17%)
Query: 339 ELLGKGCVGATYKVVLDG-----GDVVVVKRIRERKKK--------REVDEWLRVIGGLR 385
E +G+G TY VV G G +V +K+IR ++ RE+ ++ L+
Sbjct: 6 EKIGEG----TYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREIS----LLKELQ 57
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL 445
H NIV ++ + L+L++++L L L M + K +G+
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVK--SYLYQILQGI 114
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------FINDAYNAPE 499
F H + H L N+++D G ++D G+ + F P + Y APE
Sbjct: 115 LFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE 171
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGEL 541
+ S R + D++S G + E+ T K + GD E+
Sbjct: 172 VLLG-----SPR-YSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 54/281 (19%), Positives = 115/281 (40%), Gaps = 49/281 (17%)
Query: 341 LGKGCVGATYKVV--LDGGDVVVVK----RIRERKKKREVDEWLRVIGGLRHSNIVSIRA 394
+G+G Y+ LD V + K + + K +++ + + ++ L H N++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVD---WNKRLKLASDSAKGLAFLHGY 451
+EL +V + G L ++ + R+ + W ++L S A H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS------AVEHMH 123
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGV-----------HQLFHTPFFINDAYNAPEL 500
++ + H + +N+ + G + D+G+ H L TP+ Y +PE
Sbjct: 124 SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-----YMSPER 177
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560
N N+ + D++S G +L E+ + ++ + Q + Q
Sbjct: 178 IHENGYNF-------KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-------C 223
Query: 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601
D+ + + E++R L+ +C+ P P RP++ VH++
Sbjct: 224 DYPPLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 341 LGKGCVGATYKVVLDGGDVVV-VKRIR---ERKKKREVDEWLRVIGGLRHSNIVSIRAYC 396
LGKG G+ YKV+ V + +K IR + K ++ L ++ IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
+ +++ +Y+ GSL L G +P D +R+ A KGL FL + ++
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLK--EEHNI 124
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVH-QLFHTPFFIN---DAYNAPE----LKFNNNNNY 508
H + +N++V+ G + D GV L + N +Y APE N N Y
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTY 184
Query: 509 SQRKFWQRCDVYSFGVVLLEILTGKMAKG 537
+ + DV+S G+ +LE MA G
Sbjct: 185 TVQS-----DVWSLGLSILE-----MALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 51/210 (24%), Positives = 78/210 (37%), Gaps = 51/210 (24%)
Query: 355 DGGDVVVVKRIR------ERKKKREVDEWLRVIGGLRHSNIVSI--RAYCNGKDELFLVY 406
G V +K +R E ++ R E + L H NIV++ LF V+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRE-TALCARLYHPNIVALLDSGEA-PPGLLFAVF 58
Query: 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNI 466
+Y+P +L +L G +P RL L LA H + H L NI
Sbjct: 59 EYVPGRTLREVLAAD---GALPAGETGRLML--QVLDALACAH---NQGIVHRDLKPQNI 110
Query: 467 VVDQLG---NACISDIGV------------------HQLFHTPFFINDAYNAPELKFNNN 505
+V Q G +A + D G+ ++ TP Y APE +
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTP-----TYCAPE-QLRGE 164
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKMA 535
D+Y++G++ LE LTG+
Sbjct: 165 PVTPN------SDLYAWGLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 37/169 (21%), Positives = 66/169 (39%), Gaps = 44/169 (26%)
Query: 399 KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVD-WNKRLKLASDSAKGLAFLHGYNKAHLF 457
K L+L+ ++LP G + +LL + LA D+ L F+
Sbjct: 73 KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFI--------- 123
Query: 458 HGHLSSSNIVVDQLGNACISDI----GVHQLFHTPFFINDAYNAP-ELKFNNNNNYSQRK 512
H + N+++D G+ +SD G+ + T F+ N +N P + F N N+ + +
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 513 FWQR-----------------------------CDVYSFGVVLLEILTG 532
W++ CD +S GV++ E+L G
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.002
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 56/199 (28%)
Query: 358 DVVVVKRI-RERKKKREVDEWLRVIGGLRHSNIVSIRA-----YCNGKDELFLVYDYLPH 411
D++ KRI RE ++++ LRH NI+ + +++++V + +
Sbjct: 39 DLIDAKRILRE----------IKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET 88
Query: 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK--------GLAFLHGYNKAHLFHGHLSS 463
LH ++ S P L D + GL +LH A++ H L
Sbjct: 89 -DLHKVIK-SPQP------------LTDDHIQYFLYQILRGLKYLH---SANVIHRDLKP 131
Query: 464 SNIVVDQLGNACISDIG---------VHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFW 514
SNI+V+ + I D G + F T + + Y APEL +++ Y++
Sbjct: 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR-YTKA--- 187
Query: 515 QRCDVYSFGVVLLEILTGK 533
D++S G + E+LT K
Sbjct: 188 --IDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 56/283 (19%), Positives = 124/283 (43%), Gaps = 48/283 (16%)
Query: 327 FRNVGDLLKSSAELLGKGCVGATYKVV-LDGGDVVVVKRI-----RERKKKREVDEWLRV 380
F+ + L + +G G GA Y + +VV +K++ + +K +++ + ++
Sbjct: 19 FKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 381 IGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS- 439
+ ++H N + + + +LV +Y GS LL + P + +++A+
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKP-------LQEVEIAAI 130
Query: 440 --DSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG-------VHQLFHTPFF 490
+ +GLA+LH +N + H + + NI++ + G ++D G + TP++
Sbjct: 131 THGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYW 187
Query: 491 INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM 550
+ APE+ + + ++ + DV+S G+ +E+ K + + + + +
Sbjct: 188 M-----APEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHI 236
Query: 551 GQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP 593
Q+ES + E + R + CL +P+DRP
Sbjct: 237 AQNESP-------TLQSNEWSDYFRNFVDS---CLQKIPQDRP 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 35/131 (26%), Positives = 59/131 (45%), Gaps = 25/131 (19%)
Query: 92 QLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151
L+ L L +N + S L + P+LK+L LS N + P +S+L +L +DLS N
Sbjct: 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 152 GEIP----------------------MTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189
++P ++ L+ L NL L L +N+ L + ++
Sbjct: 200 -DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNL 257
Query: 190 LDFNVSNNQLS 200
++SNNQ+S
Sbjct: 258 ETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 55/267 (20%), Positives = 117/267 (43%), Gaps = 44/267 (16%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRI-----RERKKKREVDEWLRVIGGLRHSNIVSIRA 394
+G G GA Y +VV VK++ + +K +++ + ++ + L+H N + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 395 YCNGKDEL-FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
C K+ +LV +Y GS LL + P+ + + + +GLA+LH +N
Sbjct: 89 -CYLKEHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIG-------VHQLFHTPFFINDAYNAPELKFNNNN 506
+ H + + NI++ + G ++D G + TP+++ APE+ +
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWM-----APEVILAMD- 193
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566
+ ++ + DV+S G+ +E+ K + + + + + Q++S +
Sbjct: 194 ---EGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQNDSP-------TLQ 241
Query: 567 DKEMEEEMRALLQVALLCLAPLPKDRP 593
E + R + CL +P++RP
Sbjct: 242 SNEWTDSFRGFVD---YCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 339 ELLGKGCVGATYKVVL----DGGDVVVVKRIRERK--KKREVDEWL---RVIGGLRHSNI 389
+LLGKG G KV+L G +K +++ K EV L RV+ RH +
Sbjct: 1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
S++ KD L V +Y+ G L H SR R+ + R ++ L +LH
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSR--ERVFSEDRTRF-YGAEIVSALDYLH 112
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------PFFINDAYNAPELKFN 503
+ + L N+++D+ G+ I+D G+ + T F Y APE+
Sbjct: 113 ---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL-- 167
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGKM 534
+N+Y + W + GVV+ E++ G++
Sbjct: 168 EDNDYGRAVDW-----WGLGVVMYEMMCGRL 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 38/139 (27%), Positives = 55/139 (39%), Gaps = 17/139 (12%)
Query: 79 DLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNL------SSWPHLKHLYLSHNRFTGT--- 129
D G E L R + L+ L L NN L L L P L+ L L NR G
Sbjct: 96 DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE 155
Query: 130 -FPSGVSSLRHLRRVDLSHNAYEGE-IPMT--ELTRLPNLLTLRLEDNRFT----GTLYS 181
+ + R L+ ++L++N I L NL L L +N T L
Sbjct: 156 ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE 215
Query: 182 VNSSSRSILDFNVSNNQLS 200
+S +S+ N+ +N L+
Sbjct: 216 TLASLKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 640 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.44 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.34 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.15 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.13 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.12 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.06 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.06 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.96 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.93 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.81 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.73 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.72 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.69 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.68 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.65 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.61 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.61 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.61 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.59 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.49 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.36 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.36 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.33 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.32 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.31 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.23 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.17 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.17 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.14 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.13 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.12 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.09 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.92 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.92 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 97.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.87 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.84 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.83 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-61 Score=572.37 Aligned_cols=490 Identities=28% Similarity=0.433 Sum_probs=346.9
Q ss_pred EEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 70 VIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 70 v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
+..|+|++|.+.|..+....+++|+.|+|++|.+++..+ .+.++++|+.|+|++|+++|.+|..++++++|+.|+|++|
T Consensus 454 L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 533 (968)
T PLN00113 454 LQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533 (968)
T ss_pred CcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCC
Confidence 444555555555544334445677778888888877655 5778889999999999999999999999999999999999
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcc--cCCCCCCCCCCCcccCCCCC
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAW--MSPFGGSSFAGNKNLCGRPL 226 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~--~~~~~~~~~~gn~~lcg~~~ 226 (640)
.++|.+| ..+..+++|+.|+|++|+++|.+|..+..+.+|+.|++++|+++|.+|.. +..+....+.||+.+||.+.
T Consensus 534 ~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~ 612 (968)
T PLN00113 534 QLSGQIP-ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDT 612 (968)
T ss_pred cccccCC-hhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcc
Confidence 9999888 77889999999999999999999999888999999999999999999963 45677788999999998653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCceEEEEeeehhHHHHHHHHHhhheeeeeeccccccCCCCCccceeecccCCCCCCCC
Q 006559 227 PSDCSNRTVEPEQPPRSRPRSSRVVTVIVIVIFDAVAILVAVVTVTWCCYKRKRRSLRNGGGGVHKEVVMKRGNRKGDYG 306 (640)
Q Consensus 227 ~~~c~~~~~~~~~~~~~~~~~~~~~~vi~~~~~~~v~~~~~~~~~~~~~~rrkr~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (640)
...- . ++...++.....++++++++++++++++ +++++++||+++... .. ... ..+.
T Consensus 613 ~~~~-----~----~c~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~------~~~----~~~~-- 669 (968)
T PLN00113 613 TSGL-----P----PCKRVRKTPSWWFYITCTLGAFLVLALV-AFGFVFIRGRNNLEL-KR------VEN----EDGT-- 669 (968)
T ss_pred ccCC-----C----CCccccccceeeeehhHHHHHHHHHHHH-HHHHHHHHhhhcccc-cc------ccc----cccc--
Confidence 2100 0 0110111111112222222222222222 222222222221110 00 000 0000
Q ss_pred CCCCCCCcceeeeeccC-CCCccChHHHHHH--hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHh
Q 006559 307 GARDGGDVEEMVMFEGC-NKGFRNVGDLLKS--SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIG 382 (640)
Q Consensus 307 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~ 382 (640)
.+...+... ...+ +.++.... ..++||+|+||.||+|+. .++..||||++...... ..+|++.++
T Consensus 670 --------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~l~ 738 (968)
T PLN00113 670 --------WELQFFDSKVSKSI-TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--PSSEIADMG 738 (968)
T ss_pred --------ccccccccccchhh-hHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--cHHHHHHHh
Confidence 011111100 0011 33333333 245799999999999996 57889999998754321 234578899
Q ss_pred ccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCC
Q 006559 383 GLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLS 462 (640)
Q Consensus 383 ~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk 462 (640)
+++|||||+++|+|...+..|+|||||++|+|.++++ .++|..+.+++.|+|+||+|||+.+.++|+|||||
T Consensus 739 ~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk 810 (968)
T PLN00113 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810 (968)
T ss_pred hCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCC
Confidence 9999999999999999999999999999999999996 27899999999999999999998777889999999
Q ss_pred CCCeEECCCCCeEEccCCcccccC--CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC--
Q 006559 463 SSNIVVDQLGNACISDIGVHQLFH--TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD-- 538 (640)
Q Consensus 463 ~~NILl~~~~~~kl~DfGl~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~-- 538 (640)
|+||+++.++.+++. ||...... ....++..|+|||++ ....++.|+|||||||++|||+||+.||+.
T Consensus 811 p~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 811 PEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETR-------ETKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred HHhEEECCCCceEEE-eccccccccCCCccccccccCcccc-------cCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 999999999988875 66654432 233457899999964 445678999999999999999999999863
Q ss_pred -CCcchHHHHHHhhcccccccccchhhccC-hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 539 -GELGIVKWVQMMGQDESAWEVFDFELIMD-KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 539 -~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
......+|++...........+|+.+... ....+++.++.+++.+||+.+|++||+|.||+++|+++....+
T Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 883 GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 23457778776554433334445443221 1224566788999999999999999999999999999876433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=445.46 Aligned_cols=261 Identities=40% Similarity=0.658 Sum_probs=229.7
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccc--hHHHHHHHHHHhccCCCcccceeEEEEcCC-eEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKK--KREVDEWLRVIGGLRHSNIVSIRAYCNGKD-ELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~~gsL 414 (640)
.++||+|+||.||+|.+++|..||||++..... .++|..|+.++.+++|||+|+|+|||.+.+ +.+||||||++|+|
T Consensus 80 ~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL 159 (361)
T KOG1187|consen 80 SNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSL 159 (361)
T ss_pred hcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCH
Confidence 368999999999999999999999999887644 577999999999999999999999999988 59999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-Cc----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-PF---- 489 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-~~---- 489 (640)
.++|+..... +++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|||+++.... ..
T Consensus 160 ~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~ 236 (361)
T KOG1187|consen 160 EDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVST 236 (361)
T ss_pred HHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceee
Confidence 9999976532 789999999999999999999999988999999999999999999999999999976542 11
Q ss_pred --cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC----CCcchHHHHHHhhcccccccccchh
Q 006559 490 --FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD----GELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 490 --~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~----~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
.+|.+|+||| +...+..++|+|||||||+|+||+||+.|.+. .+..++.|+.....+....+++|+.
T Consensus 237 ~~~gt~gY~~PE-------y~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 237 TVMGTFGYLAPE-------YASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred ecCCCCccCChh-------hhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 5688999999 45667889999999999999999999988873 3455899998877777888999999
Q ss_pred hccChHH-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 564 LIMDKEM-EEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 564 ~~~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
+...... .+++.++..+|.+|++.+|++||+|.+|+++|+.+...
T Consensus 310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8632222 26888899999999999999999999999999776644
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=395.72 Aligned_cols=251 Identities=31% Similarity=0.453 Sum_probs=203.7
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCC-eEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD-ELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~~g 412 (640)
.+.||+|+||+||+|.+++...||||++.... ..++|.+|+.+|.+++|||||+|+|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 45699999999999999987779999998642 2458999999999999999999999999887 799999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccCCC---
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHTP--- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~~~--- 488 (640)
+|.++++... ...+++..+++++.|||+||.|||+..+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 126 sL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred cHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 9999998741 2369999999999999999999996532 99999999999999997 9999999999776532
Q ss_pred ---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccccccchhh
Q 006559 489 ---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 489 ---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
..+|..|||||++... ...|+.|+|||||||+||||+||+.||.+.... ....+...... .
T Consensus 201 ~~~~~GT~~wMAPEv~~~~-----~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R----------p 265 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGE-----KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR----------P 265 (362)
T ss_pred ccCCCCCccccChhhhcCC-----CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC----------C
Confidence 4668899999986432 567899999999999999999999999864331 11111111111 0
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCC
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 611 (640)
..+. ++...+..++.+||+.||++||++.+++..|+.+......
T Consensus 266 ~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 266 PIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1111 1444566777779999999999999999999998765443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=393.54 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=207.0
Q ss_pred HhhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 336 SSAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 336 ~~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
...+.||+|-||.||.|++++...||+|.++.. ...++|.+|+.+|++|+|+|||+++|+|..++.+|||||||+.|+|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 346789999999999999999989999999986 4558899999999999999999999999998899999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCccc---
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFI--- 491 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~~~--- 491 (640)
.++|+... ...+.-.+.+.++.|||+||+||++. ++|||||.++|||++++..+||+||||+|......+.
T Consensus 289 l~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 289 LDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred HHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99998732 23578889999999999999999954 4999999999999999999999999999976544332
Q ss_pred ----cccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 492 ----NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 492 ----~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...|.|||. +...+|+.|||||||||+||||+| |+.|+.. +...+.++.+.+..+ +..
T Consensus 363 ~~kfPIkWtAPEa-------~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--msn~ev~~~le~GyR--------lp~ 425 (468)
T KOG0197|consen 363 GGKFPIKWTAPEA-------LNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--MSNEEVLELLERGYR--------LPR 425 (468)
T ss_pred CCCCCceecCHHH-------HhhCCcccccceeehhhhHHHHhccCCCCCCC--CCHHHHHHHHhccCc--------CCC
Confidence 346889994 567789999999999999999999 8999864 233333333333221 111
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...++..+.++|..||+.+|++|||++.+...|+++...
T Consensus 426 ---P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 ---PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 234666788899999999999999999999999998754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=402.42 Aligned_cols=248 Identities=26% Similarity=0.447 Sum_probs=204.5
Q ss_pred hhccccccCcceEEEEEeCC------CcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLDG------GDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||+||+|+..+ .+.||||.+++. +.+++|++|+++++.++|||||+|+|+|..++.++||+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 35679999999999998543 356999999977 356889999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCC---------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEcc
Q 006559 408 YLPHGSLHSLLHGSRGP---------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 478 (640)
||..|||++||+..... .+.+++..+.+.||.|||.||+||- ..++|||||.++|+|+.++..+||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEecc
Confidence 99999999999754321 1335889999999999999999998 45599999999999999999999999
Q ss_pred CCcccccC-CCcc-------ccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHH
Q 006559 479 IGVHQLFH-TPFF-------INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQ 548 (640)
Q Consensus 479 fGl~~~~~-~~~~-------~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~ 548 (640)
|||+|-.. .+++ ...+||+|| ++..++||++||||||||+|||++| |+.||.+-.. ..++.++
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppE-------sIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPE-------SILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHH-------HhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 99998653 3332 245789998 6778899999999999999999999 9999875221 2222211
Q ss_pred HhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 549 MMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 549 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
. ..+. +..+.++.+++.+|+.||+.+|++||+++||...|+.....
T Consensus 720 ----~--------g~lL--~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 720 ----A--------GQLL--SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ----c--------CCcc--cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 1 1111 22346778899999999999999999999999999997644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=360.94 Aligned_cols=241 Identities=22% Similarity=0.363 Sum_probs=196.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCC-eEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD-ELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~~g 412 (640)
...||+|..|+|||++++ ++..+|+|.+... ..++++.+|++++++.+||+||+++|.|.... +..|+||||.+|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 567999999999999975 5788999999544 45788999999999999999999999999988 599999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----CC
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----TP 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----~~ 488 (640)
+|++++...+ .+++...-+|+.+|.+||.|||+ +.+||||||||+|||++..|++||||||.++.+. ..
T Consensus 164 SLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~t 236 (364)
T KOG0581|consen 164 SLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANT 236 (364)
T ss_pred CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhccc
Confidence 9999998653 47888999999999999999995 3679999999999999999999999999987754 45
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh-hccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE-LIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~-~~~~ 567 (640)
+++|..|||||.+ .+..|+.++||||||+.++|+++|+.|+.........|...+ ..|++.. ...+
T Consensus 237 fvGT~~YMsPERi-------~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------~~Iv~~ppP~lP 303 (364)
T KOG0581|consen 237 FVGTSAYMSPERI-------SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------CAIVDEPPPRLP 303 (364)
T ss_pred ccccccccChhhh-------cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------HHHhcCCCCCCC
Confidence 7789999999964 555778899999999999999999999975422222222221 1223311 1112
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. .+..++..++..|+++||.+||++.|+++
T Consensus 304 ~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 304 EG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cc--cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 34456777777899999999999998864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=335.18 Aligned_cols=239 Identities=21% Similarity=0.342 Sum_probs=190.9
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeE-EEEcCCe-EEEEEecc
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRA-YCNGKDE-LFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lV~Ey~ 409 (640)
..++||+|.||+|||+. +.+|..||.|.++-. +.+++...|+.+|++|+|||||++++ .+.+..+ ++||||||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 36789999999999998 678999999998733 34567889999999999999999998 4544444 89999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC--ceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH--LFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
..|+|...++..+. ....+++..+++++.|+++||.++|+.- ++ |+||||||.||+|+++|.+|++||||++++.+
T Consensus 103 ~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred cccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 99999999875543 2345899999999999999999999732 34 99999999999999999999999999998754
Q ss_pred ------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 488 ------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 488 ------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
++++|+.||+||++ ....|+.||||||+||++|||+.-++||.+. ++.+..+.+.+. |
T Consensus 181 ~~tfA~S~VGTPyYMSPE~i-------~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qg-------d 244 (375)
T KOG0591|consen 181 KTTFAHSLVGTPYYMSPERI-------HESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQG-------D 244 (375)
T ss_pred hhHHHHhhcCCCcccCHHHH-------hcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcC-------C
Confidence 46789999999975 4456778999999999999999999999865 344333333322 2
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 596 (640)
.....+...++ ++.+++..|+..||+.||+..
T Consensus 245 ~~~~p~~~YS~---~l~~li~~ci~vd~~~RP~t~ 276 (375)
T KOG0591|consen 245 YPPLPDEHYST---DLRELINMCIAVDPEQRPDTV 276 (375)
T ss_pred CCCCcHHHhhh---HHHHHHHHHccCCcccCCCcc
Confidence 22122233444 455566669999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=346.48 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=190.1
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEecccc---------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRERK---------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
.+.+|+|+||.|-+|. .++|+.||||.+.+.+ ....+.+|+++|++|+|||||+++++|...+..|||||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE 256 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE 256 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence 5679999999999998 5679999999997541 12345799999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC---CCeEEccCCcccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL---GNACISDIGVHQL 484 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGl~~~ 484 (640)
||++|+|.+.+-.++ .+.+.....++.|++.|+.||| +.+|+||||||+|||+..+ ..+||+|||+|+.
T Consensus 257 ~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 257 YVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999987654 3566677889999999999999 5569999999999999765 7899999999998
Q ss_pred cCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhcccccc
Q 006559 485 FHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDESAW 557 (640)
Q Consensus 485 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~ 557 (640)
.+. ..++|+.|.|||++...... .+..|+|+||+||+||-+++|.+||.+.... +.+-
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~----~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ----------- 393 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVE----YYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ----------- 393 (475)
T ss_pred cccceehhhhcCCccccChhheecCCee----cccchheeeeccceEEEEeccCCCcccccCCccHHHH-----------
Confidence 753 45789999999998544222 2335899999999999999999999864322 1111
Q ss_pred cccchhhccC-hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVFDFELIMD-KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~d~~~~~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+........ ....+...+.++++.+++..||++|||+.|+++
T Consensus 394 -I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 394 -ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111111111 122334456777788899999999999999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.19 Aligned_cols=187 Identities=24% Similarity=0.385 Sum_probs=165.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||+||+|+++ ++..||||.+.... ..+-...|+.+|+.++|||||++++++..++..|||||||.+|
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 345999999999999964 57889999997663 2344678999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC------CCeEEccCCcccccC
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL------GNACISDIGVHQLFH 486 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~------~~~kl~DfGl~~~~~ 486 (640)
||.+|++..+ .++......++.|+|.||++|| +.+||||||||.||||+.. -.+||+|||+++.+.
T Consensus 95 DLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 95 DLSDYIRRRG-----RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999764 5888999999999999999999 5569999999999999864 468999999999987
Q ss_pred CC-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 487 TP-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 487 ~~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
+. .++++-|||||++ ..++|+.|+|+||.|+++||+++|+.||+..
T Consensus 167 ~~~~a~tlcGSplYMAPEV~-------~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVI-------MSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred chhHHHHhhCCccccCHHHH-------HhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 53 4679999999974 4678999999999999999999999999843
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=358.55 Aligned_cols=235 Identities=23% Similarity=0.372 Sum_probs=193.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..++||+|||+.+|.++. ..|+.||+|++.++ ..++.+.+|+++.+.|+|||||+++++|++.+..|||.|+|+
T Consensus 22 ~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 22 RGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecC
Confidence 467899999999999996 88999999999764 345668899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.++++..+ ++++.+...+..||+.||.|||+. +|||||||..|++|++++++||+|||||..+..
T Consensus 102 ~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 102 RGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred CccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 999999998433 799999999999999999999954 499999999999999999999999999988763
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
..++|+.|+|||++. ...++..+||||+||+||-|++|++||+.... .+-... +...+.
T Consensus 174 rk~TlCGTPNYIAPEVl~-------k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--kety~~---------Ik~~~Y 235 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLN-------KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV--KETYNK---------IKLNEY 235 (592)
T ss_pred ccceecCCCcccChhHhc-------cCCCCCchhhhhhhhHHHhhhhCCCCcccchH--HHHHHH---------HHhcCc
Confidence 357899999999864 34555689999999999999999999975321 111111 111122
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+.....+ ..+++...|+++|.+|||+.+|+.
T Consensus 236 ~~P~~ls~~---A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 SMPSHLSAE---AKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccccccCHH---HHHHHHHHhcCCcccCCCHHHHhc
Confidence 222233333 445666799999999999999974
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=383.28 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=201.7
Q ss_pred hhccccccCcceEEEEEeCC--Cc----EEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLDG--GD----VVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~--~~----~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||.|.+.+ |. .||||.+++. +...+|.+|..+|++++|||||+++|+|.+....+|++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 45689999999999999654 33 3899999876 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCC--CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc-c
Q 006559 408 YLPHGSLHSLLHGSRGP--GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ-L 484 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~-~ 484 (640)
||++|+|..||++.+.. ....+...+.+.++.|||+|+.||+ +.++|||||.++|+||++...+||+|||+|+ .
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 99999999999977421 2346889999999999999999999 5669999999999999999999999999999 3
Q ss_pred cCCCccc-------cccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhcccc
Q 006559 485 FHTPFFI-------NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDES 555 (640)
Q Consensus 485 ~~~~~~~-------~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~ 555 (640)
+...++. ...||||| ++..+.||.|+|||||||+|||++| |..||.+... .+...+.. ..
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PE-------sl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~---gg- 921 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPE-------SLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE---GG- 921 (1025)
T ss_pred hhchheeccCccccceecCCHH-------HHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh---CC-
Confidence 3333322 34688888 4566899999999999999999999 8999975322 22221111 11
Q ss_pred cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 556 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
++.. .+.+..+++++|..||+.+|++||++..+++.++.+...
T Consensus 922 -------RL~~---P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 922 -------RLDP---PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred -------ccCC---CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1111 235666788999999999999999999999999998754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=368.32 Aligned_cols=244 Identities=22% Similarity=0.385 Sum_probs=204.2
Q ss_pred hhccccccCcceEEEEEeCC----CcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG----GDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+++||.|.||.||+|+++- ...||||.++.. +.+++|..|..+|++++||||++|.|+........||.|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 35789999999999999753 346999999976 45678999999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF 489 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~ 489 (640)
+||+|+.||+.+.+ .|.+.+...+.++||.||.||- +.++|||||.++|||++.+..+||+|||++|.+....
T Consensus 713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999997753 4899999999999999999999 5569999999999999999999999999999875422
Q ss_pred ---cc------cccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC-cchHHHHHHhhccccccc
Q 006559 490 ---FI------NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGE-LGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 490 ---~~------~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~-~~~~~~~~~~~~~~~~~~ 558 (640)
+. ...|.||| .+..+++|.+||||||||||||.++ |..||.+-. .+.+ +.+.+
T Consensus 786 ~~~ytt~GGKIPiRWTAPE-------AIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI---kaIe~------ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPE-------AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---KAIEQ------ 849 (996)
T ss_pred CccccccCCccceeecChh-------HhhhcccCchhhccccceEEEEecccCCCcccccchHHHH---HHHHh------
Confidence 22 34688998 5778999999999999999999988 999987422 1121 11111
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
+.++.. ..+++..|.++|+.||++|-.+||.+.+++..|.++...
T Consensus 850 --gyRLPp---PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 --GYRLPP---PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred --ccCCCC---CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 112211 236777899999999999999999999999999997644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=324.04 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=190.2
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.++|+|+||+|||++.+ +|+.||||++.+..+ ++-..+|+++|++++|+|+|.++++|..+..++||+|||+.--
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 46899999999999964 589999999987644 3456789999999999999999999999999999999999865
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC------C
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------T 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------~ 487 (640)
|++.-+... -++.....+++.|+++|+.|+|+. ++|||||||+|||+..+|.+||||||.|+.+. +
T Consensus 88 L~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 88 LHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred HHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 555443322 367788999999999999999955 49999999999999999999999999999876 3
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC-CcchHHH-HHHhhcc-cccccccch--
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG-ELGIVKW-VQMMGQD-ESAWEVFDF-- 562 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~-~~~~~~~-~~~~~~~-~~~~~~~d~-- 562 (640)
.++.|.+|+|||++.+ ...|+..+||||.||++.||+||++-|.+. +.+..-. ++.++.- .....++..
T Consensus 160 DYVATRWYRaPELLvG------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVG------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred hhhhhhhccChhhhcc------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 4567999999998744 356778999999999999999999988742 3332222 2222211 111111110
Q ss_pred -----hhccC---h----HHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 563 -----ELIMD---K----EMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 563 -----~~~~~---~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
.+... + .++....-+++++..|++.||++|++-++++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11111 1 1222334678999999999999999998885
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=352.55 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=200.5
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|.||+||+|+|.+ .||||.+... ..-+.|..|+..+++-+|.||+-|+|||..+.. .||..+|++-
T Consensus 396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 36789999999999999864 6899999865 234678999999999999999999999997766 9999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC------
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------ 486 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------ 486 (640)
+|+.+||..+ ..|+..+.+.||.|||+||.|||. .+|||||||+.||+|+++++|||.||||+..-.
T Consensus 473 SLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 473 SLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred hhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 9999999764 368999999999999999999995 459999999999999999999999999975421
Q ss_pred --CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 487 --TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 487 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
....+...|||||++++. ....|+..+||||||||+|||+||..||..+..+.+-|...-+ ....|..
T Consensus 546 q~~qp~gsilwmAPEvIRmq----d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG-----~l~pd~s- 615 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQ----DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG-----YLMPDLS- 615 (678)
T ss_pred ccCCCccchhhhcHHHHhhc----ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc-----ccCccch-
Confidence 122346689999998753 3568899999999999999999999999854433333322111 0111211
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
....++.+++.+++..||..++++||.+.+++..|+++..
T Consensus 616 ---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 ---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1223555667777788999999999999999999988775
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=342.47 Aligned_cols=251 Identities=20% Similarity=0.368 Sum_probs=198.7
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccc-cchHHH--HHHHHHHhccC-CCcccceeEEEEcCC-eEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRER-KKKREV--DEWLRVIGGLR-HSNIVSIRAYCNGKD-ELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~~~~--~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~lV~Ey~~ 410 (640)
..+.||.|.||.||+|+ ...|..||||+++.+ ...++. .+|+..|++|+ |||||++.+++.+.+ .+|+|||||+
T Consensus 14 ~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md 93 (538)
T KOG0661|consen 14 VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD 93 (538)
T ss_pred HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh
Confidence 45679999999999998 567899999999877 334443 47899999999 999999999999888 9999999997
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
. +|+++++... .+|+...+..|+.||.+||+|+| +.++.|||+||+|||+.....+||+|||+||....
T Consensus 94 ~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 94 C-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred h-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 6 9999998653 47999999999999999999999 56699999999999999999999999999998753
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC-Ccc-hHHHHHHhhcccc-cccc---
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG-ELG-IVKWVQMMGQDES-AWEV--- 559 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~-~~~-~~~~~~~~~~~~~-~~~~--- 559 (640)
.++.|.+|+|||++. ....|+.+.||||+||+++|+++-++-|.+. +.+ +-+..+.++.... .|..
T Consensus 166 YTeYVSTRWYRAPEvLL------rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLL------RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cchhhhcccccchHHhh------hccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 456699999999974 4566788999999999999999999888742 322 3333444443221 1110
Q ss_pred ------cchhhcc----ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 560 ------FDFELIM----DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 560 ------~d~~~~~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
++..... ..-+.....+.++++.+|+++||.+|||+.++++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000000 01123355678889999999999999999998763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.59 Aligned_cols=248 Identities=23% Similarity=0.410 Sum_probs=193.9
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~~ 410 (640)
.++||+|.||.||+|+ ..+|..||+|+++-... -.-..+||.+|++|+||||++|.+..... ..+|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 5679999999999999 67899999999986532 24456899999999999999999998876 68999999998
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
. ||.-++.... ..|+..++..++.|++.||+||| ..+|+|||||.+|||||.+|.+||+|||||+++...
T Consensus 202 h-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 202 H-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred c-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 8 8888876532 46899999999999999999999 456999999999999999999999999999987542
Q ss_pred -----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC-Ccc-hHHHHHHhhc-cccccccc
Q 006559 489 -----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG-ELG-IVKWVQMMGQ-DESAWEVF 560 (640)
Q Consensus 489 -----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~-~~~-~~~~~~~~~~-~~~~~~~~ 560 (640)
.+.|.+|+|||+++++ ..|+.++|+||.||||.||++|++.+.+. +.. +....+.++. .+..|...
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~------t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGA------TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cccccceEEeeccChHHhcCC------cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 3458999999998654 56778999999999999999999998753 222 2223333332 23334432
Q ss_pred chh--------hccChHHHHH----HHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 561 DFE--------LIMDKEMEEE----MRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 561 d~~--------~~~~~~~~~~----~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
+.. ..+...+.+. ....++++-.+|..||.+|.|+.+++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 222 1111112222 23567777778999999999988876
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=329.77 Aligned_cols=229 Identities=23% Similarity=0.366 Sum_probs=186.0
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..++||+|+||+||.++. +.++.+|+|.++++ ...+....|..+|.+++||.||++...|++.+.+|||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 357899999999999985 55889999999876 234567789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
||.|..+|...+ .++......++.+|+.||.||| +.+||||||||+|||||++|+++|+||||++..-
T Consensus 109 GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 109 GGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred CccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999998664 5888888889999999999999 5569999999999999999999999999998642
Q ss_pred --CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 487 --TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 487 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
..+++|..|||||++.. ..|+..+|+||+||++|||++|.+||.... ..++.+...+... .
T Consensus 181 ~t~tfcGT~eYmAPEil~~-------~gy~~~vDWWsLGillYeML~G~pPF~~~~--~~~~~~~I~~~k~--------~ 243 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLG-------KGYDKAVDWWSLGILLYEMLTGKPPFYAED--VKKMYDKILKGKL--------P 243 (357)
T ss_pred ccccccCCccccChHHHhc-------CCCCcccchHhHHHHHHHHhhCCCCCcCcc--HHHHHHHHhcCcC--------C
Confidence 34678999999998643 467789999999999999999999997543 3444444333220 1
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCC
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRP 593 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 593 (640)
..+.....+.++ +....+..||++|-
T Consensus 244 ~~p~~ls~~ard---ll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 LPPGYLSEEARD---LLKKLLKRDPRQRL 269 (357)
T ss_pred CCCccCCHHHHH---HHHHHhccCHHHhc
Confidence 111223344444 44558899999995
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=351.31 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=195.9
Q ss_pred hccccccCcceEEEEEeCC--C--cE-EEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLDG--G--DV-VVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~--~--~~-vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
.++||+|+||.||+|++.. + .. ||||..+.. ...+++..|.++|++++|||||+++|++..+..+++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 3789999999999999643 2 23 899998852 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
+|++|+|.++|+...+ .++..++++++.+.|+||+|||+ ..+|||||.++|||++.++.+||+|||+++.-..
T Consensus 242 l~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred ecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 9999999999997653 48899999999999999999995 4599999999999999999999999999876531
Q ss_pred ------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhcccccccc
Q 006559 488 ------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 488 ------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 559 (640)
.......|+|||. .....|+.++|||||||++||+++ |..||.+-.. ....++....
T Consensus 315 ~~~~~~~~klPirWLAPEt-------l~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~-------- 379 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPET-------LNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG-------- 379 (474)
T ss_pred eeeccccccCcceecChhh-------hccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC--------
Confidence 1112457999994 566689999999999999999999 8889875332 2222221111
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
.....+...+. .+..++..||..+|++||+|.++.+.++.+.....
T Consensus 380 --~r~~~~~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 --YRMPIPSKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --ccCCCCCCCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11111122233 34555668999999999999999999999886543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=344.96 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=206.0
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.++||-|-||.||.|.|+. .-.||||.+++. ..-++|..|..+|+.++|||+|+|+|+|..+..+|||.|||..|+|.
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL 351 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL 351 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence 4689999999999999865 456999999987 45688999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCccc----
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFI---- 491 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~~~---- 491 (640)
+||++... ..++--..+.+|.||+.||+||. +.++|||||.++|+|+.++-.+||+||||++++....+.
T Consensus 352 dYLRecnr---~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 352 DYLRECNR---SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred HHHHHhch---hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence 99997653 34566678899999999999999 566999999999999999999999999999998643322
Q ss_pred ---cccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 492 ---NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 492 ---~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...|.||| ......|+.|+|||+|||+|||+.| |..||.+-+...+ ...+... .++.
T Consensus 426 AKFPIKWTAPE-------sLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV--Y~LLEkg--------yRM~-- 486 (1157)
T KOG4278|consen 426 AKFPIKWTAPE-------SLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YGLLEKG--------YRMD-- 486 (1157)
T ss_pred ccCcccccCcc-------cccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH--HHHHhcc--------cccc--
Confidence 44688888 5667788999999999999999999 8889875332211 1111111 1111
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCCC
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSID 612 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 612 (640)
..+.|..+++++|+.||+++|.+||+++|+++.++.+....++.
T Consensus 487 -~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 487 -GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred -CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 22356678999999999999999999999999999988776654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=344.27 Aligned_cols=237 Identities=24% Similarity=0.407 Sum_probs=191.9
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHh
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSL 417 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 417 (640)
.+-||.|+.|.||+|+++ ++.||||++++- -+.+|+-|++|+||||+.|.|+|....-+|||||||+.|-|+++
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-----kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-----KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh-----hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 356999999999999987 477899987643 23467889999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----Ccccc
Q 006559 418 LHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-----PFFIN 492 (640)
Q Consensus 418 l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-----~~~~~ 492 (640)
|+..+ ++.-.....+..+||.||.|||.+ +|||||||+-||||..+..+||+|||.++.+.. .+.+|
T Consensus 203 Lka~~-----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT 274 (904)
T KOG4721|consen 203 LKAGR-----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT 274 (904)
T ss_pred HhccC-----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence 98654 577788889999999999999954 499999999999999999999999999887643 46789
Q ss_pred ccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHH
Q 006559 493 DAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEE 572 (640)
Q Consensus 493 ~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 572 (640)
..|||||++. ....++|+||||||||||||+||..||.+.+...+-|-.. . .-..+.++ +.
T Consensus 275 VaWMAPEvIr-------nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG--s-------NsL~LpvP---st 335 (904)
T KOG4721|consen 275 VAWMAPEVIR-------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG--S-------NSLHLPVP---ST 335 (904)
T ss_pred HhhhCHHHhh-------cCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc--C-------CcccccCc---cc
Confidence 9999999754 4556689999999999999999999997654333333111 0 01112222 34
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 573 EMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 573 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
++.-+.-++.+||+..|..||++++++..|+-...
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 45556666778999999999999999988865433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=306.69 Aligned_cols=251 Identities=23% Similarity=0.400 Sum_probs=197.6
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+++|+|.||.||+|+ ..+|+.||||+++.... .....+|+..|+.++|+||+.+.++|...+.+-||+|||+.
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT 85 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence 35679999999999999 56799999999987633 34567899999999999999999999999999999999986
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc--
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF-- 489 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~-- 489 (640)
+|...++... ..+...++..++.++.+||+|||. ..|+||||||.|+|++++|.+||+|||+++.+.++.
T Consensus 86 -dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 86 -DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred -cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9999998654 468889999999999999999995 459999999999999999999999999999987532
Q ss_pred ----cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC-CCcchH-HHHHHhhcc-ccccc----
Q 006559 490 ----FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD-GELGIV-KWVQMMGQD-ESAWE---- 558 (640)
Q Consensus 490 ----~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~-~~~~~~-~~~~~~~~~-~~~~~---- 558 (640)
+.|.+|+|||++. ..+.|+..+||||.||++.||+-|.+-|.+ .+.+.. ...+.++.. +..|.
T Consensus 158 ~~~~V~TRWYRAPELLf------Gsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLF------GSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cccceeeeeccChHHhc------cchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 4588999999974 456788899999999999999998876653 222222 223333321 22221
Q ss_pred ccchhh-------ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 559 VFDFEL-------IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 559 ~~d~~~-------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
.-|... ....-...+..++++++..++..||.+|++++|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111110 0000122344567899999999999999999998753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=337.72 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=200.6
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|-||.|.++...++..||||.++.. ..+++|.+|+++|.+++|||||.++|+|..++.+++|+|||++|+
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 35789999999999999999999999999976 345789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-Cc---
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-PF--- 489 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-~~--- 489 (640)
|.+|+..+..+ .+.-...++|+.|||.||+||.+.+ +|||||.++|||+|.++++||+|||+++.+.. ++
T Consensus 622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999877532 2345667889999999999999665 99999999999999999999999999986543 22
Q ss_pred ----cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh--CCCCCCCCC-cchHHHHHHhhcccccccccch
Q 006559 490 ----FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT--GKMAKGDGE-LGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 490 ----~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t--g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
+....|||+| .+.-+++|+++|||+|||++||+++ .+.||.+-. ...++-...+..+....
T Consensus 696 qgr~vlpiRwmawE-------sillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~----- 763 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWE-------SILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ----- 763 (807)
T ss_pred ecceeeeeeehhHH-------HHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc-----
Confidence 2246799999 4566789999999999999999987 678887422 12222222222211111
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.......-+...+++++++||..+-++||++++++..|++.
T Consensus 764 --~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 --VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 01111234566788999999999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=340.61 Aligned_cols=250 Identities=21% Similarity=0.378 Sum_probs=190.7
Q ss_pred hhccccccCcceEEEEEe------CCCcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcC-CeEEEE
Q 006559 337 SAELLGKGCVGATYKVVL------DGGDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGK-DELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~------~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lV 405 (640)
..++||+|+||.||+|.. ..+..||||.++... ..+.+..|++++.++ +||||++++++|... +..++|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 357899999999999974 234679999997542 234577899999999 899999999998764 468999
Q ss_pred EeccCCCCHHHhhccCCCC---------------------------------------------------------CCCC
Q 006559 406 YDYLPHGSLHSLLHGSRGP---------------------------------------------------------GRMP 428 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~ 428 (640)
|||+++|+|.+++...... ...+
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 9999999999998753210 0135
Q ss_pred cCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--------ccccccccCCcc
Q 006559 429 VDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--------FFINDAYNAPEL 500 (640)
Q Consensus 429 l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~ 500 (640)
+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ...+..|+|||+
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 7888999999999999999994 56999999999999999999999999999764321 122467999996
Q ss_pred ccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHH
Q 006559 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQ 579 (640)
Q Consensus 501 ~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~ 579 (640)
+ ....++.++|||||||++|||+| |+.||....... ...+....... . . .+ ......+.+
T Consensus 248 ~-------~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~-~-----~--~~---~~~~~~l~~ 308 (338)
T cd05102 248 I-------FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGTR-M-----R--AP---ENATPEIYR 308 (338)
T ss_pred h-------hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhcCCC-C-----C--CC---CCCCHHHHH
Confidence 4 34557789999999999999997 999997533221 11111111100 0 0 01 112335778
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 580 VALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 580 l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
++.+||+.||++|||+.|++++|+++..+
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 88899999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=329.75 Aligned_cols=244 Identities=18% Similarity=0.264 Sum_probs=192.5
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc-c----hHHHHHHHHHHhccCCCcccceeEEEEc----CCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK-K----KREVDEWLRVIGGLRHSNIVSIRAYCNG----KDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~----~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey 408 (640)
...||+|++|.||+|.+ +|+.||||.++... . .+.+.+|++++++++|||||+++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 45799999999999998 57899999987542 1 2556789999999999999999999876 3478999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP 488 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~ 488 (640)
+++|+|.+++.... .++|....+++.|++.||.|||.. .+++||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 99999999997643 578999999999999999999953 25789999999999999999999999998865432
Q ss_pred ---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 489 ---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 489 ---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
..++..|+|||++.+ ....++.++|||||||++|||+||+.||..... ............ ...
T Consensus 177 ~~~~~~~~~y~aPE~~~~-----~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~~~i~~~~~-------~~~ 242 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLND-----IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIYDLIINKNN-------SLK 242 (283)
T ss_pred cccccCcccccCHHHhhh-----ccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCC-------CCC
Confidence 345778999997532 124678999999999999999999999975322 222222211110 001
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.+. .....+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 243 ~~~---~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 LPL---DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCC---cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111 12334667788899999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.30 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=189.0
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCC--eEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD--ELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lV~Ey~~~ 411 (640)
..+.||+|+||.||++... +|...|||.+.... ..+.+++|+++|.+++|||||+++|...... .+++.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 4678999999999999965 48999999987552 1456889999999999999999999855444 69999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCcccccCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~~~~~--- 487 (640)
|+|.+++...++ .++...+.+++.||++||+|||+ .+||||||||+|||++. ++.+||+|||+++....
T Consensus 101 GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 101 GSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred CcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999987652 48899999999999999999994 55999999999999999 79999999999876542
Q ss_pred ------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 488 ------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 488 ------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
...+|+.|||||+... ......++||||+||++.||+||+.||.+. .....++-........
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~~----- 241 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRN------GEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDSL----- 241 (313)
T ss_pred cccccccccCCccccCchhhcC------CCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCCC-----
Confidence 3456899999997632 112225899999999999999999999753 2223332222222111
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
+ ..+...+++ ..+++..|++.+|++|||+.++++.---
T Consensus 242 P--~ip~~ls~~---a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 242 P--EIPDSLSDE---AKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred C--CCCcccCHH---HHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1 112223343 4455666999999999999999765433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.83 Aligned_cols=235 Identities=21% Similarity=0.344 Sum_probs=188.7
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccc-----cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRER-----KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
+.+.||+|+|++||+|+ ...+.++|||++.++ +..+-+..|-..|.+| .||.||+|+..|++...+|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 47889999999999999 456889999998765 2234456677778888 8999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC---
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--- 486 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~--- 486 (640)
++|+|.+++++.+ .|+......++.+|..||+|||+ .+||||||||+|||||+||++||.|||-++.+.
T Consensus 157 ~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 157 PNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred CCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999775 58888888999999999999994 559999999999999999999999999988763
Q ss_pred ----------------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHh
Q 006559 487 ----------------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM 550 (640)
Q Consensus 487 ----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 550 (640)
..+++|..|.+||++ .....+..+|+|+|||+||+|+.|++||.+....+. +
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-------~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-F---- 296 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELL-------NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-F---- 296 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHh-------cCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-H----
Confidence 125679999999975 344566789999999999999999999975321111 1
Q ss_pred hcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 551 GQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 551 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+|.+.....++..++. +.+++.+.+..||.+|++.+++.+
T Consensus 297 ------qkI~~l~y~fp~~fp~~---a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 ------QKIQALDYEFPEGFPED---ARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ------HHHHHhcccCCCCCCHH---HHHHHHHHHccCccccccHHHHhh
Confidence 12233333333333444 344555578899999999988864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=318.14 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=193.6
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..++||.|..++||+|+ .+.++.||||++.-.+ .-.++.+|+..++.++||||++++..|..+..+|+||.||.+|
T Consensus 30 L~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 30 LQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCC
Confidence 35789999999999999 5678999999997552 2366788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC------
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------ 486 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------ 486 (640)
++.++++..-.. -+++..+..|.+++.+||.||| ..+.||||||+.||||+.+|.+||+|||.+..+.
T Consensus 110 S~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 110 SLLDIIKTYYPD---GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999865432 3788889999999999999999 5569999999999999999999999999754432
Q ss_pred ----CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 487 ----TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 487 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
..+.+++.|||||+++. ....|+.|+||||||++..||++|..||......-+-..+......... .
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q-----~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~----t 254 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQ-----QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL----T 254 (516)
T ss_pred eEeeccccCcccccChHHhhh-----cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc----c
Confidence 34567999999998743 3356789999999999999999999999753322111111111111110 0
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....++.....+.+.+++..|+..||++|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 01111122233345667777799999999999999873
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.73 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=195.6
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHh--ccCCCcccceeEEEEcCC----eEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIG--GLRHSNIVSIRAYCNGKD----ELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~~----~~~lV~Ey~~ 410 (640)
..++||+|+||.||||++.+ +.||||++... .++.+..|-++.+ .++|+||++|+++-.... +++||+||.+
T Consensus 214 l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ-EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred hHHHhhcCccceeehhhccC-ceeEEEecCHH-HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 35689999999999999875 89999998754 3344555555444 679999999999876555 8999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC------CCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY------NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
+|+|.+||..+ .++|....+|+..+++||+|||+. .+++|+|||||++|||+.+|+++.|+|||+|..
T Consensus 292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999876 589999999999999999999964 357899999999999999999999999999987
Q ss_pred cCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCC--CCCcchHHHHHHhhccc
Q 006559 485 FHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG--DGELGIVKWVQMMGQDE 554 (640)
Q Consensus 485 ~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~--~~~~~~~~~~~~~~~~~ 554 (640)
+... .++|.+|||||++.++..... ...-.+.||||+|.|||||+++-..++ ........+-..++..+
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d-~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD-RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhccccc-HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 7532 367999999999987755432 333357999999999999999764332 11111112222222222
Q ss_pred cccccc--------chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 555 SAWEVF--------DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 555 ~~~~~~--------d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...++- .+.+...=.....+.-+.+.+-.||..||+.|-|+.=|.+.+.++..-
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111110 011100000013355677788889999999999999999999887754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=330.37 Aligned_cols=236 Identities=21% Similarity=0.328 Sum_probs=191.4
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
-+.||+|+.|.||.++ ...++.||||++... ..++-+..|+.+|+..+|+|||.+++.|.-.+++|.|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 3579999999999998 567889999999765 3344577999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+.+... .+++.++..|++++++||+||| ..+|+|||||.+|||++.+|.+||+|||++..+.. .
T Consensus 358 TDvVt~~------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 358 TDVVTKT------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred hhhhhcc------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 9999765 3889999999999999999999 45599999999999999999999999999877643 3
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
.++|+.|||||+ .....|++|.||||||++++||+-|++||-.+.--.+-|+-... -.+++...+
T Consensus 429 mVGTPYWMAPEV-------vtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n--------g~P~lk~~~ 493 (550)
T KOG0578|consen 429 MVGTPYWMAPEV-------VTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------GTPKLKNPE 493 (550)
T ss_pred ccCCCCccchhh-------hhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc--------CCCCcCCcc
Confidence 567999999996 45667889999999999999999999999743221121211111 112222223
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.++.+ +.++..+|+..||++||++.|+++
T Consensus 494 klS~~---~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 494 KLSPE---LKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ccCHH---HHHHHHHHhhcchhcCCCHHHHhc
Confidence 33333 445556699999999999999975
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=324.10 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=187.8
Q ss_pred hccccccCcceEEEEEeCC-----------------CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEE
Q 006559 338 AELLGKGCVGATYKVVLDG-----------------GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCN 397 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~ 397 (640)
.+.||+|+||.||+|..++ +..||+|.+.... ...++.+|++++.+++||||+++++++.
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 5679999999999997532 3369999987642 2456888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHhhccCCC--------------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCC
Q 006559 398 GKDELFLVYDYLPHGSLHSLLHGSRG--------------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSS 463 (640)
Q Consensus 398 ~~~~~~lV~Ey~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~ 463 (640)
..+..++||||+++|+|.+++..... .....++|..+.+++.|++.||+|||+ .+|+||||||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dlkp 166 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLAT 166 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCcch
Confidence 99999999999999999999864321 011247888999999999999999995 4599999999
Q ss_pred CCeEECCCCCeEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh--CC
Q 006559 464 SNIVVDQLGNACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT--GK 533 (640)
Q Consensus 464 ~NILl~~~~~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t--g~ 533 (640)
+|||++.++.+||+|||+++..... ...+..|+|||++ ....++.++|||||||++|||++ +.
T Consensus 167 ~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI-------LMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred hheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH-------hcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999998765321 1225679999964 33457789999999999999987 55
Q ss_pred CCCCCCC-cchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 534 MAKGDGE-LGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 534 ~p~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
.||.... ......+.......... .. ...+ ..+...+.+++.+||+.+|++||||.+|++.|++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~---~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQ-VY---LFRP---PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhcccc-cc---ccCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6776421 11222221111110000 00 0000 1223457788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.94 Aligned_cols=250 Identities=20% Similarity=0.255 Sum_probs=202.0
Q ss_pred HhhccccccCcceEEEEEeCCC-cEEEEEEeccc--cchHHHHHHHHHHhccC-CCcccceeEE-EEc------CCeEEE
Q 006559 336 SSAELLGKGCVGATYKVVLDGG-DVVVVKRIRER--KKKREVDEWLRVIGGLR-HSNIVSIRAY-CNG------KDELFL 404 (640)
Q Consensus 336 ~~~~~iG~G~fg~Vy~~~~~~~-~~vavK~l~~~--~~~~~~~~e~~~l~~l~-H~niv~l~~~-~~~------~~~~~l 404 (640)
...++|.+|||+.||.|....+ ..+|+|++-.. ..-+.+.+|+++|++|+ |+|||.+++. ... .-+++|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3467899999999999997665 99999998654 34567889999999998 9999999993 221 237899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
.||||++|.|-+++...... .|+..++++|+.|+|+|+++||.. +++|||||||-+||||..++..||||||-+..
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred ehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 99999999999998754321 389999999999999999999976 68899999999999999999999999997653
Q ss_pred cCC---------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHH
Q 006559 485 FHT---------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQM 549 (640)
Q Consensus 485 ~~~---------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~ 549 (640)
--. ..+.|+.|++||++. .+....+++|+||||+||+||.|+..+.||++.+
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID----lysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------- 262 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID----LYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------- 262 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHh----hhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------
Confidence 210 124588999999863 4667789999999999999999999999997542
Q ss_pred hhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 550 MGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 550 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
...|++.....++. +.....+.+|+..||+++|.+||++-+|+..+-++..+.
T Consensus 263 ------~laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 ------KLAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------ceeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12344444333321 344455667777899999999999999999999987653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=328.16 Aligned_cols=243 Identities=21% Similarity=0.297 Sum_probs=192.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-------cchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-------KKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|.||+||.|+. ..+..||+|.+..+ ...+.+.+|+.+++.++ ||||+++++++......|+||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 56799999999999974 56799999976653 12345667999999999 99999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-CCeEEccCCcccccC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-GNACISDIGVHQLFH- 486 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGl~~~~~- 486 (640)
+.+|+|.+++.... ++.+....+++.|++.|++|||+ .+|+||||||+|||+|.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 102 CSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred cCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 99999999998733 57788999999999999999994 559999999999999999 999999999998772
Q ss_pred -----CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 487 -----TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 487 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
...++++.|+|||++.+.+. ....++||||+||+||.|++|+.||++........ . +..
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~-----Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~--k---------i~~ 237 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGT-----YSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR--K---------IRK 237 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCC-----cCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH--H---------Hhc
Confidence 24578999999998754431 11468999999999999999999998633221111 1 111
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
.+...+.... ..++..++.+|+..+|.+|+++.++. .-..++.
T Consensus 238 ~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 238 GEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1111222221 33466677789999999999999998 5555554
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=333.40 Aligned_cols=247 Identities=22% Similarity=0.345 Sum_probs=189.4
Q ss_pred hhccccccCcceEEEEEe------CCCcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVL------DGGDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~------~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||+|+. ..+..||||+++... ..+.+.+|++++..+ +||||++++++|...+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 467899999999999973 235579999987542 234577899999999 8999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCC--------------------------------------------------------------
Q 006559 407 DYLPHGSLHSLLHGSRGP-------------------------------------------------------------- 424 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~-------------------------------------------------------------- 424 (640)
|||++|+|.++++.....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999999999998653210
Q ss_pred --------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--------
Q 006559 425 --------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------- 488 (640)
Q Consensus 425 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------- 488 (640)
....++|..+.+++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 11257899999999999999999994 56999999999999999999999999998765321
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||....... .+.+........ . .+
T Consensus 276 ~~~~~~y~aPE~~-------~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~---~-----~~ 339 (375)
T cd05104 276 ARLPVKWMAPESI-------FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYRM---L-----SP 339 (375)
T ss_pred CCCCcceeChhHh-------cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCccC---C-----CC
Confidence 1124569999964 33457789999999999999998 888886432111 111111111000 0 00
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
. ....++.+++..||+.||++||+|.+|+++|++.
T Consensus 340 ~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 E---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 1123567788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=317.64 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=190.2
Q ss_pred hhccccccCcceEEEEEeC----CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD----GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|.+. .+..||+|.++... ..+.+.+|+..+++++||||+++++++...+..++||||+
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeC
Confidence 3578999999999999853 35679999988652 2346788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++.... ..++|..++.++.|++.||+||| +.+++||||||+|||++.++.+|++|||........
T Consensus 89 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 89 SNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999997543 25889999999999999999999 456999999999999999999999999987654221
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
...+..|+|||++ ....++.++|||||||++||+++ |+.||..... ....+.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~~~------ 226 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAI-------QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QDVIKAVEDGFR------ 226 (266)
T ss_pred hhcccCCCCceeecCHHHH-------hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCCC------
Confidence 1224579999964 34567789999999999999875 9999974321 112222211100
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.... ......+.+++..||+.+|++||++.++.+.|+++
T Consensus 227 --~~~~---~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 --LPAP---RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCC---CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011 12334577788899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=303.61 Aligned_cols=259 Identities=23% Similarity=0.381 Sum_probs=196.5
Q ss_pred CccChHHHHHHhhccccccCcceEEEEEe-CCCcEEEEEEeccccchH----HHHHHHHHHhccCCCcccceeEEEEc--
Q 006559 326 GFRNVGDLLKSSAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKR----EVDEWLRVIGGLRHSNIVSIRAYCNG-- 398 (640)
Q Consensus 326 ~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~----~~~~e~~~l~~l~H~niv~l~~~~~~-- 398 (640)
..+++++..+ .+.|++|.||.||+|+. +++++||+|+++-.+.+. -..+||.+|.+.+|||||.+..+...
T Consensus 71 gCrsv~efe~--lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 71 GCRSVEEFEK--LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred CcccHHHHHH--HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 3446665543 57899999999999994 568899999998664332 24689999999999999999988765
Q ss_pred CCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEcc
Q 006559 399 KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478 (640)
Q Consensus 399 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 478 (640)
-+..|||||||+. +|..++..-. .++...+...+..|+.+|++|||+. .|+|||||++|+|+.+.|.+||+|
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaD 220 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIAD 220 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecc
Confidence 3679999999987 9999998654 3688889999999999999999954 599999999999999999999999
Q ss_pred CCcccccCCC------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC-CCcc-hHHHHHHh
Q 006559 479 IGVHQLFHTP------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD-GELG-IVKWVQMM 550 (640)
Q Consensus 479 fGl~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~-~~~~-~~~~~~~~ 550 (640)
||+|+.++.+ .+.|.+|+|||++.++ ..|++..||||+|||+.||+++++-|.+ .+.+ +....+.+
T Consensus 221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~------~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll 294 (419)
T KOG0663|consen 221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGA------KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL 294 (419)
T ss_pred cchhhhhcCCcccCcceEEEeeecCHHHhcCC------cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence 9999998765 3458999999998554 5567899999999999999999988874 2333 33334444
Q ss_pred hc-ccccccccchhh-------ccCh--HHH----H--HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 551 GQ-DESAWEVFDFEL-------IMDK--EME----E--EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 551 ~~-~~~~~~~~d~~~-------~~~~--~~~----~--~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+. .+..|.-++.-. ...+ ... . -...-.++....+..||++|-|+.|.++
T Consensus 295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 42 233333221110 0000 000 0 1134456667789999999999998864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=321.82 Aligned_cols=233 Identities=21% Similarity=0.330 Sum_probs=188.9
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-cch---HHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-KKK---REVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~---~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|.||.||||+.+ +.+.||+|.+.+. +.. +.+.+|++++++++|||||.++++|+...++|+|.||+.+
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 3567999999999999954 5788999998765 222 4578899999999999999999999999999999999976
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
+|+.+|.... .++++.+..++.++..||.|||+ .+|+|||+||.|||++..|.+|+||||+++.+..
T Consensus 86 -~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 86 -DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred -hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9999998654 58899999999999999999995 5599999999999999999999999999998754
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...+|+-|||||+.. .+.|+..+|.||+||++||+++|++||... .+.+.++.+..++..+
T Consensus 157 ltsikGtPlYmAPElv~-------e~pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d~v~~-------- 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVE-------EQPYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKDPVKP-------- 219 (808)
T ss_pred eeeccCcccccCHHHHc-------CCCccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcCCCCC--------
Confidence 345699999999754 455667899999999999999999999743 2333444444332221
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
+. +....+..+....+.+||.+|-+-.+++
T Consensus 220 -p~---~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 220 -PS---TASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred -cc---cccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 11 2223345555567899999999988775
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=323.49 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=203.8
Q ss_pred hHHHHHHhhccccccCcceEEEEEeCC---Cc--EEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCe
Q 006559 330 VGDLLKSSAELLGKGCVGATYKVVLDG---GD--VVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDE 401 (640)
Q Consensus 330 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~---~~--~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 401 (640)
+...+....+.||.|-||.||+|.+.+ |. -||||.-+.. ...+.|.+|.-+|++++|||||+|.|+|. ...
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccc
Confidence 334444567899999999999999644 22 3889988765 34667999999999999999999999998 457
Q ss_pred EEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCc
Q 006559 402 LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV 481 (640)
Q Consensus 402 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 481 (640)
.|||||.++-|.|.+||+..+. .++......++.||+.||+|||+. ++|||||.++|||+.....+|++|||+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 9999999999999999987652 578888999999999999999954 499999999999999999999999999
Q ss_pred ccccCCCccc-------cccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcc
Q 006559 482 HQLFHTPFFI-------NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 482 ~~~~~~~~~~-------~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 553 (640)
++.+....+. ...||||| +...++||.+||||-|||.+||++. |..||.+-....+ ...-
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPE-------SINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----I~~i 605 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPE-------SINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----IGHI 605 (974)
T ss_pred hhhccccchhhccccccceeecCcc-------ccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----EEEe
Confidence 9987653221 34677777 7888999999999999999999987 9999974221111 0000
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCC
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 611 (640)
+ ...++. ..+.|+..++.++.+||+.+|.+||.+.++...|.++..+.+.
T Consensus 606 E-----nGeRlP---~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 606 E-----NGERLP---CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred c-----CCCCCC---CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 0 011222 2246777899999999999999999999999999998775443
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=318.81 Aligned_cols=239 Identities=28% Similarity=0.515 Sum_probs=182.5
Q ss_pred hccccccCcceEEEEEeC-----CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD-----GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||.|.||.||+|.+. .+..|+||.++... ..+++.+|++.+++++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999977 24579999996542 2467889999999999999999999999888899999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
++|+|.++|+... ...+++..+..|+.|||+||+|||+. +++|+||+++||+++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 84 PGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999998762 23589999999999999999999954 599999999999999999999999999887621
Q ss_pred ------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 488 ------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 488 ------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
.......|+|||.+ ....++.++||||||+++|||+| |+.|+.+. ....+..........
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~-------~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~~~~~~~---- 224 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVL-------KDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKLKQGQRL---- 224 (259)
T ss_dssp SEEESTTSESGGGGS-HHHH-------HHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHHHTTEET----
T ss_pred cccccccccccccccccccc-------cccccccccccccccccccccccccccccccc--ccccccccccccccc----
Confidence 12235679999964 34457889999999999999999 67888643 223333333221110
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
..+ ......+.+++..||+.+|++||+|.++++.|
T Consensus 225 ----~~~---~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ----PIP---DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TSB---TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eec---cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 001 11233466788889999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=331.71 Aligned_cols=248 Identities=21% Similarity=0.342 Sum_probs=189.4
Q ss_pred hhccccccCcceEEEEEeC------CCcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLD------GGDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||+|+.. ++..||||+++... ....+.+|+++++.+ +|+|||+++++|...+..++||
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence 4678999999999998742 23579999997542 234577899999999 8999999999999999999999
Q ss_pred eccCCCCHHHhhccCCC---------------------------------------------------------------
Q 006559 407 DYLPHGSLHSLLHGSRG--------------------------------------------------------------- 423 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~--------------------------------------------------------------- 423 (640)
||+++|+|.++++....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 99999999999864310
Q ss_pred --CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--------ccccc
Q 006559 424 --PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--------FFIND 493 (640)
Q Consensus 424 --~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--------~~~~~ 493 (640)
....++++....+++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ...+.
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 278 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence 011257889999999999999999994 56999999999999999999999999998765321 11235
Q ss_pred cccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHH
Q 006559 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEE 572 (640)
Q Consensus 494 ~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 572 (640)
.|+|||++ ....++.++|||||||++|||++ |+.||....... .+.+...... ... ....
T Consensus 279 ~y~aPE~~-------~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~---~~~-----~~~~--- 339 (374)
T cd05106 279 KWMAPESI-------FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGY---QMS-----RPDF--- 339 (374)
T ss_pred ceeCHHHh-------cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHccc---Ccc-----CCCC---
Confidence 69999964 33457789999999999999998 999997532211 1111111100 000 0001
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 573 EMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 573 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
...++.+++.+||+.||++||++.+|+++|+++.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1235677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=311.02 Aligned_cols=238 Identities=23% Similarity=0.392 Sum_probs=189.9
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||++.+.++..+|+|.+... ....++..|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 88 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 4579999999999999988888999988754 345678889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~ 489 (640)
+++...+ .++|..+..++.|++.||+||| ..+|+||||||+||++++++.+||+|||+++..... .
T Consensus 89 ~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 89 YLRQRQG----KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred HHHhCcc----CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 9875432 4789999999999999999999 456999999999999999999999999998764321 1
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+..|+|||+. ....++.++|||||||++|||+| |+.||..... .+.+......... ..+.
T Consensus 162 ~~~~~y~aPE~~-------~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~---~~~~----- 224 (256)
T cd05114 162 KFPVKWSPPEVF-------NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRL---YRPK----- 224 (256)
T ss_pred CCchhhCChhhc-------ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCC---CCCC-----
Confidence 224579999964 33456789999999999999999 8999864321 1112222111110 0111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
.....+.+++.+||+.+|++||+|.++++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1123577888999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=327.56 Aligned_cols=235 Identities=22% Similarity=0.364 Sum_probs=191.4
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++.||+|+-|.|-.|+ ..+|+.+|||.+... .....+++|+.+|+-+.||||++++++++++.++|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 5679999999999998 467999999999765 1234578999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|.|++++-.++ ++...+..+++.||..|+.|+|+.+ |+||||||+|+|||..+.+||+|||+|..-.
T Consensus 97 GELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 97 GELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred chhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 99999998664 5888899999999999999999655 9999999999999999999999999997643
Q ss_pred CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 487 TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 487 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...++++.|.+||+..+.++. +.++||||.|||||.|+||+.||+++... .....+.+ ....+
T Consensus 169 eTSCGSPHYA~PEIV~G~pYd------G~~sDVWSCGVILfALLtG~LPFdDdNir--~LLlKV~~---------G~f~M 231 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYD------GRPSDVWSCGVILFALLTGKLPFDDDNIR--VLLLKVQR---------GVFEM 231 (786)
T ss_pred cccCCCcccCCchhhcCCCCC------CCccccchhHHHHHHHHhCCCCCCCccHH--HHHHHHHc---------CcccC
Confidence 346789999999998766554 35899999999999999999999864322 11111111 11112
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+..+.. +.-+++.+|+..||++|.|++||.+
T Consensus 232 Ps~Is~---eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 232 PSNISS---EAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CCcCCH---HHHHHHHHHhccCccccccHHHHhh
Confidence 222233 3445666799999999999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.07 Aligned_cols=233 Identities=20% Similarity=0.297 Sum_probs=183.8
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
++||+|+||.||+++. .+|+.||+|.++... ....+.+|++++++++||||+++.+++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 468899999987541 1234667899999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc
Confidence 9999987543 57899999999999999999995 4599999999999999999999999999875321
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||....... ......... ...
T Consensus 153 ~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~~~~~~---------~~~ 214 (323)
T cd05571 153 KTFCGTPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEE---------IRF 214 (323)
T ss_pred cceecCccccChhhh-------cCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHHHHcCC---------CCC
Confidence 23468899999965 33456789999999999999999999997533211 111111110 001
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
+... ..++.+++.+||+.||++|| ++.++++
T Consensus 215 p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTL---SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCC---CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1112 23456677789999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=311.26 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=191.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCC-----eEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD-----ELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~Ey~~~ 411 (640)
.+++|.|+||.||+|++. .++.||||+...... .-..|+.+|++++|||||+|..+|.... ...+||||||.
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~ 106 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE 106 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence 568999999999999964 468899999875532 2346788999999999999998886532 24589999997
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-CCeEEccCCcccccCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-GNACISDIGVHQLFHT--- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGl~~~~~~--- 487 (640)
+|.++++.... ....++...+.-+..|+.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||-|+.+..
T Consensus 107 -tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 107 -TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred -HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 99998874211 11235556677799999999999995 569999999999999966 9999999999998743
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC--cchHHHHHHhhccccc--c----
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE--LGIVKWVQMMGQDESA--W---- 557 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~--~---- 557 (640)
.+..|..|+|||++.+ ...|+.+.||||.|||+.||+-|++-|.++. ..++..++.++....- .
T Consensus 182 niSYicSRyYRaPELifg------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 182 NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred ceeEEEeccccCHHHHcC------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 3455889999999754 4567789999999999999999999887533 2355566666543211 0
Q ss_pred ---cccchhhccCh----HHHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHHHHhhcc
Q 006559 558 ---EVFDFELIMDK----EMEEEMRALLQVALLCLAPLPKDRPNMSIVH--RMIEDIRTK 608 (640)
Q Consensus 558 ---~~~d~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~--~~L~~i~~~ 608 (640)
+...+.+.... .......+.++++.+++..+|.+|.++.|++ ....+++..
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 01111111111 1123345788899999999999999999886 356666654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=310.50 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=192.3
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||+|...++..||+|.+... ...+.+.+|+.++++++|+||+++++++...+..++||||+++|+|.+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD 90 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence 5679999999999999888889999998754 335678889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~ 489 (640)
+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..... .
T Consensus 91 ~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05072 91 FLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164 (261)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence 9975432 257888999999999999999994 56999999999999999999999999999765431 1
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhcccccccccchhhccC
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..+..|+|||.. ....++.++|||||||++|||+| |+.||..... ....++.... ... ..
T Consensus 165 ~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------~~~--~~ 226 (261)
T cd05072 165 KFPIKWTAPEAI-------NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---------RMP--RM 226 (261)
T ss_pred ccceecCCHHHh-------ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---------CCC--CC
Confidence 224579999964 33456789999999999999999 9999964321 1121111100 000 00
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.....++.+++.+||+.+|++||++.++.+.|+++
T Consensus 227 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ---ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223567788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=320.39 Aligned_cols=246 Identities=20% Similarity=0.312 Sum_probs=191.2
Q ss_pred hhccccccCcceEEEEEeC-CCc----EEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLD-GGD----VVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~----~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..+.||+|+||.||+|++. ++. .||+|.++.. ...+++.+|+.+++.++||||++++|+|... ..++|+||
T Consensus 11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence 3567999999999999853 333 3899998754 2345678899999999999999999999764 67899999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP 488 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~ 488 (640)
+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 90 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred CCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999998643 247889999999999999999995 45999999999999999999999999999876421
Q ss_pred --------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 489 --------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 --------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||.+.... ++.+........
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~-------~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~--- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESI-------LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERL--- 230 (316)
T ss_pred CcceeccCCccceeecChHHh-------ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCCCC---
Confidence 1124579999964 34567789999999999999998 99999753221 121111111100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
..+ ..+..++.+++..||+.+|++||++.+++..+.++..+..
T Consensus 231 -----~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 231 -----PQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred -----CCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 000 1122356778889999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=311.09 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=184.1
Q ss_pred cccccCcceEEEEEeCC---CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 340 LLGKGCVGATYKVVLDG---GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.||+|+||.||+|...+ +..+|+|.++... ....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998654 3468999887542 23467789999999999999999999999899999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|.++++..........++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975432223356778888999999999999994 55999999999999999999999999998654321
Q ss_pred ---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcc-hHHHHHHhhcccccccccchh
Q 006559 489 ---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELG-IVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 489 ---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~ 563 (640)
..++..|+|||++...........++.++|||||||++|||++ |+.||...... ...+. .. .......++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~~-~~~~~~~~~~ 234 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VR-EQQLKLPKPR 234 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---hh-cccCCCCCCc
Confidence 2235679999976422111112346789999999999999997 99999643211 11111 00 0011111111
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
+.. ...+ .+.+++..|| .+|++|||+.||++.|+
T Consensus 235 ~~~--~~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LKL--PLSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCC--CCCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111 1112 3455667798 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.85 Aligned_cols=238 Identities=19% Similarity=0.248 Sum_probs=184.9
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||++.. .+++.||||.+.... ....+.+|++++++++|+||+++.+++...+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 46799999999999985 578999999986531 223467899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99998876432 1258899999999999999999994 5699999999999999999999999999876532
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-H-HHHHHhhcccccccccchhh
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-V-KWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-~-~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++ ....++.++|||||||++|||++|+.||....... . ....... ....
T Consensus 159 ~~~~g~~~y~aPE~~-------~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~ 222 (285)
T cd05631 159 RGRVGTVGYMAPEVI-------NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK---------EDQE 222 (285)
T ss_pred cCCCCCCCccCHhhh-------cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh---------cccc
Confidence 23458899999964 34567889999999999999999999997532211 1 1111100 0000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPN-----MSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~ 600 (640)
...... ..++.+++.+||+.||++||+ +.++.+
T Consensus 223 ~~~~~~---s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKF---SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccC---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111112 234667788899999999997 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.86 Aligned_cols=231 Identities=22% Similarity=0.296 Sum_probs=181.4
Q ss_pred ccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 341 LGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 341 iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
||+|+||.||+|+.. ++..||+|.++.. .....+..|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5788999998753 1234566789999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence 99997543 47889999999999999999994 5699999999999999999999999999875421 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||++ ....++.++|||||||++|||+||+.||..... .+..+..... ....+.
T Consensus 153 ~~gt~~y~aPE~~-------~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--~~~~~~~~~~---------~~~~~~ 214 (312)
T cd05585 153 FCGTPEYLAPELL-------LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--NEMYRKILQE---------PLRFPD 214 (312)
T ss_pred ccCCcccCCHHHH-------cCCCCCCccceechhHHHHHHHhCCCCcCCCCH--HHHHHHHHcC---------CCCCCC
Confidence 3468899999965 344577899999999999999999999975432 2222221111 011111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+ .++.+++.+||+.||++||++..+.+
T Consensus 215 ~~~---~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 215 GFD---RDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred cCC---HHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 122 34566778899999999986544433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.71 Aligned_cols=243 Identities=23% Similarity=0.414 Sum_probs=193.8
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|...++..||+|.++.. ...+++.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred eEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 35789999999999999888888999998765 34567889999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCcc-----
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFF----- 490 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~~----- 490 (640)
+++.... ...+++..+..++.|++.||.||| ..+|+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 9997543 125789999999999999999999 45699999999999999999999999999887643211
Q ss_pred --ccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 491 --INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 491 --~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
.+..|+|||+. ....++.++|||||||++|||+| |+.||...... .-........ . ....
T Consensus 164 ~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~------~--~~~~ 226 (261)
T cd05068 164 AKFPIKWTAPEAA-------LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGY------R--MPCP 226 (261)
T ss_pred CcCceeccCcccc-------ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC------C--CCCC
Confidence 12469999954 34567789999999999999999 99998643211 1111111100 0 0001
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
......+.+++.+|++.+|++||++.++.+.|+++
T Consensus 227 ---~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 ---PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 12234577888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=310.75 Aligned_cols=256 Identities=28% Similarity=0.378 Sum_probs=189.0
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHh--ccCCCcccceeEEEEcC----CeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIG--GLRHSNIVSIRAYCNGK----DELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~----~~~~lV~Ey~~~ 411 (640)
.+.||+|.||.||+|+|+ |+.||||++.... ++...+|.++.+ .|+|+||+.|.+.-... .++|||.||.+.
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~ 293 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEH 293 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEecccc-hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccC
Confidence 478999999999999998 5779999987542 333334444443 57999999999886543 379999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhc-----CCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG-----YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
|||++||... .++-...++++..+|.||+|||. +++|.|.|||||+.|||+..++.+.|+|+|||-...
T Consensus 294 GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 294 GSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred CcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 9999999864 58999999999999999999994 578899999999999999999999999999986542
Q ss_pred ----------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCC----------CCCCCC---Ccch
Q 006559 487 ----------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK----------MAKGDG---ELGI 543 (640)
Q Consensus 487 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~----------~p~~~~---~~~~ 543 (640)
++.++|..|||||++......-.... -..+||||||.|+||++-+- .||.+- +-..
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fes-yk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ 446 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFES-YKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF 446 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhh-hhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence 23567999999999854322111111 24699999999999998632 355421 1111
Q ss_pred HHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 544 VKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 544 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
.+ ++...-... +.|.+...-...+.+..+.++|..||..+|+.|-|+=.+.+.|.++..
T Consensus 447 ee-MrkVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 447 EE-MRKVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HH-Hhcceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11 111110111 111111111234677889999999999999999999999999988863
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=327.12 Aligned_cols=249 Identities=21% Similarity=0.344 Sum_probs=190.6
Q ss_pred hhccccccCcceEEEEEeCC------CcEEEEEEecccc---chHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG------GDVVVVKRIRERK---KKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 406 (640)
..++||+|+||.||+|+... +..||||+++... ..+.+..|+++++++. ||||++++++|...+..|+||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 35789999999999998532 3469999997542 2356788999999996 999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCC--------------------------------------------------------------
Q 006559 407 DYLPHGSLHSLLHGSRGP-------------------------------------------------------------- 424 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~-------------------------------------------------------------- 424 (640)
|||++|+|.++++.....
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999988643210
Q ss_pred -----------------------------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeE
Q 006559 425 -----------------------------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC 475 (640)
Q Consensus 425 -----------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 475 (640)
....+++..+++++.|+++||+|||+ .+|+||||||+|||+++++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEE
Confidence 01247888899999999999999994 5599999999999999999999
Q ss_pred EccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHH
Q 006559 476 ISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKW 546 (640)
Q Consensus 476 l~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~ 546 (640)
|+|||+++..... ...+..|+|||++ ....++.++|||||||++|||++ |..||.........+
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI-------FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhh-------cCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999998765321 1235679999964 33456789999999999999997 899986432111111
Q ss_pred HHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 547 VQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 547 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
. ...... ..... .....++.+++.+||+.+|++||++.+|.++|+++..
T Consensus 351 ~-~~~~~~--------~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 N-KIKSGY--------RMAKP---DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H-HHhcCC--------CCCCC---ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1 111000 00001 1223457788899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=312.13 Aligned_cols=245 Identities=25% Similarity=0.418 Sum_probs=190.4
Q ss_pred hccccccCcceEEEEEeCCC------cEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLDGG------DVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~------~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|...+. ..||+|.++... ...++.+|++.+++++||||+++++++...+..+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 56799999999999986432 468999987542 245678899999999999999999999988999999999
Q ss_pred cCCCCHHHhhccCCCCC-----------CCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEc
Q 006559 409 LPHGSLHSLLHGSRGPG-----------RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACIS 477 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~ 477 (640)
+++|+|.+++....... ...+++..++.++.|++.||.|||+ .+++||||||+||++++++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L~ 166 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKIS 166 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEEEC
Confidence 99999999997542111 1357889999999999999999994 559999999999999999999999
Q ss_pred cCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 006559 478 DIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQ 548 (640)
Q Consensus 478 DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~ 548 (640)
|||+++.... ....+..|+|||.+ ....++.++|||||||++|||+| |..||.+.... +..+
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~ 237 (283)
T cd05048 167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI-------LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE 237 (283)
T ss_pred CCcceeeccccccccccCCCcccccccCHHHh-------ccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence 9999876422 12235679999964 33457789999999999999998 99998643211 1111
Q ss_pred HhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 549 MMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 549 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
...... .. .. ......++.+++.+||+.+|++||++.+|.+.|+++
T Consensus 238 ~i~~~~-~~-------~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 MIRSRQ-LL-------PC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHcCC-cC-------CC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111110 00 00 112345677888899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=310.56 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=182.1
Q ss_pred cccccCcceEEEEEeCC---CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 340 LLGKGCVGATYKVVLDG---GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.||+|+||.||+|...+ ...+|+|.+.... ....+.+|++.++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3468888776442 23457789999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|.+++...........++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976543222345678889999999999999994 55999999999999999999999999998653211
Q ss_pred ---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 489 ---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 489 ---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+..|+|||+............++.++|||||||++|||++ |+.||........ ........ .....++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~--~~~~~~~~~ 235 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVREQ--DIKLPKPQL 235 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhcc--CccCCCCcc
Confidence 1234569999976433222234566789999999999999999 7888864321110 11111100 000111111
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
+.... ..+.+++..|| .||++||++.+|.+.|
T Consensus 236 --~~~~~---~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 236 --DLKYS---DRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred --cccCC---HHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11112 23444566688 4999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=332.23 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=199.0
Q ss_pred HHHHHhhccccccCcceEEEEEe-CCCc----EEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEE
Q 006559 332 DLLKSSAELLGKGCVGATYKVVL-DGGD----VVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELF 403 (640)
Q Consensus 332 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~----~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 403 (640)
|.......+||+|+||+||+|.+ +.|+ +||+|.+.+. +...++.+|+-.|.+++|||+++|+|+|.... +.
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 33334467899999999999985 4443 5899998876 34678899999999999999999999998665 88
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 404 LVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
||++|||.|+|.++++..++ ++.-...+.+..|||+||.||| +.++|||||.++|||+.+-..+||.|||+++
T Consensus 774 lvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhh
Confidence 99999999999999998664 5778899999999999999999 5669999999999999999999999999999
Q ss_pred ccCCCcc--------ccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccc
Q 006559 484 LFHTPFF--------INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDE 554 (640)
Q Consensus 484 ~~~~~~~--------~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 554 (640)
.+..... ....|||-| ......|+.++|||||||++||++| |..|+++-....+ -..+...+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale-------~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--~dlle~ge 917 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALE-------SIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--PDLLEKGE 917 (1177)
T ss_pred ccCcccccccccccccCcHHHHHH-------HhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--hHHHhccc
Confidence 8764321 133455555 5677899999999999999999999 9999875322211 11111111
Q ss_pred ccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 555 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
++. ..+.+..++..++.+||..|++.||+++++...+.++..+
T Consensus 918 --------RLs---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 --------RLS---QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred --------cCC---CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 111 2235667899999999999999999999999888887654
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=325.82 Aligned_cols=240 Identities=24% Similarity=0.354 Sum_probs=191.5
Q ss_pred cccccCcceEEEEEeCC-CcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 340 LLGKGCVGATYKVVLDG-GDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
++|+|.||+||-|+..+ ...+|||.+.++ ...+...+|+.+.+.|+|.|||+++|.|.+.+.+-|.||-+|+|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999554 556999999876 345678899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccCCcccccC------CCc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGVHQLFH------TPF 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl~~~~~------~~~ 489 (640)
+|+...++ ..=.+...-.+..||.+||.||| +..|||||||..|||++ -.|.+||+|||.++.+. ..+
T Consensus 662 LLrskWGP--lKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGP--LKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHhccCC--CccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 99988753 22266778889999999999999 55699999999999997 46899999999988764 356
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.+|..|||||++. ...+.|+.++|||||||++.||.||++||-+-+...+...+... . .+.+. .+.+
T Consensus 737 TGTLQYMAPEvID-----qG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm-----y-KvHP~--iPee 803 (1226)
T KOG4279|consen 737 TGTLQYMAPEVID-----QGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM-----Y-KVHPP--IPEE 803 (1226)
T ss_pred ccchhhhChHhhc-----cCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc-----e-ecCCC--CcHH
Confidence 7899999999984 34466788999999999999999999999753322221111100 0 01111 2222
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+ ..+...++++|..+||.+||++.+++.
T Consensus 804 l---saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 L---SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred H---HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 3 335666888999999999999998864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=322.14 Aligned_cols=239 Identities=22% Similarity=0.346 Sum_probs=181.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. +++.||||.+.... ..+.+.+|++++++++|+||+++++++...+..++||||+++|+
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 567999999999999864 68899999986542 24568889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+.. ...+..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 159 L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 159 LEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred ccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence 86532 24566778899999999999994 4599999999999999999999999999876542
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...++..|+|||++.... ......+.++|||||||++|||++|+.||...... .|........ ........
T Consensus 227 ~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~-----~~~~~~~~ 297 (353)
T PLN00034 227 SSVGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAIC-----MSQPPEAP 297 (353)
T ss_pred ccccCccccCcccccccc--ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHh-----ccCCCCCC
Confidence 235688999999753221 11223346899999999999999999999732211 1211111000 00000001
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....++.+++.+||+.||++||++.|+++
T Consensus 298 ---~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 298 ---ATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ---CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112235677888899999999999999876
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=320.77 Aligned_cols=233 Identities=21% Similarity=0.300 Sum_probs=182.8
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
++||+|+||.||+++. .+|..||+|.++... ....+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999985 468899999987541 2234567899999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcc
Confidence 9999887543 57899999999999999999995 4599999999999999999999999999875321
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||........ .+..... ....
T Consensus 153 ~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~~~~~~---------~~~~ 214 (323)
T cd05595 153 KTFCGTPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELILME---------EIRF 214 (323)
T ss_pred ccccCCcCcCCcccc-------cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHhcC---------CCCC
Confidence 23467899999964 344677899999999999999999999975332111 1111100 0001
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
+.... .++.+++..||+.||++|| ++.++++
T Consensus 215 p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCC---HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11122 2455677789999999998 7777754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.47 Aligned_cols=238 Identities=24% Similarity=0.373 Sum_probs=186.0
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
+.||+|+||.||+|+. .+++.||+|.+... .....+.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999986 46888999987654 2245688899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc-----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF----- 489 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~----- 489 (640)
.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99997532 247899999999999999999994 559999999999999999999999999987643211
Q ss_pred ---cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 490 ---FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 490 ---~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
..+..|+|||.+ ....++.++|||||||++|||++ |..||........ ........ ...
T Consensus 154 ~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~~~~~~~--------~~~ 216 (252)
T cd05084 154 GMKQIPVKWTAPEAL-------NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REAIEQGV--------RLP 216 (252)
T ss_pred CCCCCceeecCchhh-------cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HHHHHcCC--------CCC
Confidence 113459999964 34457789999999999999998 8888864221111 11111100 000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
.+ ......+.+++.+|++.+|++||++.++.++|+
T Consensus 217 ~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CP---ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred Cc---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11 112345777888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=304.52 Aligned_cols=236 Identities=22% Similarity=0.334 Sum_probs=192.9
Q ss_pred HhhccccccCcceEEEEE-eCCCcEEEEEEecccc--ch---HHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 336 SSAELLGKGCVGATYKVV-LDGGDVVVVKRIRERK--KK---REVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 336 ~~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~--~~---~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
...+.||+|.||.|-++. ...|+.||||.+++.+ ++ -.+.+|+++|..|+||||+.++.+|..++...|||||.
T Consensus 56 E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYa 135 (668)
T KOG0611|consen 56 EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYA 135 (668)
T ss_pred HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEec
Confidence 457789999999999998 4779999999998763 22 34678999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
.+|.|++|+.+.+ .++..+...+++||..|+.|+| +.+++|||||.+|||||.++++||+||||+..+..
T Consensus 136 S~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 136 SGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred CCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999998765 5889999999999999999999 66799999999999999999999999999988764
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
.+++++-|..||+.-+.|+. .+.+|-||+||+||-|+.|.+||++.+... .++.+... ....+
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~------GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--lvrQIs~G----aYrEP-- 273 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYK------GPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--LVRQISRG----AYREP-- 273 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCC------CCccchhhHHHHHHHHhhcccccCCchHHH--HHHHhhcc----cccCC--
Confidence 46788899999986544432 478999999999999999999998654321 12221111 00111
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+...+..-++.+++..+|++|-|+.+|..
T Consensus 274 -------~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 274 -------ETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -------CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 11223445677799999999999998864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.63 Aligned_cols=248 Identities=17% Similarity=0.320 Sum_probs=195.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+. .++..||||.+... .....+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 56799999999999995 46889999987532 2234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++..... ....++......++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++....
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~ 162 (267)
T cd08228 87 GDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence 999988854321 12257888999999999999999994 5699999999999999999999999999877543
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...++..|+|||.+ ....++.++|||||||++|||+||+.||.........+.+...... .+...
T Consensus 163 ~~~~~~~~~~~aPE~~-------~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~ 229 (267)
T cd08228 163 AHSLVGTPYYMSPERI-------HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------YPPLP 229 (267)
T ss_pred HhcCCCCccccChhhh-------ccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC------CCCCC
Confidence 22456789999964 3345678899999999999999999999765444444443322211 00110
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
......++.+++.+||+.+|++||++.+|++.+++++
T Consensus 230 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 ----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1122345777888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.87 Aligned_cols=188 Identities=22% Similarity=0.325 Sum_probs=161.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+++.. ++..+|+|.+... ...+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 467999999999999965 5778999988754 224568889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----Cc
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----PF 489 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----~~ 489 (640)
|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 90 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 90 LDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 999997543 478889999999999999999952 3599999999999999999999999999876532 23
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
.++..|+|||++ ....++.++|||||||++|||+||+.||...
T Consensus 163 ~g~~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 163 VGTRSYMSPERL-------QGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred CCCcCcCCHhHh-------cCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 468899999964 3345778999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.51 Aligned_cols=242 Identities=23% Similarity=0.365 Sum_probs=192.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+.||+|+||.||+|... .+..||+|.+.... ...++.+|++++++++|+||+++++++...+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHH
Confidence 567999999999999864 57889999987553 3456888999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------ 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~------ 489 (640)
+++.... ...+++..++.++.|+++||+|||. .+++||||||+||++++++.+||+|||+++......
T Consensus 91 ~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 91 DYLRECN---RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred HHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 9987543 2358899999999999999999994 569999999999999999999999999988764321
Q ss_pred -cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 490 -FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 490 -~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..+..|+|||.+ ....++.++|||||||++|||+| |..|+..... .+..+....... .. ..
T Consensus 165 ~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~------~~--~~ 227 (263)
T cd05052 165 AKFPIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKGYR------ME--RP 227 (263)
T ss_pred CCCccccCCHHHh-------ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC------CC--CC
Confidence 124579999954 34567789999999999999998 8999864322 222222111100 00 01
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
. .....+.+++.+||+.+|++||++.++.++|+.+
T Consensus 228 ~---~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 E---GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred C---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1 1224577788899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.85 Aligned_cols=239 Identities=23% Similarity=0.369 Sum_probs=189.4
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||+++..++..+|+|.++.. ....++.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 88 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence 4579999999999999888778999998765 335668899999999999999999999998889999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc-------
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------- 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~------- 489 (640)
++..... .+++..++.++.|++.||+||| ..+++|+||||+||+++.++.+||+|||+++......
T Consensus 89 ~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 89 YLREHGK----RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred HHHhcCC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 9975431 5789999999999999999999 4569999999999999999999999999987653221
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+..|++||.. ....++.++|||||||++|||+| |+.||...... ............. ..
T Consensus 162 ~~~~~y~~pe~~-------~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~--------~~- 223 (256)
T cd05113 162 KFPVRWSPPEVL-------LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRLY--------RP- 223 (256)
T ss_pred ccChhhCCHHHH-------hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCCCC--------CC-
Confidence 124569999964 33457789999999999999999 99998643211 1111111111000 00
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 012345778888999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=319.65 Aligned_cols=233 Identities=21% Similarity=0.322 Sum_probs=183.8
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
++||+|+||.||+++. .++..||||.+... .....+.+|+++++.++||||+++.+++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 46889999998754 12345677899999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccc
Confidence 9999887543 58899999999999999999994 5699999999999999999999999999875321
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||..... ....+...... ...
T Consensus 153 ~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~~~~~~~~~~~---------~~~ 214 (328)
T cd05593 153 KTFCGTPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILMED---------IKF 214 (328)
T ss_pred ccccCCcCccChhhh-------cCCCCCccCCccccchHHHHHhhCCCCCCCCCH--HHHHHHhccCC---------ccC
Confidence 23468899999964 344567899999999999999999999975322 11111111110 001
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
+.... .++.+++.+|++.||++|| ++.++++
T Consensus 215 p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 215 PRTLS---ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCC---HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 11122 2456677789999999997 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=293.95 Aligned_cols=188 Identities=23% Similarity=0.376 Sum_probs=166.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
...||.|+||.|.+++.+ +|..+|+|.+...+ ..+....|.++|+.+.||.++++.+.|.+.+.+||||||.++
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 567999999999999964 57889999997652 234566789999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|.|..++++.+ +++......+|.||+.||+|||+. .|++|||||+|||||.+|.+||.|||.++.+...
T Consensus 129 GElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~T 200 (355)
T KOG0616|consen 129 GELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWT 200 (355)
T ss_pred ccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCcEEE
Confidence 99999999765 588889999999999999999954 4999999999999999999999999999987653
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE 540 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~ 540 (640)
.++|+.|+|||++ ....+..++|.|||||++|||+.|.+||.+..
T Consensus 201 lCGTPeYLAPEii-------~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 201 LCGTPEYLAPEII-------QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred ecCCccccChHHh-------hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 4679999999974 45667788999999999999999999997543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=313.44 Aligned_cols=227 Identities=19% Similarity=0.357 Sum_probs=179.5
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
...+||+|+||.||+|+- .+|.++|+|++++.. .-+.+..|-.+|...++|+||+|+..|++.+.+||||||+|
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 356899999999999995 568999999998762 23456778889999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
||++..+|.... .|+......++.+++.|++-|| +.++|||||||+|+|||..|++||+||||+.-+.
T Consensus 225 GGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 225 GGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred CccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999998664 6888888889999999999999 5669999999999999999999999999864210
Q ss_pred ----------------------C---------------------------CccccccccCCccccCCCCccccCCCCCcc
Q 006559 487 ----------------------T---------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRC 517 (640)
Q Consensus 487 ----------------------~---------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~ 517 (640)
. ..++|+.|+|||+++ +..|+..+
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-------~kgY~~~c 369 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-------GKGYGKEC 369 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-------cCCCCccc
Confidence 0 124578899999864 34577889
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCcc-----hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCC
Q 006559 518 DVYSFGVVLLEILTGKMAKGDGELG-----IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDR 592 (640)
Q Consensus 518 DV~SfGvvl~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R 592 (640)
|+||+|||+|||+.|-+||..+... ++.|........ ....+ .+..+++.+|+. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~------------~~~~s---~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE------------EVDLS---DEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC------------cCccc---HHHHHHHHHHhc-CHHHh
Confidence 9999999999999999999864322 222332222110 11112 345556666777 99999
Q ss_pred CC
Q 006559 593 PN 594 (640)
Q Consensus 593 Ps 594 (640)
--
T Consensus 434 LG 435 (550)
T KOG0605|consen 434 LG 435 (550)
T ss_pred cC
Confidence 75
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=286.96 Aligned_cols=252 Identities=21% Similarity=0.234 Sum_probs=197.0
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEc-----CCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNG-----KDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~~lV~Ey~ 409 (640)
.+.+|+|||+-||.++ ..++..+|+|++.-. +..+...+|++..++++|||+++++++... ..+.||+++|.
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy 105 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY 105 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence 5679999999999998 677889999998654 445667889999999999999999888653 34699999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
..|+|.+.+...... ...++..+.+.|+.+|++||++||+. .++++||||||.|||+.+.+.+++.|||-+....-
T Consensus 106 ~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i 183 (302)
T KOG2345|consen 106 KRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQI 183 (302)
T ss_pred ccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEe
Confidence 999999998765432 23589999999999999999999976 46799999999999999999999999998765421
Q ss_pred -------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccc
Q 006559 488 -------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE 554 (640)
Q Consensus 488 -------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 554 (640)
...-|..|+|||++--. .....++++|||||||+||+|+.|..||+.. ..+.+
T Consensus 184 ~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk----~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----------~~~Gg 249 (302)
T KOG2345|consen 184 EGSRQALRLQEWAEERCTIPYRAPELFNVK----SHCTITERTDIWSLGCTLYAMMFGESPFERI----------YQQGG 249 (302)
T ss_pred echHHHHHHHHHHHHhCCCcccCchheecc----cCcccccccchhhhhHHHHHHHHcCCcchHH----------hhcCC
Confidence 11237789999986422 2345789999999999999999999999731 01111
Q ss_pred c-cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 555 S-AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 555 ~-~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
. ...+....+..+.. ......+.+++..|++.||.+||++.+++..++++.
T Consensus 250 SlaLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eEEEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1 12233333322221 123446778888899999999999999999988764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.80 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=193.2
Q ss_pred hhccccccCcceEEEEEeC------CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLD------GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..+.||+|+||.||++... ++..+|+|.+... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 3567999999999999742 3456899988754 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCC--------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCC
Q 006559 409 LPHGSLHSLLHGSRG--------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG 480 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 480 (640)
+++|+|.+++..... .....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccCC
Confidence 999999999875431 112358999999999999999999994 569999999999999999999999999
Q ss_pred cccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhh
Q 006559 481 VHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMG 551 (640)
Q Consensus 481 l~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 551 (640)
+++..... ...+..|+|||++ ....++.++|||||||++|||+| |+.||...... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~~~i~ 236 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECIT 236 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 98754321 1224579999964 34567789999999999999999 89998643211 1111111
Q ss_pred cccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 552 QDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 552 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
... ... ... ....++.+++.+||+.+|.+|||+.+|...|+++...
T Consensus 237 ~~~-~~~-------~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 QGR-VLQ-------RPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred cCC-cCC-------CCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 110 000 000 1223578888999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.38 Aligned_cols=236 Identities=22% Similarity=0.316 Sum_probs=181.2
Q ss_pred ccccccCcceEEEEEeCCC-------------cEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEE
Q 006559 339 ELLGKGCVGATYKVVLDGG-------------DVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELF 403 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~-------------~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 403 (640)
+.||+|+||.||+|++... ..|++|.+... .....+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999985321 24888887654 23346778889999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC-------eEE
Q 006559 404 LVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN-------ACI 476 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~-------~kl 476 (640)
+||||+++|+|..+++... .++++..+++++.||++||+||| ..+|+||||||+|||++.++. +|+
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999999887543 25889999999999999999999 456999999999999987664 899
Q ss_pred ccCCcccccCC--CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHH-hCCCCCCCCCcchHHHHHHhhcc
Q 006559 477 SDIGVHQLFHT--PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEIL-TGKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 477 ~DfGl~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~-tg~~p~~~~~~~~~~~~~~~~~~ 553 (640)
+|||++..... ....+..|+|||++. ....++.++|||||||++|||+ +|+.|+........... ....
T Consensus 154 ~d~g~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~~~~ 225 (262)
T cd05077 154 SDPGIPITVLSRQECVERIPWIAPECVE------DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF--YEGQ 225 (262)
T ss_pred CCCCCCccccCcccccccccccChhhhc------CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH--HhcC
Confidence 99999876543 234577899999642 2345678999999999999998 58888864322111111 0000
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
. .. .. ....++.+++.+||+.||++||++.++++.+
T Consensus 226 ---~-----~~-~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 ---C-----ML-VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---c-----cC-CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 00 00 1123567788899999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=306.12 Aligned_cols=242 Identities=23% Similarity=0.320 Sum_probs=185.7
Q ss_pred hccccccCcceEEEEEeC-CCc----EEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD-GGD----VVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||+||+|++. ++. .+++|.+..... .+++..|+..+++++||||+++++++. ....++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 467999999999999863 344 377787764422 245666777889999999999999886 45678999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++....+ .++|.....++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 91 PLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred CCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 99999999975432 58899999999999999999994 55999999999999999999999999999765321
Q ss_pred -------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcch-HHHHHHhhcccccccc
Q 006559 489 -------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGI-VKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 -------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 559 (640)
..++..|+|||.+ ....++.++|||||||++|||+| |+.||.+..... ..+++. ....
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~-------~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---~~~~--- 230 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESI-------LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK---GERL--- 230 (279)
T ss_pred cccccCCCCCcccccCHHHh-------ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCcC---
Confidence 1234579999964 34557789999999999999998 999997543221 112111 1000
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..+. .+...+.+++.+||..+|++||++.|+.+.|+.+..+
T Consensus 231 ~~~~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 231 AQPQ--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCCC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0000 1123456678889999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.26 Aligned_cols=242 Identities=21% Similarity=0.335 Sum_probs=190.9
Q ss_pred hhccccccCcceEEEEEeCC----CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG----GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|++.. ...||||.++... ...++..|+.++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 35789999999999998743 3579999887542 2456788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
++|+|.+++....+ .+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 88 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 88 ENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 99999999976432 58899999999999999999994 5699999999999999999999999999987641
Q ss_pred C------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 488 P------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 488 ~------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
. ...+..|+|||.. ....++.++||||||+++|||++ |..||.+... ....+........
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~-------~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~---- 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAI-------AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAVEDGYRL---- 227 (266)
T ss_pred cceeccCCCCCccccChhhh-------ccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHHcCCCC----
Confidence 1 1124579999953 44567889999999999999998 9999864221 1111111111000
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
... ......+.+++.+||+.+|++||++.+|.+.|+++
T Consensus 228 ----~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ----PPP---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 12234577888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.59 Aligned_cols=239 Identities=23% Similarity=0.369 Sum_probs=189.4
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||++...++..+|+|.+... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 35679999999999999887778999998754 33456888999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------ 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~------ 489 (640)
+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 88 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 88 NYLRERKG----KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred HHHHhccc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 99975432 57899999999999999999994 559999999999999999999999999987653321
Q ss_pred -cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 490 -FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 490 -~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..+..|+|||++ ....++.++|||||||++|||+| |+.||...... +........ .... .+
T Consensus 161 ~~~~~~y~~Pe~~-------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~------~~~~--~~ 223 (256)
T cd05059 161 TKFPVKWAPPEVF-------DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAG------YRLY--RP 223 (256)
T ss_pred CCCCccccCHHHh-------ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcC------CcCC--CC
Confidence 113469999964 34557789999999999999999 89998643211 111111111 0000 01
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
. ....++.+++.+||+.+|++||+|.|+++.|
T Consensus 224 ~---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 K---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred C---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1 1234577889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.70 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=188.8
Q ss_pred hccccccCcceEEEEEe-----CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-----DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 407 (640)
.+.||+|+||+||++.+ .++..||+|.++... ....+.+|++++++++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 46799999999988653 357789999987542 345678899999999999999999998753 46899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 89 ~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 89 YVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999753 48999999999999999999994 5699999999999999999999999999876542
Q ss_pred C---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhh---cccc
Q 006559 488 P---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG---QDES 555 (640)
Q Consensus 488 ~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~---~~~~ 555 (640)
. ...+..|+|||.. ....++.++|||||||++|||+||+.|+............... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~-------~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECL-------KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHh-------cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 1 1224468999954 3345778999999999999999999998643211111000000 0000
Q ss_pred cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 556 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
..+..+..... +.......++.+++..||+.+|++||++++++++|+++.
T Consensus 233 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00001100000 001122356778889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=311.96 Aligned_cols=249 Identities=20% Similarity=0.314 Sum_probs=183.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. +++.||||.++... ....+.+|+++++.++||||+++++++...+..++||||++ ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 467999999999999965 68899999987542 23456789999999999999999999999999999999996 68
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 89 LCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 888876543 247888899999999999999995 4599999999999999999999999999875431
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhcc--ccccc-----
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQD--ESAWE----- 558 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~--~~~~~----- 558 (640)
...++..|+|||++.+ ...++.++||||+||++|||+||+.||.+.... ....+...... ...+.
T Consensus 162 ~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 162 NEVVTLWYRPPDVLLG------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCcccCCCCChHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 2345778999997532 234678899999999999999999999753211 11111110000 00000
Q ss_pred -ccchh---hccChHHHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 -VFDFE---LIMDKEMEE------EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 -~~d~~---~~~~~~~~~------~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..++. ...+....+ ....+.+++..|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 000011111 1134667888899999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=307.26 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=191.1
Q ss_pred hhccccccCcceEEEEEeCC------CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLDG------GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|...+ +..||||.++... ..+.+.+|++++++++|+||+++++++......++|||
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEe
Confidence 45789999999999998643 4679999987652 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC---------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEcc
Q 006559 408 YLPHGSLHSLLHGSRG---------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 478 (640)
|+++|+|.+++..... .....+++.....++.|++.||+|||. .+++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEEECC
Confidence 9999999999975431 122357899999999999999999994 5699999999999999999999999
Q ss_pred CCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 006559 479 IGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQM 549 (640)
Q Consensus 479 fGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~ 549 (640)
||+++.... ....+..|+|||++ ....++.++|||||||++|||++ |+.||...... +....
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~ 236 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIEC 236 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhh-------ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 999875422 11225679999964 34557789999999999999999 99998643221 11111
Q ss_pred hhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 550 MGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 550 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
.... .... .. ......+.+++.+||+.+|++||++.||++.|++
T Consensus 237 ~~~~-~~~~-------~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ITQG-RLLQ-------RP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHcC-CcCC-------CC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1110 0000 00 1123457788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=321.38 Aligned_cols=241 Identities=22% Similarity=0.327 Sum_probs=194.3
Q ss_pred hhccccccCcceEEEEEeCC--Cc--EEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG--GD--VVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~--~~--~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..|+||+|.||+|++|.|.. |+ .||||+++.. ....+|.+|+.+|-+|+|+|+|+|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 46789999999999999753 44 4899999876 245679999999999999999999999986 7889999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
+.|+|.+.|++.. +..|-......++.|||.||+||.+ .++|||||.++|+||.....+||+||||.+.+...
T Consensus 193 plGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred ccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999732 2357778888999999999999994 55999999999999999999999999999887531
Q ss_pred -c-------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 489 -F-------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 -~-------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
+ .....|.||| .+..++|+.++|||+|||++|||+| |+.||-+-. -...++.+...+
T Consensus 267 d~Yvm~p~rkvPfAWCaPE-------sLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g~qIL~~iD~~e----- 332 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPE-------SLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--GIQILKNIDAGE----- 332 (1039)
T ss_pred cceEecCCCcCcccccCHh-------HhccccccccchhhhhhhhHHhhhccCCCCCCCCC--HHHHHHhccccc-----
Confidence 1 2245788999 5778899999999999999999999 789986422 122222222111
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
.+..+ +.|.++++++|..||+.+|++||++..+.+.+-.
T Consensus 333 ---rLpRP---k~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 333 ---RLPRP---KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ---cCCCC---CCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 12222 3566789999999999999999999999754433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.59 Aligned_cols=233 Identities=20% Similarity=0.246 Sum_probs=184.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +++.||+|.+... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 467999999999999965 6889999998643 1234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 157 (291)
T cd05612 86 GELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157 (291)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCccc
Confidence 99999997543 57888999999999999999994 55999999999999999999999999998876432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||++. ...++.++|||||||++|||+||+.||..... ....+..... ....+.
T Consensus 158 ~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~~~~i~~~---------~~~~~~ 219 (291)
T cd05612 158 LCGTPEYLAPEVIQ-------SKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGIYEKILAG---------KLEFPR 219 (291)
T ss_pred ccCChhhcCHHHHc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC---------CcCCCc
Confidence 34688999999753 34567899999999999999999999975322 1111111111 001111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPN-----MSIVH 599 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~ 599 (640)
.. ...+.+++.+||+.||++||+ +.++.
T Consensus 220 ~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 220 HL---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred cC---CHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 11 224566778899999999995 66655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.99 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=189.4
Q ss_pred hhccccccCcceEEEEEeC------CCcEEEEEEeccccc---hHHHHHHHHHHhcc-CCCcccceeEEEEcC-CeEEEE
Q 006559 337 SAELLGKGCVGATYKVVLD------GGDVVVVKRIRERKK---KREVDEWLRVIGGL-RHSNIVSIRAYCNGK-DELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~---~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lV 405 (640)
..++||+|+||.||+|+.. .++.||+|+++.... .+.+..|+.++.++ +|+||++++++|... ...++|
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 4678999999999999742 246899999875432 24466789999999 899999999988754 578999
Q ss_pred EeccCCCCHHHhhccCCCC--------------------------------------------------------CCCCc
Q 006559 406 YDYLPHGSLHSLLHGSRGP--------------------------------------------------------GRMPV 429 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l 429 (640)
|||+++|+|.+++...... ...++
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999998643210 01268
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--------ccccccccCCccc
Q 006559 430 DWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--------FFINDAYNAPELK 501 (640)
Q Consensus 430 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~ 501 (640)
+|..+.+++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+... ...+..|+|||++
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 999999999999999999994 56999999999999999999999999999865321 1224579999964
Q ss_pred cCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHH
Q 006559 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQV 580 (640)
Q Consensus 502 ~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l 580 (640)
....++.++|||||||++|||++ |+.||........ ......... .. ..+ .....++.++
T Consensus 248 -------~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~-~~-------~~~---~~~~~~~~~l 308 (337)
T cd05054 248 -------FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLKEGT-RM-------RAP---EYATPEIYSI 308 (337)
T ss_pred -------cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHhccC-CC-------CCC---ccCCHHHHHH
Confidence 34567889999999999999998 9999864322111 111111100 00 001 1223457788
Q ss_pred HHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 581 ALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 581 ~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
+.+||+.+|++||++.|+++.|+++..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.12 Aligned_cols=189 Identities=22% Similarity=0.323 Sum_probs=161.7
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||++... ++..+|+|.+.... ....+.+|++++++++||||++++++|...+..++||||+++|
T Consensus 9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence 3567999999999999965 57788999887542 2356788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----C
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----P 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----~ 488 (640)
+|.+++.... .+++.....++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++..... .
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 161 (333)
T cd06650 89 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (333)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcccc
Confidence 9999997543 478888999999999999999952 3599999999999999999999999999876532 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
..++..|+|||++ ....++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~y~aPE~~-------~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 162 FVGTRSYMSPERL-------QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCCCccccCHHHh-------cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 3467899999965 3345678999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.36 Aligned_cols=243 Identities=16% Similarity=0.221 Sum_probs=188.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +++.||||+++... ..+.+..|++++..++||||+++++++...+..|+||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 567999999999999965 57899999987541 234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---C
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---P 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---~ 488 (640)
|+|.+++.... .+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~ 157 (333)
T cd05600 86 GDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS 157 (333)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCC
Confidence 99999997543 47888999999999999999994 5599999999999999999999999999876543 3
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||++ ....++.++|||||||++|||++|+.||...... +.......... .........+
T Consensus 158 ~~gt~~y~aPE~~-------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~---~~~~~~~~~~ 225 (333)
T cd05600 158 VVGSPDYMAPEVL-------RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENLKYWKE---TLQRPVYDDP 225 (333)
T ss_pred cccCccccChhHh-------cCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHHHhccc---cccCCCCCcc
Confidence 4568899999965 3346778999999999999999999999753321 11111110000 0000000000
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
......++.+++.+|+..+|++||++.++++.
T Consensus 226 -~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 -RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01123346677778999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=320.04 Aligned_cols=233 Identities=17% Similarity=0.258 Sum_probs=184.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +++.||||.+... ...+.+.+|+.++++++||||+++++++...+..|+||||+++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 568999999999999965 5788999998754 1234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 174 (329)
T PTZ00263 103 GELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT 174 (329)
T ss_pred ChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence 99999997543 47788888999999999999995 55999999999999999999999999999876432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||++ ....++.++|||||||++|||+||+.||.+... .+..+..... ....+.
T Consensus 175 ~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~---------~~~~p~ 236 (329)
T PTZ00263 175 LCGTPEYLAPEVI-------QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIYEKILAG---------RLKFPN 236 (329)
T ss_pred ecCChhhcCHHHH-------cCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHHHHHhcC---------CcCCCC
Confidence 3468889999965 334567899999999999999999999975321 1111111111 000111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPN-----MSIVH 599 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~ 599 (640)
..+ .++.+++..||+.||++||+ +.+++
T Consensus 237 ~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 237 WFD---GRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 111 23567788899999999997 56665
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=304.37 Aligned_cols=237 Identities=22% Similarity=0.334 Sum_probs=185.2
Q ss_pred cccccCcceEEEEEe---CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 340 LLGKGCVGATYKVVL---DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~---~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.||+|+||.||+|.+ .++..+|+|.++... ..+++..|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 356789999986442 2456788899999999999999999885 45779999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc---
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF--- 489 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~--- 489 (640)
+|.+++.... .+++.....++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999997543 5789999999999999999999 4569999999999999999999999999987654221
Q ss_pred ------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 490 ------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 490 ------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
..+..|+|||.+ ....++.++|||||||++|||+| |+.||..... ..+.+....... . +
T Consensus 153 ~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~~-~---~- 218 (257)
T cd05116 153 KAKTHGKWPVKWYAPECM-------NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGER-M---E- 218 (257)
T ss_pred eecCCCCCCccccCHhHh-------ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC-C---C-
Confidence 113579999954 33456779999999999999998 9999975322 222222221110 0 0
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.+. ....++.+++.+||+.||++||+|.+|++.|++.
T Consensus 219 ---~~~---~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 ---CPQ---RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CCC---CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111 1223466788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.80 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=191.3
Q ss_pred hccccccCcceEEEEEeC------CCcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD------GGDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|+.. +...+++|.+..... .+.+..|+.+++.++||||+++++.+...+..++|+||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 467999999999999853 235688888875432 34577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCC-------------------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC
Q 006559 409 LPHGSLHSLLHGSRG-------------------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD 469 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~ 469 (640)
+++|+|.+++..... ....++++..++.++.|++.||+||| ..+|+||||||+|||++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill~ 161 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVA 161 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEEc
Confidence 999999999864321 11235889999999999999999999 45699999999999999
Q ss_pred CCCCeEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 006559 470 QLGNACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGE 540 (640)
Q Consensus 470 ~~~~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~ 540 (640)
+++.+||+|||+++..... ...+..|+|||.. ....++.++|||||||++|||+| |+.||....
T Consensus 162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-------FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred CCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-------ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999998754221 1234579999954 34457789999999999999999 999986432
Q ss_pred cchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 541 LGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..+......... ... .+ .....++.+++..||+.+|++||++.++++.|+++..+
T Consensus 235 --~~~~~~~~~~~~------~~~--~~---~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 235 --PERLFNLLKTGY------RME--RP---ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --HHHHHHHHhCCC------CCC--CC---CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 112222111110 000 01 11223577788899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=301.95 Aligned_cols=258 Identities=19% Similarity=0.336 Sum_probs=193.7
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEc-----CCeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNG-----KDELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~~lV~E 407 (640)
.+.||+|+||.|..+.. .+|+.||||++... ...+...+|+++|+.++|+||+.+++.+.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 46799999999999984 56899999998743 334566789999999999999999999876 247999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH- 486 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~- 486 (640)
+|+ -+|+..++... .++......+..|+.+||.|+|+.+ |+||||||+|+|++.+...||+|||+|+...
T Consensus 107 lMe-tDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 107 LME-TDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred HHh-hHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccc
Confidence 995 49999998653 4788888889999999999999655 9999999999999999999999999999884
Q ss_pred -------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC-cchHHHH-HHhhccc-c-
Q 006559 487 -------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE-LGIVKWV-QMMGQDE-S- 555 (640)
Q Consensus 487 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~-~~~~~~~-~~~~~~~-~- 555 (640)
+.++.|.+|+|||++ .....||...||||.||++.||++|++-|.+.+ .+....+ ...+... .
T Consensus 178 ~~~~~~mTeYVaTRWYRAPEll------l~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELL------LNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred cCcccchhcceeeeeecCHHHH------hccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 345679999999986 345678899999999999999999999887532 2222222 1222110 0
Q ss_pred ccccc--------c-hhhccCh----HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhccCC
Q 006559 556 AWEVF--------D-FELIMDK----EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRTKGS 610 (640)
Q Consensus 556 ~~~~~--------d-~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~~~~ 610 (640)
...+- . ....... -.+..-...+++.-+++..||.+|+|++|+++ .|.......-
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 00000 0 0000000 01122235677777899999999999999864 6666654433
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.27 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=192.9
Q ss_pred hccccccCcceEEEEEeC------CCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD------GGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|+.. ++..+++|.+.... ..+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 467999999999999743 34568899887653 3356888999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCC-----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEcc
Q 006559 410 PHGSLHSLLHGSRG-----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478 (640)
Q Consensus 410 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 478 (640)
++++|.+++..... .....++|..++.++.|++.||+||| ..+|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~d 166 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGD 166 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEECC
Confidence 99999999975421 01124789999999999999999999 45699999999999999999999999
Q ss_pred CCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 006559 479 IGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQM 549 (640)
Q Consensus 479 fGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~ 549 (640)
||+++..... ...+..|+|||.+ ....++.++|||||||++|||+| |+.||...... ...+.
T Consensus 167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~ 237 (291)
T cd05094 167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVIEC 237 (291)
T ss_pred CCcccccCCCceeecCCCCCcceeecChHHh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence 9998754321 2235679999954 34567789999999999999999 99998643221 11111
Q ss_pred hhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 550 MGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 550 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..... ... .. ......+.+++.+||+.+|++||++.+|.++|+++...
T Consensus 238 ~~~~~-~~~-------~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 ITQGR-VLE-------RP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HhCCC-CCC-------CC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11110 000 00 11234577888899999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.52 Aligned_cols=249 Identities=18% Similarity=0.281 Sum_probs=184.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. ++..||+|.++.. .....+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence 467999999999999864 6788999998744 223456789999999999999999999999999999999997 59
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 89 l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 89 LKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 999886543 246888999999999999999994 5699999999999999999999999999876432
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH-HHHHhhcc-cccccc-----
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK-WVQMMGQD-ESAWEV----- 559 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~-~~~~~~~~-~~~~~~----- 559 (640)
...++..|+|||++. ....++.++||||+||++|||+||+.||...... ... ..+..... ...+..
T Consensus 162 ~~~~~~~y~aPE~~~------~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 162 NEVVTLWYRPPDVLL------GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred CceecccccChHHhc------CCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 224577899999753 2245678999999999999999999999753321 111 11111110 000000
Q ss_pred -----cchhhccCh---HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 -----FDFELIMDK---EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 -----~d~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+.....+ .......+..+++.+|+..||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000 00011234677888899999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.43 Aligned_cols=242 Identities=22% Similarity=0.424 Sum_probs=194.3
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..++||+|+||.||+|...++..+++|.+.... ...++..|+++++.++|+||+++++++...+..++||||+++|+|
T Consensus 10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (261)
T cd05148 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL 89 (261)
T ss_pred HhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCH
Confidence 467899999999999998889999999987653 356788899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc-----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF----- 489 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~----- 489 (640)
.++++...+ ..+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~ 163 (261)
T cd05148 90 LAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD 163 (261)
T ss_pred HHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccccccC
Confidence 999976432 257899999999999999999994 559999999999999999999999999987654321
Q ss_pred -cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhcccccccccchhhcc
Q 006559 490 -FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 490 -~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..+..|+|||.. ....++.++|||||||++|||++ |+.||..... ....... ... . ...
T Consensus 164 ~~~~~~~~~PE~~-------~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~------~--~~~ 225 (261)
T cd05148 164 KKIPYKWTAPEAA-------SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AGY------R--MPC 225 (261)
T ss_pred CCCceEecCHHHH-------ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hCC------c--CCC
Confidence 224579999964 34456789999999999999998 8999864321 1111111 110 0 000
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
. ......+.+++.+||+.+|++|||+.++.+.|+.+
T Consensus 226 ~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 P---AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred C---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1 12234567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.10 Aligned_cols=233 Identities=20% Similarity=0.286 Sum_probs=182.0
Q ss_pred ccccccCcceEEEEEe----CCCcEEEEEEecccc------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 339 ELLGKGCVGATYKVVL----DGGDVVVVKRIRERK------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~----~~~~~vavK~l~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
+.||+|+||.||+++. ..++.||||.++... ....+..|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999985 357789999987531 223467889999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+++|+|.+++.... .+.+.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999987543 46778888899999999999995 4599999999999999999999999999875321
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ..........
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--~~~~~~~~~~--------- 215 (323)
T cd05584 154 GTVTHTFCGTIEYMAPEILM-------RSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--KKTIDKILKG--------- 215 (323)
T ss_pred CCcccccCCCccccChhhcc-------CCCCCCcceecccHHHHHHHhcCCCCCCCCCH--HHHHHHHHcC---------
Confidence 234678999999653 34467899999999999999999999975432 1111111111
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
....+... ..++.+++.+||+.+|++|| ++.++.+
T Consensus 216 ~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 216 KLNLPPYL---TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCC---CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11111111 23456777889999999999 6777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.66 Aligned_cols=245 Identities=23% Similarity=0.351 Sum_probs=185.9
Q ss_pred hccccccCcceEEEEEeCCCc---EEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEE
Q 006559 338 AELLGKGCVGATYKVVLDGGD---VVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~---~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~l 404 (640)
.++||+|+||.||+|+..+.. .||+|.++.. ...+.+..|+++++.++|+||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 567999999999999975432 5899988654 2235577889999999999999999987532 25789
Q ss_pred EEeccCCCCHHHhhccCC-CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 405 VYDYLPHGSLHSLLHGSR-GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
||||+++|+|.+++...+ ......+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCccc
Confidence 999999999999874332 1122358899999999999999999994 569999999999999999999999999988
Q ss_pred ccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccc
Q 006559 484 LFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDE 554 (640)
Q Consensus 484 ~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 554 (640)
..... ...+..|++||.. ....++.++|||||||++|||++ |+.||..... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~-------~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~ 231 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESL-------ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQGN 231 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHc-------cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCC
Confidence 75321 1234578999953 44567889999999999999999 7889864321 12112111111
Q ss_pred ccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 555 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.. .... .....+.+++.+||+.+|++|||+.++.+.|+++
T Consensus 232 ~~--------~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL--------KQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC--------CCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 0011 1233467888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=300.89 Aligned_cols=238 Identities=24% Similarity=0.368 Sum_probs=188.3
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
++||+|+||.||+|...++..+|+|.+.... ....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888999999987552 2345778999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------- 488 (640)
+++.... ..+++..+..++.|++.||.|+| ..+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 9987543 24789999999999999999999 456999999999999999999999999998754321
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+..|+|||+. ....++.++|||||||++||+++ |..||...... ........... .. ..
T Consensus 154 ~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~------~~--~~ 216 (250)
T cd05085 154 KQIPIKWTAPEAL-------NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYR------MS--CP 216 (250)
T ss_pred CCCcccccCHHHh-------ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCC------CC--CC
Confidence 1224569999964 34457789999999999999999 99998643211 11111111100 00 01
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
.....++.+++.+|++.+|++||++.|+.+.|.
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 ---QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 112345778888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=305.24 Aligned_cols=244 Identities=23% Similarity=0.375 Sum_probs=187.7
Q ss_pred hccccccCcceEEEEEe-----CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVL-----DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|+. ..+..|++|.++... ....+.+|++++++++||||+++++++...+..|+||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 56799999999999984 345789999987542 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCC------------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEc
Q 006559 410 PHGSLHSLLHGSRG------------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACIS 477 (640)
Q Consensus 410 ~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~ 477 (640)
++|+|.+++..... .....+++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~kl~ 166 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKIS 166 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEEec
Confidence 99999999853321 112357889999999999999999994 569999999999999999999999
Q ss_pred cCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 006559 478 DIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQ 548 (640)
Q Consensus 478 DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~ 548 (640)
|||+++..... ...+..|+|||.+ ....++.++|||||||++|||+| |..||..... ....+
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~ 237 (283)
T cd05090 167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAI-------MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIE 237 (283)
T ss_pred cccccccccCCcceecccCCCccceecChHHh-------ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence 99998765321 2224569999964 33457789999999999999999 9999864321 11111
Q ss_pred HhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 549 MMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 549 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
....... ..... ....++.+++.+||+.+|++||++.++.+.|..
T Consensus 238 ~~~~~~~--------~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQL--------LPCSE---DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCc--------CCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111110 00111 122346677888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=285.19 Aligned_cols=237 Identities=20% Similarity=0.288 Sum_probs=190.8
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|.||.||.|+.+ ++-.||+|++.+. ...+++.+|+++-..|+||||++++++|.+....||++||.+
T Consensus 26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~ 105 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP 105 (281)
T ss_pred ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence 4678999999999999964 5778999998755 345778899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
+|++...|.+.+. ..++......++.|+|.||.|+| .++||||||||+|+|++..+..|++|||-+-.-.
T Consensus 106 ~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR 179 (281)
T KOG0580|consen 106 RGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKR 179 (281)
T ss_pred CchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCc
Confidence 9999999985542 24777778889999999999999 5669999999999999999999999999876542
Q ss_pred CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 487 TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 487 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...++|.-|.+||+ .....++.++|+|++||+.||++.|.+||.....+ ..+ .++....+..
T Consensus 180 ~tlcgt~dyl~pEm-------v~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etY----------krI~k~~~~~ 241 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEM-------VEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETY----------KRIRKVDLKF 241 (281)
T ss_pred eeeecccccCCHhh-------cCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHH----------HHHHHccccC
Confidence 23567899999996 45566778999999999999999999999754311 111 1111112222
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+..... ...+++.+|+..+|.+|.+..||+.
T Consensus 242 p~~is~---~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 PSTISG---GAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CcccCh---hHHHHHHHHhccCccccccHHHHhh
Confidence 222333 3556777899999999999998865
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=319.66 Aligned_cols=234 Identities=18% Similarity=0.225 Sum_probs=184.0
Q ss_pred hccccccCcceEEEEEeCC--CcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLDG--GDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~--~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|+..+ +..||+|.+... ...+.+.+|+++++.++||||+++++++...+..|+||||++
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 5679999999999998543 358999998643 223456789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~ 186 (340)
T PTZ00426 115 GGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY 186 (340)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence 999999997543 47888999999999999999994 5699999999999999999999999999987643
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+|..|+|||++. ...++.++|||||||++|||+||+.||....... ..+..... ....+
T Consensus 187 ~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~i~~~---------~~~~p 248 (340)
T PTZ00426 187 TLCGTPEYIAPEILL-------NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IYQKILEG---------IIYFP 248 (340)
T ss_pred eecCChhhcCHHHHh-------CCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HHHHHhcC---------CCCCC
Confidence 234688999999753 3456789999999999999999999997543211 11111111 01111
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
..... .+.+++.+|++.||++|+ +++++.+
T Consensus 249 ~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 249 KFLDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11222 345677789999999995 7777754
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=306.12 Aligned_cols=235 Identities=23% Similarity=0.316 Sum_probs=179.0
Q ss_pred cccccCcceEEEEEeCC-------------------------CcEEEEEEecccc--chHHHHHHHHHHhccCCCcccce
Q 006559 340 LLGKGCVGATYKVVLDG-------------------------GDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSI 392 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l 392 (640)
.||+|+||.||+|++.. ...|++|.+.... ...++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 1248888886542 23567788899999999999999
Q ss_pred eEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC
Q 006559 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG 472 (640)
Q Consensus 393 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~ 472 (640)
+++|...+..++||||+++|+|..++....+ .+++..++.++.|+++||+||| ..+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccC
Confidence 9999999999999999999999999875332 4788889999999999999999 45699999999999998644
Q ss_pred -------CeEEccCCcccccCC--CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHH-hCCCCCCCCCcc
Q 006559 473 -------NACISDIGVHQLFHT--PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEIL-TGKMAKGDGELG 542 (640)
Q Consensus 473 -------~~kl~DfGl~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~-tg~~p~~~~~~~ 542 (640)
.+|++|||++..... ....+..|+|||.+.. ...++.++|||||||++|||+ +|+.||......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPG------GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cccCccceeeecCCccccccccccccccCCcccCchhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 379999998765432 2334678999996422 245678999999999999995 699998643221
Q ss_pred hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
..... ... ....... ...++.+++.+||+.+|++||+|.+|++.|
T Consensus 229 ~~~~~--~~~----------~~~~~~~---~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 EKERF--YEK----------KHRLPEP---SCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH--HHh----------ccCCCCC---CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11111 000 0000010 113467788899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=316.41 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=182.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC-----CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK-----DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 407 (640)
.++||+|+||.||+|+. .++..||||++... .....+.+|++++++++||||+++++++... ...|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 46799999999999995 46889999998743 2234577899999999999999999988643 25899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
||+ ++|.+++.... .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 85 LME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred cCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 996 68999887543 48899999999999999999995 4599999999999999999999999999875421
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhccccc-
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQDESA- 556 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~- 556 (640)
...++..|+|||++.. ....++.++|||||||++|||+||+.||..... .....+.........
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGS-----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhc-----cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 2346788999997521 124577899999999999999999999975321 111111111000000
Q ss_pred --cccc-----------chhhcc--ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 557 --WEVF-----------DFELIM--DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 557 --~~~~-----------d~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+. ...... ..........+.+++.+||+.||++||++.|+++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 000000 0000111235678889999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.96 Aligned_cols=240 Identities=20% Similarity=0.248 Sum_probs=185.8
Q ss_pred hhccccccCcceEEEEEeC-C-CcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-G-GDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~-~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|... + +..||+|.+... .....+..|+++++.++|||||++++++...+..|+||||+++|
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 3578999999999999853 3 567888876543 22345677999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.++++.... ...++++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 151 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 151 DLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 99998864321 22368889999999999999999994 5699999999999999999999999999986542
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||..... ........... .++
T Consensus 227 ~~~~~~gt~~y~aPE~~-------~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~~~~~~~~-----~~~-- 290 (478)
T PTZ00267 227 VASSFCGTPYYLAPELW-------ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIMQQVLYGK-----YDP-- 290 (478)
T ss_pred cccccCCCccccCHhHh-------CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC-----CCC--
Confidence 22468889999964 345678899999999999999999999974321 12121111110 000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+. ....++.+++..||+.+|++||++.+++.
T Consensus 291 -~~~---~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPC---PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCc---cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 001 11234667788899999999999998863
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=301.07 Aligned_cols=243 Identities=23% Similarity=0.386 Sum_probs=190.8
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|+..+...||+|+++.. ...+.+.+|++++++++||||+++++++. .+..++||||+++|+|.
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (262)
T ss_pred EeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence 35679999999999999877778999999864 33567888999999999999999999875 45689999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------ 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~------ 489 (640)
+++....+ ..+++..+..++.|++.||+||| ..+|+||||||+||++++++.+||+|||.++......
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 89 DFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred HHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 99975421 24789999999999999999999 4569999999999999999999999999987654321
Q ss_pred -cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 490 -FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 490 -~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..+..|+|||+. ....++.++|||||||++|||+| |+.||....... ......... ....
T Consensus 163 ~~~~~~y~~PE~~-------~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~--------~~~~- 224 (262)
T cd05071 163 AKFPIKWTAPEAA-------LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY--------RMPC- 224 (262)
T ss_pred CcccceecCHhHh-------ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHHHhcCC--------CCCC-
Confidence 224569999953 34557789999999999999999 888886432111 111111000 0000
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
..+....+.+++.+|++.+|++||++.++.+.|++..
T Consensus 225 --~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1223456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=301.56 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=185.2
Q ss_pred cccccCcceEEEEEeC---CCcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 340 LLGKGCVGATYKVVLD---GGDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.||+|+||.||+|++. ++..||+|.+..... .+++.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 345699999876532 356888999999999999999999885 457899999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF---- 489 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~---- 489 (640)
|.+++.... ..+++..+++++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999987533 258899999999999999999994 469999999999999999999999999987553211
Q ss_pred -----cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 490 -----FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 490 -----~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
..+..|+|||.. ....++.++|||||||++||+++ |+.||..... ..+.......... +
T Consensus 154 ~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~----~-- 218 (257)
T cd05115 154 ARSAGKWPLKWYAPECI-------NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVMSFIEQGKRL----D-- 218 (257)
T ss_pred ccCCCCCCcccCCHHHH-------ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCCCC----C--
Confidence 113579999964 33456789999999999999997 9999964321 1222221111100 0
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.+. ....++.+++..||..+|++||++.+|.+.|+.+.
T Consensus 219 --~~~---~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 219 --CPA---ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred --CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 011 12345667888899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=301.09 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=183.7
Q ss_pred ccccccCcceEEEEEeCC----CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEeccC
Q 006559 339 ELLGKGCVGATYKVVLDG----GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYDYLP 410 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~~ 410 (640)
+.||+|+||.||+|...+ ...||+|.+.... ..+.+.+|+.+++.++||||+++++++.. ++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 3569999886432 23567788899999999999999998764 556899999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++..... .+.+..++.++.|++.||+||| ..+++||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9999999975431 3577888999999999999999 45699999999999999999999999999875432
Q ss_pred -------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhC-CCCCCCCCcchHHHHHHhhcccccccc
Q 006559 488 -------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG-KMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 488 -------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
....+..|+|||.. ....++.++|||||||++|||+|| .+||... ......+.......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~~---- 220 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESL-------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYLLQGRR---- 220 (262)
T ss_pred eeecccccCcCCccccChhHh-------ccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcCCC----
Confidence 11234579999954 345577899999999999999995 5556432 12222222211110
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
...+. .....+.+++..||+.+|++||++.++++.|+++..
T Consensus 221 ----~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ----LLQPE---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCCCC---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00011 122357788899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=319.55 Aligned_cols=248 Identities=20% Similarity=0.339 Sum_probs=190.1
Q ss_pred hhccccccCcceEEEEEeCC------CcEEEEEEeccccc---hHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG------GDVVVVKRIRERKK---KREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~---~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||+|++.+ +..||||+++.... .+.+..|++++.++. |||||+++++|...+..++||
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 35789999999999998643 35799999975422 345778999999997 999999999999999999999
Q ss_pred eccCCCCHHHhhccCCC---------------------------------------------------------------
Q 006559 407 DYLPHGSLHSLLHGSRG--------------------------------------------------------------- 423 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~--------------------------------------------------------------- 423 (640)
||+++|+|.++++....
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999975421
Q ss_pred ------------------------------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 424 ------------------------------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 424 ------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
.....++|...++++.|++.||+||| ..+|+||||||+|||+++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCE
Confidence 01124778889999999999999999 456999999999999999999
Q ss_pred eEEccCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchH
Q 006559 474 ACISDIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIV 544 (640)
Q Consensus 474 ~kl~DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~ 544 (640)
+||+|||+++.... ....+..|+|||.+ ....++.++|||||||++|||++ |+.||........
T Consensus 278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-------FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEEEecCcceecccccccccCCCcCCCCceeChHHh-------cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 99999999876431 12235679999965 33456789999999999999998 8889864321111
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.......... ...+. ....++.+++..||+.+|++||+++++++.|+++.
T Consensus 351 -~~~~~~~~~~--------~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -FYNAIKRGYR--------MAKPA---HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHHHcCCC--------CCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111100 00111 11235677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=306.86 Aligned_cols=248 Identities=18% Similarity=0.243 Sum_probs=184.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 467999999999999975 57889999987542 2345778999999999999999999999999999999999988
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
.+..+.... ..+++..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 86 MLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 776554322 24788899999999999999999 45699999999999999999999999999876532
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHh-hc-----------
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMM-GQ----------- 552 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~-~~----------- 552 (640)
...++..|+|||++. ...++.++|||||||++|||++|+.||...... ...-+... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 158 YTEYVATRWYRSPELLL-------GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccccccccCCcHHHc-------CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 124577899999753 345678999999999999999999999753211 10001100 00
Q ss_pred ccccccccchhhccCh-----HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 553 DESAWEVFDFELIMDK-----EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 553 ~~~~~~~~d~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.........+...... ........+.+++.+|++.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000000 00112345788899999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=303.09 Aligned_cols=245 Identities=23% Similarity=0.363 Sum_probs=187.8
Q ss_pred ccccccCcceEEEEEeCC-Cc--EEEEEEeccc---cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLDG-GD--VVVVKRIRER---KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~-~~--~vavK~l~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|+..+ +. .+++|.++.. ...+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 33 4688888753 2335677899999999 799999999999999999999999999
Q ss_pred CCHHHhhccCCC-----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCC
Q 006559 412 GSLHSLLHGSRG-----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG 480 (640)
Q Consensus 412 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 480 (640)
|+|.+++..... .....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999875431 011247899999999999999999994 569999999999999999999999999
Q ss_pred cccccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccc
Q 006559 481 VHQLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDE 554 (640)
Q Consensus 481 l~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 554 (640)
+++.... ....+..|+|||++ ....++.++|||||||++|||+| |+.||..... ....+......
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~-------~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESL-------NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQGY 228 (270)
T ss_pred CccccchhhhccCCCCccccCChHHH-------ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHHHHHHhCCC
Confidence 9864321 11124569999953 44567789999999999999997 9999964321 11111111110
Q ss_pred ccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 555 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.. + .. .....++.+++.+||+.+|.+||++.+++..|+++.
T Consensus 229 ~~----~----~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RL----E----KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC----C----CC---CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 0 00 112235678889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.09 Aligned_cols=248 Identities=18% Similarity=0.344 Sum_probs=197.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|... +|+.||+|.++.. ...+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 567999999999999976 7889999988632 2245678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++..... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++.....
T Consensus 87 ~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 162 (267)
T cd08224 87 GDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc
Confidence 999999864321 22358899999999999999999994 56999999999999999999999999998765321
Q ss_pred ---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 489 ---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 489 ---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...+..|+|||.+ ....++.++|||||||++|||++|+.||...........+...... . +..
T Consensus 163 ~~~~~~~~~y~apE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~-~~~- 228 (267)
T cd08224 163 AHSLVGTPYYMSPERI-------HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-----Y-PPL- 228 (267)
T ss_pred cceecCCccccCHHHh-------ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-----C-CCC-
Confidence 2346679999964 3445778999999999999999999999765544433333222110 0 000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
. .......+.+++.+||..+|++||++.+|+++|++++
T Consensus 229 -~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 -P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 1123345677888899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=320.08 Aligned_cols=230 Identities=22% Similarity=0.317 Sum_probs=181.1
Q ss_pred ccccccCcceEEEEEe----CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 339 ELLGKGCVGATYKVVL----DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
+.||+|+||.||+++. .+|..||+|+++... ....+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 357899999997542 23446678999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999987543 58899999999999999999995 45999999999999999999999999998765322
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
..++..|+|||++ ....++.++|||||||++|||+||+.||...... ......... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~i~~~---------~~ 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVV-------NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTMILKA---------KL 215 (318)
T ss_pred ceecccCChhhcCHHHH-------cCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHHHHcC---------CC
Confidence 3457889999964 3345678999999999999999999999753321 111111111 01
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSI 597 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~ 597 (640)
..+... ..++.+++..||+.||++||++.+
T Consensus 216 ~~p~~~---~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFL---SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCC---CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111111 224566778899999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.04 Aligned_cols=240 Identities=20% Similarity=0.304 Sum_probs=181.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||+||+|+. .++..||||++.... ..+.+..|++++++++||||+++++++.+.+..|+||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 46799999999999985 457889999997541 234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|.+++.... .+++.....++.|++.||+|||. .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 86 GDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999987543 47888888899999999999994 569999999999999999999999999875321
Q ss_pred ------------------------------------------------CCccccccccCCccccCCCCccccCCCCCccc
Q 006559 487 ------------------------------------------------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCD 518 (640)
Q Consensus 487 ------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~D 518 (640)
....+|..|+|||++ ....++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-------~~~~~~~~~D 230 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL-------LRKGYTQLCD 230 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH-------cCCCCCCccc
Confidence 113467899999975 3345778999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006559 519 VYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIV 598 (640)
Q Consensus 519 V~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v 598 (640)
||||||++|||+||+.||......... .+....... ...........+..+++.-+ .|+..+|.+||++.++
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~-~~i~~~~~~------~~~~~~~~~s~~~~dli~~l-l~~~~~~~~R~~~~~~ 302 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQ-LKVINWENT------LHIPPQVKLSPEAVDLITKL-CCSAEERLGRNGADDI 302 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHH-HHHHccccc------cCCCCCCCCCHHHHHHHHHH-ccCcccccCCCCHHHH
Confidence 999999999999999999754322111 111100000 00000011223333333322 3778888889999999
Q ss_pred HH
Q 006559 599 HR 600 (640)
Q Consensus 599 ~~ 600 (640)
+.
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=302.16 Aligned_cols=249 Identities=17% Similarity=0.302 Sum_probs=195.3
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||++.. .++..+|||.+... ....++.+|+++++.++||||+++++++...+..++||||++
T Consensus 6 ~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecC
Confidence 356799999999999995 57889999987643 223467789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+++|.+++..... ....+++.....++.|++.||.||| ..+++|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 9999998864221 1235889999999999999999999 45699999999999999999999999999876532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||.. ....++.++||||||+++|||++|+.||.........+.+..... ..+..
T Consensus 162 ~~~~~~~~~~~~ape~~-------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~ 228 (267)
T cd08229 162 AAHSLVGTPYYMSPERI-------HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC------DYPPL 228 (267)
T ss_pred ccccccCCcCccCHHHh-------cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC------CCCCC
Confidence 12456789999964 334567899999999999999999999975443333332222111 00111
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.. ......+.+++.+||+.+|++||||.+|.++++++.
T Consensus 229 ~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PS----DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred Cc----ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00 122335677788899999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=305.49 Aligned_cols=244 Identities=21% Similarity=0.321 Sum_probs=187.5
Q ss_pred hccccccCcceEEEEEeC------CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD------GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|... .+..||||.+.... ...++.+|+.+++.++||||+++++++......++||||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence 567999999999998753 24579999886542 234577899999999999999999999988999999999
Q ss_pred cCCCCHHHhhccCCCC-----CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 409 LPHGSLHSLLHGSRGP-----GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
+++|+|.++++..... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~ 167 (277)
T cd05062 91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167 (277)
T ss_pred CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCCCcc
Confidence 9999999998753311 12246788999999999999999994 569999999999999999999999999987
Q ss_pred ccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccc
Q 006559 484 LFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDE 554 (640)
Q Consensus 484 ~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 554 (640)
..... ...+..|+|||++ ....++.++|||||||++|||+| |+.||..... ....+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~ 238 (277)
T cd05062 168 DIYETDYYRKGGKGLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFVMEGG 238 (277)
T ss_pred ccCCcceeecCCCCccCHhhcChhHh-------hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCC
Confidence 54321 1225579999964 34557789999999999999999 6888864321 12222111111
Q ss_pred ccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 555 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
. .+ .. ......+.+++.+||+.+|++||++.|+++.|++
T Consensus 239 -~---~~----~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 239 -L---LD----KP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -c---CC----CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0 00 00 1123357778889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=303.20 Aligned_cols=242 Identities=20% Similarity=0.350 Sum_probs=190.3
Q ss_pred hhccccccCcceEEEEEeCC-C---cEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG-G---DVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|+... + ..+|+|.++... ..+.+..|++++++++|+||+++.+++...+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 35789999999999998642 3 368999987542 2456788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF 489 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~ 489 (640)
++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+|++|||++.......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999997543 258899999999999999999994 459999999999999999999999999987653211
Q ss_pred ---------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 490 ---------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 490 ---------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
..+..|+|||++ ....++.++|||||||++|||+| |+.||..... .++.+........
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~-------~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~~~~~--- 229 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAI-------AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGFRL--- 229 (268)
T ss_pred ccceeccCCCcCceecCHHHh-------hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhcCCCC---
Confidence 113469999954 34567789999999999999998 9999864321 1222222111000
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
+...+....+.+++.+||+.+|++||+|.+|++.|+++
T Consensus 230 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 --------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00012234577889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=302.45 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=188.3
Q ss_pred hccccccCcceEEEEEeCC----CcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCe------EE
Q 006559 338 AELLGKGCVGATYKVVLDG----GDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDE------LF 403 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~ 403 (640)
.+.||+|+||.||+|.... +..||+|+++... ....+..|++.++.++||||+++++++...+. .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4679999999999998642 3679999987542 12457788999999999999999999876544 79
Q ss_pred EEEeccCCCCHHHhhccCCC-CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 404 LVYDYLPHGSLHSLLHGSRG-PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
+||||+++|+|..++..... .....+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccce
Confidence 99999999999999864431 122358899999999999999999994 45999999999999999999999999998
Q ss_pred cccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcc
Q 006559 483 QLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 483 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 553 (640)
+..... ...+..|+|||.+ ....++.++|||||||++|||++ |..||.+... .+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-------~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~~~ 231 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESL-------ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHG 231 (273)
T ss_pred eeccccccccccccccCCccccCHhhc-------ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC
Confidence 865322 1124579999954 34556789999999999999999 8889864322 1222222111
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
... . .. .....++.+++.+||+.||++||++.|+++.|+++
T Consensus 232 ~~~------~--~~---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRL------K--QP---EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC------C--CC---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 0 01 12334677888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=297.46 Aligned_cols=259 Identities=21% Similarity=0.357 Sum_probs=193.6
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccccc----hHHHHHHHHHHhccCCCc-ccceeEEEEcCC------eEEEE
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSN-IVSIRAYCNGKD------ELFLV 405 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------~~~lV 405 (640)
.+.||+|.||+||+|+ ..+|+.||+|+++.... .....+|+-++++++|+| ||.+++++.... .+++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 4569999999999999 46788999999986533 233568899999999999 999999998876 89999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 406 YDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
+||+.. +|..++....... ..++-..+..++.|+++||+|||+. +|+||||||.|||++++|.+||+|||+|+.+
T Consensus 96 fe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 999976 9999987654221 2355578899999999999999954 5999999999999999999999999999876
Q ss_pred C------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC-cc-hHHHHHHhhcc-ccc
Q 006559 486 H------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE-LG-IVKWVQMMGQD-ESA 556 (640)
Q Consensus 486 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~-~~-~~~~~~~~~~~-~~~ 556 (640)
. ++.+.|.+|+|||++.+. ..|++..||||+||++.||++++.-|.+.. .+ +....+.++.. +..
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs------~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGS------TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCC------CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 5 234568899999997543 346788999999999999999998887432 11 22223333322 222
Q ss_pred cccc----chh-----hccChHHH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhhc
Q 006559 557 WEVF----DFE-----LIMDKEME----EEMRALLQVALLCLAPLPKDRPNMSIVHRM--IEDIRT 607 (640)
Q Consensus 557 ~~~~----d~~-----~~~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~ 607 (640)
|.-+ +.. ........ ....+..+++..|++.+|++|.|+..++.. +.++..
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 2211 111 00011111 111367788899999999999999998764 555543
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.68 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=187.8
Q ss_pred hccccccCcceEEEEEeC-----CCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD-----GGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey 408 (640)
.+.||+|+||.||++... ++..||+|++.... ..+.+..|++++++++||||+++.+++.. ....++||||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 567999999999999753 47789999987552 24567889999999999999999998754 3468999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP 488 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~ 488 (640)
+++|+|.+++.... ..++|..+..++.|++.||+|||. .+|+||||||+||++++++.+||+|||+++.....
T Consensus 89 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 89 LPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred cCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999997543 247899999999999999999994 56999999999999999999999999998865321
Q ss_pred c---------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc-
Q 006559 489 F---------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE- 558 (640)
Q Consensus 489 ~---------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 558 (640)
. ..+..|+|||+. ....++.++|||||||++|||++|..|+..... .+.+..........
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 231 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESL-------TESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQGQMI 231 (284)
T ss_pred CcceeecCCCCCceEeeCHHHh-------ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccccccc
Confidence 1 123358999964 334567899999999999999998877543221 12222111111000
Q ss_pred ------ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 559 ------VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 559 ------~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
........ +.......++.+++.+||+.+|++|||+.+|++.|++++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 232 VYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00000000 000122345778888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.17 Aligned_cols=229 Identities=21% Similarity=0.326 Sum_probs=182.4
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
...+||+|.||+|+++..+ +++.+|||.+++. ..-+..+.|.+++... +||.++.++..|++++++|+||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 3578999999999999975 4778999999876 2234456677766655 5999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc----
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF---- 485 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~---- 485 (640)
.+|++..+.+.. .++......||..|+.||+||| +.+||+||||.+|||||.+|.+||+|||+++..
T Consensus 452 ~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 452 AGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred CCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 999966555533 4889999999999999999999 556999999999999999999999999999863
Q ss_pred --CCCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 486 --HTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 486 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
+..+++|+.|+|||++ ....|+..+|.|||||+||||+.|+.||.+++.+.+ .. .|+..+
T Consensus 523 ~~TsTfCGTpey~aPEil-------~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~--Fd---------sI~~d~ 584 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVL-------TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV--FD---------SIVNDE 584 (694)
T ss_pred CccccccCChhhcChhhh-------ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HH---------HHhcCC
Confidence 2457889999999975 456788999999999999999999999985432111 11 111112
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
..++..++ .+.+.++.+.+..+|++|--+
T Consensus 585 ~~yP~~ls---~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 VRYPRFLS---KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCccc---HHHHHHHHHHhccCcccccCC
Confidence 22333333 345667777999999999876
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=304.20 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=193.6
Q ss_pred hhccccccCcceEEEEEeCC-----CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLDG-----GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 407 (640)
..++||+|+||.||+|.... +..|++|.+.... ..+.+.+|+.++++++|+||+++++++.. ....++++|
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 35789999999999999765 6789999887542 23557788999999999999999999876 468999999
Q ss_pred ccCCCCHHHhhccCCCC---CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 408 YLPHGSLHSLLHGSRGP---GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
|+++|+|.+++...... ....+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 99999999998654311 1235899999999999999999999 45699999999999999999999999999986
Q ss_pred cCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccc
Q 006559 485 FHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDES 555 (640)
Q Consensus 485 ~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 555 (640)
+... ...+..|+|||++ ....++.++|||||||++||+++ |+.||.... ..++.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~-------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~ 237 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESL-------VNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLKDGYR 237 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHH-------hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHHcCCC
Confidence 5321 2235579999964 33456789999999999999999 999997432 2222222211110
Q ss_pred cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 556 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
. ... ......+.+++.+||..+|++|||+.++++.|+++..+
T Consensus 238 ~--------~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 L--------AQP---INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred C--------CCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0 000 11223567888899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.51 Aligned_cols=234 Identities=21% Similarity=0.299 Sum_probs=183.1
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
+.||+|+||.||+++. .++..||+|.+.... ....+..|++++..++||||+++.+++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 468899999987541 2244567888999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... .+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 9999887543 58899999999999999999995 24699999999999999999999999999875321
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||...... ...+..... ....
T Consensus 154 ~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i~~~---------~~~~ 215 (325)
T cd05594 154 KTFCGTPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME---------EIRF 215 (325)
T ss_pred ccccCCcccCCHHHH-------ccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHHhcC---------CCCC
Confidence 23468899999965 3345678999999999999999999999753321 111111110 0001
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
+... ..++.+++.+|++.||++|+ ++.++++
T Consensus 216 p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 PRTL---SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCC---CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1111 22456677789999999997 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=305.05 Aligned_cols=236 Identities=18% Similarity=0.292 Sum_probs=182.3
Q ss_pred ccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 341 LGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 341 iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
||+|+||.||+++. .+|+.+|+|.+.... ..+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 458899999986431 233455689999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----c
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-----F 489 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-----~ 489 (640)
.+++.... ...+++..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeecc
Confidence 98886432 235789999999999999999999 456999999999999999999999999998765432 3
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch--HHHHHHhhcccccccccchhhccC
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI--VKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
.++..|+|||++ ....++.++||||+||++|||++|+.||....... ....+..... .....
T Consensus 155 ~~~~~y~aPE~~-------~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~ 218 (277)
T cd05607 155 AGTNGYMAPEIL-------KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED---------EVKFE 218 (277)
T ss_pred CCCCCccCHHHH-------ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc---------ccccc
Confidence 457799999964 33447789999999999999999999997432211 1111111110 00000
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......++.+++..||+.||++||+++|+++
T Consensus 219 --~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 219 --HQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred --cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 0112234677788899999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=317.68 Aligned_cols=187 Identities=20% Similarity=0.338 Sum_probs=160.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||+||+++.. +++.||||.+.... ....+..|+.++.+++|+||+++++.+.+....|+||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 467999999999999854 57899999987531 224567789999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 86 GDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999997543 58899999999999999999994 5699999999999999999999999999865321
Q ss_pred -------------------------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHH
Q 006559 488 -------------------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEIL 530 (640)
Q Consensus 488 -------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~ 530 (640)
...+|..|+|||++ ....++.++|||||||++|||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-------~~~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF-------MQTGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH-------cCCCCCCchhhhhhHHHHHHHH
Confidence 12468899999975 3345778999999999999999
Q ss_pred hCCCCCCCC
Q 006559 531 TGKMAKGDG 539 (640)
Q Consensus 531 tg~~p~~~~ 539 (640)
+|+.||...
T Consensus 231 ~G~~Pf~~~ 239 (363)
T cd05628 231 IGYPPFCSE 239 (363)
T ss_pred hCCCCCCCC
Confidence 999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.93 Aligned_cols=231 Identities=17% Similarity=0.259 Sum_probs=177.1
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+++.. +++.||+|.++... ..+.+..|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 57889999987541 223456777777665 899999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 99998886543 58889999999999999999995 459999999999999999999999999987532
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC------cchHHHHHHhhcccccccc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE------LGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~------~~~~~~~~~~~~~~~~~~~ 559 (640)
....++..|+|||++ ....++.++|||||||++|||+||+.||.... .....++......
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~------ 219 (329)
T cd05618 153 TSTFCGTPNYIAPEIL-------RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------ 219 (329)
T ss_pred cccccCCccccCHHHH-------cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc------
Confidence 123468899999965 34456789999999999999999999995211 1111121111110
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
.....+... ..++.+++.+||+.||++||+.
T Consensus 220 --~~~~~p~~~---~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 --KQIRIPRSL---SVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CCCCCCCCC---CHHHHHHHHHHhcCCHHHcCCC
Confidence 001111111 2345677888999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.44 Aligned_cols=234 Identities=21% Similarity=0.349 Sum_probs=187.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccccch---HHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKK---REVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|.||.||+|.. ..++.||+|.+.....+ +++++|+.++..++|+||.+++|.+..+..++++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 47899999999999994 56889999999866443 457789999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC------C
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------T 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------~ 487 (640)
+.+.++... .++...+.-+.+++..||.|||+.+ .+|||||+.|||+..+|.+|++|||++.... .
T Consensus 98 v~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 98 VLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred hhhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 999997553 3466667778899999999999654 9999999999999999999999999986653 3
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch-hhcc
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF-ELIM 566 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~-~~~~ 566 (640)
.+++|+.|||||++ ....|+.|+||||+|++.+||++|.+|+.+-+.. +. ...|... ....
T Consensus 170 tfvGTPfwMAPEVI-------~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----rv------lflIpk~~PP~L 231 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVI-------KQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----RV------LFLIPKSAPPRL 231 (467)
T ss_pred cccccccccchhhh-------ccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----eE------EEeccCCCCCcc
Confidence 56789999999975 3557889999999999999999999999753210 00 0111110 0011
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+. .....+.+++..|++.+|+.||++.++++
T Consensus 232 ~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DG---DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cc---ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 11 23334556667799999999999998863
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.29 Aligned_cols=243 Identities=21% Similarity=0.324 Sum_probs=189.2
Q ss_pred hccccccCcceEEEEEe-CCCc----EEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVL-DGGD----VVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~----~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.++||+|+||+||+|++ .++. .||+|.++... ..+++.+|+.+++.++||||+++++++.. ...+++|||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 56899999999999985 3444 37999987542 24567788899999999999999999975 4578999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF 489 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~ 489 (640)
++|+|.++++... ..+++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 91 ~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 91 PYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred CCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999997543 248899999999999999999994 569999999999999999999999999988654211
Q ss_pred --------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcc-hHHHHHHhhcccccccc
Q 006559 490 --------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELG-IVKWVQMMGQDESAWEV 559 (640)
Q Consensus 490 --------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 559 (640)
..+..|+|||.. ....++.++|||||||++|||+| |+.||...... ...++......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~-------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------ 230 (279)
T cd05109 164 TEYHADGGKVPIKWMALESI-------LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL------ 230 (279)
T ss_pred ceeecCCCccchhhCCHHHh-------ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC------
Confidence 124579999964 34457789999999999999999 89998643221 22222111100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
. .. .....++.+++..||+.||++||++.++++.|+++..+.
T Consensus 231 ---~--~~---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ---P--QP---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---C--CC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0 00 112345677888999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=313.88 Aligned_cols=239 Identities=21% Similarity=0.374 Sum_probs=190.6
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||.|+||.||.++ ..+.++||||++.-. ....++..|++.|.+++|||+|.+.|+|..+...|||||||-
T Consensus 30 dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl 109 (948)
T KOG0577|consen 30 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL 109 (948)
T ss_pred HHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh
Confidence 34569999999999999 466789999998643 345778999999999999999999999999999999999995
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--C
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--P 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--~ 488 (640)
|+-.+++.-.++ ++....+..|+.+...||+|||+.+ .||||||+.||||.+.|.+|++|||-+....+ .
T Consensus 110 -GSAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns 181 (948)
T KOG0577|consen 110 -GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS 181 (948)
T ss_pred -ccHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence 577777754432 5788899999999999999999765 89999999999999999999999999887754 6
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
+++|+.|||||++.. ...+.|+.|+||||+|++..||..+++|.... +...-+-.+.+. +.......
T Consensus 182 FvGTPywMAPEVILA----MDEGqYdgkvDvWSLGITCIELAERkPPlFnM--NAMSALYHIAQN-------esPtLqs~ 248 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILA----MDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQN-------ESPTLQSN 248 (948)
T ss_pred ccCCccccchhHhee----ccccccCCccceeeccchhhhhhhcCCCccCc--hHHHHHHHHHhc-------CCCCCCCc
Confidence 789999999999763 45578899999999999999999999996532 222211111221 11112223
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
+.++ .+..++-.|++.-|.+|||..+++
T Consensus 249 eWS~---~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 249 EWSD---YFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred hhHH---HHHHHHHHHHhhCcccCCcHHHHh
Confidence 3334 455566669999999999988765
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=300.22 Aligned_cols=239 Identities=27% Similarity=0.376 Sum_probs=186.9
Q ss_pred ccccccCcceEEEEEeCC----CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLDG----GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|++.. +..+|+|.+.... ..+++..|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999998532 2579999988653 3456788999999999999999999876 4568999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc--
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF-- 489 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~-- 489 (640)
|+|.+++.... .+++..+..++.|++.||+|||. .+++||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999997543 57899999999999999999994 459999999999999999999999999987653211
Q ss_pred -------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 490 -------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 490 -------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
..+..|+|||.. ....++.++|||||||++|||++ |+.||..... .+..+........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~----- 217 (257)
T cd05060 152 YRATTAGRWPLKWYAPECI-------NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL----- 217 (257)
T ss_pred cccccCccccccccCHHHh-------cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC-----
Confidence 112469999954 34557789999999999999998 9999974322 1122211111100
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
... ......+.+++.+||..+|++||++.++++.|+++.
T Consensus 218 ---~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ---PRP---EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 001 112345778888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.49 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=189.9
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEE-cCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCN-GKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||++..+ +..||+|.++.....+.+..|+.++++++|+|++++++++. ..+..++||||+++|+|.+
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHH
Confidence 567999999999999865 67789999877666677889999999999999999999865 4567899999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---Cccccc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---PFFIND 493 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---~~~~~~ 493 (640)
+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.... ....+.
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 163 (256)
T cd05082 90 YLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 163 (256)
T ss_pred HHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccCCCCccce
Confidence 9875432 247899999999999999999994 4599999999999999999999999999876532 222355
Q ss_pred cccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHH
Q 006559 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEE 572 (640)
Q Consensus 494 ~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 572 (640)
.|+|||+. ....++.++|||||||++|||++ |+.||..... ............ . . .. ..
T Consensus 164 ~y~aPE~~-------~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~-~-----~--~~---~~ 223 (256)
T cd05082 164 KWTAPEAL-------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYK-M-----D--AP---DG 223 (256)
T ss_pred eecCHHHH-------ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCC-C-----C--CC---CC
Confidence 79999964 33456789999999999999998 9999864322 222222111100 0 0 00 12
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 573 EMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 573 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
....+.+++.+||+.+|++|||+.++.+.|+++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 234567788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.96 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=189.3
Q ss_pred hhccccccCcceEEEEEeCC------CcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLDG------GDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+..+ +..||+|+++.... .+.+.+|+.++++++||||+++++++...+..++++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEE
Confidence 35679999999999998643 46799999975532 3557789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCC-----------CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEE
Q 006559 408 YLPHGSLHSLLHGSR-----------GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACI 476 (640)
Q Consensus 408 y~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl 476 (640)
|+++++|.+++.... ......+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+||
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceEe
Confidence 999999999985321 0112357888999999999999999994 56999999999999999999999
Q ss_pred ccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHH
Q 006559 477 SDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWV 547 (640)
Q Consensus 477 ~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~ 547 (640)
+|||+++..... ...+..|+|||.+ ....++.++|||||||++|||+| |..||.+.. ...+.
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~ 236 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQDVI 236 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHH-------hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--HHHHH
Confidence 999998765321 1235679999964 33456789999999999999998 888886432 22233
Q ss_pred HHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 548 QMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 548 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
+........ ... ......+.+++..||+.+|++||++.+|+..|+.
T Consensus 237 ~~i~~~~~~--------~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVL--------PCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcC--------CCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222221100 001 1233446778889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=312.27 Aligned_cols=231 Identities=22% Similarity=0.311 Sum_probs=176.6
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHh-ccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIG-GLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|+.. +++.||||.++... ..+.+..|.+++. ..+||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 47789999987541 1223344555555 35899999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 99999987543 47888899999999999999995 5699999999999999999999999999875421
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...++..|+|||++ ....++.++|||||||++|||++|+.||...... +........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~---------~~~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEIL-------KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFDSILND---------RPH 214 (316)
T ss_pred cccccCCccccCHHHH-------cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC---------CCC
Confidence 23468899999965 3445778999999999999999999999754321 111111111 000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHH-HH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMS-IV 598 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v 598 (640)
.+... ..++.+++..||+.+|++||++. ++
T Consensus 215 ~~~~~---~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 215 FPRWI---SKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred CCCCC---CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 11111 22355677789999999999975 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=311.38 Aligned_cols=232 Identities=23% Similarity=0.324 Sum_probs=178.7
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhc-cCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGG-LRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
+.||+|+||.||+|+.. ++..||||.++... ..+.+..|.+++.. ++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999965 47889999987541 22334556666664 5899999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 99999987542 47888999999999999999994 569999999999999999999999999987532
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....++..|+|||++ ....++.++|||||||++|||+||+.||..... ....+...... +.
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~~-------~~-- 214 (316)
T cd05619 153 TCTFCGTPDYIAPEIL-------LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMDN-------PC-- 214 (316)
T ss_pred eeeecCCccccCHHHH-------cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC-------CC--
Confidence 123457899999965 334577899999999999999999999975332 11111111100 00
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMS-IVH 599 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v~ 599 (640)
.+.... .++.+++.+||+.||++||++. ++.
T Consensus 215 ~~~~~~---~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YPRWLT---REAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCccCC---HHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111112 2456677889999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.95 Aligned_cols=228 Identities=21% Similarity=0.303 Sum_probs=177.8
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|+.. +++.||||.++... ..+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999964 57899999987531 223455677777765 699999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|.+++.... .+++..+..++.|++.||+||| ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 99999987543 4788999999999999999999 4569999999999999999999999999987532
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....++..|+|||++ ....++.++|||||||++|||+||+.||..... ....+...... ..
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~~i~~~~---------~~ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEIL-------QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEAILNDE---------VV 214 (320)
T ss_pred ccccccCccccCHHHH-------cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhcCC---------CC
Confidence 123468899999965 334567899999999999999999999975332 11122211110 01
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
.+... ..++.+++..|++.||++||++
T Consensus 215 ~~~~~---~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWL---SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCC---CHHHHHHHHHHcccCHHHCCCC
Confidence 11111 2245667788999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.75 Aligned_cols=240 Identities=22% Similarity=0.397 Sum_probs=188.2
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||++...++..+|+|.+... ...+.+.+|++++++++|+|++++++++. .+..++||||+++|+|.+
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLD 89 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHH
Confidence 4679999999999999888778999988754 34466888999999999999999999875 456899999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~ 489 (640)
+++... ...++|..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++..... .
T Consensus 90 ~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 90 FLKEGD---GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHhhCC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 997543 124789999999999999999999 456999999999999999999999999998765322 1
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+..|+|||.. ....++.++|||||||++|||+| |+.||.+.... +..+....... ....
T Consensus 164 ~~~~~y~~Pe~~-------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~- 225 (260)
T cd05069 164 KFPIKWTAPEAA-------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYR--------MPCP- 225 (260)
T ss_pred ccchhhCCHHHh-------ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--------CCCC-
Confidence 224579999953 34567789999999999999999 89998653211 11111111100 0011
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
......+.+++.+||+.+|++||++.+|.+.|++
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 --QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223456777888999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.29 Aligned_cols=232 Identities=20% Similarity=0.315 Sum_probs=179.8
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|+.. +++.||||.++... ..+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 47889999987541 223455677777755 799999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 99999887543 47889999999999999999994 559999999999999999999999999987532
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....++..|+|||++ ....++.++|||||||++|||+||+.||..... ....+...... ..
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--~~~~~~i~~~~---------~~ 214 (321)
T cd05591 153 TTTFCGTPDYIAPEIL-------QELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--DDLFESILHDD---------VL 214 (321)
T ss_pred ccccccCccccCHHHH-------cCCCCCCccceechhHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC---------CC
Confidence 123457899999964 344677899999999999999999999975332 11111111111 00
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCC-------CHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRP-------NMSIVH 599 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-------s~~~v~ 599 (640)
.+... ..++.+++..|++.||++|| ++.++.
T Consensus 215 ~p~~~---~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 215 YPVWL---SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred CCCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 11111 13456677889999999999 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.82 Aligned_cols=230 Identities=18% Similarity=0.261 Sum_probs=178.1
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+++.. ++..||||.++... ..+.+..|..++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999864 57889999997541 223466788888887 799999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|.+++.... .+++..+..++.|++.||+||| ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 99999886543 5889999999999999999999 4569999999999999999999999999987521
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC------cchHHHHHHhhcccccccc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE------LGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~------~~~~~~~~~~~~~~~~~~~ 559 (640)
....++..|+|||++ ....++.++|||||||++|||+||+.||.... .....+.......
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------ 219 (329)
T cd05588 153 TSTFCGTPNYIAPEIL-------RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE------ 219 (329)
T ss_pred cccccCCccccCHHHH-------cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc------
Confidence 123468899999965 33456789999999999999999999996311 1111121111111
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCC
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPN 594 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs 594 (640)
.....+... ..++.+++.+|++.||++||+
T Consensus 220 --~~~~~p~~~---~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 220 --KQIRIPRSL---SVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred --CCCCCCCCC---CHHHHHHHHHHhccCHHHcCC
Confidence 011111111 234667788899999999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.07 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=191.3
Q ss_pred hccccccCcceEEEEEeCC-Cc--EEEEEEeccc---cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLDG-GD--VVVVKRIRER---KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~--~vavK~l~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.++||+|+||.||+|+..+ +. .+++|.++.. ...+.+..|++++.++ +||||+++++++...+..++||||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 5679999999999998654 32 4788887743 2335678899999998 79999999999999999999999999
Q ss_pred CCCHHHhhccCCCC-----------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccC
Q 006559 411 HGSLHSLLHGSRGP-----------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDI 479 (640)
Q Consensus 411 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 479 (640)
+|+|.++++..... ....+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEECCc
Confidence 99999999754210 1124788999999999999999999 456999999999999999999999999
Q ss_pred CcccccCCC-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcc
Q 006559 480 GVHQLFHTP-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 480 Gl~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 553 (640)
|++...... ...+..|+|||+. ....++.++|||||||++|||+| |+.||..... ..........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--~~~~~~~~~~ 234 (297)
T cd05089 164 GLSRGEEVYVKKTMGRLPVRWMAIESL-------NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--AELYEKLPQG 234 (297)
T ss_pred CCCccccceeccCCCCcCccccCchhh-------ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcC
Confidence 998653211 1124469999954 34557789999999999999998 9999964322 1112211111
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCC
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 611 (640)
. ... ... .....+.+++.+||+.+|.+||++.++++.|+++..+...
T Consensus 235 ~------~~~--~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 235 Y------RME--KPR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred C------CCC--CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 000 011 1223567788899999999999999999999998866543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.37 Aligned_cols=232 Identities=19% Similarity=0.243 Sum_probs=178.7
Q ss_pred ccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 341 LGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 341 iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
||+|+||+||++... +++.||||.+.... ..+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 67899999986542 124456789999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.... .
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 988754321 12358899999999999999999994 5699999999999999999999999999876532 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch--HHHHHHhhcccccccccchhhcc
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI--VKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||++ ....++.++|||||||++|||+||+.||....... ....+.. .......
T Consensus 157 ~~g~~~y~aPE~~-------~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~ 220 (280)
T cd05608 157 YAGTPGFMAPELL-------QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI---------LNDSVTY 220 (280)
T ss_pred cCCCcCccCHHHh-------cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh---------cccCCCC
Confidence 3457789999964 34466789999999999999999999997532211 1111111 1111111
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
+. .....+.+++..||+.||++||++
T Consensus 221 ~~---~~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 221 PD---KFSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred cc---cCCHHHHHHHHHHhcCCHHHhcCC
Confidence 11 122346677788999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.94 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=181.0
Q ss_pred cccccCcceEEEEEeCCCc---EEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 340 LLGKGCVGATYKVVLDGGD---VVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~~~---~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.||+|+||.||++...++. .+++|.+.... ..+.+.+|+.+++.++||||++++++|......|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999854433 45677665432 34567888899999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------- 486 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------- 486 (640)
|.++++..... ...+++.....++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999754321 2245677788999999999999994 559999999999999999999999999976421
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
....++..|+|||+............++.++|||||||++|||++ |+.||.... ..+........ ......++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~-~~~~~~~~~~ 234 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DREVLNHVIKD-QQVKLFKPQL 234 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhh-cccccCCCcc
Confidence 122346789999976432211223356789999999999999997 566775422 11212111111 1111222222
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
... ..+ ++.+++..|| .+|++||++++|++.|.
T Consensus 235 ~~~--~~~---~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 ELP--YSE---RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCC--CcH---HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 122 3455666799 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.93 Aligned_cols=241 Identities=23% Similarity=0.391 Sum_probs=190.1
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|...++..+|+|.+... ...+.+.+|+.++++++|+|++++++++. ....++||||+++++|.
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence 35679999999999999888888999998764 34567889999999999999999999875 45689999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------ 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~------ 489 (640)
++++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 89 DFLKDGE---GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 9997542 1247899999999999999999994 559999999999999999999999999987654321
Q ss_pred -cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 490 -FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 490 -~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..+..|+|||+. ....++.++|||||||++|||++ |+.||.+... .+..+....... .. ..
T Consensus 163 ~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~------~~--~~ 225 (260)
T cd05070 163 AKFPIKWTAPEAA-------LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVERGYR------MP--CP 225 (260)
T ss_pred CCCCccccChHHH-------hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC------CC--CC
Confidence 123469999964 33457789999999999999999 8899864321 111221111100 00 01
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
......+.+++.+|+..+|++|||+.++.+.|++
T Consensus 226 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 ---QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223457788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.42 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=188.1
Q ss_pred HhhccccccCcceEEEEEe-----CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEE
Q 006559 336 SSAELLGKGCVGATYKVVL-----DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLV 405 (640)
Q Consensus 336 ~~~~~iG~G~fg~Vy~~~~-----~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV 405 (640)
...+.||+|+||.||++++ .++..||+|.++.. .....+.+|++++++++||||+++.+++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence 4456799999999999984 34678999998744 2235678899999999999999999998875 568999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 406 YDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
|||+++++|.+++.... ..++|..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||+++..
T Consensus 87 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 87 MEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999986542 24789999999999999999999 456999999999999999999999999998765
Q ss_pred CCC---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-------------h
Q 006559 486 HTP---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-------------I 543 (640)
Q Consensus 486 ~~~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-------------~ 543 (640)
... ...+..|+|||++ ....++.++|||||||++|||+|++.|....... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~-------~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECL-------IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHh-------ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence 321 2234569999964 3345778999999999999999987764321110 1
Q ss_pred HHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 544 VKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 544 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
..++....... .... ......++.+++.+||+.+|++||++.++++.++++
T Consensus 233 ~~~~~~~~~~~--------~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGK--------RLPR---PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCc--------cCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111000 0000 012334688889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=303.05 Aligned_cols=240 Identities=22% Similarity=0.271 Sum_probs=184.6
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccccc----------------hHHHHHHHHHHhccCCCcccceeEEEEcC-
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK----------------KREVDEWLRVIGGLRHSNIVSIRAYCNGK- 399 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~----------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~- 399 (640)
.+.||+|.||.|-+|+ ..+++.||||++.+... -+.+.+||.+|++++|||||+|+++..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 4579999999999999 45789999999865311 13577899999999999999999998764
Q ss_pred -CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEcc
Q 006559 400 -DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478 (640)
Q Consensus 400 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 478 (640)
+.+|||+|||..|.+...-.. ...++..+..+|.+++..||+|||.++ ||||||||+|+||+++|++||+|
T Consensus 182 s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred cCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeec
Confidence 589999999999987543221 112888999999999999999999654 99999999999999999999999
Q ss_pred CCcccccCC-----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHH
Q 006559 479 IGVHQLFHT-----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWV 547 (640)
Q Consensus 479 fGl~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~ 547 (640)
||.+..+.. ...+|+.|+|||+.++... ....+.+.||||+||+||-|+.|+.||-++. ..+..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~---~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--~~~l~ 328 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS---FSYSGFALDIWALGVTLYCLLFGQLPFFDDF--ELELF 328 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC---ccccchhhhhhhhhhhHHHhhhccCCcccch--HHHHH
Confidence 999886621 2357999999998765321 1223467899999999999999999997532 11111
Q ss_pred HHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 548 QMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 548 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..|+...+..+ ..++...++.+++.++|.+||++|.+..+|..
T Consensus 329 ---------~KIvn~pL~fP-~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 329 ---------DKIVNDPLEFP-ENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred ---------HHHhcCcccCC-CcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 12223233222 22244456677788899999999999888864
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.20 Aligned_cols=247 Identities=22% Similarity=0.379 Sum_probs=190.6
Q ss_pred hhccccccCcceEEEEEeCC------CcEEEEEEeccccc---hHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG------GDVVVVKRIRERKK---KREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~---~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||++...+ ...+|+|.+..... ..++.+|+.++.++ +|+||+++++++...+..++||
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 35679999999999998642 35789999875422 24567889999999 8999999999999999999999
Q ss_pred eccCCCCHHHhhccCCC-----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeE
Q 006559 407 DYLPHGSLHSLLHGSRG-----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC 475 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 475 (640)
||+++|+|.++++.... .....+++..+++++.|++.||+||| ..+|+||||||+||+++.++.+|
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeEE
Confidence 99999999999864320 11236889999999999999999999 45699999999999999999999
Q ss_pred EccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHH
Q 006559 476 ISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKW 546 (640)
Q Consensus 476 l~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~ 546 (640)
|+|||+++..... ...+..|+|||+. ....++.++|||||||++|||++ |..||...... +.
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 243 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-------FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--EL 243 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHh-------ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--HH
Confidence 9999998865421 1124569999954 34567789999999999999998 88998643211 11
Q ss_pred HHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 547 VQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 547 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.+........ ... .....++.+++.+||+.+|++|||+.++++.|+++.
T Consensus 244 ~~~~~~~~~~--------~~~---~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLKEGYRM--------EKP---QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHcCCcC--------CCC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111000 000 122345778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.09 Aligned_cols=249 Identities=20% Similarity=0.357 Sum_probs=192.3
Q ss_pred hhccccccCcceEEEEEeC--------CCcEEEEEEeccc---cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVLD--------GGDVVVVKRIRER---KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~--------~~~~vavK~l~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
..+.||+|+||.||+++.. ++..||+|.+... ...+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 98 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence 3578999999999999742 2347999988754 2235678899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCC-----------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 405 VYDYLPHGSLHSLLHGSRGP-----------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
||||+++|+|.+++...... ....++|..++.++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~~~~ 175 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNV 175 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcCCCc
Confidence 99999999999999754321 12357889999999999999999994 56999999999999999999
Q ss_pred eEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchH
Q 006559 474 ACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIV 544 (640)
Q Consensus 474 ~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~ 544 (640)
+||+|||+++..... ...+..|+|||++ ....++.++|||||||++|||+| |..||.... ..
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~ 246 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VE 246 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhh-------ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HH
Confidence 999999998765321 1224579999964 33457789999999999999999 788886432 22
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
++.+........ ... ......+.+++.+||+.+|++||+|.++++.|+++...
T Consensus 247 ~~~~~~~~~~~~--------~~~---~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 ELFKLLKEGHRM--------DKP---ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHcCCcC--------CCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 222222211100 001 12234567788889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=299.82 Aligned_cols=239 Identities=23% Similarity=0.328 Sum_probs=187.7
Q ss_pred ccccccCcceEEEEEeCC--Cc--EEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLDG--GD--VVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~--~~--~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|.+.. +. .||||.+..... .+.+..|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 32 589999986633 4567889999999999999999999988 899999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++..... ..++|.....++.|++.||+||| ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999976431 35899999999999999999999 456999999999999999999999999998765431
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
...+..|+|||.+ ....++.++|||||||++|||+| |+.||..... .+..+........
T Consensus 154 ~~~~~~~~~~~~y~~pE~~-------~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~----- 219 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESL-------RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQILKKIDKEGER----- 219 (257)
T ss_pred eecccCCCCCceecCHHHh-------cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcCCc-----
Confidence 2235679999953 44567789999999999999999 9999864221 1111111111100
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
.... ......+.+++.+||+.+|++||++.++++.|.
T Consensus 220 --~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 --LERP---EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCC---ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0001 112345777888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.20 Aligned_cols=241 Identities=23% Similarity=0.388 Sum_probs=189.0
Q ss_pred hhccccccCcceEEEEEeCC-C---cEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG-G---DVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~---~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|.... + ..||||.+... ...+++..|+.++++++||||+++.+++......++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 35789999999999998643 3 36999998754 23457888999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF 489 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~ 489 (640)
++|+|.+++....+ .+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+|++|||+++......
T Consensus 88 ~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 88 ENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999875432 47899999999999999999994 569999999999999999999999999987653211
Q ss_pred -----c------ccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhccccc
Q 006559 490 -----F------INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDESA 556 (640)
Q Consensus 490 -----~------~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~ 556 (640)
. .+..|+|||.+ ....++.++|||||||++||+++ |+.||..... ....++. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~-------~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~~-- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAI-------AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QDY-- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHh-------ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCC--
Confidence 1 12369999953 44567889999999999999987 9999864321 1222221 110
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
..... .+....+.+++..||+.+|++||+|.+|...|+++
T Consensus 229 ------~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ------RLPPP---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------cCCCc---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011 12234567788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.17 Aligned_cols=236 Identities=26% Similarity=0.368 Sum_probs=183.0
Q ss_pred ccccccCcceEEEEEeCCCc-----------EEEEEEeccccc-hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEE
Q 006559 339 ELLGKGCVGATYKVVLDGGD-----------VVVVKRIRERKK-KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 406 (640)
+.||+|+||.||+|...+.. .+++|.+..... ...+.+|+.++++++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999975433 477787765533 5678889999999999999999999988 7889999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-------CeEEccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-------NACISDI 479 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-------~~kl~Df 479 (640)
||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 80 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 80 EYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999976432 57889999999999999999994 5699999999999999888 7999999
Q ss_pred CcccccCC--CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccc
Q 006559 480 GVHQLFHT--PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESA 556 (640)
Q Consensus 480 Gl~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 556 (640)
|+++.... ....+..|+|||++... ...++.++|||||||++|||++ |..|+.... ...+........
T Consensus 153 g~a~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~~~~~~~~~~~-- 223 (259)
T cd05037 153 GIPITVLSREERVERIPWIAPECIRNG-----QASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SSEKERFYQDQH-- 223 (259)
T ss_pred CcccccccccccccCCCccChhhhcCC-----CCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--chhHHHHHhcCC--
Confidence 99887543 23346679999965321 1356789999999999999999 577775432 111111111100
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
..... . ...+.+++.+||..+|++||++.++++.|
T Consensus 224 ------~~~~~-~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 ------RLPMP-D----CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ------CCCCC-C----chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00000 0 14677888999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.61 Aligned_cols=191 Identities=23% Similarity=0.401 Sum_probs=155.9
Q ss_pred hccccccCcceEEEEEeC---CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD---GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~g 412 (640)
..+||+|+||+||+|+.. .+..||+|.+........+.+|++++++++||||+++++++.. ....++||||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 457999999999999864 4578999999766556667889999999999999999999864 456899999986 4
Q ss_pred CHHHhhccCCC----CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE----CCCCCeEEccCCcccc
Q 006559 413 SLHSLLHGSRG----PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV----DQLGNACISDIGVHQL 484 (640)
Q Consensus 413 sL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl~~~ 484 (640)
+|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 88887753321 112358888999999999999999995 459999999999999 4668999999999987
Q ss_pred cCC---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 485 FHT---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 485 ~~~---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
... ...+|..|+|||++.+ ...++.++||||+||++|||+||+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcC------CCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 542 2345788999997532 23467899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.54 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=188.6
Q ss_pred hccccccCcceEEEEEeCC-----------------CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEE
Q 006559 338 AELLGKGCVGATYKVVLDG-----------------GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCN 397 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~ 397 (640)
.+.||+|+||.||+++..+ +..||+|.+.... ..+++.+|++++++++||||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 5679999999999988543 2458999987652 3456788999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHhhccCCCC------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC
Q 006559 398 GKDELFLVYDYLPHGSLHSLLHGSRGP------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL 471 (640)
Q Consensus 398 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~ 471 (640)
..+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili~~~ 166 (296)
T cd05051 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKN 166 (296)
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceeecCC
Confidence 999999999999999999999765421 12258999999999999999999995 459999999999999999
Q ss_pred CCeEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh--CCCCCCCCCc
Q 006559 472 GNACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT--GKMAKGDGEL 541 (640)
Q Consensus 472 ~~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t--g~~p~~~~~~ 541 (640)
+.++|+|||+++..... ...+..|+|||++ ....++.++|||||||++|||++ |..||.....
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV-------LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred CceEEccccceeecccCcceeecCcCCCCceecCHHHh-------hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999998764321 1235579999964 33457789999999999999998 6777754221
Q ss_pred -chHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 542 -GIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 542 -~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
.................... .. .....++.+++.+||+.+|++||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLP----RP---PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHHhccccccccccCC----Cc---cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111111000000000 00 112246788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.57 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=178.3
Q ss_pred hccccccCcceEEEEEe--CCCcEEEEEEecccc----chHHHHHHHHHHhc---cCCCcccceeEEEEc-----CCeEE
Q 006559 338 AELLGKGCVGATYKVVL--DGGDVVVVKRIRERK----KKREVDEWLRVIGG---LRHSNIVSIRAYCNG-----KDELF 403 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~--~~~~~vavK~l~~~~----~~~~~~~e~~~l~~---l~H~niv~l~~~~~~-----~~~~~ 403 (640)
.+.||+|+||.||+|+. .++..||||.++... ....+.+|+.+++. ++||||++++++|.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 46799999999999985 346789999886432 22345556665554 479999999999852 35689
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 404 LVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
+||||++ ++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 86 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 9999996 699999875432 247899999999999999999994 559999999999999999999999999987
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHH-Hhhcc---
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQ-MMGQD--- 553 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~-~~~~~--- 553 (640)
.... ...++..|+|||++. ...++.++|||||||++|||++|+.||..... +....+. .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred eccCCcccccccccccccChHHHh-------CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 6542 234578899999653 34567899999999999999999999975321 1111111 11100
Q ss_pred ccccc------ccchhhccC--hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 554 ESAWE------VFDFELIMD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 554 ~~~~~------~~d~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..... .+....... .........+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000000 000112235667889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.75 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=185.8
Q ss_pred hccccccCcceEEEEEeCC---------------CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcC
Q 006559 338 AELLGKGCVGATYKVVLDG---------------GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGK 399 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 399 (640)
.+.||+|+||.||+++..+ ...||+|.++... ....+.+|++++++++|+||+++++++...
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 89 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD 89 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 5679999999999987542 2248999987542 234688899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHhhccCCC-------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC
Q 006559 400 DELFLVYDYLPHGSLHSLLHGSRG-------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG 472 (640)
Q Consensus 400 ~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~ 472 (640)
+..++||||+++++|.+++..... .....++|..++.++.|++.||+|||+ .+++||||||+||++++++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~~~~ 166 (295)
T cd05097 90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHY 166 (295)
T ss_pred CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEcCCC
Confidence 999999999999999999864321 011247889999999999999999994 4599999999999999999
Q ss_pred CeEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh--CCCCCCCCCc-
Q 006559 473 NACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT--GKMAKGDGEL- 541 (640)
Q Consensus 473 ~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t--g~~p~~~~~~- 541 (640)
.+||+|||+++..... ...+..|+|||+. ....++.++|||||||++|||++ |..||.....
T Consensus 167 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI-------LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred cEEecccccccccccCcceeccCcCcCceeecChhhh-------ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999998764321 1224579999964 33457789999999999999998 5667753211
Q ss_pred chHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 542 GIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
............... ... ....+ .....+.+++.+||+.+|++||+|.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~-~~~---~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQGR-QIY---LSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhccc-ccc---CCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111110100000 000 00001 122467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.46 Aligned_cols=244 Identities=18% Similarity=0.238 Sum_probs=182.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||++.. ..++.||+|... ...+.+|++++++++|||||++++++......++|+||+. ++|.
T Consensus 96 ~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~ 170 (391)
T PHA03212 96 ILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY 170 (391)
T ss_pred EEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence 356799999999999985 567889999754 2346789999999999999999999999999999999995 7898
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-------C
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-------P 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-------~ 488 (640)
+++.... .+++..++.++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+++.... .
T Consensus 171 ~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 171 CYLAAKR-----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 8886543 47899999999999999999995 4699999999999999999999999999875321 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc---------chHHHHHHhhcccccc--
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL---------GIVKWVQMMGQDESAW-- 557 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~---------~~~~~~~~~~~~~~~~-- 557 (640)
..+|..|+|||++ ....++.++|||||||++|||+||+.|+..... .+...++..+......
T Consensus 243 ~~gt~~y~aPE~~-------~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 243 WAGTIATNAPELL-------ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccCccCCCChhhh-------cCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 3568899999965 334577899999999999999999987643210 0111111111100000
Q ss_pred ---cccc-------------hhh-ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 ---EVFD-------------FEL-IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ---~~~d-------------~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...+ +.. ...........++.+++.+|++.||++|||+.|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000 000111223446788899999999999999999974
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.96 Aligned_cols=229 Identities=20% Similarity=0.294 Sum_probs=177.0
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHH-HHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWL-RVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||+||+|+.. +|+.||+|.+.... ..+++..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999964 68899999987541 122333343 356789999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence 99999987543 57888999999999999999994 4599999999999999999999999999875321
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...++..|+|||++ ....++.++|||||||++|||++|+.||..... .+..+..... ...
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~---------~~~ 214 (323)
T cd05575 153 TSTFCGTPEYLAPEVL-------RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--AEMYDNILNK---------PLR 214 (323)
T ss_pred cccccCChhhcChhhh-------cCCCCCccccccccchhhhhhhcCCCCCCCCCH--HHHHHHHHcC---------CCC
Confidence 23468899999964 334577899999999999999999999975322 1211111111 011
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 596 (640)
..+.. ...+.+++.+|++.||++||++.
T Consensus 215 ~~~~~---~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNI---SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCC---CHHHHHHHHHHhhcCHHhCCCCC
Confidence 11111 23456677789999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.53 Aligned_cols=241 Identities=23% Similarity=0.412 Sum_probs=190.8
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..++||+|+||.||+|...+++.||+|.+... ....++.+|+.++++++|+||+++++++. .+..++||||+++|+|.
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 10 LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence 35689999999999999888999999998865 34567889999999999999999999874 56789999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------- 488 (640)
+++....+ ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 89 ~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 89 DFLKTPEG---IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 99875432 258899999999999999999994 56999999999999999999999999998765421
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+..|+|||+. ....++.++|||||||++|||++ |+.||..... ....+....... ....
T Consensus 163 ~~~~~~y~~pe~~-------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~--------~~~~ 225 (260)
T cd05067 163 AKFPIKWTAPEAI-------NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLERGYR--------MPRP 225 (260)
T ss_pred CcccccccCHHHh-------ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCCC--------CCCC
Confidence 1224579999964 34456789999999999999999 9999974321 122222211100 0001
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
. ....++.+++.+||+.+|++||+++++.+.|+.
T Consensus 226 ~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 D---NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 122357778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.35 Aligned_cols=249 Identities=21% Similarity=0.367 Sum_probs=191.8
Q ss_pred hhccccccCcceEEEEEeCC--------CcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG--------GDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
..+.||+|+||.||+++..+ +..+|+|.++... ...++..|+.++.++ +||||+++++++...+..|+
T Consensus 22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (307)
T cd05098 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 101 (307)
T ss_pred EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 35689999999999997532 3469999987542 234577789999998 79999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCC-----------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 405 VYDYLPHGSLHSLLHGSRGP-----------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
||||+++|+|.+++...... ....++|..+++++.|++.||+||| +.+++||||||+||+++.++.
T Consensus 102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~ 178 (307)
T cd05098 102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNV 178 (307)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEcCCCc
Confidence 99999999999999764321 1125889999999999999999999 456999999999999999999
Q ss_pred eEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchH
Q 006559 474 ACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIV 544 (640)
Q Consensus 474 ~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~ 544 (640)
+||+|||+++..... ...+..|+|||.+ ....++.++|||||||++|||++ |+.||.... ..
T Consensus 179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--~~ 249 (307)
T cd05098 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-------FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VE 249 (307)
T ss_pred EEECCCcccccccccchhhccccCCCccceeChHHh-------ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC--HH
Confidence 999999998754321 1123579999964 33456789999999999999998 888886432 22
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...+...... . .... .....++.+++.+||+.+|++||+|.+|++.|+++...
T Consensus 250 ~~~~~~~~~~-~-------~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKLLKEGH-R-------MDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHcCC-C-------CCCC---CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 2222221111 0 0001 12234566788899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.63 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=190.0
Q ss_pred hhccccccCcceEEEEEeC-CCc--EEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD-GGD--VVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~--~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|... ++. .+++|.++... ..+.+.+|+.++.++ +||||+++++++...+..|+||||+
T Consensus 11 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (303)
T cd05088 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 90 (303)
T ss_pred eeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence 3578999999999999864 343 46777776432 335677899999999 8999999999999999999999999
Q ss_pred CCCCHHHhhccCCC-----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEcc
Q 006559 410 PHGSLHSLLHGSRG-----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478 (640)
Q Consensus 410 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 478 (640)
++|+|.++++.... .....+++..++.++.|++.||+||| ..+|+||||||+|||+++++.+||+|
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~d 167 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIAD 167 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEeCc
Confidence 99999999975431 11125789999999999999999999 45699999999999999999999999
Q ss_pred CCcccccCC---C--ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhc
Q 006559 479 IGVHQLFHT---P--FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQ 552 (640)
Q Consensus 479 fGl~~~~~~---~--~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 552 (640)
||+++.... . ...+..|+|||+. ....++.++|||||||++|||+| |..||..... .+..+....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~ 238 (303)
T cd05088 168 FGLSRGQEVYVKKTMGRLPVRWMAIESL-------NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQ 238 (303)
T ss_pred cccCcccchhhhcccCCCcccccCHHHH-------hccCCcccccchhhhhHHHHHHhcCCCCcccCCh--HHHHHHHhc
Confidence 999864321 1 1124569999954 33456789999999999999998 9999864321 111221111
Q ss_pred ccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 553 DESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 553 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.. ... ... .....+.+++.+||+.+|++||++.++++.|+++..+
T Consensus 239 ~~------~~~--~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 239 GY------RLE--KPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred CC------cCC--CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 10 000 000 1223467788899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.94 Aligned_cols=228 Identities=20% Similarity=0.303 Sum_probs=176.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHH---HhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRV---IGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|... +++.||||.++... ..+.+..|+++ ++.++||||+++++++...+..|+||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 457999999999999864 58899999997541 12344555554 4577899999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC--
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-- 486 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~-- 486 (640)
+++|+|..+++.. .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999888643 48899999999999999999994 569999999999999999999999999986532
Q ss_pred ----CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 487 ----TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 487 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
....++..|+|||++ ....++.++|||||||++|||++|+.||...... ..........
T Consensus 155 ~~~~~~~~g~~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~-------- 217 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVL-------TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDE-------- 217 (324)
T ss_pred CCcccccccCccccCHhHh-------cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC--------
Confidence 123468899999964 3445778999999999999999999999754321 1111111110
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
...+... ...+.+++.+||+.||++||++
T Consensus 218 -~~~p~~~---~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 218 -VRYPRFL---SREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred -CCCCCCC---CHHHHHHHHHHhhcCHhHcCCC
Confidence 0011111 2345678888999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.56 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=187.3
Q ss_pred hccccccCcceEEEEEeCC------CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLDG------GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|...+ +..||+|.+.... ....+..|+.++++++|+||+++++++.+.+..++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 5679999999999999754 4578899876442 234578899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCC--CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC---CeEEccCCccc
Q 006559 409 LPHGSLHSLLHGSRGP--GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG---NACISDIGVHQ 483 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGl~~ 483 (640)
+++|+|.+++...+.. ....++|..+++++.||+.||+|||+ .+++||||||+||+++.++ .+||+|||+++
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCcccc
Confidence 9999999998765321 12358999999999999999999995 4599999999999998654 69999999988
Q ss_pred ccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccc
Q 006559 484 LFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDE 554 (640)
Q Consensus 484 ~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 554 (640)
..... ...+..|+|||++ ....++.++|||||||++|||+| |+.||...... ...+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~ 238 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAF-------LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVTGGG 238 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHH-------hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCC
Confidence 65321 1123569999964 34567889999999999999997 99998743211 1122211111
Q ss_pred ccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 555 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
.. ..+. .....+.+++.+||+.+|++||++.+|++.|+
T Consensus 239 ~~--------~~~~---~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 RL--------DPPK---GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cC--------CCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 0011 12245777888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.32 Aligned_cols=239 Identities=20% Similarity=0.288 Sum_probs=194.3
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCe-EEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDE-LFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lV~Ey~~ 410 (640)
..+++|+|+||.++.++.+ ++..+|+|++.-. ..++...+|+.++++++|||||.+.+.|..++. .+|||+||+
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence 3578999999999998854 4667999988754 234466789999999999999999999999888 999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
+|++.+.+...++ ..++.+++.+++.|++.|+.||| +.+|+|||||+.||++..++.+||.|||+++.+++.
T Consensus 88 Gg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 88 GGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred CCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999999987752 36899999999999999999999 556999999999999999999999999999998764
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
..+|+.|+.||++ ....|..|+||||+||++|||++-+++|...+..... .. ++...
T Consensus 162 ~a~tvvGTp~YmcPEil-------~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li--~k---------i~~~~- 222 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEIL-------SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI--LK---------INRGL- 222 (426)
T ss_pred hhheecCCCcccCHHHh-------CCCCCCccCcchhhcchHHHHHhcccccCccchHHHH--HH---------Hhhcc-
Confidence 4679999999975 4566778999999999999999999999865433221 11 11111
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
..+-......++..++..|+..+|+.||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 011112233456667778999999999999999864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=309.74 Aligned_cols=232 Identities=22% Similarity=0.296 Sum_probs=178.5
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhc-cCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGG-LRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|+.. +|..||+|.++... ..+....|.+++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999965 57889999987541 22344556666654 5899999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 99999987543 47888999999999999999994 569999999999999999999999999987431
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....++..|+|||++ ....++.++|||||||++|||++|+.||..... .+..+...... +.
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~-------~~-- 214 (316)
T cd05620 153 ASTFCGTPDYIAPEIL-------QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDT-------PH-- 214 (316)
T ss_pred eeccCCCcCccCHHHH-------cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC-------CC--
Confidence 123468899999965 344577899999999999999999999975432 11111111100 00
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMS-IVH 599 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v~ 599 (640)
.+... ..++.+++.+|++.||++||++. ++.
T Consensus 215 ~~~~~---~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWI---TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCC---CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01111 22455677789999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.00 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=187.8
Q ss_pred hhccccccCcceEEEEEeC------CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLD------GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..++||+|+||.||++... .+..+|+|.+... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 3568999999999999742 3557899988754 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCC----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEcc
Q 006559 409 LPHGSLHSLLHGSRG----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 478 (640)
+++|+|.+++..... .....+++..++.++.|++.||+||| ..+++||||||+|||+++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEECC
Confidence 999999999875431 01124789999999999999999999 45699999999999999999999999
Q ss_pred CCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHH
Q 006559 479 IGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQM 549 (640)
Q Consensus 479 fGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~ 549 (640)
||+++..... ...+..|+|||.. ....++.++|||||||++|||+| |+.||..... ......
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~ 236 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-------LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEAIEC 236 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHh-------ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHHHHH
Confidence 9998754321 1224579999954 34557789999999999999999 8999864221 111111
Q ss_pred hhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 550 MGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 550 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
....... .... .....+.+++.+||+.||++||++.+|.+.|+
T Consensus 237 ~~~~~~~--------~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGREL--------ERPR---TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccC--------CCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111000 0001 12234667888899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=302.15 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=187.3
Q ss_pred hhccccccCcceEEEEEeC-----------------CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEE
Q 006559 337 SAELLGKGCVGATYKVVLD-----------------GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYC 396 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~ 396 (640)
..+.||+|+||.||++... ++..||+|.+.... ...++.+|++++++++|+||+++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05095 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC 88 (296)
T ss_pred eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3567999999999998532 23468999987542 245688999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHhhccCCCC------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC
Q 006559 397 NGKDELFLVYDYLPHGSLHSLLHGSRGP------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ 470 (640)
Q Consensus 397 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~ 470 (640)
...+..++||||+++|+|.+++...... ....+++.....++.|++.||+|||+ .+++||||||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili~~ 165 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEEcC
Confidence 9999999999999999999998754311 11247888999999999999999995 45999999999999999
Q ss_pred CCCeEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh--CCCCCCCCC
Q 006559 471 LGNACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT--GKMAKGDGE 540 (640)
Q Consensus 471 ~~~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t--g~~p~~~~~ 540 (640)
++.+||+|||+++.+... ...+..|++||+. ....++.++|||||||++|||+| |..||....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-------~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI-------LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH-------hcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999998765321 1224578999954 33457789999999999999998 678886321
Q ss_pred cchHHHHHHhhc---ccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 541 LGIVKWVQMMGQ---DESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 541 ~~~~~~~~~~~~---~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
..+++..... .... ....+ .. ..+...+.+++.+||+.||++||+|.+|++.|++
T Consensus 239 --~~~~~~~~~~~~~~~~~-~~~~~---~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 --DEQVIENTGEFFRDQGR-QVYLP---KP---ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --hHHHHHHHHHHHhhccc-cccCC---CC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1121111110 0000 00000 00 1123467788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=301.02 Aligned_cols=236 Identities=22% Similarity=0.314 Sum_probs=180.4
Q ss_pred ccccccCcceEEEEEeCC--------CcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 339 ELLGKGCVGATYKVVLDG--------GDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~--------~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
+.||+|+||.||+|.... ...|++|.+... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 224788877644 2235678889999999999999999999998999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC--------eEEccCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN--------ACISDIG 480 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~--------~kl~DfG 480 (640)
+++|+|.++++.... .+++..++.++.|++.||+||| ..+|+||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999976432 4789999999999999999999 456999999999999987765 5999999
Q ss_pred cccccCC--CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCC-CCCCCCCcchHHHHHHhhcccccc
Q 006559 481 VHQLFHT--PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 481 l~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
++..... ....+..|+|||++. ....++.++|||||||++|||++|. .|+...+. ...........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~--- 222 (258)
T cd05078 154 ISITVLPKEILLERIPWVPPECIE------NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKLQFYEDRH--- 222 (258)
T ss_pred cccccCCchhccccCCccCchhcc------CCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--HHHHHHHHccc---
Confidence 9876543 234577899999652 2234678899999999999999985 55543221 11111111100
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
. .+. ....++.+++.+||+.+|++|||++++++.|
T Consensus 223 -----~--~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 223 -----Q--LPA---PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----c--CCC---CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 011 1123467788889999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=312.68 Aligned_cols=232 Identities=19% Similarity=0.266 Sum_probs=176.7
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHH-HHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEW-LRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e-~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
+.||+|+||.||+|+.. ++..||+|.+.... ....+..| ..+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 56789999987542 12233333 3456789999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|.+++.... .+.......++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence 99999997543 46777888899999999999995 559999999999999999999999999987532
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....++..|+|||++ ....++.++|||||||++|||++|+.||..... .+..+..... ...
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~---------~~~ 214 (325)
T cd05602 153 TSTFCGTPEYLAPEVL-------HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILNK---------PLQ 214 (325)
T ss_pred cccccCCccccCHHHH-------cCCCCCCccccccccHHHHHHhcCCCCCCCCCH--HHHHHHHHhC---------CcC
Confidence 123468899999965 334577899999999999999999999975322 1111111111 011
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
..+... ..+.+++..|++.+|++||++.+.+
T Consensus 215 ~~~~~~---~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 215 LKPNIT---NSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCC---HHHHHHHHHHcccCHHHCCCCCCCH
Confidence 111122 2355667779999999999977443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=295.56 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=191.9
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccccc-hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKK-KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|... ++.||+|.+..... .+.+..|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 10 ~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred ceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 3578999999999999875 68899999987643 567888999999999999999999999889999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---cccc
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---FFIN 492 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---~~~~ 492 (640)
+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.++..... ...+
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 89 DYLRSRGR---AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 99975431 258899999999999999999994 55999999999999999999999999998876432 1224
Q ss_pred ccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHH
Q 006559 493 DAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEME 571 (640)
Q Consensus 493 ~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 571 (640)
..|+|||.. ....++.++||||||+++||+++ |+.||....... ......... .. . .. .
T Consensus 163 ~~~~ape~~-------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~-~~-----~--~~---~ 222 (256)
T cd05039 163 VKWTAPEAL-------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGY-RM-----E--AP---E 222 (256)
T ss_pred ccccCchhh-------cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcCC-CC-----C--Cc---c
Confidence 579999954 34456789999999999999998 999986432111 111111100 00 0 01 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 572 EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 572 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.....+.+++.+||..+|++||++.+++++|+.+
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1234577788889999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=315.30 Aligned_cols=237 Identities=21% Similarity=0.318 Sum_probs=185.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +++.||||+++.. .....+.+|++++..++||||+++++++.+.+..|+||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 467999999999999965 6889999998754 2234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 86 GDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999997652 57888999999999999999994 56999999999999999999999999998765322
Q ss_pred --------------------------------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 489 --------------------------------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 489 --------------------------------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
..++..|+|||++ ....++.++|||||||++|||++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-------RGTPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHH-------cCCCCCCceeeEecchhhhhhccCCCCC
Confidence 2357889999975 3346778999999999999999999999
Q ss_pred CCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 006559 537 GDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPN-MSIVHR 600 (640)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~~v~~ 600 (640)
...... ..+.+........ ....... ...++.+++..|+. +|++||+ +.++++
T Consensus 231 ~~~~~~-~~~~~i~~~~~~~------~~p~~~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 231 YSDTLQ-ETYNKIINWKESL------RFPPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCCCHH-HHHHHHhccCCcc------cCCCCCC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 754321 1111111100000 0000011 12345566777997 9999999 999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=299.17 Aligned_cols=243 Identities=20% Similarity=0.321 Sum_probs=186.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+|+. .++..||+|.+... .....+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L 93 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence 56799999999999995 56788999998754 2334577899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.++++... ++++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.... .
T Consensus 94 ~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 94 QDIYHVTG-----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence 99987542 57889999999999999999994 5699999999999999999999999999876532 1
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||.+... ....++.++|||||||++|||++|+.|+....... . ....... ....+...
T Consensus 166 ~~~~~~y~~PE~~~~~----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-~-~~~~~~~----~~~~~~~~--- 232 (267)
T cd06646 166 FIGTPYWMAPEVAAVE----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-A-LFLMSKS----NFQPPKLK--- 232 (267)
T ss_pred cccCccccCHhHcccc----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-h-heeeecC----CCCCCCCc---
Confidence 2346789999965321 23346779999999999999999999985321100 0 0000000 00000010
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
........+.+++.+||..+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 011223456778888999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=294.02 Aligned_cols=237 Identities=27% Similarity=0.379 Sum_probs=187.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. ++..|++|.+... ...+++..|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 467999999999999864 6788999988643 23456778899999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.++++.... ..+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 ~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 85 DLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred cHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 99999976421 25889999999999999999999 456999999999999999999999999998765432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||+. ....++.++|||||||++|||+||+.||..... ....+...... .. ..
T Consensus 159 ~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~-~~-----~~-- 221 (256)
T cd08529 159 NTIVGTPYYLSPELC-------EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIRGV-FP-----PV-- 221 (256)
T ss_pred hccccCccccCHHHh-------cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCC-CC-----CC--
Confidence 2346789999964 334567899999999999999999999975431 11111111110 00 00
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......+.+++.+||+.+|++||+|.++++
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ---ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 0122345778888999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.88 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=191.2
Q ss_pred hccccccCcceEEEEEeC-----CCcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLD-----GGDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~E 407 (640)
.+.||+|+||.||++++. .+..+|||.+..... .+++..|++++++++|+||+++++++.. ....++|||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 467999999999999864 367899999986533 5678899999999999999999999887 557999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 89 YLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred cCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999976431 48899999999999999999994 5699999999999999999999999999887642
Q ss_pred C---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccc--
Q 006559 488 P---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA-- 556 (640)
Q Consensus 488 ~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 556 (640)
. ...+..|++||.. ....++.++||||||+++|||+||+.|+.........++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~-------~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECL-------RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred CCcceeccCCCCCcccccCcHHH-------ccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 1 1123458999954 334567889999999999999999999764322111100000000000
Q ss_pred -ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 557 -WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 557 -~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.+........ +....+..++.+++.+||+.+|++||+|.||+++|++++
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 235 LLELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 0000000000 001122346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.34 Aligned_cols=240 Identities=21% Similarity=0.352 Sum_probs=188.2
Q ss_pred hccccccCcceEEEEEeC-C---CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-G---GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~---~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|... + +..+|+|.++... ..+.+..|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 568999999999999853 2 3368999887542 23567889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc-
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF- 489 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~- 489 (640)
+|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+|||++.++.+|++|||+++......
T Consensus 89 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 89 NGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999997543 24789999999999999999999 4569999999999999999999999999987654321
Q ss_pred --------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhcccccccc
Q 006559 490 --------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 490 --------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 559 (640)
..+..|+|||.+ ....++.++|||||||++||+++ |+.||.+... .....+ .....
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~-------~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~---~~~~~---- 227 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAI-------AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI---EEGYR---- 227 (267)
T ss_pred eeeecCCCccceeecCHhHh-------ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH---hCCCc----
Confidence 113469999954 44567889999999999999887 9999864321 111111 11100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.... ......+.+++.+|++.+|++||+|.++++.|+++
T Consensus 228 ----~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ----LPAP---MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCC---CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0000 11233567788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.59 Aligned_cols=249 Identities=21% Similarity=0.339 Sum_probs=188.0
Q ss_pred hhccccccCcceEEEEEe------CCCcEEEEEEeccccc---hHHHHHHHHHHhcc-CCCcccceeEEEEcC-CeEEEE
Q 006559 337 SAELLGKGCVGATYKVVL------DGGDVVVVKRIRERKK---KREVDEWLRVIGGL-RHSNIVSIRAYCNGK-DELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~---~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lV 405 (640)
..+.||+|+||.||+|+. .+++.||||.++.... ...+..|+.++.++ +||||++++++|... ...++|
T Consensus 11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence 467899999999999973 3467899999976432 34577899999999 689999999988654 468999
Q ss_pred EeccCCCCHHHhhccCCCC-------------------------------------------------------------
Q 006559 406 YDYLPHGSLHSLLHGSRGP------------------------------------------------------------- 424 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~------------------------------------------------------------- 424 (640)
|||+++|+|.++++.....
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 9999999999998643210
Q ss_pred -CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--------ccccccc
Q 006559 425 -GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--------FFINDAY 495 (640)
Q Consensus 425 -~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--------~~~~~~y 495 (640)
....++|..+.+++.|+++||+||| ..+|+||||||+|||++.++.+||+|||+++..... ...+..|
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 247 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence 0124688899999999999999999 456999999999999999999999999998764221 1224569
Q ss_pred cCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHH
Q 006559 496 NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEM 574 (640)
Q Consensus 496 ~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 574 (640)
+|||++ ....++.++|||||||++|||++ |..||....... ........... .. .+.. ..
T Consensus 248 ~aPE~~-------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~-~~-------~~~~---~~ 308 (343)
T cd05103 248 MAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR-MR-------APDY---TT 308 (343)
T ss_pred ECcHHh-------cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCC-CC-------CCCC---CC
Confidence 999964 33457789999999999999997 899986432211 11111111100 00 0000 11
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 575 RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 575 ~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
.++.+++..||+.+|++||++.|+++.|+.+..
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 347788899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.53 Aligned_cols=240 Identities=20% Similarity=0.284 Sum_probs=185.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCC--------eEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD--------ELF 403 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~ 403 (640)
..++||+|+||+||+|+. .+++.||||.+.... ....+.+|+..+..++|+||+++.+.+...+ ..+
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 357899999999999984 568999999986542 2345677899999999999999887765432 378
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 404 LVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
+||||+++|+|.++++.... ...++++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 99999999999999875432 22368889999999999999999994 569999999999999999999999999987
Q ss_pred ccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccc
Q 006559 484 LFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDES 555 (640)
Q Consensus 484 ~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 555 (640)
.+.. ...+|..|+|||++ ....++.++|||||||++|||+||+.||..... ...++......
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~-------~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--~~~~~~~~~~~- 261 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIW-------RRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--EEVMHKTLAGR- 261 (496)
T ss_pred eccccccccccccccCCcceeCHHHh-------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhcCC-
Confidence 6532 23468899999965 334577899999999999999999999975432 22222211110
Q ss_pred cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 556 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.++ .+. ....++.+++..||+.+|++||++.++++
T Consensus 262 ----~~~---~~~---~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 262 ----YDP---LPP---SISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred ----CCC---CCC---CCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 000 111 12234667788899999999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.45 Aligned_cols=233 Identities=23% Similarity=0.313 Sum_probs=181.4
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
+.||+|+||.||+|+.. ++..||||.++... ....+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 47789999987541 223455677777766 799999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|..++.... .+++.....++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 99999887543 58899999999999999999994 569999999999999999999999999986531
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....++..|+|||++ ....++.++|||||||++|||+||+.||..... ........... ..
T Consensus 153 ~~~~~g~~~y~aPE~~-------~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~~~---------~~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEIL-------SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILEDE---------VR 214 (318)
T ss_pred ccceecCccccCHHHh-------cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcCC---------CC
Confidence 123457889999965 334577899999999999999999999975432 11111111110 00
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNM-----SIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~~v~~ 600 (640)
.+... ...+.+++.+||+.||++||++ .+++.
T Consensus 215 ~~~~~---~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWL---SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcC---CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11111 2346677888999999999998 66653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.33 Aligned_cols=237 Identities=19% Similarity=0.243 Sum_probs=181.0
Q ss_pred hccccccCcceEEEEEe----CCCcEEEEEEecccc------chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL----DGGDVVVVKRIRERK------KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~----~~~~~vavK~l~~~~------~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
.+.||+|+||.||+++. .++..||+|.+.... ..+.+..|++++..+ +|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 46799999999999885 357889999986431 224466788899998 4899999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 85 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 85 DYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999987543 47889999999999999999994 559999999999999999999999999987642
Q ss_pred C-------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-c-hHHHHHHhhcccccc
Q 006559 487 T-------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-G-IVKWVQMMGQDESAW 557 (640)
Q Consensus 487 ~-------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~-~~~~~~~~~~~~~~~ 557 (640)
. ...++..|+|||++.+ ...++.++|||||||++|||+||+.||..... . .....+.....
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---- 226 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRG------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC---- 226 (332)
T ss_pred ccCCCccccccCCccccCHHHhcC------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC----
Confidence 2 2346889999997532 22356789999999999999999999964221 1 11111111110
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
++. ..... ...+.+++.+||+.||++|| ++.++++
T Consensus 227 ---~~~--~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 ---DPP--FPSFI---GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCC--CCCCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111 11111 22356677789999999999 5666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=310.43 Aligned_cols=229 Identities=20% Similarity=0.290 Sum_probs=176.3
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHH-HHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWL-RVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|+.. ++..||+|.+.... ....+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 57889999987541 122334444 467889999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|..++.... .++......++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence 99998886543 47778888899999999999994 4599999999999999999999999999875321
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...++..|+|||++ ....++.++|||||||++|||++|+.||...+. ....+..... ...
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~---------~~~ 214 (321)
T cd05603 153 TSTFCGTPEYLAPEVL-------RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQMYDNILHK---------PLQ 214 (321)
T ss_pred cccccCCcccCCHHHh-------cCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--HHHHHHHhcC---------CCC
Confidence 23457889999964 344577899999999999999999999975432 1111111111 111
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 596 (640)
.+.. ...++.+++..|++.+|++||+..
T Consensus 215 ~~~~---~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGG---KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCC---CCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111 123466778889999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=298.56 Aligned_cols=242 Identities=23% Similarity=0.352 Sum_probs=188.4
Q ss_pred hccccccCcceEEEEEeCC------CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLDG------GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|...+ +..||+|.+.... ....+.+|+.+++.++||||+++++++......++||||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 90 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL 90 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence 5679999999999998643 3579999987552 234677889999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCC-----CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 409 LPHGSLHSLLHGSRGP-----GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
+++|+|.+++...... ....++|..++.++.|++.||.||| ..+|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg~~~ 167 (277)
T cd05032 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167 (277)
T ss_pred CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCcccch
Confidence 9999999998754311 1224788999999999999999999 4569999999999999999999999999987
Q ss_pred ccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcc-hHHHHHHhhcc
Q 006559 484 LFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELG-IVKWVQMMGQD 553 (640)
Q Consensus 484 ~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~-~~~~~~~~~~~ 553 (640)
..... ...+..|+|||.+ ....++.++|||||||++||++| |+.||...... ...+.. ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~ 237 (277)
T cd05032 168 DIYETDYYRKGGKGLLPVRWMAPESL-------KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI---DG 237 (277)
T ss_pred hhccCcccccCCCCCccccccCHHHH-------hcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh---cC
Confidence 54321 2235679999964 34457789999999999999999 89998643211 111111 11
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
.... .+. ....++.+++.+||+.+|++|||+.++++.|+
T Consensus 238 -~~~~-------~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 -GHLD-------LPE---NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -CCCC-------CCC---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000 011 12345778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=293.49 Aligned_cols=238 Identities=23% Similarity=0.425 Sum_probs=190.0
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||++...++..+|+|.+... ....++.+|++++++++||||+++++++......++||||+++|+|.+
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 88 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence 4679999999999999877888999998755 335678899999999999999999999999899999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~ 489 (640)
++....+ .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..... .
T Consensus 89 ~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 89 YLRAQRG----KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred HHHhCcc----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 9875432 47899999999999999999994 45999999999999999999999999998754322 1
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+..|+|||+. ....++.++|||||||++|||++ |+.||..... ....+...... ....+..
T Consensus 162 ~~~~~~~aPe~~-------~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~---~~~~~~~---- 225 (256)
T cd05112 162 KFPVKWSSPEVF-------SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINAGF---RLYKPRL---- 225 (256)
T ss_pred ccchhhcCHhHh-------ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHhCCC---CCCCCCC----
Confidence 124579999954 34557789999999999999998 9999874332 12222211110 0011111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
....+.+++.+||+.+|++||++.+|++.|
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124577889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.06 Aligned_cols=249 Identities=21% Similarity=0.280 Sum_probs=191.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||.||+|+.. +++.||+|+++.. ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 467999999999999864 5889999998754 1235678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCC------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 412 GSLHSLLHGSRG------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 412 gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
|+|.+++..... .....+++..+++++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i 163 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcceec
Confidence 999999864211 112246678889999999999999994 56999999999999999999999999998765
Q ss_pred CC------------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc
Q 006559 486 HT------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL 541 (640)
Q Consensus 486 ~~------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~ 541 (640)
.. ...+|..|+|||+. ....++.++|||||||++|||+||+.||.....
T Consensus 164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l-------~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL-------LGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred ccccccccccccccccccccccccCCCCCCCCCCCCHHHh-------cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 10 12468899999964 344567899999999999999999999975322
Q ss_pred chHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhhc
Q 006559 542 GIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP-NMSIVHRMIEDIRT 607 (640)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~ 607 (640)
....+.... .++.... ...+....+.+++.+|++.||++|| +++++.+.|+....
T Consensus 237 ~ki~~~~~i---------~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 237 RKISYRDVI---------LSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhhhhc---------cChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 211111110 0100000 0112234567788899999999996 57788888888654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=307.19 Aligned_cols=190 Identities=20% Similarity=0.248 Sum_probs=156.3
Q ss_pred hcccccc--CcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKG--CVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.++||+| +|++||+++. .+|+.||+|++.... ..+.+.+|+++++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 6889999985 568899999987542 23456778999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
+|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++++|||......
T Consensus 83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999865321 147899999999999999999995 459999999999999999999999998643221
Q ss_pred ---------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 487 ---------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 487 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
.....+..|+|||++.. ....++.++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQ-----NLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhc-----ccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01123567999997532 113467899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.13 Aligned_cols=239 Identities=19% Similarity=0.224 Sum_probs=184.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||.||++.. .++..||||.+.... ....+.+|++++++++||||+++++.+...+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 46799999999999985 468899999987542 123466799999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 85 GDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred CcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 99998886432 1258899999999999999999995 4599999999999999999999999999876532
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH-HHHHHhhcccccccccchhhc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV-KWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...++..|+|||++ ....++.++|||||||++|||++|+.||........ +.+..... .....
T Consensus 159 ~~~~~~~~y~aPE~~-------~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~ 223 (285)
T cd05605 159 RGRVGTVGYMAPEVV-------KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK--------EDQEE 223 (285)
T ss_pred ccccCCCCccCcHHh-------cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh--------hcccc
Confidence 12457889999964 344567899999999999999999999975332111 11111000 00000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
... .....+.+++..||+.||++|| ++.++.+
T Consensus 224 ~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 224 YSE---KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cCc---ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111 1223466788889999999999 6667643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=302.41 Aligned_cols=244 Identities=20% Similarity=0.320 Sum_probs=188.6
Q ss_pred hhccccccCcceEEEEEeC------CCcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLD------GGDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||++... .+..||||.++... ..+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 118 (302)
T cd05055 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT 118 (302)
T ss_pred EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence 4678999999999999742 24579999887542 234578899999999 7999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++|+|.++++.... ..+++.++..++.|++.||+|||+ .+|+|+||||+|||++.++.+|++|||+++...
T Consensus 119 e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 119 EYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 99999999999975432 237999999999999999999994 459999999999999999999999999987643
Q ss_pred CC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccc
Q 006559 487 TP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 487 ~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
.. ...+..|+|||.+ ....++.++|||||||++|||+| |+.||....... ...+..... .
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~-~-- 261 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESI-------FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEG-Y-- 261 (302)
T ss_pred CCCceeecCCCCcccccCCHhhh-------ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcC-C--
Confidence 21 1234579999964 33456789999999999999998 999986433211 111111100 0
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
. ..... ....++.+++.+||+.+|++||++.++++.|+++
T Consensus 262 ~-----~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 R-----MAQPE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred c-----CCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 00001 1123577788889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=304.80 Aligned_cols=191 Identities=23% Similarity=0.419 Sum_probs=155.3
Q ss_pred hccccccCcceEEEEEeCC---CcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLDG---GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~g 412 (640)
..+||+|+||.||+|+..+ +..||+|.+........+.+|++++++++||||+++++++.. ....++||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 3579999999999999653 467999998766555677889999999999999999999854 4578999999875
Q ss_pred CHHHhhccCCC----CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE----CCCCCeEEccCCcccc
Q 006559 413 SLHSLLHGSRG----PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV----DQLGNACISDIGVHQL 484 (640)
Q Consensus 413 sL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl~~~ 484 (640)
+|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 77777653211 122358889999999999999999995 459999999999999 5678999999999986
Q ss_pred cCCC---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 485 FHTP---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 485 ~~~~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
.... ..++..|+|||++.+ ...++.++|||||||++|||+||+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcC------CCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 5421 234778999997532 23467899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.61 Aligned_cols=241 Identities=18% Similarity=0.264 Sum_probs=184.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++.. ++..||+|.+... ...+.+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 567999999999999864 5789999998643 1234467889999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++... .++......++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 128 g~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 128 GDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 9999998753 36677788899999999999994 5699999999999999999999999999876532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++.... ....++.++|||||||++|||+||+.||...... ..+.+....... . ..
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~-~-----~~ 268 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHKNS-L-----TF 268 (370)
T ss_pred cCCCCCCCcCeECHHHhccCC---CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCCCc-C-----CC
Confidence 234688999999764321 1234678999999999999999999999754321 111111111000 0 00
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKD--RPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~v~~ 600 (640)
...... ..++.+++..|++.+|++ ||++.++++
T Consensus 269 ~~~~~~---s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 269 PDDIEI---SKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCcCCC---CHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 000111 234556777799999988 999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=295.05 Aligned_cols=241 Identities=24% Similarity=0.424 Sum_probs=192.4
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||++..+++..||||.+... ...+++.+|+.++++++|+||+++++++......++||||+++++|.+
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 90 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHH
Confidence 5679999999999999888888999998865 345678899999999999999999999998889999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~ 489 (640)
++....+ ..+++..+..++.|++.||+|||. .+++|+||||+||++++++.+|++|||+++..... .
T Consensus 91 ~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 91 FLKSGEG---KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred HHhcccc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 9976431 258899999999999999999994 45999999999999999999999999998765421 1
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+..|+|||.+ ....++.++|||||||++||++| |+.||...... ...+...... ....+.
T Consensus 165 ~~~~~y~~PE~~-------~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~--------~~~~~~ 227 (261)
T cd05034 165 KFPIKWTAPEAA-------NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERGY--------RMPRPP 227 (261)
T ss_pred CCCccccCHHHh-------ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC--------CCCCCC
Confidence 224579999964 34456789999999999999999 99998643211 1111111100 000011
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
....++.+++.+|++.+|++||++.++.+.|+.
T Consensus 228 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 ---NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 113357778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.32 Aligned_cols=237 Identities=17% Similarity=0.276 Sum_probs=181.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +++.||||++... .....+.+|++++..++||||+++++++...+..|+||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 568999999999999964 5889999999753 1234567899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 86 GDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred cHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999997543 48889999999999999999994 5599999999999999999999999999865321
Q ss_pred ----------------------------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHH
Q 006559 488 ----------------------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLL 527 (640)
Q Consensus 488 ----------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~ 527 (640)
...+|..|+|||++ ....++.++|||||||++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-------LQTGYNKECDWWSLGVIMY 230 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH-------cCCCCCCeeeeecchhHHH
Confidence 12368899999964 3456778999999999999
Q ss_pred HHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 006559 528 EILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPN---MSIVHR 600 (640)
Q Consensus 528 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~~v~~ 600 (640)
||++|+.||...... +..+......... .........+. +.+++.+|+. +|.+|++ +.++++
T Consensus 231 el~~G~~Pf~~~~~~--~~~~~i~~~~~~~-----~~~~~~~~s~~---~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 231 EMLVGYPPFCSDNPQ--ETYRKIINWKETL-----QFPDEVPLSPE---AKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HhhcCCCCCCCCCHH--HHHHHHHcCCCcc-----CCCCCCCCCHH---HHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999999754321 1111111100000 00001112233 3445555775 8999998 777754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=299.54 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=188.1
Q ss_pred hccccccCcceEEEEEeCC------CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLDG------GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|..++ +..||+|.+.... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 5689999999999997532 4579999886542 234567788999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCC-----CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 409 LPHGSLHSLLHGSRG-----PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
+++|+|.+++..... .+...+++..+..++.|++.||+||| ..+|+||||||+||++++++.+||+|||+++
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg~~~ 167 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcCCccc
Confidence 999999999975321 11234677888999999999999999 4569999999999999999999999999987
Q ss_pred ccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccc
Q 006559 484 LFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDE 554 (640)
Q Consensus 484 ~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 554 (640)
..... ...+..|+|||.+ ....++.++|||||||++|||++ |+.||..... .++.+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~~pE~~-------~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~ 238 (288)
T cd05061 168 DIYETDYYRKGGKGLLPVRWMAPESL-------KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFVMDGG 238 (288)
T ss_pred cccccccccccCCCcccccccCHHHh-------ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC
Confidence 54321 1224569999954 34456789999999999999999 7888864221 12222211111
Q ss_pred ccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 555 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.. . .. ......+.+++.+|++.+|++||++.++++.|++..
T Consensus 239 ~~------~--~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 239 YL------D--QP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CC------C--CC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00 0 00 112345778888999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=301.11 Aligned_cols=244 Identities=21% Similarity=0.376 Sum_probs=189.1
Q ss_pred hccccccCcceEEEEEeC------CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD------GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+++.. ++..||+|.+.... ..+++.+|+.++++++||||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 467999999999999864 35789999987542 245688899999999999999999999998999999999
Q ss_pred cCCCCHHHhhccCCC-----------------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC
Q 006559 409 LPHGSLHSLLHGSRG-----------------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL 471 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~ 471 (640)
+++|+|.+++..... .....+++..++.++.|++.||+|||. .+++||||||+||+++++
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~ 166 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 166 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCC
Confidence 999999999874321 112357889999999999999999994 569999999999999999
Q ss_pred CCeEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcc
Q 006559 472 GNACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELG 542 (640)
Q Consensus 472 ~~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~ 542 (640)
+.+||+|||+++..... ...+..|+|||.. ....++.++|||||||++|||++ |..||....
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-- 237 (288)
T cd05050 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-------FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-- 237 (288)
T ss_pred CceEECccccceecccCccccccCCCccChhhcCHHHH-------hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999998754221 1224569999953 34567789999999999999998 888885321
Q ss_pred hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
..++........ ... .+ .....++.+++.+||+.+|++||++.|+++.|++
T Consensus 238 ~~~~~~~~~~~~-~~~-------~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEEVIYYVRDGN-VLS-------CP---DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHhcCC-CCC-------CC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122222221111 000 01 1223457788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=301.31 Aligned_cols=236 Identities=20% Similarity=0.308 Sum_probs=185.7
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+|+. .++..|++|.+... ...+.+.+|+.+++.++|+||+++++.+......++||||+++|+|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 45799999999999985 56789999988754 3345677899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.... .
T Consensus 105 ~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9998643 37888999999999999999995 4599999999999999999999999999875432 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||.+ ....++.++|||||||++|||+||+.||...... ..+..... .. .+.+...
T Consensus 176 ~~~~~~y~aPE~~-------~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-~~~~~~~~-~~------~~~~~~~- 239 (296)
T cd06654 176 MVGTPYWMAPEVV-------TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIAT-NG------TPELQNP- 239 (296)
T ss_pred ccCCccccCHHHH-------cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-HhHHHHhc-CC------CCCCCCc-
Confidence 2456789999964 3345678999999999999999999999754321 11111110 00 0000011
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......+.+++.+||..+|++||++.++++
T Consensus 240 --~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 --EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred --cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112234667888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=312.09 Aligned_cols=231 Identities=19% Similarity=0.276 Sum_probs=178.0
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHH-HHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWL-RVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|+. .+|+.+|+|.+.... ..+.+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999985 468899999987541 223344444 357789999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|..++.... .+++.....++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence 99998887543 57889999999999999999994 559999999999999999999999999987532
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....++..|+|||++ ....++.++|||||||++|||++|+.||...... +..+..... ...
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~~~~~---------~~~ 214 (325)
T cd05604 153 TTTFCGTPEYLAPEVI-------RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMYDNILHK---------PLV 214 (325)
T ss_pred cccccCChhhCCHHHH-------cCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HHHHHHHcC---------Ccc
Confidence 123467889999965 3345678999999999999999999999754321 111111111 111
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIV 598 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v 598 (640)
..+. ....+.+++..|++.+|++||++++.
T Consensus 215 ~~~~---~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 215 LRPG---ASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred CCCC---CCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 1111 12345567788999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.30 Aligned_cols=187 Identities=23% Similarity=0.356 Sum_probs=159.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||.||+|+. .+++.||+|.+.... ..+.+.+|++++++++|||||++++++.+.+..|+|||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 46799999999999985 457889999987542 234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 86 GDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999987543 47788888899999999999995 459999999999999999999999999974321
Q ss_pred ------------------------------------------------CCccccccccCCccccCCCCccccCCCCCccc
Q 006559 487 ------------------------------------------------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCD 518 (640)
Q Consensus 487 ------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~D 518 (640)
....+|..|+|||++. ...++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~~~D 230 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-------RTGYTQLCD 230 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-------CCCCCCeee
Confidence 0124578899999753 345778999
Q ss_pred hHHHHHHHHHHHhCCCCCCCC
Q 006559 519 VYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 519 V~SfGvvl~el~tg~~p~~~~ 539 (640)
||||||++|||+||+.||...
T Consensus 231 iwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred EEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.30 Aligned_cols=187 Identities=23% Similarity=0.362 Sum_probs=159.5
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++. .+++.||||.+.... ..+.+..|++++++++||||+++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 46799999999999985 468899999986531 224567899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 g~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 86 GDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999987543 47888888999999999999994 5599999999999999999999999999863210
Q ss_pred -------------------------------------------------CccccccccCCccccCCCCccccCCCCCccc
Q 006559 488 -------------------------------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCD 518 (640)
Q Consensus 488 -------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~D 518 (640)
...+|..|+|||++ ....++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~D 230 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF-------LQQGYGQECD 230 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH-------ccCCCCCcee
Confidence 12467889999964 3445778999
Q ss_pred hHHHHHHHHHHHhCCCCCCCC
Q 006559 519 VYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 519 V~SfGvvl~el~tg~~p~~~~ 539 (640)
||||||++|||+||+.||...
T Consensus 231 iwSlGvil~elltG~~Pf~~~ 251 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSE 251 (377)
T ss_pred eEecchhhhhhhcCCCCCCCC
Confidence 999999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=293.14 Aligned_cols=242 Identities=28% Similarity=0.396 Sum_probs=191.2
Q ss_pred ccccccCcceEEEEEeCC----CcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLDG----GDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
+.||+|+||.||+|.... +..|++|.+..... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999654 77899999986633 46788899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCC----CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 412 GSLHSLLHGSRGP----GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 412 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+|.+++...... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999864210 01368999999999999999999994 5699999999999999999999999999887643
Q ss_pred C--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccccc
Q 006559 488 P--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 488 ~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
. ...+..|+|||.+ ....++.++||||+||++|||++ |+.||.... .....+.......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~--- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESL-------KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRKGYR--- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHh-------ccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC---
Confidence 2 2346789999964 33367789999999999999999 699987542 1222222211100
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
..... ....++.+++.+||+.+|++||++.++++.|+
T Consensus 226 -----~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -----LPKPE---YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCc---cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111 11345777888899999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.66 Aligned_cols=232 Identities=18% Similarity=0.259 Sum_probs=178.3
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||.||+|+.. ++..||+|.++... ..+.+..|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 57889999997542 223466788888777 699999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 99999886543 58899999999999999999995 459999999999999999999999999987531
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC----CcchHHHHHHhhcccccccccc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG----ELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~d 561 (640)
....++..|+|||++ ....++.++|||||||++|||+||+.||... ......+.......
T Consensus 153 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 217 (327)
T cd05617 153 TSTFCGTPNYIAPEIL-------RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-------- 217 (327)
T ss_pred eecccCCcccCCHHHH-------CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------
Confidence 123468899999964 3456678999999999999999999999631 11111111111110
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 596 (640)
.....+...+ ..+.+++.+|++.||++||++.
T Consensus 218 ~~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 218 KPIRIPRFLS---VKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCCCC---HHHHHHHHHHhccCHHHcCCCC
Confidence 0011111112 2356677889999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=296.21 Aligned_cols=243 Identities=19% Similarity=0.306 Sum_probs=184.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-cchHHHHHHHHHHhcc-CCCcccceeEEEEcC------CeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGK------DELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~------~~~~lV~Ey 408 (640)
.+.||+|+||.||+|... .++.||+|.+... .....+..|+.++.++ +|+||+++.+++... ...|+||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 467999999999999864 5788999998654 3345677888888888 699999999998753 468999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 99999999987543 2358899999999999999999995 4599999999999999999999999999876532
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...++..|+|||++.... .....++.++|||||||++|||++|+.||.+...... .... ... ...
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-~~~~-~~~------~~~ 234 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDE--NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLI-PRN------PAP 234 (272)
T ss_pred cccCCcccccccccCHhHhcccc--CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-HHHH-hcC------CCC
Confidence 124577899999764321 1134577899999999999999999999964321111 1100 000 000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ... ....++.+++.+||..+|.+||++.++++
T Consensus 235 ~~-~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 235 RL-KSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC-CCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11 011 12235677888999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.78 Aligned_cols=248 Identities=17% Similarity=0.256 Sum_probs=183.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCC-----eEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD-----ELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~E 407 (640)
.+.||+|+||.||+++. .+++.||||++... ...+.+.+|+++++.++|+||+++++++...+ ..|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 56799999999999995 56889999998653 22356778999999999999999999998776 7999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 85 LMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred ccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 997 58888876432 58899999999999999999995 4599999999999999999999999999876432
Q ss_pred -------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccccc
Q 006559 488 -------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAWEV 559 (640)
Q Consensus 488 -------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 559 (640)
....+..|+|||++.+ ...++.++|||||||++|||++|+.||...... ....+............
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMG------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcC------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 2234778999997532 234678999999999999999999999753211 11111100000000000
Q ss_pred ----------cchhhccChH-------HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 ----------FDFELIMDKE-------MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ----------~d~~~~~~~~-------~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+.......+. ......++.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000000 0011345678888999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.75 Aligned_cols=244 Identities=20% Similarity=0.271 Sum_probs=186.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++. .+++.||+|.++... ..+.+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 56799999999999985 468899999997542 234577889999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++.... ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 86 GDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999997642 258889999999999999999994 55999999999999999999999999998765421
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
..++..|+|||++...... ....++.++|||||||++|||+||+.||..... ............... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~~~~i~~~~~~~~-----~ 230 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--AKTYNNIMNFQRFLK-----F 230 (330)
T ss_pred eeecccCCccccCHHHhcccccc-ccCCCCCcceeecccceeeeeccCCCCCCCCCH--HHHHHHHHcCCCccC-----C
Confidence 2457889999976432111 244677899999999999999999999975322 111111111100000 0
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
....... .++.+++..|+. +|++||++.+++.
T Consensus 231 ~~~~~~~---~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 PEDPKVS---SDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCCCC---HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0011112 234556666887 9999999998874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.89 Aligned_cols=253 Identities=21% Similarity=0.367 Sum_probs=194.5
Q ss_pred hhccccccCcceEEEEEeCC--------CcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG--------GDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
..+.||+|+||.||+++..+ +..||+|.++... ..+++.+|+++++++ +||||++++++|...+..++
T Consensus 16 i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (334)
T cd05100 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 95 (334)
T ss_pred ecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEE
Confidence 45789999999999997421 2368999887542 235678899999999 79999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCC-----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 405 VYDYLPHGSLHSLLHGSRG-----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
||||+++|+|.+++..... .....++|..++.++.|++.||+||| ..+|+||||||+|||++.++.
T Consensus 96 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~~~~ 172 (334)
T cd05100 96 LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNV 172 (334)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCc
Confidence 9999999999999875421 11235889999999999999999999 456999999999999999999
Q ss_pred eEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchH
Q 006559 474 ACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIV 544 (640)
Q Consensus 474 ~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~ 544 (640)
+||+|||+++..... ...+..|+|||++ ....++.++|||||||++|||++ |..||.... ..
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~ 243 (334)
T cd05100 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-------FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--VE 243 (334)
T ss_pred EEECCcccceecccccccccccCCCcCceEcCHHHh-------ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--HH
Confidence 999999998765321 1123469999964 34456789999999999999999 888886432 22
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCCC
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSID 612 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 612 (640)
++.+........ . .. .....++.+++.+||+.+|++||+|.|+++.|+++......+
T Consensus 244 ~~~~~~~~~~~~-~-------~~---~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~~ 300 (334)
T cd05100 244 ELFKLLKEGHRM-D-------KP---ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD 300 (334)
T ss_pred HHHHHHHcCCCC-C-------CC---CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCCC
Confidence 233222211100 0 00 112335778888999999999999999999999998655443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=293.58 Aligned_cols=239 Identities=25% Similarity=0.387 Sum_probs=187.7
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHh
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSL 417 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 417 (640)
.+.||+|+||.||++.. .+..||+|.++.......+.+|+.++++++||||+++++++.. +..++||||+++|+|.++
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~ 88 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNF 88 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCCCHHHH
Confidence 56899999999999875 5678999998766556678899999999999999999999875 457999999999999999
Q ss_pred hccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---cccccc
Q 006559 418 LHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---FFINDA 494 (640)
Q Consensus 418 l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---~~~~~~ 494 (640)
+.... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++..... ...+..
T Consensus 89 l~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 162 (254)
T cd05083 89 LRTRG---RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK 162 (254)
T ss_pred HHhcC---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCCce
Confidence 97543 225788999999999999999999 456999999999999999999999999998764322 222457
Q ss_pred ccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHH
Q 006559 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEE 573 (640)
Q Consensus 495 y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 573 (640)
|+|||.+ ....++.++|||||||++|||++ |+.||..... ..+........ . .+ .. ...
T Consensus 163 y~~pe~~-------~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~---~-~~----~~---~~~ 222 (254)
T cd05083 163 WTAPEAL-------KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--KEVKECVEKGY---R-ME----PP---EGC 222 (254)
T ss_pred ecCHHHh-------ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhCCC---C-CC----CC---CcC
Confidence 9999954 34467789999999999999998 9999865332 12222211110 0 00 01 112
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 574 MRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 574 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
...+.+++.+||+.+|++||++.+++..|++
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 3456678889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=293.65 Aligned_cols=240 Identities=21% Similarity=0.396 Sum_probs=189.6
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc-chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||++...++..+|+|.+.... ....+.+|++++++++|+||+++.+++.. ...++||||+++|+|.
T Consensus 10 ~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 356799999999999998888889999887653 34568889999999999999999999887 7889999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------ 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~------ 489 (640)
+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 89 DFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred HHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 99976432 257889999999999999999994 569999999999999999999999999987654211
Q ss_pred -cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcc-hHHHHHHhhcccccccccchhhcc
Q 006559 490 -FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELG-IVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 490 -~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..+..|+|||++ ....++.++|||||||++||++| |+.||...... ...+.. ... ....
T Consensus 163 ~~~~~~y~~PE~~-------~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---~~~--------~~~~ 224 (260)
T cd05073 163 AKFPIKWTAPEAI-------NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE---RGY--------RMPR 224 (260)
T ss_pred CcccccccCHhHh-------ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh---CCC--------CCCC
Confidence 123569999964 33456789999999999999999 89998743221 121111 110 0000
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
. .....++.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 ~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 P---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred c---ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1 1223457778889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=301.27 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=186.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+++.. ++..+|+|.+.... ...++.+|++++.+++||||++++++|...+..++||||+++|+
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 567999999999999854 57788999886542 23457789999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----Cc
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----PF 489 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----~~ 489 (640)
|.++++... .+++.....++.|+++||.|||+. .+++||||||+|||++.++.+||+|||++..... ..
T Consensus 86 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (308)
T cd06615 86 LDQVLKKAG-----RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158 (308)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence 999997543 578889999999999999999952 3699999999999999999999999999876532 23
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccc-----------
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAW----------- 557 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~----------- 557 (640)
.++..|+|||+. ....++.++|||||||++|||+||+.||...... ...+...........
T Consensus 159 ~~~~~~~aPE~~-------~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 159 VGTRSYMSPERL-------QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred CCCcCccChhHh-------cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 457789999964 3345678999999999999999999998643211 111111100000000
Q ss_pred ---------cccchhhc-cChHH--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 558 ---------EVFDFELI-MDKEM--EEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 558 ---------~~~d~~~~-~~~~~--~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
+..+.... ..+.. .....++.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 00000 0112357788999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.51 Aligned_cols=238 Identities=25% Similarity=0.385 Sum_probs=188.0
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
++||+|+||.||++...+++.||+|.+.... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 3689999999999998778999999987652 3456888999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------- 488 (640)
+++..... .+++..+..++.+++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 81 TFLRKKKN----RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 99975431 47888999999999999999994 45999999999999999999999999998765421
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...+..|+|||.+ ....++.++|||||||++|||+| |..||...... .......... ....
T Consensus 154 ~~~~~~~y~~PE~~-------~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~--------~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEAL-------NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY--------RMPA 216 (251)
T ss_pred cCcceeccCChHhh-------ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC--------CCCC
Confidence 1124469999964 33456789999999999999999 78888643211 1111111100 0001
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
+ ......+.+++.+|+..+|++||++.|+++.|+
T Consensus 217 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 P---QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred C---ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1 112335777888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.96 Aligned_cols=229 Identities=20% Similarity=0.287 Sum_probs=177.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|+.. ++..||||.+.... ..+.+..|.+++..+ +|++|+++.+++...+..|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 467999999999999865 56789999987542 122345566666665 58999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 85 GGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999987543 47889999999999999999994 569999999999999999999999999987532
Q ss_pred --CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 487 --TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 487 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
....++..|+|||++ ....++.++|||||||++|||+||+.||....... ..+..... ..
T Consensus 157 ~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~~~i~~~---------~~ 218 (323)
T cd05616 157 TTKTFCGTPDYIAPEII-------AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIMEH---------NV 218 (323)
T ss_pred ccccCCCChhhcCHHHh-------cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HHHHHHhC---------CC
Confidence 123468899999965 34557789999999999999999999997543211 11111110 11
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
..+... ..++.+++.+|++.+|++|++.
T Consensus 219 ~~p~~~---s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSM---SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcC---CHHHHHHHHHHcccCHHhcCCC
Confidence 111112 2345677888999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.05 Aligned_cols=187 Identities=23% Similarity=0.361 Sum_probs=159.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++. .+++.||||.+... .....+.+|++++++++|+||+++++.+...+..|+||||+++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 46799999999999985 45889999998653 1234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|.+++.... .++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.
T Consensus 86 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 86 GDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999997543 47788888899999999999994 559999999999999999999999999974221
Q ss_pred --------------------------------------------CCccccccccCCccccCCCCccccCCCCCccchHHH
Q 006559 487 --------------------------------------------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSF 522 (640)
Q Consensus 487 --------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~Sf 522 (640)
....+|..|+|||++ ....++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSl 230 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-------LRTGYTQLCDWWSV 230 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-------cCCCCCcceeeeec
Confidence 012467889999975 33456789999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 006559 523 GVVLLEILTGKMAKGDG 539 (640)
Q Consensus 523 Gvvl~el~tg~~p~~~~ 539 (640)
||++|||+||+.||...
T Consensus 231 Gvilyell~G~~Pf~~~ 247 (376)
T cd05598 231 GVILYEMLVGQPPFLAD 247 (376)
T ss_pred cceeeehhhCCCCCCCC
Confidence 99999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.63 Aligned_cols=249 Identities=17% Similarity=0.309 Sum_probs=184.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. ++..||+|.++.. .....+.+|++++++++||||+++++++..++..++||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 467999999999999864 5778999998744 2234567899999999999999999999999999999999975 8
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 90 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 90 LKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 888876543 247888899999999999999994 5699999999999999999999999999876432
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH-HHHHhhcc-ccccccc----
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK-WVQMMGQD-ESAWEVF---- 560 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~-~~~~~~~~-~~~~~~~---- 560 (640)
....+..|+|||++.+ ...++.++|||||||++|||+||+.||...... ... ..+..... ...+...
T Consensus 163 ~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 163 NEVVTLWYRPPDVLLG------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cccccccccCCHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 1234778999997532 235678999999999999999999999754321 111 11111110 0001000
Q ss_pred ---chhhc--cC----hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 ---DFELI--MD----KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 ---d~~~~--~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+.... .. ........++.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 00 000112235677888999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=292.63 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=188.9
Q ss_pred hhccccccCcceEEEEEeCC-CcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDG-GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|+... +..+++|.+......+++.+|++++++++|+||+++++++......|+++||+++++|.
T Consensus 7 ~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 86 (256)
T cd06612 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS 86 (256)
T ss_pred hhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHH
Confidence 35679999999999999765 78899999876655678899999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC------c
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------F 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------~ 489 (640)
+++.... ..+++.....++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++...... .
T Consensus 87 ~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (256)
T cd06612 87 DIMKITN----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV 159 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence 9986533 258999999999999999999994 45999999999999999999999999998765432 2
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.++..|+|||++ ....++.++|||||||++|||+||+.||....... ... ..... ........
T Consensus 160 ~~~~~y~~PE~~-------~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-~~~-~~~~~------~~~~~~~~-- 222 (256)
T cd06612 160 IGTPFWMAPEVI-------QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-AIF-MIPNK------PPPTLSDP-- 222 (256)
T ss_pred cCCccccCHHHH-------hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-hhh-hhccC------CCCCCCch--
Confidence 346789999964 33467789999999999999999999987432110 000 00000 00000011
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......+.+++.+||+.+|++||++.+|++
T Consensus 223 -~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 -EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112235677788899999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.20 Aligned_cols=244 Identities=20% Similarity=0.320 Sum_probs=189.4
Q ss_pred hhccccccCcceEEEEEeCCC----cEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDGG----DVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~----~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|...+. ..||||...... ..+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 356899999999999986432 468899887543 34568889999999999999999999875 5678999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 89 PLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999997543 247899999999999999999994 55999999999999999999999999998765322
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcc-hHHHHHHhhccccccccc
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELG-IVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 560 (640)
...+..|+|||.. ....++.++|||||||++||+++ |+.||...... ...+.. .....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~~~---- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESI-------NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE---NGERL---- 227 (270)
T ss_pred ceecCCCCccccccChhhh-------ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---cCCcC----
Confidence 1123469999953 34567789999999999999996 99999753221 111111 11000
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
.... .....+.+++.+|+..+|++|||+.++++.|+++..+.
T Consensus 228 ----~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 ----PMPP---NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ----CCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0111 12235677888899999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.78 Aligned_cols=249 Identities=20% Similarity=0.384 Sum_probs=190.5
Q ss_pred hhccccccCcceEEEEEeC--------CCcEEEEEEeccccc---hHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVLD--------GGDVVVVKRIRERKK---KREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~---~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
..+.||+|+||.||+++.. ....+|+|.++.... ..++..|+++++++ +||||+++++++...+..++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 3578999999999999742 245689998875432 34567889999988 69999999999998899999
Q ss_pred EEeccCCCCHHHhhccCCCC-----------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 405 VYDYLPHGSLHSLLHGSRGP-----------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
||||+++|+|.+++...... ....++|..+++++.|++.||+||| ..+|+||||||+|||++.++.
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNV 172 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCCCc
Confidence 99999999999999754310 1135889999999999999999999 456999999999999999999
Q ss_pred eEEccCCcccccCCC------c--cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchH
Q 006559 474 ACISDIGVHQLFHTP------F--FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIV 544 (640)
Q Consensus 474 ~kl~DfGl~~~~~~~------~--~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~ 544 (640)
+||+|||+++..... . ..+..|+|||++ ....++.++|||||||++|||++ |..||..... .
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~ 243 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL-------FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--E 243 (314)
T ss_pred EEEccccccccccccccccccccCCCCccccCHHHH-------ccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 999999999765321 1 123469999964 33456789999999999999999 8889864321 1
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.......... .. + .. .....++.+++.+||+.+|++||++.++++.|+++...
T Consensus 244 ~~~~~~~~~~-~~---~----~~---~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ELFKLLREGH-RM---D----KP---SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHcCC-CC---C----CC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1111111110 00 0 01 11223566788899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.88 Aligned_cols=244 Identities=18% Similarity=0.270 Sum_probs=186.1
Q ss_pred hhccccccCcceEEEEEeCC-CcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVLDG-GDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||.||+|.... +..+++|.+.... ..+.+..|+++++.++||||+++++++...+..++||||+++|+
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 34679999999999999654 6778888886542 33567788999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|..++.... .++++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 89 l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 89 VDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 999876432 258999999999999999999994 5699999999999999999999999999865432
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...++..|+|||++.... .....++.++|||||||++|||++|+.||..... ...+....... .+....+
T Consensus 162 ~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~------~~~~~~~ 231 (282)
T cd06643 162 SFIGTPYWMAPEVVMCET--SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKSE------PPTLAQP 231 (282)
T ss_pred cccccccccCHhhccccC--CCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHHHhhcC------CCCCCCc
Confidence 234577899999764221 1234567899999999999999999999864321 11111111100 0000111
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ...++.+++..||+.+|.+||++.++++
T Consensus 232 ~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 232 SR---WSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred cc---cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1234667788899999999999988753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.33 Aligned_cols=241 Identities=23% Similarity=0.293 Sum_probs=183.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
...||+|+||.||+|+.. ++..|++|.+... ...+.+.+|+.++++++|+||+++++++...+..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 347999999999999954 5678999988755 2345788899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCcccccCC------
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~~~~~------ 487 (640)
.++++.... ....++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++.....
T Consensus 93 ~~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 167 (268)
T cd06624 93 SALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167 (268)
T ss_pred HHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence 999975432 1112778888999999999999994 56999999999999986 67999999999876432
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-HHHHHHhhcccccccccchhhcc
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-VKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...++..|+|||++.. ....++.++|||||||++|||++|+.||....... ..|....... .+. .
T Consensus 168 ~~~~~~~~~aPE~~~~-----~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~--~ 233 (268)
T cd06624 168 TFTGTLQYMAPEVIDK-----GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI-------HPE--I 233 (268)
T ss_pred cCCCCccccChhhhcc-----ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhcc-------CCC--C
Confidence 1234678999997522 12346789999999999999999999986432211 1111110000 000 1
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+. ....++.+++.+||+.+|++||++.+++.
T Consensus 234 ~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 234 PE---SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred Cc---ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11 12234667788899999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=295.20 Aligned_cols=242 Identities=25% Similarity=0.394 Sum_probs=186.1
Q ss_pred cccccCcceEEEEEeCC-------CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 340 LLGKGCVGATYKVVLDG-------GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.||+|+||.||+|+..+ +..+|+|.+.... ...++.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998643 2468999876542 3456788999999999999999999999989999999999
Q ss_pred CCCCHHHhhccCCCC--CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-----CeEEccCCcc
Q 006559 410 PHGSLHSLLHGSRGP--GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-----NACISDIGVH 482 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-----~~kl~DfGl~ 482 (640)
++|+|.+++...... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++ .+|++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999753211 12347899999999999999999994 5599999999999999877 8999999998
Q ss_pred cccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcc
Q 006559 483 QLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 483 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 553 (640)
+..... ...+..|+|||++ ....++.++|||||||++|||+| |+.||..... .+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~ 229 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESL-------LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTAG 229 (269)
T ss_pred cccccccccccCcccCCCccccCHHHH-------ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhcC
Confidence 754221 1225679999964 34557789999999999999998 9999864321 1111111111
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
. ...... .....+.+++.+||+.+|++||++.++.+.|++
T Consensus 230 ~--------~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G--------RLQKPE---NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C--------ccCCcc---cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 000111 123456778889999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.06 Aligned_cols=229 Identities=20% Similarity=0.286 Sum_probs=177.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCC-cccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHS-NIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|+.. +++.||||.+... ...+.+..|.+++..++|+ +|+++++++...+..|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 467999999999999865 4678999998754 1234466788888888765 58889999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 85 GGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999987543 47889999999999999999994 5699999999999999999999999999875321
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||...... ...+..... ..
T Consensus 157 ~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~---------~~ 218 (324)
T cd05587 157 TTRTFCGTPDYIAPEII-------AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIMEH---------NV 218 (324)
T ss_pred ceeeecCCccccChhhh-------cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC---------CC
Confidence 23468899999965 3345678999999999999999999999754321 111111110 00
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
..+... ..++.+++.+|++.||++||+.
T Consensus 219 ~~~~~~---~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSL---SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCC---CHHHHHHHHHHhhcCHHHcCCC
Confidence 011111 2245677788999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.07 Aligned_cols=258 Identities=18% Similarity=0.337 Sum_probs=182.9
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcC--------CeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGK--------DELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~lV~E 407 (640)
..++||+|+||.||+|+. ..+..||||++.... ....+|+.+++.++|||||++++++... ..+++|||
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE 147 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEe
Confidence 357899999999999986 467899999886432 2345789999999999999999887432 24679999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFH 486 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~ 486 (640)
|+++ +|.+++..... ....+++.....++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.+.
T Consensus 148 ~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 148 FIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred cCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 9985 77776643211 12258889999999999999999995 4599999999999999664 79999999998653
Q ss_pred C-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhcccc-ccc
Q 006559 487 T-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDES-AWE 558 (640)
Q Consensus 487 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~-~~~ 558 (640)
. ...++..|+|||++. ....++.++|||||||++|||+||++||.+... .+...++..+.... ...
T Consensus 223 ~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 223 AGQRSVSYICSRFYRAPELML------GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred CCCCcccCCCCcCccCHHHhc------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 2 234578899999753 223577899999999999999999999975321 11222222111100 000
Q ss_pred ccchhh-------ccChHHH-----HHHHHHHHHHHHccCCCCCCCCCHHHHH--HHHHHhhc
Q 006559 559 VFDFEL-------IMDKEME-----EEMRALLQVALLCLAPLPKDRPNMSIVH--RMIEDIRT 607 (640)
Q Consensus 559 ~~d~~~-------~~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~v~--~~L~~i~~ 607 (640)
...+.. ....... ....++.+++.+||..||++|||+.|++ ..++++..
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000000 0000111 1224677888999999999999999987 45555543
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.85 Aligned_cols=243 Identities=22% Similarity=0.341 Sum_probs=187.6
Q ss_pred hccccccCcceEEEEEeC-CCc----EEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD-GGD----VVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|... ++. .||+|.+..... ..++.+|+.++++++||||++++|+|... ..++|+||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 467999999999999853 343 478888875432 33677889999999999999999998754 577999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 91 PHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 9999999987543 247889999999999999999994 56999999999999999999999999999865321
Q ss_pred -------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhcccccccc
Q 006559 489 -------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 -------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 559 (640)
...+..|+|||.+ ....++.++|||||||++|||+| |+.||.+... ....+++ .....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~-------~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~--- 230 (303)
T cd05110 164 KEYNADGGKMPIKWMALECI-------HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE---KGERL--- 230 (303)
T ss_pred cccccCCCccccccCCHHHh-------ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---CCCCC---
Confidence 1224579999954 34557789999999999999998 8999864321 1222221 11100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
... .....++.+++..||..+|++||+|.++++.|+++..+.
T Consensus 231 -----~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 231 -----PQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -----CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 000 112235677888999999999999999999999986553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=310.90 Aligned_cols=190 Identities=19% Similarity=0.295 Sum_probs=160.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++.. +++.+|+|.+... ...+.+.+|+.+++.++||||+++++++..++..|+||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999965 5788999998643 1234567889999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 128 g~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 128 GDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 9999999643 36778888999999999999994 5699999999999999999999999999886532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
...+|..|+|||++.... ....++.++||||+||++|||+||+.||...
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~---~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred ecccCCCCcccCCHHHHhccC---CCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 234688999999864321 1123678999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=293.00 Aligned_cols=243 Identities=22% Similarity=0.353 Sum_probs=190.1
Q ss_pred hccccccCcceEEEEEeCC-Cc----EEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLDG-GD----VVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|.... |. .+|+|.+.... ...++.+|+..+++++||||+++++++.. ...++||||+
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 5689999999999998643 33 58899887653 23567789999999999999999999987 7899999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF 489 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~ 489 (640)
++|+|.+++..... .+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 91 ~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 91 PLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred CCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999976432 48899999999999999999995 569999999999999999999999999987654221
Q ss_pred --------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 490 --------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 490 --------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
..+..|+|||.. ....++.++|||||||++||++| |+.||..... .++.+.......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~-------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~----- 229 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESI-------LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGER----- 229 (279)
T ss_pred cceecCCCcccccccCHHHh-------hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCCC-----
Confidence 113469999953 34556789999999999999999 9999975322 222222211100
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...+. .+..++.+++.+||..+|++||++.++++.|.++..+
T Consensus 230 ---~~~~~---~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 ---LPQPP---ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---CCCCC---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00011 1123466778899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.47 Aligned_cols=238 Identities=21% Similarity=0.309 Sum_probs=185.1
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc-------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..+.||+|+||.||++.. .++..||+|.+.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 357899999999999985 468899999886431 124577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+++++|.+++.... .+++.....++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||+++....
T Consensus 86 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 86 MPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999987543 47888899999999999999994 5699999999999999999999999999875432
Q ss_pred --------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 488 --------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 488 --------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
...++..|+|||++. ...++.++|||||||++|||++|+.||...+..... .+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~-~~~--- 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVIS-------GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIATQ-PTN--- 225 (263)
T ss_pred ccccccccCCCcCccccCcceec-------cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-HHHhcc-CCC---
Confidence 123456899999753 344778999999999999999999999653221111 111110 000
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
...+. .....+.+++.+||..+|++||++.++++.
T Consensus 226 ----~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ----PQLPS---HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCc---cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00111 122346677788999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.30 Aligned_cols=235 Identities=21% Similarity=0.359 Sum_probs=185.5
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|... ++..||+|.+.... ..+.+..|++++++++||||+++++++...+..++||||++++
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence 3467999999999999854 57789999887442 2346788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++... .+++..+..++.|+++|+.|||+ .+++|+||+|+||++++++.+|++|||+++.....
T Consensus 88 ~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 88 SALDLLKPG------PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 999998642 47889999999999999999994 56999999999999999999999999998765432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||.. ....++.++|||||||++|||+||+.|+....... +........ .+.+
T Consensus 159 ~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~------~~~~-- 221 (277)
T cd06642 159 NTFVGTPFWMAPEVI-------KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNS------PPTL-- 221 (277)
T ss_pred hcccCcccccCHHHh-------CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCC------CCCC--
Confidence 2346689999964 34456789999999999999999999986422111 111111000 0000
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ......+.+++.+||+.+|++||+|.++++
T Consensus 222 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 222 E---GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred C---cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 122345677888899999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=297.49 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=190.9
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||+||++... ++..||+|.+... ...+.+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG 88 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCC
Confidence 3567999999999999854 6888999987644 23466888999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----C
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----P 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----~ 488 (640)
+|.+++.... ++++.....++.+++.||.|||+. .+++||||||+||++++++.++|+|||++..... .
T Consensus 89 ~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~ 161 (284)
T cd06620 89 SLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161 (284)
T ss_pred CHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCc
Confidence 9999987543 578999999999999999999952 3599999999999999999999999999865422 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc---------hHHHHHHhhcccccccc
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG---------IVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~---------~~~~~~~~~~~~~~~~~ 559 (640)
..++..|+|||++ ....++.++|||||||++|||+||+.||...... ...+.+......
T Consensus 162 ~~~~~~~~aPE~~-------~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 162 FVGTSTYMSPERI-------QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred cccCcccCCHHHH-------ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 3457889999964 2346678999999999999999999999743211 111221111110
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.+.+ . ..+...++.+++.+||+.||++||++.|+.++.--+
T Consensus 230 -~~~~--~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 230 -PPRL--P--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred -CCCC--C--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0000 0 011334577788889999999999999998864333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.73 Aligned_cols=238 Identities=19% Similarity=0.310 Sum_probs=186.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+++.. ++..+|+|.++.. ...+.+..|+.+++.++|+||+++.+++...+..|+||||+++|+
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 467999999999999854 5788999988643 233567788999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|.+++..... ..++......++.|++.||.||| ..+|+|+||||+||++++++.++++|||+++.....
T Consensus 85 l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 85 LMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred HHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9998865332 24788899999999999999999 456999999999999999999999999998765432
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..++..|+|||++ ....++.++||||||+++|||++|+.||........ ........ ... .+
T Consensus 159 ~~~~~~~~~aPE~~-------~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~-~~~-------~~ 221 (255)
T cd08219 159 TYVGTPYYVPPEIW-------ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--ILKVCQGS-YKP-------LP 221 (255)
T ss_pred cccCCccccCHHHH-------ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--HHHHhcCC-CCC-------CC
Confidence 3456779999964 334577899999999999999999999975432111 11111110 000 01
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
. .....+.+++.+||+.||++||++.+++..
T Consensus 222 ~---~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 S---HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred c---ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1 112346677888999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.86 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=185.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. ++..||+|.++.. ...+.+.+|+.++++++||||+++++++..++..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 457999999999999964 6889999998643 123567789999999999999999999999999999999997 6
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++..... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 84 DLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred CHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 89888865331 2358899999999999999999994 56999999999999999999999999998765322
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch--HHHHHHhhcc-ccccc----c
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI--VKWVQMMGQD-ESAWE----V 559 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~-~~~~~----~ 559 (640)
...+..|+|||++.+ ...++.++|||||||++|||+||+.||....... ....+..... +..+. .
T Consensus 159 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 159 THEVVTLWYRAPEVLLG------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred cCCcccccccChHHhcC------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 234678999996532 2345788999999999999999999997532211 1111111100 00000 0
Q ss_pred cchhhccC--------hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDFELIMD--------KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~~~~~~--------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+.....+ ........++.+++.+||+.||++|||+.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 000112245667888999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.82 Aligned_cols=243 Identities=20% Similarity=0.315 Sum_probs=185.8
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||.||+|+. .++..||+|.++... ....+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS 92 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence 456799999999999985 468889999987542 23456778999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++.... .+++.....++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 93 L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 93 LQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 999987543 57889999999999999999995 4599999999999999999999999999865432
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...++..|+|||++... ....++.++|||||||++|||++|+.||.........+.. ....... +...
T Consensus 165 ~~~~~~~y~aPE~~~~~----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~~~~~~----~~~~-- 232 (267)
T cd06645 165 SFIGTPYWMAPEVAAVE----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKSNFQP----PKLK-- 232 (267)
T ss_pred cccCcccccChhhhccc----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hccCCCC----Cccc--
Confidence 23457789999975211 2344678999999999999999999998643211111110 0000000 0000
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........+.+++.+|++.+|++||++.+++.
T Consensus 233 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 -DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00011224667888899999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=297.36 Aligned_cols=235 Identities=20% Similarity=0.318 Sum_probs=182.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.++||+|+||.||+|+. .++..||+|.+... ...+++..|++++++++||||+++++++...+..++||||+++|+
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 46799999999999985 56788999998644 223567889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----Cc
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----PF 489 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----~~ 489 (640)
|..+. .+++.....++.|++.||+||| ..+|+|+||||+|||++.++.+||+|||++..... ..
T Consensus 86 l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (279)
T cd06619 86 LDVYR---------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY 153 (279)
T ss_pred hHHhh---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCC
Confidence 97552 3577888899999999999999 45699999999999999999999999999876533 23
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-----hHHHHHHhhcccccccccchhh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-----IVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
.++..|+|||++ ....++.++|||||||++|||+||+.||...... ...+.+...... ....
T Consensus 154 ~~~~~y~aPE~~-------~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 220 (279)
T cd06619 154 VGTNAYMAPERI-------SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL 220 (279)
T ss_pred CCChhhcCceee-------cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC
Confidence 457789999964 3345678999999999999999999998632110 111111111100 0000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
.. .....++.+++.+|++.+|++||++.|+++.
T Consensus 221 ~~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PV----GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 1112346778888999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=294.21 Aligned_cols=237 Identities=21% Similarity=0.345 Sum_probs=184.5
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc--------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK--------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|...+++.+|||.++... ....+.+|++++++++|+||+++.+++...+..++||||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 46799999999999998888999999886431 1234678899999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
++|+|.+++.... ++++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 85 PGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999997543 47888999999999999999995 4599999999999999999999999999875421
Q ss_pred ----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccc
Q 006559 488 ----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 488 ----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
...++..|+|||+. ....++.++|||||||++|||+||+.||...+... .......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~-------~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~- 226 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVI-------NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAHRG-L- 226 (265)
T ss_pred ccccccccccccCCCccccChhhh-------cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhccC-C-
Confidence 12346789999964 34456789999999999999999999997432111 1111000000 0
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+.. +. ....++.+++.+||+.+|++||++.++++
T Consensus 227 ---~~~~--~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ---MPRL--PD---SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCC--CC---CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001 11 12234667788899999999999998864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=296.06 Aligned_cols=243 Identities=16% Similarity=0.273 Sum_probs=186.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+|+.. ++..+++|.+.... ..+.+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 96 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV 96 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence 567999999999999965 47889999987542 345677899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
..++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..... .
T Consensus 97 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 169 (292)
T cd06644 97 DAIMLELD----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169 (292)
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence 98876432 248899999999999999999994 5699999999999999999999999999765432 1
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
...+..|+|||++.... .....++.++|||||||++|||+||+.||..... ........... .+.....
T Consensus 170 ~~~~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~------~~~~~~~- 238 (292)
T cd06644 170 FIGTPYWMAPEVVMCET--MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKSE------PPTLSQP- 238 (292)
T ss_pred ecCCccccCceeecccc--ccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHHHHHhcCC------CccCCCC-
Confidence 23467899999764321 1234467899999999999999999999865321 11111111110 0011111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....++.+++.+||+.+|++||++.++++
T Consensus 239 --~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 239 --SKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 112234667888899999999999998864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=326.65 Aligned_cols=249 Identities=18% Similarity=0.296 Sum_probs=187.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+++.. .+..||+|.+... .....+..|+.++++++|||||+++++|.. ...+||||||++
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 567999999999999964 4678899988643 224567889999999999999999998864 357999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC----CCceecCCCCCCeEECC----------------
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK----AHLFHGHLSSSNIVVDQ---------------- 470 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrdlk~~NILl~~---------------- 470 (640)
+|+|.++|..... ....+++..++.|+.||+.||+|||.... .+||||||||+||||+.
T Consensus 98 gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 98 AGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 9999999875321 11258999999999999999999996431 45999999999999964
Q ss_pred -CCCeEEccCCcccccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH
Q 006559 471 -LGNACISDIGVHQLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV 544 (640)
Q Consensus 471 -~~~~kl~DfGl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~ 544 (640)
...+||+|||+++.... ...++..|+|||++.. ....++.++|||||||+||||+||+.||.... ...
T Consensus 177 g~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g-----e~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-~~~ 250 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH-----ETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-NFS 250 (1021)
T ss_pred CCCceEEccCCccccccccccccccCCCccccCHHHHhc-----cCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-cHH
Confidence 23589999999886542 2356889999997632 22456789999999999999999999997432 222
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHHHHh
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH--RMIEDI 605 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~--~~L~~i 605 (640)
..+..+.... .+.. .....++.+++..||+.+|++||++.+++ ..+..+
T Consensus 251 qli~~lk~~p--------~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 251 QLISELKRGP--------DLPI----KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHhcCC--------CCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 2222211110 0100 01123567788889999999999999997 445444
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.58 Aligned_cols=236 Identities=21% Similarity=0.314 Sum_probs=185.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+++. .++..||+|.+... ...+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence 46799999999999995 57889999998754 2345577889999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++..... .
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 104 TDVVTET------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 9998643 47888999999999999999994 5699999999999999999999999999876432 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||.. ....++.++|||||||++|||+||+.||........ ....... ..+.....
T Consensus 175 ~~~~~~y~aPE~~-------~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~~~~~------~~~~~~~~- 238 (297)
T cd06656 175 MVGTPYWMAPEVV-------TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATN------GTPELQNP- 238 (297)
T ss_pred ccCCccccCHHHH-------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eeeeccC------CCCCCCCc-
Confidence 2456789999964 345567899999999999999999999964321100 0000000 00000011
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......+.+++.+||+.+|++||++.++++
T Consensus 239 --~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 --ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112234567788899999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.42 Aligned_cols=244 Identities=21% Similarity=0.305 Sum_probs=180.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCC------eEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD------ELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lV~ 406 (640)
.+.||+|+||.||+++. ..|..||||++... .....+.+|+.+++.++||||+++++++...+ ..|+||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 56899999999999985 45889999998643 23455678899999999999999999986543 579999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++ +|.+.++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 99975 56666642 36788888999999999999994 569999999999999999999999999987653
Q ss_pred C-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccc-ccc-
Q 006559 487 T-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA-WEV- 559 (640)
Q Consensus 487 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~- 559 (640)
. ...++..|+|||++ ....++.++|||||||++|||+||+.||...+. ...|.......... ...
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred cCccCCCCcccCCCCCchhc-------cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCcHHHH
Confidence 2 23457889999965 334577899999999999999999999975321 22222111110000 000
Q ss_pred ----------cc--h------------hhccCh---HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 ----------FD--F------------ELIMDK---EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ----------~d--~------------~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. + ....+. .......++.+++.+|++.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0 000000 00011235678888999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=295.45 Aligned_cols=237 Identities=21% Similarity=0.332 Sum_probs=195.6
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|.|++|-+++ .-.|..||||++.+.+ ....+.+|++.|+-++|||||+||++......+|||+|.-.+
T Consensus 22 LekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~ 101 (864)
T KOG4717|consen 22 LEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDG 101 (864)
T ss_pred hhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCC
Confidence 35679999999999988 4579999999997652 345678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE-CCCCCeEEccCCcccccCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV-DQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl-~~~~~~kl~DfGl~~~~~~--- 487 (640)
|+|++|+-+... -+.+....+++.||..|+.|+| +.++|||||||+||.+ ..-|-+|+.|||++..+.+
T Consensus 102 GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 102 GDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred chHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999976542 3778888999999999999999 6679999999999976 5678999999999987764
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
..+++..|-|||++.+..+. .+++||||+||+||-|+.|+.||++... .+....|.|-...
T Consensus 175 L~TsCGSLAYSAPEILLGDsYD------APAVDiWSLGVILyMLVCGq~PFqeAND-----------SETLTmImDCKYt 237 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYD------APAVDIWSLGVILYMLVCGQPPFQEAND-----------SETLTMIMDCKYT 237 (864)
T ss_pred hhcccchhhccCchhhhcCccC------CcchhhhHHHHHHHHHHhCCCccccccc-----------hhhhhhhhccccc
Confidence 45778899999998766433 2689999999999999999999985321 2233445666666
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+.....+.++ ++..|+..||++|.+..||+.
T Consensus 238 vPshvS~eCrd---LI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 VPSHVSKECRD---LIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CchhhhHHHHH---HHHHHHhcCchhhccHHHHhc
Confidence 66666665555 555699999999999888864
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=292.68 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=189.6
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+++.. .+..||+|.++... ....+.+|+.++++++|+||+++++++...+..++||||++++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (286)
T cd06622 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAG 84 (286)
T ss_pred hhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCC
Confidence 3567999999999999975 68899999887542 2356778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----C
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----P 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----~ 488 (640)
+|.+++.... ....+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++..+.. .
T Consensus 85 ~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (286)
T cd06622 85 SLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT 160 (286)
T ss_pred CHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcccc
Confidence 9999987532 12258999999999999999999995 23699999999999999999999999999876532 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH-HHHHHhhcccccccccchhhccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV-KWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..++..|+|||++...... ....++.++|||||||++|||+||+.||........ ......... .. +. ..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~-----~~--~~ 231 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPN-QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-DP-----PT--LP 231 (286)
T ss_pred CCCccCccCcchhcCCCCC-ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc-CC-----CC--CC
Confidence 2346689999976433211 234567899999999999999999999964322111 111111000 00 00 11
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....++.+++.+||+.+|++||++.+++.
T Consensus 232 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 232 ---SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ---cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 123345667888899999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=293.01 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=186.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|+.++++++|+||+++++++......++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 457999999999999975 58899999886442 2355778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
.|..++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 86 VLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred HHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 8888775432 48899999999999999999995 56999999999999999999999999998865432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-HHH-HHHhhccc-ccccc----
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-VKW-VQMMGQDE-SAWEV---- 559 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-~~~-~~~~~~~~-~~~~~---- 559 (640)
...+..|+|||++.+ ...++.++|||||||++|||+||+.||.+..... ... .+...... .....
T Consensus 158 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 158 TDYVATRWYRAPELLVG------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cCcccccccCCHHHHhC------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 234678999996522 2346789999999999999999999997533211 111 11110000 00000
Q ss_pred --------cchhhccC--hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 --------FDFELIMD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 --------~d~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.++....+ .........+.+++.+||+.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000 001112346778899999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=290.37 Aligned_cols=236 Identities=20% Similarity=0.348 Sum_probs=186.4
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|... ++..||+|.+.... ....+..|+.++++++||||+++++++......++||||+++|
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 3467999999999999864 57889999887542 2345778899999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++... ++++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 88 ~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 88 SALDLLRAG------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999998643 47888899999999999999994 56999999999999999999999999998765321
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...+..|+|||++ ....++.++|||||||++|||+||+.||...... ......... . .
T Consensus 159 ~~~~~~~~y~apE~~-------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~-~----------~ 218 (277)
T cd06640 159 NTFVGTPFWMAPEVI-------QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--RVLFLIPKN-N----------P 218 (277)
T ss_pred ccccCcccccCHhHh-------ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHhhhhhcC-C----------C
Confidence 2346679999964 3345678999999999999999999998643211 111111000 0 0
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
+.........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00112334567788889999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=305.57 Aligned_cols=228 Identities=19% Similarity=0.277 Sum_probs=171.9
Q ss_pred ccccCcceEEEEEeC-CCcEEEEEEecccc--ch---HHHHHHHHHHhcc---CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 341 LGKGCVGATYKVVLD-GGDVVVVKRIRERK--KK---REVDEWLRVIGGL---RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 341 iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~---~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
||+|+||+||+|+.. ++..||||++.... .. .....|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 58899999986431 11 2233444555544 699999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 99999987543 47889999999999999999995 4599999999999999999999999999875321
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...++..|+|||++.. ...++.++|||||||++|||+||+.||...... +..+...... ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~~~~i~~~~-------~~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLD------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QMYRNIAFGK-------VRFP 217 (330)
T ss_pred ccCccCCccccCHHHHcC------CCCCCCccceeccccEEEEeccCCCCCCCCCHH--HHHHHHHcCC-------CCCC
Confidence 2346889999997532 234678999999999999999999999754321 1111111110 0000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
.... ..++.+++.+||+.||++||++
T Consensus 218 -~~~~---~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 218 -KNVL---SDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred -CccC---CHHHHHHHHHHcCCCHHHCCCC
Confidence 0111 2235567778999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=293.94 Aligned_cols=234 Identities=19% Similarity=0.246 Sum_probs=181.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||+||++.. .+++.||+|.+.... ....+.+|++++++++|+||+++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 35799999999999986 468899999986542 123466799999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 85 GDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99998886432 1258999999999999999999994 5699999999999999999999999999865432
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch--HHHHHHhhcccccccccchhh
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI--VKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||....... ..+...... ...
T Consensus 159 ~~~~g~~~~~aPE~~-------~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~---------~~~ 222 (285)
T cd05632 159 RGRVGTVGYMAPEVL-------NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE---------TEE 222 (285)
T ss_pred cCCCCCcCccChHHh-------cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc---------ccc
Confidence 23457899999964 34557789999999999999999999997432211 111111110 000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 596 (640)
..... ....+.+++..|++.||++||++.
T Consensus 223 ~~~~~---~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 VYSAK---FSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCcc---CCHHHHHHHHHHccCCHhHcCCCc
Confidence 11111 123456777889999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=277.10 Aligned_cols=245 Identities=18% Similarity=0.291 Sum_probs=192.5
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc------c----hHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK------K----KREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~----~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
..+++|+|..++|-++.. .+|...|+|++.... . .++..+|+.+|+++ .||+|+++.++|..+...++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 357899999999988774 568889999886431 1 23345688899987 59999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
|+|.|+.|.|.++|...- .++.++..+|+.|+..|++|||. ..||||||||+|||+|++..+||+|||.+..
T Consensus 101 VFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeec
Confidence 999999999999998654 68899999999999999999995 4599999999999999999999999999988
Q ss_pred cCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 485 FHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 485 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
+.. ..++|++|.|||.+....+ -....|+..+|+||.||+||-|+.|.+||......+ .+++.... ..+.
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~-e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml--MLR~ImeG--kyqF 247 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMY-ENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML--MLRMIMEG--KYQF 247 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecc-cCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH--HHHHHHhc--cccc
Confidence 765 3578999999998754432 245678899999999999999999999996321111 11111111 0111
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
- .++..+....+.+++.+|++.||++|.|.+|++.
T Consensus 248 ~------speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 248 R------SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred C------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 1233344455667788899999999999999864
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.02 Aligned_cols=190 Identities=19% Similarity=0.281 Sum_probs=160.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++.. +++.+|+|.+... ...+.+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 567999999999999965 5788999998643 1234467889999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++... .++......++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 128 g~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 128 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 9999998743 36777888899999999999994 5699999999999999999999999999876532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
...+|..|+|||++.... ....++.++|||||||++|||++|+.||...
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~---~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQG---GDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred cccCcccCccccCHHHHhccC---CCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 234688999999864321 1234678999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=294.87 Aligned_cols=239 Identities=19% Similarity=0.254 Sum_probs=184.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||.||++... +++.||||.+.... ..+.+..|+.++++++|+||+++.+.+...+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 467999999999999854 57899999986542 123466789999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... ...+++..+..++.|++.||.||| ..+|+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999886432 225888999999999999999999 45699999999999999999999999999876432
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH-HHHHHhhcccccccccchhhc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV-KWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...++..|+|||++ ....++.++|||||||++|||++|+.||........ .-....... ....
T Consensus 159 ~~~~g~~~y~aPE~~-------~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~--------~~~~ 223 (285)
T cd05630 159 KGRVGTVGYMAPEVV-------KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--------VQEE 223 (285)
T ss_pred cCCCCCccccChHHH-------cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh--------hhhh
Confidence 12457789999964 345677899999999999999999999975322110 000000000 0000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPN-----MSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~ 600 (640)
... ....++.+++..||+.||++||+ +.|+.+
T Consensus 224 ~~~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSE---KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCc---cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011 12234667788899999999999 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=292.17 Aligned_cols=245 Identities=21% Similarity=0.366 Sum_probs=185.6
Q ss_pred hccccccCcceEEEEEeC----CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCC------eEE
Q 006559 338 AELLGKGCVGATYKVVLD----GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD------ELF 403 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~ 403 (640)
.++||+|+||.||+|.+. .+..||||.+... ...+++.+|++++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 467999999999999853 3578999998754 22345778999999999999999999886532 357
Q ss_pred EEEeccCCCCHHHhhccCC-CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 404 LVYDYLPHGSLHSLLHGSR-GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
+++||+++|+|.+++.... ......+++....+++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||++
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccccc
Confidence 8999999999998875332 1122357888999999999999999995 45999999999999999999999999998
Q ss_pred cccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhc
Q 006559 483 QLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQ 552 (640)
Q Consensus 483 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~ 552 (640)
+..... ...+..|++||.+ ....++.++|||||||++|||++ |+.||..... ....+.. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-------~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~ 230 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESL-------ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI---K 230 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHH-------hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---c
Confidence 865321 1224568888853 44556789999999999999999 8888864321 1111111 1
Q ss_pred ccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 553 DESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 553 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
... .... ......+.+++.+||+.+|++||++.++.+.|+++.
T Consensus 231 ~~~--------~~~~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 231 GNR--------LKQP---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred CCc--------CCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 100 0000 122346788899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.12 Aligned_cols=193 Identities=19% Similarity=0.283 Sum_probs=161.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++.. +++.||+|.+... ...+.+.+|+.++..++|+||+++++++...+..|+||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 467999999999999964 5889999998642 1234577888999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++.... ..+++..+..++.||+.||+||| ..+|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 86 GDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999997532 14788889999999999999999 456999999999999999999999999998764321
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
..++..|+|||++.... .....++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cccceeccccccCHHHHhhcc--ccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 24688999999763211 11245678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.74 Aligned_cols=229 Identities=19% Similarity=0.285 Sum_probs=177.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.++||+|+||.||+|+.. ++..||+|.+.... ..+.+..|.+++..+. |++|+++.+++...+..|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 467999999999999854 68899999987541 2234566777887775 5778889999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999987543 58899999999999999999994 5699999999999999999999999999875321
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||...... ...+..... ..
T Consensus 157 ~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~---------~~ 218 (323)
T cd05615 157 TTRTFCGTPDYIAPEII-------AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIMEH---------NV 218 (323)
T ss_pred cccCccCCccccCHHHH-------cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------CC
Confidence 23468899999965 3345678999999999999999999999754321 111111110 11
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
..+... ..++.+++.+|++.+|++|++.
T Consensus 219 ~~p~~~---~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSL---SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccC---CHHHHHHHHHHcccCHhhCCCC
Confidence 111111 2345677888999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=294.47 Aligned_cols=236 Identities=21% Similarity=0.334 Sum_probs=185.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||.|+||.||+|+. .+++.|++|.+... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 45799999999999984 56889999988654 2345677899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..... .
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 9998643 47899999999999999999994 5699999999999999999999999999876532 1
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||.+ ....++.++|||||||++|||+||+.||...... .......... . +.+....
T Consensus 175 ~~~~~~y~aPE~~-------~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--~~~~~~~~~~-~-----~~~~~~~ 239 (296)
T cd06655 175 MVGTPYWMAPEVV-------TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNG-T-----PELQNPE 239 (296)
T ss_pred cCCCccccCcchh-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC-C-----cccCCcc
Confidence 2356789999954 3455778999999999999999999999753221 1111111000 0 0000111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....+.+++.+||..+|++||++.+++.
T Consensus 240 ---~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 ---KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ---cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11234666788899999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=294.06 Aligned_cols=244 Identities=19% Similarity=0.289 Sum_probs=187.9
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||.||+++.. ++..+|+|.+.... ..+.+..|+.++++++||||+++++++...+..|+||||+++|+
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 3567999999999999964 57889999986542 33567789999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|.+++.... .++++.....++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 89 L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 89 LDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999987543 258899999999999999999995 45999999999999999999999999987654321
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..++..|++||++... ......++.++|||||||++|||++|+.||..... ............ +.+..+
T Consensus 162 ~~~~~~~y~~PE~~~~~--~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~------~~~~~~ 231 (280)
T cd06611 162 TFIGTPYWMAPEVVACE--TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--MRVLLKILKSEP------PTLDQP 231 (280)
T ss_pred eeecchhhcCHHHHhhc--ccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--HHHHHHHhcCCC------CCcCCc
Confidence 2357789999975422 12234567899999999999999999999975321 111111111100 001011
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ....++.+++..||+.+|++||++.++++
T Consensus 232 ~---~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 232 S---KWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred c---cCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1 11234667788899999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=284.46 Aligned_cols=238 Identities=20% Similarity=0.316 Sum_probs=196.4
Q ss_pred HhhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 336 SSAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 336 ~~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
...++||+|+||.||++.+ ..|+++|||++....+-+++.+|+.++++.+.|++|+++|.|.....+|+|||||-.|++
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 4566899999999999985 569999999999888889999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+.++..+ .++...++-.+....++||+|||. .+-||||||+.||||+.+|.+|++|||++-.+.. .
T Consensus 116 SDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 116 SDIMRARR----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred HHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 99998654 378999999999999999999994 4578999999999999999999999999877643 4
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccccc-chhhccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF-DFELIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~~~ 567 (640)
..+|+.|||||++ ....|++++||||+|+...||..|++||.+-+-.-+ +.-+- .+.. .-
T Consensus 189 VIGTPFWMAPEVI-------~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-----------IFMIPT~PPP-TF 249 (502)
T KOG0574|consen 189 VIGTPFWMAPEVI-------EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-----------IFMIPTKPPP-TF 249 (502)
T ss_pred cccCcccccHHHH-------HHhccchhhhHhhhcchhhhhhcCCCCcccccccce-----------eEeccCCCCC-CC
Confidence 5679999999975 445678999999999999999999999975221100 00000 0111 11
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
...++...++-+++..|+-..|++|-|+.+++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLC 281 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHh
Confidence 12245566788889999999999999887765
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=285.05 Aligned_cols=243 Identities=22% Similarity=0.358 Sum_probs=187.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+|... ++..+++|.+... ...+.+.+|+.++++++||||+++++++...+..|++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 467999999999999864 5778999998754 2346788899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++.... ..++...+..++.|++.||+|||. .+|+|+||||+||++++++.+||+|||++..... .
T Consensus 88 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 88 QDIYQVTR----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99987542 257889999999999999999994 4599999999999999999999999999876532 1
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
...+..|+|||+.... ....++.++|||||||++|||+||+.||.+...... ........ +.+....
T Consensus 161 ~~~~~~y~~Pe~~~~~----~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~~~~-----~~~~~~~-- 227 (262)
T cd06613 161 FIGTPYWMAPEVAAVE----RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLISKSN-----FPPPKLK-- 227 (262)
T ss_pred ccCCccccCchhhccc----ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcc-----CCCcccc--
Confidence 2346679999964221 112667899999999999999999999875321111 10111000 0000000
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++.+||..+|.+||++.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11123345778888999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=294.41 Aligned_cols=249 Identities=16% Similarity=0.281 Sum_probs=184.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. ++..||+|.++.. .....+.+|++++++++||||+++++++...+..++||||++ ++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 467999999999999865 5788999998643 223456789999999999999999999999999999999997 58
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++.... ..+++.....++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 90 l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 90 LKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 998887543 247888999999999999999994 5699999999999999999999999999876432
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhc--ccccccc-----
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQ--DESAWEV----- 559 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~--~~~~~~~----- 559 (640)
....+..|+|||++.+ ...++.++|||||||++|||+||+.||...... ....+..... ....+..
T Consensus 163 ~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 163 NEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred ccceeecccCcHHHhC------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 1234678999997532 234667899999999999999999999754321 1111111100 0000100
Q ss_pred ----cchhhccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 ----FDFELIMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ----~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+........ .......+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 0011234667888999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.84 Aligned_cols=246 Identities=25% Similarity=0.402 Sum_probs=194.6
Q ss_pred hhccccccCcceEEEEEeCC--------CcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG--------GDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
..+.+|+|.||.|++|...+ ...||||.++... ..+.+..|+.+|+.+ +|+||+.++|+|..++..++
T Consensus 300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~ 379 (609)
T KOG0200|consen 300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV 379 (609)
T ss_pred ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence 34589999999999998431 3469999998763 346788899999887 59999999999999999999
Q ss_pred EEeccCCCCHHHhhccCC---------CCCC--CCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 405 VYDYLPHGSLHSLLHGSR---------GPGR--MPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
|+||+..|+|.++|+..+ .... ..++..+.+.++.|||.||+||+ ..++|||||.++|||+.++..
T Consensus 380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCE
Confidence 999999999999998776 1111 23888999999999999999999 455999999999999999999
Q ss_pred eEEccCCcccccCC-Ccc--------ccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC--Cc
Q 006559 474 ACISDIGVHQLFHT-PFF--------INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDG--EL 541 (640)
Q Consensus 474 ~kl~DfGl~~~~~~-~~~--------~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~--~~ 541 (640)
+||+|||+++.... .++ ....||||| ......|+.|+|||||||+||||+| |..|+.+- ..
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApE-------sl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPE-------SLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHH-------HhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 99999999985432 111 123588888 4556789999999999999999999 88998751 12
Q ss_pred chHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 542 GIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
++.++++...+. +....+..+++++|..||+.+|++||++.++++.++...
T Consensus 530 ~l~~~l~~G~r~--------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 530 ELLEFLKEGNRM--------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHhcCCCC--------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 222222221111 111233456778999999999999999999999999954
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.37 Aligned_cols=244 Identities=20% Similarity=0.261 Sum_probs=180.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 406 (640)
.+.||+|+||.||++.. ..+..||||++... ...+.+.+|+.+++.++||||+++++++... ...|+||
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 46799999999999985 45788999998753 2234566789999999999999999988643 3579999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++ ++.+.+.. .+++..+..++.|++.||+||| ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 99975 67666642 3778889999999999999999 4569999999999999999999999999998754
Q ss_pred C-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccc-------
Q 006559 487 T-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE------- 554 (640)
Q Consensus 487 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~------- 554 (640)
. ...++..|+|||++ ....++.++|||||||++|||++|+.||..... ...|......-.
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CccccCCccccCCccCHHHH-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 3 23468899999965 334577899999999999999999999975331 111111111000
Q ss_pred ---------------ccccccchhh------ccCh-HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 555 ---------------SAWEVFDFEL------IMDK-EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 555 ---------------~~~~~~d~~~------~~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......+.. ..+. .......++.+++.+|++.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000000 0000 00111245678889999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=294.64 Aligned_cols=248 Identities=19% Similarity=0.300 Sum_probs=182.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +|..||+|.++... ....+.+|++++++++||||+++++++.+....++|+||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 467999999999999964 68899999986431 23456789999999999999999999999999999999997 5
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... ..+++.....++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 84 DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 8888776432 248899999999999999999994 5599999999999999999999999999876542
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHh----hc-ccccc----
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM----GQ-DESAW---- 557 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~----~~-~~~~~---- 557 (640)
....+..|+|||++.+ ...++.++|||||||++|||+||+.|+....... +..+.. .. ....+
T Consensus 157 ~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 157 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CCCccccCCcChHHHhC------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhh
Confidence 1234678999997532 2345789999999999999999998864322111 111110 00 00000
Q ss_pred cccch--------hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVFDF--------ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~d~--------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...+. .............++.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 00000001112345667888899999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=289.06 Aligned_cols=235 Identities=23% Similarity=0.363 Sum_probs=183.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV 405 (640)
...||+|+||.||+|.. .++..+|+|.+.... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 45799999999999985 457889999886431 113567889999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 406 YDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 85 LEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999997543 57888999999999999999994 45999999999999999999999999998766
Q ss_pred CCC------------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcc
Q 006559 486 HTP------------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 486 ~~~------------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~ 553 (640)
... ..++..|+|||.+ ....++.++|||||||++|||+||+.||...... .-+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~-------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~ 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVV-------KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKIGEN 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHh-------ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHHHHhcc
Confidence 421 1245679999964 3445678899999999999999999999753211 111110000
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+.. +. .....+.+++.+||+.+|++||++.++++
T Consensus 228 ------~~~~~--~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ------ASPEI--PS---NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------CCCcC--Cc---ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00111 11 12234666778899999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=285.92 Aligned_cols=238 Identities=20% Similarity=0.280 Sum_probs=187.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.++||+|+||.||.++. .++..+++|.+... ...+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 46799999999999884 55788999987643 23456778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.....
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 85 TLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999997543 1257899999999999999999995 45999999999999999999999999998765332
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|.|||+.. ...++.++||||||+++|||++|+.||..... .+......... ...
T Consensus 159 ~~~~~~~~y~ape~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~~~~-~~~-------- 220 (256)
T cd08221 159 ETVVGTPYYMSPELCQ-------GVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVKIVQGN-YTP-------- 220 (256)
T ss_pred cccCCCccccCHhhcC-------CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCC-CCC--------
Confidence 34577899999642 33466789999999999999999999965322 12221111110 000
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
.......++.+++..||+.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 001223456677888999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=307.77 Aligned_cols=187 Identities=20% Similarity=0.352 Sum_probs=160.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++.. ++..||+|.++.. .....+..|+.++..++||||+++++.+...+..|+||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999864 5889999998743 1234567789999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++.....++.|++.||+||| ..+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 86 GDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999997543 4788899999999999999999 45699999999999999999999999999764321
Q ss_pred -------------------------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHH
Q 006559 488 -------------------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEIL 530 (640)
Q Consensus 488 -------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~ 530 (640)
...+|..|+|||++ ....++.++|||||||++|||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-------~~~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-------MQTGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-------cCCCCCCcceeccccceeeecc
Confidence 12467889999975 3455778999999999999999
Q ss_pred hCCCCCCCC
Q 006559 531 TGKMAKGDG 539 (640)
Q Consensus 531 tg~~p~~~~ 539 (640)
||+.||...
T Consensus 231 tG~~Pf~~~ 239 (360)
T cd05627 231 IGYPPFCSE 239 (360)
T ss_pred cCCCCCCCC
Confidence 999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.11 Aligned_cols=236 Identities=18% Similarity=0.286 Sum_probs=182.9
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
...||+|+||.||++.. .++..||||.+... ...+.+.+|+..+++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 35699999999999985 45788999998654 2345577899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++..... .
T Consensus 107 ~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 107 TDIVTHT------RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 9988543 37889999999999999999995 4599999999999999999999999999875432 1
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||+. ....++.++|||||||++|||++|+.||...... .-...... ..........
T Consensus 178 ~~~~~~y~aPE~~-------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~------~~~~~~~~~~ 242 (292)
T cd06658 178 LVGTPYWMAPEVI-------SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRD------NLPPRVKDSH 242 (292)
T ss_pred eecCccccCHHHH-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh------cCCCcccccc
Confidence 2356789999964 3345678999999999999999999998743211 11111110 0011111111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... .+.+++..||..||++|||+.++++
T Consensus 243 ~~~~---~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 243 KVSS---VLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ccCH---HHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122 3555677799999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=288.61 Aligned_cols=235 Identities=22% Similarity=0.374 Sum_probs=177.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-------cchHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-------KKKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~E 407 (640)
.+.||+|+||.||+|.. ..+..|++|++... ...+.+.+|+.++++++||||+++++++.. ....+++||
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 56899999999999986 45889999988633 112457789999999999999999999875 357899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++++|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 87 YMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 999999999997543 47888899999999999999994 5599999999999999999999999999875432
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
....+..|+|||.+ ....++.++|||||||++|||+||+.||..... ...+.......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--~~~~~~~~~~~---- 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVI-------SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--MAAIFKIATQP---- 225 (266)
T ss_pred ccccCCccccCCccccccCHHHh-------CCCCCCchhhhHHHHHHHHHHHHCCCCccccch--HHHHHHHhcCC----
Confidence 12346689999964 344567899999999999999999999974321 11111111100
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+.. +....+.. .++ ..||..+|++||+|.||++
T Consensus 226 -~~~~~--~~~~~~~~---~~l-i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQL--PSHISEHA---RDF-LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCC--chhcCHHH---HHH-HHHhcCChhhCcCHHHHhc
Confidence 00111 11112222 223 3688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=293.87 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=186.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|..+ +++.||+|.+.... ..+.+.+|+++++.++||||+++++++..++..++||||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 467999999999999975 58899999876542 2346778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.++..... .++|..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++.....
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 86 VLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred HHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9988775432 47899999999999999999995 4599999999999999999999999999876532
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccc----cccc--
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA----WEVF-- 560 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~-- 560 (640)
....+..|+|||++. ....++.++|||||||++|||++|+.||..... ...+.+........ ....
T Consensus 158 ~~~~~~~~y~aPE~~~------~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 158 TDYVATRWYRAPELLV------GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred CcccceeeccCcHHhc------cccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhcc
Confidence 123467899999752 223456789999999999999999999864321 11111111000000 0000
Q ss_pred --------chhhccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 --------DFELIMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 --------d~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+....... .......+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 0122346788899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=293.19 Aligned_cols=248 Identities=20% Similarity=0.368 Sum_probs=186.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccc-------hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK-------KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|... +++.||||.++.... ...+..|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 457999999999999964 688999999875422 234567899999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
+|+|.+++.... ..+++..+..++.|+++||+|||+ .+|+|+||||+||+++.++.+||+|||+++.....
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 899999997543 258999999999999999999995 45999999999999999999999999998876432
Q ss_pred -----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHH---hhcc-cccc--
Q 006559 489 -----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQM---MGQD-ESAW-- 557 (640)
Q Consensus 489 -----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~-~~~~-- 557 (640)
...+..|+|||.+. ....++.++|||||||++|||++|.+||.... ......+. .... ...+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~------~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLF------GARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred ccccccccceeeeCHHHHh------CCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHHHHHHHHcCCCchhhhhh
Confidence 12356799999652 23456789999999999999999987776432 11111111 1000 0000
Q ss_pred -----cccchhhcc----ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 -----EVFDFELIM----DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 -----~~~d~~~~~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......... .........++.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000 0001122356788899999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=291.69 Aligned_cols=249 Identities=20% Similarity=0.332 Sum_probs=183.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++|+||+++++++...+..++||||++ ++
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TD 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CC
Confidence 467999999999999965 67899999986542 23456679999999999999999999999999999999998 49
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++..... .+++.....++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 89 L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 89 LKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence 9998875432 57889999999999999999994 5599999999999999999999999999865431
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHH---HHhhc-cccccc-----
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWV---QMMGQ-DESAWE----- 558 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~---~~~~~-~~~~~~----- 558 (640)
....+..|+|||++.+ ...++.++|||||||++|||++|+.||.........+. +.... ....+.
T Consensus 162 ~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 162 NEVVTLWYRPPDVLLG------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred ccccccccCCcHHhhc------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1224667999996532 23467899999999999999999999965431111110 00000 000000
Q ss_pred --ccc--hhhccChHHH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 --VFD--FELIMDKEME------EEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 --~~d--~~~~~~~~~~------~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... .......... ....++.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000000 01145678889999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=286.60 Aligned_cols=236 Identities=25% Similarity=0.353 Sum_probs=185.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|... ++..|++|.+.... ..+.+..|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 467999999999999975 78899999886432 2356778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
++++|.+++.... ++++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.+||+|||++.....
T Consensus 85 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 85 PGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999997542 47899999999999999999995 4599999999999999999999999999876432
Q ss_pred ---CccccccccCCccccCCCCccccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQR-KFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~-~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...++..|++||... .. .++.++|||||||++|||++|+.||..... ...............
T Consensus 157 ~~~~~~~~~~y~~pe~~~-------~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~----- 222 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIA-------QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIGRSKELPP----- 222 (258)
T ss_pred cccccCCCcceeCHHHhc-------CCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHHhcccCCC-----
Confidence 233567799999642 22 367889999999999999999999975431 111111111000000
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ....++.+++.+||+.+|++||++.+++.
T Consensus 223 --~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 --IPD---HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --cCC---CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011 11234566788899999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=292.73 Aligned_cols=249 Identities=21% Similarity=0.296 Sum_probs=178.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhc---cCCCcccceeEEEEc-----CCeEEE
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGG---LRHSNIVSIRAYCNG-----KDELFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~---l~H~niv~l~~~~~~-----~~~~~l 404 (640)
.+.||+|+||.||+|+.. +++.||+|.++... ....+.+|+++++. ++||||+++++++.. ....++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 457999999999999864 68899999987531 22345566665554 479999999998864 245899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
||||++ ++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 85 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 85 VFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 999998 489888875431 247899999999999999999995 4599999999999999999999999999876
Q ss_pred cCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhccc---
Q 006559 485 FHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDE--- 554 (640)
Q Consensus 485 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~--- 554 (640)
... ...++..|+|||++. ...++.++|||||||++|||++|++||...... ..+.........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccCcccCCCccccccccCchHhh-------CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 542 234577899999753 345778999999999999999999998643221 111111111000
Q ss_pred cccc------ccchhhcc--ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 555 SAWE------VFDFELIM--DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 555 ~~~~------~~d~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... .+...... .....+...++.+++.+|++.||++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00000000 0000112345678888999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=295.10 Aligned_cols=236 Identities=17% Similarity=0.281 Sum_probs=184.4
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..||+|+||.||++.. .++..||+|.+... ...+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 3699999999999985 46889999998644 33456778899999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------Cc
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------PF 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~~ 489 (640)
+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 107 ~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 107 DIVSQT------RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred HHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 987542 47899999999999999999994 4599999999999999999999999999875432 23
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.++..|+|||++ ....++.++|||||||++|||++|+.||...... ...+........ ......
T Consensus 178 ~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~------~~~~~~- 241 (297)
T cd06659 178 VGTPYWMAPEVI-------SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPP------KLKNAH- 241 (297)
T ss_pred ecCccccCHHHH-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCC------CccccC-
Confidence 457789999965 3345678999999999999999999998643211 111111111000 000001
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
.....+.+++..||+.+|++||++.++++.
T Consensus 242 --~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 --KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 112345677888999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=292.96 Aligned_cols=247 Identities=21% Similarity=0.290 Sum_probs=184.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-chHHHHHHHHHHhcc-CCCcccceeEEEE-----cCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-KKREVDEWLRVIGGL-RHSNIVSIRAYCN-----GKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~e~~~l~~l-~H~niv~l~~~~~-----~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+++. .+++.+|+|.+.... ...++..|+.+++++ +||||+++++++. ..+..++||||+
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 46799999999999985 457889999886542 345677888999998 6999999999884 345689999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
++|+|.++++.... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 103 NGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred CCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 99999998764321 12257888999999999999999994 4599999999999999999999999999876532
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...++..|+|||++.... .....++.++|||||||++|||+||+.|+..... .....+. ... ..+.
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~~~~~-~~~------~~~~ 248 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQ--QLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRALFKI-PRN------PPPT 248 (286)
T ss_pred CccccccCCCcccChhhhchhh--hccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHHHhhc-ccc------CCCc
Confidence 123577899999753211 1234577899999999999999999999864321 1111110 000 0000
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
..... ....++.+++.+||+.+|++||++.|+++.
T Consensus 249 ~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 249 LHQPE---LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccCCC---CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 10011 112346778889999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=289.78 Aligned_cols=244 Identities=22% Similarity=0.374 Sum_probs=186.9
Q ss_pred hccccccCcceEEEEEeC------CCcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD------GGDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
...||+|+||.||+|+.. +...|++|.+..... ..++..|++++++++|+||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 456999999999999864 245789998865533 35688899999999999999999999988999999999
Q ss_pred cCCCCHHHhhccCCCCC----CCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 409 LPHGSLHSLLHGSRGPG----RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||+++.
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccccc
Confidence 99999999997544111 1258999999999999999999995 4599999999999999999999999999865
Q ss_pred cCC-------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccc
Q 006559 485 FHT-------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESA 556 (640)
Q Consensus 485 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 556 (640)
... ....+..|+|||.+ ....++.++|||||||++|||++ |..||..... ...+.........
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~-------~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~~~~~~~ 237 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAV-------QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRLQAGKLE 237 (275)
T ss_pred cCcccccccCCceeEEeecChhhh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHHHcCCcC
Confidence 422 12235569999964 23345678999999999999999 7888853211 1111111111100
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
+. ... .....+.+++.+||+.+|++||++.+++..|.
T Consensus 238 ~~-------~~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LP-------VPE---GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC-------CCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 10 011 12235777888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=286.81 Aligned_cols=237 Identities=22% Similarity=0.367 Sum_probs=187.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+++. .++..||+|.+... ...+++.+|++++++++||||+++.+++...+..++||||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 56799999999999985 46789999998643 23356788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 85 DLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 99999875431 247889999999999999999995 46999999999999999999999999998766432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||++ .....+.++|||||||+++||+||+.||..... ...+....... . +. .
T Consensus 159 ~~~~~~~~~~~pe~~-------~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~~~~-~-----~~--~ 221 (256)
T cd08218 159 RTCIGTPYYLSPEIC-------ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLVLKIIRGS-Y-----PP--V 221 (256)
T ss_pred hhccCCccccCHHHh-------CCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--HHHHHHHhcCC-C-----CC--C
Confidence 2346679999964 334567899999999999999999999874322 11121111110 0 00 0
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. .....++.+++.+||+.+|++||+|.+|++
T Consensus 222 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 S---SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred c---ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 122345677888899999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=307.30 Aligned_cols=180 Identities=18% Similarity=0.241 Sum_probs=152.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||+++.. .++.||||.... ..+.+|++++++++|+|||++++++...+..++||||+. ++|.+
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~ 248 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYT 248 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEecccc----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHH
Confidence 467999999999999965 467899996432 235678999999999999999999999999999999995 78988
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--------C
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--------P 488 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--------~ 488 (640)
++.... ..++|..++.++.|+++||+|||+ .+||||||||+|||++.++.+||+|||+++.... .
T Consensus 249 ~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 249 YLGARL----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 886532 258999999999999999999995 4599999999999999999999999999876532 1
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
..+|..|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 322 ~~GT~~Y~APE~~-------~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 322 IAGTVDTNAPEVL-------AGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cCCCcCCcCHHHH-------cCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 2468899999965 3345778999999999999999987654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=290.09 Aligned_cols=241 Identities=27% Similarity=0.445 Sum_probs=185.7
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEeccccchH----HHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRERKKKR----EVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||+||+++... ++.+|+|.+....... ....|+..+++++||||+++++++......++||||++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 4679999999999999655 5689999998763222 2345889999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC------
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------ 486 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------ 486 (640)
+|.+++.... .+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||.+....
T Consensus 84 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 84 SLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp BHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred cccccccccc-----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999998322 589999999999999999999954 59999999999999999999999999987521
Q ss_pred CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhcccccccccchhhc
Q 006559 487 TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
.....+..|+|||+.. ....++.++||||+|+++|||++|+.||..... +............ ......
T Consensus 156 ~~~~~~~~y~aPE~~~------~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 224 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQ------QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-----LPSSSQ 224 (260)
T ss_dssp SSSSSSGGGSCHHHHT------TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-----HHHHTT
T ss_pred cccccccccccccccc------ccccccccccccccccccccccccccccccccchhhhhhhhhccccc-----cccccc
Confidence 2334578899999642 245678899999999999999999999975411 1111111100000 000000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........+.+++..||+.||++||++.++++
T Consensus 225 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011256788888999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=278.32 Aligned_cols=238 Identities=19% Similarity=0.258 Sum_probs=182.8
Q ss_pred HhhccccccCcceEEEEE-eCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 336 SSAELLGKGCVGATYKVV-LDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 336 ~~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
...++||+|.|+.||++. .+.|+.+|+|.+..+ ...+++++|+++.+.|+|||||+|.+.+.+....|||+|+|.
T Consensus 14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~ 93 (355)
T KOG0033|consen 14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 93 (355)
T ss_pred hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEeccc
Confidence 346789999999999987 466888888887644 345778899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCC
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHT 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~ 487 (640)
+|+|..-+-.. ..+++...-.++.||.++|.|+|. .+|||||+||+|+||.. .--+|++|||++..+..
T Consensus 94 G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 94 GGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred chHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99997544321 245666777789999999999995 45999999999999953 34689999999988764
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC-CcchHHHHHHhhcccccccccc
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG-ELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~d 561 (640)
...+|++|||||++ ....|+..+|||+-||+||-|+.|.+||.++ ...+.+-+.... .|
T Consensus 166 g~~~~G~~GtP~fmaPEvv-------rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~--------yd 230 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVL-------KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA--------YD 230 (355)
T ss_pred ccccccccCCCcccCHHHh-------hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc--------cC
Confidence 24679999999975 4456678899999999999999999999863 322322111100 11
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
..- ++++....+..+++.+|+..||++|.|+.|++
T Consensus 231 ~~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 231 YPS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CCC---cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 111 11222223345566779999999999988765
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=296.42 Aligned_cols=241 Identities=18% Similarity=0.232 Sum_probs=186.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||++... .++.||+|.+.... ....+.+|+++++.++||||+++++.+...+..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 467999999999999864 46789999987542 234567889999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 86 GDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999997543 57888999999999999999995 4599999999999999999999999999864210
Q ss_pred -----------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHh
Q 006559 488 -----------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM 550 (640)
Q Consensus 488 -----------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 550 (640)
...++..|+|||.+ ....++.++|||||||++|||+||+.||.+.... ++.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~~~~ 228 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVI-------LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQV 228 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhc-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 11235679999964 3345778999999999999999999999743221 111111
Q ss_pred hcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHH
Q 006559 551 GQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604 (640)
Q Consensus 551 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 604 (640)
..... ..+.. . .....++.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~~----~~~~~--~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDDI----EWPEG--D---EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhccc----CCCCc--c---ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11100 00000 0 0123346778888999999999998877777766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=300.35 Aligned_cols=247 Identities=19% Similarity=0.293 Sum_probs=181.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 406 (640)
.+.||+|+||.||+|.. .++..||||++.... ..+.+.+|++++++++||||+++++++... ...|+++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 46799999999999985 567889999987541 234566899999999999999999887543 3579999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 100 ~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 100 NLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 988 77998887642 48899999999999999999995 459999999999999999999999999988764
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhccc-ccc-cc
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDE-SAW-EV 559 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~-~~~-~~ 559 (640)
. ...++..|+|||++.+ ...++.++|||||||++|||++|+.||...... +..+........ ... .+
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 170 DEMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred CCcCCccccccccCchHhcC------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 3 2356889999997532 235678999999999999999999999753211 111111111100 000 00
Q ss_pred cc-------hhh--ccChHHH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FD-------FEL--IMDKEME----EEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d-------~~~--~~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ..+ ....... .....+.+++.+|++.||++|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000 0000000 01124678888999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=288.12 Aligned_cols=244 Identities=20% Similarity=0.326 Sum_probs=185.5
Q ss_pred hccccccCcceEEEEEeCC--CcEEEEEEecccc------------chHHHHHHHHHHh-ccCCCcccceeEEEEcCCeE
Q 006559 338 AELLGKGCVGATYKVVLDG--GDVVVVKRIRERK------------KKREVDEWLRVIG-GLRHSNIVSIRAYCNGKDEL 402 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~--~~~vavK~l~~~~------------~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~ 402 (640)
.+.||+|+||.||+|.... +..+|+|.+.... ...++..|+.++. .++||||+++++++...+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 5679999999999999765 6789999875321 1133556777665 47999999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 403 FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 403 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999998753221 12358889999999999999999995 245999999999999999999999999998
Q ss_pred cccCCC-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccc
Q 006559 483 QLFHTP-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 483 ~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
...... ..++..|++||.+ ....++.++||||||+++|||++|+.||..... ........... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~-------~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~-~~ 231 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIV-------KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLATKIVEAV-YE 231 (269)
T ss_pred eecccccccccccCcccCcChhhh-------cCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HHHHHHHhhcc-CC
Confidence 765432 3346789999964 334577899999999999999999999864322 22222211110 00
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
.. .. ......+.+++.+||+.||++||++.||..+++
T Consensus 232 ~~------~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PL------PE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC------Cc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 00 012235677888899999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=285.08 Aligned_cols=237 Identities=22% Similarity=0.379 Sum_probs=184.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++.. +++.||+|++... ...+.+.+|++++++++|+|++++.+.+.. ....++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 467999999999999854 5778999998643 223457788999999999999999998764 4468999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
++|.+++..... ..+++.++..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 85 GDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred CcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 999999975421 257899999999999999999994 56999999999999999999999999998765421
Q ss_pred ---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 489 ---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 489 ---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
..++..|+|||+. ....++.++|||||||+++||++|+.||...+. ..+....... .. +.
T Consensus 159 ~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~-~~-----~~-- 221 (257)
T cd08223 159 ASTLIGTPYYMSPELF-------SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--NSLVYRIIEG-KL-----PP-- 221 (257)
T ss_pred cccccCCcCccChhHh-------cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhc-CC-----CC--
Confidence 2346789999964 344567899999999999999999999875332 1221111111 00 00
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ......+.+++.+|++.+|++||++.++++
T Consensus 222 ~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 MP---KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred Cc---cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 01 122235677888899999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.67 Aligned_cols=241 Identities=22% Similarity=0.341 Sum_probs=185.6
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|+.. +++.||+|.+... ...+++.+|+++++.++||||+++.++|...+..++||||++
T Consensus 19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 3567999999999999864 6889999988643 122457789999999999999999999999999999999997
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--C
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--P 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--~ 488 (640)
|++.+++.... .++++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++..... .
T Consensus 99 -g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 99 -GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred -CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 67777765432 258899999999999999999995 4599999999999999999999999999876543 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
...+..|+|||++... ....++.++|||||||++|||+||+.||....... ........+. +.. .
T Consensus 171 ~~~~~~y~aPE~~~~~----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~------~~~-~-- 235 (307)
T cd06607 171 FVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNDS------PTL-S-- 235 (307)
T ss_pred ccCCccccCceeeecc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcCCC------CCC-C--
Confidence 3456789999975321 23457789999999999999999999986432111 1111111000 000 0
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
.......+.+++.+||+.+|++||+|.+++..
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 -SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11233457788889999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=303.86 Aligned_cols=246 Identities=17% Similarity=0.245 Sum_probs=181.8
Q ss_pred hhccccccCcceEEEEEeCC---CcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVLDG---GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||.||++...+ +..||||.+... +...+|++++++++|||||++++++......++||||+. ++
T Consensus 96 i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 171 (392)
T PHA03207 96 ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CD 171 (392)
T ss_pred EEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CC
Confidence 35679999999999997543 467899987643 335678999999999999999999999999999999996 68
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 172 l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 172 LFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 888884332 58999999999999999999995 4599999999999999999999999999876532
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-----hHHHHHHhhccccccc--
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-----IVKWVQMMGQDESAWE-- 558 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~-- 558 (640)
...+|..|+|||++ ....++.++|||||||++|||++|+.||...... +...++..........
T Consensus 244 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 244 CYGWSGTLETNSPELL-------ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred ccccccccCccCHhHh-------cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 13468899999965 3345678999999999999999999998643221 1111111111000000
Q ss_pred --------------ccchhhccChHH--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 559 --------------VFDFELIMDKEM--EEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 559 --------------~~d~~~~~~~~~--~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
...+....+... .....++.+++.+|+..||++||++.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 0112346677888999999999999998764
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=312.31 Aligned_cols=254 Identities=18% Similarity=0.245 Sum_probs=179.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-cchHHHHHHHHHHhccCC------CcccceeEEEEcC-CeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-KKKREVDEWLRVIGGLRH------SNIVSIRAYCNGK-DELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H------~niv~l~~~~~~~-~~~~lV~E 407 (640)
..++||+|+||+||+|+. ..++.||||+++.. ...++...|+++++.++| .+++++.+++... ...|+|||
T Consensus 133 i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~ 212 (467)
T PTZ00284 133 ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP 212 (467)
T ss_pred EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence 356899999999999985 45788999999653 233445556666665544 5588888888764 57899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC---------------
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG--------------- 472 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~--------------- 472 (640)
++ +++|.+++.... .+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 213 ~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 213 KY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred cc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 88 678988887543 588999999999999999999952 4699999999999998765
Q ss_pred -CeEEccCCcccccC---CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHH
Q 006559 473 -NACISDIGVHQLFH---TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWV 547 (640)
Q Consensus 473 -~~kl~DfGl~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~ 547 (640)
.+||+|||.+.... ....+|..|+|||++. ...++.++|||||||++|||+||+.||..... .....+
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~-------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVL-------GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhh-------cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 49999999876532 2345688999999753 34577899999999999999999999975332 111111
Q ss_pred -HHhhccccc----------ccc----------cchhhc----cChHHH--HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 548 -QMMGQDESA----------WEV----------FDFELI----MDKEME--EEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 548 -~~~~~~~~~----------~~~----------~d~~~~----~~~~~~--~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+..+..... ..+ .++... ...... .....+.+++..||..||++|||+.|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 111100000 000 000000 000000 01235678999999999999999999975
Q ss_pred --HHHHh
Q 006559 601 --MIEDI 605 (640)
Q Consensus 601 --~L~~i 605 (640)
.+.+.
T Consensus 438 Hp~~~~~ 444 (467)
T PTZ00284 438 HPYVLKY 444 (467)
T ss_pred Ccccccc
Confidence 45443
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=304.41 Aligned_cols=236 Identities=22% Similarity=0.363 Sum_probs=183.9
Q ss_pred HhhccccccCcceEEEEEeC-CCcEEE---EEEec---cccchHHHHHHHHHHhccCCCcccceeEEEEcCCe--EEEEE
Q 006559 336 SSAELLGKGCVGATYKVVLD-GGDVVV---VKRIR---ERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDE--LFLVY 406 (640)
Q Consensus 336 ~~~~~iG~G~fg~Vy~~~~~-~~~~va---vK~l~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lV~ 406 (640)
.+.++||+|+|-+||||... .|..|| ||.-. .....+.|.+|+++|+.|+|||||+++.++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34678999999999999853 466666 33211 11233568899999999999999999999987654 88899
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccCCccccc
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGVHQLF 485 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl~~~~ 485 (640)
|.|..|+|+.|+++.+ .++.+...++++||.+||.|||+. .|||||||||-.||+|+ ..|.+||+|+|||...
T Consensus 123 EL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 9999999999998776 467788999999999999999997 57899999999999998 5689999999999887
Q ss_pred CC----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhc---cccccc
Q 006559 486 HT----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQ---DESAWE 558 (640)
Q Consensus 486 ~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~ 558 (640)
.. ..++|+.|||||+. ...|++.+||||||+.++||+|+..||.+-. +.++.-+.+.. ......
T Consensus 197 r~s~aksvIGTPEFMAPEmY--------EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 197 RKSHAKSVIGTPEFMAPEMY--------EENYNELVDVYAFGMCMLEMVTSEYPYSECT-NPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred hccccceeccCccccChHHH--------hhhcchhhhhhhhhHHHHHHHhccCChhhhC-CHHHHHHHHHcCCCHHHhhc
Confidence 54 34789999999952 3678899999999999999999999997532 22222222221 111111
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+-| .++.+++-.|+.. .++|||+.|++.
T Consensus 268 V~d-------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VKD-------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cCC-------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111 2355566779999 899999988864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.85 Aligned_cols=235 Identities=21% Similarity=0.361 Sum_probs=186.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||.|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++|+||+++.+++.+....++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 457999999999999964 57889999986542 23467789999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|.+++... ++++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++.....
T Consensus 86 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 86 CLDLLKPG------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 99998753 57899999999999999999994 55999999999999999999999999998776432
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..++..|+|||++ ....++.++|||||||++|||+||+.||..... ........... .+.+..
T Consensus 157 ~~~~~~~y~~PE~~-------~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~------~~~~~~- 220 (274)
T cd06609 157 TFVGTPFWMAPEVI-------KQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--MRVLFLIPKNN------PPSLEG- 220 (274)
T ss_pred cccCCccccChhhh-------ccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--HHHHHHhhhcC------CCCCcc-
Confidence 2346679999964 334477899999999999999999999964331 11111111110 001000
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ....++.+++.+||..+|++||+++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 02234667888899999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=289.70 Aligned_cols=236 Identities=19% Similarity=0.242 Sum_probs=177.2
Q ss_pred cccccCcceEEEEEe-CCCcEEEEEEecccc----c-hHHHHHHH---HHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 340 LLGKGCVGATYKVVL-DGGDVVVVKRIRERK----K-KREVDEWL---RVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~-~~~~~~e~---~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
+||+|+||.||++.. .++..+|+|.+.... . ...+.+|. +++...+||||+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999996 458899999886541 1 12233333 34445579999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 999999987543 58999999999999999999995 4599999999999999999999999999875432
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...++..|+|||... ....++.++|||||||++|||+||+.||................. .+.. .
T Consensus 153 ~~~~~~~~y~aPE~~~------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~~~--~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQ------KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------VNVE--L 218 (279)
T ss_pred cCcCCCcCccCHHHhc------CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc------CCcC--C
Confidence 234578999999642 134567899999999999999999999975332222222111110 0000 1
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
+.. ...++.+++..|+..||++|| +++|+++
T Consensus 219 ~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 219 PDS---FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ccc---cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 111 223466677889999999999 5777755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.25 Aligned_cols=239 Identities=27% Similarity=0.407 Sum_probs=188.0
Q ss_pred hccccccCcceEEEEEeCC-----CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLDG-----GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+++..+ +..||+|.+.... ..+.+..|++.++.++|+||+++++++...+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4679999999999999654 3789999997653 3457888999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 84 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 84 EGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred CCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999975431 127899999999999999999994 46999999999999999999999999998765432
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
...+..|+|||.. ....++.++||||+||+++||++ |+.||.... .....+........
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~-------~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~----- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESL-------KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEYLKKGYRL----- 223 (258)
T ss_pred ccccccCCCcccccChHHh-------ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCCC-----
Confidence 1234679999954 34556789999999999999999 788886422 12222222111100
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
... .....++.+++.+|+..+|++|||+.++++.|
T Consensus 224 ---~~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PKP---ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCC---CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 11234577788899999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=297.07 Aligned_cols=193 Identities=21% Similarity=0.291 Sum_probs=161.0
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||.||+++... +..+|+|.+.+. .....+.+|+.++..++|+||+++++++...+..|+||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 4679999999999999654 678999998643 1223467888899999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.++++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 86 GDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999975321 47888899999999999999994 5699999999999999999999999999865421
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
...+|..|+|||++.... .....++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAME--DGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred eecccccCccccCHHHHhccc--cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 134688999999764221 11345778999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=302.35 Aligned_cols=244 Identities=18% Similarity=0.274 Sum_probs=180.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 406 (640)
.+.||+|+||.||++.. ..++.||||++... ...+.+.+|+.+++.++||||+++++++... ...|+||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 56799999999999985 45788999998753 2235567889999999999999999987643 3579999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++ +|.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 109 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 109 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred eCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 99975 77777642 36788899999999999999994 569999999999999999999999999998654
Q ss_pred C-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccc----cc
Q 006559 487 T-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDES----AW 557 (640)
Q Consensus 487 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~ 557 (640)
. ...++..|+|||++ ....++.++|||||||++|||+||+.||..... ...|.+....... ..
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCcccCCcccCCcCCHHHH-------hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence 3 23557899999975 334577899999999999999999999975321 1111111110000 00
Q ss_pred cccc----------------------hhhcc--Ch-HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVFD----------------------FELIM--DK-EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~d----------------------~~~~~--~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... +.... +. .......++.+++.+|++.||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 00000 00 00011235678889999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.19 Aligned_cols=245 Identities=20% Similarity=0.292 Sum_probs=181.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHH-HHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLR-VIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+++.. +|..||+|+++... ....+..|+. .++.++||||+++++++...+..|+||||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 467999999999999965 58999999987542 2233444544 4667789999999999999999999999997 6
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++...... ...+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (283)
T cd06617 85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT 161 (283)
T ss_pred cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 888887653321 23689999999999999999999953 26999999999999999999999999998765321
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..++..|+|||++.+. .....++.++|||||||++|||++|+.||.............. ... .+....
T Consensus 162 ~~~~~~~y~aPE~~~~~---~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~------~~~~~~- 230 (283)
T cd06617 162 IDAGCKPYMAPERINPE---LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEP------SPQLPA- 230 (283)
T ss_pred cccCCccccChhhcCCc---ccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcC------CCCCCc-
Confidence 2346789999975432 1124567899999999999999999999964222111111111 000 001100
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....++.+++..||+.+|++||++.++++
T Consensus 231 ---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 ---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 012235677888899999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.90 Aligned_cols=181 Identities=20% Similarity=0.324 Sum_probs=151.0
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|+.. .+..||+|...... ...|+.++++++||||+++++++...+..++||||+. |+|.
T Consensus 70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~ 144 (357)
T PHA03209 70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT----TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLY 144 (357)
T ss_pred EEEEecCCCCeEEEEEEECCCCceEEEEeCCccc----cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHH
Confidence 3568999999999999965 46788998754332 3457889999999999999999999999999999995 6898
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----Ccc
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-----PFF 490 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-----~~~ 490 (640)
+++.... .++++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 145 ~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 145 TYLTKRS----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 8886533 258999999999999999999995 4599999999999999999999999999875322 234
Q ss_pred ccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 491 INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 491 ~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
++..|+|||++ ....++.++|||||||++|||+++..|+
T Consensus 218 gt~~y~aPE~~-------~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 218 GTVETNAPEVL-------ARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccCCeec-------CCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 57889999964 3445778999999999999999965443
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.95 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=184.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----c-------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----K-------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 404 (640)
.+.||+|+||.||+|.. .+++.||+|.++.. . ..+.+..|+.++++++||||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 46799999999999985 46889999987532 0 01346778999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
||||+++|+|.+++.... ++++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++++|||+++.
T Consensus 86 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999997642 57888999999999999999995 4599999999999999999999999999876
Q ss_pred cCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccc
Q 006559 485 FHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA 556 (640)
Q Consensus 485 ~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 556 (640)
.... ..++..|+|||++... ...++.++||||||+++||+++|+.||...... ..+.+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSY-----SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-AAMFKLGNKR-SA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-HHHHHhhccc-cC
Confidence 5321 2346689999975321 124678999999999999999999999643221 1111111110 00
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+.... ..+....+.+++..||+.+|++||++.+|++
T Consensus 231 -~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 -PPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -CcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0011110 1122345677788899999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=284.73 Aligned_cols=236 Identities=20% Similarity=0.368 Sum_probs=186.1
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|.. .++..||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred hheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 356799999999999985 467889999876442 2346778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++... .+++.....++.|++.|+.||| ..+++|+||||+||+++.++.++|+|||+++.....
T Consensus 88 ~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 88 SALDLLEPG------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 999998643 4789999999999999999999 456999999999999999999999999998765432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||.. ....++.++|||||||++|||++|+.||..... ..+......... +. .
T Consensus 159 ~~~~~~~~y~~PE~~-------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~------~~--~ 221 (277)
T cd06641 159 NTFVGTPFWMAPEVI-------KQSAYDSKADIWSLGITAIELAKGEPPHSELHP--MKVLFLIPKNNP------PT--L 221 (277)
T ss_pred ccccCCccccChhhh-------ccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--HHHHHHHhcCCC------CC--C
Confidence 2346789999964 334567899999999999999999999864321 112211111100 00 0
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
. .....++.+++.+||+.+|++||++.++++.
T Consensus 222 ~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 E---GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred C---cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 1122346677888999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=291.19 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=184.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-chHHHHHHHHHHhcc-CCCcccceeEEEEcC-----CeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-KKREVDEWLRVIGGL-RHSNIVSIRAYCNGK-----DELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-----~~~~lV~Ey~ 409 (640)
.+.||+|+||.||++.. .+++.+|+|.+.... ...++.+|+.++.++ +|||++++++++... +..++||||+
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 46799999999999986 568889999987542 345677888888888 899999999998753 3589999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
++|+|.++++.... ....+++..+..++.|++.||+|||. .+|+||||||+||++++++.+||+|||+++....
T Consensus 107 ~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 107 NGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 99999998864321 12257899999999999999999994 5699999999999999999999999999876432
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...++..|+|||++.... .....++.++|||||||++|||++|+.||...... .-+...... ....+.+
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~~~~~-~~~~~~~-- 255 (291)
T cd06639 183 LRRNTSVGTPFWMAPEVIACEQ--QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFKIPRN-PPPTLLH-- 255 (291)
T ss_pred ccccCccCCccccChhhhcCCC--CcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHHHhcC-CCCCCCc--
Confidence 223467899999753321 11234678999999999999999999998643211 101011000 0000101
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. .+....+.+++.+||+.+|++||++.++++
T Consensus 256 ---~---~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 256 ---P---EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---c---cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 122235777888999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.23 Aligned_cols=193 Identities=19% Similarity=0.272 Sum_probs=160.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++.. ++..||+|.+... .....+.+|..++..++|+||+++++++...+..|+||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999965 5778999998653 1223467788899999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++.... ..+++.....++.|++.||+||| ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 86 GDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999997532 14788889999999999999999 456999999999999999999999999998765421
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
..++..|+|||++.... .....++.++|||||||++|||+||+.||...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAME--DGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred eeccccCCcccCCHHHHhccc--cCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 24688999999753211 01135678999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=287.86 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=180.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|.. .++..||+|.+.... ....+.+|+++++.++|+||+++.+++...+..|+||||++ ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 46799999999999985 468899999986542 22456788999999999999999999999999999999996 67
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
+.+++.... ..+.+..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 89 LAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 777765432 146778888899999999999995 4599999999999999999999999999875422
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHH---hhc-ccccccc----
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQM---MGQ-DESAWEV---- 559 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~---~~~-~~~~~~~---- 559 (640)
....+..|+|||++.+ ...++.++|||||||++|||+||+.||...........+. ... ....+..
T Consensus 162 ~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 162 SEVVTLWYRPPDVLLG------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CccccccccCCceeec------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1234678999996532 2345678999999999999999999997432211111110 000 0000000
Q ss_pred --cchhhc---cChHHH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 --FDFELI---MDKEME------EEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 --~d~~~~---~~~~~~------~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...... ...... .....+.+++.+|++.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 000000 01235667888899999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=283.36 Aligned_cols=243 Identities=20% Similarity=0.298 Sum_probs=187.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||++.. .++..+|+|.+... ...+.+..|++++++++||||+++++++.. ....+++|||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 45799999999999985 46788999988643 223457788999999999999999998764 456899999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--CCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN--KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+++|.+++..... ...++++...+.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 9999999875421 1236899999999999999999999443 45699999999999999999999999999887543
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...++..|+|||++ ....++.++||||||+++|+|++|+.||.... .....+...... . +
T Consensus 164 ~~~~~~~~~~~~~~~pE~~-------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~-----~ 228 (265)
T cd08217 164 SSFAKTYVGTPYYMSPEQL-------NHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGK-F-----R 228 (265)
T ss_pred cccccccccCCCccChhhh-------cCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCC-C-----C
Confidence 22457789999964 33456789999999999999999999997543 222222211110 0 0
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
. .. .....++.+++.+|++.+|++||++.+|++.
T Consensus 229 ~--~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 R--IP---YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C--Cc---cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 11 1223457788889999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=287.96 Aligned_cols=250 Identities=20% Similarity=0.330 Sum_probs=184.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. ++..||||.+.... ....+..|++++++++||||+++++++...+..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 457999999999999864 68899999887542 23467889999999999999999999999999999999996 6
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++..... ..+++..+..++.|++.||+|||. .+++||||+|+||++++++.+||+|||+++.....
T Consensus 84 ~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 84 DLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred CHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 89988865432 258899999999999999999994 55999999999999999999999999998765321
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhcccc-cccccch-
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDES-AWEVFDF- 562 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~-~~~~~d~- 562 (640)
...+..|+|||++.+ ...++.++|||||||++|||+||+.||..... ...+..+....... .+...+.
T Consensus 158 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 158 THEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ccccccccccCCeEEec------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 223667999996532 23356789999999999999999999874321 11111221111110 0000000
Q ss_pred ---hh----ccChHH----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ---EL----IMDKEM----EEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ---~~----~~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ...... .....++.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 000000 011234667888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=299.98 Aligned_cols=188 Identities=26% Similarity=0.400 Sum_probs=161.0
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEecccc-chHHHHHHHHHHhccC-C-----CcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRERK-KKREVDEWLRVIGGLR-H-----SNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~e~~~l~~l~-H-----~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..++||+|.||.|.+|. ..+++.||||+++... ..++...|+++|..|+ | -|+|+++++|...++.|||+|.
T Consensus 190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfEL 269 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFEL 269 (586)
T ss_pred EEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehh
Confidence 46789999999999998 4568999999999774 3456678899999887 4 4899999999999999999998
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC--CCeEEccCCcccccC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL--GNACISDIGVHQLFH 486 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~--~~~kl~DfGl~~~~~ 486 (640)
+.. +|+++++.+... .++...+..|+.||+.||.+|| +.+|||+||||+||||.+. ..+||+|||.+....
T Consensus 270 L~~-NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 270 LST-NLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred hhh-hHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 865 999999977643 4888999999999999999999 5569999999999999754 379999999998765
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
. .++.+..|+|||++. +..|+.+.||||||||+.||+||.+-|.+
T Consensus 343 q~vytYiQSRfYRAPEVIL-------GlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 343 QRVYTYIQSRFYRAPEVIL-------GLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred Ccceeeeeccccccchhhc-------cCCCCCccceeehhhhHHhHhcCccccCC
Confidence 4 345688999999864 45677899999999999999999877764
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.96 Aligned_cols=253 Identities=21% Similarity=0.359 Sum_probs=184.9
Q ss_pred hccccccCcceEEEEEeC---CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLD---GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~---~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 407 (640)
.+.||+|+||.||+|+.. .+..||+|.+... ...+.+.+|+.++++++||||+++++++... +..++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 456999999999999964 4789999998763 2345677889999999999999999999987 78999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC----CCCeEEccCCccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ----LGNACISDIGVHQ 483 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~----~~~~kl~DfGl~~ 483 (640)
|+++ ++.+++..........++......++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9975 67776654332222357888999999999999999994 45999999999999999 9999999999987
Q ss_pred ccCCC---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-----------
Q 006559 484 LFHTP---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI----------- 543 (640)
Q Consensus 484 ~~~~~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~----------- 543 (640)
..... ...+..|+|||+.. ....++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLL------GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHh------CCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 65321 23467799999642 22346789999999999999999999997433221
Q ss_pred HHHHHHhhcccc-cc----------c---ccchhhccChHHH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 544 VKWVQMMGQDES-AW----------E---VFDFELIMDKEME-------EEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 544 ~~~~~~~~~~~~-~~----------~---~~d~~~~~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...+..+..... .+ . ............. ....++.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111111111000 00 0 0000000000000 12346788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=283.57 Aligned_cols=240 Identities=24% Similarity=0.371 Sum_probs=188.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||++... +++.+|+|.+.... ..+++.+|++++++++||||+++++++......++|+||+++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS 85 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence 467999999999999975 58889999987652 33567789999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----Cc
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----PF 489 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----~~ 489 (640)
|.+++.... .+++......++.|++.||+|||+ ..+++|+||||+||++++++.+||+|||.+..... ..
T Consensus 86 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 86 LDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred HHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 999997542 257888999999999999999995 15699999999999999999999999999876532 23
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC---cchHHHHHHhhcccccccccchhhcc
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE---LGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..+..|+|||.+ ....++.++|||||||++|||++|+.||.... ......++....... +. .
T Consensus 160 ~~~~~y~~PE~~-------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~--~ 224 (265)
T cd06605 160 VGTSSYMAPERI-------QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------PR--L 224 (265)
T ss_pred cCChhccCHHHH-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC------CC--C
Confidence 456789999964 33467789999999999999999999986432 122222222211110 00 0
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ....++.+++..||..+|++||++.+++.
T Consensus 225 ~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 PSG--KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred Chh--hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 010 12345677888899999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=286.10 Aligned_cols=236 Identities=22% Similarity=0.371 Sum_probs=185.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc---cchHHHHHHHHHHhccC---CCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER---KKKREVDEWLRVIGGLR---HSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|.. .++..||+|.+... ....++.+|+.++++++ |||++++++++......++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 46799999999999995 56889999998654 22355778888888886 9999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
+++|.+++... ++++.....++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++......
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999998643 58899999999999999999994 56999999999999999999999999998765422
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
..++..|+|||.+. ....++.++|||||||++|||++|+.||.... ...+....... ..+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~------~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~--~~~~~~~~~~~------~~~~~ 222 (277)
T cd06917 157 KRSTFVGTPYWMAPEVIT------EGKYYDTKADIWSLGITIYEMATGNPPYSDVD--AFRAMMLIPKS------KPPRL 222 (277)
T ss_pred ccccccCCcceeCHHHhc------cCCccccchhHHHHHHHHHHHHhCCCCCCCCC--hhhhhhccccC------CCCCC
Confidence 23466799999642 22346789999999999999999999997432 11111111100 00111
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. .....++.+++.+||+.||++||++.++++
T Consensus 223 ~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 ED----NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Cc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 10 012345777888999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=285.85 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=186.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-chHHHHHHHHHHhcc-CCCcccceeEEEEcCC------eEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKD------ELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~------~~~lV~Ey 408 (640)
.+.||+|+||.||+|... +++.+++|.+.... ..+.+.+|+.+++++ +|+||+++++++.... ..++||||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 90 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence 567999999999999974 57789999987653 346688899999998 7999999999997544 48999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.....
T Consensus 91 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 91 CGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred CCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 999999998865321 12358899999999999999999994 4599999999999999999999999999875432
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...++..|+|||++.... .....++.++|||||||++|||+||+.||..... .....+. ... ..+
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~-~~~------~~~ 236 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDE--QPDASYDARSDVWSLGITAIELADGKPPLCDMHP-MRALFKI-PRN------PPP 236 (275)
T ss_pred hhhhcCccccccccCHhHhcccc--cccCCccccccHHHhHHHHHHHHhCCCCccccch-HHHHHHh-hcc------CCC
Confidence 233577899999764322 1234567899999999999999999999964221 1111111 100 000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... ......++.+++.+||..||++|||+.++++
T Consensus 237 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 237 TLKS---PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCc---hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 1123345677888899999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=287.62 Aligned_cols=243 Identities=19% Similarity=0.316 Sum_probs=183.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-cchHHHHHHHHHHhcc-CCCcccceeEEEEc------CCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-KKKREVDEWLRVIGGL-RHSNIVSIRAYCNG------KDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|+. ..++.+|+|.+... ....++..|+.++.++ +|+||+++++++.. .+..|+||||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 46799999999999996 56788999988654 2345677788888888 69999999999853 4578999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.....
T Consensus 101 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 101 CGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred CCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 999999999875432 247788888999999999999995 4599999999999999999999999999875432
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...++..|+|||++.... .....++.++|||||||++|||+||+.||...... .. ....... ...
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~--~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~-~~~~~~~------~~~ 244 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDE--NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-RA-LFLIPRN------PPP 244 (282)
T ss_pred ccCCCcccccccccCHhhcCccc--CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-hh-hhhHhhC------CCC
Confidence 233577899999764221 12345678999999999999999999999643211 00 0000000 000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ......++.+++.+||..||++||++.|+++
T Consensus 245 ~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 245 KLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 0122345778888999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=283.99 Aligned_cols=238 Identities=21% Similarity=0.367 Sum_probs=184.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc--------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK--------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+++. .++..||+|.+.... ..+.+..|++.+++++|+||+++++++...+..++||||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999984 668899999986432 234677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHT 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~~ 487 (640)
+++++|.+++.... ++++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||++.....
T Consensus 85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 85 MAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred cCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999997543 57889999999999999999995 4699999999999998776 599999999876542
Q ss_pred C----------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhccccc
Q 006559 488 P----------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQDESA 556 (640)
Q Consensus 488 ~----------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~ 556 (640)
. ..++..|+|||++ ....++.++||||+||++|||++|+.||..... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~-------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVL-------RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-- 227 (268)
T ss_pred ccccCCccccccccccceeCHhHh-------ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--
Confidence 1 2346689999964 234567899999999999999999999964322 1111111100000
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ...+ .....++.+++.+|+..+|++||++.++++
T Consensus 228 ---~~--~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ---TA--PSIP---EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CC--CCCc---hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00 0011 122345677888999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=281.68 Aligned_cols=230 Identities=19% Similarity=0.276 Sum_probs=182.4
Q ss_pred ccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 341 LGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 341 iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
||+|+||.||+++.. ++..+|+|.+.... ..+.+..|+.++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 47889999986532 235678899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----c
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-----F 489 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-----~ 489 (640)
.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||+++..... .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccc
Confidence 99997643 47888999999999999999994 56999999999999999999999999998876432 3
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.++..|++||.+ ....++.++|+||||+++|||++|+.||.....+.....+....... ....+..
T Consensus 153 ~~~~~~~~PE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 218 (262)
T cd05572 153 CGTPEYVAPEII-------LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-------KLEFPNY 218 (262)
T ss_pred cCCcCccChhHh-------cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-------CCCCCcc
Confidence 347789999964 33456789999999999999999999997544323333222221000 0001111
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
...++.+++.+||+.+|++||++
T Consensus 219 ---~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 219 ---IDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred ---cCHHHHHHHHHHccCChhhCcCC
Confidence 13457788888999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=281.27 Aligned_cols=237 Identities=22% Similarity=0.315 Sum_probs=185.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||++.. .+++.+|+|.+... ...+.+..|++++++++||||+++++.+...+..++||||++++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 46799999999999985 46788999998654 22456788999999999999999999999899999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-CCeEEccCCcccccCCC---
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-GNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGl~~~~~~~--- 488 (640)
+|.+++.... ...+++..+..++.|++.||+|||+ .+|+|+||||+||+++++ +.+||+|||+++.....
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 85 TLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 9999997543 2257899999999999999999995 469999999999999855 46899999998866432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||.+ ....++.++|||||||++|||++|+.||...... ..+....... ... .
T Consensus 159 ~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~-~~~-----~-- 221 (256)
T cd08220 159 YTVVGTPCYISPELC-------EGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGT-FAP-----I-- 221 (256)
T ss_pred cccccCCcccCchhc-------cCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHhcC-CCC-----C--
Confidence 2346789999964 3345678999999999999999999999753321 1111111100 000 0
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. .....++.+++..||+.+|++|||+.++++
T Consensus 222 ~---~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 S---DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C---CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 112335677888899999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=288.94 Aligned_cols=237 Identities=21% Similarity=0.324 Sum_probs=184.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||++.. .++..||+|.+... ...+.+..|+.++++++||||+++++++...+..|+|+||+++|+|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 46799999999999985 46788999998643 3345677889999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC------
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------ 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------ 488 (640)
.+++... .+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|||++......
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 104 TDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 9998753 3688899999999999999999 456999999999999999999999999987654321
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|++||.. ....++.++|||||||++||+++|+.||........ +........ +....
T Consensus 175 ~~~~~~y~~PE~~-------~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~~~~~~------~~~~~-- 237 (293)
T cd06647 175 MVGTPYWMAPEVV-------TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNGT------PELQN-- 237 (293)
T ss_pred ccCChhhcCchhh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeehhcCCC------CCCCC--
Confidence 2346679999964 334567899999999999999999999974321110 000000000 00000
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
.......+.+++.+||+.+|++||++.+++..
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 -PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122346678888999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=279.21 Aligned_cols=237 Identities=23% Similarity=0.287 Sum_probs=184.4
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||.|.-|+||++++.+ +..+|+|++.+.. .-...+.|.+||+.++||.++.|++.|..+...|+|||||++
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 4579999999999999876 4789999997651 223455678899999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc------
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF------ 485 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~------ 485 (640)
|+|+..++.+.+ ..++......++.+|..||+||| -.+||.|||||+||||.++|++.|+||-|+...
T Consensus 162 GdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 162 GDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred ccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999987653 25888889999999999999999 556999999999999999999999999974211
Q ss_pred -------------------------------C-------------------------CCccccccccCCccccCCCCccc
Q 006559 486 -------------------------------H-------------------------TPFFINDAYNAPELKFNNNNNYS 509 (640)
Q Consensus 486 -------------------------------~-------------------------~~~~~~~~y~aPE~~~~~~~~~~ 509 (640)
. ..+++|..|.|||++.
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~------- 308 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR------- 308 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee-------
Confidence 0 0123467899999754
Q ss_pred cCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCC
Q 006559 510 QRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLP 589 (640)
Q Consensus 510 ~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P 589 (640)
+...+.++|+|+|||++|||+.|+.||.+..... .....+.+ .+..+ +..+....+.+++...|.+||
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~NIv~~----------~l~Fp-~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRNIVGQ----------PLKFP-EEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHHHhcC----------CCcCC-CCCcchhHHHHHHHHHhccCh
Confidence 4556678999999999999999999998643221 11112221 11111 112334556677788999999
Q ss_pred CCCCC----HHHHH
Q 006559 590 KDRPN----MSIVH 599 (640)
Q Consensus 590 ~~RPs----~~~v~ 599 (640)
++|-. +.||.
T Consensus 377 ~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhccccchHHhh
Confidence 99987 66664
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=287.59 Aligned_cols=246 Identities=21% Similarity=0.355 Sum_probs=187.8
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+++. .++..||+|.+... .....+..|++++++++|||++++++++...+..++||||++
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 456799999999999995 46789999998643 122457789999999999999999999999999999999997
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--C
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--P 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--~ 488 (640)
|+|.+++.... .+++|..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++..... .
T Consensus 109 -g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (317)
T cd06635 109 -GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180 (317)
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence 58877775432 258899999999999999999994 5599999999999999999999999999876543 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||++.. .....++.++|||||||++|||++|+.||...... ............ ..
T Consensus 181 ~~~~~~y~aPE~~~~----~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~------~~---- 244 (317)
T cd06635 181 FVGTPYWMAPEVILA----MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNESP------TL---- 244 (317)
T ss_pred ccCCccccChhhhhc----CCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhccCC------CC----
Confidence 345778999997532 12345778999999999999999999998643211 111111111000 00
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
........+.+++.+||+.+|++||++.++++..-.+.
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 01122334677888999999999999999987654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=281.61 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=187.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|.. .++..+++|++.... ..+.+.+|+..++.++|+||+++.+.+...+..++||||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 56799999999999995 467889999986542 34567889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|.++++.... ...+++.....++.|++.||+||| ..+|+||||||+||++++++.+||+|||++..+...
T Consensus 86 l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 86 LLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred HHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999975431 125789999999999999999999 456999999999999999999999999998665321
Q ss_pred -----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 489 -----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 489 -----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
..++..|++||++.. ...++.++|||||||++|||++|+.||...... ....+...... +.
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~-------~~ 226 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQ------VHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDP-------PS 226 (267)
T ss_pred cccccccCChhhcChHHHcc------ccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCC-------CC
Confidence 234678999996532 125678999999999999999999999743211 11111111100 01
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.............+.+++..||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111122345677888899999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=285.81 Aligned_cols=248 Identities=20% Similarity=0.348 Sum_probs=186.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+. .++..||+|++.... ....+.+|+.++++++||||+++++++......++||||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 46799999999999996 468899999987542 2456888999999999999999999999999999999999 99
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++.... .++++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 84 DLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999987543 258899999999999999999995 45999999999999999999999999998765432
Q ss_pred ---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhh--cccc--cc----
Q 006559 489 ---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG--QDES--AW---- 557 (640)
Q Consensus 489 ---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~--~~~~--~~---- 557 (640)
..++..|+|||.+. ....++.++||||+||++|||+||++||.... ....+.+... .... .+
T Consensus 157 ~~~~~~~~~y~aPE~~~------~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 157 YSHQVATRWYRAPELLY------GARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred cccccCcccccCceeee------ccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHHHHHHHHcCCCChHHHhhcc
Confidence 23467899999752 23345789999999999999999988876432 1111111111 0000 00
Q ss_pred cccch---------hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVFDF---------ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~d~---------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+..+. .........+....+.+++.+|++.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000 00000001122356778888999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=280.02 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=185.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|... ++..|++|.++... ..+.+..|+.++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 467999999999999864 68899999987552 3456788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 85 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 85 TLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999997542 47888999999999999999994 55999999999999999999999999998765321
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...+..|++||++.... ...++.++||||||+++||+++|+.||....... ......... ..+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~~------~~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGK----GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAG------HKP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCC----CCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhcC------CCC
Confidence 22366899999753221 1236789999999999999999999996432111 111111100 000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... . .......+.+++..||+.+|++||++.+++.
T Consensus 226 ~~~--~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIP--D-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC--c-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 110 0 0111334567888999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.68 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=185.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|... +++.||||.++.. ...+.+.+|++++++++|+||+++.+++...+..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 567999999999999965 5788999988754 22456788999999999999999999999999999999999987
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
.+..+..... .+++.....++.|++.||+|||. .+++|+||+|+||++++++.+||+|||++......
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 86 LLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 7776654322 47889999999999999999994 56999999999999999999999999998765432
Q ss_pred ---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHH-HHHhh-c-----------
Q 006559 489 ---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKW-VQMMG-Q----------- 552 (640)
Q Consensus 489 ---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~-~~~~~-~----------- 552 (640)
...+..|+|||++... ..++.++||||||+++|||++|+.||.........| ..... .
T Consensus 158 ~~~~~~~~~~~~PE~~~~~------~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 158 LTDYVATRWYRAPELLVGD------TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred ccCcccccCCcCCchhcCC------CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 2346779999975321 256789999999999999999999987432211111 10000 0
Q ss_pred ccccccccchhhccChHH-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 553 DESAWEVFDFELIMDKEM-----EEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 553 ~~~~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........-+........ .....++.+++.+||..+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000000000000 012456888899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=287.53 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=183.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccC-CCcccceeEEEEcCCe-----EEEEE
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDE-----LFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~-----~~lV~ 406 (640)
.+.||+|+||.||+|... +++.||+|.++... ....+.+|+.++++++ ||||+++++++...+. .|+||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 467999999999999964 68899999876542 2356778999999995 6999999999887655 89999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCccccc
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLF 485 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~~~ 485 (640)
||+++ +|.+++..........+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.+
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99985 89888865432223468999999999999999999994 56999999999999998 899999999998765
Q ss_pred CCC------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHH---hhcc-cc
Q 006559 486 HTP------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQM---MGQD-ES 555 (640)
Q Consensus 486 ~~~------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~-~~ 555 (640)
... ...+..|+|||++. ....++.++|||||||++|||+||+.||..... .....+. .... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 162 SIPVKSYTHEIVTLWYRAPEVLL------GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-LQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred CCCccccCCcccccCCCChHHhh------CCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHhCCCChh
Confidence 322 23366799999652 223467899999999999999999999874321 1111111 1000 00
Q ss_pred ccc-c---cc---hhhccCh----HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 556 AWE-V---FD---FELIMDK----EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 556 ~~~-~---~d---~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+. . .+ ....... ..+....++.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0 00 0000000 01122345778889999999999999998864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=283.81 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=185.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~~~ 411 (640)
.+.||+|++|.||++... +++.+|+|.+.... ....+.+|++++++++||||++++++|... +..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 467999999999999974 57889999887542 345678899999999999999999998653 478999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
++|.+++..... ....+++.....++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG 161 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccccc
Confidence 999988754221 12357888999999999999999995 5599999999999999999999999999875432
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc---chHHHHHHhhcccccccccchhh
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL---GIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
....+..|+|||.+ ....++.++||||+||++|||+||+.||..... ...+.......... .. .....
T Consensus 162 ~~~~~~~y~~pE~~-------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~ 232 (287)
T cd06621 162 TFTGTSFYMAPERI-------QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-PE-LKDEP 232 (287)
T ss_pred cccCCccccCHHHh-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-hh-hccCC
Confidence 22346789999964 344577899999999999999999999975421 11222211111000 00 00000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ......+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNG---IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCC---CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 112345778889999999999999999876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=284.40 Aligned_cols=248 Identities=18% Similarity=0.251 Sum_probs=182.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc---chHHHHHHHHHHhccC-CCcccceeEEEEcC--CeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK---KKREVDEWLRVIGGLR-HSNIVSIRAYCNGK--DELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|+. .++..||+|+++... .......|+..+.++. |+||+++++++.+. +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 45799999999999985 468899999987541 2223446777888875 99999999999987 88999999997
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
|+|.+++.... ..++|..+..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++....
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 58888886543 258999999999999999999994 45999999999999999 9999999999876542
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC-cchHHHHHHhhccccc--c-----
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE-LGIVKWVQMMGQDESA--W----- 557 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~--~----- 557 (640)
....+..|+|||+.. ....++.++|||||||++|||++|+.||...+ .+...+.......... .
T Consensus 155 ~~~~~~~~~y~aPE~~~------~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 155 YTEYISTRWYRAPECLL------TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred cCCCCCCcccCChhHhh------cCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 223467899999642 22346789999999999999999999997432 2222222211110000 0
Q ss_pred -cccchhhc--cC----hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 -EVFDFELI--MD----KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 -~~~d~~~~--~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...+.... .. .........+.+++.+||+++|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 00 001123467888999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=287.03 Aligned_cols=236 Identities=19% Similarity=0.280 Sum_probs=185.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|++|.||++.. .++..+++|++... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 45799999999999985 46788999988644 2344577889999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++... ++++..+..++.|++.||+|||+ .+|+||||+|+||+++.++.++|+|||++..... .
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 104 TDIVTHT------RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 9998752 47889999999999999999995 4599999999999999999999999998765432 1
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||.. ....++.++|||||||++|||++|+.||.... .....+...... . +.....
T Consensus 175 ~~~~~~y~aPE~~-------~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--~~~~~~~~~~~~-~-----~~~~~~- 238 (285)
T cd06648 175 LVGTPYWMAPEVI-------SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--PLQAMKRIRDNL-P-----PKLKNL- 238 (285)
T ss_pred ccCCccccCHHHh-------cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHhcC-C-----CCCccc-
Confidence 2357789999964 33456789999999999999999999986432 122222211110 0 000000
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......+.+++.+||+.+|++||++.++++
T Consensus 239 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 --HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 112235778888899999999999998875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=280.92 Aligned_cols=235 Identities=20% Similarity=0.324 Sum_probs=177.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-------chHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-------KKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 407 (640)
.++||+|+||.||+|.. .++..||+|.+.... ..+.+.+|++++++++||||+++++++.+. ..+++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 56899999999999986 458899999875321 124567799999999999999999988763 46889999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++.... .+++....+++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 87 HMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 999999999987542 47788889999999999999995 4599999999999999999999999999875431
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
...++..|+|||++ ....++.++|||||||++|||++|+.||..... .....+. .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~-~~~~~--- 226 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVI-------SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-MAAIFKI-ATQPT--- 226 (265)
T ss_pred ccccccccccCCCCccccChhhh-------cCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-HHHHHHH-hcCCC---
Confidence 12356789999964 334567899999999999999999999964321 1111111 11000
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+ ..+. .....+.+++.+|+. +|++||+++++++
T Consensus 227 --~~--~~~~---~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 --NP--VLPP---HVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CC--CCch---hhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 0111 122344556666774 8999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=281.34 Aligned_cols=237 Identities=23% Similarity=0.376 Sum_probs=185.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|... +|..+|+|.+... ...+.+.+|+.++++++|+||+++++.+...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 467999999999999965 5788999998653 23456778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccCCC---
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHTP--- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~~~--- 488 (640)
+|.+++....+ ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+......
T Consensus 85 ~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 85 DLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99999875432 247899999999999999999995 4599999999999999885 4699999998765432
Q ss_pred ---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 489 ---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 489 ---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
..++..|+|||+. ....++.++|||||||++|||++|+.||.... ..+++....... ..+
T Consensus 159 ~~~~~~~~~~~ape~~-------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-----~~~--- 221 (257)
T cd08225 159 AYTCVGTPYYLSPEIC-------QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--LHQLVLKICQGY-----FAP--- 221 (257)
T ss_pred ccccCCCccccCHHHH-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHhccc-----CCC---
Confidence 2346679999964 33456789999999999999999999996432 222222221111 000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+ ....++.+++.+||+.+|++|||+.++++
T Consensus 222 ~~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ISP---NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCC---CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001 11234667788899999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=285.79 Aligned_cols=248 Identities=21% Similarity=0.265 Sum_probs=181.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+++.. ++..||+|.+... .....+..|+.++.++. |+||+++++++..++..+++|||++.
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 467999999999999854 5789999998754 23456778888888886 99999999999998999999999864
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
++.++...........+++.....++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 165 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT 165 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc
Confidence 554433210000113588999999999999999999953 36999999999999999999999999998765322
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..++..|+|||++.... ...++.++|||||||++|||++|+.||.... .....+........ +.+...
T Consensus 166 ~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~ 234 (288)
T cd06616 166 RDAGCRPYMAPERIDPSA----RDGYDVRSDVWSLGITLYEVATGKFPYPKWN-SVFDQLTQVVKGDP------PILSNS 234 (288)
T ss_pred cccCccCccCHHHhcccc----ccCCcchhhhhHHHHHHHHHHhCCCCchhcc-hHHHHHhhhcCCCC------CcCCCc
Confidence 23467899999753211 1357789999999999999999999996432 11111111111000 011000
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++.+||+.+|++||++.+|++
T Consensus 235 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 235 -EEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00123345778888999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=283.48 Aligned_cols=250 Identities=21% Similarity=0.351 Sum_probs=185.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|++|.||+|.. .+|..||+|++.... ....+..|++++++++|||++++++++...+..|+||||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 46799999999999986 468999999986442 23457789999999999999999999999999999999995 6
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++..... ..+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||+++.....
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 83 DLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred CHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 99999875431 258899999999999999999995 46999999999999999999999999998765321
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhccc-cccc----c
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDE-SAWE----V 559 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~-~~~~----~ 559 (640)
...+..|+|||++.+ ...++.++|||||||++|||+||+.||...+.. .....+...... ..+. .
T Consensus 157 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 157 THEVVTLWYRAPEILLG------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred CccccccCCCCCceeec------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 223667999996522 234567899999999999999999999753321 111111111100 0000 0
Q ss_pred cch-----hhcc---ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDF-----ELIM---DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~-----~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
-+. .... ..........+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0000 0000111245778899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=289.07 Aligned_cols=257 Identities=19% Similarity=0.239 Sum_probs=186.7
Q ss_pred cccccc--CcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKG--CVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
+.||+| +||+||+++. ..|+.||+|.+.... ..+.+.+|+.+++.++||||++++++|...+..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356776 8999999986 478999999987542 124577888899999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++||+.......
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999999875431 247888899999999999999994 5699999999999999999999999975432210
Q ss_pred -------C--ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccc-ccc
Q 006559 488 -------P--FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE-SAW 557 (640)
Q Consensus 488 -------~--~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~ 557 (640)
. ...+..|+|||++... ...++.++|||||||++|||++|+.||......... ........ ..+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~ 231 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQD-----LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML-LQKLKGPPYSPL 231 (328)
T ss_pred ccccccccccccCccCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH-HHHhcCCCCCCc
Confidence 0 1124469999975322 134678999999999999999999999743211111 00000000 000
Q ss_pred ----------------------------------cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HH
Q 006559 558 ----------------------------------EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH--RM 601 (640)
Q Consensus 558 ----------------------------------~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~--~~ 601 (640)
.+.+..+ ..+........+.+++.+||+.||++|||+.|++ ..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000000 0111223445788899999999999999999995 46
Q ss_pred HHHhhcc
Q 006559 602 IEDIRTK 608 (640)
Q Consensus 602 L~~i~~~ 608 (640)
++.+...
T Consensus 311 ~~~~~~~ 317 (328)
T cd08226 311 FKQVKEQ 317 (328)
T ss_pred HHHHHHh
Confidence 6666543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=290.43 Aligned_cols=237 Identities=22% Similarity=0.300 Sum_probs=183.0
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|...+ +..||+|.+.... ..+.+.+|+++++.++|+||+++++.+......|+||||+++
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 4579999999999999654 8899999987542 234577889999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
++|.+++.... ...+++.....++.|++.||+|||. .+++|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 86 GELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred CCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999987542 1258899999999999999999994 5699999999999999999999999998765421
Q ss_pred -------------------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 488 -------------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 488 -------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
...++..|+|||++ ....++.++|||||||++|||++|+.||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-------~~~~~~~~~Di~slG~ll~~l~~g~~pf 232 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI-------SGDGHGSAVDWWTLGILLYEMLYGTTPF 232 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH-------cCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence 11346679999964 3345678999999999999999999999
Q ss_pred CCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 537 GDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
...... ..+.+..... ..... .......+.+++.+||+.+|++||++...+
T Consensus 233 ~~~~~~-~~~~~~~~~~----------~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 233 KGSNRD-ETFSNILKKE----------VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred CCCchH-HHHHHHhcCC----------ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 743321 1111111110 00000 011234577788889999999999944443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=282.88 Aligned_cols=236 Identities=20% Similarity=0.238 Sum_probs=177.6
Q ss_pred cccccCcceEEEEEe-CCCcEEEEEEeccccc-----hHHHHHH---HHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 340 LLGKGCVGATYKVVL-DGGDVVVVKRIRERKK-----KREVDEW---LRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~e---~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
+||+|+||.||+++. ..++.||+|.+..... ...+..| ++.++...||||+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4588999998865411 1122233 334555689999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 999999886432 58999999999999999999994 5599999999999999999999999999875532
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...++..|+|||+.. ....++.++||||+||++|||++|+.||................. .+..+
T Consensus 153 ~~~~~~~~y~aPE~~~------~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~-- 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------MAVEL-- 218 (278)
T ss_pred cCcCCCcCCcCcHHhc------CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc------cCCCC--
Confidence 234578899999642 123467899999999999999999999975422111111111000 01111
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
+.. ...++.+++.+|+..+|++|| ++.++.+
T Consensus 219 ~~~---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDS---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCc---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111 123566777889999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=288.90 Aligned_cols=237 Identities=19% Similarity=0.287 Sum_probs=189.7
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEecccc-----chHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRERK-----KKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.+.||+|.||.||+++.+. |+.+|+|.+.+.. ....+.+|+++|+++. |||||.+.++|...+..++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 4789999999999999765 8999999997652 2357889999999998 9999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC----CCeEEccCCcccccC
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL----GNACISDIGVHQLFH 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGl~~~~~ 486 (640)
+|.|.+.+... .++......++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||++....
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999998754 27888999999999999999995 569999999999999643 579999999998876
Q ss_pred CC-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 487 TP-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 487 ~~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
.. .++|+.|+|||++ ....|+..+||||.||++|.|+.|.+||.......... .. ...+ +++.+
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl-------~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i-~~~~--~~f~~ 259 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVL-------GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AI-LRGD--FDFTS 259 (382)
T ss_pred CCceEeeecCCccccCchhh-------cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HH-HcCC--CCCCC
Confidence 52 4679999999975 33677889999999999999999999998644222111 11 1100 01111
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+ ........+-+++..|+..||.+|+++.++++
T Consensus 260 ~------~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 260 E------PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred C------CccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1 11122334555666799999999999999987
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=278.22 Aligned_cols=239 Identities=24% Similarity=0.376 Sum_probs=188.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|++|.||+++.. ++..|+||++.... ..+.+..|++.+.+++|+||+++++++...+..++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 467999999999999976 48899999987653 35678889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|.+++.... ++++..+..++.|+++||+|||+ ..+++||||+|+||+++.++.++|+|||++......
T Consensus 86 L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 86 LADLLKKVG-----KIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 999997542 58899999999999999999994 056999999999999999999999999998765431
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhcccccccccchhhcc
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...+..|+|||.. ....++.++||||||+++|||+||+.||..... ......+...... .+..
T Consensus 159 ~~~~~~~y~~pE~~-------~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------~~~~-- 223 (264)
T cd06623 159 TFVGTVTYMSPERI-------QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP------PPSL-- 223 (264)
T ss_pred ceeecccccCHhhh-------CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC------CCCC--
Confidence 2346789999964 334667899999999999999999999975431 1111111111100 0000
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... .....+.+++..||+++|++||++.++++
T Consensus 224 ~~~--~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 PAE--EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred Ccc--cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011 02345777788899999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=292.37 Aligned_cols=245 Identities=18% Similarity=0.278 Sum_probs=188.0
Q ss_pred HHhhccccccCcceEEEEEeCCCcEEEEEEeccc----cchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEecc
Q 006559 335 KSSAELLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 335 ~~~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
....+.||+||.+.||++.-.+.+.+|+|++... +.-..|..|+..|.+|+ |.+||+|++|-..++.+||||||-
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 3456789999999999999888889998887644 23356889999999996 899999999999999999999986
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
+ -+|..+|+.... ...+| .+..+..|++.++.++| +.+|||.||||.|.|+-. |.+||+|||+|.....
T Consensus 443 d-~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 443 D-IDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred c-ccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 4 499999987653 23456 67789999999999999 556999999999999865 7899999999987643
Q ss_pred ------CccccccccCCccccCCCCcc----ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccc
Q 006559 488 ------PFFINDAYNAPELKFNNNNNY----SQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 488 ------~~~~~~~y~aPE~~~~~~~~~----~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
..++|..||+||.+....... ..-+.+.++||||+||+||+|+.|+.||+.-. -.|.+. .
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl-------~ 583 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKL-------H 583 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHH-------H
Confidence 346799999999765332221 12347789999999999999999999996421 122222 2
Q ss_pred cccchhh--ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVFDFEL--IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~d~~~--~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+.|+.- ..+.. ....+++++|..||+.||++||+..|+++
T Consensus 584 aI~~P~~~Iefp~~--~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 AITDPNHEIEFPDI--PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hhcCCCccccccCC--CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2233311 11111 11123888999999999999999999874
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=295.82 Aligned_cols=240 Identities=18% Similarity=0.305 Sum_probs=188.2
Q ss_pred cccccCcceEEEEEeCCC-cEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 340 LLGKGCVGATYKVVLDGG-DVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~~-~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.||.|+||.||+++.+.. -..|.|.+... ..-++|.-||.+|...+||+||+|++.|+-.+.+||..|||++|-...
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 489999999999996654 44567776544 234567788999999999999999999999999999999999999988
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc------CCCcc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF------HTPFF 490 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~------~~~~~ 490 (640)
++-.-. .++...++..++.|++.||.|||+.+ |||||||+.|||+.-+|.++|+|||++... ...++
T Consensus 119 imlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI 191 (1187)
T KOG0579|consen 119 IMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI 191 (1187)
T ss_pred HHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence 776543 26889999999999999999999654 999999999999999999999999997543 24678
Q ss_pred ccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHH
Q 006559 491 INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEM 570 (640)
Q Consensus 491 ~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 570 (640)
+|++|||||+.+.. ......|+.++||||||+.|.||.-+.+|..+- +....+-.+...+ -+.+..+
T Consensus 192 GTPYWMAPEVvmCE--T~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--npMRVllKiaKSe------PPTLlqP--- 258 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCE--TFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--NPMRVLLKIAKSE------PPTLLQP--- 258 (1187)
T ss_pred CCcccccchheeec--cccCCCchhhhhHHhhhhHHHHHhccCCCcccc--chHHHHHHHhhcC------CCcccCc---
Confidence 99999999987654 456678999999999999999999999997642 1111111111110 1122222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 571 EEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 571 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
+.+...+-++...|+..+|..||++++++
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 23444566666779999999999999886
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=282.00 Aligned_cols=233 Identities=19% Similarity=0.258 Sum_probs=184.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. ++..||+|.+... ...+.+.+|++++++++||||+++++++......++|+||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 467999999999999965 5888999998754 2235678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
++|.+++.... ++++.....++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 85 GDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred CCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence 99999997542 57889999999999999999994 45999999999999999999999999998765432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||+. ....++.++||||||+++|+|++|+.||.........+....... .....
T Consensus 157 ~~~~~~~~y~~PE~~-------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 221 (258)
T cd05578 157 TSTSGTPGYMAPEVL-------CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--------ADVLY 221 (258)
T ss_pred cccCCChhhcCHHHH-------cccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--------ccccC
Confidence 3346689999964 334477899999999999999999999975433222222211111 00001
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMS 596 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 596 (640)
+. .....+.+++.+||+.||++||++.
T Consensus 222 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 222 PA---TWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred cc---cCcHHHHHHHHHHccCChhHcCCcc
Confidence 11 1224567788889999999999993
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=281.80 Aligned_cols=236 Identities=22% Similarity=0.335 Sum_probs=184.1
Q ss_pred ccccCcceEEEEEeCC-CcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 341 LGKGCVGATYKVVLDG-GDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 341 iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
||+|+||.||+++... ++.+++|.+.... ..+.+.+|++++++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 8899999986542 234577889999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC------
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------ 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------ 488 (640)
.+++.... .+++..+..++.|++.||+||| ..+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99997543 5789999999999999999999 456999999999999999999999999997654321
Q ss_pred --------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 489 --------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 489 --------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
...+..|++||... ....+.++||||||+++||++||+.||...... ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~-------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~----- 218 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVIL-------GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQNILNGKI----- 218 (265)
T ss_pred cccccccCcccCccccCHHHhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcCCc-----
Confidence 23456799999643 334677899999999999999999999754321 11111111000
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
. .... ......+.+++.+||+.+|++||++.++.+.|+
T Consensus 219 ~----~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 E----WPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C----CCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 0000 011345677888899999999999977766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=292.13 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=183.8
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccccch----------------HHHHHHHHHHhccCCCcccceeEEEEcC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKK----------------REVDEWLRVIGGLRHSNIVSIRAYCNGK 399 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----------------~~~~~e~~~l~~l~H~niv~l~~~~~~~ 399 (640)
..+.||+|+||.||+|+.. +++.||||.++..... ..+.+|+++++.++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3567999999999999854 6889999988644211 2466899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccC
Q 006559 400 DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDI 479 (640)
Q Consensus 400 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 479 (640)
+..++||||++ |+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCc
Confidence 99999999997 69999986432 47888999999999999999994 56999999999999999999999999
Q ss_pred CcccccCC--------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 480 GVHQLFHT--------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 480 Gl~~~~~~--------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
|+++.... ....+..|+|||.+.+ ...++.++|||||||++|||+||+.||...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG------AEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhccc------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99876541 1123567999997532 234578999999999999999999999743
Q ss_pred Cc-chHHHHHH-hhccc-cccc-c-----cch-hhccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 540 EL-GIVKWVQM-MGQDE-SAWE-V-----FDF-ELIMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 540 ~~-~~~~~~~~-~~~~~-~~~~-~-----~d~-~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+. .....+.. ..... ..+. . ..+ ....+.. ......++.+++..|++.+|++||++.+++.
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 32 11111111 11000 0000 0 000 0000000 1112345778889999999999999999975
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.71 Aligned_cols=238 Identities=22% Similarity=0.356 Sum_probs=187.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccc-hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK-KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+.||+|+||.||+|... ++..+++|.+..... .+.+..|++.+++++|+||+++++++...+..++|+||+++++|.
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 467999999999999976 678899999876533 566788999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC------c
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------F 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------~ 489 (640)
+++.... ..+++..+..++.|++.||+|||. .+|+|+||+|+||+++.++.++|+|||++...... .
T Consensus 104 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 104 DIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 9998643 258999999999999999999994 56999999999999999999999999987654321 2
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
..+..|++||++ ....++.++|||||||++|||+||+.||...... .......... ... . ..
T Consensus 177 ~~~~~y~~PE~~-------~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~~~~~-~~~-----~---~~ 238 (286)
T cd06614 177 VGTPYWMAPEVI-------KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLITTKG-IPP-----L---KN 238 (286)
T ss_pred cCCcccCCHhHh-------cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC-CCC-----C---cc
Confidence 346689999964 3345678999999999999999999998743211 1111111100 000 0 01
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......+.+++.+||+.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112345677888899999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=284.85 Aligned_cols=248 Identities=21% Similarity=0.372 Sum_probs=182.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|... +++.+|+|.++.... ...+.+|+.++.+++||||+++++++... +..|+||||++
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 567999999999999975 578899999875421 23456789999999999999999998877 89999999997
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
++|.+++..... .+++.....++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.....
T Consensus 90 -~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 90 -HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred -cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 599998875431 58899999999999999999995 45999999999999999999999999998866432
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH-HHHHhhcc-ccccc---
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK-WVQMMGQD-ESAWE--- 558 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~-~~~~~~~~-~~~~~--- 558 (640)
...+..|+|||.+.+ ...++.++|||||||++|||++|+.||...... ... ........ ...+.
T Consensus 162 ~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLG------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccccccccccccCchhhcC------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 234667999996532 223568999999999999999999999743211 100 00000000 00000
Q ss_pred -----------ccchhhccChHHHH--HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 -----------VFDFELIMDKEMEE--EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 -----------~~d~~~~~~~~~~~--~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
....... ...... ....+.+++..||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000 000111 1345677888899999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=285.22 Aligned_cols=248 Identities=18% Similarity=0.175 Sum_probs=178.3
Q ss_pred cccccCcceEEEEEeCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 340 LLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+|.|+++.||+++. ++..||||++... ...+.+..|+++++.++|+||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344555555555544 6889999998654 23356888999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-------- 487 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-------- 487 (640)
+++..... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||.+.....
T Consensus 88 ~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 88 DLLKTHFP---EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99975432 247788889999999999999994 4599999999999999999999999998764421
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcc-c-------
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQD-E------- 554 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~------- 554 (640)
....+..|+|||++... ...++.++|||||||++|||++|+.||........ ..+..... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQN-----LQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccCHHHhcCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCc
Confidence 12235679999976321 13467899999999999999999999975322111 11110000 0
Q ss_pred ------cccc----ccchhhcc---ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 555 ------SAWE----VFDFELIM---DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 555 ------~~~~----~~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... ..+..... .........++.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 00000000 0001122345777888999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=278.56 Aligned_cols=239 Identities=19% Similarity=0.207 Sum_probs=178.6
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEecccc--ch---HHHHHHHH-HHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERK--KK---REVDEWLR-VIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~---~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
+.||+|+||.||+|.. .+++.||||.+.... .. ..+..|.. .....+|+||+++++++...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 3589999999999986 457899999986531 11 22233333 34456899999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--Cc
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--PF 489 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--~~ 489 (640)
|+|.+++.... ++++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF 153 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccccccC
Confidence 99999997543 47888899999999999999995 4599999999999999999999999999876432 23
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.++..|++||.+. ...++.++||||||+++|||+||+.||...... ........... +.....
T Consensus 154 ~~~~~y~~pe~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-----~~~~~~--- 216 (260)
T cd05611 154 VGTPDYLAPETIL-------GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVFDNILSRRI-----NWPEEV--- 216 (260)
T ss_pred CCCcCccChhhhc-------CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhccc-----CCCCcc---
Confidence 4577899999642 334678999999999999999999999753321 11111111000 000000
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
.......+.+++.+||+.+|++||++.++.+.|
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 012234577888889999999999876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=284.48 Aligned_cols=227 Identities=20% Similarity=0.258 Sum_probs=179.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++.. +++.||+|.+... ...+.+..|++++++++||||+++++++...+..++||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 467999999999999964 5889999998653 1234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||+++.....
T Consensus 86 ~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 157 (290)
T cd05580 86 GELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT 157 (290)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCC
Confidence 99999997543 57888999999999999999994 56999999999999999999999999998876432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||.. .....+.++||||||+++|||+||+.||...... ..+ +.... .....+.
T Consensus 158 ~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~-~~~~~---------~~~~~~~ 219 (290)
T cd05580 158 LCGTPEYLAPEII-------LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIY-EKILE---------GKVRFPS 219 (290)
T ss_pred CCCCccccChhhh-------cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHhc---------CCccCCc
Confidence 2357789999964 3345678899999999999999999999754311 111 11111 0111111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCC
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRP 593 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RP 593 (640)
.. ...+.+++.+||+.+|++||
T Consensus 220 ~~---~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 220 FF---SPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred cC---CHHHHHHHHHHccCCHHHcc
Confidence 11 23456677889999999999
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=281.32 Aligned_cols=233 Identities=18% Similarity=0.228 Sum_probs=178.2
Q ss_pred ccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 341 LGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 341 iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
||+|+||+||++.. .+|..+|+|.+.... ..+.+..|++++++++||||+++.+++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 468899999986431 233456789999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----Cc
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-----PF 489 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-----~~ 489 (640)
.+++..... ..+++..+..++.|++.||.|||. .+++||||+|+||++++++.+||+|||++..... ..
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccc
Confidence 999875432 258899999999999999999994 5699999999999999999999999999876532 12
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+..|+|||+. ....++.++|||||||++|||++|+.||...... ....+... ..........
T Consensus 155 ~~~~~y~~PE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 219 (277)
T cd05577 155 AGTPGYMAPEVL-------QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--------TLEMAVEYPD 219 (277)
T ss_pred cCCCCcCCHHHh-------cCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--------cccccccCCc
Confidence 346689999964 3344678999999999999999999999753321 11101000 0000000111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSI 597 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~ 597 (640)
. ....+.+++.+||+.+|++||+.++
T Consensus 220 ~---~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 K---FSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred c---CCHHHHHHHHHHccCChhHccCCCc
Confidence 1 1234667788899999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=283.31 Aligned_cols=235 Identities=20% Similarity=0.311 Sum_probs=183.3
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+||+|+||.||++.. .++..||||++... .....+..|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999986 46889999988644 23445778999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC------c
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------F 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------~ 489 (640)
+++... .+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++...... .
T Consensus 106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 987542 47889999999999999999994 46999999999999999999999999987654321 2
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.++..|+|||.. ....++.++|||||||++|||++|+.||..... .+.+....... ......
T Consensus 177 ~~~~~y~~pE~~-------~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~------~~~~~~--- 238 (292)
T cd06657 177 VGTPYWMAPELI-------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNL------PPKLKN--- 238 (292)
T ss_pred ccCccccCHHHh-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhC------CcccCC---
Confidence 346789999954 334567899999999999999999999864321 11111111100 000000
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......+.+++.+||+.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0112234566778899999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=291.36 Aligned_cols=254 Identities=17% Similarity=0.302 Sum_probs=185.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcC-----CeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK-----DELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~Ey 408 (640)
.+.||+|+||.||+|+. .+|+.||+|.+... .....+.+|+.++++++|+||+++++++... ...|+|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 56899999999999985 56889999998643 2234567899999999999999999987643 358999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+++ +|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~-~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 90 MET-DLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ccc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 974 888877643 48899999999999999999995 5599999999999999999999999999876532
Q ss_pred --------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHH-HHhhcc--cc
Q 006559 488 --------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWV-QMMGQD--ES 555 (640)
Q Consensus 488 --------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~-~~~~~~--~~ 555 (640)
...++..|+|||.+. ....++.++|||||||++|||+||+.||...+.. ..... ...... +.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIML------NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhh------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 123467899999642 2245678999999999999999999999753221 11111 111110 00
Q ss_pred cccccchh-------hcc--C----hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhhc
Q 006559 556 AWEVFDFE-------LIM--D----KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM--IEDIRT 607 (640)
Q Consensus 556 ~~~~~d~~-------~~~--~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~ 607 (640)
...+.+.. ... . ........++.+++.+||+.+|++||++.++++. ++....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000000 000 0 0011223467889999999999999999999875 655543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=278.19 Aligned_cols=230 Identities=17% Similarity=0.210 Sum_probs=174.0
Q ss_pred ccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHhhc
Q 006559 341 LGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLH 419 (640)
Q Consensus 341 iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~ 419 (640)
||+|+||.||+++. .++..+|+|.+....... .+.+...+ ..+||||+++++++...+..++||||+++|+|.+++.
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~e~~~~~~-~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~ 101 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-IEPMVHQL-MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK 101 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-hhHHHHHH-hhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHH
Confidence 69999999999985 467889999886542211 11111111 1279999999999999999999999999999999997
Q ss_pred cCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccCCC--cccccccc
Q 006559 420 GSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHTP--FFINDAYN 496 (640)
Q Consensus 420 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~~~--~~~~~~y~ 496 (640)
... ++++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+++..... ..++..|+
T Consensus 102 ~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~ 173 (267)
T PHA03390 102 KEG-----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYF 173 (267)
T ss_pred hcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCccc
Confidence 543 58999999999999999999994 5599999999999999988 9999999998765432 34577899
Q ss_pred CCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch---HHHHHHhhcccccccccchhhccChHHHHH
Q 006559 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI---VKWVQMMGQDESAWEVFDFELIMDKEMEEE 573 (640)
Q Consensus 497 aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 573 (640)
|||++ ....++.++|||||||++|||+||+.||....... ..+...... ..... ...
T Consensus 174 aPE~~-------~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~---~~~ 233 (267)
T PHA03390 174 SPEKI-------KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----------KLPFI---KNV 233 (267)
T ss_pred Chhhh-------cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc----------cCCcc---ccc
Confidence 99964 33456789999999999999999999997432221 222221110 00001 122
Q ss_pred HHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 006559 574 MRALLQVALLCLAPLPKDRPN-MSIVHR 600 (640)
Q Consensus 574 ~~~l~~l~~~Cl~~~P~~RPs-~~~v~~ 600 (640)
...+.+++.+||+.+|++||+ ++++++
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 234666777899999999996 577763
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=282.74 Aligned_cols=242 Identities=22% Similarity=0.360 Sum_probs=184.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|+. .++..+|+|.+... ...+++.+|+++++.++|+|++++.+++......++||||+.
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 456799999999999995 45788999988632 123456789999999999999999999999999999999997
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
|++.+++.... .++++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 99 -~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (308)
T cd06634 99 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170 (308)
T ss_pred -CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence 68887775432 247889999999999999999994 45999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||.+.. .....++.++|||||||++|||++|+.|+...... ............ ...
T Consensus 171 ~~~~~~y~aPE~~~~----~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~------~~~--- 235 (308)
T cd06634 171 FVGTPYWMAPEVILA----MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNESP------ALQ--- 235 (308)
T ss_pred ccCCccccCHHHHhh----cccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHhhcCCC------CcC---
Confidence 345778999997531 12244678999999999999999999998643211 111111111000 000
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
.......+.+++.+||+.+|++||++.++++.-
T Consensus 236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 012234466788889999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=280.75 Aligned_cols=251 Identities=21% Similarity=0.341 Sum_probs=185.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|++|.||+|+.. +|..||||.++... ....+.+|++++++++|+||+++++++...+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 467999999999999964 58889999987542 234567889999999999999999999999999999999985 8
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+|++|||+++....
T Consensus 84 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 84 LKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred HHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 8888865431 2358999999999999999999995 4599999999999999999999999999876532
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH-HHHHhhc-cccccc------
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK-WVQMMGQ-DESAWE------ 558 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~-~~~~~~~-~~~~~~------ 558 (640)
....+..|++||++.+ ...++.++|||||||++|||+||+.||...... ... ..+.... ....+.
T Consensus 159 ~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 159 NEVVTLWYRAPDVLLG------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred cccccccccChHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 2234678999997532 234567899999999999999999999753221 100 0000000 000000
Q ss_pred ccchhhcc------ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIM------DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........ ....+.....+.+++..|++.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0001122345778888999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=284.49 Aligned_cols=235 Identities=22% Similarity=0.269 Sum_probs=181.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
-++||+||||.||-++. .+|+.+|.|++.++ +.......|-.+|.+++.+.||.+-.+|.+++.+++|+..|.+
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 46899999999999985 46889999988654 2334456788899999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|+-+|..... .-++....+.+|.+|+.||++|| ..+||.|||||+|||||++|+++|+|+|||..+..
T Consensus 270 GDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 270 GDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred CceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 999988876543 24899999999999999999999 55699999999999999999999999999987642
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++|.+|||||++ ....|+...|.||+||++|||+.|+.||...... ++|-+. -..+.......
T Consensus 344 ~~rvGT~GYMAPEvl-------~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-vk~eEv------drr~~~~~~ey 409 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVL-------QNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-VKREEV------DRRTLEDPEEY 409 (591)
T ss_pred ccccCcccccCHHHH-------cCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-hhHHHH------HHHHhcchhhc
Confidence 24679999999975 4455778899999999999999999999742211 111000 00111111112
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
+...+++.+.+.+ .-++.||++|--.
T Consensus 410 ~~kFS~eakslc~---~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 410 SDKFSEEAKSLCE---GLLTKDPEKRLGC 435 (591)
T ss_pred ccccCHHHHHHHH---HHHccCHHHhccC
Confidence 2233444454444 4788999999743
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=291.39 Aligned_cols=235 Identities=22% Similarity=0.298 Sum_probs=186.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
...||+|.|+.|.+++. ..+..||+|.+.+.. ..+.+.+|+++|+.++|||||+++.+......+|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 56799999999999985 458899999998762 2344788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
.+++++..... ........++.|+..|++|||+.+ |||||||++||||+.++.+||+|||++.++..
T Consensus 141 e~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 141 ELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred hhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccccccc
Confidence 99999987642 334677788999999999999654 99999999999999999999999999988753
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
.+++++.|.|||++.+.. ..++++|+||+||++|-|+.|..||++....... .+++...+..+
T Consensus 213 t~cgsppyAaPEl~~g~~------y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~rvl~gk~rIp 275 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKK------YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PRVLRGKYRIP 275 (596)
T ss_pred ccCCCCCccChHhhcCcc------cCCcceehhhhhhhheeeeecccccCCccccccc-----------chheeeeeccc
Confidence 567899999999875443 2357899999999999999999999864322111 11111111122
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+..+.+ +++.+.+-.+|.+|++++++.+
T Consensus 276 ~~ms~dce---~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 276 FYMSCDCE---DLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ceeechhH---HHHHHhhccCccccCCHHHhhh
Confidence 22233333 3445577889999999998864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=269.35 Aligned_cols=192 Identities=23% Similarity=0.405 Sum_probs=161.4
Q ss_pred hccccccCcceEEEEEeCC-----CcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLDG-----GDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 407 (640)
...||+|.||.||+|+-.+ ...+|+|+++..+ .....-+|+.+++.++|||||.|..++.. +...++++|
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd 108 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD 108 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence 3569999999999996432 2368999998662 24566789999999999999999998877 678999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC----CCeEEccCCccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL----GNACISDIGVHQ 483 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGl~~ 483 (640)
|.+. +|.++++..+.+....++-.....|..||..|+.|||+.. |+||||||.|||+..+ |.+||+|||+++
T Consensus 109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR 184 (438)
T KOG0666|consen 109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLAR 184 (438)
T ss_pred hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence 9987 8988887666544456888889999999999999999655 9999999999999877 999999999999
Q ss_pred ccCCC---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 484 LFHTP---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 484 ~~~~~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
.+..+ .+.|.+|+|||++.++ ..||++.||||.||++.||+|-++-|...
T Consensus 185 ~~~~plkpl~s~d~VVVTiWYRAPELLLGa------~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 185 LFNNPLKPLASLDPVVVTIWYRAPELLLGA------RHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HhhccccccccCCceEEEEEecChHHhccc------ccccchhhhHHHHHHHHHHHccCccccch
Confidence 87643 3458999999997544 56788999999999999999998887643
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=272.72 Aligned_cols=237 Identities=24% Similarity=0.362 Sum_probs=188.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~~ 410 (640)
.+.||+|++|.||+|... ++..|++|.+.... ..+.+.+|+..+++++|+||+++++.+... ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999976 68899999987653 245678899999999999999999999988 89999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
+++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999987543 58999999999999999999995 56999999999999999999999999998765432
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...+..|++||.. .....+.++||||||+++|||++|+.||.... .................
T Consensus 157 ~~~~~~~~~~~~y~~pE~~-------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~---- 224 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVI-------RGEEYGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSSGEPPE---- 224 (260)
T ss_pred cccccCCCCCccccCHhhh-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHhccccCCCcC----
Confidence 2346789999964 33347789999999999999999999997544 11111111110000000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+. .....+.+++.+|++.+|++||++.+++.
T Consensus 225 ---~~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 ---IPE---HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---CCc---ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111 11345777888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=279.39 Aligned_cols=249 Identities=21% Similarity=0.346 Sum_probs=185.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|+.. ++..+|+|.+.... ..+.+..|++++++++|+|++++++++... +..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 457999999999999965 47889999997652 235677899999999999999999999987 89999999998
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
+ +|.+++.... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 84 ~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 84 H-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred c-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 5 8988886542 258899999999999999999995 45999999999999999999999999998766432
Q ss_pred -----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcc--ccccc--
Q 006559 489 -----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQD--ESAWE-- 558 (640)
Q Consensus 489 -----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~--~~~~~-- 558 (640)
...+..|+|||.+.+ ...++.++||||||+++|||+||+.||...... ....+...... ...+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLG------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred ccccccccccccCCceeeEc------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 123667999996422 234678999999999999999999999753321 11111110000 00000
Q ss_pred -------ccchhhccCh----HHHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 -------VFDFELIMDK----EMEE-EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 -------~~d~~~~~~~----~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......... .... +...+.+++.+||..+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000 0111 1456888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=272.91 Aligned_cols=238 Identities=23% Similarity=0.363 Sum_probs=188.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|++|.||++... ++..+++|++.... ..+.+.+|++.+++++|+||+++.+++......++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 467999999999999975 68889999987664 556788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----c
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-----F 489 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-----~ 489 (640)
.+++.... ..+++..+..++.|++.||.|||. .+++||||+|+||++++++.++|+|||.+...... .
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99987642 258999999999999999999994 56999999999999999999999999998765432 2
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.++..|++||.. ....++.++||||||+++|||++|+.||...... ......... .... ....
T Consensus 158 ~~~~~~~~PE~~-------~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~-~~~~-----~~~~-- 220 (253)
T cd05122 158 VGTPYWMAPEVI-------NGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIATN-GPPG-----LRNP-- 220 (253)
T ss_pred ecCCcccCHHHH-------cCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhc-CCCC-----cCcc--
Confidence 346789999964 2334678999999999999999999999753211 111111110 0000 0000
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......+.+++.+||+.||++|||+.++++
T Consensus 221 -~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 -EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011235677888899999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=289.55 Aligned_cols=255 Identities=20% Similarity=0.335 Sum_probs=185.5
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEc----CCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNG----KDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|+. .++..||+|++... ...+.+..|+.++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 46799999999999985 46889999998754 223456678999999999999999998763 3468999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+. |+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 90 ~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 90 ME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred hh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 96 68999886543 48899999999999999999994 5599999999999999999999999999876532
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHh-hccc--
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMM-GQDE-- 554 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~-~~~~-- 554 (640)
...++..|+|||.+. ....++.++|||||||++|||++|+.||...+.. ........ +...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~------~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLL------SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred CcCCCcccccccccccccChHHhc------CCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 123467899999652 2234678999999999999999999999753321 11111111 1000
Q ss_pred --------ccccc---cchhhcc--ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhc
Q 006559 555 --------SAWEV---FDFELIM--DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRT 607 (640)
Q Consensus 555 --------~~~~~---~d~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~ 607 (640)
..... ....... .........++.+++.+||+.+|++||++.+++. .+++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 00000 0000000 0001122456788889999999999999998865 4444433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=281.97 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=181.0
Q ss_pred hhccccccCcceEEEEEeCC-CcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVLDG-GDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|+||.||+|+..+ ++.||||.++... ...++..|+.++.+. .||||+++++++......|+||||++
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 97 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS- 97 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-
Confidence 35789999999999999765 8899999987542 234455566656555 49999999999999999999999985
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
+++.+++.... .++++..+..++.|+++||+|||+. .+|+||||+|+||++++++.+||+|||++..+...
T Consensus 98 ~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 98 TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 47777765432 2588999999999999999999952 36999999999999999999999999998765321
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...+..|+|||.+..... ...++.++||||||+++|||++|+.||...... .+.......... +....
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~------~~~~~ 241 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDP---NPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEEP------PSLPP 241 (296)
T ss_pred cCCCCCccccCHhhcCCCCC---ccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCCC------CCCCC
Confidence 224568999997532211 234678999999999999999999999642211 111111111100 00000
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
. .....++.+++.+||+.||++||++.++++.
T Consensus 242 ~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 N---EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C---CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0123356778889999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.07 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=184.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccc---hHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK---KREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. ++..|+||++..... .....+|+..+++++ |+||+++++++...+..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 467999999999999975 478899999876522 223456788899999 999999999999999999999999 88
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||+++....
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 9999887643 1257899999999999999999995 4599999999999999999999999999876643
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH-------------HHHHhhcc
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK-------------WVQMMGQD 553 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~-------------~~~~~~~~ 553 (640)
....+..|+|||++. ....++.++||||||+++|||+||+.||...... ... |.......
T Consensus 157 ~~~~~~~~~aPE~~~------~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 157 DYVSTRWYRAPEILL------RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CCCCcccccCceeee------cCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 233467899999652 2344678999999999999999999998643211 111 11100000
Q ss_pred cccccccchhhc--cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 554 ESAWEVFDFELI--MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 554 ~~~~~~~d~~~~--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......+..... ..........++.+++.+||+.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000 00001111356788899999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=281.75 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=180.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +++.||+|.+.... ..+.+.+|++++++++||||+++++++...+..|+||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 467999999999999965 68899999886432 23457789999999999999999999999999999999996 5
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCcccccCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~~~~~---- 487 (640)
+|.+++.... ...+++.....++.|++.||+|||+ .+++||||+|+||+++. ++.+||+|||+++....
T Consensus 86 ~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 86 DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 8888775432 1235778888999999999999994 45999999999999985 56799999999876432
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHh---hc-ccccccc--
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM---GQ-DESAWEV-- 559 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~---~~-~~~~~~~-- 559 (640)
....+..|+|||++.+ ...++.++|||||||++|||+||+.||...... ....+.. .. .+..+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLG------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cccCceeecccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhccccc
Confidence 1233678999996522 234678999999999999999999999743211 1111111 00 0001100
Q ss_pred --cchhhc----cCh----HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 --FDFELI----MDK----EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 --~d~~~~----~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+.... ... .......++.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 000 00112234677888899999999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=274.30 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=179.2
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEecccc---chHHHHHHHH-HHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERK---KKREVDEWLR-VIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..||.|+||+|+|..+ +.|+..|||+++... .++.+..|.. +++.-+.||||+++|.+..++..|+.||.|.- +
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 4599999999999875 568999999998653 3455666665 45555789999999999999999999999954 6
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|..+.+.--.-....+++...-+|+.-...||.||-. ..+|||||+||+|||+|..|.+||||||++-.+..+
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~ 226 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV 226 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence 6544321100011247777778888889999999985 557999999999999999999999999998665432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc-cC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI-MD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~ 567 (640)
..+...|||||.+. -....|+-+|||||+|++|+|+.||+.|+..=. +..+.+...... |+... .+
T Consensus 227 daGCrpYmAPERi~-----p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-svfeql~~Vv~g-------dpp~l~~~ 293 (361)
T KOG1006|consen 227 DAGCRPYMAPERID-----PSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-SVFEQLCQVVIG-------DPPILLFD 293 (361)
T ss_pred ccCCccccChhccC-----CccCCcchhhhhhhhcceEeeeecCCCCcchHH-HHHHHHHHHHcC-------CCCeecCc
Confidence 34567899999763 233368899999999999999999999986411 122222222211 22221 12
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+.-+....+..++..|+.+|-..||+..++.+
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 221223345666777799999999999988764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=281.70 Aligned_cols=244 Identities=14% Similarity=0.141 Sum_probs=168.5
Q ss_pred hhccccccCcceEEEEEeCCC----cEEEEEEeccccch--H-----------HHHHHHHHHhccCCCcccceeEEEEcC
Q 006559 337 SAELLGKGCVGATYKVVLDGG----DVVVVKRIRERKKK--R-----------EVDEWLRVIGGLRHSNIVSIRAYCNGK 399 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~--~-----------~~~~e~~~l~~l~H~niv~l~~~~~~~ 399 (640)
..++||+|+||.||+|...++ ..+|+|........ . ....+...+..++|+||+++++++...
T Consensus 16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK 95 (294)
T ss_pred EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence 356899999999999997554 45566653322110 0 111223456677999999999876544
Q ss_pred C----eEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeE
Q 006559 400 D----ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC 475 (640)
Q Consensus 400 ~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 475 (640)
. ..++++|++.. ++.+.+.... ..++..+..++.|+++||+|||+ .+|+||||||+|||++.++.++
T Consensus 96 ~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 96 RCRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred cCCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEE
Confidence 3 45788888754 6666665332 35677888999999999999994 5699999999999999999999
Q ss_pred EccCCcccccCC-------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc
Q 006559 476 ISDIGVHQLFHT-------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG 542 (640)
Q Consensus 476 l~DfGl~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~ 542 (640)
|+|||+++.+.. ...+|..|+|||+. ....++.++|||||||++|||+||+.||......
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-------~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-------NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHh-------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 999999876521 12467889999964 3456788999999999999999999999754211
Q ss_pred hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
.. .+..... +....+...... .......+.+++..|++.+|++||++.++.+.+
T Consensus 240 ~~-~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 GN-LIHAAKC-DFIKRLHEGKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hH-HHHHhHH-HHHHHhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10 0100000 000011111111 112234567777789999999999999998876
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=286.81 Aligned_cols=254 Identities=20% Similarity=0.329 Sum_probs=184.2
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhcc-CCCcccceeEEEEcC--CeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGK--DELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~~lV~Ey 408 (640)
..+.||+|+||.||+|... ++..+|||++... .....+..|+.+++++ +||||++++++|... ...|+||||
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 4578999999999999965 5788999988542 2234566789999999 999999999998654 368999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
++ ++|..++... .++|..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 91 ME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 97 5999888643 47888999999999999999994 5699999999999999999999999999875432
Q ss_pred ----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHH-HHhhccc-
Q 006559 488 ----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWV-QMMGQDE- 554 (640)
Q Consensus 488 ----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~-~~~~~~~- 554 (640)
.+.++..|+|||++. ....++.++|||||||++|||+||+.||...... ..... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILL------GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred cccccCcchhcccccccccCceeee------ccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 123467899999642 2244668899999999999999999998642211 11100 0000000
Q ss_pred ---------ccccccc----hhhc-cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhh
Q 006559 555 ---------SAWEVFD----FELI-MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM--IEDIR 606 (640)
Q Consensus 555 ---------~~~~~~d----~~~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~ 606 (640)
....+.+ .... ......+...++.+++.+||+.+|++|||+.++++. ++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0000000 0000 000011123467888999999999999999999863 54543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=279.91 Aligned_cols=231 Identities=20% Similarity=0.287 Sum_probs=177.6
Q ss_pred hccccccCcceEEEEEe----CCCcEEEEEEeccc------cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL----DGGDVVVVKRIRER------KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~----~~~~~vavK~l~~~------~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
.+.||+|+||.||+++. .+|..||+|.++.. ...+.+..|++++.++ +|+||+++++++......++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 46799999999999985 36788999998753 1235577899999999 5899999999999889999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++++|.+++.... ++++.....++.|+++||+|||+ .+++||||+|+|||++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 85 DYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999997543 47888888899999999999994 569999999999999999999999999987654
Q ss_pred C-------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhcccccc
Q 006559 487 T-------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDESAW 557 (640)
Q Consensus 487 ~-------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~ 557 (640)
. ...++..|+|||.... ....++.++|||||||++|||+||+.||..... ....+.+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--- 228 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRG-----GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--- 228 (290)
T ss_pred cccccccccccCCcccCChhhccC-----CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC---
Confidence 3 1235678999996532 122456789999999999999999999863211 1122222111110
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCC
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP 593 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 593 (640)
+. .+. .....+.+++.+||+.+|++||
T Consensus 229 ----~~--~~~---~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 229 ----PP--YPQ---EMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred ----CC--CCc---cCCHHHHHHHHHHhcCCHHHhc
Confidence 00 111 1123456778889999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=282.29 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=182.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|.. .+|+.||+|.++.... ...+.+|++++++++|+||+++++++... +..++||||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 56799999999999996 4588999999864421 23456789999999999999999998764 56899999997
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 92 -~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 92 -QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred -CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 48888886532 258999999999999999999995 45999999999999999999999999998876432
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHH-hhcc-ccccccc-
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQM-MGQD-ESAWEVF- 560 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~-~~~~-~~~~~~~- 560 (640)
...+..|+|||++.+ ...++.++||||+||++|||++|+.||...... ...-+.. .... ...+..+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLG------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCCcccccccccChhhhcC------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 123567999997532 234678999999999999999999999743211 1111111 1100 0000000
Q ss_pred --------chhhccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 --------DFELIMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 --------d~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......... ......++.+++..|++.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0112345677888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.89 Aligned_cols=237 Identities=27% Similarity=0.402 Sum_probs=182.3
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
...||.|.||.||-|. ..+|...|||.++-. +.-+...+|+.++..++|||+|+++|+=...+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4579999999999998 677899999987643 33456789999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+.+...+ ..+..-...+..|++.|+.||| +.+||||||||.||+|+.+|.+|++|||.|......
T Consensus 1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999997554 2455556668899999999999 456999999999999999999999999998876432
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
..+|+.|||||++.+.. ......+.||||+|||++||+||+.||.+-+. +|.-+..-.. ...|
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~----~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V~~----gh~P 1460 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTK----GKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHVAA----GHKP 1460 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccc----cCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHHhc----cCCC
Confidence 35799999999986532 23344679999999999999999999974322 2322211000 0001
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIV 598 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v 598 (640)
+ .+..+..+-+ +++-.|++.||++|.++.|+
T Consensus 1461 q--~P~~ls~~g~---dFle~Cl~~dP~~Rw~~~ql 1491 (1509)
T KOG4645|consen 1461 Q--IPERLSSEGR---DFLEHCLEQDPKMRWTASQL 1491 (1509)
T ss_pred C--CchhhhHhHH---HHHHHHHhcCchhhhHHHHH
Confidence 1 1122334334 44556999999999876643
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=280.79 Aligned_cols=247 Identities=21% Similarity=0.364 Sum_probs=185.6
Q ss_pred ChHHHHHHhhccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeE
Q 006559 329 NVGDLLKSSAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDEL 402 (640)
Q Consensus 329 ~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~ 402 (640)
++++... ..+.||+|+||.||+|+. .++..|++|.+.... ..+.+.+|++++++++|||++++.+++.+.+..
T Consensus 18 ~~~~~~~-~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 18 DPEEIFV-GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CHHHHhh-cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3344432 345699999999999985 467889999986431 124567889999999999999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 403 FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 403 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
|+||||++ |++.+++.... .++++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred EEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCC
Confidence 99999996 57877776432 258899999999999999999994 45999999999999999999999999998
Q ss_pred cccCC--CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 483 QLFHT--PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 483 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
..... ...++..|+|||++... ....++.++|||||||++|||++|+.|+..... ...+.........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~~~---- 238 (313)
T cd06633 169 SKSSPANSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNDSP---- 238 (313)
T ss_pred cccCCCCCccccccccChhhcccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCC----
Confidence 65432 23457789999975321 234567899999999999999999999865321 1111111111100
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ... .....+.+++.+||+.+|.+||++.+++.
T Consensus 239 --~~-~~~---~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 239 --TL-QSN---EWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred --CC-Ccc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001 11234667788899999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=281.23 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=182.1
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCC----------e
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD----------E 401 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----------~ 401 (640)
..+.||+|+||.||+|... +++.||+|.++... ....+..|++++++++||||+++++++.... .
T Consensus 11 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCc
Confidence 3568999999999999975 57889999986432 2345677899999999999999999987654 7
Q ss_pred EEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCc
Q 006559 402 LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV 481 (640)
Q Consensus 402 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 481 (640)
.++|+||+++ ++...+.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred EEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 9999999986 7777765432 258899999999999999999994 5699999999999999999999999999
Q ss_pred ccccCCC-------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHh-hc
Q 006559 482 HQLFHTP-------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMM-GQ 552 (640)
Q Consensus 482 ~~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~-~~ 552 (640)
+...... ...+..|+|||.+. ....++.++|||||||++|||++|+.||...+. .....+... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~------~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLL------GEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred cccccCCcccccccceeccCccChHHhc------CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 8765421 12356799999642 223457889999999999999999999974321 111111111 11
Q ss_pred c-ccccc-c--------cchhhcc----ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 553 D-ESAWE-V--------FDFELIM----DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 553 ~-~~~~~-~--------~d~~~~~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ...+. + .+..... ..........+.+++..||+.+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000 0 0000000 0001112346778888899999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=286.39 Aligned_cols=256 Identities=18% Similarity=0.315 Sum_probs=186.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC-----CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK-----DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 407 (640)
.+.||+|+||.||+++. .++..||||.+... .....+.+|+.+++.++|+||+++++++... ...|+|||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 45799999999999985 46889999998653 2234566789999999999999999988654 35899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+. ++|.+++.... ++++.....++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 90 LMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 996 68988886542 58899999999999999999994 4599999999999999999999999999876533
Q ss_pred C------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH-HHHHhhcc-cccc-
Q 006559 488 P------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK-WVQMMGQD-ESAW- 557 (640)
Q Consensus 488 ~------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~-~~~~~~~~-~~~~- 557 (640)
. ..++..|+|||.+.. ...++.++|||||||++|||++|+.||...+.. ... ........ ...+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLN------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred CcccccccccccCccChHHHhc------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 2 345678999996532 234678999999999999999999999643211 000 01110000 0000
Q ss_pred cccchh-------------hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhhcc
Q 006559 558 EVFDFE-------------LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM--IEDIRTK 608 (640)
Q Consensus 558 ~~~d~~-------------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~~ 608 (640)
.+.+.. ............++.+++.+||+.+|++|||+.++++. ++.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000000 00000011234567788999999999999999999865 6665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=280.86 Aligned_cols=249 Identities=19% Similarity=0.350 Sum_probs=179.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCC--------eEEE
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD--------ELFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~l 404 (640)
.+.||+|+||.||+|+.. +++.||||.+.... ....+.+|++++++++||||++++++|...+ ..++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 467999999999999964 58899999886432 1234567899999999999999999987643 4599
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
||||+++ +|.+++.... ..+++.....++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 97 v~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 97 VFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 9999974 8888876432 247899999999999999999995 4599999999999999999999999999876
Q ss_pred cCCC----------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcc
Q 006559 485 FHTP----------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQD 553 (640)
Q Consensus 485 ~~~~----------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~ 553 (640)
.... ...+..|+|||++.+ ...++.++||||||+++|||+||+.||...... ....+......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcC------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 5321 123567999996522 233567899999999999999999998753221 11111111100
Q ss_pred --cccc------cccch-hhccC--hHHHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 554 --ESAW------EVFDF-ELIMD--KEMEE------EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 554 --~~~~------~~~d~-~~~~~--~~~~~------~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...+ ...+. ..... ..... ....+.+++.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 00000 00000 00000 1234668899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=272.24 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=191.2
Q ss_pred hccccccCcceEEEEEeCC------CcEEEEEEeccccchH---HHHHHHHHHhccCCCcccceeEEEEcC-CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLDG------GDVVVVKRIRERKKKR---EVDEWLRVIGGLRHSNIVSIRAYCNGK-DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~---~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lV~E 407 (640)
.-++-+|.||.||+|.|.+ .+.|.||.++....+- .+..|...+..+.|||+.++.+++.+. +..+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 3468899999999997653 3456778777654433 355666778888999999999998764 57889999
Q ss_pred ccCCCCHHHhhccCCC---CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 408 YLPHGSLHSLLHGSRG---PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
|+..|+|+.+|...++ .....+.-.+...++.|++.|++|||. .+|||.||.++|++||+...+||+|=.++|-
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence 9999999999984332 234467778889999999999999994 5599999999999999999999999999886
Q ss_pred cCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccc
Q 006559 485 FHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDES 555 (640)
Q Consensus 485 ~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 555 (640)
+-+. ......||+|| ......|+.++|||||||+||||+| |+.|+.+-+ -.+...++.+..
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslE-------al~n~~yssasDvWsfGVllWELmtlg~~PyaeID--PfEm~~ylkdGy- 515 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLE-------ALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--PFEMEHYLKDGY- 515 (563)
T ss_pred cCcccccccCCCCCCcccccCHH-------HHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--HHHHHHHHhccc-
Confidence 5322 22355788888 4566788899999999999999999 999986422 222111211111
Q ss_pred cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 556 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
++.. .-+++.++..+|..||+.+|++||++++++.-|.++...
T Consensus 516 -------RlaQ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 516 -------RLAQ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -------eecC---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 1111 125667899999999999999999999999999998743
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=262.55 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=179.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccchHH---HHHHHHHHhc-cCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKRE---VDEWLRVIGG-LRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
...||.|..|.|++++.+ .|..+|||.+.....+++ +...++++.+ -+.|.||+.+|||......++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 345999999999999965 488999999987644433 3334444333 3469999999999999999999999853
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
.+..+++.-.+ ++++...-++...+.+||.||.. +.+|+|||+||+|||+|+.|.+|+||||++-.+...
T Consensus 176 C~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 176 CAEKLLKRIKG----PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 55556654432 57777788899999999999986 557999999999999999999999999998766432
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..+.+.|||||.+... ...+|+.++|||||||.|+||+||+.||.....+....-+.+..+. +.+...
T Consensus 250 rsAGC~~YMaPERidp~----~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-------P~L~~~ 318 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPP----DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-------PLLPGH 318 (391)
T ss_pred cccCCccccCccccCCC----CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-------CCCCcc
Confidence 3456789999976322 2457889999999999999999999999864443322111111111 111111
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....++.++...|+..|+.+||...++++
T Consensus 319 ---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 ---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ---cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 113445667777799999999998877653
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.82 Aligned_cols=252 Identities=16% Similarity=0.236 Sum_probs=170.9
Q ss_pred hccccccCcceEEEEEeCC--CcEEEEE------------------Eeccc-cchHHHHHHHHHHhccCCCcccceeEEE
Q 006559 338 AELLGKGCVGATYKVVLDG--GDVVVVK------------------RIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYC 396 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~ 396 (640)
.+.||+|+||+||++..+. +..+++| .+... .....+.+|++++++++|||||++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 232 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence 4679999999999987543 2222222 11111 1234577899999999999999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEE
Q 006559 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACI 476 (640)
Q Consensus 397 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl 476 (640)
...+..|+|+||+. ++|.+++..................++.|++.||+|||+ .+||||||||+|||++.++.+||
T Consensus 233 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~~vkL 308 (501)
T PHA03210 233 RSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVL 308 (501)
T ss_pred EECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999985 577777654321111122345667899999999999995 45999999999999999999999
Q ss_pred ccCCcccccCC-------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCC-CCCCCcch-HHHH
Q 006559 477 SDIGVHQLFHT-------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGI-VKWV 547 (640)
Q Consensus 477 ~DfGl~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p-~~~~~~~~-~~~~ 547 (640)
+|||+++.+.. ...++..|+|||++ ....++.++|||||||++|||++|+.+ +....... ....
T Consensus 309 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEIL-------AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred EeCCCceecCcccccccccccCCcCCCCchhh-------cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999986542 23468899999965 334577899999999999999998754 43322111 1111
Q ss_pred HHhhccc----c-------cccccch-hhcc-ChHHHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 548 QMMGQDE----S-------AWEVFDF-ELIM-DKEMEE------EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 548 ~~~~~~~----~-------~~~~~d~-~~~~-~~~~~~------~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+...... . .+..++. .+.. ...... ...++.+++.+|++.||++|||+.|++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111000 0 0000000 0000 000000 1124566778899999999999999975
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=285.00 Aligned_cols=243 Identities=19% Similarity=0.298 Sum_probs=180.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 406 (640)
.+.||+|+||.||+|+. .++..||+|.+... .....+.+|+.++++++||||+++++++... ...|+||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 46799999999999985 46889999998643 2234566789999999999999999998643 3579999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||++ ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 101 ELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred eccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 9996 588887753 26788889999999999999995 459999999999999999999999999998764
Q ss_pred CC-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhh---ccc-ccc
Q 006559 487 TP-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG---QDE-SAW 557 (640)
Q Consensus 487 ~~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~---~~~-~~~ 557 (640)
.. ..++..|+|||++ ....++.++|||||||++|||++|+.||...+. ...|..... ... ...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CCCCCCCCcccccccCHHHH-------hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence 32 2346789999964 334577899999999999999999999974321 111211110 000 000
Q ss_pred -----------------------cccchhhccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 -----------------------EVFDFELIMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 -----------------------~~~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+.. ...... .......+.+++.+|++.||++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPD-VLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcc-cccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 000000 0122345678899999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=269.09 Aligned_cols=235 Identities=23% Similarity=0.370 Sum_probs=185.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|++|.||+++.. ++..|++|.+.... ....+.+|++++++++|+|++++++++......++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 467999999999999864 57889999987653 2356788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 85 ~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 85 SLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred cHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 9999987542 58899999999999999999994 56999999999999999999999999998876432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...+..|+|||.. .....+.++||||+|+++|||++|+.|+.........|. .. ... . .. .
T Consensus 157 ~~~~~~~~y~~pe~~-------~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~-~~~-~-----~~--~ 219 (254)
T cd06627 157 ASVVGTPYWMAPEVI-------EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IV-QDD-H-----PP--L 219 (254)
T ss_pred cccccchhhcCHhhh-------cCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-Hh-ccC-C-----CC--C
Confidence 2346789999964 223367889999999999999999999875332111111 11 100 0 00 0
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. .....+.+++.+||..+|++||++.+++.
T Consensus 220 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PE---GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CC---CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11 11234667788899999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=278.71 Aligned_cols=244 Identities=19% Similarity=0.233 Sum_probs=185.9
Q ss_pred hccccccCcceEEEEEe----CCCcEEEEEEeccc------cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL----DGGDVVVVKRIRER------KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~----~~~~~vavK~l~~~------~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
.+.||+|+||.||+++. .++..||||.++.. ...+.+..|++++.++ +||||+++.+.+......++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 46799999999999884 35678999998743 1234567889999999 5999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++|+|.+++.... .+++.....++.|+++||+|||+ .+++||||||+||+++.++.++|+|||+++...
T Consensus 85 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 85 DYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred ecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999987532 57888999999999999999994 569999999999999999999999999987643
Q ss_pred CC-------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhcccccc
Q 006559 487 TP-------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDESAW 557 (640)
Q Consensus 487 ~~-------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~ 557 (640)
.. ..++..|+|||..... ....+.++||||||+++|||+||+.||...... ...+.+.....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 227 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGG-----SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS---- 227 (288)
T ss_pred cccccccccccCCccccCHHHhcCC-----CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc----
Confidence 21 2346789999964221 123567899999999999999999998632211 11111111110
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
...... .....+.+++.+||+.+|++|||+.+|.+.|+...
T Consensus 228 -----~~~~~~---~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 -----KPPFPK---TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred -----CCCCCc---ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 000111 11234567788899999999999999988776643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=291.32 Aligned_cols=259 Identities=24% Similarity=0.290 Sum_probs=188.8
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~E 407 (640)
.+.||+|+||.||+|+ -..|..||||..+.. ...+....|++++++++|+|||++++.=.+. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4679999999999999 567999999999874 3345566899999999999999999885543 36889999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC--CCC--CeEEccCCccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD--QLG--NACISDIGVHQ 483 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~--~~~--~~kl~DfGl~~ 483 (640)
||++|||+..+.... ...-|+....+.+..+++.||.||| +.+||||||||.||++- .+| .-||+|||.|+
T Consensus 98 yC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred ecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999998654 2345889999999999999999999 55699999999999984 444 46999999999
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc----hHHHHHHhhccc
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG----IVKWVQMMGQDE 554 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~----~~~~~~~~~~~~ 554 (640)
.+.. +.++|..|.+||+... ...|+..+|.|||||++||.+||..||...... .+.|.....+..
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYER------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhh------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 8764 4578999999997422 467788899999999999999999999743222 133433322221
Q ss_pred ccccccch----------hhccChH-HHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHHhhc
Q 006559 555 SAWEVFDF----------ELIMDKE-MEEEMRALLQVALLCLAPLPKDRP--NMSIVHRMIEDIRT 607 (640)
Q Consensus 555 ~~~~~~d~----------~~~~~~~-~~~~~~~l~~l~~~Cl~~~P~~RP--s~~~v~~~L~~i~~ 607 (640)
......+. .+..+.. .+.....+......++..+|++|- .+.+....+.+|..
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11110010 1111111 122233344445557777888888 66666665555543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=274.81 Aligned_cols=249 Identities=20% Similarity=0.276 Sum_probs=180.5
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEecccc----chHHHHHHHHHHh---ccCCCcccceeEEEEcCCe-----EEE
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRERK----KKREVDEWLRVIG---GLRHSNIVSIRAYCNGKDE-----LFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~e~~~l~---~l~H~niv~l~~~~~~~~~-----~~l 404 (640)
.+.||+|+||.||+|+... +..||+|.++... ....+..|+.+++ +++|+||+++.+++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 4679999999999999764 8899999997431 1234555665554 4579999999999988776 999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
+|||++ ++|.+++..... ..+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 84 ~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred Eehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999997 489988865431 258899999999999999999994 5599999999999999999999999999877
Q ss_pred cCCC-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhcccc--
Q 006559 485 FHTP-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDES-- 555 (640)
Q Consensus 485 ~~~~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~-- 555 (640)
.... ...+..|+|||++ ....++.++|||||||++|||+||+.||...... ...+.+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~-------~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVL-------LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred ccCCcccccccccccccChHHh-------ccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 6432 2346679999965 3345678999999999999999999998743211 1111111110000
Q ss_pred -c------ccccchhhcc--ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 556 -A------WEVFDFELIM--DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 556 -~------~~~~d~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ...+...... .....+....+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000000 0111223356778889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=271.61 Aligned_cols=239 Identities=22% Similarity=0.308 Sum_probs=187.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+++. .+++.+|+|.+... ....++.+|++++++++|+||+++.+++......++||||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 46799999999999985 46788999998753 22345678899999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+|++|||+++.....
T Consensus 85 ~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 85 DLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred CHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 99999865321 12358899999999999999999994 55999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|++||.+ ....++.++|+||||+++|||++|+.||...+.. +........ .. ..
T Consensus 161 ~~~~~~~~~Pe~~-------~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~-~~----------~~ 220 (256)
T cd08530 161 QIGTPHYMAPEVW-------KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQRG-KY----------PP 220 (256)
T ss_pred ccCCccccCHHHH-------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcC-CC----------CC
Confidence 2346789999964 3345677899999999999999999999754321 111111110 00 00
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01123445788888999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=275.38 Aligned_cols=249 Identities=20% Similarity=0.364 Sum_probs=186.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|++|.||+++.. +++.+++|.+.... ....+..|++++++++|+||+++++++...+..++||||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 356999999999999864 68889999987542 235677889999999999999999999999999999999975
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||.+......
T Consensus 83 ~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 83 DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 8888886542 258899999999999999999995 45999999999999999999999999998766432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHH-HHhhcc-cccccccch-
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWV-QMMGQD-ESAWEVFDF- 562 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~-~~~~~~-~~~~~~~d~- 562 (640)
...+..|+|||.+. ....++.++||||||+++|||+||+.||...+. +..... ...... ...+.....
T Consensus 156 ~~~~~~~~~~~PE~~~------~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 156 THYVVTRWYRAPELLL------GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred cCccCcccccCcHHHh------cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 23466799999752 223577899999999999999999999864332 111111 000000 000000000
Q ss_pred ------------hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ------------ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ------------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........++...++.+++..||++||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000111233456888999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=268.35 Aligned_cols=239 Identities=21% Similarity=0.341 Sum_probs=188.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||++... ++..+|+|++... ...+++.+|++++++++|+|++++.+.+...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 467999999999999965 5788999998754 23456788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++..... ....+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 85 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 85 DLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999876431 12368999999999999999999995 46999999999999999999999999998765432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||.. ....++.++||||+|+++|+|++|+.||...+ ..+......... .. .+
T Consensus 161 ~~~~~~~~y~~pe~~-------~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~-----~~-- 223 (258)
T cd08215 161 KTVVGTPYYLSPELC-------QNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--LLELALKILKGQ-YP-----PI-- 223 (258)
T ss_pred cceeeeecccChhHh-------ccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--HHHHHHHHhcCC-CC-----CC--
Confidence 2346679999964 33456789999999999999999999996543 222222211111 00 00
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ....++.+++.+||..+|++||++.++++
T Consensus 224 ~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PS---QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 01 12235677888899999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=278.89 Aligned_cols=248 Identities=20% Similarity=0.296 Sum_probs=181.9
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++. .++..||||++... ...+.+..|++++++++||||+++.+++.. ....++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 56899999999999985 47889999987643 234567789999999999999999999876 45789999998 5
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
++|.++++.. ++++.....++.|+++||+|||+ .+|+||||+|+||++++++.+||+|||+++.....
T Consensus 94 ~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 164 (328)
T cd07856 94 TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG 164 (328)
T ss_pred cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence 6898888643 46778888899999999999994 55999999999999999999999999998765432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhccc-c-cccccch--
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDE-S-AWEVFDF-- 562 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~-~-~~~~~d~-- 562 (640)
...+..|+|||.+. ....++.++|||||||++|||+||+.||...... ...+.+...... . ...+.+.
T Consensus 165 ~~~~~~y~aPE~~~------~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 165 YVSTRYYRAPEIML------TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred CcccccccCceeee------ccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 33467899999642 2235678999999999999999999999643321 111111111100 0 0000000
Q ss_pred -------hh--ccC--hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 563 -------EL--IMD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 563 -------~~--~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
.. ..+ ........++.+++.+|++.+|++||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000 0011123567788899999999999999988643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=282.55 Aligned_cols=253 Identities=18% Similarity=0.281 Sum_probs=183.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 406 (640)
.+.||+|+||.||+|+. .+++.||||++... .....+.+|++++++++||||+++++++... ...++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46799999999999985 46889999998643 1234577899999999999999999998654 3579999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+.. +|..+... .+++..+..++.|+++||+|||. .+|+||||||+||+++.++.+||+|||+++...
T Consensus 100 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 100 PYMQT-DLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred ccccc-CHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 99974 77766531 47888999999999999999995 459999999999999999999999999987654
Q ss_pred CC---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhccc--cc----
Q 006559 487 TP---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDE--SA---- 556 (640)
Q Consensus 487 ~~---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~--~~---- 556 (640)
.. ...+..|+|||++.. ...++.++|||||||++|||++|+.||...... ...-........ ..
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILN------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCCCceeeecccChhhhcC------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 32 344678999996522 234678999999999999999999999754311 111000000000 00
Q ss_pred -----ccccch-hhccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhc
Q 006559 557 -----WEVFDF-ELIMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRT 607 (640)
Q Consensus 557 -----~~~~d~-~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~ 607 (640)
....+. ....... ......++.+++.+||+.||++||++.+++. .++.++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000 0000000 0112245678888999999999999999984 4666653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=279.79 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=181.9
Q ss_pred hccccccCcceEEEEEeCC---CcEEEEEEecccc----chHHHHHHHHHHhcc-CCCcccceeEEEEcC----CeEEEE
Q 006559 338 AELLGKGCVGATYKVVLDG---GDVVVVKRIRERK----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGK----DELFLV 405 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~---~~~vavK~l~~~~----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~~~lV 405 (640)
.+.||+|+||.||+++... +..||+|++.... ..+.+..|+++++++ +||||+++++++... ...|++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 4679999999999999643 6789999987531 234567788999988 599999999875432 457899
Q ss_pred EeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 406 YDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
+||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 85 ~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 85 EELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred Eeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 99986 68999886433 58899999999999999999994 45999999999999999999999999998754
Q ss_pred CC----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHH-HHHhhcc
Q 006559 486 HT----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKW-VQMMGQD 553 (640)
Q Consensus 486 ~~----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~-~~~~~~~ 553 (640)
.. ...++..|+|||+.. ....++.++|||||||++|||++|+.||..... ..... +...+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIML------SFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred ccccccccccccCcccCccccCcHHHh------CCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 32 124577899999642 223567899999999999999999999874321 11111 1100000
Q ss_pred -c-ccccccch-------------hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhcc
Q 006559 554 -E-SAWEVFDF-------------ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRTK 608 (640)
Q Consensus 554 -~-~~~~~~d~-------------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~~ 608 (640)
. ....+.++ ..............+.+++.+|++.+|++|||+.+++. .+++.+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 0 00000000 00000000011345778899999999999999999863 45544443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=279.38 Aligned_cols=256 Identities=19% Similarity=0.299 Sum_probs=190.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCC-----eEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD-----ELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~E 407 (640)
.+.||+|+||.||+|+.. .+..||||++... ...+.+.+|+.+++.++|+||+++.+++...+ ..|+|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 467999999999999965 4889999998754 23456788999999999999999999988765 7899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|++ ++|.+++.... ++++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 85 ~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 85 LME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred chh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 998 58988887543 58899999999999999999995 4599999999999999999999999999876543
Q ss_pred C---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcc-c-c
Q 006559 488 P---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQD-E-S 555 (640)
Q Consensus 488 ~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~-~-~ 555 (640)
. ...+..|+|||++... ..++.++||||||+++|||+||+.||...... ....+...... . .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSS------SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred cccccccccccccccCcCCceeeecc------cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence 2 2346779999975321 25678999999999999999999999753321 11111110000 0 0
Q ss_pred ccc---------ccch-hhccCh----HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhcc
Q 006559 556 AWE---------VFDF-ELIMDK----EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRTK 608 (640)
Q Consensus 556 ~~~---------~~d~-~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~~ 608 (640)
.+. .+.. ...... ........+.+++.+||+.+|++||++.+++. .++++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 000 0000 000000 00112345778889999999999999999987 47776654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=266.75 Aligned_cols=228 Identities=23% Similarity=0.313 Sum_probs=181.3
Q ss_pred ccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 341 LGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 341 iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
||+|+||.||++... +++.+|+|.+.... ....+..|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 48889999987542 234677889999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++.... .+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence 99997543 47899999999999999999995 5699999999999999999999999999876533 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
...+..|++||.. .....+.++|+||||+++||+++|+.||...+. ....+..... ....+.
T Consensus 153 ~~~~~~~~~Pe~~-------~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~---------~~~~~~ 214 (250)
T cd05123 153 FCGTPEYLAPEVL-------LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILKD---------PLRFPE 214 (250)
T ss_pred CcCCccccChHHh-------CCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhcC---------CCCCCC
Confidence 3346789999964 334467889999999999999999999975432 1111111110 011111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSI 597 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~ 597 (640)
.. ..++.+++.+||..||++||++.+
T Consensus 215 ~~---~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FL---SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CC---CHHHHHHHHHHhcCCHhhCCCccc
Confidence 11 234667888899999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=267.00 Aligned_cols=235 Identities=22% Similarity=0.351 Sum_probs=178.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-------cchHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-------KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 407 (640)
.+.||+|+||.||+|.. .++..||+|.+... ...+.+.+|++++++++|+||+++++++... ...++|+|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 56899999999999985 45889999987432 1224577899999999999999999998764 46889999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++++|.+++.... .+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++....
T Consensus 87 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 87 YMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred eCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 999999999987542 47788899999999999999994 4599999999999999999999999999876432
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
...++..|+|||++ ....++.++|||||||++|||++|+.||.+.... ....+......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---- 226 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVI-------SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-AAIFKIATQPT---- 226 (264)
T ss_pred ccccCccccccCCcccccCHhhh-------cCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-HHHHHHHcCCC----
Confidence 12356789999964 3345678999999999999999999999743211 11111111100
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
....+.... ..+.+++.+|+. +|.+||+..++..
T Consensus 227 ----~~~~p~~~~---~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ----KPMLPDGVS---DACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCCCCcccC---HHHHHHHHHHhc-CcccCccHHHHhc
Confidence 000111222 345566677998 5799999987754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=276.99 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=178.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCC--------eEEE
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD--------ELFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~l 404 (640)
.+.||+|+||.||+|+.. +++.+|||++.... ....+.+|++++++++||||+++++++.... ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 567999999999999964 57889999886442 2235678899999999999999999875433 4799
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
||||+.. ++...+.... ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 93 v~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 93 VTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred EEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 9999975 6777766432 258899999999999999999995 4599999999999999999999999999876
Q ss_pred cCCC-----------------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHH-
Q 006559 485 FHTP-----------------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVK- 545 (640)
Q Consensus 485 ~~~~-----------------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~- 545 (640)
.... ..++..|+|||++. ....++.++|||||||++|||++|+.||..... ...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL------GERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhh------CCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5321 12255699999642 223467899999999999999999999874321 1111
Q ss_pred HHHHhhcc-ccccc-------cc----chhhccC--hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 546 WVQMMGQD-ESAWE-------VF----DFELIMD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 546 ~~~~~~~~-~~~~~-------~~----d~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........ +..+. .. ....... .........+.+++.+|++.+|++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111100 00000 00 0000000 001112246778899999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=272.48 Aligned_cols=233 Identities=20% Similarity=0.289 Sum_probs=182.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+++.. ++..||+|.+... ...+.+..|..++.+++ ||||+++++++...+..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 457999999999999964 6889999998653 22355677888999998 9999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc-
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF- 489 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~- 489 (640)
+++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++.......
T Consensus 86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999997543 58999999999999999999994 459999999999999999999999999987653221
Q ss_pred -------------------------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH
Q 006559 490 -------------------------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV 544 (640)
Q Consensus 490 -------------------------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~ 544 (640)
..+..|+|||+. .....+.++||||||++++|+++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~-------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-- 228 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-------NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-- 228 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHh-------CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--
Confidence 235679999964 3344678999999999999999999999754311
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCH----HHHH
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM----SIVH 599 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~----~~v~ 599 (640)
.-.+... +......... ...+.+++.+||+.+|++||++ .+++
T Consensus 229 ~~~~~~~---------~~~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 229 LTFQKIL---------KLEYSFPPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHHHHHH---------hcCCCCCCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1011111 0011111111 3346778888999999999999 6654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=279.68 Aligned_cols=253 Identities=19% Similarity=0.298 Sum_probs=184.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCC------eEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD------ELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lV~ 406 (640)
.+.||+|+||.||++.. .++..||||++... ...+.+..|++++++++||||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 46799999999999984 56889999998643 12345778999999999999999999987543 468999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+ +++|.+++... .+++..+..++.|+++||+|||. .+|+||||||+||+++.++.+||+|||++....
T Consensus 100 e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 100 PFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 999 67998887642 47899999999999999999994 569999999999999999999999999988654
Q ss_pred CC---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 487 TP---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 487 ~~---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
.. ...+..|+|||.+.. ...++.++|||||||++||+++|+.||...... ....+...........+...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 170 SEMTGYVVTRWYRAPEVILN------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cCccccccCCcccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHh
Confidence 32 344778999997521 134678899999999999999999999753211 11111000000000000000
Q ss_pred h--------------ccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHHHHhhc
Q 006559 564 L--------------IMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVH--RMIEDIRT 607 (640)
Q Consensus 564 ~--------------~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~--~~L~~i~~ 607 (640)
+ ..... ......++.+++.+|++.||++|||+.+++ ..++.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0 00000 011233577889999999999999999987 45555543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.66 Aligned_cols=247 Identities=20% Similarity=0.265 Sum_probs=177.5
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcC--------------C
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK--------------D 400 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------------~ 400 (640)
.+.||+|+||.||+|.. .++..||+|++... ...+.+.+|++++++++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 56799999999999985 45889999988654 3345678899999999999999999776543 3
Q ss_pred eEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccC
Q 006559 401 ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDI 479 (640)
Q Consensus 401 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~Df 479 (640)
..++||||++ ++|.+++... .+++.....++.|++.||.|||+ .+|+||||||+||+++ +++.+|++||
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCc
Confidence 5799999997 5898888642 47889999999999999999994 4599999999999998 4567899999
Q ss_pred CcccccCCC---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hH-HHHH
Q 006559 480 GVHQLFHTP---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IV-KWVQ 548 (640)
Q Consensus 480 Gl~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~-~~~~ 548 (640)
|+++..... ..++..|+|||++. ....++.++|||||||++|||++|+.||...... .. ....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL------SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHh------CccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 998765321 23466799999642 2234678999999999999999999999643211 00 0000
Q ss_pred Hhhcc-c----cccc-----cc-chhhccC---hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 549 MMGQD-E----SAWE-----VF-DFELIMD---KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 549 ~~~~~-~----~~~~-----~~-d~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..... . .... .. +...... ........++.+++..|++.||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0 0000 00 0000000 000112245778889999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=238.27 Aligned_cols=189 Identities=22% Similarity=0.421 Sum_probs=161.0
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
-|+||+|.||+||+|+ ...++.||+|+++.... .....+|+.+++.++|.|||+++++...+..+-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 4679999999999999 55688899999875422 34567899999999999999999999999999999999965
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|..+.....+ .++......++.|+.+||.|+|+.+ +.|||+||.|.||+.+|+.|++|||+++.++-+
T Consensus 86 dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 86 DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 88888765543 4788889999999999999999655 999999999999999999999999999988744
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGE 540 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~ 540 (640)
.+.|.+|++|.++.++ .-|++..|+||.||++.|+.. |++.|.+++
T Consensus 159 saevvtlwyrppdvlfga------kly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGA------KLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred eceeeeeeccCcceeeee------ehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 3458899999997544 456788999999999999987 676676543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=269.48 Aligned_cols=238 Identities=21% Similarity=0.273 Sum_probs=178.8
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEeccc-------cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRER-------KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+++... +..+++|.++.. ....++..|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 4679999999999998543 444555555431 12234567888999999999999999999889999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+||++++ +.+||+|||+++....
T Consensus 85 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 85 EGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred CCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 99999998864321 12358999999999999999999994 56999999999999975 5699999999876532
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...++..|+|||.. ....++.++||||||+++|||++|+.||.... ............ .+.
T Consensus 160 ~~~~~~~~~~~~~~pe~~-------~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~------~~~ 224 (260)
T cd08222 160 DLATTFTGTPYYMSPEAL-------KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--FLSVVLRIVEGP------TPS 224 (260)
T ss_pred ccccCCCCCcCccCHHHH-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHcCC------CCC
Confidence 22346689999954 33456778999999999999999999996432 222211111110 000
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+ .....++.+++.+||..+|++||++.++++
T Consensus 225 --~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 --LP---ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --Cc---chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 122345677888999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=278.18 Aligned_cols=247 Identities=17% Similarity=0.269 Sum_probs=179.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 406 (640)
.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|++++++++||||+++.+++... ...|+++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 46799999999999984 568899999987531 234567799999999999999999988643 3478888
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
|++ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 887 78998887643 47899999999999999999994 559999999999999999999999999987654
Q ss_pred CC---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhccc-ccc-cc
Q 006559 487 TP---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDE-SAW-EV 559 (640)
Q Consensus 487 ~~---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~-~~~-~~ 559 (640)
.. ..++..|+|||+.. ....++.++|||||||++|||++|+.||...... .....+...... ... .+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~------~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 172 DEMTGYVATRWYRAPEIML------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccccccCCCccCHHHHh------CccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 32 34477899999642 2234678999999999999999999998643211 111111111000 000 00
Q ss_pred cch-------hhc--cChHHH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDF-------ELI--MDKEME----EEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~-------~~~--~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+. .+. ...... ....++.+++..|++.||++||++.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000 000 000000 11235678888999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=280.24 Aligned_cols=247 Identities=19% Similarity=0.301 Sum_probs=181.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCe------EEEEE
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDE------LFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lV~ 406 (640)
.+.||+|+||.||+|+.. ++..||||++... ...+.+..|+.++++++||||+++.+++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 467999999999999964 5788999988643 123456678999999999999999998766554 89999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++....
T Consensus 100 e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 100 HLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 998 56999988742 48899999999999999999994 569999999999999999999999999987654
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHH-HHhhccc-cc-ccc
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWV-QMMGQDE-SA-WEV 559 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~-~~~~~~~-~~-~~~ 559 (640)
. ....+..|+|||+... ...++.++|||||||++|||+||+.||...... ..... ....... .. ..+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 170 DEMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccccCCcccccccCHHHHhC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 3 2345778999996521 224678999999999999999999999743221 11111 1000000 00 000
Q ss_pred c--------c-hhhccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 F--------D-FELIMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~--------d-~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. . ........ ......++.+++.+|++.+|++|||+.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 0 00000000 0112356788999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=270.16 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=185.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +++.+|+|.+.... ..+.+..|+.++++++|+||+++++++...+..++||||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 356999999999999965 48899999987642 23566788999999999999999999999999999999998 5
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||+++.....
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 9999997542 258899999999999999999995 45999999999999999999999999998765432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhc--ccccccc----
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQ--DESAWEV---- 559 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~--~~~~~~~---- 559 (640)
...+..|+|||.+. ....++.++|||||||++|||++|+.||..... .....+..... .+..+..
T Consensus 156 ~~~~~~~~~~aPE~~~------~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 156 THEVVTLWYRAPEILL------GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred CccccCcCcCChHHhc------CCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 22356799999652 223567899999999999999999999875321 11111111000 0000000
Q ss_pred --cch---hhcc---ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 --FDF---ELIM---DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 --~d~---~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+. .... ..........+.+++..||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 0000 0001112346888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=285.88 Aligned_cols=244 Identities=18% Similarity=0.306 Sum_probs=196.0
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccc-cchHHHHHHHHHHhcc-CCCcccceeEEEEc-----CCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRER-KKKREVDEWLRVIGGL-RHSNIVSIRAYCNG-----KDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-----~~~~~lV~Ey 408 (640)
..++||+|.+|.||+++ .++++.+|||++... ...++++.|.++++.+ .|||++.++|++.. ++++||||||
T Consensus 23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 36789999999999999 567889999998765 4466788888888877 58999999999864 5789999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
|.+|+..++++...+ ..+.|..+..|++++++|++||| ..+++|||+|-.|||++.++.+|++|||++..++.
T Consensus 103 C~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred cCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 999999999987652 35899999999999999999999 56699999999999999999999999999877653
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
..++|+.|||||++..... ....|+.++|+||+|++..||.-|.+|+.+-.- + + .+..+...
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~--~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--m---r------aLF~IpRN 243 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDES--PDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--M---R------ALFLIPRN 243 (953)
T ss_pred cccccCcCCCcccccceeeecccC--CCCCcccccchhhccceeehhcCCCCCccCcch--h---h------hhccCCCC
Confidence 4577999999998754422 234578899999999999999999999854221 1 1 11122111
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
........+....++.+++..|+..|-++||++.+.+
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 1111123356777888899999999999999998876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=265.11 Aligned_cols=219 Identities=21% Similarity=0.242 Sum_probs=168.8
Q ss_pred cCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHhhccCC
Q 006559 344 GCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSR 422 (640)
Q Consensus 344 G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~ 422 (640)
|.||.||+++. .+++.+|+|.+.... .+..|...+....||||+++++++...+..++||||+++|+|.+++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc
Confidence 89999999995 567899999987542 23344455555679999999999999999999999999999999987543
Q ss_pred CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---ccccccccCCc
Q 006559 423 GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---FFINDAYNAPE 499 (640)
Q Consensus 423 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---~~~~~~y~aPE 499 (640)
.+++.....++.|++.||+||| +.+|+||||||+||+++.++.++++|||.+...... ...+..|+|||
T Consensus 81 -----~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 81 -----NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred -----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 4889999999999999999999 456999999999999999999999999987665432 23356799999
Q ss_pred cccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHH
Q 006559 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQ 579 (640)
Q Consensus 500 ~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~ 579 (640)
.. ....++.++||||+||++|||++|+.|+....... .. ... +..+.. ...++.+
T Consensus 153 ~~-------~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------~~-----~~~--~~~~~~---~~~~~~~ 207 (237)
T cd05576 153 VG-------GISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------NT-----HTT--LNIPEW---VSEEARS 207 (237)
T ss_pred cc-------CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------cc-----ccc--cCCccc---CCHHHHH
Confidence 53 34456789999999999999999998875321100 00 000 001111 1234667
Q ss_pred HHHHccCCCCCCCCCHHHH
Q 006559 580 VALLCLAPLPKDRPNMSIV 598 (640)
Q Consensus 580 l~~~Cl~~~P~~RPs~~~v 598 (640)
++.+|++.||++||++.+.
T Consensus 208 li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHccCCHHHhcCCCcc
Confidence 7888999999999997544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=259.50 Aligned_cols=256 Identities=22% Similarity=0.287 Sum_probs=192.2
Q ss_pred ChHHHHHHhhccccccCcceEEEEE-eCCCcEEEEEEeccc--cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 329 NVGDLLKSSAELLGKGCVGATYKVV-LDGGDVVVVKRIRER--KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 329 ~~~~~~~~~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
.++|+++-+.++||+|+|+.|--++ +.+|.++|||++.+. ..+..+.+|++++..- .|+||++|+++|.++..+||
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 4688888889999999999998887 788999999999766 4456677888887765 59999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC---CeEEccCCc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG---NACISDIGV 481 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGl 481 (640)
|||-|.+|.|..++++.+ .++..+.-++..+||.||.||| ..+|.||||||+|||-.... -+|||||-|
T Consensus 154 VfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999998654 6889999999999999999999 56699999999999986543 589999987
Q ss_pred ccccC---------C----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 006559 482 HQLFH---------T----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQ 548 (640)
Q Consensus 482 ~~~~~---------~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~ 548 (640)
..-.. + ..+++..|||||+...- ......|+.+.|.||+|||||-|+.|.+||.+.-...--|-+
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~f--v~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVF--VDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhh--ccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 54321 1 13456789999975311 223456889999999999999999999999854333333321
Q ss_pred Hhhcc-----------cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 549 MMGQD-----------ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 549 ~~~~~-----------~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.-.-. +-..++-|.++ ..++.+.++++ ...+..||.+|-++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdW---ahIS~eakdli---snLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEFPDKDW---AHISSEAKDLI---SNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcCChhhh---HHhhHHHHHHH---HHHHhccHHhhhhhhhccC
Confidence 11100 00111111111 12344444444 4466689999999888875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=297.29 Aligned_cols=237 Identities=23% Similarity=0.331 Sum_probs=172.9
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEE------------------
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYC------------------ 396 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~------------------ 396 (640)
++||+||||.|||++- -||..+|||++.-... ...+.+|+.++++|+|||||+++..+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 5799999999999994 4799999999986632 34567899999999999999997321
Q ss_pred ------------------------------------------E------c------------------------------
Q 006559 397 ------------------------------------------N------G------------------------------ 398 (640)
Q Consensus 397 ------------------------------------------~------~------------------------------ 398 (640)
. .
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence 0 0
Q ss_pred ---------------C--------CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 006559 399 ---------------K--------DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455 (640)
Q Consensus 399 ---------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 455 (640)
+ ..+||=||||+.-.++++++.+... -.-...++++++|++||.|+| ..+
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYIH---~~g 717 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYIH---DQG 717 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHHH---hCc
Confidence 0 1368889999998888888765411 034677889999999999999 455
Q ss_pred ceecCCCCCCeEECCCCCeEEccCCcccccC------------------------CCccccccccCCccccCCCCccccC
Q 006559 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFH------------------------TPFFINDAYNAPELKFNNNNNYSQR 511 (640)
Q Consensus 456 ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------------------------~~~~~~~~y~aPE~~~~~~~~~~~~ 511 (640)
||||||||.||+||++..+||+|||++.... +..++|.-|+|||++... ...
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~----~~~ 793 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT----SSN 793 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc----ccc
Confidence 9999999999999999999999999987621 124568889999987432 124
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh-HHHHHHHHHHHHHHHccCCCCC
Q 006559 512 KFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK-EMEEEMRALLQVALLCLAPLPK 590 (640)
Q Consensus 512 ~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~l~~l~~~Cl~~~P~ 590 (640)
.|+.|+|+||+|||++||+. ||... +.-+..+..+.. ..+..+. ...+.+..-.+++.++++.||.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~Ts-MERa~iL~~LR~---------g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTS-MERASILTNLRK---------GSIPEPADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCch-HHHHHHHHhccc---------CCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence 78999999999999999996 56421 222222222221 1111110 0112223334567779999999
Q ss_pred CCCCHHHHH
Q 006559 591 DRPNMSIVH 599 (640)
Q Consensus 591 ~RPs~~~v~ 599 (640)
+|||+.|++
T Consensus 861 kRPtA~eLL 869 (1351)
T KOG1035|consen 861 KRPTATELL 869 (1351)
T ss_pred cCCCHHHHh
Confidence 999999886
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=259.68 Aligned_cols=228 Identities=23% Similarity=0.341 Sum_probs=180.6
Q ss_pred HhhccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHH---HHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 336 SSAELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREV---DEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 336 ~~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~---~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.++||+|.||+|-+++- ..++.+|+|++++. ..+.++ ..|-++|+.-+||.+..|...|+..+.+|+||||+
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 3467899999999999985 46889999999876 234443 35778999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc----
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF---- 485 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~---- 485 (640)
.+|.|.-+|...+ .++......+-.+|..||.|||+.+ ||.||||.+|.|||.+|++||+|||+++.-
T Consensus 251 nGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 251 NGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred cCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccccc
Confidence 9999998887654 5777777888999999999999654 999999999999999999999999998753
Q ss_pred --CCCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccccccch
Q 006559 486 --HTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 486 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~ 562 (640)
...+++|+.|.|||++ ....|+..+|.|.+||++|||+.|+.||...+.+ +.+.+ .-.
T Consensus 323 ~t~kTFCGTPEYLAPEVl-------eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI------------l~e 383 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVL-------EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI------------LME 383 (516)
T ss_pred ceeccccCChhhcCchhh-------ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH------------Hhh
Confidence 2357889999999975 4556778999999999999999999999854332 22211 111
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCC
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRP 593 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 593 (640)
.+..+..+..+.+.++ ...+..||++|-
T Consensus 384 d~kFPr~ls~eAktLL---sGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 DLKFPRTLSPEAKTLL---SGLLKKDPKKRL 411 (516)
T ss_pred hccCCccCCHHHHHHH---HHHhhcChHhhc
Confidence 1222223334444443 447889999996
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=298.32 Aligned_cols=138 Identities=22% Similarity=0.344 Sum_probs=122.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|... .+..||||+++... ....+..|+.++..++||||+++++++...+..|+||||+++
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999965 68899999987542 135677889999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
|+|.+++.... .+++...+.|+.||+.||+|||. .+||||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999997543 47888899999999999999995 469999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=264.47 Aligned_cols=243 Identities=21% Similarity=0.286 Sum_probs=182.8
Q ss_pred ccccccCcceEEEEE-eCCCcEEEEEEeccccch---------HHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEe
Q 006559 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKK---------REVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYD 407 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~---------~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 407 (640)
++||+|||+.||++. +...+.||||+-...+.. +...+|.++.+.|+||.||++++++.- .+.+|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 579999999999998 566788999986544221 234567889999999999999999864 578999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC---CCCCeEEccCCcccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD---QLGNACISDIGVHQL 484 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGl~~~ 484 (640)
||++.+|.-||+..+ .++..+...|+.||..||.||... +++|||-||||.||||. ..|.+||.||||++.
T Consensus 549 YceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999998665 578889999999999999999976 57899999999999995 568999999999998
Q ss_pred cCCC-------------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhh
Q 006559 485 FHTP-------------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG 551 (640)
Q Consensus 485 ~~~~-------------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~ 551 (640)
+... ..+|-+|.+||.+.-.. ...+++.|+||||.||++|..+.|+.||+.+... -..+
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk---ePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdIL---- 694 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK---EPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDIL---- 694 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCC---CCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHH----
Confidence 7532 34577899999874321 1356789999999999999999999999854221 1111
Q ss_pred cccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006559 552 QDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIV 598 (640)
Q Consensus 552 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v 598 (640)
++..+...-.......+....+ .-.++.+|++..-++|-...++
T Consensus 695 qeNTIlkAtEVqFP~KPvVsse---AkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 695 QENTILKATEVQFPPKPVVSSE---AKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hhhchhcceeccCCCCCccCHH---HHHHHHHHHHhhhhhhhhHHHH
Confidence 1111111111122222223333 3456677999999999765544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=288.53 Aligned_cols=256 Identities=18% Similarity=0.254 Sum_probs=161.3
Q ss_pred hhccccccCcceEEEEEeCC-----CcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEE------EEcCCeEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG-----GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAY------CNGKDELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------~~~~~~~~lV 405 (640)
..+.||+|+||.||+|+..+ +..||||++......+....+ .+....+.+++.+... +......++|
T Consensus 136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV 213 (566)
T PLN03225 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLV 213 (566)
T ss_pred EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence 35789999999999999754 578999988654322221111 1222223333332221 2345689999
Q ss_pred EeccCCCCHHHhhccCCCC---------------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC
Q 006559 406 YDYLPHGSLHSLLHGSRGP---------------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ 470 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~ 470 (640)
|||+++++|.+++...... .........+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~~ 290 (566)
T PLN03225 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSE 290 (566)
T ss_pred EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEeC
Confidence 9999999999998753210 00011223456789999999999994 46999999999999985
Q ss_pred -CCCeEEccCCcccccC-------CCccccccccCCccccCCCCccc---------------cCCCCCccchHHHHHHHH
Q 006559 471 -LGNACISDIGVHQLFH-------TPFFINDAYNAPELKFNNNNNYS---------------QRKFWQRCDVYSFGVVLL 527 (640)
Q Consensus 471 -~~~~kl~DfGl~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~---------------~~~~~~k~DV~SfGvvl~ 527 (640)
++.+||+|||+++.+. .....++.|+|||.+.+...... ...++.++|||||||+||
T Consensus 291 ~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~ 370 (566)
T PLN03225 291 GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370 (566)
T ss_pred CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence 6899999999997643 23455789999996543322111 123567889999999999
Q ss_pred HHHhCCCCCCCCCcchHHHHHHhhccc---cccc-ccchhhccC-----hHHHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006559 528 EILTGKMAKGDGELGIVKWVQMMGQDE---SAWE-VFDFELIMD-----KEMEEEMRALLQVALLCLAPLPKDRPNMSIV 598 (640)
Q Consensus 528 el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~-~~d~~~~~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v 598 (640)
||+++..+++.. ...+.+...... ..|. ........+ +..........+++.+|++.||++|||+.++
T Consensus 371 el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~ 447 (566)
T PLN03225 371 QMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA 447 (566)
T ss_pred HHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHH
Confidence 999988776432 111111111100 0000 000000000 0000111234578888999999999999999
Q ss_pred HH
Q 006559 599 HR 600 (640)
Q Consensus 599 ~~ 600 (640)
++
T Consensus 448 L~ 449 (566)
T PLN03225 448 LA 449 (566)
T ss_pred hC
Confidence 76
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=289.11 Aligned_cols=192 Identities=20% Similarity=0.289 Sum_probs=164.6
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..++||+|+||.|..++++ .++++|+|++.+. ....-|.+|-.+|..-+.+.||.+...|.+...+|+|||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 3568999999999999975 5788999999763 334568888889988889999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
||+|-.++.... +++..-...++..|..||.-|| ..++|||||||+|||||.+|++||+|||-+-.+.
T Consensus 159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999998653 4666667778999999999999 5669999999999999999999999999876554
Q ss_pred ---CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 487 ---TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 487 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
...++|+.|++||++..... ..+.|+..+|.||+||++|||+.|..||..
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~--~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGD--GKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcC--CccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 23568999999999864322 246789999999999999999999999974
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=261.41 Aligned_cols=228 Identities=21% Similarity=0.300 Sum_probs=175.3
Q ss_pred hhccccccCcceEEEEEeCC-CcEEEEEEeccccc-----hHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG-GDVVVVKRIRERKK-----KREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-----~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
+..+||+|+||.|.++..++ .+.+|||++++.-. -+--+.|-++|.-. +-|.++++..+|+..+.+|+||||+
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyv 432 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYV 432 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEe
Confidence 35789999999999998655 56799999987611 11123455555543 4688999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc----
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF---- 485 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~---- 485 (640)
.+|+|--+++... .+.+.....+|.+||-||-||| ..+||.||||..|||||.+|++||+|||+.+.-
T Consensus 433 nGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 433 NGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred cCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 9999988887554 3666678889999999999999 556999999999999999999999999998753
Q ss_pred --CCCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 486 --HTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 486 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...+++|+.|+|||++ ..+.|+..+|.|||||+||||+.|++||++++.+.+ ...|.+..
T Consensus 505 ~TTkTFCGTPdYiAPEIi-------~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-----------F~aI~ehn 566 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEII-------AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-----------FQAIMEHN 566 (683)
T ss_pred cceeeecCCCcccccceE-------EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-----------HHHHHHcc
Confidence 2356789999999975 456677889999999999999999999986543211 12233334
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCC
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRP 593 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 593 (640)
...++.++.+... +...-+...|.+|-
T Consensus 567 vsyPKslSkEAv~---ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 VSYPKSLSKEAVA---ICKGLLTKHPGKRL 593 (683)
T ss_pred CcCcccccHHHHH---HHHHHhhcCCcccc
Confidence 4455555554443 44446777888875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=250.79 Aligned_cols=231 Identities=23% Similarity=0.367 Sum_probs=183.3
Q ss_pred CcceEEEEEeCC-CcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHhhcc
Q 006559 345 CVGATYKVVLDG-GDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHG 420 (640)
Q Consensus 345 ~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 420 (640)
+||.||+|+..+ ++.+|+|.+..... .+.+.+|++.+++++|+||+++.+++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 88999999876533 57788999999999999999999999998999999999999999999875
Q ss_pred CCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----ccccccc
Q 006559 421 SRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-----FFINDAY 495 (640)
Q Consensus 421 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-----~~~~~~y 495 (640)
.. .+++..+..++.++++++.|||. .+++|+||+|+||++++++.++++|||.+...... ...+..|
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCC
Confidence 43 27889999999999999999994 46999999999999999999999999998876542 3446789
Q ss_pred cCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHH
Q 006559 496 NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMR 575 (640)
Q Consensus 496 ~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 575 (640)
++||.. ....++.++||||||+++|||++|+.||.... ......+........ ..........
T Consensus 153 ~~pE~~-------~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~~ 215 (244)
T smart00220 153 MAPEVL-------LGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPP---------FPPPEWKISP 215 (244)
T ss_pred CCHHHH-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCC---------CccccccCCH
Confidence 999964 34556789999999999999999999986521 112222222211100 0000000234
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 576 ALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 576 ~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
++.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 5777888999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=249.69 Aligned_cols=241 Identities=20% Similarity=0.245 Sum_probs=180.8
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHh-ccCCCcccceeEEEEc----CCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIG-GLRHSNIVSIRAYCNG----KDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~----~~~~~lV~Ey~~ 410 (640)
+.++||-|-.|.|..+.. ..|+.+|+|.+.+... ..+|+++.- .-.|||||.++++|.. ...+.+|||.|+
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K---ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK---ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhcCHH---HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 457899999999999885 4678899999886632 233444322 2369999999999864 456889999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCC
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHT 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~ 487 (640)
+|.|.+.++..+ ...+++.+.-.|+.||+.|+.|||+.+ |.||||||+|+|... |-.+||+|||+|+....
T Consensus 143 GGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 143 GGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred chHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999998764 346999999999999999999999655 999999999999964 55799999999998653
Q ss_pred C-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccccccc
Q 006559 488 P-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 488 ~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d 561 (640)
. .+.|+.|.|||++ ...+|+...|+||+||++|-|+.|-+||..+..- +..-++...... ..++-+
T Consensus 217 ~~~L~TPc~TPyYvaPevl-------g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g-qy~FP~ 288 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG-QYEFPE 288 (400)
T ss_pred CccccCCcccccccCHHHh-------CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc-CccCCC
Confidence 2 3458899999964 5567888999999999999999999999854332 111111111000 011111
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
++.++..++..+++...+..+|++|-|+.+++.
T Consensus 289 ------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 289 ------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 233344445556667789999999999998864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=235.97 Aligned_cols=195 Identities=21% Similarity=0.326 Sum_probs=156.7
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccc---cchHHHHHHHHH-HhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRER---KKKREVDEWLRV-IGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|++|.|-+-+ ..+|+..|||+++.. +.++....|+.+ ++....|.+|.++|........++.||.|..
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 35679999999998887 467999999999866 233444556654 4456789999999999999999999999965
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc--
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF-- 489 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~-- 489 (640)
||..+-++.-.. ...+++...-+||..|..||.|||+ +..|||||+||+|||++.+|.+|+||||++-.+..+.
T Consensus 130 -Sldkfy~~v~~~-g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 130 -SLDKFYRKVLKK-GGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred -hHHHHHHHHHhc-CCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 777664432211 1257788889999999999999997 5679999999999999999999999999988775432
Q ss_pred ---cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 490 ---FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 490 ---~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
.+...|||||.+-.. .....|+-|+||||+|+.+.||.+++.||+.
T Consensus 206 t~daGCkpYmaPEri~~e---~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPE---LNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHhcCCCccCChhhcCcc---cCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 345689999976443 2334789999999999999999999999964
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=272.07 Aligned_cols=230 Identities=20% Similarity=0.281 Sum_probs=176.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHh-ccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIG-GLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
...+|.|+|+.|-++.. ..++..+||++.+. ..+..+|+.++. .-+||||+++.+.+.+..+.|+|||++.+|-+.
T Consensus 327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred ccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 34599999999988874 56788999998765 223334554433 347999999999999999999999999999888
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE-CCCCCeEEccCCcccccCCC---ccc
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV-DQLGNACISDIGVHQLFHTP---FFI 491 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl-~~~~~~kl~DfGl~~~~~~~---~~~ 491 (640)
+.+.... .+. ..+..|+.+++.|+.|||. .+||||||||+|||+ ++.+.++|+|||.++..... .+.
T Consensus 405 ~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~ 475 (612)
T KOG0603|consen 405 RRIRSKP-----EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL 475 (612)
T ss_pred HHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence 8776543 122 5677799999999999994 569999999999999 58999999999999887654 345
Q ss_pred cccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHH
Q 006559 492 NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEME 571 (640)
Q Consensus 492 ~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 571 (640)
|..|.|||++ ....+|+++|+||||++||||++|+.||.....+ .+....+... .. ....+
T Consensus 476 t~~y~APEvl-------~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~---------~~--s~~vS 536 (612)
T KOG0603|consen 476 TLQYVAPEVL-------AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMP---------KF--SECVS 536 (612)
T ss_pred hhcccChhhh-------ccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCC---------cc--ccccC
Confidence 8899999974 3667889999999999999999999999865443 2212111111 00 02233
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 572 EEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 572 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+. ..+++..|++.||.+||+|.++..
T Consensus 537 ~~---AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 537 DE---AKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HH---HHHHHHHhccCChhhCcChhhhcc
Confidence 44 445566799999999999999853
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=248.57 Aligned_cols=249 Identities=19% Similarity=0.377 Sum_probs=182.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---c-chHHHHHHHHHHhccCCCcccceeEEEEcC--------CeEEE
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---K-KKREVDEWLRVIGGLRHSNIVSIRAYCNGK--------DELFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~l 404 (640)
..+||+|.||.||+|+.+ .|+.||+|++--. . ......+|+++|..++|+|++.+.+.|... ..+|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 357999999999999954 4667887765321 1 223456889999999999999998887542 35999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
||++|+. +|..+|.... ..++...+.+++.++..||.|+| +..|+|||+|+.|+||+.+|.+||+|||+++.
T Consensus 102 Vf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 9999987 8888886542 35788899999999999999999 55699999999999999999999999999977
Q ss_pred cCCC----------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHh-hc
Q 006559 485 FHTP----------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMM-GQ 552 (640)
Q Consensus 485 ~~~~----------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~-~~ 552 (640)
+... .+.|.+|++||.+. ..+.|+++.|||..||++.||.||.+-+.++.. .....+..+ +.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllL------G~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLL------GDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhh------cccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 6421 23488999999874 456778999999999999999999988875322 222222221 11
Q ss_pred -ccccccccch---------hhccCh---HHHHHHH------HHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 553 -DESAWEVFDF---------ELIMDK---EMEEEMR------ALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 553 -~~~~~~~~d~---------~~~~~~---~~~~~~~------~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
....|.-+|. +..... ..++.++ +.++++-..+..||.+|++..+++.
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1222332221 100000 1223333 5666777789999999999888763
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=271.72 Aligned_cols=198 Identities=21% Similarity=0.278 Sum_probs=144.4
Q ss_pred hhccccccCcceEEEEEe-----------------CCCcEEEEEEeccccc--hHH--------------HHHHHHHHhc
Q 006559 337 SAELLGKGCVGATYKVVL-----------------DGGDVVVVKRIRERKK--KRE--------------VDEWLRVIGG 383 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~--~~~--------------~~~e~~~l~~ 383 (640)
..++||+|+||+||+|.. ..+..||||++..... .++ ...|+..+.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 467899999999999964 2346799999864311 112 2235566677
Q ss_pred cCCCcc-----cceeEEEEc--------CCeEEEEEeccCCCCHHHhhccCCCC-------------------CCCCcCH
Q 006559 384 LRHSNI-----VSIRAYCNG--------KDELFLVYDYLPHGSLHSLLHGSRGP-------------------GRMPVDW 431 (640)
Q Consensus 384 l~H~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~~-------------------~~~~l~~ 431 (640)
++|.++ ++++++|.. ++..+|||||+++|+|.++++...+. ....++|
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 766654 677888753 35789999999999999998753211 0123578
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------ccccccccCCccccCC
Q 006559 432 NKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------FFINDAYNAPELKFNN 504 (640)
Q Consensus 432 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~~~~~~y~aPE~~~~~ 504 (640)
..+..++.|++.||.|||. .+|+||||||+|||++.++.+||+|||+++..... ...++.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 8889999999999999994 45999999999999999999999999998754321 1236789999986533
Q ss_pred CCcccc---------------CCCCCccchHHHHHHHHHHHhCCC-CCC
Q 006559 505 NNNYSQ---------------RKFWQRCDVYSFGVVLLEILTGKM-AKG 537 (640)
Q Consensus 505 ~~~~~~---------------~~~~~k~DV~SfGvvl~el~tg~~-p~~ 537 (640)
...... .....+.||||+||+++||++|.. |+.
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 211000 012235799999999999999986 654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=232.18 Aligned_cols=246 Identities=17% Similarity=0.288 Sum_probs=186.4
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccccchHHHHHHHHHHhccC-CCcccceeEEEEcC--CeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGGLR-HSNIVSIRAYCNGK--DELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~Ey~~~g 412 (640)
..+.+|+|.|+.||.|. ..+.+.++||.++.-+ ++.+.+|+.+|..|+ ||||+++++...++ ....||+||+.+-
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~ 120 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT 120 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeechHH-HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence 35679999999999998 5677889999998653 456889999999998 99999999998765 4688999999998
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCcccccCCC---
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~~~~~~--- 488 (640)
+...+.. .++-..+..++.++.+||.|+|+ .+|+|||+||.|+++|. ...++|+|.|+|.++.+.
T Consensus 121 Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 121 DFKQLYP--------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred cHHHHhh--------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 8876654 35666788899999999999995 55999999999999994 568999999999998653
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc---chHHHHHHhhcccccccccchh
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL---GIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
.+.+..|..||++ ...+.|+-.-|+|||||++.+|+..+.||-.++. .+++.++.++.++....+....
T Consensus 190 nVRVASRyfKGPELL------Vdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 190 NVRVASRYFKGPELL------VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred eeeeehhhcCCchhe------eechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 2346678999986 3445666778999999999999999999874333 3555556555443221111111
Q ss_pred hccChHHHH---------------------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEE---------------------EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~---------------------~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+..++...+ ...+.+++.-..+..|.++|||++|++.
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111111 0135666667788999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=260.11 Aligned_cols=188 Identities=22% Similarity=0.376 Sum_probs=158.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.++||+|-||+||-|+. ++|+.||||.+.+. +.+.++..|+.+|++++||.||.+.-.|+..+..+.|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 57899999999999985 57999999999754 3456688999999999999999999999999999999999955
Q ss_pred CHHHh-hccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC---CCeEEccCCcccccCC-
Q 006559 413 SLHSL-LHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL---GNACISDIGVHQLFHT- 487 (640)
Q Consensus 413 sL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGl~~~~~~- 487 (640)
+..+. |...++ .++...-..++.||..||.|||. .+|||.||||+||||.+. -.+||||||.+++...
T Consensus 648 DMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSSEKG----RLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 55554 443332 47777778899999999999995 459999999999999743 2699999999998764
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE 540 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~ 540 (640)
..++|+.|.|||++. ...|...-|+||.||++|--++|..||.+++
T Consensus 721 sFRrsVVGTPAYLaPEVLr-------nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLR-------NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred hhhhhhcCCccccCHHHHh-------hccccccccceeeeEEEEEEecccccCCCcc
Confidence 456799999999864 4556677899999999999999999998543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=259.57 Aligned_cols=185 Identities=24% Similarity=0.384 Sum_probs=156.7
Q ss_pred ccccccCcceEEEEE-eCCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
+.||-|+||+|.+++ .+....+|.|.+++.. ....+..|-.||...+.+.||+|+..|.+++.+|+||||+++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 359999999999987 4556789999997652 2234667888999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc-------
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF------- 485 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~------- 485 (640)
++-.+|-... -|.+.....++.++..|+++.| +.++|||||||+|||||.+|++||.||||+.-+
T Consensus 715 DmMSLLIrmg-----IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 715 DMMSLLIRMG-----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred cHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 9999887553 4777777888999999999999 778999999999999999999999999996432
Q ss_pred --CC---------------------------------------CccccccccCCccccCCCCccccCCCCCccchHHHHH
Q 006559 486 --HT---------------------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGV 524 (640)
Q Consensus 486 --~~---------------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGv 524 (640)
.. ..++|..|+|||++ ....++..+|.||.||
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl-------~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL-------ARTGYTQLCDWWSVGV 859 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh-------cccCccccchhhHhhH
Confidence 10 01347789999975 4456778899999999
Q ss_pred HHHHHHhCCCCCCC
Q 006559 525 VLLEILTGKMAKGD 538 (640)
Q Consensus 525 vl~el~tg~~p~~~ 538 (640)
|||||+.|+.||-.
T Consensus 860 il~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLA 873 (1034)
T ss_pred HHHHHhhCCCCccC
Confidence 99999999999974
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=248.35 Aligned_cols=249 Identities=20% Similarity=0.264 Sum_probs=184.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-chHHHHHHHHHHhccCC--C----cccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-KKREVDEWLRVIGGLRH--S----NIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~e~~~l~~l~H--~----niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
...+|+|.||.|-.+... .+..||||+++.-. .++...-|+++++++.+ | -+|.+.++|.-.++.+||+|.+
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 356999999999998843 46889999998763 34556678999998843 2 2688889998899999999987
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-------------------
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ------------------- 470 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~------------------- 470 (640)
+-|+.+++..+. ..+++...+..|+.|++++++||| +.+++|-||||+|||+-+
T Consensus 174 -G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 174 -GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred -ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 459999998753 347888999999999999999999 455999999999999842
Q ss_pred -CCCeEEccCCcccccCCC---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHH
Q 006559 471 -LGNACISDIGVHQLFHTP---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVK 545 (640)
Q Consensus 471 -~~~~kl~DfGl~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~ 545 (640)
+..+||+|||-+.+.... .+.|..|+|||++++ ..++.++||||+||||+|++||...|...+. .-..
T Consensus 247 ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLg-------LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILG-------LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred CCcceEEEecCCcceeccCcceeeeccccCCchheec-------cCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 235799999999876543 356999999998644 4566789999999999999999998875431 1111
Q ss_pred HHHHhhcc-cc--c-------------------------ccccchhhccC---hHHHHHHHHHHHHHHHccCCCCCCCCC
Q 006559 546 WVQMMGQD-ES--A-------------------------WEVFDFELIMD---KEMEEEMRALLQVALLCLAPLPKDRPN 594 (640)
Q Consensus 546 ~~~~~~~~-~~--~-------------------------~~~~d~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs 594 (640)
.++.+... +. + ..+.++..... ...+.+..++.+++..++..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 22222111 00 0 00111110000 012355678999999999999999999
Q ss_pred HHHHHH
Q 006559 595 MSIVHR 600 (640)
Q Consensus 595 ~~~v~~ 600 (640)
++|++.
T Consensus 400 l~EAL~ 405 (415)
T KOG0671|consen 400 LREALS 405 (415)
T ss_pred HHHHhc
Confidence 999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=227.12 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=182.5
Q ss_pred hhccccccCcceEEEEEeCC-CcEEEEEEeccc-cchHHHHHHHHHHhcc-CCCcccceeEE-EEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLDG-GDVVVVKRIRER-KKKREVDEWLRVIGGL-RHSNIVSIRAY-CNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~Ey~~~g 412 (640)
..+.+|+|.||.+-++.++. .+.+|+|.+... ...++|.+|..---.| .|.||+.-++. |+..+.+++++||+|.|
T Consensus 28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~g 107 (378)
T KOG1345|consen 28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRG 107 (378)
T ss_pred HHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccc
Confidence 45679999999999999765 567889988765 4567788876532223 58999987654 66778899999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE-C-CCCCeEEccCCcccccCCCc-
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV-D-QLGNACISDIGVHQLFHTPF- 489 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl-~-~~~~~kl~DfGl~~~~~~~~- 489 (640)
+|.+-+...+ +.+....+++.|++.|++|||+.+ +||||||.+|||+ + +..++||||||+.+..+...
T Consensus 108 dL~snv~~~G------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 108 DLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred hhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 9998886543 667788899999999999999655 9999999999998 3 34589999999988766432
Q ss_pred --cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC---cchHHHHHHhhcccccccccchhh
Q 006559 490 --FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE---LGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 490 --~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
-.+..|.+||+...-++ ......+.+|||.||++++.++||++||+... ....+|.+...+...
T Consensus 179 ~~~~~~~y~~pe~~~~~~n--e~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~--------- 247 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVN--EKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP--------- 247 (378)
T ss_pred hhhhhcccCCcHHHhhccc--cceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---------
Confidence 12557889997644322 12345678999999999999999999998432 234445444332211
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..+.........++++-.+-+.++|++|-...++.++......+
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 01111112223445555667899999998888887777665544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=252.06 Aligned_cols=185 Identities=18% Similarity=0.291 Sum_probs=160.9
Q ss_pred cccccCcceEEEEEeCCCc-EEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 340 LLGKGCVGATYKVVLDGGD-VVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~~~-~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.||-||||.|-+++..+.. .+|+|.+++. +..+.+..|-++|...+.|.||+++-.|.+....|+.||-|-+|.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 5999999999999876654 3888888765 234456678889999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----C
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-----P 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-----~ 488 (640)
|...|+... .|+......++..+.+|++||| ..+||.|||||+|.+||.+|.+||.|||.|+.... .
T Consensus 507 lWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT 578 (732)
T KOG0614|consen 507 LWTILRDRG-----SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT 578 (732)
T ss_pred hhhhhhhcC-----CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCceee
Confidence 999998654 5788888889999999999999 45599999999999999999999999999998764 4
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
+++|+.|.|||++. ....+..+|.||+|+++|||+||++||...
T Consensus 579 FcGTpEYVAPEIIL-------nKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 579 FCGTPEYVAPEIIL-------NKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred ecCCcccccchhhh-------ccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 67899999999764 345567899999999999999999999854
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=262.44 Aligned_cols=238 Identities=24% Similarity=0.296 Sum_probs=172.3
Q ss_pred HHhhccccccCcce-EEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 335 KSSAELLGKGCVGA-TYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 335 ~~~~~~iG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
....+++|.|+-|+ ||+|.+. |+.||||++-.... .-..+|+..|+.- +|||||++++.=.+....||+.|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~-~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF-DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH-HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 35578899999985 7999986 57999999865422 2345678777765 599999999988888999999999965
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---C--CCeEEccCCcccccCC
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---L--GNACISDIGVHQLFHT 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~--~~~kl~DfGl~~~~~~ 487 (640)
+|.+++.... .......-...+.+..|++.||+|||+. +||||||||.||||+. + .+++|+|||+++.+..
T Consensus 588 sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 SLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999998641 1111111134466788999999999964 5999999999999975 3 5799999999988753
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhC-CCCCCCCCcchHHHHHHhhcccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG-KMAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
...+|.+|+|||++... .-+.++||+|+||++|..+|| ++||++.-...+-.+. ..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~-------~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~---~~---- 729 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLRED-------RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT---GN---- 729 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhcc-------ccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---Cc----
Confidence 23468899999986443 234589999999999999995 9999853211110000 00
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
. .+..-....++ +..+++.++++++|..||++.+|+
T Consensus 730 --~--~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 730 --Y--TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred --c--ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 00000111122 566777889999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=223.61 Aligned_cols=203 Identities=27% Similarity=0.465 Sum_probs=173.9
Q ss_pred ccccCcceEEEEEeCC-CcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 341 LGKGCVGATYKVVLDG-GDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 341 iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
||+|.+|.||++...+ ++.+++|.+..... .+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 88999999987644 3678899999999999999999999999899999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCcccccCCC------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLFHTP------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~~~~~~------~ 489 (640)
++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+...... .
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 987542 247889999999999999999995 46999999999999999 899999999998766433 3
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.....|++||..... ...+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~------~~~~~~~D~~~lg~~~~~l---------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGK------GYYSEKSDIWSLGVILYEL---------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhccc------CCCCchhhhHHHHHHHHHH----------------------------------------
Confidence 346789999964221 2567889999999999998
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 346667788999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=233.61 Aligned_cols=185 Identities=21% Similarity=0.400 Sum_probs=153.7
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC-----CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK-----DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 407 (640)
.+-||-|+||+||-+.. ++|+.||.|++..- ...+.+-+|+.++...+|.|++..++..... .++|.|.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 34699999999998884 67899999998654 2346677889999999999999998887654 36889999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
.|.. +|+.++-.. .+++-..+.-+..||.+||.|||+. +|.||||||.|.|++.+-..||||||+++..+.
T Consensus 138 LmQS-DLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHh-hhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 9964 888887643 2577777788899999999999954 599999999999999999999999999998753
Q ss_pred C-------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 006559 488 P-------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537 (640)
Q Consensus 488 ~-------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~ 537 (640)
. .+.|..|+|||++++ .+.|+.+.||||.||++.|++-++..|.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMG------aRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMG------ARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhc------chhhcCccceehhhHHHHHHHhhhhhhh
Confidence 2 344788999999754 4567789999999999999998887776
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=228.79 Aligned_cols=186 Identities=19% Similarity=0.309 Sum_probs=155.2
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccccc-----hHHHHHHHHHHhc-cCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK-----KREVDEWLRVIGG-LRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
...+||+|+|++|..+++. ..+.+|+|++++... -.-++.|-.+..+ -+||.+|.+..+|+.+..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 3568999999999999864 577899999876511 1123344444443 47999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc----
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF---- 485 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~---- 485 (640)
++|+|.-+.+.++ .++.+....+..+|+.||.||| +.+||.||||..|||+|..|.+|+.|+|+.+.-
T Consensus 334 ~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 334 NGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred cCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 9999987777654 5888888889999999999999 566999999999999999999999999998763
Q ss_pred --CCCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 006559 486 --HTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537 (640)
Q Consensus 486 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~ 537 (640)
.+.+++|+.|+|||++.+ ..|.-.+|.|++||+++||+.|+.||+
T Consensus 406 d~tstfcgtpnyiapeilrg-------eeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRG-------EEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred cccccccCCCcccchhhhcc-------cccCceehHHHHHHHHHHHHcCCCCcc
Confidence 345788999999998654 445567999999999999999999998
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=230.38 Aligned_cols=127 Identities=15% Similarity=0.235 Sum_probs=103.6
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccccc-hHHHHHHHHHHhccC-----C---CcccceeEEEEc----CCeE
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK-KREVDEWLRVIGGLR-----H---SNIVSIRAYCNG----KDEL 402 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~e~~~l~~l~-----H---~niv~l~~~~~~----~~~~ 402 (640)
..++||.|.|++||++. ..+.+.||+|+.+..+. .+....||++|++++ | ..||+|++.|.. ..++
T Consensus 82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV 161 (590)
T KOG1290|consen 82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV 161 (590)
T ss_pred EEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence 35689999999999998 45677899999987643 455678899998774 3 369999999975 3589
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC
Q 006559 403 FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD 469 (640)
Q Consensus 403 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~ 469 (640)
+||+||+ +-+|..+|....- .-++...+.+|+.||+.||.|||..| +|||-||||+|||+.
T Consensus 162 CMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 162 CMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred EEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 9999998 5588888875431 23677889999999999999999855 899999999999995
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=224.41 Aligned_cols=241 Identities=22% Similarity=0.312 Sum_probs=176.4
Q ss_pred cccccCcceEEEEE-eCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEEec
Q 006559 340 LLGKGCVGATYKVV-LDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVYDY 408 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~Ey 408 (640)
.+|.|.- .|.-+. .-.++.||+|++... ...+...+|..++..++|+||++++.+|... .+.|+||||
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 3566655 333333 223678999987543 3345567788999999999999999998653 368999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC--
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-- 486 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~-- 486 (640)
|. .+|...++- .++......|..|++.|++||| ..+|+||||||+||++..+..+||.|||+++.-+
T Consensus 103 m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 103 MD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 95 589888872 3677888999999999999999 4569999999999999999999999999998754
Q ss_pred ---CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch-
Q 006559 487 ---TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF- 562 (640)
Q Consensus 487 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~- 562 (640)
++++.+..|.|||++.+. .+.+.+||||.||++.||++|+.-|. ++..+.+|-+....-+.....+-.
T Consensus 172 ~~mtpyVvtRyyrapevil~~-------~~ke~vdiwSvGci~gEli~~~Vlf~-g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGELILGTVLFP-GKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCchhheeeccCchheecc-------CCcccchhhhhhhHHHHHhhceEEec-CchHHHHHHHHHHHhcCCCHHHHHH
Confidence 456678899999987533 26689999999999999999998876 334556665544332211110000
Q ss_pred ---------------------hhccC-------hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ---------------------ELIMD-------KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ---------------------~~~~~-------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+...+ +...-....+.+++.+++-.+|++|-+++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00000 000112234667888899999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=216.62 Aligned_cols=188 Identities=26% Similarity=0.451 Sum_probs=161.7
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|++|.||++...+ +..+++|.+.... ..+.+..|++.+++++|+|++++++++...+..++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4679999999999999765 8889999998653 45677889999999999999999999998899999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|.+++..... .+++.....++.+++.++.|||. .+++|+|++++||+++.++.++|+|||.+......
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999976531 17889999999999999999995 46999999999999999999999999998776432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
...+..|++||... ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLL------GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhc------CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 23466799999642 445666799999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=237.26 Aligned_cols=186 Identities=19% Similarity=0.270 Sum_probs=155.3
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEeccccch----------HHHHHHHHHHhccC---CCcccceeEEEEcCCeEE
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRERKKK----------REVDEWLRVIGGLR---HSNIVSIRAYCNGKDELF 403 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----------~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~ 403 (640)
-..+|+|+||.|+.|.++. ..+|+||.+.+.+.- -.+-.|+.+|..++ |+||++++++|++.+.+|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 4579999999999999754 567899988654211 12346889999887 999999999999999999
Q ss_pred EEEecc-CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 404 LVYDYL-PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 404 lV~Ey~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
|+||-. ++-+|.+++..+. .+++.+...|+.||+.|++|||++ +|||||||-+||.+|.+|-+||+|||-+
T Consensus 646 l~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred EEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence 999975 4559999997654 478888899999999999999954 5999999999999999999999999998
Q ss_pred cccCC----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 006559 483 QLFHT----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537 (640)
Q Consensus 483 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~ 537 (640)
..... .+.+|..|.|||++.+.++. ...-|||++|++||-++....||.
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~------gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYL------GKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccC------CCcchhhhhhheeeEEEeccCCCc
Confidence 87654 35679999999988665433 346799999999999999888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-27 Score=243.50 Aligned_cols=241 Identities=21% Similarity=0.336 Sum_probs=187.0
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
...+|.|.||.|||++ .+.++.+|||.++-. ..-.-+.+|+-+++.-+|||||.++|.+...+..|++||||.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 4579999999999999 567889999998755 3345567788888999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC------CC
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------TP 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------~~ 488 (640)
++.-+... +++..++-.++++..+||+|||+.. =+|||||-.|||+.+.|.+|++|||.+..++ ..
T Consensus 100 Qdiy~~Tg-----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 100 QDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred cceeeecc-----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 99888654 6888888899999999999999654 6799999999999999999999999976654 25
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
+.+|+.|||||+... .....|..++|||+.|+...|+-.-++|..+-. -.+-...+.. .-+++.-..++
T Consensus 172 fiGtpywmapEvaav----erkggynqlcdiwa~gitAiel~eLqpplfdlh--pmr~l~LmTk-----S~~qpp~lkDk 240 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAV----ERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PMRALFLMTK-----SGFQPPTLKDK 240 (829)
T ss_pred ccCCccccchhHHHH----HhcccccccccccccccchhhhhhcCCcccccc--hHHHHHHhhc-----cCCCCCcccCC
Confidence 678999999997532 234578899999999999999988887743211 1111111111 11222222222
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
.....-+.+++..|+-.+|++||++...+
T Consensus 241 --~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 241 --TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred --ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 23344566677779999999999987543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=213.95 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=183.0
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+|.+...|+.|+|++++..+| +|++... ...++|.+|.-.++-+.||||..++|.|..+..+.++..|||.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34588889999999999876654 5666543 345789999988888999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-Ccccc
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-PFFIN 492 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-~~~~~ 492 (640)
|+..|++..+ ...+..+..+++.++|+|++|||+.. +-|..--|.+..|++|++.+++|+--..-..++. .....
T Consensus 274 lynvlhe~t~---vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~ 349 (448)
T KOG0195|consen 274 LYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYS 349 (448)
T ss_pred HHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeeccccccC
Confidence 9999997652 35677889999999999999999874 4466678999999999999988753111111221 22346
Q ss_pred ccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHH
Q 006559 493 DAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEE 572 (640)
Q Consensus 493 ~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 572 (640)
+.|++||.+...++... -..+|+|||++++||+.|+..||.+-.....- ++.. .+-. +...++....
T Consensus 350 pawmspealqrkped~n----~raadmwsfaillwel~trevpfadlspmecg-mkia------legl--rv~ippgis~ 416 (448)
T KOG0195|consen 350 PAWMSPEALQRKPEDLN----IRAADMWSFAILLWELNTREVPFADLSPMECG-MKIA------LEGL--RVHIPPGISR 416 (448)
T ss_pred cccCCHHHHhcCchhcc----hhhhhHHHHHHHHHHhhccccccccCCchhhh-hhhh------hccc--cccCCCCccH
Confidence 78999998766655432 24689999999999999999999742110000 0000 0001 1122333344
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 573 EMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 573 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
-+.++ +.-|...||.+||.+..|+-.|+++.
T Consensus 417 hm~kl---m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 417 HMNKL---MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHH---HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 44444 44599999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-26 Score=262.27 Aligned_cols=189 Identities=17% Similarity=0.173 Sum_probs=135.0
Q ss_pred hccCC-CcccceeEEE-------EcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 006559 382 GGLRH-SNIVSIRAYC-------NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453 (640)
Q Consensus 382 ~~l~H-~niv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 453 (640)
+.++| +||++++++| ...+.++.++||+ .++|+++|.... ..+++..++.++.||++||+|||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~--- 98 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHS--- 98 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHh---
Confidence 34566 6888888887 2334678889988 559999997432 258899999999999999999994
Q ss_pred CCceecCCCCCCeEEC-------------------CCCCeEEccCCcccccCC----------------------Ccccc
Q 006559 454 AHLFHGHLSSSNIVVD-------------------QLGNACISDIGVHQLFHT----------------------PFFIN 492 (640)
Q Consensus 454 ~~ivHrdlk~~NILl~-------------------~~~~~kl~DfGl~~~~~~----------------------~~~~~ 492 (640)
.+|+||||||+||||+ .++.+|++|||+++.... ...+|
T Consensus 99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 5599999999999994 456678888888764211 02346
Q ss_pred ccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHH
Q 006559 493 DAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEE 572 (640)
Q Consensus 493 ~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 572 (640)
..|+|||++. ...++.++|||||||+||||++|..|+.........+.. .... +....
T Consensus 179 ~~Y~APE~~~-------~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~---------~~~~------~~~~~ 236 (793)
T PLN00181 179 SWYTSPEEDN-------GSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH---------RVLP------PQILL 236 (793)
T ss_pred cceEChhhhc-------cCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH---------hhcC------hhhhh
Confidence 7799999753 345678999999999999999998887532111111100 0011 11111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 573 EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 573 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...+...++..||+++|.+||+|.|+++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 2234557778899999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=226.36 Aligned_cols=186 Identities=22% Similarity=0.308 Sum_probs=153.3
Q ss_pred cccccCcceEEEEEe-CCCcEEEEEEeccc-cchHHHHHHHHHHhccC------CCcccceeEEEEcCCeEEEEEeccCC
Q 006559 340 LLGKGCVGATYKVVL-DGGDVVVVKRIRER-KKKREVDEWLRVIGGLR------HSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~------H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..|+|-|++|..|.. ..|..||||+|+.. ...+.-..|+++|++|+ -.|+++|+-.|....++|||+|-+.
T Consensus 439 ~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls- 517 (752)
T KOG0670|consen 439 YTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS- 517 (752)
T ss_pred ccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-
Confidence 479999999999984 34779999999876 33455567899999985 3478999999999999999999774
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-CCeEEccCCcccccCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-GNACISDIGVHQLFHT--- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGl~~~~~~--- 487 (640)
-+|.++|+..+.. .-|....+..++.|+..||.+|- ..+|+|.||||.|||+++. ..+||||||-|.....
T Consensus 518 lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei 592 (752)
T KOG0670|consen 518 LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI 592 (752)
T ss_pred chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccccccccccc
Confidence 5999999876532 23566788889999999999998 4569999999999999865 5789999999887653
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
++..+..|.|||++.+- .|+...|+||.||.||||+||+..|.+
T Consensus 593 tPYLVSRFYRaPEIiLG~-------~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 593 TPYLVSRFYRAPEIILGL-------PYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cHHHHHHhccCcceeecC-------cccCCccceeeceeeEEeeccceecCC
Confidence 45567889999987554 445679999999999999999988764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=199.00 Aligned_cols=171 Identities=18% Similarity=0.209 Sum_probs=122.1
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-Ccc
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-PFF 490 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-~~~ 490 (640)
|+|.++++... .+++|..+..++.|+++||+|||+.+ ||+|||++.++.+|+ ||+++.... ...
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~ 65 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQSR 65 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccccCC
Confidence 78999997543 25899999999999999999999532 999999999999999 999887643 335
Q ss_pred ccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHH
Q 006559 491 INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEM 570 (640)
Q Consensus 491 ~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 570 (640)
++..|+|||++ ....++.++|||||||++|||+||+.||..... .....+......... ++........
T Consensus 66 g~~~y~aPE~~-------~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~ 134 (176)
T smart00750 66 VDPYFMAPEVI-------QGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNGMPAD---DPRDRSNLES 134 (176)
T ss_pred CcccccChHHh-------cCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHHhccC---CccccccHHH
Confidence 68899999975 344567899999999999999999999964321 111111111100000 0000000000
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 571 EEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 571 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.....++.+++.+||+.+|++||++.++++.+..+..+
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 11112578889999999999999999999988876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-24 Score=213.43 Aligned_cols=184 Identities=21% Similarity=0.324 Sum_probs=154.9
Q ss_pred hccccccCcceEEEEEeC----CCcEEEEEEeccccchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD----GGDVVVVKRIRERKKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.++||+|.|++||++... ....||+|.+.....-..+..|+++|..+. |.||+++.+++...+...+|+||++.-
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~ 120 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHD 120 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCcc
Confidence 568999999999999843 456799999987766667889999988875 899999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCcccccC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLFH----- 486 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~~~~----- 486 (640)
...++... ++...+..+.+.+.+||+|+| ..+||||||||+|+|.+. .+.-.|.|||++...+
T Consensus 121 ~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 121 RFRDLYRS--------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred CHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 99998863 567788899999999999999 556999999999999984 4677899999976210
Q ss_pred ------------C---------------------------------CccccccccCCccccCCCCccccCCCCCccchHH
Q 006559 487 ------------T---------------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYS 521 (640)
Q Consensus 487 ------------~---------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~S 521 (640)
. ...+|++|+|||++. ....-++++||||
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~------k~~~QttaiDiws 263 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF------RCPRQTTAIDIWS 263 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh------hccCcCCccceee
Confidence 0 013478999999874 3445578999999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 006559 522 FGVVLLEILTGKMAKGD 538 (640)
Q Consensus 522 fGvvl~el~tg~~p~~~ 538 (640)
-||+++-+++++.||..
T Consensus 264 ~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFK 280 (418)
T ss_pred ccceeehhhcccccccc
Confidence 99999999999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=239.15 Aligned_cols=184 Identities=33% Similarity=0.545 Sum_probs=122.7
Q ss_pred CChhhHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCceEecCCCCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCC
Q 006559 22 SPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKN 100 (640)
Q Consensus 22 ~~~~~~~~ll~~k~~~~~~~~~~~sW~~~~~~c~~~w~gv~C~~~~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~ 100 (640)
....|..+|+.||+++.++...+.+|+...+|| .|.||+|+.. ++|+.|+|.+++++|.. ..+..+++|+.|+|++
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~-~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNS-SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSN 102 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC--cCcceecCCC-CcEEEEEecCCCccccCChHHhCCCCCCEEECCC
Confidence 356899999999999965555567896555655 8999999864 69999999999988865 5678888888888888
Q ss_pred CcCCCCCC-C-CCCCCCCcEEEccccccccc----------------------CCccCCCCCCCCEEEcccCCCCCCCCc
Q 006559 101 NLLSSSNL-N-LSSWPHLKHLYLSHNRFTGT----------------------FPSGVSSLRHLRRVDLSHNAYEGEIPM 156 (640)
Q Consensus 101 N~l~~~~~-~-~~~l~~L~~L~Ls~N~l~g~----------------------~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 156 (640)
|.+++..| . +..+++|++|+|++|+++|. +|..++++++|++|+|++|.+.+.+|
T Consensus 103 n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p- 181 (968)
T PLN00113 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP- 181 (968)
T ss_pred CccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC-
Confidence 88876544 2 33555666666666655554 44445555555555555555555555
Q ss_pred hhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCC
Q 006559 157 TELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSP 209 (640)
Q Consensus 157 ~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~ 209 (640)
..+.++++|++|+|++|++++.+|..+..+.+|+.|+|++|++++.+|..++.
T Consensus 182 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 234 (968)
T PLN00113 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG 234 (968)
T ss_pred hhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhc
Confidence 44555555555555555555555555555555555555555555555554443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=202.54 Aligned_cols=147 Identities=16% Similarity=0.176 Sum_probs=114.1
Q ss_pred hhccccccCcceEEEEEeC--CCcEEEEEEeccc-------cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD--GGDVVVVKRIRER-------KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~--~~~~vavK~l~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||+||+|+.. +++.||||++... ...+.+.+|++++++++|+|++..+.. .+..|+|||
T Consensus 22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE 98 (365)
T PRK09188 22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRG 98 (365)
T ss_pred EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEE
Confidence 3568999999999999864 5777899987532 123458899999999999999963322 246899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCC-CCCCeEECCCCCeEEccCCcccccC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHL-SSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdl-k~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
|+++++|... .. .. ...++.|+++||+|||+ .+|+|||| ||+|||++.++.+||+|||+++.+.
T Consensus 99 ~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 99 WTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred ccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 9999999732 11 01 14578899999999994 56999999 9999999999999999999998654
Q ss_pred CC--------------ccccccccCCccc
Q 006559 487 TP--------------FFINDAYNAPELK 501 (640)
Q Consensus 487 ~~--------------~~~~~~y~aPE~~ 501 (640)
.. ...+..|+|||++
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 32 1235568999965
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=208.29 Aligned_cols=219 Identities=25% Similarity=0.368 Sum_probs=164.9
Q ss_pred HhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecC
Q 006559 381 IGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGH 460 (640)
Q Consensus 381 l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrd 460 (640)
|+.+.|.|+.++.|.+.+....+.|.+||..|+|.+.+.... ..++|.....+.+++++||+|+|+. +-..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNS--PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcC--cceeeee
Confidence 456899999999999999999999999999999999998632 4689999999999999999999953 3339999
Q ss_pred CCCCCeEECCCCCeEEccCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhC
Q 006559 461 LSSSNIVVDQLGNACISDIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532 (640)
Q Consensus 461 lk~~NILl~~~~~~kl~DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg 532 (640)
++++|+++|....+|++|||+...... ......-|.|||++............+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999999877631 111234589999886553332223367889999999999999999
Q ss_pred CCCCCCCCcch--HHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 533 KMAKGDGELGI--VKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 533 ~~p~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
+.||+...... .+.+..+... ....+.+.+.... +...+++.++..||..+|++||++..|-..++.+.....
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~--~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~ 229 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKG--GSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGS 229 (484)
T ss_pred cCccccccccCChHHHHHHHHhc--CCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccccc
Confidence 99998522211 1222111110 1111222222111 233368889999999999999999999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=177.68 Aligned_cols=139 Identities=15% Similarity=0.156 Sum_probs=106.3
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccc---h-------------------------HHHHHHHHHHhccCCCccc
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK---K-------------------------REVDEWLRVIGGLRHSNIV 390 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~-------------------------~~~~~e~~~l~~l~H~niv 390 (640)
..||+|+||.||+|...+|+.||||+++.... . .....|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 46999999999999988899999999875411 0 1123488889999888775
Q ss_pred ceeEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC
Q 006559 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ 470 (640)
Q Consensus 391 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~ 470 (640)
....+.. ...+|||||++++++........ +++......++.|++.+|.|+|+ ..+|+||||||+|||++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~- 152 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-
Confidence 4433322 22389999999887765432221 47888999999999999999942 34599999999999998
Q ss_pred CCCeEEccCCcccccCC
Q 006559 471 LGNACISDIGVHQLFHT 487 (640)
Q Consensus 471 ~~~~kl~DfGl~~~~~~ 487 (640)
++.++|+|||++...+.
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 47899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-19 Score=183.08 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=180.8
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc-----chHHHHHHHHHHhccCCC-cccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHS-NIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||.|+||.||++... ..+++|.+.... ....+.+|+.+++.+.|+ +|+++.+++......++++||+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 356899999999999977 788999987652 245688889999999988 799999999777778999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFH---- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~---- 486 (640)
+++.+++...... ..+.......+..|++.+++|+|.. +++|||+||+||+++..+ .++++|||.++.+.
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999777644211 2477788999999999999999954 499999999999999988 79999999987543
Q ss_pred --------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhccccc
Q 006559 487 --------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDESA 556 (640)
Q Consensus 487 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~ 556 (640)
....++..|++||...... ...+....|+||+|++++++++|..|+...... ...-..........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLS----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 2234588999999753210 145667899999999999999999997644321 11111111111000
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
........... ......+.++...|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 1112345667777888999999998877654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.7e-20 Score=204.57 Aligned_cols=138 Identities=29% Similarity=0.495 Sum_probs=88.8
Q ss_pred ChhhHHHHHHhhhcCCCCCCCCCCCCCCCCCCC---CCCCceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCC
Q 006559 23 PYSDISTLLSFKASVTGSSDSLSSWVNSTDPCF---DSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLK 99 (640)
Q Consensus 23 ~~~~~~~ll~~k~~~~~~~~~~~sW~~~~~~c~---~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls 99 (640)
...|..+|+.+|..+..+.. .+|+ + ++|+ +.|.||+|+.... .+ ...++.|+|+
T Consensus 370 ~~~~~~aL~~~k~~~~~~~~--~~W~-g-~~C~p~~~~w~Gv~C~~~~~------------~~-------~~~v~~L~L~ 426 (623)
T PLN03150 370 LLEEVSALQTLKSSLGLPLR--FGWN-G-DPCVPQQHPWSGADCQFDST------------KG-------KWFIDGLGLD 426 (623)
T ss_pred CchHHHHHHHHHHhcCCccc--CCCC-C-CCCCCcccccccceeeccCC------------CC-------ceEEEEEECC
Confidence 45689999999999854432 3794 3 5553 3799999963210 00 0123445555
Q ss_pred CCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceec
Q 006559 100 NNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGT 178 (640)
Q Consensus 100 ~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~ 178 (640)
+|.|+|..+ .+..+++|+.|+|++|.|+|.+|..++++++|+.|||++|+|+|.+| ..++++++|+.|+|++|+|+|.
T Consensus 427 ~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP-~~l~~L~~L~~L~Ls~N~l~g~ 505 (623)
T PLN03150 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP-ESLGQLTSLRILNLNGNSLSGR 505 (623)
T ss_pred CCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCc-hHHhcCCCCCEEECcCCccccc
Confidence 565555433 46666677777777777777777777777777777777777777666 5566677777777777666666
Q ss_pred ccCCcC
Q 006559 179 LYSVNS 184 (640)
Q Consensus 179 ~~~~~~ 184 (640)
+|..+.
T Consensus 506 iP~~l~ 511 (623)
T PLN03150 506 VPAALG 511 (623)
T ss_pred CChHHh
Confidence 665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=207.71 Aligned_cols=249 Identities=19% Similarity=0.257 Sum_probs=172.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEec----cccchHH----HHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIR----ERKKKRE----VDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~----~~~~~~~----~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+++|.|++|.|+.... ......+.|..+ .....+. +..|..+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 467899999997777663 333334444332 2111111 4456667778899999988887777776666799
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
||+. +|..++.... .+...++..++.|+..|++|+|+ .+|.|||+|++|+++..+|.+||+|||.+..+..
T Consensus 402 ~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 9999987652 36677888899999999999995 5599999999999999999999999999866532
Q ss_pred ----------CccccccccCCccccCCCCccccCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccc
Q 006559 488 ----------PFFINDAYNAPELKFNNNNNYSQRKFWQ-RCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA 556 (640)
Q Consensus 488 ----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~-k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 556 (640)
...++..|+|||++.. ..|++ ..||||.||++..|++|+.||.........+....... .
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~-------~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~--~ 543 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTG-------KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD--Q 543 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccc-------cccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc--c
Confidence 2456889999997533 33433 58999999999999999999974222111110000000 0
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
..+.... ..-..........++.++++.+|.+|-||.+|++ .+++|.
T Consensus 544 ~~~~~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 544 RNIFEGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred cccccCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 0011100 0112233345566788899999999999999975 444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=169.00 Aligned_cols=246 Identities=17% Similarity=0.191 Sum_probs=174.6
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccccchHHHHHHHHHHhccCC-CcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGGLRH-SNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+.||.|+||.+|.|. ..+|..||||.-.......+..-|.++.+.|+| ..|..++.|..++..-.+|||.+ +.+|.
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLE 98 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLE 98 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHH
Confidence 4679999999999998 788999999987666555667778888888876 57777888888888999999987 77999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCCC----
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~~---- 488 (640)
+...-.. ..++..+.+-+|-|+..-++|+|.. ++|||||||+|.|+.- ...+.++|||+++.+.+.
T Consensus 99 dLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 99 DLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred HHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 8876443 2588899999999999999999954 4999999999999863 346789999999876421
Q ss_pred ---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 489 ---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 ---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
..+|..|.+-... ....-+.+-|+=|+|-+|...--|..||.+-..... .+.. ..|
T Consensus 172 HIpyre~r~ltGTaRYASinAh-------~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--~QKy------EkI 236 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAH-------LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--KQKY------EKI 236 (341)
T ss_pred cCccccCCccceeeeehhhhhh-------hhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH--HHHH------HHH
Confidence 2346667654421 222334578999999999999999999975221111 1110 111
Q ss_pred cchhhccChH--HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 560 FDFELIMDKE--MEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 560 ~d~~~~~~~~--~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.......+.+ ....+.++.-.+.-|-..--++-|....+.++.+-+.
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1111111111 1122334455556688888888898877776666543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=171.34 Aligned_cols=138 Identities=17% Similarity=0.197 Sum_probs=107.7
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccc----------------------------hHHHHHHHHHHhccCCCccc
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK----------------------------KREVDEWLRVIGGLRHSNIV 390 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----------------------------~~~~~~e~~~l~~l~H~niv 390 (640)
..||+|+||.||+|+..+|+.||||.++.... ......|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 46999999999999987899999999875411 01124678888899999886
Q ss_pred ceeEEEEcCCeEEEEEeccCCCCHHHh-hccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC
Q 006559 391 SIRAYCNGKDELFLVYDYLPHGSLHSL-LHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD 469 (640)
Q Consensus 391 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~ 469 (640)
....+... ..+|||||++++++... +... .++......++.|++.++.|+|+ ..+|+||||||+|||++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~ 152 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH 152 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence 55544433 24899999998865433 3321 35677888999999999999995 14699999999999999
Q ss_pred CCCCeEEccCCcccccCC
Q 006559 470 QLGNACISDIGVHQLFHT 487 (640)
Q Consensus 470 ~~~~~kl~DfGl~~~~~~ 487 (640)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 89999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-18 Score=178.88 Aligned_cols=249 Identities=19% Similarity=0.184 Sum_probs=174.6
Q ss_pred hhccccccCcceEEEEEeCCC--cEEEEEEeccccch--HHHHHHHHHHhccCC----CcccceeEEE-EcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLDGG--DVVVVKRIRERKKK--REVDEWLRVIGGLRH----SNIVSIRAYC-NGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~--~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~~lV~E 407 (640)
..+.||+|+||.||++..... ..+|+|........ ..+..|..++..+.+ +++..+.+.. ......|+||+
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 356899999999999996553 47888876654221 256677777777762 5788888888 47778999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-----CCeEEccCCcc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-----GNACISDIGVH 482 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-----~~~kl~DfGl~ 482 (640)
.+ +.+|.++..... ...++....++|+.|+..+|++|| ..+++||||||.|+++... ..+.|.|||++
T Consensus 102 l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred cc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 76 779999775443 235888999999999999999999 5569999999999999854 46899999999
Q ss_pred cccC--C--------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH
Q 006559 483 QLFH--T--------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK 545 (640)
Q Consensus 483 ~~~~--~--------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~ 545 (640)
+.+. . .+.+|..|.++.. ......+.+.|+||++-++.|+..|..||...... ...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~-------H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~ 247 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINV-------HLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS 247 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHH-------hCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence 8321 0 1225667777773 45556678999999999999999999999643221 111
Q ss_pred HHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 546 WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 546 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
-+......... .. .....+.+ +.++...+-..+..++|....+...+++...+.
T Consensus 248 ~~~~~~~~~~~----~~---~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 248 KFEKDPRKLLT----DR---FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHhhhhcc----cc---ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111110000 00 00111223 333444455578999999999999998877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=164.84 Aligned_cols=175 Identities=16% Similarity=0.116 Sum_probs=129.2
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccc------hHHHHHHHHHHhccCC-CcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKK------KREVDEWLRVIGGLRH-SNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
...|++|+||+||.+.- ++..++.+.+..... ..-+.+|+++|++|.| ++|++++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 45799999999997665 667777777765532 2247789999999964 789999886 34799999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCC-CCCCeEECCCCCeEEccCCcccccCCCc
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHL-SSSNIVVDQLGNACISDIGVHQLFHTPF 489 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdl-k~~NILl~~~~~~kl~DfGl~~~~~~~~ 489 (640)
+.+|.+.+.. ....++.|++.+|+++|. .+|+|||| ||+|||++.++.++|+|||++.......
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9998754321 113467899999999994 55999999 7999999999999999999998543221
Q ss_pred -------------------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 006559 490 -------------------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537 (640)
Q Consensus 490 -------------------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~ 537 (640)
..++.|+.|+.. ......--.+.+.++-|.-+|.++||..++.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~-----~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVER-----RVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHH-----hhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 014445555521 1111122245688999999999999998865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.6e-19 Score=171.83 Aligned_cols=162 Identities=12% Similarity=0.148 Sum_probs=122.6
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccc--hH---------HHHHHHHHHhccCCCcccceeEEEEcC-------
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKK--KR---------EVDEWLRVIGGLRHSNIVSIRAYCNGK------- 399 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~---------~~~~e~~~l~~l~H~niv~l~~~~~~~------- 399 (640)
.+++|.|+||.||.... ++..+|+|.+++... .+ .+++|++.+.+++|++|..+.+++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 57899999999999665 566899999976521 11 157888899999999999998886532
Q ss_pred -CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEcc
Q 006559 400 -DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478 (640)
Q Consensus 400 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 478 (640)
...+|||||+++.+|.++.. ++. ....+++.+|..+| ..+++|||+||+||+++.++ ++++|
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEE
Confidence 35899999999999988732 222 24558999999999 45699999999999999988 99999
Q ss_pred CCcccccCCCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHH
Q 006559 479 IGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEIL 530 (640)
Q Consensus 479 fGl~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~ 530 (640)
||......... |-+. ....+.+..++|+||||+.+.-..
T Consensus 178 fg~~~~~~e~~-------a~d~------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRK-------AKDR------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchh-------hHHH------HHHHhHhcccccccceeEeehHHH
Confidence 99876553221 1111 122334556899999999876654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.8e-20 Score=194.89 Aligned_cols=182 Identities=22% Similarity=0.320 Sum_probs=149.5
Q ss_pred cccccCcceEEEEE----eCCCcEEEEEEecccc----chHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccC
Q 006559 340 LLGKGCVGATYKVV----LDGGDVVVVKRIRERK----KKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~----~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
++|+|.||.|+.++ .+.|..+|.|.+++.. .+.....|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999765 3446778888876541 1123344556777776 9999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
+|+|...+.... .++......+...+|-+++++| +.+|+|||+|++||+++.+|.+|+.|||+++..-..
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999998887543 4666777778889999999999 556999999999999999999999999999886443
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
.++|..|||||+.- .....+|.||||++++||+||..||..
T Consensus 153 ~cgt~eymApEI~~---------gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN---------GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cccchhhhhhHhhh---------ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 35589999999752 345689999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.7e-18 Score=163.79 Aligned_cols=250 Identities=15% Similarity=0.198 Sum_probs=180.6
Q ss_pred hhccccccCcceEEEEE-eCCCcEEEEEEeccccchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..++||+|.||+.+.|+ +-+++.||||.-..+....++..|.+..+.|. -++|...+.|-.+.-.-.||+|.+ +.+|
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSL 110 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSL 110 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCH
Confidence 47789999999999998 66789999998665555566777777776665 488888887777777888999987 7788
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-----CCeEEccCCcccccCCC-
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-----GNACISDIGVHQLFHTP- 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-----~~~kl~DfGl~~~~~~~- 488 (640)
.++..-.. ..|+.+.+..+|.|+..-++|+|+ ..+|.|||||+|.||... ..+.++|||+++.+..+
T Consensus 111 EDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 111 EDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred HHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 88876443 258999999999999999999995 459999999999999743 35789999999987532
Q ss_pred ------------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccc
Q 006559 489 ------------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDES 555 (640)
Q Consensus 489 ------------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~ 555 (640)
..+|..||... ...++.-+.+-|+=|+|-+++..+-|..||.+-... ..+--+.++....
T Consensus 184 TkqHIPYrE~KSLsGTARYMSIN-------THlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSIN-------THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred ccccCccccccccccceeeeEee-------ccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 23578888766 344555667889999999999999999999852211 2222222222222
Q ss_pred cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 556 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...+-+.. ...++++...+..+. ..+-.+-|....+...+.++...
T Consensus 257 ~T~i~~Lc----~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 257 STPIEVLC----EGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cCCHHHHH----hcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHh
Confidence 11111111 123444444444433 35667889999888888887543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-19 Score=194.28 Aligned_cols=242 Identities=19% Similarity=0.185 Sum_probs=170.4
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc---chHHHHHHHHH--HhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK---KKREVDEWLRV--IGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~e~~~--l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.+|++.|=+|.+|+.+.|. |+||++-+.. .-+.+.+.++. ...++|||.+.+.-+-......|||=+|..+
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 3567999999999999988887 7788775442 23444443332 4456899999987776666778888899866
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----C
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----T 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----~ 487 (640)
+|++.|... .-+...+..-|+.|+..||.-+| +.+|+|+|||.+|||+..-..+.|+||.--+... .
T Consensus 106 -nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 106 -NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred -hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 899988743 24666778889999999999999 5669999999999999999999999997655421 1
Q ss_pred C---------ccccccccCCccccCCCCccc---c-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcc
Q 006559 488 P---------FFINDAYNAPELKFNNNNNYS---Q-RKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 488 ~---------~~~~~~y~aPE~~~~~~~~~~---~-~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 553 (640)
+ ......|.|||.+..+..... . ...+++-||||.||++.||++ |++||.-. .+..+....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--QL~aYr~~~--- 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--QLLAYRSGN--- 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--HHHhHhccC---
Confidence 1 011347999998865432211 1 226789999999999999988 78888521 111111110
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
..|++.... .++ -..+..+++.|++.||++|-++.+.++.
T Consensus 252 -----~~~~e~~Le-~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 -----ADDPEQLLE-KIE--DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -----ccCHHHHHH-hCc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 112211111 011 1146677888999999999999998865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.1e-18 Score=162.47 Aligned_cols=132 Identities=16% Similarity=0.135 Sum_probs=101.2
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc--cchHHHHHHHHHHhcc-----CCCcccceeEEEEcCC---e-EEEEE
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER--KKKREVDEWLRVIGGL-----RHSNIVSIRAYCNGKD---E-LFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~-~~lV~ 406 (640)
.++||+|+||.||. .+.....+||++... ...+.+.+|+++++.+ +||||++++|++.++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 56799999999996 433333468887643 3456788999999998 6799999999998763 4 33789
Q ss_pred ec--cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHH-HHhhcCCCCCceecCCCCCCeEECC----CCCeEEccC
Q 006559 407 DY--LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL-AFLHGYNKAHLFHGHLSSSNIVVDQ----LGNACISDI 479 (640)
Q Consensus 407 Ey--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrdlk~~NILl~~----~~~~kl~Df 479 (640)
|| +++|+|.+++... .++.. ..++.|+..++ +|||+ .+||||||||+|||++. +..++|+||
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 99 6689999999653 24444 35677888788 99994 55999999999999974 347999995
Q ss_pred Ccc
Q 006559 480 GVH 482 (640)
Q Consensus 480 Gl~ 482 (640)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=156.31 Aligned_cols=132 Identities=20% Similarity=0.380 Sum_probs=109.9
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccc----------hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK----------KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
+.||+|++|.||+|.. .|..|++|....... ...+..|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 566788887653311 13466788899999999998888887777889999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
+++++|.+++... .+ .+..++.+++.+|.++|. .+++|+|++|.|||++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998642 12 778899999999999994 5699999999999999 78999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=158.23 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=104.6
Q ss_pred hhccccccCcceEEEEE--eCCCcEEEEEEeccccc--------------------------hHHHHHHHHHHhccCCCc
Q 006559 337 SAELLGKGCVGATYKVV--LDGGDVVVVKRIRERKK--------------------------KREVDEWLRVIGGLRHSN 388 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~--------------------------~~~~~~e~~~l~~l~H~n 388 (640)
..+.||+|+||.||+|. ..+|+.||||.++.... ...+..|++.+.++.|..
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 45789999999999998 67899999999874310 112457888888887633
Q ss_pred --ccceeEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC-ceecCCCCCC
Q 006559 389 --IVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH-LFHGHLSSSN 465 (640)
Q Consensus 389 --iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrdlk~~N 465 (640)
+.+.+++ ...++||||+++++|........ .+.......++.|++.+++||| ..+ |+||||||+|
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N 179 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN 179 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence 2333332 23589999999988876543221 2445566789999999999999 556 9999999999
Q ss_pred eEECCCCCeEEccCCcccccC
Q 006559 466 IVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 466 ILl~~~~~~kl~DfGl~~~~~ 486 (640)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-17 Score=160.56 Aligned_cols=196 Identities=18% Similarity=0.198 Sum_probs=131.7
Q ss_pred CCCcccceeEEEEc---------------------------CCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHH
Q 006559 385 RHSNIVSIRAYCNG---------------------------KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKL 437 (640)
Q Consensus 385 ~H~niv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 437 (640)
+|||||++.++|.+ ...+|+||.-++. +|++++.... .+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 69999999877632 2358999988765 9999997553 344455668
Q ss_pred HHHHHHHHHHhhcCCCCCceecCCCCCCeEE--CCCC--CeEEccCCcccccCC---------C---ccccccccCCccc
Q 006559 438 ASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV--DQLG--NACISDIGVHQLFHT---------P---FFINDAYNAPELK 501 (640)
Q Consensus 438 ~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl--~~~~--~~kl~DfGl~~~~~~---------~---~~~~~~y~aPE~~ 501 (640)
..|+.+|+.||| +.+|.|||+|++|||+ |+|+ ...|+|||.+-..+. . .-+...-||||+.
T Consensus 347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 899999999999 5569999999999998 4555 457899997533221 1 1234568999986
Q ss_pred cCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHH
Q 006559 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVA 581 (640)
Q Consensus 502 ~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~ 581 (640)
-.-|.-.....| .|+|.|+.|-+.||+++...||...+....+-.. .++. ++. .-.+.+...+.+++
T Consensus 424 ta~PGp~avvny-~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--Yqe~--------qLP--alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 424 TAVPGPNAVVNY-EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--YQES--------QLP--ALPSRVPPVARQLV 490 (598)
T ss_pred hcCCCCceeecc-chhhhhhhhhhHHHHhccCCcccccchheechhh--hhhh--------hCC--CCcccCChHHHHHH
Confidence 433322222223 5899999999999999999999753322211111 1110 110 01122334566777
Q ss_pred HHccCCCCCCCCCHHHHHHHHH
Q 006559 582 LLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 582 ~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
...+++||.+||+..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 7889999999999776655554
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=152.87 Aligned_cols=128 Identities=22% Similarity=0.335 Sum_probs=103.9
Q ss_pred cccccCcceEEEEEeCCCcEEEEEEecccc----------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 340 LLGKGCVGATYKVVLDGGDVVVVKRIRERK----------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
+||+|+||.||+|.+. +..|++|...... ....+..|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999864 5778888754321 1134567899999999988766666666677789999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
++++|.+++.... . .++.+++.+|.++| ..+++|+|++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 0 78999999999999 45699999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=175.83 Aligned_cols=132 Identities=23% Similarity=0.353 Sum_probs=107.2
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-c--------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-K--------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||+||+|.+.+...++.++.... . ..+.+..|++++++++|++++....++......++|||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 35789999999999999876554443333221 1 12346789999999999999988888877778899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
|+++++|.+++. ....++.+++++|.||| ..+++|||+||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998875 24568999999999999 4569999999999999 6789999999998763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=151.73 Aligned_cols=133 Identities=16% Similarity=0.128 Sum_probs=103.4
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc------------------------chHHHHHHHHHHhccCCCc--cc
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK------------------------KKREVDEWLRVIGGLRHSN--IV 390 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~------------------------~~~~~~~e~~~l~~l~H~n--iv 390 (640)
..+.||+|+||.||++...+|+.||||++.... .......|..++.++.|++ +.
T Consensus 19 ~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~ 98 (198)
T cd05144 19 LGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVP 98 (198)
T ss_pred cCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCC
Confidence 457899999999999998889999999865421 0112456777888887774 44
Q ss_pred ceeEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC
Q 006559 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ 470 (640)
Q Consensus 391 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~ 470 (640)
..++ ....++||||+++++|...... .....++.+++.++.++|. .+|+||||||+||++++
T Consensus 99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 99 KPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred ceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 4443 2456899999999998765431 1245688899999999995 56999999999999999
Q ss_pred CCCeEEccCCcccccCC
Q 006559 471 LGNACISDIGVHQLFHT 487 (640)
Q Consensus 471 ~~~~kl~DfGl~~~~~~ 487 (640)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-15 Score=151.00 Aligned_cols=232 Identities=20% Similarity=0.286 Sum_probs=136.0
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEeccc-----cchHHHHHHHHHHhccCC----------CcccceeEE------
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRER-----KKKREVDEWLRVIGGLRH----------SNIVSIRAY------ 395 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H----------~niv~l~~~------ 395 (640)
.+.||.|+|+.||.++... ++.+|||..... ..-+++.+|.-.+..+.+ -.++--++.
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 5679999999999999654 889999987533 122444555433333222 112211111
Q ss_pred ---EEcCC--------eEEEEEeccCCCCHHHhhcc---CCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCC
Q 006559 396 ---CNGKD--------ELFLVYDYLPHGSLHSLLHG---SRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHL 461 (640)
Q Consensus 396 ---~~~~~--------~~~lV~Ey~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdl 461 (640)
+.... ..+++|+-+ .+||.+++.. ... ....+....++.+..|+.+.+++||+. ++||+||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11111 246778876 5688887542 111 112345566778889999999999965 4999999
Q ss_pred CCCCeEECCCCCeEEccCCcccccCCCc---cccccccCCccccCCCC-ccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 006559 462 SSSNIVVDQLGNACISDIGVHQLFHTPF---FINDAYNAPELKFNNNN-NYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537 (640)
Q Consensus 462 k~~NILl~~~~~~kl~DfGl~~~~~~~~---~~~~~y~aPE~~~~~~~-~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~ 537 (640)
||+|++++.+|.+.|+||+-....++.. ..+..|.+||+...... ......++.+.|.|++|+++|.|..|..||+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 9999999999999999998766654432 23567889986432110 0022356789999999999999999999997
Q ss_pred CCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCC
Q 006559 538 DGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDR 592 (640)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R 592 (640)
....... .+ .....-..+++ .+.+++...++++|.+|
T Consensus 252 ~~~~~~~--------~~-------~~f~~C~~~Pe---~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEAD--------PE-------WDFSRCRDMPE---PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGST--------SG-------GGGTTSS---H---HHHHHHHHHT-SSGGGS
T ss_pred CCCcccc--------cc-------ccchhcCCcCH---HHHHHHHHHccCCcccC
Confidence 4321100 00 01111112333 45556667899999887
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.3e-15 Score=134.47 Aligned_cols=133 Identities=21% Similarity=0.216 Sum_probs=111.6
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCC--CcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRH--SNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
+.||+|.++.||++...+ ..+++|..........+..|+..++.++| .+++++++++...+..+++|||++++.+..
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~ 82 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE 82 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeeccc
Confidence 468999999999999765 67899988665434568888888988877 588999988887788999999999877654
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
+ +......++.+++++++++|.....+++|+|++|+||+++..+.+++.|||.++.
T Consensus 83 ~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 83 V------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred C------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 3 3456677899999999999976556799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.2e-15 Score=142.02 Aligned_cols=135 Identities=21% Similarity=0.270 Sum_probs=94.1
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccc----hHHH----------------------HHHHHHHhccCCCc--cc
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK----KREV----------------------DEWLRVIGGLRHSN--IV 390 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----~~~~----------------------~~e~~~l~~l~H~n--iv 390 (640)
+.||+|+||.||+|...+++.||||.++.... ...+ ..|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 56999999999999988899999998875311 1111 23344444443332 33
Q ss_pred ceeEEEEcCCeEEEEEeccCCCCHHHh-hccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC
Q 006559 391 SIRAYCNGKDELFLVYDYLPHGSLHSL-LHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD 469 (640)
Q Consensus 391 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~ 469 (640)
+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. ..+|+||||||+||+++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 33332 246899999999654211 11110 11 4567889999999999995 15699999999999999
Q ss_pred CCCCeEEccCCcccccCC
Q 006559 470 QLGNACISDIGVHQLFHT 487 (640)
Q Consensus 470 ~~~~~kl~DfGl~~~~~~ 487 (640)
++.++++|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=163.79 Aligned_cols=181 Identities=19% Similarity=0.308 Sum_probs=136.9
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccC---CCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLR---HSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
...||+|+||.||+|...+|+.||+|.=+.....+ |.--.+++.+|+ -+-|..+...+.-.+.-++|+||.+.|+|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtl 781 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTL 781 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCcee-eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccH
Confidence 45799999999999998889999999876543221 211223344444 12344444444556788999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-------CCCCeEEccCCccccc--
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-------QLGNACISDIGVHQLF-- 485 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-------~~~~~kl~DfGl~~~~-- 485 (640)
.+++...+ ..+|...+.++.|+++-+++|| ..+|||+||||+|.||. +..-++|+|||-+--+
T Consensus 782 ld~~N~~~-----~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 782 LDLINTNK-----VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred HHhhccCC-----CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 99998443 4789999999999999999999 56699999999999995 2346899999986432
Q ss_pred -CC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCC
Q 006559 486 -HT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM 534 (640)
Q Consensus 486 -~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~ 534 (640)
.. ..+.|..+-.+|++. ++..+-..|-|.++-+++-|+.|+.
T Consensus 854 fp~~~~F~~~~~td~f~C~EM~~-------grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 854 FPDGTKFKAVWHTDLFDCIEMRE-------GRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cCCCcEEeeeeccccchhHHHhc-------CCCCchhhhhHHHHHHHHHHHHHHH
Confidence 11 234577888999754 4445567999999999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.6e-14 Score=139.65 Aligned_cols=136 Identities=19% Similarity=0.225 Sum_probs=103.8
Q ss_pred Hhhcccc-ccCcceEEEEEeCCCcEEEEEEeccc---------------cchHHHHHHHHHHhccCCCcc--cceeEEEE
Q 006559 336 SSAELLG-KGCVGATYKVVLDGGDVVVVKRIRER---------------KKKREVDEWLRVIGGLRHSNI--VSIRAYCN 397 (640)
Q Consensus 336 ~~~~~iG-~G~fg~Vy~~~~~~~~~vavK~l~~~---------------~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~ 397 (640)
....+|| .||.|+||++... +..++||.+... .....+.+|++++.+++|++| ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 4456898 8999999999876 567788877431 112345678999999999885 66676644
Q ss_pred cCC----eEEEEEeccCC-CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC
Q 006559 398 GKD----ELFLVYDYLPH-GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG 472 (640)
Q Consensus 398 ~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~ 472 (640)
... ..++||||+++ .+|.+++... +++.. .+.+++.+|.+|| ..+|+||||||.|||++.++
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDG 179 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCC
Confidence 322 23599999997 6999888642 23332 3568999999999 55699999999999999989
Q ss_pred CeEEccCCccccc
Q 006559 473 NACISDIGVHQLF 485 (640)
Q Consensus 473 ~~kl~DfGl~~~~ 485 (640)
.++|+|||.++..
T Consensus 180 ~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 KFWLIDFDRGELR 192 (239)
T ss_pred CEEEEECCCcccC
Confidence 9999999998763
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.4e-15 Score=154.87 Aligned_cols=116 Identities=21% Similarity=0.322 Sum_probs=98.4
Q ss_pred eEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCC
Q 006559 401 ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG 480 (640)
Q Consensus 401 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 480 (640)
.+|+.|++|...+|.+|+...+. ....+|...+.++.|++.|++| .+.+|||+||.||....+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 58899999999999999975542 2346788899999999999999 348999999999999999999999999
Q ss_pred cccccCC------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh
Q 006559 481 VHQLFHT------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531 (640)
Q Consensus 481 l~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t 531 (640)
+...... ...+|..||+|| .+.+..|+.|+||||+|++|+|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPE-------Qi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPE-------QIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHH-------HHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9755432 234588999999 4566788899999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-14 Score=160.45 Aligned_cols=153 Identities=24% Similarity=0.442 Sum_probs=106.2
Q ss_pred hhccccccCcceEEEEEeCC-CcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDG-GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..++|..|+||.||.++++. .+.+|.| +.++. - +++ ||..+ .+..+.| |+=.
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~k-iNkq~---l------ilR-----nilt~------a~npfvv------gDc~ 139 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN---L------ILR-----NILTF------AGNPFVV------GDCA 139 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhc-ccccc---h------hhh-----ccccc------cCCccee------chhh
Confidence 35689999999999998654 4556763 32210 0 111 12221 1222333 4444
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC---------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--------- 486 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~--------- 486 (640)
..++.- +..+. +++.+++|+|+ .+|+|||+||+|.+|..-|++|+.|||+.+..-
T Consensus 140 tllk~~---g~lPv----------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 140 TLLKNI---GPLPV----------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhcccC---CCCcc----------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 444432 22232 22778999995 459999999999999999999999999876421
Q ss_pred ------------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 487 ------------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 487 ------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
...++|+.|+|||++ ..+.|...+|+|++|+++||.+-|+.||.++
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVi-------lrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVI-------LRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhh-------hhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 123679999999975 3456778999999999999999999999864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.6e-15 Score=133.20 Aligned_cols=138 Identities=25% Similarity=0.379 Sum_probs=119.6
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.+++.|.|++|.++..++.+..|.+|+.|++++|++...|.+++++++|+.|+++-|++. .+|..|+.++.|++|||++
T Consensus 33 s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlty 111 (264)
T KOG0617|consen 33 SNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTY 111 (264)
T ss_pred hhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccc
Confidence 478899999999999888999999999999999999999999999999999999999997 7899999999999999999
Q ss_pred CCCCC-CCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCC
Q 006559 148 NAYEG-EIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSP 209 (640)
Q Consensus 148 N~l~g-~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~ 209 (640)
|+++- .+| ..|..++.|+.|+|++|.|. .+|+..+.+++|+.|.+..|.+- .+|..++.
T Consensus 112 nnl~e~~lp-gnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~ 171 (264)
T KOG0617|consen 112 NNLNENSLP-GNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGD 171 (264)
T ss_pred cccccccCC-cchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHH
Confidence 99974 355 56677788888888888887 56666777888888888888875 56766554
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-12 Score=147.32 Aligned_cols=116 Identities=32% Similarity=0.533 Sum_probs=104.5
Q ss_pred CCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEc
Q 006559 115 HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNV 194 (640)
Q Consensus 115 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~l 194 (640)
.++.|+|++|.|+|.+|..+++|++|+.|+|++|+|+|.+| ..++.+++|+.|+|++|+|+|.+|..+..+++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP-~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP-PSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCC-hHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 47899999999999999999999999999999999999999 77999999999999999999999999999999999999
Q ss_pred ccCcCcccCCcccCCC----CCCCCCCCcccCCCCCCCCCC
Q 006559 195 SNNQLSGQIPAWMSPF----GGSSFAGNKNLCGRPLPSDCS 231 (640)
Q Consensus 195 s~N~l~g~ip~~~~~~----~~~~~~gn~~lcg~~~~~~c~ 231 (640)
++|+|+|.+|..+... ....+.+|+.+|+.|....|.
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 9999999999987543 245678999999876444463
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.3e-12 Score=127.72 Aligned_cols=192 Identities=21% Similarity=0.356 Sum_probs=130.6
Q ss_pred HhccCCCcccceeEEEEcC-----CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 006559 381 IGGLRHSNIVSIRAYCNGK-----DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455 (640)
Q Consensus 381 l~~l~H~niv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 455 (640)
|-.+.|.|||++..|+.+. .+..++.|||..|++..+|++.+... ..+......+++.||..||.|||+. .++
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 4456799999999988653 45788999999999999998654322 2355666778999999999999986 688
Q ss_pred ceecCCCCCCeEECCCCCeEEccCCcccccCC-----------CccccccccCCccccCCCCccccCCCCCccchHHHHH
Q 006559 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGV 524 (640)
Q Consensus 456 ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGv 524 (640)
|+|+++..+.|++..+|-+|+.--.- ..... -.....+|.+|| +......+..+|||+||+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~-------sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPE-------SGTTTNTTGASDIYKFGM 270 (458)
T ss_pred cccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCC-------cCcccccccchhhhhhhH
Confidence 99999999999999999888743211 11110 112345788998 455556678899999999
Q ss_pred HHHHHHhCCCCCCCCCcchHHHHHHhhcccccc-cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 525 VLLEILTGKMAKGDGELGIVKWVQMMGQDESAW-EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 525 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
..+||..+..-....+.... + ++... -++. ..... =...+..|++..|..||+|++..
T Consensus 271 cAlemailEiq~tnseS~~~--~-----ee~ia~~i~~----len~l------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSESKVE--V-----EENIANVIIG----LENGL------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHHHHHheeccCCCcceee--h-----hhhhhhheee----ccCcc------ccCcCcccccCCCCCCcchhhhh
Confidence 99999988754322111100 0 00000 0000 00000 01244569999999999999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.2e-12 Score=138.74 Aligned_cols=138 Identities=20% Similarity=0.221 Sum_probs=95.3
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccch--------------------------------H----------HHHH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKK--------------------------------R----------EVDE 376 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------------------------------~----------~~~~ 376 (640)
+.||.|++|.||+|++.+|+.||||+.+....+ + ++..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 569999999999999999999999998653100 0 1222
Q ss_pred HHHHHhcc----CCCcccceeEEEEc-CCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHH-HHHHhhc
Q 006559 377 WLRVIGGL----RHSNIVSIRAYCNG-KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK-GLAFLHG 450 (640)
Q Consensus 377 e~~~l~~l----~H~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~ 450 (640)
|.+.+.++ +|.+-+.+-.++.+ ....+|||||+++++|.++...... .. .+.+++..++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~- 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL- 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH-
Confidence 33333322 23333333333322 3457999999999999887653211 12 23456666665 467788
Q ss_pred CCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 451 ~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
..+++|+|++|.||+++.++.+++.|||++..+.
T Consensus 275 --~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 --RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 4569999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-13 Score=153.53 Aligned_cols=237 Identities=20% Similarity=0.240 Sum_probs=164.1
Q ss_pred ccccccCcceEEEEEeCC--CcEEEEEEecccc-c---hHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLDG--GDVVVVKRIRERK-K---KREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~--~~~vavK~l~~~~-~---~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
+.||+|.|+.|-...... ...+|+|.+.... . ......|..+-..+. |.|++++++.....+..++++||..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 348999999998776433 3446666665432 1 222334555666666 99999999999999999999999999
Q ss_pred CCHHHhh-ccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccCC--
Q 006559 412 GSLHSLL-HGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHT-- 487 (640)
Q Consensus 412 gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~~-- 487 (640)
|++.+-+ +.... ..+......+..|+..++.|+|. ..++.|||+||+|.+++..+ ..|++|||++..+..
T Consensus 106 ~~~f~~i~~~~~~----~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 106 GSLFSKISHPDST----GTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cccccccccCCcc----CCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9998888 33220 12334556688999999999994 23499999999999999999 999999999876533
Q ss_pred -------Cccc-cccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc---hHHHHHHhhccccc
Q 006559 488 -------PFFI-NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG---IVKWVQMMGQDESA 556 (640)
Q Consensus 488 -------~~~~-~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~ 556 (640)
...+ +..|+|||...+. ....+..|+||.|+++.-+++|..|+...... ...|.......
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~------~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 250 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGK------AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF--- 250 (601)
T ss_pred CcceeeecccCCCCCCCCcccccch------hhcCCCcccccccccccccccCCCCccccccccccceeeccccccc---
Confidence 2345 8889999975332 23356789999999999999999998742211 12222211000
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
..... .......+++...++..+|..|.+.+++.
T Consensus 251 ------~~~~~---~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 251 ------TQLPW---NSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ------ccCcc---ccCChhhhhcccccccCCchhcccccccc
Confidence 00011 11122344555567778999999877664
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.2e-13 Score=122.60 Aligned_cols=138 Identities=24% Similarity=0.382 Sum_probs=123.6
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccc-cCCccCCCCCCCCEEEccc
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG-TFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~ 147 (640)
.+..|++.+|++...+..++.|+.|+.|+++-|++.-.|..|++++.|+.|||..|+++. .+|..|..+..|+.|+|+.
T Consensus 57 nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~d 136 (264)
T KOG0617|consen 57 NLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGD 136 (264)
T ss_pred hhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcC
Confidence 345567888888888889999999999999999999988899999999999999999975 4899999999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
|.|. .+| .+++++++||.|.+.+|.+- ++|...+.+..|++|.+.+|+++ .+|..++++
T Consensus 137 ndfe-~lp-~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 137 NDFE-ILP-PDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred CCcc-cCC-hhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 9998 677 77999999999999999987 67888889999999999999998 667666544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.1e-11 Score=111.15 Aligned_cols=129 Identities=16% Similarity=0.107 Sum_probs=94.1
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEecccc-chHHHHHHHHHHhccCCCccc-ceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIV-SIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
+.++.|.++.||++... +..+++|...... ....+..|++.++.+.+.+++ +++++. ....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 45788999999999876 6678999876553 233467788888877665554 344443 334589999999987754
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--CCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN--KAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
. . . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~-~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 E-D---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c-c---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 3 0 0 11235678999999999654 23369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.5e-11 Score=133.76 Aligned_cols=137 Identities=15% Similarity=0.132 Sum_probs=86.7
Q ss_pred ccccccCcceEEEEEeCC-CcEEEEEEeccccc------------------------------------hHH------HH
Q 006559 339 ELLGKGCVGATYKVVLDG-GDVVVVKRIRERKK------------------------------------KRE------VD 375 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~------------------------------------~~~------~~ 375 (640)
+.||.|++|.||+|++++ |+.||||+++.... .+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999987 99999999874310 001 12
Q ss_pred HHHHHHhcc----CCCcccceeEEEEc-CCeEEEEEeccCCCCHHHh--hccCCCCCCCCcCHHHHHHHHHHHHHHHHHh
Q 006559 376 EWLRVIGGL----RHSNIVSIRAYCNG-KDELFLVYDYLPHGSLHSL--LHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448 (640)
Q Consensus 376 ~e~~~l~~l----~H~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL 448 (640)
.|+.-+.++ .+.+.+.+-.++.+ ....+|||||++++.+.++ +.... ..+..+.......++.|+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Qi------- 276 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQV------- 276 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHHH-------
Confidence 222222222 23333444344433 3457899999999999874 22211 011112222222233333
Q ss_pred hcCCCCCceecCCCCCCeEECCCC----CeEEccCCcccccC
Q 006559 449 HGYNKAHLFHGHLSSSNIVVDQLG----NACISDIGVHQLFH 486 (640)
Q Consensus 449 H~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGl~~~~~ 486 (640)
+ ..+++|+|+||.||+++.++ .+++.|||+...+.
T Consensus 277 f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 2 34599999999999999888 99999999987654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.4e-13 Score=137.82 Aligned_cols=132 Identities=31% Similarity=0.404 Sum_probs=95.6
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEccccccccc-CCccCCCCCCCCEEEcc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT-FPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~Ls 146 (640)
.+++.|.|+...|.-.++.++.|.+|+.|++++|+|....-.++.++.|+.+++.+|+|... ||+.+..|..|+.||||
T Consensus 32 t~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLS 111 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLS 111 (1255)
T ss_pred hheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecc
Confidence 36888888888887777788888888888888888776555677777777777777777433 67777777777777777
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
+|+|. ..| ..+.+..++-+|+||+|++...+.+.+.++..|..||||+|++.-
T Consensus 112 hNqL~-EvP-~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~ 164 (1255)
T KOG0444|consen 112 HNQLR-EVP-TNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM 164 (1255)
T ss_pred hhhhh-hcc-hhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh
Confidence 77776 566 556666777777777777765555556666677777777777763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.4e-11 Score=127.84 Aligned_cols=242 Identities=21% Similarity=0.179 Sum_probs=161.6
Q ss_pred ChHHHHHHhhccccc--cCcceEEEEEe---CCCcEEEEEEeccc----cchHHHHHHHHHHhcc-CCCcccceeEEEEc
Q 006559 329 NVGDLLKSSAELLGK--GCVGATYKVVL---DGGDVVVVKRIRER----KKKREVDEWLRVIGGL-RHSNIVSIRAYCNG 398 (640)
Q Consensus 329 ~~~~~~~~~~~~iG~--G~fg~Vy~~~~---~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~ 398 (640)
+..+.......-+|+ |.+|.||.+.. .++..+|+|+-+.. .....-.+|+....++ .|+|.++....+.+
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 344444455667899 99999999886 45677888873321 1222222333333344 49999998888998
Q ss_pred CCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHH----HHHHhhcCCCCCceecCCCCCCeEECCC-CC
Q 006559 399 KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK----GLAFLHGYNKAHLFHGHLSSSNIVVDQL-GN 473 (640)
Q Consensus 399 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrdlk~~NILl~~~-~~ 473 (640)
.+..|+=+|++. .+|.++.+.... .++......+..+... ||.++|+. .++|-|+||.||++..+ ..
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccce
Confidence 999999999885 688888765432 2444455556666666 99999954 59999999999999988 88
Q ss_pred eEEccCCcccccCCCc-----------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc
Q 006559 474 ACISDIGVHQLFHTPF-----------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG 542 (640)
Q Consensus 474 ~kl~DfGl~~~~~~~~-----------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~ 542 (640)
.++.|||+...+.... .+...|++||+. ...++..+|+||+|.+..|..++..++..+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~--------~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-- 331 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL--------NGLATFASDIFSLGEVILEAILGSHLPSVGK-- 331 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh--------ccccchHhhhcchhhhhHhhHhhcccccCCC--
Confidence 9999999977664322 224469999953 3456778999999999999999876553210
Q ss_pred hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
...|.+ ++...+.++....-..++..+...+++.+|..|++.+++.
T Consensus 332 ~~~W~~-----------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 332 NSSWSQ-----------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred CCCccc-----------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 011211 1111111111111122333366778999999999876653
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.7e-11 Score=124.68 Aligned_cols=141 Identities=26% Similarity=0.277 Sum_probs=109.7
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.+..|++++|.|+... ..|-+|++|+.++|..|.|+..|...+...+|+.|+|.+|.++..-..++.-++.|+.||||.
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 5667999999998754 678899999999999999987654444455688899999988877777788888888888888
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
|.++ .||...|..-.++++|+|++|+++..-...|.++.+|..|.|++|+++-..+..|.++
T Consensus 159 N~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L 220 (873)
T KOG4194|consen 159 NLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRL 220 (873)
T ss_pred chhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhc
Confidence 8887 6776667666788888888888887666777778888888888888884333344433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.7e-11 Score=126.42 Aligned_cols=141 Identities=28% Similarity=0.325 Sum_probs=107.0
Q ss_pred CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCC-CCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEE
Q 006559 67 THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSN-LNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144 (640)
Q Consensus 67 ~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 144 (640)
++|++.|+|.+|-++... +.+..++.|+.||||.|.|+..+ +.+..-.++++|+|++|+++..--..|.+|.+|..|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 468888888888776543 67888999999999999998764 3666667899999999999877777888999999999
Q ss_pred cccCCCCCCCCchhcCCCCCCcEEEccCCcceecccC------------------------CcCCCCCCcEEEcccCcCc
Q 006559 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYS------------------------VNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 145 Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~------------------------~~~~~~~L~~l~ls~N~l~ 200 (640)
|++|.++ .+|...|.+|++|+.|+|..|++.-.--. .|-.+.+++.|+|+.|+++
T Consensus 204 LsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~ 282 (873)
T KOG4194|consen 204 LSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ 282 (873)
T ss_pred cccCccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence 9999998 68878888899999998888887532112 2333455666666666666
Q ss_pred ccCCcccC
Q 006559 201 GQIPAWMS 208 (640)
Q Consensus 201 g~ip~~~~ 208 (640)
..--.|+.
T Consensus 283 ~vn~g~lf 290 (873)
T KOG4194|consen 283 AVNEGWLF 290 (873)
T ss_pred hhhccccc
Confidence 54444543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.1e-12 Score=127.04 Aligned_cols=128 Identities=26% Similarity=0.356 Sum_probs=98.3
Q ss_pred EEEEEeCCCCCCCC------------------------chhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEccccc
Q 006559 70 VIKLVLEDLDLTGP------------------------AEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNR 125 (640)
Q Consensus 70 v~~l~l~~~~l~g~------------------------~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~ 125 (640)
|+.++++.|.+.-. +..++.+++|+.|+|++|.+...|.+++.+..|+.||+|+|+
T Consensus 390 Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~Nr 469 (565)
T KOG0472|consen 390 VTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNR 469 (565)
T ss_pred eEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccc
Confidence 88888888776542 234566777777777777777777677777777777777777
Q ss_pred ccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCc
Q 006559 126 FTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 126 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
|. .+|..+..+..|+.+-.++|++. .+++..+.++.+|..|||.+|.+. .+|+.++++.+|+.|++.+|.|.
T Consensus 470 Fr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 470 FR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 75 56666666666666666667775 566566889999999999999998 68888999999999999999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.3e-12 Score=128.83 Aligned_cols=145 Identities=26% Similarity=0.332 Sum_probs=85.4
Q ss_pred EEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCC
Q 006559 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151 (640)
Q Consensus 72 ~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 151 (640)
.++..+|+++..++.+.++.+|..|++.+|.+...++..-+|+.|++||..+|-+. .+|+.++.|.+|..|+|.+|++.
T Consensus 141 dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~ 219 (565)
T KOG0472|consen 141 DLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR 219 (565)
T ss_pred hhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc
Confidence 34445555555555555555555555555555555444333555555555555543 45555555555555555555443
Q ss_pred C---------------------CCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCC
Q 006559 152 G---------------------EIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 152 g---------------------~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
- .+|.+....+++|.+|||.+|+++ +.|....-+++|..||+|+|.|++ +|..++++
T Consensus 220 ~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl 297 (565)
T KOG0472|consen 220 FLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL 297 (565)
T ss_pred cCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc
Confidence 1 355344457888888888888887 466666667888888899888885 56666655
Q ss_pred --CCCCCCCCc
Q 006559 211 --GGSSFAGNK 219 (640)
Q Consensus 211 --~~~~~~gn~ 219 (640)
......|||
T Consensus 298 hL~~L~leGNP 308 (565)
T KOG0472|consen 298 HLKFLALEGNP 308 (565)
T ss_pred eeeehhhcCCc
Confidence 223334554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.8e-10 Score=108.02 Aligned_cols=140 Identities=23% Similarity=0.298 Sum_probs=107.7
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEecccc---chHHHHHHHHHHhccCCC--cccceeEEEEcC---CeEEEEEeccC
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHS--NIVSIRAYCNGK---DELFLVYDYLP 410 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~---~~~~lV~Ey~~ 410 (640)
+.|+.|.++.||++...+|..+++|...... ....+..|.++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 4589999999999998777889999876543 345678888888888763 456677776654 26789999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN-------------------------------------- 452 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 452 (640)
+.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888765531 13566777788888888888888531
Q ss_pred ---------------CCCceecCCCCCCeEECC--CCCeEEccCCcccc
Q 006559 453 ---------------KAHLFHGHLSSSNIVVDQ--LGNACISDIGVHQL 484 (640)
Q Consensus 453 ---------------~~~ivHrdlk~~NILl~~--~~~~kl~DfGl~~~ 484 (640)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 66788999987754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2e-09 Score=115.48 Aligned_cols=161 Identities=17% Similarity=0.271 Sum_probs=117.8
Q ss_pred eCCCcEEEEEEeccccc--hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCH
Q 006559 354 LDGGDVVVVKRIRERKK--KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDW 431 (640)
Q Consensus 354 ~~~~~~vavK~l~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~ 431 (640)
..++.+|.|...+.... .....+.++.++.+|||||++++..+..++..|||+|-+. -|..++... ..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HH
Confidence 45677888888776544 3345666788999999999999999999999999999873 566666543 22
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC------ccccccccCCccccCCC
Q 006559 432 NKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------FFINDAYNAPELKFNNN 505 (640)
Q Consensus 432 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------~~~~~~y~aPE~~~~~~ 505 (640)
....-.+.||+.||.|||+ +.+++|++|.-..|+++..|+-||++|-+....... ...-..|..|+..
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~---- 177 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEI---- 177 (690)
T ss_pred HHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhc----
Confidence 3444467899999999996 447999999999999999999999999876443211 1112234555521
Q ss_pred CccccCCCCCccchHHHHHHHHHHHhCCCC
Q 006559 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKMA 535 (640)
Q Consensus 506 ~~~~~~~~~~k~DV~SfGvvl~el~tg~~p 535 (640)
.. -+-..|.|-|||++||++.|..+
T Consensus 178 ---~~--s~~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 178 ---DP--SEWSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred ---Cc--cccchhhhhHHHHHHHHhCcccC
Confidence 10 00235999999999999999443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=9e-12 Score=130.63 Aligned_cols=157 Identities=24% Similarity=0.364 Sum_probs=132.9
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
+.+..+||+.|+|.-.++.+-++.+|+.|+||+|.|+......+.|.+|++|+||.|+|+ .+|..+.+|+.|+.|.+.+
T Consensus 222 ~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~ 300 (1255)
T KOG0444|consen 222 HNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANN 300 (1255)
T ss_pred hhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhcc
Confidence 457788999999998888999999999999999999988777888999999999999998 6899999999999999999
Q ss_pred CCCCC-CCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC---CCCCCCCCCCcccCC
Q 006559 148 NAYEG-EIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS---PFGGSSFAGNKNLCG 223 (640)
Q Consensus 148 N~l~g-~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~---~~~~~~~~gn~~lcg 223 (640)
|+|+- .|| +.++.|.+|+++.+++|.+. .+|..+..+..|+.|.|+.|++- ++|+.+- .+.......|++|.-
T Consensus 301 NkL~FeGiP-SGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVM 377 (1255)
T KOG0444|consen 301 NKLTFEGIP-SGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVM 377 (1255)
T ss_pred CcccccCCc-cchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccC
Confidence 98862 377 78999999999999999886 67888888999999999999986 6787653 344555667888877
Q ss_pred CCCCC
Q 006559 224 RPLPS 228 (640)
Q Consensus 224 ~~~~~ 228 (640)
+|-|.
T Consensus 378 PPKP~ 382 (1255)
T KOG0444|consen 378 PPKPN 382 (1255)
T ss_pred CCCcc
Confidence 76553
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=9.2e-11 Score=117.42 Aligned_cols=68 Identities=22% Similarity=0.292 Sum_probs=49.3
Q ss_pred CCCCCCC---CceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCc
Q 006559 52 DPCFDSW---RGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLK 117 (640)
Q Consensus 52 ~~c~~~w---~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~ 117 (640)
.+|.|+- .-|.|..+ ....|.|.|..|+++..+ ..|+.+.+|+.||||+|.|+...| .|..+++|.
T Consensus 39 ~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~ 118 (498)
T KOG4237|consen 39 APCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLL 118 (498)
T ss_pred CCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhh
Confidence 4565555 55778754 236789999999998754 789999999999999999986544 344444443
Q ss_pred EE
Q 006559 118 HL 119 (640)
Q Consensus 118 ~L 119 (640)
.|
T Consensus 119 ~L 120 (498)
T KOG4237|consen 119 SL 120 (498)
T ss_pred HH
Confidence 33
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.4e-10 Score=121.39 Aligned_cols=238 Identities=17% Similarity=0.174 Sum_probs=158.3
Q ss_pred hccccccCcceEEEEEe--CCCcEEEEEEecccc--chHHH--HHHHHHHhc-cCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVL--DGGDVVVVKRIRERK--KKREV--DEWLRVIGG-LRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~--~~~~~vavK~l~~~~--~~~~~--~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
...||.|.|+.||+... .++..+++|.+.+.. ...++ ..|+-+... ..|.+++.+...+...+..|+-.||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 34699999999998874 467789999887652 11111 122222222 258899998888888888889999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-CCeEEccCCcccccC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-GNACISDIGVHQLFH--- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGl~~~~~--- 486 (640)
++++...+.-. ..++...++++..|++.++.++| .+.++|+|+||+||++..+ +..++.|||++..+.
T Consensus 350 ~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 350 GGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred CcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceec
Confidence 99887665221 24667788899999999999999 5669999999999999886 888999999986432
Q ss_pred CCcccccccc-CCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 TPFFINDAYN-APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 ~~~~~~~~y~-aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
.......++. ..|++.. ...+-.+.|++|||.-+.|.+++..--... ..|.. +......
T Consensus 422 ~~~~~~~r~~p~~~~~~e------~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~~~~~----------i~~~~~p 481 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLE------DYPHLSKADIFSLGLSVDEAITGSPLSESG----VQSLT----------IRSGDTP 481 (524)
T ss_pred ccccccccccccchhhcc------ccccccccccccccccccccccCcccCccc----cccee----------eeccccc
Confidence 2222233444 2554322 234457899999999999999987533211 11111 1111111
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
..+....+ +..++..+..+++..||.+.+.....+..+
T Consensus 482 ~~~~~~~~---~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 482 NLPGLKLQ---LQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred CCCchHHh---hhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 11221222 333344478899999999888766655444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=2e-09 Score=101.96 Aligned_cols=133 Identities=11% Similarity=0.129 Sum_probs=93.3
Q ss_pred cccccCcceEEEEEeCC-------CcEEEEEEeccc----c--------c------------hHHH----HHHHHHHhcc
Q 006559 340 LLGKGCVGATYKVVLDG-------GDVVVVKRIRER----K--------K------------KREV----DEWLRVIGGL 384 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~-------~~~vavK~l~~~----~--------~------------~~~~----~~e~~~l~~l 384 (640)
.||.|.=+.||.|.-.+ +..+|||..+.. + . .+.+ ++|.+.|.++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 58999999999998543 478999987421 0 0 1122 2678888877
Q ss_pred CC--CcccceeEEEEcCCeEEEEEeccCCCCHHH-hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHh-hcCCCCCceecC
Q 006559 385 RH--SNIVSIRAYCNGKDELFLVYDYLPHGSLHS-LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL-HGYNKAHLFHGH 460 (640)
Q Consensus 385 ~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrd 460 (640)
.- -++.+.+++ ..-+|||||+.++.+.. .++.. .++......+..+++.+|.+| | +.+|||+|
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD 150 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD 150 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 54 345555654 45789999997654421 22211 234445567788999999999 6 45699999
Q ss_pred CCCCCeEECCCCCeEEccCCcccccC
Q 006559 461 LSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 461 lk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
|++.|||++ ++.+.|+|||-+-...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4679999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.9e-10 Score=106.77 Aligned_cols=109 Identities=30% Similarity=0.408 Sum_probs=30.6
Q ss_pred ccCCCCCCEEeCCCCcCCCCCCCCC-CCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhc-CCCCC
Q 006559 87 LSRLTQLRLLSLKNNLLSSSNLNLS-SWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTEL-TRLPN 164 (640)
Q Consensus 87 l~~l~~L~~L~Ls~N~l~~~~~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~~l~~ 164 (640)
+.+...++.|+|++|.|+.. ..++ .+.+|+.||||+|.++. ++ .+..++.|+.|+|++|.++. ++ +.+ ..+|+
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~-~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-IS-EGLDKNLPN 89 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--C-HHHHHH-TT
T ss_pred cccccccccccccccccccc-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cc-cchHHhCCc
Confidence 33444566677777776653 2343 45667777777777763 22 35566777777777777763 43 223 34667
Q ss_pred CcEEEccCCcceecc-cCCcCCCCCCcEEEcccCcCc
Q 006559 165 LLTLRLEDNRFTGTL-YSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 165 L~~L~L~~N~l~g~~-~~~~~~~~~L~~l~ls~N~l~ 200 (640)
|+.|+|++|++...- -..+..+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 777777777765421 122445666777777777665
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7e-11 Score=129.73 Aligned_cols=126 Identities=29% Similarity=0.393 Sum_probs=104.2
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
.+..|.|.+|.|+... +.+-+..+|++|+|++|+|...+. .+.+|..|+.|+||+|+|+ .+|..+.++..|++|...
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ah 438 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAH 438 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhc
Confidence 4566777778887765 778889999999999999988766 5888999999999999998 688889999999999999
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCc
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQ 198 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~ 198 (640)
+|++. .+| ++..+++|+.+||+.|+|+...-...-.+++|++|||++|.
T Consensus 439 sN~l~-~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 439 SNQLL-SFP--ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred CCcee-ech--hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 99998 566 68899999999999999986543333334889999999997
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.1e-09 Score=94.86 Aligned_cols=129 Identities=22% Similarity=0.329 Sum_probs=95.1
Q ss_pred cccccCcceEEEEEeCCCcEEEEEEecccc----------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 340 LLGKGCVGATYKVVLDGGDVVVVKRIRERK----------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+++|+=+.+|.+.+.+.. +++|.-..+. .......|.+++.+++--.|..-.=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775544 5555432221 1123456888888877666655555566778889999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
++-.|.+.+... ...++..+-.-+.-|| ..+|||+||.++||++..+. +.++||||+..-
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888643 1345666667777899 56699999999999998765 899999998754
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.6e-10 Score=124.40 Aligned_cols=103 Identities=27% Similarity=0.358 Sum_probs=63.0
Q ss_pred CCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEc
Q 006559 91 TQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRL 170 (640)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L 170 (640)
.+|+.|+|++|+|++.++. .++|+.|++++|.|++ +|... .+|+.|+|++|+|++ +| .. .++|+.|++
T Consensus 342 ~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~N~Lt~-LP-~l---~s~L~~LdL 409 (788)
T PRK15387 342 SGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLTS-LP-VL---PSELKELMV 409 (788)
T ss_pred cccceEecCCCccCCCCCC---Ccccceehhhcccccc-Ccccc---cccceEEecCCcccC-CC-Cc---ccCCCEEEc
Confidence 3788899999998876532 2456667777777764 55432 456677777777763 55 21 245666777
Q ss_pred cCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCC
Q 006559 171 EDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 171 ~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
++|+|++ +|.. ..+|+.|++++|+|+ .+|..+..+
T Consensus 410 S~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L 444 (788)
T PRK15387 410 SGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHL 444 (788)
T ss_pred cCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhc
Confidence 7777664 4432 234556666666665 566554433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=2e-09 Score=100.00 Aligned_cols=123 Identities=28% Similarity=0.351 Sum_probs=50.1
Q ss_pred cEEEEEeCCCCCCCCchhcc-CCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccC-CCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTGPAEVLS-RLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls 146 (640)
+...|+|.++.++-. +.++ .+++|+.|+|++|.++.. ..+..++.|+.|+|++|+++. ++..+ ..+++|+.|+|+
T Consensus 20 ~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 20 KLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-T
T ss_pred ccccccccccccccc-cchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECc
Confidence 567788888888753 3455 588999999999999875 367788999999999999985 44334 468999999999
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceeccc---CCcCCCCCCcEEEc
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLY---SVNSSSRSILDFNV 194 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~---~~~~~~~~L~~l~l 194 (640)
+|++...--...+..+++|+.|+|.+|.++...- -.+..+++|+.||-
T Consensus 97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 97 NNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp TS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 9999754333457788999999999999875321 12345677777653
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=1e-08 Score=115.81 Aligned_cols=125 Identities=27% Similarity=0.393 Sum_probs=61.5
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCC-----------------CCCCcEEEcccccccccCC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSS-----------------WPHLKHLYLSHNRFTGTFP 131 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-----------------l~~L~~L~Ls~N~l~g~~p 131 (640)
++..|++.+|.++..+. .+++|++|+|++|+|+..+..+.+ +++|+.|+|++|+|+. +|
T Consensus 223 ~L~~L~L~~N~Lt~LP~---lp~~Lk~LdLs~N~LtsLP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt~-LP 298 (788)
T PRK15387 223 HITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LP 298 (788)
T ss_pred CCCEEEccCCcCCCCCC---CCCCCcEEEecCCccCcccCcccccceeeccCCchhhhhhchhhcCEEECcCCcccc-cc
Confidence 46666777776665332 246677777777776654321100 1123333444444432 22
Q ss_pred ccCCCCCCCCEEEcccCCCCCCCCc--hh----------cCC---C-CCCcEEEccCCcceecccCCcCCCCCCcEEEcc
Q 006559 132 SGVSSLRHLRRVDLSHNAYEGEIPM--TE----------LTR---L-PNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVS 195 (640)
Q Consensus 132 ~~~~~l~~L~~L~Ls~N~l~g~~p~--~~----------~~~---l-~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls 195 (640)
. .+++|+.|+|++|+|++ +|. .. +.. + ++|+.|+|++|+|++ +|.. ..+|..|+++
T Consensus 299 ~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls 370 (788)
T PRK15387 299 V---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAY 370 (788)
T ss_pred c---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccCC-CCCC---Ccccceehhh
Confidence 2 12456666666666664 331 00 011 1 256777777777764 3332 2345555555
Q ss_pred cCcCcccCCcc
Q 006559 196 NNQLSGQIPAW 206 (640)
Q Consensus 196 ~N~l~g~ip~~ 206 (640)
+|+|++ +|..
T Consensus 371 ~N~L~~-LP~l 380 (788)
T PRK15387 371 NNRLTS-LPAL 380 (788)
T ss_pred cccccc-Cccc
Confidence 555553 4443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=8.7e-09 Score=116.97 Aligned_cols=119 Identities=28% Similarity=0.368 Sum_probs=83.0
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
..+.|+|.+++++..+..+. ++|+.|+|++|.|+..+..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|
T Consensus 179 ~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N 251 (754)
T PRK15370 179 NKTELRLKILGLTTIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSIN 251 (754)
T ss_pred CceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCC
Confidence 47789999988887654342 578888999888887665443 57888888888887 4565443 46778888888
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
++. .+| ..+. ++|+.|+|++|+|+. +|..+ ..+|+.|+|++|+|++
T Consensus 252 ~L~-~LP-~~l~--s~L~~L~Ls~N~L~~-LP~~l--~~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 252 RIT-ELP-ERLP--SALQSLDLFHNKISC-LPENL--PEELRYLSVYDNSIRT 297 (754)
T ss_pred ccC-cCC-hhHh--CCCCEEECcCCccCc-ccccc--CCCCcEEECCCCcccc
Confidence 777 566 3332 467777777777773 45443 2467777777777774
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.4e-08 Score=89.96 Aligned_cols=140 Identities=16% Similarity=0.278 Sum_probs=97.6
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEE-eccc---------cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKR-IRER---------KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~-l~~~---------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
.++|-+|+=+.|+++.+.+ +.++||. ..+. -.++...+|++.+.+++--.|.--.-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4568899999999998864 5545554 2221 113445678888887765555544445556666789999
Q ss_pred ccCC-CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC---CeEEccCCccc
Q 006559 408 YLPH-GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG---NACISDIGVHQ 483 (640)
Q Consensus 408 y~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGl~~ 483 (640)
|.++ -++.+++...-... ..-.....++..|-+.+.-|| ...|||+||..+||+|..++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9976 47888876543211 111223567888888999999 55699999999999997655 45799999976
Q ss_pred c
Q 006559 484 L 484 (640)
Q Consensus 484 ~ 484 (640)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.7e-09 Score=80.71 Aligned_cols=60 Identities=38% Similarity=0.572 Sum_probs=31.9
Q ss_pred CCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcc
Q 006559 115 HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRF 175 (640)
Q Consensus 115 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l 175 (640)
+|++|+|++|+|+...+..|.++++|++|+|++|+++ .+|+..|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCcC
Confidence 4555555555555444445555555555555555555 23334555555555555555543
|
... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.1e-08 Score=113.83 Aligned_cols=123 Identities=28% Similarity=0.392 Sum_probs=97.7
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
..++.|+|.+|.++..+..+. ++|+.|+|++|.|+..+..+ .++|+.|+|++|++. .+|..+. ++|+.|+|++
T Consensus 199 ~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~l--~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~ 271 (754)
T PRK15370 199 EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPATL--PDTIQEMELSINRIT-ELPERLP--SALQSLDLFH 271 (754)
T ss_pred cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChhh--hccccEEECcCCccC-cCChhHh--CCCCEEECcC
Confidence 368899999999987664443 58999999999999765544 347999999999998 6787664 5899999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCc
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA 205 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~ 205 (640)
|+|+ .+| ..+ .++|+.|+|++|+|++ +|..+ ..+|+.|++++|+|++ +|.
T Consensus 272 N~L~-~LP-~~l--~~sL~~L~Ls~N~Lt~-LP~~l--p~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 272 NKIS-CLP-ENL--PEELRYLSVYDNSIRT-LPAHL--PSGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred CccC-ccc-ccc--CCCCcEEECCCCcccc-Ccccc--hhhHHHHHhcCCcccc-CCc
Confidence 9998 577 333 2589999999999996 44443 2578999999999985 554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.1e-09 Score=79.45 Aligned_cols=61 Identities=36% Similarity=0.479 Sum_probs=57.1
Q ss_pred CCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcC
Q 006559 138 RHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQL 199 (640)
Q Consensus 138 ~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l 199 (640)
++|+.|+|++|+++ .+|...|..+++|++|++++|.++...+..+..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57999999999999 67878899999999999999999998889999999999999999986
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4e-07 Score=95.14 Aligned_cols=169 Identities=23% Similarity=0.262 Sum_probs=124.3
Q ss_pred cceEEEEE-eCCCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEc----CCeEEEEEeccCC-CCHHHh
Q 006559 346 VGATYKVV-LDGGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNG----KDELFLVYDYLPH-GSLHSL 417 (640)
Q Consensus 346 fg~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~~ 417 (640)
-.+.||+. -.+|..++.|++.-.+ .......-++..+++.|+|+|+|.+++.. +..+++||+|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 34679998 4578889999994321 11122344667889999999999998863 3479999999986 578776
Q ss_pred hccCCC----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 418 LHGSRG----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 418 l~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
-..... ......++...+.++.|+..||.++|+.+ +.-+-|.+.+||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543221 11234677889999999999999999654 88899999999999999999999888877654
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA 535 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p 535 (640)
... |.+ . --.+-|.-.||.+++.|.||..-
T Consensus 446 d~~--------~~l-------e---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT--------EPL-------E---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC--------cch-------h---HHhhhhHHHHHHHHHHHhhcccc
Confidence 321 111 0 01357999999999999999643
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.4e-10 Score=122.35 Aligned_cols=128 Identities=29% Similarity=0.336 Sum_probs=104.8
Q ss_pred CCCCCEEeCCCCcCCCC-CCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEE
Q 006559 90 LTQLRLLSLKNNLLSSS-NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTL 168 (640)
Q Consensus 90 l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L 168 (640)
+..|+.|+|.+|.|+.. .|.+.++++|+.|+|++|+|.......+.+|..|+.|+||+|+|+ .+| ..+.+++.|++|
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp-~tva~~~~L~tL 435 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLP-DTVANLGRLHTL 435 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhh-HHHHhhhhhHHH
Confidence 45678899999999875 457889999999999999997433346789999999999999998 788 788999999999
Q ss_pred EccCCcceecccCCcCCCCCCcEEEcccCcCc-ccCCccc--CCCCCCCCCCCccc
Q 006559 169 RLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS-GQIPAWM--SPFGGSSFAGNKNL 221 (640)
Q Consensus 169 ~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~-g~ip~~~--~~~~~~~~~gn~~l 221 (640)
...+|++.- +| .+..+++|+.+|+|.|+|+ +.+|..+ .++....+.||.++
T Consensus 436 ~ahsN~l~~-fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 436 RAHSNQLLS-FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhcCCceee-ch-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999999984 44 7778999999999999997 4455443 34556677788753
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.72 E-value=5e-08 Score=117.97 Aligned_cols=127 Identities=22% Similarity=0.250 Sum_probs=89.4
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
.++.|+|.++.+......+..+++|+.|+|++|...+..|.++.+++|+.|+|++|.....+|..++++++|+.|+|++|
T Consensus 612 ~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 612 NLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred CCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence 56677777777665555667788888888887765555567788888888888887777778888888888888888886
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
..-..+| ..+ ++++|+.|+|++|...+.+|.. ..+|+.|++++|.++
T Consensus 692 ~~L~~Lp-~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 692 ENLEILP-TGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE 738 (1153)
T ss_pred CCcCccC-CcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence 5555677 333 6777777777777655555433 234556666666554
|
syringae 6; Provisional |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.7e-07 Score=92.48 Aligned_cols=140 Identities=17% Similarity=0.109 Sum_probs=95.6
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccc-------------hHHHHHHHHHHhccCCCcc--cceeEEEEc----
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKK-------------KREVDEWLRVIGGLRHSNI--VSIRAYCNG---- 398 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------~~~~~~e~~~l~~l~H~ni--v~l~~~~~~---- 398 (640)
.+++-......|++..+ +|+.+.||+...... ...+.+|.+.+.++...+| ....++...
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444455677666 456788897643221 1136677777776654444 344555533
Q ss_pred -CCeEEEEEeccCCC-CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC------
Q 006559 399 -KDELFLVYDYLPHG-SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ------ 470 (640)
Q Consensus 399 -~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~------ 470 (640)
...-++|+|++++- +|.+++..... .+.+...+..++.+++..+.-|| ..+|+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCC
Confidence 23578999999976 89888753211 12345567789999999999999 556999999999999985
Q ss_pred -CCCeEEccCCcccc
Q 006559 471 -LGNACISDIGVHQL 484 (640)
Q Consensus 471 -~~~~kl~DfGl~~~ 484 (640)
++.+.++||+.++.
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46889999998764
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.8e-09 Score=104.48 Aligned_cols=110 Identities=27% Similarity=0.351 Sum_probs=83.2
Q ss_pred hhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCC
Q 006559 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPN 164 (640)
Q Consensus 85 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~ 164 (640)
..+.....|+.||||+|.++....+..-+|.++.|++|+|.+... +.+..|++|+.||||+|.|+ .+- .+-..|-+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~-Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECV-GWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhh-hhHhhhcC
Confidence 344556778899999999887766777788899999999998632 23777889999999999887 343 34456778
Q ss_pred CcEEEccCCcceecccCCcCCCCCCcEEEcccCcCc
Q 006559 165 LLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 165 L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
.+.|.|+.|.+.. -+.+..+-+|.+||+++|+|.
T Consensus 354 IKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 354 IKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred EeeeehhhhhHhh--hhhhHhhhhheeccccccchh
Confidence 8888898887753 233556778888899988886
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.3e-09 Score=111.03 Aligned_cols=126 Identities=29% Similarity=0.395 Sum_probs=78.4
Q ss_pred EEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCC
Q 006559 70 VIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149 (640)
Q Consensus 70 v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 149 (640)
.+-++|+.|+++..+..++.|+ |+.|-+++|+++..+..++.+..|..||.+.|++. .+|+.++.|.+|+.|.+..|+
T Consensus 123 lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~ 200 (722)
T KOG0532|consen 123 LTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNH 200 (722)
T ss_pred HHHhhhccchhhcCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhh
Confidence 4445555555555555555554 55666666666555555555556666666666665 455566666666666666666
Q ss_pred CCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 150 YEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 150 l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
+. .+| +++..| .|..||++.|+++ .+|..|..|+.|++|-|.+|.|..
T Consensus 201 l~-~lp-~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 201 LE-DLP-EELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hh-hCC-HHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 65 455 444444 3777777777777 567777777777777777777763
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=114.14 Aligned_cols=115 Identities=19% Similarity=0.190 Sum_probs=69.5
Q ss_pred CCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEE
Q 006559 89 RLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTL 168 (640)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L 168 (640)
.+.+|+.|+|++|.+...+..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+| ..+.++++|+.|
T Consensus 609 ~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp-~si~~L~~L~~L 686 (1153)
T PLN03210 609 RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELP-SSIQYLNKLEDL 686 (1153)
T ss_pred CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccc-hhhhccCCCCEE
Confidence 34566666666666655544555666666666666554455553 5666666666666665555666 456666666666
Q ss_pred EccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcc
Q 006559 169 RLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAW 206 (640)
Q Consensus 169 ~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~ 206 (640)
++++|..-+.+|... ++++|+.|++++|...+.+|..
T Consensus 687 ~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~ 723 (1153)
T PLN03210 687 DMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI 723 (1153)
T ss_pred eCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc
Confidence 666654444555443 4666666666666555555543
|
syringae 6; Provisional |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.2e-09 Score=115.92 Aligned_cols=185 Identities=21% Similarity=0.192 Sum_probs=122.4
Q ss_pred cccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 340 LLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
-+-+|.|+.++-++-. .|...+.|...... .-+....+-.++-..+||-++.....+......+||++|+.+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 5667888888776532 23333333332210 01111111112212245666655555556778999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------- 486 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------- 486 (640)
|..-++.... .+..-.......+..+++|||+. .+.|||++|.|.+...++..+++|||+.....
T Consensus 891 ~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 891 LPSKLHNSGC-----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred chhhhhcCCC-----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 9999886542 22222233556677899999954 38999999999999999999999998432210
Q ss_pred ------------------------------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 487 ------------------------------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 487 ------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
....+|..|.+||.. .+......+|+|++|++++|.++|..||
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~-------lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL-------LGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCccc-------ccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 012347789999964 3445557899999999999999999999
Q ss_pred CCC
Q 006559 537 GDG 539 (640)
Q Consensus 537 ~~~ 539 (640)
...
T Consensus 1036 na~ 1038 (1205)
T KOG0606|consen 1036 NAE 1038 (1205)
T ss_pred CCc
Confidence 753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.4e-09 Score=113.85 Aligned_cols=130 Identities=27% Similarity=0.393 Sum_probs=108.3
Q ss_pred CchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCC
Q 006559 83 PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRL 162 (640)
Q Consensus 83 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l 162 (640)
.+..+++|..|++|||+.|+++..+..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|++. .+| ..++.+
T Consensus 113 ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slp-sql~~l 188 (722)
T KOG0532|consen 113 IPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLP-SQLGYL 188 (722)
T ss_pred cchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hch-HHhhhH
Confidence 34568899999999999999999988888888 999999999997 78889999999999999999998 688 789999
Q ss_pred CCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC---CCCCCCCc
Q 006559 163 PNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG---GSSFAGNK 219 (640)
Q Consensus 163 ~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~---~~~~~gn~ 219 (640)
.+|+.|.+..|++.. +|..+. .-.|..||+|.|+++ .||..|..+. ...++.||
T Consensus 189 ~slr~l~vrRn~l~~-lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 189 TSLRDLNVRRNHLED-LPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred HHHHHHHHhhhhhhh-CCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCC
Confidence 999999999999985 444444 456889999999998 8898776543 33444554
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.2e-08 Score=105.97 Aligned_cols=133 Identities=26% Similarity=0.311 Sum_probs=95.5
Q ss_pred CcEEEEEeCCCCCCCCc-----hhccCC-CCCCEEeCCCCcCCCCCC-----CCCCCCCCcEEEccccccccc----CCc
Q 006559 68 HRVIKLVLEDLDLTGPA-----EVLSRL-TQLRLLSLKNNLLSSSNL-----NLSSWPHLKHLYLSHNRFTGT----FPS 132 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-----~~l~~l-~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~g~----~p~ 132 (640)
.++..|+++++.+++.. ..+..+ ++|+.|+|++|.+++... .+..+++|+.|+|++|.+++. ++.
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 35888999988887421 345666 889999999999985321 355677899999999999852 344
Q ss_pred cCCCCCCCCEEEcccCCCCCCCCc---hhcCCCCCCcEEEccCCcceecccCCc-----CCCCCCcEEEcccCcCc
Q 006559 133 GVSSLRHLRRVDLSHNAYEGEIPM---TELTRLPNLLTLRLEDNRFTGTLYSVN-----SSSRSILDFNVSNNQLS 200 (640)
Q Consensus 133 ~~~~l~~L~~L~Ls~N~l~g~~p~---~~~~~l~~L~~L~L~~N~l~g~~~~~~-----~~~~~L~~l~ls~N~l~ 200 (640)
.+..+++|+.|+|++|.+++.-.. ..+..+++|++|++++|.+++.....+ .....|+.|++++|.++
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 556667999999999988743210 345677889999999999886322111 12478999999999887
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.1e-08 Score=106.18 Aligned_cols=133 Identities=29% Similarity=0.391 Sum_probs=84.8
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCC---CCCEEeCCCCcCCCCCC-----CCCCC-CCCcEEEccccccccc----CCcc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLT---QLRLLSLKNNLLSSSNL-----NLSSW-PHLKHLYLSHNRFTGT----FPSG 133 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~---~L~~L~Ls~N~l~~~~~-----~~~~l-~~L~~L~Ls~N~l~g~----~p~~ 133 (640)
.++..|+|+++.+.+.. ..+..+. +|+.|++++|.+++... .+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 46777888777776432 3333333 38888888887764211 23455 7778888888887742 3334
Q ss_pred CCCCCCCCEEEcccCCCCCC----CCchhcCCCCCCcEEEccCCcceec----ccCCcCCCCCCcEEEcccCcCcc
Q 006559 134 VSSLRHLRRVDLSHNAYEGE----IPMTELTRLPNLLTLRLEDNRFTGT----LYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 134 ~~~l~~L~~L~Ls~N~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~----~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
+..+.+|+.|+|++|.+++. ++ ..+..+++|++|+|++|.+++. +...+..+++|+.|++++|.+++
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~-~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALA-EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHH-HHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 55667788888888887742 12 2344556788888888877643 23344556778888888887775
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.6e-07 Score=88.80 Aligned_cols=124 Identities=23% Similarity=0.267 Sum_probs=78.6
Q ss_pred eEEEEEeCCCcEEEEEEeccc---------------c--------c-----hHHHHHHHHHHhccCCC--cccceeEEEE
Q 006559 348 ATYKVVLDGGDVVVVKRIRER---------------K--------K-----KREVDEWLRVIGGLRHS--NIVSIRAYCN 397 (640)
Q Consensus 348 ~Vy~~~~~~~~~vavK~l~~~---------------~--------~-----~~~~~~e~~~l~~l~H~--niv~l~~~~~ 397 (640)
.||.|...+|..+|||..+.. . . +....+|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999999999999987531 0 0 11245688889888765 455555442
Q ss_pred cCCeEEEEEeccC--CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHh-hcCCCCCceecCCCCCCeEECCCCCe
Q 006559 398 GKDELFLVYDYLP--HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL-HGYNKAHLFHGHLSSSNIVVDQLGNA 474 (640)
Q Consensus 398 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrdlk~~NILl~~~~~~ 474 (640)
.-+|||||++ +..+..+.... ++......++.++...+..+ | ..+|||+||.+.|||++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eE
Confidence 3479999998 54444332211 11223455667777766654 6 5579999999999999987 89
Q ss_pred EEccCCcccccC
Q 006559 475 CISDIGVHQLFH 486 (640)
Q Consensus 475 kl~DfGl~~~~~ 486 (640)
.++|||-+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999876544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.59 E-value=7.3e-09 Score=100.34 Aligned_cols=128 Identities=23% Similarity=0.286 Sum_probs=71.4
Q ss_pred EEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCC
Q 006559 70 VIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149 (640)
Q Consensus 70 v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 149 (640)
++.+||++|.++-..++..-++.++.|+||.|.+.... .+..+++|+.||||+|.++ .+-.+-.+|.+.+.|.|+.|.
T Consensus 286 LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~ 363 (490)
T KOG1259|consen 286 LTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNK 363 (490)
T ss_pred hhhccccccchhhhhhhhhhccceeEEeccccceeeeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhh
Confidence 44555555555544455556666666666666665432 2555666666666666665 233333455566666666666
Q ss_pred CCCCCCchhcCCCCCCcEEEccCCcceecc-cCCcCCCCCCcEEEcccCcCccc
Q 006559 150 YEGEIPMTELTRLPNLLTLRLEDNRFTGTL-YSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 150 l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~-~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
+.. + +.+..|-+|.+||+++|++...- -..+++++-|+.+.|.+|.+++.
T Consensus 364 iE~-L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 364 IET-L--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred Hhh-h--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 652 1 33555556666666666664321 12344555566666666666543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.8e-07 Score=65.53 Aligned_cols=39 Identities=54% Similarity=0.997 Sum_probs=27.8
Q ss_pred hhhHHHHHHhhhcCCC-CCCCCCCCCCC--CCCCCCCCCceEec
Q 006559 24 YSDISTLLSFKASVTG-SSDSLSSWVNS--TDPCFDSWRGVTCN 64 (640)
Q Consensus 24 ~~~~~~ll~~k~~~~~-~~~~~~sW~~~--~~~c~~~w~gv~C~ 64 (640)
+.|.++|++||+++.. +...+.+|+.. .+|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C--~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC--SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC--CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe--eeccEEeC
Confidence 5799999999999974 54667799765 4566 89999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.8e-07 Score=91.96 Aligned_cols=92 Identities=24% Similarity=0.269 Sum_probs=80.1
Q ss_pred CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCC
Q 006559 109 NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188 (640)
Q Consensus 109 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~ 188 (640)
.|..+++|+.|+|++|.+++.-+.+|.++..|+.|.|..|++. .+....|.++..|+.|+|.+|+|+-.-|..|..+.+
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence 4788899999999999999888889999999999999999987 455467888999999999999999888889988999
Q ss_pred CcEEEcccCcCcc
Q 006559 189 ILDFNVSNNQLSG 201 (640)
Q Consensus 189 L~~l~ls~N~l~g 201 (640)
|..|+|-.|.|..
T Consensus 348 l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 348 LSTLNLLSNPFNC 360 (498)
T ss_pred eeeeehccCcccC
Confidence 9999998888764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.5e-06 Score=83.06 Aligned_cols=131 Identities=19% Similarity=0.237 Sum_probs=88.0
Q ss_pred HHHhhccccccCcceEEEEEeCCCcEEEEEEecccc------------------------chHHHHHHHHHHhccCCC--
Q 006559 334 LKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRERK------------------------KKREVDEWLRVIGGLRHS-- 387 (640)
Q Consensus 334 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~------------------------~~~~~~~e~~~l~~l~H~-- 387 (640)
+.+.++.||-|.=+.||.|..+.|..+|||.=+... .+...++|.+.|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345678999999999999999999999999754210 012245677778777543
Q ss_pred cccceeEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHH-HHHHHHHHHHHhhcCCCCCceecCCCCCCe
Q 006559 388 NIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK-LASDSAKGLAFLHGYNKAHLFHGHLSSSNI 466 (640)
Q Consensus 388 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~-i~~~ia~gL~yLH~~~~~~ivHrdlk~~NI 466 (640)
.+.+.+++ +...+||||+++-.|...--. .-....++. |+.++..+. ..+|||+|+..=||
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~-------~en~~~il~~il~~~~~~~-------~~GiVHGDlSefNI 233 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRLD-------VENPDEILDKILEEVRKAY-------RRGIVHGDLSEFNI 233 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccCc-------ccCHHHHHHHHHHHHHHHH-------HcCccccCCchheE
Confidence 45555543 456899999988666543210 111223332 333333332 24599999999999
Q ss_pred EECCCCCeEEccCCcc
Q 006559 467 VVDQLGNACISDIGVH 482 (640)
Q Consensus 467 Ll~~~~~~kl~DfGl~ 482 (640)
+++++|.+.++||-=+
T Consensus 234 lV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 234 LVTEDGDIVVIDWPQA 249 (304)
T ss_pred EEecCCCEEEEeCccc
Confidence 9999999999998433
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.6e-05 Score=78.90 Aligned_cols=191 Identities=15% Similarity=0.176 Sum_probs=115.9
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccc--hHHHHHHHHHHhc-cCCCcccceeEE----EE--cCC-eEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKK--KREVDEWLRVIGG-LRHSNIVSIRAY----CN--GKD-ELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~e~~~l~~-l~H~niv~l~~~----~~--~~~-~~~lV~E 407 (640)
...||+|+-+.+|-.-.-. .. +.|+...... +.+.. ..|.+ -.||-+-.=+.+ .. +.. ..-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~~-d~-VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR-DQ-VAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchhh-ch-hheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4569999999999643221 22 3455543311 11111 22222 245533220111 01 112 2456666
Q ss_pred ccCCC-CHHHhhccCC-CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 408 YLPHG-SLHSLLHGSR-GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 408 y~~~g-sL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
.+++. -...++.... .......+|...+++++.+|.+.+-||. .+.+-+|+.++|+|+.+++.+.+.|----..-
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 66543 2233332111 1122357899999999999999999995 45788999999999999999999873221111
Q ss_pred -----CCCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhC-CCCCCC
Q 006559 486 -----HTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG-KMAKGD 538 (640)
Q Consensus 486 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg-~~p~~~ 538 (640)
....++...|.+||+-... ++.+..-+...|-|.+||++++++.| ++||.+
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~--sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLP--SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred cCCceEecccCccccCCHHHhccc--cccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 1123457789999964311 33444556789999999999999886 999874
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.4e-07 Score=96.20 Aligned_cols=133 Identities=23% Similarity=0.230 Sum_probs=85.0
Q ss_pred CcEEEEEeCCCCCCCC---chhccCCCCCCEEeCCCCcCCCCCCC--CC-------------------------CCCCCc
Q 006559 68 HRVIKLVLEDLDLTGP---AEVLSRLTQLRLLSLKNNLLSSSNLN--LS-------------------------SWPHLK 117 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~---~~~l~~l~~L~~L~Ls~N~l~~~~~~--~~-------------------------~l~~L~ 117 (640)
.+|+.|||+.|-+..- ......|++|+.|+|+.|.|.-...+ -. .||+|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 4789999988876642 25667899999999999988643221 11 245556
Q ss_pred EEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceec-ccCC-----cCCCCCCcE
Q 006559 118 HLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGT-LYSV-----NSSSRSILD 191 (640)
Q Consensus 118 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~-~~~~-----~~~~~~L~~ 191 (640)
.|+|..|...+........+..|+.|||++|++-..-.....+.+|.|+.|+++.+.++.. +|+. ...+++|++
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~ 305 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEY 305 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccccee
Confidence 6666665422222233345667777888877776432223456777777777777777643 2332 345677888
Q ss_pred EEcccCcCc
Q 006559 192 FNVSNNQLS 200 (640)
Q Consensus 192 l~ls~N~l~ 200 (640)
|+++.|++.
T Consensus 306 L~i~~N~I~ 314 (505)
T KOG3207|consen 306 LNISENNIR 314 (505)
T ss_pred eecccCccc
Confidence 888888875
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.4e-06 Score=80.00 Aligned_cols=140 Identities=16% Similarity=0.216 Sum_probs=84.9
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcc--cceeEEEEcCCeEEEEEeccCCCC-HH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNI--VSIRAYCNGKDELFLVYDYLPHGS-LH 415 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~~~~~lV~Ey~~~gs-L~ 415 (640)
+.||+|..+.||+. .+..+++|............+|.+.++.+....+ .+.+++....+...+|||++++.. +.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 46899999999984 2445678887765555667888888887765444 566777777777889999998863 21
Q ss_pred Hh---------------------hccCCCCCCCCcC--HHHHHHHH-------HHHHH-HHHHhhcC-CCCCceecCCCC
Q 006559 416 SL---------------------LHGSRGPGRMPVD--WNKRLKLA-------SDSAK-GLAFLHGY-NKAHLFHGHLSS 463 (640)
Q Consensus 416 ~~---------------------l~~~~~~~~~~l~--~~~~~~i~-------~~ia~-gL~yLH~~-~~~~ivHrdlk~ 463 (640)
.. +|..... ...+. +....... ..+.. ...+|... ..+.++|+|+.|
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 11 1211000 01111 00000000 00011 11222211 234578999999
Q ss_pred CCeEECCCCCeEEccCCccc
Q 006559 464 SNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 464 ~NILl~~~~~~kl~DfGl~~ 483 (640)
.||++++++ +.|.||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.8e-06 Score=89.89 Aligned_cols=148 Identities=16% Similarity=0.212 Sum_probs=92.5
Q ss_pred ChHHHHHHhh-ccccccCcceEEEEEeCCCcEEEEEEeccccch--------------------------------HH--
Q 006559 329 NVGDLLKSSA-ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKK--------------------------------RE-- 373 (640)
Q Consensus 329 ~~~~~~~~~~-~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------------------------------~~-- 373 (640)
.+++...++. +-|+.++-|.||+|++++|+.||||+.+..-.+ ++
T Consensus 120 ~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 120 PIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred CHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 5666666655 679999999999999999999999998542100 01
Q ss_pred --------HHHHHHHHhcc----CCCcccceeEEEEc-CCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHH
Q 006559 374 --------VDEWLRVIGGL----RHSNIVSIRAYCNG-KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASD 440 (640)
Q Consensus 374 --------~~~e~~~l~~l----~H~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ 440 (640)
+..|..-+.++ ++.-=+++-.+|.+ .....|+|||++|-.+.+....... .++-.. ++..
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~k~---ia~~ 272 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GIDRKE---LAEL 272 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCCHHH---HHHH
Confidence 11222222222 22222333344433 4578999999999888877422111 133222 2222
Q ss_pred HHHHH-HHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 441 SAKGL-AFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 441 ia~gL-~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
++++. ..+- .-+++|.|..|-||+++.+|+..+.|||+.....
T Consensus 273 ~~~~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 273 LVRAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 22211 1111 2349999999999999999999999999976654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.23 E-value=6.5e-07 Score=96.06 Aligned_cols=123 Identities=30% Similarity=0.386 Sum_probs=92.0
Q ss_pred EEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCC-CCcEEEcccccccccCCccCCCCCCCCEEEcccCCC
Q 006559 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAY 150 (640)
Q Consensus 72 ~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 150 (640)
.+++..+.+......+..++.++.|++.+|.++..++....++ +|+.|++++|.+. .+|..+..+++|+.|++++|++
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l 175 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL 175 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchh
Confidence 4666666665555566677888888888888888777777774 8888888888887 5666778888888888888888
Q ss_pred CCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCc
Q 006559 151 EGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQ 198 (640)
Q Consensus 151 ~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~ 198 (640)
+ .+| ...+.+++|+.|++++|+++. +|........|..|.+++|.
T Consensus 176 ~-~l~-~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 176 S-DLP-KLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNS 220 (394)
T ss_pred h-hhh-hhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCc
Confidence 8 566 444477888888888888874 44443345668888888885
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=6.8e-07 Score=96.83 Aligned_cols=142 Identities=22% Similarity=0.282 Sum_probs=89.9
Q ss_pred HHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c--------cccccccCCccccC
Q 006559 439 SDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F--------FINDAYNAPELKFN 503 (640)
Q Consensus 439 ~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~--------~~~~~y~aPE~~~~ 503 (640)
.+++.|+.|+|. .+++||++|.|++|.+++.+..||+.|+.......+ + .....|.|||++
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~-- 181 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL-- 181 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh--
Confidence 455689999995 678999999999999999999999999875443220 0 113468899964
Q ss_pred CCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHH
Q 006559 504 NNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVAL 582 (640)
Q Consensus 504 ~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~ 582 (640)
.....+.++|+||+||++|-+.. |+.-+..... ...+-......+... +. .. .+...++.+-+.
T Consensus 182 -----~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~--~~----~s---~~~p~el~~~l~ 246 (700)
T KOG2137|consen 182 -----LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGA--FG----YS---NNLPSELRESLK 246 (700)
T ss_pred -----ccccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhccccccc--cc----cc---ccCcHHHHHHHH
Confidence 33455689999999999999994 5544443221 111111111111000 00 11 122233444455
Q ss_pred HccCCCCCCCCCHHHHH
Q 006559 583 LCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 583 ~Cl~~~P~~RPs~~~v~ 599 (640)
+.+..++.-||++.++.
T Consensus 247 k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHhcCCcccCcchhhhh
Confidence 57888999999776653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.8e-05 Score=74.07 Aligned_cols=135 Identities=17% Similarity=0.144 Sum_probs=97.2
Q ss_pred cccCcceEEEEEeCCCcEEEEEEeccc--------cchHHHHHHHHHHhccCCCcc--cceeEEEE-c----CCeEEEEE
Q 006559 342 GKGCVGATYKVVLDGGDVVVVKRIRER--------KKKREVDEWLRVIGGLRHSNI--VSIRAYCN-G----KDELFLVY 406 (640)
Q Consensus 342 G~G~fg~Vy~~~~~~~~~vavK~l~~~--------~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~-~----~~~~~lV~ 406 (640)
|+||-+-|+...+.+. .+-+|+-... ..+..|.+|...|.+|...+| .+.. ++. . .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6788888998777655 5778875421 235678899988888764433 3333 332 1 12578999
Q ss_pred eccCC-CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC--eEEccCCccc
Q 006559 407 DYLPH-GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN--ACISDIGVHQ 483 (640)
Q Consensus 407 Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGl~~ 483 (640)
|-+++ -+|.+++..... .+.+...+..+..++++.+.-|| ..++.|+|+-+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97763 588888864321 13456677889999999999999 556999999999999986666 9999997655
Q ss_pred c
Q 006559 484 L 484 (640)
Q Consensus 484 ~ 484 (640)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-05 Score=78.12 Aligned_cols=105 Identities=27% Similarity=0.347 Sum_probs=77.4
Q ss_pred HHHHHHHHHhccCCCc--ccceeEEEEcC----CeEEEEEeccCCC-CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHH
Q 006559 373 EVDEWLRVIGGLRHSN--IVSIRAYCNGK----DELFLVYDYLPHG-SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL 445 (640)
Q Consensus 373 ~~~~e~~~l~~l~H~n--iv~l~~~~~~~----~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL 445 (640)
...+|.+.+..+.... +.+.+++.... ...++|+|++++- +|.+++.... ..+......++.++++.+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHHH
Confidence 3455666555554333 45566666542 2468999999874 8999887532 134456778999999999
Q ss_pred HHhhcCCCCCceecCCCCCCeEECCCC---CeEEccCCccccc
Q 006559 446 AFLHGYNKAHLFHGHLSSSNIVVDQLG---NACISDIGVHQLF 485 (640)
Q Consensus 446 ~yLH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGl~~~~ 485 (640)
.-|| ..+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 55699999999999999887 8899999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.5e-08 Score=106.06 Aligned_cols=122 Identities=26% Similarity=0.273 Sum_probs=84.0
Q ss_pred EEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCcc-CCCCCCCCEEEcccCCCC
Q 006559 73 LVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSG-VSSLRHLRRVDLSHNAYE 151 (640)
Q Consensus 73 l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~ 151 (640)
++.+.|.|.-...++.-++.|+.|||++|++.... .+..|++|++|||+.|.|. .+|.. ...+. |+.|.|++|.++
T Consensus 169 a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~ 245 (1096)
T KOG1859|consen 169 ASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT 245 (1096)
T ss_pred hhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH
Confidence 33444444444466777888899999999887754 6777888999999999887 34432 22333 888888888887
Q ss_pred CCCCchhcCCCCCCcEEEccCCcceeccc-CCcCCCCCCcEEEcccCcCc
Q 006559 152 GEIPMTELTRLPNLLTLRLEDNRFTGTLY-SVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 152 g~~p~~~~~~l~~L~~L~L~~N~l~g~~~-~~~~~~~~L~~l~ls~N~l~ 200 (640)
. + ..+.+|.+|+.|||++|-|.+.-- ..+..+.+|..|+|.+|.+-
T Consensus 246 t-L--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 246 T-L--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred h-h--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 3 2 346788888888888888776321 11233566777777777664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.4e-06 Score=93.48 Aligned_cols=128 Identities=30% Similarity=0.370 Sum_probs=92.5
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
.+..+++.++.+.-.+..+..+++|+.|++++|++...++..+.++.|+.|++++|+++ .+|.....+..|+.|++++|
T Consensus 141 nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N 219 (394)
T COG4886 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN 219 (394)
T ss_pred hcccccccccchhhhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCC
Confidence 57778888887776556789999999999999999988776668889999999999997 56666556666888888888
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
.+. .++ ..+.++.++..|.+.+|++... +.....+.+++.|++++|.++
T Consensus 220 ~~~-~~~-~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 220 SII-ELL-SSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred cce-ecc-hhhhhcccccccccCCceeeec-cchhccccccceecccccccc
Confidence 433 233 3456666666666666666542 344445556666666666665
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.7e-07 Score=94.20 Aligned_cols=116 Identities=26% Similarity=0.263 Sum_probs=85.3
Q ss_pred hhccCCCCCCEEeCCCCcCCCCCC---CCCCCCCCcEEEcccccccccCCccC-CCCCCCCEEEcccCCCCCCCCchhcC
Q 006559 85 EVLSRLTQLRLLSLKNNLLSSSNL---NLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELT 160 (640)
Q Consensus 85 ~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~~~~~ 160 (640)
.....+++++.||||.|.|..+.+ -...|++|+.|+||.|+|.-...... ..+++|+.|.|+.+.|+-.--..-+.
T Consensus 140 ~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~ 219 (505)
T KOG3207|consen 140 EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILL 219 (505)
T ss_pred hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHH
Confidence 467789999999999999988654 24679999999999999975444322 36788999999999887211112235
Q ss_pred CCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCc
Q 006559 161 RLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 161 ~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
.+|+|+.|+|+.|..-+.-......+..|+.|||++|++-
T Consensus 220 ~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li 259 (505)
T KOG3207|consen 220 TFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI 259 (505)
T ss_pred hCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence 6789999999999633333333444678899999999875
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.6e-08 Score=105.13 Aligned_cols=127 Identities=29% Similarity=0.384 Sum_probs=94.2
Q ss_pred CCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEcc
Q 006559 92 QLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLE 171 (640)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~ 171 (640)
.|..-+.+.|.|......+.-++.|++|||++|+|+..- .+..|+.|++|||++|.|. .+|--....+ .|+.|.|+
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 355667777777665556677889999999999998543 7888999999999999998 5663333344 49999999
Q ss_pred CCcceecccCCcCCCCCCcEEEcccCcCcccC---Ccc-cCCCCCCCCCCCcccCCC
Q 006559 172 DNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI---PAW-MSPFGGSSFAGNKNLCGR 224 (640)
Q Consensus 172 ~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~i---p~~-~~~~~~~~~~gn~~lcg~ 224 (640)
+|.++..- .+.++.+|..|||++|-|++.- |-| +..+....+.|||--|.+
T Consensus 241 nN~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 241 NNALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ccHHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99998533 2446889999999999998753 211 233344567899877753
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=7.6e-05 Score=80.99 Aligned_cols=148 Identities=14% Similarity=0.194 Sum_probs=94.2
Q ss_pred ChHHHHHHhh-ccccccCcceEEEEEeCCCcEEEEEEeccccch-----------------------------H------
Q 006559 329 NVGDLLKSSA-ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKK-----------------------------R------ 372 (640)
Q Consensus 329 ~~~~~~~~~~-~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------~------ 372 (640)
.++++..... +.||.-+.|.||+|++++|+.||||+-+..-.. +
T Consensus 156 ~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L 235 (538)
T KOG1235|consen 156 PIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSL 235 (538)
T ss_pred CHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhh
Confidence 5666666654 679999999999999999999999986543100 0
Q ss_pred ----HHHHHHH----HHhccCCCcc---cceeEEEEc-CCeEEEEEeccCCCCHHHh--hccCCCCCCCCcCHHHHHHHH
Q 006559 373 ----EVDEWLR----VIGGLRHSNI---VSIRAYCNG-KDELFLVYDYLPHGSLHSL--LHGSRGPGRMPVDWNKRLKLA 438 (640)
Q Consensus 373 ----~~~~e~~----~l~~l~H~ni---v~l~~~~~~-~~~~~lV~Ey~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~ 438 (640)
+|..|.+ ..+.++|-+. |..-.++.+ .....|+||||+|..+.+. +.+.+ ++-..+..-+
T Consensus 236 ~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g------i~~~~i~~~l 309 (538)
T KOG1235|consen 236 PQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG------ISPHDILNKL 309 (538)
T ss_pred HhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC------CCHHHHHHHH
Confidence 1222222 2233445551 223333333 3578999999999876554 43332 3434444433
Q ss_pred HHHHHHHHHhhcCCCCCceecCCCCCCeEECC----CCCeEEccCCcccccCC
Q 006559 439 SDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ----LGNACISDIGVHQLFHT 487 (640)
Q Consensus 439 ~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~----~~~~kl~DfGl~~~~~~ 487 (640)
.++..-+-+- .+++|.|-.|-||++.. ++++.+-|||+......
T Consensus 310 ~~~~~~qIf~-----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 310 VEAYLEQIFK-----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHHh-----cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3333223333 35999999999999983 67899999999876543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.8e-07 Score=78.24 Aligned_cols=84 Identities=21% Similarity=0.313 Sum_probs=41.3
Q ss_pred CCCCCEEeCCCCcCCCCCCCCC-CCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEE
Q 006559 90 LTQLRLLSLKNNLLSSSNLNLS-SWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTL 168 (640)
Q Consensus 90 l~~L~~L~Ls~N~l~~~~~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L 168 (640)
...|+..+|++|.|...++.|. .++.++.|+|++|.++ .+|.++..++.|+.|++++|.|. ..| ..+..|.+|-.|
T Consensus 52 ~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p-~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEP-RVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cch-HHHHHHHhHHHh
Confidence 3344444555555555444332 2334555555555554 34555555555555555555554 233 233334555555
Q ss_pred EccCCcce
Q 006559 169 RLEDNRFT 176 (640)
Q Consensus 169 ~L~~N~l~ 176 (640)
+..+|.+.
T Consensus 129 ds~~na~~ 136 (177)
T KOG4579|consen 129 DSPENARA 136 (177)
T ss_pred cCCCCccc
Confidence 55555443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.5e-06 Score=90.84 Aligned_cols=107 Identities=30% Similarity=0.293 Sum_probs=52.4
Q ss_pred CCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEE
Q 006559 90 LTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLR 169 (640)
Q Consensus 90 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~ 169 (640)
+..+..|+|..|.+......+..+++|+.|+|..|.|... ...+..+++|++|+|++|.++... .+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~---~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE---GLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhhhhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc---chhhccchhhhe
Confidence 4444455555555544323345555555555555555532 222444555555555555555322 234445555555
Q ss_pred ccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 170 LEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 170 L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
+++|.++. ...+..+..|+.+++++|.++..
T Consensus 147 l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~i 177 (414)
T KOG0531|consen 147 LSGNLISD--ISGLESLKSLKLLDLSYNRIVDI 177 (414)
T ss_pred eccCcchh--ccCCccchhhhcccCCcchhhhh
Confidence 55555543 12222345555555555555533
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.3e-05 Score=72.53 Aligned_cols=103 Identities=18% Similarity=0.214 Sum_probs=78.7
Q ss_pred HHHHHHhccCC-CcccceeEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCC
Q 006559 376 EWLRVIGGLRH-SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454 (640)
Q Consensus 376 ~e~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 454 (640)
.|.-+++.+.+ +++.+++|+|- .++|.||.+.+++...-..- ..-..-+|..|.+||.++.+.++++++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 46667777776 69999999994 36789999887664320000 0011358999999999999999999976545
Q ss_pred CceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 455 ~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
.+.-.|++++|+-+++++++|+.|....-.
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 588899999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0002 Score=71.27 Aligned_cols=140 Identities=17% Similarity=0.177 Sum_probs=81.4
Q ss_pred ccccCc-ceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCCCCHHHhh
Q 006559 341 LGKGCV-GATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLL 418 (640)
Q Consensus 341 iG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l 418 (640)
|-.|.+ ..||+....+ ..++||...... ......|+++++.+. +--+.+++++....+..++||||+++.++.+..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~ 83 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALW 83 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhh
Confidence 444555 6789987654 677788765442 334566777776663 333456777776666789999999987776432
Q ss_pred -------------------ccCCCCCCCCcCH--HHHHHH-----------------------HHHHHHHHHHhh-cCCC
Q 006559 419 -------------------HGSRGPGRMPVDW--NKRLKL-----------------------ASDSAKGLAFLH-GYNK 453 (640)
Q Consensus 419 -------------------~~~~~~~~~~l~~--~~~~~i-----------------------~~~ia~gL~yLH-~~~~ 453 (640)
|.... ...++.. ...... ..++...|.... ....
T Consensus 84 ~~~~~~~~~~~l~~~l~~lH~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 84 EELEPERLVDALAEALRRLHALPV-ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred cccCHHHHHHHHHHHHHHHhcCCc-ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 11110 0111110 011100 111111111100 1123
Q ss_pred CCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 454 ~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999998778899998664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.83 E-value=1.8e-05 Score=55.52 Aligned_cols=36 Identities=44% Similarity=0.745 Sum_probs=15.4
Q ss_pred CCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcce
Q 006559 139 HLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176 (640)
Q Consensus 139 ~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~ 176 (640)
+|++|+|++|+++ .+| ..+.+|++|+.|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~-~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLP-PELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHG-GHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccC-chHhCCCCCCEEEecCCCCC
Confidence 3444444444444 233 23444444444444444444
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 640 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-07 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-07 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 640 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-55 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-53 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 5e-52 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-46 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 9e-42 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-30 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-40 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-39 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-38 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-25 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-24 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-24 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-24 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-23 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-22 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-21 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-17 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-38 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-38 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 7e-38 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-37 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-36 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-33 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-32 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-32 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-30 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-30 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 9e-30 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-29 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-20 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-19 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-18 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-17 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-16 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-16 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-15 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-15 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-14 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-14 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-19 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-18 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-18 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-17 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-16 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-15 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-14 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-12 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-11 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-06 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-18 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-18 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 7e-18 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-17 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-17 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-17 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-17 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-15 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-15 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-13 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-13 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-13 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-11 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-10 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-16 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-16 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-14 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-13 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-11 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-10 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-09 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-09 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-17 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-16 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-15 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-14 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-13 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-11 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-10 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-16 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-16 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-16 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-16 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-16 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 9e-12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-10 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-09 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 9e-16 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-15 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-13 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-09 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-05 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-15 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-15 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-15 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-15 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-15 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-15 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-14 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-11 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-10 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-15 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-15 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-15 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-15 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-14 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-12 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-11 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-10 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-07 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-05 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-10 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-10 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-15 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 9e-15 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 9e-15 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 9e-15 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-14 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-11 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-10 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-10 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-14 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-14 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-11 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-09 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-14 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-14 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-14 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-14 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-11 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-06 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-05 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-05 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-12 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-12 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-12 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-14 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-14 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-14 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-14 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-14 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-14 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-14 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-13 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-13 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-12 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-11 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-10 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-07 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-13 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-13 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-13 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-13 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-13 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-13 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-11 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-09 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-13 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-13 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-09 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-13 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-12 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-10 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-09 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-08 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-10 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-10 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-08 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-12 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-11 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-10 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-10 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-09 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-08 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-12 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-11 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-08 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-07 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-13 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-12 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-11 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-11 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-10 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-07 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-07 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 7e-13 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-07 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-04 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 9e-13 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-10 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-09 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 9e-13 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-12 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-12 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-12 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-12 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-12 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-11 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-08 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-07 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-05 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-12 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-08 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-08 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-11 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-09 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-09 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-06 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-12 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-08 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-06 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-10 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-07 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-06 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-11 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-11 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-07 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-07 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 9e-12 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 9e-12 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-11 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-04 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-11 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-11 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-11 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-11 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-11 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-06 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-11 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-09 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-08 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-11 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-10 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-08 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-11 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-11 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-06 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-11 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-11 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-11 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-10 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-09 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-07 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 9e-11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-09 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-08 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-08 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-04 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-06 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-09 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-08 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-06 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-06 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-10 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 5e-09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-08 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-06 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-05 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-10 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 7e-10 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-09 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-07 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-07 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-04 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 5e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-09 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-09 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-08 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-05 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-04 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 6e-10 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-09 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-09 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 6e-05 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-10 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-09 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-08 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 8e-09 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-07 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-09 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-09 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-09 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-09 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-09 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 5e-09 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-09 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 6e-09 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-08 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-08 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-04 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-08 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-08 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-04 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-08 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-08 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 7e-08 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-07 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-07 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-07 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-07 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-07 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-07 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-07 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-06 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-04 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-05 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-07 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-07 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-07 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-07 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-06 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-06 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-06 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-06 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-06 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-06 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-05 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-06 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-06 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-06 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 7e-06 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-06 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-05 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-05 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-05 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-05 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-05 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-05 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-05 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-04 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-05 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-05 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-05 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-05 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-05 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-05 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 6e-05 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 7e-04 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-05 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-05 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 7e-05 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-05 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 7e-05 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 8e-05 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 9e-05 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-04 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-04 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-04 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-04 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-04 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-04 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-04 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-04 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-04 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-04 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-04 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-04 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 7e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-04 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 7e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-04 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-55
Identities = 89/289 (30%), Positives = 149/289 (51%), Gaps = 35/289 (12%)
Query: 336 SSAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSI 392
S+ +LG+G G YK L G +V VKR++E + + ++ +I H N++ +
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
R +C E LVY Y+ +GS+ S L R + P+DW KR ++A SA+GLA+LH +
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA-----------YNAPELK 501
+ H + ++NI++D+ A + D G+ +L D + APE
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY----KDTHVTTAVRGTIGHIAPE-- 205
Query: 502 FNNNNNYSQR-KFWQRCDVYSFGVVLLEILTGKMA------KGDGELGIVKWVQMMGQDE 554
Y K ++ DV+ +GV+LLE++TG+ A D ++ ++ WV+ + +++
Sbjct: 206 ------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603
+ D +L +EE+ L+QVALLC P +RP MS V RM+E
Sbjct: 260 KLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 78/305 (25%), Positives = 133/305 (43%), Gaps = 49/305 (16%)
Query: 325 KGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREV---DEWL--- 378
F + +G+G G YK ++ V VK++ ++
Sbjct: 25 NNFDE--RPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEELKQQFDQEI 81
Query: 379 RVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLA 438
+V+ +H N+V + + + D+L LVY Y+P+GSL L G P+ W+ R K+A
Sbjct: 82 KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIA 139
Query: 439 SDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND----- 493
+A G+ FLH H+ H + S+NI++D+ A ISD G+ +
Sbjct: 140 QGAANGINFLH--ENHHI-HRDIKSANILLDEAFTAKISDFGLARASEK----FAQTVMT 192
Query: 494 -------AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA--KGDGELGIV 544
AY APE + + + D+YSFGVVLLEI+TG A + ++
Sbjct: 193 SRIVGTTAYMAPE--------ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 545 KWVQMMGQDESAWEVFDFELIMDKEME----EEMRALLQVALLCLAPLPKDRPNMSIVHR 600
+ + +E E +DK+M + A+ VA CL RP++ V +
Sbjct: 245 DIKEEIEDEEK-----TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 601 MIEDI 605
+++++
Sbjct: 300 LLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-52
Identities = 79/296 (26%), Positives = 133/296 (44%), Gaps = 50/296 (16%)
Query: 336 SSAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWL---RVIGGLRHSNIVSI 392
L+G G G YK VL G V +KR R + + ++E+ + RH ++VS+
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
+C+ ++E+ L+Y Y+ +G+L L+GS P M + W +RL++ +A+GL +LH
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLH--- 156
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF------H-------TPFFINDAYNAPE 499
+ H + S NI++D+ I+D G+ + H T Y PE
Sbjct: 157 TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL-----GYIDPE 211
Query: 500 LKFNNNNNYSQR-KFWQRCDVYSFGVVLLEILTGK----MAKGDGELGIVKWVQMMGQDE 554
Y + + ++ DVYSFGVVL E+L + + + + +W +
Sbjct: 212 --------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 555 SAWEVFDFELIMDKEME-----EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
E I+D + E +R A+ CLA +DRP+M V +E
Sbjct: 264 ------QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-46
Identities = 65/300 (21%), Positives = 110/300 (36%), Gaps = 46/300 (15%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLR-----VIGGLRHSNIVSIR 393
E+ +G G +K L V V K ++ W + G++H NI+
Sbjct: 30 EVKARGRFGCVWKAQLLNEYVAV-KIF----PIQDKQSWQNEYEVYSLPGMKHENILQFI 84
Query: 394 AYC----NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+ +L+L+ + GSL L + V WN+ +A A+GLA+LH
Sbjct: 85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLH 138
Query: 450 -------GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA-------- 494
+K + H + S N+++ ACI+D G+ F D
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG----DGELGIVKWVQMM 550
Y APE+ N+ + F R D+Y+ G+VL E+ + A + L + +
Sbjct: 199 YMAPEV-LEGAINFQRDAF-LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256
Query: 551 GQDESAWEVFDFEL----IMDK-EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
E EV + + D + M L + C + R + V I +
Sbjct: 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-42
Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 16/192 (8%)
Query: 25 SDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTH--RVIKLVLEDLDLTG 82
D LL K + + +LSSW+ +TD C +W GV C+ T RV L L L+L
Sbjct: 6 QDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 83 PAEV---LSRLTQLRLLSL-KNNLLS----SSNLNLSSWPHLKHLYLSHNRFTGTFPSGV 134
P + L+ L L L + N L + L+ L +LY++H +G P +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT---QLHYLYITHTNVSGAIPDFL 121
Query: 135 SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL-YSVNSSSRSILDFN 193
S ++ L +D S+NA G +P ++ LPNL+ + + NR +G + S S S+
Sbjct: 122 SQIKTLVTLDFSYNALSGTLP-PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 194 VSNNQLSGQIPA 205
+S N+L+G+IP
Sbjct: 181 ISRNRLTGKIPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 38/191 (19%)
Query: 75 LEDLDL-----TG--PAEVLSRLTQLRLLSLKNNLLSSS-------------NLNLS--- 111
L LD +G P +S L L ++ N +S + ++ +S
Sbjct: 127 LVTLDFSYNALSGTLPPS-ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 112 ---SWP------HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRL 162
P +L + LS N G S ++ +++ L+ N+ ++ ++
Sbjct: 186 LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG--KVGLS 243
Query: 163 PNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA--WMSPFGGSSFAGNKN 220
NL L L +NR GTL + + + NVS N L G+IP + F S++A NK
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 221 LCGRPLPSDCS 231
LCG PLP+ C+
Sbjct: 304 LCGSPLPA-CT 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 70/340 (20%), Positives = 115/340 (33%), Gaps = 66/340 (19%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKK---REVDEWLRVIGGLRHSNIVSIRAY 395
EL+G+G GA YK LD V V K ++ E + + + + H NI
Sbjct: 19 ELIGRGRYGAVYKGSLDERPVAV-KVFSFANRQNFINEKNIYR--VPLMEHDNIARFIVG 75
Query: 396 C-----NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH- 449
+G+ E LV +Y P+GSL L DW +LA +GLA+LH
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 450 -----GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA---------- 494
+ K + H L+S N++V G ISD G+ +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 495 ----YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQM- 549
Y APE+ N ++ D+Y+ G++ EI G V QM
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG--ESVPEYQMA 247
Query: 550 ----MGQDESAWEVFDFELIMDK---------EMEEEMRALLQVALLCLAPLPKDRPNMS 596
+G + ++ + E +R+L + C + R
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
Query: 597 IVHRMIEDIRTKGSIDGCANSIMNNISSDSSPSQSENTYN 636
+ +M + S S + + ++
Sbjct: 308 XAEERMA-------------ELMMIWERNKSVSPTAHHHH 334
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-38
Identities = 49/199 (24%), Positives = 84/199 (42%), Gaps = 14/199 (7%)
Query: 15 FSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLV 74
F S S Y +I L+SFK + + L W ++ +PC ++ GVTC +V +
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLP-DKNLLPDWSSNKNPC--TFDGVTCR--DDKVTSID 56
Query: 75 LEDLDLTGP----AEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
L L + L LT L L L N+ ++ S L L LS N +G
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPV 116
Query: 131 PSGVS--SLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL---YSVNSS 185
+ S S L+ +++S N + ++ +L +L L L N +G + ++
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 186 SRSILDFNVSNNQLSGQIP 204
+ +S N++SG +
Sbjct: 177 CGELKHLAISGNKISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-25
Identities = 51/168 (30%), Positives = 74/168 (44%), Gaps = 13/168 (7%)
Query: 75 LEDLDL-----TG--PAEVLSRLTQLRLLSLKNNLLSSS-NLNLSSWPHLKHLYLSHNRF 126
L L L +G P+ L L++LR L L N+L L L+ L L N
Sbjct: 420 LVSLHLSFNYLSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 127 TGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSS 186
TG PSG+S+ +L + LS+N GEIP + RL NL L+L +N F+G + +
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIP-KWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 187 RSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRT 234
RS++ +++ N +G IPA S N N
Sbjct: 538 RSLIWLDLNTNLFNGTIPAA---MFKQSGKIAANFIAGKRYVYIKNDG 582
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 37/143 (25%), Positives = 58/143 (40%), Gaps = 15/143 (10%)
Query: 75 LEDLDL-------TGPAEVLSRLTQLRLLSLKNNLLS----SSNLNLSSWPHLKHLYLSH 123
L+ L++ G +L L +L L N +S + LKHL +S
Sbjct: 128 LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISG 187
Query: 124 NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN 183
N+ +G VS +L +D+S N + IP L L L + N+ +G
Sbjct: 188 NKISGDVD--VSRCVNLEFLDVSSNNFSTGIP--FLGDCSALQHLDISGNKLSGDFSRAI 243
Query: 184 SSSRSILDFNVSNNQLSGQIPAW 206
S+ + N+S+NQ G IP
Sbjct: 244 STCTELKLLNISSNQFVGPIPPL 266
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-24
Identities = 50/194 (25%), Positives = 78/194 (40%), Gaps = 38/194 (19%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLS----SSNL-----------NLS- 111
L+ LD++G +S T+L+LL++ +N L +
Sbjct: 225 LQHLDISGNKLSGDFSRA-ISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTG 283
Query: 112 --------SWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP 163
+ L L LS N F G P S L + LS N + GE+PM L ++
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 164 NLLTLRLEDNRFTGTL-YSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSS----FAGN 218
L L L N F+G L S+ + S S+L ++S+N SG I + ++ + N
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 219 KNLCGRPLPSDCSN 232
G +P SN
Sbjct: 404 NGFTG-KIPPTLSN 416
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-24
Identities = 39/192 (20%), Positives = 64/192 (33%), Gaps = 34/192 (17%)
Query: 87 LSRLTQLRLLSLKNNLLSSS---NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRV 143
+ + NLL + L+ ++ + G + + +
Sbjct: 578 IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
Query: 144 DLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203
D+S+N G IP E+ +P L L L N +G++ R + ++S+N+L G+I
Sbjct: 638 DMSYNMLSGYIP-KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
Query: 204 PAWMS-------------------PFGG-------SSFAGNKNLCGRPLPSDCSNRTVEP 237
P MS P G + F N LCG PLP +
Sbjct: 697 PQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS----N 752
Query: 238 EQPPRSRPRSSR 249
RS
Sbjct: 753 ADGYAHHQRSHH 764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 36/142 (25%), Positives = 67/142 (47%), Gaps = 14/142 (9%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT 127
L+ L ++G +SR L L + +N S+ L L+HL +S N+ +
Sbjct: 180 LKHLAISGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLS 236
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL-YSVNSSS 186
G F +S+ L+ +++S N + G IP L +L L L +N+FTG + ++ +
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGAC 293
Query: 187 RSILDFNVSNNQLSGQIPAWMS 208
++ ++S N G +P +
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFG 315
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 45/157 (28%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 75 LEDLDL-----TG--PAEVLSRLTQLRLLSLKNNLLS---SSNLNLSSWPHLKHLYLSHN 124
L+ LDL +G P + + L L L +N S NL + L+ LYL +N
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404
Query: 125 RFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNS 184
FTG P +S+ L + LS N G IP + L L L L+L N G +
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIP-SSLGSLSKLRDLKLWLNMLEGEIPQELM 463
Query: 185 SSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+++ + N L+G+IP S + NL
Sbjct: 464 YVKTLETLILDFNDLTGEIP--------SGLSNCTNL 492
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-21
Identities = 35/139 (25%), Positives = 56/139 (40%), Gaps = 9/139 (6%)
Query: 73 LVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLS----SSNLNLSSWPHLKHLYLSHNRFTG 128
L + + + L + L+ L + N LS + + LK L +S N+F G
Sbjct: 205 LDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTE---LKLLNISSNQFVG 261
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188
P L+ L+ + L+ N + GEIP L L L N F G + S
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 189 ILDFNVSNNQLSGQIPAWM 207
+ +S+N SG++P
Sbjct: 320 LESLALSSNNFSGELPMDT 338
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-17
Identities = 38/149 (25%), Positives = 58/149 (38%), Gaps = 22/149 (14%)
Query: 75 LEDLDL-----TG--PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW----PHLKHLYLSH 123
LE L L TG P+ LS T L +SL NN L+ + W +L L LS+
Sbjct: 468 LETLILDFNDLTGEIPSG-LSNCTNLNWISLSNNRLTGE---IPKWIGRLENLAILKLSN 523
Query: 124 NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV- 182
N F+G P+ + R L +DL+ N + G IP + + + N G Y
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP-AAMFKQSGKIA----ANFIAGKRYVYI 578
Query: 183 -NSSSRSILDFNVSNNQLSGQIPAWMSPF 210
N + + + G ++
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 42/304 (13%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEW-LRVIGGLRHSNIVSIRAYC- 396
E +GKG G ++ G +V V K R+++ E + LRH NI+ A
Sbjct: 48 ESIGKGRFGEVWRGKWRGEEVAV-KIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 397 ---NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH---- 449
+L+LV DY HGSL L+ R V +KLA +A GLA LH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 450 -GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA----------YNAP 498
K + H L S NI+V + G CI+D+G+ + D Y AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558
E+ +++ N + ++R D+Y+ G+V EI G E + + ++ D S E
Sbjct: 221 EV-LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 559 VFDF-----------ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
+ E M +++ C R + + + +
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLSQLSQ 336
Query: 608 KGSI 611
+ I
Sbjct: 337 QEGI 340
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 3e-38
Identities = 64/283 (22%), Positives = 121/283 (42%), Gaps = 40/283 (14%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRA 394
L + G +K G D+VV K ++ R +K R+ +E + H N++ +
Sbjct: 16 TKLNENHSGELWKGRWQGNDIVV-KVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 395 YCNG--KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
C L+ ++P+GSL+++LH VD ++ +K A D A+G+AFLH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFALDMARGMAFLHTLE 131
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------TPFFINDAYNAPELKFNNNN 506
+ L+S ++++D+ A IS V F P A+ APE
Sbjct: 132 PL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP-----AWVAPEALQKKPE 185
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFELI 565
+ ++R D++SF V+L E++T ++ + I V + G
Sbjct: 186 DTNRRS----ADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----------RPT 231
Query: 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608
+ + + L++ +C+ P RP ++ ++E ++ K
Sbjct: 232 IPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 70/300 (23%), Positives = 116/300 (38%), Gaps = 46/300 (15%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAY 395
+ +GKG G + G V V K ++ RE + + V +RH NI+ A
Sbjct: 43 KQIGKGRYGEVWMGKWRGEKVAV-KVFFTTEEASWFRETEIYQTV--LMRHENILGFIAA 99
Query: 396 C----NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+L+L+ DY +GSL+ L +D LKLA S GL LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 452 NKAHLF-----HGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA----------YN 496
+ H L S NI+V + G CI+D+G+ F + D Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA 556
PE+ + + N + + + D+YSFG++L E+ ++ G E + + ++ D S
Sbjct: 214 PPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 557 WEVFDF-----------ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
++ + E +M L+ C A P R V + + +
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLAKM 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 67/297 (22%), Positives = 113/297 (38%), Gaps = 40/297 (13%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKK---REVDEWLRVIGGLRHSNIVSIRAY 395
E +GKG G ++ G +V V K R +K RE + L LRH NI+ A
Sbjct: 14 ECVGKGRYGEVWRGSWQGENVAV-KIFSSRDEKSWFRETE--LYNTVMLRHENILGFIAS 70
Query: 396 C----NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ +L+L+ Y GSL+ L +D L++ A GLA LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 452 NKAHLF-----HGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN---------- 496
H L S NI+V + G CI+D+G+ + D N
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA 556
APE+ + ++R D+++FG+VL E+ ++ G E + ++ D S
Sbjct: 185 APEV-LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 557 WEVFDF--------ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
++ + + + +L ++ C P R + + + I
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 59/279 (21%), Positives = 115/279 (41%), Gaps = 37/279 (13%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNG 398
E++G+G G K DV + K+I +++ LR + + H NIV + C
Sbjct: 14 EVVGRGAFGVVCKAKWRAKDVAI-KQIESESERKAFIVELRQLSRVNHPNIVKLYGAC-- 70
Query: 399 KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFH 458
+ + LV +Y GSL+++LHG+ + ++G+A+LH L H
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 459 GHLSSSNIVVDQLGNAC-ISDIGVHQLFH--------TPFFINDAYNAPELKFNNNNNYS 509
L N+++ G I D G + A+ APE+ +NYS
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA-----AWMAPEV--FEGSNYS 181
Query: 510 QRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569
++CDV+S+G++L E++T + + + + + + K
Sbjct: 182 -----EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--------PPLIKN 228
Query: 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608
+ + + +L+ C + P RP+M + +++ +
Sbjct: 229 LPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 43/282 (15%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK--------KREVDEWLRVIGGLRHSNIV 390
E +G G G ++ G DV V K + E+ REV ++ LRH NIV
Sbjct: 43 EKIGAGSFGTVHRAEWHGSDVAV-KILMEQDFHAERVNEFLREV----AIMKRLRHPNIV 97
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
L +V +YL GSL+ LLH + R +D +RL +A D AKG+ +LH
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA------YNAPELKFNN 504
N + H +L S N++VD+ + D G+ +L + F + + + APE+
Sbjct: 156 RNPPIV-HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL--R 212
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFE 563
+ + ++ DVYSFGV+L E+ T + +V V +
Sbjct: 213 DEPSN-----EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK----------R 257
Query: 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
L + + + ++ A+++ C P RP+ + + ++ +
Sbjct: 258 LEIPRNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 56/291 (19%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRE------RKKKREVDEWLRVIGGLRHSNIVSI 392
E++G G G Y+ G +V V K R + V + ++ L+H NI+++
Sbjct: 13 EIIGIGGFGKVYRAFWIGDEVAV-KAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
R C + L LV ++ G L+ +L G R + + + A A+G+ +LH
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDEA 125
Query: 453 KAHLFHGHLSSSNIVVDQLGNAC--------ISDIGVHQLFH---------TPFFINDAY 495
+ H L SSNI++ Q I+D G+ + +H A+
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAY-----AW 180
Query: 496 NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDE 554
APE+ + +S + DV+S+GV+L E+LTG++ +G L + V M
Sbjct: 181 MAPEVI--RASMFS-----KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL-- 231
Query: 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
L + E L++ C P P RP+ + + + I
Sbjct: 232 --------ALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 58/294 (19%)
Query: 339 ELLGKGCVGATYKVVLDG-GDVVVVKRIRERKK-------------KREVDEWLRVIGGL 384
+ +GKG G +K L VV +K + +REV ++ L
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV----FIMSNL 80
Query: 385 RHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKG 444
H NIV + + +V +++P G L+ L P + W+ +L+L D A G
Sbjct: 81 NHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALG 134
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC-----ISDIGVHQLFH--------TPFFI 491
+ ++ N + H L S NI + L ++D G+ Q
Sbjct: 135 IEYMQNQNPPIV-HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNF--- 190
Query: 492 NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG 551
+ APE +Y+++ D YSF ++L ILTG+ + G +K++ M+
Sbjct: 191 --QWMAPETIGAEEESYTEK-----ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 552 QDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
++ + ++ +R +++ LC + PK RP+ S + + + ++
Sbjct: 244 EE-------GLRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 56/290 (19%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK--------KREVDEWLRVIGGLRHSNIV 390
+ +G G G YK G V VK + K EV V+ RH NI+
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEV----GVLRKTRHVNIL 83
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
Y +L +V + SL+ LH S + K + +A +A+G+ +LH
Sbjct: 84 LFMGYST-APQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHA 138
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND--------AYNAPE-LK 501
+ + H L S+NI + + I D G+ + + APE ++
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561
++N YS + DVY+FG+VL E++TG++ + + +D+ V
Sbjct: 196 MQDSNPYSFQ-----SDVYAFGIVLYELMTGQLP----------YSNINNRDQIIEMV-G 239
Query: 562 FELIMDKEME------EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ + + M+ L+ CL +RP+ + IE++
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 65/298 (21%), Positives = 113/298 (37%), Gaps = 58/298 (19%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAY 395
E+LGKGC G KV V+V + R + +L+ V+ L H N++
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
L + +Y+ G+L ++ W++R+ A D A G+A+LH N
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHSMN--- 128
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------------- 496
+ H L+S N +V + N ++D G+ +L +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 497 -APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDES 555
APE+ N +Y ++ DV+SFG+VL EI+ A D +
Sbjct: 189 MAPEMI--NGRSYD-----EKVDVFSFGIVLCEIIGRVNADPDY---------LPRTM-- 230
Query: 556 AWEVFDFELIMDKEMEEEM-----RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608
DF L + ++ + + + C P+ RP+ + +E +R
Sbjct: 231 -----DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/288 (20%), Positives = 105/288 (36%), Gaps = 47/288 (16%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK--------KREVDEWLRVIGGLRHSNIV 390
EL+GKG G Y G V ++ I + KREV RH N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREV----MAYRQTRHENVV 92
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
C L ++ +L+S++ ++ +D NK ++A + KG+ +LH
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLHA 148
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND-----------AYNAPE 499
+ H L S N+ D G I+D G+ + + APE
Sbjct: 149 KG---ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 500 LKFNNNNNYSQRK--FWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557
+ + + + K F + DV++ G + E+ + + W G
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK---- 260
Query: 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ M +E+ +L C A ++RP + + M+E +
Sbjct: 261 -----PNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKL 300
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 59/276 (21%), Positives = 106/276 (38%), Gaps = 53/276 (19%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR----VIGGLRHSNIV--- 390
+G+G YK + + V +++RK + + + ++ GL+H NIV
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 391 -SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
S + GK + LV + + G+L + L + M + + KGL FLH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSW--CRQILKGLQFLH 146
Query: 450 GYNKAHLFHGHLSSSNIVVD-QLGNACISDIGVHQLFH---------TPFFINDAYNAPE 499
+ H L NI + G+ I D+G+ L TP F+ APE
Sbjct: 147 TRTPPII-HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM-----APE 200
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM--AKGDGELGIVKWVQMMGQDESAW 557
+ Y + DVY+FG+ +LE+ T + ++ I + V + S
Sbjct: 201 MY---EEKYDES-----VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252
Query: 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP 593
+V E++ +++ C+ +R
Sbjct: 253 KVAI----------PEVKEIIE---GCIRQNKDERY 275
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-19
Identities = 34/156 (21%), Positives = 60/156 (38%), Gaps = 18/156 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFT 127
L LD+ E+ +L L++L+L++N LS + + +L L+L N
Sbjct: 51 LTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ 110
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV--NSS 185
+ ++L +DLSHN + +L NL L L +N+ +
Sbjct: 111 KIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169
Query: 186 SRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+ S+ +S+NQ+ P F L
Sbjct: 170 NSSLKKLELSSNQIKEFSP--------GCFHAIGRL 197
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 33/149 (22%), Positives = 57/149 (38%), Gaps = 12/149 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPH-----LKHLYLSH 123
LE L++ + + + L L+ LSL N+ S L ++ L L L+
Sbjct: 331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTK 390
Query: 124 NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN 183
N+ + S L HL +DL N E+ E L N+ + L N++ +
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450
Query: 184 SSSRSILDFNVSNNQLSGQIPAWMSPFGG 212
+ S+ + L + + SPF
Sbjct: 451 ALVPSLQRLMLRRVALKN-VDSSPSPFQP 478
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 32/163 (19%), Positives = 55/163 (33%), Gaps = 24/163 (14%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW---PHLKHLYLSHNR 125
+ ++ L+ + + L+ L L+ L + + + S + +L L LS+N
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 126 FTGTFPSGVSSLRHLRRVDLSHN-------AYEGEIPMTELTRLPNLLTLRLEDNRFTGT 178
+ L L +DL HN P+ L L +L L LE N F
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 179 LYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
V + ++ N L+ S F +L
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPA--------SVFNNQVSL 586
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 32/152 (21%), Positives = 60/152 (39%), Gaps = 13/152 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFT 127
L +L L + L L L +N LSS+ L +L+ L LS+N+
Sbjct: 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158
Query: 128 GTFPS--GVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL---YSV 182
+ + L++++LS N + P + L L L + + +L +
Sbjct: 159 ALKSEELDIFANSSLKKLELSSNQIKEFSP-GCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 183 NSSSRSILDFNVSNNQLSGQIPAWMSPFGGSS 214
++ SI + ++SN+QLS ++
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-16
Identities = 26/149 (17%), Positives = 55/149 (36%), Gaps = 13/149 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS---SNLNLSSWPHLKHLYLSHNR 125
L LDL+ +L L+ L L NN + + L++ + LK L LS N+
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 126 FTGTFPSGVSSLRHLRRVDLSHNAYEGEIP--MTELTRLPNLLTLRLEDNRFTGTLYSV- 182
P ++ L + L++ + + ++ L L +++ + T +
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 183 -NSSSRSILDFNVSNNQLSGQIPAWMSPF 210
++ ++S N L+ +
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWL 271
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 28/140 (20%), Positives = 49/140 (35%), Gaps = 10/140 (7%)
Query: 79 DLTGPAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT--------GT 129
++ L L +L L NN +++ ++ L L+ L L HN G
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189
+ L HL ++L N ++ L L + L N SV ++ S+
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEV-FKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586
Query: 190 LDFNVSNNQLSGQIPAWMSP 209
N+ N ++ P
Sbjct: 587 KSLNLQKNLITSVEKKVFGP 606
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 26/134 (19%), Positives = 48/134 (35%), Gaps = 1/134 (0%)
Query: 71 IKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFTGT 129
+ + + + GP L L+ L +L+L++N + LK + L N
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189
S ++ L+ ++L N NL L + N F T S+ I
Sbjct: 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI 635
Query: 190 LDFNVSNNQLSGQI 203
+ + + +LS
Sbjct: 636 NETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 29/153 (18%), Positives = 52/153 (33%), Gaps = 17/153 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
E D + P ++ + +T L L N L N + + L L + N +
Sbjct: 6 HEVADCSHLKLTQVPDDLPTNITVLNLTH--NQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188
P L L+ ++L HN + NL L L N + ++
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 189 ILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
++ ++S+N LS + +NL
Sbjct: 123 LITLDLSHNGLSSTKL--------GTQVQLENL 147
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 28/147 (19%), Positives = 59/147 (40%), Gaps = 17/147 (11%)
Query: 75 LEDLDLTG------PAEVLS--RLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNR 125
+ +L L+ + T L +L L N L+ + + P L++ +L +N
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN 283
Query: 126 FTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTR--------LPNLLTLRLEDNRFTG 177
F + L ++R ++L + + I + L + L L L +EDN G
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
Query: 178 TLYSVNSSSRSILDFNVSNNQLSGQIP 204
++ + ++ ++SN+ S +
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTL 370
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-19
Identities = 33/146 (22%), Positives = 54/146 (36%), Gaps = 11/146 (7%)
Query: 75 LEDLDLTG--------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRF 126
LE LDL+ ++ T L+ L L N + + + N L+HL H+
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN-S 184
V SLR+L +D+SH L +L L++ N F +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 185 SSRSILDFNVSNNQLSGQIPAWMSPF 210
R++ ++S QL P +
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSL 493
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-18
Identities = 34/172 (19%), Positives = 54/172 (31%), Gaps = 20/172 (11%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRF 126
LE LD V L L L + + + + L+ L ++ N F
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSS 185
F + + LR+L +DLS E P L +L L + N F
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTA-FNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 186 SRSILDFNVSNNQLSGQIPAWMSPFGGS----SFAGNKNLCGRPLPSDCSNR 233
S+ + S N + + F S + N C C ++
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC------TCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-18
Identities = 30/154 (19%), Positives = 54/154 (35%), Gaps = 15/154 (9%)
Query: 75 LEDLDL-----TGPAEVLSRLTQLRLLSLKNNLLSSSNLN--LSSWPHLKHLYLSHNRFT 127
L+ LDL + L QL L +++ L + S +L +L +SH
Sbjct: 375 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
F + L L + ++ N+++ T L NL L L + + +S
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 188 SILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
S+ N+S+N + +L
Sbjct: 495 SLQVLNMSHNNFFSLDT--------FPYKCLNSL 520
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 29/141 (20%), Positives = 50/141 (35%), Gaps = 11/141 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFT 127
L+ LDL+ L+ L L L N + S L S L+ L
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG----TLYSVN 183
+ L+ L+ ++++HN + + L NL L L N+ L ++
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 184 SSSRSILDFNVSNNQLSGQIP 204
L ++S N ++ P
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQP 194
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 30/153 (19%), Positives = 44/153 (28%), Gaps = 12/153 (7%)
Query: 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW---PHLKHLYLSHNRFTG 128
+L L L L L N LS S LK+L LS N
Sbjct: 329 RLTFTSNKGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188
T S L L +D H+ + + L NL+ L + + + S
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 189 ILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+ ++ N F +NL
Sbjct: 447 LEVLKMAGNSFQENFLP-------DIFTELRNL 472
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 29/144 (20%), Positives = 44/144 (30%), Gaps = 10/144 (6%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRF 126
LE L + G ++ + L L L L L + +S L+ L +SHN F
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
Query: 127 TGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV--NS 184
L L+ +D S N +L L L N F T
Sbjct: 507 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 566
Query: 185 SSRSILDFNVSNNQLSGQIPAWMS 208
+ V ++ P+
Sbjct: 567 WIKDQRQLLVEVERMECATPSDKQ 590
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 30/171 (17%), Positives = 54/171 (31%), Gaps = 21/171 (12%)
Query: 52 DPCFDSWRGVTCNPSTHRVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNLNL 110
+PC + +T +L+ P + L L N L + +
Sbjct: 1 EPCVEVVPNITYQ----------CMELNFYKIPDNLPFSTKNLDLSF--NPLRHLGSYSF 48
Query: 111 SSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRL 170
S+P L+ L LS SL HL + L+ N + + L +L L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL-GAFSGLSSLQKLVA 107
Query: 171 EDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+ +++ + NV++N + F+ NL
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKL-------PEYFSNLTNL 151
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 37/236 (15%), Positives = 61/236 (25%), Gaps = 32/236 (13%)
Query: 9 FSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLS-SWVNSTDPCFDSWRGVTCNPST 67
F L L L N+ S + L + +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 68 HRVIKLVLEDLDLTG--PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNR 125
+ + L LD ++ + LT + SL + + + S +HL L + +
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK-DFSYNFGWQHLELVNCK 315
Query: 126 FT-------------------GTFPSGVSSLRHLRRVDLSHNA-YEGEIPMTELTRLPNL 165
F G L L +DLS N +L
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 166 LTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
L L N T+ S + + ++ L S F +NL
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE-------FSVFLSLRNL 423
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 26/149 (17%), Positives = 44/149 (29%), Gaps = 19/149 (12%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRL----LSLKNNLLSSSNLNLSSWPHLKHLYLSHN 124
LE LDL+ L L Q+ L L L N ++ L L L +N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 125 RFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTR--LPNLLTLRLEDNRFTGTLYS 181
+ L L L + E + + + L L L +E+ R Y
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 182 VNSSSRSILDF------NVSNNQLSGQIP 204
++ ++ + +
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 24/164 (14%), Positives = 48/164 (29%), Gaps = 12/164 (7%)
Query: 67 THRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLN--LSSWPHLKHLYLSHN 124
+ L L + + +L L+L+NN S + + + L+ L
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 125 RFTGTF------PSGVSSLRHLR--RVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
F S + L +L L++ Y + + L N+ + L
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 177 GTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKN 220
+ L+ + N + + +F NK
Sbjct: 296 RVKDFSYNFGWQHLE--LVNCKFGQFPTLKLKSLKRLTFTSNKG 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 58/292 (19%)
Query: 339 ELLGKGCVGATYKVVLDGGDV-VVVKRIRERKKKREVDEWL---RVIGGLRHSNIVSIRA 394
E +G+G G + L + V VK RE ++L R++ H NIV +
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
C K +++V + + G + L + L++ D+A G+ +L
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN-------------APE-L 500
H L++ N +V + ISD G+ + + Y APE L
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGM-----SREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560
+ ++ DV+SFG++L E + LG + + Q +
Sbjct: 288 NYG--------RYSSESDVWSFGILLWETFS---------LGASPYPNLSNQ-----QTR 325
Query: 561 DFELIMDKE-MEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608
+F + + A+ ++ C A P RP+ S +++ ++ IR +
Sbjct: 326 EF--VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 66/301 (21%), Positives = 112/301 (37%), Gaps = 57/301 (18%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
LG+G G Y DG +V VK ++ + W + ++ L H +I+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 391 SIRAYC--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
+ C G L LV +Y+P GSL L + + L A +G+A+L
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYL 150
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYN----------- 496
H H H L++ N+++D I D G+ + ++ Y
Sbjct: 151 H---AQHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFW 203
Query: 497 -APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE 554
APE LK KF+ DV+SFGV L E+LT + ++ + +
Sbjct: 204 YAPECLKE--------YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 555 SAWEVFDFELIMDKE-ME------EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
+ + EL+ E + E+ L+ C RP + +++ +
Sbjct: 256 TVLRL--TELLERGERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILKTVHE 310
Query: 608 K 608
K
Sbjct: 311 K 311
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 63/298 (21%), Positives = 110/298 (36%), Gaps = 55/298 (18%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
LG+G G Y D V VK ++ + + + ++ L H NIV
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 391 SIRAYC--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
+ C +G + + L+ ++LP GSL L ++ ++ ++LK A KG+ +L
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 142
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYN----------- 496
H L++ N++V+ + I D G+ + T + Y
Sbjct: 143 G---SRQYVHRDLAARNVLVES-EHQVKIGDFGLTKAIETD---KEYYTVKDDRDSPVFW 195
Query: 497 -APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE 554
APE L KF+ DV+SFGV L E+LT D + + M
Sbjct: 196 YAPECLMQ--------SKFYIASDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGPT 243
Query: 555 ----SAWEVFDFELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ + + L K + + Q+ C P +R + + E +
Sbjct: 244 HGQMTVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 74/307 (24%), Positives = 123/307 (40%), Gaps = 67/307 (21%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
+ LGKG G Y + D VV VK+++ ++ + ++ R ++ L+H NIV
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIV 105
Query: 391 SIRAYC--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
+ C G+ L L+ +YLP+GSL L + +D K L+ S KG+ +L
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 161
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYN----------- 496
H L++ NI+V+ N I D G+ ++ + Y
Sbjct: 162 G---TKRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQD---KEYYKVKEPGESPIFW 214
Query: 497 -APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT------GKMAKGDGELGIVKWVQ 548
APE L KF DV+SFGVVL E+ T A+ +G K Q
Sbjct: 215 YAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266
Query: 549 MMGQDESAWEVFDFELIMDKE-ME------EEMRALLQVALLCLAPLPKDRPNMSIVHRM 601
M+ + EL+ + + +E+ ++ C RP+ +
Sbjct: 267 MIVF-----HL--IELLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALR 316
Query: 602 IEDIRTK 608
++ IR +
Sbjct: 317 VDQIRDQ 323
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 73/307 (23%), Positives = 122/307 (39%), Gaps = 67/307 (21%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
+ LGKG G Y + D VV VK+++ ++ + ++ R ++ L+H NIV
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIV 74
Query: 391 SIRAYC--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
+ C G+ L L+ +YLP+GSL L + +D K L+ S KG+ +L
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 130
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYN----------- 496
H L++ NI+V+ N I D G+ ++ + +
Sbjct: 131 G---TKRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQD---KEFFKVKEPGESPIFW 183
Query: 497 -APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT------GKMAKGDGELGIVKWVQ 548
APE L KF DV+SFGVVL E+ T A+ +G K Q
Sbjct: 184 YAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 549 MMGQDESAWEVFDFELIMDKE-ME------EEMRALLQVALLCLAPLPKDRPNMSIVHRM 601
M+ + EL+ + + +E+ ++ C RP+ +
Sbjct: 236 MIVF-----HL--IELLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALR 285
Query: 602 IEDIRTK 608
++ IR
Sbjct: 286 VDQIRDN 292
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 25/148 (16%), Positives = 50/148 (33%), Gaps = 14/148 (9%)
Query: 75 LEDLDL------TGPAEV-LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT 127
++ + + T P E L ++ +L +L N L S L L L++N+ T
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG-------TLY 180
+ + + +HN + + + + + + N L
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 181 SVNSSSRSILDFNVSNNQLSGQIPAWMS 208
++ N+SNNQ+S S
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFS 454
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 26/157 (16%), Positives = 57/157 (36%), Gaps = 16/157 (10%)
Query: 75 LEDLDLTGPAEVLSRLTQLRLLSLKNNLLSS--SNLNLSSWPHLKHLYLSHNRFTGTFPS 132
+ L E L + L+ N L+ + ++ P+L + LS+N F+ FP+
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 133 GVSSLRHLRRVDLSHNAY------EGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSS 186
+ L+ + + E P +T P+L L++ N +
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWP-EGITLCPSLTQLQIGSNDIRKV---NEKIT 586
Query: 187 RSILDFNVSNNQLSGQIPAWMSPFGGSS---FAGNKN 220
+I ++ +N +++ P+ + +K
Sbjct: 587 PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 19/153 (12%), Positives = 47/153 (30%), Gaps = 23/153 (15%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLN--------LSSWPHLKHL 119
+E+L ++ + + N + S + ++ +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 120 YLSHNRFTGTFPSGVSSLRHLRRVDLSHN------AYEGEIPMTELTRLPNLLTLRLEDN 173
LS+N+ + S+ L ++L N + L ++ L N
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498
Query: 174 RFTGTLYSVNSSS-RSILDFNVSNNQLSGQIPA 205
+ T +++ ++ ++S N S P
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 26/149 (17%), Positives = 54/149 (36%), Gaps = 35/149 (23%)
Query: 75 LEDLDL-----TG-PAEVLSRLTQLRLLSLKNNLLSS--------SNLNLSSWPHLKHLY 120
+ ++L + P E+ S + L ++L N+L+ N N + L +
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSID 494
Query: 121 LSHNRFTGTFPS-GVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL 179
L N+ T ++L +L +DLS+N++ P T+ L + + R
Sbjct: 495 LRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FP-TQPLNSSTLKGFGIRNQR----- 547
Query: 180 YSVNSSSRSILDFNVSNNQLSGQIPAWMS 208
+ N+ + P ++
Sbjct: 548 -------------DAQGNRTLREWPEGIT 563
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 16/143 (11%), Positives = 46/143 (32%), Gaps = 14/143 (9%)
Query: 75 LEDLDLTG---PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFP 131
L + AE + + + +L + L + + + P
Sbjct: 208 LRQFYMGNSPFVAENICEAWENENSEY-AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266
Query: 132 SGVSSLRHLRRVDLSHN--------AYEGEIPMTELTRLPNLLTLRLEDNRF-TGTLYSV 182
+ + +L ++ ++++ N + + + + + + N T + +
Sbjct: 267 TFLKALPEMQLINVACNRGISGEQLKDDWQAL-ADAPVGEKIQIIYIGYNNLKTFPVETS 325
Query: 183 NSSSRSILDFNVSNNQLSGQIPA 205
+ + NQL G++PA
Sbjct: 326 LQKMKKLGMLECLYNQLEGKLPA 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 23/171 (13%), Positives = 57/171 (33%), Gaps = 28/171 (16%)
Query: 40 SSDSLSSWVNSTDPC-FDSWRGVTCNPSTHRVIKLVLEDLDLTG--PAEVLSRLTQLRLL 96
+ ++W + + + + GV+ N + RV L LE +G P + +LT+L +L
Sbjct: 53 GTQPGANWNFNKELDMWGAQPGVSLNSNG-RVTGLSLEGFGASGRVPDA-IGQLTELEVL 110
Query: 97 SLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPM 156
+L ++ + P G+S+ + Y+
Sbjct: 111 ALGSHGEKVNERL-------------------FGPKGISANMSDEQKQKMRMHYQKTFV- 150
Query: 157 TELTRL--PNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA 205
R +L+ + + ++ + + +N ++ +
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSK 200
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 22/171 (12%), Positives = 52/171 (30%), Gaps = 37/171 (21%)
Query: 73 LVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-------HLKHLYLSHNR 125
L + + S + + ++LK+ + + N++ L+ Y+ ++
Sbjct: 159 SDLIKDCINSDPQQKS-IKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSP 217
Query: 126 FTG-------------------TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLL 166
F T +L+ L V++ + ++P T L LP +
Sbjct: 218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP-TFLKALPEMQ 276
Query: 167 TLRLEDNRFTGTLYSVNS--------SSRSILDFNVSNNQL-SGQIPAWMS 208
+ + NR + I + N L + + +
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 21/144 (14%), Positives = 43/144 (29%), Gaps = 27/144 (18%)
Query: 75 LEDLDLTG------PAEV-LSRLTQLRLLSLKNNLLSS-----SNL-NLSSWPHLKHLYL 121
L +DL + + L L + L N S N L +
Sbjct: 490 LTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDA 549
Query: 122 SHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP-----NLLTLRLEDNRFT 176
NR +P G++ L ++ + N ++ ++ N+ L ++DN
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSN---------DIRKVNEKITPNISVLDIKDNPNI 600
Query: 177 GTLYSVNSSSRSILDFNVSNNQLS 200
S + + ++
Sbjct: 601 SIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 19/185 (10%), Positives = 48/185 (25%), Gaps = 29/185 (15%)
Query: 25 SDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPA 84
+ + LS A +L ++ + S +G P
Sbjct: 16 AIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQP------------------- 56
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
+ + L + S L+S + L L +G P + L L +
Sbjct: 57 --GANWNFNKELDMWGAQPGVS---LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLA 111
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV-----NSSSRSILDFNVSNNQL 199
L + + + + ++ + + ++ ++++
Sbjct: 112 LGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQ 171
Query: 200 SGQIP 204
I
Sbjct: 172 QKSIK 176
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-17
Identities = 30/158 (18%), Positives = 49/158 (31%), Gaps = 16/158 (10%)
Query: 72 KLVLEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNR 125
++ +E ++L + + L+ L L LS L LK L LS N+
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANK 312
Query: 126 FTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSS 185
F S+ L + + N E+ L L NL L L + +
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 186 S--RSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+ N+S N+ +F L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKT--------EAFKECPQL 402
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 25/148 (16%), Positives = 45/148 (30%), Gaps = 10/148 (6%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW---PHLKHLYLSHN 124
L L + G L L LR L L ++ + +S+ HL+ L LS+N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386
Query: 125 RFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNS 184
L +DL+ + + + L L L L + + +
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 185 SSRSILDFNVSNNQLSGQIPAWMSPFGG 212
++ N+ N +
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQT 474
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 25/148 (16%), Positives = 44/148 (29%), Gaps = 8/148 (5%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFT 127
E L+ + SRL L L L + + + S L L L+ N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
+ +S + L+ + I L L +L L N + +
Sbjct: 95 FMAETALSGPKALKHLFFIQT-GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 188 SILDFNVSNNQLSGQIPAWMSPFGGSSF 215
+ + NN + MS ++
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATN 181
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 41/175 (23%), Positives = 62/175 (35%), Gaps = 26/175 (14%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRF 126
LE LDL L L++L+L ++LL S+ P L+HL L N F
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 127 TGTF---PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN 183
+ + +L L + LS I T L + + L NR T +
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLS-SIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
Query: 184 SSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLC-----GRPLPSDCSNR 233
S + + N+++N +S +P S PL CSN
Sbjct: 521 SHLKG-IYLNLASNHISIILP--------SLLPILSQQRTINLRQNPLDCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 29/139 (20%), Positives = 45/139 (32%), Gaps = 11/139 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L+ L LT LS L+ L +SS + L + L+ LYL N +
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNL--LTLRLEDNRFTGTLYSVNSS 185
L+ +D +NA + +++ L L+L L N +
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFD 200
Query: 186 SRSILDFNVSNNQLSGQIP 204
S N Q I
Sbjct: 201 SAVFQSLNFGGTQNLLVIF 219
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 21/135 (15%), Positives = 44/135 (32%), Gaps = 9/135 (6%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
+ L + + +S + ++ + L + F + L+ +DL+
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAW 206
E+P + L L L L L N+F S+ S+ ++ N ++
Sbjct: 287 ATHLS-ELP-SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT- 343
Query: 207 MSPFGGSSFAGNKNL 221
+NL
Sbjct: 344 ------GCLENLENL 352
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 23/127 (18%), Positives = 35/127 (27%), Gaps = 14/127 (11%)
Query: 100 NNLLSSSNLNLSSWP-----HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEI 154
N + NL L+ P + L S N + S L +L +DL+
Sbjct: 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 155 PMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSS 214
T L TL L N + S +++ +S
Sbjct: 74 EDT-FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF--------IP 124
Query: 215 FAGNKNL 221
K L
Sbjct: 125 LHNQKTL 131
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/138 (13%), Positives = 34/138 (24%), Gaps = 14/138 (10%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLR--HLRRVD 144
+ L +N L+ L S+ L P+ L + ++
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR-SILDFNVSNNQLSGQI 203
L + + T L L L + + S L S N+
Sbjct: 261 LQKHYFFNISSNT-FHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVL--SANKFENLC 317
Query: 204 PAWMSPFGGSSFAGNKNL 221
S + +L
Sbjct: 318 Q--------ISASNFPSL 327
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 10/93 (10%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLK--HLYLSHNRF 126
LE L L+ + L + + L +N L+S ++ + HLK +L L+ N
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS--SSIEALSHLKGIYLNLASNHI 535
Query: 127 TGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTEL 159
+ PS + L R ++L N +
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCTCSNIYF 568
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 27/154 (17%), Positives = 50/154 (32%), Gaps = 15/154 (9%)
Query: 75 LEDLDL-----TGPAEVLSRLTQLRLLSLKNNLLSS--SNLNLSSWPHLKHLYLSHNRFT 127
L LDL + L +L+ L +++ L S L +L +S+
Sbjct: 378 LRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
F L L + ++ N+++ NL L L + + V +
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 188 SILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+ N+S+N L S + +L
Sbjct: 498 RLQLLNMSHNNLLFLDS--------SHYNQLYSL 523
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 26/137 (18%), Positives = 50/137 (36%), Gaps = 11/137 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFT 127
L+ LDL+ + L L L L N + S + S L++L +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG----TLYSVN 183
+ L L++++++HN + L NL+ + L N L +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 184 SSSRSILDFNVSNNQLS 200
+ + L ++S N +
Sbjct: 178 ENPQVNLSLDMSLNPID 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 29/173 (16%), Positives = 49/173 (28%), Gaps = 23/173 (13%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRF 126
L+ LD L +L L + L L ++ N F
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSS 185
S V ++ +L +DLS E +I L L L + N S +
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLE-QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519
Query: 186 SRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLC-----GRPLPSDCSNR 233
S+ + S N++ K+L + C ++
Sbjct: 520 LYSLSTLDCSFNRIETSKG--------ILQHFPKSLAFFNLTNNSVACICEHQ 564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 33/157 (21%), Positives = 52/157 (33%), Gaps = 19/157 (12%)
Query: 75 LEDLDLTG------PAEVLSRL--TQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRF 126
L LDL+ S L LR L L N + N L+HL H+
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTL 411
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN-S 184
SL L +D+S+ + + L +L TL++ N F S +
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI-FLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 185 SSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
++ ++ ++S QL F L
Sbjct: 471 NTTNLTFLDLSKCQLEQISW--------GVFDTLHRL 499
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 27/157 (17%), Positives = 45/157 (28%), Gaps = 33/157 (21%)
Query: 90 LTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG--------------------- 128
L L+ L+L N S S + P L +L LS N +
Sbjct: 327 LPFLKSLTLTMNKGSIS-FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 129 ----TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNS 184
+ L L+ +D H+ + + L LL L + +
Sbjct: 386 NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 185 SSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
S+ ++ N + + FA NL
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLS-------NVFANTTNL 475
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 30/173 (17%), Positives = 56/173 (32%), Gaps = 21/173 (12%)
Query: 50 STDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNL 108
S +PC + +T D L+ P ++ S + L N L +
Sbjct: 3 SLNPCIEVVPNITYQ----------CMDQKLSKVPDDIPSSTKNIDLSF--NPLKILKSY 50
Query: 109 NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTL 168
+ S++ L+ L LS L HL + L+ N + + L +L L
Sbjct: 51 SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENL 109
Query: 169 RLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+ + ++ NV++N + + F+ NL
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKL-------PAYFSNLTNL 155
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 27/151 (17%), Positives = 40/151 (26%), Gaps = 23/151 (15%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYL 121
L+ L++ S LT L + L N + + L + L +
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP-QVNLSLDM 188
Query: 122 SHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGT--L 179
S N L + L N I T L L L RL F L
Sbjct: 189 SLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247
Query: 180 YSVNSS------SRSILDFNVSNNQLSGQIP 204
S +I +F ++
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 64/284 (22%), Positives = 122/284 (42%), Gaps = 38/284 (13%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVV-VKRIRERKKKRE--VDEWLRVIGGLRHSNIVSIRAY 395
LG G G Y+ V + V VK ++E + E + E V+ ++H N+V +
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE-AAVMKEIKHPNLVQLLGV 284
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
C + +++ +++ +G+L L R R V L +A+ + + +L K +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQ 510
H +L++ N +V + ++D G+ +L D Y A +K+ + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPESLAY 393
Query: 511 RKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEM 570
KF + DV++FGV+L EI T G+ + + +V++ L D M
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT---------YGMSPYPGIDLS-----QVYEL-LEKDYRM 438
Query: 571 EEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611
E + ++ C P DRP+ + +H+ E + + SI
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 71/303 (23%), Positives = 113/303 (37%), Gaps = 72/303 (23%)
Query: 339 ELLGKGCVGATYK-----VVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNI 389
LG+G G Y+ VV D + V +K + E RE E+L V+ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSR-----GPGRMPVDWNKRLKLASDSAKG 444
V + + ++ + + G L S L R P P +K +++A + A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN-------- 496
+A+L N H L++ N +V + I D G+ + + D Y
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDYYRKGGKGLLP 203
Query: 497 ----APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG 551
+PE LK F DV+SFGVVL EI T L + +
Sbjct: 204 VRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIAT---------LAEQPYQGL-- 244
Query: 552 QDESAWEVFDFEL---IMDK------EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602
S +V F + ++DK + E MR C PK RP+ + I
Sbjct: 245 ---SNEQVLRFVMEGGLLDKPDNCPDMLFELMRM-------CWQYNPKMRPSFLEIISSI 294
Query: 603 EDI 605
++
Sbjct: 295 KEE 297
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 33/296 (11%), Positives = 66/296 (22%), Gaps = 59/296 (19%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVD-----EWLRVIGGLRHSNIVSI 392
E L G + V ++ + +K + + E L +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 393 RAYCN--------------------------GKDELFLVYDYLPHGSLHSLLH--GSRGP 424
R L+ L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYV 186
Query: 425 GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG---- 480
R L + + A L L HGH + N+ + G + D+
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 481 ---VHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537
P Y E + ++ + + G+ + + + G
Sbjct: 244 VGTRGPASSVPVT----YAPREFLNASTATFTHA-----LNAWQLGLSIYRVWCLFLPFG 294
Query: 538 DGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP 593
GI + + F + + ++ L+ L + R
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGS--CTPLPDFVKTLIG---RFLNFDRRRRL 345
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 65/302 (21%), Positives = 106/302 (35%), Gaps = 66/302 (21%)
Query: 339 ELLGKGCVGATYK-----VVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNI 389
LG G G Y+ + D + V VK + E +++ ++L +I H NI
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR--LKLASDSAKGLAF 447
V F++ + + G L S L +R P L +A D A G +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGN---ACISDIGVHQLFHTPFFINDAYN-------- 496
L + H H +++ N ++ G A I D G+ + + Y
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----AGYYRKGGCAMLP 249
Query: 497 ----APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG 551
PE F + D +SFGV+L EI + LG + +
Sbjct: 250 VKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSK-- 290
Query: 552 QDESAWEVFDFELIMDKEME------EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
S EV +F + M+ + ++ C P+DRPN +I+ IE
Sbjct: 291 ---SNQEVLEF-VTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYC 343
Query: 606 RT 607
Sbjct: 344 TQ 345
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 65/302 (21%), Positives = 106/302 (35%), Gaps = 66/302 (21%)
Query: 339 ELLGKGCVGATYK-----VVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNI 389
LG G G Y+ + D + V VK + E +++ ++L +I H NI
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR--LKLASDSAKGLAF 447
V F++ + + G L S L +R P L +A D A G +
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGN---ACISDIGVHQLFHTPFFINDAYN-------- 496
L + H H +++ N ++ G A I D G+ + + Y
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----ASYYRKGGCAMLP 208
Query: 497 ----APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG 551
PE F + D +SFGV+L EI + LG + +
Sbjct: 209 VKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSK-- 249
Query: 552 QDESAWEVFDFELIMDKEME------EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
S EV +F + M+ + ++ C P+DRPN +I+ IE
Sbjct: 250 ---SNQEVLEF-VTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYC 302
Query: 606 RT 607
Sbjct: 303 TQ 304
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 66/292 (22%), Positives = 120/292 (41%), Gaps = 54/292 (18%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVV-VKRIRERKKKRE--VDEWLRVIGGLRHSNIVSIRAY 395
LG G G Y+ V + V VK ++E + E + E V+ ++H N+V +
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE-AAVMKEIKHPNLVQLLGV 77
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
C + +++ +++ +G+L L R R V L +A+ + + +L K +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL---EKKN 131
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE-LKF 502
H L++ N +V + ++D G+ +L D Y APE L +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-----GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562
KF + DV++FGV+L EI T G+ + + +V++
Sbjct: 187 --------NKFSIKSDVWAFGVLLWEIAT---------YGMSPYPGI-----DLSQVYEL 224
Query: 563 ELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611
L D ME + ++ C P DRP+ + +H+ E + + SI
Sbjct: 225 -LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 8e-16
Identities = 40/183 (21%), Positives = 64/183 (34%), Gaps = 14/183 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
L ++DL+ ++ +L L + NN L + NL P LK L LSHN
Sbjct: 256 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL- 314
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188
L + L HN I +L+ L L L N + S+ + R+
Sbjct: 315 HVERNQPQFDRLENLYLDHN----SIVTLKLSTHHTLKNLTLSHNDWDCN--SLRALFRN 368
Query: 189 ILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSNRTVEPEQPPRSRPRSS 248
+ V + +I + G +K R L VE Q + R ++
Sbjct: 369 VARPAVDDADQHCKIDYQLEH-GLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSAT 427
Query: 249 RVV 251
+
Sbjct: 428 DTI 430
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 27/138 (19%), Positives = 48/138 (34%), Gaps = 20/138 (14%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L L L P + +L LS+ NN L + + L++L LS NR T
Sbjct: 125 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
+ + L ++S+N ++ L + L N + +
Sbjct: 185 -HVDLSL--IPSLFHANVSYN------LLSTLAIPIAVEELDASHNSIN-VVRGPVNVEL 234
Query: 188 SILDFNVSNNQLSGQIPA 205
+IL + +N L+
Sbjct: 235 TILK--LQHNNLT-DTAW 249
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 26/133 (19%), Positives = 52/133 (39%), Gaps = 15/133 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
+E+LD + V LT L+L ++N L+ + L ++P L + LS+N
Sbjct: 213 VEELDASHNSINVVRGPVNVELTILKL---QHNNLTDTA-WLLNYPGLVEVDLSYNELE- 267
Query: 129 TFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
++ L R+ +S+N + + +P L L L N +
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLV-ALNLY-GQPIPTLKVLDLSHNHLL-HVERNQPQFD 324
Query: 188 SILDFNVSNNQLS 200
+ + + +N +
Sbjct: 325 RLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 18/137 (13%), Positives = 37/137 (27%), Gaps = 12/137 (8%)
Query: 87 LSRLTQLRLLSLKNNLLS-SSNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVD 144
L + + + + K + ++ P+ + S R + ++
Sbjct: 23 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLN 81
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
L+ E EI + L + N V + + + N LS +P
Sbjct: 82 LNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLP 139
Query: 205 AWMSPFGGSSFAGNKNL 221
F L
Sbjct: 140 R-------GIFHNTPKL 149
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 60/303 (19%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
LGKG G Y + D +V VK+++ ++ ++ R ++ L IV
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIV 87
Query: 391 SIRAYC--NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
R G+ L LV +YLP G L L R +D ++ L +S KG+ +L
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYL 143
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYN----------- 496
H L++ NI+V+ I+D G+ +L D Y
Sbjct: 144 G---SRRCVHRDLAARNILVES-EAHVKIADFGLAKLLPLD---KDYYVVREPGQSPIFW 196
Query: 497 -APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553
APE L F ++ DV+SFGVVL E+ T + ++++MMG +
Sbjct: 197 YAPESLSD--------NIFSRQSDVWSFGVVLYELFTYCDKSC----SPSAEFLRMMGCE 244
Query: 554 ESAWEVFD-FELIMDKE-ME------EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ EL+ + + + E+ L+ LC AP P+DRP+ S + ++ +
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQLDML 301
Query: 606 RTK 608
+
Sbjct: 302 WSG 304
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 60/290 (20%), Positives = 111/290 (38%), Gaps = 56/290 (19%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAY 395
+ +G G G + D V +K IRE ++++ V+ L H +V +
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
C + + LV +++ HG L L RG L + D +G+A+L +A
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET----LLGMCLDVCEGMAYL---EEAC 124
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE-LKF 502
+ H L++ N +V + +SD G+ + +D Y +PE F
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL-----DDQYTSSTGTKFPVKWASPEVFSF 179
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562
++ + DV+SFGV++ E+ + G + + EV +
Sbjct: 180 --------SRYSSKSDVWSFGVLMWEVFS---------EGKIPYENRSNS-----EVVED 217
Query: 563 ELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609
+ + + + Q+ C P+DRP S + R + +I G
Sbjct: 218 -ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 52/212 (24%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKRE--VDEWLRVIGGLRHSNIVSIRAYC 396
E LG G G + +G V VK +++ + + E ++ L+H +V + A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAE-ANLMKQLQHQRLVRLYAVV 77
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
++ ++++ +Y+ +GSL L + P + + NK L +A+ A+G+AF+ + +
Sbjct: 78 T-QEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNY 130
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAY------------NAPE-LKFN 503
H L ++NI+V + I+D G+ +L ++ Y APE + +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIE-----DNEYTAREGAKFPIKWTAPEAINY- 184
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILT-GKM 534
F + DV+SFG++L EI+T G++
Sbjct: 185 -------GTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 29/151 (19%), Positives = 55/151 (36%), Gaps = 21/151 (13%)
Query: 80 LTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRH 139
+T ++ + RLT+L+++ N+ + N+ + + + + S+L+
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVD----WEDANSDYAKQYENEELSWSNLKD 492
Query: 140 LRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR---------SIL 190
L V+L + ++P L LP L +L + NR +R I
Sbjct: 493 LTDVELYNCPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 191 DFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
F + N L PA +S L
Sbjct: 552 IFYMGYNNLEE-FPA------SASLQKMVKL 575
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 20/151 (13%), Positives = 46/151 (30%), Gaps = 21/151 (13%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYL 121
+E L + + + + N + S +++ + + L
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 122 SHNRFTGTFPSGVSSLRHLRRVDLSHN------AYEGEIPMTELTRLPNLLTLRLEDNRF 175
S+N ++ + + LS+N + L T+ L N+
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 176 TGTLYSVNSSS-RSILDFNVSNNQLSGQIPA 205
T +++ + + +VS N S P
Sbjct: 741 TSLSDDFRATTLPYLSNMDVSYNCFSS-FPT 770
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 8e-15
Identities = 19/151 (12%), Positives = 47/151 (31%), Gaps = 23/151 (15%)
Query: 75 LEDLDLTG------PAEV-LSRLTQLRLLSLKNNLLSS----SNLNLSSWPHLKHLYLSH 123
++ + PA L ++ +L LL +N + L L L +
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEAFGTN-----VKLTDLKLDY 604
Query: 124 NRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV 182
N+ P + + + SHN + + + + ++ N+ ++
Sbjct: 605 NQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663
Query: 183 NSS-----SRSILDFNVSNNQLSGQIPAWMS 208
+ S + +S N++ +
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFA 694
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 25/149 (16%), Positives = 52/149 (34%), Gaps = 35/149 (23%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS--------SNLNLSSWPHLKHLY 120
+ L+ P E+ + + + + L NNL++S + N + L +
Sbjct: 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTID 734
Query: 121 LSHNRFTGTFPS-GVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL 179
L N+ T ++L +L +D+S+N + P T+ L + R
Sbjct: 735 LRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFP-TQPLNSSQLKAFGIRHQR----- 787
Query: 180 YSVNSSSRSILDFNVSNNQLSGQIPAWMS 208
+ N++ Q P ++
Sbjct: 788 -------------DAEGNRILRQWPTGIT 803
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 25/144 (17%), Positives = 51/144 (35%), Gaps = 22/144 (15%)
Query: 75 LEDLDLTG------PAEV-LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSH---- 123
L +DL + + L L + + N SS + LK + H
Sbjct: 730 LTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDA 789
Query: 124 --NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT----G 177
NR +P+G+++ L ++ + N ++ +L P L L + DN
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD-EKL--TPQLYILDIADNPNISIDVT 845
Query: 178 TLYSVNSSSRSILDFNVSNNQLSG 201
++ + +L ++ + G
Sbjct: 846 SVCPYIEAGMYVLLYD-KTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 20/186 (10%), Positives = 41/186 (22%), Gaps = 17/186 (9%)
Query: 25 SDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPA 84
D L + ++ G + S + +W + L++
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN------ 322
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
R+T L L + LK L + T + +
Sbjct: 323 ---GRVTGLSLAG--FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT-----GTLYSVNSSSRSILDFNVSNNQL 199
+ L L L + + + S N++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 200 SGQIPA 205
+ I
Sbjct: 438 TF-ISK 442
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 59/296 (19%), Positives = 104/296 (35%), Gaps = 53/296 (17%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK------KREVDEWLRVIGGLRHSNIVS 391
+ LG+G V L G +KRI ++ +RE + H NI+
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREA----DMHRLFNHPNILR 90
Query: 392 IRAYC----NGKDELFLVYDYLPHGSLHSLL-HGSRGPGRMPVDWNKRLKLASDSAKGLA 446
+ AYC K E +L+ + G+L + + + D + L L +GL
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED--QILWLLLGICRGLE 148
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG-VHQLFHTPFFINDA----------- 494
+H H L +NI++ G + D+G ++Q A
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 495 ---YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMM 550
Y APEL + S +R DV+S G VL ++ G+ + G + +
Sbjct: 206 TISYRAPEL----FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 551 GQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
Q + + LL + P RP++ ++ +E ++
Sbjct: 262 NQ---------LSIPQSPRHSSALWQLLNS---MMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 56/291 (19%), Positives = 106/291 (36%), Gaps = 56/291 (19%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAY 395
+ LG G G G V +K I+E DE++ V+ L H +V +
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
C + +F++ +Y+ +G L + L R + L++ D + + +L
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ----LLEMCKDVCEAMEYL---ESKQ 140
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE-LKF 502
H L++ N +V+ G +SD G+ + +D Y PE L +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-----DDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562
KF + D+++FGV++ EI + LG + + + E +
Sbjct: 196 --------SKFSSKSDIWAFGVLMWEIYS---------LGKMPYERFTNS-----ETAEH 233
Query: 563 ELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610
+ + + + C +RP I+ I D+ + S
Sbjct: 234 -IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 53/296 (17%), Positives = 110/296 (37%), Gaps = 60/296 (20%)
Query: 339 ELLGKGCVGATYKVVLDGGD----VVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
++GKG G Y +K + + ++V+ +LR ++ GL H N+++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 392 IRAYCNGKDE-LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ + ++ Y+ HG L + + + + A+G+ +L
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK----DLISFGLQVARGMEYL-- 140
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN-------------- 496
+ H L++ N ++D+ ++D G+ + + Y+
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD----REYYSVQQHRHARLPVKWT 195
Query: 497 APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDES 555
A E L+ +F + DV+SFGV+L E+LT G + +
Sbjct: 196 ALESLQT--------YRFTTKSDVWSFGVLLWELLT---------RGAPPY-----RHID 233
Query: 556 AWEVFDFELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608
+++ F L + + + +L QV C P RP ++ +E I +
Sbjct: 234 PFDLTHF-LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 61/285 (21%), Positives = 121/285 (42%), Gaps = 40/285 (14%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKRE--VDEWLRVIGGLRHSNIVSIRAYC 396
LG+GC G + +G V +K ++ E + E +V+ LRH +V + A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE-AQVMKKLRHEKLVQLYAVV 248
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
+ ++ +++V +Y+ GSL L +G + + + +A+ A G+A++ + +
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQR 511
H L ++NI+V + ++D G+ +L ++ Y A + +K+
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIE-----DNEYTARQGAKFPIKWTAPEAALYG 356
Query: 512 KFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE-M 570
+F + DV+SFG++L E+ T G V + M+ + EV + + M
Sbjct: 357 RFTIKSDVWSFGILLTELTT---------KGRVPYPGMVNR-----EV--LDQVERGYRM 400
Query: 571 EEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSID 612
+L + C P++RP + +ED T
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 46/207 (22%), Positives = 89/207 (42%), Gaps = 34/207 (16%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKRE--VDEWLRVIGGLRHSNIVSIRAYC 396
+ LG G G + + V VK ++ E + E V+ L+H +V + A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAE-ANVMKTLQHDKLVKLHAVV 252
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
K+ ++++ +++ GSL L + K + ++ A+G+AF+ + +
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNY 305
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APELKFNN 504
H L ++NI+V I+D G+ ++ ++ Y APE
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIE-----DNEYTAREGAKFPIKWTAPE----- 355
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILT 531
+ F + DV+SFG++L+EI+T
Sbjct: 356 --AINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 27/137 (19%), Positives = 49/137 (35%), Gaps = 11/137 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L+ LDL+ L+ L L L N + S + S L+ L
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT----GTLYSVN 183
+ L+ L+ ++++HN + + L NL L L N+ L ++
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 184 SSSRSILDFNVSNNQLS 200
L ++S N ++
Sbjct: 174 QMPLLNLSLDLSLNPMN 190
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 36/157 (22%), Positives = 58/157 (36%), Gaps = 19/157 (12%)
Query: 75 LEDLDLTG--------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRF 126
LE LDL+ ++ T L+ L L N + + + N L+HL H+
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSS 185
V SLR+L +D+SH L +L L++ N F +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 186 SRSILDF-NVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
L F ++S QL Q+ ++F +L
Sbjct: 468 ELRNLTFLDLSQCQLE-QLSP-------TAFNSLSSL 496
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 23/112 (20%), Positives = 47/112 (41%), Gaps = 9/112 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN--LSSWPHLKHLYLSHNRF 126
L LD++ + + L+ L +L + N + L + +L L LS +
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 127 TGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGT 178
P+ +SL L+ ++++ N + +P RL +L + L N + +
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 31/138 (22%), Positives = 44/138 (31%), Gaps = 8/138 (5%)
Query: 75 LEDLDLT----GPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW---PHLKHLYLSHNRFT 127
L+ L T G A L L L L N LS S LK+L LS N
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
T S L L +D H+ + + L NL+ L + + +
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 188 SILDFNVSNNQLSGQIPA 205
S+ ++ N
Sbjct: 446 SLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 37/219 (16%), Positives = 60/219 (27%), Gaps = 19/219 (8%)
Query: 7 FFFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSS---WVNSTDPCFDSWRGVTC 63
L L + + L F S +L+ + D D +
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 64 NPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSH 123
+ LV ++ L L++ K + L LK L +
Sbjct: 280 CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKL-----KSLKRLTFTS 334
Query: 124 NRFTGTFPSGVSSLRHLRRVDLSHNA-YEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV 182
N+ F L L +DLS N +L L L N T+ S
Sbjct: 335 NKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN 391
Query: 183 NSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+ + ++ L Q+ S F +NL
Sbjct: 392 FLGLEQLEHLDFQHSNLK-QMSE------FSVFLSLRNL 423
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 29/152 (19%), Positives = 56/152 (36%), Gaps = 18/152 (11%)
Query: 52 DPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRL-TQLRLLSLKNNLLSS-SNLN 109
+PC + +T +L+ ++ L + L L N L + +
Sbjct: 1 EPCVEVVPNITYQ----------CMELNFY---KIPDNLPFSTKNLDLSFNPLRHLGSYS 47
Query: 110 LSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTL 168
S+P L+ L LS T G SL HL + L+ N + + + + L +L L
Sbjct: 48 FFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKL 105
Query: 169 RLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
+ +++ + NV++N +
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 27/145 (18%), Positives = 47/145 (32%), Gaps = 19/145 (13%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRL----LSLKNNLLSSSNLNLSSWPHLKHLYLSHN 124
LE LDL+ L L Q+ L L L N ++ L L L +N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 125 RFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTR--LPNLLTLRLEDNRFTGTLYS 181
+ L L L + E + + + L L L +E+ R Y
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 182 VNSSS------RSILDFNVSNNQLS 200
++ ++ F++ + +
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 14/65 (21%), Positives = 27/65 (41%), Gaps = 7/65 (10%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFT 127
L LDL+ + L+ L++L++ +N L S L+ ++L N +
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
Query: 128 GTFPS 132
+ P
Sbjct: 532 CSCPR 536
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 33/151 (21%), Positives = 61/151 (40%), Gaps = 14/151 (9%)
Query: 69 RVIKLVLEDLDLTG---PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW-----PHLKHLY 120
+ +L LE+L++TG P + + L +L+L+N ++ + L+ P LK L
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 121 LSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTE---LTRLPNLLTLRLEDNRFT- 176
++ V L +DLS N GE + + P L L L +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 177 --GTLYSVNSSSRSILDFNVSNNQLSGQIPA 205
G ++ ++ + ++S+N L A
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 29/156 (18%), Positives = 49/156 (31%), Gaps = 12/156 (7%)
Query: 55 FDSWRGVTCNPSTHRVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSN-----L 108
D+W + L + E + L L L +N L
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 109 NLSSWPHLKHLYLSHNRFT---GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNL 165
+P L+ L L + G + ++ L+ +DLSHN+ L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 166 LTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201
+L L + + S+LD +S N+L
Sbjct: 256 NSLNLSFTGLK-QVPKGLPAKLSVLD--LSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 25/150 (16%), Positives = 53/150 (35%), Gaps = 10/150 (6%)
Query: 64 NPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSN----LNLSSWPHLKHL 119
S ++K V + DL +++ + L+ L+++ + S L + L+ L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDII-KSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 120 YLSHNRFTGTFPSGV-----SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNR 174
L + TGT P + L L ++S + + + P L L +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 175 FTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
++ ++S+N G+
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 27/105 (25%), Positives = 38/105 (36%), Gaps = 9/105 (8%)
Query: 75 LEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSS-NLNLSSWP-HLKHLYLSHNRFTGTFPS 132
+E A + + QL+ L L +N L + WP L L LS
Sbjct: 213 METPSGVCSA-LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG 271
Query: 133 GVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG 177
+ L L DLS+N + P LP + L L+ N F
Sbjct: 272 LPAKLSVL---DLSYNRLD-RNP--SPDELPQVGNLSLKGNPFLD 310
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 70/345 (20%), Positives = 118/345 (34%), Gaps = 85/345 (24%)
Query: 339 ELLGKGCVGATYKVVLDGGD--------VVVVKRIRERKKKREVDEWLR------VIGGL 384
+ LG+G G G D V VK ++ ++++ + + +IG
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-- 132
Query: 385 RHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR---------- 434
+H NI+++ C L+++ +Y G+L L R PG
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 435 -LKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND 493
+ A A+G+ +L H L++ N++V + I+D G+ + H D
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH----ID 245
Query: 494 AYN------------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE 540
Y APE L R + + DV+SFGV+L EI T
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIFT--------- 288
Query: 541 LGIVKWVQMMGQDESAWEVFDFEL---IMDK------EMEEEMRALLQVALLCLAPLPKD 591
LG + + E+F MDK E+ MR C +P
Sbjct: 289 LGGSPYPGV-----PVEELFKLLKEGHRMDKPSNCTNELYMMMRD-------CWHAVPSQ 336
Query: 592 RPNMSIVHRMIEDIRTKGSIDGCANSIMNNISSDSSPSQSENTYN 636
RP + ++ I S ++ P+ +N
Sbjct: 337 RPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFN 381
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 49/285 (17%), Positives = 109/285 (38%), Gaps = 43/285 (15%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR--ERKKKREVDEWL---RVIGGLRHSNIVSI 392
+ +G+G Y+ L G V +K+++ + + + + ++ L H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
A +EL +V + G L ++ + R + K L +H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTVWKYFVQLCSALEHMHSRR 156
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFH----------TPFFINDAYNAPELK 501
H + +N+ + G + D+G+ TP+ Y +PE
Sbjct: 157 V---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-----YMSPERI 208
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561
+ N Y+ + D++S G +L E+ + ++ + + + Q D
Sbjct: 209 --HENGYN-----FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-------D 254
Query: 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
+ + EE+R L+ +C+ P P+ RP+++ V+ + + +
Sbjct: 255 YPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMH 296
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 40/216 (18%), Positives = 80/216 (37%), Gaps = 45/216 (20%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
++LG G G + + + V +K +RE + E L V+ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMP--VDWNKRLKLASDSAKGLAFL 448
+ C + L+ +P G L + + ++W AKG+ +L
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------ 496
L H L++ N++V + I+D G+ +L +
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA----EEKEYHAEGGKVPIKWM 186
Query: 497 APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
A E + R + + DV+S+GV + E++T
Sbjct: 187 ALESILH--------RIYTHQSDVWSYGVTVWELMT 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 9e-15
Identities = 61/285 (21%), Positives = 121/285 (42%), Gaps = 40/285 (14%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKRE--VDEWLRVIGGLRHSNIVSIRAYC 396
LG+GC G + +G V +K ++ E + E +V+ LRH +V + A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE-AQVMKKLRHEKLVQLYAVV 331
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
+ ++ +++V +Y+ GSL L +G + + + +A+ A G+A++ + +
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE-----LKFNNNNNYSQR 511
H L ++NI+V + ++D G+ +L ++ Y A + +K+
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIE-----DNEYTARQGAKFPIKWTAPEAALYG 439
Query: 512 KFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE-M 570
+F + DV+SFG++L E+ T G V + M+ + EV + + M
Sbjct: 440 RFTIKSDVWSFGILLTELTT---------KGRVPYPGMVNR-----EV--LDQVERGYRM 483
Query: 571 EEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSID 612
+L + C P++RP + +ED T
Sbjct: 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 56/297 (18%), Positives = 103/297 (34%), Gaps = 63/297 (21%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDV----VVVKRIRERKKKREVDEWLR---VIGGLRHS 387
E LG+G + V D G + V++K + + + + + ++ L H
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS-ESFFEAASMMSKLSHK 72
Query: 388 NIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
++V C DE LV +++ GSL + L ++ + +L++A A + F
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL----WKLEVAKQLAAAMHF 128
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNAC--------ISDIGVHQLFHTPFFINDAYN--- 496
L + L HG++ + NI++ + + +SD G+ D
Sbjct: 129 L---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERI 181
Query: 497 ---APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQD 553
PE N + D +SFG L EI + G + Q
Sbjct: 182 PWVPPECIENP------KNLNLATDKWSFGTTLWEICS---------GGDKPLSALDSQ- 225
Query: 554 ESAWEVFDF---ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
F + E+ L+ C+ P RP+ + R + + T
Sbjct: 226 ----RKLQFYEDRHQLPAPKAAELANLI---NNCMDYEPDHRPSFRAIIRDLNSLFT 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 48/210 (22%), Positives = 79/210 (37%), Gaps = 30/210 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKK--REVDEWLRVIGGLRHSNIVSIRAY 395
+LGKG G Y L + +K I ER + + + E + + L+H NIV
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
+ + + + +P GSL +LL GP + + +GL +LH H
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 456 LFHGHLSSSNIVVDQLGNAC-ISDIGV-----------HQLFHTPFFINDAYNAPELKFN 503
+ N++++ ISD G T Y APE+
Sbjct: 146 R---DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-----YMAPEIIDK 197
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y + D++S G ++E+ TGK
Sbjct: 198 GPRGYG-----KAADIWSLGCTIIEMATGK 222
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 18/155 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L LD++ + L L+ L + +N L S+ S L+ L L T
Sbjct: 106 LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSS 186
+ P+ S L L + L H I RL L L + + T+
Sbjct: 166 -SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 187 RSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
++ ++++ L+ +P + L
Sbjct: 224 LNLTSLSITHCNLT-AVPY-------LAVRHLVYL 250
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 8/109 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
LE L L P E LS L L +L L++ +++ + + LK L +SH +
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
T +L + ++H +P + L L L L N +
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 37/170 (21%), Positives = 64/170 (37%), Gaps = 26/170 (15%)
Query: 54 CFDSWRGVTCNPSTHRVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNLNLSS 112
C R V C+ P + + L L N + + + +S
Sbjct: 9 CSAQDRAVLCH------------RKRFVAVPEGIPTETRLLDLGK--NRIKTLNQDEFAS 54
Query: 113 WPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLE 171
+PHL+ L L+ N + G ++L +LR + L N + IP+ T L NL L +
Sbjct: 55 FPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDIS 112
Query: 172 DNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+N+ L + ++ V +N L I +F+G +L
Sbjct: 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISH-------RAFSGLNSL 154
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 26/134 (19%), Positives = 50/134 (37%), Gaps = 10/134 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L+ L+++ L LS+ + L++ L + +L+ L LS+N +
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSS 186
T + L L+ + L + L L L + N+ T SV S
Sbjct: 262 -TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV 319
Query: 187 RSILDFNVSNNQLS 200
++ + +N L+
Sbjct: 320 GNLETLILDSNPLA 333
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 71/310 (22%), Positives = 118/310 (38%), Gaps = 77/310 (24%)
Query: 339 ELLGKGCVG----ATYKVVLDGGD--VVVVKRIRERKKKREVDEWLR---VIGGLRHSNI 389
LG+G G A + D +V VK +++ ++ R ++ L+H +I
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEHI 79
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR-----------LKLA 438
V C D L +V++Y+ HG L+ L + VD R L +A
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 439 SDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYN- 496
S A G+ +L H H L++ N +V I D G+ + ++ D Y
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGA-NLLVKIGDFGMSRDVYS----TDYYRV 191
Query: 497 -----------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV 544
PE + + KF DV+SFGV+L EI T G
Sbjct: 192 GGHTMLPIRWMPPESIMYR--------KFTTESDVWSFGVILWEIFT---------YGKQ 234
Query: 545 KWVQMMGQDESAWEVFDFELIMD-KEME------EEMRALLQVALLCLAPLPKDRPNMSI 597
W Q+ S EV E I + +E +E+ ++ L C P+ R N+
Sbjct: 235 PWFQL-----SNTEV--IECITQGRVLERPRVCPKEVYDVM---LGCWQREPQQRLNIKE 284
Query: 598 VHRMIEDIRT 607
+++++ +
Sbjct: 285 IYKILHALGK 294
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 27/108 (25%), Positives = 40/108 (37%), Gaps = 11/108 (10%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
L ++DL+ ++ +L L + NN L + NL P LK L LSHN
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL- 308
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
L + L HN+ + L+ L L L N +
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV-TLK---LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 27/138 (19%), Positives = 48/138 (34%), Gaps = 20/138 (14%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L L L P + +L LS+ NN L + + L++L LS NR T
Sbjct: 119 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
+ + L ++S+N ++ L + L N + +
Sbjct: 179 -HVDLSL--IPSLFHANVSYN------LLSTLAIPIAVEELDASHNSIN-VVRGPVNVEL 228
Query: 188 SILDFNVSNNQLSGQIPA 205
+IL + +N L+
Sbjct: 229 TILK--LQHNNLT-DTAW 243
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 26/133 (19%), Positives = 51/133 (38%), Gaps = 15/133 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
+E+LD + V LT L L++N L+ + L ++P L + LS+N
Sbjct: 207 VEELDASHNSINVVRGPVNVELTIL---KLQHNNLTDTA-WLLNYPGLVEVDLSYNELE- 261
Query: 129 TFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
++ L R+ +S+N + + +P L L L N +
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLY-GQPIPTLKVLDLSHNHLL-HVERNQPQFD 318
Query: 188 SILDFNVSNNQLS 200
+ + + +N +
Sbjct: 319 RLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 18/137 (13%), Positives = 37/137 (27%), Gaps = 12/137 (8%)
Query: 87 LSRLTQLRLLSLKNNLLS-SSNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVD 144
L + + + + K + ++ P+ + S R + ++
Sbjct: 17 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLN 75
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
L+ E EI + L + N V + + + N LS +P
Sbjct: 76 LNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLP 133
Query: 205 AWMSPFGGSSFAGNKNL 221
F L
Sbjct: 134 R-------GIFHNTPKL 143
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 59/293 (20%), Positives = 112/293 (38%), Gaps = 60/293 (20%)
Query: 339 ELLGKGCVGATYKVVLDGGD----VVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
E++G+G G Y L D VK + EV ++L ++ H N++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 392 IRAYC-NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C + +V Y+ HG L + + + + AKG+ +L
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK----DLIGFGLQVAKGMKYL-- 144
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN-------------- 496
H L++ N ++D+ ++D G+ + + + Y+
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD----KEYYSVHNKTGAKLPVKWM 199
Query: 497 APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDES 555
A E L+ +KF + DV+SFGV+L E++T G + D +
Sbjct: 200 ALESLQT--------QKFTTKSDVWSFGVLLWELMT---------RGAPPY-----PDVN 237
Query: 556 AWEVFDFELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+++ + L+ + + + L +V L C P + RP+ S + I I
Sbjct: 238 TFDITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 62/301 (20%), Positives = 119/301 (39%), Gaps = 67/301 (22%)
Query: 339 ELLGKGCVGATYKVVLDGGDV---VVVKRIRERKKKREVDEWLR---VIGGL-RHSNIVS 391
+++G+G G K + + +KR++E K + ++ V+ L H NI++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR-----------LKLASD 440
+ C + L+L +Y PHG+L L SR P L A+D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 441 SAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN---- 496
A+G+ +L ++ H L++ NI+V + A I+D G+ + + Y
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTM 200
Query: 497 --------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWV 547
A E L + + DV+S+GV+L EI++ LG +
Sbjct: 201 GRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVS---------LGGTPYC 243
Query: 548 QMMGQDESAWEVFDFELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIED 604
M + E+++ L +E+ + + + C P +RP+ + + +
Sbjct: 244 GM-----TCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297
Query: 605 I 605
+
Sbjct: 298 M 298
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 59/271 (21%), Positives = 91/271 (33%), Gaps = 52/271 (19%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-ERKKKREVDEWLRVIGGL----RHSNIVS- 391
LG G G +KV + G + VKR + ++ L +G +H V
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+A+ G L+L + SL +P + D+ LA LH
Sbjct: 123 EQAWEEG-GILYLQTELC-GPSLQQHC--EAWGASLPEA--QVWGYLRDTLLALAHLHSQ 176
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA-----YNAPELKFNNNN 506
HL + +NI + G + D G+ T Y APEL
Sbjct: 177 GLVHL---DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL---LQG 230
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566
+Y DV+S G+ +LE+ GE W Q+ + +
Sbjct: 231 SYGTA-----ADVFSLGLTILEVACNMELPHGGEG----WQQL------------RQGYL 269
Query: 567 DKEMEE----EMRALLQVALLCLAPLPKDRP 593
E E+R++L + L P PK R
Sbjct: 270 PPEFTAGLSSELRSVLV---MMLEPDPKLRA 297
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 38/207 (18%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKRE-VDEWLRVIGGLRHSNIVSIRAYC- 396
+ +GKG G G V V K I+ + + E V+ LRHSN+V +
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAV-KCIKNDATAQAFLAE-ASVMTQLRHSNLVQLLGVIV 256
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
K L++V +Y+ GSL L R GR + + LK + D + + +L +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APELKFNN 504
H L++ N++V + A +SD G+ + +A + APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPE----- 356
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILT 531
++KF + DV+SFG++L EI +
Sbjct: 357 --ALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 58/287 (20%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKRE-VDEWLRVIGGLRHSNIVSIRAYC- 396
+ +GKG G G V V K I+ + + E V+ LRHSN+V +
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKVAV-KCIKNDATAQAFLAE-ASVMTQLRHSNLVQLLGVIV 84
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
K L++V +Y+ GSL L R GR + + LK + D + + +L +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 457 FHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE-LKFN 503
H L++ N++V + A +SD G +A + APE L+
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFG---------LTKEASSTQDTGKLPVKWTAPEALRE- 188
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563
+KF + DV+SFG++L EI + G V + ++ + +V
Sbjct: 189 -------KKFSTKSDVWSFGILLWEIYS---------FGRVPYPRIPLK-----DVVPR- 226
Query: 564 LIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
+ +M+ A+ +V C RP+ + +E I+T
Sbjct: 227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 32/154 (20%), Positives = 59/154 (38%), Gaps = 26/154 (16%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
+ +T A + ++ L L N LS S +L+ + L+ L LS N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
T + SL LR +DL++N + EL P++ TL +N + S +
Sbjct: 72 ETLD--LESLSTLRTLDLNNNY------VQELLVGPSIETLHAANNNISRVSCSRGQGKK 123
Query: 188 SILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+I ++NN+++ + +
Sbjct: 124 NI---YLANNKIT-MLRD-------LDEGCRSRV 146
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 29/148 (19%), Positives = 51/148 (34%), Gaps = 14/148 (9%)
Query: 75 LEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSG 133
L LDL + L + L NN +S ++ S K++YL++N+ T
Sbjct: 82 LRTLDLNNNYVQELLVGPSIETLHAANNNISR--VSCSRGQGKKNIYLANNKITMLRDLD 139
Query: 134 VSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFN 193
++ +DL N + L L L+ N V + LD
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD-- 197
Query: 194 VSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+S+N+L+ + F +
Sbjct: 198 LSSNKLA-FMGP--------EFQSAAGV 216
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 18/125 (14%), Positives = 43/125 (34%), Gaps = 9/125 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
LE L+L +V+ +L+ L L +N L+ S + + L +N+
Sbjct: 171 LEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV- 227
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188
+ ++L DL N + ++ + T+ + + + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 189 ILDFN 193
+ +
Sbjct: 288 LGHYG 292
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 26/122 (21%), Positives = 50/122 (40%), Gaps = 10/122 (8%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRV 143
E+ + ++ + ++ L + + S ++K L LS N + + ++ L +
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 144 DLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203
+LS N E +L L L TL L +N L SI + +NN +S ++
Sbjct: 64 NLSSNVLY-ETL--DLESLSTLRTLDLNNNYVQ-EL----LVGPSIETLHAANNNIS-RV 114
Query: 204 PA 205
Sbjct: 115 SC 116
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 20/109 (18%), Positives = 32/109 (29%), Gaps = 11/109 (10%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRF-T 127
L+ LDL+ E + +SL+NN L L +L+H L N F
Sbjct: 193 LKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC 251
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
GT S + ++ V ++
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 14/161 (8%), Positives = 40/161 (24%), Gaps = 6/161 (3%)
Query: 14 LFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKL 73
L L + + + F + + + + T + P+
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT----VPTLGHYGAY 294
Query: 74 VLEDLDLTGPAEVLS-RLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPS 132
EDL +++ + + LLS + + + + + ++
Sbjct: 295 CCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQ 354
Query: 133 GVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
+ ++ A + E L +
Sbjct: 355 VTLRKQAKITLEQKKKALD-EQVSNGRRAHAELDGTLQQAV 394
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 15/140 (10%), Positives = 38/140 (27%), Gaps = 11/140 (7%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT 127
LE DL G + S+ +++ ++ + + N +
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK-QTVKKLTGQNEEECTVPTLGHYGAYCCE 297
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIP---MTELTRLPNLLTLRLEDNRFTGTLYSVNS 184
L L+R + + + +G E + ++ + V
Sbjct: 298 DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTL 357
Query: 185 SSRSILDFNVSNNQLSGQIP 204
++ + L Q+
Sbjct: 358 RKQAKITLEQKKKALDEQVS 377
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 45/216 (20%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
++LG G G + + + V +K I ++ ++ IG L H++IV
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMP--VDWNKRLKLASDSAKGLAFL 448
+ C L LV YLP GSL + RG ++W AKG+ +L
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 131
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------ 496
+ + H +L++ N+++ ++D GV L +D
Sbjct: 132 E---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP----DDKQLLYSEAKTPIKWM 184
Query: 497 APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
A E + F K+ + DV+S+GV + E++T
Sbjct: 185 ALESIHF--------GKYTHQSDVWSYGVTVWELMT 212
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 31/155 (20%), Positives = 59/155 (38%), Gaps = 28/155 (18%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
+ +T A + ++ L L N LS S +L+ + L+ L LS N
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSS- 186
+ SL LR +DL++N + EL P++ TL +N + V+ S
Sbjct: 72 E--TLDLESLSTLRTLDLNNNY------VQELLVGPSIETLHAANNNIS----RVSCSRG 119
Query: 187 RSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+ + ++NN+++ + +
Sbjct: 120 QGKKNIYLANNKIT-MLRD-------LDEGCRSRV 146
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 29/148 (19%), Positives = 51/148 (34%), Gaps = 14/148 (9%)
Query: 75 LEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSG 133
L LDL + L + L NN +S ++ S K++YL++N+ T
Sbjct: 82 LRTLDLNNNYVQELLVGPSIETLHAANNNISR--VSCSRGQGKKNIYLANNKITMLRDLD 139
Query: 134 VSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFN 193
++ +DL N + L L L+ N V + LD
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD-- 197
Query: 194 VSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+S+N+L+ + F +
Sbjct: 198 LSSNKLA-FMGP--------EFQSAAGV 216
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 18/125 (14%), Positives = 43/125 (34%), Gaps = 9/125 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
LE L+L +V+ +L+ L L +N L+ S + + L +N+
Sbjct: 171 LEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV- 227
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188
+ ++L DL N + ++ + T+ + + + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 189 ILDFN 193
+ +
Sbjct: 288 LGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 26/122 (21%), Positives = 50/122 (40%), Gaps = 10/122 (8%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRV 143
E+ + ++ + ++ L + + S ++K L LS N + + ++ L +
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 144 DLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203
+LS N E +L L L TL L +N L SI + +NN +S ++
Sbjct: 64 NLSSNVLY-ETL--DLESLSTLRTLDLNNNYVQ-EL----LVGPSIETLHAANNNIS-RV 114
Query: 204 PA 205
Sbjct: 115 SC 116
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 49/283 (17%), Positives = 99/283 (34%), Gaps = 56/283 (19%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRI-------RERKK-KREVDEWLRVIGGLRHSNI 389
+G G G K+ G ++V K + E++ EV ++ L+H NI
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV----NLLRELKHPNI 67
Query: 390 VSIRA--YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
V L++V +Y G L S++ + +D L++ + L
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKE 126
Query: 448 LHGYNKAHLF--HGHLSSSNIVVDQLGNACISDIGVHQLFH-----------TPFFINDA 494
H + H L +N+ +D N + D G+ ++ + TP+
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY----- 181
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQD 553
Y +PE N +Y+++ D++S G +L E+ + + + G+
Sbjct: 182 YMSPEQM--NRMSYNEK-----SDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKF 233
Query: 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ +E+ ++ L RP++
Sbjct: 234 RRIPYRYS----------DELNEIIT---RMLNLKDYHRPSVE 263
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 48/293 (16%), Positives = 106/293 (36%), Gaps = 61/293 (20%)
Query: 339 ELLGKGCVGATYKVVLDGGDV----VVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
+LG+G G Y+ V V VK ++ ++++ ++ L H +IV
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ ++ +++ + P+G L L ++ ++ + + K +A+L
Sbjct: 78 LIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVL----TLVLYSLQICKAMAYL--- 129
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE 499
+ H ++ NI+V + D G+ + + ++ Y +PE
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGL-----SRYIEDEDYYKASVTRLPIKWMSPE 184
Query: 500 -LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558
+ F R+F DV+ F V + EIL+ G + + + +
Sbjct: 185 SINF--------RRFTTASDVWMFAVCMWEILS---------FGKQPFFWLENK-----D 222
Query: 559 VFDFELIMDKE-MEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
V ++ + + + L + C P DRP + + + D+
Sbjct: 223 V--IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 33/273 (12%), Positives = 77/273 (28%), Gaps = 40/273 (14%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEW--------LRVIGGLRHSNIV 390
LLG+G Y+ + K+ K ++ + W + + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ ++ LV + +G+L + ++ + + + A + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 451 YNKAH--------LFHGHLSSSNIVVDQLGNACISDIGV---------HQLFHTPFFIND 493
H + + D + D+G +F
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA-KCETS 249
Query: 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG-- 551
+ E+ +N ++ + D + + +L G K E G K +
Sbjct: 250 GFQCVEML--SNKPWN-----YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL 302
Query: 552 -QDESAWEVFDFELIMDK----EMEEEMRALLQ 579
+ E F L + + +R L+
Sbjct: 303 PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 49/293 (16%), Positives = 97/293 (33%), Gaps = 61/293 (20%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
+G+G G Y + V +K + +++L+ + H +IV
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ ++ ++++ + G L S L + + + A + LA+L
Sbjct: 81 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLA----SLILYAYQLSTALAYL--- 132
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE 499
H +++ N++V + D G+ + + + Y APE
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGL-----SRYMEDSTYYKASKGKLPIKWMAPE 187
Query: 500 -LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558
+ F R+F DV+ FGV + EIL G+ + + +
Sbjct: 188 SINF--------RRFTSASDVWMFGVCMWEILM---------HGVKPFQGVKNN-----D 225
Query: 559 VFDFELIMDKE-MEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
V I + E + L + C A P RP + + + I
Sbjct: 226 V--IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 63/318 (19%), Positives = 115/318 (36%), Gaps = 79/318 (24%)
Query: 339 ELLGKGCVGATYKVVLDGGD--------VVVVKRIRERKKKREVDEWLR------VIGGL 384
+ LG+G G G D V VK +++ ++++ + + +IG
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-- 98
Query: 385 RHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR---------- 434
+H NI+++ C L+++ +Y G+L L R PG R
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 435 -LKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND 493
+ A+G+ +L H L++ N++V + I+D G+ + + D
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----ID 211
Query: 494 AYN------------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE 540
Y APE L R + + DV+SFGV++ EI T
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFT--------- 254
Query: 541 LGIVKWVQMMGQDESAWEVFDFELIMDKEME------EEMRALLQVALLCLAPLPKDRPN 594
LG + + E+F L M+ E+ ++ C +P RP
Sbjct: 255 LGGSPYPGI-----PVEELFKL-LKEGHRMDKPANCTNELYMMM---RDCWHAVPSQRPT 305
Query: 595 MSIVHRMIEDIRTKGSID 612
+ ++ I T + +
Sbjct: 306 FKQLVEDLDRILTLTTNE 323
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 60/314 (19%), Positives = 119/314 (37%), Gaps = 67/314 (21%)
Query: 339 ELLGKGCVGATYKVVLDGGD----VVVVKRIRER-KKKREVDEWLR---VIGGLRHSNIV 390
+LGKG G+ + L D V VK ++ +++E+LR + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 391 SIRAYC------NGKDELFLVYDYLPHGSLHSLLHGSRGPGR-MPVDWNKRLKLASDSAK 443
+ ++ ++ HG LH+ L SR + ++ D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 444 GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------- 496
G+ +L + + H L++ N ++ + C++D G+ + ++ D Y
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS----GDYYRQGCASKL 201
Query: 497 -----APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM 550
A E L N + DV++FGV + EI+T G + +
Sbjct: 202 PVKWLALESLADN--------LYTVHSDVWAFGVTMWEIMT---------RGQTPYAGI- 243
Query: 551 GQDESAWEVFDFELIMDKEME------EEMRALLQVALLCLAPLPKDRPNMSIVHRMIED 604
E++++ LI ++ EE+ L+ C + PK RP+ + + +E+
Sbjct: 244 ----ENAEIYNY-LIGGNRLKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMELEN 295
Query: 605 IRTKGSIDGCANSI 618
I S+ +
Sbjct: 296 ILGHLSVLSTSQDP 309
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 60/293 (20%)
Query: 339 ELLGKGCVGATYKVVLDGGD----VVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
E++G+G G Y L D VK + EV ++L ++ H N++S
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 392 IRAYCNGKDE-LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C + +V Y+ HG L + + + + AKG+ FL
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK----DLIGFGLQVAKGMKFL-- 208
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN-------------- 496
H L++ N ++D+ ++D G+ + + + +
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD----KEFDSVHNKTGAKLPVKWM 263
Query: 497 APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDES 555
A E L+ +KF + DV+SFGV+L E++T G + D +
Sbjct: 264 ALESLQT--------QKFTTKSDVWSFGVLLWELMT---------RGAPPY-----PDVN 301
Query: 556 AWEVFDFELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+++ + L+ + + + L +V L C P + RP+ S + I I
Sbjct: 302 TFDITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 29/151 (19%), Positives = 56/151 (37%), Gaps = 20/151 (13%)
Query: 75 LEDLDLTG----PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
L L L L+ LT L + N ++ +++ L L + +N+ T
Sbjct: 179 LYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDIT-PVANMTRLNSLKIGNNKITDL- 236
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
S +++L L +++ N + + L L L + N+ + SV ++ +
Sbjct: 237 -SPLANLSQLTWLEIGTNQISD---INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLN 290
Query: 191 DFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
++NNQL + G NL
Sbjct: 291 SLFLNNNQLGNEDM--------EVIGGLTNL 313
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 30/130 (23%), Positives = 51/130 (39%), Gaps = 10/130 (7%)
Query: 75 LEDLDLTGPA----EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
L L + L+ L+QL L + N +S N + LK L + N+ +
Sbjct: 223 LNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISD-- 279
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
S +++L L + L++N E + L NL TL L N T +S +
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDM-EVIGGLTNLTTLFLSQNHITD--IRPLASLSKMD 336
Query: 191 DFNVSNNQLS 200
+ +N +
Sbjct: 337 SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 7e-12
Identities = 28/135 (20%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 75 LEDLDL-----TGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT 129
L +L L + L+ LT++ L+L N S LS+ L +L ++ ++
Sbjct: 112 LRELYLNEDNISDI-SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD- 169
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189
+ +++L L + L++N E P L L +L N+ T + ++ +
Sbjct: 170 -VTPIANLTDLYSLSLNYNQIEDISP---LASLTSLHYFTAYVNQITDI--TPVANMTRL 223
Query: 190 LDFNVSNNQLSGQIP 204
+ NN+++ P
Sbjct: 224 NSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 30/142 (21%), Positives = 59/142 (41%), Gaps = 16/142 (11%)
Query: 75 LEDLDLTGPA----EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
+ L + G + + LT L L+L N ++ + LS+ L +LY+ N+ T
Sbjct: 46 ITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDIS-PLSNLVKLTNLYIGTNKITD-- 102
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
S + +L +LR + L+ + P L L + +L L N L + S+ +
Sbjct: 103 ISALQNLTNLRELYLNEDNISDISP---LANLTKMYSLNLGANHNLSDLSPL-SNMTGLN 158
Query: 191 DFNVSNNQLSGQIPAWMSPFGG 212
V+ +++ ++P
Sbjct: 159 YLTVTESKVKD-----VTPIAN 175
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 17/115 (14%), Positives = 43/115 (37%), Gaps = 8/115 (6%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
+ L + L+ ++ + + L ++ + G+ L +L ++L+
Sbjct: 18 DADLAEGIRAVLQKASVTDV-VTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLN 74
Query: 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201
N P L+ L L L + N+ T S + ++ + ++ + +S
Sbjct: 75 GNQITDISP---LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 16/111 (14%), Positives = 33/111 (29%), Gaps = 11/111 (9%)
Query: 90 LTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149
L L N + + L T L + ++ ++
Sbjct: 2 AATLATLPAPINQIF----PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEK 55
Query: 150 YEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
+ + L NL L L N+ T S S+ + + + N+++
Sbjct: 56 VAS---IQGIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKIT 101
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 57/308 (18%), Positives = 108/308 (35%), Gaps = 74/308 (24%)
Query: 339 ELLGKGCVG----ATYKVVLDGGD--VVVVKRIRERKKKREVDEWLR---VIGGLRHSNI 389
E LG+ G G V +K ++++ + +E+ + L+H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR-----------LKLA 438
V + L +++ Y HG LH L + + R + L
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 439 SDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYN- 496
+ A G+ +L + H+ H L++ N++V ISD+G+ + + D Y
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYD-KLNVKISDLGLFREVYA----ADYYKL 186
Query: 497 -----------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV 544
APE + + KF D++S+GVVL E+ + G+
Sbjct: 187 LGNSLLPIRWMAPEAIMY--------GKFSIDSDIWSYGVVLWEVFS---------YGLQ 229
Query: 545 KWVQMMGQDESAWEVFDFELIMDKEME------EEMRALLQVALLCLAPLPKDRPNMSIV 598
+ S +V + + + + + AL+ + C P RP +
Sbjct: 230 PYCGY-----SNQDVVEM-IRNRQVLPCPDDCPAWVYALM---IECWNEFPSRRPRFKDI 280
Query: 599 HRMIEDIR 606
H +
Sbjct: 281 HSRLRAWG 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 34/211 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-ERKKKREVDEWL---RVIGGLRHSNIVSIR 393
+ +G+G G V + G V+K I R +E +E V+ ++H NIV R
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
L++V DY G L ++ +G + ++ L L +H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH---D 143
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-----------TPFFINDAYNAPELKF 502
+ H + S NI + + G + D G+ ++ + TP+ Y +PE+
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY-----YLSPEIC- 197
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
N Y+ + D+++ G VL E+ T K
Sbjct: 198 -ENKPYN-----NKSDIWALGCVLYELCTLK 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 50/297 (16%), Positives = 100/297 (33%), Gaps = 61/297 (20%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
+G+G G Y + V +K + +++L+ + H +IV
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ ++ ++++ + G L S L + +D + A + LA+L
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYL--- 507
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE 499
H +++ N++V + D G+ + + + Y APE
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGL-----SRYMEDSTYYKASKGKLPIKWMAPE 562
Query: 500 -LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558
+ F R+F DV+ FGV + EIL G+ + + +
Sbjct: 563 SINF--------RRFTSASDVWMFGVCMWEILM---------HGVKPFQGVKNN-----D 600
Query: 559 VFDFELIMDKE-MEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611
V I + E + L + C A P RP + + + I + +
Sbjct: 601 V--IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKL 655
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 51/223 (22%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-ERKK-KREVDEWLRVIGGLRHSNIV----- 390
EL+G G G +K G V+KR++ +K +REV + + L H NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREV----KALAKLDHVNIVHYNGC 72
Query: 391 -----------SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS 439
S + + LF+ ++ G+L + RG +D L+L
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFE 129
Query: 440 DSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-----HQLFH-----TPF 489
KG+ ++H L + L SNI + I D G+ + T
Sbjct: 130 QITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR 186
Query: 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
Y +PE ++ +Y + D+Y+ G++L E+L
Sbjct: 187 -----YMSPEQI--SSQDYGKE-----VDLYALGLILAELLHV 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 60/289 (20%), Positives = 106/289 (36%), Gaps = 56/289 (19%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRAY 395
+ LG G G G V VK I+E DE+ + + L H +V
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
C+ + +++V +Y+ +G L + L L++ D +G+AFL
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ----LLEMCYDVCEGMAFL---ESHQ 124
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE-LKF 502
H L++ N +VD+ +SD G+ + +D Y APE +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL-----DDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562
K+ + DV++FG+++ E+ + LG + + EV
Sbjct: 180 --------FKYSSKSDVWAFGILMWEVFS---------LGKMPYDLYTNS-----EVVLK 217
Query: 563 ELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608
+ + + Q+ C LP+ RP + IE +R K
Sbjct: 218 -VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 48/320 (15%), Positives = 102/320 (31%), Gaps = 60/320 (18%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
++LG G G + + + V +K +RE + E L V+ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C + L+ +P G L + + + L AKG+ +L
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYLE- 134
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------AP 498
L H L++ N++V + I+D G+ +L + A
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA----EEKEYHAEGGKVPIKWMAL 188
Query: 499 E-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557
E + R + + DV+S+GV + E++T G + +
Sbjct: 189 ESILH--------RIYTHQSDVWSYGVTVWELMT---------FGSKPYDGIPAS----- 226
Query: 558 EVFDFELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDI-RTKGSIDG 613
E+ L + + + + + + C RP + + R
Sbjct: 227 EISSI-LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285
Query: 614 CANSIMNNISSDSSPSQSEN 633
++ S + +
Sbjct: 286 IQGDERMHLPSPTDSNFYRA 305
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 36/231 (15%), Positives = 75/231 (32%), Gaps = 55/231 (23%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR--------ERKKKREVDEWLRVIGGLRHSNI 389
E +G G G+ +K V G + +KR + E+ REV V+G +HS++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA-HAVLG--QHSHV 73
Query: 390 VS-IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
V A+ D + + +Y GSL + + + L +GL ++
Sbjct: 74 VRYFSAWAED-DHMLIQNEYCNGGSLADAISENYRIMS-YFKEAELKDLLLQVGRGLRYI 131
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---------------------- 486
H + H+ + SNI + + + +
Sbjct: 132 HSMSLVHM---DIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 487 ----TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ A E+ N + + D+++ + ++ +
Sbjct: 189 VEEGDSR-----FLANEV-LQENYTHL-----PKADIFALALTVVCAAGAE 228
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 29/107 (27%), Positives = 34/107 (31%), Gaps = 10/107 (9%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L+ L L P + L L L L N +SS L L L NR
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
L L + L N +P L L L LRL DN
Sbjct: 191 -HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 31/140 (22%), Positives = 42/140 (30%), Gaps = 21/140 (15%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYL 121
LE LDL+ L +L L L L L L++LYL
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL-----AALQYLYL 136
Query: 122 SHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLY 180
N P L +L + L N +P L +L L L NR
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 181 SVNSSSRSILDFNVSNNQLS 200
++ + N LS
Sbjct: 195 HAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 24/110 (21%), Positives = 37/110 (33%), Gaps = 9/110 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
+ + L G PA L +L L +N+L+ + L+ L LS N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
+ L L + L + E+ L L L L+DN
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 19/88 (21%), Positives = 32/88 (36%), Gaps = 3/88 (3%)
Query: 91 TQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHN 148
+ + L N +S + + +L L+L N + + L L ++DLS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90
Query: 149 AYEGEIPMTELTRLPNLLTLRLEDNRFT 176
A + L L TL L+
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 62/302 (20%), Positives = 122/302 (40%), Gaps = 66/302 (21%)
Query: 339 ELLGKGCVGATYKVVLDGGD----VVVVKRIR-ERKKKREVDEWLR---VIGGLRHSNIV 390
++LG+G G+ + L D V VK ++ + +RE++E+L + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 391 SIRAYC-----NGKDELFLVYDYLPHGSLHSLLHGSR-GPGRMPVDWNKRLKLASDSAKG 444
+ C G + ++ ++ +G LH+ L SR G + LK D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN-------- 496
+ +L + + H L++ N ++ C++D G+ + ++ D Y
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS----GDYYRQGRIAKMP 212
Query: 497 ----APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG 551
A E L R + + DV++FGV + EI T G+ + +
Sbjct: 213 VKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIAT---------RGMTPYPGV-- 253
Query: 552 QDESAWEVFDFELIMDKEME------EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
E++D+ L+ ++ +E+ ++ C P DRP S++ +E +
Sbjct: 254 ---QNHEMYDY-LLHGHRLKQPEDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLEKL 306
Query: 606 RT 607
Sbjct: 307 LE 308
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 55/293 (18%), Positives = 116/293 (39%), Gaps = 61/293 (20%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
+++G G G K +V V +K ++ +++ ++L ++G H NI+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ + + ++ +Y+ +G+L L G + + + + A G+ +L
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL----QLVGMLRGIAAGMKYL-- 163
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYN------------A 497
+ H L++ NI+V+ C +SD G+ ++ +A A
Sbjct: 164 -ANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLED---DPEATYTTSGGKIPIRWTA 218
Query: 498 PE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA 556
PE + + RKF DV+SFG+V+ E++T G + ++
Sbjct: 219 PEAISY--------RKFTSASDVWSFGIVMWEVMT---------YGERPYWELSNH---- 257
Query: 557 WEVFDFELIMDKE-MEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
EV + I D + M A+ Q+ + C RP + + +++ +
Sbjct: 258 -EV--MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 64/322 (19%), Positives = 115/322 (35%), Gaps = 87/322 (27%)
Query: 339 ELLGKGCVGATYKVVLDGGD--------VVVVKRIRERKKKREVDEWLR------VIGGL 384
+ LG+GC G G D V VK +++ ++++ + + +IG
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-- 144
Query: 385 RHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR---------- 434
+H NI+++ C L+++ +Y G+L L R PG R
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 435 -LKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG----VHQLFHTPF 489
+ A+G+ +L H L++ N++V + I+D G ++
Sbjct: 205 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN------ 255
Query: 490 FINDAYN------------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536
D Y APE L R + + DV+SFGV++ EI T
Sbjct: 256 --IDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFT----- 300
Query: 537 GDGELGIVKWVQMMGQDESAWEVFDFELIMDKEME------EEMRALLQVALLCLAPLPK 590
LG + + E+F L M+ E+ ++ C +P
Sbjct: 301 ----LGGSPYPGI-----PVEELFKL-LKEGHRMDKPANCTNELYMMM---RDCWHAVPS 347
Query: 591 DRPNMSIVHRMIEDIRTKGSID 612
RP + ++ I T + +
Sbjct: 348 QRPTFKQLVEDLDRILTLTTNE 369
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-13
Identities = 24/122 (19%), Positives = 54/122 (44%), Gaps = 7/122 (5%)
Query: 79 DLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLR 138
DLTG + ++ L++ N ++ N +S +L+ L + T +S L
Sbjct: 58 DLTG----IEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLT 112
Query: 139 HLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQ 198
L +D+SH+A++ + +T++ LP + ++ L N + + + N+ +
Sbjct: 113 SLTLLDISHSAHD-DSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG 170
Query: 199 LS 200
+
Sbjct: 171 VH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 27/128 (21%), Positives = 48/128 (37%), Gaps = 25/128 (19%)
Query: 75 LEDLDLTG----PAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGT 129
++DL + +S L+ L L + ++S + NLS L L +SH+ +
Sbjct: 68 IKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIP----MTELTRL----------------PNLLTLR 169
+ +++L + +DLS+N +I + EL L P L L
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLY 187
Query: 170 LEDNRFTG 177
G
Sbjct: 188 AFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 20/151 (13%), Positives = 54/151 (35%), Gaps = 14/151 (9%)
Query: 72 KLVLEDLDLTGPAEV-LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
+ L + A + +++ L ++L N ++ + ++K L +++ T
Sbjct: 24 AYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNY- 81
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
+ +S L +L R+ + + L+ L +L L + + ++ + ++ +
Sbjct: 82 -NPISGLSNLERLRIMGKDVTSDKI-PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
Query: 191 DFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
++S N I L
Sbjct: 140 SIDLSYNGAITDI---------MPLKTLPEL 161
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 31/111 (27%), Positives = 41/111 (36%), Gaps = 10/111 (9%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW---PHLKHLYLSHNR 125
L+L P V +LTQL LSL +N LS S LK+L LS N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 126 FTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
T S L L +D H+ + + L NL+ L +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 139
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 27/139 (19%), Positives = 50/139 (35%), Gaps = 18/139 (12%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN--LSSWPHLKHLYLSHNRF 126
L LD++ + + L+ L +L + N + L + +L L LS +
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT----GTLYS 181
+SL L+ +++SHN + + L +L L N L
Sbjct: 188 E-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245
Query: 182 VNSSSRSILDFNVSNNQLS 200
SS + N++ N +
Sbjct: 246 FPSSLAFL---NLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 28/158 (17%), Positives = 55/158 (34%), Gaps = 22/158 (13%)
Query: 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSS-------SNLNLSSWPHLKHLYLSHN 124
L L + + L QL L +++ L +L +L +L +SH
Sbjct: 82 YLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL-----RNLIYLDISHT 136
Query: 125 RFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN 183
+G+ + L L + ++ N+++ T L NL L L + +
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195
Query: 184 SSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
+S S+ N+S+N + + +L
Sbjct: 196 NSLSSLQVLNMSHNNFF-SLDT-------FPYKCLNSL 225
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 23/122 (18%), Positives = 38/122 (31%), Gaps = 14/122 (11%)
Query: 106 SNLNLSSWP-----HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA-YEGEIPMTEL 159
++ L+S P L L N+ L L ++ LS N
Sbjct: 15 NSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSD 74
Query: 160 TRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNK 219
+L L L N T+ S + + ++ L Q+ + S F +
Sbjct: 75 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF------SVFLSLR 126
Query: 220 NL 221
NL
Sbjct: 127 NL 128
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 28/145 (19%), Positives = 51/145 (35%), Gaps = 17/145 (11%)
Query: 62 TCNPSTHRVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHL 119
+C+ + + LT P + S T+L L++N L S + L L
Sbjct: 6 SCSGTE-----IRCNSKGLTSVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKL 57
Query: 120 YLSHNRFT-GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG 177
LS N + S L+ +DLS N + L L L + +
Sbjct: 58 SLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLK- 114
Query: 178 TLYSVN--SSSRSILDFNVSNNQLS 200
+ + S R+++ ++S+
Sbjct: 115 QMSEFSVFLSLRNLIYLDISHTHTR 139
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 57/287 (19%), Positives = 105/287 (36%), Gaps = 50/287 (17%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
+++G G G +V V +K ++ +R+ ++L ++G H NI+
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ +V +Y+ +GSL + L G + + + G+ +L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYL--- 167
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE 499
+ H L++ N++VD +SD G+ ++ DA APE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD---PDAAYTTTGGKIPIRWTAPE 224
Query: 500 -LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558
+ F R F DV+SFGVV+ E+L G + M +D
Sbjct: 225 AIAF--------RTFSSASDVWSFGVVMWEVLA---------YGERPYWNMTNRD--VIS 265
Query: 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ + AL Q+ L C RP S + +++ +
Sbjct: 266 SVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 31/120 (25%), Positives = 49/120 (40%), Gaps = 25/120 (20%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYLS 122
L LDL+ + S L L +L L NN + ++ L+ LYLS
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM-----AQLQKLYLS 144
Query: 123 HNRFT----GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNL--LTLRLEDNRFT 176
N+ + + L L +DLS N + ++P+T+L +LP L L +N
Sbjct: 145 QNQISRFPVELI-KDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 31/140 (22%), Positives = 52/140 (37%), Gaps = 19/140 (13%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L L L+ +E + LR L L +N L + S L+ L L +N
Sbjct: 66 LHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV 125
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPM---TELTRLPNLLTLRLEDNRFT----GTL 179
+ L+++ LS N P+ + +LP L+ L L N+ L
Sbjct: 126 -VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183
Query: 180 YSVNSSSRSILDFNVSNNQL 199
+ + ++ L + NN L
Sbjct: 184 QKLPAWVKNGLYLH--NNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 37/175 (21%), Positives = 63/175 (36%), Gaps = 27/175 (15%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYL 121
LDL+ +RLT L L L +N L+ + P+L++L L
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPV-----PNLRYLDL 95
Query: 122 SHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT---- 176
S N T + S L+ L + L +N + + L L L N+ +
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPV 153
Query: 177 GTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCS 231
+ N ++ ++S+N+L ++P + L PL DC
Sbjct: 154 ELIKDGNKLP-KLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 23/113 (20%), Positives = 40/113 (35%), Gaps = 13/113 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT- 127
L L L+ L+ LR L L NN L L+ +++ +YL +N +
Sbjct: 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 277
Query: 128 ---GTF--PSGVSSLRHLRRVDLSHNAYE-GEIPMTELTRLPNLLTLRLEDNR 174
F P + V L N + EI + + ++L + +
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 23/135 (17%), Positives = 51/135 (37%), Gaps = 14/135 (10%)
Query: 75 LEDLDLTG--------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRF 126
+ ++L + +L + + + +++ + P L L+L N+
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT--IPQGLPPSLTELHLDGNKI 204
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSS 185
T + L +L ++ LS N+ + L P+L L L +N+ + +
Sbjct: 205 T-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
Query: 186 SRSILDFNVSNNQLS 200
+ I + NN +S
Sbjct: 262 HKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 32/168 (19%)
Query: 62 TCNPSTHRVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHL 119
C+ + DL L P ++ L L+NN ++ + + + +L L
Sbjct: 30 QCHLRV-----VQCSDLGLEKVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTL 81
Query: 120 YLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP-----NLLTLRLEDNR 174
L +N+ + P + L L R+ LS N +L LP L LR+ +N
Sbjct: 82 ILINNKISKISPGAFAPLVKLERLYLSKN---------QLKELPEKMPKTLQELRVHENE 132
Query: 175 FTGTLYSVNSSSRSILDFNVSNNQL-SGQIPAWMSPFGGSSFAGNKNL 221
T SV + ++ + N L S I +F G K L
Sbjct: 133 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN-------GAFQGMKKL 173
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 32/134 (23%), Positives = 56/134 (41%), Gaps = 17/134 (12%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L+ L+L E L L++L+L NLL + N P + ++ L N
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
L L+ +DL NA +T + +P++ + L N+ TL +N ++
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNA------LTTIHFIPSIPDIFLSGNKLV-TLPKINLTAN 404
Query: 188 SILDFNVSNNQLSG 201
I ++S N+L
Sbjct: 405 LI---HLSENRLEN 415
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 28/137 (20%), Positives = 46/137 (33%), Gaps = 12/137 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSS--NLNLSSWPHLKHLYLSHNRF 126
E L L+ A L QL+LL L + + + P+L+ L L ++
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNA-YEGEIPMTELTRLPNLLTLRLEDNRFTG-TLYSVN 183
L HL + L + + L L L L N+ L+
Sbjct: 86 Y-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSF 144
Query: 184 SSSRSILDFNVSNNQLS 200
S+ + S+NQ+
Sbjct: 145 GKLNSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 26/141 (18%), Positives = 49/141 (34%), Gaps = 12/141 (8%)
Query: 85 EVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRR 142
+V L L L N + + + + L+ L L T +L +LR
Sbjct: 18 QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRI 77
Query: 143 VDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN--SSSRSILDFNVSNNQLS 200
+DL + + L +L LRL + + + +++ ++S NQ+
Sbjct: 78 LDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
Query: 201 GQIPAWMSPFGGSSFAGNKNL 221
S + SF +L
Sbjct: 137 -------SLYLHPSFGKLNSL 150
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 25/166 (15%), Positives = 59/166 (35%), Gaps = 10/166 (6%)
Query: 44 LSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTG------PAEVLSRL--TQLRL 95
+S + D + ++ + + ++ + + L + +R
Sbjct: 211 VSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 96 LSLKNNLLSSSNLNLSSW-PHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEI 154
L L + + S N + LK L L++N+ L +L+ ++LS+N E+
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-EL 329
Query: 155 PMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
+ LP + + L+ N + ++ +N L+
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 48/236 (20%), Positives = 80/236 (33%), Gaps = 38/236 (16%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW------PHLKHLYL 121
L+ L L + S L L L N+L + W HL+ LYL
Sbjct: 428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487
Query: 122 SHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYS 181
+HN P S L LR + L+ N + +L NL L + N+ +
Sbjct: 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL--PANLEILDISRNQLL----A 540
Query: 182 VNSSSRSILD-FNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCSN-------- 232
N L ++++N+ + +S F N + G P C
Sbjct: 541 PNPDVFVSLSVLDITHNKFICECE--LSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVS 598
Query: 233 -RTVEPEQPPRSRPRSSRVVTVIVIVIFDAVAILVAVVTVT------WCCYKRKRR 281
++ E S ++ ++ L+ ++TVT + CYK +R
Sbjct: 599 LFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQR 654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 23/129 (17%), Positives = 35/129 (27%), Gaps = 10/129 (7%)
Query: 97 SLKNNLLSSSNLNLSS----WPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEG 152
S + NL+ + L LS N S L L+ ++L
Sbjct: 3 SFDGRIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 153 EIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGG 212
I LPNL L L ++ + + + LS +
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV------LKD 116
Query: 213 SSFAGNKNL 221
F K L
Sbjct: 117 GYFRNLKAL 125
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 23/136 (16%), Positives = 42/136 (30%), Gaps = 12/136 (8%)
Query: 75 LEDLDLTG--------PAEVLSRLTQLRLLSLKNNLLSSSNLN--LSSWPHLKHLYLSHN 124
L +L L L L L L N + S L+ LK + S N
Sbjct: 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158
Query: 125 RFTGTFPSGVSSLR--HLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSV 182
+ + L+ L L+ N+ + + + + LE +G ++V
Sbjct: 159 QIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTV 218
Query: 183 NSSSRSILDFNVSNNQ 198
+ + + S
Sbjct: 219 DITGNFSNAISKSQAF 234
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 40/214 (18%), Positives = 75/214 (35%), Gaps = 43/214 (20%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-ERKKKREVDEWLRVIGGLRHSNIVSIRAYC 396
+G+G G +++ G VK++R E + E+ GL IV +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV----ACAGLSSPRIVPLYGAV 119
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
+ + + L GSL L+ + G +P D + +GL +LH
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRAL--YYLGQALEGLEYLHTRRIL-- 172
Query: 457 FHGHLSSSNIVVDQLGNAC-ISDIGV----------------HQLFHTPFFINDAYNAPE 499
HG + + N+++ G+ + D G + T + APE
Sbjct: 173 -HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-----HMAPE 226
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ + D++S ++L +L G
Sbjct: 227 VV--MGKPCD-----AKVDIWSSCCMMLHMLNGC 253
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 30/135 (22%), Positives = 56/135 (41%), Gaps = 10/135 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFT 127
++ LDL+ L L++L LK++ +++ + S L+HL LS N +
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLED-NRFTGTLYSVNSS 185
+ S L L+ ++L N Y+ + L NL TLR+ + F+ +
Sbjct: 88 -SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 186 SRSILDFNVSNNQLS 200
S+ + + L
Sbjct: 147 LTSLNELEIKALSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 20/136 (14%), Positives = 44/136 (32%), Gaps = 10/136 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS--SNLNLSSWPHLKHLYLSHNRF 126
LE LDL+ + L+ L+ L+L N + + +L+ L + +
Sbjct: 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSS 185
+ L L +++ + L + ++ L L + L
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194
Query: 186 SRSILDFNVSNNQLSG 201
S+ + + L+
Sbjct: 195 LSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 25/143 (17%), Positives = 47/143 (32%), Gaps = 18/143 (12%)
Query: 79 DLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLR 138
+ E+L L L L + N + ++ L LS + + +
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQ 431
Query: 139 HLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQ 198
L +D+S+N + + LP L L + N+ + ++ +S NQ
Sbjct: 432 TLEVLDVSNNNLD-SFSL----FLPRLQELYISRNKLKTLPDASLFPVLLVMK--ISRNQ 484
Query: 199 LSGQIPAWMSPFGGSSFAGNKNL 221
L +P F +L
Sbjct: 485 LK-SVPD-------GIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 28/162 (17%), Positives = 58/162 (35%), Gaps = 13/162 (8%)
Query: 64 NPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSH 123
+ S + ++KL+ L+L+ L L + + + S + + ++ L++
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET-VTIRRLHIPQ 295
Query: 124 NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN 183
+ S L ++R+ + ++ +P + L +L L L +N Y N
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV-EEYLKN 353
Query: 184 SSSRSILD----FNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
S+ + +S N L G KNL
Sbjct: 354 SACKGAWPSLQTLVLSQNHLR------SMQKTGEILLTLKNL 389
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 21/109 (19%), Positives = 38/109 (34%), Gaps = 3/109 (2%)
Query: 92 QLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151
+ ++ +S L+ +K L LS N+ T + + +L+ + L +
Sbjct: 6 ASGVCDGRSRSFTSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 152 GEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
I L +L L L DN + S S+ N+ N
Sbjct: 64 -TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 19/127 (14%), Positives = 43/127 (33%), Gaps = 1/127 (0%)
Query: 86 VLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145
VL+ + LL L +L S + + + G +RR+ +
Sbjct: 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293
Query: 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA 205
Y T + L + + +E+++ S + +S+ ++S N + +
Sbjct: 294 PQF-YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 206 WMSPFGG 212
+ G
Sbjct: 353 NSACKGA 359
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 37/132 (28%), Positives = 55/132 (41%), Gaps = 14/132 (10%)
Query: 75 LEDLDL-----TGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT 129
L++L L L+ LT L L L NN +S+ LS L L L N+ +
Sbjct: 223 LDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNI 280
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189
S ++ L L ++L+ N E P ++ L NL L L N + S SS +
Sbjct: 281 --SPLAGLTALTNLELNENQLEDISP---ISNLKNLTYLTLYFNNISDI--SPVSSLTKL 333
Query: 190 LDFNVSNNQLSG 201
NN++S
Sbjct: 334 QRLFFYNNKVSD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 17/136 (12%)
Query: 75 LEDLDL-----TGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTG 128
L L+L + LS LT L+ LS N + L NL++ L+ L +S N+ +
Sbjct: 136 LNRLELSSNTISDI-SALSGLTSLQQLSFGNQVTDLKPLANLTT---LERLDISSNKVSD 191
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188
S ++ L +L + ++N P L L NL L L N+ +S +
Sbjct: 192 --ISVLAKLTNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKDI--GTLASLTN 244
Query: 189 ILDFNVSNNQLSGQIP 204
+ D +++NNQ+S P
Sbjct: 245 LTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 27/132 (20%), Positives = 54/132 (40%), Gaps = 9/132 (6%)
Query: 70 VIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT 129
+K VL ++T + L Q+ L + S + + +L + S+N+ T
Sbjct: 26 KMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTD- 82
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189
+ + +L L + +++N P L L NL L L +N+ T + ++
Sbjct: 83 -ITPLKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFNNQITDI--DPLKNLTNL 136
Query: 190 LDFNVSNNQLSG 201
+S+N +S
Sbjct: 137 NRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 28/133 (21%), Positives = 52/133 (39%), Gaps = 10/133 (7%)
Query: 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFP 131
L + L + + + L L ++ NN L+ L + L + +++N+
Sbjct: 50 TLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIAD--I 105
Query: 132 SGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILD 191
+ +++L +L + L +N P L L NL L L N + +S L
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDP---LKNLTNLNRLELSSNTISDISALSGLTSLQQLS 162
Query: 192 FNVSNNQLSGQIP 204
F NQ++ P
Sbjct: 163 F---GNQVTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 20/118 (16%), Positives = 45/118 (38%), Gaps = 8/118 (6%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
+ L + L ++ + ++ + + L GV L +L +++ S
Sbjct: 20 DTALAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 76
Query: 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
+N P L L L+ + + +N+ N ++ + L + NNQ++ P
Sbjct: 77 NNQLTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLT--LFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 15/113 (13%), Positives = 35/113 (30%), Gaps = 12/113 (10%)
Query: 97 SLKNNLLSSSNL-----NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151
L + ++ ++ L T T + L + + +
Sbjct: 2 PLGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 152 GEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
+ + L NL + +N+ T N + + ++NNQ++ P
Sbjct: 60 S---IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDIL--MNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-07
Identities = 19/135 (14%), Positives = 44/135 (32%), Gaps = 11/135 (8%)
Query: 75 LEDLDL-----TGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT 129
L+ L + L+ LT + LS +N +S L++ + L L+ +T
Sbjct: 333 LQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLT-PLANLTRITQLGLNDQAWTNA 390
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189
+ +++ + N I ++ + + N + V+ +
Sbjct: 391 PVNYKANVSIP---NTVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQP 446
Query: 190 LDFNVSNNQLSGQIP 204
+ SG +
Sbjct: 447 VTIGKGTTTFSGTVT 461
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 68/325 (20%), Positives = 115/325 (35%), Gaps = 96/325 (29%)
Query: 339 ELLGKGCVGATYK-----VVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNI 389
+ LG+G G K + G V VK ++E E+ + L V+ + H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR--------------- 434
+ + C+ L L+ +Y +GSL L SR G +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 435 ----LKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG----VHQLFH 486
+ A ++G+ +L + L H L++ NI+V + ISD G V++
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE--- 202
Query: 487 TPFFINDAYN------------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
D+Y A E L + + DV+SFGV+L EI+T
Sbjct: 203 -----EDSYVKRSQGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVLLWEIVT-- 247
Query: 534 MAKGDGELGIVKWVQMMGQDESAWEVFDFELI----MDK------EMEEEMRALLQVALL 583
LG + + +F+ L M++ EM M
Sbjct: 248 -------LGGNPYPGI-----PPERLFNL-LKTGHRMERPDNCSEEMYRLMLQ------- 287
Query: 584 CLAPLPKDRPNMSIVHRMIEDIRTK 608
C P RP + + + +E + K
Sbjct: 288 CWKQEPDKRPVFADISKDLEKMMVK 312
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 60/322 (18%), Positives = 124/322 (38%), Gaps = 61/322 (18%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
+++G G G K+ V +K ++ +++ ++L ++G H NI+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ + +V +Y+ +GSL S L + + + A G+ +L
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYL--- 163
Query: 452 NKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLFHTPFFINDAYN------------AP 498
+ H L++ NI+++ C +SD G+ ++ +A +P
Sbjct: 164 SDMGYVHRDLAARNILINS-NLVCKVSDFGLGRVLE---DDPEAAYTTRGGKIPIRWTSP 219
Query: 499 E-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557
E + + RKF DV+S+G+VL E+++ G + +M Q
Sbjct: 220 EAIAY--------RKFTSASDVWSYGIVLWEVMS---------YGERPYWEMSNQ----- 257
Query: 558 EVFDFELIMDKE-MEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIED-IRTKGSID 612
+V + + + + M AL Q+ L C +RP + +++ IR GS+
Sbjct: 258 DV--IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLK 315
Query: 613 GCANSIMNNISSDSSPSQSENT 634
++ + S + T
Sbjct: 316 IITSAAARPSNLLLDQSNVDIT 337
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 8e-13
Identities = 30/135 (22%), Positives = 48/135 (35%), Gaps = 3/135 (2%)
Query: 42 DSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNN 101
D + + V L L DLT L +L + L L +N
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHN 473
Query: 102 LLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTR 161
L + L++ L+ L S N GV++L L+ + L +N + + L
Sbjct: 474 RLRALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 162 LPNLLTLRLEDNRFT 176
P L+ L L+ N
Sbjct: 532 CPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 25/136 (18%)
Query: 79 DLTGPAEVLSRLTQLRLL---------SLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT 129
L E L + L+ + L++ L +++ + ++ L+L+H T
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV- 455
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT-----GTLYSVNS 184
+ L + +DLSHN +P L L L L+ DN L +
Sbjct: 456 -LCHLEQLLLVTHLDLSHNRLR-ALP-PALAALRCLEVLQASDNALENVDGVANLPRLQ- 511
Query: 185 SSRSILDFNVSNNQLS 200
+ + NN+L
Sbjct: 512 ------ELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 1e-04
Identities = 26/130 (20%), Positives = 46/130 (35%), Gaps = 8/130 (6%)
Query: 75 LEDLDLTGPAEVLSRLTQLR----LLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
L++L+ +L+ + +R LL K L S L +L ++F
Sbjct: 374 LQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN 433
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
+R + L+H + L +L + L L NR L ++ R +
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLE 489
Query: 191 DFNVSNNQLS 200
S+N L
Sbjct: 490 VLQASDNALE 499
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 27/110 (24%), Positives = 40/110 (36%), Gaps = 11/110 (10%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT 127
L LDL L+ LR L+L L NL+ L L LS N +
Sbjct: 162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-NLTPLIKLDELDLSGNHLS 220
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
G L HL+++ + + + I L +L+ + L N T
Sbjct: 221 -AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 12/107 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L L+L P L+ L +L L L N LS+ + HL+ L++ ++
Sbjct: 187 LRYLNLAMCNLREIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
+L+ L ++L+HN +P T L +L + L N
Sbjct: 245 -VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 33/181 (18%), Positives = 62/181 (34%), Gaps = 47/181 (25%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS------------SNLNLSSW--- 113
L L+L P L++L+ L L+NN + S L+L
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 114 -----------PHLKHLYLSHNRFT--GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELT 160
+L++L L+ + L L +DLS N I
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLREIPNL----TPLIKLDELDLSGNHLS-AIRPGSFQ 228
Query: 161 RLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKN 220
L +L L + ++ + + +S+++ N+++N L+ +P F +
Sbjct: 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPH-------DLFTPLHH 280
Query: 221 L 221
L
Sbjct: 281 L 281
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 33/140 (23%), Positives = 51/140 (36%), Gaps = 30/140 (21%)
Query: 54 CFDSWRGVTCNPSTHRVIKLV-------LEDLDLTG------PAEVLSRLTQLRLLSLKN 100
C + + V C + ++ V L+L L L +L L
Sbjct: 41 CSNQFSKVICV---RKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSR 97
Query: 101 NLLSS------SNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGE 153
N + + + L +L L L NR T T P+G L L+ + L +N E
Sbjct: 98 NHIRTIEIGAFNGL-----ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-S 150
Query: 154 IPMTELTRLPNLLTLRLEDN 173
IP R+P+L L L +
Sbjct: 151 IPSYAFNRIPSLRRLDLGEL 170
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 30/121 (24%), Positives = 43/121 (35%), Gaps = 14/121 (11%)
Query: 106 SNLNLSSWP-----HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELT 160
NL P + + L L N+ + LRHL + LS N I +
Sbjct: 51 VRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFN 109
Query: 161 RLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKN 220
L NL TL L DNR T + + + NN + IP+ +F +
Sbjct: 110 GLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPS-------YAFNRIPS 161
Query: 221 L 221
L
Sbjct: 162 L 162
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 61/316 (19%), Positives = 103/316 (32%), Gaps = 85/316 (26%)
Query: 339 ELLGKGCVGATYKVVLDGGD------VVVVKRIRERKKKREVDEWLR------VIGGLRH 386
+ LG+G G + G D V VK ++E E + IG H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG--HH 90
Query: 387 SNIVSIRAYCNGKDE-LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR----------- 434
N+V++ C L ++ ++ G+L + L R +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 435 LKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA 494
+ + AKG+ FL H L++ NI++ + I D G+ + + +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK----DPD 203
Query: 495 YN------------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL 541
Y APE + R + + DV+SFGV+L EI + L
Sbjct: 204 YVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFS---------L 246
Query: 542 GIVKWVQMMGQDESAWEVFDFELI----MDK------EMEEEMRALLQVALLCLAPLPKD 591
G + + + E L M EM + M C P
Sbjct: 247 GASPYPGV----KIDEEFCRR-LKEGTRMRAPDYTTPEMYQTMLD-------CWHGEPSQ 294
Query: 592 RPNMSIVHRMIEDIRT 607
RP S + + ++
Sbjct: 295 RPTFSELVEHLGNLLQ 310
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 56/287 (19%)
Query: 341 LGKGCVGATYKVVL--DGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
LG G G+ + V + V +K +++ +K + +E +R ++ L + IV +
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
C + L LV + G LH L G R + + +L + G+ +L +
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL---EEK 455
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE-LK 501
+ H +L++ N+++ A ISD G+ + + Y APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECIN 512
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561
F RKF R DV+S+GV + E L+ G + +M G EV
Sbjct: 513 F--------RKFSSRSDVWSYGVTMWEALS---------YGQKPYKKMKGP-----EVMA 550
Query: 562 FELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
F + K ME L + C +DRP+ V + +
Sbjct: 551 F-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 63/297 (21%), Positives = 105/297 (35%), Gaps = 58/297 (19%)
Query: 332 DLLKSSAELLGKGCVGATYKVVLDGGDV---VVVKRIRE-RKKKREVDEWLR---VIGGL 384
LL + LG G G K V V VK ++ DE L V+ L
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 385 RHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKG 444
+ IV + C + LV + G L+ L +R V ++L + G
Sbjct: 76 DNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMG 129
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN-------- 496
+ +L +++ H L++ N+++ A ISD G+ + + Y
Sbjct: 130 MKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWP 183
Query: 497 ----APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG 551
APE + + KF + DV+SFGV++ E + G + M G
Sbjct: 184 VKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFS---------YGQKPYRGMKG 226
Query: 552 QDESAWEVFDFELIMDKEMEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
EV L + M R + + LC ++RP + V + +
Sbjct: 227 S-----EVTAM-LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 58/290 (20%)
Query: 341 LGKGCVGATYKVVL--DGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
LG G G+ + V + V +K +++ +K + +E +R ++ L + IV +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
C + L LV + G LH L G R + + +L + G+ +L +
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL---EEK 129
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN------------APE-LK 501
+ H L++ N+++ A ISD G+ + + Y APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECIN 186
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561
F RKF R DV+S+GV + E L+ G + +M G EV
Sbjct: 187 F--------RKFSSRSDVWSYGVTMWEALS---------YGQKPYKKMKGP-----EV-- 222
Query: 562 FELIMDKE-MEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
I + ME L + C +DRP+ V + +
Sbjct: 223 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 60/318 (18%), Positives = 102/318 (32%), Gaps = 82/318 (25%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDV--VVVKRIRERKKKREVDEWLR------VIGGLRH 386
+ LG G G AT ++ V VK ++ E + + +G H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--NH 86
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR------------ 434
NIV++ C ++ +Y +G L + L R
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 435 -LKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND 493
L + AKG+AFL + H L++ NI++ I D G+ + +
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN----DS 199
Query: 494 AYN------------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL 541
Y APE FN + DV+S+G+ L E+ + L
Sbjct: 200 NYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFS---------L 243
Query: 542 GIVKWVQMMGQDESAWEVFDFEL---IMDK------EMEEEMRALLQVALLCLAPLPKDR 592
G + M + + M EM + M+ C P R
Sbjct: 244 GSSPYPGMPVDS----KFYKMIKEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKR 292
Query: 593 PNMSIVHRMIEDIRTKGS 610
P + ++IE ++ +
Sbjct: 293 PTFKQIVQLIEKQISEST 310
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 60/326 (18%), Positives = 122/326 (37%), Gaps = 88/326 (26%)
Query: 339 ELLGKGCVGATYK-----VVLDGGDVVV-VKRIRERKKKREVDEWLR---VIGGLRHSNI 389
+G+G G ++ ++ +V VK ++E ++ R ++ + NI
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR--------------- 434
V + C + L+++Y+ +G L+ L + +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 435 ----LKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFF 490
L +A A G+A+L ++ H L++ N +V + I+D G+ + ++
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS--- 226
Query: 491 INDAYN------------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537
D Y PE + + ++ DV+++GVVL EI +
Sbjct: 227 -ADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFS------ 271
Query: 538 DGELGIVKWVQMMGQDESAWEVFDFEL---IMDK------EMEEEMRALLQVALLCLAPL 588
G+ + M + EV + I+ E+ MR C + L
Sbjct: 272 ---YGLQPYYGM-----AHEEVIYYVRDGNILACPENCPLELYNLMRL-------CWSKL 316
Query: 589 PKDRPNMSIVHRMIEDI--RTKGSID 612
P DRP+ +HR+++ + R +G++
Sbjct: 317 PADRPSFCSIHRILQRMCERAEGTVG 342
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 26/139 (18%), Positives = 45/139 (32%), Gaps = 18/139 (12%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYLS 122
L+ L LT + S L L L L N LS+ L L L L
Sbjct: 78 LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPL-----SSLTFLNLL 132
Query: 123 HNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYS 181
N + + + S L L+ + + + +I + L L L ++ +
Sbjct: 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192
Query: 182 VNSSSRSILDFNVSNNQLS 200
S +++ + Q
Sbjct: 193 SLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 15/117 (12%), Positives = 39/117 (33%), Gaps = 17/117 (14%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN---------LSSWPHLKHL 119
+ L L + + + L L++ L + + + L +++
Sbjct: 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259
Query: 120 YLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
++ ++ + L ++ S N + +P RL +L + L N +
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 16/118 (13%), Positives = 37/118 (31%), Gaps = 17/118 (14%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
LE+L++ + L + + L L + + ++ L L
Sbjct: 176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD 235
Query: 128 GT----FPSGVSS----LRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG 177
+G ++ R V ++ + + + L ++ LL L N+
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL--LNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 22/91 (24%), Positives = 33/91 (36%), Gaps = 11/91 (12%)
Query: 68 HRVIKLVLEDLDL---------TGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKH 118
V L L D DL TG L + R + + + L L+ L
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLE 281
Query: 119 LYLSHNRFTGTFPSGV-SSLRHLRRVDLSHN 148
L S N+ + P G+ L L+++ L N
Sbjct: 282 LEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 24/103 (23%), Positives = 40/103 (38%), Gaps = 10/103 (9%)
Query: 80 LTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-----HLKHLYLSHNRFTGTFPSGV 134
++ E S L N + S+ +L+S P +K L LS+NR T +
Sbjct: 15 ISLSKEESSNQASLSCDR--NGICKGSSGSLNSIPSGLTEAVKSLDLSNNRIT-YISNSD 71
Query: 135 -SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
+L+ + L+ N I + L +L L L N +
Sbjct: 72 LQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS 113
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 23/114 (20%), Positives = 46/114 (40%), Gaps = 10/114 (8%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
++ TQL LL + ++ L+LS P L +LYL++ T VS L+ +
Sbjct: 293 VTHNTQLYLLDCQAAGITE--LDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCV 347
Query: 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
+ + + + ++P L + + +++ L VS + L
Sbjct: 348 NAHIQ-DFS--SVGKIPALNNNFEAEGQTITMPKETLTNNS--LTIAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 24/131 (18%), Positives = 47/131 (35%), Gaps = 14/131 (10%)
Query: 72 KLVLEDLDLTGPAEV-LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
V ++ + +L L L N+ ++ + L L + N T T
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNNIT-TL 79
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
+S +L + N ++ ++T L L L + N+ T ++ S +L
Sbjct: 80 D--LSQNTNLTYLACDSN----KLTNLDVTPLTKLTYLNCDTNKLT----KLDVSQNPLL 129
Query: 191 -DFNVSNNQLS 200
N + N L+
Sbjct: 130 TYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 23/119 (19%), Positives = 51/119 (42%), Gaps = 14/119 (11%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
+ +LT L L +N +++ L+LS +L +L N+ T V+ L L ++
Sbjct: 60 IEKLTGLTKLICTSNNITT--LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCD 114
Query: 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN-SSSRSILDFNVSNNQLSGQIP 204
N ++ ++++ P L L N T ++ S + + + + N+ ++
Sbjct: 115 TN----KLTKLDVSQNPLLTYLNCARNTLT----EIDVSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 27/115 (23%), Positives = 45/115 (39%), Gaps = 13/115 (11%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
+S TQL L N + L+++ L L S N+ T VS + L R++
Sbjct: 144 VSHNTQLTELDCHLNKKITK-LDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCD 199
Query: 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSS-RSILDFNVSNNQLS 200
N I +L + L L N+ T ++ + + F+ S N L+
Sbjct: 200 TN----NITKLDLNQNIQLTFLDCSSNKLT----EIDVTPLTQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 17/112 (15%), Positives = 41/112 (36%), Gaps = 13/112 (11%)
Query: 90 LTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149
+ + + ++ L L ++ T +G+ L L ++ + N
Sbjct: 20 FASEVAAAFEMQATDT--ISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSN- 74
Query: 150 YEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN-SSSRSILDFNVSNNQLS 200
I +L++ NL L + N+ T +++ + + N N+L+
Sbjct: 75 ---NITTLDLSQNTNLTYLACDSNKLT----NLDVTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 19/115 (16%), Positives = 41/115 (35%), Gaps = 13/115 (11%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
++ LTQL N L+ L++S+ L L+ ++ L
Sbjct: 229 VTPLTQLTYFDCSVNPLTE--LDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAE 283
Query: 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN-SSSRSILDFNVSNNQLS 200
+I ++T L L + T ++ S + ++ ++N +L+
Sbjct: 284 GC---RKIKELDVTHNTQLYLLDCQAAGIT----ELDLSQNPKLVYLYLNNTELT 331
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 41/220 (18%), Positives = 73/220 (33%), Gaps = 41/220 (18%)
Query: 339 ELLGKGC--VGATYKVV-LDGGDVVVVKRIR-ERKKKREVDEWLR---VIGGLRHSNIVS 391
++GKG + G+ V V+RI E V V H NIV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV- 89
Query: 392 IRAYCN--GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAKGLA 446
+EL++V ++ +GS L+ + M +A K L
Sbjct: 90 -PYRATFIADNELWVVTSFMAYGSAKDLIC-THFMDGMNELA-----IAYILQGVLKALD 142
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHT-----------PFFINDA 494
++H H + +S+I++ G +S + + + +
Sbjct: 143 YIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 495 Y-NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+PE+ N Y + D+YS G+ E+ G
Sbjct: 200 PWLSPEVLQQNLQGYDAK-----SDIYSVGITACELANGH 234
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 24/110 (21%), Positives = 39/110 (35%), Gaps = 11/110 (10%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT 127
L LDL L L+ L+L + NL+ L+ L +S N F
Sbjct: 173 LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP-NLTPLVGLEELEMSGNHFP 231
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
G L L+++ + ++ I L +L+ L L N +
Sbjct: 232 -EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 12/107 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFT 127
L+ L+L P L+ L L L + N + LK L++ +++ +
Sbjct: 198 LKYLNLGMCNIKDMPN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
L L ++L+HN +P T L L+ L L N
Sbjct: 256 -LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 35/181 (19%), Positives = 64/181 (35%), Gaps = 47/181 (25%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS------------SNLNLSSW--- 113
L L+L P+ L++LR L L+NN + S L+L
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL 184
Query: 114 -----------PHLKHLYLSHNRFT--GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELT 160
+LK+L L + L L +++S N + EI
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIKDMPNL----TPLVGLEELEMSGNHFP-EIRPGSFH 239
Query: 161 RLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKN 220
L +L L + +++ + + S+++ N+++N LS +P F +
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPH-------DLFTPLRY 291
Query: 221 L 221
L
Sbjct: 292 L 292
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 35/140 (25%), Positives = 49/140 (35%), Gaps = 30/140 (21%)
Query: 54 CFDSWRGVTCNPSTHRVIKLV-------LEDLDLTG------PAEVLSRLTQLRLLSLKN 100
C + + V C R + V L+L A+ L L +L L
Sbjct: 52 CSNQFSKVVCT---RRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGR 108
Query: 101 NLLSS------SNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGE 153
N + + L L L L N T PSG L LR + L +N E
Sbjct: 109 NSIRQIEVGAFNGL-----ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-S 161
Query: 154 IPMTELTRLPNLLTLRLEDN 173
IP R+P+L+ L L +
Sbjct: 162 IPSYAFNRVPSLMRLDLGEL 181
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 27/125 (21%), Positives = 44/125 (35%), Gaps = 22/125 (17%)
Query: 106 SNLNLSSWP-----HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELT 160
+ LS P + ++L L N L HL + L N+ +I +
Sbjct: 62 TRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFN 120
Query: 161 RLPNLLTLRLEDNRFT----GTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFA 216
L +L TL L DN T G + + + + NN + IP+ +F
Sbjct: 121 GLASLNTLELFDNWLTVIPSGAFEYL----SKLRELWLRNNPIE-SIPS-------YAFN 168
Query: 217 GNKNL 221
+L
Sbjct: 169 RVPSL 173
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 60/298 (20%), Positives = 105/298 (35%), Gaps = 68/298 (22%)
Query: 339 ELLGKGCVGATYKVVLDGGDV----VVVKRIRE--RKKKREVDEWLR---VIGGLRHSNI 389
E LG G G + D V VK ++ + +D+++R + L H N+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMP--VDWNKRLKLASDSAKGLAF 447
+ + + +V + P GSL L +G + + A A+G+ +
Sbjct: 84 IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGY 136
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN----------- 496
L H L++ N+++ I D G+ + +D Y
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVPFAW 190
Query: 497 -APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE 554
APE LK R F D + FGV L E+ T G W+ + G
Sbjct: 191 CAPESLKT--------RTFSHASDTWMFGVTLWEMFT---------YGQEPWIGLNGS-- 231
Query: 555 SAWEVFDFELIMDKE---MEEEM---RALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
++ +DKE + + + V + C A P+DRP + + + +
Sbjct: 232 ---QILHK---IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 42/227 (18%), Positives = 77/227 (33%), Gaps = 46/227 (20%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
+ LG+G G ++ +KRIR ++ ++ +R + L H IV
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 395 YCNGKDE------------LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSA 442
K+ L++ +L ++G + + L + A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIA 128
Query: 443 KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-------HQLFHTPFFINDA- 494
+ + FLH L H L SNI + D G+ + +
Sbjct: 129 EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 495 ----------YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
Y +PE + N+YS + D++S G++L E+L
Sbjct: 186 RHTGQVGTKLYMSPEQI--HGNSYS-----HKVDIFSLGLILFELLY 225
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 32/148 (21%), Positives = 46/148 (31%), Gaps = 34/148 (22%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS----------SNLNLSSWP---- 114
LE L + P L L + + LS SN L P
Sbjct: 93 LESLVASCNSLTELPEL-PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQN 151
Query: 115 --HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLED 172
LK + + +N P SL + +N E E+P EL LP L + ++
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELP--ELQNLPFLTAIYADN 204
Query: 173 NRFTGTLYSVNSSSRSILDFNVSNNQLS 200
N + S+ NN L
Sbjct: 205 NSLK----KLPDLPLSLESIVAGNNILE 228
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 36/170 (21%), Positives = 54/170 (31%), Gaps = 47/170 (27%)
Query: 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSS-----NLNLS---------SWPHLK 117
L + D LT E+ LT L + + LS LN S P L+
Sbjct: 261 ALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLE 320
Query: 118 HLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP----NLLTLRLEDN 173
L +S+N+ P+ L L S N L +P NL L +E N
Sbjct: 321 ELNVSNNKLI-ELPALPPRLERL---IASFN---------HLAEVPELPQNLKQLHVEYN 367
Query: 174 RFT------GTLYS--VNSSSRSILDF-------NVSNNQLSGQIPAWMS 208
++ +NS + + +V N L + P
Sbjct: 368 PLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPE 416
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 40/139 (28%), Positives = 56/139 (40%), Gaps = 22/139 (15%)
Query: 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW-PHLKHLYLSHNRFTGTF 130
+V + L E L L L + NNLL + L P L+ L + N T
Sbjct: 219 SIVAGNNILEELPE-LQNLPFLTTIYADNNLLKT----LPDLPPSLEALNVRDNYLT-DL 272
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP-NLLTLRLEDNRFTGTLYSVNSSSRSI 189
P SL L D+S N + + L+ LP NL L N S+ S+
Sbjct: 273 PELPQSLTFL---DVSENIF------SGLSELPPNLYYLNASSNEIR----SLCDLPPSL 319
Query: 190 LDFNVSNNQLSGQIPAWMS 208
+ NVSNN+L ++PA
Sbjct: 320 EELNVSNNKLI-ELPALPP 337
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 31/136 (22%), Positives = 54/136 (39%), Gaps = 15/136 (11%)
Query: 75 LEDLDLTGPA--EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPS 132
L+ +D+ + ++ L ++ NN L L + P L +Y +N P
Sbjct: 155 LKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLK-KLPD 212
Query: 133 GVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDF 192
SL + +N E E+P EL LP L T+ ++N ++ S+
Sbjct: 213 LPLSLESI---VAGNNILE-ELP--ELQNLPFLTTIYADNNLLK----TLPDLPPSLEAL 262
Query: 193 NVSNNQLSGQIPAWMS 208
NV +N L+ +P
Sbjct: 263 NVRDNYLT-DLPELPQ 277
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 34/147 (23%), Positives = 50/147 (34%), Gaps = 19/147 (12%)
Query: 64 NPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNL-SSWPHLKHLYLS 122
+ E ++ Q L L N LSS L PHL+ L S
Sbjct: 44 SEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS----LPELPPHLESLVAS 99
Query: 123 HNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLT-LRLEDNRFTGTLYS 181
N T P SL+ L + + L+ LP LL L + +N+ L
Sbjct: 100 CNSLT-ELPELPQSLKSLLVDNNNLK---------ALSDLPPLLEYLGVSNNQLE-KL-P 147
Query: 182 VNSSSRSILDFNVSNNQLSGQIPAWMS 208
+S + +V NN L ++P
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-KLPDLPP 173
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 25/153 (16%), Positives = 51/153 (33%), Gaps = 45/153 (29%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-HLKHLYLSHNRFT 127
LE+L+++ PA +L L N L+ + P +LK L++ +N
Sbjct: 319 LEELNVSNNKLIELPAL----PPRLERLIASFNHLAE----VPELPQNLKQLHVEYNPLR 370
Query: 128 GTFPSGVSSLR----------------HLRRVDLSHNAYEGEIPMTELTRLPNLLT---- 167
FP S+ +L+++ + N L P++
Sbjct: 371 -EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETN---------PLREFPDIPESVED 420
Query: 168 LRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
LR+ R + ++ + D ++
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 23/132 (17%), Positives = 43/132 (32%), Gaps = 27/132 (20%)
Query: 90 LTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLR----------- 138
T L+ ++ L+ + + Y + + + P G R
Sbjct: 10 NTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 139 --HLRRVDLSHNAYEGEIPMTELTRLP----NLLTLRLEDNRFTGTLYSVNSSSRSILDF 192
++L++ L+ LP +L +L N T L + S +S+L
Sbjct: 70 DRQAHELELNNL---------GLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVD 119
Query: 193 NVSNNQLSGQIP 204
N + LS P
Sbjct: 120 NNNLKALSDLPP 131
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 45/213 (21%), Positives = 81/213 (38%), Gaps = 43/213 (20%)
Query: 340 LLGKGCVGATYKVV-LDGGDVVVVKRIR---------ERKKKREVDEWLRVIGGLRHSNI 389
LGKG G Y ++ +K + E + +REV + LRH NI
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV----EIQSHLRHPNI 71
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+ + Y + ++L+ +Y P G+++ L + + ++ A L++ H
Sbjct: 72 LRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTAT--YITELANALSYCH 126
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIG--VHQLFH-------TPFFINDAYNAPEL 500
+ H + N+++ G I+D G VH T Y PE+
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL-----DYLPPEM 178
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ ++ D++S GV+ E L GK
Sbjct: 179 I--EGRMHD-----EKVDLWSLGVLCYEFLVGK 204
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 27/141 (19%), Positives = 61/141 (43%), Gaps = 10/141 (7%)
Query: 72 KLVLEDLDLTG----PAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRF 126
+ +++ ++G S+++ L NNLL+ + N L+ L L N+
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 127 T--GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNS 184
+ ++ L+++D+S N+ + + + +LL+L + N T T++
Sbjct: 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP 420
Query: 185 SSRSILDFNVSNNQLSGQIPA 205
+LD + +N++ IP
Sbjct: 421 PRIKVLD--LHSNKIK-SIPK 438
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 24/108 (22%), Positives = 45/108 (41%), Gaps = 10/108 (9%)
Query: 75 LEDLDL-------TGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT 127
L+ LD+ S L L++ +N+L+ + P +K L L N+
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-CLPPRIKVLDLHSNKIK 434
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRF 175
+ P V L L+ ++++ N + +P RL +L + L N +
Sbjct: 435 -SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 33/195 (16%), Positives = 70/195 (35%), Gaps = 8/195 (4%)
Query: 12 FCLFSLCLSNSPYSD--ISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHR 69
L +L L+N + +L T S+S+ F + +
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 70 VIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-HLKHLYLSHNRFTG 128
+ ++V + + + + + + + + ++ S HL S+N T
Sbjct: 280 IHQVVSDVFG-FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTE--LTRLPNLLTLRLEDNRFTGTLYSVN-SS 185
T L L + L N + E+ T++ +L L + N + + S
Sbjct: 339 TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 186 SRSILDFNVSNNQLS 200
++S+L N+S+N L+
Sbjct: 398 TKSLLSLNMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 24/100 (24%), Positives = 43/100 (43%), Gaps = 8/100 (8%)
Query: 80 LTGPAEVLSRLTQLRLLSL-KNNLLSSSNLNLSSWP-HLKHLYLSHNRFT-GTFPSGVSS 136
L+ AE+ +++ L+ L + +N++ SW L L +S N T F
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR 422
Query: 137 LRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
++ L DL N + IP ++ +L L L + N+
Sbjct: 423 IKVL---DLHSNKIK-SIPK-QVVKLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 25/115 (21%), Positives = 44/115 (38%), Gaps = 12/115 (10%)
Query: 91 TQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHN 148
+ +L++ N +S ++ S L+ L +SHNR V + L +DLSHN
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79
Query: 149 AYEGEIPMTELT--RLPNLLTLRLEDNRFTG-TLYSVNSSSRSILDFNVSNNQLS 200
+ +++ NL L L N F + + + +S L
Sbjct: 80 ------KLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 25/162 (15%), Positives = 47/162 (29%), Gaps = 16/162 (9%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRF 126
L+ L + L+ L +L L N + +L+ L L+
Sbjct: 56 LQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNL 115
Query: 127 TGTF-PSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT----GTLY 180
G L L + L N + P + + L L N+ L
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL 175
Query: 181 SVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLC 222
+ ++L +S+ L W+ + N ++
Sbjct: 176 NFQGKHFTLLR--LSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 37/179 (20%), Positives = 60/179 (33%), Gaps = 12/179 (6%)
Query: 8 FFSFFCLFSLCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNP-- 65
F + +L LS + + + F A SL +
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 66 STHRVIKLVLEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKH 118
+ + ++ DL+ V S T L L+L N ++ + HL
Sbjct: 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLK 327
Query: 119 LYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
L LS N + S + +L L +DLS+N + LPNL L L+ N+
Sbjct: 328 LNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 29/114 (25%), Positives = 40/114 (35%), Gaps = 20/114 (17%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYLS 122
LE L L LT L L+L N L S NL L+ L LS
Sbjct: 301 LEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENL-----DKLEVLDLS 355
Query: 123 HNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRF 175
+N L +L+ + L N + +P RL +L + L N +
Sbjct: 356 YNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 26/137 (18%), Positives = 47/137 (34%), Gaps = 12/137 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN--LSSWPHLKHLYLSHNRF 126
+ +DL+ SRL L+ L ++ N L L L +N+F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 127 TGTFPSGV-SSLRHLRRVDLSHNA-YEGEIPMTELTRLPNLLTLRLEDNRFTG-TLYSVN 183
+G + L +L + L+ + L +L L L DN S
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 184 SSSRSILDFNVSNNQLS 200
+ R +++ N++
Sbjct: 151 LNMRRFHVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 5/114 (4%)
Query: 91 TQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHN 148
+ + L N ++ + + S L+ L + + L L + L +N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNS--SSRSILDFNVSNNQLS 200
+ ++ L NL L L G + S N S+ + +N +
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 18/105 (17%), Positives = 37/105 (35%), Gaps = 5/105 (4%)
Query: 106 SNLNLSSWP----HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTR 161
N L P H+ ++ LS N + S L+ L+ + + I
Sbjct: 18 INRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG 77
Query: 162 LPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQL-SGQIPA 205
L +L+ L+L+ N+F + ++ ++ L +
Sbjct: 78 LSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG 122
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 60/327 (18%), Positives = 105/327 (32%), Gaps = 95/327 (29%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDV--VVVKRIRERKKKREVDEWLR------VIGGLRH 386
++LG G G AT + G V VK ++E+ E + + +G H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG--SH 108
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR------------ 434
NIV++ C ++L+++Y +G L + L R +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 435 ------LKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG----VHQL 484
L A AKG+ FL H L++ N++V I D G +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS- 224
Query: 485 FHTPFFINDAYN------------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
+ Y APE F + + DV+S+G++L EI +
Sbjct: 225 -------DSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIFS- 269
Query: 533 KMAKGDGELGIVKWVQMMGQDESAWEVFDFEL---IMDK------EMEEEMRALLQVALL 583
LG+ + + + MD+ E+ M++
Sbjct: 270 --------LGVNPYPGI----PVDANFYKLIQNGFKMDQPFYATEEIYIIMQS------- 310
Query: 584 CLAPLPKDRPNMSIVHRMIEDIRTKGS 610
C A + RP+ + +
Sbjct: 311 CWAFDSRKRPSFPNLTSFLGCQLADAE 337
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 68/314 (21%), Positives = 112/314 (35%), Gaps = 78/314 (24%)
Query: 339 ELLGKGCVGATYKVVLDGGD------VVVVKRIRERKKKREVDEWLR---VIGGLRHSNI 389
LG+G G + +V VK ++E + ++ R ++ L+H +I
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHI 105
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR----------LKLAS 439
V C L +V++Y+ HG L+ L ++ L +AS
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 440 DSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYN--- 496
A G+ +L H H L++ N +V Q I D G+ + ++ D Y
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGG 218
Query: 497 ---------APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKW 546
PE + + RKF DV+SFGVVL EI T G W
Sbjct: 219 RTMLPIRWMPPESILY--------RKFTTESDVWSFGVVLWEIFT---------YGKQPW 261
Query: 547 VQMMGQDESAWEVFDFEL---IMDK------EMEEEMRALLQVALLCLAPLPKDRPNMSI 597
Q+ S E D +++ E+ MR C P+ R ++
Sbjct: 262 YQL-----SNTEAIDCITQGRELERPRACPPEVYAIMRG-------CWQREPQQRHSIKD 309
Query: 598 VHRMIEDIRTKGSI 611
VH ++ + +
Sbjct: 310 VHARLQALAQAPPV 323
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 31/110 (28%), Positives = 45/110 (40%), Gaps = 1/110 (0%)
Query: 64 NPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSH 123
P+ R + L + + + L LSL N L S + NL P LK L LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVS-NLPKLPKLKKLELSE 80
Query: 124 NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
NR G L +L ++LS N + + L +L L +L L +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 22/108 (20%), Positives = 43/108 (39%), Gaps = 10/108 (9%)
Query: 96 LSLKNNL-LSSSNLNLSSWPHLKHLYLSHNRFT-GTFPSGVSSLRHLRRVDLSHNAYEGE 153
+ +K + L N ++ ++ L L + + G + +L + L +
Sbjct: 8 MDMKRRIHLELRNRTPAA---VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV----G 60
Query: 154 IPMTE-LTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
+ L +LP L L L +NR G L + ++ N+S N+L
Sbjct: 61 LISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 56/313 (17%), Positives = 106/313 (33%), Gaps = 86/313 (27%)
Query: 339 ELLGKGCVG----ATYKVVLDGGDV--VVVKRIRERKKKREVDEWLR------VIGGLRH 386
+ LG G G AT + V V VK ++ E + + +G +H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QH 109
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR---------LKL 437
NIV++ C + ++ +Y +G L + L + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 438 ASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG----VHQLFHTPFFIND 493
+S A+G+AFL + H +++ N+++ A I D G + +
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN--------DS 218
Query: 494 AYN------------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL 541
Y APE F+ + + DV+S+G++L EI + L
Sbjct: 219 NYIVKGNARLPVKWMAPESIFD-------CVYTVQSDVWSYGILLWEIFS---------L 262
Query: 542 GIVKWVQMMGQDESAWEVFDFEL---IMDK------EMEEEMRALLQVALLCLAPLPKDR 592
G+ + ++ + + M + + M+A C A P R
Sbjct: 263 GLNPYPGIL----VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA-------CWALEPTHR 311
Query: 593 PNMSIVHRMIEDI 605
P + +++
Sbjct: 312 PTFQQICSFLQEQ 324
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 51/219 (23%), Positives = 77/219 (35%), Gaps = 40/219 (18%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSI-- 392
E LG G G + + D G+ V +K+ R+ + + W ++ L H N+VS
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 393 ----RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
D L +Y G L L+ + L SD + L +L
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PIRTLLSDISSALRYL 137
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNAC---ISDIGVHQLFH----------TPFFINDAY 495
H + + H L NIV+ I D+G + T Y
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL-----QY 189
Query: 496 NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM 534
APEL Q+K+ D +SFG + E +TG
Sbjct: 190 LAPEL-------LEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 60/338 (17%), Positives = 105/338 (31%), Gaps = 57/338 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
++LG+G ++ GD+ +K R VD +R V+ L H NIV + A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 395 Y--CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
L+ ++ P GSL+++L +P + L + D G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLRENG 132
Query: 453 KAH---------LFHGHLSSSNI-VVDQLGNACISDIGVHQLFH----TPFFINDAYNAP 498
H G S + D G A + + F T Y P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTD-FGAARELEDD--EQFVSLYGTE-----EYLHP 184
Query: 499 E-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG------------------KMAKGDG 539
+ + Q+K+ D++S GV TG K+ G
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 540 ELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVAL-LCLAPLPKDRPNMSIV 598
I + E+ + ++ + + ++ LL L L +
Sbjct: 245 SGAISGV----QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 599 HRMIEDIRTKGSIDGCANSIMNNISSDSSPSQSENTYN 636
DI + I + +++ S NT
Sbjct: 301 FAETSDILHRMVIH---VFSLQQMTAHKIYIHSYNTAT 335
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIR----ERKKKREVDEWLRVIGGLRHSNIVSIR 393
LG G G +KV G V+ K I + + + E L+V+ IV
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE-LQVLHECNSPYIVGFY 97
Query: 394 -AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
A+ + E+ + +++ GSL +L + GR+P K++ KGL +L
Sbjct: 98 GAFYSD-GEISICMEHMDGGSLDQVL---KKAGRIPEQILG--KVSIAVIKGLTYLR--E 149
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVH-QLFH--------TPFFINDAYNAPELKFN 503
K + H + SNI+V+ G + D GV QL T Y +PE
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS-----YMSPERL-- 202
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+YS + D++S G+ L+E+ G+
Sbjct: 203 QGTHYSVQ-----SDIWSMGLSLVEMAVGR 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 53/307 (17%), Positives = 108/307 (35%), Gaps = 60/307 (19%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRI------RERKKKREVDEWLRVIGGLRHSNIVS 391
+L +G Y+ + G +KR+ + R +EV ++ G H NIV
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG---HPNIVQ 90
Query: 392 I-------RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKG 444
+ + FL+ L G L L G + D LK+ + +
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD--TVLKIFYQTCRA 148
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG-VHQLFHTPFFINDA--------- 494
+ +H K + H L N+++ G + D G + H P + A
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 495 --------YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVK 545
Y PE+ + YS ++ D+++ G +L + + + +L IV
Sbjct: 208 ITRNTTPMYRTPEI----IDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263
Query: 546 WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
G+ + + +L++ L P++R +++ V +++I
Sbjct: 264 -----GK---------YSIPPHDTQYTVFHSLIRA---MLQVNPEERLSIAEVVHQLQEI 306
Query: 606 RTKGSID 612
+++
Sbjct: 307 AAARNVN 313
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-11
Identities = 29/110 (26%), Positives = 44/110 (40%), Gaps = 1/110 (0%)
Query: 64 NPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSH 123
PS + + L + + +L LS N L+S NL LK L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIA-NLPKLNKLKKLELSD 73
Query: 124 NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
NR +G +L ++LS N + + L +L NL +L L +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 19/88 (21%), Positives = 34/88 (38%), Gaps = 6/88 (6%)
Query: 115 HLKHLYLSHNRFT-GTFPSGVSSLRHLRRVDLSHNAYEGEIP-MTELTRLPNLLTLRLED 172
+K L L ++R G L + + + + L +L L L L D
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV----GLTSIANLPKLNKLKKLELSD 73
Query: 173 NRFTGTLYSVNSSSRSILDFNVSNNQLS 200
NR +G L + ++ N+S N++
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 4/103 (3%)
Query: 85 EVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRV 143
LS + LR+LSL NL+ NL+ + L+ L++S+N+ SG+ L +LR +
Sbjct: 64 SSLSGMENLRILSLGRNLIKKIENLD-AVADTLEELWISYNQIASL--SGIEKLVNLRVL 120
Query: 144 DLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSS 186
+S+N + +L L L L L N N++S
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 24/117 (20%), Positives = 48/117 (41%), Gaps = 9/117 (7%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
V + ++ L + + LS+ KHL LS N S +S + +LR +
Sbjct: 20 VVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILS 76
Query: 145 LSHNAYEGEIPMTELTRLPNLL-TLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
L N + + L + + L L + N+ +L + ++ +SNN+++
Sbjct: 77 LGRNLIKK---IENLDAVADTLEELWISYNQIA-SLSGI-EKLVNLRVLYMSNNKIT 128
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 46/216 (21%), Positives = 75/216 (34%), Gaps = 31/216 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
++LG+G ++ GD+ +K R VD +R V+ L H NIV + A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 395 Y--CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
L+ ++ P GSL+++L +P + L + D G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLRENG 132
Query: 453 KAH---------LFHGHLSSSNI-VVDQLGNACISDIGVHQLFH----TPFFINDAYNAP 498
H G S + D G A + + F T Y P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTD-FGAARELEDD--EQFVSLYGTE-----EYLHP 184
Query: 499 E-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ + Q+K+ D++S GV TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 51/294 (17%), Positives = 91/294 (30%), Gaps = 50/294 (17%)
Query: 324 NKGFRNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRI---RERKKKREVDEWLRV 380
VG + ++LG G G + V VKRI REV + LR
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREV-QLLRE 73
Query: 381 IGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASD 440
H N++ + ++ + +L + + + ++ + L
Sbjct: 74 S--DEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLE---PITLLQQ 126
Query: 441 SAKGLAFLHGYNKAH--------LFHGHLSSSNIVV---DQLGNACISDIGVHQLFHTPF 489
+ GLA LH N H L + I D G +G H
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD-FGLCKKLAVGRHSFSRRSG 185
Query: 490 FIN-DAYNAPE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM----AKGDGELGI 543
+ + APE L + N + D++S G V +++ + I
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPT-----YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI 240
Query: 544 VKWVQMMGQDESAWEVFDFE-LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ + L +K + R L++ +A P+ RP+
Sbjct: 241 LL------------GACSLDCLHPEKHEDVIARELIE---KMIAMDPQKRPSAK 279
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 30/144 (20%), Positives = 53/144 (36%), Gaps = 16/144 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNL-SSWPHLKHLYLSHNRFT 127
L+ LDL+ L+ L L L N + S L S L+ L
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTEL-TRLPNLLTLRLEDNRFT----GTLYS 181
+ + L+ L+ ++++HN + + E + L NL L L N+ L
Sbjct: 114 -SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 182 VNSSSRSILDFNVSNNQLSGQIPA 205
++ L ++S N ++ I
Sbjct: 172 LHQMPLLNLSLDLSLNPMN-FIQP 194
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 22/151 (14%), Positives = 42/151 (27%), Gaps = 40/151 (26%)
Query: 52 DPCFDSWRGVTCNPSTHRV-------------IKLVLEDLDLTG------PAEVLSRLTQ 92
+PC + ++LDL+ + +
Sbjct: 1 EPC-------VEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPE 53
Query: 93 LRLLSLKNNLLSS------SNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDL 145
L++L L + + +L HL L L+ N + G S L L+++
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSL-----SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107
Query: 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
+ + L L L + N
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 25/109 (22%), Positives = 38/109 (34%), Gaps = 9/109 (8%)
Query: 72 KLVLEDLDLT--GPAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLK----HLYLSHN 124
+L + + E S LT L L L +N + S +L + L LS N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 125 RFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
G L+ + L N + +P RL +L + L N
Sbjct: 188 PMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 55/314 (17%), Positives = 100/314 (31%), Gaps = 69/314 (21%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR---------ERKKKREVDEWLRVIGGLRHSN 388
+LG+ A + + G+ V ++ K EV R++ G+++
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL-RLLRGIKNQK 137
Query: 389 IVS--------------------IRAYCNGKDE----LFLVYDYLPHGSLHSLLH--GSR 422
IR + +D F +Y +L + S
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY-PRMQSNLQTFGEVLLSH 196
Query: 423 GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482
+ + RL+L + LA LH Y L H +L +IV+DQ G ++
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 483 QLFHTPFFIN--DAYNAPEL----KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA- 535
+ + PEL + + + D ++ G+V+ I +
Sbjct: 254 VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 536 KGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595
D LG +W+ K + + +RALL+ L +DR
Sbjct: 314 TKDAALGGSEWI----------------FRSCKNIPQPVRALLE---GFLRYPKEDRLLP 354
Query: 596 S--IVHRMIEDIRT 607
+ E +RT
Sbjct: 355 LQAMETPEYEQLRT 368
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGGL---RHSNIVSIRA 394
E++G G + V +KRI K + +DE L+ I + H NIV
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV--SY 78
Query: 395 YCN--GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAKGLAFLH 449
Y + KDEL+LV L GS+ ++ G +A+ + +GL +LH
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH-QLFH---------------TPFFIND 493
+ H + + NI++ + G+ I+D GV L TP ++
Sbjct: 139 KNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM-- 193
Query: 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
APE+ Y + D++SFG+ +E+ TG
Sbjct: 194 ---APEV-MEQVRGYDFK-----ADIWSFGITAIELATGA 224
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 29/159 (18%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLK--HLYLSHNRF 126
L +L + P V S L + + + N L +S ++ LK +L +S +
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
Query: 127 TGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT----GTLYSV 182
T P + L + L HN + I + +L R L L L N+ G+L +
Sbjct: 185 T-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240
Query: 183 NSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
++ + ++ NN+LS ++PA K L
Sbjct: 241 ----PTLRELHLDNNKLS-RVPAG--------LPDLKLL 266
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 25/113 (22%), Positives = 37/113 (32%), Gaps = 13/113 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT- 127
L L L LS L LR L L NN LS L L+ +YL N T
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITK 278
Query: 128 ---GTFPS--GVSSLRHLRRVDLSHNAYE-GEIPMTELTRLPNLLTLRLEDNR 174
F + + L +N E+ + + L ++ + +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 32/169 (18%), Positives = 59/169 (34%), Gaps = 38/169 (22%)
Query: 73 LVLEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNR 125
L L L ++ P ++ L +L L +N + + +L + L L L HN+
Sbjct: 172 LKLNYLRISEAKLTGIPKDLPETLNELHL---DHNKIQAIELEDLLRYSKLYRLGLGHNQ 228
Query: 126 FT----GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNR------- 174
G+ S + +LR L L +N +P L L L + L N
Sbjct: 229 IRMIENGSL-SFLPTLREL---HLDNNKLS-RVP-AGLPDLKLLQVVYLHTNNITKVGVN 282
Query: 175 -FTGTLYSVNSSSRSILDFNVSNNQLS-GQIPAWMSPFGGSSFAGNKNL 221
F + V + + + NN + ++ ++F +
Sbjct: 283 DFCPVGFGVKRAYYNGISL--FNNPVPYWEVQP-------ATFRCVTDR 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 36/147 (24%), Positives = 56/147 (38%), Gaps = 26/147 (17%)
Query: 62 TCNPSTHRVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHL 119
C+ + DL L P E+ T L L+NN +S + HL L
Sbjct: 32 HCHLRV-----VQCSDLGLKAVPKEISPDTTLL---DLQNNDISELRKDDFKGLQHLYAL 83
Query: 120 YLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLP-----NLLTLRLEDN 173
L +N+ + S LR L+++ +S N L +P +L+ LR+ DN
Sbjct: 84 VLVNNKIS-KIHEKAFSPLRKLQKLYISKN---------HLVEIPPNLPSSLVELRIHDN 133
Query: 174 RFTGTLYSVNSSSRSILDFNVSNNQLS 200
R V S R++ + N L
Sbjct: 134 RIRKVPKGVFSGLRNMNCIEMGGNPLE 160
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 29/125 (23%), Positives = 48/125 (38%), Gaps = 24/125 (19%)
Query: 88 SRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147
+ Q L L LSS L + P + L ++ N + P +SL +L D
Sbjct: 56 CLINQFSELQLNRLNLSS--LPDNLPPQITVLEITQNALI-SLPELPASLEYL---DACD 109
Query: 148 NAYEGEIPMTELTRLP----NLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203
N L+ LP +L L +++N+ T + + N NNQL+ +
Sbjct: 110 N---------RLSTLPELPASLKHLDVDNNQLT----MLPELPALLEYINADNNQLT-ML 155
Query: 204 PAWMS 208
P +
Sbjct: 156 PELPT 160
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 29/143 (20%), Positives = 48/143 (33%), Gaps = 14/143 (9%)
Query: 75 LEDLDLTG--PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-HLKHLYLSHNRFTGTFP 131
LE ++ + T L +LS++NN L+ L P L+ L +S N + P
Sbjct: 142 LEYINADNNQLTMLPELPTSLEVLSVRNNQLTF----LPELPESLEALDVSTNLLE-SLP 196
Query: 132 SGVSSLRHLRRV----DLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR 187
+ H N IP + L T+ LEDN + + S
Sbjct: 197 AVPVRNHHSEETEIFFRCRENRIT-HIP-ENILSLDPTCTIILEDNPLSSRIRESLSQQT 254
Query: 188 SILDFNVSNNQLSGQIPAWMSPF 210
+ D++ S +
Sbjct: 255 AQPDYHGPRIYFSMSDGQQNTLH 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 16/124 (12%), Positives = 33/124 (26%), Gaps = 21/124 (16%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
L+Q + + + W + N + + L+
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLN 67
Query: 147 HNAYEGEIPMTELTRLP-----NLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201
L+ LP + L + N S+ S+ + +N+LS
Sbjct: 68 RL---------NLSSLPDNLPPQITVLEITQNALI----SLPELPASLEYLDACDNRLS- 113
Query: 202 QIPA 205
+P
Sbjct: 114 TLPE 117
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 39/172 (22%), Positives = 64/172 (37%), Gaps = 21/172 (12%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-HLKHLYLSHNRFT 127
L L L PA + L L L + +N L + + + +L L L N+
Sbjct: 63 LRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK 122
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSS 186
+ P V SL L + L +N + +P +L +L LRL +N+
Sbjct: 123 -SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKL 180
Query: 187 RSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPL---PSDCSNRTV 235
+ + NNQL ++P +F + L L P DC+ +
Sbjct: 181 TELKTLKLDNNQLK-RVPE-------GAFDSLEKLKMLQLQENPWDCTCNGI 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 45/273 (16%), Positives = 91/273 (33%), Gaps = 53/273 (19%)
Query: 359 VVVVKRIRERKKKREVDEWLRVIGG---LRHSNIVSIRAYCNGKDELFLVYDYL----PH 411
V+ ++ +R K +++ LR I ++ + + +++++ +
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188
Query: 412 GSLHSLLH--GSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD 469
+L + S + + RL+L + LA LH Y L H +L +IV+D
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLD 245
Query: 470 QLGNACISDIG------------VHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRC 517
Q G ++ + + F P A + +
Sbjct: 246 QRGGVFLTGFEHLVRDGASAVSPIGRGFAPP-----ETTAERML--PFGQHHPTLMTFAF 298
Query: 518 DVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRA 576
D ++ G+ + I + D LG +W+ K + + +RA
Sbjct: 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWI----------------FRSCKNIPQPVRA 342
Query: 577 LLQVALLCLAPLPKDRPNMS--IVHRMIEDIRT 607
LL+ L +DR + E +RT
Sbjct: 343 LLE---GFLRYPKEDRLLPLQAMETPEYEQLRT 372
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 26/111 (23%), Positives = 43/111 (38%), Gaps = 8/111 (7%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
L+ L L PA ++ L L+ L ++N+ LS+ + P L+ L L
Sbjct: 185 LQSLRLEWTGIRSLPAS-IANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALR 243
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL 179
+P L+R+ L + +P ++ RL L L L L
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLP-LDIHRLTQLEKLDLRGCVNLSRL 293
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 30/151 (19%), Positives = 54/151 (35%), Gaps = 30/151 (19%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
L+L P + RL+ L+ +++ L + + L+ L L+ N
Sbjct: 83 RVALELRSVPLPQFPDQ-AFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR- 140
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIP--------MTELTRLPNLLTLRLEDNRFT---- 176
P+ ++SL LR + + E+P E L NL +LRLE
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPA 200
Query: 177 --GTLYSVNSSSRSILDFNVSNNQLSGQIPA 205
L +++ + N+ LS +
Sbjct: 201 SIANL-------QNLKSLKIRNSPLS-ALGP 223
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 21/130 (16%), Positives = 35/130 (26%), Gaps = 31/130 (23%)
Query: 75 LEDLDLTG--------------------------PAEVLSRLTQLRLLSLKNNLLSS--S 106
E+L G A + ++ + L +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD 73
Query: 107 NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLL 166
L ++ P L L FP L HL+ + + E+P + + L
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP-DTMQQFAGLE 130
Query: 167 TLRLEDNRFT 176
TL L N
Sbjct: 131 TLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 23/115 (20%), Positives = 46/115 (40%), Gaps = 20/115 (17%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSL-KNNLLSS---------SNLNLSSWPHLKH 118
LE L L PA ++ L +LR LS+ L+ ++ +L+
Sbjct: 129 LETLTLARNPLRALPAS-IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
Query: 119 LYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
L L + P+ +++L++L+ + + ++ + + LP L L L
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALG-PAIHHLPKLEELDLRGC 239
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 54/299 (18%), Positives = 104/299 (34%), Gaps = 72/299 (24%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKK-----REVDEWLRVIGGLRHSNIVSI 392
+LG+G G K +K+IR ++K EV ++ L H +V
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV----MLLASLNHQYVVRY 67
Query: 393 -------------RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS 439
K LF+ +Y +G+L+ L+H + ++ +L
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYWRLFR 123
Query: 440 DSAKGLAFLHGYNKAHLFHGH--LSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA--- 494
+ L+++H H L NI +D+ N I D G+ + H I
Sbjct: 124 QILEALSYIHSQGII-----HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 495 -----------------YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537
Y A E+ + +Y+ ++ D+YS G++ E++ + G
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEV-LDGTGHYN-----EKIDMYSLGIIFFEMIYP-FSTG 231
Query: 538 DGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ I+K ++ +F D + + +++ L + P RP
Sbjct: 232 MERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGAR 279
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 32/134 (23%), Positives = 47/134 (35%), Gaps = 16/134 (11%)
Query: 75 LEDLDLTGPA----EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
L+ L L L L QL L L NN ++ LS L L L N+ +
Sbjct: 114 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDI- 171
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIP-MTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189
++ L L+ + LS N I + L L NL L L + + +S
Sbjct: 172 -VPLAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQECL----NKPINHQSN 222
Query: 190 LDFNVSNNQLSGQI 203
L + G +
Sbjct: 223 LVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 30/133 (22%), Positives = 54/133 (40%), Gaps = 8/133 (6%)
Query: 75 LEDLDLTGPA----EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
LE L L VLSRLT+L LSL++N +S L+ L++LYLS N +
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL- 193
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
++ L++L ++L P+ + L T++ D +
Sbjct: 194 -RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 251
Query: 191 DFNVSNNQLSGQI 203
+ + + ++
Sbjct: 252 NVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 30/130 (23%), Positives = 56/130 (43%), Gaps = 12/130 (9%)
Query: 75 LEDLDLTGPA----EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
++ + + + L + L L N L+ L++ +L L+L N+
Sbjct: 48 IDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDL- 105
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
S + L+ L+ + L HN +I L LP L +L L +N+ T +V S +
Sbjct: 106 -SSLKDLKKLKSLSLEHNGIS-DI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLD 159
Query: 191 DFNVSNNQLS 200
++ +NQ+S
Sbjct: 160 TLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 13/91 (14%), Positives = 36/91 (39%), Gaps = 8/91 (8%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
+ +LK ++ + + + + +++ G+ L ++ ++ L+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76
Query: 147 HNAYEGEIP-MTELTRLPNLLTLRLEDNRFT 176
N ++ + L L NL L L++N+
Sbjct: 77 GN----KLTDIKPLANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 12/85 (14%), Positives = 30/85 (35%), Gaps = 12/85 (14%)
Query: 98 LKNNLLSSSN-----LNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEG 152
L + ++ + ++ L T + L + ++ +++
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNS---- 56
Query: 153 EIP-MTELTRLPNLLTLRLEDNRFT 176
+I + + LPN+ L L N+ T
Sbjct: 57 DIKSVQGIQYLPNVTKLFLNGNKLT 81
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 44/217 (20%), Positives = 88/217 (40%), Gaps = 38/217 (17%)
Query: 339 ELLGKGCVGATYK-VVLDGGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAY 395
+ G+G G G V +K++ + + RE+ ++ + L H NIV +++Y
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSY 87
Query: 396 -----CNGKDELFL--VYDYLPHGSLHSLL-HGSRGPGRMPVDWNKR-----LKLASDSA 442
+ +++L V +Y+P +LH + R P K +
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI------- 139
Query: 443 KGLAFLHGYNKAHLFHGHLSSSNIVVDQL-GNACISDIG-----VHQLFHTPFFINDAYN 496
+ + LH ++ H + N++V++ G + D G + + + Y
Sbjct: 140 RSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR 198
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
APEL F N +Y+ D++S G + E++ G+
Sbjct: 199 APELIF-GNQHYT-----TAVDIWSVGCIFAEMMLGE 229
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 1/105 (0%)
Query: 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFP 131
+L L + + + L Q + +N + + LK L +++NR
Sbjct: 23 ELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICRIGE 81
Query: 132 SGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
+L L + L++N+ + L L +L L + N T
Sbjct: 82 GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 20/92 (21%), Positives = 34/92 (36%), Gaps = 5/92 (5%)
Query: 84 AEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRR 142
A + + R L L+ + NL ++ + S N G LR L+
Sbjct: 12 AAQYTNAVRDRELDLRGYKIPVIENLG-ATLDQFDAIDFSDNEIRKL--DGFPLLRRLKT 68
Query: 143 VDLSHNAYEGEIPMTELTRLPNLLTLRLEDNR 174
+ +++N I LP+L L L +N
Sbjct: 69 LLVNNNRIC-RIGEGLDQALPDLTELILTNNS 99
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 19/106 (17%), Positives = 40/106 (37%), Gaps = 7/106 (6%)
Query: 96 LSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIP 155
+ L L+ + ++ + L L + + ++L +D S N EI
Sbjct: 2 VKLTAELIEQA-AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIR 55
Query: 156 MTE-LTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
+ L L TL + +NR ++ + + + ++NN L
Sbjct: 56 KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 53/298 (17%), Positives = 97/298 (32%), Gaps = 46/298 (15%)
Query: 328 RNVGDLLKSSAELLGKGCVGATYKVVLDGGDVVVVKRI---RERKKKREVDEWLRVIGGL 384
+++ +L+ S ++LG G G G V VKR+ E+ + L
Sbjct: 11 QSLKNLVVSE-KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEI-KLLTES--D 66
Query: 385 RHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLL--HGSRGPGRMPVDWNKRLKLASDSA 442
H N++ L++ + +L L+ + L A
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 443 KGLAFLHGYNKAH--------LF--HGHLSSSNIVVDQLGNACISDIG-----VHQLFHT 487
G+A LH H L ++ + ISD G
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 488 PFFINDA-----YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM----AKGD 538
+N+ + APEL +NN ++R+ + D++S G V IL+ K
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 539 GELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
E I++ + + + + + D+ + E L+ + P RP
Sbjct: 246 RESNIIR---------GIFSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAM 291
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 28/113 (24%), Positives = 42/113 (37%), Gaps = 15/113 (13%)
Query: 72 KLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYLSHN 124
++ LE + P S +LR + L NN +S L L L L N
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL-----RSLNSLVLYGN 90
Query: 125 RFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
+ T P + L L+ + L+ N + + L NL L L DN+
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 22/107 (20%), Positives = 37/107 (34%), Gaps = 10/107 (9%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNL-SSWPHLKHLYLSHNRFT 127
L +DL+ + L L L L N ++ +L L+ L L+ N+
Sbjct: 58 LRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN 117
Query: 128 GTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
L +L + L N + I + L + T+ L N
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 51/214 (23%)
Query: 4 SRIFFFSFFCLFSLCLSN-SPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGV- 61
+ F F C +L + + +P+S+ V S+ +L+ V
Sbjct: 7 PIVGSFHFVCALALIVGSMTPFSNELES-----MVDYSNRNLTH--------------VP 47
Query: 62 TCNPSTHRVIKLVLEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS------SNLN 109
P + L L+ +S L++LR+L L +N + S
Sbjct: 48 KDLPPR-------TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFN- 99
Query: 110 LSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTEL-TRLPNLLTL 168
L++L +SHNR ++SLRHL DLS N ++ +P+ + L L L
Sbjct: 100 ----QDLEYLDVSHNRLQNISCCPMASLRHL---DLSFNDFD-VLPVCKEFGNLTKLTFL 151
Query: 169 RLEDNRFT-GTLYSVNSSSRSILDFNVSNNQLSG 201
L +F L V S + ++ + + G
Sbjct: 152 GLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKG 185
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 29/120 (24%), Positives = 49/120 (40%), Gaps = 26/120 (21%)
Query: 80 LTGPAEVLSRLTQLRLLSLKNNLLSS-------------SNLNLSS-----------WPH 115
A + ++ L L + N L+S LNLSS P
Sbjct: 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK 451
Query: 116 LKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRF 175
+K L L +NR + P V+ L+ L+ ++++ N + +P RL +L + L DN +
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 24/130 (18%), Positives = 43/130 (33%), Gaps = 21/130 (16%)
Query: 83 PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-HLKHLYLSHNRFTGTFPSGVSSLRHLR 141
+ S ++ + L + ++ P L + N FT + G S+L+ L+
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380
Query: 142 RVDLSHNAYEGEIPMTELTRLP-------NLLTLRLEDNRFTGTLYSVNSS----SRSIL 190
+ L N L N+ +L D + SIL
Sbjct: 381 TLILQRN---------GLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431
Query: 191 DFNVSNNQLS 200
N+S+N L+
Sbjct: 432 VLNLSSNMLT 441
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 11/140 (7%)
Query: 68 HRVIKLVLEDLDLTGPAE------VLSRLTQLRLLSLKNNLLSSSNLNLSSW-PHLKHLY 120
V L + +L +T + + L L + +KN + S L S +
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 121 LSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL 179
LS + T S ++ + N + + + L L TL L+ N
Sbjct: 336 LSISD-TPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLK-NF 392
Query: 180 YSVNSSSRSILDFNVSNNQL 199
+ V ++++ + L
Sbjct: 393 FKVALMTKNMSSLETLDVSL 412
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 35/196 (17%), Positives = 67/196 (34%), Gaps = 47/196 (23%)
Query: 351 KVVLDGGDVVVVKR-IRERKKKREVDEWLRVIGGLRHSNIVSIRAY-----CNGKDELFL 404
K ++ GD + ER + + + H +IV I + +G ++
Sbjct: 112 KGLVHSGDAEAQAMAMAER----------QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161
Query: 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSS 464
V +Y+ SL ++PV + + L++LH L + L
Sbjct: 162 VMEYVGGQSLKRSKGQ-----KLPVAE--AIAYLLEILPALSYLH---SIGLVYNDLKPE 211
Query: 465 NIVVDQLGNACISDIGV-------HQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRC 517
NI++ + + D+G L+ TP + APE+ +
Sbjct: 212 NIMLTE-EQLKLIDLGAVSRINSFGYLYGTP-----GFQAPEI--------VRTGPTVAT 257
Query: 518 DVYSFGVVLLEILTGK 533
D+Y+ G L +
Sbjct: 258 DIYTVGRTLAALTLDL 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 30/198 (15%), Positives = 77/198 (38%), Gaps = 34/198 (17%)
Query: 351 KVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410
+ + + + + K E+ ++I +++ ++ DE++++Y+Y+
Sbjct: 71 RDFTKSNNDKISIKSKYDDFKNEL----QIITDIKNEYCLTCEGIITNYDEVYIIYEYME 126
Query: 411 HGSLHSLLHGSRGPGRMPVDWNKRL------KLASDSAKGLAFLHGYNKAHLFHGHLSSS 464
+ S+ + ++ + + +++H N+ ++ H + S
Sbjct: 127 NDSILKFD---EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPS 181
Query: 465 NIVVDQLGNACISDIGVHQLFH---------TPFFINDAYNAPELKFNNNNNYSQRKFWQ 515
NI++D+ G +SD G + T + PE F+N ++Y+ K
Sbjct: 182 NILMDKNGRVKLSDFGESEYMVDKKIKGSRGTY-----EFMPPEF-FSNESSYNGAK--- 232
Query: 516 RCDVYSFGVVLLEILTGK 533
D++S G+ L +
Sbjct: 233 -VDIWSLGICLYVMFYNV 249
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 37/159 (23%), Positives = 56/159 (35%), Gaps = 44/159 (27%)
Query: 72 KLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSS--------SNLNLS---------SW 113
KL + LT P L+ LS+ +N L+S L
Sbjct: 125 KLWIFGNQLTSLPVL----PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLP 180
Query: 114 PHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLT----LR 169
L+ L +S N+ + P+ S L L +N LT LP L + L
Sbjct: 181 SGLQELSVSDNQLA-SLPTLPSELYKL---WAYNN---------RLTSLPALPSGLKELI 227
Query: 170 LEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208
+ NR T S+ + + VS N+L+ +P S
Sbjct: 228 VSGNRLT----SLPVLPSELKELMVSGNRLT-SLPMLPS 261
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 42/156 (26%), Positives = 58/156 (37%), Gaps = 50/156 (32%)
Query: 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSS-------------SNLNLSSWP---- 114
KL + LT + + L+ LS+ +N L+S N L+S P
Sbjct: 165 KLWAYNNQLT---SLPMLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPS 221
Query: 115 HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP----NLLTLRL 170
LK L +S NR T + P S L+ L +S N LT LP LL+L +
Sbjct: 222 GLKELIVSGNRLT-SLPVLPSELKEL---MVSGN---------RLTSLPMLPSGLLSLSV 268
Query: 171 EDNRFT------GTLYSVNSSSRSILDFNVSNNQLS 200
N+ T L S N+ N LS
Sbjct: 269 YRNQLTRLPESLIHL-------SSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 31/135 (22%), Positives = 53/135 (39%), Gaps = 26/135 (19%)
Query: 89 RLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148
+L++ + L++ L H+ L + N T + P+ LR L ++S N
Sbjct: 38 LNNGNAVLNVGESGLTT--LPDCLPAHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 149 A--------------YEGEIPMTELTRLP-NLLTLRLEDNRFTGTLYSVNSSSRSILDFN 193
P+T L LP L L + N+ T S+ + + +
Sbjct: 92 QLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT----SLPVLPPGLQELS 147
Query: 194 VSNNQLSGQIPAWMS 208
VS+NQL+ +PA S
Sbjct: 148 VSDNQLA-SLPALPS 161
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 28/138 (20%)
Query: 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFP 131
LV+ D +LT + + +LR L + N L+S + L
Sbjct: 65 TLVIPDNNLT---SLPALPPELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLP---- 117
Query: 132 SGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLT----LRLEDNRFTGTLYSVNSSSR 187
+ L ++ + N +LT LP L L + DN+ S+ +
Sbjct: 118 ---ALPSGLCKLWIFGN---------QLTSLPVLPPGLQELSVSDNQLA----SLPALPS 161
Query: 188 SILDFNVSNNQLSGQIPA 205
+ NNQL+ +P
Sbjct: 162 ELCKLWAYNNQLT-SLPM 178
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 23/140 (16%), Positives = 40/140 (28%), Gaps = 12/140 (8%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
L L + P L L+ ++L+ N LS L + +
Sbjct: 263 LLSLSVYRNQLTRLPES-LIHLSSETTVNLEGNPLSE--RTLQALREITSAPGYSGPIIR 319
Query: 129 TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188
+G S+ R R + L+ + E EDN
Sbjct: 320 FDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDN--ADAFSLFLDRLSE 377
Query: 189 ILDFNVSNNQLSGQIPAWMS 208
+F + QI +W++
Sbjct: 378 TENFI-KDAGFKAQISSWLA 396
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 16/115 (13%), Positives = 31/115 (26%), Gaps = 9/115 (7%)
Query: 92 QLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151
+ + L + + T T P + H+ + + N
Sbjct: 18 AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT 74
Query: 152 GEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAW 206
+P P L TL + N+ T +L + + F+ L
Sbjct: 75 -SLP----ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGL 123
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 31/130 (23%), Positives = 54/130 (41%), Gaps = 12/130 (9%)
Query: 75 LEDLDLTGPA----EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
+ L G E + L L L LK+N ++ L + + L LS N
Sbjct: 43 ITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLA-PLKNLTKITELELSGNPLKN-- 99
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
S ++ L+ ++ +DL+ +T L L NL L L+ N+ T S + ++
Sbjct: 100 VSAIAGLQSIKTLDLTSTQITD---VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQ 154
Query: 191 DFNVSNNQLS 200
++ N Q+S
Sbjct: 155 YLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 22/132 (16%), Positives = 53/132 (40%), Gaps = 11/132 (8%)
Query: 70 VIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT 129
IK+ ++T + L + LS +++ + +L L L N+ T
Sbjct: 21 AIKIAAGKSNVTDT-VTQADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITD- 77
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIP-MTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188
+ + +L + ++LS N + ++ + L ++ TL L + T + + +
Sbjct: 78 -LAPLKNLTKITELELSGN----PLKNVSAIAGLQSIKTLDLTSTQITDV--TPLAGLSN 130
Query: 189 ILDFNVSNNQLS 200
+ + NQ++
Sbjct: 131 LQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 6/92 (6%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
L+ LT L+ LS+ N +S L++ L L N+ + S ++SL +L V
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKISDI--SPLASLPNLIEVH 201
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
L +N P L NL + L + T
Sbjct: 202 LKNNQISDVSP---LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 20/119 (16%), Positives = 42/119 (35%), Gaps = 10/119 (8%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
L ++ + ++ + + + L T GV L +L ++L
Sbjct: 15 DPALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 147 HNAYEGEIP-MTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
N +I + L L + L L N S + +SI ++++ Q++ P
Sbjct: 72 DN----QITDLAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 22/121 (18%), Positives = 52/121 (42%), Gaps = 11/121 (9%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
L+ L++L L +N +S + L+S P+L ++L +N+ + S +++ +L V
Sbjct: 167 TPLANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVT 223
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
L++ I + NL+ + G + + S + ++ L+ +
Sbjct: 224 LTNQ----TITNQPVFYNNNLVVPNVVKGPS-GAPIAPATISDNG---TYASPNLTWNLT 275
Query: 205 A 205
+
Sbjct: 276 S 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 14/92 (15%), Positives = 30/92 (32%), Gaps = 7/92 (7%)
Query: 109 NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTL 168
+ + + + T + L + + + + L NL+ L
Sbjct: 14 PDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT---IEGVQYLNNLIGL 68
Query: 169 RLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
L+DN+ T + + I + +S N L
Sbjct: 69 ELKDNQITD--LAPLKNLTKITELELSGNPLK 98
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 48/215 (22%), Positives = 98/215 (45%), Gaps = 42/215 (19%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRI--RERKKKREVDEWLRVIGGLRHSNIVS-IRA 394
E +G+G G Y + + G V ++++ +++ KK + + V+ ++ NIV+ + +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
Y G DEL++V +YL GSL ++ M + + + L FLH
Sbjct: 86 YLVG-DELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAV--CRECLQALEFLHSNQV- 137
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGV-HQLFH----------TPFFINDAYNAPELKFN 503
H + S NI++ G+ ++D G Q+ TP+++ APE+
Sbjct: 138 --IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM-----APEV--- 187
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538
+++ + + D++S G++ +E M +G+
Sbjct: 188 ----VTRKAYGPKVDIWSLGIMAIE-----MIEGE 213
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 8/93 (8%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
L L +L+ LSL++N +S N L P L+ LYL +N+ T + +S L L +
Sbjct: 103 SSLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLS 159
Query: 145 LSHNAYEGEIP-MTELTRLPNLLTLRLEDNRFT 176
L N +I + L L L L L N +
Sbjct: 160 LEDN----QISDIVPLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 30/131 (22%), Positives = 56/131 (42%), Gaps = 14/131 (10%)
Query: 75 LEDLDLTGPA----EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
++ + + + L + L L N L+ L++ +L L+L N+
Sbjct: 45 IDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIK-PLTNLKNLGWLFLDENKIKDL- 102
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEI-PMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189
S + L+ L+ + L HN I + L LP L +L L +N+ T +V S +
Sbjct: 103 -SSLKDLKKLKSLSLEHN----GISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKL 155
Query: 190 LDFNVSNNQLS 200
++ +NQ+S
Sbjct: 156 DTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 26/119 (21%), Positives = 50/119 (42%), Gaps = 4/119 (3%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
VLSRLT+L LSL++N +S L+ L++LYLS N + ++ L++L ++
Sbjct: 147 TVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLE 203
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203
L P+ + L T++ D + + + + ++
Sbjct: 204 LFSQECL-NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 14/91 (15%), Positives = 37/91 (40%), Gaps = 8/91 (8%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146
+ +LK ++ + + + + +++ G+ L ++ ++ L+
Sbjct: 17 DDAFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 73
Query: 147 HNAYEGEIP-MTELTRLPNLLTLRLEDNRFT 176
N ++ + LT L NL L L++N+
Sbjct: 74 GN----KLTDIKPLTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 12/84 (14%), Positives = 30/84 (35%), Gaps = 11/84 (13%)
Query: 98 LKNNLLSSSNLN----LSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGE 153
+ + S+ + ++ L T + L + ++ +++ +
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNS----D 54
Query: 154 IP-MTELTRLPNLLTLRLEDNRFT 176
I + + LPN+ L L N+ T
Sbjct: 55 IKSVQGIQYLPNVTKLFLNGNKLT 78
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 16/138 (11%), Positives = 36/138 (26%), Gaps = 2/138 (1%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
L+ LT+L+ L L N +S L+ +L L L + S+L V
Sbjct: 169 VPLAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227
Query: 145 LSHNAYEGEIPMTELTRLPNL-LTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203
+ + +++ + L + + +
Sbjct: 228 NTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLK 287
Query: 204 PAWMSPFGGSSFAGNKNL 221
+ + +
Sbjct: 288 EVYTVSYDVDGTVIKTKV 305
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 29/106 (27%), Positives = 43/106 (40%), Gaps = 4/106 (3%)
Query: 72 KLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
L L + L L T+L L+L L+ + + P L L LSHN+ +
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQ-SL 92
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
P +L L +D+S N +P+ L L L L L+ N
Sbjct: 93 PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 33/115 (28%), Positives = 48/115 (41%), Gaps = 21/115 (18%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYLS 122
L LDL+ P + L L +L + N L+S L L+ LYL
Sbjct: 79 LGTLDLSHNQLQSLPL-LGQTLPALTVLDVSFNRLTSLPLGALRGL-----GELQELYLK 132
Query: 123 HNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
N T P G+ + L ++ L++N E+P L L NL TL L++N
Sbjct: 133 GNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 29/119 (24%), Positives = 44/119 (36%), Gaps = 35/119 (29%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYLS 122
L LD++ P L L +L+ L LK N L + + P L+ L L+
Sbjct: 102 LTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT-----PKLEKLSLA 156
Query: 123 HNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLP-------NLLTLRLEDN 173
+N T P+G+ + L +L + L N L +P L L N
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQEN---------SLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 22/105 (20%), Positives = 42/105 (40%), Gaps = 10/105 (9%)
Query: 106 SNLNLSSWP-----HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELT 160
NL++ P L+LS N + + L +++L ++
Sbjct: 18 DKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ--VDG 74
Query: 161 RLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA 205
LP L TL L N+ +L + + ++ +VS N+L+ +P
Sbjct: 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 49/210 (23%), Positives = 80/210 (38%), Gaps = 29/210 (13%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR----VIGGLRHSNIVSIR 393
+G G G +K+ G V+ VK++R K E L V+ IV +
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV--Q 88
Query: 394 AYCN--GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ ++F+ + + L R G +P K+ K L +L
Sbjct: 89 CFGTFITNTDVFIAMELM-GTCAEKLK--KRMQGPIPERILG--KMTVAIVKALYYLK-- 141
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVH-QLFHTPFFINDA----YNAPE---LKFN 503
K + H + SNI++D+ G + D G+ +L A Y APE
Sbjct: 142 EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+Y R DV+S G+ L+E+ TG+
Sbjct: 202 TKPDYDIR-----ADVWSLGISLVELATGQ 226
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 47/215 (21%), Positives = 79/215 (36%), Gaps = 36/215 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR------ERKK-KREVDEWLRVIGGLRHSNIV 390
+G+G G+ K+V G ++ VKRIR E+K+ ++D +R IV
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS---DCPYIV 84
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ + ++ + + S + K+ + K L L
Sbjct: 85 QFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK- 142
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVH-QLFH---------TPFFINDAYNAPE- 499
+ H + SNI++D+ GN + D G+ QL Y APE
Sbjct: 143 -ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP-----YMAPER 196
Query: 500 -LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ Y R DV+S G+ L E+ TG+
Sbjct: 197 IDPSASRQGYDVR-----SDVWSLGITLYELATGR 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 43/215 (20%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRI--RERKKKREVDEWLRVIGGLRHSNIVS-IRA 394
+G+G G G V VK + R+++++ + + ++ +H N+V ++
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
Y G +EL+++ ++L G+L ++ R+ + + + LA+LH
Sbjct: 111 YLVG-EELWVLMEFLQGGALTDIVS----QVRLNEEQIATV--CEAVLQALAYLHAQGVI 163
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGV-HQLFH----------TPFFINDAYNAPELKFN 503
H + S +I++ G +SD G Q+ TP+++ APE+
Sbjct: 164 HR---DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM-----APEV--- 212
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538
S+ + D++S G++++E M G+
Sbjct: 213 ----ISRSLYATEVDIWSLGIMVIE-----MVDGE 238
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 22/109 (20%), Positives = 41/109 (37%), Gaps = 6/109 (5%)
Query: 72 KLVLEDLDLTG--PAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFTG 128
+L L + + T + +L QLR ++ NN ++ + + L+ NR
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE- 94
Query: 129 TFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
+ L L+ + L N + L ++ L L DN+ T
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 22/112 (19%), Positives = 35/112 (31%), Gaps = 20/112 (17%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYLS 122
L ++ + + + + L +N L + L LK L L
Sbjct: 59 LRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGL-----ESLKTLMLR 113
Query: 123 HNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
NR T + L +R + L N + L +L TL L N
Sbjct: 114 SNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 45/209 (21%), Positives = 82/209 (39%), Gaps = 35/209 (16%)
Query: 340 LLGKGCVGATYKVV-LDGGDVVVVKRIRERK-KKREVDEWLR----VIGGLRHSNIVSIR 393
LGKG G Y ++ +K + + + +K V+ LR + LRH NI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
Y + + ++L+ ++ P G L+ L + GR + + A L + H +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSAT--FMEELADALHYCH---E 132
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIG--VHQLFH-------TPFFINDAYNAPELKFNN 504
+ H + N+++ G I+D G VH T Y PE+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTL-----DYLPPEMI--E 185
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ ++ D++ GV+ E L G
Sbjct: 186 GKTHD-----EKVDLWCAGVLCYEFLVGM 209
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 23/119 (19%), Positives = 44/119 (36%), Gaps = 23/119 (19%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSL-KNNLLSS------SNLNLSSWPHLKHLY 120
+ + ++ + L+++ + + L+ L P LK L
Sbjct: 57 ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKEL-----PLLKFLG 111
Query: 121 LSHNRFTGTFP--SGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLL-TLRLEDNRFT 176
+ + FP + V S ++++ N Y IP+ L N TL+L +N FT
Sbjct: 112 IFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 23/149 (15%), Positives = 49/149 (32%), Gaps = 14/149 (9%)
Query: 62 TCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLY 120
C+ + D+ + S + L L L + + S+ P++ +Y
Sbjct: 9 ECHQEED----FRVTCKDIQ---RIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61
Query: 121 LSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT--- 176
+S + S +L + +++ + I L LP L L + +
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP 121
Query: 177 GTLYSVNSSSRSILDFNVSNNQLSGQIPA 205
++ IL+ N ++ IP
Sbjct: 122 DLTKVYSTDIFFILEIT-DNPYMT-SIPV 148
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 22/138 (15%), Positives = 39/138 (28%), Gaps = 37/138 (26%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSS-------------------SNL 108
+ +++ + L L L+ L + N L N
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNP 141
Query: 109 NLSSWP---------HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTEL 159
++S P L L +N FT + + L V L+ N Y I
Sbjct: 142 YMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAF 200
Query: 160 TRLPNLLT-LRLEDNRFT 176
+ + + L + T
Sbjct: 201 GGVYSGPSLLDVSQTSVT 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 46/216 (21%), Positives = 84/216 (38%), Gaps = 39/216 (18%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR------ERKK-KREVDEWLRVIGGLRHSNIV 390
LG+G G K+ + G ++ VKRIR E+K+ ++D +R + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR---TVDCPFTV 69
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLL-HGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+ + ++++ + + SL +P D K+A K L LH
Sbjct: 70 TFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG--KIAVSIVKALEHLH 126
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH-QLFH---------TPFFINDAYNAPE 499
+K + H + SN++++ LG + D G+ L Y APE
Sbjct: 127 --SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP-----YMAPE 179
Query: 500 --LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
N YS + D++S G+ ++E+ +
Sbjct: 180 RINPELNQKGYSVK-----SDIWSLGITMIELAILR 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIR--ERKKKREVDEWLRVIGGLRHSNIVSIRAY- 395
+++G G G ++ L D V +K++ +R K RE+ + +R+ ++H N+V ++A+
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL-QIMRI---VKHPNVVDLKAFF 101
Query: 396 ---CNGKDE--LFLVYDYLPHGSLHSLL-HGSRGPGRMPVDWNKR----LKLASDSAKGL 445
+ KDE L LV +Y+P +++ H ++ MP+ K L + L
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL------LRSL 154
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQL-GNACISDIGV-HQLFHTPFFINDA----YNAPE 499
A++H + H + N+++D G + D G L ++ Y APE
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPE 211
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
L F N Y+ D++S G V+ E++ G+
Sbjct: 212 LIFGATN-YTTN-----IDIWSTGCVMAELMQGQ 239
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 44/214 (20%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS-IR 393
E +GKG G +K + VV +K I + + E+++ + V+ +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAKGLAFLHG 450
+Y +L+++ +YL GS LL PG + +A+ + KGL +LH
Sbjct: 88 SYLKD-TKLWIIMEYLGGGSALDLLE----PGPLDETQ-----IATILREILKGLDYLHS 137
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFH----------TPFFINDAYNAPE 499
K H + ++N+++ + G ++D GV QL TPF++ APE
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM-----APE 189
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ Q + + D++S G+ +E+ G+
Sbjct: 190 V-------IKQSAYDSKADIWSLGITAIELARGE 216
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 47/219 (21%), Positives = 79/219 (36%), Gaps = 50/219 (22%)
Query: 339 ELLGKGCVGATYK---VVLD------------GGDVVVVKRIRERKKKREVDEWLRVIGG 383
L+G+G +G Y+ V + D V R++ RE R G
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ-----REA----RTAGR 90
Query: 384 LRHSNIVSIRAYCNGKDE--LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDS 441
L+ ++V I + G+ + L++ + L ++L R G + + + +
Sbjct: 91 LQEPHVVPI--HDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPP--RAVAIVRQI 143
Query: 442 AKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV------HQLFHTPFFI-NDA 494
L H A H + NI+V A + D G+ +L +
Sbjct: 144 GSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY 200
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y APE ++ Y R D+Y+ VL E LTG
Sbjct: 201 YMAPERFSESHATY-------RADIYALTCVLYECLTGS 232
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 49/216 (22%), Positives = 96/216 (44%), Gaps = 44/216 (20%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVS-IRAYC 396
E LG+G G+ YK + + G +V +K++ +E+ + + ++ ++V +Y
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAKGLAFLHGYNK 453
+L++V +Y GS+ ++ + D +A+ + KGL +LH K
Sbjct: 95 KN-TDLWIVMEYCGAGSVSDIIRLRNKT--LTEDE-----IATILQSTLKGLEYLHFMRK 146
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFH----------TPFFINDAYNAPELKF 502
H + + NI+++ G+A ++D GV QL TPF++ APE+
Sbjct: 147 IHR---DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWM-----APEV-- 196
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538
+ + D++S G+ +E MA+G
Sbjct: 197 -----IQEIGYNCVADIWSLGITAIE-----MAEGK 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 41/221 (18%), Positives = 87/221 (39%), Gaps = 47/221 (21%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRI--RERKKKREVDEWLRVIGGLRHSNIVS-IRA 394
LG G G YK + G + K I + ++ + + ++ H IV + A
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAKGLAFLHGY 451
Y + +L+++ ++ P G++ +++ + + + L FLH
Sbjct: 85 YYHD-GKLWIMIEFCPGGAVDAIMLELDRG--LTEPQ-----IQVVCRQMLEALNFLHSK 136
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFH----------TPFFINDAYNAPEL 500
H L + N+++ G+ ++D GV + TP+++ APE+
Sbjct: 137 RI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM-----APEV 188
Query: 501 ---KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538
+ + Y + D++S G+ L+E MA+ +
Sbjct: 189 VMCETMKDTPYD-----YKADIWSLGITLIE-----MAQIE 219
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 42/216 (19%)
Query: 339 ELLGKGCVGATYK-VVLDGGDVVVVKRIR--ERKKKREVDEWLRVIGGLRHSNIVSIRAY 395
+++G G G Y+ + D G++V +K++ +R K RE+ + +R L H NIV +R +
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL-QIMRK---LDHCNIVRLRYF 115
Query: 396 ----CNGKDE--LFLVYDYLPHGSLHSLL-HGSRGPGRMPVDWNKR-----LKLASDSAK 443
KDE L LV DY+P +++ + H SR +PV + K +
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF-------R 167
Query: 444 GLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGV-HQLFHTPFFINDA----YNA 497
LA++H + + H + N+++D + D G QL ++ Y A
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 224
Query: 498 PELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
PEL F +Y+ DV+S G VL E+L G+
Sbjct: 225 PELIF-GATDYT-----SSIDVWSAGCVLAELLLGQ 254
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 44/281 (15%), Positives = 98/281 (34%), Gaps = 49/281 (17%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRI-RERKKKREVDEWLRVIG---GLRH--SNIVSI 392
+ +G G ++V+ + + +K + E + +D + I L+ I+ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
Y +++V + + L+S L + + K + + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKK--SIDPWERKSY--WKNMLEAVHTIH--- 172
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-------------TPFFINDAYNAPE 499
+ + H L +N ++ G + D G+ Y PE
Sbjct: 173 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVN-----YMPPE 226
Query: 500 L----KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDES 555
+ N S+ K + DV+S G +L + GK I K ++ +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+F I +K++++ ++ L+ PK R ++
Sbjct: 287 ----IEFPDIPEKDLQDVLKCCLKRD-------PKQRISIP 316
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 20/204 (9%), Positives = 50/204 (24%), Gaps = 50/204 (24%)
Query: 339 ELLGKGCVGATYK---VVLDGGDVVVVKRIR------ERKKKREVDEWLRVIGGLRHSNI 389
G ++ LD V + + + + + + + +
Sbjct: 37 IFHGGVPPLQFWQALDTALD--RQVALTFVDPQGVLPDDVLQETLSR-TLRLSRIDKPGV 93
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+ + + +V +++ GSL + S P ++ A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA-------IRAMQSLAAAADAAH 146
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYS 509
+A + S + V G+ ++
Sbjct: 147 ---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------------TMPDA---------- 179
Query: 510 QRKFWQRCDVYSFGVVLLEILTGK 533
+ D+ G L +L +
Sbjct: 180 ----NPQDDIRGIGASLYALLVNR 199
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 36/218 (16%), Positives = 78/218 (35%), Gaps = 38/218 (17%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRI-RERKKKREVDEWLRVIGGLR-----HSNIVSI 392
+ +G G ++V+ + + +K + E + +D + I L I+ +
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
Y +++V + + L+S L + +D +R + + + +H +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKS----IDPWERKSYWKNMLEAVHTIHQHG 128
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-------------TPFFINDAYNAPE 499
+ H L +N ++ G + D G+ T ++ PE
Sbjct: 129 ---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM-----PPE 179
Query: 500 L----KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ N S+ K + DV+S G +L + GK
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 23/156 (14%), Positives = 43/156 (27%), Gaps = 7/156 (4%)
Query: 100 NNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTE 158
+ S +L +L LY+ + + L LR + + + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 159 LTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQL----SGQIPAWMSPFGGSS 214
P L L L N +L S+ + +S N L + + G
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGG 134
Query: 215 FAGNKNLCGRPLPSDCSNRTVEPEQPPRSRPRSSRV 250
K C P + + ++ V
Sbjct: 135 VPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASV 170
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 3e-06
Identities = 18/87 (20%), Positives = 27/87 (31%), Gaps = 19/87 (21%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYL 121
L +L + L L +LR L++ + L P L L L
Sbjct: 33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT-----PRLSRLNL 87
Query: 122 SHNRFTGTFPSGVSSLRHLRRVDLSHN 148
S N + L+ + LS N
Sbjct: 88 SFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 20/99 (20%), Positives = 30/99 (30%), Gaps = 18/99 (18%)
Query: 87 LSRLTQLRLLSLKNNLLSSS--NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
L L L ++N +L L++L + + P L R++
Sbjct: 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86
Query: 145 LSHNAYEGEIPMTELTRLP-------NLLTLRLEDNRFT 176
LS NA L L +L L L N
Sbjct: 87 LSFNA---------LESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 13/59 (22%), Positives = 20/59 (33%), Gaps = 6/59 (10%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT 127
L +L + + +L L+L N L S + L+ L LS N
Sbjct: 58 LRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 23/117 (19%), Positives = 46/117 (39%), Gaps = 11/117 (9%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
+ T L+ L L +N +S + L L+ L ++ NR + L L
Sbjct: 57 AGMQFFTNLKELHLSHNQISDLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSRL---F 112
Query: 145 LSHNAYEGEIP-MTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200
L +N E+ L L NL L + +N+ ++ + + ++ N+++
Sbjct: 113 LDNN----ELRDTDSLIHLKNLEILSIRNNKLK-SIVML-GFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 23/130 (17%), Positives = 50/130 (38%), Gaps = 13/130 (10%)
Query: 75 LEDLDLTGPA----EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF 130
+L + L+ ++ + N+ + S + + +LK L+LSHN+ +
Sbjct: 21 AVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDL- 78
Query: 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
S + L L + ++ N + L L L++N T +++
Sbjct: 79 -SPLKDLTKLEELSVNRN----RLKNLNGIPSACLSRLFLDNNELRDT--DSLIHLKNLE 131
Query: 191 DFNVSNNQLS 200
++ NN+L
Sbjct: 132 ILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 8/66 (12%), Positives = 18/66 (27%), Gaps = 5/66 (7%)
Query: 109 NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTL 168
+ L T L ++ + ++ + + + NL L
Sbjct: 14 PDPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQS---LAGMQFFTNLKEL 68
Query: 169 RLEDNR 174
L N+
Sbjct: 69 HLSHNQ 74
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 35/218 (16%), Positives = 77/218 (35%), Gaps = 38/218 (17%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRI-RERKKKREVDEWLRVIG---GLRH--SNIVSI 392
+ +G G ++V+ + + +K + E + +D + I L+ I+ +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
Y +++V + + L+S L + + K + + + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKS--YWKNMLEAVHTIH--- 144
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-------------TPFFINDAYNAPE 499
+ + H L +N ++ G + D G+ T ++ PE
Sbjct: 145 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM-----PPE 198
Query: 500 L----KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ N S+ K + DV+S G +L + GK
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 53/244 (21%), Positives = 102/244 (41%), Gaps = 44/244 (18%)
Query: 339 ELLGKGCVGATYKVVLDG-----GDVVVVKRIRERKKK--------REVDEWLRVIGGLR 385
L+G+G +Y +V+ G +V +K+ E RE+ +++ LR
Sbjct: 31 GLVGEG----SYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREI----KLLKQLR 82
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL 445
H N+V++ C K +LV++++ H ++ L P + + K G+
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQ--KYLFQIINGI 137
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--FFIND----AYNAPE 499
F H +N + H + NI+V Q G + D G + P + ++ Y APE
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMG-QDESA 556
L + Y + DV++ G ++ E+ G+ + GD ++ + + +G
Sbjct: 195 LLV-GDVKYG-----KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248
Query: 557 WEVF 560
E+F
Sbjct: 249 QELF 252
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 48/224 (21%), Positives = 92/224 (41%), Gaps = 51/224 (22%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRV-IGGLR----HSNIVS- 391
EL+G G G YK + G + +K + + +E ++ I L+ H NI +
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 392 -----IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAK 443
+ D+L+LV ++ GS+ L+ ++G + +W +A + +
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEW-----IAYICREILR 140
Query: 444 GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFH----------TPFFIN 492
GL+ LH + H + N+++ + + D GV QL TP+++
Sbjct: 141 GLSHLHQHKVIHR---DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM- 196
Query: 493 DAYNAPEL---KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
APE+ N + Y + D++S G+ +E+ G
Sbjct: 197 ----APEVIACDENPDATYD-----FKSDLWSLGITAIEMAEGA 231
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 46/217 (21%)
Query: 339 ELLGKGCVGATYK---VVLDGGDVVVVKRIRE---------RKKKREVDEWLRVIGGLRH 386
+ LG G + Y +L+ V +K I ++ +REV L H
Sbjct: 17 DKLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREV----HNSSQLSH 70
Query: 387 SNIVSIRAYCNGKDE--LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKG 444
NIVS+ +++ +LV +Y+ +L + S G P+ + + + G
Sbjct: 71 QNIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIE-SHG----PLSVDTAINFTNQILDG 123
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV------HQLFHTPFFINDA-YNA 497
+ H + H + NI++D I D G+ L T + Y +
Sbjct: 124 IKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180
Query: 498 PELKFNNNNNYSQRKFW-QRCDVYSFGVVLLEILTGK 533
PE ++ + + D+YS G+VL E+L G+
Sbjct: 181 PEQ--------AKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 47/232 (20%), Positives = 84/232 (36%), Gaps = 46/232 (19%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR----VIGGLRHSNIVSIR 393
+ LG G G +K IR+ + L V+ L H NI+ +
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAK----GLAF 447
+ K +LV + G L + R + A+ K G+ +
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEII-HRM----------KFNEVDAAVIIKQVLSGVTY 151
Query: 448 LHGYNKAH--------LFHGHLSSSNIVVDQLGNACISDIG--VHQLFHTPFFINDAYNA 497
LH +N H L + I + G + + + + + T + Y A
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY-----YIA 206
Query: 498 PELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQ 548
PE+ ++K+ ++CDV+S GV+L +L G G + I++ V+
Sbjct: 207 PEV--------LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 53/247 (21%), Positives = 99/247 (40%), Gaps = 50/247 (20%)
Query: 339 ELLGKGCVGATYKVVLDG-----GDVVVVKRIRERKKK--------REVDEWLRVIGGLR 385
+G+G +Y VV G +V +K+ E + RE+ R++ L+
Sbjct: 9 GKIGEG----SYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREI----RMLKQLK 60
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK---LASDSA 442
H N+V++ K L LV++Y H ++ L R +P K + L
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTL----- 112
Query: 443 KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--FFINDA----YN 496
+ + F H K + H + NI++ + + D G +L P ++ ++ Y
Sbjct: 113 QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMG-QD 553
+PEL + Y DV++ G V E+L+G + G ++ + + +G
Sbjct: 170 SPELLV-GDTQYG-----PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI 223
Query: 554 ESAWEVF 560
+VF
Sbjct: 224 PRHQQVF 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 54/240 (22%), Positives = 102/240 (42%), Gaps = 43/240 (17%)
Query: 339 ELLGKGCVGATYKVVLDG----GDVVVVKRIRERKKK--------REVDEWLRVIGGLRH 386
E +G+G TY VV G +V +KRIR + RE+ ++ L H
Sbjct: 27 EKVGEG----TYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKELHH 78
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLA 446
NIVS+ + + L LV++++ L +L ++ + K +G+A
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG--LQDSQIK--IYLYQLLRGVA 133
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF--FINDA----YNAPEL 500
H + + H L N++++ G ++D G+ + F P + ++ Y AP++
Sbjct: 134 HCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMGQ-DESAW 557
+ YS D++S G + E++TGK + G + + K ++G + W
Sbjct: 191 LM-GSKKYS-----TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 19/136 (13%), Positives = 37/136 (27%), Gaps = 35/136 (25%)
Query: 75 LEDLDLTG-------PAEVLSRLTQLRLLSLKNNLLSS------------------SNLN 109
L ++ + E L L+ L + N + N+N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 110 LSSWPH---------LKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELT 160
+ + L+L+ N + + L ++LS N E+P
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 161 RLPNLLTLRLEDNRFT 176
+ L + R
Sbjct: 200 GASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 18/103 (17%), Positives = 29/103 (28%), Gaps = 12/103 (11%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFT 127
L L + L NN L + L +S R
Sbjct: 156 SVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
Query: 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRL 170
G+ +L+ LR + ++P L +L L+ L
Sbjct: 216 SLPSYGLENLKKLRARSTYNLK---KLPT--LEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 24/186 (12%), Positives = 40/186 (21%), Gaps = 52/186 (27%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNN-------------LLSSSNLNLSSW-- 113
+L S L + + N L + +
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 114 ------------PHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELT 160
P+L++L +S+ P +D+ N I
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 161 RLPNLL-TLRLEDNRFT----GTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSF 215
L L L N ++ D NN L ++P F
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSD----NNNLE-ELPN-------DVF 198
Query: 216 AGNKNL 221
G
Sbjct: 199 HGASGP 204
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 14/80 (17%), Positives = 26/80 (32%), Gaps = 7/80 (8%)
Query: 100 NNLLSSSNLNLSSWP-----HLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGE 153
N + ++ P + L + G S L ++++S N
Sbjct: 11 NRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 154 IPMTELTRLPNLLTLRLEDN 173
I + LP L +R+E
Sbjct: 70 IEADVFSNLPKLHEIRIEKA 89
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 30/135 (22%), Positives = 51/135 (37%), Gaps = 18/135 (13%)
Query: 84 AEVLSRLTQLRLLSLKNNLLSSSNLNL------SSWPHLKHLYLSHNRFTGT----FPSG 133
+ L L L+L++N L ++ + ++ L L + TG S
Sbjct: 49 SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108
Query: 134 VSSLRHLRRVDLSHNA--YEGEIPMTELTRLPN--LLTLRLEDNRFTGT----LYSVNSS 185
+ +L L+ + LS N G + E P L L+LE + L SV +
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 186 SRSILDFNVSNNQLS 200
+ VSNN ++
Sbjct: 169 KPDFKELTVSNNDIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 27/135 (20%), Positives = 51/135 (37%), Gaps = 18/135 (13%)
Query: 84 AEVLSRLTQLRLLSLKNNLLSSSNLN------LSSWPHLKHLYLSHNRFTGT----FPSG 133
+ L L L+ L L +NLL + L L L+ L L + + S
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165
Query: 134 VSSLRHLRRVDLSHNA--YEGEIPMTELTRLPN--LLTLRLEDNRFT----GTLYSVNSS 185
+ + + + +S+N G + + + L L+LE T L + +S
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 186 SRSILDFNVSNNQLS 200
S+ + + +N+L
Sbjct: 226 KASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 31/135 (22%), Positives = 51/135 (37%), Gaps = 18/135 (13%)
Query: 84 AEVLSRLTQLRLLSLKNNLLSSSNLNL------SSWPHLKHLYLSHNRFTGT----FPSG 133
VL L+ LSL N L L L+ L++ FT F S
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 336
Query: 134 VSSLRHLRRVDLSHNA--YEGEIPMTELTRLPN--LLTLRLEDNRFT----GTLYSVNSS 185
++ R L + +S+N G + + P L L L D + +L + +
Sbjct: 337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 396
Query: 186 SRSILDFNVSNNQLS 200
+ S+ + ++SNN L
Sbjct: 397 NHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 30/135 (22%), Positives = 53/135 (39%), Gaps = 18/135 (13%)
Query: 84 AEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKHLYLSHNRFT----GTFPSG 133
+++ LR L+L +N L L L+ L++ T G
Sbjct: 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279
Query: 134 VSSLRHLRRVDLSHNA--YEGEIPMTELTRLPN--LLTLRLEDNRFTGT----LYSVNSS 185
+ + L+ + L+ N EG + E P L +L ++ FT SV +
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 186 SRSILDFNVSNNQLS 200
+R +L+ +SNN+L
Sbjct: 340 NRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 21/124 (16%), Positives = 45/124 (36%), Gaps = 14/124 (11%)
Query: 91 TQLRLLSLKNNLLSSSNLN--LSSWPHLKHLYLSHNRFTGT----FPSGVSSLRHLRRVD 144
++ L ++ LS + L + + L T S + L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 145 LSHNA--YEGEIPMTELTRLPN--LLTLRLEDNRFTGT----LYSVNSSSRSILDFNVSN 196
L N G + + + P+ + L L++ TG L S + ++ + ++S+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 197 NQLS 200
N L
Sbjct: 123 NLLG 126
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 48/218 (22%), Positives = 85/218 (38%), Gaps = 45/218 (20%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWL-----RVIGGLRHSNIVS- 391
+G G GA Y + +VV +K++ K+ R + LRH N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS---DSAKGLAFL 448
Y +LV +Y GS LL + P + +A+ + +GLA+L
Sbjct: 120 RGCYLRE-HTAWLVMEYCL-GSASDLLEVHKKP--LQEVE-----IAAVTHGALQGLAYL 170
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFH------TPFFINDAYNAPEL- 500
H +N H + + NI++ + G + D G + TP+++ APE+
Sbjct: 171 HSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWM-----APEVI 222
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538
+ Y + DV+S G+ +E +A+
Sbjct: 223 LAMDEGQYD-----GKVDVWSLGITCIE-----LAERK 250
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 59/242 (24%), Positives = 105/242 (43%), Gaps = 42/242 (17%)
Query: 339 ELLGKGCVGATYKVV-----LDGGDVVVVKRIRERKKK-------REVDEWLRVIGGLRH 386
E LG G TY V G V +K ++ ++ RE+ ++ L+H
Sbjct: 11 EKLGNG----TYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREI----SLMKELKH 62
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAKG 444
NIV + + +++L LV++++ + L + SR G P L +G
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMD-SRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF--FINDA----YNAP 498
LAF H + + H L N+++++ G + D G+ + F P F ++ Y AP
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMGQ-DES 555
++ + YS D++S G +L E++TGK + G + + +MG +ES
Sbjct: 178 DVLM-GSRTYS-----TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 556 AW 557
W
Sbjct: 232 LW 233
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 31/163 (19%)
Query: 384 LRHSNIVSIR--AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDS 441
L H N+V + +D L++V++ + G + + + D + D
Sbjct: 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSED--QARFYFQDL 146
Query: 442 AKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-----------TPFF 490
KG+ +LH + H + SN++V + G+ I+D GV F TP
Sbjct: 147 IKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTP-- 201
Query: 491 INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
A+ APE +S + DV++ GV L + G+
Sbjct: 202 ---AFMAPESLSETRKIFSGKA----LDVWAMGVTLYCFVFGQ 237
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 7e-07
Identities = 55/236 (23%), Positives = 102/236 (43%), Gaps = 35/236 (14%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKK--------REVDEWLRVIGGLRHSNIV 390
E +G+G G YK + G+ +K+IR K+ RE+ ++ L+HSNIV
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI----SILKELKHSNIV 63
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ + K L LV+++L L LL G + K G+A+ H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAK--SFLLQLLNGIAYCH- 117
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF--FINDA----YNAPELKFNN 504
+ H L N+++++ G I+D G+ + F P + ++ Y AP++
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM-G 174
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMGQ-DESAW 557
+ YS D++S G + E++ G + G E +++ +++G + W
Sbjct: 175 SKKYS-----TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 1e-06
Identities = 49/245 (20%), Positives = 94/245 (38%), Gaps = 51/245 (20%)
Query: 339 ELLGKGCVGATYKVV-----LDGGDVVVVKRIRERKKK--------REVDEWLRVIGGLR 385
E +G+G TY V + ++V +KR+R RE+ ++ L+
Sbjct: 8 EKIGEG----TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKELK 59
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK---LASDSA 442
H NIV + + +L LV+++ L G + + K L
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLL----- 111
Query: 443 KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF--FINDA----YN 496
KGL F H ++ H L N+++++ G +++ G+ + F P + + Y
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA--KGDGELG-IVKWVQMMGQ- 552
P++ F YS D++S G + E+ G+ + + +++G
Sbjct: 169 PPDVLF-GAKLYS-----TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 553 DESAW 557
E W
Sbjct: 223 TEEQW 227
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 48/218 (22%), Positives = 80/218 (36%), Gaps = 46/218 (21%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVD-EWLR----VIGGLRHSNIVSI 392
+LGKG G G VK I +R+ K++ D E L ++ L H NI+ +
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAK----GLA 446
+ K +LV + G L + SR R A+ + G+
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEII-SRK----------RFSEVDAARIIRQVLSGIT 140
Query: 447 FLHGYNKAH--------LFHGHLSSSNIVVDQLGNACISDIG--VHQLFHTPFFINDAYN 496
++H H L +NI + G + + + T + Y
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-----YI 195
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM 534
APE+ + ++CDV+S GV+L +L+G
Sbjct: 196 APEV--------LHGTYDEKCDVWSTGVILYILLSGCP 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 48/213 (22%), Positives = 92/213 (43%), Gaps = 40/213 (18%)
Query: 339 ELLGKGCVGATYKVVLDG-----GDVVVVKRIRERKKK-------REVDEWLRVIGGLRH 386
+ LG+G TY V G ++V +K IR ++ REV ++ L+H
Sbjct: 8 DKLGEG----TYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREV----SLLKDLKH 59
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLA 446
+NIV++ + + L LV++YL L L + + K +GLA
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI--INMHNVK--LFLFQLLRGLA 114
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF--FINDA----YNAPEL 500
+ H + + H L N+++++ G ++D G+ + P + N+ Y P++
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ +YS + D++ G + E+ TG+
Sbjct: 172 LL-GSTDYS-----TQIDMWGVGCIFYEMATGR 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 43/225 (19%), Positives = 88/225 (39%), Gaps = 50/225 (22%)
Query: 349 TYKVV-----LDGGDVVVVKRIRERKKK--------REVDEWLRVIGGLRHSNIVSIR-- 393
T+ V G V +K++ +K RE+ +++ L+H N+V++
Sbjct: 29 TFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI----KILQLLKHENVVNLIEI 84
Query: 394 ------AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
Y K ++LV+D+ H L LL S + + K ++ GL +
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIK--RVMQMLLNGLYY 139
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA----------YNA 497
+H + + H + ++N+++ + G ++D G+ + F Y
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196
Query: 498 PELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGEL 541
PEL +Y D++ G ++ E+ T + +G+ E
Sbjct: 197 PELLL-GERDYG-----PPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 42/218 (19%), Positives = 74/218 (33%), Gaps = 49/218 (22%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR---------ERKKKREVDEWLRVIGGLRHSN 388
LGKG +++ D +V K + K E+ R L H +
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI-SIHRS---LAHQH 102
Query: 389 IVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAKGLA 446
+V + D +F+V + SL L + + + ++ G
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVL----GCQ 155
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-----------TPFFINDAY 495
+LH + + H L N+ +++ I D G+ TP Y
Sbjct: 156 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP-----NY 207
Query: 496 NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
APE+ + +S DV+S G ++ +L GK
Sbjct: 208 IAPEVL--SKKGHS-----FEVDVWSIGCIMYTLLVGK 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 47/225 (20%), Positives = 86/225 (38%), Gaps = 51/225 (22%)
Query: 332 DLLKSSAELLGKGCVGATYKVVL----DGGDVVVVKRIRER--KKKREVD------EWLR 379
+ + ++G+G G +V D G + +K + ++ K K+ L
Sbjct: 192 SVHR----IIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 380 VIGGLRHSNIVSIRAYCN-GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKL- 437
++ IV + +Y D+L + D + G LH L + V ++
Sbjct: 245 LVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS------QHGVFSEADMRFY 297
Query: 438 ASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---------TP 488
A++ GL +H + + L +NI++D+ G+ ISD+G+ F T
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354
Query: 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y APE+ Y W +S G +L ++L G
Sbjct: 355 -----GYMAPEV-LQKGVAYDSSADW-----FSLGCMLFKLLRGH 388
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 43/223 (19%), Positives = 86/223 (38%), Gaps = 42/223 (18%)
Query: 332 DLLKSSAELLGKGCVGATYKVVL----DGGDVVVVKRIRERK--KKREVDEWL---RVIG 382
++LK ++G+G +V + G V +K + + K+ EV + V+
Sbjct: 64 EILK----VIGRGAFS---EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 383 GLRHSNIVSIRAYC-NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNK----RLKL 437
I + + ++ L+LV +Y G L +LL S+ R+P + + + +
Sbjct: 117 NGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMARFYLAEIVM 173
Query: 438 ASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG------VHQLFHTPFFI 491
A + +H H + NI++D+ G+ ++D G + +
Sbjct: 174 A------IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 492 N--DAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
D Y +PE+ + CD ++ GV E+ G
Sbjct: 225 GTPD-YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 35/111 (31%), Positives = 45/111 (40%), Gaps = 18/111 (16%)
Query: 75 LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW-----PHLKHLYLSH 123
L L L P V LTQL L L N L S L S LK L L+
Sbjct: 85 LGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS----LPSGVFDRLTKLKELRLNT 140
Query: 124 NRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
N+ + P+G L +L+ + LS N + +P RL L T+ L N
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 30/108 (27%), Positives = 45/108 (41%), Gaps = 5/108 (4%)
Query: 72 KLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-HLKHLYLSHNRFTGT 129
KL L+ L LT+L L+L N L + + + L L L++N+ +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 130 FPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
P GV L L ++ L N + +P RL L LRL N+
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 48/174 (27%)
Query: 383 GLRHSNIVSIRAYCNGKDEL------FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK 436
L H IV++ Y G+ E ++V +Y+ +L ++H G M + ++
Sbjct: 68 ALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPK--RAIE 120
Query: 437 LASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV--------HQLFHTP 488
+ +D+ + L F H + + H + +NI++ + D G+ + + T
Sbjct: 121 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 489 FFINDA-YNAPELKFNNNNNYSQRKFWQ--------RCDVYSFGVVLLEILTGK 533
I A Y +PE Q R DVYS G VL E+LTG+
Sbjct: 178 AVIGTAQYLSPE---------------QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 31/104 (29%), Positives = 44/104 (42%), Gaps = 4/104 (3%)
Query: 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSS-SNLNLSSWPHLKHLYLSHNRFTGTF 130
+L L+ T + LS L L+ L NN +S+ SN + S+ L L LS+NR
Sbjct: 35 ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 131 PSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
P L+ LR + L N +P L L L + N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 51/246 (20%), Positives = 96/246 (39%), Gaps = 50/246 (20%)
Query: 339 ELLGKGCVGATYKVV-----LDGGDVVVVKRIRERKKK--------REVDEWLRVIGGLR 385
LG+G TY V + V +KRIR ++ REV ++ L+
Sbjct: 40 TKLGEG----TYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV----SLLKELQ 91
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL 445
H NI+ +++ + L L+++Y + L + + + + K G+
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN---PDVSMRVIK--SFLYQLINGV 145
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNAC-----ISDIGVHQLFHTPF--FINDA---- 494
F H H L N+++ + I D G+ + F P F ++
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMGQ 552
Y PE+ + +YS D++S + E+L + GD E+ + K +++G
Sbjct: 203 YRPPEILL-GSRHYS-----TSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256
Query: 553 -DESAW 557
D++ W
Sbjct: 257 PDDTTW 262
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 34/209 (16%)
Query: 341 LGKGCVGATYKVVL----DGGDVVVVKRI-RERKKKREVDEWLRVIG---GLRHSNIVSI 392
+GKG KV L G V +K I + + + + R + L H NIV +
Sbjct: 23 IGKGNFA---KVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAKGLAFLHG 450
+ L+L+ +Y G + L GRM + ++ S + + H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVS----AVQYCH- 131
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND-----AYNAPELKFNNN 505
+ + H L + N+++D N I+D G F ++ Y APEL
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF--QG 187
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKM 534
Y + DV+S GV+L +++G +
Sbjct: 188 KKYDGPE----VDVWSLGVILYTLVSGSL 212
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 34/111 (30%), Positives = 44/111 (39%), Gaps = 18/111 (16%)
Query: 72 KLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWP--------HLKHLYLS 122
+L L L P V LTQL +L L N L+ P HLK L++
Sbjct: 68 ELYLGSNQLGALPVGVFDSLTQLTVLDLGTN-------QLTVLPSAVFDRLVHLKELFMC 120
Query: 123 HNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
N+ T P G+ L HL + L N + IP RL +L L N
Sbjct: 121 CNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFGN 169
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 41/214 (19%), Positives = 75/214 (35%), Gaps = 41/214 (19%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRI-RERKKKREVDEWLR----VIGGLRHSNIVSI 392
LGKG +++ D +V K + + K E + + L H ++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAKGLAFLHG 450
+ D +F+V + SL L + + + ++ G +LH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVL----GCQYLH- 132
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-----------TPFFINDAYNAPE 499
+ + H L N+ +++ I D G+ TP Y APE
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP-----NYIAPE 185
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ + +S DV+S G ++ +L GK
Sbjct: 186 VL--SKKGHS-----FEVDVWSIGCIMYTLLVGK 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 43/215 (20%), Positives = 84/215 (39%), Gaps = 44/215 (20%)
Query: 340 LLGKGCVGATYKVV-LDGGDVVVVKRIR---------ERKKKREVDEWLRVIGGLRHSNI 389
LLGKG Y+ + G V +K I ++ + EV + L+H +I
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV-KIHCQ---LKHPSI 73
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+ + Y + ++LV + +G ++ L P + ++ + G+ +LH
Sbjct: 74 LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT----GMLYLH 129
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIG--VH-----QLFHT----PFFINDAYNAP 498
+ H L+ SN+++ + N I+D G + +T P Y +P
Sbjct: 130 ---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP-----NYISP 181
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
E+ + + DV+S G + +L G+
Sbjct: 182 EIA--TRSAHG-----LESDVWSLGCMFYTLLIGR 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 32/167 (19%), Positives = 53/167 (31%), Gaps = 30/167 (17%)
Query: 384 LRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK 443
N V + K L++ +L + +R + L + A+
Sbjct: 118 FSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAE 175
Query: 444 GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV----------HQLFHTPFFIND 493
+ FLH L H L SNI + D G+ +
Sbjct: 176 AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 494 A--------YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
Y +PE + NNYS + D++S G++L E+L
Sbjct: 233 HTGQVGTKLYMSPEQI--HGNNYSHK-----VDIFSLGLILFELLYS 272
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 46/242 (19%), Positives = 80/242 (33%), Gaps = 62/242 (25%)
Query: 339 ELLGKGCVGATYK-VVLDGGDVVVVKRIRE--RKKKREVDEWLRVIGGLRHSNIVSIRA- 394
+ LG G G + ++ G +K++ + R K RE L ++ L H NI+ +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDY 68
Query: 395 -YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGR------------------MPVDWNKRL 435
Y G +E H L +G + +P +K L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 436 KLASDSA----------------KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC---I 476
K S + + F+H + H + N++V+ +
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNS--KDNTLKL 183
Query: 477 SDIG-----VHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
D G + + + Y APEL Y+ D++S G V E++
Sbjct: 184 CDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATE-YTPS-----IDLWSIGCVFGELIL 237
Query: 532 GK 533
GK
Sbjct: 238 GK 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 55/246 (22%), Positives = 102/246 (41%), Gaps = 46/246 (18%)
Query: 339 ELLGKGCVGATYKVV------LDGGDVVVVKRIRERKKK--------REVDEWLRVIGGL 384
+G+G Y V +GG V +KR+R + + REV LR +
Sbjct: 17 AEIGEG----AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETF 71
Query: 385 RHSNIVSIR-----AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS 439
H N+V + + + + +L LV++++ L + L PG +P + K +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-VPTETIK--DMMF 127
Query: 440 DSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF-FINDA---- 494
+GL FLH + + H L NI+V G ++D G+ +++ +
Sbjct: 128 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMMGQ 552
Y APE+ Q + D++S G + E+ K + +G ++ + K + ++G
Sbjct: 185 YRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 553 -DESAW 557
E W
Sbjct: 238 PGEEDW 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 44/216 (20%), Positives = 74/216 (34%), Gaps = 47/216 (21%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR----VIGGLRHSNIVSIR 393
+LGKG G K VK I + K + + ++ L H NI+ +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAK----GLAF 447
++V + G L + R R A+ K G+ +
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEII-KRK----------RFSEHDAARIIKQVFSGITY 136
Query: 448 LHGYNKAH--------LFHGHLSSSNIVVDQLGNACISDIG--VHQLFHTPFFINDAYNA 497
+H +N H L +I + G + + T ++I A
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI-----A 191
Query: 498 PE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
PE L+ Y ++CDV+S GV+L +L+G
Sbjct: 192 PEVLR----GTYD-----EKCDVWSAGVILYILLSG 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 41/219 (18%), Positives = 75/219 (34%), Gaps = 54/219 (24%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKK------REVDEWLRVIGGLRHSNIVS 391
E LG G G ++ V G V V K I E+ ++ L H +++
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS----IMNQLHHPKLIN 112
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAK----GL 445
+ K E+ L+ ++L G L + + ++ + + GL
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRI----------AAEDYKMSEAEVINYMRQACEGL 162
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNAC--ISDIG----------VHQLFHTPFFIND 493
+H ++ HL + NI+ + + I D G V T F
Sbjct: 163 KHMHEHSIVHL---DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA-- 217
Query: 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
APE+ + D+++ GV+ +L+G
Sbjct: 218 ---APEIV--DREPVG-----FYTDMWAIGVLGYVLLSG 246
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 58/230 (25%), Positives = 89/230 (38%), Gaps = 65/230 (28%)
Query: 339 ELLGKGCVGATYKVVL----DGGDVVVVKRIRERKK-----------KREVDEWLRVIGG 383
+LLG+G G KV + VK I ++KK K+E+ + LR
Sbjct: 11 DLLGEGSYG---KVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEI-QLLRR--- 62
Query: 384 LRHSNIVSIR--AYCNGKDELFLVYDYLPHGS---LHSLLHGSRGPGRMPVDWNKRL--K 436
LRH N++ + Y K ++++V +Y G L S+ R PV +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-----RFPVCQAHGYFCQ 117
Query: 437 LASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV---------HQLFHT 487
L GL +LH + H + N+++ G IS +GV T
Sbjct: 118 LID----GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
P A+ PE+ N + +S K D++S GV L I TG
Sbjct: 171 SQGSP-----AFQPPEI-ANGLDTFSGFK----VDIWSAGVTLYNITTGL 210
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 22/138 (15%), Positives = 43/138 (31%), Gaps = 22/138 (15%)
Query: 84 AEVLSRL-TQLRLLSLKNNLLSSSNLN-----LSSWPHLKHLYLSHNRFTGTFPSGVSSL 137
A + S + + L+L N L +L S HL+ +YL ++ +L
Sbjct: 217 AYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKAL 276
Query: 138 -------RHLRRVDLSHNA--YEGEIPMTELTRLPN--LLTLRLEDNRFT-----GTLYS 181
+ + VD + IP++ L R + L + T
Sbjct: 277 GAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIE 336
Query: 182 VNSSSRSILDFNVSNNQL 199
+ + + + L
Sbjct: 337 DLNIPDELRESIQTCKPL 354
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 51/225 (22%)
Query: 332 DLLKSSAELLGKGCVGATYKVVL----DGGDVVVVKRIRERK--KKREVD----EWLRVI 381
++L+ +GKG G KV + D + +K + ++K ++ EV E L+++
Sbjct: 18 EILR----AIGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE-LQIM 69
Query: 382 GGLRHSNIVSIRAYC-NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKL-AS 439
GL H +V++ Y ++++F+V D L G L L + + +KL
Sbjct: 70 QGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK---EETVKLFIC 122
Query: 440 DSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----------TPF 489
+ L +L + H + NI++D+ G+ I+D + + T
Sbjct: 123 ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTK- 178
Query: 490 FINDAYNAPE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y APE YS D +S GV E+L G+
Sbjct: 179 ----PYMAPEMFSSRKGAGYS-----FAVDWWSLGVTAYELLRGR 214
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 25/172 (14%), Positives = 43/172 (25%), Gaps = 40/172 (23%)
Query: 84 AEVLSRLTQLRLLSLKNNLLSSSNLN-----------LSSWPHLKHLYLSHNRFTGTFPS 132
+E ++ L + + L P L + LS N F P+
Sbjct: 53 SENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG---PT 109
Query: 133 GVSSL-------RHLRRVDLSHN------------AYEGEIPMTELTRLPNLLTLRLEDN 173
L L + L +N A + + P L ++ N
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169
Query: 174 RFT--GTLY--SVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNL 221
R S R + + N + P + A + L
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIR---PEGIEHLLLEGLAYCQEL 218
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 31/143 (21%), Positives = 50/143 (34%), Gaps = 32/143 (22%)
Query: 84 AEVLSRLTQLRLLSLKNN---------LLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGV 134
A+ L + + N LL L+ LK L L N FT G
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG---LAYCQELKVLDLQDNTFT---HLGS 233
Query: 135 SSL-------RHLRRVDLSHNA--YEGEIPMTE-LTRLPN--LLTLRLEDNRFTGT---- 178
S+L +LR + L+ G + + ++L N L TLRL+ N
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 293
Query: 179 -LYSVNSSSRSILDFNVSNNQLS 200
++ +L ++ N+ S
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRFS 316
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 41/217 (18%), Positives = 76/217 (35%), Gaps = 50/217 (23%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKK------REVDEWLRVIGGLRHSNIVS 391
E LG G G ++V G+ K + + +E+ + LRH +V+
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQ----TMSVLRHPTLVN 218
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAK----GL 445
+ +E+ ++Y+++ G L + D + ++ A + + GL
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKV----------ADEHNKMSEDEAVEYMRQVCKGL 268
Query: 446 AFLHGYNKAH--------LFHGHLSSSNIVVDQLGNACISDIG--VHQLFHTPFFINDAY 495
+H N H +F S+ ++D G D V T F
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLID-FGLTAHLDPKQSVKVTTGTAEFA---- 323
Query: 496 NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
APE+ D++S GV+ +L+G
Sbjct: 324 -APEVA--EGKPVG-----YYTDMWSVGVLSYILLSG 352
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 45/213 (21%), Positives = 81/213 (38%), Gaps = 37/213 (17%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK-----KREVD--EWLRVIGGLRHSNIV 390
+++GKG G K V +K +R K+ E+ E LR N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ ++ + + ++ L +L+ L+ ++ G + + K A + L LH
Sbjct: 163 HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG-FSLPLVR--KFAHSILQCLDALH- 217
Query: 451 YNKAHLFHGHLSSSNIVVDQ----------LGNACISDIGVHQLFHTPFFINDAYNAPEL 500
K + H L NI++ Q G++C V+ + F Y APE+
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEV 270
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
D++S G +L E+LTG
Sbjct: 271 ILGARYGMP-------IDMWSLGCILAELLTGY 296
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 47/226 (20%), Positives = 89/226 (39%), Gaps = 50/226 (22%)
Query: 332 DLLKSSAELLGKGCVGATYKVVL----DGGDVVVVKRIRERK--KKREVDEWL---RVIG 382
++LK ++G+G G +V + + V +K + + + K+ E + V+
Sbjct: 77 EILK----VIGRGAFG---EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 383 GLRHSNIVSIRAYC-NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNK----RLKL 437
I ++ Y + L+LV DY G L +LL S+ R+P + + + +
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEMVI 186
Query: 438 ASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG------VHQLFHTPFFI 491
A + +H + H + NI++D G+ ++D G + +
Sbjct: 187 A------IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 492 N--DAYNAPEL---KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
D Y +PE+ Y CD +S GV + E+L G
Sbjct: 238 GTPD-YISPEILQAMEGGKGRYGPE-----CDWWSLGVCMYEMLYG 277
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 54/248 (21%), Positives = 93/248 (37%), Gaps = 48/248 (19%)
Query: 339 ELLGKGCVGATYKVV-----LDGGDVVVVKRIRERKKK-----------REVDEWLRVIG 382
+G G Y V G V +K +R REV LR +
Sbjct: 15 AEIGVG----AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV-ALLRRLE 69
Query: 383 GLRHSNIVSIR-----AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKL 437
H N+V + + + + ++ LV++++ L + L + PG +P + K L
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG-LPAETIK--DL 125
Query: 438 ASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF-FINDA-- 494
+GL FLH + H L NI+V G ++D G+ +++
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182
Query: 495 --YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELG-IVKWVQMM 550
Y APE+ Q + D++S G + E+ K + G+ E + K ++
Sbjct: 183 LWYRAPEVLL-------QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235
Query: 551 GQ-DESAW 557
G E W
Sbjct: 236 GLPPEDDW 243
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 41/232 (17%), Positives = 72/232 (31%), Gaps = 70/232 (30%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK--------------KREVDEWLRVIGG 383
+ LG G G V ++ I +RK + E++ ++
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE----ILKK 196
Query: 384 LRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDW-NKRLKLASDSA 442
L H I+ I+ + + +D ++V + + G L D +L +
Sbjct: 197 LNHPCIIKIKNFFDAED-YYIVLELMEGGEL--------------FDKVVGNKRLKEATC 241
Query: 443 K--------GLAFLHGYNKAH--------LFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486
K + +LH H L I I+D G ++
Sbjct: 242 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK--------ITDFGHSKILG 293
Query: 487 TPFFINDA-----YNAPE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
+ Y APE L Y+ + D +S GV+L L+G
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYN-----RAVDCWSLGVILFICLSG 340
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 16/79 (20%), Positives = 33/79 (41%), Gaps = 6/79 (7%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK--KREVDEWLRVIGGLRHSNIVSIRAY 395
E +G G + + VK I + K+ E++ LR H NI++++
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ---HPNIITLKDV 84
Query: 396 CNGKDELFLVYDYLPHGSL 414
+ +++V + + G L
Sbjct: 85 YDDGKYVYVVTELMKGGEL 103
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 39/126 (30%), Positives = 50/126 (39%), Gaps = 41/126 (32%)
Query: 72 KLV-LEDLDLTG------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPH--------L 116
+L L L LTG P V +LT L+ L L N L S P L
Sbjct: 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN-------QLQSLPDGVFDKLTNL 135
Query: 117 KHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLP--------NLLT 167
+L L+HN+ + P GV L +L +DLS+N +L LP L
Sbjct: 136 TYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYN---------QLQSLPEGVFDKLTQLKD 185
Query: 168 LRLEDN 173
LRL N
Sbjct: 186 LRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 30/101 (29%), Positives = 40/101 (39%), Gaps = 20/101 (19%)
Query: 86 VLSRLTQLRLLSLKNNLLSSSNLNLSSWP-HLKHLYLSHNRFTGTFPSGV-SSLRHLRRV 143
L LT L L L N L S + +LK L L N+ + P GV L +L +
Sbjct: 80 ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYL 138
Query: 144 DLSHNAYEGEIPMTELTRLP--------NLLTLRLEDNRFT 176
+L+HN +L LP NL L L N+
Sbjct: 139 NLAHN---------QLQSLPKGVFDKLTNLTELDLSYNQLQ 170
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 18/77 (23%), Positives = 33/77 (42%), Gaps = 1/77 (1%)
Query: 339 ELLGKGCVGATYKVVLDG-GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCN 397
LG+G Y+ G +K +++ K+ V + V+ L H NI+ ++
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 398 GKDELFLVYDYLPHGSL 414
E+ LV + + G L
Sbjct: 119 TPTEISLVLELVTGGEL 135
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 48/243 (19%), Positives = 84/243 (34%), Gaps = 57/243 (23%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGG-------------- 383
LG G G +G +K I++ + +
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 384 -LRHSNIVSIRAYCNGKDELFLVYDYLPHGSL-HSLLHGSRGPGRMPVDWNKRLKLASDS 441
L H NI+ + K +LV ++ G L +++ + A++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD----------AANI 151
Query: 442 AK----GLAFLHGYNKAH--------LFHGHLSSSNIVVDQLGNACISDIG--VHQLFHT 487
K G+ +LH +N H L S NI + G + + T
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 488 PFFINDAYNAPE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVK 545
++I APE LK +K+ ++CDV+S GV++ +L G G + I+K
Sbjct: 212 AYYI-----APEVLK---------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257
Query: 546 WVQ 548
V+
Sbjct: 258 KVE 260
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 7e-05
Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 46/217 (21%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
LG G G + V G V+K I + + + +++ V+ L H NI+ I
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 395 YCNGKDELFLVYDYLPHGSL-HSLLHGSRGPGRMPVDWNKRLKLASDSAK----GLAFLH 449
+++V + G L ++ + ++ K LA+ H
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE------GYVAELMKQMMNALAYFH 141
Query: 450 GYNKAH--------LFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA-----YN 496
+ H LF S I I D G+ +LF + +A Y
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPI--------KIIDFGLAELFKSDEHSTNAAGTALYM 193
Query: 497 APE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
APE K + + +CD++S GVV+ +LTG
Sbjct: 194 APEVFK----RDVT-----FKCDIWSAGVVMYFLLTG 221
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 42/193 (21%), Positives = 76/193 (39%), Gaps = 38/193 (19%)
Query: 384 LRHSNIVSIRAYCNGKDE--LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDS 441
L+H N++S++ + ++L++DY H L ++ R K ++L
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN----KKPVQLPRGM 129
Query: 442 AK--------GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC----ISDIGVHQLFHTP- 488
K G+ +LH + H L +NI+V G I+D+G +LF++P
Sbjct: 130 VKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 489 --FFINDA------YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDG 539
D Y APEL +Y+ + D+++ G + E+LT + +
Sbjct: 187 KPLADLDPVVVTFWYRAPELLL-GARHYT-----KAIDIWAIGCIFAELLTSEPIFHCRQ 240
Query: 540 ELGIVKWVQMMGQ 552
E Q
Sbjct: 241 EDIKTSNPYHHDQ 253
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 34/232 (14%), Positives = 82/232 (35%), Gaps = 47/232 (20%)
Query: 325 KGFRNVGDLLKSSAELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---- 379
+ N + +++ LG+G + + G K +++R++ ++ +
Sbjct: 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 380 VIGGLRHS-NIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--K 436
V+ + ++++ E+ L+ +Y G + S + + +
Sbjct: 81 VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS---------LCLPELAEMVSEN 131
Query: 437 LASDSAK----GLAFLHGYNKAH--------LFHGHLSSSNI-VVDQLGNACISDIG--V 481
K G+ +LH N H L +I +VD G + +
Sbjct: 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD-FGMSRKIGHACEL 190
Query: 482 HQLFHTPFFINDAYNAPE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
++ TP ++ APE L + + + D+++ G++ +LT
Sbjct: 191 REIMGTPEYL-----APEILNY---DPIT-----TATDMWNIGIIAYMLLTH 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 8e-05
Identities = 37/215 (17%), Positives = 76/215 (35%), Gaps = 47/215 (21%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKRE-VDEWLRVIGGLRHSNIVSIRAYC 396
E LG+G G ++ V + K ++ + + V + + ++ RH NI+ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--KLASDSAK----GLAFLHG 450
+EL ++++++ + + L + L FLH
Sbjct: 71 ESMEELVMIFEFISGLDIFERI----------NTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNAC--ISDIG----------VHQLFHTPFFINDAYNAP 498
+N H + NI+ ++ I + G LF P + AP
Sbjct: 121 HNIGHF---DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY-----AP 172
Query: 499 E-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
E ++ S D++S G ++ +L+G
Sbjct: 173 EVH---QHDVVS-----TATDMWSLGTLVYVLLSG 199
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 38/256 (14%), Positives = 77/256 (30%), Gaps = 75/256 (29%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKK-----------REVDEWLRVIGGLRH 386
+G+G G + + +K + + K + EV ++ L H
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR----LMKKLHH 87
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSL-------------HSLLHGSRGPGRMPVDWNK 433
NI + + + LV + G L + + + N+
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 434 RLKLASDSAKGLAFLHGYNK---AHLFH------GHLSSSNIV------------VDQLG 472
S + + +++ +L + I ++
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 473 NACISDIGVHQLFH---------------TPFFINDAYNAPELKFNNNNNYSQRKFWQRC 517
+ D G+ + F+ TP+F+ APE+ N +Y +C
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV-----APEVLNTTNESYG-----PKC 257
Query: 518 DVYSFGVVLLEILTGK 533
D +S GV+L +L G
Sbjct: 258 DAWSAGVLLHLLLMGA 273
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 42/214 (19%)
Query: 340 LLGKGCVGATYKVVL----DGGDVVVVKRIRER--KKKREVDEWL---RVIGGLRHSNIV 390
+LGKG G +V G + K++ ++ KK++ L +++ + +V
Sbjct: 191 VLGKGGFG---EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKL-ASDSAKGLAFLH 449
S+ KD L LV + G L ++ G P R A++ GL LH
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEA---RAVFYAAEICCGLEDLH 303
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIG----------VHQLFHTPFFINDAYNAPE 499
+ + L NI++D G+ ISD+G + T Y APE
Sbjct: 304 RER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV-----GYMAPE 355
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ N +S D ++ G +L E++ G+
Sbjct: 356 VVKNERYTFS-------PDWWALGCLLYEMIAGQ 382
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 22/81 (27%), Positives = 33/81 (40%), Gaps = 5/81 (6%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERK-KKREVDEWLR---VIGGLRHSNIVSIR 393
E LGKG + V G K I +K R+ + R + L+H NIV +
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 394 AYCNGKDELFLVYDYLPHGSL 414
+ +LV+D + G L
Sbjct: 72 DSIQEESFHYLVFDLVTGGEL 92
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 48/225 (21%), Positives = 85/225 (37%), Gaps = 49/225 (21%)
Query: 332 DLLKSSAELLGKGCVGATYKVVL----DGGDVVVVKRIRER--KKKREVDEWL---RVIG 382
+ +LG+G G +V G + K++ ++ KK++ + +++
Sbjct: 188 LDFR----VLGRGGFG---EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 383 GLRHSNIVSIRAYC-NGKDELFLVYDYLPHGSLHS-LLHGSRGPGRMPVDWNKRLKL-AS 439
+ IVS+ AY K +L LV + G + + + R +
Sbjct: 241 KVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAIFYTA 296
Query: 440 DSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIG--VHQLFH---------TP 488
GL LH N + + L N+++D GN ISD+G V TP
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
F+ APEL ++S D ++ GV L E++ +
Sbjct: 354 GFM-----APELLLGEEYDFS-------VDYFALGVTLYEMIAAR 386
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 40/243 (16%), Positives = 83/243 (34%), Gaps = 59/243 (24%)
Query: 329 NVGDLLKSS----AELLGKGCVGATYKVVL----DGGDVVVVKRIRERKK-----KREVD 375
G+ K + LG G V L V +K +R K + E+
Sbjct: 11 FKGEPYKDARYILVRKLGWGHFS---TVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK 67
Query: 376 --EWLRVIGGLRHS-----NIVSIR---AYCNGKDE-LFLVYDYLPHGSLHSLLHGSRGP 424
+ + + +I+ + + + +V++ L +L +L+
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR 126
Query: 425 GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-------------- 470
G +P+ + K +++ GL ++H + + H + N++++
Sbjct: 127 G-IPLIYVK--QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 471 LGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEIL 530
LGNAC D T Y +PE+ D++S ++ E++
Sbjct: 182 LGNACWYDEHYTNSIQTRE-----YRSPEVLLGAPWGCG-------ADIWSTACLIFELI 229
Query: 531 TGK 533
TG
Sbjct: 230 TGD 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 36/210 (17%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIRE--RKK---KREVDEWLRVIGGLRHSNIVSIR- 393
+G G G V +K++ + + KR E L ++ + H NI+S+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE-LVLMKCVNHKNIISLLN 128
Query: 394 -----AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
+++LV + + +L ++ +M +D + L G+ L
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGIKHL 180
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA-----YNAPELKFN 503
H A + H L SNIVV I D G+ + T F + Y APE+
Sbjct: 181 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y + D++S G ++ E++ K
Sbjct: 238 MG--YKEN-----VDIWSVGCIMGEMVRHK 260
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 17/81 (20%), Positives = 28/81 (34%), Gaps = 5/81 (6%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR----VIGGLRHSNIVSIR 393
+LGKG G K VK I + K + + ++ L H NI+ +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 394 AYCNGKDELFLVYDYLPHGSL 414
++V + G L
Sbjct: 88 EILEDSSSFYIVGELYTGGEL 108
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 18/79 (22%), Positives = 33/79 (41%), Gaps = 3/79 (3%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEW--LRVIGGLRHSNIVSIRAY 395
E+LG G + V G + +K I++ R+ + V+ ++H NIV++
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 396 CNGKDELFLVYDYLPHGSL 414
+LV + G L
Sbjct: 75 YESTTHYYLVMQLVSGGEL 93
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 22/81 (27%), Positives = 33/81 (40%), Gaps = 5/81 (6%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERK-KKREVDEWLR---VIGGLRHSNIVSIR 393
E LGKG + V G K I +K R+ + R + L+H NIV +
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 394 AYCNGKDELFLVYDYLPHGSL 414
+ +LV+D + G L
Sbjct: 95 DSIQEESFHYLVFDLVTGGEL 115
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 38/216 (17%), Positives = 82/216 (37%), Gaps = 54/216 (25%)
Query: 341 LGKGCVGATYKVV-LDGGDVVVVKRIR---ERKKKREVDEWLRVIGGLRHSNIVS----I 392
LG+G ++ + + + VVVK ++ ++K KRE+ + L + G NI++ +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI-KILENLRG--GPNIITLADIV 100
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSA---------K 443
+ + LV++++ D+ + + +D K
Sbjct: 101 KDPVSRTP--ALVFEHV-----------------NNTDFKQLYQTLTDYDIRFYMYEILK 141
Query: 444 GLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGVHQLFHTPFFINDA-----YNA 497
L + H + H + N+++D + + D G+ + +H N +
Sbjct: 142 ALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 198
Query: 498 PELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
PEL + Y D++S G +L ++ K
Sbjct: 199 PELLVDYQM-YDYS-----LDMWSLGCMLASMIFRK 228
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 26/140 (18%)
Query: 84 AEVL-SRLTQLRLLSLKNNLLSSSNLN-----LSSWPHLKHLYLSHNRFTGTFPSGVSSL 137
++L Q+ L L NN L+++ + L+ + HL L H G+ L
Sbjct: 147 RDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG---DEGLELL 203
Query: 138 -------RHLRRVDLSHNA--YEGEIPMTE-LTRLPNLLTLRLEDNRFTGT-------LY 180
R L+ +++++N + + P+L L L N + L
Sbjct: 204 AAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLG 263
Query: 181 SVNSSSRSILDFNVSNNQLS 200
++ +S
Sbjct: 264 GAAEGGARVVVSLTEGTAVS 283
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 5/81 (6%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR----VIGGLRHSNIVSIR 393
E LGKG + V + G I +K + L + L+H NIV +
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 394 AYCNGKDELFLVYDYLPHGSL 414
+ + +L++D + G L
Sbjct: 77 DSISEEGHHYLIFDLVTGGEL 97
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 43/301 (14%), Positives = 80/301 (26%), Gaps = 120/301 (39%)
Query: 349 TYKVVLDGGDVVVVKRIRERKKK-REVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407
+ L + V K R + ++ + L LR + V
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL---ELRPAKNV----------------- 153
Query: 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLK--LASDSAKGLAFLHGYNKAHLFH------G 459
L+ G G G K +A D + F
Sbjct: 154 ---------LIDGVLGSG----------KTWVALDVCLSYKVQCKMD----FKIFWLNLK 190
Query: 460 HLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDV 519
+ +S V++ L +Q+ +D + +L+ ++ +R +
Sbjct: 191 NCNSPETVLEMLQKLL------YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK--- 241
Query: 520 YSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF----------------- 562
+ LL +L V + AW F+
Sbjct: 242 -PYENCLL-VL-------LN----V-Q------NAKAWNAFNLSCKILLTTRFKQVTDFL 281
Query: 563 ------ELIMDKEM----EEEMRALLQVALLCLAPLPKDRPN---------MSIVHRMIE 603
+ +D +E+++LL L L P+D P +SI+ I
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLL---LKYLDCRPQDLPREVLTTNPRRLSIIAESIR 338
Query: 604 D 604
D
Sbjct: 339 D 339
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 49/227 (21%), Positives = 77/227 (33%), Gaps = 61/227 (26%)
Query: 334 LKSSAELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNI 389
L + LG+G K V VK I +R + ++E+ L++ G H NI
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI-TALKLCEG--HPNI 68
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRL--------KLASDS 441
V + + + FLV + L G L R+ AS
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFE-----------------RIKKKKHFSETEASYI 111
Query: 442 AK----GLAFLHGYNKAH--------LFHGHLSSSNIVVDQLGNACISDIGVHQLFH--- 486
+ ++ +H H LF + I + G A + L
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 487 TPFFINDAYNAPE-LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG 532
T + APE L N Y + CD++S GV+L +L+G
Sbjct: 172 TLHYA-----APELLN---QNGYD-----ESCDLWSLGVILYTMLSG 205
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 41/220 (18%), Positives = 78/220 (35%), Gaps = 41/220 (18%)
Query: 332 DLLKSSAELLGKGCVGATYKVVL----DGGDVVVVKRIRERK--KKREVDEWL---RVIG 382
K +LG+G VVL +K + +R K+ +V V+
Sbjct: 33 KFGK----ILGEGSFS---TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 383 GLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKL-ASDS 441
L H V + ++L+ Y +G L + R G + ++
Sbjct: 86 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDET---CTRFYTAEI 139
Query: 442 AKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA------- 494
L +LHG + H L NI++++ + I+D G ++ A
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 495 -YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y +PEL + S D+++ G ++ +++ G
Sbjct: 197 QYVSPELLTEKSACKS-------SDLWALGCIIYQLVAGL 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 48/227 (21%)
Query: 329 NVGDLLKSSAELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK------KREVDEWLRVI 381
D+ + ++LG+G + L VK I ++ REV+ +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 382 GGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR--LKLAS 439
G H N++ + + +D +LV++ + GS+ S +H R +N+ +
Sbjct: 69 G---HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH-KRRH------FNELEASVVVQ 118
Query: 440 DSAKGLAFLHGYNKAH--------LFHGHLSSSNI-VVD-------QLGNACISDIGVHQ 483
D A L FLH AH L S + + D +L C S I +
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC-SPISTPE 177
Query: 484 LFH---TPFFINDAYNAPE-LKFNNNNNYSQRKFWQRCDVYSFGVVL 526
L + ++ APE ++ + + +RCD++S GV+L
Sbjct: 178 LLTPCGSAEYM-----APEVVE---AFSEEASIYDKRCDLWSLGVIL 216
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 34/109 (31%), Positives = 46/109 (42%), Gaps = 13/109 (11%)
Query: 72 KLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSW-----PHLKHLYLSHNR 125
+L LE L P V +LTQL LSL N + S L L LYL N+
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS----LPDGVFDKLTKLTILYLHENK 87
Query: 126 FTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
+ P+GV L L+ + L N + +P RL +L + L N
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 24/116 (20%), Positives = 40/116 (34%), Gaps = 14/116 (12%)
Query: 65 PSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSS------SNLNLSSWPHLKH 118
P + L +L + RL L L LK N L+ + H++
Sbjct: 28 PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS-----HIQE 82
Query: 119 LYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173
L L N+ + + L L+ ++L N + L +L +L L N
Sbjct: 83 LQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 44/227 (19%), Positives = 74/227 (32%), Gaps = 55/227 (24%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK--------------KREVDEWLRVIGGL 384
+ G GA V G V +KR+ KR + E +R++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE-IRLLNHF 86
Query: 385 RHSNIVSIR-----AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLAS 439
H NI+ +R +L+LV + + L ++H R ++
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIV------------ISP 133
Query: 440 DSA--------KGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFI 491
GL LH A + H L NI++ + I D + +
Sbjct: 134 QHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 492 NDA-----YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
Y APEL ++ + D++S G V+ E+ K
Sbjct: 191 THYVTHRWYRAPELVM-QFKGFT-----KLVDMWSAGCVMAEMFNRK 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 26/120 (21%), Positives = 46/120 (38%), Gaps = 26/120 (21%)
Query: 424 PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483
+ + + + AKG+ FL H L++ NI++ + I D G+ +
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 241
Query: 484 LFHTPFFINDAYN------------APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531
+ + Y APE F+ + + DV+SFGV+L EI +
Sbjct: 242 DIYK----DPDYVRKGDARLPLKWMAPETIFDR-------VYTIQSDVWSFGVLLWEIFS 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 46/213 (21%), Positives = 86/213 (40%), Gaps = 35/213 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK-----KREVD--EWLRVIGGLRHSNIV 390
L+GKG G K + V +K I+ +K + EV E + IV
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
++ + ++ L LV++ L +L+ LL + G + ++ + K A L FL
Sbjct: 120 HLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRG-VSLNLTR--KFAQQMCTALLFLAT 175
Query: 451 YNKAHLFHGHLSSSNIVVDQ----------LGNACISDIGVHQLFHTPFFINDAYNAPEL 500
+ + H L NI++ G++C ++Q + F Y +PE+
Sbjct: 176 -PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEV 229
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ + D++S G +L+E+ TG+
Sbjct: 230 LLGMPYDLA-------IDMWSLGCILVEMHTGE 255
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 640 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.89 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.88 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.84 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.75 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.72 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.71 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.71 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.71 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.71 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.69 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.69 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.68 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.67 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.67 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.66 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.65 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.65 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.65 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.65 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.64 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.64 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.64 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.63 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.63 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.62 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.61 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.61 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.61 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.6 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.6 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.59 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.59 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.59 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.57 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.56 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.55 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.55 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.54 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.54 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.53 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.53 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.53 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.53 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.53 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.52 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.52 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.52 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.52 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.51 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.51 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.51 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.51 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.5 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.5 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.5 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.5 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.49 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.49 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.49 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.48 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.48 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.47 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.47 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.47 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.46 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.46 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.46 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.45 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.45 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.45 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.44 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.44 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.44 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.44 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.44 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.44 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.43 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.43 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.43 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.42 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.42 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.42 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.4 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.39 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.38 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.37 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.37 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.37 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.36 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.34 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.32 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.31 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.3 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.26 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.25 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.21 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.2 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.13 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.1 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.94 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.86 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.83 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.75 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.67 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.57 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.53 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.51 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.4 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.19 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.08 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.04 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.02 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.01 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.96 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.92 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.83 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.79 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.79 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.57 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.31 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.18 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.06 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.0 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.87 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.77 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.71 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.69 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.55 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.51 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.45 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.26 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.07 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.03 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.72 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.67 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.37 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.29 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.24 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.95 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.42 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.16 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=432.12 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=198.2
Q ss_pred hccccccCcceEEEEEeC------CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD------GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||+||+|++. ++..||||+++.. ...++|.+|++++++++|||||+++|+|.+++..|||||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 568999999999999864 3678999999765 33567999999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCC--------CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCc
Q 006559 410 PHGSLHSLLHGSR--------GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV 481 (640)
Q Consensus 410 ~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 481 (640)
++|+|.++|+... ......++|.++++|+.|||+||+|||+ .+||||||||+||||++++.+||+|||+
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFGl 174 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGM 174 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCccc
Confidence 9999999997542 1223469999999999999999999995 4599999999999999999999999999
Q ss_pred ccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhc
Q 006559 482 HQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQ 552 (640)
Q Consensus 482 ~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 552 (640)
++.... ...+|..|||||++ ....|+.|+|||||||++|||+| |+.||.+... .+.+.....
T Consensus 175 a~~~~~~~~~~~~~~~~gt~~ymAPE~~-------~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~~ 245 (299)
T 4asz_A 175 SRDVYSTDYYRVGGHTMLPIRWMPPESI-------MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECITQ 245 (299)
T ss_dssp HHHHTGGGCEEETTTEEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHH
T ss_pred ceecCCCCceeecCceecChhhcCHHHH-------cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc
Confidence 986532 12457889999964 45678899999999999999999 8999975332 222222211
Q ss_pred ccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 553 DESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 553 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
... ...+. .+..++.+++.+||+.||++||||.+|++.|+++...
T Consensus 246 ~~~--------~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 246 GRV--------LQRPR---TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TCC--------CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC--------CCCCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 110 01111 2234577788899999999999999999999998753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=434.31 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=196.0
Q ss_pred hccccccCcceEEEEEeC------CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD------GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.++||+|+||+||+|++. ++..||||+++.. ...++|.+|++++++++|||||+++|+|.+.+..|||||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 568999999999999875 3678999999865 33567999999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCC----------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccC
Q 006559 410 PHGSLHSLLHGSRGP----------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDI 479 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 479 (640)
++|+|.++++..... ...+++|.++++|+.|||+||+|||+ .+||||||||+||||++++.+||+||
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~DF 202 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDF 202 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEccc
Confidence 999999999764321 12369999999999999999999995 45999999999999999999999999
Q ss_pred CcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHh
Q 006559 480 GVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMM 550 (640)
Q Consensus 480 Gl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~ 550 (640)
|+++.... ...+|..|||||++ ....++.++|||||||+||||+| |+.||.+... .+.+...
T Consensus 203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~-------~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i 273 (329)
T 4aoj_A 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESI-------LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAIDCI 273 (329)
T ss_dssp C----------------CCCCGGGCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHHHH
T ss_pred ccceeccCCCcceecCcccccccccChhhh-------cCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 99986532 23468899999964 45678899999999999999999 8999975322 2222222
Q ss_pred hcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 551 GQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 551 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..... +..+. .+..++.+++.+||+.||++||||.||++.|+.+...
T Consensus 274 ~~g~~--------~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGRE--------LERPR---ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCC--------CCCCT---TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCC--------CCCcc---cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11110 11111 2234567788899999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=432.48 Aligned_cols=245 Identities=23% Similarity=0.345 Sum_probs=197.1
Q ss_pred hccccccCcceEEEEEeC------CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD------GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||+||+|++. +++.||||+++.. ...++|.+|+.++++++|||||+++|+|.+.+..+|||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 567999999999999973 4578999999755 3357899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCC-----------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEc
Q 006559 409 LPHGSLHSLLHGSRGP-----------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACIS 477 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~ 477 (640)
|++|+|.++|+..... ....++|..+++|+.|||+||+|||+. +||||||||+||||++++.+||+
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~ 187 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKIS 187 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEEC
Confidence 9999999999754311 123589999999999999999999954 59999999999999999999999
Q ss_pred cCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 006559 478 DIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQ 548 (640)
Q Consensus 478 DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~ 548 (640)
|||+++.... ...+|..|||||++ ....|+.++|||||||+||||+| |+.||.+... .+.++
T Consensus 188 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-------~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~ 258 (308)
T 4gt4_A 188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAI-------MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVE 258 (308)
T ss_dssp CSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHH
T ss_pred CcccceeccCCCceeEecccccCCcccCHHHH-------hCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHH
Confidence 9999986532 23467899999964 45678899999999999999999 8999975332 22222
Q ss_pred HhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 549 MMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 549 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.+..... ...+. ++..++.+++.+||+.||++||||.||++.|+.+
T Consensus 259 ~i~~~~~--------~~~p~---~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIRNRQV--------LPCPD---DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHTTCC--------CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcCCC--------CCCcc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2221110 01111 2334577888999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=427.00 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=194.3
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||+||+|++++ .||||.++.. ...+.|.+|++++++++|||||+++|+|.+ +.+|||||||++|+
T Consensus 41 ~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs 117 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS 117 (307)
T ss_dssp EEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred eeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence 5689999999999999764 5899998743 234568899999999999999999999864 57899999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.++|+.... +++|..++.|+.|||+||+|||+ .+||||||||+||||++++.+||+|||+++....
T Consensus 118 L~~~l~~~~~----~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 118 LYKHLHVQET----KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp HHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred HHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 9999976532 58999999999999999999995 4599999999999999999999999999986532
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccccccchhh
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|+.|||||++... ....|+.|+|||||||+||||+||+.||.+.... ..... ..... ..+.+
T Consensus 191 ~~~~~GT~~ymAPE~l~~~----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--~~~~~-----~~p~~ 259 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQ----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--VGRGY-----ASPDL 259 (307)
T ss_dssp ---CCCCTTSCCHHHHHCC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHTTC-----CCCCS
T ss_pred ecccccCCCccCHHHhhcc----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--HhcCC-----CCCCc
Confidence 23579999999976422 2345889999999999999999999999753221 11111 11110 01110
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
. ....++..++.+++.+||+.||++||||.||++.|+.++..
T Consensus 260 ~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 260 S--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp T--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred c--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 0 00112334577788899999999999999999999988743
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=430.31 Aligned_cols=260 Identities=26% Similarity=0.337 Sum_probs=197.3
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccch-HHHHHHHHHHhccCCCcccceeEEEEcCC----eEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKK-REVDEWLRVIGGLRHSNIVSIRAYCNGKD----ELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lV~Ey~~~g 412 (640)
.+.||+|+||+||+|+++ |+.||||++...... ..++.|+..+.+++|||||+++|+|..++ .+|||||||++|
T Consensus 8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 568999999999999984 789999999765332 22345677778899999999999998653 689999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-----CCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY-----NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
+|.++++.. +++|..+.+++.|+|+||+|||+. ..++||||||||+|||||.++.+||+|||+++....
T Consensus 87 sL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999854 489999999999999999999975 245799999999999999999999999999986532
Q ss_pred ----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-------------H
Q 006559 488 ----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-------------V 544 (640)
Q Consensus 488 ----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-------------~ 544 (640)
...+|..|||||++.+... .....++.|+|||||||+||||+||+.|+....... .
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~-~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSIN-MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSC-TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCceeeecccccccccccCHHHhccccc-ccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 1357999999998754321 122346789999999999999999988775322111 1
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
...+.... ...++.+.......+....+.+++.+||+.||++||||.||++.|+++..+.+
T Consensus 240 ~~~~~~~~-----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 240 EMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHhc-----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 11111111 11122221111223456678899999999999999999999999999986643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=412.16 Aligned_cols=241 Identities=18% Similarity=0.217 Sum_probs=193.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||+||+|+. .+|+.||||+++.... ..+|++++++++|||||++++++.+.+.+|||||||++|+|.+
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~ 139 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence 46799999999999996 4689999999975432 2468999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccCC--------
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHT-------- 487 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~~-------- 487 (640)
+++... ++++.....++.||+.||+|||+ .+||||||||+||||+.++ .+||+|||+++.+..
T Consensus 140 ~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 140 LIKQMG-----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 997643 58999999999999999999995 5599999999999999988 699999999987532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccccccchh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~ 563 (640)
..++|+.|||||++. ...|+.++|||||||++|||+||+.||.+.... +...+.. ......
T Consensus 212 ~~~~~~GT~~YmAPE~~~-------~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~~------ 276 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVM-------GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS--EPPPIR------ 276 (336)
T ss_dssp --CCCCCCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH--SCCGGG------
T ss_pred cCCccccCccccCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc--CCCCch------
Confidence 135799999999753 356788999999999999999999999753322 2211111 110000
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..++.. ...+.+++.+||+.||++|||+.|+++.|......
T Consensus 277 -~~~~~~---s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 277 -EIPPSC---APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -GSCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -hcCccC---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 011222 23456677889999999999999999998886643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=400.49 Aligned_cols=238 Identities=21% Similarity=0.329 Sum_probs=187.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEc----CCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNG----KDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey 408 (640)
.++||+|+||+||+|+.. ++..||||++.... ..+.+.+|++++++++|||||+++++|.. ++.+||||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 457999999999999964 57889999997542 24568899999999999999999999865 3468999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccCCcccccCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGVHQLFHT 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl~~~~~~ 487 (640)
|++|+|.++++... ++++..+..++.||+.||+|||+.+ ++||||||||+||||+ .++.+||+|||+|+....
T Consensus 111 ~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999997643 5899999999999999999999643 4599999999999998 479999999999986543
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
..++|+.|||||++. ..|+.++|||||||++|||+||+.||.+... .....+......... .
T Consensus 185 ~~~~~~~GTp~YmAPE~~~--------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~~i~~~~~~~-----~ 250 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPA-----S 250 (290)
T ss_dssp TSBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCCCG-----G
T ss_pred CccCCcccCccccCHHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-HHHHHHHHHcCCCCC-----C
Confidence 346799999999752 3578999999999999999999999975322 222222222111000 0
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+.. ...++.+++.+||+.||++|||+.|+++
T Consensus 251 --~~~~---~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 --FDKV---AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGC---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCcc---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 1124667788899999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=409.12 Aligned_cols=236 Identities=19% Similarity=0.299 Sum_probs=190.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||+||+|+.. +|+.||||++... ...+.+.+|++++++++|||||+++++|.+++.+|||||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 457999999999999964 6899999999654 3445688999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++... .+++.....++.||+.||+|||+. +||||||||+||||+.++.+||+|||+++.+.. .
T Consensus 159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999753 488999999999999999999954 599999999999999999999999999987642 3
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
.++|+.|||||++ ....|+.++||||+||++|||+||+.||.+... .+..+...... .+.+....
T Consensus 230 ~~GTp~YmAPEvl-------~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~------~~~~~~~~ 294 (346)
T 4fih_A 230 LVGTPYWMAPELI-------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNL------PPRLKNLH 294 (346)
T ss_dssp CCSCGGGCCHHHH-------TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSS------CCCCSCGG
T ss_pred cccCcCcCCHHHH-------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCC------CCCCCccc
Confidence 5679999999975 345678899999999999999999999975422 12122211110 00111111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+ .++.+++.+||+.||++|||+.|+++
T Consensus 295 ~~s---~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVS---PSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122 34566778899999999999998865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=410.80 Aligned_cols=238 Identities=21% Similarity=0.363 Sum_probs=186.7
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|++++++++|||||++++++.+.+.+|||||||++
T Consensus 28 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~g 107 (350)
T 4b9d_A 28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107 (350)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 357899999999999995 56899999999754 2245688999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++...+. ..+++.....|+.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++....
T Consensus 108 g~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 108 GDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred CcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 999999975432 257888999999999999999995 4599999999999999999999999999987653
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
..++|+.|||||++. ...|+.++||||+||++|||+||+.||..... .+........... .
T Consensus 182 ~~~~~GT~~YmAPE~l~-------~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~~--------~ 244 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICE-------NKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLKIISGSFP--------P 244 (350)
T ss_dssp HHHHHSCCTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCC--------C
T ss_pred ccccCCCccccCHHHHC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC--------C
Confidence 245799999999753 45678899999999999999999999975432 2222221111100 0
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....+ .++.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~s---~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHYS---YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122 34566778899999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=413.93 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=196.2
Q ss_pred hhccccccCcceEEEEEeCC------CcEEEEEEecccc---chHHHHHHHHHHhccCC-CcccceeEEEEcC-CeEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG------GDVVVVKRIRERK---KKREVDEWLRVIGGLRH-SNIVSIRAYCNGK-DELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~-~~~~lV 405 (640)
..+.||+|+||+||+|++.+ ++.||||.++... ..+++.+|++++.+++| ||||+++|+|... +.+|||
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 35789999999999998643 3579999998653 34568899999999976 8999999999764 578999
Q ss_pred EeccCCCCHHHhhccCCC-----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCe
Q 006559 406 YDYLPHGSLHSLLHGSRG-----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNA 474 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 474 (640)
||||++|+|.++|+.... .....++|..++.++.|||+||+|||+. +||||||||+|||+++++.+
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~v 224 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVV 224 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCE
Confidence 999999999999975431 1123589999999999999999999954 59999999999999999999
Q ss_pred EEccCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHH
Q 006559 475 CISDIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVK 545 (640)
Q Consensus 475 kl~DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~ 545 (640)
||+|||+++.... ...+|..|||||++ ....|+.++|||||||+||||+| |+.||.+......
T Consensus 225 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-------~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 225 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred EECcchhhhhcccCCCceeeccccccccccCHHHH-------hcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999987532 12457889999964 45678899999999999999999 8999975432211
Q ss_pred HHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 546 WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 546 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..+.+..... +..+. .+..++.+++..||+.||++||||.||++.|+++.+.
T Consensus 297 ~~~~i~~g~~--------~~~p~---~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 FCRRLKEGTR--------MRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHTCC--------CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCC--------CCCCc---cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1111111100 01111 1233567788899999999999999999999998643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=409.75 Aligned_cols=236 Identities=19% Similarity=0.300 Sum_probs=191.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+++|++++|||||+++++|...+.+|||||||++|+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999996 46899999999754 3455688999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.++++.. .+++..+..|+.||+.||+|||+. +||||||||+||||+.+|.+||+|||+++.+.. .
T Consensus 236 ~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 236 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999754 488999999999999999999954 599999999999999999999999999987642 3
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
.++|+.|||||++ ....|+.++|||||||++|||++|+.||.+... .+..+...... .+.+....
T Consensus 307 ~~GTp~YmAPEvl-------~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~------~~~~~~~~ 371 (423)
T 4fie_A 307 LVGTPYWMAPELI-------SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNL------PPRLKNLH 371 (423)
T ss_dssp CEECTTTCCHHHH-------TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSC------CCCCSCTT
T ss_pred cccCcCcCCHHHH-------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCC------CCCCcccc
Confidence 4679999999975 345678899999999999999999999975432 12122211110 00111111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+ .++.+++.+||+.||++|||+.|+++
T Consensus 372 ~~s---~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVS---PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122 34566778899999999999999865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=396.99 Aligned_cols=234 Identities=17% Similarity=0.247 Sum_probs=191.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..++||+|+||+||+|+. .+++.||||++... ...+.+.+|++++++++|||||++++++.+++..|||||||+
T Consensus 36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 357899999999999995 56889999999753 234568899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++.....++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.+..
T Consensus 116 gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 116 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999997643 589999999999999999999954 599999999999999999999999999987631
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
..++|+.|||||++ ....|+.++||||+||++|||+||+.||...... ...+.....
T Consensus 188 ~~~~~~~~GTp~YmAPEvl-------~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~--------- 249 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELL-------TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--LIFAKIIKL--------- 249 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHH-------HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT---------
T ss_pred cccccCcccCcccCCHHHH-------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC---------
Confidence 34689999999975 3456778999999999999999999999754322 111111111
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
....+...+. ++.+++.+||+.||++|||+.|+.
T Consensus 250 ~~~~p~~~s~---~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 250 EYDFPEKFFP---KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCCCTTCCH---HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCCCcccCH---HHHHHHHHHccCCHhHCcChHHHc
Confidence 1111122222 356677889999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=386.51 Aligned_cols=234 Identities=18% Similarity=0.282 Sum_probs=179.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|++++++++|||||++++++.+++..|+||||| +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 56899999999999995 56899999998654 22456889999999999999999999999999999999999 6
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... ++++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 97 g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 97 NELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 89999997643 589999999999999999999954 599999999999999999999999999987542
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++|+.|+|||++.+.+ .++.++||||+||++|||+||+.||.+... ....+...... ...
T Consensus 169 ~~~~GT~~Y~APE~~~~~~------y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~~~~---------~~~ 231 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKL------YAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNISNGV---------YTL 231 (275)
T ss_dssp ------CTTSCHHHHSSSS------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC---------CCC
T ss_pred CCeeECcccCChhhhcCCC------CCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCC---------CCC
Confidence 346799999999864322 235789999999999999999999975432 22222221111 111
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+...+. ++.+++.+||+.||++|||+.|+++
T Consensus 232 p~~~s~---~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFLSP---GAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCH---HHHHHHHHHccCChhHCcCHHHHHc
Confidence 112222 3566778899999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=392.61 Aligned_cols=230 Identities=21% Similarity=0.300 Sum_probs=180.4
Q ss_pred hhccccccCcceEEEEEeC----CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLD----GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..+.||+|+||+||+|+.. .++.||||.++.. .....+.+|++++++++|||||++++++.+++..||||||
T Consensus 28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEc
Confidence 3578999999999999852 4678999999754 2334678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC--
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-- 486 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~-- 486 (640)
|++|+|.+++.... .+++.....++.|++.||+|||+. +||||||||+|||++.++.+||+|||+++...
T Consensus 108 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 108 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp CTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999998653 589999999999999999999954 59999999999999999999999999998642
Q ss_pred ----CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 487 ----TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 487 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...++|+.|||||++ ....|+.++||||+||++|||+||+.||.+... .+........
T Consensus 180 ~~~~~~~~GT~~YmAPE~~-------~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~--------- 241 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVV-------NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETMTMILKA--------- 241 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHH-------HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC---------
T ss_pred CccccccccCcccCCHHHh-------ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHHHHHHcC---------
Confidence 235679999999975 345677899999999999999999999975432 2222221111
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
....+...+. ++.+++.+||+.||++|||+
T Consensus 242 ~~~~p~~~s~---~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 242 KLGMPQFLSP---EAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCCCTTSCH---HHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCCCcCCH---HHHHHHHHHcccCHHHCCCC
Confidence 1111112222 45667788999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=384.52 Aligned_cols=236 Identities=19% Similarity=0.266 Sum_probs=178.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCC------------e
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD------------E 401 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------------~ 401 (640)
.+.||+|+||+||+|+. .+|+.||||+++... ..+.+.+|++++++++|||||++++++...+ .
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 46899999999999996 468899999987542 3456889999999999999999999987543 3
Q ss_pred EEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCc
Q 006559 402 LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV 481 (640)
Q Consensus 402 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 481 (640)
.|+|||||++|+|.+++..... ....++...+.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCcc
Confidence 7999999999999999986532 12356777889999999999999954 599999999999999999999999999
Q ss_pred ccccCC------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch
Q 006559 482 HQLFHT------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI 543 (640)
Q Consensus 482 ~~~~~~------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~ 543 (640)
++.... ..++|+.|||||++. ...|+.++|||||||++|||++ ||.... ..
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-------~~~y~~~~DiwSlGvilyell~---Pf~~~~-~~ 233 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-------GNSYSHKVDIFSLGLILFELLY---PFSTQM-ER 233 (299)
T ss_dssp C--------------------------CCCTTSCHHHHT-------TCCCCTHHHHHHHHHHHHHHHS---CCSSHH-HH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHc-------CCCCCCHHHHHHHHHHHHHHcc---CCCCcc-HH
Confidence 987532 135799999999753 4567889999999999999997 775321 11
Q ss_pred HHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 544 VKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 544 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......... ...++...+....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~-----------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVRN-----------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHT-----------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhc-----------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111110 0112222333445667888999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=379.44 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=186.9
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEc------CCeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNG------KDELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lV~ 406 (640)
.+.||+|+||+||+|+. .+|+.||||+++... ..+.+.+|+++|++++|||||++++++.. .+.+||||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 56899999999999996 568999999997542 23557789999999999999999999764 35799999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
|||+ |+|.+++.... ++++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.+.
T Consensus 139 E~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 139 DLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp ECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred eCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 9996 78999997643 589999999999999999999954 59999999999999999999999999998652
Q ss_pred ----------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHH-HHhhccc
Q 006559 487 ----------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWV-QMMGQDE 554 (640)
Q Consensus 487 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~-~~~~~~~ 554 (640)
...++|+.|+|||++.+ ...++.++||||+||++|||+||+.||.+... +....+ ...+...
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~------~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLS------LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cCccccccccccceeChHhcCHHHhcC------CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 23567999999997633 23467899999999999999999999975432 121111 1111110
Q ss_pred -ccccccch--------hhc--cChHH----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 555 -SAWEVFDF--------ELI--MDKEM----EEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 555 -~~~~~~d~--------~~~--~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+..... ... ..... .....++.+++.+||..||++|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 000 00000 011235677888999999999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=375.02 Aligned_cols=187 Identities=18% Similarity=0.300 Sum_probs=161.1
Q ss_pred hhccccccCcceEEEEEeC----CCcEEEEEEeccccchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVLD----GGDVVVVKRIRERKKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|+||+||+|+.+ .++.||||++........+.+|+++++.+ +|||||++++++...+..|+|||||++
T Consensus 25 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g 104 (361)
T 4f9c_A 25 IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH 104 (361)
T ss_dssp EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence 3568999999999999853 46789999998776667788999999988 699999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-CCeEEccCCcccccCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-GNACISDIGVHQLFHT--- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGl~~~~~~--- 487 (640)
|+|.+++. .+++.....++.|++.||+|||+ .+||||||||+|||++.+ +.+||+|||+|+....
T Consensus 105 ~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 105 ESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred ccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999984 37888999999999999999995 459999999999999876 7999999999975421
Q ss_pred -------------------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 488 -------------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 488 -------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
..++|+.|+|||++.+. ..++.++||||+||++|||+||+.||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC------PNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTC------SCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCC------CCCCCccchhhhHHHHHHHHHCCCCC
Confidence 23579999999986432 34678999999999999999999999
Q ss_pred CCCC
Q 006559 537 GDGE 540 (640)
Q Consensus 537 ~~~~ 540 (640)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=384.94 Aligned_cols=236 Identities=19% Similarity=0.231 Sum_probs=185.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHH---HHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVD---EWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.++||+|+||+||+|+.. +|+.||||++... .....+. .++.+++.++|||||+++++|.+.+.+||||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 467999999999999964 6899999999653 1122233 345677888999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
|++|+|.++|.... .+++.....|+.||+.||+|||+ .+||||||||+||||+.+|.+||+|||+++.+..
T Consensus 274 ~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 274 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp CCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999997643 58999999999999999999994 5599999999999999999999999999987643
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhcccccccccchh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
..++|+.|||||++. ....|+.++||||+||++|||+||+.||.+... ......+.... ..
T Consensus 346 ~~~t~~GTp~YmAPEvl~------~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~---------~~ 410 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------MA 410 (689)
T ss_dssp CCCSCCSCGGGCCHHHHS------TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH---------CC
T ss_pred CCCCccCCcCccCHHHHh------CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC---------CC
Confidence 457899999999753 234577899999999999999999999975322 12111111111 11
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCC-----HHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPN-----MSIVH 599 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~ 599 (640)
...+...+. ++.+++..||+.||++|++ +.||.
T Consensus 411 ~~~p~~~S~---~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 VELPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp CCCCTTSCH---HHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CCCCccCCH---HHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 111222223 3566777899999999998 56664
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=357.89 Aligned_cols=261 Identities=33% Similarity=0.554 Sum_probs=214.5
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+|+..+++.||||++.... ....+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 35 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 114 (326)
T 3uim_A 35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114 (326)
T ss_dssp TTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBH
T ss_pred ceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCH
Confidence 56899999999999998889999999997652 234688999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-------
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------- 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------- 487 (640)
.+++..... ...+++|..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 193 (326)
T 3uim_A 115 ASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193 (326)
T ss_dssp HHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEEC
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccc
Confidence 999986542 233589999999999999999999976445799999999999999999999999999986542
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCC------CCCcchHHHHHHhhcccccccccc
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG------DGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~------~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||. ........|+.............+
T Consensus 194 ~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 3uim_A 194 AVRGTIGHIAPEYL-------STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266 (326)
T ss_dssp CCCSCGGGCCHHHH-------HHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC
T ss_pred cccCCcCccCHHHh-------ccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC
Confidence 23368899999964 33456789999999999999999999996 234456667666555544444444
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
...... ...+....+.+++..||+.||++|||+.||++.|+....
T Consensus 267 ~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 267 VDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTCTTS-CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhhccc-cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 443222 234667789999999999999999999999999987543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.51 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=209.6
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+.||+|+||.||+|+..++..||||++... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 5679999999999999888999999998755 33467889999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-------- 487 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-------- 487 (640)
+++..... ....++|..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 99976532 22358999999999999999999995 4599999999999999999999999999876432
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC----CcchHHHHHHhhcccccccccchh
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG----ELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||... ......|..............++.
T Consensus 200 ~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 200 VVKGTLGYIDPEYF-------IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp CCEEETTTCCHHHH-------HHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred ccCCCccccCHHHh-------cCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 12357889999965 3345778999999999999999999998742 233455554433333333444433
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
.... ...+....+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 273 ~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 273 LADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CTTC-SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccc-cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 3211 124566778889999999999999999999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=380.62 Aligned_cols=240 Identities=18% Similarity=0.248 Sum_probs=191.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||+||+|+. .+|+.||+|++... ...+.+.+|+++|+.++|||||+++++|.+.+.+|||||||++|+
T Consensus 161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 357899999999999996 46899999998755 334668899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC--CCeEEccCCcccccCCC---
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL--GNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~--~~~kl~DfGl~~~~~~~--- 488 (640)
|.+++.... ..+++.....++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 241 L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 241 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp HHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred HHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999997543 2589999999999999999999954 59999999999999854 89999999999887542
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
.++|+.|+|||++. ...|+.++||||+||++|||++|+.||.+.... +.......... . +...
T Consensus 314 ~~~~GT~~y~APEv~~-------~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~~~~--~-~~~~--- 378 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCDW--N-MDDS--- 378 (573)
T ss_dssp EEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCC--C-CCSG---
T ss_pred eeeEECccccCHHHhC-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHhCCC--C-CCcc---
Confidence 35799999999753 345778999999999999999999999754321 11111111100 0 0000
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++.+||+.||++|||+.|+++
T Consensus 379 --~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111234567788899999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.83 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=197.2
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc-chHHHHHHHHHHhccCCCcccceeEEEEcCC----eEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD----ELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lV~Ey~~~ 411 (640)
..++||+|+||.||+|+.. ++.||||++.... .......|+.++++++||||+++++++.... ..++||||+++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 3578999999999999876 6899999997653 3345567888999999999999999998743 47999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-------CCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY-------NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
|+|.++++.. .++|..+..++.|++.||+|||+. ..++|+||||||+|||++.++.+||+|||+++.
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 9999999754 489999999999999999999954 011699999999999999999999999999976
Q ss_pred cCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhcccc
Q 006559 485 FHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQDES 555 (640)
Q Consensus 485 ~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~ 555 (640)
... ...+|..|+|||++.+... ....++.++|||||||++|||+||+.||..... ....+.........
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAIN--FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCC--CCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccCccccccCccCccccCHhhcccccc--cCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 532 1346889999998643211 113456789999999999999999999974221 11111111111110
Q ss_pred cccc--------cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 556 AWEV--------FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 556 ~~~~--------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...+ ..+.+...........++.+++.+||+.||++|||+.||++.|+++...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000 0000000001123455688899999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=346.54 Aligned_cols=253 Identities=27% Similarity=0.385 Sum_probs=190.4
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|+. .+..||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 41 i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 357899999999999987 57889999987552 2346788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 196 (309)
T 3p86_A 120 SLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196 (309)
T ss_dssp BHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred cHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccccccc
Confidence 9999998643 1124889999999999999999999532 2399999999999999999999999999876543
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...+|..|+|||++. ...++.++|||||||++|||+||+.||...... ............ ...
T Consensus 197 ~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~~~-------~~~ 260 (309)
T 3p86_A 197 KSAAGTPEWMAPEVLR-------DEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKCKR-------LEI 260 (309)
T ss_dssp -----CCTTSCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSCCC-------CCC
T ss_pred ccCCCCccccChhhhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCC-------CCC
Confidence 234688999999753 345678999999999999999999999753321 111111100000 001
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCCC
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSID 612 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 612 (640)
+... ..++.+++.+||+.||++|||+.++++.|+.+......+
T Consensus 261 ~~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 261 PRNL---NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred CccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 1111 234667888899999999999999999999998765443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=346.73 Aligned_cols=246 Identities=26% Similarity=0.447 Sum_probs=196.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.++||+|+||.||+|+.. ++..||+|++... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 578999999999999964 5889999988654 3456788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-------
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------- 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------- 487 (640)
.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 95 RGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp HHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99998643 2589999999999999999999954 599999999999999999999999999976532
Q ss_pred -------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccc
Q 006559 488 -------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE 554 (640)
Q Consensus 488 -------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 554 (640)
...+|..|+|||++ ....++.++|||||||++|||++|..|+........... .
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------~ 234 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMI-------NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------L 234 (310)
T ss_dssp ------------CCCCSCGGGCCHHHH-------TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------B
T ss_pred cccccccccccccccCCCcceeCHHHh-------cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------h
Confidence 23467889999975 345677899999999999999999999864221100000 0
Q ss_pred ccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 555 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
......+.. .+. .....+.+++.+||+.||++|||+.++++.|++++..
T Consensus 235 ~~~~~~~~~--~~~---~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 235 NVRGFLDRY--CPP---NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp CHHHHHHHT--CCT---TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhcccccc--CCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000000000 011 1123467788889999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.50 Aligned_cols=244 Identities=23% Similarity=0.383 Sum_probs=198.7
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||+|+..++..||+|++... ...+++.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 94 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHH
Confidence 5679999999999999988899999999866 356778999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-------Cc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-------PF 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-------~~ 489 (640)
++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 95 ~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 95 YLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp HHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHHhcCc----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence 9975432 588999999999999999999954 599999999999999999999999999986542 12
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+..|+|||++ ....++.++||||+||++|||+| |+.||...... ........... .. .+.
T Consensus 168 ~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~---~~-----~~~ 230 (269)
T 4hcu_A 168 KFPVKWASPEVF-------SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR---LY-----KPR 230 (269)
T ss_dssp TCCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC---CC-----CCT
T ss_pred ccccccCCHHHh-------cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCcc---CC-----CCC
Confidence 335679999964 34567889999999999999999 99999754321 11222111100 00 011
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.. ...+.+++..||+.||++||++.++++.|+++...
T Consensus 231 ~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 231 LA---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11 23466778889999999999999999999998865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.94 Aligned_cols=249 Identities=20% Similarity=0.361 Sum_probs=195.9
Q ss_pred hhccccccCcceEEEEEeC--------CCcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVLD--------GGDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
..+.||+|+||.||+|+.. ++..||||.++... ..+.+.+|+++++++ +||||++++++|...+..|+
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 3578999999999999852 34579999997653 235678899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCC-----------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 405 VYDYLPHGSLHSLLHGSRGP-----------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 241 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNV 241 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCC
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCCC
Confidence 99999999999999865321 11247899999999999999999995 45999999999999999999
Q ss_pred eEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchH
Q 006559 474 ACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIV 544 (640)
Q Consensus 474 ~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~ 544 (640)
+||+|||+++..... ...+..|+|||++. ...++.++|||||||++|||+| |+.||.......
T Consensus 242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~- 313 (370)
T 2psq_A 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 313 (370)
T ss_dssp EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-------TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred EEEccccCCcccCcccceecccCCCcccceECHhHhc-------CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 999999999865421 23356899999753 3567789999999999999999 999997543221
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
........... ..+. ....++.+++..||+.||++||++.|+++.|+++...
T Consensus 314 -~~~~~~~~~~~--------~~~~---~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 314 -LFKLLKEGHRM--------DKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp -HHHHHHTTCCC--------CCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHhcCCCC--------CCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111000 0111 1223567788889999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.52 Aligned_cols=236 Identities=20% Similarity=0.310 Sum_probs=189.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 46799999999999984 56889999998654 3456688999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... .
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 9999754 378999999999999999999954 599999999999999999999999999876542 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|..|+|||++ ....++.++|||||||++|||+||+.||.........+........ ......
T Consensus 176 ~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~ 240 (297)
T 3fxz_A 176 MVGTPYWMAPEVV-------TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--------ELQNPE 240 (297)
T ss_dssp CCSCGGGCCHHHH-------HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC--------CCSCGG
T ss_pred ccCCcCccChhhh-------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCCCcc
Confidence 3568899999975 3456778999999999999999999999754321111111101000 000111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ....+.+++.+||+.||++|||+.|+++
T Consensus 241 ~---~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 241 K---LSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp G---SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 2234667788899999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=358.13 Aligned_cols=245 Identities=22% Similarity=0.354 Sum_probs=195.8
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|+.. ++..||||.++.... .+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 3578999999999999976 688999999876522 345778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc---
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF--- 489 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~--- 489 (640)
+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999997542 2488999999999999999999954 59999999999999999999999999998654321
Q ss_pred -----cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 490 -----FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 490 -----~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
..+..|+|||++ ....++.++|||||||++|||+| |+.||....... ..+.......
T Consensus 271 ~~~~~~~~~~y~aPE~~-------~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~-------- 333 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEAL-------NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEKGGR-------- 333 (377)
T ss_dssp CSSCCEEEGGGSCHHHH-------HHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHTTCC--------
T ss_pred cCCCCCCCcCcCCHhHh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------
Confidence 125579999965 33457789999999999999999 999997533211 1111111100
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...+. ....++.+++..||+.||++|||+.++++.|+++..+
T Consensus 334 ~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 LPCPE---LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 00111 1223567788889999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.66 Aligned_cols=246 Identities=21% Similarity=0.310 Sum_probs=195.2
Q ss_pred hhccccccCcceEEEEEeC----CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD----GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~----~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|+.. .+..||||.++.. ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 3578999999999999974 3456999999864 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 133 ENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999997543 2589999999999999999999954 5999999999999999999999999999876432
Q ss_pred --------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 489 --------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 --------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
...|..|+|||++ ....++.++|||||||++|||++ |+.||...... ...........
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~---- 272 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAI-------AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGYR---- 272 (325)
T ss_dssp -CCEECC---CCGGGSCHHHH-------HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCC----
T ss_pred cceeeccCCCCcccccCHhHh-------cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCC----
Confidence 1225579999964 33457789999999999999999 99999753321 11111111100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
...+. .....+.+++..||+.||++|||+.+|++.|+.+....
T Consensus 273 ----~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 ----LPAPM---GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ----CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ----CCCCC---CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 00111 12235677888899999999999999999999987553
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=353.94 Aligned_cols=245 Identities=21% Similarity=0.337 Sum_probs=188.0
Q ss_pred hhccccccCcceEEEEEeC----CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD----GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~----~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|+.. ++..||||.++.. ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence 3578999999999999864 5678999999754 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF 489 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~ 489 (640)
++|+|.++++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 129 ENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999997543 258999999999999999999995 459999999999999999999999999998764321
Q ss_pred ---------cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 490 ---------FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 490 ---------~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
..+..|+|||++ ....++.++|||||||++|||++ |+.||..... ....+.......
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i~~~~~---- 268 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAI-------AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDEGYR---- 268 (373)
T ss_dssp ------------CTTSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHHHTTEE----
T ss_pred ccceeccCCCcCCCccChhhh-------ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC----
Confidence 124579999964 34567889999999999999998 9999975332 111221111100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.... ......+.+++..||+.||++||+|.+|+++|+++...
T Consensus 269 ----~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 ----LPPP---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ----CCCC---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCC---ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0001 12234577888899999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=333.13 Aligned_cols=245 Identities=22% Similarity=0.362 Sum_probs=196.0
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||++...++..||||+++.. ...+++.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHH
Confidence 5689999999999999998889999999866 356778999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-------Cc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-------PF 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-------~~ 489 (640)
++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 109 ~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 109 YLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp HHHCGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence 997632 258999999999999999999995 4599999999999999999999999999986542 12
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+..|+|||++ ....++.++|||||||++|||+| |+.||...... ............ . .+.
T Consensus 182 ~~~~~y~aPE~~-------~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~---~-----~~~ 244 (283)
T 3gen_A 182 KFPVRWSPPEVL-------MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRL---Y-----RPH 244 (283)
T ss_dssp TSCGGGCCHHHH-------HHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCC---C-----CCT
T ss_pred ccCcccCCHHHh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccCC---C-----CCC
Confidence 335679999964 34457789999999999999999 99999753321 111111111000 0 011
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
.. ...+.+++..||+.||++|||+.++++.|+++..+.
T Consensus 245 ~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 245 LA---SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 11 234667888899999999999999999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=358.32 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=197.3
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCC-eEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD-ELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||+|... ++.||||.++.....+.+.+|++++++++|||||++++++...+ ..++|||||++|+|.+
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~ 276 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 276 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHH
Confidence 568999999999999986 67899999987777788999999999999999999999987765 7999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---ccccc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---FFIND 493 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---~~~~~ 493 (640)
++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...+.
T Consensus 277 ~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 350 (450)
T 1k9a_A 277 YLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 350 (450)
T ss_dssp HHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------CCCT
T ss_pred HHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCc
Confidence 998643 22478999999999999999999954 5999999999999999999999999999865422 23467
Q ss_pred cccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHH
Q 006559 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEE 572 (640)
Q Consensus 494 ~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 572 (640)
.|+|||++ ....++.++|||||||++|||+| |+.||....... .......... ...+. .
T Consensus 351 ~y~aPE~~-------~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~--------~~~p~---~ 410 (450)
T 1k9a_A 351 KWTAPEAL-------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYK--------MDAPD---G 410 (450)
T ss_dssp TTSCHHHH-------HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTCC--------CCCCT---T
T ss_pred ceeCHHHh-------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------CCCCC---c
Confidence 89999964 34567889999999999999999 999997533221 1111111100 00111 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 573 EMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 573 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...++.+++..||+.||++|||+.++++.|+++...
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 234567788889999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=332.59 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=197.2
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||+|+..++..||||.++.. ...+++.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN 92 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHH
Confidence 5679999999999999998889999999866 356778999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~ 489 (640)
++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 93 ~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 93 YLRSHG----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp HHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred HHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 997542 248899999999999999999995 45999999999999999999999999999865432 1
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+..|+|||++ ....++.++||||||+++|||+| |+.||...... ............ .. +.
T Consensus 166 ~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~---~~-----~~ 228 (268)
T 3sxs_A 166 KFPVKWSAPEVF-------HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVVLKVSQGHRL---YR-----PH 228 (268)
T ss_dssp CCCGGGCCHHHH-------HHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCC---CC-----CT
T ss_pred CcCcccCCHHHH-------hccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--HHHHHHHcCCCC---CC-----CC
Confidence 235579999964 33456789999999999999999 99999753321 111111111100 00 11
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.. ...+.+++..||+.||++|||+.++++.|++++.+
T Consensus 229 ~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 229 LA---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TS---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred cC---hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11 22466788889999999999999999999999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.30 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=192.9
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHh
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSL 417 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 417 (640)
.+.||+|+||.||+|+.. ++.||||.+......+.+.+|++++++++||||+++++++. +..++||||+++|+|.++
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~ 89 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNV 89 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHH
Confidence 578999999999999986 67899999987666778899999999999999999999886 457999999999999999
Q ss_pred hccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC-eEEccCCcccccCC---Cccccc
Q 006559 418 LHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN-ACISDIGVHQLFHT---PFFIND 493 (640)
Q Consensus 418 l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~-~kl~DfGl~~~~~~---~~~~~~ 493 (640)
+..... ...+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.... ...++.
T Consensus 90 l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~ 167 (307)
T 2eva_A 90 LHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA 167 (307)
T ss_dssp HHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------CCT
T ss_pred HhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCCCC
Confidence 986431 124788899999999999999999754467999999999999998886 79999999876543 234688
Q ss_pred cccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHH
Q 006559 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEE 573 (640)
Q Consensus 494 ~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 573 (640)
.|+|||++ ....++.++|||||||++|||+||+.||................... +.. .. ..
T Consensus 168 ~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~--~~---~~ 229 (307)
T 2eva_A 168 AWMAPEVF-------EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR------PPL--IK---NL 229 (307)
T ss_dssp TSSCHHHH-------TCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC------CCC--BT---TC
T ss_pred ceEChhhh-------CCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC------CCc--cc---cc
Confidence 99999975 33467789999999999999999999997543332222211111100 000 01 11
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 574 MRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 574 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
...+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 234667888899999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.55 Aligned_cols=235 Identities=20% Similarity=0.262 Sum_probs=188.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 56899999999999996 678999999997542 2345778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 100 EVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence 9999997543 488999999999999999999954 599999999999999999999999999976542
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+|..|+|||++.+. ...+.++||||+||++|||+||+.||...... ...+...... ...+
T Consensus 172 ~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~---------~~~p 234 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGK------KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLRGK---------YRIP 234 (328)
T ss_dssp TTSSSGGGCCHHHHHTC------CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC---------CCCC
T ss_pred cccCCcceeCcccccCC------CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC---------CCCC
Confidence 34568899999975322 12247899999999999999999999754322 2222211110 0111
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ..++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~---s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 235 FYM---STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp TTS---CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCC---CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 224566778899999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.94 Aligned_cols=245 Identities=21% Similarity=0.373 Sum_probs=197.6
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|+..++..||||.++.. ...+.+.+|++++++++|||||++++++. .+..++|||||++|+|.
T Consensus 192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 35789999999999999988899999999865 45678999999999999999999999986 66789999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------- 488 (640)
++++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 271 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 271 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp HHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred HHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 9997532 12478889999999999999999954 5999999999999999999999999999876421
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||.+... .+..+....... ...+
T Consensus 345 ~~~~~~y~aPE~~-------~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~--------~~~~ 407 (454)
T 1qcf_A 345 AKFPIKWTAPEAI-------NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR--------MPRP 407 (454)
T ss_dssp SSSCGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHHTCC--------CCCC
T ss_pred CcccccccCHHHh-------ccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC--------CCCC
Confidence 2235679999964 34567889999999999999999 9999975322 121222111100 0011
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
. ....++.+++.+||+.||++||||.+|++.|+++...
T Consensus 408 ~---~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 408 E---NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1 2234577788899999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=335.46 Aligned_cols=255 Identities=25% Similarity=0.314 Sum_probs=188.3
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHh--ccCCCcccceeEEEEc----CCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIG--GLRHSNIVSIRAYCNG----KDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~----~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|+. +++.||||++.... ...+..|.+++. .++||||+++++++.. ....++||||++
T Consensus 12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EEEeeccCCCcEEEEEEE-CCEEEEEEEecccc-chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 357899999999999988 57889999987543 333444444444 4899999999999754 346899999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-----CCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY-----NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
+|+|.++++.. .+++..++.++.|++.||+|||+. ...+|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 90 MGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp TCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 99999999643 489999999999999999999932 1346999999999999999999999999998764
Q ss_pred CC----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhC----------CCCCCCCC---cc
Q 006559 486 HT----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG----------KMAKGDGE---LG 542 (640)
Q Consensus 486 ~~----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg----------~~p~~~~~---~~ 542 (640)
.. ...+|..|+|||++...... ....++.++|||||||++|||+|| +.||.... ..
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV-DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCT-TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccccccccccccceeChhhhcCcCCC-CcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 32 22568899999976432111 001345789999999999999999 77876421 11
Q ss_pred hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
.....+....... .+.............++.+++..||+.||++|||+.+|++.|++|
T Consensus 243 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 243 FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111111111110 111111111124456788899999999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.88 Aligned_cols=236 Identities=18% Similarity=0.275 Sum_probs=189.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+|+.. +|+.||||++... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 50 ~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 129 (321)
T 2c30_A 50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129 (321)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred cEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence 457999999999999976 6899999998754 3456688999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 130 ~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 130 TDIVSQV------RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 9998743 48999999999999999999995 4599999999999999999999999999876542 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|..|+|||++ ....++.++|||||||++|||+||+.||..... ........... .+......
T Consensus 201 ~~gt~~y~aPE~~-------~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~------~~~~~~~~ 265 (321)
T 2c30_A 201 LVGTPYWMAPEVI-------SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSP------PPKLKNSH 265 (321)
T ss_dssp CCSCGGGCCHHHH-------TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSS------CCCCTTGG
T ss_pred ccCCccccCHhhh-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCC------CCCcCccc
Confidence 3568899999975 334577899999999999999999999975322 12122111110 00010111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ....+.+++.+||+.||++|||+.++++
T Consensus 266 ~---~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 266 K---VSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp G---SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1234666778899999999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.68 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=199.8
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccc------cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRER------KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
+.||+|+||.||+|+. ++..||||++... ...+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 37 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 115 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115 (307)
T ss_dssp CEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred CccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCC
Confidence 6799999999999986 5788999998643 22466889999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++..... ..+++|..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 116 ~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 116 SLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp BHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred cHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 99999874321 2358999999999999999999995 4599999999999999999999999999876532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhcccc-cccccc
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDES-AWEVFD 561 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~-~~~~~d 561 (640)
...++..|+|||++. ..++.++|||||||++|||+||+.||..... ....+.+....... ....++
T Consensus 191 ~~~~~~g~~~y~aPE~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALR--------GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID 262 (307)
T ss_dssp ECSSCCSCGGGCCHHHHT--------TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSC
T ss_pred cccccCCCcCcCChHHhc--------CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcc
Confidence 234688999999652 2367899999999999999999999975322 12233332222111 112222
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
.... .........+.+++..||+.||++|||+.+|++.|+++..
T Consensus 263 ~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 263 KKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2221 1123455678889999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=329.82 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=193.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccc---------hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKK---------KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||+|+. .+++.||||.+..... .+.+.+|++++++++||||+++++++.+.. ++||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~ 100 (287)
T 4f0f_A 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVM 100 (287)
T ss_dssp EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEE
T ss_pred ehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEE
Confidence 356899999999999996 4688999999864311 156889999999999999999999997655 7999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC-----eEEccCCc
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN-----ACISDIGV 481 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~-----~kl~DfGl 481 (640)
||+++|+|.+++.... .++++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+|||+
T Consensus 101 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp ECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 9999999999887543 25899999999999999999999532 23999999999999988776 99999999
Q ss_pred ccccCCC---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 482 HQLFHTP---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 482 ~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
++..... ..++..|+|||++.. ....++.++|||||||++|||+||+.||.........+............
T Consensus 176 ~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 176 SQQSVHSVSGLLGNFQWMAPETIGA-----EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CBCCSSCEECCCCCCTTSCGGGSSC-----SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred cccccccccccCCCccccCchhhcc-----CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 9865432 356889999997521 23446789999999999999999999998655444433333222111100
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
... ....++.+++..||+.||++|||+.++++.|+++
T Consensus 251 -------~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 -------IPE---DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -------CCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -------CCc---ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 1223567788889999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=362.74 Aligned_cols=247 Identities=22% Similarity=0.351 Sum_probs=199.1
Q ss_pred hhccccccCcceEEEEEeCC-CcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVLDG-GDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..+.||+|+||.||+|++.. +..||||.++.. ...+++.+|++++++++|||||+++++|...+..++|||||++|+|
T Consensus 224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 35789999999999999765 788999999865 3467789999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC------
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------ 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------ 488 (640)
.++++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 304 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 304 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 99997643 23588999999999999999999954 5999999999999999999999999999876432
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||....... ..+...... ....
T Consensus 378 ~~~~~~~y~aPE~~-------~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~--------~~~~ 440 (495)
T 1opk_A 378 GAKFPIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDY--------RMER 440 (495)
T ss_dssp TCCCCGGGCCHHHH-------HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTC--------CCCC
T ss_pred CCcCCcceeCHhHH-------hcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC--------CCCC
Confidence 1235679999965 34457789999999999999999 999997543221 111111110 0011
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
+. ....++.+++..||+.||++||||.++++.|+.+....
T Consensus 441 ~~---~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 441 PE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CC---CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 11 12235677888899999999999999999999886543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.31 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=192.4
Q ss_pred hhccccccCcceEEEEEe-----CCCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL-----DGGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 407 (640)
..+.||+|+||.||+|++ .+++.||||++.... ..+.+.+|++++++++||||+++++++... ...++|||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence 357899999999999985 357889999997653 346688999999999999999999999654 46899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred eCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999997653 248899999999999999999995 4599999999999999999999999999987532
Q ss_pred C---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccc-
Q 006559 488 P---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW- 557 (640)
Q Consensus 488 ~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 557 (640)
. ..++..|+|||++ ....++.++|||||||++|||+||..|+..... .+.+.........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESL-------TESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDKQGQM 236 (295)
T ss_dssp ---------CTTCGGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH---HHHHHHCTTCCTHH
T ss_pred CcceeeeccCCCCccceeCcHHh-------cCCCCChHHHHHHHHHHHHHHHhcccccCCChH---HHHhhhcCccccch
Confidence 1 2235569999964 345678899999999999999999999864221 1111111110000
Q ss_pred ------cccc--hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 558 ------EVFD--FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 558 ------~~~d--~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
+... .....+ .....++.+++..||+.||++|||+.|+++.|+++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRP---DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccCcCCCC---cCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0000 000011 12234577788899999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=340.73 Aligned_cols=265 Identities=24% Similarity=0.297 Sum_probs=190.9
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHH--HHHHHHhccCCCcccceeEEEEc-----CCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVD--EWLRVIGGLRHSNIVSIRAYCNG-----KDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~--~e~~~l~~l~H~niv~l~~~~~~-----~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|+. +++.||||++.... ...+. .++..+..++||||+++++++.. ....++||||++
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 95 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP 95 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCT
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCC
Confidence 56899999999999987 57899999987543 22233 34444556899999999986542 236789999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC------CCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN------KAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
+|+|.+++.... .++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~ 169 (336)
T 3g2f_A 96 NGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169 (336)
T ss_dssp TCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence 999999997543 588999999999999999999651 12699999999999999999999999999976
Q ss_pred cCC--------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-c--hHHHH
Q 006559 485 FHT--------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-G--IVKWV 547 (640)
Q Consensus 485 ~~~--------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~--~~~~~ 547 (640)
+.. ...+|..|+|||++.+.........++.++|||||||++|||+||+.|+..... . ...+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 249 (336)
T 3g2f_A 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249 (336)
T ss_dssp CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence 532 224688999999875433222224566789999999999999999776542111 0 00000
Q ss_pred HHhhc------------ccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCCCC
Q 006559 548 QMMGQ------------DESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSIDG 613 (640)
Q Consensus 548 ~~~~~------------~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~ 613 (640)
..... .......+..... .......++.+++.+||+.||++|||+.|+++.|+++......++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWK---ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCTTCC---CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred cccCCCchHHHHHhhhcccccCCCCCcccc---cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 00000 0000000000000 112344568888999999999999999999999999987766554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.21 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=198.1
Q ss_pred hhccccccCcceEEEEEeC--------CCcEEEEEEeccccc---hHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVLD--------GGDVVVVKRIRERKK---KREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~---~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
..+.||+|+||.||+|+.. .+..||||+++.... .+.+.+|+++++++ +||||+++++++...+..++
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 3578999999999999852 235799999976532 35678899999999 99999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCC-----------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 405 VYDYLPHGSLHSLLHGSRGP-----------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
||||+++|+|.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 229 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNV 229 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCc
Confidence 99999999999999765321 123589999999999999999999954 5999999999999999999
Q ss_pred eEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchH
Q 006559 474 ACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIV 544 (640)
Q Consensus 474 ~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~ 544 (640)
+||+|||+++..... ..++..|+|||++ ....++.++|||||||++|||+| |+.||..... .
T Consensus 230 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~ 300 (382)
T 3tt0_A 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-------FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--E 300 (382)
T ss_dssp EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH-------HSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H
T ss_pred EEEcccCcccccccccccccccCCCCCcceeCHHHh-------cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 999999999865421 2336689999965 34567789999999999999999 9999975432 2
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCC
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 611 (640)
+..+........ . ... ....++.+++..||+.||++|||+.||++.|+++......
T Consensus 301 ~~~~~~~~~~~~------~--~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 301 ELFKLLKEGHRM------D--KPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHHHTTCCC------C--CCS---SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHcCCCC------C--CCc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 222222211100 0 011 1223467788889999999999999999999999866443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=340.00 Aligned_cols=249 Identities=14% Similarity=0.153 Sum_probs=197.7
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..+.||+|+||.||+|+. .+++.||||.+......+.+..|+++++++ +||||+++++++...+..++||||+ +|+|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 357899999999999995 578899999987665556788999999999 9999999999999999999999999 9999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC-----eEEccCCcccccCC--
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN-----ACISDIGVHQLFHT-- 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~-----~kl~DfGl~~~~~~-- 487 (640)
.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.+..
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 92 EDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99998642 2589999999999999999999954 5999999999999998887 99999999986532
Q ss_pred -----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhcccc
Q 006559 488 -----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQDES 555 (640)
Q Consensus 488 -----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~ 555 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||..... ......+.....
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-- 235 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTH-------LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-- 235 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH--
T ss_pred CCccccccccCCcCCCccccChHHH-------cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh--
Confidence 23468899999975 345577899999999999999999999985332 222222221110
Q ss_pred cccccchhhccChH-HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 556 AWEVFDFELIMDKE-MEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 556 ~~~~~d~~~~~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
....... ......++.+++..||+.||++||++.++.+.|+++..+.
T Consensus 236 -------~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 236 -------KRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -------HHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------hccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000000 0011126778888899999999999999999999987553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.07 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=194.7
Q ss_pred hhccccccCcceEEEEEeC------CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD------GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|++. ++..||||+++.. .....+.+|+.++++++||||+++++++......++|||
T Consensus 75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence 3568999999999999954 3567999999754 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC--CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC---CeEEccCCcc
Q 006559 408 YLPHGSLHSLLHGSRG--PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG---NACISDIGVH 482 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGl~ 482 (640)
|+++|+|.+++..... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 9999999999975432 1223589999999999999999999954 599999999999999555 5999999998
Q ss_pred cccC--------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcc
Q 006559 483 QLFH--------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 483 ~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 553 (640)
+... ....+|..|+|||++ ....++.++|||||||++|||+| |+.||...... ...+.....
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~i~~~ 302 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAF-------MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSG 302 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTT
T ss_pred cccccccccccCCCcCCcccEECHHHh-------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC
Confidence 7542 123347789999964 34567889999999999999998 99999754322 112221111
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
... .... .....+.+++..||+.||++||++.+|++.|+.+...
T Consensus 303 ~~~--------~~~~---~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRM--------DPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCC--------CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC--------CCCc---cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 100 0011 1123466788889999999999999999999998765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=330.46 Aligned_cols=243 Identities=27% Similarity=0.403 Sum_probs=184.9
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|+.. +..||||+++... ..+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (271)
T 3dtc_A 11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCT
T ss_pred eeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCC
Confidence 3568999999999999975 7889999987541 23567889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC--------CCCeEEccCCcc
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ--------LGNACISDIGVH 482 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~--------~~~~kl~DfGl~ 482 (640)
+|+|.+++... .+++..+..++.|++.||+|||+.+..+|+||||||+|||++. ++.+||+|||++
T Consensus 90 ~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 90 GGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp TEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999999643 4889999999999999999999765445999999999999986 778999999999
Q ss_pred cccCC----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 483 QLFHT----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 483 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
+.... ...++..|+|||++ ....++.++||||||+++|||+||+.||.........+...... ..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-- 232 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVI-------RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK--LA-- 232 (271)
T ss_dssp ------------CCGGGSCHHHH-------HHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC--CC--
T ss_pred cccccccccCCCCccceeCHHHh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC--CC--
Confidence 76543 23568899999964 34557789999999999999999999997543222211111110 00
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
..... .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 -----~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 -----LPIPS---TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----CCCCc---ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00111 1123467788889999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=330.95 Aligned_cols=248 Identities=19% Similarity=0.261 Sum_probs=193.7
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+. .++..||+|.+... ...+.+.+|++++++++||||+++++++...+..|+||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 56899999999999995 46889999998543 2235678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... ++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 96 PTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999997543 589999999999999999999954 599999999999999999999999999986542
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||......... .+.. .... .....
T Consensus 168 ~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~-~~~~----~~~~~ 234 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQA-------KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-IKHI-QDSV----PNVTT 234 (294)
T ss_dssp -------CCSSCCHHHH-------HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-HHHH-SSCC----CCHHH
T ss_pred ccCccccCccccCHhHh-------cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHh-hccC----CCcch
Confidence 23468899999965 3345678999999999999999999999754321111 1111 1100 00000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhhccC
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRP-NMSIVHRMIEDIRTKG 609 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~~~ 609 (640)
.... .....+.+++.+|++.||++|| +++++.+.|+.+..+.
T Consensus 235 ~~~~---~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 235 DVRK---DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HSCT---TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred hccc---CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0111 1223567788889999999999 8999999999876553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.06 Aligned_cols=244 Identities=20% Similarity=0.319 Sum_probs=188.9
Q ss_pred hhccccccCcceEEEEEeC-CCcE----EEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDV----VVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~----vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..+.||+|+||.||+|+.. ++.. ||+|.++.. ...+.+.+|++++++++||||++++++|... ..++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEEC
T ss_pred cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEe
Confidence 3578999999999999954 3443 688887644 3456788999999999999999999999865 48899999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP 488 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~ 488 (640)
+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 98 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CTTCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred cCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 999999999986532 589999999999999999999954 5999999999999999999999999999875422
Q ss_pred --------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 489 --------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 --------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
..++..|+|||++ ....++.++|||||||++|||+| |+.||.......... ........
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~~~~~~~~--- 238 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESI-------LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS--ILEKGERL--- 238 (327)
T ss_dssp CC-------CCCGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH--HHHTTCCC---
T ss_pred cccccccCCCccccccChHHh-------ccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH--HHHcCCCC---
Confidence 2236689999964 34567889999999999999999 999997543322211 11111000
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.... ....++.+++.+||+.||++||++.++++.|+++...
T Consensus 239 -----~~~~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 -----PQPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCT---TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCc---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0011 1223567788899999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.25 Aligned_cols=238 Identities=20% Similarity=0.280 Sum_probs=187.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++...+..|+||||+++|+
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 568999999999999965 68899999986542 23567889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------- 486 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------- 486 (640)
|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 999997543 58999999999999999999995 459999999999999999999999999997653
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....+|..|+|||++... ..++.++|||||||++|||+||+.||.........+......... ..+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----~~~--- 230 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----LNP--- 230 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCS------SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----STT---
T ss_pred cCCCccCcCccCcHHhccC------CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----CCc---
Confidence 234568899999975322 223568999999999999999999997543332222221111100 000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......+.+++.+||+.||++|||+.|+++
T Consensus 231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0112234567888899999999999999865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=333.58 Aligned_cols=249 Identities=20% Similarity=0.308 Sum_probs=188.8
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||+||+|+..+++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence 56899999999999999889999999997542 23567889999999999999999999999999999999998 58
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 105 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (311)
T 3niz_A 105 LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177 (311)
T ss_dssp HHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence 888887543 248899999999999999999995 4599999999999999999999999999987642
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chH-HHHHHhhcccc-cccccch-h
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIV-KWVQMMGQDES-AWEVFDF-E 563 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~-~~~~~~~~~~~-~~~~~d~-~ 563 (640)
...+|..|+|||++.+ ...++.++|||||||++|||+||+.||..... ... ........... .+..... .
T Consensus 178 ~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMG------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CCCCCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred CCcccCCcCCHHHhcC------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 2345889999997532 24567899999999999999999999974322 222 22222211110 0000000 0
Q ss_pred --------hccC----hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 --------LIMD----KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 --------~~~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... ........++.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 000112245678888999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.52 Aligned_cols=252 Identities=13% Similarity=0.141 Sum_probs=197.7
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..+.||+|+||.||+|+. .+++.||||.+......+.+.+|+++++++ +|+|++++++++......++||||+ +|+|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 356799999999999995 678899999987666666788899999998 7999999999999999999999999 9999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC-----eEEccCCcccccCC--
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN-----ACISDIGVHQLFHT-- 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~-----~kl~DfGl~~~~~~-- 487 (640)
.+++.... .++++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 93 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 93 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99998643 248999999999999999999994 56999999999999987776 99999999986542
Q ss_pred -----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccc
Q 006559 488 -----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDES 555 (640)
Q Consensus 488 -----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~ 555 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||...... .............
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTH-------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccCccCCCCCcccCCchhh-------cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 22457899999965 3345678999999999999999999999753221 1111111110000
Q ss_pred cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 556 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
. ............++.+++..||+.||++||++.+|++.|+++..+..
T Consensus 239 ~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 239 S-------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp H-------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred C-------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 0 00000001123457778888999999999999999999999886543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=324.22 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=198.0
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||+|+..++..||+|.+... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHH
Confidence 5679999999999999988889999999866 345678899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-------Cc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-------PF 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-------~~ 489 (640)
++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 93 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 93 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp HHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 997643 2578999999999999999999954 599999999999999999999999999886532 12
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
.++..|+|||++ ....++.++||||||+++|||+| |+.||...... ........... .. .+.
T Consensus 166 ~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~---~~-----~~~ 228 (267)
T 3t9t_A 166 KFPVKWASPEVF-------SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR---LY-----KPR 228 (267)
T ss_dssp TCCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC---CC-----CCT
T ss_pred cccccccChhhh-------cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCc---CC-----CCc
Confidence 345679999965 33456789999999999999999 89999754321 11221111100 00 011
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
. ....+.+++.+||+.||++||++.++++.|+++...
T Consensus 229 ~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 229 L---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c---CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 123466788889999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=341.67 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=196.2
Q ss_pred hhccccccCcceEEEEEeCC------CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLDG------GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+..+ +..||||.++... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 35679999999999999743 4789999997652 24568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCC-------------------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE
Q 006559 408 YLPHGSLHSLLHGSRGP-------------------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV 468 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl 468 (640)
|+++|+|.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEE
Confidence 99999999999764211 114689999999999999999999954 59999999999999
Q ss_pred CCCCCeEEccCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 006559 469 DQLGNACISDIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDG 539 (640)
Q Consensus 469 ~~~~~~kl~DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~ 539 (640)
+.++.+||+|||+++.... ...++..|+|||++ ....++.++|||||||++|||+| |+.||...
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-------FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh-------ccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999999999999876432 22346789999964 34457889999999999999999 99999754
Q ss_pred CcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 540 ELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
... ............ ..+. ....++.+++..||+.||++||++.++++.|+++..+..
T Consensus 281 ~~~--~~~~~~~~~~~~--------~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 281 AHE--EVIYYVRDGNIL--------ACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp CHH--HHHHHHHTTCCC--------CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred ChH--HHHHHHhCCCcC--------CCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 321 122221111100 0111 122356778888999999999999999999999886543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.71 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=194.3
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.+ +..||||.++.. ...+.+.+|++++++++||||+++++++... +..++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 568999999999999986 788999998754 2245688899999999999999999999887 788999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-Ccc
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-PFF 490 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-~~~ 490 (640)
|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.++|+|||++..... ...
T Consensus 94 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 169 (271)
T 3kmu_A 94 GSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM 169 (271)
T ss_dssp CBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTTCB
T ss_pred CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecccCcc
Confidence 99999998643 225899999999999999999999532 3399999999999999999999998888765433 345
Q ss_pred ccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHH
Q 006559 491 INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEM 570 (640)
Q Consensus 491 ~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 570 (640)
+|..|+|||++..... ..++.++|||||||++|||+||+.||....... ........... +. .+...
T Consensus 170 ~t~~y~aPE~~~~~~~----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~-----~~--~~~~~ 236 (271)
T 3kmu_A 170 YAPAWVAPEALQKKPE----DTNRRSADMWSFAVLLWELVTREVPFADLSNME--IGMKVALEGLR-----PT--IPPGI 236 (271)
T ss_dssp SCGGGSCHHHHHSCGG----GSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH--HHHHHHHSCCC-----CC--CCTTC
T ss_pred CCccccChhhhccCCC----CCCCchhhHHHHHHHHHHHHhCCCCccccChHH--HHHHHHhcCCC-----CC--CCCCC
Confidence 6889999997643211 223447999999999999999999997533211 11111111000 00 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 571 EEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 571 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
..++.+++..||+.||++|||+.++++.|+++..
T Consensus 237 ---~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 237 ---SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 2346677888999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.31 Aligned_cols=234 Identities=21% Similarity=0.301 Sum_probs=188.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +|+.||+|.++.. .....+.+|+++++.++||||+++++++...+..|+||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 568999999999999965 6889999999754 2345678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----- 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----- 486 (640)
|+|.+++.... .+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 90 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 99999997543 588999999999999999999954 59999999999999999999999999987632
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....+|..|+|||++ ....++.++|||||||++|||++|+.||...... ...+...... ..
T Consensus 162 ~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~---------~~ 223 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILMEE---------IR 223 (337)
T ss_dssp BCCCEECGGGCCGGGG-------SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC---------CC
T ss_pred ccccccChhhCChhhh-------cCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHHHcCC---------CC
Confidence 234568899999975 3345778999999999999999999999754321 1111111110 11
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
.+...+ .++.+++.+||+.||++|| ++.|+++
T Consensus 224 ~p~~~s---~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 FPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111122 2456677789999999999 8888864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=355.68 Aligned_cols=245 Identities=23% Similarity=0.389 Sum_probs=194.1
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|+..++..||||.++.. ...+++.+|++++++++||||+++++++.. +..++||||+++|+|.
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 35689999999999999988888999999865 345778999999999999999999999876 6789999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------- 488 (640)
+++....+ ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 267 ~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 267 DFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp HHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 99974321 248899999999999999999995 45999999999999999999999999999875432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||..... .+.......... ...+
T Consensus 341 ~~~~~~y~aPE~~-------~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~--------~~~~ 403 (452)
T 1fmk_A 341 AKFPIKWTAPEAA-------LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYR--------MPCP 403 (452)
T ss_dssp --CCGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCC--------CCCC
T ss_pred CcccccccCHhHH-------hcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC--------CCCC
Confidence 1235679999964 34567889999999999999999 9999975322 111222111100 0111
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
. .....+.+++.+||+.||++|||+.++++.|+++...
T Consensus 404 ~---~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 P---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred C---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1 2233567788899999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.05 Aligned_cols=240 Identities=17% Similarity=0.207 Sum_probs=177.8
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|+.. +++.||||.++.....+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 136 (349)
T 2w4o_A 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF 136 (349)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHH
Confidence 3568999999999999976 478899999987666677888999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCC-----
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~----- 487 (640)
+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 137 ~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 137 DRIVEKG-----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp HHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 9997543 588999999999999999999954 5999999999999975 88999999999886543
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+|..|+|||++. ...++.++|||||||++|||+||+.||.........+........ ....
T Consensus 209 ~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~---~~~~------ 272 (349)
T 2w4o_A 209 TVCGTPGYCAPEILR-------GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY---YFIS------ 272 (349)
T ss_dssp ----CGGGSCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC---CCCT------
T ss_pred cccCCCCccCHHHhc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC---ccCC------
Confidence 234688999999753 345778999999999999999999999754332211111111110 0000
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+...+...++.+++.+||+.||++|||+.++++
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112235667888899999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=339.07 Aligned_cols=239 Identities=18% Similarity=0.254 Sum_probs=190.2
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc--------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK--------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+.. +|..||||.+.... ..+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEE
Confidence 3578999999999999965 58899999997542 24678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC----CeEEccCCccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG----NACISDIGVHQ 483 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGl~~ 483 (640)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 ~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp CCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 999999999997543 589999999999999999999954 599999999999998877 79999999998
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
.... ...+|+.|+|||++ ....++.++|||||||++|||++|+.||..... ............
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~~~~~i~~~~~--- 235 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANITAVSY--- 235 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHH-------TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHTTCC---
T ss_pred EcCCCCccccCCCCccEECchHH-------cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCC---
Confidence 7643 24568899999975 334577899999999999999999999975432 111111111100
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.++... .......+.+++..||..||++|||+.|+++
T Consensus 236 ~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 DFDEEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCchh-----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111 1112234667788899999999999999873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.43 Aligned_cols=259 Identities=24% Similarity=0.313 Sum_probs=189.2
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHh--ccCCCcccceeEEEEcC----CeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIG--GLRHSNIVSIRAYCNGK----DELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~----~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|+.. +..||||++..... .....|.+++. .++||||+++++++... ...++||||++
T Consensus 41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 118 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118 (337)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred EEeEeecCCCeEEEEEEEC-CceEEEEEEecccc-chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence 3578999999999999986 78999999865432 23333444444 45999999999999876 68999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC-----CCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN-----KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
+|+|.++++.. .+++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+||+|||+++..
T Consensus 119 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 119 NGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 99999999754 4889999999999999999999641 226999999999999999999999999998765
Q ss_pred CC----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhC----------CCCCCCCCc---c
Q 006559 486 HT----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG----------KMAKGDGEL---G 542 (640)
Q Consensus 486 ~~----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg----------~~p~~~~~~---~ 542 (640)
.. ...+|..|+|||++....... ....+.++|||||||++|||+|| +.||..... .
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN-HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTTCCCTT-CTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccCCCCCCccCcceeChhhcccccCCc-cccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 32 235688999999764332110 01112359999999999999999 555543111 1
Q ss_pred hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
...+....... . ..+.........+...++.+++..||+.||++|||+.+|++.|+++....
T Consensus 272 ~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 272 YEDMREIVCIK-K----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHTTS-C----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhhHHHHhhh-c----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 11111111110 0 01111111112245667888999999999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=343.94 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=193.3
Q ss_pred hhccccccCcceEEEEEe------CCCcEEEEEEeccccc---hHHHHHHHHHHhcc-CCCcccceeEEEEcCC-eEEEE
Q 006559 337 SAELLGKGCVGATYKVVL------DGGDVVVVKRIRERKK---KREVDEWLRVIGGL-RHSNIVSIRAYCNGKD-ELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~---~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lV 405 (640)
..+.||+|+||.||+|++ .+++.||||+++.... .+.+.+|++++.++ +||||+++++++...+ ..++|
T Consensus 26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 357899999999999974 2357899999986532 35688899999999 7899999999998765 49999
Q ss_pred EeccCCCCHHHhhccCCCCC------------------------------------------------------------
Q 006559 406 YDYLPHGSLHSLLHGSRGPG------------------------------------------------------------ 425 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~------------------------------------------------------------ 425 (640)
|||+++|+|.++++......
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 99999999999997653210
Q ss_pred -CCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--------Ccccccccc
Q 006559 426 -RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--------PFFINDAYN 496 (640)
Q Consensus 426 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--------~~~~~~~y~ 496 (640)
...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ...+|..|+
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 262 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGC
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeE
Confidence 11288999999999999999999954 599999999999999999999999999986532 123467899
Q ss_pred CCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHH
Q 006559 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMR 575 (640)
Q Consensus 497 aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 575 (640)
|||++ ....++.++|||||||++|||+| |+.||............. ..... ...+.. ...
T Consensus 263 aPE~~-------~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~--------~~~~~~---~~~ 323 (359)
T 3vhe_A 263 APETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTR--------MRAPDY---TTP 323 (359)
T ss_dssp CHHHH-------HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH-HHTCC--------CCCCTT---CCH
T ss_pred Chhhh-------cCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH-HcCCC--------CCCCCC---CCH
Confidence 99964 34567889999999999999999 999997543322111111 11000 000111 123
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 576 ALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 576 ~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
++.+++..||+.||++|||+.|+++.|+++..
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 46777888999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=334.79 Aligned_cols=239 Identities=18% Similarity=0.263 Sum_probs=190.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+.||+|+||.||+|+.. ++..||+|.+... .....+.+|+++++.++||||+++++++...+..++||||+++|+|.
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHH
Confidence 567999999999999965 5788999998755 33456788999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC--CCCeEEccCCcccccCCC-----
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ--LGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGl~~~~~~~----- 488 (640)
+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 90 ~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 90 ERINTSA----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp HHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 9997543 2588999999999999999999954 5999999999999997 789999999999876432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+++.|+|||++. ...++.++|||||||++|||++|+.||..... ............. ++..
T Consensus 163 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~---~~~~----- 225 (321)
T 1tki_A 163 LFTAPEYYAPEVHQ-------HDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAEYT---FDEE----- 225 (321)
T ss_dssp EESCGGGSCHHHHT-------TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTCCC---CCHH-----
T ss_pred ccCChhhcCcHHhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHcCCCC---CChh-----
Confidence 34588999999753 33467899999999999999999999975432 1222221111100 0000
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++.+||..||++|||+.|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122345677888999999999999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=334.76 Aligned_cols=236 Identities=18% Similarity=0.263 Sum_probs=184.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCC-------------
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD------------- 400 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------------- 400 (640)
.+.||+|+||.||+|+.. +++.||||+++.. ...+.+.+|++++++++||||++++++|.+..
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 568999999999999975 7899999998743 23467889999999999999999999986543
Q ss_pred --------------------------------------------eEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHH
Q 006559 401 --------------------------------------------ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLK 436 (640)
Q Consensus 401 --------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~ 436 (640)
..++||||+++|+|.+++..... ....++..++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 168 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCLH 168 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHHH
Confidence 38999999999999999986542 23467778899
Q ss_pred HHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC------------------ccccccccCC
Q 006559 437 LASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------------------FFINDAYNAP 498 (640)
Q Consensus 437 i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------------------~~~~~~y~aP 498 (640)
++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ..+|..|+||
T Consensus 169 i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 99999999999995 45999999999999999999999999998875432 2468899999
Q ss_pred ccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHH
Q 006559 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALL 578 (640)
Q Consensus 499 E~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~ 578 (640)
|++ ....++.++|||||||++|||++|..|+.. .......... ...+........++.
T Consensus 246 E~~-------~~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~~~~-----------~~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 246 EQI-------HGNNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITDVRN-----------LKFPLLFTQKYPQEH 303 (332)
T ss_dssp HHH-------HCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHHHHT-----------TCCCHHHHHHCHHHH
T ss_pred HHh-------cCCCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHHhhc-----------cCCCcccccCChhHH
Confidence 965 344678899999999999999998776521 1111111110 011122233445567
Q ss_pred HHHHHccCCCCCCCCCHHHHHH
Q 006559 579 QVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 579 ~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+++..||+.||++|||+.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 8889999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=333.11 Aligned_cols=239 Identities=18% Similarity=0.284 Sum_probs=190.1
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc--------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK--------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+.. ++..||||.+.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 4578999999999999965 58899999987542 24678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC----CeEEccCCccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG----NACISDIGVHQ 483 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGl~~ 483 (640)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 95 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp CCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999997543 589999999999999999999954 599999999999999887 89999999998
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
.... ...+|..|+|||++ ....++.++|||||||++|||+||+.||...... .......... ..
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~--~~ 235 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVN--YE 235 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHH-------TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHTC--CC
T ss_pred ECCCCCccccccCCcCcCCceee-------cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHhcC--CC
Confidence 7642 23568899999975 3345778999999999999999999999753321 1111111100 00
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... ........+.+++..||+.||++|||+.++++
T Consensus 236 -~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 -FEDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCHH-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cCcc-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 01112234667888899999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.03 Aligned_cols=254 Identities=20% Similarity=0.315 Sum_probs=184.9
Q ss_pred hhccccccCcceEEEEEeCCCc----EEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeE------
Q 006559 337 SAELLGKGCVGATYKVVLDGGD----VVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDEL------ 402 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~----~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~------ 402 (640)
..+.||+|+||.||+|+..... .||||.++.. ...+.+.+|++++++++||||+++++++......
T Consensus 27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CE
T ss_pred EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCcc
Confidence 3578999999999999965432 7999998754 2346688999999999999999999999876654
Q ss_pred EEEEeccCCCCHHHhhccCCC-CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCc
Q 006559 403 FLVYDYLPHGSLHSLLHGSRG-PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV 481 (640)
Q Consensus 403 ~lV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 481 (640)
++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccc
Confidence 999999999999999864321 1223589999999999999999999954 599999999999999999999999999
Q ss_pred ccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhc
Q 006559 482 HQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQ 552 (640)
Q Consensus 482 ~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 552 (640)
++..... ...+..|+|||++ ....++.++|||||||++|||+| |+.||....... .......
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~ 254 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESL-------ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNYLIG 254 (323)
T ss_dssp -----------------CCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT
T ss_pred cccccccccccccccccCcccccCchhh-------cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHHHhc
Confidence 9765321 2235679999964 34567789999999999999999 899997533221 1111111
Q ss_pred ccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCCCC
Q 006559 553 DESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSIDG 613 (640)
Q Consensus 553 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~ 613 (640)
... ..... ....++.+++.+||+.||++|||+.++++.|+++.......+
T Consensus 255 ~~~--------~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 255 GNR--------LKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp TCC--------CCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CCC--------CCCCC---ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 100 00111 122356778888999999999999999999999987765544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=331.42 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=195.5
Q ss_pred hhccccccCcceEEEEEe------CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL------DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~------~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+. .++..||||.++... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 357899999999999985 345789999997653 23567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCC-------------------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE
Q 006559 408 YLPHGSLHSLLHGSRGP-------------------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV 468 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl 468 (640)
|+++|+|.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli 183 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILV 183 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEE
Confidence 99999999999764321 112488999999999999999999954 59999999999999
Q ss_pred CCCCCeEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 006559 469 DQLGNACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDG 539 (640)
Q Consensus 469 ~~~~~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~ 539 (640)
+.++.+||+|||+++..... ...+..|+|||++ ....++.++|||||||++|||+| |+.||...
T Consensus 184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-------FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH-------HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcccccChhhh-------cCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999998765321 2335679999965 33456789999999999999999 99999754
Q ss_pred CcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 540 ELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..... ......... ..... ....++.+++.+||+.||++||++.++++.|+++..+
T Consensus 257 ~~~~~--~~~~~~~~~--------~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PPERL--FNLLKTGHR--------MERPD---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CGGGH--HHHHHTTCC--------CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHHH--HHHhhcCCc--------CCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 32211 111111100 00111 1223467788889999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=339.73 Aligned_cols=238 Identities=20% Similarity=0.303 Sum_probs=189.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+++.. +++.||+|.+... ...+.+.+|+++++.++|||||++++++...+..|+||||+++
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999965 5788999998653 2345678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 100 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 100 GDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp EEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence 99999998643 589999999999999999999954 599999999999999999999999999987542
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhcccccccccchhhc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...+|..|+|||++... ....++.++|||||||++|||+||+.||..... ............. ..
T Consensus 172 ~~~~gt~~Y~aPE~~~~~----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------~~ 238 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSR----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV---------VT 238 (384)
T ss_dssp CCCCSCGGGCCGGGTCCC----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC---------CC
T ss_pred eccCCCccccCCeeeccC----CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc---------cC
Confidence 34578899999976321 134578899999999999999999999974322 2222222211110 01
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCC-HHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPN-MSIVH 599 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~~v~ 599 (640)
.+... ...+.+++..||+.||++||+ +.++.
T Consensus 239 ~p~~~---s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 239 YPSAW---SQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CCTTS---CHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CCCcC---CHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 11111 234667788899999999998 66654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=340.46 Aligned_cols=254 Identities=13% Similarity=0.111 Sum_probs=189.9
Q ss_pred hhccccccCcceEEEEEeCC------CcEEEEEEeccccch-------------HHHHHHHHHHhccCCCcccceeEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG------GDVVVVKRIRERKKK-------------REVDEWLRVIGGLRHSNIVSIRAYCN 397 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-------------~~~~~e~~~l~~l~H~niv~l~~~~~ 397 (640)
..+.||+|+||.||+|+... +..||||.+...... ..+..|+..+..++||||+++++++.
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 118 (364)
T 3op5_A 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118 (364)
T ss_dssp EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence 35789999999999999765 367999998654211 12234555678889999999999987
Q ss_pred cC----CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC--CC
Q 006559 398 GK----DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD--QL 471 (640)
Q Consensus 398 ~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~--~~ 471 (640)
.. ...|+||||+ +|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ .+
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence 64 4589999999 999999997642 2589999999999999999999954 599999999999999 88
Q ss_pred CCeEEccCCcccccCC-------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 006559 472 GNACISDIGVHQLFHT-------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD 538 (640)
Q Consensus 472 ~~~kl~DfGl~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~ 538 (640)
+.+||+|||+++.+.. ...+|..|+|||++ ....++.++|||||||++|||+||+.||.+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH-------NGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh-------CCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999999976532 12368899999965 344578899999999999999999999974
Q ss_pred CCcc--hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 539 GELG--IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 539 ~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
.... ...+...... .......+..+.. .....++.+++..||+.+|++||++.++++.|+++.....
T Consensus 264 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 264 NLKDPKYVRDSKIRYR-ENIASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp GTTCHHHHHHHHHHHH-HCHHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccCHHHHHHHHHHhh-hhHHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 2211 1111111111 1111111211110 1113456778888999999999999999999999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=338.96 Aligned_cols=242 Identities=14% Similarity=0.194 Sum_probs=188.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-------cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-------KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+++++.++||||+++++++...+..|+||||
T Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 457899999999999986 46889999998643 1356788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC---eEEccCCccccc
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN---ACISDIGVHQLF 485 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl~~~~ 485 (640)
+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 108 ~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 108 MDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp CSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999888754321 122478999999999999999999954 5999999999999986654 999999999876
Q ss_pred CC------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 486 HT------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 486 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
.. ...+|..|+|||++. ...++.++|||||||++|||+||+.||......... ....... .
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~i~~~~~--~- 250 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVK-------REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE---GIIKGKY--K- 250 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHH---HHHHTCC--C-
T ss_pred cCCCeeecCCcCCcCccCHHHHc-------CCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHH---HHHcCCC--C-
Confidence 43 235688999999753 345678999999999999999999999754321111 1111000 0
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.++. .......++.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 MNPR-----QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 01112335677888899999999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=331.15 Aligned_cols=233 Identities=21% Similarity=0.300 Sum_probs=188.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +|+.||+|.++.. ...+.+.+|..+++.++||||+++++++.+.+..|+||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 568999999999999964 6889999999754 2345677899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---C
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---P 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---~ 488 (640)
|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 91 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~ 162 (318)
T 1fot_A 91 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162 (318)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCcccc
Confidence 99999998643 58899999999999999999994 5699999999999999999999999999987643 3
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|..|+|||++. ...++.++|||||||++|||++|+.||..... ....+..... ....+.
T Consensus 163 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~---------~~~~p~ 224 (318)
T 1fot_A 163 LCGTPDYIAPEVVS-------TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEKILNA---------ELRFPP 224 (318)
T ss_dssp CCSCTTTCCHHHHT-------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHC---------CCCCCT
T ss_pred ccCCccccCHhHhc-------CCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC---------CCCCCC
Confidence 45688999999753 34577899999999999999999999975432 1111111111 111111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRP-----NMSIVH 599 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~ 599 (640)
.... ++.+++.+|++.||++|| ++.++.
T Consensus 225 ~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 225 FFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp TSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CCCH---HHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 2222 456677789999999999 788876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.56 Aligned_cols=266 Identities=18% Similarity=0.208 Sum_probs=198.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCC--eEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD--ELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lV~Ey~~~ 411 (640)
.++||+|+||.||+|+.. +++.||||++... ...+.+.+|++++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 568999999999999965 4889999999754 23466778999999999999999999998755 78999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE----CCCCCeEEccCCcccccCC
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV----DQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl~~~~~~ 487 (640)
|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 94 ~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp CBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 999999986432 22389999999999999999999954 59999999999999 7888899999999987643
Q ss_pred -----CccccccccCCccccCCCC-ccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhc-c--ccc
Q 006559 488 -----PFFINDAYNAPELKFNNNN-NYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQ-D--ESA 556 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~-~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~-~--~~~ 556 (640)
...+|..|+|||++..... ......++.++|||||||++|||+||+.||..... .....+..... . ...
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (319)
T 4euu_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (319)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence 2346889999997532110 11135678899999999999999999999963221 11111111111 1 000
Q ss_pred ccc-------cc--hhhccC-hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 557 WEV-------FD--FELIMD-KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 557 ~~~-------~d--~~~~~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..+ ++ ...... .........+.+++..||+.||++|||+.|+++...+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 000 00 000000 11133445677788889999999999999999988876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=360.92 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=193.0
Q ss_pred cccccCcceEEEEEeC---CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 340 LLGKGCVGATYKVVLD---GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~---~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.||+|+||.||+|.+. ++..||||+++.. ...+++.+|++++++++|||||+++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 4567999999864 345778999999999999999999999976 56999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-----
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP----- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~----- 488 (640)
|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999997543 2589999999999999999999954 5999999999999999999999999999876421
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||...... +..+.......
T Consensus 495 ~~~~~~~~~~y~APE~~-------~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~-------- 557 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECI-------NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR-------- 557 (613)
T ss_dssp -------CCTTSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTCC--------
T ss_pred eccCCCCccceeCHhhh-------cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC--------
Confidence 1224679999964 44567889999999999999998 99999753322 11111111110
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
...+. .+..++.+++..||+.||++||++.+|++.|+.+....
T Consensus 558 ~~~p~---~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 558 MECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCCCT---TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCC---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 00111 22345777888999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=326.71 Aligned_cols=249 Identities=21% Similarity=0.364 Sum_probs=188.2
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+..+++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 46799999999999999889999999986542 236678999999999999999999999999999999999985 9
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++....+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 86 LKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp HHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 9998875432 47899999999999999999995 4599999999999999999999999999876542
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhccc-cccc------
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDE-SAWE------ 558 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~-~~~~------ 558 (640)
...+|..|+|||++.+ ...++.++|||||||++|||+||+.||...... .....+...... ..+.
T Consensus 159 ~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccCchheeC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 2345889999997532 235678999999999999999999999753321 111111111110 0000
Q ss_pred ccchhhcc------ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIM------DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..++.... .........++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00100000 0000112235667888899999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=333.32 Aligned_cols=243 Identities=24% Similarity=0.339 Sum_probs=188.7
Q ss_pred hccccccCcceEEEEEeC-CCcE----EEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD-GGDV----VVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~----vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|+.. ++.. ||+|.+.... ..+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 568999999999999964 3443 7888775442 2345678899999999999999999986 56799999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 97 PLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp TTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred CCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999997643 2578889999999999999999954 5999999999999999999999999999876321
Q ss_pred -------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 489 -------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 489 -------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
..++..|+|||++ ....++.++|||||||++|||+| |+.||......... ......... .
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~~~---~ 237 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESI-------HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP--DLLEKGERL---A 237 (325)
T ss_dssp TCCC-----CCTTTSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH--HHHHTTCBC---C
T ss_pred ccccccCCCCcccccChHHh-------ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH--HHHHcCCCC---C
Confidence 2345689999964 34567889999999999999999 99999754332221 111111000 0
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.+. ....++.+++..||+.||++||++.++++.|+++...
T Consensus 238 ~~~--------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 238 QPQ--------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CCT--------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCC--------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000 0112356678889999999999999999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.19 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=185.4
Q ss_pred hccccccCcceEEEEEeC--CC--cEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD--GG--DVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|+.. ++ ..||||.++... ..+.+.+|+.++++++||||++++++|.. .+..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 568999999999999863 22 358999987542 34568889999999999999999999765 45789999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 174 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 174 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999997543 2478999999999999999999954 5999999999999999999999999999765321
Q ss_pred ---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhcccccc
Q 006559 489 ---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDESAW 557 (640)
Q Consensus 489 ---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~ 557 (640)
...+..|+|||++ ....++.++|||||||++|||+| |.+||..... .....+.. ....
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---~~~~- 315 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESL-------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---GRRL- 315 (373)
T ss_dssp -----------CCGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT---TCCC-
T ss_pred cccccccCCCCCcccccChHHh-------cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc---CCCC-
Confidence 2235679999964 34567889999999999999999 6777764322 22222111 1000
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
..+. .....+.+++..||+.||++||++.++++.|+++.....
T Consensus 316 -------~~p~---~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 -------LQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -------CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -------CCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0111 122346778888999999999999999999999986644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=336.75 Aligned_cols=239 Identities=18% Similarity=0.239 Sum_probs=188.1
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|+||.||+|+.. ++..||||.+.... ..+.+.+|++++++++||||+++++++...+..|+||||+++
T Consensus 33 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 3578999999999999964 58899999997542 235677899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC---CCeEEccCCcccccCC-
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL---GNACISDIGVHQLFHT- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGl~~~~~~- 487 (640)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 113 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 113 GELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999987543 588999999999999999999954 59999999999999865 4599999999987643
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...+|..|+|||++. ...++.++|||||||++|||+||+.||...... ........... ....
T Consensus 185 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~i~~~~~--~~~~-- 251 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAY--DYPS-- 251 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCC--CCCT--
T ss_pred cccccCCCCccccCHHHHc-------cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCC--CCCc--
Confidence 235688999999753 345778999999999999999999999754321 11111111100 0000
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+.......++.+++.+||+.||++||++.++++
T Consensus 252 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 252 ----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001112234667788899999999999998864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.86 Aligned_cols=239 Identities=17% Similarity=0.219 Sum_probs=187.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|+||.||+|.. .+|..+|+|.+.... ..+.+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 357899999999999985 568899999987552 235678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC---CCCCeEEccCCcccccCC-
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD---QLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGl~~~~~~- 487 (640)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 95 g~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 95 GELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999987643 588999999999999999999954 599999999999998 567899999999977643
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...+|..|+|||++ ....++.++||||+||++|||++|+.||.+.... ...+....... ....+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l-------~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~--~~~~~ 235 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVL-------RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQQIKAGAY--DFPSP 235 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHH-------TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTCC--CCCTT
T ss_pred CceeecccCCcccCCHHHh-------cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhCCC--CCCcc
Confidence 23568899999975 3345778999999999999999999999754321 11111111100 00000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++..||+.||++|||+.|+++
T Consensus 236 ------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 ------EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00112234667788899999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=327.48 Aligned_cols=244 Identities=19% Similarity=0.281 Sum_probs=184.0
Q ss_pred hhccccccCcceEEEEEeCC----CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG----GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|+... +..||+|.+.... ..+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~ 97 (281)
T 1mp8_A 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 97 (281)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecC
Confidence 35789999999999998643 4569999987542 3456788999999999999999999985 56789999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 98 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999997543 258899999999999999999995 45999999999999999999999999999876432
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
...+..|+|||++ ....++.++|||||||++|||++ |+.||....... ..........
T Consensus 171 ~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~~------ 235 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESI-------NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGER------ 235 (281)
T ss_dssp --------CCGGGCCHHHH-------HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC------
T ss_pred ccccccCCCcccccChhhc-------ccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCCC------
Confidence 2235679999964 34567789999999999999997 999997533221 1111111100
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..... .....+.+++..||+.||++|||+.++++.|+++...
T Consensus 236 --~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 236 --LPMPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00111 1223466788889999999999999999999998643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=333.46 Aligned_cols=234 Identities=19% Similarity=0.270 Sum_probs=186.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+++++.++||||+++++++...+..++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 56899999999999996 57889999998653 22456889999999999999999999999999999999999 7
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 93 GELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 89999887543 588999999999999999999954 599999999999999999999999999987543
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...+|..|+|||++.+. ...+.++|||||||++|||++|+.||.+...... ...+.......
T Consensus 165 ~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------~~~i~~~~~~~ 227 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGK------LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------FKKVNSCVYVM 227 (336)
T ss_dssp CCCTTSTTTSCGGGSCCS------GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------BCCCCSSCCCC
T ss_pred ccccCCcCcCCHHHHcCC------CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------HHHHHcCCCCC
Confidence 34568899999975322 1125789999999999999999999975321110 00111111111
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 228 p~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 228 PDFLS---PGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CTTSC---HHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cccCC---HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122 34567788899999999999999965
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=331.59 Aligned_cols=251 Identities=21% Similarity=0.331 Sum_probs=196.8
Q ss_pred hhccccccCcceEEEEEe------CCCcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVL------DGGDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~------~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||+|+. .++..||||.++... ..+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 357899999999999985 346789999997653 345688999999999 9999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCC-------------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 407 DYLPHGSLHSLLHGSRGP-------------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
||+++|+|.+++...... ...++++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 183 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCC
Confidence 999999999999765321 122589999999999999999999954 5999999999999999999
Q ss_pred eEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchH
Q 006559 474 ACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIV 544 (640)
Q Consensus 474 ~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~ 544 (640)
+||+|||+++..... ..++..|+|||++ ....++.++|||||||++|||+| |+.||........
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-------FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHh-------cCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999876432 2235679999965 34567789999999999999999 9999975433221
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
. .+...... . ...... ...++.+++..||+.||++|||+.++++.|+++..+.
T Consensus 257 ~-~~~~~~~~------~--~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 F-YKMIKEGF------R--MLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp H-HHHHHHTC------C--CCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H-HHHhccCC------C--CCCccc---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1 11111000 0 000111 1234677888899999999999999999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=338.42 Aligned_cols=244 Identities=20% Similarity=0.276 Sum_probs=187.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.++||+|+||.||+|+. .+|..||+|+++.. ...+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999986 46889999999765 3456788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE--CCCCCeEEccCCcccccCC-----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV--DQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl--~~~~~~kl~DfGl~~~~~~----- 487 (640)
.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99886542 2588999999999999999999954 59999999999999 6778999999999987643
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||..... ........... +....
T Consensus 247 ~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~--~~~~~------ 309 (373)
T 2x4f_A 247 VNFGTPEFLAPEVV-------NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--AETLNNILACR--WDLED------ 309 (373)
T ss_dssp CCCSSCTTCCHHHH-------TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTC--CCSCS------
T ss_pred cccCCCcEeChhhc-------cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcc--CCCCh------
Confidence 23468899999975 334567899999999999999999999975432 11111111110 00000
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHh
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDI 605 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i 605 (640)
........++.+++..||+.||++||++.|+++ .+.+.
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 011112235677888899999999999999976 55443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=332.45 Aligned_cols=244 Identities=20% Similarity=0.325 Sum_probs=187.7
Q ss_pred hhccccccCcceEEEEEeC-CCcE----EEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDV----VVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~----vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..+.||+|+||.||+|+.. +++. ||+|.+... ...+.+.+|++++++++||||+++++++.... .++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~ 97 (327)
T 3lzb_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL 97 (327)
T ss_dssp EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECC
T ss_pred EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEe
Confidence 3578999999999999954 4443 577777543 34577889999999999999999999998654 8899999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP 488 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~ 488 (640)
+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 98 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CSSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred cCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 999999999976532 588999999999999999999954 5999999999999999999999999999875421
Q ss_pred --------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 489 --------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 --------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
..++..|+|||++ ....++.++|||||||++|||+| |+.||......... +.......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--~~~~~~~~---- 237 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESI-------LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--SILEKGER---- 237 (327)
T ss_dssp ---------CCCGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHHHTTCC----
T ss_pred cccccccCCCccccccCHHHH-------cCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH--HHHHcCCC----
Confidence 2235679999964 34567889999999999999999 99999754332221 11111100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...... ...++.+++..||+.||++||++.|+++.|+++...
T Consensus 238 ----~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 238 ----LPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----CCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 001111 123466788889999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=327.42 Aligned_cols=238 Identities=19% Similarity=0.273 Sum_probs=182.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccccc----------------------------hHHHHHHHHHHhccCCCc
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERKK----------------------------KREVDEWLRVIGGLRHSN 388 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----------------------------~~~~~~e~~~l~~l~H~n 388 (640)
.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 56899999999999986 4678899999865421 245788999999999999
Q ss_pred ccceeEEEEc--CCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCe
Q 006559 389 IVSIRAYCNG--KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNI 466 (640)
Q Consensus 389 iv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NI 466 (640)
|+++++++.. .+..++||||+++|+|.+++... ++++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 9999999986 56899999999999998875432 589999999999999999999954 599999999999
Q ss_pred EECCCCCeEEccCCcccccCC------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006559 467 VVDQLGNACISDIGVHQLFHT------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE 540 (640)
Q Consensus 467 Ll~~~~~~kl~DfGl~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~ 540 (640)
|++.++.+||+|||+++.... ...+|..|+|||++..... ..++.++|||||||++|||++|+.||....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRK----IFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCC----CEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCC----CCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999987643 2356889999997633211 113578999999999999999999997543
Q ss_pred cchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 541 LGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ..+.......... ...... ...++.+++.+||+.||++||++.|+++
T Consensus 245 ~--~~~~~~~~~~~~~-------~~~~~~---~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 I--MCLHSKIKSQALE-------FPDQPD---IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H--HHHHHHHHHCCCC-------CCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H--HHHHHHHhcccCC-------CCCccc---cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2 2222211111000 000111 1234667788899999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.40 Aligned_cols=192 Identities=21% Similarity=0.248 Sum_probs=163.2
Q ss_pred hhcccccc--CcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKG--CVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+| +||.||+|+.. +++.||||++.... ..+.+.+|++++++++|||||++++++...+..|+|||||
T Consensus 29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEcc
Confidence 35789999 99999999975 68899999997552 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC---
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--- 486 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~--- 486 (640)
++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+....
T Consensus 109 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 109 AYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp TTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred CCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 99999999976532 2488999999999999999999954 59999999999999999999999999875431
Q ss_pred ----------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 487 ----------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 487 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
....+|..|+|||++... ...++.++|||||||++|||+||+.||.+.
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTT-----SSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccccccccccccccCHHHHhcc-----CCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 112457789999976321 245788999999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=331.66 Aligned_cols=239 Identities=20% Similarity=0.296 Sum_probs=174.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|+++++.+. ||||+++++++.+....|+||||+++|+|.
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 467999999999999975 5889999998654 3456778899999987 999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC---CeEEccCCcccccCC-----
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG---NACISDIGVHQLFHT----- 487 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGl~~~~~~----- 487 (640)
+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++....
T Consensus 95 ~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 95 ERIKKKK-----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp HHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 9998653 58999999999999999999995 4599999999999997665 899999999986532
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-----chHHHHHHhhcccccccccc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-----GIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~d 561 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||..... ...+..+........ .
T Consensus 167 ~~~~~t~~y~aPE~~-------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~---~- 235 (325)
T 3kn6_A 167 KTPCFTLHYAAPELL-------NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS---F- 235 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC---C-
T ss_pred cccCCCcCccCHHHh-------cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC---C-
Confidence 23458899999964 344577899999999999999999999975322 111222221111000 0
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..........++.+++..||+.||++|||+.++++
T Consensus 236 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 ----EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ----CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ----CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 01111223345777888899999999999998863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=323.50 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=197.8
Q ss_pred hhccccccCcceEEEEEeCC-CcEEEEEEecccc-chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVLDG-GDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..+.||+|+||.||+|+... +..||+|.+.... ..+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 17 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 35689999999999999764 7889999998653 456788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc-----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF----- 489 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~----- 489 (640)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 97 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp HHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred HHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 99997643 23589999999999999999999954 59999999999999999999999999998765322
Q ss_pred --cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 490 --FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 490 --~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..+..|+|||++ ....++.++|||||||++|||++ |+.||........ .+....... ...
T Consensus 171 ~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~~~~~~~~~--------~~~ 233 (288)
T 3kfa_A 171 GAKFPIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLEKDYR--------MER 233 (288)
T ss_dssp TEEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHHTTCC--------CCC
T ss_pred CCccccCcCChhhh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHhccCC--------CCC
Confidence 235679999964 34567789999999999999999 9999975432211 111111100 001
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.. .....+.+++..||+.||++|||+.++++.|+++..+
T Consensus 234 ~~---~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 234 PE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1123467788889999999999999999999998765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=358.37 Aligned_cols=245 Identities=23% Similarity=0.389 Sum_probs=196.9
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|++.++..||||+++.. ...+++.+|++++++++|||||++++++.. +..|+|||||++|+|.
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred hheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 35689999999999999988888999999865 345779999999999999999999999876 6789999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------- 488 (640)
++++...+ ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 350 ~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 350 DFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp HHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred HHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 99974321 247899999999999999999995 45999999999999999999999999999876421
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||..... .+....+..... ....
T Consensus 424 ~~~~~~y~aPE~~-------~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~--------~~~~ 486 (535)
T 2h8h_A 424 AKFPIKWTAPEAA-------LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYR--------MPCP 486 (535)
T ss_dssp TTSCGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHHHHTTCC--------CCCC
T ss_pred CcCcccccCHHHh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC--------CCCC
Confidence 2235679999964 34567889999999999999999 9999975322 122222111100 0011
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
. .....+.+++..||+.||++|||+.+|++.|+++...
T Consensus 487 ~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 P---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1 1233567788899999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.11 Aligned_cols=233 Identities=22% Similarity=0.232 Sum_probs=178.8
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhc-cCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGG-LRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..++||+|+||+||+|+.. +++.||||++.... .......|+..+.+ .+||||++++++|...+..++||||+
T Consensus 61 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~- 139 (311)
T 3p1a_A 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC- 139 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-
T ss_pred eeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-
Confidence 3568999999999999975 78999999986541 12233344444444 48999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... ..++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 140 ~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 140 GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 679998887543 2589999999999999999999954 599999999999999999999999999877643
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...+|..|+|||++. ..++.++|||||||++|||++|..|+... ..|..... . ...+..
T Consensus 213 ~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~-~-----~~~~~~- 273 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQ--------GSYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQ-G-----YLPPEF- 273 (311)
T ss_dssp --CCCCCGGGCCGGGGG--------TCCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTT-T-----CCCHHH-
T ss_pred CcccCCCccccCHhHhc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhc-c-----CCCccc-
Confidence 234688999999652 25778999999999999999997665431 11111111 0 001111
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......++.+++..||+.||++|||+.|+++
T Consensus 274 ----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 ----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1112345777888899999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.70 Aligned_cols=230 Identities=20% Similarity=0.288 Sum_probs=182.5
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..++||+|+||.||+|+.. +++.||||+++.. ...+.+..|.+++..+ +||||+++++++...+..|+||||+
T Consensus 27 ~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 106 (353)
T 3txo_A 27 FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCC
Confidence 3578999999999999965 5889999999754 2334567788888877 7999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC---
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--- 486 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~--- 486 (640)
++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 107 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 107 NGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 9999999997643 588999999999999999999954 59999999999999999999999999988632
Q ss_pred ---CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 487 ---TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 487 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
....+|..|+|||++ ....++.++|||||||++|||+||+.||...... ...+..... .
T Consensus 179 ~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~---------~ 240 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEIL-------QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILND---------E 240 (353)
T ss_dssp -------CCGGGCCHHHH-------HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC---------C
T ss_pred ccccccCCCcCeEChhhc-------CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHHHcC---------C
Confidence 234578999999975 3345778999999999999999999999754321 111111111 1
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
...+.... .++.+++..|++.||++||++
T Consensus 241 ~~~p~~~~---~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 241 VVYPTWLH---EDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCCCTTSC---HHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCC---HHHHHHHHHHhhhCHHHccCC
Confidence 11111122 235667788999999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=358.70 Aligned_cols=240 Identities=23% Similarity=0.303 Sum_probs=191.2
Q ss_pred ccccccCcceEEEEEeC---CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLD---GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~---~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
+.||+|+||.||+|.+. .+..||||+++... ..+++.+|++++++++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 45789999997642 24678999999999999999999999974 568999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.+++.... .+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.+...
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999997543 589999999999999999999954 5999999999999999999999999999865421
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
..++..|+|||++ ....++.++|||||||++|||+| |+.||...... +..+........
T Consensus 526 ~~~~~~~~~t~~y~APE~~-------~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~~----- 591 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECI-------NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGERM----- 591 (635)
T ss_dssp ---------CGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC-----
T ss_pred cccccCCCCceeeeChhhh-------cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC-----
Confidence 1235679999964 44567889999999999999999 99999754322 111221111100
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
..+. ....++.+++..||+.||++||++.+|++.|+++..
T Consensus 592 ---~~p~---~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 ---GCPA---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ---CCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCC---CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111 123456778888999999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=334.67 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=192.8
Q ss_pred hhccccccCcceEEEEEe------CCCcEEEEEEeccc---cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVL------DGGDVVVVKRIRER---KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~------~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||+|+. ..+..||||.+... ...+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 357899999999999995 23557999999754 2346788999999999 8999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCC------------------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE
Q 006559 407 DYLPHGSLHSLLHGSRGP------------------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV 468 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl 468 (640)
||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll 205 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLV 205 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEE
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEE
Confidence 999999999999765321 01247899999999999999999995 459999999999999
Q ss_pred CCCCCeEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 006559 469 DQLGNACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDG 539 (640)
Q Consensus 469 ~~~~~~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~ 539 (640)
+.++.+||+|||+++..... ..++..|+|||++ ....++.++|||||||++|||+| |+.||...
T Consensus 206 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-------FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh-------ccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999765321 2235679999965 33457789999999999999998 99999754
Q ss_pred CcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 540 ELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...... .+...... . . ..+.. ...++.+++..||+.||++|||+.++++.|+.+...
T Consensus 279 ~~~~~~-~~~~~~~~-~-----~--~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVDANF-YKLIQNGF-K-----M--DQPFY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCSHHH-HHHHHTTC-C-----C--CCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcHHHH-HHHHhcCC-C-----C--CCCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 322111 11111100 0 0 00111 123466788889999999999999999999998755
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.20 Aligned_cols=260 Identities=26% Similarity=0.352 Sum_probs=197.0
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhc--cCCCcccceeEEEEcCC----eEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGG--LRHSNIVSIRAYCNGKD----ELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|+.. ++.||||.+... ..+.+..|.+++.. ++||||+++++++...+ ..++||||++
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~ 123 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123 (342)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred EEeeecCCCCcEEEEEEEc-CccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence 3578999999999999984 889999998754 34456677777765 79999999999998775 8999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC-----CCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN-----KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
+|+|.+++... .+++..++.++.|++.||+|||... ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 124 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 124 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197 (342)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence 99999999753 4889999999999999999999321 345999999999999999999999999998765
Q ss_pred CC----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhC----------CCCCCCCC---cc
Q 006559 486 HT----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG----------KMAKGDGE---LG 542 (640)
Q Consensus 486 ~~----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg----------~~p~~~~~---~~ 542 (640)
.. ...++..|+|||++...... ....++.++|||||||++|||+|| +.||.... ..
T Consensus 198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 276 (342)
T 1b6c_B 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276 (342)
T ss_dssp ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT-TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccCCcCcccCCHhhhcccccc-cccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence 32 22468899999986433211 011234689999999999999999 67876421 12
Q ss_pred hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
...+.+...... ..+.+.......+....+.+++.+||+.||++|||+.+|++.|+++..+..
T Consensus 277 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 277 VEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 223332222111 011111000112455678889999999999999999999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.73 Aligned_cols=244 Identities=20% Similarity=0.340 Sum_probs=189.9
Q ss_pred hccccccCcceEEEEEeCC-----CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLDG-----GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|+... +..||||.++... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 5789999999999998643 2359999997642 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 129 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999997643 2588999999999999999999954 5999999999999999999999999999875421
Q ss_pred --------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 489 --------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 --------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||...... ...+.......
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~~---- 268 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAI-------SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGFR---- 268 (333)
T ss_dssp ---------CCCGGGSCHHHH-------HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC----
T ss_pred ccccccCCCCccccccCchhc-------ccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCCc----
Confidence 1235679999965 34567789999999999999999 99999753321 11222111100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..... .....+.+++.+||+.||++||++.++++.|+++...
T Consensus 269 ----~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 269 ----LPTPM---DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----CCCCT---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCcc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00111 1223467788889999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.15 Aligned_cols=249 Identities=18% Similarity=0.276 Sum_probs=184.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 467999999999999964 58899999997542 235677899999999999999999999999999999999986
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 86 DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 5655554432 2589999999999999999999954 599999999999999999999999999987642
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH---HHHHHhhcc-cccccccch
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV---KWVQMMGQD-ESAWEVFDF 562 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~---~~~~~~~~~-~~~~~~~d~ 562 (640)
...+|..|+|||++.+ ...++.++|||||||++|||+||..|+........ ...+..... ...+.....
T Consensus 159 ~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred cCCccccCCcChHHHcC------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 2345888999997532 23467899999999999999999888643222111 111111111 000000000
Q ss_pred ------------hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ------------ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ------------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.............++.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000000112234667888899999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=335.33 Aligned_cols=240 Identities=23% Similarity=0.376 Sum_probs=188.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 346799999999999995 578899999986431 23567889999999999999999999999999999999997
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--C
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--P 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--~ 488 (640)
|+|.+++.... .++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... .
T Consensus 138 -g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 138 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp -EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 68888875432 2589999999999999999999954 599999999999999999999999999987653 3
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|..|+|||++... ....++.++|||||||++|||+||+.||..... ............. .. ...
T Consensus 210 ~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~------~~-~~~ 276 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESP------AL-QSG 276 (348)
T ss_dssp CCSCGGGCCHHHHHTT----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCC------CC-CCT
T ss_pred ccCCcceeCHhhhccc----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCC------CC-CCC
Confidence 4578899999976321 234678899999999999999999999975322 1212111111100 00 011
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ...+.+++..||+.||++|||+.++++
T Consensus 277 ~~---~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 277 HW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC---CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11 224566778899999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=328.92 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=190.1
Q ss_pred hhccccccCcceEEEEEeCC-C-------cEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG-G-------DVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||+|+... + ..||+|.+... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence 35789999999999998543 3 46999998654 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC--------eEEcc
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN--------ACISD 478 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~--------~kl~D 478 (640)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 92 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp ECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred ECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999998643 2488999999999999999999954 5999999999999998887 99999
Q ss_pred CCcccccCCC--ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCC-CCCCCCcchHHHHHHhhcccc
Q 006559 479 IGVHQLFHTP--FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM-AKGDGELGIVKWVQMMGQDES 555 (640)
Q Consensus 479 fGl~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~-p~~~~~~~~~~~~~~~~~~~~ 555 (640)
||+++..... ..++..|+|||++.. ...++.++|||||||++|||+||.. |+...... ...........
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~~~~~~~~ 236 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIEN------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQFYEDRHQ 236 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHC------GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCC
T ss_pred CcccccccCccccCCcCcccCHHHhCC------CCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHHHhhccCC
Confidence 9998766432 235778999997532 2457789999999999999999654 44432211 11111111100
Q ss_pred cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 556 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
. +... ..++.+++..||+.||++|||+.++++.|+++.....
T Consensus 237 ~----------~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 237 L----------PAPK---AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp C----------CCCS---SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred C----------CCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 0 0000 1235677888999999999999999999999886543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=334.51 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=194.2
Q ss_pred hhccccccCcceEEEEEeC-----CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLD-----GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 406 (640)
..+.||+|+||.||++.+. +++.||||+++... ..+.+.+|++++++++||||+++++++.. ....++||
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence 3578999999999998753 57889999998653 24568899999999999999999999987 46789999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999754 388999999999999999999954 59999999999999999999999999998764
Q ss_pred CC---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcc---c
Q 006559 487 TP---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQD---E 554 (640)
Q Consensus 487 ~~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---~ 554 (640)
.. ..++..|+|||++ ....++.++|||||||++|||+||+.||.........+....... .
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECL-------KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHH-------HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHh-------cCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 32 2346679999965 334566899999999999999999999864221111110000000 0
Q ss_pred ccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 555 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
...+..+..... +.......++.+++..||+.||++|||+.++++.|+++..+.
T Consensus 259 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 259 RLTELLERGERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 000000000000 000122345777888999999999999999999999997653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.01 Aligned_cols=234 Identities=16% Similarity=0.234 Sum_probs=189.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +|+.||||.+... ...+.+.+|+++++.++||||+++++++.+.+..|+||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 568999999999999965 6889999998654 2345677899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---C
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---P 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---~ 488 (640)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~ 197 (350)
T 1rdq_E 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCccc
Confidence 99999997543 48899999999999999999995 4599999999999999999999999999987653 3
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|..|+|||++. ...++.++|||||||++|||++|+.||..... ....+..... ....+.
T Consensus 198 ~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~---------~~~~p~ 259 (350)
T 1rdq_E 198 LCGTPEALAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSG---------KVRFPS 259 (350)
T ss_dssp CEECGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC---------CCCCCT
T ss_pred ccCCccccCHHHhc-------CCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHHHHHcC---------CCCCCC
Confidence 45689999999753 34577899999999999999999999975432 2222221111 111111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPN-----MSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~ 600 (640)
.. ..++.+++.+||+.||++||+ +.++.+
T Consensus 260 ~~---~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 260 HF---SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TC---CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC---CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 12 234667778899999999998 777753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=331.42 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=190.1
Q ss_pred hhccccccCcceEEEEEe-----CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcC--CeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVL-----DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK--DELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-----~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 406 (640)
..+.||+|+||.||+|++ .+++.||||++... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence 357899999999999984 35788999998754 2346788999999999999999999999876 6789999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 105 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp ECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999996543 248899999999999999999995 459999999999999999999999999998754
Q ss_pred CC---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccc
Q 006559 487 TP---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 487 ~~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
.. ..++..|+|||++ ....++.++|||||||++|||+||+.|+.... ..+...........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECL-------MQSKFYIASDVWSFGVTLHELLTYCDSDSSPM---ALFLKMIGPTHGQM 247 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHH-------HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH---HHHHHHHCSCCGGG
T ss_pred CCCcceeccCCCCCCccccCCeee-------cCCCCCcchhHHHHHHHHHHHHHccCCCcchh---hHHhhccCCccccc
Confidence 32 2346679999964 33456689999999999999999999864211 11111111100000
Q ss_pred ---cc---cch--hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 558 ---EV---FDF--ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 558 ---~~---~d~--~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.+ ... ...... ....++.+++..||+.||++|||+.++++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPP---NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCC---CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00 000 000111 12245777888899999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.56 Aligned_cols=259 Identities=21% Similarity=0.335 Sum_probs=183.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. +++.||||+++.. ...+.+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 88 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND 88 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence 567999999999999854 5889999998754 234678889999999999999999999999999999999998 69
Q ss_pred HHHhhccCC-CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 414 LHSLLHGSR-GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 414 L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
|.+++.... ......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCC
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccC
Confidence 999886432 1112358899999999999999999995 4599999999999999999999999999987542
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHH-HHHhhcc-ccccccc---
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKW-VQMMGQD-ESAWEVF--- 560 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~-~~~~~~~-~~~~~~~--- 560 (640)
...+|..|+|||++.+ ...++.++|||||||++|||+||+.||...... .... .+..... ...+...
T Consensus 166 ~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 166 SSEVVTLWYRAPDVLMG------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CCCCSCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCCcccccccCchHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 2345889999997532 235678999999999999999999999754321 1111 1111110 0011000
Q ss_pred ---chhhc--cChHH---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 561 ---DFELI--MDKEM---------EEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 561 ---d~~~~--~~~~~---------~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
.+... ..... .....++.+++.+||+.||++|||+.|+++ .+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 00000 00000 011235778888999999999999999865 344443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.55 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=184.7
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|+..+ .||||.++... ..+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 28 ~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 35789999999999998654 59999987542 235688899999999999999999965 456789999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 105 SLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999997543 2589999999999999999999954 599999999999999999999999999876432
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++.. .....++.++|||||||++|||+||+.||...... ....+......... +...
T Consensus 178 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~---~~~~ 249 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRM----QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLSP---DLSK 249 (289)
T ss_dssp ------CCCTTCCHHHHC--------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHHHHHTSCCC---CTTS
T ss_pred cccccCCCccccCchhhcc----cCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-HHHHHHhcccccCc---chhh
Confidence 2345889999997531 12345678999999999999999999999753221 11111111111000 0000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
.. .....++.+++..||+.||++|||+.++++.|+++..
T Consensus 250 -~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 -VR---SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -SC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -cc---ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 1223457778888999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.93 Aligned_cols=255 Identities=17% Similarity=0.303 Sum_probs=190.8
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|.. .++..||||+++.. ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 357899999999999995 56889999998742 234567889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 9999999864211 112588999999999999999999954 599999999999999999999999999876542
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++. ...++.++|||||||++|||+||+.||...........+........ ..
T Consensus 192 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~ 258 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIH-------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------PL 258 (310)
T ss_dssp -------CCSSCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC------CC
T ss_pred cccccCCCeeEeChHHhC-------CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC------CC
Confidence 234578899999653 34577899999999999999999999976544444443333221110 00
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCCC
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSID 612 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 612 (640)
.... ...++.+++..||+.||++|||+.+|++.|+++......+
T Consensus 259 -~~~~---~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 259 -PSDH---YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -CTTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -cccc---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 0011 1234667788899999999999999999999998765543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=321.94 Aligned_cols=244 Identities=22% Similarity=0.326 Sum_probs=188.5
Q ss_pred hhccccccCcceEEEEEeCCC----cEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLDGG----DVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~----~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey 408 (640)
..++||+|+||.||+|+..+. ..||+|.+.... ..+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 357899999999999986432 258999987543 23567889999999999999999999754 5678999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP 488 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~ 488 (640)
+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 109 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 109 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999997543 2578999999999999999999954 5999999999999999999999999999765321
Q ss_pred ----------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhccccc
Q 006559 489 ----------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDESA 556 (640)
Q Consensus 489 ----------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~ 556 (640)
..++..|+|||++ ....++.++|||||||++|||+| |.+||..... ...... ......
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~ 251 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESL-------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRL 251 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH---HTTCCC
T ss_pred chhccccccCCCCCccccChHHh-------cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---hcCCCC
Confidence 2335679999964 34567789999999999999999 5566654322 111111 111000
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
. .+... ...+.+++..||+.||++|||+.++++.|+++...
T Consensus 252 ---~-----~~~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 252 ---L-----QPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ---C-----CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---C-----CCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 01111 23467788889999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.78 Aligned_cols=249 Identities=20% Similarity=0.360 Sum_probs=194.5
Q ss_pred hhccccccCcceEEEEEeC--------CCcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVLD--------GGDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 404 (640)
..+.||+|+||.||+|+.. ++..||||+++... ..+.+.+|+++++++ +||||+++++++...+..++
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence 3578999999999999863 46789999997653 235677899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCC-----------CCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 405 VYDYLPHGSLHSLLHGSRGPG-----------RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
||||+++|+|.+++......+ ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 195 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCC
Confidence 999999999999998654211 12488999999999999999999954 5999999999999999999
Q ss_pred eEEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchH
Q 006559 474 ACISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIV 544 (640)
Q Consensus 474 ~kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~ 544 (640)
+||+|||+++..... ...+..|+|||++. ...++.++|||||||++|||+| |+.||......
T Consensus 196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 266 (334)
T 2pvf_A 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 266 (334)
T ss_dssp EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-------HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEEccccccccccccccccccCCCCcccceeChHHhc-------CCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence 999999999765432 23356799999653 3456789999999999999999 99999754322
Q ss_pred HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 545 KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 545 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...+........ .... ....++.+++..||+.||++||++.++++.|+++...
T Consensus 267 ~~~~~~~~~~~~--------~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 267 ELFKLLKEGHRM--------DKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHHHHHTCCC--------CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCC--------CCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 222211111000 0011 1223467788889999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.47 Aligned_cols=245 Identities=25% Similarity=0.411 Sum_probs=195.2
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|+..++..||||.+... ...+.+.+|++++++++||||+++++++. .+..++||||+++|+|.
T Consensus 17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred heeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 35689999999999999988889999999765 34677889999999999999999999986 45689999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------- 488 (640)
+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 96 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 9997432 12488999999999999999999954 5999999999999999999999999999876432
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||..... .+..+....... ....
T Consensus 170 ~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~--------~~~~ 232 (279)
T 1qpc_A 170 AKFPIKWTAPEAI-------NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLERGYR--------MVRP 232 (279)
T ss_dssp CCCCTTTSCHHHH-------HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCC--------CCCC
T ss_pred CCCccCccChhhh-------ccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHHHHHHhcccC--------CCCc
Confidence 2235679999965 33456789999999999999999 8999975322 122222111100 0011
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.. ...++.+++..||+.||++|||+.++++.|+++...
T Consensus 233 ~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 233 DN---CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cc---ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 11 123566788889999999999999999999998755
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.15 Aligned_cols=243 Identities=23% Similarity=0.290 Sum_probs=192.7
Q ss_pred ccccccCcceEEEEEeC---CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVLD---GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
+.||+|+||.||+|... ++..||||.++... ..+.+.+|++++++++||||+++++++. .+..++||||+++|
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCC
Confidence 47999999999999853 57789999998642 3456888999999999999999999994 56799999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 95 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 9999997543 2589999999999999999999954 5999999999999999999999999999876321
Q ss_pred -----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 489 -----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 489 -----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
..++..|+|||++ ....++.++|||||||++|||+| |+.||...... ...........
T Consensus 168 ~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~~------- 231 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECI-------NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR------- 231 (287)
T ss_dssp CCCCSSCCCGGGCCHHHH-------HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCC-------
T ss_pred eccccccccccccCHHHh-------ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCCc-------
Confidence 1236789999965 33456789999999999999999 99999753321 11111111100
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
...+. ....++.+++..||+.||++||++.++++.|+++....
T Consensus 232 -~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 232 -MECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -CCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCC---CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00111 12235667888899999999999999999999987553
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.41 Aligned_cols=240 Identities=18% Similarity=0.266 Sum_probs=189.8
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||.||+|+.. ++..||+|.+... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 3568999999999999964 6889999998755 234568899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC--CCCeEEccCCcccccCCC---
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ--LGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGl~~~~~~~--- 488 (640)
|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 135 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 135 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999997543 2589999999999999999999954 5999999999999974 578999999999876532
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..+|..|+|||++. ...++.++|||||||++|||+||+.||..... ............. ++...
T Consensus 208 ~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~---~~~~~-- 273 (387)
T 1kob_A 208 KVTTATAEFAAPEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWE---FDEDA-- 273 (387)
T ss_dssp EEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCCC---CCSST--
T ss_pred eeeccCCCccCchhcc-------CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC---CCccc--
Confidence 34688999999753 34567899999999999999999999975432 1222221111100 01000
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......++.+++..||+.||++|||+.++++
T Consensus 274 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 ---FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0112234667888899999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.52 Aligned_cols=233 Identities=17% Similarity=0.259 Sum_probs=182.0
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..++||+|+||.||+|+.. +++.||||+++... ..+.+..|..++.++ +|||||++++++...+..|+||||+
T Consensus 56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 3578999999999999965 57789999997542 223467788888776 8999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC---
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--- 486 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~--- 486 (640)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 136 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 9999999997543 589999999999999999999954 59999999999999999999999999998632
Q ss_pred ---CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc------hHHHHHHhhcccccc
Q 006559 487 ---TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG------IVKWVQMMGQDESAW 557 (640)
Q Consensus 487 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~ 557 (640)
....+|..|+|||++. ...++.++|||||||++|||++|+.||...... ...++..
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~-------~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~-------- 272 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------- 272 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH--------
T ss_pred CccccccCCcccCCchhhc-------CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH--------
Confidence 2346789999999753 345778999999999999999999999632111 0111100
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
.+.......+...+ .++.+++..||+.||++||++
T Consensus 273 ~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 273 VILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHCCCCCCTTSC---HHHHHHHHHHTCSCTTTSTTC
T ss_pred HHhccccCCCCcCC---HHHHHHHHHHhcCCHhHcCCC
Confidence 01111111112222 345677788999999999995
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.38 Aligned_cols=239 Identities=20% Similarity=0.214 Sum_probs=181.2
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..+.||+|+||.||+++.. +++.||||++... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 24 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 3568999999999999965 6889999999765 3456788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC--eEEccCCcccccC-----C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN--ACISDIGVHQLFH-----T 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGl~~~~~-----~ 487 (640)
.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++... .
T Consensus 104 ~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 104 YERICNAG-----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 99987543 58899999999999999999995 45999999999999987765 9999999987532 2
Q ss_pred CccccccccCCccccCCCCccccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhcccccccccchhh
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFW-QRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~-~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++.. ..++ .++|||||||++|||++|+.||..... ......+....... ..
T Consensus 176 ~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~ 241 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLR-------QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-------SI 241 (361)
T ss_dssp -----CTTSCHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-------CC
T ss_pred CCcCCCCcCChhhhcC-------CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-------CC
Confidence 3456889999997533 2333 348999999999999999999974321 22222222111100 00
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..... ...++.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~---~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 PDDIR---ISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CTTSC---CCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcCC---CCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 00001 1234667888899999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.26 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=185.7
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+++. .++..||+|++.... ..+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred ecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 367899999999999996 457889999987652 3467889999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE---CCCCCeEEccCCcccccCC--
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV---DQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGl~~~~~~-- 487 (640)
+|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 106 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 106 ELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp BHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred cHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 99998854311 01258899999999999999999995 459999999999999 4568899999999976542
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++. ..++.++|||||||++|||++|+.||......... ............
T Consensus 182 ~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~----- 246 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK--------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--QKATYKEPNYAV----- 246 (285)
T ss_dssp -----CTTGGGCCHHHHT--------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCCCCCCC-----
T ss_pred cCcCcccccCcCChHHhc--------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--hhhccCCccccc-----
Confidence 234688999999652 34678999999999999999999999754322211 111111000000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++.+||+.||++|||+.|+++
T Consensus 247 ----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001234667888899999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=324.18 Aligned_cols=250 Identities=14% Similarity=0.189 Sum_probs=191.9
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEE-EcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYC-NGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lV~Ey~~~gsL 414 (640)
..+.||+|+||.||+|+. .+++.||||.+........+.+|+++++.++|++++..++++ ...+..++||||+ +|+|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 4hgt_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence 357899999999999995 668899999877665556688899999999998888777666 5567889999999 9999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE---CCCCCeEEccCCcccccCC----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV---DQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGl~~~~~~---- 487 (640)
.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 92 EDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 999975432 589999999999999999999954 59999999999999 7889999999999986532
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAW 557 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~ 557 (640)
...++..|+|||++. ...++.++|||||||++|||+||+.||...... .........
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------ 231 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------ 231 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH------
T ss_pred ccCCCCcccccCCCccccchHHhc-------CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh------
Confidence 234588999999753 345678999999999999999999999742211 111111100
Q ss_pred cccchhhccCh--HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 558 EVFDFELIMDK--EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 558 ~~~d~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
......+. .......++.+++..||+.||++|||+.++++.|+++..+..
T Consensus 232 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 232 ---EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ---HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ---cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00000000 001113457778888999999999999999999999886644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.55 Aligned_cols=250 Identities=15% Similarity=0.135 Sum_probs=184.2
Q ss_pred hhccccccCcceEEEEEeC----CCcEEEEEEeccccc-------------hHHHHHHHHHHhccCCCcccceeEEEEc-
Q 006559 337 SAELLGKGCVGATYKVVLD----GGDVVVVKRIRERKK-------------KREVDEWLRVIGGLRHSNIVSIRAYCNG- 398 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-------------~~~~~~e~~~l~~l~H~niv~l~~~~~~- 398 (640)
..+.||+|+||.||+|+.. .+..+|||.+..... .+.+.+|+..++.++||||+++++++..
T Consensus 41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence 3578999999999999975 567899999875421 1235567788899999999999999987
Q ss_pred ---CCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC--C
Q 006559 399 ---KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG--N 473 (640)
Q Consensus 399 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~--~ 473 (640)
....|+||||+ +++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTS
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCc
Confidence 67899999999 999999997543 589999999999999999999954 599999999999999877 9
Q ss_pred eEEccCCcccccCC-------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 006559 474 ACISDIGVHQLFHT-------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE 540 (640)
Q Consensus 474 ~kl~DfGl~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~ 540 (640)
+||+|||+++.+.. ...++..|+|||++ ....++.++|||||||++|||+||+.||....
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH-------KGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH-------HTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHh-------cCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 99999999976531 23468899999965 33457889999999999999999999996422
Q ss_pred cchHHH--HHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 541 LGIVKW--VQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 541 ~~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
...... .......... ..... .... .....++.+++..||+.||++||++.+|++.|+++..
T Consensus 265 ~~~~~~~~~~~~~~~~~~-~~~~~-~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPVAVQTAKTNLLDELP-QSVLK-WAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHHHHHHHHHHHHHTTT-HHHHH-HSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccHHHHHHHHhhccccc-HHHHh-hccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 221111 1110000000 00000 0000 0122357778888999999999999999999988764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=335.93 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=191.8
Q ss_pred hhccccccCcceEEEEEe-----CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL-----DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-----~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~E 407 (640)
..+.||+|+||.||+|++ .++..||||++... ...+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence 357899999999999984 45788999999765 234568899999999999999999999874 457999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred ecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999997532 258999999999999999999995 4599999999999999999999999999986542
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||......................
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESL-------SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHH-------HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred CCccceeeccCCccccccCHHHh-------ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 12346679999964 33456789999999999999999999986422111110000000000000
Q ss_pred ---ccch--hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 559 ---VFDF--ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 559 ---~~d~--~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
.... ...... .....+.+++..||+.||++|||+.++++.|+.+....
T Consensus 253 ~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 253 LLELLEEGQRLPAPP---ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHhhcccCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0000 000111 22345677888899999999999999999999987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=319.95 Aligned_cols=247 Identities=20% Similarity=0.271 Sum_probs=190.2
Q ss_pred hhccccccCcceEEEEEeCC-C---cEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeE-EEEEec
Q 006559 337 SAELLGKGCVGATYKVVLDG-G---DVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDEL-FLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lV~Ey 408 (640)
..++||+|+||.||+|+..+ + ..||+|.+.... ..+.+.+|++++++++||||+++++++...+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 35789999999999998532 2 269999987543 235678899999999999999999999876654 999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+.+|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 105 MCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999997643 2578999999999999999999954 599999999999999999999999999975432
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCC-CCCCCcchHHHHHHhhcccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
...++..|+|||.+ ....++.++|||||||++|||+||..| +....... ..........
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~-- 246 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESL-------QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFLAQGRR-- 246 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHHHTTCC--
T ss_pred cccccccCcCCCCCccccChhhh-------ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHhhcCCC--
Confidence 12346789999964 344677899999999999999996555 44322111 1111111100
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
...... ....+.+++..||+.||++|||+.++++.|+++.....
T Consensus 247 ------~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 247 ------LPQPEY---CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ------CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ------CCCCcc---chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 001111 12346678888999999999999999999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=332.16 Aligned_cols=243 Identities=13% Similarity=0.151 Sum_probs=187.6
Q ss_pred hhccccccCcceEEEEE------eCCCcEEEEEEeccccchHHHHHHHHHHhccC---CCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVV------LDGGDVVVVKRIRERKKKREVDEWLRVIGGLR---HSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|. ...++.||||++... ...++..|+++++.++ |+||+++++++...+..|+|||
T Consensus 69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 35789999999999994 456888999999754 3456677777777766 9999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-----------CCCeEE
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-----------LGNACI 476 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-----------~~~~kl 476 (640)
||++|+|.+++..........++|..++.++.|++.||+|||+ .+||||||||+|||++. ++.+||
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl 224 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCCEEE
Confidence 9999999999974322222368999999999999999999995 55999999999999998 899999
Q ss_pred ccCCcccccC--------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHH
Q 006559 477 SDIGVHQLFH--------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQ 548 (640)
Q Consensus 477 ~DfGl~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~ 548 (640)
+|||+++.+. ....+|..|+|||++ ....++.++|||||||++|||+||+.||......
T Consensus 225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------ 291 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML-------SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG------ 291 (365)
T ss_dssp CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH-------TTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT------
T ss_pred eeCchhhhhhccCCCceeeeecCCCCCCChHHh-------cCCCCCccccHHHHHHHHHHHHhCCCccccCCCC------
Confidence 9999996542 234568999999975 3345788999999999999999999998632110
Q ss_pred HhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHHhhcc
Q 006559 549 MMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDR-PNMSIVHRMIEDIRTK 608 (640)
Q Consensus 549 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Ps~~~v~~~L~~i~~~ 608 (640)
.+. .+...... ...+.. .+++..|++.+|.+| |+++++.+.|+++...
T Consensus 292 -------~~~-~~~~~~~~-~~~~~~---~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 292 -------ECK-PEGLFRRL-PHLDMW---NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -------EEE-ECSCCTTC-SSHHHH---HHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------cee-echhcccc-CcHHHH---HHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 000 00000000 112333 345556999999998 6788999999987755
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=320.99 Aligned_cols=245 Identities=25% Similarity=0.348 Sum_probs=189.5
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcC-CeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGK-DELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||++... |..||||.++.....+.+.+|++++++++||||+++++++... +..++||||+++|+|.
T Consensus 25 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103 (278)
T ss_dssp EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred EEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence 3578999999999999875 7889999998776677889999999999999999999997654 4789999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---cccc
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---FFIN 492 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---~~~~ 492 (640)
+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ...+
T Consensus 104 ~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 177 (278)
T 1byg_A 104 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177 (278)
T ss_dssp HHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred HHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccccCCCcc
Confidence 9997532 12378899999999999999999954 5999999999999999999999999998765432 2346
Q ss_pred ccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHH
Q 006559 493 DAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEME 571 (640)
Q Consensus 493 ~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 571 (640)
..|+|||++ ....++.++||||||+++|||+| |+.||...... ........... ......
T Consensus 178 ~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~--------~~~~~~-- 238 (278)
T 1byg_A 178 VKWTAPEAL-------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK--------MDAPDG-- 238 (278)
T ss_dssp TTTSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCC--------CCCCTT--
T ss_pred ccccCHHHh-------CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCC--------CCCccc--
Confidence 789999964 34567789999999999999999 99999754322 11111111100 001111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 572 EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 572 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
....+.+++..||+.||++||++.++++.|+++...
T Consensus 239 -~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 239 -CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 123466778889999999999999999999999865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=342.12 Aligned_cols=235 Identities=19% Similarity=0.314 Sum_probs=189.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+|+++++.++||||+++++++...+..|+||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 567999999999999965 68999999997542 235688999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 101 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 101 GELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 99999997543 58999999999999999999994 5699999999999999999999999999987643
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
...+|..|+|||++.+. ...+.++||||+||++|||++|+.||.+.... ...+..... ....
T Consensus 173 ~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~---------~~~~ 235 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGR------LYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKICDG---------IFYT 235 (476)
T ss_dssp CCCCSCSTTCCHHHHTTC------CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHHHTT---------CCCC
T ss_pred cccCCCcCeEChhhccCC------CCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcC---------CcCC
Confidence 23568899999976432 12357899999999999999999999754322 111111111 0011
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+.... .++.+++.+||+.||++|||+.++++
T Consensus 236 p~~~s---~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 PQYLN---PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccCC---HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11111 24667788899999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=322.28 Aligned_cols=251 Identities=14% Similarity=0.184 Sum_probs=194.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEE-EcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYC-NGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lV~Ey~~~gsL 414 (640)
..+.||+|+||.||+|+. .+++.||||.+......+.+.+|+++++.++|++++..++++ ...+..++||||+ +|+|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 3uzp_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCH
Confidence 357899999999999995 678899999988766667788999999999998877766665 5567889999999 8999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE---CCCCCeEEccCCcccccCC----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV---DQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGl~~~~~~---- 487 (640)
.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 92 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99997443 2589999999999999999999954 59999999999999 4889999999999876532
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAW 557 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~ 557 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||...... .........
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------ 231 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTH-------LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------ 231 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH------
T ss_pred cccccccccccccccccCChhhh-------cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc------
Confidence 22457889999975 3345678999999999999999999999742211 100010000
Q ss_pred cccchhhccCh--HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCC
Q 006559 558 EVFDFELIMDK--EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611 (640)
Q Consensus 558 ~~~d~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 611 (640)
........ .......++.+++..||+.||++||++.++++.|+++..+...
T Consensus 232 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 232 ---EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ---HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ---ccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00000000 0011224577788889999999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=316.34 Aligned_cols=238 Identities=20% Similarity=0.277 Sum_probs=187.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. +++.||||.+.... ..+.+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 568999999999999965 68899999987542 34668889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------- 486 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------- 486 (640)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 92 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred HHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 999997542 588999999999999999999954 59999999999999999999999999987542
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....++..|+|||++... ..++.++|||||||++|||+||+.||.........+......... ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~--- 230 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----LNP--- 230 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCS------SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT----STT---
T ss_pred ccCCccccCccChHHHhcC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc----cCc---
Confidence 223468889999975322 223578999999999999999999997543322222211111100 000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. .....+.+++..||+.||++|||+.++++
T Consensus 231 -~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 -WK---KIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -GG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -hh---hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01 11234567788899999999999998865
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.92 Aligned_cols=253 Identities=19% Similarity=0.215 Sum_probs=185.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhc-cCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGG-LRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.++||+|+||.||+|+. .+++.||||++... ...+.+.+|++++.+ ++||||+++++++...+..|+||||+++|+
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 35799999999999994 56889999999754 335678889999888 579999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC---eEEccCCcccccCC---
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN---ACISDIGVHQLFHT--- 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl~~~~~~--- 487 (640)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 98 ILSHIHKRR-----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999997543 588999999999999999999954 5999999999999998776 99999999876431
Q ss_pred ----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcc----
Q 006559 488 ----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQD---- 553 (640)
Q Consensus 488 ----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---- 553 (640)
...+|..|+|||++.... .....++.++|||||||++|||+||+.||.........|.......
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFS--EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTS--HHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred cccccccccccccCCcCccChHHhhccc--ccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 123688999999753210 0113467899999999999999999999975432211111000000
Q ss_pred cccccccchhhccCh-HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 554 ESAWEVFDFELIMDK-EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....+.......+. .......++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000000000010 01112345778888999999999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.46 Aligned_cols=233 Identities=22% Similarity=0.341 Sum_probs=185.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.++||+|+||.||+|+.. +++.||||.++.. ...+.+..|.+++..+ +||||+++++++...+..|+||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 578999999999999975 5888999999754 2334566788888766 89999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 102 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 999999997543 588999999999999999999954 59999999999999999999999999987642
Q ss_pred --CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 487 --TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 487 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
....+|..|+|||++. ...++.++|||||||++|||++|+.||...... ...+...... .
T Consensus 174 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~---------~ 235 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILL-------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDN---------P 235 (345)
T ss_dssp CBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC---------C
T ss_pred cccCCCCCcccCChhhhc-------CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHhCC---------C
Confidence 2345688999999753 345778999999999999999999999754321 1111111110 0
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMS-IVH 599 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v~ 599 (640)
..+...+ .++.+++.+||+.||++||++. ++.
T Consensus 236 ~~p~~~s---~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 FYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCTTSC---HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCcccC---HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0111122 2456677889999999999997 654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=328.25 Aligned_cols=235 Identities=18% Similarity=0.255 Sum_probs=180.2
Q ss_pred hhccccccCcceEEEEEe----CCCcEEEEEEecccc------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVL----DGGDVVVVKRIRERK------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~----~~~~~vavK~l~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||+++. .+++.||+|+++... ....+.+|++++++++||||+++++++...+..|+||
T Consensus 21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence 357899999999999986 478899999997542 2345678999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 101 EYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred eCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999997543 478899999999999999999954 59999999999999999999999999987542
Q ss_pred ------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 487 ------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 487 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
....+|..|+|||++. ...++.++|||||||++|||++|+.||...... ...+.....
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~------- 236 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILM-------RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTIDKILKC------- 236 (327)
T ss_dssp ------CTTSSCCTTSCHHHHT-------TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHT-------
T ss_pred cCCccccccCCCcCccCHhhCc-------CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhC-------
Confidence 2245688999999753 345678999999999999999999999754321 111111111
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
....+.... .++.+++.+||+.||++|| ++.++++
T Consensus 237 --~~~~p~~~~---~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 --KLNLPPYLT---QEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --CCCCCTTSC---HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --CCCCCCCCC---HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111111122 3456777889999999999 5666653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=324.52 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=187.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +|+.||||++..... .+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 467999999999999975 588999999865532 355778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 9999887543 488999999999999999999954 599999999999999999999999999987642
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-HHHHHHhhcc------------
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-VKWVQMMGQD------------ 553 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~------------ 553 (640)
...++..|+|||++.+ ...++.++|||||||++|||+||+.||....... ...+......
T Consensus 160 ~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 160 DDEVATRWYRSPELLVG------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------GGGCCHHHHHT------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred CCCcCCccccChHHHhc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 2345888999997532 2456789999999999999999999997543221 1111111000
Q ss_pred ccc--ccccchhhccC--hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 554 ESA--WEVFDFELIMD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 554 ~~~--~~~~d~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ....++..... .........+.+++..||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00000000000 001122345778889999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.97 Aligned_cols=267 Identities=18% Similarity=0.209 Sum_probs=198.4
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCC--eEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD--ELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lV~Ey~~ 410 (640)
..++||+|+||.||+|+.. +++.||||++... ...+.+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 3568999999999999975 4889999999754 23466778999999999999999999998755 7899999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE----CCCCCeEEccCCcccccC
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV----DQLGNACISDIGVHQLFH 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl~~~~~ 486 (640)
+|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 93 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp TEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999976432 12389999999999999999999954 59999999999999 788889999999998764
Q ss_pred C-----CccccccccCCccccCCCCc-cccCCCCCccchHHHHHHHHHHHhCCCCCCCCC--cchHHHHHHhh-ccc-cc
Q 006559 487 T-----PFFINDAYNAPELKFNNNNN-YSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGE--LGIVKWVQMMG-QDE-SA 556 (640)
Q Consensus 487 ~-----~~~~~~~y~aPE~~~~~~~~-~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~--~~~~~~~~~~~-~~~-~~ 556 (640)
. ...+|..|+|||++...... .....++.++|||||||++|||+||+.||.... ....+.+.... ... ..
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 3 23568899999975321100 001356678999999999999999999986321 11122221111 110 00
Q ss_pred cc-c-------cc--hhhccCh-HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 557 WE-V-------FD--FELIMDK-EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 557 ~~-~-------~d--~~~~~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
+. . ++ ....... ........+.+++..||+.||++||++.++++.++++..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00 0 00 0000000 1133445667788889999999999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=323.71 Aligned_cols=248 Identities=19% Similarity=0.222 Sum_probs=188.6
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|+.. +++.||||.+.... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 3578999999999999965 68889999987542 13567889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+++|.+++.... ++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 118 GVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999997543 588999999999999999999954 599999999999999999999999999876543
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...++..|+|||++ ....++.++||||||+++|||+||+.||........ ......... .+.
T Consensus 190 ~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~-----~~~ 255 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERF-------SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM--GAHINQAIP-----RPS 255 (309)
T ss_dssp -------CCGGGCCGGGT-------CC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH--HHHHHSCCC-----CGG
T ss_pred ccccccCCCcCccCHHHH-------cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH--HHHhccCCC-----Ccc
Confidence 23457889999965 334567899999999999999999999975432211 111111100 000
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhhccCC
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRP-NMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~~~~ 610 (640)
.... ....++.+++.+||+.||++|| ++.++++.|+++.....
T Consensus 256 -~~~~---~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 256 -TVRP---GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -GTST---TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -ccCC---CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0011 1122466778889999999999 99999999999876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=331.08 Aligned_cols=229 Identities=21% Similarity=0.288 Sum_probs=183.3
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEeccc-----cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRER-----KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.++||+|+||.||+|+... ++.||||+++.. ...+.+..|.+++..+ +||||+++++++...+..|+||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 5689999999999999764 788999999754 2345577888899887 79999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 999999997543 488999999999999999999954 59999999999999999999999999998632
Q ss_pred --CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 487 --TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 487 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
....+|..|+|||++. ...++.++|||||||++|||++|+.||..... ....+..... ..
T Consensus 177 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~---------~~ 238 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEH---------NV 238 (353)
T ss_dssp CBCCCCSCGGGCCHHHHT-------TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC---------CC
T ss_pred ccccccCCccccChhhhc-------CCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHHhC---------CC
Confidence 2345689999999753 34577899999999999999999999975432 1222221111 11
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
..+...+ .++.+++..||+.||++||++
T Consensus 239 ~~p~~~s---~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 239 AYPKSMS---KEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CCCTTSC---HHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCC---HHHHHHHHHHhhcCHHHcCCC
Confidence 1111222 346667788999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.52 Aligned_cols=251 Identities=15% Similarity=0.168 Sum_probs=188.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-------cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-------KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..+.||+|+||.||+|+. .++..||+|.+... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 357899999999999996 46788999998643 2335688899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCC-----------------------------------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCC
Q 006559 409 LPHGSLHSLLHGSRG-----------------------------------PGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~-----------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 453 (640)
+++|+|.+++..... .....+++..+..++.|++.||+|||+.
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 187 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-- 187 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 999999999852110 0011345677888999999999999954
Q ss_pred CCceecCCCCCCeEECCCC--CeEEccCCcccccCC----------CccccccccCCccccCCCCccccCCCCCccchHH
Q 006559 454 AHLFHGHLSSSNIVVDQLG--NACISDIGVHQLFHT----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYS 521 (640)
Q Consensus 454 ~~ivHrdlk~~NILl~~~~--~~kl~DfGl~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~S 521 (640)
+|+||||||+|||++.++ .+||+|||+++.+.. ...+|..|+|||++.. ....++.++||||
T Consensus 188 -~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~Diws 261 (345)
T 3hko_A 188 -GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT-----TNESYGPKCDAWS 261 (345)
T ss_dssp -TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC-----SSSCCCTHHHHHH
T ss_pred -CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc-----CCCCCCcHHHHHH
Confidence 599999999999998776 899999999976421 2346888999997632 2246778999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-
Q 006559 522 FGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR- 600 (640)
Q Consensus 522 fGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~- 600 (640)
|||++|||+||+.||...... ............. .. +........+.+++..||+.||++||++.++++
T Consensus 262 lG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~--~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCF--EN------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCT--TS------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHCCCCCCCCChH--HHHHHHHhccccc--CC------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999754322 1111111111000 00 111112234667788899999999999999975
Q ss_pred -HHHHh
Q 006559 601 -MIEDI 605 (640)
Q Consensus 601 -~L~~i 605 (640)
.++++
T Consensus 332 p~~~~~ 337 (345)
T 3hko_A 332 PWISQF 337 (345)
T ss_dssp HHHHTT
T ss_pred hhhccC
Confidence 44443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=324.14 Aligned_cols=240 Identities=23% Similarity=0.293 Sum_probs=189.1
Q ss_pred cccccCcceEEEEEe---CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 340 LLGKGCVGATYKVVL---DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~---~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.||+|+||.||+|.. ..+..||||.++... ..+++.+|++++++++||||+++++++ ..+..++||||+++|
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 799999999999964 346789999987542 246688999999999999999999999 567789999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 9999998643 488999999999999999999954 5999999999999999999999999998876432
Q ss_pred -----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 489 -----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 489 -----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||....... ..+........
T Consensus 175 ~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~------ 239 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECI-------NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERM------ 239 (291)
T ss_dssp EC----CCCGGGCCHHHH-------HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCC------
T ss_pred cccccCCCCceeeChHHh-------ccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCC------
Confidence 1234679999965 33456789999999999999999 999997543221 11111111000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..+. .....+.+++..||+.||++||++.++++.|+++...
T Consensus 240 --~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 240 --GCPA---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --CCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0111 1223567788889999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=316.88 Aligned_cols=243 Identities=16% Similarity=0.212 Sum_probs=191.3
Q ss_pred hhccccccCcceEEEEEeCC-CcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVLDG-GDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||.||+|+... +..||+|++... ...+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 35689999999999999654 678999998764 345678899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE---CCCCCeEEccCCcccccCC---
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV---DQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGl~~~~~~--- 487 (640)
|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++.....
T Consensus 93 L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 93 LFERVVHKR-----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp HHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 999987543 58899999999999999999995 459999999999999 7889999999999876543
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...++..|+|||++. ..++.++|||||||++|||+||+.||...... ............ ...
T Consensus 165 ~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~--~~~---- 228 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLE--------GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIREGTFT--FPE---- 228 (277)
T ss_dssp BCCCCSCTTTCCHHHHT--------TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCC--CCH----
T ss_pred hhccCCCCCccChHHhc--------ccCCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCCC--CCc----
Confidence 234688999999752 23778999999999999999999999754321 111111111000 000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHh
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDI 605 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i 605 (640)
.........+.+++..||+.||++||++.++++ .+++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 229 --KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp --HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred --hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 000112345677888899999999999999974 44443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=341.46 Aligned_cols=246 Identities=16% Similarity=0.175 Sum_probs=186.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||.||+++.. +++.||||++... ...+.+.+|..++..++||||+++++++.+.+..|+||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 468999999999999974 6899999999753 1223477889999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 146 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 146 GDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999997532 148899999999999999999995 4599999999999999999999999999976542
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++...........++.++|||||||++|||+||+.||...... +......... ...
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~-------~~~ 289 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--ETYGKIVHYK-------EHL 289 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHH-------HHC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--HHHHHHHhcc-------cCc
Confidence 2357899999997642111111345788999999999999999999999754321 1111111100 000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDR---PNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~~v~~ 600 (640)
..+........++.+++.+||. +|++| |++.|+.+
T Consensus 290 ~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0010001122346677788999 99998 58888853
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.76 Aligned_cols=245 Identities=16% Similarity=0.212 Sum_probs=187.0
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||+||+|+... ++.||||++.... ....+.+|..++..++||||++++++|.+.+..|+|||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 5689999999999999764 7889999997531 223478899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... ..+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+++....
T Consensus 159 g~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 159 GDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 99999998632 258999999999999999999995 4599999999999999999999999999976532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++.... .....++.++|||||||++|||+||+.||...... +......... ...
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~--~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~-------~~~ 300 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAME--GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHK-------ERF 300 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHH--TSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHH-------HHC
T ss_pred ccccccCCcCeeChHHHhhcc--cCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--HHHHhhhhcc-------ccc
Confidence 245799999999763100 01345788999999999999999999999754321 1111111000 000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKD--RPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~v~~ 600 (640)
..+........++.+++.+|+..+|++ ||++.|+.+
T Consensus 301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 001000011223556677788888888 999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=317.87 Aligned_cols=234 Identities=20% Similarity=0.308 Sum_probs=186.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. ++..||||.+... .....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 567999999999999865 5678999998653 2345688899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 165 (279)
T 3fdn_A 94 GTVYRELQKLS-----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 165 (279)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccccc
Confidence 99999987543 5889999999999999999999 45699999999999999999999999999865432
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...++..|+|||++ ....++.++||||||+++|||++|+.||...... ...+..... ....+
T Consensus 166 ~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---------~~~~~ 227 (279)
T 3fdn_A 166 DLCGTLDYLPPEMI-------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRV---------EFTFP 227 (279)
T ss_dssp --CCCCTTCCHHHH-------TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT---------CCCCC
T ss_pred ccCCCCCccCHhHh-------ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHhC---------CCCCC
Confidence 23568899999965 3345678999999999999999999999754321 111111110 00011
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ...+.+++..||+.||++|||+.|+++
T Consensus 228 ~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 228 DFV---TEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp TTS---CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcC---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 224567788899999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=335.10 Aligned_cols=243 Identities=16% Similarity=0.213 Sum_probs=184.9
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc----chHHHHHHHHHHhccC--CCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK----KKREVDEWLRVIGGLR--HSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||++...+++.||||++.... ..+.+.+|++++++++ ||||+++++++...+..|+||| +.
T Consensus 60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~ 138 (390)
T 2zmd_A 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 138 (390)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence 357899999999999998889999999986542 2356788999999997 5999999999999999999999 56
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 139 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 139 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp SEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 889999998653 57888999999999999999995 4599999999999996 58999999999986532
Q ss_pred -----CccccccccCCccccCCCCc----cccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 488 -----PFFINDAYNAPELKFNNNNN----YSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~----~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
...+|..|+|||++...... .....++.++|||||||++|||++|+.||....... .............
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~~~~~~~~~- 287 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDPNHEI- 287 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHCTTSCC-
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHHHhCccccC-
Confidence 23568899999986432111 112467889999999999999999999997532221 1111111111000
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+... ..++.+++..||+.||++||++.|+++
T Consensus 288 ------~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 288 ------EFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ------CCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CCCccc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 001111 224667788899999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=337.83 Aligned_cols=239 Identities=18% Similarity=0.272 Sum_probs=180.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 406 (640)
.+.||+|+||.||+|.. .+++.||||.+.... ....+.+|++++++++||||+++++++. .+..|+||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~ 218 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL 218 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence 56799999999999986 457899999987542 1124778999999999999999999986 45689999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC---CCeEEccCCccc
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL---GNACISDIGVHQ 483 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGl~~ 483 (640)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 219 e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 219 ELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp ECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccce
Confidence 9999999999987543 589999999999999999999954 59999999999999754 459999999998
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhccccc
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDESA 556 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~ 556 (640)
.... ...+|..|+|||++.. .....++.++|||||||++|||+||+.||..... .....+.....
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~---- 362 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVS----VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY---- 362 (419)
T ss_dssp SCC-----------CTTCCTTTTC--------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC----
T ss_pred ecCCCccccccCCCCCccCceeeec----CCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC----
Confidence 7653 2346889999997532 1234577899999999999999999999975322 12211111000
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ..+ .........+.+++.+||+.||++||++.|+++
T Consensus 363 -~-~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 -N-FIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -C-CCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -C-CCc-----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 000 011122345777888999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.02 Aligned_cols=189 Identities=22% Similarity=0.281 Sum_probs=161.9
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-cchHHHHHHHHHHhccC-----CCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-KKKREVDEWLRVIGGLR-----HSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~-----H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|+. .+++.||||+++.. ...+.+..|++++++++ ||||+++++++...+..++||||+
T Consensus 39 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 357899999999999996 56889999999754 33456677888888876 999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-------------------
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ------------------- 470 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~------------------- 470 (640)
+++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 119 -~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 119 -GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp -CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred -CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 8999999976532 248899999999999999999995 45999999999999985
Q ss_pred ------CCCeEEccCCcccccCC---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 471 ------LGNACISDIGVHQLFHT---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 471 ------~~~~kl~DfGl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
++.+||+|||+++.... ...+|..|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL-------NLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHc-------CCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 78999999999986543 345688999999753 345778999999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.71 Aligned_cols=238 Identities=22% Similarity=0.339 Sum_probs=185.7
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEc----CCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNG----KDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|.. .++..||+|.+.... ..+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 56799999999999986 457789999987542 23567889999999999999999999865 3568999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccCCcccccCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGVHQLFHT 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl~~~~~~ 487 (640)
+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||||+|||++ .++.+||+|||++.....
T Consensus 111 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred cCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999997543 5889999999999999999999542 3499999999999998 789999999999976543
Q ss_pred C----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 P----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ~----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
. ..++..|+|||++. ..++.++|||||||++|||+||+.||..... .....+......... ..
T Consensus 185 ~~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~-~~--- 251 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPA-SF--- 251 (290)
T ss_dssp TSBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCCCG-GG---
T ss_pred cccccccCCcCcCCHHHHh--------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-HHHHHHHHhccCCcc-cc---
Confidence 2 34688999999642 3477899999999999999999999975332 222222211111000 00
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+. ....++.+++..||+.||++|||+.++++
T Consensus 252 ---~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 ---DK---VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GG---CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CC---CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00 11134677888899999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=318.45 Aligned_cols=242 Identities=20% Similarity=0.280 Sum_probs=189.1
Q ss_pred hhccccccCcceEEEEEeCC----CcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG----GDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|+..+ +..||||.+... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence 35789999999999998543 235999998765 234668889999999999999999999864 4578999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 95 PYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp TTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999997543 248899999999999999999995 45999999999999999999999999998865432
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcc-hHHHHHHhhccccccccc
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELG-IVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 560 (640)
...+..|+|||++ ....++.++|||||||++|||+| |+.||...... ....+.. ....
T Consensus 168 ~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---~~~~---- 233 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESI-------NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRL---- 233 (281)
T ss_dssp -----CCCCCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH---TCCC----
T ss_pred ccccccCCCCcceeCchhh-------ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc---CCCC----
Confidence 2336679999964 34567789999999999999999 99999743222 2111111 1000
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
..... ....+.+++.+||+.||++||++.++++.|+++..
T Consensus 234 ----~~~~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 ----PKPDL---CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ----CCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCC---CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 00111 12346678888999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=334.24 Aligned_cols=238 Identities=16% Similarity=0.231 Sum_probs=178.5
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHH-hccCCCcccceeEEEEc----CCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVI-GGLRHSNIVSIRAYCNG----KDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~~g 412 (640)
++||+|+||+||+++.. +++.||||+++.. ..+.+|+.++ +..+||||+++++++.. .+..|+|||||++|
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg 144 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSE
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc---hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCC
Confidence 57999999999999964 6889999998643 3456677665 44589999999999875 56799999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCC--
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~-- 487 (640)
+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 145 ~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 145 ELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp EHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred cHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999998643 23589999999999999999999954 5999999999999997 78999999999987642
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH--HHHHHhhcccccccccch
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV--KWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~d~ 562 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||........ .......... .....+
T Consensus 219 ~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~--~~~~~~ 289 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--YEFPNP 289 (400)
T ss_dssp --------CTTCCGGGS-------CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC--CCCCTT
T ss_pred ccccCCCCCCccCHhhc-------CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc--ccCCCc
Confidence 23458899999975 345678899999999999999999999975322110 0011110000 000000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++..||+.||++|||+.|+++
T Consensus 290 ------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 290 ------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp ------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01112235677888899999999999999976
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=329.58 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=185.3
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCC----eEEEEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD----ELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lV~ 406 (640)
..+.||+|+||.||+|+. .+++.||||+++... ....+.+|++++++++||||+++++++.... ..|+||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEE
Confidence 357899999999999995 668899999997642 1245778999999999999999999987643 359999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+++|+|.++++... ++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 96 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 96 EYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp ECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999997543 589999999999999999999954 59999999999999999999999999987653
Q ss_pred C---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccc
Q 006559 487 T---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 487 ~---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
. ...++..|+|||++ ....++.++|||||||++|||+||+.||.........+..... .. .
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~-~- 237 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQA-------RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DP-I- 237 (311)
T ss_dssp --------------CCTTCCHHHH-------HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-CC-C-
T ss_pred ccccccccccccCcCcccCCHHHh-------cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-CC-C-
Confidence 2 12458899999975 3345778999999999999999999999754322221111111 00 0
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHH-HHHHHHHhhcc
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSI-VHRMIEDIRTK 608 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~-v~~~L~~i~~~ 608 (640)
.+. ... .....++.+++.+||+.||++||+..+ +...+.++...
T Consensus 238 ---~~~-~~~---~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 238 ---PPS-ARH---EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ---CHH-HHS---TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ---Ccc-ccc---CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 000 000 112335677888899999999997554 55666666543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.48 Aligned_cols=236 Identities=20% Similarity=0.296 Sum_probs=182.0
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+|+. .+++.||||++... .....+.+|+++++.++||||++++++|...+..|+||||++
T Consensus 152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 357899999999999995 46889999999754 123456678899999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 232 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 232 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp SCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 999999997543 58899999999999999999995 1459999999999999999999999999987642
Q ss_pred --CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 487 --TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 487 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
....+|..|+|||++ ....++.++|||||||++|||+||+.||...... .......... .
T Consensus 305 ~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~---------~ 366 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEE---------I 366 (446)
T ss_dssp --CCSSSCGGGCCHHHH-------HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC---------C
T ss_pred ccccccCCccccCHhhc-------CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHhCC---------C
Confidence 234568899999975 3456788999999999999999999999754322 1111111110 0
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
..+.... .++.+++..||+.||++|| ++.|+++
T Consensus 367 ~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 RFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCTTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCC---HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0111112 3466778889999999999 8888864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.61 Aligned_cols=251 Identities=16% Similarity=0.114 Sum_probs=191.6
Q ss_pred hhccccccCcceEEEEEeCC---------CcEEEEEEeccccchHHHHHHHHHHhccCCCcccc---------------e
Q 006559 337 SAELLGKGCVGATYKVVLDG---------GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVS---------------I 392 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~---------------l 392 (640)
..+.||+|+||.||+|+... ++.||||.+... +.+.+|++++++++||||++ +
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~ 122 (352)
T 2jii_A 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122 (352)
T ss_dssp EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence 35789999999999999764 788999998754 45778899999999999988 6
Q ss_pred eEEEEc-CCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC
Q 006559 393 RAYCNG-KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL 471 (640)
Q Consensus 393 ~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~ 471 (640)
++++.. .+..++||||+ +|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETT
T ss_pred hhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCC
Confidence 777765 67899999999 999999998642 12589999999999999999999954 59999999999999999
Q ss_pred C--CeEEccCCcccccCC-------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 472 G--NACISDIGVHQLFHT-------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 472 ~--~~kl~DfGl~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
+ .+||+|||+++.+.. ...++..|+|||++ ....++.++|||||||++|||+||+.||
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH-------KGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH-------ccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 8 999999999976532 22568899999965 3345778999999999999999999999
Q ss_pred CCCCcchH---HHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 537 GDGELGIV---KWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 537 ~~~~~~~~---~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
........ .......... ....+.... .... ..++.+++..||+.||++||++.++++.|+++..+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKP--GPFVGPCGH-WIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSC--CCEECTTSC-EECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCcCHHHHHHHHHhccCCh--hhhhhhccc-cCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 75322211 1111111110 001110000 0011 2346677888999999999999999999999886644
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.51 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=185.2
Q ss_pred hhccccccCcceEEEEEeC----CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCC-----eEE
Q 006559 337 SAELLGKGCVGATYKVVLD----GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD-----ELF 403 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 403 (640)
..+.||+|+||.||+|+.. .+..||||.+.... ..+.+.+|++++++++||||+++++++...+ ..+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 4578999999999999854 24479999987542 2355788999999999999999999998754 359
Q ss_pred EEEeccCCCCHHHhhccCCC-CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 404 LVYDYLPHGSLHSLLHGSRG-PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
+||||+++|+|.+++..... .....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCcc
Confidence 99999999999999853321 122368999999999999999999994 56999999999999999999999999998
Q ss_pred cccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcc
Q 006559 483 QLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 483 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 553 (640)
+..... ..++..|+|||++ ....++.++|||||||++|||+| |+.||....... ........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~ 265 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESL-------ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDYLLHG 265 (313)
T ss_dssp ----------------CCGGGSCHHHH-------HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTT
T ss_pred eecccccccCcccccCCCccccCchhh-------cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHHHcC
Confidence 765321 2346689999964 34567789999999999999999 889987543221 11111111
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
... .... ....++.+++..||+.||++||++.++++.|+++...
T Consensus 266 ~~~--------~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 266 HRL--------KQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCC--------CCBT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC--------CCCc---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 000 0011 1223567788889999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.83 Aligned_cols=241 Identities=17% Similarity=0.240 Sum_probs=187.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||.||+|+.. +++.||+|+++.. ...+.+.+|+++++.++|||||+++++|.+.+..|+|||||++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999975 5789999998753 2234577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.++++.. .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 9999999753 378889999999999999999954 599999999999999999999999999976543
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++..... ...++.++|||||||++|||+||+.||...... ...+....... ....
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~---~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~-----~~~~ 294 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGG---DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKN-----SLTF 294 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTT---TCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHH-----HCCC
T ss_pred cccCCcCCccccCHHHhhccCC---CcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHHHHHhccc-----cccC
Confidence 3457899999998643211 112678999999999999999999999754321 11111111000 0000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKD--RPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~v~~ 600 (640)
......+. ++.+++.+|+..+|++ ||++.||.+
T Consensus 295 p~~~~~s~---~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 295 PDDNDISK---EAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CTTCCCCH---HHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CCcccccH---HHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 00011222 4556777799999988 999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.89 Aligned_cols=231 Identities=18% Similarity=0.267 Sum_probs=181.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+|+.. +++.||+|+++... ..+.+.+|..++.++ +||||+++++++...+..|+||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 568999999999999975 57889999997542 224467788888877 89999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 94 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 999999997543 588999999999999999999954 59999999999999999999999999998632
Q ss_pred --CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc------hHHH-HHHhhcccccc
Q 006559 487 --TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG------IVKW-VQMMGQDESAW 557 (640)
Q Consensus 487 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~------~~~~-~~~~~~~~~~~ 557 (640)
....+|..|+|||++. ...++.++|||||||++|||++|+.||...... .... .+...
T Consensus 166 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~------ 232 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL------ 232 (345)
T ss_dssp CBCCCCSCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH------
T ss_pred cccccCCCccccCccccC-------CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH------
Confidence 2345688999999753 345678999999999999999999999642110 0011 11111
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
......+...+ .++.+++.+||+.||++||++
T Consensus 233 ---~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 233 ---EKQIRIPRSLS---VKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---HCCCCCCTTSC---HHHHHHHHHHTCSSTTTSTTC
T ss_pred ---cCCCCCCCCCC---HHHHHHHHHHhcCCHhHCCCC
Confidence 11111111222 346667788999999999995
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=327.75 Aligned_cols=243 Identities=17% Similarity=0.227 Sum_probs=184.9
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc----chHHHHHHHHHHhccCC--CcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK----KKREVDEWLRVIGGLRH--SNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||++...+++.||||++.... ..+.+.+|++++++++| |||+++++++...+..++||| +.
T Consensus 13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 91 (343)
T 3dbq_A 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 91 (343)
T ss_dssp EEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CC
Confidence 356899999999999998889999999987542 23567889999999987 999999999999999999999 56
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 92 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 92 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp SEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 889999998653 588999999999999999999954 599999999999997 57899999999987532
Q ss_pred -----CccccccccCCccccCCCCc----cccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 488 -----PFFINDAYNAPELKFNNNNN----YSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~----~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
...+|..|+|||++...... .....++.++|||||||++|||+||+.||.................. ..
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~- 240 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-EI- 240 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS-CC-
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc-cc-
Confidence 23568899999976431111 11256788999999999999999999999753322222211111110 00
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+... ..++.+++..||+.||++|||+.|+++
T Consensus 241 ------~~~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 241 ------EFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ------CCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CCcccC---CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 001111 124667788899999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.45 Aligned_cols=239 Identities=17% Similarity=0.255 Sum_probs=190.4
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc--------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK--------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+.. +|..||||.+.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 3578999999999999965 58899999987542 24678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC----CeEEccCCccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG----NACISDIGVHQ 483 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGl~~ 483 (640)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 96 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999997543 589999999999999999999954 599999999999999888 79999999998
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
.... ...++..|+|||++ ....++.++|||||||++|||+||+.||..... ............
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~--- 235 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANITSVSY--- 235 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHH-------TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHTTCC---
T ss_pred ecCccccccccCCCCCccCcccc-------cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhccc---
Confidence 7643 23468899999965 334567899999999999999999999975322 111111111100
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+... .......+.+++..||+.||++|||+.|+++
T Consensus 236 ~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHH-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhh-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011110 0112234677888999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=323.90 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=190.8
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEE----cCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCN----GKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+++. .+++.||||++... ...+.+.+|++++++++||||+++++++. .....++||||+
T Consensus 33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 367899999999999996 67889999988644 34566889999999999999999999987 345789999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999999875321 123589999999999999999999954 5999999999999999999999999998765321
Q ss_pred --------------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCC---CCcchHHHHHHhh
Q 006559 489 --------------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGD---GELGIVKWVQMMG 551 (640)
Q Consensus 489 --------------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~---~~~~~~~~~~~~~ 551 (640)
..++..|+|||++.... ...++.++|||||||++|||++|+.||.. ...........
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 262 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQS----HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-- 262 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS----EEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred ccccccccccccccccCCcccCCHhHhccCC----CcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence 12378899999753221 12357899999999999999999999852 11111111100
Q ss_pred cccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 552 QDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 552 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
. ....... .....+.+++.+||+.||++||++.++++.|+++...
T Consensus 263 -~--------~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 263 -Q--------LSIPQSP---RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp -C----------CCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred -c--------CCCCccc---cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0 0000011 1123567788889999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.59 Aligned_cols=235 Identities=20% Similarity=0.321 Sum_probs=173.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+. .+++.||||.+.... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 56899999999999996 578899999986542 235688899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 96 GEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp EEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred CcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999998543 2589999999999999999999954 599999999999999999999999999887542
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...++..|+|||++. ...++.++|||||||++|||+||+.||........ .... ......
T Consensus 169 ~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~---------~~~~~~ 230 (278)
T 3cok_A 169 HYTLCGTPNYISPEIAT-------RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--LNKV---------VLADYE 230 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------C---------CSSCCC
T ss_pred ceeccCCCCcCCcchhc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--HHHH---------hhcccC
Confidence 234578899999653 34567899999999999999999999975332110 0000 000011
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+... ..++.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~---~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSFL---SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Ccccc---CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11111 234667888899999999999998875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=328.05 Aligned_cols=229 Identities=19% Similarity=0.246 Sum_probs=184.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 406 (640)
.+.||+|+||.||+|+. .++..||||.+.... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 46899999999999985 568889999987542 2234667999999999999999999999999999999
Q ss_pred eccCCC-CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 407 DYLPHG-SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 407 Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
||+..| +|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 109 EKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp ECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999887 9999998653 589999999999999999999954 5999999999999999999999999999876
Q ss_pred CCC-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 486 HTP-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 486 ~~~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
... ..+|..|+|||++... ..++.++|||||||++|||++|+.||..... . .....
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~------~~~~~ 241 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGN------PYRGPELEMWSLGVTLYTLVFEENPFCELEE-------T------VEAAI 241 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTC------CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------G------TTTCC
T ss_pred CCCCceeccCCCccccChhhhcCC------CCCCCcccchhHHHHHHHHHhCCCchhhHHH-------H------Hhhcc
Confidence 432 3468899999975322 1236789999999999999999999964110 0 00000
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. .+... ..++.+++..||+.||++|||+.++++
T Consensus 242 ~----~~~~~---~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 242 H----PPYLV---SKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp C----CSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----CCccc---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 11111 124667788899999999999999976
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.12 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=193.1
Q ss_pred hhccccccCcceEEEEEeCC-C-----cEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDG-G-----DVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~-~-----~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..+.||+|+||.||+|+... + ..||+|.+.... ..+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 35789999999999999643 2 379999997652 345678899999999 8999999999999999999999
Q ss_pred eccCCCCHHHhhccCCC---------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEc
Q 006559 407 DYLPHGSLHSLLHGSRG---------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACIS 477 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~ 477 (640)
||+++|+|.+++..... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 206 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIG 206 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBC
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEEC
Confidence 99999999999864310 0012578999999999999999999954 59999999999999999999999
Q ss_pred cCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHH
Q 006559 478 DIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQ 548 (640)
Q Consensus 478 DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~ 548 (640)
|||+++..... ..++..|+|||++ ....++.++|||||||++|||+| |+.||.........+ +
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~ 278 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESI-------FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-K 278 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-H
T ss_pred ccccccccccccceeecCCCCCCccccCHHHh-------ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-H
Confidence 99999865321 2235679999964 34457789999999999999999 999997543222111 1
Q ss_pred HhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 549 MMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 549 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
....... ...+.. ....+.+++..||+.||++|||+.++++.|+++..+
T Consensus 279 ~~~~~~~--------~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 LVKDGYQ--------MAQPAF---APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHTCC--------CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCC--------CCCCCC---CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1110000 000111 123467788889999999999999999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=326.68 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=194.2
Q ss_pred hhccccccCcceEEEEEeC------CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD------GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+.. .+..||||.+.... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEE
Confidence 3578999999999999864 36789999997653 23457889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC-----CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 408 YLPHGSLHSLLHGSRG-----PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
|+++|+|.+++..... ....++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccc
Confidence 9999999999874320 1112568999999999999999999954 5999999999999999999999999998
Q ss_pred cccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcc
Q 006559 483 QLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 483 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 553 (640)
+..... ..++..|+|||++ ....++.++|||||||++|||+| |+.||..... ....+.....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~ 256 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRFVMEG 256 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHHHHHHTT
T ss_pred cccccccccccccCCCCCCCccChhhh-------ccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HHHHHHHHcC
Confidence 765321 2336789999964 34557789999999999999999 8999875322 1112211111
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
... . ... .....+.+++.+||+.||++|||+.++++.|+++...
T Consensus 257 ~~~----~----~~~---~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 257 GLL----D----KPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp CCC----C----CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CcC----C----CCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 100 0 011 1223466778889999999999999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=333.03 Aligned_cols=186 Identities=26% Similarity=0.452 Sum_probs=150.5
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccC-CCcccceeEEEEcCC--eEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKD--ELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.++.++. ||||+++++++...+ ..|+|||||
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 56899999999999985 56889999998643 23345678899999997 999999999997544 799999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
+ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 8 6999998753 478899999999999999999954 599999999999999999999999999976421
Q ss_pred -------------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 488 -------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 488 -------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
...+|..|+|||++.+ ...++.++|||||||++|||++|+.||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG------STKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2356889999997632 245778999999999999999999999754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=325.39 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=193.4
Q ss_pred hhccccccCcceEEEEEe------CCCcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCC-eEEEE
Q 006559 337 SAELLGKGCVGATYKVVL------DGGDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKD-ELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~------~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lV 405 (640)
..+.||+|+||.||+|+. .+++.||||.++... ..+.+.+|++++.++ +||||+++++++...+ ..++|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 357899999999999984 345789999997653 235678899999999 7899999999998754 59999
Q ss_pred EeccCCCCHHHhhccCCCCC-----------CCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCe
Q 006559 406 YDYLPHGSLHSLLHGSRGPG-----------RMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNA 474 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 474 (640)
|||+++|+|.+++....... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~ 187 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVV 187 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCE
Confidence 99999999999998654210 12388999999999999999999954 59999999999999999999
Q ss_pred EEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHH
Q 006559 475 CISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVK 545 (640)
Q Consensus 475 kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~ 545 (640)
||+|||+++..... ..++..|+|||++ ....++.++|||||||++|||+| |+.||.........
T Consensus 188 kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 188 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred EECCCccccccccCccceeccCCCcceeecCchhh-------ccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 99999999865321 2346689999965 34567789999999999999999 99999754322211
Q ss_pred HHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 546 WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 546 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.......... ..... ...++.+++..||+.||++|||+.++++.|+++...
T Consensus 261 -~~~~~~~~~~--------~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 261 -CRRLKEGTRM--------RAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp -HHHHHHTCCC--------CCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHhccCccC--------CCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111111000 00111 123467788889999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.23 Aligned_cols=233 Identities=19% Similarity=0.264 Sum_probs=177.9
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHHHH-HhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWLRV-IGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..++||+|+||.||+|+.. ++..||||+++... ..+.+..|..+ ++.++||||+++++++...+..|+||||+
T Consensus 42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 3578999999999999975 57889999997652 12334455554 57789999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC---
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--- 486 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~--- 486 (640)
++|+|.+++.... .+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 122 NGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999997543 478889999999999999999954 59999999999999999999999999997632
Q ss_pred ---CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 487 ---TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 487 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
....+|..|+|||++. ...++.++|||||||++|||++|+.||..... .+..+..... .
T Consensus 194 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~---------~ 255 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLH-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILNK---------P 255 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HHHHHHHHHS---------C
T ss_pred CccccccCCccccCHHHhC-------CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhc---------c
Confidence 2345789999999753 34577899999999999999999999975432 1111111111 1
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIV 598 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v 598 (640)
......... .+.+++..||+.||++||++.+.
T Consensus 256 ~~~~~~~~~---~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 256 LQLKPNITN---SARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp CCCCSSSCH---HHHHHHHHHTCSSGGGSTTTTTT
T ss_pred cCCCCCCCH---HHHHHHHHHcccCHHhCCCCCCC
Confidence 111112222 45667778999999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.89 Aligned_cols=201 Identities=23% Similarity=0.401 Sum_probs=154.7
Q ss_pred ChHHHHHHhhccccccCcceEEEEEeC---CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEc--CCeEE
Q 006559 329 NVGDLLKSSAELLGKGCVGATYKVVLD---GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELF 403 (640)
Q Consensus 329 ~~~~~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~ 403 (640)
.+++.+.-..++||+|+||.||+|+.. ++..||||++........+.+|++++++++|||||++++++.. ....|
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 344444334568999999999999965 4778999999877666778899999999999999999999954 67899
Q ss_pred EEEeccCCCCHHHhhccCC----CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE----CCCCCeE
Q 006559 404 LVYDYLPHGSLHSLLHGSR----GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV----DQLGNAC 475 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl----~~~~~~k 475 (640)
+||||++ |+|.+++.... ......+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999997 58887775221 11122488999999999999999999954 59999999999999 7789999
Q ss_pred EccCCcccccCC---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 476 ISDIGVHQLFHT---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 476 l~DfGl~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
|+|||+++.... ...+|..|+|||++.+ ...++.++|||||||++|||+||+.||...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTT------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcC------CCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999987542 2345889999997632 234778999999999999999999999743
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=314.49 Aligned_cols=248 Identities=19% Similarity=0.299 Sum_probs=194.9
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc--------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK--------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+.. +++.||||.++... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence 3568999999999999975 68899999986541 25678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC----CeEEccCCccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG----NACISDIGVHQ 483 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGl~~ 483 (640)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++
T Consensus 89 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 89 LVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred ecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999997543 58999999999999999999995 4599999999999999877 89999999998
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
.... ...++..|+|||++ ....++.++||||||+++|||+||+.||...... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~--- 228 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTNISAVNY--- 228 (283)
T ss_dssp ECC--------CCCGGGCCHHHH-------TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTCC---
T ss_pred eccCCCcccccCCCcCccCccee-------cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHHhHhccc---
Confidence 7543 23468889999965 3345778999999999999999999999754321 11111111000
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhccC
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRTKG 609 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~~~ 609 (640)
..+.. ........+.+++.+||+.||++||++.++++ .+++++...
T Consensus 229 ~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 229 DFDEE-----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp CCCHH-----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred CCcch-----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 00100 01112235677888999999999999999986 677776553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=340.73 Aligned_cols=180 Identities=22% Similarity=0.345 Sum_probs=143.5
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC-----CeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK-----DELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~ 406 (640)
..++||+|+||+||+|+.. +++.||||++... ...+.+.+|++++++++|||||++++++... ...|+||
T Consensus 57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence 3578999999999999854 6889999998653 2345678899999999999999999999543 5799999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+. |+|.+++.... .+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~~-~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 137 EIAD-SDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eccc-cchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9985 79999987543 589999999999999999999954 59999999999999999999999999998753
Q ss_pred C---------------------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh
Q 006559 487 T---------------------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531 (640)
Q Consensus 487 ~---------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t 531 (640)
. ...+|..|+|||++. ....++.++|||||||++|||+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL------LQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHT------TCCCCCTHHHHHHHHHHHHHHHT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhh------CCCCCCcHhHHHHHHHHHHHHHH
Confidence 1 224588899999742 33457889999999999999999
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.48 Aligned_cols=238 Identities=18% Similarity=0.246 Sum_probs=187.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|... ++..||+|++.... ..+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 567999999999999864 58899999987542 2355778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC---eEEccCCcccccCCC-
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN---ACISDIGVHQLFHTP- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl~~~~~~~- 488 (640)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 91 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 91 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9998887543 588999999999999999999954 5999999999999986655 999999998766432
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
..++..|+|||++ ....++.++|||||||++|||++|+.||...... ........... ....+
T Consensus 163 ~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~--~~~~~-- 229 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVL-------KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAY--DYPSP-- 229 (284)
T ss_dssp BCCCSCSCGGGCCHHHH-------TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCC--CCCTT--
T ss_pred cccCCCCCcCCcCchhh-------cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhccc--cCCch--
Confidence 3568899999975 3345678999999999999999999999754322 11111111100 00000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++..||+.||++|||+.|+++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 ----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00112234667788899999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=320.04 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=186.6
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+||+|+||.||+|+. .++..||||.+... ...+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999995 56788999998765 33567889999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCcccccCC------C
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~~~~~------~ 488 (640)
+++..... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.... .
T Consensus 108 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 182 (295)
T 2clq_A 108 ALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182 (295)
T ss_dssp HHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred HHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence 99976532 2356788899999999999999995 45999999999999987 89999999999876542 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||++... ...++.++|||||||++|||+||+.||...........+..... ..+. .+.
T Consensus 183 ~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~~~--~~~ 249 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKG-----PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK------VHPE--IPE 249 (295)
T ss_dssp CCCCGGGCCHHHHHHG-----GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC------CCCC--CCT
T ss_pred cCCCccccChhhhcCC-----CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc------cccc--ccc
Confidence 3467899999975321 12367899999999999999999999964322111111110000 0001 111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ..++.+++.+||+.||++||++.++++
T Consensus 250 ~~---~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 SM---SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TS---CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cC---CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 234667788899999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.03 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=192.8
Q ss_pred hhccccccCcceEEEEEe-----CCCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCC--eEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL-----DGGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD--ELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lV~E 407 (640)
..+.||+|+||.||++++ .+++.||||++.... ..+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 357899999999999984 357889999997653 3457889999999999999999999987654 7899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999998653 258899999999999999999995 4599999999999999999999999999987643
Q ss_pred C---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccc--
Q 006559 488 P---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA-- 556 (640)
Q Consensus 488 ~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 556 (640)
. ...+..|+|||++. ...++.++|||||||++|||+||+.|+.... ..+.+........
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~tg~~~~~~~~---~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLT-------ESKFSVASDVWSFGVVLYELFTYIEKSKSPP---AEFMRMIGNDKQGQM 267 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHH-------HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH---HHHHHHHCTTCCTHH
T ss_pred cccccccccCCCCceeEECchhhc-------CCCCCchhhHHHHHHHHHHHHhcCCCCCCCH---HHHHHhhccccchhh
Confidence 2 22355799999653 3456789999999999999999999875321 1111111111000
Q ss_pred -----ccccch--hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 557 -----WEVFDF--ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 557 -----~~~~d~--~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.+.+.. ...... ....++.+++..||+.||++|||+.++++.|++++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPD---GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCT---TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000000 000111 2234577788899999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=326.53 Aligned_cols=257 Identities=17% Similarity=0.317 Sum_probs=187.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccch---HHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKK---REVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. +++.||||++...... ..+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 467999999999999965 6889999998754221 234568999999999999999999999999999999997 59
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 86 LKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 999887643 2588999999999999999999954 599999999999999999999999999876542
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHH-HHhhcc-ccccc-ccchh
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWV-QMMGQD-ESAWE-VFDFE 563 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~-~~~~~~-~~~~~-~~d~~ 563 (640)
...+|..|+|||++.+ ...++.++|||||||++|||+||+.||...... ....+ +..... ...+. .....
T Consensus 159 ~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----CGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cccCcccccChhhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2345889999997532 245678999999999999999999999754322 11111 111111 00010 00000
Q ss_pred ---------hccC---hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhcc
Q 006559 564 ---------LIMD---KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRTK 608 (640)
Q Consensus 564 ---------~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~~ 608 (640)
.... ........++.+++.+||+.||++|||+.|+++ .+.++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 0000 000111235677888999999999999999976 55555443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.19 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=193.9
Q ss_pred hhccccccCcceEEEEEeC-CCcE--EEEEEeccc---cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDV--VVVKRIRER---KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~--vavK~l~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|+.. ++.. ||||.++.. ...+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (327)
T 1fvr_A 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 108 (327)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence 3578999999999999864 4554 489988753 2345688899999999 8999999999999999999999999
Q ss_pred CCCCHHHhhccCCC-----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEcc
Q 006559 410 PHGSLHSLLHGSRG-----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISD 478 (640)
Q Consensus 410 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 478 (640)
++|+|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~D 185 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD 185 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECC
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEcc
Confidence 99999999976430 112358999999999999999999995 4599999999999999999999999
Q ss_pred CCcccccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhc
Q 006559 479 IGVHQLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQ 552 (640)
Q Consensus 479 fGl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 552 (640)
||+++.... ....+..|+|||++ ....++.++|||||||++|||+| |+.||..... .........
T Consensus 186 fg~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~~~ 256 (327)
T 1fvr_A 186 FGLSRGQEVYVKKTMGRLPVRWMAIESL-------NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQ 256 (327)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHH-------HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHGGG
T ss_pred cCcCccccccccccCCCCCccccChhhh-------ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--HHHHHHhhc
Confidence 999875431 22346789999965 33456789999999999999998 9999975432 222222211
Q ss_pred ccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 553 DESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 553 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
... ...... ...++.+++.+||+.||++|||+.++++.|+++..+..
T Consensus 257 ~~~--------~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 257 GYR--------LEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TCC--------CCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCC--------CCCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 100 001111 12346678888999999999999999999999876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=325.31 Aligned_cols=240 Identities=18% Similarity=0.282 Sum_probs=186.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +++.||||++... .....+.+|+.++.+++ ||||+++++++...+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 378999999999999965 5889999998754 23567888999999885 69999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCCC
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHTP 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~~ 488 (640)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 114 ~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 114 GEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999986542 22589999999999999999999954 5999999999999997 789999999999876432
Q ss_pred -----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 489 -----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 489 -----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
..++..|+|||++ ....++.++|||||||++|||+||+.||........ ........ .+..
T Consensus 188 ~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~-----~~~~ 253 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEIL-------NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--YLNISQVN-----VDYS 253 (327)
T ss_dssp ------CCCGGGCCHHHH-------TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHTC-----CCCC
T ss_pred cccccccCCcCccCCeee-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHHHhcc-----cccC
Confidence 3568899999965 344677899999999999999999999975432211 11111100 0000
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. .........+.+++..||+.||++|||+.++++
T Consensus 254 ~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 254 E---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp T---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 001112234667788899999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.85 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=191.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+.. ++..||+|.+... ...+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 467999999999999965 6889999998754 234567889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----CCc
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----TPF 489 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----~~~ 489 (640)
|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++... ...
T Consensus 118 L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 190 (360)
T 3eqc_A 118 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190 (360)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCC
Confidence 999997643 488999999999999999999952 259999999999999999999999999986542 334
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccc---------------
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE--------------- 554 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~--------------- 554 (640)
.++..|+|||++ ....++.++|||||||++|||+||+.||..................
T Consensus 191 ~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 191 VGTRSYMSPERL-------QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp CCCCTTCCHHHH-------TTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred CCCCCeECHHHH-------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 568899999975 3345778999999999999999999999754432222111000000
Q ss_pred ------------ccccccchhhc---cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 555 ------------SAWEVFDFELI---MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 555 ------------~~~~~~d~~~~---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
...+..+.... ..........++.+++..||+.||++|||+.|+++ .+++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 00000000000 00000011235778888999999999999999975 444443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.06 Aligned_cols=250 Identities=18% Similarity=0.223 Sum_probs=192.8
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCC-cccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHS-NIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..++||+|+||.||+|+. .+++.||||++.......++..|+++++.++|+ +|..+..++...+..++||||+ +++|
T Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL 89 (483)
T 3sv0_A 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (483)
T ss_dssp CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence 356899999999999995 568899999987765666688899999999885 5555666667788999999999 9999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE---CCCCCeEEccCCcccccCC----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV---DQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGl~~~~~~---- 487 (640)
.+++..... .+++..++.|+.||+.||+|||+. +||||||||+|||+ +.++.+||+|||+++.+..
T Consensus 90 ~~ll~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 90 EDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp HHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 999975432 589999999999999999999954 59999999999999 6889999999999986542
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAW 557 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~ 557 (640)
...+|..|+|||++ ....++.++|||||||++|||++|+.||...... ............ ..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~-------~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~ 234 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTH-------LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-VA 234 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-HH
T ss_pred cccccccccccCCCccccCHHHh-------cCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-cc
Confidence 23468899999965 3445778999999999999999999999753221 111111111100 00
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
... .........++.+++..||+.+|++||++.+|+++|+++...
T Consensus 235 ~~~------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 235 TSI------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp SCH------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccH------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 000 000012234677888889999999999999999999998543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.54 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=183.5
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-------chHHHHHHHHHHhcc---CCCcccceeEEEEcCC-----e
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-------KKREVDEWLRVIGGL---RHSNIVSIRAYCNGKD-----E 401 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~-----~ 401 (640)
.+.||+|+||+||+|+. .+++.||||++.... ....+.+|+++++++ +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 56799999999999995 568899999986431 134566677666655 5999999999998654 5
Q ss_pred EEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCc
Q 006559 402 LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV 481 (640)
Q Consensus 402 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 481 (640)
.++||||+. |+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred EEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 899999997 699999986542 2489999999999999999999954 499999999999999999999999999
Q ss_pred ccccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hH-HHHHHhhccc
Q 006559 482 HQLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IV-KWVQMMGQDE 554 (640)
Q Consensus 482 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~-~~~~~~~~~~ 554 (640)
++.... ...+|..|+|||++ ....++.++|||||||++|||+||+.||...... .. ...+......
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVL-------LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHH-------HTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccCCCcccCCccccccccCchHH-------cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 986543 23458899999975 3345778999999999999999999999754322 11 1111111110
Q ss_pred -cccc----ccchhh----ccC--hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 555 -SAWE----VFDFEL----IMD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 555 -~~~~----~~d~~~----~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+. ..+... ... ....+....+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 000000 000 000112245677888899999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.02 Aligned_cols=251 Identities=18% Similarity=0.281 Sum_probs=179.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccC-CCcccceeEEEE--------cCCeEEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLR-HSNIVSIRAYCN--------GKDELFL 404 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~-H~niv~l~~~~~--------~~~~~~l 404 (640)
..++||+|+||.||+|+. .+++.||||++... ...+.+.+|+.++.++. ||||+++++++. .....++
T Consensus 32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence 467899999999999996 46889999988654 33456788999999996 999999999994 3446899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
||||+. |+|.+++..... ..++++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 112 v~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 112 LTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred EEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 999996 799998864221 125899999999999999999999532 3399999999999999999999999999987
Q ss_pred cCC------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 006559 485 FHT------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKW 546 (640)
Q Consensus 485 ~~~------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~ 546 (640)
... ...++..|+|||++.. .....++.++|||||||++|||+||+.||...... ..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~ 261 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL----YSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--RI 261 (337)
T ss_dssp CSSCC-------------------------------C----CTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhc----cccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--Hh
Confidence 543 1235778999997521 13456788999999999999999999999743211 11
Q ss_pred HHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCCC
Q 006559 547 VQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611 (640)
Q Consensus 547 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 611 (640)
...... ..... .....+.+++..||+.||++||++.|+++.|+++......
T Consensus 262 ~~~~~~-------~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 262 VNGKYS-------IPPHD-------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ----CC-------CCTTC-------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred hcCccc-------CCccc-------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 100000 00000 0112356678889999999999999999999999866444
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=325.46 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=186.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 568999999999999965 48899999986542 2345678999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 110 ILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp HHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred hHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence 9998876443 488999999999999999999954 599999999999999999999999999976532
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-H-HHHHHhhcc-----------
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-V-KWVQMMGQD----------- 553 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-~-~~~~~~~~~----------- 553 (640)
...++..|+|||++.. ...++.++|||||||++|||+||+.||....... . .........
T Consensus 182 ~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVG------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --CCCCCTTCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred CCCcCCccccCcccccC------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 2356888999997532 2356789999999999999999999997543211 1 111111100
Q ss_pred cccccccchhhccC----hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 554 ESAWEVFDFELIMD----KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 554 ~~~~~~~d~~~~~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........+..... .........+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000000 001122346778888999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=330.18 Aligned_cols=239 Identities=20% Similarity=0.274 Sum_probs=185.9
Q ss_pred hhccccccCcceEEEEEe----CCCcEEEEEEeccc------cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEE
Q 006559 337 SAELLGKGCVGATYKVVL----DGGDVVVVKRIRER------KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~----~~~~~vavK~l~~~------~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV 405 (640)
..+.||+|+||.||+++. .+++.||||+++.. ...+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 137 (355)
T 1vzo_A 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 137 (355)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEE
Confidence 357899999999999997 46889999998753 2234566788889988 699999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 406 YDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 138 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999997543 588999999999999999999954 5999999999999999999999999998765
Q ss_pred CC-------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhccccc
Q 006559 486 HT-------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDESA 556 (640)
Q Consensus 486 ~~-------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~ 556 (640)
.. ...+|..|+|||++.+. ...++.++|||||||++|||+||+.||..... ....+.+......
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-- 282 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGG-----DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-- 282 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTC-----C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--
T ss_pred ccCCCCcccCcccCcCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--
Confidence 32 23568899999976321 23467899999999999999999999974321 2222222211110
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
...+... ...+.+++.+||+.||++|| ++.|+++
T Consensus 283 -------~~~~~~~---~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 283 -------PPYPQEM---SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp -------CCCCTTS---CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCCccc---CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 0011111 23456778889999999999 8888765
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.60 Aligned_cols=244 Identities=17% Similarity=0.273 Sum_probs=189.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----------chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEE
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----------KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV 405 (640)
.+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|+.+++++ +||||+++++++......++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 368999999999999975 68999999986542 134567889999998 799999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 406 YDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 179 ~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp ECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999997542 588999999999999999999954 5999999999999999999999999998765
Q ss_pred CC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 486 HT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 486 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
.. ...+|..|+|||++.+.... ....++.++|||||||++|||+||+.||...... ...+....... ...
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~--~~~ 325 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDE-THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRMIMEGQY--QFS 325 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCT-TSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCC--CCC
T ss_pred CCCcccccCCCCCCccChhhccccccc-cCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCC--CCC
Confidence 43 23568899999976432111 1235788999999999999999999999753321 11111111100 000
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+ ........+.+++.+||+.||++|||+.++++
T Consensus 326 ~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 326 SP------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Cc------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 01112235677888899999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.33 Aligned_cols=239 Identities=19% Similarity=0.313 Sum_probs=187.1
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|+.. +|..||||.+......+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 112 (314)
T 3com_A 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112 (314)
T ss_dssp EEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred hheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHH
Confidence 3567999999999999975 588999999987766778899999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------Cc
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------PF 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~~ 489 (640)
+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..... ..
T Consensus 113 ~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 185 (314)
T 3com_A 113 DIIRLRN----KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185 (314)
T ss_dssp HHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCC
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCcc
Confidence 9986322 2588999999999999999999954 599999999999999999999999999876543 23
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.++..|+|||++ ....++.++|||||||++|||++|+.||.........+ ....... +.......
T Consensus 186 ~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~------~~~~~~~~ 250 (314)
T 3com_A 186 IGTPFWMAPEVI-------QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--MIPTNPP------PTFRKPEL 250 (314)
T ss_dssp CSCGGGCCHHHH-------SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSCC------CCCSSGGG
T ss_pred CCCCCccChhhc-------CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhcCCC------cccCCccc
Confidence 457889999975 33457789999999999999999999997533211111 1111100 00000111
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
....+.+++..||+.||++|||+.++++
T Consensus 251 ---~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 251 ---WSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1234667888899999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.88 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=191.1
Q ss_pred hhccccccCcceEEEEEe------CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL------DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~------~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+. .++..||||.+... .....+.+|+.++++++||||+++++++...+..|+|||
T Consensus 34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence 357899999999999984 34678999999754 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCC--CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcc
Q 006559 408 YLPHGSLHSLLHGSRGP--GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVH 482 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~ 482 (640)
|+++|+|.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. +..+||+|||++
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccc
Confidence 99999999999865321 123588999999999999999999954 5999999999999994 456999999998
Q ss_pred cccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcc
Q 006559 483 QLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 483 ~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 553 (640)
+.... ...++..|+|||++ ....++.++|||||||++|||+| |+.||...... .........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~ 261 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAF-------MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSG 261 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTT
T ss_pred cccccccccccCCCcCCCcceeCHhHh-------cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHhcC
Confidence 75421 12346789999965 33457789999999999999999 99999754321 112111111
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
... + .... ....+.+++..||+.||++||++.++++.|+.+...
T Consensus 262 ~~~----~----~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 GRM----D----PPKN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCC----C----CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC----C----CCCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 100 0 0111 123466788889999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=334.33 Aligned_cols=244 Identities=19% Similarity=0.284 Sum_probs=180.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 406 (640)
.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+++++.++|||||++++++... ...|+||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 56899999999999985 45888999999754 2345677899999999999999999999654 4689999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
|||++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 147 E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 147 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp ECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred eCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 99986 46666643 378899999999999999999954 59999999999999999999999999998764
Q ss_pred C-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHH---HHhhccc-ccc
Q 006559 487 T-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWV---QMMGQDE-SAW 557 (640)
Q Consensus 487 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~---~~~~~~~-~~~ 557 (640)
. ...+|..|+|||++. ...++.++||||+||++|||++|+.||.+... ...+. +..+... ..+
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp -CCCC----CCCTTCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred CCcccCCCcccccccCHHHHc-------CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence 3 345688999999753 34577899999999999999999999975432 11111 1111100 000
Q ss_pred c-----------------------ccchh-hccC-hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 E-----------------------VFDFE-LIMD-KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~-----------------------~~d~~-~~~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. .+... .... ........++.+++.+||..||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000 0000 111122456788899999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=325.27 Aligned_cols=249 Identities=19% Similarity=0.296 Sum_probs=181.9
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|+||.||+|+. .+++.||||+++.... .+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 116 (329)
T 3gbz_A 38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE- 116 (329)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-
Confidence 357899999999999985 4688999999975422 3456789999999999999999999999999999999998
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE-----CCCCCeEEccCCcccccC
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV-----DQLGNACISDIGVHQLFH 486 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl-----~~~~~~kl~DfGl~~~~~ 486 (640)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 117 ~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 117 NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 59999997653 488999999999999999999954 59999999999999 455569999999997654
Q ss_pred C------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch--HHHHHHhhccc-ccc
Q 006559 487 T------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI--VKWVQMMGQDE-SAW 557 (640)
Q Consensus 487 ~------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~-~~~ 557 (640)
. ...+|..|+|||++.. ...++.++|||||||++|||++|+.||....... ....+...... ..+
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLG------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp -----------CCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred CcccccCCCcCCccccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 2 2345889999997532 2346789999999999999999999997543211 11111111110 000
Q ss_pred cccc----h--hh--ccChHHHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVFD----F--EL--IMDKEMEE-----EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~d----~--~~--~~~~~~~~-----~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... . .. ........ ...++.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 0 00 00000000 1245678888999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=319.81 Aligned_cols=240 Identities=23% Similarity=0.358 Sum_probs=190.2
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEc----------------C
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNG----------------K 399 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----------------~ 399 (640)
..+.||+|+||.||+|+.. +++.||+|.+.... ..+.+|++++++++||||+++++++.. .
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT 92 (284)
T ss_dssp EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence 3578999999999999975 78999999987543 356788999999999999999998854 3
Q ss_pred CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccC
Q 006559 400 DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDI 479 (640)
Q Consensus 400 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 479 (640)
...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 93 KCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp EEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred ceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcc
Confidence 45899999999999999997542 12588999999999999999999954 5999999999999999999999999
Q ss_pred CcccccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccc
Q 006559 480 GVHQLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE 554 (640)
Q Consensus 480 Gl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 554 (640)
|+++.... ...++..|+|||++ ....++.++|||||||++|||+||..|+... ..+.......
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~~~- 234 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQI-------SSQDYGKEVDLYALGLILAELLHVCDTAFET----SKFFTDLRDG- 234 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHH-------HCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----HHHHHHHHTT-
T ss_pred hhheeccccccccccCCcccccChhhh-------ccCCCcchhhhHHHHHHHHHHHhcCCcchhH----HHHHHHhhcc-
Confidence 99877643 23468899999965 3445778999999999999999999887421 1111111110
Q ss_pred ccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 555 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
. .....+ .++.+++..||+.||++||++.|+++.|+.+....
T Consensus 235 ~----------~~~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 235 I----------ISDIFD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp C----------CCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred c----------ccccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 0 001111 23566778899999999999999999999988653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=315.18 Aligned_cols=239 Identities=17% Similarity=0.269 Sum_probs=187.6
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc--chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||.||+++.. +|+.||+|.++... ..+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 3578999999999999964 68899999997652 34568899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE---CCCCCeEEccCCcccccCCC--
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV---DQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGl~~~~~~~-- 488 (640)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 93 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 93 LFDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp HHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 999987543 588999999999999999999954 59999999999999 78899999999998765432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||++ ....++.++|||||||++|||+||+.||...... ............ .... .
T Consensus 165 ~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~---~~~~--~ 230 (304)
T 2jam_A 165 STACGTPGYVAPEVL-------AQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEKIKEGYYE---FESP--F 230 (304)
T ss_dssp HHHHSCCCBCCTTTB-------SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHCCCC---CCTT--T
T ss_pred ccccCCCCccChHHh-------ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCC---CCcc--c
Confidence 2358899999965 3345778999999999999999999999753321 111111111000 0000 0
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. .....+.+++..||+.||++||++.++++
T Consensus 231 ~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WD---DISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TT---TSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cc---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01 12234667888899999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=320.69 Aligned_cols=249 Identities=19% Similarity=0.331 Sum_probs=185.4
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEc--------CCeEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNG--------KDELFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~~~~l 404 (640)
.+.||+|+||.||+|+. .+|+.||||++.... ....+.+|++++++++||||+++++++.. .+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 56899999999999997 568899999986542 24567889999999999999999999976 346899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 102 v~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 9999985 7877776543 2588999999999999999999954 599999999999999999999999999876
Q ss_pred cCC----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHh-hc
Q 006559 485 FHT----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMM-GQ 552 (640)
Q Consensus 485 ~~~----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~-~~ 552 (640)
+.. ...+|..|+|||++.+ ...++.++|||||||++|||+||+.||...... ....+... ..
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ccccccccccccCCcccccCccCchhhcC------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 531 2345888999997532 244678999999999999999999999854322 11111111 11
Q ss_pred c-cccccccch-hh--------ccChHHHHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 553 D-ESAWEVFDF-EL--------IMDKEMEEE------MRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 553 ~-~~~~~~~d~-~~--------~~~~~~~~~------~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ...+...+. .. .......+. ...+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 000100000 00 000001111 234778899999999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=314.95 Aligned_cols=235 Identities=20% Similarity=0.361 Sum_probs=188.7
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||.||+|+. .+++.||||.+... ...+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 56799999999999985 46889999998754 234678899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++... ++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 107 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 107 ALDLLEPG------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp HHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence 99999643 488999999999999999999954 599999999999999999999999999876543
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||...... ........... +. ..
T Consensus 178 ~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~------~~--~~ 240 (303)
T 3a7i_A 178 TFVGTPFWMAPEVI-------KQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNP------PT--LE 240 (303)
T ss_dssp CCCSCGGGCCHHHH-------TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC------CC--CC
T ss_pred ccCCCcCccCHHHH-------hcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCC------CC--Cc
Confidence 23457889999975 3345678999999999999999999999753221 11111111100 00 01
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM 601 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 601 (640)
... ...+.+++..||+.||++|||+.++++.
T Consensus 241 ~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GNY---SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SSC---CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccc---CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111 2346677888999999999999999763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.37 Aligned_cols=245 Identities=16% Similarity=0.261 Sum_probs=186.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccC-CCcccceeEEEEc--CCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLR-HSNIVSIRAYCNG--KDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|+. .+++.||||.++.. ..+.+.+|++++++++ ||||+++++++.. ....++||||++++
T Consensus 40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEEEecccCCeEEEEEEECCCCcEEEEEEeccc-chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 357899999999999985 56889999998743 4567889999999997 9999999999987 56799999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHT---- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~~---- 487 (640)
+|.+++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++....
T Consensus 119 ~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 119 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp CHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred hHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 9999985 367889999999999999999954 599999999999999776 899999999986543
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHH---HHhhccccccccc---
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWV---QMMGQDESAWEVF--- 560 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~--- 560 (640)
...++..|+|||++. ....++.++|||||||++|||+||+.||........... +..... ......
T Consensus 188 ~~~~~~~~y~aPE~~~------~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~ 260 (330)
T 3nsz_A 188 NVRVASRYFKGPELLV------DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE-DLYDYIDKY 260 (330)
T ss_dssp CSCCSCGGGCCHHHHT------TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH-HHHHHHHHT
T ss_pred ccccccccccChhhhc------CCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc-hhhhHHHHh
Confidence 234578899999752 224577899999999999999999999964332221111 111100 000000
Q ss_pred ----chh---------------hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 ----DFE---------------LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 ----d~~---------------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
++. ............++.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000000112345778888999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.76 Aligned_cols=238 Identities=18% Similarity=0.263 Sum_probs=182.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+.||+|+||.||+|+.. +++.||||.+..... ...+|++++.++ +||||+++++++.+.+..|+||||+++|+|.
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~ 104 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL 104 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHH
Confidence 568999999999999965 578899999975522 234567777776 7999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC----CCeEEccCCcccccCC----
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL----GNACISDIGVHQLFHT---- 487 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGl~~~~~~---- 487 (640)
+++.... .+++.....++.|++.||+|||+. +|+||||||+|||+.++ +.+||+|||+++....
T Consensus 105 ~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 176 (342)
T 2qr7_A 105 DKILRQK-----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176 (342)
T ss_dssp HHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred HHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence 9997543 589999999999999999999954 59999999999998533 3599999999986532
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHHHHhhcccccccccchhh
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++. ...++.++|||||||++|||++|+.||..... ...+........... . ...
T Consensus 177 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~--~-~~~- 245 (342)
T 2qr7_A 177 LMTPCYTANFVAPEVLE-------RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS--L-SGG- 245 (342)
T ss_dssp BCCSSCCSSCCCHHHHH-------HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC--C-CST-
T ss_pred eeccCCCccccCHHHhc-------CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc--c-Ccc-
Confidence 234588999999753 33467899999999999999999999975322 222222222211100 0 000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..... ..++.+++..||+.||++||++.++++
T Consensus 246 -~~~~~---s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 246 -YWNSV---SDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -TTTTS---CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -ccccC---CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00112 234566778899999999999999865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=321.36 Aligned_cols=235 Identities=18% Similarity=0.275 Sum_probs=188.1
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+++.. +++.||+|.+... ...+.+.+|+.++++++||||+++++++...+..|+||||++
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 3578999999999999965 4788999998654 234567889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 125 RRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp TCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999987543 588999999999999999999954 599999999999999999999999999976532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||...... .......... .
T Consensus 197 ~~~~~~gt~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~---------~ 258 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVL-------SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKKNE---------Y 258 (335)
T ss_dssp CBCCCCSCCSSCCHHHH-------HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTC---------C
T ss_pred cccccCCCccccCHHHh-------ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHhcCC---------C
Confidence 23457889999975 3345678999999999999999999999754321 1111111110 0
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
....... ..+.+++.+||+.||++||++.|+++
T Consensus 259 ~~~~~~~---~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 SIPKHIN---PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCTTSC---HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111111 24566788899999999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=335.82 Aligned_cols=237 Identities=19% Similarity=0.272 Sum_probs=188.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.++||+|+||+||+|+.. +++.||||++... .....+.+|++++++++||||+++++++......|+||||+++|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 578999999999999965 6889999998643 34567889999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC---CCCCeEEccCCcccccCC--
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD---QLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGl~~~~~~-- 487 (640)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 107 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999887543 588999999999999999999954 599999999999995 456899999999986643
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|+.|+|||++. ..++.++||||+||++|||++|+.||..... ....+......... + .
T Consensus 179 ~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~---~--~ 243 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLR--------GTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAF---D--L 243 (486)
T ss_dssp ---CCTTGGGGCCGGGGG--------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCS---C--S
T ss_pred ccCCCcCCCCCCCHHHhC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCC---C--C
Confidence 245688999999753 2477899999999999999999999975432 11122211111000 0 0
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+.......++.+++..||+.||++|||+.++++
T Consensus 244 ---~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 244 ---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ---GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011112234667788899999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=337.44 Aligned_cols=243 Identities=20% Similarity=0.286 Sum_probs=187.5
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
..+.||+|+||.||+|+.. ++..||||++... .....+.+|+++++.++|||||+++++|......|+||||+++
T Consensus 41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 3578999999999999965 6788999998754 2356788999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCC-
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHT- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~- 487 (640)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 121 g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 121 GELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999887543 588999999999999999999954 5999999999999976 45599999999987643
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...+|..|+|||++. ..++.++||||+||++|||++|+.||...... ...+........ ++.
T Consensus 193 ~~~~~~~gt~~y~aPE~l~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~---~~~- 258 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR--------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGKYT---FDS- 258 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC---CCS-
T ss_pred ccccccCCCcCeeCHHHHc--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC---CCc-
Confidence 235688999999752 35778999999999999999999999754322 222221111100 000
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHh
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDI 605 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i 605 (640)
+........+.+++..||+.||++|||+.++++ .+.+.
T Consensus 259 ----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 259 ----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 011112234667788899999999999999974 35444
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.98 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=174.0
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|+. .+++.||||.+... ...+++.+|++++++++||||+++++++...+..++||||+++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 357899999999999985 46889999998654 23456778899999999999999999999999999999999999
Q ss_pred CHHHhhccC---CCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 413 SLHSLLHGS---RGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 413 sL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
+|.+++... .......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 999998631 111123589999999999999999999954 599999999999999999999999999876532
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccc-
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW- 557 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 557 (640)
...++..|+|||++. ....++.++|||||||++|||+||+.||.....................
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVME------QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp ------------CCCTTCCHHHHH------HHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred CccchhhhcccCCCccccCHHHhc------cccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 234578899999752 1235678999999999999999999999754322111111111100000
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...+.... . ....++.+++.+||+.||++||++.++++
T Consensus 250 ~~~~~~~~--~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 250 GVQDKEML--K---KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -----CCC--C---CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccchhh--h---hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00011110 1 11234667888899999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.34 Aligned_cols=234 Identities=18% Similarity=0.258 Sum_probs=188.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. ++..||||.+... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 568999999999999965 5778999998643 2245688999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (284)
T 2vgo_A 99 GELYKELQKHG-----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170 (284)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccccc
Confidence 99999997543 48899999999999999999994 5699999999999999999999999999876543
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...++..|+|||++. ...++.++||||||+++|||++|+.||...... ...+..... ....+
T Consensus 171 ~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~---------~~~~~ 232 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIE-------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHRRIVNV---------DLKFP 232 (284)
T ss_dssp CCCSCGGGCCHHHHT-------TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTT---------CCCCC
T ss_pred cccCCCCcCCHHHhc-------cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHHHHhcc---------ccCCC
Confidence 235688999999753 345678999999999999999999999754321 111111110 01111
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...+ .++.+++..|++.||++||++.++++
T Consensus 233 ~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFLS---DGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTSC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcCC---HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1122 24567788899999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=318.48 Aligned_cols=251 Identities=18% Similarity=0.255 Sum_probs=179.9
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+. .+++.||||+++.... .+.+.++...++.++||||+++++++...+..++||||++ |
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-E
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-c
Confidence 56899999999999996 5788999999976522 2234445556888999999999999999999999999997 5
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++..... ....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (290)
T 3fme_A 91 SLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD 167 (290)
T ss_dssp EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred chHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence 88877653211 112589999999999999999999963 25999999999999999999999999998765432
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..++..|+|||++... .....++.++|||||||++|||+||+.||...........+....... .. ..
T Consensus 168 ~~~~t~~y~aPE~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~-~~ 236 (290)
T 3fme_A 168 IDAGCKPYMAPERINPE---LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-------QL-PA 236 (290)
T ss_dssp --CCCCCCSCHHHHSCC---TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC-------CC-CT
T ss_pred ccCCCccccChhhcChh---hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC-------Cc-cc
Confidence 3468899999975211 234557789999999999999999999997543333222222221110 00 00
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
. ....++.+++.+||+.||++|||+.|+++ .+....
T Consensus 237 ~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 237 D---KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred c---cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 1 11234677888899999999999999976 554443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=310.20 Aligned_cols=235 Identities=19% Similarity=0.294 Sum_probs=182.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +++.||||.+... ...+.+.+|++.++.++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 567999999999999975 6889999998654 2245678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 96 GELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred CcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 99999997543 478999999999999999999954 5999999999999999999999999998876432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..++..|+|||++... ...+.++||||||+++|||++|+.||..... ....+...... ...
T Consensus 168 ~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~---------~~~ 230 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGR------LYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRGGV---------FYI 230 (276)
T ss_dssp ---------CCTGGGTTS------CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC---------CCC
T ss_pred ecccCCccccCHHHHcCC------CCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcCc---------ccC
Confidence 3457889999975322 1235789999999999999999999975432 11111111110 001
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+... ...+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~---~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 231 PEYL---NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhc---CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1111 234667788899999999999999976
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.68 Aligned_cols=240 Identities=20% Similarity=0.281 Sum_probs=184.3
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc----------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEE
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV 405 (640)
..+.||+|+||.||+|+.. +++.||||.+.... ....+.+|++++++++||||+++++++...+ .|+|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEE
Confidence 3578999999999999964 57889999986431 1234778999999999999999999997655 8999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC---eEEccCCcc
Q 006559 406 YDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN---ACISDIGVH 482 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl~ 482 (640)
|||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 93 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 93 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 99999999999987543 588999999999999999999954 5999999999999987654 999999999
Q ss_pred cccCCC-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhcccc
Q 006559 483 QLFHTP-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDES 555 (640)
Q Consensus 483 ~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~ 555 (640)
+..... ..++..|+|||++.. .....++.++|||||||++|||+||+.||..... .....+.....
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 237 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVS----VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY--- 237 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHH----TTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC---
T ss_pred eecccccccccccCCcCccCchhhcc----CCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc---
Confidence 876543 245889999997521 1234577899999999999999999999975322 22221111000
Q ss_pred cccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 556 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ..+. .......++.+++.+||+.||++||++.++++
T Consensus 238 --~-~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 --N-FIPE-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --C-CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --c-cCch-----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 0000 01122345777888999999999999999873
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.06 Aligned_cols=235 Identities=18% Similarity=0.275 Sum_probs=188.0
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+++.. +++.||+|.+... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 3578999999999999975 5788999998654 224567789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 ~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 99 RRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp TCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999987543 588999999999999999999954 599999999999999999999999999876532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...++..|+|||++ ....++.++||||||+++|||+||+.||...... .......... .
T Consensus 171 ~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~---------~ 232 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVL-------SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKKNE---------Y 232 (294)
T ss_dssp CBCCCCSCCSSCCHHHH-------TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTC---------C
T ss_pred ccccccCCCCcCCcchh-------ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhhcc---------C
Confidence 23457889999975 3345678999999999999999999999754321 1111111110 0
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+.... ..+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SIPKHIN---PVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCTTSC---HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCccccC---HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0111112 24566788899999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=339.82 Aligned_cols=238 Identities=18% Similarity=0.220 Sum_probs=188.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||.||+|+.. +|+.||||++... .....+.+|++++++++|||||++++++.+.+..|+||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 467999999999999974 6899999999653 2345577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... ...+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence 99999997543 22489999999999999999999954 599999999999999999999999999987643
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhcccccccccchhh
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++. ...++.++|||||||++|||+||+.||...... .....+..... ..
T Consensus 343 ~~~~GT~~Y~APEvl~-------~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---------~~ 406 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVK-------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------PE 406 (576)
T ss_dssp ECCCSCGGGCCHHHHT-------TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---------CC
T ss_pred cccCCCccccCHHHHc-------CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---------cc
Confidence 245689999999753 345678999999999999999999999753221 11111111111 00
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
......+ .++.+++..||+.||++|| ++.||.+
T Consensus 407 ~~p~~~s---~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EYSERFS---PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCTTSC---HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCccCC---HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0111122 3466677889999999999 6677753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.24 Aligned_cols=189 Identities=23% Similarity=0.338 Sum_probs=159.7
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc-chHHHHHHHHHHhcc------CCCcccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-KKREVDEWLRVIGGL------RHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
..++||+|+||.||+|+.. +++.||||+++... ..+++.+|+++++.+ +|+||+++++++...+..++||||
T Consensus 101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 3578999999999999864 57899999997653 345666777777665 677999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC--eEEccCCcccccC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN--ACISDIGVHQLFH 486 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGl~~~~~ 486 (640)
+. |+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 181 ~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 181 LS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp CC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred cC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 96 699999876532 2489999999999999999999954 5999999999999999887 9999999997654
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
. ...+|..|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 254 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 254 QRVYTYIQSRFYRAPEVIL-------GARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCCCSSCSCGGGCCHHHHH-------TBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcccccCCCCCccChHHHh-------CCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 3 345688999999753 345788999999999999999999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=337.07 Aligned_cols=244 Identities=20% Similarity=0.309 Sum_probs=192.6
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..++||+|+||.||+|+.. +++.||||++... ...+.+.+|++++++++||||+++++++...+..|+||||++
T Consensus 30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 3578999999999999965 6889999998643 335678899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE---CCCCCeEEccCCcccccCC
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV---DQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGl~~~~~~ 487 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 110 ~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 110 GGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp SCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999987543 589999999999999999999954 59999999999999 4678999999999987654
Q ss_pred C-----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 P-----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 ~-----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
. ..+|..|+|||++. ..++.++||||+||++|||++|+.||...... ...+.........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~----- 246 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLH--------GTYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKGKYTF----- 246 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHH--------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCC-----
T ss_pred ccccccCCCCccccCceeec--------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCCCC-----
Confidence 2 34688999999752 24778999999999999999999999754321 1122211111000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
.. +........+.+++.+||+.||++|||+.++++ .++...
T Consensus 247 ~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 247 EL---PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CS---GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CC---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 00 011112234667788899999999999999975 555443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.43 Aligned_cols=185 Identities=19% Similarity=0.324 Sum_probs=156.2
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC-----CeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK-----DELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~ 406 (640)
..+.||+|+||.||+|+.. +++.||||++... ...+.+.+|++++++++||||+++++++... ...|+||
T Consensus 30 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 3578999999999999964 5788999999754 2345678899999999999999999999765 5799999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||++ |+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 110 e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 110 EIAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp ECCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred ecCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 9987 69999997543 589999999999999999999954 59999999999999999999999999998653
Q ss_pred ----------------------------CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 487 ----------------------------TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 487 ----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
....+|..|+|||++. ....++.++||||+||++|||+||..||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL------LQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHT------TCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHh------cCCCCCcccccchHHHHHHHHHhccccc
Confidence 2345688999999742 3345788999999999999999865544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.85 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=182.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCC------eEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD------ELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lV~ 406 (640)
.+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+++++.++||||+++++++.... ..|+||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 56799999999999996 56899999998643 22356778999999999999999999997653 469999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 110 e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 110 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 999 78999999753 478999999999999999999954 59999999999999999999999999998764
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH-HHHHhhcccc-cc-cc
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK-WVQMMGQDES-AW-EV 559 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~-~~~~~~~~~~-~~-~~ 559 (640)
. ...+|..|+|||++.+ ...++.++||||+||++|||++|+.||.+.... ... ..+..+.... .. .+
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccCcCcCCCCcCCHHHHhC------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 3 3456889999997532 245788999999999999999999999754321 111 1111111100 00 00
Q ss_pred cch-------hh------ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHh
Q 006559 560 FDF-------EL------IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDI 605 (640)
Q Consensus 560 ~d~-------~~------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i 605 (640)
... .+ ............+.+++.+||+.||++|||+.|+++ .++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000 00 000000112345677888899999999999999876 34443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=331.87 Aligned_cols=249 Identities=21% Similarity=0.237 Sum_probs=182.7
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.++||+|+||+||.+...+|+.||||++.... .+.+.+|++++.++ +|||||++++++...+..|+||||+. |+|.+
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~ 97 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQD 97 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHH
Confidence 46799999999987777789999999986542 34567889988876 89999999999999999999999996 69999
Q ss_pred hhccCCCCCC--CCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-------------CCeEEccCCc
Q 006559 417 LLHGSRGPGR--MPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-------------GNACISDIGV 481 (640)
Q Consensus 417 ~l~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-------------~~~kl~DfGl 481 (640)
++........ ....+..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~ 174 (434)
T 2rio_A 98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174 (434)
T ss_dssp HHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred HHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence 9986542111 0112334578999999999999954 59999999999999654 4899999999
Q ss_pred ccccCC----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHh
Q 006559 482 HQLFHT----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMM 550 (640)
Q Consensus 482 ~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~ 550 (640)
++.... ...+|..|+|||++.+.........++.++|||||||++|||+| |+.||.+.........+..
T Consensus 175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~ 254 (434)
T 2rio_A 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 254 (434)
T ss_dssp CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTC
T ss_pred ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCC
Confidence 987643 12468899999987554333334678899999999999999999 9999975432222222111
Q ss_pred hcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 551 GQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 551 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... ....... .....++.+++.+||+.||++|||+.+|++
T Consensus 255 ~~~~------~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 255 FSLD------EMKCLHD---RSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CCCC------CCTTCCC---HHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcc------ccccccc---ccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1100 0011111 233456778888999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.50 Aligned_cols=246 Identities=17% Similarity=0.175 Sum_probs=180.5
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHH---HHHhccCCCccccee-------EEEEcCC-
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWL---RVIGGLRHSNIVSIR-------AYCNGKD- 400 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~---~~l~~l~H~niv~l~-------~~~~~~~- 400 (640)
.+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+ +.+++++|||||+++ +++...+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 57899999999999995 56899999998643 2346678888 566677899999998 6666553
Q ss_pred ----------------eEEEEEeccCCCCHHHhhccCCC--CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCC
Q 006559 401 ----------------ELFLVYDYLPHGSLHSLLHGSRG--PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLS 462 (640)
Q Consensus 401 ----------------~~~lV~Ey~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk 462 (640)
..|+||||+ +|+|.+++..... .....++|..++.++.|++.||+|||+. +|+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 289999999 6899999975321 1112456788999999999999999964 59999999
Q ss_pred CCCeEECCCCCeEEccCCcccccCC---CccccccccCCccccCCCC----ccccCCCCCccchHHHHHHHHHHHhCCCC
Q 006559 463 SSNIVVDQLGNACISDIGVHQLFHT---PFFINDAYNAPELKFNNNN----NYSQRKFWQRCDVYSFGVVLLEILTGKMA 535 (640)
Q Consensus 463 ~~NILl~~~~~~kl~DfGl~~~~~~---~~~~~~~y~aPE~~~~~~~----~~~~~~~~~k~DV~SfGvvl~el~tg~~p 535 (640)
|+|||++.++.+||+|||+++.... ...+ ..|+|||++..... ......++.++|||||||++|||+||+.|
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred HHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999987543 2345 88999997532100 00012578899999999999999999999
Q ss_pred CCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 536 KGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
|....... ....+... .... ..++.+++.+||+.||++||++.++++ .++++.
T Consensus 313 f~~~~~~~-----------~~~~~~~~----~~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 313 ITKDAALG-----------GSEWIFRS----CKNI---PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp C------C-----------CSGGGGSS----CCCC---CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred Cccccccc-----------chhhhhhh----ccCC---CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 96432100 00011110 0111 234667788899999999999999985 555554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=323.76 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=188.1
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||.||+|+..+ .+|+|.++.. ...+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence 35789999999999999764 4899998743 22345678899999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 115 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 115 TLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp EHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 9999997643 2578899999999999999999954 599999999999998 68999999999765421
Q ss_pred ------CccccccccCCccccCCCCc--cccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 488 ------PFFINDAYNAPELKFNNNNN--YSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 488 ------~~~~~~~y~aPE~~~~~~~~--~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
...++..|+|||++...... .....++.++|||||||++|||+||+.||.........+ .......
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~---- 260 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW--QMGTGMK---- 260 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH--HHHTTCC----
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HhccCCC----
Confidence 12357789999986432111 123457889999999999999999999997544322221 1111100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
+... ... ...++.+++..||+.||++|||+.+++++|+++..+.
T Consensus 261 --~~~~-~~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 261 --PNLS-QIG---MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp --CCCC-CSS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred --CCCC-cCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000 001 1123667788899999999999999999999988664
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=313.18 Aligned_cols=244 Identities=18% Similarity=0.240 Sum_probs=185.9
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~ 410 (640)
.+.||+|+||.||+++.. +++.||+|.+... ...+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 567999999999999965 6889999998754 234567889999999999999999998854 568999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--CCCceecCCCCCCeEECCCCCeEEccCCcccccCCC
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN--KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~ 488 (640)
+|+|.+++..... ....+++..+..++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~ 169 (279)
T 2w5a_A 91 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169 (279)
T ss_dssp TEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---
T ss_pred CCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc
Confidence 9999999875321 1224899999999999999999999543 123999999999999999999999999998876432
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
..++..|+|||++. ...++.++|||||||++|||+||+.||...... .......... ..
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~-~~----- 234 (279)
T 2w5a_A 170 TSFAKTFVGTPYYMSPEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGK-FR----- 234 (279)
T ss_dssp CHHHHHHHSCCTTCCHHHHH-------CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTC-CC-----
T ss_pred cccccccCCCccccChHHhc-------cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHHhhcc-cc-----
Confidence 24578899999753 345678999999999999999999999754321 1111111110 00
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 602 (640)
. .+.. ...++.+++.+||+.||++||++.|+++.+
T Consensus 235 ~--~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 R--IPYR---YSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp C--CCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred c--CCcc---cCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 0 0111 123466778889999999999999998755
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=336.59 Aligned_cols=237 Identities=21% Similarity=0.331 Sum_probs=186.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc---------------chHHHHHHHHHHhccCCCcccceeEEEEcCCe
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---------------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDE 401 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 401 (640)
.+.||+|+||+||+|+.. ++..||||.+.... ..+.+.+|++++++++||||+++++++.....
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 578999999999999965 57889999987531 23567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC---CeEEcc
Q 006559 402 LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG---NACISD 478 (640)
Q Consensus 402 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~---~~kl~D 478 (640)
.|+|||||++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999987543 589999999999999999999954 599999999999999776 699999
Q ss_pred CCcccccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcc
Q 006559 479 IGVHQLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 479 fGl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~ 553 (640)
||+++.... ...+|..|+|||++. ..++.++||||+||++|||++|+.||..... ..........
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~ 262 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK--------KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDIIKKVEKG 262 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhc--------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcC
Confidence 999987643 245688999999752 3577899999999999999999999975432 2222222111
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ++. +.......++.+++..||+.||++|||+.|+++
T Consensus 263 ~~~---~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 KYY---FDF-----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCC---CCH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC---CCc-----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 100 000 011112235677788899999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.46 Aligned_cols=235 Identities=18% Similarity=0.261 Sum_probs=186.4
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
++||+|+||.||+|+.. +|+.||||++... ...+.+..|++++++++||||+++++++...+..|+||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 56999999999999975 6899999999754 22356778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+|.+++..... ....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~ 346 (543)
T 3c4z_A 271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346 (543)
T ss_dssp BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCB
T ss_pred CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCccc
Confidence 99999875432 123589999999999999999999954 599999999999999999999999999986542
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhcccccccccchhh
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++. ...++.++|||||||++|||+||+.||..... ......+..... ..
T Consensus 347 ~~~~GT~~Y~APE~l~-------~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---------~~ 410 (543)
T 3c4z_A 347 KGYAGTPGFMAPELLL-------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---------AV 410 (543)
T ss_dssp CCCCSCTTTSCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC---------CC
T ss_pred ccccCCccccChhhhc-------CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc---------cc
Confidence 236789999999753 34677899999999999999999999975321 122222221111 11
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 596 (640)
..+...+ ..+.+++..||+.||++||++.
T Consensus 411 ~~p~~~s---~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 TYPDKFS---PASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp CCCTTSC---HHHHHHHHHHSCSSGGGSCCCB
T ss_pred CCCcccC---HHHHHHHHHhccCCHhHCCCCc
Confidence 1111222 3456677789999999999763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=315.24 Aligned_cols=243 Identities=16% Similarity=0.296 Sum_probs=185.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||.||+|+.. ++..||+|.+... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 567999999999999975 5889999998754 3456788899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC------CC
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------TP 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------~~ 488 (640)
.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.... ..
T Consensus 104 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 104 DAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 99987532 2488999999999999999999954 59999999999999999999999999875421 23
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..++..|+|||++... ......++.++|||||||++|||+||+.||..... ............. ......
T Consensus 177 ~~~~~~y~aPE~~~~~--~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~------~~~~~~ 246 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCE--TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKSDPP------TLLTPS 246 (302)
T ss_dssp --CCGGGCCHHHHHHH--HTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCC------CCSSGG
T ss_pred ccCChhhcCCeeeccc--cCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHHHHHhccCCc------ccCCcc
Confidence 4568899999975311 01244577899999999999999999999975332 1111111111100 000111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. ....+.+++..||+.||++|||+.++++
T Consensus 247 ~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 247 K---WSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp G---SCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c---cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 1234667788899999999999998864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=312.37 Aligned_cols=237 Identities=17% Similarity=0.267 Sum_probs=183.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +++.||||.+... ....++.+|+..+.++ +||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 578999999999999975 7899999998754 2345677788888888 999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-------------------C
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-------------------G 472 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-------------------~ 472 (640)
|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.+ .
T Consensus 96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CC
T ss_pred CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 999999975321 012588999999999999999999954 59999999999999844 4
Q ss_pred CeEEccCCcccccCCC--ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHh
Q 006559 473 NACISDIGVHQLFHTP--FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM 550 (640)
Q Consensus 473 ~~kl~DfGl~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 550 (640)
.+||+|||++...... ..++..|+|||++.. ...++.++|||||||++|||++|+.++.... .+....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~ 241 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWHEIR 241 (289)
T ss_dssp CEEECCCTTCEETTCSCCCCCCGGGCCHHHHTT------CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----HHHHHH
T ss_pred EEEEcccccccccCCccccCCCccccChhHhcC------CCCCCchhhHHHHHHHHHHHhcCCCCCcchh----HHHHHH
Confidence 7999999998876543 346889999997632 2245579999999999999999998764321 111111
Q ss_pred hcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 551 GQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 551 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... . +. .+... ...+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~--~-----~~--~~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 242 QGR--L-----PR--IPQVL---SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp TTC--C-----CC--CSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCC--C-----CC--CCccc---CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 100 0 00 01111 234667788899999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=321.92 Aligned_cols=249 Identities=20% Similarity=0.341 Sum_probs=185.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 94 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence 568999999999999964 58899999987431 1245778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 95 ET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp SE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred CC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 86 8988887543 2577888999999999999999954 599999999999999999999999999987642
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-h-HHHHHHhhcc-ccccc-c
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-I-VKWVQMMGQD-ESAWE-V 559 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~-~~~~~~~~~~-~~~~~-~ 559 (640)
...+|..|+|||++.+ ...++.++|||||||++|||++|+.||...... . ....+..... ...+. .
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCcccccccccCchHhhC------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 2345889999997532 234678999999999999999999998754321 1 1111111111 00000 0
Q ss_pred c---ch---h-hc-cC--hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 F---DF---E-LI-MD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~---d~---~-~~-~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. +. . .. .. ........++.+++..||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00 0 00 00 000112245778888899999999999999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=320.52 Aligned_cols=251 Identities=14% Similarity=0.206 Sum_probs=190.5
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccccc-----h--------------HHHHHHHHHHhccCCCcccceeEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKK-----K--------------REVDEWLRVIGGLRHSNIVSIRAYCN 397 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----~--------------~~~~~e~~~l~~l~H~niv~l~~~~~ 397 (640)
..+.||+|+||.||+|+. ++..||||.+..... . +.+.+|++++++++||||+++++++.
T Consensus 35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 113 (348)
T 2pml_X 35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 356899999999999999 899999999875411 1 77899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHh------hccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC
Q 006559 398 GKDELFLVYDYLPHGSLHSL------LHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL 471 (640)
Q Consensus 398 ~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~ 471 (640)
..+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+ ..+|+||||||+||+++.+
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTT
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCC
Confidence 99999999999999999998 54321 2368999999999999999999995 1569999999999999999
Q ss_pred CCeEEccCCcccccCC----CccccccccCCccccCCCCccccCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCcchHHH
Q 006559 472 GNACISDIGVHQLFHT----PFFINDAYNAPELKFNNNNNYSQRKFWQ-RCDVYSFGVVLLEILTGKMAKGDGELGIVKW 546 (640)
Q Consensus 472 ~~~kl~DfGl~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~-k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~ 546 (640)
+.+||+|||+++.... ...++..|+|||++... ..++. ++|||||||++|||+||+.||...... ...
T Consensus 189 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~ 261 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNE------SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VEL 261 (348)
T ss_dssp SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSC------CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHH
T ss_pred CcEEEeccccccccccccccCCCCCcCccCchhhcCC------CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHH
Confidence 9999999999987543 34568899999975322 13444 899999999999999999999754331 112
Q ss_pred HHHhhcccccccc----cchhhccC---hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 547 VQMMGQDESAWEV----FDFELIMD---KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 547 ~~~~~~~~~~~~~----~d~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+........... ........ ........++.+++.+||+.||++||++.|+++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2222111100000 00000000 000122345777888899999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=348.43 Aligned_cols=229 Identities=20% Similarity=0.279 Sum_probs=184.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.++||+|+||.||+|+.. +++.||||+++.. ...+.+..|.+++..+ +||||+++++++.+.+.+|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 568999999999999965 5788999999753 2335567788888887 79999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---- 486 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~---- 486 (640)
+|+|.+++.... .+++..+..++.||+.||+|||+. +||||||||+||||+.++.+||+|||+++...
T Consensus 426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 999999998643 589999999999999999999954 59999999999999999999999999998632
Q ss_pred --CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 487 --TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 487 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
....+|..|+|||++ ....++.++|||||||++|||+||+.||..... .+..+..... ..
T Consensus 498 ~~~~~~GT~~Y~APE~l-------~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~---------~~ 559 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEII-------AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEH---------NV 559 (674)
T ss_dssp CBCCCCSCSSSCCHHHH-------TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHSS---------CC
T ss_pred ccccccCCCcccCHhhh-------cCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHHHHHHhC---------CC
Confidence 234578999999975 345678899999999999999999999975432 2222222211 11
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
..+..... ++.+++..||+.||++||++
T Consensus 560 ~~p~~~s~---~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 AYPKSMSK---EAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CCCTTSCH---HHHHHHHHHSCSSSTTCTTC
T ss_pred CCCccCCH---HHHHHHHHHccCCHHHCCCC
Confidence 11222223 45667778999999999997
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.77 Aligned_cols=245 Identities=21% Similarity=0.305 Sum_probs=183.1
Q ss_pred hhccccccCcceEEEEEeC--CCc--EEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD--GGD--VVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~--~~~--~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|++. ++. .||||.++.. ...+.+.+|++++++++||||+++++++.... .++|||
T Consensus 22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence 3578999999999999853 333 5899988743 23456788999999999999999999998654 899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999997542 2588999999999999999999954 599999999999999999999999999877542
Q ss_pred C---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccc
Q 006559 488 P---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 488 ~---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
. ...+..|+|||++ ....++.++|||||||++|||+| |+.||..... .............
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~- 243 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESL-------KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKIDKEGER- 243 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHH-------HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTSCCC-
T ss_pred cccchhhhccCCCCceeeCchhh-------cCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--HHHHHHHHccCCC-
Confidence 2 2235679999965 33456789999999999999999 9999975432 2222222111100
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..... ....++.+++..||+.||++||++.++++.|+++...
T Consensus 244 ------~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 ------LPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ------CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ------CCCCc---CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00111 1223567788889999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.77 Aligned_cols=249 Identities=20% Similarity=0.266 Sum_probs=180.7
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccc-------------hHHHHHHHHHHhccCCCcccceeEEEEc-----C
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKK-------------KREVDEWLRVIGGLRHSNIVSIRAYCNG-----K 399 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~ 399 (640)
.+.||+|+||.||+|+..+|..||||++..... .+.+.+|++++++++||||+++++++.. .
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 568999999999999988899999999864311 2668899999999999999999999853 3
Q ss_pred CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccC
Q 006559 400 DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDI 479 (640)
Q Consensus 400 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 479 (640)
...|+||||++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCT
T ss_pred ceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEec
Confidence 46899999998 68888887543 2589999999999999999999954 5999999999999999999999999
Q ss_pred CcccccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hH-HHHHHhhc
Q 006559 480 GVHQLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IV-KWVQMMGQ 552 (640)
Q Consensus 480 Gl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~-~~~~~~~~ 552 (640)
|+++.... ...++..|+|||++.. ...++.++|||||||++|||+||+.||...... .. ..+.....
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQ------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TC---------------CGGGCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred CcccccccccccceecccceecCcHHhcC------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99975432 2345788999997532 245778999999999999999999999754321 11 11111111
Q ss_pred ccccc----------cccchhh---cc---ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 553 DESAW----------EVFDFEL---IM---DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 553 ~~~~~----------~~~d~~~---~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..... ....... .. ..........+.+++..||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00000 0000000 00 0000111245778888999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.95 Aligned_cols=250 Identities=14% Similarity=0.042 Sum_probs=170.4
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc-----chHHHHHHH---HHHhccCCCccccee-------EEEEcC-
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----KKREVDEWL---RVIGGLRHSNIVSIR-------AYCNGK- 399 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~e~---~~l~~l~H~niv~l~-------~~~~~~- 399 (640)
..+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+ +.++. +||||++++ +++...
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETT
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCC
Confidence 3578999999999999964 68899999998642 234456674 55556 799987754 455432
Q ss_pred ----------------CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHH------HHHHHHHHHHHHHhhcCCCCCce
Q 006559 400 ----------------DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKR------LKLASDSAKGLAFLHGYNKAHLF 457 (640)
Q Consensus 400 ----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv 457 (640)
...|+|||||+ |+|.+++..... .+.+..+ ..++.|++.||+|||+. +|+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 34899999999 899999975421 2344455 77889999999999954 599
Q ss_pred ecCCCCCCeEECCCCCeEEccCCcccccCCC---ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCC
Q 006559 458 HGHLSSSNIVVDQLGNACISDIGVHQLFHTP---FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM 534 (640)
Q Consensus 458 Hrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~ 534 (640)
||||||+|||++.++.+||+|||+++..... ...+..|+|||++.. ....++.++|||||||++|||+||+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNA-----STATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTC-----SEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccC-----CCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876542 345789999997521 12457889999999999999999999
Q ss_pred CCCCCCcchHH-HHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 535 AKGDGELGIVK-WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 535 p~~~~~~~~~~-~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
||......... |... ............+ ........+.+++.+||+.||++|||+.++++ .++++.
T Consensus 292 Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRP-----SLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp STTBCCTTCTTCCCBC-----CTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCCcCcccccchhhh-----hhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 99754221110 0000 0000000011000 00112335667888899999999999999964 444443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=322.04 Aligned_cols=248 Identities=17% Similarity=0.303 Sum_probs=186.1
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcC-----CeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGK-----DELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 407 (640)
..+.||+|+||.||+|+.. ++..||||++.... ..+.+.+|++++++++||||+++++++... ...|+|||
T Consensus 31 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 31 NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEc
Confidence 3578999999999999854 67889999997542 235678899999999999999999999764 36899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 111 ~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 111 LME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 997 5999998753 488999999999999999999954 599999999999999999999999999976542
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHHHH-HHhhcccc-
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVKWV-QMMGQDES- 555 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~~~-~~~~~~~~- 555 (640)
...+|..|+|||++. ....++.++|||||||++|||+||+.||..... .....+ ........
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHH------TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred CCCccccccccccccCCCCCHHhc------CCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 235688999999752 234467899999999999999999999975432 221111 11111100
Q ss_pred -cccccch-------hhc----c--ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 556 -AWEVFDF-------ELI----M--DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 556 -~~~~~d~-------~~~----~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....+. ... . .........++.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 000 0 0000112245778888999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.71 Aligned_cols=244 Identities=17% Similarity=0.259 Sum_probs=179.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCC------eEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD------ELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lV~ 406 (640)
.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.+++.++||||+++++++...+ ..|+||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 56899999999999985 46888999998753 22355778999999999999999999997654 789999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 110 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 110 ELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp ECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 9997 578888863 378899999999999999999954 59999999999999999999999999998764
Q ss_pred C-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccc----cc
Q 006559 487 T-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDES----AW 557 (640)
Q Consensus 487 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~ 557 (640)
. ...+|..|+|||++. ...++.++|||||||++|||+||+.||..... ...+......... ..
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -----------CTTCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHC-CCCCCHHHH
T ss_pred cccccCCceecCCccCHHHhc-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 3 245688999999753 34577899999999999999999999975432 1112111110000 00
Q ss_pred ccc-----------------c-----hhh--cc-ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVF-----------------D-----FEL--IM-DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~-----------------d-----~~~--~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... . +.. .. .........++.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 0 000 00 0111223456888999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=316.82 Aligned_cols=244 Identities=18% Similarity=0.320 Sum_probs=184.1
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-cchHHHHHHHHHHhcc-CCCcccceeEEEEc------CCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-KKKREVDEWLRVIGGL-RHSNIVSIRAYCNG------KDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------~~~~~lV~E 407 (640)
..+.||+|+||.||+|+. .+++.||||.+... ...+.+.+|+.+++++ +||||+++++++.. .+..++|||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 357899999999999996 46889999998755 3456788999999998 79999999999976 468999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 108 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp CCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred cCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 999999999997542 12588899999999999999999954 599999999999999999999999999876542
Q ss_pred ------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 488 ------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 488 ------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
...++..|+|||++.... .....++.++|||||||++|||+||+.||.........+ .......
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~------ 251 (326)
T 2x7f_A 182 TVGRRNTFIGTPYWMAPEVIACDE--NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--LIPRNPA------ 251 (326)
T ss_dssp ---------CCGGGCCHHHHC----------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSCC------
T ss_pred CccccccccCCccccChhhhcccc--ccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH--HhhcCcc------
Confidence 234688999999764221 113457789999999999999999999997533211111 1111100
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+.. ..... ...+.+++..||+.||++||++.++++
T Consensus 252 ~~~-~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRL-KSKKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCC-SCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccC-Ccccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 00111 234667788899999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=346.73 Aligned_cols=244 Identities=19% Similarity=0.288 Sum_probs=191.5
Q ss_pred hhccccccCcceEEEEEeCC----CcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG----GDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|+... +..||||.++... ..+.+.+|+.++++++||||+++++++. .+..|+||||+
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcC
Confidence 35679999999999998643 4569999987542 2366888999999999999999999985 46789999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 473 ~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 473 TLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp TTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999997543 2588999999999999999999954 5999999999999999999999999999876432
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
..++..|+|||++ ....++.++|||||||++|||++ |+.||.+.... ...........
T Consensus 546 ~~~~~~~~~t~~y~aPE~~-------~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~------ 610 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESI-------NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER------ 610 (656)
T ss_dssp --------CCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCC------
T ss_pred ceeccCCCCCcceeCHHHh-------cCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCC------
Confidence 2235689999964 34567889999999999999997 99999753321 11111111100
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...+. .....+.+++..||+.||++||++.++++.|+++..+
T Consensus 611 --~~~~~---~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 611 --LPMPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCc---cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00111 1223567788889999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.47 Aligned_cols=247 Identities=18% Similarity=0.281 Sum_probs=170.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~ 406 (640)
.+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+++++.++||||+++++++... ...|+|+
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 56899999999999985 56889999998653 2345677899999999999999999999754 5689999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 114 e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 114 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp ECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred ccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 999 68999988642 48899999999999999999995 459999999999999999999999999998764
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHH-HHHHhhcccc-cc-cc
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVK-WVQMMGQDES-AW-EV 559 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~-~~~~~~~~~~-~~-~~ 559 (640)
. ...+|..|+|||++.+ ...++.++|||||||++|||+||+.||.+... .... ..+..+.... .. .+
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 184 DEMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------CCCTTCCHHHHTT------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccCCCcCcCcCccChHHHcC------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 3 3456889999997532 24577899999999999999999999975432 1111 1111111100 00 00
Q ss_pred cch-------hhc--cChHH----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDF-------ELI--MDKEM----EEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~-------~~~--~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... .+. ..... ......+.+++.+||..||++|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000 000 00000 011235678888999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.91 Aligned_cols=245 Identities=19% Similarity=0.289 Sum_probs=177.6
Q ss_pred hccccccCcceEEEEEeCC-CcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEE--------------cCC
Q 006559 338 AELLGKGCVGATYKVVLDG-GDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCN--------------GKD 400 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~--------------~~~ 400 (640)
.+.||+|+||.||+|+... ++.||||++... ...+.+.+|++++++++||||+++++++. ...
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 5679999999999999764 889999998754 23466788999999999999999999874 346
Q ss_pred eEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccC
Q 006559 401 ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDI 479 (640)
Q Consensus 401 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~Df 479 (640)
..++||||++ |+|.+++... ++++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+||
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 7899999998 6999999643 478899999999999999999954 599999999999997 5679999999
Q ss_pred CcccccCC---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHh
Q 006559 480 GVHQLFHT---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM 550 (640)
Q Consensus 480 Gl~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 550 (640)
|+++.... ...++..|+|||++. ....++.++|||||||++|||+||+.||...... ...+..
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~ 237 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL------SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLI 237 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHH------CTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred ccccccCCCcccccccccccccccccCcHHhc------CcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 99986532 123477899999753 2245778999999999999999999999754321 111111
Q ss_pred hcc-ccc-----ccc-------cchhhccC-----hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 551 GQD-ESA-----WEV-------FDFELIMD-----KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 551 ~~~-~~~-----~~~-------~d~~~~~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ... .+. ........ ........++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 100 000 000 00000000 000112345778889999999999999999965
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.66 Aligned_cols=238 Identities=21% Similarity=0.357 Sum_probs=179.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEc-------------CCeE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNG-------------KDEL 402 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------------~~~~ 402 (640)
.+.||+|+||.||+|+. .+++.||||.+... ...+.+.+|++++++++||||+++++++.. .+..
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTL 90 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCce
Confidence 56899999999999996 47889999999754 334668889999999999999999998864 3578
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 403 FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 403 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 91 FIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred EEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 99999999999999997543 2578889999999999999999954 5999999999999999999999999998
Q ss_pred cccCC--------------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc
Q 006559 483 QLFHT--------------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG 542 (640)
Q Consensus 483 ~~~~~--------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~ 542 (640)
+.... ...++..|+|||++.+ ...++.++|||||||++|||++ ||.... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~---p~~~~~-~ 233 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG------TGHYNEKIDMYSLGIIFFEMIY---PFSTGM-E 233 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTS------CSCCCTHHHHHHHHHHHHHHHS---CCSSHH-H
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccC------CCCCcchhhHHHHHHHHHHHHh---ccCCch-h
Confidence 76531 1235778999997532 2357789999999999999998 553211 1
Q ss_pred hHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....+....... .+... .. ......+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~---~~~~~--~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RVNILKKLRSVSI---EFPPD--FD---DNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHSTTC---CCCTT--CC---TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcccccc---ccCcc--cc---ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111111111100 00000 11 122234667888899999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.01 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=188.1
Q ss_pred hhccccccCcceEEEEEe--CCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCc------ccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL--DGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSN------IVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~--~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|.. .++..||||+++.. ...+.+.+|+++++.++|+| ++++++++...+..++|||
T Consensus 18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 356799999999999986 36788999999765 33456778888888887665 9999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-----------------
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ----------------- 470 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~----------------- 470 (640)
|+ +++|.+++.... ..++++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 98 ~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 98 LL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred CC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99 889999997653 23588999999999999999999954 5999999999999987
Q ss_pred --CCCeEEccCCcccccCC---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-H
Q 006559 471 --LGNACISDIGVHQLFHT---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-V 544 (640)
Q Consensus 471 --~~~~kl~DfGl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-~ 544 (640)
++.+||+|||+++.... ...+|..|+|||++. ...++.++|||||||++|||+||+.||....... .
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL-------ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHT-------TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccCCCceEeeCcccccCccccccccCCccccChHHhh-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 67899999999987543 345688999999753 3457789999999999999999999997543221 1
Q ss_pred HHHHHhhc-ccc-c----------------cccc-----------chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 545 KWVQMMGQ-DES-A----------------WEVF-----------DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 545 ~~~~~~~~-~~~-~----------------~~~~-----------d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
..+..... ... . |... .+.............++.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 11111110 000 0 0000 00000000011334568889999999999999999
Q ss_pred HHHHH
Q 006559 596 SIVHR 600 (640)
Q Consensus 596 ~~v~~ 600 (640)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=325.23 Aligned_cols=257 Identities=18% Similarity=0.327 Sum_probs=183.2
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcCC------eEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGKD------ELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lV~Ey~~ 410 (640)
..++||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+ ..++||||++
T Consensus 44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~ 121 (394)
T 4e7w_A 44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121 (394)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence 3578999999999999987777799998865421 2236889999999999999999996543 3889999998
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccCCcccccCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl~~~~~~-- 487 (640)
++.+........ ....+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 122 ~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 122 ETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp EEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred ccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 754443332111 112588999999999999999999954 599999999999999 799999999999987532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhccccc-ccccc
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDESA-WEVFD 561 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~-~~~~d 561 (640)
...+|..|+|||++.+ ...++.++|||||||++|||++|+.||.+.... +...++..+..... ....+
T Consensus 197 ~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 197 PNVSYICSRYYRAPELIFG------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CCCSSCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCcccccCcCccCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 3456889999997532 235778999999999999999999999754321 22222222111000 00000
Q ss_pred hhh-------ccChHHH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 562 FEL-------IMDKEME-----EEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 562 ~~~-------~~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
+.. ....... ....++.+++.+||+.||++|||+.|+++ .+++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000 0000000 12245778888999999999999999975 344444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.32 Aligned_cols=261 Identities=17% Similarity=0.295 Sum_probs=175.6
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCe-------EEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDE-------LFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-------~~lV~Ey 408 (640)
.+.||+|+||.||+|+.. ++..||||++... .......++++.++.++||||+++++++...+. .++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~ 107 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence 567999999999999974 6889999988654 334456677888888999999999999975433 8899999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCcccccCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLFHT 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~~~~~ 487 (640)
+++ +|.+.+..... ....+++..+..++.|++.||.|||.. ..+|+||||||+|||++. ++.+||+|||+++....
T Consensus 108 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~ 184 (360)
T 3e3p_A 108 VPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184 (360)
T ss_dssp CSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCT
T ss_pred ccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCC
Confidence 986 55444331100 112578889999999999999999932 345999999999999996 89999999999987643
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhcccc-cccc
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDES-AWEV 559 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~-~~~~ 559 (640)
...+|..|+|||++. ....++.++|||||||++|||+||+.||...... ....++....... .+..
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 185 SEPNVAYICSRYYRAPELIF------GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp TSCCCSTTSCGGGCCHHHHT------TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCCcccccCCcceeCHHHHc------CCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 234588999999753 2334678999999999999999999999754321 1111221111100 0000
Q ss_pred cch-----hh----------ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhc
Q 006559 560 FDF-----EL----------IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRT 607 (640)
Q Consensus 560 ~d~-----~~----------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~ 607 (640)
.++ .. ...........++.+++.+||+.||++|||+.|+++ .++++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 000 00 000000112456788889999999999999999975 4555543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.73 Aligned_cols=237 Identities=20% Similarity=0.303 Sum_probs=182.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc------cchHHHHHHHHHHhccCCCcccceeEEEE--cCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER------KKKREVDEWLRVIGGLRHSNIVSIRAYCN--GKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~lV~Ey 408 (640)
.+.||+|+||.||++.. .++..||||.+... ...+.+.+|++++++++||||+++++++. .....++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 56899999999999996 46789999999754 23456889999999999999999999985 34589999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+++| |.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 90 CVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp CSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9877 7777764321 2588999999999999999999954 599999999999999999999999999876532
Q ss_pred -------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 488 -------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 488 -------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
...++..|+|||++... ...++.++|||||||++|||+||+.||.... .....+......
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i~~~~------ 229 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGL-----DTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--IYKLFENIGKGS------ 229 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCC-----SCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCC------
T ss_pred ccccccccCCCCCCCcChhhccCc-----ccCCcchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHHhcCC------
Confidence 23458899999976321 1223578999999999999999999997543 222222221111
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
...... ....+.+++.+||+.||++|||+.++++
T Consensus 230 ---~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 230 ---YAIPGD---CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ---CCCCSS---SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---CCCCCc---cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001111 1234567788899999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.15 Aligned_cols=244 Identities=18% Similarity=0.240 Sum_probs=188.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc-----------chHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEE
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-----------KKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----------~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 404 (640)
.+.||+|+||.||+|+.. +++.||||.+.... ..+.+.+|+++++++. ||||+++++++...+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 568999999999999975 57899999986431 1345678899999995 9999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 102 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999997542 58899999999999999999995 4599999999999999999999999999877
Q ss_pred cCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 485 FHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 485 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
... ...++..|+|||++..... .....++.++|||||||++|||++|+.||...... ...+........ .
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~--~ 248 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMN-DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLRMIMSGNYQ--F 248 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHC-TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC--C
T ss_pred cCCCcccccccCCccccCHHHhccccc-cccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HHHHHHhcCCcc--c
Confidence 543 2345889999997532110 12345778999999999999999999999753321 111111111000 0
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. +........+.+++.+||+.||++|||+.++++
T Consensus 249 ~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 249 GS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00 011122335677888899999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.46 Aligned_cols=251 Identities=17% Similarity=0.227 Sum_probs=185.3
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-cchHHHHHHHHHHhccC--------CCcccceeEEEE----cCCeE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-KKKREVDEWLRVIGGLR--------HSNIVSIRAYCN----GKDEL 402 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~----~~~~~ 402 (640)
..+.||+|+||.||+|+. .+++.||||+++.. ...+.+.+|+++++.++ |+||+++++++. .....
T Consensus 41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred EEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 356899999999999985 56788999999765 33466788999888885 888999999987 55689
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC----------
Q 006559 403 FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG---------- 472 (640)
Q Consensus 403 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~---------- 472 (640)
++||||+ +|+|.+++.... ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 9999999 566666665432 125889999999999999999999641 699999999999999775
Q ss_pred ---------------------------------------CeEEccCCcccccCC---CccccccccCCccccCCCCcccc
Q 006559 473 ---------------------------------------NACISDIGVHQLFHT---PFFINDAYNAPELKFNNNNNYSQ 510 (640)
Q Consensus 473 ---------------------------------------~~kl~DfGl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~ 510 (640)
.+||+|||+++.... ...+|..|+|||++. .
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~-------~ 267 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI-------G 267 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHH-------T
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhc-------C
Confidence 899999999987643 345688999999753 3
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--------hHHHHHHhhcccc--------cccccch----------h-
Q 006559 511 RKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--------IVKWVQMMGQDES--------AWEVFDF----------E- 563 (640)
Q Consensus 511 ~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~--------~~~~~d~----------~- 563 (640)
..++.++|||||||++|||+||+.||...... +....+....... ....+.. .
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 45778999999999999999999999743211 0111111111000 0000000 0
Q ss_pred -------hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 -------LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 -------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........+....+.+++.+||+.||++|||+.|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000011344567888999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.89 Aligned_cols=255 Identities=21% Similarity=0.321 Sum_probs=184.6
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcC----------------
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGK---------------- 399 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~---------------- 399 (640)
..+.||+|+||.||+|+. .+|+.||||++.... +...+|+++++.++|||||++++++...
T Consensus 11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (383)
T 3eb0_A 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88 (383)
T ss_dssp EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence 357899999999999985 578999999986542 2234689999999999999999998543
Q ss_pred ----------------------CeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 006559 400 ----------------------DELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457 (640)
Q Consensus 400 ----------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 457 (640)
...++||||++ |+|.+.+..... ....+++..+..++.|+++||+|||+ .+|+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi~ 163 (383)
T 3eb0_A 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHS---LGIC 163 (383)
T ss_dssp ---------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEE
T ss_pred ccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CcCc
Confidence 34889999998 588777653111 11258899999999999999999994 5699
Q ss_pred ecCCCCCCeEEC-CCCCeEEccCCcccccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh
Q 006559 458 HGHLSSSNIVVD-QLGNACISDIGVHQLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT 531 (640)
Q Consensus 458 Hrdlk~~NILl~-~~~~~kl~DfGl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t 531 (640)
||||||+|||++ .++.+||+|||+++.... ...++..|+|||++.+ ...++.++||||+||++|||++
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG------ATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHH
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC------CCCCCcchhhhhHHHHHHHHHh
Confidence 999999999998 689999999999986532 2355888999997532 2347789999999999999999
Q ss_pred CCCCCCCCCcc--hHHHHHHhhccccc---------ccc-------cchhhccChHHHHHHHHHHHHHHHccCCCCCCCC
Q 006559 532 GKMAKGDGELG--IVKWVQMMGQDESA---------WEV-------FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP 593 (640)
Q Consensus 532 g~~p~~~~~~~--~~~~~~~~~~~~~~---------~~~-------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 593 (640)
|+.||...... +...++..+..... ... .+.....+. ....++.+++.+||+.||++||
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE---GTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCT---TCCHHHHHHHHHHCCSSGGGSC
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCC---CCCHHHHHHHHHHccCChhhCC
Confidence 99999753321 12222222111000 000 000000111 1223577888899999999999
Q ss_pred CHHHHHH--HHHHhhc
Q 006559 594 NMSIVHR--MIEDIRT 607 (640)
Q Consensus 594 s~~~v~~--~L~~i~~ 607 (640)
|+.|+++ .+++++.
T Consensus 315 t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 315 NPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CHHHHHTSGGGHHHHH
T ss_pred CHHHHhcCHHHHHHHh
Confidence 9999973 5555544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=318.06 Aligned_cols=191 Identities=24% Similarity=0.321 Sum_probs=158.7
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc-chHHHHHHHHHHhccC-CC-----cccceeEEEEcCCeEEEEEec
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-KKREVDEWLRVIGGLR-HS-----NIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~~~~lV~Ey 408 (640)
..+.||+|+||.||+|+.. +++.||||+++... ...++..|+++++.++ |+ +|+++.+++...+..++||||
T Consensus 58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 137 (382)
T 2vx3_A 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137 (382)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence 3578999999999999865 57889999997653 3455667777777664 44 499999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC--CCCCeEEccCCcccccC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD--QLGNACISDIGVHQLFH 486 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGl~~~~~ 486 (640)
++ |+|.+++..... ..+++..+..++.|++.||+|||+. +.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 138 ~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 138 LS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp CC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred CC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 96 599999976531 2488999999999999999999963 35799999999999994 57889999999998765
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDG 539 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~ 539 (640)
. ...+|..|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 213 ~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 213 QRIYQYIQSRFYRSPEVLL-------GMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCCCSSCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCCccccChHHHc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3 345688999999753 345778999999999999999999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.27 Aligned_cols=248 Identities=17% Similarity=0.291 Sum_probs=185.6
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcC-----CeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGK-----DELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 407 (640)
..+.||+|+||.||+|+.. +|+.||||++.... ....+.+|++++++++||||+++++++... ...++|||
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred EeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence 3568999999999999965 68899999997542 235577899999999999999999998754 67999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 95 LMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 997 6999998753 488999999999999999999954 599999999999999999999999999886532
Q ss_pred ----------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-HH-HHHH
Q 006559 488 ----------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-VK-WVQM 549 (640)
Q Consensus 488 ----------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-~~-~~~~ 549 (640)
...+|..|+|||++. ....++.++|||||||++|||++|+.||....... .. ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVML------TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHH------SCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccCccccccchhhccccccccCCeeec------cCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 124578899999752 23457789999999999999999999997543211 11 1111
Q ss_pred hhccc--cccccc-ch-------hhc---cC---hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 550 MGQDE--SAWEVF-DF-------ELI---MD---KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 550 ~~~~~--~~~~~~-d~-------~~~---~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..... ...... .. .+. .. ........++.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11100 000000 00 000 00 000122345678888999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=316.91 Aligned_cols=246 Identities=18% Similarity=0.265 Sum_probs=182.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeE------EEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDEL------FLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~------~lV~ 406 (640)
.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+.+++.++||||+++++++...+.. ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 56799999999999985 468899999997542 235677899999999999999999999876654 9999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 127 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 127 PFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp ECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 9997 689888742 378999999999999999999954 59999999999999999999999999998764
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-h-HHHHHHhhcccc-ccccc
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-I-VKWVQMMGQDES-AWEVF 560 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~-~~~~~~~~~~~~-~~~~~ 560 (640)
. ...+|..|+|||++.. ...++.++|||||||++|||+||+.||...... . ....+....... .....
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----CTTCCCTTSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cCcCCcccCccccCHHHhcC------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 3 3456889999997532 245778999999999999999999999754321 1 111111111000 00000
Q ss_pred c-h-------hhc--cChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 D-F-------ELI--MDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 d-~-------~~~--~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+ . ... .... .......+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 0 000 0000 0112346778888999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.21 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=183.4
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~Ey~ 409 (640)
..++||+|+||.||+|+.. +++.||||++.... +...+|++++++++|||||+++++|... ...++||||+
T Consensus 58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~ 135 (420)
T 1j1b_A 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135 (420)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence 3568999999999999975 58999999986542 2234689999999999999999998542 2367999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC-CCeEEccCCcccccCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL-GNACISDIGVHQLFHT- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGl~~~~~~- 487 (640)
++ ++.+.+..... ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++....
T Consensus 136 ~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 136 PE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp CE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred cc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 86 66665542110 11258899999999999999999994 569999999999999965 5789999999986532
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc--chHHHHHHhhcccc------
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL--GIVKWVQMMGQDES------ 555 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~------ 555 (640)
...+|..|+|||++.+ ...++.++|||||||++|||++|+.||.+... .+...++..+....
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred CCceeeeeCCCcCCHHHHcC------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 3456889999997532 23577899999999999999999999975432 12222222221100
Q ss_pred ---cccccchhhccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 556 ---AWEVFDFELIMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 556 ---~~~~~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
..+..-+.+..... ......++.+++.+||+.||++||++.|+++ .+++++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00000000000000 0011245778888999999999999999974 455554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=304.14 Aligned_cols=242 Identities=19% Similarity=0.273 Sum_probs=189.2
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +++.||||.+... ...+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 568999999999999975 6889999998654 23567889999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC---CCeEEccCCcccccCCC-
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL---GNACISDIGVHQLFHTP- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGl~~~~~~~- 488 (640)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||+++.....
T Consensus 107 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999886543 588999999999999999999954 59999999999999754 47999999998865432
Q ss_pred ----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 489 ----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 489 ----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
..++..|+|||++. ..++.++||||||+++|||+||+.||..... ....+......... + .
T Consensus 179 ~~~~~~~~~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~---~--~ 243 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLR--------GTYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAF---D--L 243 (287)
T ss_dssp SCSCHHHHHTTCCHHHHT--------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCC---C--S
T ss_pred ccccccCcccccChHHhc--------CCCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCC---C--c
Confidence 23477899999753 2367899999999999999999999975432 12222221111000 0 0
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHh
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDI 605 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i 605 (640)
+.......++.+++..||+.||++|||+.++++ .+++.
T Consensus 244 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 244 ---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp ---GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred ---hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 001112234677888899999999999999986 44443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=310.72 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=182.8
Q ss_pred hhccccccCcceEEEEEe--CCCcEEEEEEecccc----chHHHHHHHHHHhcc---CCCcccceeEEEE-----cCCeE
Q 006559 337 SAELLGKGCVGATYKVVL--DGGDVVVVKRIRERK----KKREVDEWLRVIGGL---RHSNIVSIRAYCN-----GKDEL 402 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~--~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l---~H~niv~l~~~~~-----~~~~~ 402 (640)
..+.||+|+||.||+|+. .+++.||||++.... ....+.+|+.+++.+ +||||+++++++. .....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 356899999999999997 467889999987542 123455666666555 8999999999987 45679
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 403 FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 403 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
++||||++ |+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccc
Confidence 99999998 699999976532 2488999999999999999999954 5999999999999999999999999998
Q ss_pred cccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH-HHHHhhccc-
Q 006559 483 QLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK-WVQMMGQDE- 554 (640)
Q Consensus 483 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~-~~~~~~~~~- 554 (640)
+.... ...++..|+|||++. ...++.++|||||||++|||+||+.||...... ... .+.......
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ccccCCCCccccccccceeCHHHHh-------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 76542 234588999999753 345778999999999999999999999754321 111 111111100
Q ss_pred cccc--------ccchh--hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 555 SAWE--------VFDFE--LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 555 ~~~~--------~~d~~--~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+. .+... .............+.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00000 0000000112234667888899999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=312.87 Aligned_cols=240 Identities=18% Similarity=0.244 Sum_probs=163.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEc----CCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNG----KDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~~g 412 (640)
.++||+|+||.||+|+.. +++.||||++.... +...+....++.++||||+++++++.. ....++||||+++|
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg 111 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG 111 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence 457999999999999975 68899999987542 222223344566799999999999876 44589999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCC--
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~-- 487 (640)
+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 112 ~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~ 185 (336)
T 3fhr_A 112 ELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185 (336)
T ss_dssp EHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence 99999986532 3589999999999999999999954 5999999999999986 45699999999986543
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHH--HHHHhhcccccccccchh
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVK--WVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~d~~ 563 (640)
...++..|+|||++ ....++.++|||||||++|||+||+.||......... ..+..... ...
T Consensus 186 ~~~~~~t~~y~aPE~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~ 251 (336)
T 3fhr_A 186 LQTPCYTPYYVAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG-------QYG 251 (336)
T ss_dssp -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------C
T ss_pred cccCCCCcCccChhhh-------CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc-------ccc
Confidence 23458899999964 3345678999999999999999999999743221110 00000000 000
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. .+.......++.+++..||+.||++|||+.|+++
T Consensus 252 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 252 FP-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CC-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cC-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0001122334667888899999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.62 Aligned_cols=243 Identities=17% Similarity=0.231 Sum_probs=183.6
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc----chHHHHHHHHHHhccC--CCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK----KKREVDEWLRVIGGLR--HSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||.||+++..+++.||||.+.... ..+.+.+|++++++++ ||||+++++++...+..++||| +.
T Consensus 32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 110 (313)
T 3cek_A 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 110 (313)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC
Confidence 356899999999999998889999999986542 2356788999999997 4999999999999999999999 56
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++ +.+||+|||+++....
T Consensus 111 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 111 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp SEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 889999998643 588999999999999999999954 5999999999999964 8999999999986532
Q ss_pred -----CccccccccCCccccCCCCc----cccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 488 -----PFFINDAYNAPELKFNNNNN----YSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~----~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
...++..|+|||++...... .....++.++|||||||++|||+||+.||................. ...
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~- 259 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN-HEI- 259 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT-SCC-
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc-ccc-
Confidence 22458899999986432111 1124678899999999999999999999975332222211111111 000
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+... ..++.+++.+||+.||++||++.|+++
T Consensus 260 ------~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 260 ------EFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ------CCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CCcccc---hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 001111 234667788899999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.50 Aligned_cols=255 Identities=20% Similarity=0.251 Sum_probs=170.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccc---hHHHHHHHH-HHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK---KREVDEWLR-VIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +++.||||++..... ..++..|+. +++.++||||+++++++...+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 567999999999999974 688999999976522 233444444 77888999999999999999999999999985
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|.+++..........+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 183 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccc
Confidence 887776531111122588999999999999999999953 15999999999999999999999999999775432
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..++..|+|||++... .....++.++|||||||++|||+||+.||....... .......... .+.+..
T Consensus 184 ~~~gt~~y~aPE~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~------~~~~~~- 252 (327)
T 3aln_A 184 RDAGCRPYMAPERIDPS---ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-DQLTQVVKGD------PPQLSN- 252 (327)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCCCSC------CCCCCC-
T ss_pred cCCCCccccCceeeccc---cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-HHHHHHhcCC------CCCCCC-
Confidence 2467889999975221 123457889999999999999999999997432111 1111100000 000000
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhh
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIR 606 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~ 606 (640)
........++.+++..||+.||++||++.++++ .+.+..
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 000112235677888899999999999999975 444443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=322.55 Aligned_cols=239 Identities=18% Similarity=0.218 Sum_probs=176.2
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+....|+|||||+ |+|.
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 3578999999997665567789999999865422 2356788899988 79999999999999999999999996 6999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-----CCCeEEccCCcccccCC---
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-----LGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-----~~~~kl~DfGl~~~~~~--- 487 (640)
+++..... .+.+.....++.|++.||+|||+. +|+||||||+|||++. ...+||+|||+++....
T Consensus 106 ~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 106 EYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp HHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred HHHHhcCC----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 99976542 233445678999999999999954 5999999999999953 34688999999986542
Q ss_pred ------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 488 ------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 488 ------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
...+|..|+|||++... ....++.++|||||||++|||+| |+.||........... .... .....
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~---~~~~-~~~~~ 250 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSED----CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL---LGAC-SLDCL 250 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC-------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH---TTCC-CCTTS
T ss_pred ceeeccccCCCcCccChhhhhcc----cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH---hccC-Ccccc
Confidence 23468999999976321 13456779999999999999999 8999965432222111 1100 00000
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
. ... .....+.+++.+||+.||++|||+.+|+
T Consensus 251 ~----~~~---~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 251 H----PEK---HEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp C----TTC---HHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred C----ccc---cccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 0 111 2223456788889999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=314.37 Aligned_cols=246 Identities=17% Similarity=0.249 Sum_probs=181.7
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCe------EEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDE------LFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lV~ 406 (640)
.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+.++++++||||+++++++...+. .|+||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 56799999999999996 468899999997542 23567789999999999999999999987643 59999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 9997 688887742 378999999999999999999954 59999999999999999999999999998764
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHH-HHHHhhcccc-c-ccc
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVK-WVQMMGQDES-A-WEV 559 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~-~~~~~~~~~~-~-~~~ 559 (640)
. ...++..|+|||++.. ...++.++|||||||++|||+||+.||...... ... ..+..+.... . ..+
T Consensus 178 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 178 AEMTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------CCSBCCSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCccccccCcCcCCHHHHhC------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 3 2356889999997532 245678999999999999999999999754321 111 1111111000 0 000
Q ss_pred cch-------------hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDF-------------ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~-------------~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+. .............++.+++.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00000000122345777888899999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.68 Aligned_cols=250 Identities=19% Similarity=0.230 Sum_probs=185.3
Q ss_pred hhccccccCcceEEEEEeC-C-CcEEEEEEeccc-cchHHHHHHHHHHhccCCCc------ccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD-G-GDVVVVKRIRER-KKKREVDEWLRVIGGLRHSN------IVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~-~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||.||+|+.. + +..||||.++.. ...+.+.+|++++++++|++ ++.+.+++...+..++|||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 3568999999999999864 3 368999999765 33556778898888888766 8999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE-------------------
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV------------------- 468 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl------------------- 468 (640)
|+ +|++.+++..... .++++..+..++.|++.||+|||+ .+|+||||||+|||+
T Consensus 103 ~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 103 LL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp CC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred cc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99 6677777765431 258899999999999999999994 569999999999999
Q ss_pred CCCCCeEEccCCcccccCC---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hH
Q 006559 469 DQLGNACISDIGVHQLFHT---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IV 544 (640)
Q Consensus 469 ~~~~~~kl~DfGl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~ 544 (640)
+.++.+||+|||+++.... ...+|..|+|||++. ...++.++|||||||++|||+||+.||...... ..
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL-------ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeee-------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5678999999999987543 345688999999753 345778999999999999999999999754321 11
Q ss_pred HHHHHhh-ccccc--------ccccchhhc--------------------cChHHHHHHHHHHHHHHHccCCCCCCCCCH
Q 006559 545 KWVQMMG-QDESA--------WEVFDFELI--------------------MDKEMEEEMRALLQVALLCLAPLPKDRPNM 595 (640)
Q Consensus 545 ~~~~~~~-~~~~~--------~~~~d~~~~--------------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 595 (640)
..+.... ..... ......... ..........++.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 1111111 00000 000000000 000011234467889999999999999999
Q ss_pred HHHHH
Q 006559 596 SIVHR 600 (640)
Q Consensus 596 ~~v~~ 600 (640)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.60 Aligned_cols=249 Identities=20% Similarity=0.260 Sum_probs=171.4
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccc----hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK----KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|+.. +|+.||||++..... .+.+.++..+++.++||||+++++++...+..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 567999999999999975 688999999976522 223444556788899999999999999999999999999 45
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
.+..+..... ..+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 109 ~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (318)
T 2dyl_A 109 CAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182 (318)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence 5555544322 2588999999999999999999952 2599999999999999999999999999876532
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
...++..|+|||++... ......++.++|||||||++|||+||+.||.........+......... .....
T Consensus 183 ~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~~~ 253 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPP--DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP-------LLPGH 253 (318)
T ss_dssp ----CCTTCCHHHHC----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-------CCCSS
T ss_pred ccCCCccccChhhcccc--cccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-------CCCcc
Confidence 23468899999976321 1123457789999999999999999999997533222222211111100 00000
Q ss_pred hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHh
Q 006559 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDI 605 (640)
Q Consensus 568 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i 605 (640)
. ....++.+++..||+.||++||++.++++ .+++.
T Consensus 254 ~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 254 M---GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp S---CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred C---CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 1 11234667788899999999999999975 44443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=314.94 Aligned_cols=248 Identities=16% Similarity=0.258 Sum_probs=184.5
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-cchHHHHHHHHHHhccC-----------CCcccceeEEEEcCC---
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-KKKREVDEWLRVIGGLR-----------HSNIVSIRAYCNGKD--- 400 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~~~--- 400 (640)
..+.||+|+||.||+|+. .+++.||||++... ...+.+.+|++++++++ ||||+++++++...+
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 357899999999999995 56889999999755 33456778888888776 899999999998654
Q ss_pred -eEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC------CCCC
Q 006559 401 -ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD------QLGN 473 (640)
Q Consensus 401 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~------~~~~ 473 (640)
..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+. .+|+||||||+|||++ ..+.
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCcce
Confidence 789999999 8999999976432 2488999999999999999999964 1599999999999994 4458
Q ss_pred eEEccCCcccccCC---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--------
Q 006559 474 ACISDIGVHQLFHT---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-------- 542 (640)
Q Consensus 474 ~kl~DfGl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-------- 542 (640)
+||+|||+++.... ...+|..|+|||++. ...++.++|||||||++|||+||+.||......
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHH-------TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHh-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 99999999987653 345688999999753 345778999999999999999999999743211
Q ss_pred hHHHHHHhhcccc-----------------cc------------cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCC
Q 006559 543 IVKWVQMMGQDES-----------------AW------------EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP 593 (640)
Q Consensus 543 ~~~~~~~~~~~~~-----------------~~------------~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 593 (640)
+....+....... .. .+....... ......++.+++..||+.||++||
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF---SKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCC---CHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccC---CcchHHHHHHHHHHHhccCccccC
Confidence 1111111111000 00 000000001 124456788899999999999999
Q ss_pred CHHHHHH
Q 006559 594 NMSIVHR 600 (640)
Q Consensus 594 s~~~v~~ 600 (640)
|+.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=298.25 Aligned_cols=225 Identities=10% Similarity=0.008 Sum_probs=172.5
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccc-----hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKK-----KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+.. +++.||||.+..... .+.+.+|++.+.+++||||+++++++...+..|+||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 468999999999999975 488999999976522 25678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCccc
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFI 491 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 491 (640)
++|.+++... ....+..+++.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999999532 23446788999999999999954 59999999999999999999998543
Q ss_pred cccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-HHHHHHhhcccccccccchhhccC-hH
Q 006559 492 NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-VKWVQMMGQDESAWEVFDFELIMD-KE 569 (640)
Q Consensus 492 ~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~-~~ 569 (640)
|++| ++.++|||||||++|||+||+.||....... .. ............. ..
T Consensus 175 ---~~~~--------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 ---TMPD--------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---------PAERDTAGQPIEPADI 228 (286)
T ss_dssp ---CCTT--------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---------ECCBCTTSCBCCHHHH
T ss_pred ---ccCC--------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---------HHHHHhccCCCChhhc
Confidence 3332 3578999999999999999999997533210 00 0000000000000 00
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
......++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 01122346778888999999999 99999999999886543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=310.27 Aligned_cols=230 Identities=17% Similarity=0.326 Sum_probs=181.9
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc--------chHHHHHHHHHHhccC--CCcccceeEEEEcCCeEEEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK--------KKREVDEWLRVIGGLR--HSNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lV 405 (640)
..+.||+|+||.||+|+. .+++.||||.+.... ..+.+..|+.++++++ |+||+++++++...+..++|
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv 126 (320)
T 3a99_A 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126 (320)
T ss_dssp EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEE
Confidence 357899999999999985 568889999987542 1234567888888886 59999999999999999999
Q ss_pred EeccCC-CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccCCccc
Q 006559 406 YDYLPH-GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGVHQ 483 (640)
Q Consensus 406 ~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl~~ 483 (640)
|||+.. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||+++
T Consensus 127 ~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 127 LERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 999976 89999997543 58899999999999999999995 4599999999999999 78999999999988
Q ss_pred ccCCC----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 484 LFHTP----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 484 ~~~~~----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
..... ..++..|+|||++... ..++.++|||||||++|||+||+.||.... .... ..
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~~---~~------ 259 (320)
T 3a99_A 199 LLKDTVYTDFDGTRVYSPPEWIRYH------RYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EIIR---GQ------ 259 (320)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHHH---CC------
T ss_pred ccccccccCCCCCccCCChHHhccC------CCCCccchHHhHHHHHHHHHHCCCCCCChh----hhhc---cc------
Confidence 76532 3468899999975321 223578999999999999999999996421 1000 00
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
....... ..++.+++.+||+.||++|||+.++++
T Consensus 260 ----~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 ----VFFRQRV---SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----CCCSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----ccccccC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001111 124667788899999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=299.07 Aligned_cols=223 Identities=15% Similarity=0.204 Sum_probs=169.3
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHH-hccCCCcccceeEEEEc----CCeEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVI-GGLRHSNIVSIRAYCNG----KDELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~~g 412 (640)
++||+|+||.||+++. .+++.||||.++.. ..+.+|+.++ +.++||||+++++++.. ....++||||+++|
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~ 100 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 100 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc---HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCC
Confidence 6799999999999996 56889999998643 4456677766 56699999999999876 66799999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCCCc
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHTPF 489 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~~~ 489 (640)
+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 101 ~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-- 172 (299)
T 3m2w_A 101 ELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-- 172 (299)
T ss_dssp BHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT--
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc--
Confidence 99999986532 258999999999999999999995 45999999999999998 78999999999865431
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC-h
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD-K 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~ 568 (640)
..++.++|||||||++|||+||+.||......... . .....+........ .
T Consensus 173 ---------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~-----~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 173 ---------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P-----GMKTRIRMGQYEFPNP 224 (299)
T ss_dssp ---------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC---------C-----CSCCSSCTTCCSSCHH
T ss_pred ---------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--H-----HHHHHHhhccccCCch
Confidence 23457899999999999999999999743211100 0 00000000000011 0
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.......++.+++..||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11122345777888899999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.39 Aligned_cols=230 Identities=20% Similarity=0.324 Sum_probs=176.3
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccc--------hHHHHHHHHHHhcc----CCCcccceeEEEEcCCeEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKK--------KREVDEWLRVIGGL----RHSNIVSIRAYCNGKDELF 403 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~e~~~l~~l----~H~niv~l~~~~~~~~~~~ 403 (640)
..+.||+|+||.||+|+. .+++.||||.+..... ...+..|+.++.++ +||||+++++++...+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~ 114 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114 (312)
T ss_dssp EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence 357899999999999985 5688999999965421 12344677777777 8999999999999889999
Q ss_pred EEEec-cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccCCc
Q 006559 404 LVYDY-LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGV 481 (640)
Q Consensus 404 lV~Ey-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl 481 (640)
+|||| +++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 99999 78999999997643 589999999999999999999954 599999999999999 889999999999
Q ss_pred ccccCC----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccc
Q 006559 482 HQLFHT----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW 557 (640)
Q Consensus 482 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (640)
++.... ...++..|+|||++.. ....+.++|||||||++|||+||+.||.... .... .
T Consensus 187 ~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~---~----- 248 (312)
T 2iwi_A 187 GALLHDEPYTDFDGTRVYSPPEWISR------HQYHALPATVWSLGILLYDMVCGDIPFERDQ----EILE---A----- 248 (312)
T ss_dssp CEECCSSCBCCCCSCTTTSCHHHHHH------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHHH---T-----
T ss_pred hhhcccCcccccCCcccccCceeeec------CCCCCccchHHHHHHHHHHHHHCCCCCCChH----HHhh---h-----
Confidence 887643 2345788999997532 1222458999999999999999999996421 1100 0
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........ ..++.+++.+||+.||++||++.|+++
T Consensus 249 -----~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 -----ELHFPAHV---SPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -----CCCCCTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----ccCCcccC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011111 224667788899999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=327.48 Aligned_cols=259 Identities=24% Similarity=0.289 Sum_probs=190.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEc------CCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNG------KDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lV~ 406 (640)
..+.||+|+||.||+|.. .+|..||||++... ...+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 357899999999999986 46889999998754 234567889999999999999999998765 66789999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC---eEEccCCccc
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN---ACISDIGVHQ 483 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl~~ 483 (640)
||+++|+|.+++..... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+++
T Consensus 98 Ey~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp ECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 99999999999986432 2247888899999999999999995 45999999999999997665 9999999998
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccc--
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA-- 556 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 556 (640)
.... ...++..|+|||++ ....++.++|||||||++|||+||+.||.... ....|..........
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l-------~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELL-------EQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-QPVQWHGKVREKSNEHI 244 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSS-------CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-HHHHSSTTCC------C
T ss_pred ccccccccccccCCcccCChHHh-------ccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-chhhhhhhhhcccchhh
Confidence 7643 23568899999964 34567889999999999999999999996432 222222211111000
Q ss_pred --ccc------cchhhccCh-HHHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHHHhhcc
Q 006559 557 --WEV------FDFELIMDK-EMEEEMRALLQVALLCLAPLPKDRPNMSI-----VHRMIEDIRTK 608 (640)
Q Consensus 557 --~~~------~d~~~~~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~-----v~~~L~~i~~~ 608 (640)
... +........ ........+.+++..||+.||++|||+.+ ..+.++++...
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000 000000000 01123345777888899999999999988 45667776654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=329.04 Aligned_cols=230 Identities=16% Similarity=0.217 Sum_probs=180.3
Q ss_pred hccccccCcceEEEEEeC--CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCe-----EEEEEe
Q 006559 338 AELLGKGCVGATYKVVLD--GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDE-----LFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~--~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----~~lV~E 407 (640)
.+.||+|+||.||+|+.. +++.||||.+.... ....+.+|++++++++||||+++++++...+. .|+|||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 567999999999999975 58899999986542 23467789999999999999999999987654 799999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++++|.+++.. .++|..++.++.||+.||+|||+. +||||||||+|||++.+ .+||+|||+++....
T Consensus 165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 9999999987753 489999999999999999999954 59999999999999985 899999999987654
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...+|..|+|||++.. ..+.++|||||||++|||++|..|+...... . +.
T Consensus 234 ~~~~~gt~~y~aPE~~~~--------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~----~~----- 285 (681)
T 2pzi_A 234 FGYLYGTPGFQAPEIVRT--------GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------G----LP----- 285 (681)
T ss_dssp CSCCCCCTTTSCTTHHHH--------CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------S----CC-----
T ss_pred CCccCCCccccCHHHHcC--------CCCCceehhhhHHHHHHHHhCCCCCcccccc-----------c----cc-----
Confidence 3457899999997532 2367999999999999999999887532100 0 00
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHHhh
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPN-MSIVHRMIEDIR 606 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~~v~~~L~~i~ 606 (640)
...........+.+++.+||+.||++||+ +.++...+..+.
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00011122345777888999999999995 666666666653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.02 Aligned_cols=239 Identities=16% Similarity=0.089 Sum_probs=168.8
Q ss_pred hccccccCcceEEEEE-eCCCcEEEEEEeccc-----cchHHHHHHHHHHhccCC-Ccccce---------eEE------
Q 006559 338 AELLGKGCVGATYKVV-LDGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRH-SNIVSI---------RAY------ 395 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H-~niv~l---------~~~------ 395 (640)
.++||+|+||+||+|+ ..+|+.||||++... ...+.+.+|+.+++.++| +|.... ...
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 5689999999999999 456899999998733 224668889999998887 322111 111
Q ss_pred ------EEc-----CCeEEEEEeccCCCCHHHhhccCC--CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCC
Q 006559 396 ------CNG-----KDELFLVYDYLPHGSLHSLLHGSR--GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLS 462 (640)
Q Consensus 396 ------~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk 462 (640)
+.. ....+++|+++ .++|.+++.... .....++++..++.++.|+++||+|||+ .+|||||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcc
Confidence 111 22467777765 689999884110 0112358899999999999999999995 459999999
Q ss_pred CCCeEECCCCCeEEccCCcccccCC---CccccccccCCccccCCC--Ccc-ccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 463 SSNIVVDQLGNACISDIGVHQLFHT---PFFINDAYNAPELKFNNN--NNY-SQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 463 ~~NILl~~~~~~kl~DfGl~~~~~~---~~~~~~~y~aPE~~~~~~--~~~-~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
|+|||++.++.+||+|||+++.... ...+ ..|+|||++.... ... ....++.++|||||||++|||+||+.||
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999876543 2345 8999999763211 000 3345778999999999999999999999
Q ss_pred CCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 537 GDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
...... .....++... ... ..++.+++..||+.||++||++.+++
T Consensus 318 ~~~~~~-----------~~~~~~~~~~----~~~---~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 318 TDDAAL-----------GGSEWIFRSC----KNI---PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp CTTGGG-----------SCSGGGGSSC----CCC---CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCcchh-----------hhHHHHHhhc----ccC---CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 753211 0001111100 111 13467778889999999999977764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-33 Score=292.04 Aligned_cols=234 Identities=13% Similarity=0.121 Sum_probs=171.6
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc----------chHHHHHHHHHHhccC---------CCcccceeEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK----------KKREVDEWLRVIGGLR---------HSNIVSIRAYCN 397 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------~~~~~~~e~~~l~~l~---------H~niv~l~~~~~ 397 (640)
..+.||+|+||+||+|+. +|+.||||++.... ..+.+.+|+++++.++ |||||++.+++.
T Consensus 24 ~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~ 102 (336)
T 2vuw_A 24 RCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC 102 (336)
T ss_dssp TCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEE
T ss_pred heeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeE
Confidence 467899999999999998 67999999997542 1267888888888775 777777666542
Q ss_pred -----------------c-------------CCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHH
Q 006559 398 -----------------G-------------KDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447 (640)
Q Consensus 398 -----------------~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~y 447 (640)
. .+..|+||||+++|++.+.+... .+++..+..++.|++.||+|
T Consensus 103 ~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------LSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT------CCCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc------CCCHHHHHHHHHHHHHHHHH
Confidence 2 67899999999999777666432 47899999999999999999
Q ss_pred hh-cCCCCCceecCCCCCCeEECCCC--------------------CeEEccCCcccccCCC-ccccccccCCccccCCC
Q 006559 448 LH-GYNKAHLFHGHLSSSNIVVDQLG--------------------NACISDIGVHQLFHTP-FFINDAYNAPELKFNNN 505 (640)
Q Consensus 448 LH-~~~~~~ivHrdlk~~NILl~~~~--------------------~~kl~DfGl~~~~~~~-~~~~~~y~aPE~~~~~~ 505 (640)
|| +.+ |+||||||+|||++.++ .+||+|||+++..... ..+|..|+|||++.+.
T Consensus 177 lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~- 252 (336)
T 2vuw_A 177 AEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD- 252 (336)
T ss_dssp HHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCC-
T ss_pred HHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCC-
Confidence 99 655 99999999999999887 8999999999877543 4578999999976432
Q ss_pred CccccCCCCCccchHHHHHH-HHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHc
Q 006559 506 NNYSQRKFWQRCDVYSFGVV-LLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLC 584 (640)
Q Consensus 506 ~~~~~~~~~~k~DV~SfGvv-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C 584 (640)
.+.++||||++++ .+++++|..||.. ..|........ ....................++.+++.+|
T Consensus 253 -------~~~~~Diwsl~~~~~~~~~~g~~p~~~-----~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 253 -------GDYQFDIYRLMKKENNNRWGEYHPYSN-----VLWLHYLTDKM-LKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp -------SSHHHHHHHHHHHHHTTCTTSCCTHHH-----HHHHHHHHHHH-HHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred -------CccceehhhhhCCCCcccccccCCCcc-----hhhhhHHHHhh-hhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 2578999998777 7788899999842 22322111100 00000000001122234556678888899
Q ss_pred cCCCCCCCCCHHHHH
Q 006559 585 LAPLPKDRPNMSIVH 599 (640)
Q Consensus 585 l~~~P~~RPs~~~v~ 599 (640)
|+.| |+.|++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9976 888776
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-28 Score=269.22 Aligned_cols=176 Identities=17% Similarity=0.067 Sum_probs=123.9
Q ss_pred cccccCcceEEEEE-eCCCcEEEEEEeccc------------cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEE
Q 006559 340 LLGKGCVGATYKVV-LDGGDVVVVKRIRER------------KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~-~~~~~~vavK~l~~~------------~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV 405 (640)
..+.|++|.++.++ .--|+.++||.+... ...+++.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777766654 345888999998643 1235688999999999 699999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 406 YDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
|||++||+|.++|.... +++.. +|+.||+.||+|+|+ .+||||||||+|||++++|.+||+|||+++..
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999999998653 45543 488999999999995 45999999999999999999999999999876
Q ss_pred CCC------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCC
Q 006559 486 HTP------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM 534 (640)
Q Consensus 486 ~~~------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~ 534 (640)
... .++|+.|+|||++.+ .+..++|+||+|++++++.++..
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g--------~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAE--------NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC-------------------------CCCCTTHH
T ss_pred CCCCccccCceechhhccHHHhCC--------CCCCcccccccccchhhhccccc
Confidence 432 346889999997532 34567999999999888766543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=241.56 Aligned_cols=188 Identities=30% Similarity=0.526 Sum_probs=168.0
Q ss_pred CChhhHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCceEecCCC--CcEEEEEeCCCCCCC---CchhccCCCCCCEE
Q 006559 22 SPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPST--HRVIKLVLEDLDLTG---PAEVLSRLTQLRLL 96 (640)
Q Consensus 22 ~~~~~~~~ll~~k~~~~~~~~~~~sW~~~~~~c~~~w~gv~C~~~~--~~v~~l~l~~~~l~g---~~~~l~~l~~L~~L 96 (640)
+...|.+||++||+++.++. .+.+|+.+.+||.+.|.||+|+..+ ++|+.|+|.++.++| .++.+.++++|++|
T Consensus 3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 45689999999999996554 5678976677774459999998765 799999999999998 34789999999999
Q ss_pred eCCC-CcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCc
Q 006559 97 SLKN-NLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNR 174 (640)
Q Consensus 97 ~Ls~-N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~ 174 (640)
+|++ |.+.+..| .+..+++|++|+|++|.+++.+|..|.++++|++|+|++|.+++.+| ..+..+++|++|+|++|+
T Consensus 82 ~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP-PSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCC-GGGGGCTTCCEEECCSSC
T ss_pred eCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCC-hHHhcCCCCCeEECcCCc
Confidence 9995 99987655 79999999999999999999999999999999999999999999898 789999999999999999
Q ss_pred ceecccCCcCCCC-CCcEEEcccCcCcccCCcccCCCC
Q 006559 175 FTGTLYSVNSSSR-SILDFNVSNNQLSGQIPAWMSPFG 211 (640)
Q Consensus 175 l~g~~~~~~~~~~-~L~~l~ls~N~l~g~ip~~~~~~~ 211 (640)
++|.+|..+..+. +|+.|++++|+++|.+|..+..+.
T Consensus 161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 198 (313)
T 1ogq_A 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence 9999999998888 999999999999999998876553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=247.97 Aligned_cols=175 Identities=15% Similarity=0.181 Sum_probs=137.2
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc----------chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK----------KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
.++||+|+||.||+|... +..+++|+...+. ..+.+.+|++++++++||||+++..++...+..|+|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999544 5778888764331 12347889999999999999977777777778899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++.. +..++.|+++||+|||+ .+|+||||||+|||++. .+||+|||+++....
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999874 35799999999999995 45999999999999999 999999999988754
Q ss_pred -------------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 488 -------------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 488 -------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
...+|..|+|||++.. ....|+.++|+||..+-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~-----~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWER-----FLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHH-----HHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHH-----HHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2345889999997632 1234667889999999988888877665
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=240.76 Aligned_cols=177 Identities=28% Similarity=0.376 Sum_probs=110.5
Q ss_pred CCChhhHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCceEecCCCCcEEEEEeCCCCCCCC----chhccC-------
Q 006559 21 NSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGP----AEVLSR------- 89 (640)
Q Consensus 21 ~~~~~~~~~ll~~k~~~~~~~~~~~sW~~~~~~c~~~w~gv~C~~~~~~v~~l~l~~~~l~g~----~~~l~~------- 89 (640)
+....|++||++||+++.++. .+++|+.++||| +|.||+|+ +++|+.|+|++.++.|. .+.+.+
T Consensus 8 ~~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C--~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKN-LLPDWSSNKNPC--TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGG--GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cCCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCc--CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 345789999999999997666 778997566655 89999999 58999999999999885 233444
Q ss_pred ----------------CCCCCEEeCCCCcCCCCCC---CCCCCCCCcEEEcccccccccCCccC-CCCCCCCEEEcccCC
Q 006559 90 ----------------LTQLRLLSLKNNLLSSSNL---NLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNA 149 (640)
Q Consensus 90 ----------------l~~L~~L~Ls~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~ 149 (640)
+++|++|+|++|.++|..+ .++++++|++|+|++|.+++.+|..+ .++++|++|||++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 4555555555555544222 34445555555555555554444433 445555555555555
Q ss_pred CCCCCCchh---cCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCc
Q 006559 150 YEGEIPMTE---LTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA 205 (640)
Q Consensus 150 l~g~~p~~~---~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~ 205 (640)
+++..| .. +.++++|++|+|++|.+++.++. ..+++|+.|++++|++++.+|.
T Consensus 163 l~~~~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~ 218 (768)
T 3rgz_A 163 ISGANV-VGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF 218 (768)
T ss_dssp CEEETH-HHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB
T ss_pred cCCcCC-hhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc
Confidence 554433 22 44555555555555555554443 4466677777777777766665
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-23 Score=240.33 Aligned_cols=181 Identities=23% Similarity=0.349 Sum_probs=153.3
Q ss_pred hhhHHHHHHhhhcCCCCCCCCCCCCCCC-----CCCCCCC------------CceEecCCCCcEEEEEeCCCCCCCCc-h
Q 006559 24 YSDISTLLSFKASVTGSSDSLSSWVNST-----DPCFDSW------------RGVTCNPSTHRVIKLVLEDLDLTGPA-E 85 (640)
Q Consensus 24 ~~~~~~ll~~k~~~~~~~~~~~sW~~~~-----~~c~~~w------------~gv~C~~~~~~v~~l~l~~~~l~g~~-~ 85 (640)
..|..||++||+++.++ +|+.+. +||+|+| .||+|+. .+||+.|+|++++++|.. +
T Consensus 268 ~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 268 IKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG
T ss_pred hHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch
Confidence 56999999999999654 675443 5655699 9999987 489999999999999875 7
Q ss_pred hccCCCCCCEEeC-CCCcCCCC----------------------------------------------------------
Q 006559 86 VLSRLTQLRLLSL-KNNLLSSS---------------------------------------------------------- 106 (640)
Q Consensus 86 ~l~~l~~L~~L~L-s~N~l~~~---------------------------------------------------------- 106 (640)
.+++|++|+.|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 8999999999999 88865432
Q ss_pred -------------------CCCCCCCCCCcEEEcccccccc-----------------cCCccCC--CCCCCCEEEcccC
Q 006559 107 -------------------NLNLSSWPHLKHLYLSHNRFTG-----------------TFPSGVS--SLRHLRRVDLSHN 148 (640)
Q Consensus 107 -------------------~~~~~~l~~L~~L~Ls~N~l~g-----------------~~p~~~~--~l~~L~~L~Ls~N 148 (640)
|..++++++|++|+|++|.|+| .+|..++ ++++|+.|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 2357788999999999999999 4999988 9999999999999
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCc-cee-cccCCcCC-------CCCCcEEEcccCcCcccCCc--ccCCCCC
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNR-FTG-TLYSVNSS-------SRSILDFNVSNNQLSGQIPA--WMSPFGG 212 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~-l~g-~~~~~~~~-------~~~L~~l~ls~N~l~g~ip~--~~~~~~~ 212 (640)
++.|.+| ..+.++++|+.|+|++|+ |+| .+|..+.. +++|+.|+|++|+|+ .+|. .+..+..
T Consensus 502 ~l~~~iP-~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~ 574 (876)
T 4ecn_A 502 PNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK 574 (876)
T ss_dssp TTCCSCC-GGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred CCCccCh-HHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence 9999999 789999999999999998 998 78865544 449999999999999 8888 6765543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.6e-23 Score=231.88 Aligned_cols=184 Identities=21% Similarity=0.334 Sum_probs=155.7
Q ss_pred hhhHHHHHHhhhcCCCCCCC--------CCCCCCCCCCCCCCC---CceEecCCCCcEEEEEeCCCCCCCCc-hhccCCC
Q 006559 24 YSDISTLLSFKASVTGSSDS--------LSSWVNSTDPCFDSW---RGVTCNPSTHRVIKLVLEDLDLTGPA-EVLSRLT 91 (640)
Q Consensus 24 ~~~~~~ll~~k~~~~~~~~~--------~~sW~~~~~~c~~~w---~gv~C~~~~~~v~~l~l~~~~l~g~~-~~l~~l~ 91 (640)
..|+.||.+++.++.++.+. ..+|+.+.++| .| .||+|+.. +||+.|+|++++++|.. +.+++|+
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c--~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD--MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG--GTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc--cccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCc
Confidence 46899999999998654332 23797666665 89 99999876 89999999999999865 7899999
Q ss_pred CCCEEeCCCCcC--------------------------------------------------------------------
Q 006559 92 QLRLLSLKNNLL-------------------------------------------------------------------- 103 (640)
Q Consensus 92 ~L~~L~Ls~N~l-------------------------------------------------------------------- 103 (640)
+|+.|+|++|.+
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 999999999954
Q ss_pred ----------CCCCCCCCCCCCCcEEEccccccccc-----------------CCccCC--CCCCCCEEEcccCCCCCCC
Q 006559 104 ----------SSSNLNLSSWPHLKHLYLSHNRFTGT-----------------FPSGVS--SLRHLRRVDLSHNAYEGEI 154 (640)
Q Consensus 104 ----------~~~~~~~~~l~~L~~L~Ls~N~l~g~-----------------~p~~~~--~l~~L~~L~Ls~N~l~g~~ 154 (640)
++.|..++++++|++|+|++|.|+|. +|..++ ++++|++|+|++|++.|.+
T Consensus 186 l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 186 TQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp TTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred hhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 23334578899999999999999996 999999 9999999999999999999
Q ss_pred CchhcCCCCCCcEEEccCCc-cee-cccCCcCCC------CCCcEEEcccCcCcccCCc--ccCCCCC
Q 006559 155 PMTELTRLPNLLTLRLEDNR-FTG-TLYSVNSSS------RSILDFNVSNNQLSGQIPA--WMSPFGG 212 (640)
Q Consensus 155 p~~~~~~l~~L~~L~L~~N~-l~g-~~~~~~~~~------~~L~~l~ls~N~l~g~ip~--~~~~~~~ 212 (640)
| ..++++++|++|+|++|+ ++| .+|..+..+ ++|+.|++++|+++ .+|. .+..+..
T Consensus 266 p-~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~ 331 (636)
T 4eco_A 266 P-TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKK 331 (636)
T ss_dssp C-TTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTT
T ss_pred h-HHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCC
Confidence 9 789999999999999998 999 888877665 89999999999999 8888 6765543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=198.19 Aligned_cols=137 Identities=15% Similarity=0.134 Sum_probs=111.1
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc--------------------chHHHHHHHHHHhccCCCcccceeEEEE
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK--------------------KKREVDEWLRVIGGLRHSNIVSIRAYCN 397 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------------~~~~~~~e~~~l~~l~H~niv~l~~~~~ 397 (640)
.+.||+|+||.||+|+..+|+.||||.++... ....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 37899999999999999779999999996431 2345788999999998 5 66666554
Q ss_pred cCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEc
Q 006559 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACIS 477 (640)
Q Consensus 398 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~ 477 (640)
. +..|+||||+++|+|.+ +... ....++.|++.||+|||+ .+|+||||||+|||++ ++.+||+
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~~-----------~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRVE-----------NPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCCS-----------CHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEEC
T ss_pred c-cceEEEEEecCCCcHHH-cchh-----------hHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEE
Confidence 3 55699999999999998 5321 234699999999999995 4599999999999999 9999999
Q ss_pred cCCcccccCCCccccccccCCccc
Q 006559 478 DIGVHQLFHTPFFINDAYNAPELK 501 (640)
Q Consensus 478 DfGl~~~~~~~~~~~~~y~aPE~~ 501 (640)
|||+++.. ..++|||++
T Consensus 235 DFG~a~~~-------~~~~a~e~l 251 (282)
T 1zar_A 235 DFPQSVEV-------GEEGWREIL 251 (282)
T ss_dssp CCTTCEET-------TSTTHHHHH
T ss_pred ECCCCeEC-------CCCCHHHHH
Confidence 99999754 346788864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=224.78 Aligned_cols=120 Identities=33% Similarity=0.550 Sum_probs=110.2
Q ss_pred CCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCc
Q 006559 111 SSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190 (640)
Q Consensus 111 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~ 190 (640)
..+++|+.|||++|+|+|.+|..|+++++|+.|+|++|+++|.+| ..++++++|+.|||++|+++|.+|..+..+++|+
T Consensus 629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip-~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP-DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCC-GGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCC-hHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 345778999999999999999999999999999999999999999 7899999999999999999999999999999999
Q ss_pred EEEcccCcCcccCCcc--cCCCCCCCCCCCcccCCCCCCCCCCC
Q 006559 191 DFNVSNNQLSGQIPAW--MSPFGGSSFAGNKNLCGRPLPSDCSN 232 (640)
Q Consensus 191 ~l~ls~N~l~g~ip~~--~~~~~~~~~~gn~~lcg~~~~~~c~~ 232 (640)
.|||++|+|+|.||.. +.++...+|.||+++||.|++ .|..
T Consensus 708 ~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp EEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred EEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 9999999999999974 677888899999999999987 5854
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-21 Score=202.48 Aligned_cols=184 Identities=19% Similarity=0.259 Sum_probs=151.4
Q ss_pred CChhhHHHHHHhhhcCC-CCCCCCCCCC----CCCCCCCCCCCceEecC--------CCCcEEEEEeCCCCCCCCchhcc
Q 006559 22 SPYSDISTLLSFKASVT-GSSDSLSSWV----NSTDPCFDSWRGVTCNP--------STHRVIKLVLEDLDLTGPAEVLS 88 (640)
Q Consensus 22 ~~~~~~~~ll~~k~~~~-~~~~~~~sW~----~~~~~c~~~w~gv~C~~--------~~~~v~~l~l~~~~l~g~~~~l~ 88 (640)
...+|..+|++||..+. ++.....+|. ...++| .|.|+.|+. ...+|+.|+|+++.++..++.+.
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~--~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~~lp~~l~ 101 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE--TRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAF 101 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC--CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCSSCCSCGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhccccccccccc--ccCCcchhhhHHHHhcccccceeEEEccCCCchhcChhhh
Confidence 34678999999999883 4433345783 233344 899999952 34689999999999997777788
Q ss_pred CCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcC--------
Q 006559 89 RLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELT-------- 160 (640)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~-------- 160 (640)
.+++|++|+|++|.++..+..+..+++|++|+|++|.|+ .+|..++++++|++|+|++|++.+.+| ..+.
T Consensus 102 ~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p-~~~~~~~~~~~~ 179 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP-EPLASTDASGEH 179 (328)
T ss_dssp GGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCC-SCSEEEC-CCCE
T ss_pred hCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccC-hhHhhccchhhh
Confidence 899999999999999966667999999999999999999 789999999999999999999999998 4444
Q ss_pred -CCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC
Q 006559 161 -RLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG 211 (640)
Q Consensus 161 -~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~ 211 (640)
++++|++|+|++|+++ .+|..+..+++|+.|+|++|++++ +|..+..++
T Consensus 180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~ 229 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP 229 (328)
T ss_dssp EESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCT
T ss_pred ccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCC
Confidence 4899999999999998 778888889999999999999986 555555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.8e-19 Score=169.86 Aligned_cols=152 Identities=24% Similarity=0.262 Sum_probs=128.5
Q ss_pred CCCCCCCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCCC-CCCCCCCcEEE
Q 006559 52 DPCFDSWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLY 120 (640)
Q Consensus 52 ~~c~~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~ 120 (640)
+.|.|+|++|.|... ..+++.|+|+++.+++.. ..+..+++|+.|+|++|.+++.++. +..+++|++|+
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 356679999999753 236888999999998765 4578999999999999999987664 68899999999
Q ss_pred cccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCc
Q 006559 121 LSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 121 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
|++|.+++..+..|.++++|+.|+|++|++++ +|...+..+++|++|+|++|++++..+..+..+++|+.|++++|.+.
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCcc-cCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 99999997777778999999999999999985 45466888999999999999999877777888899999999999887
Q ss_pred ccCC
Q 006559 201 GQIP 204 (640)
Q Consensus 201 g~ip 204 (640)
+..|
T Consensus 162 ~~~~ 165 (208)
T 2o6s_A 162 CTCP 165 (208)
T ss_dssp CCTT
T ss_pred cCCC
Confidence 7666
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=9.8e-19 Score=171.49 Aligned_cols=154 Identities=23% Similarity=0.257 Sum_probs=101.3
Q ss_pred CCCCCCCCCCCCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCC
Q 006559 47 WVNSTDPCFDSWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPH 115 (640)
Q Consensus 47 W~~~~~~c~~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~ 115 (640)
|+.+...| +|++|.|... ...+..|+|+++.+++.. ..+..+++|+.|+|++|.|+..++ .+..+++
T Consensus 12 ~~~~~~~C--s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 89 (229)
T 3e6j_A 12 ACPSQCSC--SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ 89 (229)
T ss_dssp CCCTTCEE--ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred cCCCCCEE--eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCC
Confidence 33344444 8999999753 124566677777766653 456667777777777777766554 3566777
Q ss_pred CcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcc
Q 006559 116 LKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVS 195 (640)
Q Consensus 116 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls 195 (640)
|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+| ..+..+++|++|+|++|+|++..+..+..+++|+.|+|+
T Consensus 90 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 167 (229)
T 3e6j_A 90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELP-RGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF 167 (229)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCC-TTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccC-cccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence 777777777776655555666777777777777776 566 456666777777777777776555566666777777777
Q ss_pred cCcCcccCC
Q 006559 196 NNQLSGQIP 204 (640)
Q Consensus 196 ~N~l~g~ip 204 (640)
+|.+++..+
T Consensus 168 ~N~~~c~c~ 176 (229)
T 3e6j_A 168 GNPWDCECR 176 (229)
T ss_dssp TSCBCTTBG
T ss_pred CCCccCCcc
Confidence 777665544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-18 Score=171.75 Aligned_cols=153 Identities=23% Similarity=0.282 Sum_probs=122.4
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
.+..|+|.++.+++.. ..+..+++|+.|+|++|.|++.++ .+..+++|++|+|++|.|++..|..|.++++|+.|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 5677888888888765 468889999999999999988766 47888999999999999988777788889999999999
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC---CCCCCCCcccC
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG---GSSFAGNKNLC 222 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~---~~~~~gn~~lc 222 (640)
+|++++ +|...+..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++..|..+..+. ...+.+|+..|
T Consensus 116 ~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 116 GNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp SSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CCcCCC-cChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 999985 5546678889999999999999887777788888999999999999877776665443 33445555443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.5e-19 Score=171.66 Aligned_cols=152 Identities=18% Similarity=0.224 Sum_probs=90.1
Q ss_pred CCCCCCCCceEecCCC---------CcEEEEEeCCCCCCCCc--hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEE
Q 006559 52 DPCFDSWRGVTCNPST---------HRVIKLVLEDLDLTGPA--EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHL 119 (640)
Q Consensus 52 ~~c~~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~--~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L 119 (640)
+.|.|.|+.+.|.... ..+..|+|++|.+++.. ..+..+++|+.|+|++|.|++.++ .+..+++|++|
T Consensus 7 ~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 7 EKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 3465678877776421 23445666666665542 335566666666666666665544 45666666666
Q ss_pred EcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcC
Q 006559 120 YLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQL 199 (640)
Q Consensus 120 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l 199 (640)
+|++|.|++..|..|.++++|+.|+|++|++++..| ..|..+++|++|+|++|+|++..|..+..+++|+.|+|++|.|
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGN-DSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCT-TSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECH-hHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 666666665555556666666666666666665434 4556666666666666666665566666666666666666666
Q ss_pred cccCC
Q 006559 200 SGQIP 204 (640)
Q Consensus 200 ~g~ip 204 (640)
++..+
T Consensus 166 ~c~c~ 170 (220)
T 2v70_A 166 NCNCY 170 (220)
T ss_dssp ECSGG
T ss_pred cCCCc
Confidence 55443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-18 Score=166.72 Aligned_cols=156 Identities=22% Similarity=0.274 Sum_probs=110.2
Q ss_pred CCCCCCCCceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccC
Q 006559 52 DPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTF 130 (640)
Q Consensus 52 ~~c~~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~ 130 (640)
..|.|.|..|.|.. ++++..+..+. ++|+.|+|++|.|++.++ .+..+++|++|+|++|.+++..
T Consensus 7 ~~C~C~~~~v~c~~------------~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~ 72 (220)
T 2v9t_B 7 AACTCSNNIVDCRG------------KGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELA 72 (220)
T ss_dssp TTSEEETTEEECTT------------SCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEEC
T ss_pred CCCEECCCEEEcCC------------CCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcC
Confidence 34656788888864 33333332222 577888888888877655 5777888888888888888777
Q ss_pred CccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCC
Q 006559 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 131 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
|..|.++++|+.|+|++|+++ .+|...|..+++|++|+|++|+|++..|..+..+++|+.|+|++|+|++..|..+..+
T Consensus 73 ~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 151 (220)
T 2v9t_B 73 PDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151 (220)
T ss_dssp TTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred HHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCC
Confidence 778888888888888888887 4564667778888888888888887777777778888888888888887666655544
Q ss_pred CC---CCCCCCcccC
Q 006559 211 GG---SSFAGNKNLC 222 (640)
Q Consensus 211 ~~---~~~~gn~~lc 222 (640)
.. ..+.+|+..|
T Consensus 152 ~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 152 RAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTCCEEECCSSCEEC
T ss_pred CCCCEEEeCCCCcCC
Confidence 32 3445665554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=7.6e-18 Score=160.40 Aligned_cols=158 Identities=23% Similarity=0.352 Sum_probs=126.2
Q ss_pred CCCCCCCceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCC--CCCCCCCcEEEcccccccccC
Q 006559 53 PCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLN--LSSWPHLKHLYLSHNRFTGTF 130 (640)
Q Consensus 53 ~c~~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~--~~~l~~L~~L~Ls~N~l~g~~ 130 (640)
.|.|.|+.+.|. +++++..+..+. .+|+.|+|++|.|++.++. +..+++|++|+|++|.|++..
T Consensus 5 ~C~C~~~~l~~s------------~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 70 (192)
T 1w8a_A 5 MCHCEGTTVDCT------------GRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE 70 (192)
T ss_dssp TSEEETTEEECT------------TSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBC
T ss_pred CCEECCCEEEcC------------CCCcCcCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcC
Confidence 455567666664 445554443332 3899999999999988764 889999999999999999999
Q ss_pred CccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCc-ccCC
Q 006559 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA-WMSP 209 (640)
Q Consensus 131 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~-~~~~ 209 (640)
|..|.++++|+.|+|++|++++..| ..|..+++|++|+|++|+|++.+|..+..+++|+.|+|++|.|++..+- |+..
T Consensus 71 ~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~ 149 (192)
T 1w8a_A 71 PNAFEGASHIQELQLGENKIKEISN-KMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE 149 (192)
T ss_dssp TTTTTTCTTCCEEECCSCCCCEECS-SSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHH
T ss_pred HhHcCCcccCCEEECCCCcCCccCH-HHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHH
Confidence 9999999999999999999997555 7789999999999999999999999999999999999999999998763 2211
Q ss_pred -CCCCCCCCCcccCCCC
Q 006559 210 -FGGSSFAGNKNLCGRP 225 (640)
Q Consensus 210 -~~~~~~~gn~~lcg~~ 225 (640)
+....+.++...|+.|
T Consensus 150 ~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 150 WLRKKSLNGGAARCGAP 166 (192)
T ss_dssp HHHHHCCSGGGCBBCSS
T ss_pred HHHHcCCCCCCCCCCCC
Confidence 1112334555567665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.6e-18 Score=173.11 Aligned_cols=132 Identities=15% Similarity=0.142 Sum_probs=101.9
Q ss_pred hccccccCcceEEEEEe-CCCcE--EEEEEecccc-c-------------------------hHHHHHHHHHHhccCCCc
Q 006559 338 AELLGKGCVGATYKVVL-DGGDV--VVVKRIRERK-K-------------------------KREVDEWLRVIGGLRHSN 388 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~-~-------------------------~~~~~~e~~~l~~l~H~n 388 (640)
.+.||+|+||.||+|.. .+|.. ||||.++... . ...+.+|++.+.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 46799999999999997 67888 9999875431 0 125678899999999886
Q ss_pred c--cceeEEEEcCCeEEEEEeccCC-C----CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhh-cCCCCCceecC
Q 006559 389 I--VSIRAYCNGKDELFLVYDYLPH-G----SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH-GYNKAHLFHGH 460 (640)
Q Consensus 389 i--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrd 460 (640)
+ ...+++ +..+|||||+.+ | +|.++... .++.....++.|++.||.||| +.+ |+|||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 5 333332 356899999942 4 67766432 123356789999999999999 654 99999
Q ss_pred CCCCCeEECCCCCeEEccCCcccccC
Q 006559 461 LSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 461 lk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
|||+|||++. .++|+|||++....
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999998 99999999997653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=178.92 Aligned_cols=159 Identities=28% Similarity=0.409 Sum_probs=112.5
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCC-CCc-----------------------EEEcc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWP-HLK-----------------------HLYLS 122 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~-~L~-----------------------~L~Ls 122 (640)
++..|+|++|.+++.. ..+..+++|++|+|++|.+++..+ .+..++ +|+ .|+|+
T Consensus 126 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls 205 (313)
T 1ogq_A 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS 205 (313)
T ss_dssp TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECC
T ss_pred CCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECc
Confidence 5666777777666533 456666666666666666664322 344444 444 45555
Q ss_pred cccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 123 HNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 123 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
+|.+++.+|..|.++++|+.|+|++|.+++.+| . +..+++|++|+|++|++++.+|..+..+++|+.|+|++|+|+|.
T Consensus 206 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 283 (313)
T 1ogq_A 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp SSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-G-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred CCcccCcCCHHHhcCCCCCEEECCCCceeeecC-c-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccccc
Confidence 555555555566667777777777777776555 2 67788888888888999888888888899999999999999999
Q ss_pred CCcc--cCCCCCCCCCCCcccCCCCCCCCC
Q 006559 203 IPAW--MSPFGGSSFAGNKNLCGRPLPSDC 230 (640)
Q Consensus 203 ip~~--~~~~~~~~~~gn~~lcg~~~~~~c 230 (640)
+|.. +..+....+.+|+.+||.|++. |
T Consensus 284 ip~~~~l~~L~~l~l~~N~~lc~~p~~~-C 312 (313)
T 1ogq_A 284 IPQGGNLQRFDVSAYANNKCLCGSPLPA-C 312 (313)
T ss_dssp CCCSTTGGGSCGGGTCSSSEEESTTSSC-C
T ss_pred CCCCccccccChHHhcCCCCccCCCCCC-C
Confidence 9875 3345566788999999988774 6
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=4.3e-17 Score=152.97 Aligned_cols=138 Identities=21% Similarity=0.246 Sum_probs=116.7
Q ss_pred CCCCCCCCceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccC
Q 006559 52 DPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTF 130 (640)
Q Consensus 52 ~~c~~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~ 130 (640)
+.|.|+|++|.|... +++..+. ...++|+.|+|++|.+++.++ .+..+++|++|+|++|.|++..
T Consensus 3 ~~C~C~~~~l~~~~~------------~l~~~p~--~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK------------GLTSVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLP 68 (177)
T ss_dssp TTCEEETTEEECCSS------------CCSSCCT--TCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCCEeCCCEEEecCC------------CCccCCC--CCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeC
Confidence 356679999999753 3333222 224789999999999998776 4789999999999999999877
Q ss_pred CccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 131 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
+..|.++++|+.|+|++|++++ +|...+..+++|++|+|++|+|++..+..+..+++|+.|+|++|.+++..|
T Consensus 69 ~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 69 DGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhHccCCCccCEEECCCCCccc-cCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7778999999999999999996 454678899999999999999998777777889999999999999998876
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-16 Score=160.64 Aligned_cols=153 Identities=24% Similarity=0.262 Sum_probs=131.9
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCC-CCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
.++..|+|+++.+++. +.+..+++|++|+|++|.+++.++. +..+++|++|+|++|++++..|..|.++++|+.|+|+
T Consensus 63 ~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 141 (272)
T 3rfs_A 63 PNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA 141 (272)
T ss_dssp TTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECC
Confidence 4688999999999885 5789999999999999999988764 7899999999999999998888889999999999999
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCC---CCCCCCcccC
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGG---SSFAGNKNLC 222 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~---~~~~gn~~lc 222 (640)
+|++++ +|...+..+++|+.|+|++|++++..+..+..+++|+.|++++|+|++..|..+..+.. ..+.+|+..|
T Consensus 142 ~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 142 HNQLQS-LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp SSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccCc-cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 999996 45467889999999999999999888888888999999999999999988876655443 3445665544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=9.6e-17 Score=161.42 Aligned_cols=139 Identities=24% Similarity=0.278 Sum_probs=91.9
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCCC-CCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
.+..|+|+++.+++.. ..+..+++|++|+|++|.++..++. +..+++|++|+|++|.+++..+..|.++++|+.|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 3556666666666544 3566777777777777777665553 4667777777777777776555566777777777777
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
+|++++. |...+..+++|++|+|++|.+++..+..+..+++|+.|+|++|++++..|..+.
T Consensus 118 ~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 178 (270)
T 2o6q_A 118 RNQLKSL-PPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFD 178 (270)
T ss_dssp SSCCCCC-CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred CCccCee-CHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhc
Confidence 7777643 335566777777777777777766555566667777777777777665554443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.71 E-value=8.9e-17 Score=156.46 Aligned_cols=135 Identities=22% Similarity=0.196 Sum_probs=122.1
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
..++.|+|++|.+++.. ..+..+++|+.|+|++|.+++..+ .+..+++|++|+|++|.|+...+..|.++++|+.|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 46899999999998765 478999999999999999998755 7999999999999999999766667899999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccC
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~i 203 (640)
++|++++..| ..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|.|...-
T Consensus 112 ~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 112 NANKINCLRV-DAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CSSCCCCCCT-TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCCCEeCH-HHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 9999997655 78999999999999999999988888999999999999999998643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-16 Score=155.57 Aligned_cols=156 Identities=19% Similarity=0.215 Sum_probs=131.6
Q ss_pred CceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC--CCCCCCCCcEEEcccccccccCCccCCC
Q 006559 59 RGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL--NLSSWPHLKHLYLSHNRFTGTFPSGVSS 136 (640)
Q Consensus 59 ~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 136 (640)
.+-+|.. ..++++++.++..+..+ ...++.|+|++|.|++.++ .+..+++|++|+|++|.|++..|..|.+
T Consensus 7 ~~C~C~~-----~~l~~s~n~l~~iP~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~ 79 (220)
T 2v70_A 7 EKCRCEG-----TTVDCSNQKLNKIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEG 79 (220)
T ss_dssp TTCEEET-----TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTT
T ss_pred CCCEECC-----CEeEeCCCCcccCccCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCC
Confidence 4556753 26889999998766544 3457899999999998754 3889999999999999999988889999
Q ss_pred CCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCC---C
Q 006559 137 LRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGG---S 213 (640)
Q Consensus 137 l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~---~ 213 (640)
+++|+.|+|++|++++ +|...|..+++|++|+|++|+|++..|..+..+++|+.|+|++|+|++..|..+..+.. .
T Consensus 80 l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 158 (220)
T 2v70_A 80 ASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL 158 (220)
T ss_dssp CTTCCEEECCSSCCCC-CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccCc-cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEE
Confidence 9999999999999996 45477999999999999999999999999999999999999999999998988776543 3
Q ss_pred CCCCCcccC
Q 006559 214 SFAGNKNLC 222 (640)
Q Consensus 214 ~~~gn~~lc 222 (640)
.+.+|+..|
T Consensus 159 ~L~~N~l~c 167 (220)
T 2v70_A 159 NLLANPFNC 167 (220)
T ss_dssp ECCSCCEEC
T ss_pred EecCcCCcC
Confidence 445665544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-17 Score=174.85 Aligned_cols=171 Identities=20% Similarity=0.182 Sum_probs=139.3
Q ss_pred CCCCCCCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhcc-CCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEE
Q 006559 52 DPCFDSWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLS-RLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHL 119 (640)
Q Consensus 52 ~~c~~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~-~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L 119 (640)
..|.|.+..|.|... ...+..|+|++|.+++.. ..+. .+++|+.|+|++|.|++.++ .+..+++|++|
T Consensus 14 ~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 93 (361)
T 2xot_A 14 ANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYL 93 (361)
T ss_dssp TTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEE
Confidence 346678899999652 234778999999998865 4465 89999999999999998776 58999999999
Q ss_pred EcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCc---CCCCCCcEEEccc
Q 006559 120 YLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVN---SSSRSILDFNVSN 196 (640)
Q Consensus 120 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~---~~~~~L~~l~ls~ 196 (640)
+|++|+|++..+..|.++++|+.|+|++|++++..| ..|..+++|+.|+|++|+|++..+..+ ..+++|+.|+|++
T Consensus 94 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~ 172 (361)
T 2xot_A 94 DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDR-NAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSS 172 (361)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCS
T ss_pred ECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECH-HHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCC
Confidence 999999998888889999999999999999996555 789999999999999999998666555 5689999999999
Q ss_pred CcCcccCCcccCCCC-----CCCCCCCcccCC
Q 006559 197 NQLSGQIPAWMSPFG-----GSSFAGNKNLCG 223 (640)
Q Consensus 197 N~l~g~ip~~~~~~~-----~~~~~gn~~lcg 223 (640)
|+|++..+..+..++ ...+.+|+..|.
T Consensus 173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp SCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence 999965544554443 345677777664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=158.96 Aligned_cols=135 Identities=25% Similarity=0.315 Sum_probs=122.9
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.++..|+|++|.+++.. ..+..+++|+.|+|++|.|++.++ .+..+++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 138 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence 47899999999999865 558999999999999999998876 5789999999999999999877778899999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccC
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~i 203 (640)
++|++++ +|...+..+++|++|+|++|+|++..+..+..+++|+.|+|++|.|++..
T Consensus 139 s~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 139 NTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred cCCcCCc-cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 9999995 55467999999999999999999988888999999999999999999873
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3e-16 Score=159.47 Aligned_cols=131 Identities=24% Similarity=0.299 Sum_probs=75.3
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.+..|+|++|.+++.. ..+..+++|+.|+|++|.|++.++. ..+++|++|+|++|.|+ .+|..+.++++|+.|+|++
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~ 109 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCC
Confidence 5666777777766543 4566666666666666666554322 45555666666666555 4555555555666666666
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
|++++ +|+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++.
T Consensus 110 N~l~~-l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 163 (290)
T 1p9a_G 110 NRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (290)
T ss_dssp SCCCC-CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred CcCcc-cCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCcc
Confidence 66553 3324455555566666666655555555555555555555555555533
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.6e-16 Score=155.28 Aligned_cols=154 Identities=21% Similarity=0.254 Sum_probs=132.0
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.++..|+|+++.++... ..+..+++|++|+|++|.+++.++ .+..+++|++|+|++|.+++..|..|.++++|+.|+|
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 46889999999998765 456899999999999999998876 5789999999999999999988888999999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC---CCCCCCCcccC
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG---GSSFAGNKNLC 222 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~---~~~~~gn~~lc 222 (640)
++|.+++ +|...+..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|++..+..+..+. ...+.+|+..|
T Consensus 141 s~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 141 GYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCcCCc-cCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 9999995 5646789999999999999999998888888899999999999999976665555443 33455665544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.67 E-value=8.9e-16 Score=150.35 Aligned_cols=156 Identities=21% Similarity=0.218 Sum_probs=127.3
Q ss_pred CCceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCC
Q 006559 58 WRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSS 136 (640)
Q Consensus 58 w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 136 (640)
|..-.|.. ..++..+++++..+..+ .++|+.|+|++|.|++.++ .+..+++|++|+|++|+|++..+..|.+
T Consensus 14 ~~~~~Cs~-----~~v~c~~~~l~~ip~~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 86 (229)
T 3e6j_A 14 PSQCSCSG-----TTVDCRSKRHASVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS 86 (229)
T ss_dssp CTTCEEET-----TEEECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCCEEeC-----CEeEccCCCcCccCCCC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhccc
Confidence 55666753 24778888887765433 3899999999999999865 6899999999999999998766677899
Q ss_pred CCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCC---C
Q 006559 137 LRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGG---S 213 (640)
Q Consensus 137 l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~---~ 213 (640)
+++|+.|+|++|++++ +|...|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+.. .
T Consensus 87 l~~L~~L~Ls~N~l~~-l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 164 (229)
T 3e6j_A 87 LTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164 (229)
T ss_dssp CTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCEEECCCCcCCc-cChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 9999999999999995 55477899999999999999999 67888889999999999999999776665654433 3
Q ss_pred CCCCCcccC
Q 006559 214 SFAGNKNLC 222 (640)
Q Consensus 214 ~~~gn~~lc 222 (640)
.+.+|+..|
T Consensus 165 ~l~~N~~~c 173 (229)
T 3e6j_A 165 YLFGNPWDC 173 (229)
T ss_dssp ECTTSCBCT
T ss_pred EeeCCCccC
Confidence 445665444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=162.83 Aligned_cols=158 Identities=23% Similarity=0.277 Sum_probs=110.9
Q ss_pred CCCCCCCCceEecCCC---------CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCC---CCCCCCCCCCcE
Q 006559 52 DPCFDSWRGVTCNPST---------HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSS---NLNLSSWPHLKH 118 (640)
Q Consensus 52 ~~c~~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~---~~~~~~l~~L~~ 118 (640)
+.|.|.|++|.|+... ..++.|+|+++.++..+ ..+..+++|+.|+|++|.++.. +..+..+++|++
T Consensus 3 ~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 3566799999997532 47899999999998765 4578999999999999998754 224455677777
Q ss_pred EEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCc
Q 006559 119 LYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQ 198 (640)
Q Consensus 119 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~ 198 (640)
|+|++|.+++ +|..+.++++|+.|+|++|++++..+...+..+++|++|+|++|.+++..+..+..+++|+.|++++|.
T Consensus 83 L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 83 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161 (306)
T ss_dssp EECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred EECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence 7777777763 555566777777777777777643332456666777777777777776666666666777777777777
Q ss_pred Ccc-cCCcccCCC
Q 006559 199 LSG-QIPAWMSPF 210 (640)
Q Consensus 199 l~g-~ip~~~~~~ 210 (640)
+++ .+|..+..+
T Consensus 162 l~~~~~~~~~~~l 174 (306)
T 2z66_A 162 FQENFLPDIFTEL 174 (306)
T ss_dssp EGGGEECSCCTTC
T ss_pred cccccchhHHhhC
Confidence 765 455555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.66 E-value=8.7e-16 Score=154.57 Aligned_cols=137 Identities=25% Similarity=0.296 Sum_probs=124.0
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCCC-CCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNLN-LSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.++..|+|+++.+++.. ..+..+++|+.|+|++|.+++.++. +..+++|++|+|++|.+++..|..+.++++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 47899999999999866 4579999999999999999988774 789999999999999999888888899999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCc
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA 205 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~ 205 (640)
++|++++ +|...+..+++|++|+|++|++++.++..+..+++|+.|++++|.+.|..|.
T Consensus 165 ~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 165 SYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCCcCc-cCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 9999996 4447789999999999999999998888889999999999999999888773
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-16 Score=164.88 Aligned_cols=142 Identities=15% Similarity=0.204 Sum_probs=122.4
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCC---------CCCCCcEEEcccccccccCCccCCCC
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLS---------SWPHLKHLYLSHNRFTGTFPSGVSSL 137 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~---------~l~~L~~L~Ls~N~l~g~~p~~~~~l 137 (640)
.++..|+|++|.++..+..+..+++|+.|+|++|.+.+..| .+. .+++|++|+|++|.|+ .+|..++++
T Consensus 127 ~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l 205 (328)
T 4fcg_A 127 AGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANL 205 (328)
T ss_dssp TTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGC
T ss_pred CCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCC
Confidence 36888999999998767789999999999999987777554 444 4899999999999998 788889999
Q ss_pred CCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCC
Q 006559 138 RHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGG 212 (640)
Q Consensus 138 ~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~ 212 (640)
++|+.|+|++|++++ +| ..+..+++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|.++..+..
T Consensus 206 ~~L~~L~L~~N~l~~-l~-~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~ 278 (328)
T 4fcg_A 206 QNLKSLKIRNSPLSA-LG-PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278 (328)
T ss_dssp TTCCEEEEESSCCCC-CC-GGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTT
T ss_pred CCCCEEEccCCCCCc-Cc-hhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCC
Confidence 999999999999985 66 46889999999999999999999999989999999999999999999987765543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.6e-16 Score=148.10 Aligned_cols=126 Identities=20% Similarity=0.182 Sum_probs=108.0
Q ss_pred eCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCC
Q 006559 75 LEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEI 154 (640)
Q Consensus 75 l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~ 154 (640)
+++++++..+..+ .++|+.|+|++|.|+..+..+..+++|+.|+|++|.|++..|..|.++++|+.|+|++|++++..
T Consensus 17 ~~~~~l~~ip~~~--~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~ 94 (193)
T 2wfh_A 17 CSNKGLKVLPKGI--PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94 (193)
T ss_dssp CTTSCCSSCCSCC--CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred cCCCCCCcCCCCC--CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeC
Confidence 3344555443323 35899999999999987778999999999999999999988889999999999999999999654
Q ss_pred CchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccC
Q 006559 155 PMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203 (640)
Q Consensus 155 p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~i 203 (640)
| ..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|.+.+.-
T Consensus 95 ~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 95 P-RTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp T-TTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred H-HHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 4 78999999999999999999877778888999999999999998643
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.7e-16 Score=164.51 Aligned_cols=155 Identities=23% Similarity=0.253 Sum_probs=119.7
Q ss_pred CCCCCCceEecCC-----------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEE
Q 006559 54 CFDSWRGVTCNPS-----------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLY 120 (640)
Q Consensus 54 c~~~w~gv~C~~~-----------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~ 120 (640)
|.|.|.|+ |+.. ..++..|+|+++.+++.. ..+..+++|+.|+|++|.+++.++ .+..+++|++|+
T Consensus 28 ~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 28 LSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp CEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 33489988 7642 136778888888887755 368888888888888888887655 588888888888
Q ss_pred cccccccccCCccCCCCCCCCEEEcccCCCCCCCCc-hhcCCCCCCcEEEccCC-cceecccCCcCCCCCCcEEEcccCc
Q 006559 121 LSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPM-TELTRLPNLLTLRLEDN-RFTGTLYSVNSSSRSILDFNVSNNQ 198 (640)
Q Consensus 121 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~~l~~L~~L~L~~N-~l~g~~~~~~~~~~~L~~l~ls~N~ 198 (640)
|++|.+++..+..|.++++|++|+|++|+++ .+|. ..+..+++|++|++++| .+++..+..+..+++|+.|++++|+
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 8888888655555888888888888888888 4664 46788888888888888 4666667778888888888888888
Q ss_pred CcccCCcccCCC
Q 006559 199 LSGQIPAWMSPF 210 (640)
Q Consensus 199 l~g~ip~~~~~~ 210 (640)
+++..|..+..+
T Consensus 186 l~~~~~~~l~~l 197 (353)
T 2z80_A 186 LQSYEPKSLKSI 197 (353)
T ss_dssp CCEECTTTTTTC
T ss_pred cCccCHHHHhcc
Confidence 888777766543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.6e-16 Score=170.49 Aligned_cols=158 Identities=17% Similarity=0.149 Sum_probs=134.8
Q ss_pred CCCCCCCceEecCCC--------CcEEEEEeCCCCCCCC-chhccCCCCCCEEeCCCCcCCCCC--CCCCCCCCCcEEEc
Q 006559 53 PCFDSWRGVTCNPST--------HRVIKLVLEDLDLTGP-AEVLSRLTQLRLLSLKNNLLSSSN--LNLSSWPHLKHLYL 121 (640)
Q Consensus 53 ~c~~~w~gv~C~~~~--------~~v~~l~l~~~~l~g~-~~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~l~~L~~L~L 121 (640)
.|.|.+..|.|.... .++..|+|+++.+++. +..+.++++|++|+|++|.+.+.. ..+..+++|++|+|
T Consensus 7 ~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 7 ECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred eeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeC
Confidence 343334447786532 4689999999999886 467999999999999999998643 36899999999999
Q ss_pred ccccccccCCccCCCCCCCCEEEcccCCCCCCCCc-hhcCCCCCCcEEEccCCcceecccCC-cCCCCCCcEEEcccCcC
Q 006559 122 SHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPM-TELTRLPNLLTLRLEDNRFTGTLYSV-NSSSRSILDFNVSNNQL 199 (640)
Q Consensus 122 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~~l~~L~~L~L~~N~l~g~~~~~-~~~~~~L~~l~ls~N~l 199 (640)
++|.+++..|..|+++++|++|+|++|++++.+|. ..+..+++|++|+|++|++++..|.. +..+++|+.|++++|++
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l 166 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence 99999999999999999999999999999986552 23889999999999999999988876 78899999999999999
Q ss_pred cccCCcccCCC
Q 006559 200 SGQIPAWMSPF 210 (640)
Q Consensus 200 ~g~ip~~~~~~ 210 (640)
++..|..+..+
T Consensus 167 ~~~~~~~l~~l 177 (455)
T 3v47_A 167 KSICEEDLLNF 177 (455)
T ss_dssp SCCCTTTSGGG
T ss_pred cccChhhhhcc
Confidence 99998877654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-15 Score=154.95 Aligned_cols=143 Identities=22% Similarity=0.232 Sum_probs=115.7
Q ss_pred CcEEEEEeCCCCCCCC-chhccCCCCCCEEeCCCCc-CCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEE
Q 006559 68 HRVIKLVLEDLDLTGP-AEVLSRLTQLRLLSLKNNL-LSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~-~~~l~~l~~L~~L~Ls~N~-l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 144 (640)
.++..|+|+++.+++. ...+..+++|+.|+|++|. +...++ .+..+++|++|+|++|.+++..|..+.++++|+.|+
T Consensus 56 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 4688888888888775 4678888889999998887 776644 678888888899988888887788888888888888
Q ss_pred cccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC
Q 006559 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG 211 (640)
Q Consensus 145 Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~ 211 (640)
|++|.+++ +|...+..+++|++|+|++|++++..+..+..+++|+.|++++|++++..|..+..++
T Consensus 136 l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 201 (285)
T 1ozn_A 136 LQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201 (285)
T ss_dssp CCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CCCCcccc-cCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcc
Confidence 88888885 4446678888888888888888877777788888888888888888888887776544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=5.1e-16 Score=156.52 Aligned_cols=140 Identities=16% Similarity=0.126 Sum_probs=124.2
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
..+..|+|+++.+++.. ..+..+++|+.|+|++|.+++.++ .+..+++|++|+|++|.+++..|..|.++++|+.|+|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 35889999999998765 478999999999999999998766 6899999999999999999988899999999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceec-ccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGT-LYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~-~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
++|.+++..+ ..+..+++|++|+|++|++++. +|..+..+++|+.|++++|++++..+..+.
T Consensus 108 ~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 170 (276)
T 2z62_A 108 VETNLASLEN-FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170 (276)
T ss_dssp TTSCCCCSTT-CCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred CCCCccccCc-hhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhh
Confidence 9999996444 5689999999999999999874 688899999999999999999987766554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.8e-16 Score=174.41 Aligned_cols=153 Identities=22% Similarity=0.230 Sum_probs=133.1
Q ss_pred CCCceEecCC-----------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEccc
Q 006559 57 SWRGVTCNPS-----------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSH 123 (640)
Q Consensus 57 ~w~gv~C~~~-----------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~ 123 (640)
.|.|+ |+.. ..+++.|+|+++.+++.. ..+..+++|++|+|++|.+++.++ .+..+++|++|+|++
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~ 83 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence 78888 8643 237899999999998864 678999999999999999998775 699999999999999
Q ss_pred ccccccCCccCCCCCCCCEEEcccCCCCC-CCCchhcCCCCCCcEEEccCCcceeccc-CCcCCCCCCcEEEcccCcCcc
Q 006559 124 NRFTGTFPSGVSSLRHLRRVDLSHNAYEG-EIPMTELTRLPNLLTLRLEDNRFTGTLY-SVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 124 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~~l~~L~~L~L~~N~l~g~~~-~~~~~~~~L~~l~ls~N~l~g 201 (640)
|.+++..|..|+++++|++|+|++|.+++ .+| ..+.++++|++|+|++|.+.+.+| ..+..+++|+.|++++|++++
T Consensus 84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 162 (549)
T 2z81_A 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT-SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162 (549)
T ss_dssp SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSS-CSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CccCccCHHHhccCCCCcEEECCCCcccccchh-hhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc
Confidence 99998888889999999999999999986 345 678999999999999999655565 578889999999999999999
Q ss_pred cCCcccCCCC
Q 006559 202 QIPAWMSPFG 211 (640)
Q Consensus 202 ~ip~~~~~~~ 211 (640)
.+|..+..+.
T Consensus 163 ~~~~~l~~l~ 172 (549)
T 2z81_A 163 YQSQSLKSIR 172 (549)
T ss_dssp ECTTTTTTCS
T ss_pred cChhhhhccc
Confidence 9998876654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.6e-16 Score=174.58 Aligned_cols=149 Identities=15% Similarity=0.212 Sum_probs=126.0
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
.+..+++.++.++..+ ..+..+++|+.|+|++|.+++.++ .+..+++|++|+|++|.|++..|..|+++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 3456677777776644 557889999999999999999776 79999999999999999999888899999999999999
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCCCCCCCC
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGN 218 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~gn 218 (640)
+|.++ .+|...|.++++|++|+|++|.+++.+|..+..+++|+.|+|++|.|++..+..+..+....+.+|
T Consensus 132 ~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 132 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp SSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred CCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 99999 466566799999999999999999999999999999999999999999865555544433333333
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.3e-15 Score=142.45 Aligned_cols=148 Identities=20% Similarity=0.185 Sum_probs=122.5
Q ss_pred EEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCC
Q 006559 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAY 150 (640)
Q Consensus 72 ~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 150 (640)
.++..+++++..+.. ..++|+.|+|++|.+++.++ .+..+++|++|+|++|++++..+..|.++++|++|+|++|++
T Consensus 11 ~v~c~~~~l~~~p~~--~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 88 (208)
T 2o6s_A 11 TVECYSQGRTSVPTG--IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88 (208)
T ss_dssp EEECCSSCCSSCCSC--CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEecCCCccCCCCC--CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcC
Confidence 567777777765533 35689999999999998776 478999999999999999977777789999999999999999
Q ss_pred CCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC---CCCCCCCcccC
Q 006559 151 EGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG---GSSFAGNKNLC 222 (640)
Q Consensus 151 ~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~---~~~~~gn~~lc 222 (640)
++ +|...+..+++|++|+|++|++++..+..+..+++|+.|++++|+|++..+..+..+. ...+.+|+..|
T Consensus 89 ~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 89 QS-LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred Cc-cCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 95 5546789999999999999999988888888999999999999999977665555443 33455665544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=7.3e-16 Score=157.81 Aligned_cols=141 Identities=20% Similarity=0.140 Sum_probs=101.5
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC--CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL--NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.++..|+|+++.++..+..+..+++|+.|+|++|.+++.++ .+..+++|++|+|++|.+++..|..+.++++|+.|+|
T Consensus 78 ~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 157 (306)
T 2z66_A 78 TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 157 (306)
T ss_dssp SCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEEC
Confidence 35777788887777655567777788888888887776553 5677777777777777777777777777777777777
Q ss_pred ccCCCCC-CCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCC
Q 006559 146 SHNAYEG-EIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSP 209 (640)
Q Consensus 146 s~N~l~g-~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~ 209 (640)
++|.+++ .+| ..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..
T Consensus 158 ~~n~l~~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 158 AGNSFQENFLP-DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp TTCEEGGGEEC-SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred CCCccccccch-hHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 7777765 344 56777777777777777777776777777777777777777777655544443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.5e-15 Score=152.25 Aligned_cols=143 Identities=17% Similarity=0.186 Sum_probs=125.3
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEccccc-ccccCCccCCCCCCCCEEE
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNR-FTGTFPSGVSSLRHLRRVD 144 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~~L~ 144 (640)
..+..|+|+++.+++.. ..+..+++|+.|+|++|.+++..+ .+..+++|++|+|++|. +....|..|.++++|+.|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 46889999999998765 568999999999999999998754 68999999999999998 7776788999999999999
Q ss_pred cccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC
Q 006559 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG 211 (640)
Q Consensus 145 Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~ 211 (640)
|++|.+++..| ..+.++++|++|+|++|++++..+..+..+++|+.|+|++|+|++..+..+..+.
T Consensus 112 l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 177 (285)
T 1ozn_A 112 LDRCGLQELGP-GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177 (285)
T ss_dssp CTTSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CCCCcCCEECH-hHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCcc
Confidence 99999997555 7789999999999999999988888888899999999999999977666665443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.9e-15 Score=163.61 Aligned_cols=152 Identities=22% Similarity=0.225 Sum_probs=89.4
Q ss_pred CCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEccccc
Q 006559 57 SWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNR 125 (640)
Q Consensus 57 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~ 125 (640)
.|..|.|... ...+..|+|+++.+++.. ..|.++++|+.|+|++|.+++.++ .+..+++|++|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 3678888643 236788889888887643 456666667777776666665443 45555555555555555
Q ss_pred ccccCCccCCCCCCCCEEEcccCCCCCCCCch-----------------------------------------------h
Q 006559 126 FTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMT-----------------------------------------------E 158 (640)
Q Consensus 126 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-----------------------------------------------~ 158 (640)
|++..+..|.++++|+.|+|++|++++ +|.. .
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~ 213 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPN 213 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCE-ECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCC
T ss_pred CCccChhhhcccCCCCEEECCCCCcce-eCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccccc
Confidence 554444444455555555555544431 1111 1
Q ss_pred cCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCC
Q 006559 159 LTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSP 209 (640)
Q Consensus 159 ~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~ 209 (640)
+..+++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..
T Consensus 214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 264 (452)
T 3zyi_A 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264 (452)
T ss_dssp CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcC
Confidence 333445555666666666666666666677777777777776666655443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=5.5e-16 Score=164.51 Aligned_cols=141 Identities=16% Similarity=0.232 Sum_probs=120.7
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
.+..+++.++.++..+ ..+..+++|++|+|++|.+++.++ .+..+++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus 46 ~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 125 (390)
T 3o6n_A 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125 (390)
T ss_dssp CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECC
Confidence 4556777777776544 457889999999999999998766 78999999999999999999888889999999999999
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCC
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
+|.++ .+|...+.++++|++|+|++|.+++..+..+..+++|+.|++++|++++.-...+..+
T Consensus 126 ~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L 188 (390)
T 3o6n_A 126 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL 188 (390)
T ss_dssp SSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTC
T ss_pred CCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcccccccccc
Confidence 99998 5775667899999999999999999888889999999999999999987543444333
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.8e-16 Score=144.39 Aligned_cols=136 Identities=26% Similarity=0.257 Sum_probs=115.2
Q ss_pred CcEEEEEeCCCCCC--CCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLT--GPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~--g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.++..|+|+++.++ ..+..+..+++|+.|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+.++++|+.|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 46888999999988 4445678899999999999999887 77889999999999999999888888888999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceeccc---CCcCCCCCCcEEEcccCcCcccCCc
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLY---SVNSSSRSILDFNVSNNQLSGQIPA 205 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~---~~~~~~~~L~~l~ls~N~l~g~ip~ 205 (640)
++|++++..+...+..+++|++|+|++|.+++..+ ..+..+++|+.|++++|.+. .+|.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 99999863222578899999999999999997665 46788999999999999986 3443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=182.22 Aligned_cols=178 Identities=22% Similarity=0.227 Sum_probs=118.6
Q ss_pred hhhHHHHHHhhhcCCCCC-CCCCCCCCCCCCCCCCCCceEecCCCCcEEEEEeCCCCCCC--------------------
Q 006559 24 YSDISTLLSFKASVTGSS-DSLSSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTG-------------------- 82 (640)
Q Consensus 24 ~~~~~~ll~~k~~~~~~~-~~~~sW~~~~~~c~~~w~gv~C~~~~~~v~~l~l~~~~l~g-------------------- 82 (640)
..+.++|+++........ .....|.....++ ..|.++++.. .+++.|+|.++++..
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPS-GTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCcc-ccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 456778888887763211 1122563333333 2798888875 356666664443322
Q ss_pred --------CchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCC
Q 006559 83 --------PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEI 154 (640)
Q Consensus 83 --------~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~ 154 (640)
+...+..++.|+.|+|++|.+...+..+..+++|++|+|++|.|+ .+|..|++|++|+.|||++|.|+ .+
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp --------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 234577889999999999999977777889999999999999999 89999999999999999999999 78
Q ss_pred CchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 155 PMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 155 p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
| ..+++|++|++|+|++|.|+ .+|..+..+++|+.|+|++|.|+|.+|..+.
T Consensus 286 p-~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (727)
T 4b8c_D 286 P-AELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILT 337 (727)
T ss_dssp C-SSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHH
T ss_pred C-hhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHh
Confidence 8 67999999999999999997 7788899999999999999999999987663
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.2e-15 Score=151.82 Aligned_cols=152 Identities=27% Similarity=0.269 Sum_probs=130.0
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|+++.+++... ...+++|+.|+|++|.|+..+..+..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 55 ~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~ 133 (290)
T 1p9a_G 55 TRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (290)
T ss_dssp TTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred CCCCEEECCCCccCcccC-CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence 478899999999987554 3889999999999999998877889999999999999999988888899999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC---CCCCCCCcccC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG---GSSFAGNKNLC 222 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~---~~~~~gn~~lc 222 (640)
|++++ +|...|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+.... ...+.+|+..|
T Consensus 134 N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 134 NELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCc-cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 99995 56577889999999999999999877777888999999999999999 6777665433 23345666555
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=171.12 Aligned_cols=141 Identities=16% Similarity=0.142 Sum_probs=125.7
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
..++.|+|++|.+++.. ..|.++++|++|+|++|.|++.++ .|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 36899999999999865 679999999999999999998776 5899999999999999999887788999999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCccee-cccCCcCCCCCCcEEEcccCcCcccCCcccCC
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG-TLYSVNSSSRSILDFNVSNNQLSGQIPAWMSP 209 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g-~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~ 209 (640)
++|++++ +|...|+++++|++|+|++|.+++ .+|..+..+++|+.|++++|+|++..|..+..
T Consensus 132 s~N~l~~-l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 195 (635)
T 4g8a_A 132 VETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 195 (635)
T ss_dssp TTSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred CCCcCCC-CChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccc
Confidence 9999996 554679999999999999999986 46777888999999999999999988876643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-15 Score=164.70 Aligned_cols=153 Identities=20% Similarity=0.193 Sum_probs=131.3
Q ss_pred CCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEccccc
Q 006559 57 SWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNR 125 (640)
Q Consensus 57 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~ 125 (640)
.|..|.|... ...+..|+|+++.+++.. ..|..+++|+.|+|++|.+++..+ .+.++++|++|+|++|.
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 5788999743 236788999999998864 678999999999999999998755 68999999999999999
Q ss_pred ccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCc
Q 006559 126 FTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA 205 (640)
Q Consensus 126 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~ 205 (640)
+++..+..|.++++|+.|+|++|++++..| ..+..+++|+.|+|++|.+++..+..+..+++|+.|+|++|++++..+.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLD-YMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCCh-hHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 997766778999999999999999997666 7789999999999999999998888899999999999999999876555
Q ss_pred ccCCC
Q 006559 206 WMSPF 210 (640)
Q Consensus 206 ~~~~~ 210 (640)
.+..+
T Consensus 171 ~l~~l 175 (477)
T 2id5_A 171 ALSHL 175 (477)
T ss_dssp HHTTC
T ss_pred Hhccc
Confidence 55443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.6e-16 Score=182.56 Aligned_cols=134 Identities=27% Similarity=0.312 Sum_probs=115.9
Q ss_pred ccCCCCCCEEeCCCCcCCCCCC--CCCCCCCCcEEEccccccc-----ccCCccCCCCCCCCEEEcccCCCCCCCCchhc
Q 006559 87 LSRLTQLRLLSLKNNLLSSSNL--NLSSWPHLKHLYLSHNRFT-----GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTEL 159 (640)
Q Consensus 87 l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~-----g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 159 (640)
+..+++|+.|+|++|.+++.++ .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|++++..| ..+
T Consensus 422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~ 500 (844)
T 3j0a_A 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPP-GVF 500 (844)
T ss_dssp HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCT-TSS
T ss_pred hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccCh-hHc
Confidence 5588999999999999987654 3667899999999999997 4455678899999999999999997555 778
Q ss_pred CCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCCCCCCCCcccCC
Q 006559 160 TRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCG 223 (640)
Q Consensus 160 ~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~gn~~lcg 223 (640)
..+++|+.|+|++|+|++.++..+. ++|+.|+|++|+|+|.+|..+..+....+.+|+..|.
T Consensus 501 ~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 501 SHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE 562 (844)
T ss_dssp SSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCS
T ss_pred cchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccc
Confidence 9999999999999999987777764 8999999999999999999888877777888888873
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=4.1e-15 Score=167.18 Aligned_cols=141 Identities=16% Similarity=0.117 Sum_probs=128.0
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.+++.|+|+++.+++.. ..+.++++|++|+|++|.+++.++ .+.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57899999999998865 489999999999999999998766 6899999999999999999998999999999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCccee-cccCCcCCCCCCcEEEcccCcCcccCCcccCC
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG-TLYSVNSSSRSILDFNVSNNQLSGQIPAWMSP 209 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g-~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~ 209 (640)
++|.+++..| ..++++++|++|+|++|.+++ .+|..+..+++|+.|++++|++++..|..+..
T Consensus 112 ~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 175 (606)
T 3vq2_A 112 VETKLASLES-FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175 (606)
T ss_dssp TTSCCCCSSS-SCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHH
T ss_pred cCCccccccc-cccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhh
Confidence 9999996544 679999999999999999987 67999999999999999999999988876543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.8e-15 Score=149.05 Aligned_cols=150 Identities=15% Similarity=0.224 Sum_probs=127.1
Q ss_pred CCCCC-CCceE--ecC------CCCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCc-CCCCCC-CCCCCCCCcEEE
Q 006559 53 PCFDS-WRGVT--CNP------STHRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNL-LSSSNL-NLSSWPHLKHLY 120 (640)
Q Consensus 53 ~c~~~-w~gv~--C~~------~~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~-l~~~~~-~~~~l~~L~~L~ 120 (640)
.|.|. |.++. |.. -...+..|+|.++.+++.. ..+..+++|+.|+|++|. +++.++ .+..+++|++|+
T Consensus 7 ~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~ 86 (239)
T 2xwt_C 7 PCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86 (239)
T ss_dssp SCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEE
T ss_pred CCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEE
Confidence 45443 36555 854 1236889999999998865 478999999999999997 887766 688999999999
Q ss_pred ccc-ccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCc---EEEccCC-cceecccCCcCCCCCCc-EEEc
Q 006559 121 LSH-NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLL---TLRLEDN-RFTGTLYSVNSSSRSIL-DFNV 194 (640)
Q Consensus 121 Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~---~L~L~~N-~l~g~~~~~~~~~~~L~-~l~l 194 (640)
|++ |.+++..+..|.++++|+.|+|++|++++ +| . +..+++|+ +|++++| ++++..+..+..+++|+ .|++
T Consensus 87 l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp-~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FP-D-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CC-C-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred CCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-cc-c-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence 999 99998777889999999999999999996 77 3 88888888 9999999 99988888899999999 9999
Q ss_pred ccCcCcccCCcc
Q 006559 195 SNNQLSGQIPAW 206 (640)
Q Consensus 195 s~N~l~g~ip~~ 206 (640)
++|+++ .+|..
T Consensus 164 ~~n~l~-~i~~~ 174 (239)
T 2xwt_C 164 YNNGFT-SVQGY 174 (239)
T ss_dssp CSCCCC-EECTT
T ss_pred CCCCCc-ccCHh
Confidence 999998 66654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=6.6e-15 Score=158.82 Aligned_cols=149 Identities=20% Similarity=0.213 Sum_probs=82.0
Q ss_pred CCCceEecCC---------CCcEEEEEeCCCCCCCCc-------------------------hhccCCCCCCEEeCCCCc
Q 006559 57 SWRGVTCNPS---------THRVIKLVLEDLDLTGPA-------------------------EVLSRLTQLRLLSLKNNL 102 (640)
Q Consensus 57 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-------------------------~~l~~l~~L~~L~Ls~N~ 102 (640)
.|..|.|... ...+..|+|+++.+++.. ..|..+++|+.|+|++|.
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 4678888642 124556666666655422 345556666666666666
Q ss_pred CCCCCC-CCCCCCCCcEEEcccccccccCCccCC-------------------------CCCCCCEEEcccCCCCCCCCc
Q 006559 103 LSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVS-------------------------SLRHLRRVDLSHNAYEGEIPM 156 (640)
Q Consensus 103 l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~-------------------------~l~~L~~L~Ls~N~l~g~~p~ 156 (640)
|++.++ .+..+++|++|+|++|.++...+..|. ++++|+.|+|++|+++ .+|
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~- 201 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP- 201 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-
Confidence 665544 366667777777777766544332333 3333333333333333 222
Q ss_pred hhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 157 TELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 157 ~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
.+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++..|..+.
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 252 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD 252 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSST
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhc
Confidence 234445556666666666666566666666666666666666655554443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=5.3e-16 Score=161.30 Aligned_cols=132 Identities=14% Similarity=0.090 Sum_probs=91.5
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEecccc----------------chHHH--------HHHHHHHhccCCCccccee
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERK----------------KKREV--------DEWLRVIGGLRHSNIVSIR 393 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~--------~~e~~~l~~l~H~niv~l~ 393 (640)
...||+|+||.||+|...+|+.||||+++... ..... ..|.+.|.++.+.++....
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 46799999999999999899999999875320 00111 2344445555433332111
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCC
Q 006559 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGN 473 (640)
Q Consensus 394 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~ 473 (640)
-+.. ...+|||||++++.|.++.... ....++.|++.+|.|||. .+||||||||.|||+++++.
T Consensus 180 p~~~--~~~~LVME~i~G~~L~~l~~~~-----------~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 180 PIAQ--SRHTIVMSLVDALPMRQVSSVP-----------DPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp EEEE--ETTEEEEECCSCEEGGGCCCCS-----------CHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEEC
T ss_pred eeec--cCceEEEEecCCccHhhhcccH-----------HHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCC
Confidence 1111 1237999999998887654311 234578999999999995 45999999999999987763
Q ss_pred ----------eEEccCCccccc
Q 006559 474 ----------ACISDIGVHQLF 485 (640)
Q Consensus 474 ----------~kl~DfGl~~~~ 485 (640)
+.|+||+-+-..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 889999865443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.8e-15 Score=161.27 Aligned_cols=140 Identities=16% Similarity=0.164 Sum_probs=87.7
Q ss_pred CcEEEEEeCCCCCCCCch-----------hcc--CCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCcc
Q 006559 68 HRVIKLVLEDLDLTGPAE-----------VLS--RLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSG 133 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~-----------~l~--~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~ 133 (640)
.++..+++.++.+.+... .+. ..++|+.|+|++|.+.+.++ .+..+++|++|+|++|.+++..|..
T Consensus 239 ~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 318 (455)
T 3v47_A 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318 (455)
T ss_dssp CCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT
T ss_pred cceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhH
Confidence 466777776664443210 111 22567777777777766544 4666677777777777777666666
Q ss_pred CCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 134 VSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 134 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
|.++++|+.|+|++|.+++..| ..+..+++|++|+|++|++++..|..+..+++|+.|+|++|+|++..+..+.
T Consensus 319 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 392 (455)
T 3v47_A 319 FWGLTHLLKLNLSQNFLGSIDS-RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFD 392 (455)
T ss_dssp TTTCTTCCEEECCSSCCCEECG-GGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred hcCcccCCEEECCCCccCCcCh-hHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhc
Confidence 6777777777777777764333 5566677777777777777766666666667777777777777654444433
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.2e-15 Score=168.01 Aligned_cols=139 Identities=17% Similarity=0.134 Sum_probs=71.1
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC--CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL--NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
++..|+|+++.+++.+..+..+++|+.|+|++|.+.+.++ .+..+++|++|+|++|.+++.+|..+.++++|+.|+|+
T Consensus 377 ~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 456 (606)
T 3vq2_A 377 SLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMA 456 (606)
T ss_dssp CCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECT
T ss_pred cccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECC
Confidence 4556666666655544445555555555555555554433 34455555555555555555555555555555555555
Q ss_pred cCCCCCC-CCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 147 HNAYEGE-IPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 147 ~N~l~g~-~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
+|.+++. +| ..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+|..+.
T Consensus 457 ~n~l~~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 518 (606)
T 3vq2_A 457 GNSFKDNTLS-NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518 (606)
T ss_dssp TCEEGGGEEC-SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTT
T ss_pred CCcCCCcchH-HhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHcc
Confidence 5555442 23 3444455555555555555554444444455555555555555544444443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-14 Score=137.95 Aligned_cols=126 Identities=18% Similarity=0.261 Sum_probs=108.6
Q ss_pred CEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCc-cCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccC
Q 006559 94 RLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPS-GVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLED 172 (640)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~ 172 (640)
+.|++++|.|+..+..+.. +|++|+|++|+|++..+. .|.++++|+.|+|++|++++..| ..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP-NAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCH-hHcCCcccCCEEECCC
Confidence 6899999999887665543 899999999999987775 48999999999999999998767 7899999999999999
Q ss_pred CcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCCC---CCCCCcccC
Q 006559 173 NRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGS---SFAGNKNLC 222 (640)
Q Consensus 173 N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~---~~~gn~~lc 222 (640)
|+|++..+..+..+++|+.|+|++|+|++.+|..+..++.. .+.+|+..|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 99999999989999999999999999999999887765443 345565443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=9.9e-16 Score=139.22 Aligned_cols=126 Identities=25% Similarity=0.232 Sum_probs=70.2
Q ss_pred cEEEEEeCCCCCC--CCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLT--GPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~--g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
++..|+++++.++ ..+..+..+++|+.|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+.++++|+.|+|+
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls 96 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence 4555566666555 2234445566666666666666555 455556666666666666665555555556666666666
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceeccc---CCcCCCCCCcEEEcc
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLY---SVNSSSRSILDFNVS 195 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~---~~~~~~~~L~~l~ls 195 (640)
+|.+++......+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 6666542111345556666666666666655443 344555566665554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.6e-15 Score=141.63 Aligned_cols=129 Identities=17% Similarity=0.240 Sum_probs=106.5
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
++..|+++++.++... .+..+++|+.|+|++|.+... +.+..+++|++|+|++|.+++..|..+.++++|+.|+|++|
T Consensus 45 ~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n 122 (197)
T 4ezg_A 45 SLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122 (197)
T ss_dssp TCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSS
T ss_pred CccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCC
Confidence 5778888888887533 688889999999999976554 36788899999999999998888888999999999999999
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
++++..| ..+..+++|++|+|++|.+.+.+| .+..+++|+.|++++|++++
T Consensus 123 ~i~~~~~-~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 123 AHDDSIL-TKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp BCBGGGH-HHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC
T ss_pred ccCcHhH-HHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC
Confidence 9987666 678889999999999998444455 57778899999999999886
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-14 Score=163.01 Aligned_cols=134 Identities=19% Similarity=0.256 Sum_probs=114.8
Q ss_pred eCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCC
Q 006559 75 LEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGE 153 (640)
Q Consensus 75 l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 153 (640)
-.+.+|+..+..+- ++++.|||++|.|++.++ .|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|++
T Consensus 38 c~~~~l~~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~- 114 (635)
T 4g8a_A 38 CMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS- 114 (635)
T ss_dssp CTTSCCSSCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-
T ss_pred CCCCCcCccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC-
Confidence 34456665443331 479999999999999876 69999999999999999999888899999999999999999995
Q ss_pred CCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc-cCCcccCCCC
Q 006559 154 IPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG-QIPAWMSPFG 211 (640)
Q Consensus 154 ~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g-~ip~~~~~~~ 211 (640)
+|...|.++++|++|+|++|++++..+..+..+++|+.|+|++|+|++ .+|..+..+.
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~ 173 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 173 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccch
Confidence 665789999999999999999999888889999999999999999976 4677665443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=9.7e-15 Score=166.46 Aligned_cols=139 Identities=22% Similarity=0.246 Sum_probs=114.5
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.+++.|+|+++.+++.. ..+.++++|++|+|++|.+++.++ .+.++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 47889999999988866 468889999999999999888765 4778888999999999888655557888899999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCccc
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWM 207 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~ 207 (640)
++|++++ +|+..+.++++|++|+|++|.+++..|..+..+++|+.|++++|++++..|..+
T Consensus 105 ~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 165 (680)
T 1ziw_A 105 MSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165 (680)
T ss_dssp CSSCCCC-CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHH
T ss_pred CCCccCc-cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHh
Confidence 9998875 444678888899999999998888888888888888888888888887766543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=170.08 Aligned_cols=151 Identities=19% Similarity=0.161 Sum_probs=130.7
Q ss_pred CCCCceEecCCCCcEEEEEeCCCCCCCC-chhccCCCCCCEEeCCCCcCCCC--CCCCCCCCCCcEEEcccccccccCCc
Q 006559 56 DSWRGVTCNPSTHRVIKLVLEDLDLTGP-AEVLSRLTQLRLLSLKNNLLSSS--NLNLSSWPHLKHLYLSHNRFTGTFPS 132 (640)
Q Consensus 56 ~~w~gv~C~~~~~~v~~l~l~~~~l~g~-~~~l~~l~~L~~L~Ls~N~l~~~--~~~~~~l~~L~~L~Ls~N~l~g~~p~ 132 (640)
++|+.|-+ ...++..|+|++|.+++. +..+.++++|++|+|++|.+.+. +..+.++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 47888877 335899999999999875 46799999999999999977654 33699999999999999999999999
Q ss_pred cCCCCCCCCEEEcccCCCCCCCCc-hhcCCCCCCcEEEccCCcceeccc-CCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 133 GVSSLRHLRRVDLSHNAYEGEIPM-TELTRLPNLLTLRLEDNRFTGTLY-SVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 133 ~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~~l~~L~~L~L~~N~l~g~~~-~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
.|.++++|++|+|++|.+++.+|. ..+.++++|++|+|++|.+++..+ ..+.++++|+.|+|++|.+++..|..+.
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~ 169 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcc
Confidence 999999999999999999987762 238899999999999999998765 5688999999999999999998887654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.9e-14 Score=145.04 Aligned_cols=136 Identities=19% Similarity=0.261 Sum_probs=95.3
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.++..|+|+++.+++.. ..+..+++|+.|+|++|.+++.++ .+..+++|++|+|++|++++..+..+.++++|+.|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 35777788887777644 467778888888888888877654 5777788888888888887766667777888888888
Q ss_pred ccCCCCC-CCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCc----EEEcccCcCcccCC
Q 006559 146 SHNAYEG-EIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL----DFNVSNNQLSGQIP 204 (640)
Q Consensus 146 s~N~l~g-~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~----~l~ls~N~l~g~ip 204 (640)
++|.+++ .+| ..+..+++|++|+|++|++++..+..+..+.+|+ .|++++|++++..+
T Consensus 132 ~~n~l~~~~l~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~ 194 (276)
T 2z62_A 132 AHNLIQSFKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194 (276)
T ss_dssp CSSCCCCCCCC-GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECT
T ss_pred cCCccceecCc-hhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCc
Confidence 8888775 245 5677778888888888877776555544444443 55566665554443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-14 Score=161.72 Aligned_cols=139 Identities=21% Similarity=0.186 Sum_probs=81.6
Q ss_pred EEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC--CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 71 IKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL--NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 71 ~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
..|+|+++.+.+....+..+++|+.|+|++|.+.+.++ .+..+++|++|+|++|.+.+.+|..+.++++|+.|+|++|
T Consensus 376 ~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 455 (570)
T 2z63_A 376 KYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455 (570)
T ss_dssp CEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTC
T ss_pred CEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCC
Confidence 33344444333333335555566666666665555433 3556666666666666666666666666666666666666
Q ss_pred CCC-CCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCC
Q 006559 149 AYE-GEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 149 ~l~-g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
.++ +.+| ..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+..+
T Consensus 456 ~l~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 517 (570)
T 2z63_A 456 SFQENFLP-DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRL 517 (570)
T ss_dssp EEGGGEEC-SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred cCccccch-hhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcc
Confidence 665 3455 556666666666666666666666666666666666666666666555544433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-14 Score=163.86 Aligned_cols=154 Identities=16% Similarity=0.101 Sum_probs=132.1
Q ss_pred CCceEecCC---------CCcEEEEEeCCCCCCCC-chhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccc
Q 006559 58 WRGVTCNPS---------THRVIKLVLEDLDLTGP-AEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRF 126 (640)
Q Consensus 58 w~gv~C~~~---------~~~v~~l~l~~~~l~g~-~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l 126 (640)
+..|.|... ...++.|+|+++.+++. +..+.++++|++|+|++|.+.+..+ .|.++++|++|+|++|.+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 566778542 24789999999999986 4689999999999999999998755 699999999999999999
Q ss_pred cccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcc
Q 006559 127 TGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAW 206 (640)
Q Consensus 127 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~ 206 (640)
++..|..|+++++|++|+|++|.+++..| ..+.++++|++|+|++|++++..++.+..+++|+.|++++|++++..|..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDF-IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGG-SCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCc-chhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99999999999999999999999996434 66899999999999999999855444445999999999999999888876
Q ss_pred cCCCCC
Q 006559 207 MSPFGG 212 (640)
Q Consensus 207 ~~~~~~ 212 (640)
++.+..
T Consensus 173 ~~~l~~ 178 (606)
T 3t6q_A 173 MSSLQQ 178 (606)
T ss_dssp HHTTTT
T ss_pred hhhhcc
Confidence 665543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=5.2e-15 Score=152.02 Aligned_cols=135 Identities=24% Similarity=0.340 Sum_probs=67.5
Q ss_pred cEEEEEeCCCCCCCCc-hhc--cCCCCCCEEeCCCCcCCCCCCCCCCC-----CCCcEEEcccccccccCCccCCCCCCC
Q 006559 69 RVIKLVLEDLDLTGPA-EVL--SRLTQLRLLSLKNNLLSSSNLNLSSW-----PHLKHLYLSHNRFTGTFPSGVSSLRHL 140 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l--~~l~~L~~L~Ls~N~l~~~~~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~~l~~L 140 (640)
++..|+|+++.+++.. ..+ ..+++|+.|+|++|.+++.+..+..+ ++|++|+|++|++++..|..|+++++|
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L 175 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence 4555555555555432 212 55555555555555555553333333 555555555555555555555555555
Q ss_pred CEEEcccCCCCCCCCc-hhc--CCCCCCcEEEccCCccee--ccc-CCcCCCCCCcEEEcccCcCcccC
Q 006559 141 RRVDLSHNAYEGEIPM-TEL--TRLPNLLTLRLEDNRFTG--TLY-SVNSSSRSILDFNVSNNQLSGQI 203 (640)
Q Consensus 141 ~~L~Ls~N~l~g~~p~-~~~--~~l~~L~~L~L~~N~l~g--~~~-~~~~~~~~L~~l~ls~N~l~g~i 203 (640)
+.|+|++|++.|.++. ..+ ..+++|++|+|++|+|++ .++ ..+..+++|+.|+|++|+|++.+
T Consensus 176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244 (312)
T ss_dssp CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence 5555555555543210 122 455555555555555552 111 22234455555555555555544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=3.9e-14 Score=131.77 Aligned_cols=106 Identities=23% Similarity=0.274 Sum_probs=59.7
Q ss_pred EEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCc
Q 006559 95 LLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNR 174 (640)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~ 174 (640)
.|++++|.|+..+..+ .++|++|+|++|+|++..|..|.++++|+.|+|++|+|++ +|...|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCc-cChhhccCCCCCCEEECCCCc
Confidence 3444444444443333 2455666666666665555556666666666666666653 333445566666666666666
Q ss_pred ceecccCCcCCCCCCcEEEcccCcCcccC
Q 006559 175 FTGTLYSVNSSSRSILDFNVSNNQLSGQI 203 (640)
Q Consensus 175 l~g~~~~~~~~~~~L~~l~ls~N~l~g~i 203 (640)
|++..+..+..+++|+.|+|++|.|++..
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 66555555555666666666666665543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=7.2e-15 Score=160.43 Aligned_cols=115 Identities=18% Similarity=0.095 Sum_probs=67.7
Q ss_pred CCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCC-CCCCCCEEEcccCCCCCCCCchhcCCCCCCc
Q 006559 89 RLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVS-SLRHLRRVDLSHNAYEGEIPMTELTRLPNLL 166 (640)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~ 166 (640)
.+++|+.|+|++|.|++.++ .++.+++|++|+|++|.|++.+|..+. ++++|+.|+|++|.+++. | .+..+++|+
T Consensus 118 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~--~~~~l~~L~ 194 (487)
T 3oja_A 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K--GQVVFAKLK 194 (487)
T ss_dssp CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E--CCCCCTTCC
T ss_pred ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c--ccccCCCCC
Confidence 34556666666666665533 455666666666666666666555554 566666666666666643 2 133466666
Q ss_pred EEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 167 TLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 167 ~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
.|+|++|.|++.+|. +..+++|+.|+|++|+|++ +|.++.
T Consensus 195 ~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~ 234 (487)
T 3oja_A 195 TLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALR 234 (487)
T ss_dssp EEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCC
T ss_pred EEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhc
Confidence 666666666654433 5556666666666666664 454443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.8e-15 Score=169.32 Aligned_cols=137 Identities=19% Similarity=0.285 Sum_probs=86.3
Q ss_pred cEEEEEeCCCCCCC------------------Cchhcc--CCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEccccc-c
Q 006559 69 RVIKLVLEDLDLTG------------------PAEVLS--RLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNR-F 126 (640)
Q Consensus 69 ~v~~l~l~~~~l~g------------------~~~~l~--~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~-l 126 (640)
++..|+|+++.++| .++.++ ++++|++|+|++|.+.+..| .++++++|++|+|++|+ |
T Consensus 207 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l 286 (636)
T 4eco_A 207 KLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286 (636)
T ss_dssp TCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTS
T ss_pred CCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCC
Confidence 45566666666666 445555 66666666666666665443 46666666666666666 6
Q ss_pred cc-cCCccCCCC------CCCCEEEcccCCCCCCCCch--hcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccC
Q 006559 127 TG-TFPSGVSSL------RHLRRVDLSHNAYEGEIPMT--ELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNN 197 (640)
Q Consensus 127 ~g-~~p~~~~~l------~~L~~L~Ls~N~l~g~~p~~--~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N 197 (640)
+| .+|..++++ ++|+.|+|++|+++ .+| . .++++++|++|+|++|+++|.+| .+..+++|+.|++++|
T Consensus 287 ~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip-~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFP-VETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363 (636)
T ss_dssp CHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCC-CHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSS
T ss_pred ccccchHHHHhhhccccCCCCCEEECCCCcCC-ccC-chhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCC
Confidence 66 666665554 66666666666666 566 3 56666666666666666666666 5556666666666666
Q ss_pred cCcccCCcccCC
Q 006559 198 QLSGQIPAWMSP 209 (640)
Q Consensus 198 ~l~g~ip~~~~~ 209 (640)
+++ .+|.++..
T Consensus 364 ~l~-~lp~~l~~ 374 (636)
T 4eco_A 364 QIT-EIPANFCG 374 (636)
T ss_dssp EEE-ECCTTSEE
T ss_pred ccc-cccHhhhh
Confidence 666 56655443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=160.36 Aligned_cols=139 Identities=24% Similarity=0.320 Sum_probs=110.1
Q ss_pred CCCCCCCCCCC---CCCce-EecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEc
Q 006559 46 SWVNSTDPCFD---SWRGV-TCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYL 121 (640)
Q Consensus 46 sW~~~~~~c~~---~w~gv-~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L 121 (640)
+|....++|.. .|.|+ .|.. .+++.|+|+++++++.+..+ +++|+.|+|++|.|+..+ ..+++|++|+|
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~lp~~l--~~~L~~L~Ls~N~l~~ip---~~l~~L~~L~L 107 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSSLPDNL--PPQITVLEITQNALISLP---ELPASLEYLDA 107 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSCCCSCC--CTTCSEEECCSSCCSCCC---CCCTTCCEEEC
T ss_pred HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCccCHhH--cCCCCEEECcCCCCcccc---cccCCCCEEEc
Confidence 56545556643 59999 7875 47999999999999866544 378999999999998655 56789999999
Q ss_pred ccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 122 SHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 122 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++
T Consensus 108 s~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 108 CDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred cCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC
Confidence 9999987 777 665 89999999999986 773 57888888998888887 554 46788888888888887
Q ss_pred cCCc
Q 006559 202 QIPA 205 (640)
Q Consensus 202 ~ip~ 205 (640)
+|.
T Consensus 175 -lp~ 177 (571)
T 3cvr_A 175 -LPE 177 (571)
T ss_dssp -CCC
T ss_pred -cch
Confidence 666
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=4.9e-14 Score=145.81 Aligned_cols=149 Identities=19% Similarity=0.297 Sum_probs=120.8
Q ss_pred CCCCCCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEc
Q 006559 53 PCFDSWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYL 121 (640)
Q Consensus 53 ~c~~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L 121 (640)
.|.|+|+.+.|... ...+..|+|+++.+++.. ..+.++++|++|+|++|.+++..+ .+..+++|++|+|
T Consensus 28 ~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 28 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp TCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 45568999999742 236788999999998865 478999999999999999998744 7899999999999
Q ss_pred ccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCccee--cccCCcCCCCCCcEEEcccCcC
Q 006559 122 SHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG--TLYSVNSSSRSILDFNVSNNQL 199 (640)
Q Consensus 122 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g--~~~~~~~~~~~L~~l~ls~N~l 199 (640)
++|.++ .+|..+. ++|+.|+|++|.+++ ++...+.++++|+.|+|++|.++. ..+..+..+++|+.|++++|++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 999998 5666554 789999999999985 454778889999999999998863 6667777888888888888888
Q ss_pred cccCCcc
Q 006559 200 SGQIPAW 206 (640)
Q Consensus 200 ~g~ip~~ 206 (640)
+. +|..
T Consensus 184 ~~-l~~~ 189 (330)
T 1xku_A 184 TT-IPQG 189 (330)
T ss_dssp CS-CCSS
T ss_pred cc-CCcc
Confidence 74 5543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-14 Score=137.69 Aligned_cols=129 Identities=21% Similarity=0.276 Sum_probs=110.1
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCC-CCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSS-NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
.++..|++.++.++.. +.+..+++|+.|+|++|.+++. +..+..+++|++|+|++|.+++..|..++.+++|+.|+|+
T Consensus 66 ~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 66 HNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp TTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 3688899999977654 4788999999999999999874 4579999999999999999999889999999999999999
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
+|.+.+.+| .+..+++|+.|++++|++++.. .+..+++|+.|++++|++.+
T Consensus 145 ~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 145 YNGAITDIM--PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SCTBCCCCG--GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC----
T ss_pred CCCCccccH--hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcccCC
Confidence 998444666 5889999999999999999743 67779999999999999875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.52 E-value=5.2e-14 Score=145.80 Aligned_cols=148 Identities=22% Similarity=0.330 Sum_probs=108.9
Q ss_pred CCCCCCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEc
Q 006559 53 PCFDSWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYL 121 (640)
Q Consensus 53 ~c~~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L 121 (640)
.|.|.|+.+.|... ..++..|+|+++.+++.. ..+..+++|+.|+|++|.+++..+ .+..+++|++|+|
T Consensus 30 ~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 30 GCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp SCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred CCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 45568999999642 135777888888877653 467888888888888888887644 5788888888888
Q ss_pred ccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcce--ecccCCcCCCCCCcEEEcccCcC
Q 006559 122 SHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT--GTLYSVNSSSRSILDFNVSNNQL 199 (640)
Q Consensus 122 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~--g~~~~~~~~~~~L~~l~ls~N~l 199 (640)
++|.++ .+|..+. ++|++|+|++|++++ +|...+..+++|+.|++++|.++ +..+..+..+ +|+.|++++|++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCC-CCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCc-cCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 888887 5665554 788888888888874 55466788888888888888885 3556666666 777888888887
Q ss_pred cccCCcc
Q 006559 200 SGQIPAW 206 (640)
Q Consensus 200 ~g~ip~~ 206 (640)
++ +|..
T Consensus 185 ~~-l~~~ 190 (332)
T 2ft3_A 185 TG-IPKD 190 (332)
T ss_dssp SS-CCSS
T ss_pred Cc-cCcc
Confidence 75 4543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-14 Score=131.87 Aligned_cols=113 Identities=17% Similarity=0.227 Sum_probs=100.4
Q ss_pred CCCCCCEEeCCCCcCC-C-CCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCc
Q 006559 89 RLTQLRLLSLKNNLLS-S-SNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLL 166 (640)
Q Consensus 89 ~l~~L~~L~Ls~N~l~-~-~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~ 166 (640)
..++|+.|+|++|.++ + .+..+..+++|++|+|++|.+++. ..+.++++|+.|+|++|.+++.+| ..+..+++|+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~ 91 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLE-VLAEKCPNLT 91 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTH-HHHHHCTTCC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHH-HHhhhCCCCC
Confidence 4578999999999998 4 445679999999999999999976 778999999999999999998777 6777899999
Q ss_pred EEEccCCcceec-ccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 167 TLRLEDNRFTGT-LYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 167 ~L~L~~N~l~g~-~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
+|+|++|++++. .+..+..+++|+.|++++|++++..+
T Consensus 92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 999999999984 45778889999999999999998765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1e-13 Score=131.77 Aligned_cols=125 Identities=22% Similarity=0.304 Sum_probs=106.2
Q ss_pred CEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCC
Q 006559 94 RLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173 (640)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N 173 (640)
+.+++++|.++..+..+. ++|++|+|++|.|+ .+|..|.++++|+.|+|++|++++ ++...|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCE-eCHhHccCCCCCCEEECCCC
Confidence 578999999998766543 68999999999998 788999999999999999999996 44478999999999999999
Q ss_pred cceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC---CCCCCCCcccC
Q 006559 174 RFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG---GSSFAGNKNLC 222 (640)
Q Consensus 174 ~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~---~~~~~gn~~lc 222 (640)
+|++..+..+..+++|+.|+|++|+|++..+..+..+. ...+.+|+..|
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 99999988999999999999999999976665555443 34456676655
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.52 E-value=6.8e-14 Score=146.75 Aligned_cols=138 Identities=22% Similarity=0.217 Sum_probs=118.6
Q ss_pred CceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCC-CC-CCCCCcEEEcccccccccCCccCCC
Q 006559 59 RGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLN-LS-SWPHLKHLYLSHNRFTGTFPSGVSS 136 (640)
Q Consensus 59 ~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~-~l~~L~~L~Ls~N~l~g~~p~~~~~ 136 (640)
..=.|.. + .+++.+++|+..+..+. ..|+.|+|++|.|++.++. +. .+++|+.|+|++|+|++..|..|.+
T Consensus 14 ~~C~C~~---~--~l~c~~~~l~~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~ 86 (361)
T 2xot_A 14 ANCLCAS---N--ILSCSKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVP 86 (361)
T ss_dssp TTCEEET---T--EEECCSSCCSSCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTT
T ss_pred CCCEECC---C--EEEeCCCCcCccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccC
Confidence 3556753 2 47888888887665443 4689999999999997764 55 8999999999999999988889999
Q ss_pred CCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 137 LRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 137 l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
+++|+.|+|++|+|++ +|...|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++..+
T Consensus 87 l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 153 (361)
T 2xot_A 87 VPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPV 153 (361)
T ss_dssp CTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCG
T ss_pred CCCCCEEECCCCcCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCH
Confidence 9999999999999985 554779999999999999999999999999999999999999999996433
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=9.9e-15 Score=149.75 Aligned_cols=138 Identities=17% Similarity=0.155 Sum_probs=97.0
Q ss_pred CcEEEEEeCCCCCCCCc-----hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEccccccccc--C--CccCCCC
Q 006559 68 HRVIKLVLEDLDLTGPA-----EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGT--F--PSGVSSL 137 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-----~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~--~--p~~~~~l 137 (640)
.++..|+|++|.+++.. ..+..+++|+.|+|++|.+.+.++ .+..+++|++|+|++|++.+. + +..++++
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 35677788888877632 233467888888888888877665 577888888888888887652 2 2234677
Q ss_pred CCCCEEEcccCCCCCCCCc---hhcCCCCCCcEEEccCCcceecccCCcCCC---CCCcEEEcccCcCcccCCccc
Q 006559 138 RHLRRVDLSHNAYEGEIPM---TELTRLPNLLTLRLEDNRFTGTLYSVNSSS---RSILDFNVSNNQLSGQIPAWM 207 (640)
Q Consensus 138 ~~L~~L~Ls~N~l~g~~p~---~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~---~~L~~l~ls~N~l~g~ip~~~ 207 (640)
++|++|+|++|+++. +|. ..+..+++|++|+|++|++++..|..+..+ ++|+.|+|++|+|+ .+|..+
T Consensus 197 ~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~ 270 (310)
T 4glp_A 197 PAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL 270 (310)
T ss_dssp CCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC
T ss_pred CCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh
Confidence 888888888888862 331 124667788888888888887766665555 57888888888887 666654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=8.4e-14 Score=130.02 Aligned_cols=105 Identities=22% Similarity=0.309 Sum_probs=62.9
Q ss_pred EEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCc
Q 006559 95 LLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNR 174 (640)
Q Consensus 95 ~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~ 174 (640)
.+++++|.|+..+..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++ +|...|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCCCc
Confidence 45555555554444332 556666666666666666666666666666666666664 443445666666666666666
Q ss_pred ceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 175 FTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 175 l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
|++..+..+..+++|+.|+|++|.|...
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred cceeCHHHhccccCCCEEEeCCCCcccc
Confidence 6655555566666666666666666543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.7e-14 Score=153.71 Aligned_cols=143 Identities=17% Similarity=0.165 Sum_probs=126.0
Q ss_pred CcEEEEEeCCCCCCCC-chhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGP-AEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~-~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.++..|+|+++.+++. +..+.++++|+.|+|++|.+++.++ .+..+++|++|+|++|.+++..|..|.++++|+.|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 4788999999999876 4678999999999999999998876 4789999999999999999999999999999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG 211 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~ 211 (640)
++|.+++..| ..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..+..+..+.
T Consensus 136 ~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~ 200 (477)
T 2id5_A 136 GDNDLVYISH-RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY 200 (477)
T ss_dssp CCTTCCEECT-TSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCT
T ss_pred CCCccceeCh-hhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCc
Confidence 9999987555 7789999999999999999987777788899999999999999987776665443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=8e-14 Score=158.84 Aligned_cols=138 Identities=24% Similarity=0.294 Sum_probs=111.7
Q ss_pred hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccC----C----ccCCCCCCCCEEEcccCCCCCCCC
Q 006559 85 EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTF----P----SGVSSLRHLRRVDLSHNAYEGEIP 155 (640)
Q Consensus 85 ~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~----p----~~~~~l~~L~~L~Ls~N~l~g~~p 155 (640)
..+..+++|+.|+|++|.+++.++ .+..+++|++|+|++|.+++.. | ..|.++++|+.|+|++|+++ .+|
T Consensus 474 ~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~ 552 (680)
T 1ziw_A 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIP 552 (680)
T ss_dssp CTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCC
T ss_pred cccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCC
Confidence 557788889999999999888766 4788899999999999988642 2 23788899999999999998 677
Q ss_pred chhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcc----cCCCCCCCCCCCcccCC
Q 006559 156 MTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAW----MSPFGGSSFAGNKNLCG 223 (640)
Q Consensus 156 ~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~----~~~~~~~~~~gn~~lcg 223 (640)
...|.++++|+.|+|++|++++..+..+..+++|+.|+|++|+|++..|.. +..+....+.+|+..|.
T Consensus 553 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred HHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 667889999999999999999877777888899999999999999877764 34555566778887774
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.51 E-value=7.9e-15 Score=150.63 Aligned_cols=110 Identities=19% Similarity=0.204 Sum_probs=71.5
Q ss_pred CCCCCCEEeCCCCcCCCCCC-CC--CCCCCCcEEEcccccccccCCccCCCC-----CCCCEEEcccCCCCCCCCchhcC
Q 006559 89 RLTQLRLLSLKNNLLSSSNL-NL--SSWPHLKHLYLSHNRFTGTFPSGVSSL-----RHLRRVDLSHNAYEGEIPMTELT 160 (640)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~-~~--~~l~~L~~L~Ls~N~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~~ 160 (640)
.+++|++|+|++|.+++..+ .+ ..+++|++|+|++|.+++. |..++++ ++|++|+|++|++++..| ..+.
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~-~~~~ 170 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSC-EQVR 170 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCT-TTCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchH-HHhc
Confidence 56777777777777765443 33 6677777777777777765 6655555 677777777777765443 5666
Q ss_pred CCCCCcEEEccCCcceecc--cCCc--CCCCCCcEEEcccCcCc
Q 006559 161 RLPNLLTLRLEDNRFTGTL--YSVN--SSSRSILDFNVSNNQLS 200 (640)
Q Consensus 161 ~l~~L~~L~L~~N~l~g~~--~~~~--~~~~~L~~l~ls~N~l~ 200 (640)
.+++|++|+|++|+++|.+ +..+ ..+++|+.|+|++|+|+
T Consensus 171 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 7777777777777766542 2222 55667777777777776
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.3e-13 Score=153.44 Aligned_cols=138 Identities=21% Similarity=0.223 Sum_probs=93.2
Q ss_pred CcEEEEEeCCCCCCCC-chhccCCCCCCEEeCCCCcCCCCCC---CCCCCCCCcEEEcccccccccCCc-cCCCCCCCCE
Q 006559 68 HRVIKLVLEDLDLTGP-AEVLSRLTQLRLLSLKNNLLSSSNL---NLSSWPHLKHLYLSHNRFTGTFPS-GVSSLRHLRR 142 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~-~~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~ 142 (640)
..+..|+|+++.+++. +..+..+++|+.|+|++|.+++.+. .+..+++|++|+|++|.+++.+|. .+..+++|+.
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 4567777777777763 3566777777777777777776432 467777777777777777775554 3667777777
Q ss_pred EEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcc-cCCC
Q 006559 143 VDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAW-MSPF 210 (640)
Q Consensus 143 L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~-~~~~ 210 (640)
|+|++|++++.+| ..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. +..+
T Consensus 433 L~l~~n~l~~~~~-~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l 496 (562)
T 3a79_B 433 LNLSSNMLTGSVF-RCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRL 496 (562)
T ss_dssp EECCSSCCCGGGG-SSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTC
T ss_pred EECCCCCCCcchh-hhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcC
Confidence 7777777776555 2222 57777777777777 45555556777777777777777 45554 4433
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-13 Score=142.73 Aligned_cols=138 Identities=20% Similarity=0.289 Sum_probs=94.5
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCC--C-CCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEE
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSS--S-NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRV 143 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~--~-~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 143 (640)
..+..|++.++.+++.. ..+..+++|+.|+|++|.+.. . +..+..+++|++|++++|.++. +|..+. ++|+.|
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L 197 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTEL 197 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEE
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEE
Confidence 35778888888887654 457888888888888888863 2 2246677777777777777764 454443 667777
Q ss_pred EcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCC
Q 006559 144 DLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 144 ~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
+|++|++++..| ..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|+ .+|.++..+
T Consensus 198 ~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 262 (330)
T 1xku_A 198 HLDGNKITKVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262 (330)
T ss_dssp ECTTSCCCEECT-GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred ECCCCcCCccCH-HHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccC
Confidence 777777765444 56677777777777777777666666666777777777777776 566655443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.50 E-value=3.2e-14 Score=140.06 Aligned_cols=139 Identities=17% Similarity=0.206 Sum_probs=106.5
Q ss_pred CcEEEEEeCCCC-CCCCc-hhccCCCCCCEEeCCC-CcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCC--
Q 006559 68 HRVIKLVLEDLD-LTGPA-EVLSRLTQLRLLSLKN-NLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLR-- 141 (640)
Q Consensus 68 ~~v~~l~l~~~~-l~g~~-~~l~~l~~L~~L~Ls~-N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~-- 141 (640)
.++..|+|+++. ++... ..+..+++|+.|+|++ |.+++.++ .+..+++|++|+|++|.+++ +|. |..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 468888888886 76644 4688889999999988 88887665 57788889999999998886 666 88888888
Q ss_pred -EEEcccC-CCCCCCCchhcCCCCCCc-EEEccCCcceecccCCcCCCCCCcEEEcccCc-CcccCCcccCCC
Q 006559 142 -RVDLSHN-AYEGEIPMTELTRLPNLL-TLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQ-LSGQIPAWMSPF 210 (640)
Q Consensus 142 -~L~Ls~N-~l~g~~p~~~~~~l~~L~-~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~-l~g~ip~~~~~~ 210 (640)
.|+|++| .+++ +|...|..+++|+ .|+|++|+++...+..+.. .+|+.|++++|+ +++..|..+..+
T Consensus 133 ~~L~l~~N~~l~~-i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l 203 (239)
T 2xwt_C 133 FILEITDNPYMTS-IPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGV 203 (239)
T ss_dssp EEEEEESCTTCCE-ECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTC
T ss_pred cEEECCCCcchhh-cCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhcc
Confidence 8999988 8874 5546688888888 8999888888433334443 788888888884 886555555544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.50 E-value=1e-13 Score=155.51 Aligned_cols=110 Identities=20% Similarity=0.176 Sum_probs=96.5
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
++..|+|+++.+++.. ..++.+++|+.|+|++|.+++.++ .++.+++|++|+|++|.|++..+..|+++++|++|+|+
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls 155 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 155 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEee
Confidence 6788999999998865 488999999999999999999877 47899999999999999997666667999999999999
Q ss_pred cCCCCCCCCchhcCCCCCCcEEEccCCcceecc
Q 006559 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL 179 (640)
Q Consensus 147 ~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~ 179 (640)
+|.+++..| ..+..+++|++|+|++|.+++..
T Consensus 156 ~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~ 187 (597)
T 3oja_B 156 NNNLERIED-DTFQATTSLQNLQLSSNRLTHVD 187 (597)
T ss_dssp SSCCCBCCT-TTTTTCTTCCEEECTTSCCSBCC
T ss_pred CCcCCCCCh-hhhhcCCcCcEEECcCCCCCCcC
Confidence 999997655 77899999999999999998753
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.2e-15 Score=170.87 Aligned_cols=140 Identities=23% Similarity=0.250 Sum_probs=121.2
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
..+..|+|++|.+...+..+..+++|+.|+|++|.|+..+..+..|++|++|+|++|.|+ .+|..|++|++|+.|+|++
T Consensus 224 ~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~ 302 (727)
T 4b8c_D 224 QLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFD 302 (727)
T ss_dssp CCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCS
T ss_pred CCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCC
Confidence 468889999999987777778999999999999999976668999999999999999999 7899999999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCC-CcEEEcccCcCcccCCcccCCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS-ILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~-L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
|.|+ .+| ..|+++++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|..+..+
T Consensus 303 N~l~-~lp-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l 364 (727)
T 4b8c_D 303 NMVT-TLP-WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFI 364 (727)
T ss_dssp SCCC-CCC-SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----
T ss_pred CCCC-ccC-hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccccee
Confidence 9997 788 56999999999999999999999887654322 2347899999999999877644
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.2e-14 Score=167.84 Aligned_cols=141 Identities=21% Similarity=0.270 Sum_probs=123.8
Q ss_pred CcEEEEEeCCCCCCC------------------Cchhcc--CCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEccccc-
Q 006559 68 HRVIKLVLEDLDLTG------------------PAEVLS--RLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNR- 125 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g------------------~~~~l~--~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~- 125 (640)
.++..|+|++|.++| .++.++ ++++|+.|+|++|.+.+..| .+.++++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 468899999999999 566766 99999999999999988766 69999999999999998
Q ss_pred ccc-cCCccCCCCC-------CCCEEEcccCCCCCCCCc-hhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEccc
Q 006559 126 FTG-TFPSGVSSLR-------HLRRVDLSHNAYEGEIPM-TELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSN 196 (640)
Q Consensus 126 l~g-~~p~~~~~l~-------~L~~L~Ls~N~l~g~~p~-~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~ 196 (640)
|+| .+|..+++++ +|+.|+|++|+++ .+|. ..+.++++|+.|+|++|+++ .+| .+..+++|+.|+|++
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDY 604 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCS
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcC
Confidence 999 8887666554 9999999999999 8993 27999999999999999999 788 888899999999999
Q ss_pred CcCcccCCcccCCCCC
Q 006559 197 NQLSGQIPAWMSPFGG 212 (640)
Q Consensus 197 N~l~g~ip~~~~~~~~ 212 (640)
|+|+ .+|.++..+..
T Consensus 605 N~l~-~lp~~l~~l~~ 619 (876)
T 4ecn_A 605 NQIE-EIPEDFCAFTD 619 (876)
T ss_dssp SCCS-CCCTTSCEECT
T ss_pred Cccc-cchHHHhhccc
Confidence 9999 89987765443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=2.1e-14 Score=134.41 Aligned_cols=128 Identities=19% Similarity=0.144 Sum_probs=101.8
Q ss_pred cEEEEEeCCCCCCCCchhccCCC-CCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLT-QLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.+..|+|+++.++... .+..+. +|+.|+|++|.|++. +.+..+++|++|+|++|.|++..|..+..+++|+.|+|++
T Consensus 20 ~L~~L~l~~n~l~~i~-~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 97 (176)
T 1a9n_A 20 RDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97 (176)
T ss_dssp SCEEEECTTSCCCSCC-CGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred CceEEEeeCCCCchhH-HhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCC
Confidence 6788889988888653 344444 899999999998876 6788889999999999999876555568889999999999
Q ss_pred CCCCCCCCc-hhcCCCCCCcEEEccCCcceecccC----CcCCCCCCcEEEcccCcCc
Q 006559 148 NAYEGEIPM-TELTRLPNLLTLRLEDNRFTGTLYS----VNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 148 N~l~g~~p~-~~~~~l~~L~~L~L~~N~l~g~~~~----~~~~~~~L~~l~ls~N~l~ 200 (640)
|+++ .+|. ..+..+++|+.|+|++|.++. +|. .+..+++|+.||+++|.+.
T Consensus 98 N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 98 NSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9986 5662 367888999999999999874 444 3677888999999888765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.49 E-value=5.6e-14 Score=130.33 Aligned_cols=121 Identities=18% Similarity=0.214 Sum_probs=103.2
Q ss_pred cCCCCCCEEeCCCCcCC-C-CCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCC
Q 006559 88 SRLTQLRLLSLKNNLLS-S-SNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNL 165 (640)
Q Consensus 88 ~~l~~L~~L~Ls~N~l~-~-~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L 165 (640)
...++|+.|+|++|.++ + .+..+..+++|++|+|++|.+++. ..+..+++|+.|+|++|++++.+| ..+..+++|
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L 97 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLD-MLAEKLPNL 97 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCC-HHHHHCTTC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHH-HHHhhCCCC
Confidence 34588999999999998 4 444678999999999999999976 789999999999999999998777 677789999
Q ss_pred cEEEccCCcceecc-cCCcCCCCCCcEEEcccCcCcccCC---cccCCCC
Q 006559 166 LTLRLEDNRFTGTL-YSVNSSSRSILDFNVSNNQLSGQIP---AWMSPFG 211 (640)
Q Consensus 166 ~~L~L~~N~l~g~~-~~~~~~~~~L~~l~ls~N~l~g~ip---~~~~~~~ 211 (640)
++|+|++|++++.. +..+..+++|+.|++++|.+++..+ ..+..++
T Consensus 98 ~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~ 147 (168)
T 2ell_A 98 THLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLP 147 (168)
T ss_dssp CEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCS
T ss_pred CEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCc
Confidence 99999999999853 3678889999999999999997655 3454443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=6.4e-14 Score=156.08 Aligned_cols=136 Identities=20% Similarity=0.250 Sum_probs=123.9
Q ss_pred cEEEEEeCCCCCCCCc--hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEccccccc-ccCCccCCCCCCCCEEE
Q 006559 69 RVIKLVLEDLDLTGPA--EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFT-GTFPSGVSSLRHLRRVD 144 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~--~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~ 144 (640)
.+..|++.++.+.+.. ..+..+++|+.|+|++|.+.+..+ .+..+++|++|+|++|.++ +.+|..+..+++|+.|+
T Consensus 397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 5778888888887654 478999999999999999988765 6889999999999999998 68999999999999999
Q ss_pred cccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCc
Q 006559 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPA 205 (640)
Q Consensus 145 Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~ 205 (640)
|++|++++..| ..+..+++|++|+|++|++++.++..+..+++|+.|++++|.++|.+|.
T Consensus 477 l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 477 LSQCQLEQLSP-TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CTTSCCCEECT-TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCCccccCCh-hhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999998667 7899999999999999999999888899999999999999999999884
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.9e-14 Score=155.60 Aligned_cols=148 Identities=20% Similarity=0.233 Sum_probs=125.4
Q ss_pred CCCceEecCCCCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCC-CCCCCcEEEcccccccccCCcc
Q 006559 57 SWRGVTCNPSTHRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLS-SWPHLKHLYLSHNRFTGTFPSG 133 (640)
Q Consensus 57 ~w~gv~C~~~~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~-~l~~L~~L~Ls~N~l~g~~p~~ 133 (640)
.+.++.|..- ..+..|+|++|.+++.. ..++.+++|+.|+|++|.|++.++ .+. .+++|++|+|++|.|++..+
T Consensus 110 ~l~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-- 186 (487)
T 3oja_A 110 NISRVSCSRG-QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-- 186 (487)
T ss_dssp CCCCEEECCC-SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--
T ss_pred cCCCCCcccc-CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--
Confidence 5777777643 57899999999999875 578899999999999999998655 454 79999999999999998733
Q ss_pred CCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCc-ccCCcccCCC
Q 006559 134 VSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS-GQIPAWMSPF 210 (640)
Q Consensus 134 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~-g~ip~~~~~~ 210 (640)
+..+++|+.|+|++|.+++ +| ..+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|.++..+
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~-~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l 261 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAF-MG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261 (487)
T ss_dssp CCCCTTCCEEECCSSCCCE-EC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTC
T ss_pred cccCCCCCEEECCCCCCCC-CC-HhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhC
Confidence 4469999999999999996 55 348899999999999999997 6777888999999999999998 7777766543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.4e-13 Score=127.99 Aligned_cols=105 Identities=19% Similarity=0.222 Sum_probs=88.7
Q ss_pred EEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCC
Q 006559 73 LVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151 (640)
Q Consensus 73 l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 151 (640)
++++++.++..+..+ .++|+.|+|++|.|++.++ .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|+
T Consensus 14 l~~s~n~l~~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~ 91 (170)
T 3g39_A 14 VDCSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK 91 (170)
T ss_dssp EECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EEeCCCCcCccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccC
Confidence 344455666655434 3889999999999999866 6899999999999999999877778899999999999999999
Q ss_pred CCCCchhcCCCCCCcEEEccCCcceeccc
Q 006559 152 GEIPMTELTRLPNLLTLRLEDNRFTGTLY 180 (640)
Q Consensus 152 g~~p~~~~~~l~~L~~L~L~~N~l~g~~~ 180 (640)
+ +|...|..+++|++|+|++|.++...+
T Consensus 92 ~-~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 92 S-IPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp C-CCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred E-eCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 6 554679999999999999999987543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=2.3e-13 Score=152.90 Aligned_cols=144 Identities=19% Similarity=0.161 Sum_probs=130.7
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.+..|++.++.+++.. ..+..+++|+.|+|++|.++..+..+..+++|++|+|++|.+++..|..+.++++|+.|+|++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 334 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCS
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCC
Confidence 6899999999998866 558999999999999999998877899999999999999999998898999999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecc--cCCcCCCCCCcEEEcccCcCcccCCcccCCCCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTL--YSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGG 212 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~--~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~ 212 (640)
|.+.+.+|...+..+++|++|+|++|.+++.. +..+..+++|+.|++++|++++..|..+..++.
T Consensus 335 n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 401 (606)
T 3t6q_A 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401 (606)
T ss_dssp CSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTT
T ss_pred CCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCcc
Confidence 99999998777999999999999999999876 778888999999999999999988887765543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=7.7e-14 Score=153.74 Aligned_cols=136 Identities=18% Similarity=0.302 Sum_probs=87.2
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCC-CCCCCCCCCcEEEcccccccc--cCCccCCCCCCCCEEEc
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSN-LNLSSWPHLKHLYLSHNRFTG--TFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~L 145 (640)
.+..|+++++.+.... ....+++|+.|+|++|.+++.. ..+..+++|++|+|++|++++ .+|..+.++++|+.|+|
T Consensus 303 ~L~~L~l~~n~l~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~L 381 (520)
T 2z7x_B 303 NIKNFTVSGTRMVHML-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDI 381 (520)
T ss_dssp CCSEEEEESSCCCCCC-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEEC
T ss_pred ceeEEEcCCCcccccc-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEEC
Confidence 3666666666655432 1256667777777777776633 356667777777777777765 45566667777777777
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
++|.+++.+|...+..+++|+.|+|++|++++.+|..+. ++|+.|++++|+|+ .+|.++.
T Consensus 382 s~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~ 441 (520)
T 2z7x_B 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV 441 (520)
T ss_dssp CSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG
T ss_pred CCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh
Confidence 777776656644466667777777777777666665542 56667777777766 5665543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.47 E-value=5.8e-13 Score=124.58 Aligned_cols=127 Identities=17% Similarity=0.187 Sum_probs=104.6
Q ss_pred CCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccC
Q 006559 93 LRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLED 172 (640)
Q Consensus 93 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~ 172 (640)
.+.+++++|.++..+..+ .++|+.|+|++|++++..+..|.++++|++|+|++|++++ +|...+..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE-eChhHccCCCccCEEECCC
Confidence 578999999998876544 3789999999999998777788999999999999999995 5547789999999999999
Q ss_pred CcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC---CCCCCCCcccC
Q 006559 173 NRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG---GSSFAGNKNLC 222 (640)
Q Consensus 173 N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~---~~~~~gn~~lc 222 (640)
|+|++..+..+..+++|+.|++++|+|++..+..+..+. ...+.+|+..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 999988888888899999999999999966555444443 33445565433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.47 E-value=3.8e-13 Score=134.48 Aligned_cols=124 Identities=20% Similarity=0.261 Sum_probs=87.0
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
++..|+++++.++... .+..+++|+.|+|++|.+++.++ +..+++|++|+|++|++++ +|... . ++|+.|+|++|
T Consensus 42 ~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L~~N 116 (263)
T 1xeu_A 42 GVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFLDNN 116 (263)
T ss_dssp TCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEECCSS
T ss_pred cCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEccCC
Confidence 5666777777776543 56777777777777777777655 7777777777777777775 33322 2 77777777777
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
++++ +| .+..+++|+.|+|++|++++. + .+..+++|+.|+|++|+|++.
T Consensus 117 ~l~~-~~--~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 117 ELRD-TD--SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CCSB-SG--GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred ccCC-Ch--hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 7775 33 467777777777777777764 2 456677777777777777765
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.47 E-value=2.2e-13 Score=138.35 Aligned_cols=124 Identities=31% Similarity=0.379 Sum_probs=87.4
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
++..|+|+++.+++..+ +..+++|+.|+|++|.+++. +.+..+++|++|+|++|.+++. +.+..+++|+.|+|++|
T Consensus 69 ~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n 144 (291)
T 1h6t_A 69 NVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNN 144 (291)
T ss_dssp TCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSS
T ss_pred CCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCC-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCC
Confidence 56777777777776555 77777777777777777664 3467777777777777777653 45667777777777777
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
++++. ..+..+++|+.|+|++|++++..+ +..+++|+.|++++|+|++
T Consensus 145 ~l~~~---~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 145 KITDI---TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CCCCC---GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred cCCcc---hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 77753 346677777777777777776554 6667777777777777765
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.46 E-value=3.9e-13 Score=142.47 Aligned_cols=110 Identities=20% Similarity=0.190 Sum_probs=92.7
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.++..|+|+++.+++.. ..+..+++|+.|+|++|.+++.++ .+..+++|++|+|++|.++...+..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 36778899999888754 578999999999999999998876 4789999999999999998554555789999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceec
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGT 178 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~ 178 (640)
++|.+++..| ..+..+++|++|+|++|++++.
T Consensus 149 ~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 149 SNNNLERIED-DTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CSSCCCBCCT-TTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCccCccCh-hhccCCCCCCEEECCCCcCCcc
Confidence 9999986544 6788899999999999998864
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=2e-14 Score=147.40 Aligned_cols=142 Identities=21% Similarity=0.228 Sum_probs=111.0
Q ss_pred cEEEEEeCCCCCCCCc-hhc--cCCCCCCEEeCCCCcCCCCCC-----CCCCCCCCcEEEcccccccccCCccCCCCCCC
Q 006559 69 RVIKLVLEDLDLTGPA-EVL--SRLTQLRLLSLKNNLLSSSNL-----NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHL 140 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l--~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 140 (640)
++..|+|.++.+++.. ..+ ..+++|+.|+|++|.+++..+ .+..+++|++|+|++|.+++..|..|+++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 3788888888888754 334 889999999999999987543 24578899999999999988888889999999
Q ss_pred CEEEcccCCCCCC--CC-chhcCCCCCCcEEEccCCcceeccc--C-CcCCCCCCcEEEcccCcCcccCCcccCCC
Q 006559 141 RRVDLSHNAYEGE--IP-MTELTRLPNLLTLRLEDNRFTGTLY--S-VNSSSRSILDFNVSNNQLSGQIPAWMSPF 210 (640)
Q Consensus 141 ~~L~Ls~N~l~g~--~p-~~~~~~l~~L~~L~L~~N~l~g~~~--~-~~~~~~~L~~l~ls~N~l~g~ip~~~~~~ 210 (640)
++|||++|++.+. ++ ...+..+++|++|+|++|+++...+ . .+..+++|+.|+|++|+|++.+|..+..+
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 9999999998753 22 1234678899999999999973221 1 24567899999999999999888766544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=152.94 Aligned_cols=109 Identities=28% Similarity=0.391 Sum_probs=100.4
Q ss_pred CCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEcc
Q 006559 92 QLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLE 171 (640)
Q Consensus 92 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~ 171 (640)
.|+.|+|++|.|++.+ .++.+++|+.|+|++|.|+ .+|..|+++++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~lp-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp--~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD--GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSSCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG--GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCCCc-CccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc--ccCCCCCCcEEECC
Confidence 5889999999999865 4999999999999999999 889999999999999999999997 66 68999999999999
Q ss_pred CCcceecc-cCCcCCCCCCcEEEcccCcCcccCCc
Q 006559 172 DNRFTGTL-YSVNSSSRSILDFNVSNNQLSGQIPA 205 (640)
Q Consensus 172 ~N~l~g~~-~~~~~~~~~L~~l~ls~N~l~g~ip~ 205 (640)
+|+|++.+ |..+..+++|+.|+|++|+|++.+|.
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 99999987 88999999999999999999987663
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.45 E-value=3.3e-13 Score=138.21 Aligned_cols=128 Identities=23% Similarity=0.320 Sum_probs=106.0
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|+++.+++... +..+++|+.|+|++|.+++. +.+..+++|++|+|++|.+++. |. +..+++|+.|+|++
T Consensus 63 ~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~ 138 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDL 138 (308)
T ss_dssp TTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCS
T ss_pred CCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCC
Confidence 468889999998888766 88999999999999998875 4688889999999999999863 43 88899999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
|.+++ ++ .+..+++|+.|+|++|++++..+ +..+++|+.|++++|++++..|
T Consensus 139 n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~ 190 (308)
T 1h6u_A 139 NQITN-IS--PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP 190 (308)
T ss_dssp SCCCC-CG--GGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG
T ss_pred CccCc-Cc--cccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh
Confidence 99985 44 27888899999999999987554 7778899999999999886544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.45 E-value=3.8e-13 Score=136.59 Aligned_cols=128 Identities=25% Similarity=0.421 Sum_probs=113.1
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+++++.+... +.+..+++|+.|+|++|.+++.++ +..+++|++|+|++|.+++ + +.+..+++|+.|+|++
T Consensus 46 ~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~ 121 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEH 121 (291)
T ss_dssp HTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTT
T ss_pred CcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-C-hhhccCCCCCEEECCC
Confidence 3588899999988765 458899999999999999999776 9999999999999999987 3 3489999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
|++++ ++ .+..+++|+.|+|++|++++. ..+..+++|+.|++++|++++..|
T Consensus 122 n~i~~-~~--~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 122 NGISD-IN--GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCC-CG--GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCC-Ch--hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 99986 43 588999999999999999985 567789999999999999998655
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=152.68 Aligned_cols=122 Identities=25% Similarity=0.228 Sum_probs=108.4
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
.+..|+|++|.+++.+. ++.+++|+.|+|++|.|+..|..++.+++|+.|+|++|.|++ +| .++++++|+.|+|++|
T Consensus 442 ~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N 518 (567)
T 1dce_A 442 DVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 518 (567)
T ss_dssp TCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CceEEEecCCCCCCCcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence 36679999999999765 999999999999999999777789999999999999999997 67 8999999999999999
Q ss_pred CCCCCC-CchhcCCCCCCcEEEccCCcceecccCC---cCCCCCCcEEEc
Q 006559 149 AYEGEI-PMTELTRLPNLLTLRLEDNRFTGTLYSV---NSSSRSILDFNV 194 (640)
Q Consensus 149 ~l~g~~-p~~~~~~l~~L~~L~L~~N~l~g~~~~~---~~~~~~L~~l~l 194 (640)
+|++.+ | ..+..+++|+.|+|++|+|++.+|.. ...+++|+.|++
T Consensus 519 ~l~~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 519 RLQQSAAI-QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CCCSSSTT-GGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCc-HHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 999876 7 78999999999999999999887643 234788888865
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.9e-13 Score=133.62 Aligned_cols=125 Identities=23% Similarity=0.304 Sum_probs=111.2
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|++|.+++..+ +..+++|+.|+|++|.+++.+. +.. ++|++|+|++|++++. +.+..+++|+.|+|++
T Consensus 63 ~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~ 137 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKNLNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRN 137 (263)
T ss_dssp TTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSCCTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTT
T ss_pred CCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCCcCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCC
Confidence 478999999999998776 9999999999999999998654 333 9999999999999974 3689999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
|++++ +| .+..+++|+.|+|++|++++. ..+..+++|+.|++++|.+++.
T Consensus 138 N~i~~-~~--~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 138 NKLKS-IV--MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp SCCCB-CG--GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CcCCC-Ch--HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 99996 44 588999999999999999987 6678899999999999999866
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.9e-13 Score=144.93 Aligned_cols=153 Identities=20% Similarity=0.251 Sum_probs=129.1
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCc-CCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEE
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNL-LSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~-l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 144 (640)
.++..|+|++|.++... ..+..+++|+.|+|++|. +...++ .+..+++|++|+|++|+++ .+| .+..+++|+.|+
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~ 213 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELD 213 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEE
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEE
Confidence 46889999999998754 578999999999999854 444444 5889999999999999998 455 488999999999
Q ss_pred cccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC---CCCCCCCccc
Q 006559 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG---GSSFAGNKNL 221 (640)
Q Consensus 145 Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~---~~~~~gn~~l 221 (640)
|++|++++..| ..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|++..+..+..+. ...+.+|+..
T Consensus 214 Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 214 LSGNHLSAIRP-GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCCccCccCh-hhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 99999997656 7899999999999999999999999999999999999999999977776665443 4456788777
Q ss_pred CC
Q 006559 222 CG 223 (640)
Q Consensus 222 cg 223 (640)
|.
T Consensus 293 Cd 294 (440)
T 3zyj_A 293 CN 294 (440)
T ss_dssp CS
T ss_pred CC
Confidence 64
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.44 E-value=3.5e-13 Score=145.79 Aligned_cols=153 Identities=18% Similarity=0.227 Sum_probs=128.8
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCC-cCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEE
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNN-LLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N-~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 144 (640)
.++..|+|++|.++... ..+..+++|+.|+|++| .+...++ .+..+++|++|+|++|++++. | .+..+++|+.|+
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~ 224 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELE 224 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEE
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEE
Confidence 46889999999998754 57899999999999984 5554444 588999999999999999864 4 588999999999
Q ss_pred cccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC---CCCCCCCccc
Q 006559 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG---GSSFAGNKNL 221 (640)
Q Consensus 145 Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~---~~~~~gn~~l 221 (640)
|++|.+++..| ..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|+|++..+..+..+. ...+.+|+..
T Consensus 225 Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 225 MSGNHFPEIRP-GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CTTSCCSEECG-GGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CcCCcCcccCc-ccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 99999997555 7899999999999999999999999999999999999999999977776665444 3456778766
Q ss_pred CC
Q 006559 222 CG 223 (640)
Q Consensus 222 cg 223 (640)
|.
T Consensus 304 Cd 305 (452)
T 3zyi_A 304 CD 305 (452)
T ss_dssp CS
T ss_pred CC
Confidence 64
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.44 E-value=3.6e-13 Score=137.90 Aligned_cols=125 Identities=22% Similarity=0.266 Sum_probs=77.1
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
++..|++.++.++... .+..+++|+.|+|++|.+.+.++ +..+++|++|+|++|.+++. +.+..+++|+.|+|++|
T Consensus 42 ~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n 117 (308)
T 1h6u_A 42 GITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTST 117 (308)
T ss_dssp TCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTS
T ss_pred CcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCC
Confidence 4556666666655432 45666666666666666666554 66666666666666666642 24666666666666666
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
++++ +| .+..+++|++|+|++|++++..+ +..+++|+.|++++|++++.
T Consensus 118 ~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~ 166 (308)
T 1h6u_A 118 QITD-VT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL 166 (308)
T ss_dssp CCCC-CG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CCCC-ch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC
Confidence 6664 33 25666666666666666665443 55566666666666666653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=9.4e-14 Score=153.02 Aligned_cols=137 Identities=18% Similarity=0.239 Sum_probs=114.4
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.+++.|+|+++.+++.. ..+..+++|++|+|++|.+++..+ .+..+++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 47888999999998866 678999999999999999988754 6889999999999999998 46665 7899999999
Q ss_pred ccCCCCC-CCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCC--cEEEcccCcC--cccCCcccCCCC
Q 006559 146 SHNAYEG-EIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI--LDFNVSNNQL--SGQIPAWMSPFG 211 (640)
Q Consensus 146 s~N~l~g-~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L--~~l~ls~N~l--~g~ip~~~~~~~ 211 (640)
++|.+++ .+| ..++++++|++|+|++|++++. .+..+++| +.|++++|++ ++.+|..+..+.
T Consensus 98 ~~N~l~~~~~p-~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~ 164 (520)
T 2z7x_B 98 SFNAFDALPIC-KEFGNMSQLKFLGLSTTHLEKS---SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164 (520)
T ss_dssp CSSCCSSCCCC-GGGGGCTTCCEEEEEESSCCGG---GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred cCCccccccch-hhhccCCcceEEEecCcccchh---hccccccceeeEEEeecccccccccccccccccc
Confidence 9999987 466 6788999999999999999873 34456667 9999999999 888888776654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.44 E-value=6.4e-13 Score=148.24 Aligned_cols=126 Identities=30% Similarity=0.370 Sum_probs=109.8
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|+++.+++..+ +..+++|+.|+|++|.|++. +.+..+++|+.|+|++|.|++. +.+..|++|+.|+|++
T Consensus 65 ~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~ 140 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKDL-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGN 140 (605)
T ss_dssp TTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCC-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCS
T ss_pred CCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCCC-hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCC
Confidence 468899999999988766 88999999999999999875 4788999999999999999863 4688999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
|.+++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++.
T Consensus 141 N~l~~l---~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 141 NKITDI---TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp SCCCCC---GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred CccCCc---hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 999864 468899999999999999998777 77899999999999999874
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=139.86 Aligned_cols=138 Identities=18% Similarity=0.221 Sum_probs=87.5
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCC--CCC-CCCCC--------------------CCCcEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSS--SNL-NLSSW--------------------PHLKHLYLSH 123 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~--~~~-~~~~l--------------------~~L~~L~Ls~ 123 (640)
..+..|+++++.+++.. ..+..+++|+.|+|++|.++. ..+ .+..+ ++|++|+|++
T Consensus 123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~ 202 (332)
T 2ft3_A 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDH 202 (332)
T ss_dssp TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCS
T ss_pred ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCC
Confidence 36888999999988765 458889999999999998853 222 33333 3455555555
Q ss_pred ccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccC
Q 006559 124 NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203 (640)
Q Consensus 124 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~i 203 (640)
|.+++..|..+.++++|+.|+|++|++++..| ..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+|++..
T Consensus 203 n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~ 280 (332)
T 2ft3_A 203 NKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN-GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVG 280 (332)
T ss_dssp SCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCT-TGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCC
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCcCCh-hHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccC
Confidence 55555555556666666666666666664333 45566666666666666666 45555555666666666666666544
Q ss_pred Cccc
Q 006559 204 PAWM 207 (640)
Q Consensus 204 p~~~ 207 (640)
+..+
T Consensus 281 ~~~~ 284 (332)
T 2ft3_A 281 VNDF 284 (332)
T ss_dssp TTSS
T ss_pred hhHc
Confidence 4433
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.5e-13 Score=150.06 Aligned_cols=133 Identities=23% Similarity=0.250 Sum_probs=63.9
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
+++.|+|++|.+++.. ..+..+++|++|+|++|.+++..+ .+..+++|++|+|++|+|+ .+|.. .+++|++|+|+
T Consensus 53 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls 129 (562)
T 3a79_B 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLS 129 (562)
T ss_dssp TCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECC
T ss_pred CcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECC
Confidence 4445555555555443 345555555555555555554433 3455555555555555554 33433 45555555555
Q ss_pred cCCCCC-CCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCC--cEEEcccCcC--cccCCcccC
Q 006559 147 HNAYEG-EIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI--LDFNVSNNQL--SGQIPAWMS 208 (640)
Q Consensus 147 ~N~l~g-~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L--~~l~ls~N~l--~g~ip~~~~ 208 (640)
+|++++ .+| ..+.++++|++|+|++|++++.. +..+.+| +.|++++|++ ++..|..+.
T Consensus 130 ~N~l~~l~~p-~~~~~l~~L~~L~L~~n~l~~~~---~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~ 192 (562)
T 3a79_B 130 FNDFDVLPVC-KEFGNLTKLTFLGLSAAKFRQLD---LLPVAHLHLSCILLDLVSYHIKGGETESLQ 192 (562)
T ss_dssp SSCCSBCCCC-GGGGGCTTCCEEEEECSBCCTTT---TGGGTTSCEEEEEEEESSCCCCSSSCCEEE
T ss_pred CCCccccCch-HhhcccCcccEEecCCCccccCc---hhhhhhceeeEEEeecccccccccCccccc
Confidence 555543 122 34555555555555555554321 2222233 5555555555 454454443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=9e-13 Score=137.66 Aligned_cols=146 Identities=20% Similarity=0.182 Sum_probs=121.3
Q ss_pred CCceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCC
Q 006559 58 WRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSS 136 (640)
Q Consensus 58 w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 136 (640)
-....|... .+ .++++++++..+..+. ++|+.|+|++|.+++.++ .+..+++|++|+|++|.+++..|..|.+
T Consensus 25 ~~~~~C~~~--~~--c~~~~~~l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (353)
T 2z80_A 25 QASLSCDRN--GI--CKGSSGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSS 98 (353)
T ss_dssp --CCEECTT--SE--EECCSTTCSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred ccCCCCCCC--eE--eeCCCCCccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCC
Confidence 357788653 33 7888888887665443 589999999999998776 6999999999999999999988999999
Q ss_pred CCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceeccc-CCcCCCCCCcEEEcccCc-CcccCCcccCCC
Q 006559 137 LRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLY-SVNSSSRSILDFNVSNNQ-LSGQIPAWMSPF 210 (640)
Q Consensus 137 l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~-~~~~~~~~L~~l~ls~N~-l~g~ip~~~~~~ 210 (640)
+++|++|+|++|++++ +|...+.++++|++|+|++|++++..+ ..+..+++|+.|++++|+ +++..|..+..+
T Consensus 99 l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l 173 (353)
T 2z80_A 99 LGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173 (353)
T ss_dssp CTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred CCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCC
Confidence 9999999999999995 675668999999999999999996554 478889999999999995 665555555443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=8e-13 Score=146.51 Aligned_cols=142 Identities=20% Similarity=0.213 Sum_probs=120.9
Q ss_pred EecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCC
Q 006559 62 TCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHL 140 (640)
Q Consensus 62 ~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 140 (640)
.|... .+ .++.+++++..+..+. ++|+.|+|++|.+++.++ .+..+++|++|+|++|++++..|..|+++++|
T Consensus 3 ~C~~~--~~--c~~~~~~l~~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 76 (549)
T 2z81_A 3 SCDAS--GV--CDGRSRSFTSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76 (549)
T ss_dssp EECTT--SE--EECTTSCCSSCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred cCCCC--ce--EECCCCccccccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccC
Confidence 57542 34 6888888887665443 799999999999998765 79999999999999999999999999999999
Q ss_pred CEEEcccCCCCCCCCchhcCCCCCCcEEEccCCccee-cccCCcCCCCCCcEEEcccCcCcccCC-cccCCC
Q 006559 141 RRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG-TLYSVNSSSRSILDFNVSNNQLSGQIP-AWMSPF 210 (640)
Q Consensus 141 ~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g-~~~~~~~~~~~L~~l~ls~N~l~g~ip-~~~~~~ 210 (640)
++|||++|.+++. |+..++++++|++|+|++|++++ .+|..+..+++|+.|++++|++.+.+| ..+..+
T Consensus 77 ~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 77 EHLDLSDNHLSSL-SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp CEEECTTSCCCSC-CHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred CEEECCCCccCcc-CHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 9999999999964 43779999999999999999997 467788999999999999999777776 455544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.42 E-value=5.8e-13 Score=138.65 Aligned_cols=131 Identities=20% Similarity=0.288 Sum_probs=77.8
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
.+..|+++++.+.+... +..+++|+.|++++|.+.+..+ +..+++|++|+|++|.+++..+ +..+++|+.|+|++|
T Consensus 178 ~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n 253 (347)
T 4fmz_A 178 DLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253 (347)
T ss_dssp TCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred CCCEEEccCCccccccc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCC
Confidence 56777777777766443 5666666666666666665443 5556666666666666654332 556666666666666
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
.+++ + ..+..+++|+.|++++|++++. +.+..+++|+.|++++|++++..|..+.
T Consensus 254 ~l~~-~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 308 (347)
T 4fmz_A 254 QISD-I--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIG 308 (347)
T ss_dssp CCCC-C--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHH
T ss_pred ccCC-C--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhh
Confidence 6654 2 2355566666666666666553 2344556666666666666655554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.9e-13 Score=140.70 Aligned_cols=114 Identities=18% Similarity=0.090 Sum_probs=68.6
Q ss_pred CCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccC-CCCCCCCEEEcccCCCCCCCCchhcCCCCCCcE
Q 006559 90 LTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGV-SSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLT 167 (640)
Q Consensus 90 l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~ 167 (640)
+++|+.|+|++|.+++.++ .+..+++|++|+|++|.+++..|..+ ..+++|+.|+|++|.+++. | ....+++|++
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~l~~L~~ 195 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K--GQVVFAKLKT 195 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E--CCCCCTTCCE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c--cccccccCCE
Confidence 5566666666666666544 45666666666666666666555554 3566666666666666642 3 1234666666
Q ss_pred EEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccC
Q 006559 168 LRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMS 208 (640)
Q Consensus 168 L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~ 208 (640)
|+|++|++++..+. +..+++|+.|+|++|+|+ .+|..+.
T Consensus 196 L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~ 234 (317)
T 3o53_A 196 LDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALR 234 (317)
T ss_dssp EECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCC
T ss_pred EECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhh
Confidence 66666666654333 555666666777766666 3454443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.9e-13 Score=140.67 Aligned_cols=138 Identities=20% Similarity=0.241 Sum_probs=116.2
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CC-CCCCCCcEEEcccccccccCCccCCCCCCCCEEE
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NL-SSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~-~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 144 (640)
..+..|+|++|.+++.. ..+..+++|+.|+|++|.+++.++ .+ ..+++|++|+|++|.+++. | ....+++|+.|+
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~ 197 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLD 197 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEE
Confidence 35777888888888764 467889999999999999998654 34 4789999999999999876 3 334599999999
Q ss_pred cccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCc-ccCCcccCCC
Q 006559 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS-GQIPAWMSPF 210 (640)
Q Consensus 145 Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~-g~ip~~~~~~ 210 (640)
|++|++++ +| ..+..+++|+.|+|++|++++ +|..+..+++|+.|++++|.++ +.+|.++..+
T Consensus 198 Ls~N~l~~-l~-~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~ 261 (317)
T 3o53_A 198 LSSNKLAF-MG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261 (317)
T ss_dssp CCSSCCCE-EC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTC
T ss_pred CCCCcCCc-ch-hhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhcc
Confidence 99999995 66 458899999999999999995 6777888999999999999999 7777776554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.39 E-value=9.3e-13 Score=146.93 Aligned_cols=128 Identities=23% Similarity=0.320 Sum_probs=114.1
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|+++.+++.. .+..+++|+.|+|++|.|.+. +.+..+++|+.|+|++|.|++. ..+..+++|+.|+|++
T Consensus 87 ~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~ 162 (605)
T 1m9s_A 87 KNLGWLFLDENKIKDLS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLED 162 (605)
T ss_dssp TTCCEEECCSSCCCCCT-TSTTCTTCCEEECTTSCCCCC-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCS
T ss_pred CCCCEEECcCCCCCCCh-hhccCCCCCEEEecCCCCCCC-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcC
Confidence 46889999999999864 789999999999999999985 5688999999999999999975 6789999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
|.+++..| +..+++|+.|+|++|+|++. +.+..+++|+.|+|++|++++...
T Consensus 163 N~l~~~~~---l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 163 NQISDIVP---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp SCCCCCGG---GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred CcCCCchh---hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence 99997544 88999999999999999985 357789999999999999987533
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.39 E-value=9.1e-13 Score=143.13 Aligned_cols=128 Identities=27% Similarity=0.333 Sum_probs=111.6
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+++++.+++..+ +..+++|+.|+|++|.+++.++ +..+++|+.|+|++|++++..| +..+++|+.|+|++
T Consensus 243 ~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~ 318 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318 (466)
T ss_dssp TTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCS
T ss_pred CCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcC
Confidence 468889999999988765 8899999999999999998765 8889999999999999987544 78899999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
|++++..| +..+++|+.|++++|.+++. ..+..+++|+.|++++|++++.+|
T Consensus 319 n~l~~~~~---~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 319 NNISDISP---VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp SCCSCCGG---GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred CcCCCchh---hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 99997544 67889999999999999985 467778999999999999998887
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.1e-12 Score=120.49 Aligned_cols=106 Identities=21% Similarity=0.301 Sum_probs=91.2
Q ss_pred EEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCC
Q 006559 71 IKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149 (640)
Q Consensus 71 ~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 149 (640)
..++++++.++..+..+. ++|+.|+|++|.|++.++ .+..+++|++|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 356778888876555443 899999999999999866 68999999999999999998766678999999999999999
Q ss_pred CCCCCCchhcCCCCCCcEEEccCCcceecc
Q 006559 150 YEGEIPMTELTRLPNLLTLRLEDNRFTGTL 179 (640)
Q Consensus 150 l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~ 179 (640)
|++ +|...|..+++|++|+|++|.|....
T Consensus 93 l~~-l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 93 LKS-IPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCC-CCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred cce-eCHHHhccccCCCEEEeCCCCccccc
Confidence 995 66466999999999999999998654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=136.30 Aligned_cols=111 Identities=23% Similarity=0.314 Sum_probs=85.6
Q ss_pred CC-CCCCCceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCC-CcCCCCCC-CCCCCCCCcEEEccccccccc
Q 006559 53 PC-FDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKN-NLLSSSNL-NLSSWPHLKHLYLSHNRFTGT 129 (640)
Q Consensus 53 ~c-~~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~-N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~ 129 (640)
.| .|.|..|.|... ++|+..+. +..+++|+.|+|++ |.|++.++ .|..+++|+.|+|++|+|++.
T Consensus 4 ~c~~C~~~~v~~~~~-----------n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 71 (347)
T 2ifg_A 4 ACCPHGSSGLRCTRD-----------GALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71 (347)
T ss_dssp SSCCSSSSCEECCSS-----------CCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEE
T ss_pred cCccccCCEEEcCCC-----------CCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCcccee
Confidence 35 458888888642 25666556 88888888888886 88888765 588888888888888888888
Q ss_pred CCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCccee
Q 006559 130 FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG 177 (640)
Q Consensus 130 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g 177 (640)
.|..|.+|++|+.|||++|+|++ +|...+..++ |+.|+|.+|.|..
T Consensus 72 ~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 72 APDAFHFTPRLSRLNLSFNALES-LSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CHHHhcCCcCCCEEeCCCCccce-eCHHHcccCC-ceEEEeeCCCccC
Confidence 88888888888888888888884 5545555555 8888888888774
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-12 Score=141.67 Aligned_cols=126 Identities=29% Similarity=0.310 Sum_probs=112.4
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|++.++.+++. +.+..+++|+.|+|++|.+++.++ +..+++|+.|+|++|.+++..| +..+++|+.|+|++
T Consensus 221 ~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~ 296 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 296 (466)
T ss_dssp TTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCC
Confidence 4688999999998875 568899999999999999998765 8899999999999999997544 88999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
|++++..| +..+++|+.|+|++|++++..| +..+++|+.|++++|++++.
T Consensus 297 n~l~~~~~---~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 297 NQLEDISP---ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp SCCSCCGG---GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CcccCchh---hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 99997433 7889999999999999999876 66799999999999999986
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.38 E-value=8.7e-13 Score=137.29 Aligned_cols=144 Identities=20% Similarity=0.289 Sum_probs=122.1
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
..+..+++.++.+.+... +..+++|+.|+|++|.+++.++ +..+++|++|+|++|.+++. +.+..+++|+.|+|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~ 274 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGS 274 (347)
T ss_dssp TTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCS
T ss_pred CccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccC
Confidence 467889999998887655 8899999999999999998766 88999999999999999874 5689999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC-cccCCCCCCCCCCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP-AWMSPFGGSSFAGN 218 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip-~~~~~~~~~~~~gn 218 (640)
|++++ +| .+..+++|+.|+|++|++++..+..+..+++|+.|++++|++++..| ..+..+....+.+|
T Consensus 275 n~l~~-~~--~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N 343 (347)
T 4fmz_A 275 NQISD-IS--VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343 (347)
T ss_dssp SCCCC-CG--GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC
T ss_pred CccCC-Ch--hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhh
Confidence 99986 44 57889999999999999999998888899999999999999998877 22333333444444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.8e-13 Score=146.02 Aligned_cols=124 Identities=21% Similarity=0.225 Sum_probs=92.1
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|++|.+++.+. +.. +|+.|+|++|.|++.+. .+++|+.|+|++|.|++ +|. .+++|+.|+|++
T Consensus 100 ~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 100 ASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTMLPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN 169 (571)
T ss_dssp TTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCCCCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence 467778888888887544 544 88899999998888554 67888888888888886 665 578888888888
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCC-------cEEEcccCcCcccCCcccCCCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI-------LDFNVSNNQLSGQIPAWMSPFG 211 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L-------~~l~ls~N~l~g~ip~~~~~~~ 211 (640)
|+|++ +|. +. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .||..+..+.
T Consensus 170 N~L~~-lp~--l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~ 230 (571)
T 3cvr_A 170 NQLTF-LPE--LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLD 230 (571)
T ss_dssp SCCSC-CCC--CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSC
T ss_pred CCCCC-cch--hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCC
Confidence 88886 773 54 78888888888888 5555 432 66 88888888888 5777665443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.37 E-value=9.3e-13 Score=123.08 Aligned_cols=115 Identities=20% Similarity=0.194 Sum_probs=98.2
Q ss_pred hhccCCCCCCEEeCCCCcCCCCCCCCCCCC-CCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCC
Q 006559 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWP-HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP 163 (640)
Q Consensus 85 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~ 163 (640)
..+.++++|+.|+|++|.++.. +.+..+. +|++|+|++|.|++. ..+..+++|+.|+|++|.+++ +|+..+..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCC
Confidence 3467789999999999999976 5566665 999999999999986 679999999999999999995 5645568999
Q ss_pred CCcEEEccCCcceecccC--CcCCCCCCcEEEcccCcCcccCCc
Q 006559 164 NLLTLRLEDNRFTGTLYS--VNSSSRSILDFNVSNNQLSGQIPA 205 (640)
Q Consensus 164 ~L~~L~L~~N~l~g~~~~--~~~~~~~L~~l~ls~N~l~g~ip~ 205 (640)
+|++|+|++|+++. +|. .+..+++|+.|++++|.++ .+|.
T Consensus 89 ~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~ 130 (176)
T 1a9n_A 89 DLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKH 130 (176)
T ss_dssp TCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTT
T ss_pred CCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHh
Confidence 99999999999964 554 6778999999999999998 4555
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.8e-12 Score=140.12 Aligned_cols=126 Identities=20% Similarity=0.119 Sum_probs=87.5
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
.+..|++.++...+.. .+..+++|+.|+|++|.+++.+ +..+++|+.|++++|++++. .++.+++|+.|+|++|
T Consensus 149 ~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N 222 (457)
T 3bz5_A 149 QLTELDCHLNKKITKL-DVTPQTQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSN 222 (457)
T ss_dssp TCCEEECTTCSCCCCC-CCTTCTTCCEEECCSSCCCCCC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSS
T ss_pred cCCEEECCCCCccccc-ccccCCcCCEEECCCCccceec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCC
Confidence 5677777777555544 4677788888888888887753 67777788888888887764 3777778888888888
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCC-------CCcEEEcccCcCcccCC
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSR-------SILDFNVSNNQLSGQIP 204 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~-------~L~~l~ls~N~l~g~ip 204 (640)
++++ +| +..+++|+.|++++|+|++..+..+..+. +|+.|++++|.+.|.+|
T Consensus 223 ~l~~-ip---~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 223 KLTE-ID---VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp CCSC-CC---CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred cccc-cC---ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 8776 55 56777788888888877776544443333 44555566666666655
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.8e-15 Score=144.53 Aligned_cols=131 Identities=21% Similarity=0.236 Sum_probs=109.4
Q ss_pred EEEEEeCCCCCCCCc-------hhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCE
Q 006559 70 VIKLVLEDLDLTGPA-------EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRR 142 (640)
Q Consensus 70 v~~l~l~~~~l~g~~-------~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 142 (640)
++.+++..+.++|.. ..+..+++|+.|+|++|.+++.+ .+..+++|++|+|++|.++ .+|..+..+++|+.
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~ 97 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEE 97 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSE
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCE
Confidence 444444444555432 37889999999999999999865 8889999999999999998 68888888899999
Q ss_pred EEcccCCCCCCCCchhcCCCCCCcEEEccCCcceeccc-CCcCCCCCCcEEEcccCcCcccCCc
Q 006559 143 VDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLY-SVNSSSRSILDFNVSNNQLSGQIPA 205 (640)
Q Consensus 143 L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~-~~~~~~~~L~~l~ls~N~l~g~ip~ 205 (640)
|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|+.|++++|.+++.+|.
T Consensus 98 L~L~~N~l~~-l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 98 LWISYNQIAS-LS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EEEEEEECCC-HH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred EECcCCcCCc-CC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9999999996 55 57889999999999999997443 4677899999999999999988775
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=2e-12 Score=134.59 Aligned_cols=106 Identities=18% Similarity=0.209 Sum_probs=95.0
Q ss_pred EEeCCCC-cCCCCCCCCCCCCCCcEEEccc-ccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccC
Q 006559 95 LLSLKNN-LLSSSNLNLSSWPHLKHLYLSH-NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLED 172 (640)
Q Consensus 95 ~L~Ls~N-~l~~~~~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~ 172 (640)
.+++++| .|++.|. +..+++|+.|+|++ |.|++..|..|++|++|+.|+|++|+|++..| ..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP-DAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT-TGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH-HHhcCCcCCCEEeCCC
Confidence 4688888 8999877 99999999999996 99999888999999999999999999998655 7899999999999999
Q ss_pred CcceecccCCcCCCCCCcEEEcccCcCcccC
Q 006559 173 NRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203 (640)
Q Consensus 173 N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~i 203 (640)
|+|++.++..+..+. |+.|+|++|.|...-
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSC 119 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCG
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCC
Confidence 999987777776665 999999999998653
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.34 E-value=7.8e-12 Score=135.18 Aligned_cols=123 Identities=20% Similarity=0.190 Sum_probs=91.3
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|+++.+++.. ++.+++|+.|+|++|.+++. .++.+++|++|++++|.+.+.+ .++.+++|+.|+|++
T Consensus 106 ~~L~~L~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~ 179 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSF 179 (457)
T ss_dssp TTCCEEECCSSCCSCCC--CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCS
T ss_pred CcCCEEECCCCcCCeec--CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCC
Confidence 46788999999988853 88899999999999999885 3777778888888888666665 366777777777777
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
|++++ +| +..+++|+.|++++|++++. .+..+++|+.|++++|+|++ +|
T Consensus 180 n~l~~-l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 180 NKITE-LD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp SCCCC-CC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC
T ss_pred Cccce-ec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC
Confidence 77775 44 56667777777777777764 25556777777777777776 44
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-11 Score=133.31 Aligned_cols=120 Identities=23% Similarity=0.357 Sum_probs=73.2
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
.+..|+++++.+++.... .++|++|+|++|.+++.+ .+..+++|++|++++|++++ +|..+ .+|+.|+|++|
T Consensus 112 ~L~~L~l~~n~l~~l~~~---~~~L~~L~L~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n 183 (454)
T 1jl5_A 112 SLKSLLVDNNNLKALSDL---PPLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNN 183 (454)
T ss_dssp TCCEEECCSSCCSCCCSC---CTTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSS
T ss_pred CCcEEECCCCccCcccCC---CCCCCEEECcCCCCCCCc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCC
Confidence 455556666555542211 156777777777777643 57777777777777777765 45432 46677777777
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
++++ +| .+.++++|++|++++|++++ +|.. ..+|+.|++++|+++ .+|
T Consensus 184 ~l~~-l~--~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp 231 (454)
T 1jl5_A 184 QLEE-LP--ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP 231 (454)
T ss_dssp CCSS-CC--CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC
T ss_pred cCCc-Cc--cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc
Confidence 7765 45 36666777777777776665 3322 235666666666666 455
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.4e-12 Score=133.12 Aligned_cols=147 Identities=16% Similarity=0.135 Sum_probs=105.7
Q ss_pred CCCCCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC--CCCCCCCCcE-EE
Q 006559 54 CFDSWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL--NLSSWPHLKH-LY 120 (640)
Q Consensus 54 c~~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~-L~ 120 (640)
|.|+|+.|.|+.. ...++.|+|++|.++..+ ..|.+|++|+.|+|++|.+.+..+ .|.++++|.. ++
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 6679999999753 135788899998888755 568889999999999998866433 4778887764 66
Q ss_pred cccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccC-CcceecccCCcCCCC-CCcEEEcccCc
Q 006559 121 LSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLED-NRFTGTLYSVNSSSR-SILDFNVSNNQ 198 (640)
Q Consensus 121 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~-N~l~g~~~~~~~~~~-~L~~l~ls~N~ 198 (640)
+++|+++...|..|.++++|+.|+|++|++++ +|...+....++..|++.+ |++....+..+..+. .++.|+|++|+
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSS-CCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred ccCCcccccCchhhhhcccccccccccccccc-CCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence 77788888888888899999999999998885 4434455555666777654 455544444444443 46667777777
Q ss_pred Ccc
Q 006559 199 LSG 201 (640)
Q Consensus 199 l~g 201 (640)
|+.
T Consensus 166 i~~ 168 (350)
T 4ay9_X 166 IQE 168 (350)
T ss_dssp CCE
T ss_pred ccC
Confidence 763
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.30 E-value=1.5e-13 Score=142.47 Aligned_cols=145 Identities=19% Similarity=0.211 Sum_probs=110.8
Q ss_pred CCCceEecCCCCcEEEEEeCCCCCCCCchhccCC--CCCCEEeCCCCcCCCCCCCCCCCCCCcEEEccccccccc-CCcc
Q 006559 57 SWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRL--TQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT-FPSG 133 (640)
Q Consensus 57 ~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~-~p~~ 133 (640)
.|.++.|++. .+..++++++.+. ...+..+ ++|+.|+|++|.+.+..+.+..+++|++|+|++|.+++. +|..
T Consensus 38 ~W~~~~~~~~--~~~~l~l~~~~~~--~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~ 113 (336)
T 2ast_B 38 RWYRLASDES--LWQTLDLTGKNLH--PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 113 (336)
T ss_dssp HHHHHHTCST--TSSEEECTTCBCC--HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHH
T ss_pred HHHHHhcCch--hheeeccccccCC--HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHH
Confidence 7888888753 4667788877766 3445556 788888888888888777777788888888888888766 7777
Q ss_pred CCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCC-cceec-ccCCcCCCCCCcEEEcccC-cCccc-CCcc
Q 006559 134 VSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN-RFTGT-LYSVNSSSRSILDFNVSNN-QLSGQ-IPAW 206 (640)
Q Consensus 134 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N-~l~g~-~~~~~~~~~~L~~l~ls~N-~l~g~-ip~~ 206 (640)
+..+++|+.|+|++|.+++..| ..+..+++|++|+|++| .+++. ++..+..+++|+.|++++| ++++. +|..
T Consensus 114 ~~~~~~L~~L~L~~~~l~~~~~-~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~ 189 (336)
T 2ast_B 114 LSQCSKLQNLSLEGLRLSDPIV-NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 189 (336)
T ss_dssp HTTBCCCSEEECTTCBCCHHHH-HHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH
T ss_pred HhhCCCCCEEeCcCcccCHHHH-HHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH
Confidence 8888888888888888876666 56778888888888888 67763 5666667788888888888 88754 4443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.28 E-value=2.4e-11 Score=131.17 Aligned_cols=135 Identities=21% Similarity=0.222 Sum_probs=101.0
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+++++.+++.+. .+++|+.|+|++|.+++.+.. .++|++|+|++|.+++ +| .|+++++|++|+|++
T Consensus 91 ~~L~~L~l~~n~l~~lp~---~~~~L~~L~l~~n~l~~l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~ 162 (454)
T 1jl5_A 91 PHLESLVASCNSLTELPE---LPQSLKSLLVDNNNLKALSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDN 162 (454)
T ss_dssp TTCSEEECCSSCCSSCCC---CCTTCCEEECCSSCCSCCCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCCCEEEccCCcCCcccc---ccCCCcEEECCCCccCcccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCC
Confidence 367788888888887443 247888888888888775321 1689999999999987 77 588999999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCCCCCCCC
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGN 218 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~gn 218 (640)
|++++ +| .. .++|++|+|++|++++ +| .+..+++|+.|++++|++++ +|.....+....+.+|
T Consensus 163 N~l~~-lp-~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~n 225 (454)
T 1jl5_A 163 NSLKK-LP-DL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLPLSLESIVAGNN 225 (454)
T ss_dssp SCCSC-CC-CC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCCTTCCEEECCSS
T ss_pred CcCcc-cC-CC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCcCcccEEECcCC
Confidence 99985 66 32 3589999999999987 45 57788999999999999986 5554444433333344
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=138.11 Aligned_cols=64 Identities=25% Similarity=0.362 Sum_probs=40.6
Q ss_pred CCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCC
Q 006559 138 RHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG 211 (640)
Q Consensus 138 ~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~ 211 (640)
++|+.|+|++|++++ +| ..+++|+.|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..+..++
T Consensus 221 ~~L~~L~Ls~N~L~~-lp----~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~ 284 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP----VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLS 284 (622)
T ss_dssp TTCCEEECCSSCCSC-CC----CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSC
T ss_pred CCCCEEEccCCccCc-CC----CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhcc
Confidence 566777777777764 55 345667777777777763 333 3566777777777777 5666554443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.25 E-value=4.1e-12 Score=141.96 Aligned_cols=137 Identities=23% Similarity=0.287 Sum_probs=86.6
Q ss_pred CCCCCCCCCCCCCCCceEec------CCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcE
Q 006559 45 SSWVNSTDPCFDSWRGVTCN------PSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKH 118 (640)
Q Consensus 45 ~sW~~~~~~c~~~w~gv~C~------~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~ 118 (640)
.+|....++| .|+|..|. .....+..|++++++++..+..+. ++|+.|+|++|.|+..+. .+++|++
T Consensus 13 ~~W~~~~~~~--~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~ 85 (622)
T 3g06_A 13 SAWRRAAPAE--ESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRT 85 (622)
T ss_dssp HHHHHTCCGG--GHHHHHHHHHHHHHHHHHCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCE
T ss_pred HHHHhcCCcc--hhccccccCcccccccCCCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCE
Confidence 3574344444 78664321 111246778888888775544343 678888888888776544 4677788
Q ss_pred EEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCc
Q 006559 119 LYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQ 198 (640)
Q Consensus 119 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~ 198 (640)
|+|++|+|++ +|. .+++|++|+|++|++++ +|. .+++|+.|+|++|++++ +|.. +++|+.|+|++|+
T Consensus 86 L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 86 LEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQ 152 (622)
T ss_dssp EEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSC
T ss_pred EEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCc
Confidence 8888887764 554 56777777777777774 552 45667777777777665 3332 3566666777766
Q ss_pred Ccc
Q 006559 199 LSG 201 (640)
Q Consensus 199 l~g 201 (640)
|++
T Consensus 153 l~~ 155 (622)
T 3g06_A 153 LAS 155 (622)
T ss_dssp CSC
T ss_pred CCC
Confidence 664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.9e-12 Score=137.01 Aligned_cols=139 Identities=20% Similarity=0.279 Sum_probs=109.8
Q ss_pred CcEEEEEeCCCCCCCC-----chhccCC---------CCCCEEeCCCCcCCC-CCC----CCCCCCCCcEEEccccccc-
Q 006559 68 HRVIKLVLEDLDLTGP-----AEVLSRL---------TQLRLLSLKNNLLSS-SNL----NLSSWPHLKHLYLSHNRFT- 127 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~-----~~~l~~l---------~~L~~L~Ls~N~l~~-~~~----~~~~l~~L~~L~Ls~N~l~- 127 (640)
.++..|+|++|.++.. ...+..+ ++|+.|+|++|.++. ..+ .+..+++|++|+|++|.++
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~ 201 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence 4688899999998642 2445555 899999999999973 222 3567889999999999997
Q ss_pred -c---cCCccCCCCCCCCEEEcccCCCC----CCCCchhcCCCCCCcEEEccCCcceec----ccCCc--CCCCCCcEEE
Q 006559 128 -G---TFPSGVSSLRHLRRVDLSHNAYE----GEIPMTELTRLPNLLTLRLEDNRFTGT----LYSVN--SSSRSILDFN 193 (640)
Q Consensus 128 -g---~~p~~~~~l~~L~~L~Ls~N~l~----g~~p~~~~~~l~~L~~L~L~~N~l~g~----~~~~~--~~~~~L~~l~ 193 (640)
| .+|..+..+++|+.|+|++|.++ +.+| ..+..+++|++|+|++|.+++. ++..+ ..+++|+.|+
T Consensus 202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~-~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~ 280 (386)
T 2ca6_A 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA-IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 280 (386)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH-HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHH-HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEE
Confidence 3 45557888999999999999996 5666 5788899999999999999876 45555 3388899999
Q ss_pred cccCcCcc----cCCccc
Q 006559 194 VSNNQLSG----QIPAWM 207 (640)
Q Consensus 194 ls~N~l~g----~ip~~~ 207 (640)
|++|.|++ .+|..+
T Consensus 281 L~~n~i~~~g~~~l~~~l 298 (386)
T 2ca6_A 281 LQYNEIELDAVRTLKTVI 298 (386)
T ss_dssp CCSSCCBHHHHHHHHHHH
T ss_pred CcCCcCCHHHHHHHHHHH
Confidence 99999998 577655
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.20 E-value=4.5e-13 Score=138.73 Aligned_cols=137 Identities=20% Similarity=0.210 Sum_probs=95.0
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCC--CCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSS--NLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~--~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
..+..+++.++.+++....+..+++|+.|+|++|.+++. +..+..+++|++|+|++|.+++..|..++++++|++|+|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 149 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149 (336)
T ss_dssp TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence 357777888887777766667778888888888877653 224667778888888888877777777777788888888
Q ss_pred ccC-CCCCC-CCchhcCCCCCCcEEEccCC-cceec-ccCCcCCCC-CCcEEEcccC--cCc-ccCCc
Q 006559 146 SHN-AYEGE-IPMTELTRLPNLLTLRLEDN-RFTGT-LYSVNSSSR-SILDFNVSNN--QLS-GQIPA 205 (640)
Q Consensus 146 s~N-~l~g~-~p~~~~~~l~~L~~L~L~~N-~l~g~-~~~~~~~~~-~L~~l~ls~N--~l~-g~ip~ 205 (640)
++| .+++. +| ..+.++++|++|+|++| .+++. ++..+..++ +|+.|++++| .++ +.+|.
T Consensus 150 ~~~~~l~~~~l~-~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~ 216 (336)
T 2ast_B 150 SGCSGFSEFALQ-TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 216 (336)
T ss_dssp TTCBSCCHHHHH-HHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHH
T ss_pred CCCCCCCHHHHH-HHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHH
Confidence 877 56642 44 44666777777777777 77654 455555566 7777777777 444 34443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.3e-13 Score=131.52 Aligned_cols=127 Identities=21% Similarity=0.253 Sum_probs=108.3
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|+++.+++.+ .+..+++|+.|+|++|.++..+..+..+++|++|+|++|.+++ +| .+..+++|+.|+|++
T Consensus 48 ~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~ 124 (198)
T 1ds9_A 48 KACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSN 124 (198)
T ss_dssp TTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESE
T ss_pred CCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCC
Confidence 36889999999998855 8899999999999999999766556677999999999999997 45 688999999999999
Q ss_pred CCCCCCCCc-hhcCCCCCCcEEEccCCcceecccCC----------cCCCCCCcEEEcccCcCc
Q 006559 148 NAYEGEIPM-TELTRLPNLLTLRLEDNRFTGTLYSV----------NSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 148 N~l~g~~p~-~~~~~l~~L~~L~L~~N~l~g~~~~~----------~~~~~~L~~l~ls~N~l~ 200 (640)
|++++ +|. ..+..+++|++|++++|.+++.+|.. +..+++|+.|| +|.++
T Consensus 125 N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 125 NKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CcCCc-hhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 99985 332 46899999999999999999987763 66788999887 66665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.4e-12 Score=137.90 Aligned_cols=133 Identities=26% Similarity=0.338 Sum_probs=67.6
Q ss_pred cEEEEEeCCCCCCCC-----chhccCCCCCCEEeCCCCcCCCCCC-C----CCCC---------CCCcEEEccccccc-c
Q 006559 69 RVIKLVLEDLDLTGP-----AEVLSRLTQLRLLSLKNNLLSSSNL-N----LSSW---------PHLKHLYLSHNRFT-G 128 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~-----~~~l~~l~~L~~L~Ls~N~l~~~~~-~----~~~l---------~~L~~L~Ls~N~l~-g 128 (640)
++..|+|++|.+++. +..+..+++|+.|+|++|.+++..+ . +..+ ++|++|+|++|+++ +
T Consensus 95 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~ 174 (386)
T 2ca6_A 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 174 (386)
T ss_dssp TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG
T ss_pred cccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcH
Confidence 455555555555542 2344555555555555555543211 1 1222 55566666666554 2
Q ss_pred cCC---ccCCCCCCCCEEEcccCCCC--C---CCCchhcCCCCCCcEEEccCCcce----ecccCCcCCCCCCcEEEccc
Q 006559 129 TFP---SGVSSLRHLRRVDLSHNAYE--G---EIPMTELTRLPNLLTLRLEDNRFT----GTLYSVNSSSRSILDFNVSN 196 (640)
Q Consensus 129 ~~p---~~~~~l~~L~~L~Ls~N~l~--g---~~p~~~~~~l~~L~~L~L~~N~l~----g~~~~~~~~~~~L~~l~ls~ 196 (640)
.+| ..+..+++|+.|+|++|.++ | .+| ..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++
T Consensus 175 ~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~-~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL-EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHH-TTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHH-HHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 333 23445556666666666554 1 111 24455556666666666654 44555555555666666666
Q ss_pred CcCccc
Q 006559 197 NQLSGQ 202 (640)
Q Consensus 197 N~l~g~ 202 (640)
|.|++.
T Consensus 254 n~i~~~ 259 (386)
T 2ca6_A 254 CLLSAR 259 (386)
T ss_dssp CCCCHH
T ss_pred CCCchh
Confidence 665544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=2.6e-10 Score=113.51 Aligned_cols=134 Identities=15% Similarity=0.098 Sum_probs=103.4
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccc--cchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRER--KKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..++.|+++.||++... +..+++|..... .....+.+|+++++.+. |..+.++++++...+..|+||||+++.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677778899998754 678999998753 22345778888888774 677888999998888999999999999998
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN------------------------------------------- 452 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 452 (640)
+.+... .....++.+++++|..||+..
T Consensus 99 ~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 764211 123467889999999999711
Q ss_pred -------------CCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 453 -------------KAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 453 -------------~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1448999999999999876666799998764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.10 E-value=5.4e-12 Score=132.24 Aligned_cols=136 Identities=19% Similarity=0.229 Sum_probs=88.9
Q ss_pred cEEEEEeCCCCCCCCc-----hhccCCC-CCCEEeCCCCcCCCCCC-CCCCC-----CCCcEEEcccccccccCCccCC-
Q 006559 69 RVIKLVLEDLDLTGPA-----EVLSRLT-QLRLLSLKNNLLSSSNL-NLSSW-----PHLKHLYLSHNRFTGTFPSGVS- 135 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-----~~l~~l~-~L~~L~Ls~N~l~~~~~-~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~- 135 (640)
.++.|+|+++.+++.. ..+..++ +|+.|+|++|.+++..+ .+..+ ++|++|+|++|.+++..+..+.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 4777888887777653 5567777 78888888887776543 23332 7788888888888766655433
Q ss_pred ---CC-CCCCEEEcccCCCCCCCCchh----cCC-CCCCcEEEccCCcceec----ccCCcCCCC-CCcEEEcccCcCcc
Q 006559 136 ---SL-RHLRRVDLSHNAYEGEIPMTE----LTR-LPNLLTLRLEDNRFTGT----LYSVNSSSR-SILDFNVSNNQLSG 201 (640)
Q Consensus 136 ---~l-~~L~~L~Ls~N~l~g~~p~~~----~~~-l~~L~~L~L~~N~l~g~----~~~~~~~~~-~L~~l~ls~N~l~g 201 (640)
.+ ++|+.|+|++|.+++..+ .. +.. .++|++|+|++|++++. ++..+.... +|+.|+|++|+|++
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~-~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSS-SEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCH-HHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHhCCCCccEEECcCCcCCcHHH-HHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 33 778888888888764332 33 233 25788888888887743 223333343 78888888888776
Q ss_pred cCCc
Q 006559 202 QIPA 205 (640)
Q Consensus 202 ~ip~ 205 (640)
..+.
T Consensus 182 ~~~~ 185 (362)
T 3goz_A 182 KNCA 185 (362)
T ss_dssp SCHH
T ss_pred hhHH
Confidence 6554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.10 E-value=6.9e-12 Score=131.42 Aligned_cols=131 Identities=22% Similarity=0.186 Sum_probs=104.8
Q ss_pred EEeCCCCCCCCchhccC-CCCCCEEeCCCCcCCCCCC-----CCCCCC-CCcEEEcccccccccCCccCCCC-----CCC
Q 006559 73 LVLEDLDLTGPAEVLSR-LTQLRLLSLKNNLLSSSNL-----NLSSWP-HLKHLYLSHNRFTGTFPSGVSSL-----RHL 140 (640)
Q Consensus 73 l~l~~~~l~g~~~~l~~-l~~L~~L~Ls~N~l~~~~~-----~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l-----~~L 140 (640)
.+|+.++++|+.+.+.. .++|+.|+|++|.+++..+ .+..++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 56788899998755544 4559999999999988764 466788 89999999999998888777665 999
Q ss_pred CEEEcccCCCCCCCCchh----cCCC-CCCcEEEccCCcceecccCCc----CC-CCCCcEEEcccCcCcccCC
Q 006559 141 RRVDLSHNAYEGEIPMTE----LTRL-PNLLTLRLEDNRFTGTLYSVN----SS-SRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 141 ~~L~Ls~N~l~g~~p~~~----~~~l-~~L~~L~L~~N~l~g~~~~~~----~~-~~~L~~l~ls~N~l~g~ip 204 (640)
+.|+|++|.+++..+ .. +..+ ++|++|+|++|++++..+..+ .. ..+|+.|+|++|+|++..+
T Consensus 83 ~~L~Ls~n~l~~~~~-~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 155 (362)
T 3goz_A 83 TSLNLSGNFLSYKSS-DELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS 155 (362)
T ss_dssp CEEECCSSCGGGSCH-HHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred cEEECcCCcCChHHH-HHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence 999999999986554 43 3444 899999999999987665443 23 3699999999999996443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=3.1e-10 Score=112.64 Aligned_cols=129 Identities=16% Similarity=0.134 Sum_probs=96.2
Q ss_pred cccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCc--ccceeEEEEcCCeEEEEEeccCCCCHHHhhc
Q 006559 342 GKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSN--IVSIRAYCNGKDELFLVYDYLPHGSLHSLLH 419 (640)
Q Consensus 342 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~ 419 (640)
+.|..+.||++...+|..+++|..... ....+..|+++++.+.+.+ +.+++++....+..++||||+++.+|. ..
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~ 105 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS 105 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC
Confidence 355568999998877888999987654 3345677888888776544 456888888878899999999998884 22
Q ss_pred cCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------------
Q 006559 420 GSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN----------------------------------------------- 452 (640)
Q Consensus 420 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------- 452 (640)
. .+ ...++.++++.|..||...
T Consensus 106 ~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 106 H--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp C--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred c--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 1 11 2256778888888888642
Q ss_pred --------CCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 453 --------KAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 453 --------~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
...++|+|++|.|||+++++.+.|+|||.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998876677999998753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.99 E-value=9.5e-10 Score=114.51 Aligned_cols=126 Identities=15% Similarity=0.097 Sum_probs=100.1
Q ss_pred EEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCc-cCCCCCCCCE-EEcccCC
Q 006559 73 LVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPS-GVSSLRHLRR-VDLSHNA 149 (640)
Q Consensus 73 l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~-L~Ls~N~ 149 (640)
++.++++|+..+..+ .++|+.|+|++|+|+..++ .|.++++|++|+|++|++.+.+|. .|.++++|+. +++++|+
T Consensus 14 v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~ 91 (350)
T 4ay9_X 14 FLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91 (350)
T ss_dssp EEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETT
T ss_pred EEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCc
Confidence 466777887655444 3689999999999998776 589999999999999998877765 6788988775 6677899
Q ss_pred CCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEccc-CcCcc
Q 006559 150 YEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSN-NQLSG 201 (640)
Q Consensus 150 l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~-N~l~g 201 (640)
++. +|+..|..+++|++|++++|++++..+..+....++..|++++ |++..
T Consensus 92 l~~-l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~ 143 (350)
T 4ay9_X 92 LLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143 (350)
T ss_dssp CCE-ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCE
T ss_pred ccc-cCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccc
Confidence 985 5547889999999999999999987777776677788888876 45553
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-09 Score=112.70 Aligned_cols=138 Identities=17% Similarity=0.291 Sum_probs=102.9
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEec--ccc---chHHHHHHHHHHhccC--CCcccceeEEEEcC---CeEEEEEec
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIR--ERK---KKREVDEWLRVIGGLR--HSNIVSIRAYCNGK---DELFLVYDY 408 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~--~~~---~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~Ey 408 (640)
+.|+.|.++.||+....+ ..+++|+.. ... ....+.+|.++++.+. +..+.++++++.+. +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 458899999999998765 567788776 331 2345778888888876 45578889888766 458999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN------------------------------------ 452 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 452 (640)
+++..+.+... ..++...+..++.++++.|..||...
T Consensus 123 v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99877743211 13567788889999999999999731
Q ss_pred -------------------CCCceecCCCCCCeEECCCCC--eEEccCCcccc
Q 006559 453 -------------------KAHLFHGHLSSSNIVVDQLGN--ACISDIGVHQL 484 (640)
Q Consensus 453 -------------------~~~ivHrdlk~~NILl~~~~~--~kl~DfGl~~~ 484 (640)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998765
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.94 E-value=1.7e-11 Score=132.61 Aligned_cols=138 Identities=16% Similarity=0.137 Sum_probs=80.9
Q ss_pred cEEEEEeCCCCCCCCc------hhccCCCCCCEEeCCCCcCCCC-----CCCCCCCCCCcEEEcccccccccCCccCC--
Q 006559 69 RVIKLVLEDLDLTGPA------EVLSRLTQLRLLSLKNNLLSSS-----NLNLSSWPHLKHLYLSHNRFTGTFPSGVS-- 135 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~------~~l~~l~~L~~L~Ls~N~l~~~-----~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-- 135 (640)
.+..|+|+++.++... ..+..+++|+.|+|++|.+++. +..+..+++|++|+|++|.+++..+..+.
T Consensus 228 ~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 307 (461)
T 1z7x_W 228 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET 307 (461)
T ss_dssp TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH
T ss_pred CccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH
Confidence 5667777777665421 1223567777777777777652 22345567777777777777543332222
Q ss_pred ---CCCCCCEEEcccCCCCCC----CCchhcCCCCCCcEEEccCCcceecccCCcC-----CCCCCcEEEcccCcCcc--
Q 006559 136 ---SLRHLRRVDLSHNAYEGE----IPMTELTRLPNLLTLRLEDNRFTGTLYSVNS-----SSRSILDFNVSNNQLSG-- 201 (640)
Q Consensus 136 ---~l~~L~~L~Ls~N~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~-----~~~~L~~l~ls~N~l~g-- 201 (640)
..++|+.|+|++|.+++. +| ..+..+++|++|+|++|.+++..+..+. ..++|+.|++++|++++
T Consensus 308 l~~~~~~L~~L~L~~n~l~~~~~~~l~-~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~ 386 (461)
T 1z7x_W 308 LLEPGCQLESLWVKSCSFTAACCSHFS-SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386 (461)
T ss_dssp HTSTTCCCCEEECTTSCCBGGGHHHHH-HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred hccCCccceeeEcCCCCCchHHHHHHH-HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence 235677777777776643 23 3445566777777777776654333221 14567777777777765
Q ss_pred --cCCccc
Q 006559 202 --QIPAWM 207 (640)
Q Consensus 202 --~ip~~~ 207 (640)
.+|..+
T Consensus 387 ~~~l~~~l 394 (461)
T 1z7x_W 387 CSSLAATL 394 (461)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 555443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.86 E-value=4.9e-11 Score=128.98 Aligned_cols=133 Identities=17% Similarity=0.153 Sum_probs=78.4
Q ss_pred cEEEEEeCCCCCCCCc-hhc-----cCCCCCCEEeCCCCcCCCC-----CCCCCCCCCCcEEEcccccccccC-----Cc
Q 006559 69 RVIKLVLEDLDLTGPA-EVL-----SRLTQLRLLSLKNNLLSSS-----NLNLSSWPHLKHLYLSHNRFTGTF-----PS 132 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l-----~~l~~L~~L~Ls~N~l~~~-----~~~~~~l~~L~~L~Ls~N~l~g~~-----p~ 132 (640)
.+..|+|+++.++... ..+ ..+++|+.|+|++|.+++. +..+..+++|++|+|++|.+++.. +.
T Consensus 171 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 250 (461)
T 1z7x_W 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPG 250 (461)
T ss_dssp TCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHH
T ss_pred CCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHH
Confidence 5677777777665421 112 1355777777777777653 123455677777777777766432 22
Q ss_pred cCCCCCCCCEEEcccCCCCCC----CCchhcCCCCCCcEEEccCCcceecccCCc-----CCCCCCcEEEcccCcCccc
Q 006559 133 GVSSLRHLRRVDLSHNAYEGE----IPMTELTRLPNLLTLRLEDNRFTGTLYSVN-----SSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 133 ~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~-----~~~~~L~~l~ls~N~l~g~ 202 (640)
.+..+++|+.|+|++|.+++. ++ ..+..+++|++|+|++|.+++..+..+ ...++|+.|++++|.+++.
T Consensus 251 ~~~~~~~L~~L~L~~n~l~~~~~~~l~-~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 328 (461)
T 1z7x_W 251 LLHPSSRLRTLWIWECGITAKGCGDLC-RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328 (461)
T ss_dssp HTSTTCCCCEEECTTSCCCHHHHHHHH-HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGG
T ss_pred HhcCCCCceEEECcCCCCCHHHHHHHH-HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchH
Confidence 333567777777777777642 34 345556777777777777654332221 1224666777777766654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.2e-11 Score=120.64 Aligned_cols=144 Identities=16% Similarity=0.186 Sum_probs=71.2
Q ss_pred CCCceEecCCCCcEEEEEeCCC---CCCCCc--hhccCCCCCCEEeCCCCcCCCCC--CCCCCCCCCcE--EEccccc--
Q 006559 57 SWRGVTCNPSTHRVIKLVLEDL---DLTGPA--EVLSRLTQLRLLSLKNNLLSSSN--LNLSSWPHLKH--LYLSHNR-- 125 (640)
Q Consensus 57 ~w~gv~C~~~~~~v~~l~l~~~---~l~g~~--~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~l~~L~~--L~Ls~N~-- 125 (640)
+|.|+.|++...+|+.+...+. .+.+.. +.+..|+. .|+..+|..++.. ..+...+.|.. ++++.|.
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 7999999987667766666542 222221 22222211 1122222222210 01333344444 5555552
Q ss_pred -ccccCCccCCCCCCCCEEEcccCCCCC--CCCchhcCCCCCCcEEEccCCcceecc-cCCcCCCCCCcEEEcccCcCcc
Q 006559 126 -FTGTFPSGVSSLRHLRRVDLSHNAYEG--EIPMTELTRLPNLLTLRLEDNRFTGTL-YSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 126 -l~g~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~~l~~L~~L~L~~N~l~g~~-~~~~~~~~~L~~l~ls~N~l~g 201 (640)
+.+.++....++++|+.|+|++|+|++ .+| ..+..+++|+.|+|++|+|++.- ...+..+ +|+.|+|++|.+++
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~-~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMS-SIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCD 234 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGT-THHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGG
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccch-hHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCcc
Confidence 222222222456666666666666665 333 34456666666666666666541 1112222 66667777777666
Q ss_pred cCC
Q 006559 202 QIP 204 (640)
Q Consensus 202 ~ip 204 (640)
.+|
T Consensus 235 ~~~ 237 (267)
T 3rw6_A 235 TFR 237 (267)
T ss_dssp GCS
T ss_pred ccC
Confidence 655
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.4e-10 Score=121.74 Aligned_cols=133 Identities=22% Similarity=0.253 Sum_probs=79.5
Q ss_pred cEEEEEeCCCCCCCCc--hhccCCCCCCEEeCCCCcCCCCCC-CC-----CCCCCCcEEEcccccccc----cCCccCCC
Q 006559 69 RVIKLVLEDLDLTGPA--EVLSRLTQLRLLSLKNNLLSSSNL-NL-----SSWPHLKHLYLSHNRFTG----TFPSGVSS 136 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~--~~l~~l~~L~~L~Ls~N~l~~~~~-~~-----~~l~~L~~L~Ls~N~l~g----~~p~~~~~ 136 (640)
.+..|+|++|.++... .....+++|+.|+|++|.|+.... .+ ...++|++|+|++|.|+. .++..+..
T Consensus 102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~ 181 (372)
T 3un9_A 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181 (372)
T ss_dssp CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence 5777777777665321 222344567777777777754321 11 245667777777777754 23344456
Q ss_pred CCCCCEEEcccCCCCCC----CCchhcCCCCCCcEEEccCCcceec----ccCCcCCCCCCcEEEcccCcCccc
Q 006559 137 LRHLRRVDLSHNAYEGE----IPMTELTRLPNLLTLRLEDNRFTGT----LYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 137 l~~L~~L~Ls~N~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~----~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
+++|++|||++|.+++. ++ ..+...++|+.|+|++|.|+.. ++..+...++|+.|+|++|.|+..
T Consensus 182 ~~~L~~L~Ls~N~l~~~g~~~L~-~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 182 NTSVTHLSLLHTGLGDEGLELLA-AQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp CSSCCEEECTTSSCHHHHHHHHH-HHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred CCCcCEEeCCCCCCCcHHHHHHH-HHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 67777777777777531 11 3345566777777777777643 233334456677777777777644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.75 E-value=5.2e-09 Score=106.59 Aligned_cols=187 Identities=18% Similarity=0.154 Sum_probs=115.9
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccC-CCc--ccceeEEEEcCC---eEEEEEeccCCC
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLR-HSN--IVSIRAYCNGKD---ELFLVYDYLPHG 412 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lV~Ey~~~g 412 (640)
+.++.|.+..||++. ..+++|+.........+..|.++++.+. +.. +.+.+......+ ..|+||||+++.
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 357889999999863 5678888665444566788888888773 333 334444433322 358999999998
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY----------------------------------------- 451 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 451 (640)
.+.+.... .++..++..++.++++.|..||..
T Consensus 102 ~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 102 PLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp ECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred ECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 87653221 245566677777777777777751
Q ss_pred --------------CCCCceecCCCCCCeEECC--CCCeEEccCCcccccCCCc--cccccc---cCCccccCCCCcccc
Q 006559 452 --------------NKAHLFHGHLSSSNIVVDQ--LGNACISDIGVHQLFHTPF--FINDAY---NAPELKFNNNNNYSQ 510 (640)
Q Consensus 452 --------------~~~~ivHrdlk~~NILl~~--~~~~kl~DfGl~~~~~~~~--~~~~~y---~aPE~~~~~~~~~~~ 510 (640)
..+.++|+|+++.||++++ ...+.|.||+.+....... .....+ ..|+....-...+..
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1235799999999999998 4567899999876543211 000000 111110000000000
Q ss_pred -------CCCCCccchHHHHHHHHHHHhCCCCC
Q 006559 511 -------RKFWQRCDVYSFGVVLLEILTGKMAK 536 (640)
Q Consensus 511 -------~~~~~k~DV~SfGvvl~el~tg~~p~ 536 (640)
....-..+.|++|.++|++.+|..++
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00111258999999999999998765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.67 E-value=5.9e-10 Score=116.88 Aligned_cols=133 Identities=18% Similarity=0.198 Sum_probs=99.4
Q ss_pred cEEEEEeCCCCCCCCc-----hhcc-CCCCCCEEeCCCCcCCCCCC-C-CCCCCCCcEEEcccccccccCCccC-----C
Q 006559 69 RVIKLVLEDLDLTGPA-----EVLS-RLTQLRLLSLKNNLLSSSNL-N-LSSWPHLKHLYLSHNRFTGTFPSGV-----S 135 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-----~~l~-~l~~L~~L~Ls~N~l~~~~~-~-~~~l~~L~~L~Ls~N~l~g~~p~~~-----~ 135 (640)
.+..|+|+++.++... ..+. ..++|+.|+|++|.++.... . ...+++|+.|+|++|.|+......+ .
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 5789999999987632 2222 33799999999999975322 2 2346789999999999975433333 3
Q ss_pred CCCCCCEEEcccCCCCCC----CCchhcCCCCCCcEEEccCCcceec----ccCCcCCCCCCcEEEcccCcCccc
Q 006559 136 SLRHLRRVDLSHNAYEGE----IPMTELTRLPNLLTLRLEDNRFTGT----LYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 136 ~l~~L~~L~Ls~N~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~----~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
..++|+.|+|++|.++.. ++ ..+..+++|++|+|++|.|+.. ++..+...++|+.|+|++|.|+..
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~-~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~ 226 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLM-EGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHH-HHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHH
T ss_pred cCCccceeeCCCCCCChHHHHHHH-HHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHH
Confidence 568999999999999741 22 3346788999999999999853 344556678999999999999853
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.57 E-value=2.2e-07 Score=95.62 Aligned_cols=89 Identities=17% Similarity=0.162 Sum_probs=67.6
Q ss_pred CCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCc-EEEccCCcceecccCCcCCCCCCcE
Q 006559 113 WPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLL-TLRLEDNRFTGTLYSVNSSSRSILD 191 (640)
Q Consensus 113 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~-~L~L~~N~l~g~~~~~~~~~~~L~~ 191 (640)
+++|+.|+|++|+++..-+..|.++++|+.|+|.+| ++ .|+...|.++++|+ .|+|.+ +++..-+..|..+.+|+.
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 667888888888887655667888888888888887 55 56767788888888 888877 676666677888888888
Q ss_pred EEcccCcCcccCC
Q 006559 192 FNVSNNQLSGQIP 204 (640)
Q Consensus 192 l~ls~N~l~g~ip 204 (640)
+++++|+++..-+
T Consensus 302 l~l~~n~i~~I~~ 314 (329)
T 3sb4_A 302 VLATGDKITTLGD 314 (329)
T ss_dssp EEECSSCCCEECT
T ss_pred EEeCCCccCccch
Confidence 8888888774433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.53 E-value=5.6e-09 Score=116.54 Aligned_cols=89 Identities=17% Similarity=0.053 Sum_probs=40.0
Q ss_pred CCCCcEEEcccc--cccccCCccCC-CCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceec-ccCCcCCCCC
Q 006559 113 WPHLKHLYLSHN--RFTGTFPSGVS-SLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGT-LYSVNSSSRS 188 (640)
Q Consensus 113 l~~L~~L~Ls~N--~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~-~~~~~~~~~~ 188 (640)
+++|++|+|+++ .+++..+..+. .+++|+.|+|++|++++......+..+++|++|+|++|.|++. ++.....+++
T Consensus 435 ~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~ 514 (592)
T 3ogk_B 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPS 514 (592)
T ss_dssp CTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSS
T ss_pred CCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCc
Confidence 444555555422 23333222222 2455555555555554311113334555555555555555433 2222233455
Q ss_pred CcEEEcccCcCcc
Q 006559 189 ILDFNVSNNQLSG 201 (640)
Q Consensus 189 L~~l~ls~N~l~g 201 (640)
|+.|+|++|++++
T Consensus 515 L~~L~ls~n~it~ 527 (592)
T 3ogk_B 515 LRYLWVQGYRASM 527 (592)
T ss_dssp CCEEEEESCBCCT
T ss_pred cCeeECcCCcCCH
Confidence 5555555555543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.43 E-value=8.9e-08 Score=94.64 Aligned_cols=80 Identities=28% Similarity=0.391 Sum_probs=59.8
Q ss_pred CCCCCCcEEEcccccccc--cCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCC--CCcEEEccCCcceecccC-----
Q 006559 111 SSWPHLKHLYLSHNRFTG--TFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP--NLLTLRLEDNRFTGTLYS----- 181 (640)
Q Consensus 111 ~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~--~L~~L~L~~N~l~g~~~~----- 181 (640)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~---~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~ 243 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE---RELDKIKGLKLEELWLDGNSLCDTFRDQSTYI 243 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG---GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc---hhhhhcccCCcceEEccCCcCccccCcchhHH
Confidence 357788888999988887 5566777888999999999998864 2334444 889999999998886653
Q ss_pred --CcCCCCCCcEEE
Q 006559 182 --VNSSSRSILDFN 193 (640)
Q Consensus 182 --~~~~~~~L~~l~ 193 (640)
.+..+++|+.||
T Consensus 244 ~~il~~~P~L~~LD 257 (267)
T 3rw6_A 244 SAIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHHCTTCCEES
T ss_pred HHHHHHCcccCeEC
Confidence 245577777764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.40 E-value=2.1e-08 Score=94.18 Aligned_cols=115 Identities=14% Similarity=0.213 Sum_probs=84.3
Q ss_pred hhccCCCCCCEEeCCCC-cCCCCC-----CCCCCCCCCcEEEccccccccc----CCccCCCCCCCCEEEcccCCCCCC-
Q 006559 85 EVLSRLTQLRLLSLKNN-LLSSSN-----LNLSSWPHLKHLYLSHNRFTGT----FPSGVSSLRHLRRVDLSHNAYEGE- 153 (640)
Q Consensus 85 ~~l~~l~~L~~L~Ls~N-~l~~~~-----~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~- 153 (640)
..+...+.|+.|+|++| .++... ..+...++|++|+|++|.|... +...+...++|++|+|++|.+...
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 45677889999999998 886531 1355678899999999998642 334455667899999999998742
Q ss_pred ---CCchhcCCCCCCcEEEc--cCCcceec----ccCCcCCCCCCcEEEcccCcCc
Q 006559 154 ---IPMTELTRLPNLLTLRL--EDNRFTGT----LYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 154 ---~p~~~~~~l~~L~~L~L--~~N~l~g~----~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
+. ..+...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 110 ~~~l~-~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALV-EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHH-HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHH-HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 22 34566788999999 88998754 3334455678999999999875
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.39 E-value=8e-07 Score=91.34 Aligned_cols=102 Identities=13% Similarity=0.052 Sum_probs=91.5
Q ss_pred CCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCC-EEEcccCCCCCCCCchhcCCCCCCcE
Q 006559 90 LTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLR-RVDLSHNAYEGEIPMTELTRLPNLLT 167 (640)
Q Consensus 90 l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~~l~~L~~ 167 (640)
+++|+.|+|++|.++..+. .|.++++|+.|+|++| +...-+..|.++++|+ .|+|.+ +++ .|+...|.++++|+.
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCE
Confidence 7899999999999988766 6999999999999998 7766677899999999 999988 676 577788999999999
Q ss_pred EEccCCcceecccCCcCCCCCCcEEEc
Q 006559 168 LRLEDNRFTGTLYSVNSSSRSILDFNV 194 (640)
Q Consensus 168 L~L~~N~l~g~~~~~~~~~~~L~~l~l 194 (640)
|+|++|+++...+..|.++++|+.++.
T Consensus 302 l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 302 VLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEeCCCccCccchhhhcCCcchhhhcc
Confidence 999999999888889999999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.5e-06 Score=86.66 Aligned_cols=135 Identities=19% Similarity=0.174 Sum_probs=89.1
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCC---cccceeEEEE-cCCeEEEEEeccCCCCH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHS---NIVSIRAYCN-GKDELFLVYDYLPHGSL 414 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~Ey~~~gsL 414 (640)
+.++.|....||+. +..+++|+-........+..|.++++.+.+. .+.+.+.++. ..+..++||||+++..+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 34778888899987 5667888754433445678899999888653 2456666664 44568899999999887
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY------------------------------------------- 451 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 451 (640)
.+.... .++...+..++.++++.|..||..
T Consensus 101 ~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 101 GEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp HHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred chhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 653211 122333334444444444444421
Q ss_pred --------------CCCCceecCCCCCCeEECC---CCC-eEEccCCcccc
Q 006559 452 --------------NKAHLFHGHLSSSNIVVDQ---LGN-ACISDIGVHQL 484 (640)
Q Consensus 452 --------------~~~~ivHrdlk~~NILl~~---~~~-~kl~DfGl~~~ 484 (640)
..+.++|+|+++.|||++. ++. +.|.||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999987 455 47999987754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=6.7e-06 Score=81.71 Aligned_cols=133 Identities=17% Similarity=0.206 Sum_probs=89.9
Q ss_pred ccccCcc-eEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCCCCHHHh
Q 006559 341 LGKGCVG-ATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSL 417 (640)
Q Consensus 341 iG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 417 (640)
+..|..| .||+.... ++..+++|.-... ...++..|.+.|+.+. +--+.++++++...+..|+|||++++.++.+.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 4556555 58987754 4567888876543 3456777888777664 22356788898888999999999999887665
Q ss_pred hccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 006559 418 LHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY---------------------------------------------- 451 (640)
Q Consensus 418 l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------- 451 (640)
..... .....++.+++..|.-||..
T Consensus 111 ~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 111 LEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 43211 11223444555555555531
Q ss_pred ---------CCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 452 ---------NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 452 ---------~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
..+-++|+|+.+.|||++.++.+-|.||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01237999999999999987777799998864
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.19 E-value=1e-07 Score=106.20 Aligned_cols=109 Identities=14% Similarity=0.159 Sum_probs=48.3
Q ss_pred CCCCCEEeCCCCcCCCCCC-CCC-CCCCCcEEEcc--c----cccccc-----CCccCCCCCCCCEEEcccCCCCCCCCc
Q 006559 90 LTQLRLLSLKNNLLSSSNL-NLS-SWPHLKHLYLS--H----NRFTGT-----FPSGVSSLRHLRRVDLSHNAYEGEIPM 156 (640)
Q Consensus 90 l~~L~~L~Ls~N~l~~~~~-~~~-~l~~L~~L~Ls--~----N~l~g~-----~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 156 (640)
+++|+.|+++.|.+++... .+. .+++|+.|+|+ + |.+++. ++..+.++++|+.|+|++ .+++..+
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~- 448 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF- 448 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH-
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHH-
Confidence 5556666555555544221 121 35555666655 2 333311 111133445555555544 3332222
Q ss_pred hhcCC-CCCCcEEEccCCcceecccCCc-CCCCCCcEEEcccCcCc
Q 006559 157 TELTR-LPNLLTLRLEDNRFTGTLYSVN-SSSRSILDFNVSNNQLS 200 (640)
Q Consensus 157 ~~~~~-l~~L~~L~L~~N~l~g~~~~~~-~~~~~L~~l~ls~N~l~ 200 (640)
..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.++
T Consensus 449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 12222 4555555555555544332222 33455555555555553
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.08 E-value=9.2e-07 Score=98.49 Aligned_cols=126 Identities=10% Similarity=-0.033 Sum_probs=83.9
Q ss_pred CcEEEEEeCCCCCCCCc-----hhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEccccccc---ccCCccCCCCCC
Q 006559 68 HRVIKLVLEDLDLTGPA-----EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFT---GTFPSGVSSLRH 139 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-----~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~---g~~p~~~~~l~~ 139 (640)
..+..|+|.++.+++.. ..+.++++|+.|+|++|.+.+.+..+..+++|+.|+++++... +..+..+..+++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~ 271 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRK 271 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTT
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhcccc
Confidence 36788899888887432 3456789999999999888775545667777888888753332 233445666777
Q ss_pred CCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceeccc-CCcCCCCCCcEEEcc
Q 006559 140 LRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLY-SVNSSSRSILDFNVS 195 (640)
Q Consensus 140 L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~-~~~~~~~~L~~l~ls 195 (640)
|+.|+++++.. +.+| ..+..+++|++|+|++|.+++... ..+..+++|+.|+++
T Consensus 272 L~~L~l~~~~~-~~l~-~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 272 LCRLGLSYMGP-NEMP-ILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp CCEEEETTCCT-TTGG-GGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred ccccCccccch-hHHH-HHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 77777776533 2455 456667777777777777665433 334556777777777
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=7.1e-06 Score=85.14 Aligned_cols=77 Identities=13% Similarity=0.092 Sum_probs=52.8
Q ss_pred ccc-cccCcceEEEEEeC-------CCcEEEEEEecccc-----chHHHHHHHHHHhccCC---CcccceeEEEEcC---
Q 006559 339 ELL-GKGCVGATYKVVLD-------GGDVVVVKRIRERK-----KKREVDEWLRVIGGLRH---SNIVSIRAYCNGK--- 399 (640)
Q Consensus 339 ~~i-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~--- 399 (640)
+.| +.|....+|+.... ++..+++|...... ....+..|.++++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 346 77888999988764 25678888765432 12456777777776643 2466778877654
Q ss_pred CeEEEEEeccCCCCHH
Q 006559 400 DELFLVYDYLPHGSLH 415 (640)
Q Consensus 400 ~~~~lV~Ey~~~gsL~ 415 (640)
+..|+||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3578999999986654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.01 E-value=4.5e-07 Score=84.96 Aligned_cols=108 Identities=18% Similarity=0.208 Sum_probs=83.8
Q ss_pred CcEEEEEeCCC-CCCCC-----chhccCCCCCCEEeCCCCcCCCCCC-----CCCCCCCCcEEEccccccccc----CCc
Q 006559 68 HRVIKLVLEDL-DLTGP-----AEVLSRLTQLRLLSLKNNLLSSSNL-----NLSSWPHLKHLYLSHNRFTGT----FPS 132 (640)
Q Consensus 68 ~~v~~l~l~~~-~l~g~-----~~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~g~----~p~ 132 (640)
..++.|+|+++ .+... ...+...++|+.|+|++|.|+.... .+...+.|++|+|++|.|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 46889999998 77642 2567778999999999999975321 244567899999999999753 456
Q ss_pred cCCCCCCCCEEEc--ccCCCCCC----CCchhcCCCCCCcEEEccCCcce
Q 006559 133 GVSSLRHLRRVDL--SHNAYEGE----IPMTELTRLPNLLTLRLEDNRFT 176 (640)
Q Consensus 133 ~~~~l~~L~~L~L--s~N~l~g~----~p~~~~~~l~~L~~L~L~~N~l~ 176 (640)
.+...++|+.|+| ++|.+... +. ..+...++|+.|+|++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~-~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIA-NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHH-HHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHH-HHHHhCCCcCEEeccCCCCC
Confidence 6777889999999 88999742 11 23455689999999999986
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=1.3e-06 Score=90.80 Aligned_cols=132 Identities=20% Similarity=0.229 Sum_probs=81.0
Q ss_pred cEEEEEeCCCCCC----------CCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCC--C
Q 006559 69 RVIKLVLEDLDLT----------GPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVS--S 136 (640)
Q Consensus 69 ~v~~l~l~~~~l~----------g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~ 136 (640)
++..|.+.++... +....+..+++|+.|+|++|.-...+ .+ .+++|+.|+|..|.++......+. .
T Consensus 140 ~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~l~-~~-~~~~L~~L~L~~~~l~~~~l~~l~~~~ 217 (362)
T 2ra8_A 140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIG-KK-PRPNLKSLEIISGGLPDSVVEDILGSD 217 (362)
T ss_dssp TCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCBCC-SC-BCTTCSEEEEECSBCCHHHHHHHHHSB
T ss_pred hhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCceec-cc-cCCCCcEEEEecCCCChHHHHHHHHcc
Confidence 5666666554321 12255677889999999887311112 23 377888888888877543333333 6
Q ss_pred CCCCCEEEccc--CCCCCCCCc----hhc--CCCCCCcEEEccCCcceecccCCc---CCCCCCcEEEcccCcCccc
Q 006559 137 LRHLRRVDLSH--NAYEGEIPM----TEL--TRLPNLLTLRLEDNRFTGTLYSVN---SSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 137 l~~L~~L~Ls~--N~l~g~~p~----~~~--~~l~~L~~L~L~~N~l~g~~~~~~---~~~~~L~~l~ls~N~l~g~ 202 (640)
+++|+.|+|+. |...|.... ..+ ..+|+|++|+|.+|.+++..+..+ ..+++|+.|+|+.|.|++.
T Consensus 218 lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp CTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred CCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 88888888853 332222100 112 347888888888888875432221 2467888888888888763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.93 E-value=6.8e-07 Score=99.56 Aligned_cols=125 Identities=18% Similarity=0.270 Sum_probs=67.7
Q ss_pred cEEEEEeCCCCCCCCc-hhcc-CCCCCCEEeCCCC-cCCCC-CCC-CCCCCCCcEEEcccccccccCCccC----CCCCC
Q 006559 69 RVIKLVLEDLDLTGPA-EVLS-RLTQLRLLSLKNN-LLSSS-NLN-LSSWPHLKHLYLSHNRFTGTFPSGV----SSLRH 139 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~-~l~~L~~L~Ls~N-~l~~~-~~~-~~~l~~L~~L~Ls~N~l~g~~p~~~----~~l~~ 139 (640)
++..|+|+++.+++.. ..+. .+++|+.|+|++| .++.. .+. +.++++|++|+|++|.+++..+..+ ..+++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~ 185 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence 4666666666655432 2232 4667777777666 33321 111 2356677777777777665433322 25556
Q ss_pred CCEEEcccCCCCCCCCchh----cCCCCCCcEEEccCC-cceecccCCcCCCCCCcEEEccc
Q 006559 140 LRRVDLSHNAYEGEIPMTE----LTRLPNLLTLRLEDN-RFTGTLYSVNSSSRSILDFNVSN 196 (640)
Q Consensus 140 L~~L~Ls~N~l~g~~p~~~----~~~l~~L~~L~L~~N-~l~g~~~~~~~~~~~L~~l~ls~ 196 (640)
|+.|+|++|. +.++... +.++++|++|+|++| .+++ ++..+..+++|+.|+++.
T Consensus 186 L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~ 244 (594)
T 2p1m_B 186 LVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGG 244 (594)
T ss_dssp CCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSB
T ss_pred CcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccccc
Confidence 7777777665 2222121 233567777777766 3333 555555566666666443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.92 E-value=4.7e-06 Score=86.49 Aligned_cols=37 Identities=11% Similarity=0.196 Sum_probs=16.9
Q ss_pred CCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCC
Q 006559 112 SWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151 (640)
Q Consensus 112 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 151 (640)
.+|+|+.|+|++|.-. .+|. + .+++|+.|+|..+.++
T Consensus 170 ~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~ 206 (362)
T 2ra8_A 170 AMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLP 206 (362)
T ss_dssp TCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCC
T ss_pred cCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCC
Confidence 3455555555554210 1222 2 2455555555555443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.83 E-value=6.5e-05 Score=79.16 Aligned_cols=124 Identities=14% Similarity=0.174 Sum_probs=79.9
Q ss_pred cEEEEEeCCCCCCC-CchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcc
Q 006559 69 RVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLS 146 (640)
Q Consensus 69 ~v~~l~l~~~~l~g-~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 146 (640)
.+..+.|+.+ +.- ....|.++++|+.++|..| +..... .|.+ .+|+.++| .|+++..-+..|.++++|+.++|.
T Consensus 204 ~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~ 279 (401)
T 4fdw_A 204 GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTY 279 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEE
T ss_pred ccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeC
Confidence 3556666543 322 2356788888999998875 333222 3444 57777777 445555556677777888888877
Q ss_pred cCCCC----CCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccC
Q 006559 147 HNAYE----GEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNN 197 (640)
Q Consensus 147 ~N~l~----g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N 197 (640)
+|.+. ..|+...|.++++|+.++|. |.++..-...|.++.+|+.++|..|
T Consensus 280 ~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 280 GSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp SSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred CccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 77664 12555667777778887777 4466555666777777777777544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.79 E-value=7e-05 Score=76.84 Aligned_cols=141 Identities=18% Similarity=0.263 Sum_probs=77.6
Q ss_pred cccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhcc-----CCCccccee-E--EEEcCCeEEEEEeccCC
Q 006559 340 LLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGL-----RHSNIVSIR-A--YCNGKDELFLVYDYLPH 411 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l-----~H~niv~l~-~--~~~~~~~~~lV~Ey~~~ 411 (640)
.|+.|..+.||++...+|. +++|+.... ...+..|.++++.| ..|.++... | +....+..++||||+++
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 4666778899999876654 888988753 22333344444333 234444311 1 12235678999999998
Q ss_pred CCHH--------------Hhhcc----CCCCC-----CCCcCHHHHH-------------------------------HH
Q 006559 412 GSLH--------------SLLHG----SRGPG-----RMPVDWNKRL-------------------------------KL 437 (640)
Q Consensus 412 gsL~--------------~~l~~----~~~~~-----~~~l~~~~~~-------------------------------~i 437 (640)
..+. ..+|. ...+. ...-.|.... .+
T Consensus 116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (346)
T 2q83_A 116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF 195 (346)
T ss_dssp BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence 6542 01111 10010 0012343211 01
Q ss_pred HHHHHHHHHHhhc----------CCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 438 ASDSAKGLAFLHG----------YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 438 ~~~ia~gL~yLH~----------~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
...+.+++++|+. .....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1223445666653 024569999999999999888889999998764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00012 Score=77.17 Aligned_cols=111 Identities=9% Similarity=0.145 Sum_probs=74.2
Q ss_pred hhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCC
Q 006559 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPN 164 (640)
Q Consensus 85 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~ 164 (640)
..|.++++|+.++|++|.+...+...-.+++|+.+.|..| +...-...|.++++|+.++|..| ++ .|+...|.+ .+
T Consensus 174 ~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~-~~ 249 (401)
T 4fdw_A 174 DIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE-SG 249 (401)
T ss_dssp STTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTT-CC
T ss_pred HHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc-Ccccccccc-CC
Confidence 4567777777777777777665543222567777777643 55455566777777777777765 43 455555655 67
Q ss_pred CcEEEccCCcceecccCCcCCCCCCcEEEcccCcCc
Q 006559 165 LLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 165 L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
|+.+.| .|.++..-...|..+.+|+.+++.+|.+.
T Consensus 250 L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 250 ITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp CSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred ccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 777777 45566555667777888888888877765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00027 Score=74.36 Aligned_cols=72 Identities=8% Similarity=0.066 Sum_probs=45.7
Q ss_pred ccccccCcceEEEEEeC-CCcEEEEEEecccc---------chHHHHHHHHHHhccCC--Cc-ccceeEEEEcCCeEEEE
Q 006559 339 ELLGKGCVGATYKVVLD-GGDVVVVKRIRERK---------KKREVDEWLRVIGGLRH--SN-IVSIRAYCNGKDELFLV 405 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~e~~~l~~l~H--~n-iv~l~~~~~~~~~~~lV 405 (640)
+.||.|.++.||++... ++..++||...... ....+..|.++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999754 46789999764321 12334567777766532 33 3455544 34456899
Q ss_pred EeccCCC
Q 006559 406 YDYLPHG 412 (640)
Q Consensus 406 ~Ey~~~g 412 (640)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00045 Score=69.94 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=89.0
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccC---CCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLR---HSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
+.|+.|.+..+|+.... +..+++|..... ....+..|.+.|+.|. ...+.+.++++...+..++||||+++..+.
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~ 119 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK 119 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence 45788999999998864 567788876543 3456777877777663 356778888888788999999999987642
Q ss_pred H-----------hhccCCC-C----------C------CCCcCHHHHH---HHHH----------------HHHHH-HHH
Q 006559 416 S-----------LLHGSRG-P----------G------RMPVDWNKRL---KLAS----------------DSAKG-LAF 447 (640)
Q Consensus 416 ~-----------~l~~~~~-~----------~------~~~l~~~~~~---~i~~----------------~ia~g-L~y 447 (640)
. .||.... + + .-.-+|.... ++.. .+... ...
T Consensus 120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~ 199 (312)
T 3jr1_A 120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT 199 (312)
T ss_dssp TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence 1 2332211 0 0 0012465322 1111 11111 223
Q ss_pred hhc-CCCCCceecCCCCCCeEECCCCCeEEccCC
Q 006559 448 LHG-YNKAHLFHGHLSSSNIVVDQLGNACISDIG 480 (640)
Q Consensus 448 LH~-~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 480 (640)
|.. ..++.+||+|+.+.|++++.++ +.|.|+.
T Consensus 200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 421 2356799999999999999887 8899973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0014 Score=65.38 Aligned_cols=72 Identities=14% Similarity=0.122 Sum_probs=51.5
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccc--cchHHHHHHHHHHhccCCC---cccceeEEEEcCCeEEEEEeccCCCC
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHS---NIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~---niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
+.+|.|..+.||+.++.+|+.|+||+.... .....+..|.+.|+.|.-. -+.+.+++. .-++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 458999999999999999999999987544 2335678888887776422 234444432 3478999998765
Q ss_pred H
Q 006559 414 L 414 (640)
Q Consensus 414 L 414 (640)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0014 Score=69.33 Aligned_cols=76 Identities=13% Similarity=0.077 Sum_probs=45.9
Q ss_pred CCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc-----c--ccccccCCccccCCCCccccCCCCCccchHHHHHH
Q 006559 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF-----F--INDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVV 525 (640)
Q Consensus 453 ~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~-----~--~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvv 525 (640)
.+.++|+|+++.|||++.++ ++|.||+.+..-...+ . ....|.+|+..... ....-....++.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQ----ENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCS----SCCSHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhccccccc----ccchHHHHHHHHHHHHH
Confidence 45699999999999999876 9999999876543210 0 01234555422100 00011123455678888
Q ss_pred HHHHHhCC
Q 006559 526 LLEILTGK 533 (640)
Q Consensus 526 l~el~tg~ 533 (640)
+|+.++++
T Consensus 306 ~~~~y~~~ 313 (420)
T 2pyw_A 306 TWNLFNKR 313 (420)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 88877754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00079 Score=58.61 Aligned_cols=56 Identities=21% Similarity=0.299 Sum_probs=29.5
Q ss_pred EEEccccccc-ccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcce
Q 006559 118 HLYLSHNRFT-GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176 (640)
Q Consensus 118 ~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~ 176 (640)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+ .+|...|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 4555555554 23443221 24566666666665 355455555666666666666543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0042 Score=63.06 Aligned_cols=142 Identities=15% Similarity=0.113 Sum_probs=78.4
Q ss_pred cccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCc--ccceeEE-----EEcCCeEEEEEeccCC
Q 006559 340 LLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSN--IVSIRAY-----CNGKDELFLVYDYLPH 411 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lV~Ey~~~ 411 (640)
.++ |....||+....+|..+++|..... .....+..|..++..+.... +.+++.. ....+..++||||+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 355 7778899988777778899998743 33455666776666553222 3334332 1224567899999987
Q ss_pred CCHH-----Hh---------hcc----CCCCCCCCcCHHHH----------------------HHHHHHHHHHHHHhh-c
Q 006559 412 GSLH-----SL---------LHG----SRGPGRMPVDWNKR----------------------LKLASDSAKGLAFLH-G 450 (640)
Q Consensus 412 gsL~-----~~---------l~~----~~~~~~~~l~~~~~----------------------~~i~~~ia~gL~yLH-~ 450 (640)
..+. .+ +|. .....+...++... ...+..+...++-+- .
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5431 10 111 10001112232211 001111112222111 1
Q ss_pred CCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 451 ~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
.....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0023 Score=64.81 Aligned_cols=144 Identities=10% Similarity=0.060 Sum_probs=77.3
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCc--ccceeEE------EEcCCeEEEEEeccC
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSN--IVSIRAY------CNGKDELFLVYDYLP 410 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~Ey~~ 410 (640)
+.|+.|....+|+....+| .+++|..........+..|.+++..+.... +.+++.. ....+..+++|||++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 3467788889999987766 577888765323344555666655543212 2222211 112356799999998
Q ss_pred CCCHHH--------------hhccC----CCCC---CCCcCHHHHHHH------------HHHHHHHHHHhhcC----CC
Q 006559 411 HGSLHS--------------LLHGS----RGPG---RMPVDWNKRLKL------------ASDSAKGLAFLHGY----NK 453 (640)
Q Consensus 411 ~gsL~~--------------~l~~~----~~~~---~~~l~~~~~~~i------------~~~ia~gL~yLH~~----~~ 453 (640)
+..+.. .+|.. ..+. .....|.....- ...+...+++++.. .+
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~ 186 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 186 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence 764311 11211 1010 001234331110 11234445555421 23
Q ss_pred CCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 454 ~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
..++|+|+.+.|||++.+..+.|.||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 468999999999999987666899998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00016 Score=66.24 Aligned_cols=81 Identities=12% Similarity=0.183 Sum_probs=41.7
Q ss_pred CCCEEeCCCCcCCCCC-CCCCCCCCCcEEEccccc-ccccCCccCCCC----CCCCEEEcccCC-CCCCCCchhcCCCCC
Q 006559 92 QLRLLSLKNNLLSSSN-LNLSSWPHLKHLYLSHNR-FTGTFPSGVSSL----RHLRRVDLSHNA-YEGEIPMTELTRLPN 164 (640)
Q Consensus 92 ~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l----~~L~~L~Ls~N~-l~g~~p~~~~~~l~~ 164 (640)
+|+.|||+++.++... ..+..+++|++|+|+++. ++..--..+..+ ++|+.|+|+++. ++.. -...+.++++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~-Gl~~L~~~~~ 140 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDK-GIIALHHFRN 140 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHH-HHHHGGGCTT
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHH-HHHHHhcCCC
Confidence 4667777776665432 235566666666666664 443221223332 256666666653 4421 1123445566
Q ss_pred CcEEEccCC
Q 006559 165 LLTLRLEDN 173 (640)
Q Consensus 165 L~~L~L~~N 173 (640)
|+.|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 666666655
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00012 Score=66.99 Aligned_cols=81 Identities=14% Similarity=0.104 Sum_probs=45.5
Q ss_pred cEEEEEeCCCCCCCC-chhccCCCCCCEEeCCCCc-CCCCCC-CCCCC----CCCcEEEccccc-ccccCCccCCCCCCC
Q 006559 69 RVIKLVLEDLDLTGP-AEVLSRLTQLRLLSLKNNL-LSSSNL-NLSSW----PHLKHLYLSHNR-FTGTFPSGVSSLRHL 140 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~-~~~l~~l~~L~~L~Ls~N~-l~~~~~-~~~~l----~~L~~L~Ls~N~-l~g~~p~~~~~l~~L 140 (640)
++..|||++..++.. ...+..+++|+.|+|+++. +++... .+..+ ++|++|+|+++. ++..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 567777776665432 2445667777777777664 443211 23332 357777777753 543222335566777
Q ss_pred CEEEcccCC
Q 006559 141 RRVDLSHNA 149 (640)
Q Consensus 141 ~~L~Ls~N~ 149 (640)
+.|+|++..
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777776654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0024 Score=55.53 Aligned_cols=55 Identities=24% Similarity=0.240 Sum_probs=39.4
Q ss_pred EEeCCCCcCC--CCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCC
Q 006559 95 LLSLKNNLLS--SSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151 (640)
Q Consensus 95 ~L~Ls~N~l~--~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 151 (640)
.++.+++.|+ ..|..+ .++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555566665 443222 235888888888888766667888899999999999886
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0046 Score=64.75 Aligned_cols=111 Identities=14% Similarity=0.169 Sum_probs=79.2
Q ss_pred hhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCC
Q 006559 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPN 164 (640)
Q Consensus 85 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~ 164 (640)
..|...+.|+.+.+.++...-....+.+++.|+.+.+. +.+...-...|.++.+|+.++|..| ++ .|....|.++.+
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~ 335 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQ 335 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTT
T ss_pred ceeeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCC
Confidence 45777888888888766543333357788888888886 4455444557888888888888754 44 466567888888
Q ss_pred CcEEEccCCcceecccCCcCCCCCCcEEEcccCcC
Q 006559 165 LLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQL 199 (640)
Q Consensus 165 L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l 199 (640)
|+.+.|.++ ++..-...|.++.+|+.+++.+|..
T Consensus 336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 888888654 5544456677888888888887754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.011 Score=60.11 Aligned_cols=32 Identities=13% Similarity=0.147 Sum_probs=27.3
Q ss_pred CCCceecCCCCCCeEECCC----CCeEEccCCcccc
Q 006559 453 KAHLFHGHLSSSNIVVDQL----GNACISDIGVHQL 484 (640)
Q Consensus 453 ~~~ivHrdlk~~NILl~~~----~~~kl~DfGl~~~ 484 (640)
...++|+|+.+.|||++.+ +.+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4569999999999999874 6789999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0038 Score=62.68 Aligned_cols=69 Identities=4% Similarity=-0.042 Sum_probs=39.7
Q ss_pred ccccccCcceEEEEEeCCCcEEEEEEeccccc-hHHHHHHHHHHhccCCCcc-cceeEEEEcCCeEEEEEecc-CCCCH
Q 006559 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKK-KREVDEWLRVIGGLRHSNI-VSIRAYCNGKDELFLVYDYL-PHGSL 414 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~-~~gsL 414 (640)
+.|+.|....+|+. ..+++|....... ......|.+.++.+....+ .++++++ .+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 45778888999998 4577887754311 1122345555555433233 3455543 33457899999 55433
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.00031 Score=65.58 Aligned_cols=114 Identities=11% Similarity=0.200 Sum_probs=73.0
Q ss_pred hccCCCCCCEEeCCCC-cCCCCCC-----CCCCCCCCcEEEccccccccc----CCccCCCCCCCCEEEcccCCCCCC--
Q 006559 86 VLSRLTQLRLLSLKNN-LLSSSNL-----NLSSWPHLKHLYLSHNRFTGT----FPSGVSSLRHLRRVDLSHNAYEGE-- 153 (640)
Q Consensus 86 ~l~~l~~L~~L~Ls~N-~l~~~~~-----~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~-- 153 (640)
.+.+-+.|+.|+|++| .|..... .+..-+.|+.|+|++|.|... +...+..-+.|+.|+|++|.+...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3456678999999885 7754211 244556789999999998632 223334557899999999988632
Q ss_pred --CCchhcCCCCCCcEEEccCC---ccee----cccCCcCCCCCCcEEEcccCcCc
Q 006559 154 --IPMTELTRLPNLLTLRLEDN---RFTG----TLYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 154 --~p~~~~~~l~~L~~L~L~~N---~l~g----~~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
+- ..+..-+.|+.|+|++| .+.. .+...+..-+.|..|+++.|.+.
T Consensus 116 ~ala-~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 116 ARLL-RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHH-HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHH-HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 11 23444567999999865 3332 13334445577888888777643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.01 Score=62.08 Aligned_cols=84 Identities=11% Similarity=0.176 Sum_probs=55.5
Q ss_pred CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCC
Q 006559 109 NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS 188 (640)
Q Consensus 109 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~ 188 (640)
.|.+++.|+.+.+..+..+ .-...|.++++|+.+.+. +.++ .|+...|.++++|+.++|..| ++..-...|..+.+
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 4667777888877665432 334467777788888775 3444 466667777788888887654 55444556777777
Q ss_pred CcEEEccc
Q 006559 189 ILDFNVSN 196 (640)
Q Consensus 189 L~~l~ls~ 196 (640)
|+.+.+..
T Consensus 336 L~~i~ip~ 343 (394)
T 4gt6_A 336 LERIAIPS 343 (394)
T ss_dssp CCEEEECT
T ss_pred CCEEEECc
Confidence 87777643
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.011 Score=61.86 Aligned_cols=84 Identities=12% Similarity=0.055 Sum_probs=50.7
Q ss_pred CCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCC
Q 006559 110 LSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSI 189 (640)
Q Consensus 110 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L 189 (640)
+..+.+|+.+.+..+ +...-...|.++.+|+.++|.++ ++ .|+...|.++++|+.+.|..| ++..-...|.++.+|
T Consensus 293 F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 293 FYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp TTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred ccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence 445666666666543 44333445667777777777543 44 455556667777777777655 554445566667777
Q ss_pred cEEEcccC
Q 006559 190 LDFNVSNN 197 (640)
Q Consensus 190 ~~l~ls~N 197 (640)
+.+++..|
T Consensus 369 ~~i~lp~~ 376 (394)
T 4fs7_A 369 KKVELPKR 376 (394)
T ss_dssp CEEEEEGG
T ss_pred CEEEECCC
Confidence 77766543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.022 Score=59.00 Aligned_cols=107 Identities=9% Similarity=0.101 Sum_probs=57.0
Q ss_pred hccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCC
Q 006559 86 VLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNL 165 (640)
Q Consensus 86 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L 165 (640)
.+....+|+.+.+..+.-.-....+..+..|+.+.+..+ ++..-...|.++.+|+.+++..+ +. .++...|..+++|
T Consensus 212 ~f~~~~~l~~i~~~~~~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSGVTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTTCCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTC
T ss_pred ccccccccceeeeccceeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-ecccccccccccc
Confidence 345556666666654422111224555666666666554 33333445556666666666433 33 3444455666666
Q ss_pred cEEEccCCcceecccCCcCCCCCCcEEEcc
Q 006559 166 LTLRLEDNRFTGTLYSVNSSSRSILDFNVS 195 (640)
Q Consensus 166 ~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls 195 (640)
+.+.+.+|.++..-...|.++.+|+.++|.
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcC
Confidence 666666665654445556566666666553
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.25 E-value=0.013 Score=62.10 Aligned_cols=70 Identities=10% Similarity=0.127 Sum_probs=46.0
Q ss_pred cccccCcceEEEEEeCC--------CcEEEEEEeccccchHHHHHHHHHHhccCCCcc-cceeEEEEcCCeEEEEEeccC
Q 006559 340 LLGKGCVGATYKVVLDG--------GDVVVVKRIRERKKKREVDEWLRVIGGLRHSNI-VSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.|+.|....+|++...+ +..+++|+.........+..|.++++.+...++ .++++.+.+ .+||||++
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~ 155 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIP 155 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeC
Confidence 46778888999998763 467888887442221445567777776643344 566766542 38999998
Q ss_pred CCC
Q 006559 411 HGS 413 (640)
Q Consensus 411 ~gs 413 (640)
+..
T Consensus 156 G~~ 158 (429)
T 1nw1_A 156 SRP 158 (429)
T ss_dssp EEE
T ss_pred Ccc
Confidence 633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.025 Score=58.58 Aligned_cols=140 Identities=11% Similarity=0.129 Sum_probs=78.7
Q ss_pred cccccCcceEEEEEeCC--------CcEEEEEEeccc-cchHHHHHHHHHHhccCCCcc-cceeEEEEcCCeEEEEEecc
Q 006559 340 LLGKGCVGATYKVVLDG--------GDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNI-VSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~ 409 (640)
.|..|-...+|++...+ +..+++|+.... .......+|.++++.+.-.++ .++++++.+ .+||||+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i 132 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI 132 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence 46667778899988653 467888876432 234455678877776643333 556666643 2999999
Q ss_pred CCCCHHH-----------------hhccCCCC-CCCCc-CHHHHHHHHHHHHH-------------------HHHH----
Q 006559 410 PHGSLHS-----------------LLHGSRGP-GRMPV-DWNKRLKLASDSAK-------------------GLAF---- 447 (640)
Q Consensus 410 ~~gsL~~-----------------~l~~~~~~-~~~~l-~~~~~~~i~~~ia~-------------------gL~y---- 447 (640)
++..|.. -||....+ ++.+. -|.++.++..++.. .++.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 8755431 12222111 11111 24455544433321 2222
Q ss_pred hhc-CCCCCceecCCCCCCeEECCC----CCeEEccCCccc
Q 006559 448 LHG-YNKAHLFHGHLSSSNIVVDQL----GNACISDIGVHQ 483 (640)
Q Consensus 448 LH~-~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGl~~ 483 (640)
|.. .....++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 221 123458999999999999876 789999997764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0097 Score=61.60 Aligned_cols=70 Identities=10% Similarity=0.031 Sum_probs=39.9
Q ss_pred cccccCcceEEEEEeCC---------CcEEEEEEeccccch-HHHHHHHHHHhccCCCcc-cceeEEEEcCCeEEEEEec
Q 006559 340 LLGKGCVGATYKVVLDG---------GDVVVVKRIRERKKK-REVDEWLRVIGGLRHSNI-VSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~-~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey 408 (640)
.|+.|....+|++...+ +..+++|........ .+...|.++++.+...++ .++++.. . -++||||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~ 115 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEW 115 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEE
Confidence 46778788999988754 257888876543211 123456666665543333 4566554 2 2689999
Q ss_pred cCCCC
Q 006559 409 LPHGS 413 (640)
Q Consensus 409 ~~~gs 413 (640)
+++..
T Consensus 116 i~G~~ 120 (369)
T 3c5i_A 116 LYGDP 120 (369)
T ss_dssp CCSEE
T ss_pred ecCCc
Confidence 98754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.03 E-value=0.029 Score=52.69 Aligned_cols=102 Identities=15% Similarity=0.107 Sum_probs=64.0
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCccc
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFI 491 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 491 (640)
-+|.++|..... +++..+.+.++.|.+++|.-+-....+ ..+=+-|..|++..+|.+...+ ..+. ..
T Consensus 33 vSL~eIL~~~~~----PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYNQ----PINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------AG 99 (229)
T ss_dssp EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcCC----CcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------cc
Confidence 478999876543 799999999999999998766211011 1222346889999999988764 2211 11
Q ss_pred cccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCC
Q 006559 492 NDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKM 534 (640)
Q Consensus 492 ~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~ 534 (640)
...+.+||.. ....+.+.=|||+|+++|.-+--..
T Consensus 100 ~~~~~~pe~~--------~~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 100 EPPPVAGKLG--------YSQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------CCS--------SSSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ccCCCChhhc--------cccchHHHHHHHHHHHHHHHhhcCC
Confidence 2245688853 1244567889999999999886333
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.72 E-value=0.038 Score=56.40 Aligned_cols=32 Identities=25% Similarity=0.285 Sum_probs=27.4
Q ss_pred CCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 453 ~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
...++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34689999999999999888899999976653
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.67 E-value=0.1 Score=53.86 Aligned_cols=106 Identities=13% Similarity=0.122 Sum_probs=75.3
Q ss_pred hhccCCCCCCEEeCCCCcCCCCC-CCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCC
Q 006559 85 EVLSRLTQLRLLSLKNNLLSSSN-LNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP 163 (640)
Q Consensus 85 ~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~ 163 (640)
..+.....|+.+.+..+ +.... ..+.++.+|+.+.+..+ +...-...|.++++|+.+++.+|.++ .|+...|.+++
T Consensus 234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~ 310 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCV 310 (379)
T ss_dssp TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCT
T ss_pred ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCC
Confidence 34667788888888765 33322 25777888888888654 44444456788888998888888777 56667788888
Q ss_pred CCcEEEccCCcceecccCCcCCCCCCcEEEc
Q 006559 164 NLLTLRLEDNRFTGTLYSVNSSSRSILDFNV 194 (640)
Q Consensus 164 ~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~l 194 (640)
+|+.+.|.++ ++..-...|.++.+|+.+.+
T Consensus 311 ~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 311 KLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred CCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 8998888655 55444566777888877654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.37 E-value=0.067 Score=56.93 Aligned_cols=72 Identities=11% Similarity=0.101 Sum_probs=44.0
Q ss_pred ccccccCcceEEEEEeCC-CcEEEEEEecccc-chHHHHHHHHHHhccCCCcc-cceeEEEEcCCeEEEEEeccCCCCH
Q 006559 339 ELLGKGCVGATYKVVLDG-GDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNI-VSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
+.|+.|-...+|++...+ +..+++|+..... ..-+...|.++++.|...++ .++++++. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 357778888999998775 4677888764331 11112467777776654445 46777763 2 259999987443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.29 E-value=0.032 Score=58.15 Aligned_cols=101 Identities=10% Similarity=0.037 Sum_probs=74.7
Q ss_pred hccCCCCCCEEeCCCCcCCCCC-CCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCC
Q 006559 86 VLSRLTQLRLLSLKNNLLSSSN-LNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPN 164 (640)
Q Consensus 86 ~l~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~ 164 (640)
.+....+|+.+.+.++ +.... ..|.++++|+.++|.++ ++-.-...|.++++|+.++|..| ++ .|+...|.++++
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~ 367 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCIN 367 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTT
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCC
Confidence 4566778888888655 43322 25889999999999755 66555678999999999999877 65 577788999999
Q ss_pred CcEEEccCCcceecccCCcCCCCCCcEE
Q 006559 165 LLTLRLEDNRFTGTLYSVNSSSRSILDF 192 (640)
Q Consensus 165 L~~L~L~~N~l~g~~~~~~~~~~~L~~l 192 (640)
|+.++|..| ++ .+...+.++.+|+.+
T Consensus 368 L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 368 LKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp CCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 999999766 22 233456667777653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.24 E-value=0.0064 Score=56.62 Aligned_cols=86 Identities=20% Similarity=0.325 Sum_probs=61.3
Q ss_pred CCCCCCcEEEcccc-ccccc----CCccCCCCCCCCEEEcccCCCCCC----CCchhcCCCCCCcEEEccCCcceec---
Q 006559 111 SSWPHLKHLYLSHN-RFTGT----FPSGVSSLRHLRRVDLSHNAYEGE----IPMTELTRLPNLLTLRLEDNRFTGT--- 178 (640)
Q Consensus 111 ~~l~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~--- 178 (640)
.+-+.|+.|+|++| .+... +-..+..-+.|+.|+|++|.+... |- ..+..-+.|+.|+|++|+|+..
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA-~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLI-ELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHH-HHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHH-HHHhcCCccCeEecCCCcCCHHHHH
Confidence 44568999999986 77421 334456678999999999999731 11 2233457899999999999854
Q ss_pred -ccCCcCCCCCCcEEEcccC
Q 006559 179 -LYSVNSSSRSILDFNVSNN 197 (640)
Q Consensus 179 -~~~~~~~~~~L~~l~ls~N 197 (640)
+...+..-..|+.|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 3334555667999999865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.31 E-value=0.51 Score=49.50 Aligned_cols=71 Identities=15% Similarity=0.072 Sum_probs=42.9
Q ss_pred cccccCcceEEEEEeCC--------CcEEEEEEecccc-chHHHHHHHHHHhccCCCcc-cceeEEEEcCCeEEEEEecc
Q 006559 340 LLGKGCVGATYKVVLDG--------GDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNI-VSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~ 409 (640)
.+..|-...+|+....+ +..+++++..... ..-+..+|.++++.+.-.++ .++++.+. -++||||+
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~efI 152 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEFI 152 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEECC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEEe
Confidence 45567777899988763 4678888764431 11123456666665543233 45565442 27899999
Q ss_pred CCCCH
Q 006559 410 PHGSL 414 (640)
Q Consensus 410 ~~gsL 414 (640)
++..|
T Consensus 153 ~G~~l 157 (424)
T 3mes_A 153 DGEPL 157 (424)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.95 E-value=3.2 Score=43.00 Aligned_cols=29 Identities=14% Similarity=0.246 Sum_probs=24.3
Q ss_pred ceecCCCCCCeEE------CCCCCeEEccCCcccc
Q 006559 456 LFHGHLSSSNIVV------DQLGNACISDIGVHQL 484 (640)
Q Consensus 456 ivHrdlk~~NILl------~~~~~~kl~DfGl~~~ 484 (640)
++|+|+.+.|||+ +++..+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.42 E-value=2.2 Score=39.86 Aligned_cols=122 Identities=8% Similarity=0.094 Sum_probs=82.0
Q ss_pred HHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 006559 378 LRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457 (640)
Q Consensus 378 ~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 457 (640)
+.+|. ..||+.+.. .+-...+.+.+.|+.-+.+-=...++ .++...+++++..|+.-.+++++ -+
T Consensus 37 l~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~-----r~ 101 (215)
T 4ann_A 37 MYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRT-----RY 101 (215)
T ss_dssp GGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGS-----SE
T ss_pred HHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcC-----ce
Confidence 33443 268888876 55666777777777544332222233 35678899999999988877763 35
Q ss_pred ecCCCCCCeEECCCCCeEEccCCcccccCCCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 006559 458 HGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKG 537 (640)
Q Consensus 458 Hrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~ 537 (640)
|--|.|+|++++.++.+++.-.|+...+ +|. ..+..-=.-.+=+++..+++++..|+
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~l-----------~P~------------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNVV-----------DPL------------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTTB-----------SCC------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEEecceEEEcCCCCEEEEEccCccCC-----------CCC------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 7789999999999999999988875433 222 01111123357788899999998875
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.16 E-value=0.22 Score=53.08 Aligned_cols=56 Identities=7% Similarity=-0.046 Sum_probs=16.1
Q ss_pred ccccccCcceEEEEEeCC-CcEEEE------EEecccc----chHHHHHHHHHHhccCCCcccceeEEEE
Q 006559 339 ELLGKGCVGATYKVVLDG-GDVVVV------KRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCN 397 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~-~~~vav------K~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~ 397 (640)
+.|| ||.||+|.+.. ...||| |..+... ....+.++..+++.++|||+++.+++..
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3455 99999999865 357888 7666532 1234667778888899999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 640 | ||||
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-44 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-34 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-34 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-33 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-29 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-29 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-23 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-23 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-22 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-20 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-06 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-18 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-15 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 |
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 9e-45
Identities = 73/301 (24%), Positives = 120/301 (39%), Gaps = 36/301 (11%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEW-LRVIGGLRHSNIVSIRAYCN 397
E +GKG G ++ G + V VK R+++ E + LRH NI+ A N
Sbjct: 9 ESIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 398 GKD----ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH---- 449
+ +L+LV DY HGSL L+ R V +KLA +A GLA LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 450 -GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----------TPFFINDAYNAP 498
K + H L S NI+V + G CI+D+G+ Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558
E+ +++ N + ++R D+Y+ G+V EI G E + + ++ D S E
Sbjct: 182 EV-LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 559 V--------FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610
+ + + E +R + ++ C R + + + + +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
Query: 611 I 611
I
Sbjct: 301 I 301
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 6e-44
Identities = 61/270 (22%), Positives = 117/270 (43%), Gaps = 20/270 (7%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRE-RKKKREVDEWLRVIGGLRHSNIVSIRAYCN 397
E LG G G + +G V VK +++ ++ L+H +V + A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457
++ ++++ +Y+ +GSL L P + + NK L +A+ A+G+AF+ + +
Sbjct: 79 -QEPIYIITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 458 HGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRC 517
H L ++NI+V + I+D G+ +L + +K+ + F +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 518 DVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRAL 577
DV+SFG++L EI+T G + + M + + ++ EE+ L
Sbjct: 192 DVWSFGILLTEIVTH---------GRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 578 LQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
+ LC P+DRP + ++ED T
Sbjct: 243 M---RLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 5e-43
Identities = 60/281 (21%), Positives = 109/281 (38%), Gaps = 36/281 (12%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIR-ERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
+ +G G G YK G V VK + +++ + V+ RH NI+
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
Y +L +V + SL+ LH + K + +A +A+G+ +LH +
Sbjct: 72 YSTA-PQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--------TPFFINDAYNAPE-LKFNNN 505
+ H L S+NI + + I D G+ + + + APE ++ +
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565
N YS + DVY+FG+VL E++TG++ + + Q
Sbjct: 184 NPYSFQ-----SDVYAFGIVLYELMTGQLPYSN--------INNRDQIIFMVGRGYLSPD 230
Query: 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
+ K +A+ ++ CL +RP + IE +
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-42
Identities = 60/273 (21%), Positives = 110/273 (40%), Gaps = 30/273 (10%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYC-N 397
+ +GKG G G + V VK I+ + V+ LRHSN+V +
Sbjct: 13 QTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457
K L++V +Y+ GSL L GR + + LK + D + + +L +
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 125
Query: 458 HGHLSSSNIVVDQLGNACISDIGVHQLF---HTPFFINDAYNAPELKFNNNNNYSQRKFW 514
H L++ N++V + A +SD G+ + + + APE ++KF
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA-------LREKKFS 178
Query: 515 QRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEM 574
+ DV+SFG++L EI + G V + ++ +D +++ +
Sbjct: 179 TKSDVWSFGILLWEIYSF---------GRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229
Query: 575 RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
++ C RP+ + +E I+T
Sbjct: 230 YEVM---KNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 3e-40
Identities = 56/279 (20%), Positives = 112/279 (40%), Gaps = 34/279 (12%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCN 397
+ +G G G + D V +K IRE + + E V+ L H +V + C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457
+ + LV++++ HG L L R L + D +G+A+L +A +
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVI 123
Query: 458 HGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND-------AYNAPELKFNNNNNYSQ 510
H L++ N +V + +SD G+ + + + + +PE+ +S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV-------FSF 176
Query: 511 RKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEM 570
++ + DV+SFGV++ E+ + + +++ + + ++ L
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGFRLYKPRLASTH-- 230
Query: 571 EEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609
+ Q+ C P+DRP S + R + +I G
Sbjct: 231 ------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 9e-39
Identities = 57/272 (20%), Positives = 111/272 (40%), Gaps = 24/272 (8%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCN 397
LG+GC G + +G V +K ++ + +V+ LRH +V + A +
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457
++ +++V +Y+ GSL L G G + + +A+ A G+A++ N
Sbjct: 83 -EEPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQIASGMAYVERMN---YV 135
Query: 458 HGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRC 517
H L ++NI+V + ++D G+ +L + +K+ +F +
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195
Query: 518 DVYSFGVVLLEILTGKMA--KGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMR 575
DV+SFG++L E+ T G ++ V+ + + E E +
Sbjct: 196 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----------GYRMPCPPECPESLH 244
Query: 576 ALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607
L+ C P++RP + +ED T
Sbjct: 245 DLM---CQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 2e-38
Identities = 61/277 (22%), Positives = 121/277 (43%), Gaps = 24/277 (8%)
Query: 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
LG G G Y+ V V VK ++ + EV+E+L+ V+ ++H N+V +
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
C + +++ +++ +G+L L R V L +A+ + + +L K
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFW 514
+ H L++ N +V + ++D G+ +L + A +K+ + + KF
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 515 QRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEM 574
+ DV++FGV+L EI T M+ G +E+ + + M++ E
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLEKDYRMERP-EGCP 242
Query: 575 RALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGSI 611
+ ++ C P DRP+ + +H+ E + + SI
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 8e-38
Identities = 60/296 (20%), Positives = 121/296 (40%), Gaps = 44/296 (14%)
Query: 339 ELLGKGCVGATYKVVLDG------GDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNI 389
+G+G G ++ G +V VK ++E ++ R ++ + NI
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRG-------------------PGRMPVD 430
V + C + L+++Y+ +G L+ L PG P+
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 431 WNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-F 489
++L +A A G+A+L H L++ N +V + I+D G+ + ++ +
Sbjct: 139 CAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQM 549
+ D +A +++ + ++ DV+++GVVL EI + + G
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG---------- 245
Query: 550 MGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
M +E + V D ++ E L + LC + LP DRP+ +HR+++ +
Sbjct: 246 MAHEEVIYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (348), Expect = 4e-37
Identities = 49/278 (17%), Positives = 106/278 (38%), Gaps = 30/278 (10%)
Query: 339 ELLGKGCVGATYKVVLDGGD----VVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
+++G G G L V +K ++ +++ ++L ++G H N++
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ + ++ +++ +GSL S L + G + + + A G+ +L
Sbjct: 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADM 147
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF----HTPFFINDAYNAPELKFNNNNN 507
N H L++ NI+V+ +SD G+ + P + + +++
Sbjct: 148 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 508 YSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567
RKF DV+S+G+V+ E+++ G + M QD D+ L
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMS---------YGERPYWDMTNQDVINAIEQDYRLPPP 255
Query: 568 KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ + Q+ L C RP + ++ +
Sbjct: 256 MDCPSALH---QLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 51/268 (19%), Positives = 106/268 (39%), Gaps = 20/268 (7%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCN 397
+ LG G G G V +K I+E + E E +V+ L H +V + C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457
+ +F++ +Y+ +G L + L R + L++ D + + +L
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 458 HGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRC 517
H L++ N +V+ G +SD G+ + + + + ++++ KF +
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 518 DVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRAL 577
D+++FGV++ EI + LG + + + + + L E++ +
Sbjct: 183 DIWAFGVLMWEIYS---------LGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 233
Query: 578 LQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ C +RP I+ I D+
Sbjct: 234 M---YSCWHEKADERPTFKILLSNILDV 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-37
Identities = 63/273 (23%), Positives = 111/273 (40%), Gaps = 28/273 (10%)
Query: 341 LGKGCVGATYKVVL---DGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
LG G G+ + V V +K +++ +K + +E +R ++ L + IV +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
C + L LV + G LH L G R + + +L + G+ +L N
Sbjct: 77 VCQA-EALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKN-- 129
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPE--LKFNNNNNYSQRK 512
H L++ N+++ A ISD G+ + A +A + LK+ + RK
Sbjct: 130 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 513 FWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEE 572
F R DV+S+GV + E L+ G + +M G + A+ + E
Sbjct: 189 FSSRSDVWSYGVTMWEALS---------YGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239
Query: 573 EMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
E+ AL+ C +DRP+ V + +
Sbjct: 240 ELYALM---SDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 44/288 (15%)
Query: 339 ELLGKGCVGATYKVVLDGGD----VVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
E++G+G G Y L D VK + EV ++L ++ H N++S
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 392 IRAYC-NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C + +V Y+ HG L + + + AKG+ FL
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLA- 147
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----------TPFFINDAYNAPEL 500
H L++ N ++D+ ++D G+ + + T + + A E
Sbjct: 148 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560
+KF + DV+SFGV+L E++T ++ + Q
Sbjct: 206 -------LQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGR------ 251
Query: 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608
L+ + + + +V L C P + RP+ S + I I +
Sbjct: 252 --RLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-35
Identities = 50/284 (17%), Positives = 110/284 (38%), Gaps = 43/284 (15%)
Query: 339 ELLGKGCVGATYKVVLDGGD-----VVVVKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
+++G G G YK +L V +K ++ +++ ++L ++G H NI+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ + + ++ +Y+ +G+L L G + + + A G+ +L
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLA- 127
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---------TPFFINDAYNAPELK 501
+ H L++ NI+V+ +SD G+ ++ + I + APE
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE-- 183
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561
S RKF DV+SFG+V+ E++T + + + +
Sbjct: 184 -----AISYRKFTSASDVWSFGIVMWEVMTYG-----------ERPYWELSNHEVMKAIN 227
Query: 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ + A+ Q+ + C RP + + +++ +
Sbjct: 228 DGFRLPTP-MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 52/298 (17%)
Query: 339 ELLGKGCVGATYKVVL------DGGDVVVVKRIRERKKKREVDEWLRVIGGL----RHSN 388
+ LG G G + D V VK ++ E + + + L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 389 IVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGP-------------GRMPVDWNKRL 435
IV++ C ++ +Y +G L + L R + +D L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 436 KLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--------T 487
+ AKG+AFL + H L++ NI++ I D G+ +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWV 547
+ + APE FN + DV+S+G+ L E+ + + G K+
Sbjct: 206 NARLPVKWMAPESIFNCVYTFE-------SDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 548 QMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+M+ + F ++ + EM ++ C P RP + ++IE
Sbjct: 259 KMIKE--------GFRMLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 54/301 (17%), Positives = 107/301 (35%), Gaps = 57/301 (18%)
Query: 339 ELLGKGCVGATYKVVLDGGD------VVVVKRIRERKKKREVDEWLRVIGGL----RHSN 388
++LG G G G V VK ++E+ E + + + + H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 389 IVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGP------------------GRMPVD 430
IV++ C ++L+++Y +G L + L R +
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 431 WNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV--------H 482
+ L A AKG+ FL H L++ N++V I D G+ +
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 483 QLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG 542
+ + + APE + + + + DV+S+G++L EI + + G
Sbjct: 220 YVVRGNARLPVKWMAPE-------SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 543 IVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMI 602
+ +++ F++ EE+ ++Q C A + RP+ + +
Sbjct: 273 DANFYKLIQN--------GFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFL 321
Query: 603 E 603
Sbjct: 322 G 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 4e-34
Identities = 47/268 (17%), Positives = 99/268 (36%), Gaps = 31/268 (11%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
LG G G YK + + K I K + E+++++ ++ H NIV +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLD 76
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
++ L+++ ++ G++ +++ P+ ++ + + L +LH
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLH---DN 129
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLF------HTPFFINDAYNAPELKFNNNNNY 508
+ H L + NI+ G+ ++D GV F + APE+
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM--CETS 187
Query: 509 SQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568
R + + DV+S G+ L+E+ + + L ++ + + + E L
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHE--LNPMRVLLKIAKSEP------PTLAQPS 239
Query: 569 EMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ L+ CL R S
Sbjct: 240 RWSSNFKDFLK---KCLEKNVDARWTTS 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 45/203 (22%), Positives = 77/203 (37%), Gaps = 22/203 (10%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
LG G G +KV G V+ K I K ++ +R V+ IV
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
E+ + +++ GSL +L + + K++ KGL +L K
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR--EKH 124
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----TPFFINDAYNAPELKFNNNNNYSQ 510
+ H + SNI+V+ G + D GV F +Y +PE
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER-------LQG 177
Query: 511 RKFWQRCDVYSFGVVLLEILTGK 533
+ + D++S G+ L+E+ G+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 4e-34
Identities = 45/274 (16%), Positives = 98/274 (35%), Gaps = 27/274 (9%)
Query: 339 ELLGKGCVGATYKVVL----DGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVS 391
+G+G G ++ + + V +K + +++L+ + H +IV
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ ++ ++++ + G L S L + +D + A + LA+L
Sbjct: 73 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLE-- 125
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQR 511
H +++ N++V + D G+ + + + +K+ + + R
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 512 KFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEME 571
+F DV+ FGV + EIL G+ + + D L M
Sbjct: 185 RFTSASDVWMFGVCMWEILMH---------GVKPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 572 EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ +L+ C A P RP + + + I
Sbjct: 236 PTLYSLM---TKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (325), Expect = 7e-34
Identities = 49/266 (18%), Positives = 100/266 (37%), Gaps = 32/266 (12%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-----ERKKKREVDEWLRVIGGLRHSNIVSI 392
+G G GA Y + +VV +K++ +K +++ + +R + LRH N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
R + +LV +Y + L + P+ + + + +GLA+LH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLH--- 132
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--TPFFINDAYNAPELKFNNNNNYSQ 510
++ H + + NI++ + G + D G + F + APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEG--- 189
Query: 511 RKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEM 570
++ + DV+S G+ +E+ K + + + +
Sbjct: 190 -QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------ESPALQSGHW 239
Query: 571 EEEMRALLQVALLCLAPLPKDRPNMS 596
E R + CL +P+DRP
Sbjct: 240 SEYFRNFVD---SCLQKIPQDRPTSE 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 57/309 (18%), Positives = 115/309 (37%), Gaps = 37/309 (11%)
Query: 339 ELLGKGCVGATYKVVLDGGD---VVVVKRIRERKKKREVDEWLRVIGGL----RHSNIVS 391
+++G+G G K + +KR++E K + ++ + L H NI++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGS-----------RGPGRMPVDWNKRLKLASD 440
+ C + L+L +Y PHG+L L S + + L A+D
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 441 SAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPEL 500
A+G+ +L + H L++ NI+V + A I+D G+ +
Sbjct: 136 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 191
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560
+ + + + DV+S+GV+L EI++ G + + + Q
Sbjct: 192 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQ-------- 241
Query: 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR--TKGSIDGCANSI 618
+ L ++E+ L+ C P +RP+ + + + + K ++
Sbjct: 242 GYRLEKPLNCDDEVYDLM---RQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK 298
Query: 619 MNNISSDSS 627
D S
Sbjct: 299 FTYAGIDCS 307
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 45/273 (16%), Positives = 95/273 (34%), Gaps = 36/273 (13%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR----ERKKKREVDEWLRVIGGLRHSNIVSIR 393
+G G G K+ G ++V K + +K+ + + ++ L+H NIV
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 394 AYCNGKDE--LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH-- 449
+ L++V +Y G L S++ R +D L++ + L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------FFINDAYNAPELKFN 503
+ H L +N+ +D N + D G+ ++ + F Y +PE
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ--- 185
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563
++ + ++ D++S G +L E+ + G+ +
Sbjct: 186 ----MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS-- 239
Query: 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+E+ ++ L RP++
Sbjct: 240 --------DELNEIIT---RMLNLKDYHRPSVE 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-33
Identities = 51/268 (19%), Positives = 107/268 (39%), Gaps = 38/268 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR--ERKKKREVDEWLRVIGGLRHSNIVSIRAY 395
E +G+G G Y + + G V ++++ ++ KK + + V+ ++ NIV+
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
DEL++V +YL GSL ++ +D + + + + L FLH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 456 LFHGHLSSSNIVVDQLGNACISDIGVHQLFH------TPFFINDAYNAPELKFNNNNNYS 509
+ H + S NI++ G+ ++D G + + APE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-------VVT 189
Query: 510 QRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568
++ + + D++S G++ +E++ G+ + L + + G EL +
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---------PELQNPE 240
Query: 569 EMEEEMRALLQVALLCLAPLPKDRPNMS 596
++ R L CL + R +
Sbjct: 241 KLSAIFRDFLN---RCLDMDVEKRGSAK 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-32
Identities = 52/270 (19%), Positives = 94/270 (34%), Gaps = 37/270 (13%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
+ LG+G G V + V VK + ++ + + + L H N+V
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
+ + +L +Y G L + + + + G+ +LH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLH---GI 122
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--------TPFFINDAYNAPELKFNNNN 506
+ H + N+++D+ N ISD G+ +F Y APEL
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL-LKRRE 181
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566
++ + DV+S G+VL +L G++ Q+ S W+ L
Sbjct: 182 FHA-----EPVDVWSCGIVLTAMLAGEL--------PWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
K+++ ALL L P R +
Sbjct: 229 WKKIDSAPLALLH---KILVENPSARITIP 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-32
Identities = 61/293 (20%), Positives = 108/293 (36%), Gaps = 52/293 (17%)
Query: 339 ELLGKGCVGATYKVVLDG------GDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNI 389
LG+G G Y+ V G V +K + E RE E+L V+ ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRG-----PGRMPVDWNKRLKLASDSAKG 444
V + + ++ + + G L S L R P P +K +++A + A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 445 LAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--------TPFFINDAYN 496
+A+L+ H L++ N +V + I D G+ + + + +
Sbjct: 146 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 497 APELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESA 556
+PE + F DV+SFGVVL EI T + Q S
Sbjct: 203 SPE-------SLKDGVFTTYSDVWSFGVVLWEIATLA--------------EQPYQGLSN 241
Query: 557 WEVFDFELIMDKEM----EEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+V +M+ + + L ++ +C PK RP+ + I++
Sbjct: 242 EQV--LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-32
Identities = 60/281 (21%), Positives = 101/281 (35%), Gaps = 44/281 (15%)
Query: 341 LGKGCVGATYKVVLDG---GDVVVVKRIR-ERKKKREVDEWLR---VIGGLRHSNIVSIR 393
LG G G K V VK ++ E DE L V+ L + IV +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
C + LV + G L+ L +R V ++L + G+ +L +
Sbjct: 75 GICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---E 125
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA---------YNAPELKFNN 504
++ H L++ N+++ A ISD G+ + A + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC---- 181
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564
+ KF + DV+SFGV++ E + G + M G + +A +
Sbjct: 182 ---INYYKFSSKSDVWSFGVLMWEAFS---------YGQKPYRGMKGSEVTAMLEKGERM 229
Query: 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
EM L+ LC ++RP + V + +
Sbjct: 230 GCPAGCPREMYDLM---NLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 50/269 (18%), Positives = 95/269 (35%), Gaps = 41/269 (15%)
Query: 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEW-----LRVIGGLRHSNIVSI 392
LGKG G Y ++ +K + + + ++ E + + LRH NI+ +
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
Y + ++L+ +Y P G+++ L D + ++ A L++ H
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCH--- 123
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIN----DAYNAPELKFNNNNNY 508
+ H + N+++ G I+D G + Y PE+
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM-------I 176
Query: 509 SQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567
R ++ D++S GV+ E L GK + + K + + E
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------EFTFP 224
Query: 568 KEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ E R L+ L P RP +
Sbjct: 225 DFVTEGARDLIS---RLLKHNPSQRPMLR 250
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 56/288 (19%), Positives = 98/288 (34%), Gaps = 48/288 (16%)
Query: 339 ELLGKGCVGATYKVVLDGGD----VVVVKRIRERK--KKREVDEWLR---VIGGLRHSNI 389
E LG G G + D V VK ++ + +D+++R + L H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+ + + +V + P GSL L +G + A A+G+ +L
Sbjct: 74 IRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 128
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGV---------HQLFHTPFFINDAYNAPEL 500
H L++ N+++ I D G+ H + + A+ APE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA--KGDGELGIVKWVQMMGQDESAWE 558
R F D + FGV L E+ T G I+ + G+ E
Sbjct: 186 -------LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238
Query: 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
++ V + C A P+DRP + + + +
Sbjct: 239 DCPQDIY-------------NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-31
Identities = 56/291 (19%), Positives = 107/291 (36%), Gaps = 39/291 (13%)
Query: 339 ELLGKGCVGATYKVVLDGGD--------VVVVKRIRERKKKREVDEWLRVIGGL----RH 386
+ LG+G G G D V VK ++ ++++ + + + + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 387 SNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPG-----------RMPVDWNKRL 435
NI+++ C L+++ +Y G+L L R PG + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 436 KLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF-HTPFFINDA 494
A A+G+ +L H L++ N++V + I+D G+ + H ++
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 495 YNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDE 554
+K+ R + + DV+SFGV+L EI T + G E
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----------PVE 244
Query: 555 SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+++ MDK L + C +P RP + ++ I
Sbjct: 245 ELFKLLKEGHRMDKP-SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 41/263 (15%), Positives = 95/263 (36%), Gaps = 25/263 (9%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKRE-VDEWLRVIGGLRHSNIVSIRAYC 396
E LG+G G ++ V + K ++ + + V + + ++ RH NI+ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
+EL ++++++ + ++ S ++ + + + L FLH ++
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 457 FHGHLSSSNIVVDQLGNA--CISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFW 514
H + NI+ ++ I + G + + APE + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE--YYAPEVHQHDVVS 181
Query: 515 QRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEE 573
D++S G ++ +L+G + I++ + + F+ KE+ E
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--------AEYTFDEEAFKEISIE 233
Query: 574 MRALLQVALLCLAPLPKDRPNMS 596
+ L K R S
Sbjct: 234 AMDFVD---RLLVKERKSRMTAS 253
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 8e-30
Identities = 56/272 (20%), Positives = 100/272 (36%), Gaps = 39/272 (14%)
Query: 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIR 393
+G+G YK + + V +++RK +++ E ++ GL+H NIV
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 394 AYC----NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
GK + LV + + G+L + L + + KGL FLH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 450 GYNKAHLFHGHLSSSNIVV-DQLGNACISDIGVHQLFHTPFFINDA----YNAPELKFNN 504
+ H L NI + G+ I D+G+ L F + APE
Sbjct: 130 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPE----- 183
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564
+ K+ + DVY+FG+ +LE+ T + + Q Q
Sbjct: 184 ---MYEEKYDESVDVYAFGMCMLEMATSEYPYSEC--------QNAAQIYRRVTSGVKPA 232
Query: 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
DK E++ +++ C+ +R ++
Sbjct: 233 SFDKVAIPEVKEIIE---GCIRQNKDERYSIK 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 118 bits (297), Expect = 1e-29
Identities = 46/269 (17%), Positives = 99/269 (36%), Gaps = 36/269 (13%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERK--KKREVDEWLRVIGGLRHSNIVSIRAY 395
E LG G G ++ V G V V K I K V + ++ L H ++++
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
K E+ L+ ++L G L + + + + + +GL +H +
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMH---EHS 147
Query: 456 LFHGHLSSSNIVVD--QLGNACISDIGVHQLFHTPFFIND-----AYNAPELKFNNNNNY 508
+ H + NI+ + + + I D G+ + + + APE+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI-------V 200
Query: 509 SQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567
+ D+++ GV+ +L+G G+ +L ++ V+ ++F+
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--------WEFDEDAF 252
Query: 568 KEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ E + ++ L P+ R +
Sbjct: 253 SSVSPEAKDFIK---NLLQKEPRKRLTVH 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 41/272 (15%), Positives = 87/272 (31%), Gaps = 43/272 (15%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSI 392
++LG+G L +K + +R K V V+ L H V +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
++L+ Y +G L + D ++ L +LH
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH--- 125
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--------TPFFINDAYNAPELKFNN 504
+ H L NI++++ + I+D G ++ F Y +PEL
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL---- 181
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564
+++ + D+++ G ++ +++ G G + ++ E
Sbjct: 182 ---LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----------EYLIFQKIIKLEY 227
Query: 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
++ + R L++ L R
Sbjct: 228 DFPEKFFPKARDLVE---KLLVLDATKRLGCE 256
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 117 bits (295), Expect = 2e-29
Identities = 43/269 (15%), Positives = 96/269 (35%), Gaps = 36/269 (13%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR--ERKKKREVDEWLRVIGGLRHSNIVSIRAY 395
E LG G G ++V G+ K + K V + ++ + LRH +V++
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 396 CNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
+E+ ++Y+++ G L + + ++ ++ KGL +H + +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMH---ENN 144
Query: 456 LFHGHLSSSNIVV--DQLGNACISDIGVHQLF-----HTPFFINDAYNAPELKFNNNNNY 508
H L NI+ + + D G+ + APE+
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-------A 197
Query: 509 SQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567
+ D++S GV+ +L+G G+ + ++ V+ ++ +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC--------DWNMDDSAF 249
Query: 568 KEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ E+ + ++ L P R +
Sbjct: 250 SGISEDGKDFIR---KLLLADPNTRMTIH 275
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 51/273 (18%), Positives = 103/273 (37%), Gaps = 38/273 (13%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKK-KREVDEWLRVIGGLRHSNIVSIRAYC 396
++LG G G ++ + +K +++ K +REV+ R + +IV I
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDVY 74
Query: 397 ----NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
G+ L +V + L G L S + RG + ++ + + +LH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFT--EREASEIMKSIGEAIQYLH--- 128
Query: 453 KAHLFHGHLSSSNIVVD---QLGNACISDIGVHQLF-----HTPFFINDAYNAPELKFNN 504
++ H + N++ ++D G + T Y APE+
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV---- 184
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFE 563
K+ + CD++S GV++ +L G + L I ++ + ++F
Sbjct: 185 ---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----YEFP 237
Query: 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
E+ EE++ L++ L P R ++
Sbjct: 238 NPEWSEVSEEVKMLIR---NLLKTEPTQRMTIT 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 1e-28
Identities = 38/268 (14%), Positives = 90/268 (33%), Gaps = 33/268 (12%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
++LG G +V +K I ++ + + V+ ++H NIV++
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
L+L+ + G L + +L + +LH
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND-----AYNAPELKFNNNNNYS 509
H + +D+ ISD G+ ++ ++ Y APE+ +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-------LA 182
Query: 510 QRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568
Q+ + + D +S GV+ +L G + + + + + ++F+
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--------AEYEFDSPYWD 234
Query: 569 EMEEEMRALLQVALLCLAPLPKDRPNMS 596
++ + + ++ + P+ R
Sbjct: 235 DISDSAKDFIR---HLMEKDPEKRFTCE 259
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 112 bits (281), Expect = 3e-28
Identities = 48/277 (17%), Positives = 99/277 (35%), Gaps = 39/277 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR--------ERKKKREVDEWLRVIGGLR---- 385
E+LG+G + + VK I + + + L+ + LR
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 386 HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL 445
H NI+ ++ FLV+D + G L L ++ + + K+ + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVI 123
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH-----TPFFINDAYNAPEL 500
LH K ++ H L NI++D N ++D G +Y APE+
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEV 559
+ N + + + D++S GV++ +L G ++ +++ +
Sbjct: 181 -IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--------GN 231
Query: 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ F + + ++ L+ L P+ R
Sbjct: 232 YQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAE 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 113 bits (284), Expect = 5e-28
Identities = 52/281 (18%), Positives = 98/281 (34%), Gaps = 40/281 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEW--------LRVIGGLRHSNI 389
++G+G G Y D G + +K + +++ K + E L ++ I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
V + + D+L + D + G LH L A++ GL +H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 450 GYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----TPFFINDAYNAPELKFNNN 505
+ + L +NI++D+ G+ ISD+G+ F Y APE+
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV-LQKG 180
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565
Y D +S G +L ++L G + + E +
Sbjct: 181 VAYD-----SSADWFSLGCMLFKLLRGHSPFRQHK--------TKDKHEIDRMTLTMAVE 227
Query: 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
+ E+R+LL+ L R + R ++++
Sbjct: 228 LPDSFSPELRSLLE---GLLQRDVNRRL--GCLGRGAQEVK 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 55/290 (18%), Positives = 103/290 (35%), Gaps = 37/290 (12%)
Query: 339 ELLGKGCVGATYKVVLDG------GDVVVVKRIRERKKKREVDEWLRVIGGL----RHSN 388
+ LG+G G + G V VK ++E E + + L H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 389 IVSIRAYCNGKDE-LFLVYDYLPHGSLHSLLHGSRGP-----------GRMPVDWNKRLK 436
+V++ C L ++ ++ G+L + L R + + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 437 LASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGV-HQLFHTPFFINDAY 495
+ AKG+ FL H L++ NI++ + I D G+ ++ P ++
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 496 NAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDES 555
LK+ R + + DV+SFGV+L EI + + G ++ + + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT- 254
Query: 556 AWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ EM Q L C P RP S + + ++
Sbjct: 255 -------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-27
Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 49/301 (16%)
Query: 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCN 397
+++G G G Y+ L D G++V +K++ + KR + L+++ L H NIV +R +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 398 GKDE------LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
E L LV DY+P H SR +P + LA++H
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP--VIYVKLYMYQLFRSLAYIH-- 139
Query: 452 NKAHLFHGHLSSSNIVVDQLGNAC-ISDIGVHQLF-----HTPFFINDAYNAPELKFNNN 505
+ H + N+++D + D G + + + + Y APEL F
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELG-IVKWVQMMGQDESAW------ 557
+ DV+S G VL E+L G+ GD + +V+ ++++G
Sbjct: 199 ------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 558 ----------EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS--IVHRMIEDI 605
+ + + E AL L P R H +++
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACAHSFFDEL 309
Query: 606 R 606
R
Sbjct: 310 R 310
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 9e-27
Identities = 51/283 (18%), Positives = 98/283 (34%), Gaps = 43/283 (15%)
Query: 339 ELLGKGCVGATYKVVL--DGGDV---VVVKRIRERKKKREVDEWLR---VIGGLRHSNIV 390
++LG G G YK + +G V V +K +RE + E L V+ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ C + L+ +P G L + + + L AKG+ +L
Sbjct: 75 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLE- 128
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH--------TPFFINDAYNAPELKF 502
L H L++ N++V + I+D G+ +L + + A E
Sbjct: 129 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES-- 184
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562
R + + DV+S+GV + E++T DG ++ E
Sbjct: 185 -----ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEK-----GE 230
Query: 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
L ++ ++ + C RP + +
Sbjct: 231 RLPQPPICTIDVYMIM---VKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (262), Expect = 1e-25
Identities = 38/284 (13%), Positives = 89/284 (31%), Gaps = 37/284 (13%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCN 397
+G G G Y + G+ V +K + K ++ ++ ++ + +C
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 398 GKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLF 457
+ + ++ L SL L + L LA + ++H +
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIH---SKNFI 125
Query: 458 HGHLSSSNIVV---DQLGNACISDIGVHQLFH-------------TPFFINDAYNAPELK 501
H + N ++ + I D G+ + + Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT- 184
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFD 561
+ + +R D+ S G VL+ G + + + + S ++
Sbjct: 185 ------HLGIEQSRRDDLESLGYVLMYFNLGSL---PWQGLKAATKRQKYERISEKKMST 235
Query: 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
++ K E L C + D+P+ S + ++ ++
Sbjct: 236 PIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 104 bits (261), Expect = 1e-25
Identities = 36/288 (12%), Positives = 83/288 (28%), Gaps = 43/288 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGGLRH-SNIVSIRAYC 396
+G+G G ++ L V +K R ++ + R L + I ++ +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHL 456
LV D L L R A + +H + L
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIH---EKSL 122
Query: 457 FHGHLSSSNIVVDQL-----GNACISDIGVHQLFHTPFFIND-------------AYNAP 498
+ + N ++ + + D G+ + + P Y +
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 499 ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAW 557
+ R+ +R D+ + G V + L G + +G + + +G+ + +
Sbjct: 183 NT-------HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605
+ + + EE + P+ + + +
Sbjct: 236 PLRE----LCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 55/271 (20%), Positives = 97/271 (35%), Gaps = 44/271 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR------ERKKKREVDEWLRVIGGLRHSNIVS 391
++LGKG G + +K ++ + + + E + H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 392 IRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY 451
+ K+ LF V +YL G L + D ++ A++ GL FLH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLH-- 120
Query: 452 NKAHLFHGHLSSSNIVVDQLGNACISDIGV------HQLFHTPFFINDAYNAPELKFNNN 505
+ + L NI++D+ G+ I+D G+ F Y APE+
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFEL 564
N+ D +SFGV+L E+L G+ G E + ++M
Sbjct: 180 YNH-------SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------NP 220
Query: 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNM 595
+ +E+E + LL P+ R +
Sbjct: 221 FYPRWLEKEAKDLLV---KLFVREPEKRLGV 248
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 101 bits (252), Expect = 2e-24
Identities = 51/275 (18%), Positives = 97/275 (35%), Gaps = 46/275 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRER--KKKREVDEWLR---VIGGLRHSNIVSI 392
E+LG G + + L V VK +R + + R L H IV++
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 393 RAYCNGKDE----LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFL 448
+ ++V +Y+ +L ++H P+ + +++ +D+ + L F
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 127
Query: 449 HGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND---------AYNAPE 499
H + + H + +NI++ + D G+ + Y +PE
Sbjct: 128 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 500 LKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWE 558
R DVYS G VL E+LTG+ GD + + E
Sbjct: 185 Q-------ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--------VRE 229
Query: 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP 593
+ + ++ A++ LA P++R
Sbjct: 230 DPIPPSARHEGLSADLDAVVL---KALAKNPENRY 261
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 9e-24
Identities = 59/300 (19%), Positives = 112/300 (37%), Gaps = 49/300 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWL----RVIGGLRHSNIVSIR 393
E +G+G G YK G+VV +K+IR + V ++ L H NIV +
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
+ +++L+LV+++L + + + +GLAF H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCH---S 120
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------FFINDAYNAPELKFNNNNN 507
+ H L N++++ G ++D G+ + F P + Y APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC--- 177
Query: 508 YSQRKFWQRCDVYSFGVVLLEILTG--------------KMAKGDGELGIVKWVQMMGQD 553
+ + D++S G + E++T ++ + G V W +
Sbjct: 178 ---KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 554 E-----SAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIV--HRMIEDIR 606
+ W DF ++ ++E+ R+LL L P R + H +D+
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLS---QMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 2e-23
Identities = 50/291 (17%), Positives = 95/291 (32%), Gaps = 47/291 (16%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR--------VIGGLRHSNI 389
E LG G K G K I++R+ K R ++ ++H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 390 VSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLH 449
+++ K ++ L+ + + G L L + + + + G+ +LH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLH 130
Query: 450 GYNKAHLFHGHLSSSNIVVDQLG----NACISDIGVHQLF-----HTPFFINDAYNAPEL 500
+ H L NI++ I D G+ F + APE+
Sbjct: 131 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 501 KFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEV 559
+ D++S GV+ +L+G GD + + V +
Sbjct: 188 -------VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV--------N 232
Query: 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIV--HRMIEDIRTK 608
++FE + ++ L PK R + H I+ T+
Sbjct: 233 YEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 3e-23
Identities = 49/286 (17%), Positives = 99/286 (34%), Gaps = 42/286 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEW-------LRVIGGLRHSNIV 390
+ LG+G YK + +V +K+I+ + D ++++ L H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 391 SIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ K + LV+D++ + S + + + +GL +LH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH- 117
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDA------YNAPELKFNN 504
+ + H L +N+++D+ G ++D G+ + F +P Y APEL
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL-LFG 174
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTG--------------KMAKGDGELGIVKWVQMM 550
Y D+++ G +L E+L ++ + G +W M
Sbjct: 175 ARMYG-----VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 551 GQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ + + LL + P R +
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 4e-23
Identities = 47/286 (16%), Positives = 92/286 (32%), Gaps = 51/286 (17%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERK--KKREVDEWLRVIG--------GLRHS 387
LLG G G+ Y + + V +K + + + E+ RV S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 388 NIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
++ + + D L+ + RG + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQLFHTPFFIN----DAYNAPELKF 502
H + H + NI++D G + D G L + + Y+ PE
Sbjct: 126 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 503 NNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562
R + V+S G++L +++ G + E E+
Sbjct: 183 Y------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------------EIIRG 219
Query: 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIV--HRMIEDIR 606
++ + + E + L++ CLA P DRP + H ++D+
Sbjct: 220 QVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQNHPWMQDVL 262
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 6e-23
Identities = 57/301 (18%), Positives = 103/301 (34%), Gaps = 46/301 (15%)
Query: 339 ELLGKGCVGATYKV--VLDGGDVVVVKRIR--------ERKKKREVDEWLRVIGGLRHSN 388
+G+G G +K + +GG V +KR+R REV LR + H N
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPN 71
Query: 389 IVSIRAYC-----NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAK 443
+V + C + + +L LV++++ L V + +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMFQLLR 127
Query: 444 GLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFN 503
GL FLH + H L NI+V G ++D G+ +++ + +
Sbjct: 128 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW--YR 182
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTG--------------KMAKGDGELGIVKWVQM 549
Q + D++S G + E+ K+ G G W +
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 550 MGQDESAWEVFDFELIMD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIV--HRMIEDI 605
+ A+ + I +++E + LL CL P R + H +D+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALSHPYFQDL 299
Query: 606 R 606
Sbjct: 300 E 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.7 bits (237), Expect = 2e-22
Identities = 51/280 (18%), Positives = 97/280 (34%), Gaps = 33/280 (11%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWL----RVIGGLRHSNIVSIRA 394
E +G+G G YK + G+ +K+IR K+ + ++ L+HSNIV +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 395 YCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
+ K L LV+++L L ++ G+A+ H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFW 514
+ H L N+++++ G I+D G+ + F P + +K+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 515 QRCDVYSFGVVLLEILTG--------------KMAKGDGELGIVKWVQMMGQDESAWEVF 560
D++S G + E++ G ++ + G W + +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 561 DFELI----MDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+E + K ++E LL L P R
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAK 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.3 bits (239), Expect = 2e-22
Identities = 50/277 (18%), Positives = 101/277 (36%), Gaps = 40/277 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-----ERKKKREVDEWLRVIGGLRHSNIVSI 392
LG G G + + G +K ++ K+ ++ ++ + H I+ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
++F++ DY+ G L SLL A++ L +LH
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLH--- 121
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFI---NDAYNAPELKFNNNNNYS 509
+ + L NI++D+ G+ I+D G + + Y APE+ S
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEV-------VS 174
Query: 510 QRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569
+ + + D +SFG+++ E+L G D ++ ++ + EL
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYD-----------SNTMKTYEKILNAELRFPPF 223
Query: 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
E+++ LL + R + ED++
Sbjct: 224 FNEDVKDLLS---RLITRDLSQRLGN--LQNGTEDVK 255
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 7e-22
Identities = 42/212 (19%), Positives = 79/212 (37%), Gaps = 32/212 (15%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLR---VIGGLRHSNIVSIRA 394
+G+G G V +K+I + + LR ++ RH NI+ I
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 395 YCNGKD----ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHG 450
+ + +L L+ LL + + +GL ++H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLK------TQHLSNDHICYFLYQILRGLKYIH- 126
Query: 451 YNKAHLFHGHLSSSNIVVDQLGNACISDIGV---------HQLFHTPFFINDAYNAPELK 501
A++ H L SN++++ + I D G+ H F T + Y APE+
Sbjct: 127 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
N+ + + D++S G +L E+L+ +
Sbjct: 185 LNSKG------YTKSIDIWSVGCILAEMLSNR 210
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 9e-21
Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 35/282 (12%)
Query: 339 ELLGKGCVGATYKVVL----DGGDVVVVKRIRERK---KKREVDEWLR---VIGGLRHS- 387
++LG G G + V D G + +K +++ K + + V+ +R S
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 388 NIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
+V++ + +L L+ DY+ G L + L R ++ + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF--HTPFFINDAYNAPELKFNNN 505
LH K + + + NI++D G+ ++D G+ + F D E +
Sbjct: 145 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 506 NNYSQRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFEL 564
+ D +S GV++ E+LTG DGE + + E
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------RILKSEP 253
Query: 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
+EM + L+Q L PK R R ++I+
Sbjct: 254 PYPQEMSALAKDLIQ---RLLMKDPKKRL--GCGPRDADEIK 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 1e-20
Identities = 59/303 (19%), Positives = 111/303 (36%), Gaps = 53/303 (17%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-----ERKKKREVDEWLRVIGGLRHSNIVSI 392
+ +G G GA V G V +K++ E KR E LR++ +RH N++ +
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE-LRLLKHMRHENVIGL 82
Query: 393 RAYCNGKD------ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLA 446
+ + +LV ++ + H + ++ L KGL
Sbjct: 83 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLR 135
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH---TPFFINDAYNAPELKFN 503
++H A + H L N+ V++ I D G+ + T + + Y APE+ N
Sbjct: 136 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILN 192
Query: 504 NNNNYSQRKFWQRCDVYSFGVVLLEILTGK--------------MAKGDGELGIVKWVQM 549
++ Q D++S G ++ E++TGK + K G ++VQ
Sbjct: 193 ------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA-EFVQR 245
Query: 550 MGQDESAWEVFDFELIMDKEMEEEMRALLQVAL----LCLAPLPKDRPNMSIV--HRMIE 603
+ DE+ + + K+ + +A+ L + R H E
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
Query: 604 DIR 606
+
Sbjct: 306 SLH 308
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 4e-19
Identities = 46/274 (16%), Positives = 95/274 (34%), Gaps = 31/274 (11%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERK--KKREVDEWLR---VIGGLRHSNIVSI 392
+LLGKG G V G +K +R+ K EV + V+ RH + ++
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
+ D L V +Y G L L + ++ L +LH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLH--- 122
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRK 512
+ + + N+++D+ G+ I+D G+ + + + ++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT-PEYLAPEVLEDND 181
Query: 513 FWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKEMEE 572
+ + D + GVV+ E++ G++ + + + E+ + +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYN-----------QDHERLFELILMEEIRFPRTLSP 230
Query: 573 EMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
E ++LL L PK R +++
Sbjct: 231 EAKSLLA---GLLKKDPKQRL--GGGPSDAKEVM 259
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (211), Expect = 5e-19
Identities = 49/287 (17%), Positives = 95/287 (33%), Gaps = 45/287 (15%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWL----RVIGGLRHSNIVSIR 393
E +G+G G +K + ++V +KR+R V ++ L+H NIV +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 394 AYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNK 453
+ +L LV+++ +D KGL F H N
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 454 AHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-----FFINDAYNAPELKFNNNNNY 508
+ H L N+++++ G +++ G+ + F P + + P Y
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 509 SQRKFWQRCDVYSFGVVLLEILTG---------------KMAKGDGELGIVKWVQMMG-- 551
S D++S G + E+ ++ + G +W M
Sbjct: 180 STS-----IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 552 --QDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMS 596
+ + + + ++ R LLQ L P R +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAE 278
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 86.0 bits (211), Expect = 6e-19
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 17 LCLSNSPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPST--HRVIKLV 74
LC D LL K + + +LSSW+ +TD C +W GV C+ T +RV L
Sbjct: 2 LCNP----QDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLD 56
Query: 75 LEDLDLTGPAEV---LSRLTQLR--LLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT 129
L L+L P + L+ L L + NNL+ ++ L +LY++H +G
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 130 FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRS- 188
P +S ++ L +D S+NA G +P ++ LPNL+ + + NR +G + S
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLP-PSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 189 ILDFNVSNNQLSGQIPAWM 207
+S N+L+G+IP
Sbjct: 176 FTSMTISRNRLTGKIPPTF 194
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.5 bits (137), Expect = 1e-09
Identities = 29/71 (40%), Positives = 39/71 (54%), Gaps = 3/71 (4%)
Query: 163 PNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAW--MSPFGGSSFAGNKN 220
NL L L +NR GTL + + + NVS N L G+IP + F S++A NK
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 221 LCGRPLPSDCS 231
LCG PLP+ C+
Sbjct: 304 LCGSPLPA-CT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.9 bits (133), Expect = 4e-09
Identities = 19/63 (30%), Positives = 30/63 (47%), Gaps = 2/63 (3%)
Query: 113 WPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLED 172
+L L L +NR GT P G++ L+ L +++S N GEIP + L +
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP--QGGNLQRFDVSAYAN 300
Query: 173 NRF 175
N+
Sbjct: 301 NKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.9 bits (107), Expect = 8e-06
Identities = 11/49 (22%), Positives = 19/49 (38%), Gaps = 1/49 (2%)
Query: 100 NNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148
N + + L+ L L +S N G P G +L+ ++N
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 84.5 bits (208), Expect = 3e-18
Identities = 44/278 (15%), Positives = 96/278 (34%), Gaps = 42/278 (15%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERK--KKREVDEWLR---VIGGLRHSNIVSI 392
+ LG G G V + G+ +K + ++K K ++++ L ++ + +V +
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 393 RAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN 452
L++V +Y+ G + S L A+ +LH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH--- 158
Query: 453 KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFIND---AYNAPELKFNNNNNYS 509
L + L N+++DQ G ++D G + + APE+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEI-------IL 211
Query: 510 QRKFWQRCDVYSFGVVLLEILTGKMA-KGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568
+ + + D ++ GV++ E+ G D + I + + ++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------KVRFPS 259
Query: 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606
+++ LL+ L R + + DI+
Sbjct: 260 HFSSDLKDLLR---NLLQVDLTKRFGN--LKNGVNDIK 292
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 3e-18
Identities = 41/295 (13%), Positives = 106/295 (35%), Gaps = 47/295 (15%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEW----LRVIGGLRHSNIVSIR 393
+G+G G +K G V +K++ +K ++++ L+H N+V++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 394 AYC--------NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGL 445
C K ++LV+D+ H L + + + KR+ L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRV-----MQMLL 127
Query: 446 AFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF----HTPFFINDAYNAPELK 501
L+ ++ + H + ++N+++ + G ++D G+ + F ++
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 502 FNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK--------------MAKGDGELGIVKWV 547
+R + D++ G ++ E+ T +++ G + W
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 548 QMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALL------CLAPLPKDRPNMS 596
+ + +E + +++++ ++A ++ L P R +
Sbjct: 248 NV--DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 76.8 bits (188), Expect = 8e-16
Identities = 32/199 (16%), Positives = 71/199 (35%), Gaps = 16/199 (8%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCN 397
LG+G ++ + + + VVVK ++ KKK+ E + NI+++
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 100
Query: 398 GKDE--LFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAH 455
LV++++ + L + + K L + H
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMG 149
Query: 456 LFHGHLSSSNIVVD-QLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFW 514
+ H + N+++D + + D G+ + +H N + K + +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV-DYQMYD 208
Query: 515 QRCDVYSFGVVLLEILTGK 533
D++S G +L ++ K
Sbjct: 209 YSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.7 bits (185), Expect = 2e-15
Identities = 44/209 (21%), Positives = 81/209 (38%), Gaps = 30/209 (14%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-----ERKKKREVDEWLRVIGGLRHSNIVSI 392
+G G G+ G V VK++ KR E LR++ ++H N++ +
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGL 82
Query: 393 RAYCNGKDEL-----FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAF 447
L + +L L++++ + + L +GL +
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK------CQKLTDDHVQFLIYQILRGLKY 136
Query: 448 LHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF---HTPFFINDAYNAPELKFNN 504
+H A + H L SN+ V++ I D G+ + T + Y APE+ N
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN- 192
Query: 505 NNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ Q D++S G ++ E+LTG+
Sbjct: 193 -----WMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.5 bits (174), Expect = 5e-14
Identities = 38/207 (18%), Positives = 73/207 (35%), Gaps = 26/207 (12%)
Query: 339 ELLGKGCVGATYKVV-LDGGDVVVVKRIR-----ERKKKREVDEWLRVIGGLRHSNIVSI 392
+ +G G G V +K++ + KR E L ++ + H NI+S+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE-LVLMKCVNHKNIISL 81
Query: 393 RAYCNGKD------ELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLA 446
+ +++LV + + + +M +D + L G+
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVI--------QMELDHERMSYLLYQMLCGIK 133
Query: 447 FLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPELKFNNNN 506
LH + H L SNIVV I D G+ + T F + +
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APE 188
Query: 507 NYSQRKFWQRCDVYSFGVVLLEILTGK 533
+ + D++S G ++ E++ K
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.8 bits (164), Expect = 1e-12
Identities = 29/224 (12%), Positives = 75/224 (33%), Gaps = 21/224 (9%)
Query: 329 NVGDLLKSS----AELLGKGCVGATYKVV-LDGGDVVVVKRIRERKKKREV--------- 374
G+ K + LG G + + V +K +R K E
Sbjct: 5 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 64
Query: 375 ---DEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDW 431
D + ++I+ + + N K + + +LL + +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 432 NKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHTPFF 490
+++ GL ++H + + H + N++++ + + I + L + ++
Sbjct: 125 IYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 491 INDAYNAP-ELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK 533
N+ ++ + + D++S ++ E++TG
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 2e-11
Identities = 27/152 (17%), Positives = 65/152 (42%), Gaps = 14/152 (9%)
Query: 8 FFSFFCLFSLCLSNSPYSDISTL----------LSFKASVTGSSDSLSSWVNSTDPCFDS 57
S L L L+N+ S+++ L L S + + + + + +
Sbjct: 237 LASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296
Query: 58 WRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLK 117
++ + + L L +++ + +S LT+L+ L NN +S + +L++ ++
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDVS-SLANLTNIN 354
Query: 118 HLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149
L HN+ + P +++L + ++ L+ A
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.4 bits (145), Expect = 2e-10
Identities = 36/178 (20%), Positives = 60/178 (33%), Gaps = 27/178 (15%)
Query: 47 WVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSS 106
+ S + +T + +L L L L+ LT L L L NN +S+
Sbjct: 198 NLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGT-LASLTNLTDLDLANNQISNL 256
Query: 107 NLNLSSWPHLKHLYLSHNRFTGTFPSGVSS--------------------LRHLRRVDLS 146
LS L L L N+ + P + L++L + L
Sbjct: 257 -APLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 315
Query: 147 HNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204
N P ++ L L L +N+ + N ++ + L +NQ+S P
Sbjct: 316 FNNISDISP---VSSLTKLQRLFFANNKVSDVSSLANLTNINWLS--AGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.5 bits (122), Expect = 2e-07
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 7/85 (8%)
Query: 113 WPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLED 172
+L +L L N + P VSSL L+R+ ++N ++ L L N+ L
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD---VSSLANLTNINWLSAGH 360
Query: 173 NRFTGTLYSVNSSSRSILDFNVSNN 197
N+ + N + + L +++
Sbjct: 361 NQISDLTPLANLTRITQLG--LNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 8e-05
Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 26/137 (18%)
Query: 88 SRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147
++LT L L NN +S L +L L L+ N+ ++SL +L +DL++
Sbjct: 194 AKLTNLESLIATNNQISDI-TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDF--------------- 192
N P L+ L L L+L N+ + ++ + L+
Sbjct: 251 NQISNLAP---LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 193 -----NVSNNQLSGQIP 204
+ N +S P
Sbjct: 308 NLTYLTLYFNNISDISP 324
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 13/76 (17%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 90 LTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149
L + L ++ + ++ + + L GV L +L +++ S+N
Sbjct: 21 LAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77
Query: 150 YEGEIPMTELTRLPNL 165
P+ LT+L ++
Sbjct: 78 LTDITPLKNLTKLVDI 93
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 3e-09
Identities = 28/105 (26%), Positives = 44/105 (41%), Gaps = 3/105 (2%)
Query: 73 LVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPS 132
L L DLT L +L + L L +N L + L++ L+ L S N
Sbjct: 3 LHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE--NVD 59
Query: 133 GVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG 177
GV++L L+ + L +N + + L P L+ L L+ N
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.002
Identities = 22/85 (25%), Positives = 30/85 (35%), Gaps = 6/85 (7%)
Query: 117 KHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176
+ L+L+H T + L + +DLSHN P L L L L+ DN
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP--ALAALRCLEVLQASDNALE 56
Query: 177 GTLYSVNSSSRSILDFNVSNNQLSG 201
N L NN+L
Sbjct: 57 NVDGVANLPRLQELLL--CNNRLQQ 79
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.3 bits (124), Expect = 7e-08
Identities = 19/132 (14%), Positives = 37/132 (28%), Gaps = 6/132 (4%)
Query: 106 SNLNLSSWP-----HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELT 160
S+L L P L L +N+ T +L++L + L +N P
Sbjct: 18 SDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA-FA 76
Query: 161 RLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKN 220
L L L L N+ + + + + ++ + ++ N
Sbjct: 77 PLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 136
Query: 221 LCGRPLPSDCSN 232
Sbjct: 137 KSSGIENGAFQG 148
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 29/168 (17%), Positives = 60/168 (35%), Gaps = 5/168 (2%)
Query: 45 SSWVNSTDPCFDSWRGVTCNPSTHRVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLL 103
+ + V + V++L L +G + +L + + + +
Sbjct: 103 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162
Query: 104 SSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP 163
++ + P L L+L N+ T + + L +L ++ LS N+ + L P
Sbjct: 163 TT--IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTP 219
Query: 164 NLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFG 211
+L L L +N+ + + I + NN +S P G
Sbjct: 220 HLRELHLNNNKLVKVPGG-LADHKYIQVVYLHNNNISAIGSNDFCPPG 266
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 37/190 (19%), Positives = 69/190 (36%), Gaps = 26/190 (13%)
Query: 53 PCFDSWRGVTCNPSTHRVIKLVLEDLDLTG-PAEVLSRLTQLRLLSLKNNLLSSSNLNLS 111
C R V C+ DL L P ++ L L + N + + +
Sbjct: 7 RCQCHLRVVQCS------------DLGLEKVPKDLPPDTALLDLQN--NKITEIKDGDFK 52
Query: 112 SWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLE 171
+ +L L L +N+ + P + L L R+ LS N + E+P L L E
Sbjct: 53 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENE 111
Query: 172 DNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSFAGNKNLCGRPLPSDCS 231
+ ++++ + +++ + + SG +F G K L + +D +
Sbjct: 112 ITKVRKSVFN-GLNQMIVVELGTNPLKSSGIEN--------GAFQGMKKLSYIRI-ADTN 161
Query: 232 NRTVEPEQPP 241
T+ PP
Sbjct: 162 ITTIPQGLPP 171
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 48.2 bits (114), Expect = 6e-07
Identities = 33/197 (16%), Positives = 58/197 (29%), Gaps = 18/197 (9%)
Query: 339 ELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNG 398
+L+G+G A + + VVK + + + R G L S + A
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 399 KDELFL----VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKA 454
+ L V L+ V ++ + +A +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HR 122
Query: 455 HLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPFFINDAYNAPEL---KFNNNNNYSQR 511
+ HG LS N++V + G I D E+ N Y R
Sbjct: 123 GIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEE-------GWREILERDVRNIITYFSR 174
Query: 512 KFWQRCDVYSFGVVLLE 528
+ D+ S +L+
Sbjct: 175 TYRTEKDINSAIDRILQ 191
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 6e-07
Identities = 21/106 (19%), Positives = 44/106 (41%), Gaps = 3/106 (2%)
Query: 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGT--FPSGVSSLRHLRRVD 144
L +L+ ++++ ++ + + P L L LS+NR S V +L+ ++
Sbjct: 38 LVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97
Query: 145 LSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSIL 190
LS N + + + L L L+ N + T ++ +I
Sbjct: 98 LSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 7e-05
Identities = 21/121 (17%), Positives = 39/121 (32%), Gaps = 3/121 (2%)
Query: 85 EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVD 144
++S+ +L L S +L + L + T ++ L ++
Sbjct: 14 LIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLN 71
Query: 145 LSHNAYEGEIPMT-ELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203
LS+N M+ + + PNL L L N + + + N LS
Sbjct: 72 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131
Query: 204 P 204
Sbjct: 132 R 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.001
Identities = 21/95 (22%), Positives = 29/95 (30%), Gaps = 6/95 (6%)
Query: 80 LTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRH 139
L E + L L L + + L + + P+LK L LS N
Sbjct: 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116
Query: 140 LRRVDLSHNAYEGEIPMTE------LTRLPNLLTL 168
L + L N+ R P LL L
Sbjct: 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 1e-06
Identities = 19/82 (23%), Positives = 31/82 (37%), Gaps = 14/82 (17%)
Query: 90 LTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149
L L++ NN L + P L+ L S N P +L+ L + +N
Sbjct: 283 PPSLEELNVSNNKLIELP---ALPPRLERLIASFNHLA-EVPELPQNLKQL---HVEYN- 334
Query: 150 YEGEIPMTELTRLPNLLT-LRL 170
P+ E +P + LR+
Sbjct: 335 -----PLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 18/78 (23%), Positives = 26/78 (33%), Gaps = 9/78 (11%)
Query: 100 NNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTEL 159
N + P L+ L +S+N+ P+ L L S N E+P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPEL-- 322
Query: 160 TRLPNLLTLRLEDNRFTG 177
NL L +E N
Sbjct: 323 --PQNLKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 6e-05
Identities = 17/69 (24%), Positives = 30/69 (43%), Gaps = 6/69 (8%)
Query: 75 LEDLDLTGP--AEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPS 132
LE+L+++ E+ + +L L N L+ + LK L++ +N FP
Sbjct: 286 LEELNVSNNKLIELPALPPRLERLIASFNHLAEVPELPQN---LKQLHVEYNPLR-EFPD 341
Query: 133 GVSSLRHLR 141
S+ LR
Sbjct: 342 IPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.002
Identities = 18/73 (24%), Positives = 27/73 (36%), Gaps = 10/73 (13%)
Query: 98 LKNNL--LSSSNLNLSSWP----HLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151
L L +NL LSS P HL+ L S N T P + L+ + + +N +
Sbjct: 36 LDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELP---ELPQSLKSLLVDNNNLK 91
Query: 152 GEIPMTELTRLPN 164
+ L
Sbjct: 92 ALSDLPPLLEYLG 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 17/91 (18%)
Query: 75 LEDLDL-------TGPAEVLSRLTQLRLLSLKNNLLSSSNLN-----LSSWPHLKHLYLS 122
++ LD+ AE+L L Q +++ L + L+ + L P L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 123 HNRFTGTFPSGVSSL-----RHLRRVDLSHN 148
N V ++++ L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 13/77 (16%), Positives = 28/77 (36%), Gaps = 8/77 (10%)
Query: 109 NLSSWPHLKHLYLSHNRFTGT----FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPN 164
L+ L+L+ + + + + + LR +DLS+N + + +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 165 ----LLTLRLEDNRFTG 177
L L L D ++
Sbjct: 424 PGCLLEQLVLYDIYWSE 440
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 20/91 (21%), Positives = 36/91 (39%), Gaps = 13/91 (14%)
Query: 91 TQLRLLSLKNNLLSSSNLN-----LSSWPHLKHLYLSHNRFTGTFPSG-VSSLRH----L 140
+ LR+L L + +S S+ + L + L+ L LS+N V S+R L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 141 RRVDLSHNAYEGEIP---MTELTRLPNLLTL 168
++ L + E+ P+L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 12/86 (13%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 140 LRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTG----TLYSVNSSSRSILDFNVS 195
++ +D+ L L +RL+D T + S + ++ + N+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 196 NNQLSGQIPAWMSPFGGSSFAGNKNL 221
+N+L + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKL 89
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 16/64 (25%), Positives = 26/64 (40%), Gaps = 5/64 (7%)
Query: 109 NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTL 168
L++ L L N+ + P ++SL +L V L +N P L NL +
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP---LANTSNLFIV 222
Query: 169 RLED 172
L +
Sbjct: 223 TLTN 226
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 11/75 (14%), Positives = 24/75 (32%), Gaps = 2/75 (2%)
Query: 88 SRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147
S++ ++ L++ +L L+LS N + + L +++L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 148 NAYEGEIPMTELTRL 162
L L
Sbjct: 65 AELTKLQVDGTLPVL 79
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 8e-04
Identities = 14/49 (28%), Positives = 16/49 (32%), Gaps = 1/49 (2%)
Query: 100 NNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148
NNL L+ +L L L N T P G L L N
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 25/132 (18%), Positives = 40/132 (30%), Gaps = 24/132 (18%)
Query: 100 NNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIP---- 155
N L + + +L HL+L NR + L L R+ L N P
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 156 -------------------MTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSN 196
L L L LRL DN + + F S+
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSS 257
Query: 197 NQLSGQIPAWMS 208
+++ +P ++
Sbjct: 258 SEVPCSLPQRLA 269
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 3e-04
Identities = 10/67 (14%), Positives = 21/67 (31%), Gaps = 2/67 (2%)
Query: 90 LTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNA 149
+ R L L+ + ++ + S N G LR L+ + +++N
Sbjct: 17 AVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNR 74
Query: 150 YEGEIPM 156
Sbjct: 75 ICRIGEG 81
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 5e-04
Identities = 17/83 (20%), Positives = 35/83 (42%), Gaps = 2/83 (2%)
Query: 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLN--LSSWPHLKHLYLSHNR 125
VI + P +++ + L N+++ S L+ LS L++L L R
Sbjct: 23 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 126 FTGTFPSGVSSLRHLRRVDLSHN 148
+ + ++ +L R++LS
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGC 105
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 16/98 (16%), Positives = 33/98 (33%), Gaps = 1/98 (1%)
Query: 96 LSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIP 155
L L L + + S R ++ +DLS++ E
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTL 63
Query: 156 MTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFN 193
L++ L L LE R + + + + + +++ N
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 6e-04
Identities = 14/113 (12%), Positives = 32/113 (28%), Gaps = 3/113 (2%)
Query: 116 LKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRF 175
L + + + +L + + + + + + +L L L L + +
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 176 TGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGSSF--AGNKNLCGRPL 226
+ + N+S N L + +GN C L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 8e-04
Identities = 11/56 (19%), Positives = 17/56 (30%), Gaps = 11/56 (19%)
Query: 110 LSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNL 165
L +S R G+ +L+ LR + L +LP L
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN-----------LKKLPTL 241
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 11/83 (13%), Positives = 27/83 (32%), Gaps = 7/83 (8%)
Query: 96 LSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSS-----LRHLRRVDLSHNAY 150
LS + + L+ L L +N + + + L ++L+ N +
Sbjct: 255 LSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314
Query: 151 EGEIPMTELTRLPNLLTLRLEDN 173
E + + + + + R
Sbjct: 315 SEEDDV--VDEIREVFSTRGRGE 335
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 2/65 (3%)
Query: 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTG 128
IK L+ +T + L + + N+ + S + P++ L+L+ N+ T
Sbjct: 25 ETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTD 82
Query: 129 TFPSG 133
P
Sbjct: 83 IKPLA 87
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 640 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.64 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.51 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.51 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.47 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.41 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.4 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.34 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.29 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.23 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.2 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.18 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.15 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.11 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.11 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.09 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.01 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.99 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.53 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.28 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.17 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.16 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.08 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.98 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.97 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.89 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.8 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.73 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.99 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.88 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=402.82 Aligned_cols=244 Identities=23% Similarity=0.364 Sum_probs=192.2
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||+||+|++.+++.||||+++.. ...+++.+|++++++++|||||+++|+|..++..++|||||++|+|.+
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 5679999999999999998899999999865 456789999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~ 489 (640)
++.... ..++|..++.++.|||.||+|||+ .+|+||||||+|||+|+++.+||+|||+++..... .
T Consensus 90 ~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 90 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp HHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred Hhhccc----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 987643 258899999999999999999995 45999999999999999999999999999876432 2
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhC-CCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG-KMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
.+|..|+|||++ ....++.|+|||||||++|||+|+ ++|+.... ..+..+....... ...+ .
T Consensus 163 ~gt~~y~aPE~l-------~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~~~---~~~p-----~ 225 (263)
T d1sm2a_ 163 KFPVKWASPEVF-------SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFR---LYKP-----R 225 (263)
T ss_dssp --CTTSCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHTCC---CCCC-----T
T ss_pred ecCcccCChHHh-------cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhcCC---CCCc-----c
Confidence 357789999975 345678999999999999999995 55554322 2222222211110 0111 1
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.+..++.+++..||+.||++||||+||++.|++|.+.
T Consensus 226 ---~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 226 ---LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 1123567788899999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=402.17 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=192.4
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||+||+|++++ .||||+++.. ...+.+.+|++++++++|||||+++|++.+ +..++|||||++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence 5689999999999998754 5999998744 234678899999999999999999999764 56899999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.++++.... .++|..++.++.|||+||+|||+ .+||||||||+|||++.++.+||+|||+++....
T Consensus 90 L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 90 LYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp HHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred HHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 9999975432 58999999999999999999995 4599999999999999999999999999977532
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
...+|..|+|||++... ....++.++|||||||++|||+||+.||.+...... .......... .+...
T Consensus 163 ~~~~~gt~~y~APE~l~~~----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~-----~p~~~ 232 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQ----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYL-----SPDLS 232 (276)
T ss_dssp ---CCCCGGGCCHHHHTTC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTSC-----CCCGG
T ss_pred ccccccCcccCCHHHHhcc----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCC-----CCcch
Confidence 23468899999986422 224578899999999999999999999975322111 1111111100 00000
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
....+...++.+++.+||+.||++||||+||++.|+.+..
T Consensus 233 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 --KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp --GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0001223456778889999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-49 Score=402.59 Aligned_cols=243 Identities=22% Similarity=0.363 Sum_probs=188.2
Q ss_pred hccccccCcceEEEEEeCC-C---cEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLDG-G---DVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~---~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.++||+|+||+||+|++.. + ..||||++... ...+++.+|++++++++|||||+++|+|...+..++|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 4689999999999999743 2 25889988754 234578899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
+|+|.+++....+ .++|.++++++.|||+||+|||+ .+||||||||+||||+.++.+||+|||+++.....
T Consensus 111 ~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 111 NGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp TEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCcceeeeccccC----CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 9999999876432 58999999999999999999995 45999999999999999999999999999875421
Q ss_pred ---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccccc
Q 006559 489 ---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 489 ---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
..+|..|+|||++ ....++.++|||||||++|||+| |+.||.+... .+.+........
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~-------~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~~~~--- 251 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAI-------QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQDYR--- 251 (299)
T ss_dssp ------------CGGGSCHHHH-------HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCC---
T ss_pred cceeeecccccCCccccCHHHH-------hcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC---
Confidence 2346789999964 44578899999999999999998 8999975332 222222221111
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
...+. +...++.+++.+||+.||++||||.||++.|+++..
T Consensus 252 -----~~~~~---~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 -----LPPPM---DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -----CCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCc---cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111 223356778888999999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=398.81 Aligned_cols=244 Identities=25% Similarity=0.398 Sum_probs=194.2
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||+|+++++..||||+++.. ...+++.+|++++++++|||||+++|++.+ +..++||||+++|+|.+
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~ 96 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD 96 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHH
Confidence 5679999999999999998899999999765 456779999999999999999999998864 56799999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~ 489 (640)
++.... ..+++|..+++|+.|||+||+|||+ .+|+||||||+||||++++.+||+|||+++..... .
T Consensus 97 ~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (272)
T d1qpca_ 97 FLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (272)
T ss_dssp HTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred HHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence 876442 2258999999999999999999995 45999999999999999999999999999876432 2
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.++..|+|||++ ....++.++|||||||++|||+||..|+.... ...+..+....... ...+..
T Consensus 171 ~gt~~y~APE~~-------~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-~~~~~~~~i~~~~~--------~~~p~~ 234 (272)
T d1qpca_ 171 KFPIKWTAPEAI-------NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYR--------MVRPDN 234 (272)
T ss_dssp CCCTTTSCHHHH-------HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCC--------CCCCTT
T ss_pred CCcccccChHHH-------hCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCC--------CCCccc
Confidence 457789999965 34567889999999999999999655543321 11122222211110 001111
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
...++.+++.+||+.||++||||.+|+++|+++..
T Consensus 235 ---~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 235 ---CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 22346778889999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-49 Score=398.05 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=198.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+.||+|+||+||+|++. +++.||||+++.. ...+++.+|++++++++|||||+++|+|.+.+..++|||||++|+|.
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~ 101 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchH
Confidence 567999999999999975 5788999999765 44577999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCCc------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTPF------ 489 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~~------ 489 (640)
+++.... ...++|..++.++.|||.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 102 ~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 175 (287)
T d1opja_ 102 DYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175 (287)
T ss_dssp HHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETT
T ss_pred HHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCceeecc
Confidence 9997543 2368999999999999999999995 459999999999999999999999999998764321
Q ss_pred -cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 -FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 -~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
.++..|+|||++ ....++.|+|||||||++|||+||..|+.... ......+...... ....+.
T Consensus 176 ~~g~~~y~aPE~~-------~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-~~~~~~~~i~~~~--------~~~~~~ 239 (287)
T d1opja_ 176 AKFPIKWTAPESL-------AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDY--------RMERPE 239 (287)
T ss_dssp EEECGGGCCHHHH-------HHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHTTC--------CCCCCT
T ss_pred ccccccccChHHH-------cCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-hHHHHHHHHhcCC--------CCCCCc
Confidence 246789999964 44567899999999999999999776654321 1222122211110 011111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
. ...++.+++..||+.||++||||.||++.|+.+..+.+
T Consensus 240 ~---~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~ 278 (287)
T d1opja_ 240 G---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278 (287)
T ss_dssp T---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred c---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence 1 22356778888999999999999999999999876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=390.33 Aligned_cols=238 Identities=20% Similarity=0.286 Sum_probs=187.9
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||+||+|+. .+|+.||||++.... ..+.+.+|++++++++|||||++++++.+++..|+|||||++|+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 56899999999999996 468999999987542 23568899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC-------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------- 486 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------- 486 (640)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 90 L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 90 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred HHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 999997543 589999999999999999999954 59999999999999999999999999998652
Q ss_pred -CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 487 -TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 487 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
....+|+.|+|||++.+.+ .++.++||||+||++|||+||+.||.........+.......... .
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~------~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~----~---- 227 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRRE------FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----N---- 227 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSS------BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS----T----
T ss_pred ccceeeCcCccCHhHhcCCC------CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----C----
Confidence 2345799999999763321 235689999999999999999999975433322222211111000 0
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.....+ .++.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~s---~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKID---SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112 34556778899999999999999854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=385.42 Aligned_cols=241 Identities=22% Similarity=0.373 Sum_probs=197.7
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||+||+|+++++..||||.++.. ...+++.+|+.++++++|||||+++|+|.+++..++||||+++|+|.+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~ 88 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHH
Confidence 5789999999999999998889999999865 456789999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------c
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-------F 489 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-------~ 489 (640)
++.... ..+++..+.+++.|+|+||+|||+ .+|+||||||+|||+++++.+||+|||+++..... .
T Consensus 89 ~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 89 YLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp HHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred hhhccc----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 976543 258899999999999999999995 45999999999999999999999999999865432 3
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
.+|..|+|||++ ....++.|+|||||||++|||+| |+.||....... ..+....... ... +.
T Consensus 162 ~~t~~y~aPE~~-------~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~~---~~~-----p~ 224 (258)
T d1k2pa_ 162 KFPVRWSPPEVL-------MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLR---LYR-----PH 224 (258)
T ss_dssp CCCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCC---CCC-----CT
T ss_pred CCCCCcCCcHHh-------cCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhCCC---CCC-----cc
Confidence 357789999965 34567889999999999999998 899997543222 2222221110 011 11
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
....++.+++.+||+.||++||||.++++.|.+|
T Consensus 225 ---~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 ---LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1223567788889999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=393.52 Aligned_cols=239 Identities=23% Similarity=0.316 Sum_probs=189.9
Q ss_pred ccccccCcceEEEEEeCC---CcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 339 ELLGKGCVGATYKVVLDG---GDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~---~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
++||+|+||+||+|.+++ ++.||||+++... ..+++.+|++++++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998653 4579999997542 24578899999999999999999999965 467899999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~--- 488 (640)
|+|.++++... +++|..+++++.|||.||+|||+ .+||||||||+|||++.++.+||+|||+++.+...
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999998653 58999999999999999999995 45999999999999999999999999999875421
Q ss_pred ------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccc
Q 006559 489 ------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFD 561 (640)
Q Consensus 489 ------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 561 (640)
..+|..|+|||++ ....++.++|||||||++|||+| |+.||.+.... +..........
T Consensus 164 ~~~~~~~~gt~~y~APE~l-------~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~~------ 228 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECI-------NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER------ 228 (277)
T ss_dssp EEC----CCCGGGCCHHHH-------HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC------
T ss_pred cccccccCCCceecCchhh-------cCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCCC------
Confidence 2457889999965 34567789999999999999998 89999754322 21222111110
Q ss_pred hhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 562 FELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 562 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
...+.. ...++.+++.+||+.||++||||++|+++|+.+.
T Consensus 229 --~~~p~~---~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 --MGCPAG---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --CCCCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCCcc---cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 011111 2235667888999999999999999999998865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=392.99 Aligned_cols=240 Identities=23% Similarity=0.308 Sum_probs=191.7
Q ss_pred cccccCcceEEEEEeC---CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 340 LLGKGCVGATYKVVLD---GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.||+|+||+||+|.++ ++..||||.++... ..+++.+|++++++++|||||+++|+|.. +..|+|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999864 34579999997552 34668899999999999999999999975 56899999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
|.+++...+ ..+++..+.+++.|||+||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 95 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 95 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred HHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 999986543 258999999999999999999995 4599999999999999999999999999987642
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
...+|..|+|||++ ....++.++|||||||++|||+| |+.||.+.... +..........
T Consensus 168 ~~~~~~gt~~y~aPE~~-------~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~~-------- 230 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECI-------NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR-------- 230 (285)
T ss_dssp CCCSSCCCGGGCCHHHH-------HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCC--------
T ss_pred cccccccCccccChHHH-------hCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--------
Confidence 12357789999964 34567889999999999999998 89999754322 22222211110
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
+..++. ...++.+++..||+.||++||||.+|++.|+.+..
T Consensus 231 ~~~p~~---~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 MECPPE---CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCc---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011111 22356778889999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=391.31 Aligned_cols=245 Identities=20% Similarity=0.327 Sum_probs=190.1
Q ss_pred hccccccCcceEEEEEeCCC-----cEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLDGG-----DVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.++||+|+||.||+|++++. ..||||++.... ...++.+|++++++++|||||+++|+|.+.+..++|||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 57899999999999997543 369999997552 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
.+|++.+++..... .++|..+++++.|||.||+|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 92 ~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 92 ENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp TTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred ccCcchhhhhcccc----cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 99999998875432 58999999999999999999995 45999999999999999999999999999875321
Q ss_pred --------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccccc
Q 006559 489 --------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 489 --------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (640)
..+|..|+|||++ ....++.++|||||||++|||+||..|+.... ...+..+.......
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l-------~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~~~----- 231 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAI-------SYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGFR----- 231 (283)
T ss_dssp ---------CCCGGGSCHHHH-------HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCC-----
T ss_pred ccceEeccCCCCccccCHHHH-------ccCCCCCcccccccHHHHHHHHhCCCCccccC-CHHHHHHHHhccCC-----
Confidence 2347789999964 44578899999999999999999766654321 12222222221110
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...+. +...++.+++.+||+.||++||||.||+++|+++...
T Consensus 232 ---~~~~~---~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 ---LPTPM---DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---CCCCT---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCCch---hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 01111 1234567788899999999999999999999998653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=392.09 Aligned_cols=243 Identities=18% Similarity=0.264 Sum_probs=192.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||+||+|+. .++..||||++... ...+.+.+|++++++++|||||++++++.+.+..|+|||||++|+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 46799999999999996 46889999998754 3346788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC------CC
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH------TP 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~------~~ 488 (640)
.+++.... .++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++... ..
T Consensus 97 ~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 97 DAVMLELE----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 99976532 2589999999999999999999954 59999999999999999999999999987653 24
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|+.|+|||++... ......++.++|||||||++|||+||+.||.+..... .......... +.+..+.
T Consensus 170 ~~Gt~~y~APE~l~~~--~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~i~~~~~------~~~~~~~ 239 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCE--TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLKIAKSEP------PTLAQPS 239 (288)
T ss_dssp CCSCCTTCCHHHHTTC--STTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHHSCC------CCCSSGG
T ss_pred cccccccCCHHHHhhc--ccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHHHHcCCC------CCCCccc
Confidence 5679999999987433 1234568899999999999999999999997533211 1111111110 0011111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ..++.+++.+||+.||++|||+.|+++
T Consensus 240 ~~---s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 240 RW---SSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GS---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12 234666778899999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=384.01 Aligned_cols=235 Identities=20% Similarity=0.303 Sum_probs=191.4
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||+||+|+.. +++.||||++... ...+.+.+|++++++++|||||++++++.+++..|+|||||+
T Consensus 10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 3578999999999999974 6889999998643 334668899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP-- 488 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~-- 488 (640)
+|+|.+++.... ++++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 90 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred CCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 999999997543 589999999999999999999954 5999999999999999999999999999876432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..+|+.|+|||++. ...++.++|||||||++|||+||+.||..... .+..+..... ....
T Consensus 162 ~~~~Gt~~Y~APE~~~-------~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~---------~~~~ 223 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRISRV---------EFTF 223 (263)
T ss_dssp EETTEEGGGCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTT---------CCCC
T ss_pred cccCCCCcccCHHHHc-------CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHHHHHHcC---------CCCC
Confidence 35689999999753 34567899999999999999999999975432 1112221111 1111
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+...++ ++.+++.+||+.||++|||+.|+++
T Consensus 224 p~~~s~---~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDFVTE---GARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCH---HHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112222 4566778899999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=394.66 Aligned_cols=261 Identities=26% Similarity=0.335 Sum_probs=197.0
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchH-HHHHHHHHHhccCCCcccceeEEEEcCC----eEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKR-EVDEWLRVIGGLRHSNIVSIRAYCNGKD----ELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lV~Ey~~~g 412 (640)
.+.||+|+||.||+|++ +|+.||||+++.....+ ..+.|+..+.+++|||||+++|+|...+ .+|+|||||++|
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 46799999999999997 47899999997653332 2334566667889999999999998653 689999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcC-----CCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGY-----NKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
+|.++++.. .++|..+++++.|+|.||+|+|+. ..++||||||||+|||++.++.+||+|||+++....
T Consensus 87 ~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 999999864 489999999999999999999964 246799999999999999999999999999886532
Q ss_pred ----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH------------H
Q 006559 488 ----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV------------K 545 (640)
Q Consensus 488 ----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~------------~ 545 (640)
...+|..|+|||++..... .....++.|+|||||||+||||+||..|+........ .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSIN-MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSC-TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCcceeccccceecccCcCChhhcccccc-ccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 2346899999998644321 1222467899999999999999999988753221111 1
Q ss_pred HHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccCC
Q 006559 546 WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKGS 610 (640)
Q Consensus 546 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 610 (640)
......... ..++.+.......+....+.+++.+||+.||++||||.||++.|+++....+
T Consensus 240 ~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 240 EMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 111111110 1111111111223455678889999999999999999999999999986543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=386.97 Aligned_cols=236 Identities=20% Similarity=0.324 Sum_probs=189.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
.+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|++++++++|||||++++++...+..|+|||||++|+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 46799999999999995 56899999998754 3456788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------C
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------P 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------~ 488 (640)
.+++... .+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++.+.. .
T Consensus 105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9988753 48899999999999999999995 4599999999999999999999999999987632 2
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|+.|+|||++. ...++.++|||||||++|||+||+.||.+...... ......... +....+.
T Consensus 176 ~~gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~------~~~~~~~ 240 (293)
T d1yhwa1 176 MVGTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATNGT------PELQNPE 240 (293)
T ss_dssp CCSCGGGCCHHHHS-------SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHHCS------CCCSSGG
T ss_pred cccCCCccChhhhc-------CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HHHHHhCCC------CCCCCcc
Confidence 35789999999753 44677899999999999999999999975432111 111111100 0011111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+ .++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~s---~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLS---AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSC---HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122 34566778899999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=380.52 Aligned_cols=238 Identities=21% Similarity=0.330 Sum_probs=186.8
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEc----CCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNG----KDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey 408 (640)
.++||+|+||+||+|+.. ++..||+|++.... ..+.+.+|++++++++|||||++++++.. ...+|+||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 457999999999999965 57889999987542 23568899999999999999999999865 3468999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC-CCCCeEEccCCcccccCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD-QLGNACISDIGVHQLFHT 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl~~~~~~ 487 (640)
+++|+|.+++.... .+++..+..++.||++||+|||+.+ ++|+||||||+|||++ +++.+||+|||+++....
T Consensus 94 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999997643 5889999999999999999999642 4499999999999996 579999999999987543
Q ss_pred C----ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchh
Q 006559 488 P----FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFE 563 (640)
Q Consensus 488 ~----~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 563 (640)
. ..+|+.|+|||++. ..++.++|||||||++|||+||+.||.+... .....+......... .
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~--------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-~~~~~~~i~~~~~~~-----~ 233 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPA-----S 233 (270)
T ss_dssp TSBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCCCG-----G
T ss_pred CccCCcccCccccCHHHhC--------CCCCCcCchhhHHHHHHHHHHCCCCCCCccc-HHHHHHHHHcCCCCc-----c
Confidence 2 35799999999752 3578899999999999999999999975332 222222221111100 0
Q ss_pred hccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 564 LIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 564 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. +.. ...++.+++.+||+.||++|||+.|+++
T Consensus 234 ~--~~~---~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 F--DKV---AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G--GGC---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--Ccc---CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0 111 1224667788899999999999999865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=381.54 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=190.4
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEeccCCCCHHH
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYDYLPHGSLHS 416 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~ 416 (640)
.+.||+|+||.||+|+++ |..||||+++.....+++.+|++++++++|||||+++|+|.+ .+.+|+||||+++|+|.+
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~ 90 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 90 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHH
Confidence 577999999999999985 678999999887777889999999999999999999999965 456899999999999999
Q ss_pred hhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC---ccccc
Q 006559 417 LLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---FFIND 493 (640)
Q Consensus 417 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---~~~~~ 493 (640)
+++... ...++|..+++++.|||.||+|||+ .+|+||||||+|||++.++.+|++|||+++..... ...+.
T Consensus 91 ~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~ 164 (262)
T d1byga_ 91 YLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 164 (262)
T ss_dssp HHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------------CCT
T ss_pred HHHhcC---CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCCccccccc
Confidence 997542 1258999999999999999999995 45999999999999999999999999999876432 34577
Q ss_pred cccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCc-chHHHHHHhhcccccccccchhhccChHHH
Q 006559 494 AYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGEL-GIVKWVQMMGQDESAWEVFDFELIMDKEME 571 (640)
Q Consensus 494 ~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 571 (640)
.|+|||++ ....++.++|||||||++|||+| |+.|+..... ....++..... ++ .+...
T Consensus 165 ~y~aPE~l-------~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~---------~~--~~~~~- 225 (262)
T d1byga_ 165 KWTAPEAL-------REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---------MD--APDGC- 225 (262)
T ss_dssp TTSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---------CC--CCTTC-
T ss_pred cCCChHHH-------hCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------CC--CCccC-
Confidence 89999964 34567899999999999999999 6888875332 22222221111 11 11111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 572 EEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 572 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
..++.+++.+||+.||++||||.+++++|++++..
T Consensus 226 --~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 226 --PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 23466788889999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=392.57 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=194.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.+.||+|+||+||+|+. .+|+.||||+++.. ...+.+.+|++++++++|||||+++++|.+++..|+|||||++|+
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 46899999999999996 46889999998754 234568899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC----CCc
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH----TPF 489 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~----~~~ 489 (640)
|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+|+... ...
T Consensus 91 L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 163 (322)
T d1s9ja_ 91 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163 (322)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence 999997543 589999999999999999999952 359999999999999999999999999998653 345
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccc------------
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAW------------ 557 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 557 (640)
.+|..|+|||++. ...++.++||||+||++|||+||+.||.....................
T Consensus 164 ~GT~~Y~APEvl~-------~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 164 VGTRSYMSPERLQ-------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp CCSSCCCCHHHHH-------CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred cCCccccCchHHc-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 7899999999763 356788999999999999999999999754333221111000000000
Q ss_pred ---cccchhhccC--hHH-------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhc
Q 006559 558 ---EVFDFELIMD--KEM-------------EEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRT 607 (640)
Q Consensus 558 ---~~~d~~~~~~--~~~-------------~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~ 607 (640)
...+...... ... .....++.+++.+||+.||++|||+.|+++ .+++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 0000000000 000 001235677888999999999999999976 5666543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=383.44 Aligned_cols=242 Identities=18% Similarity=0.266 Sum_probs=180.1
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEc--CCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNG--KDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~ 410 (640)
.+.||+|+||+||+|+. .+|+.||||.+.... ..+.+.+|++++++++|||||++++++.+ .+.+|+|||||+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 46899999999999986 468899999987542 23557889999999999999999999965 456899999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC--CCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN--KAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
+|+|.+++..... ....+++..+..++.|++.||+|||+.+ ..+||||||||+|||++.++.+||+|||+++....
T Consensus 89 ~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 89 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 9999999864321 1125899999999999999999999643 24599999999999999999999999999987642
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...+|+.|+|||++ ....++.++|||||||++|||+||+.||...... +......... ..
T Consensus 168 ~~~~~~~~gt~~Y~APE~l-------~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~~-~~----- 232 (269)
T d2java1 168 TSFAKAFVGTPYYMSPEQM-------NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGK-FR----- 232 (269)
T ss_dssp --------CCCSCCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTC-CC-----
T ss_pred CCccccCCCCcccCCHHHH-------cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHcCC-CC-----
Confidence 24568899999975 3456788999999999999999999999753321 1111111110 00
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. .+...++ ++.+++.+||+.||++|||+.|+++
T Consensus 233 ~--~~~~~s~---~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 R--IPYRYSD---ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C--CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C--CCcccCH---HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 1111222 4666778899999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=385.41 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=192.9
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
..+.||+|+||.||+|+.+++..||||+++.. ...+++.+|+.++++++|||||+++|+|. .+..++|||||++|+|.
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~ 99 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 99 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchh
Confidence 35679999999999999998889999999765 44677999999999999999999999985 45689999999999999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-------
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP------- 488 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~------- 488 (640)
+++..... ..++|..++.++.|||.||+|||+ .+|+||||||+|||+|.++.+||+|||+++.....
T Consensus 100 ~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 100 DFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp HHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhhccc---ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 98875421 248999999999999999999995 45999999999999999999999999999876422
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|..|+|||++ ....++.++|||||||++|||+||..|+.... ...+.......... ...++
T Consensus 174 ~~gt~~y~aPE~~-------~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~i~~~~~--------~~~~~ 237 (285)
T d1fmka3 174 AKFPIKWTAPEAA-------LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYR--------MPCPP 237 (285)
T ss_dssp --CCGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCC--------CCCCT
T ss_pred ccccccccChHHH-------hCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCC--------CCCCc
Confidence 3457889999964 45677899999999999999999766654322 22222222221100 00111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.. ..++.+++.+||+.||++||+|.+|+++|+++...
T Consensus 238 ~~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 238 EC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cc---CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 22 23466788899999999999999999999987643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=392.32 Aligned_cols=245 Identities=21% Similarity=0.308 Sum_probs=190.4
Q ss_pred hhccccccCcceEEEEEeCCC------cEEEEEEeccc---cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEE
Q 006559 337 SAELLGKGCVGATYKVVLDGG------DVVVVKRIRER---KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVY 406 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~------~~vavK~l~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 406 (640)
..++||+|+||+||+|+..+. ..||||.+... .....+.+|++++.++ +|||||+++++|...+..|+||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 357899999999999986432 25899998654 3345688899999988 8999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCC------------------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE
Q 006559 407 DYLPHGSLHSLLHGSRGP------------------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV 468 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl 468 (640)
|||++|+|.++++..+.. ....++|..++.++.|||+||+|||+ .+||||||||+|||+
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nill 197 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLV 197 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhcccc
Confidence 999999999999765321 11258999999999999999999995 459999999999999
Q ss_pred CCCCCeEEccCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 006559 469 DQLGNACISDIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDG 539 (640)
Q Consensus 469 ~~~~~~kl~DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~ 539 (640)
+.++.+||+|||+++.... ...+|..|+|||++ ....++.++|||||||++|||+| |+.||.+.
T Consensus 198 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l-------~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-------FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH-------cCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999999999999986542 12347889999964 44567899999999999999998 89999754
Q ss_pred CcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006559 540 ELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIE 603 (640)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 603 (640)
.....- .+...... .+..+.. ...++.+++.+||+.||++||||+||++.|.
T Consensus 271 ~~~~~~-~~~~~~~~--------~~~~p~~---~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDANF-YKLIQNGF--------KMDQPFY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHHH-HHHHHTTC--------CCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHH-HHHHhcCC--------CCCCCCc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 332111 11111110 0011111 2235677888899999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-47 Score=386.64 Aligned_cols=239 Identities=21% Similarity=0.342 Sum_probs=190.2
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|++++++++|||||++++++.+++..|+|||||++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 46799999999999985 568889999987542 224578899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--Cc
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--PF 489 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--~~ 489 (640)
|+|..++.... ++++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.... ..
T Consensus 100 g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (309)
T d1u5ra_ 100 SASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 171 (309)
T ss_dssp EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCC
T ss_pred CchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCCCcc
Confidence 99987765443 589999999999999999999954 599999999999999999999999999987653 45
Q ss_pred cccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccChH
Q 006559 490 FINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDKE 569 (640)
Q Consensus 490 ~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 569 (640)
.+|+.|+|||++.+. ....|+.++|||||||++|||+||+.||.+.... ........... +.. ....
T Consensus 172 ~GT~~Y~APE~~~~~----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~~i~~~~~------~~~-~~~~ 238 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNES------PAL-QSGH 238 (309)
T ss_dssp CSCGGGCCHHHHTTT----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC------CCC-SCTT
T ss_pred ccCccccCHHHHhcc----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCC------CCC-CCCC
Confidence 679999999986432 2345788999999999999999999999753221 11111111110 000 1111
Q ss_pred HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 570 MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 570 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+ .++.+++.+||+.||++|||+.|+++
T Consensus 239 ~s---~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 239 WS---EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC---HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 22 24666778899999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=382.12 Aligned_cols=246 Identities=21% Similarity=0.295 Sum_probs=192.4
Q ss_pred hccccccCcceEEEEEeCCC----cEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEc-CCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLDGG----DVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNG-KDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~----~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~ 409 (640)
.++||+|+||+||+|++.++ ..||||+++.. ...+++.+|++++++++|||||+++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997542 25899998743 234668999999999999999999999875 56899999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
++|+|.++++.... .+++..+++++.|+|.||.|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999886542 57888999999999999999995 45999999999999999999999999999875321
Q ss_pred ---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 489 ---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 ---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
..+|..|+|||++ ....++.++|||||||++|||+||+.||.... ....+..........
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~i~~g~~~--- 253 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESL-------QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL--- 253 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC---
T ss_pred cccceecccccccccccChHHH-------hcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC---
Confidence 2357789999964 45678899999999999999999888776422 111111111111100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
..++. ...++.+++.+||+.||++||+|.||++.|+++....
T Consensus 254 -----~~p~~---~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 254 -----LQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp -----CCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----CCccc---CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 01111 2235677888999999999999999999999998653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-47 Score=385.17 Aligned_cols=247 Identities=21% Similarity=0.361 Sum_probs=194.8
Q ss_pred hhccccccCcceEEEEEeC------CCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD------GGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||+||+|++. ++..||||+++... ..+++.+|++++++++||||++++++|...+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 3567999999999999864 35689999997652 24568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC-------------------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEE
Q 006559 408 YLPHGSLHSLLHGSRG-------------------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVV 468 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl 468 (640)
|+++|+|.++++.... .....++|..+++|+.|+|.||+|||+ .+||||||||+|||+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceEE
Confidence 9999999999864321 112358999999999999999999995 459999999999999
Q ss_pred CCCCCeEEccCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCC-CCCCCC
Q 006559 469 DQLGNACISDIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDG 539 (640)
Q Consensus 469 ~~~~~~kl~DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~-~p~~~~ 539 (640)
|.++.+||+|||+++.... ...++..|+|||++ ....++.|+|||||||++|||+||. +||...
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~-------~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-------FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH-------ccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999976532 23456789999964 4567889999999999999999986 566543
Q ss_pred CcchHHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhh
Q 006559 540 ELGIVKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIR 606 (640)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 606 (640)
.. .+....+.... .. ..+. ....++.+++.+||+.+|++||||.||+++|++|.
T Consensus 247 ~~--~e~~~~v~~~~-~~-------~~p~---~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AH--EEVIYYVRDGN-IL-------ACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CH--HHHHHHHHTTC-CC-------CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CH--HHHHHHHHcCC-CC-------CCCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22 22222221111 00 0111 12235777889999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-46 Score=380.94 Aligned_cols=239 Identities=18% Similarity=0.253 Sum_probs=178.2
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
..+.||+|+||+||+|+.. +++.||||.+... .....+.+|++++++++|||||++++++.+++..|+|||||++|
T Consensus 13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 3578999999999999964 6889999998754 22345778999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC---CCCCeEEccCCcccccCC--
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD---QLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGl~~~~~~-- 487 (640)
+|.+++.... .+++.....++.|++.||+|||+ .+||||||||+|||+. +++.+||+|||+++....
T Consensus 93 ~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 93 ELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp BHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999997643 58999999999999999999995 4599999999999994 578999999999987642
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|+.|+|||++ ....++.++|||||||++|||+||+.||.+...... .......... ....
T Consensus 165 ~~~~~~GT~~y~APE~~-------~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i~~~~~~---~~~~- 231 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVL-------AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--FEQILKAEYE---FDSP- 231 (307)
T ss_dssp --------CTTSCHHHH-------TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHTTCCC---CCTT-
T ss_pred eeeeeeeCccccCcHHH-------cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHhccCCC---CCCc-
Confidence 34578999999975 334678899999999999999999999975432211 1111111100 0000
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..+.. ..++.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~---s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 -YWDDI---SDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -TTTTS---CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cccCC---CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11112 234667788899999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=379.07 Aligned_cols=235 Identities=17% Similarity=0.236 Sum_probs=190.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
..+.||+|+||+||+|+. .+++.||||++... ...+.+.+|++++++++|||||++++++.+++..|+|||||+
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 357899999999999996 46889999998643 234568899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+||||||||+|||+++++.+||+|||+++.+..
T Consensus 92 gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 92 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999987553 58999999999999999999995 4599999999999999999999999999987632
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccch
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 562 (640)
...+|..|+|||++ ....++.++||||+||++|||+||+.||...... ...+.....
T Consensus 164 ~~~~~~~~GT~~Y~APE~~-------~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~--------- 225 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELL-------TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKIIKL--------- 225 (288)
T ss_dssp ------CCCCGGGCCHHHH-------HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHTT---------
T ss_pred ccccccccCCccccCceee-------ccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--HHHHHHHcC---------
Confidence 23578999999975 3456778999999999999999999999754321 111111111
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
....+.... .++.+++.+||+.||++|||+.|+..
T Consensus 226 ~~~~p~~~s---~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 226 EYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCCCTTCC---HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCCccCC---HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111111222 24567788899999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=371.62 Aligned_cols=243 Identities=19% Similarity=0.294 Sum_probs=185.5
Q ss_pred hhccccccCcceEEEEEeCC----CcEEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 337 SAELLGKGCVGATYKVVLDG----GDVVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~----~~~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
..+.||+|+||.||+|++.. +..||||.++.. ...+.+.+|++++++++|||||+++|++. .+..|+||||+
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 35789999999999998643 346889988654 23456889999999999999999999996 56789999999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
++|+|.+++.... ..+++..++.++.||++||+|||+ .+||||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 90 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred cCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999876543 258999999999999999999995 4599999999999999999999999999987542
Q ss_pred -----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcc-hHHHHHHhhccccccccc
Q 006559 488 -----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELG-IVKWVQMMGQDESAWEVF 560 (640)
Q Consensus 488 -----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 560 (640)
...+|..|+|||++ ....++.++|||||||++|||+| |++||...... +...+.. ...
T Consensus 163 ~~~~~~~~gt~~y~apE~l-------~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~---~~~----- 227 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESI-------NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GER----- 227 (273)
T ss_dssp --------CCGGGCCHHHH-------HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCC-----
T ss_pred ceeccceecCcccchhhHh-------ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCC-----
Confidence 22347889999964 44567889999999999999998 89998754322 2222211 110
Q ss_pred chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 561 DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 561 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...++. ...++.+++.+||+.||++|||+.||++.|+++..+
T Consensus 228 ---~~~~~~---~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 228 ---LPMPPN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCC---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 011112 223466788889999999999999999999998643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=379.22 Aligned_cols=241 Identities=20% Similarity=0.317 Sum_probs=190.2
Q ss_pred hccccccCcceEEEEEeC-CCc----EEEEEEeccc---cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVLD-GGD----VVVVKRIRER---KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~----~vavK~l~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 409 (640)
.++||+|+||+||+|++. +|+ .||||+++.. ...+++.+|++++++++|||||+++|+|.++ ..++++||+
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence 578999999999999864 343 5899988654 3457799999999999999999999999864 678889999
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC-
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP- 488 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~- 488 (640)
.+|+|.+++.... ..+++..+++++.|||+||+|||+ .+||||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 93 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp TTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred cCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 9999999887653 268999999999999999999995 45999999999999999999999999999876421
Q ss_pred -------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcch-HHHHHHhhcccccccc
Q 006559 489 -------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGI-VKWVQMMGQDESAWEV 559 (640)
Q Consensus 489 -------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 559 (640)
..+|..|+|||++ ....++.++|||||||++|||+| |+.||.+..... ...+.. ...
T Consensus 166 ~~~~~~~~~gt~~y~APE~l-------~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~---~~~---- 231 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESI-------LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GER---- 231 (317)
T ss_dssp C--------CCTTTSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH---TCC----
T ss_pred ccccccccccCccccChHHH-------hcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCC----
Confidence 2357899999965 34567899999999999999999 788987543322 221111 100
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
+..++ ....++.+++.+||+.||++||||.||++.|+++..
T Consensus 232 ----~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 ----LPQPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----CCCCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCc---ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 11111 122356778889999999999999999999988764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=371.44 Aligned_cols=239 Identities=18% Similarity=0.259 Sum_probs=190.2
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc--------cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER--------KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357899999999999996 56899999998643 124678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC----CeEEccCCccc
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG----NACISDIGVHQ 483 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGl~~ 483 (640)
||++|+|.+++.... .+++..+..++.|++.||+|||+. +||||||||+|||++.++ .+|++|||+++
T Consensus 94 ~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 94 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999997643 589999999999999999999954 599999999999999776 49999999998
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
.... ...+|..|+|||++ ....++.++|||||||++|||+||+.||.+..... ...........
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~-------~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~~~~~-- 234 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIV-------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVSAVNYE-- 234 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHH-------TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHTTCCC--
T ss_pred hcCCCccccccCCCCcccCHHHH-------cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--HHHHHHhcCCC--
Confidence 7643 23568899999975 34567889999999999999999999997543211 11111111000
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... .......++.+++.+||+.||++|||+.|+++
T Consensus 235 -~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -FEDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCHH-----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCch-----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 01112235667888999999999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.7e-45 Score=379.59 Aligned_cols=240 Identities=18% Similarity=0.242 Sum_probs=190.8
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|++++++++|||||++++++.+.+..|+|||||++|+
T Consensus 30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 357899999999999996 56889999999765 334668899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC--CCCCeEEccCCcccccCCC---
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD--QLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGl~~~~~~~--- 488 (640)
|.+++.... ..+++..+..++.||+.||+|||+. +||||||||+|||++ .++.+||+|||+++.....
T Consensus 110 L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 110 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp HHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999996543 2589999999999999999999954 599999999999996 4688999999999876542
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..+|..|+|||++. ...++.++||||+||++|||+||+.||.+... .+..+........ .+.. .
T Consensus 183 ~~~~gT~~Y~aPEv~~-------~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~---~~~~--~ 248 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKSCDWN---MDDS--A 248 (350)
T ss_dssp EEECSCTTTCCHHHHH-------TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCC---SCCG--G
T ss_pred ceecCcccccCHHHHc-------CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC---CCcc--c
Confidence 35689999999753 34567899999999999999999999975422 2222222111100 0000 0
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... ..++.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~---s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 249 FSGI---SEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGC---CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 234567788899999999999999876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=373.88 Aligned_cols=241 Identities=21% Similarity=0.304 Sum_probs=182.1
Q ss_pred hccccccCcceEEEEEeCC--C--cEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLDG--G--DVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~--~--~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.+.||+|+||.||+|++.. + ..||||+++.. ...+++.+|++++++++|||||+++|+|.+ +..++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 5679999999999998632 2 36899988653 223578899999999999999999999975 467899999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP 488 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~ 488 (640)
|++|++.+++.... .++++..++.++.|+|.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 92 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 99999999877543 258999999999999999999995 45999999999999999999999999999876422
Q ss_pred ---------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHHHHHHhhccccccc
Q 006559 489 ---------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 489 ---------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
..++..|+|||++ ....++.++|||||||++|||+| |+.||.+.... +............
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~-------~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~~~~~~- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESL-------KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGERL- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHH-------HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCCC-
T ss_pred CCcceecCccccCcccCCHHHH-------hCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHhCCCCC-
Confidence 2346689999965 34567789999999999999998 89999753322 2122222111100
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHh
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDI 605 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 605 (640)
..... ...++.+++..||+.||++||||.+|++.|++.
T Consensus 235 ------~~~~~---~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 ------PRPED---CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01111 123466788889999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.9e-45 Score=378.38 Aligned_cols=240 Identities=18% Similarity=0.259 Sum_probs=190.9
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccc--cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRER--KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
..+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|++++++++|||||++++++.+++..|+|||||++|+
T Consensus 33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 357899999999999996 56899999998765 234567889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC--CCCCeEEccCCcccccCCC---
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD--QLGNACISDIGVHQLFHTP--- 488 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGl~~~~~~~--- 488 (640)
|.+++.... .++++.....++.||+.||+|||+ .+||||||||+|||++ .++.+||+|||+++.+...
T Consensus 113 L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 113 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 998876543 258999999999999999999995 4599999999999998 6789999999999887542
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhcc
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIM 566 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 566 (640)
..+|..|+|||++ ....++.++||||+||++|||+||+.||.+.... ............ .... .
T Consensus 186 ~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~---~~~~--~ 251 (352)
T d1koba_ 186 KVTTATAEFAAPEIV-------DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDWE---FDED--A 251 (352)
T ss_dssp EEECSSGGGCCHHHH-------TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCCCC---CCSS--T
T ss_pred eeccCcccccCHHHH-------cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC---CCcc--c
Confidence 3568899999975 3455778999999999999999999999754322 111111111000 0000 0
Q ss_pred ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 567 DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 567 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ....++.+++.+||+.||++|||+.|+++
T Consensus 252 ~~---~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 252 FS---SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cc---CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01 12234667888899999999999999965
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=375.57 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=193.4
Q ss_pred hccccccCcceEEEEEeCC-Cc--EEEEEEeccc---cchHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLDG-GD--VVVVKRIRER---KKKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~-~~--~vavK~l~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.++||+|+||+||+|++.+ +. .||||+++.. ...+++.+|++++.++ +|||||+++|+|..++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 5789999999999999754 33 4788887644 2345789999999998 79999999999999999999999999
Q ss_pred CCCHHHhhccCC-----------CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccC
Q 006559 411 HGSLHSLLHGSR-----------GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDI 479 (640)
Q Consensus 411 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 479 (640)
+|+|.++++... ......++|..+.+++.|||.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEccc
Confidence 999999997542 1122368999999999999999999995 45999999999999999999999999
Q ss_pred CcccccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCC-CCCCCCCcchHHHHHHhhcc
Q 006559 480 GVHQLFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 480 Gl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~ 553 (640)
|+++.... ...+|..|+|||.+ ....++.++|||||||++|||+||. +||.... ..+..+.+...
T Consensus 172 G~a~~~~~~~~~~~~~gt~~y~aPE~l-------~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i~~~ 242 (309)
T d1fvra_ 172 GLSRGQEVYVKKTMGRLPVRWMAIESL-------NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQG 242 (309)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHH-------HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHGGGT
T ss_pred cccccccccccccceecCCcccchHHh-------ccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHhc
Confidence 99976542 23457899999965 4456788999999999999999975 5665432 22222222211
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
.. +. .+... ..++.+++.+||+.||++||||.||++.|+++....
T Consensus 243 ~~------~~--~~~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 243 YR------LE--KPLNC---DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CC------CC--CCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CC------CC--CCccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 10 11 11112 234667788899999999999999999999987653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=374.90 Aligned_cols=247 Identities=21% Similarity=0.325 Sum_probs=194.0
Q ss_pred hccccccCcceEEEEEeC------CCcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVLD------GGDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 407 (640)
.++||+|+||.||+|++. .+..||||+++... ...++.+|+.+++++ +|||||+++|+|.+.+..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 578999999999999863 35679999997652 345678899999998 69999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC-------------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCe
Q 006559 408 YLPHGSLHSLLHGSRG-------------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNA 474 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 474 (640)
||++|+|.++++.... .....+++..+.+++.|||+||+|||+. +||||||||+|||++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcc
Confidence 9999999999976532 1223589999999999999999999954 59999999999999999999
Q ss_pred EEccCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcch--
Q 006559 475 CISDIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGI-- 543 (640)
Q Consensus 475 kl~DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~-- 543 (640)
|++|||+++.... ...+|..|+|||++ ....++.++|||||||++|||+| |++|+.......
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-------FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHh-------cCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999987542 23457889999964 45667899999999999999999 555554432221
Q ss_pred HHHHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 544 VKWVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 544 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
...++...+ ...+.. ...++.+++.+||+.||++||||.+|+++|+++..+
T Consensus 258 ~~~i~~~~~-----------~~~~~~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFR-----------MLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCC-----------CCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCC-----------CCCccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111111110 011111 223567788899999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-44 Score=369.79 Aligned_cols=234 Identities=21% Similarity=0.300 Sum_probs=189.9
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||+||+|+. .+|+.||||+++.. ...+.+.+|+.++++++|||||++++++.+.+..|+|||||++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 88 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence 57899999999999996 56899999999743 2346688999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---C
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---P 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---~ 488 (640)
|+|..++.... .+++.....++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++.... .
T Consensus 89 g~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~ 160 (316)
T d1fota_ 89 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160 (316)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred ccccccccccc-----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence 99999987654 47788888999999999999994 5699999999999999999999999999988653 3
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|+.|+|||++ ....++.++||||+||++|||+||+.||.+.... +..+..... ....++
T Consensus 161 ~~Gt~~Y~APE~l-------~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~~---------~~~~p~ 222 (316)
T d1fota_ 161 LCGTPDYIAPEVV-------STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILNA---------ELRFPP 222 (316)
T ss_dssp CCSCTTTCCHHHH-------TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHC---------CCCCCT
T ss_pred ccCcccccCHHHH-------cCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHHHHHcC---------CCCCCC
Confidence 4679999999975 3445778999999999999999999999754321 111111111 111111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
..++ ++.+++.+||+.||++|| |+.++++
T Consensus 223 ~~s~---~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 223 FFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCH---HHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2222 356677789999999996 8888864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=373.38 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=196.0
Q ss_pred hhccccccCcceEEEEEeC------CCcEEEEEEeccccc---hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEe
Q 006559 337 SAELLGKGCVGATYKVVLD------GGDVVVVKRIRERKK---KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYD 407 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 407 (640)
..+.||+|+||+||+|.+. .+..||||+++.... ...+.+|+.++++++|||||+++|+|..++..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 3578999999999999864 256899999976532 3457899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCC-----CCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcc
Q 006559 408 YLPHGSLHSLLHGSR-----GPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVH 482 (640)
Q Consensus 408 y~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~ 482 (640)
||++|+|.+++.... ......++|..+.+++.|+|+||.|||+ .+|+||||||+|||+|+++.+||+|||++
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGla 180 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT 180 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeecccc
Confidence 999999999886432 1122357899999999999999999995 45999999999999999999999999999
Q ss_pred cccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCC-CCCCCCCcchHHHHHHhhcc
Q 006559 483 QLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGK-MAKGDGELGIVKWVQMMGQD 553 (640)
Q Consensus 483 ~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~ 553 (640)
+.... ...++..|+|||.+ ....++.++|||||||++|||+||. .||.+. ...++...+...
T Consensus 181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l-------~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 181 RDIYETDYYRKGGKGLLPVRWMSPESL-------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFVMEG 251 (308)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHHHHHHHTT
T ss_pred eeccCCcceeeccceecccccCCHHHH-------ccCCCCcccccccHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhC
Confidence 86532 23457889999964 4556788999999999999999985 666542 333333332221
Q ss_pred cccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 554 ESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 554 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
... + .+. .....+.+++.+||+.+|++||||.+|+++|++..+.
T Consensus 252 ~~~----~----~p~---~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 252 GLL----D----KPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp CCC----C----CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCC----C----Ccc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 110 0 111 1223577788899999999999999999999887543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=372.22 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=180.4
Q ss_pred hccccccCcceEEEEEeCC------CcEEEEEEecccc---chHHHHHHHHHHhcc-CCCcccceeEEEEcC-CeEEEEE
Q 006559 338 AELLGKGCVGATYKVVLDG------GDVVVVKRIRERK---KKREVDEWLRVIGGL-RHSNIVSIRAYCNGK-DELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~------~~~vavK~l~~~~---~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lV~ 406 (640)
.+.||+|+||.||+|+..+ ++.||||+++... ..+.+.+|...+.++ +|+|||.+++++... ...++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 5789999999999998532 4579999997652 234566666666665 689999999998765 4689999
Q ss_pred eccCCCCHHHhhccCCC-----------CCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeE
Q 006559 407 DYLPHGSLHSLLHGSRG-----------PGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNAC 475 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 475 (640)
|||++|+|.++++.... .....++|..++.++.|||+||+|||+. +||||||||+|||+++++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEE
Confidence 99999999999975431 0123589999999999999999999954 599999999999999999999
Q ss_pred EccCCcccccCC--------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhC-CCCCCCCCcchHHH
Q 006559 476 ISDIGVHQLFHT--------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTG-KMAKGDGELGIVKW 546 (640)
Q Consensus 476 l~DfGl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg-~~p~~~~~~~~~~~ 546 (640)
|+|||+++.... ...+|..|+|||++ ....++.++|||||||++|||+|| +.||....... ..
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l-------~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~ 246 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-------FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 246 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HH
T ss_pred EccCcchhhccccccccccCceeeCccccchhHh-------hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 999999986532 23468899999965 345678999999999999999997 45776433221 11
Q ss_pred HHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 547 VQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 547 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
.+........ ..+. ....++.+++.+||+.||++||||.||++.|+++.+
T Consensus 247 ~~~~~~~~~~--------~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 CRRLKEGTRM--------RAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHTCCC--------CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC--------CCCc---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111111100 0111 122356778889999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.3e-45 Score=365.39 Aligned_cols=245 Identities=18% Similarity=0.239 Sum_probs=192.4
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc-----------chHHHHHHHHHHhccC-CCcccceeEEEEcCCeEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----------KKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELF 403 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----------~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~ 403 (640)
..+.||+|+||+||+|+. .+|+.||||++.... ..+.+.+|+.++++++ |||||++++++.+++..|
T Consensus 7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 86 (277)
T d1phka_ 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 86 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceE
Confidence 357899999999999996 578899999986531 1234778999999997 999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 404 LVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
||||||++|+|.++++... ++++..+..++.||+.||+|||. .+|+||||||+|||++.++.+||+|||+++
T Consensus 87 ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999997543 58999999999999999999995 459999999999999999999999999998
Q ss_pred ccCC-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 484 LFHT-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 484 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
.... ...+|..|+|||++..... .....++.++||||+||++|||+||+.||.+....... +........
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~-~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~--~~i~~~~~~-- 233 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMN-DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--RMIMSGNYQ-- 233 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHC-TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHTCCC--
T ss_pred EccCCCceeeeeccCCCCCHHHhhcccc-ccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH--HHHHhCCCC--
Confidence 7643 2456889999998653321 22345788999999999999999999999864422211 111111000
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
......... ..++.+++.+||++||++|||+.||++
T Consensus 234 ---~~~~~~~~~---s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 234 ---FGSPEWDDY---SDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---CCTTTGGGS---CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---CCCcccccC---CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000001112 234667788899999999999999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=367.58 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=189.4
Q ss_pred hccccccCcceEEEEEeCC--------CcEEEEEEeccccc---hHHHHHHHHHHhcc-CCCcccceeEEEEcCCeEEEE
Q 006559 338 AELLGKGCVGATYKVVLDG--------GDVVVVKRIRERKK---KREVDEWLRVIGGL-RHSNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~---~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lV 405 (640)
.+.||+|+||.||+|+..+ +..||||+++.... ..++.+|...+.++ +|||||+++++|.+++..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 5689999999999998532 24699999976532 35567788888777 899999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCC-----------CCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCe
Q 006559 406 YDYLPHGSLHSLLHGSRGP-----------GRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNA 474 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 474 (640)
||||++|+|.+++...... ....+++..+++++.|+|.||+|||+ .+||||||||+|||++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCCCCe
Confidence 9999999999999765321 12358999999999999999999995 459999999999999999999
Q ss_pred EEccCCcccccCCC--------ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchHH
Q 006559 475 CISDIGVHQLFHTP--------FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILT-GKMAKGDGELGIVK 545 (640)
Q Consensus 475 kl~DfGl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~t-g~~p~~~~~~~~~~ 545 (640)
||+|||+++..... ..++..|+|||++ ....++.|+|||||||++|||+| |+.||.+.....+
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l-------~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~- 246 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-------FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 246 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH-------HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHh-------cCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH-
Confidence 99999998876432 3457789999964 45678899999999999999998 6888875443222
Q ss_pred HHHHhhcccccccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhc
Q 006559 546 WVQMMGQDESAWEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRT 607 (640)
Q Consensus 546 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 607 (640)
.+........ ..+.. ...++.+++.+||+.||++|||+.||++.|++|.+
T Consensus 247 -~~~i~~~~~~--------~~p~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 -FKLLKEGHRM--------DKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHTTCCC--------CCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHcCCCC--------CCCcc---chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111111100 01111 12346778889999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=371.40 Aligned_cols=234 Identities=21% Similarity=0.292 Sum_probs=189.6
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.++||+|+||.||+|+. .+|+.||||+++.. ...+.+.+|++++++++|||||++++++.+.+.+|+|||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 56899999999999996 56899999999754 2345678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC----
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---- 487 (640)
|+|.+++.... .++......++.|++.||+|||+. +||||||||+|||++.+|.+||+|||+++....
T Consensus 90 g~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred Cchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 99999998654 578889999999999999999954 599999999999999999999999999986532
Q ss_pred --CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhc
Q 006559 488 --PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELI 565 (640)
Q Consensus 488 --~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 565 (640)
..++|+.|+|||++ ....++.++||||+||++|||+||+.||.+..... ..+..... ...
T Consensus 162 ~~~~~GT~~Y~aPE~~-------~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~i~~~---------~~~ 223 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVL-------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILME---------EIR 223 (337)
T ss_dssp BCCCEECGGGCCGGGG-------SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC---------CCC
T ss_pred cccceeCHHHhhhhhc-------cCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHHHHhcC---------CCC
Confidence 24578999999974 44567889999999999999999999997644321 11111111 111
Q ss_pred cChHHHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006559 566 MDKEMEEEMRALLQVALLCLAPLPKDRPN-----MSIVHR 600 (640)
Q Consensus 566 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~ 600 (640)
.+...+. ++.+++..||+.||++||+ +.|+.+
T Consensus 224 ~p~~~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCH---HHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1122223 3556778899999999995 667754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-44 Score=376.64 Aligned_cols=238 Identities=19% Similarity=0.225 Sum_probs=185.7
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHH---HHHHHHhccCCCcccceeEEEEcCCeEEEEEec
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVD---EWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDY 408 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 408 (640)
.++||+|+||.||+|+.. +|+.||||++... .....+. .++++++.++|||||++++++...+..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 578999999999999964 6899999998643 1222233 346778888999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-
Q 006559 409 LPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT- 487 (640)
Q Consensus 409 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~- 487 (640)
|++|+|.+++.... .+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++.+..
T Consensus 89 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 89 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred cCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999997643 57889999999999999999995 4599999999999999999999999999987653
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|+.|+|||++. ....++.++|||||||++|||+||+.||..........+....... ..
T Consensus 161 ~~~~~~GT~~y~APE~~~------~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~--------~~ 226 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------AV 226 (364)
T ss_dssp CCCSCCSCGGGCCHHHHS------TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC--------CC
T ss_pred cccccccccccchhHHhh------cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------CC
Confidence 345799999999753 2345788999999999999999999999854332222211111110 01
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPN-----MSIVHR 600 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~ 600 (640)
..+...+. ++.+++.+||+.||++||| +.|+++
T Consensus 227 ~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCSSSCH---HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCH---HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11111222 4566778899999999999 466653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-44 Score=363.79 Aligned_cols=245 Identities=20% Similarity=0.257 Sum_probs=189.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-----chHHHHHHHHHHhccCCCcccceeEEEEcCC----eEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD----ELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lV~E 407 (640)
.+.||+|+||+||+|+. .+|+.||||+++... ..+.+.+|++++++++|||||++++++...+ ..|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 56899999999999995 578899999997542 2345788999999999999999999987643 4899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+++|+|.+++.... ++++.....++.|++.||+|||+ .+||||||||+|||++.++..+++|||.++....
T Consensus 92 ~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred CCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 999999999987553 58999999999999999999995 4599999999999999999999999998865432
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhccccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWE 558 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||...... +...........
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~-------~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~~~~~~~~-- 232 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQA-------RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDPI-- 232 (277)
T ss_dssp ---------------TTCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCCC--
T ss_pred ccccccccccccCcccccCHHHH-------cCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--HHHHHHHhcCCC--
Confidence 23568999999975 3345778999999999999999999999754322 111111111100
Q ss_pred ccchhhccChHHHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHHhhc
Q 006559 559 VFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRP-NMSIVHRMIEDIRT 607 (640)
Q Consensus 559 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~ 607 (640)
.+. ...+.. ..++.+++.+||+.||++|| |++++...|.+++.
T Consensus 233 --~~~-~~~~~~---s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 233 --PPS-ARHEGL---SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp --CGG-GTSSSC---CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred --CCc-hhccCC---CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 000 011112 23466777889999999999 89999999988763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=370.75 Aligned_cols=248 Identities=20% Similarity=0.322 Sum_probs=185.1
Q ss_pred ccccccCcceEEEEEe-CCCcEEEEEEeccccc-------hHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 339 ELLGKGCVGATYKVVL-DGGDVVVVKRIRERKK-------KREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
++||+|+||+||+|+. .+|+.||||+++.... .+.+.+|++++++++|||||++++++..++..|+||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999996 4689999999864411 2457889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
++++..+..... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 84 TDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred chHHhhhhhccc-----CCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 988777665332 57788899999999999999995 4599999999999999999999999999987643
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chHH-HHHHhhccc-cccc-c-
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGEL-GIVK-WVQMMGQDE-SAWE-V- 559 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~-~~~~-~~~~~~~~~-~~~~-~- 559 (640)
...+|..|+|||++. ....++.++|||||||++|||+||+.||..... +... ..+...... ..+. .
T Consensus 156 ~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLF------GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp CCCCSCCCCTTCCHHHHT------TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred cccceecChhhccHHHHc------cCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 235688999999753 234567899999999999999999999975322 1111 111111100 0000 0
Q ss_pred -----cch-hhc-cC--hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 -----FDF-ELI-MD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 -----~d~-~~~-~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... ... .+ ........++.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 000 00 000111245778888999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-44 Score=365.78 Aligned_cols=239 Identities=18% Similarity=0.266 Sum_probs=189.9
Q ss_pred hhccccccCcceEEEEEeC-CCcEEEEEEecccc-chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVLD-GGDVVVVKRIRERK-KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..+.||+|+||+||+|+.. +++.||||.++... ....+.+|+++++.++|||||++++++.+.+..|+|||||++|+|
T Consensus 9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 3578999999999999964 68899999998663 345678999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCC--CCeEEccCCcccccCCC----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQL--GNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~--~~~kl~DfGl~~~~~~~---- 488 (640)
.+++.... .++++.+...++.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 89 ~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 99997543 258999999999999999999995 459999999999999854 58999999999876532
Q ss_pred -ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccC
Q 006559 489 -FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMD 567 (640)
Q Consensus 489 -~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 567 (640)
..+++.|+|||+. ....++.++||||+||++|||+||+.||...... ......... ....+
T Consensus 162 ~~~~t~~y~ape~~-------~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~~---------~~~~~ 223 (321)
T d1tkia_ 162 LLFTAPEYYAPEVH-------QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNA---------EYTFD 223 (321)
T ss_dssp EEESCGGGSCHHHH-------TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT---------CCCCC
T ss_pred ccccccccccchhc-------cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------CCCCC
Confidence 2458899999964 3455778999999999999999999999754322 111111111 00011
Q ss_pred hH-HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 568 KE-MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 568 ~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. ......++.+++.+|+..||++|||+.|+++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 0112234667888899999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=365.72 Aligned_cols=240 Identities=16% Similarity=0.219 Sum_probs=183.3
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhc-cCCCcccceeEEEEc----CCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGG-LRHSNIVSIRAYCNG----KDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~----~~~~~lV~Ey~~~ 411 (640)
.++||+|+||+||+|+. .+++.||||+++.. ..+.+|+.++.+ .+|||||+++++|.+ ...+|+|||||++
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECCc---HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 35799999999999995 56899999998643 456678877654 589999999999865 4578999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC---CCCeEEccCCcccccCC-
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ---LGNACISDIGVHQLFHT- 487 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl~~~~~~- 487 (640)
|+|.+++.... ...+++.....++.|++.||+|||+ .+|+||||||+|||+++ ++.+||+|||+++....
T Consensus 94 g~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 94 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred CcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCC
Confidence 99999997542 2358999999999999999999995 45999999999999985 56799999999987543
Q ss_pred ----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccccccch
Q 006559 488 ----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAWEVFDF 562 (640)
Q Consensus 488 ----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~ 562 (640)
...+|+.|+|||++ ....++.++|||||||++|||+||+.||.+.... ....+...... .+.
T Consensus 168 ~~~~~~~gt~~y~aPE~~-------~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~------~~~ 234 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM------GQY 234 (335)
T ss_dssp CCCCCCSCCCSSCCCCCC-------CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS------CSS
T ss_pred CccccccCCcccCCcHHH-------cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc------CCC
Confidence 34579999999964 3456788999999999999999999999743221 11111110000 000
Q ss_pred hhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 563 ELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 563 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
... .+.......++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 EFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 010 1112233445777888999999999999999976
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-43 Score=367.72 Aligned_cols=234 Identities=16% Similarity=0.241 Sum_probs=189.9
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc-----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER-----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPH 411 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 411 (640)
.+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+++++.++|||||++++++......++||||+++
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 46899999999999996 46899999998643 2335678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---C
Q 006559 412 GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT---P 488 (640)
Q Consensus 412 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~---~ 488 (640)
|+|.+++.... .+++.....++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.... .
T Consensus 126 g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~ 197 (350)
T d1rdqe_ 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred cchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccccc
Confidence 99999987653 588999999999999999999954 599999999999999999999999999988754 3
Q ss_pred ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhhccCh
Q 006559 489 FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFELIMDK 568 (640)
Q Consensus 489 ~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 568 (640)
..+|+.|+|||++. ...++.++|||||||++|||+||+.||.+... ........... ...+.
T Consensus 198 ~~Gt~~Y~APE~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~~---------~~~p~ 259 (350)
T d1rdqe_ 198 LCGTPEALAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGK---------VRFPS 259 (350)
T ss_dssp CEECGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC---------CCCCT
T ss_pred ccCccccCCHHHHc-------CCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHHHhcCC---------CCCCc
Confidence 45789999999753 45577899999999999999999999975432 22222211110 11111
Q ss_pred HHHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006559 569 EMEEEMRALLQVALLCLAPLPKDRP-----NMSIVHR 600 (640)
Q Consensus 569 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~ 600 (640)
..+ .++.+++..||+.||++|+ |+.++++
T Consensus 260 ~~s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 HFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TCC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCC---HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 222 2456677789999999994 8888864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=363.24 Aligned_cols=233 Identities=22% Similarity=0.338 Sum_probs=184.1
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccc-----cchHHHHHHHHHHh-ccCCCcccceeEEEEcCCeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRER-----KKKREVDEWLRVIG-GLRHSNIVSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.+.||+|+||+||+|+.. +++.||||+++.. ...+.+..|..++. .++|||||++++++.+++..|+|||||+
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 578999999999999964 6889999999743 22334555665554 6899999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC---
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~--- 487 (640)
+|+|.+++.... .++......++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999997653 478889999999999999999954 599999999999999999999999999986532
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccccchhh
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEVFDFEL 564 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 564 (640)
...+|..|+|||++ ....++.++|||||||++|||+||+.||.+...... .+...... .
T Consensus 159 ~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~i~~~~---------~ 220 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEIL-------LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSIRMDN---------P 220 (320)
T ss_dssp CBCCCCSCGGGCCHHHH-------TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCC---------C
T ss_pred cccccCCCCCcCCHHHH-------cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHcCC---------C
Confidence 24568899999975 345678899999999999999999999975432221 11111110 0
Q ss_pred ccChHHHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006559 565 IMDKEMEEEMRALLQVALLCLAPLPKDRPNMS-IVH 599 (640)
Q Consensus 565 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v~ 599 (640)
..+...+ .++.+++.+||+.||++||++. ++.
T Consensus 221 ~~p~~~s---~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 FYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCTTSC---HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCccCC---HHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 1111222 2466778889999999999985 664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=355.28 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=185.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||+||+|+. .+|+.||||+++... ..+.+.+|++++++++|||||++++++.+.+..|+||||+.++
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~ 86 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc
Confidence 46899999999999996 568999999996542 3467889999999999999999999999999999999999765
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC-----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT----- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~----- 487 (640)
+.+++.... ...+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 87 -~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 87 -LKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp -HHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred -hhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 444443222 12589999999999999999999954 599999999999999999999999999977643
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH--HHHHHhhc-cccccccc---
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV--KWVQMMGQ-DESAWEVF--- 560 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~--~~~~~~~~-~~~~~~~~--- 560 (640)
...+|..|+|||+.... ..++.++||||+||++|||++|+.||........ ...+.... .+..+...
T Consensus 160 ~~~~gt~~y~apE~~~~~------~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGC------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp TCCBCCCTTCCHHHHTTC------SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred eeecccceeeehhhhccc------cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 23568899999975332 3356899999999999999999999975432111 11111111 11111000
Q ss_pred -ch--h--hccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 -DF--E--LIMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 -d~--~--~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
+. . ...... ......++.+++.+|+..||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 0 000000 0111245677888899999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-42 Score=352.29 Aligned_cols=249 Identities=19% Similarity=0.308 Sum_probs=188.4
Q ss_pred hccccccCcceEEEEEeCCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCCC
Q 006559 338 AELLGKGCVGATYKVVLDGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHGS 413 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 413 (640)
.++||+|+||+||+|+.++|+.||||+++.. ...+.+.+|+.++++++|||||++++++...+..++||||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 4679999999999999999999999999754 224678899999999999999999999999999999999998877
Q ss_pred HHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC------
Q 006559 414 LHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT------ 487 (640)
Q Consensus 414 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~------ 487 (640)
+..+..... .++...+..++.||+.||+|||+ .+||||||||+|||++.++.+|++|||++.....
T Consensus 87 ~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 87 KKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp HHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHHhhcC-----CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 777765443 58999999999999999999995 4599999999999999999999999999877543
Q ss_pred CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch--HHHHHHhhccc-ccccc-----
Q 006559 488 PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI--VKWVQMMGQDE-SAWEV----- 559 (640)
Q Consensus 488 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~-~~~~~----- 559 (640)
...++..|+|||++. ....++.++||||+||++|||++|+.||.+..... ....+...... ..+..
T Consensus 159 ~~~~~~~y~~pE~~~------~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLM------GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---CCCTTCCHHHHT------TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred eecccchhhhHHHHh------CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 234578899999753 23456789999999999999999999997532211 11111111100 00000
Q ss_pred -cchhhc------cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 -FDFELI------MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 -~d~~~~------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+.... ..........++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00001111235677888899999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=352.96 Aligned_cols=230 Identities=17% Similarity=0.327 Sum_probs=181.1
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEecccc--------chHHHHHHHHHHhccC--CCcccceeEEEEcCCeEEEE
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERK--------KKREVDEWLRVIGGLR--HSNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lV 405 (640)
..++||+|+||+||+|+. .+|+.||||++.... ....+.+|+.++++++ |||||++++++.+.+..|+|
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv 87 (273)
T d1xwsa_ 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 87 (273)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEE
Confidence 357899999999999996 568999999986431 1133567899999886 89999999999999999999
Q ss_pred EeccCC-CCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-CCCeEEccCCccc
Q 006559 406 YDYLPH-GSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-LGNACISDIGVHQ 483 (640)
Q Consensus 406 ~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGl~~ 483 (640)
|||+.+ +++.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 88 ~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 999976 68888886543 58999999999999999999995 45999999999999985 4799999999998
Q ss_pred ccCC----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhhcccccccc
Q 006559 484 LFHT----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMGQDESAWEV 559 (640)
Q Consensus 484 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (640)
.... ...+|..|+|||++... ..++.++||||+||++|||+||+.||.... ...+ .
T Consensus 160 ~~~~~~~~~~~GT~~y~aPE~~~~~------~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i~~----~------ 219 (273)
T d1xwsa_ 160 LLKDTVYTDFDGTRVYSPPEWIRYH------RYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EIIR----G------ 219 (273)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHHH----C------
T ss_pred ecccccccccccCCCcCCHHHHcCC------CCCCcccccccceeeehhHhhCCCCCCCch----HHhh----c------
Confidence 7643 34578999999975322 223567899999999999999999996421 0000 0
Q ss_pred cchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 560 FDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 560 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
........++ ++.+++.+||+.||++|||+.|+++
T Consensus 220 ---~~~~~~~~s~---~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ---QVFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---CCCCSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccCCCCCCCH---HHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0001111222 4566778899999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=346.48 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=178.7
Q ss_pred hccccccCcceEEEEEe-CC-CcEEEEEEecccc----chHHHHHHHHHHhcc---CCCcccceeEEEEc-----CCeEE
Q 006559 338 AELLGKGCVGATYKVVL-DG-GDVVVVKRIRERK----KKREVDEWLRVIGGL---RHSNIVSIRAYCNG-----KDELF 403 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~-~~~vavK~l~~~~----~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~~~~ 403 (640)
.+.||+|+||+||+|+. .+ ++.||||+++... ....+.+|+.+++.+ +|||||+++++|.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 56799999999999996 33 5679999986531 223455666665554 89999999999853 34789
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 404 LVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 404 lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
++|||+++|++........ ..+++.....++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+++
T Consensus 92 ~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 9999999887765544332 257889999999999999999995 459999999999999999999999999987
Q ss_pred ccC-----CCccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-h-HHHHHHhhcccc-
Q 006559 484 LFH-----TPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-I-VKWVQMMGQDES- 555 (640)
Q Consensus 484 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~-~~~~~~~~~~~~- 555 (640)
... ....+|..|+|||++. ...++.++||||+||++|||+||+.||...... . ....+.......
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~-------~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLL-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHT-------TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhcccccCCCcccChhhcCcchhc-------CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 653 2346799999999753 456788999999999999999999999754321 1 111111111100
Q ss_pred ccc--------ccchhh--ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 556 AWE--------VFDFEL--IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 556 ~~~--------~~d~~~--~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.+. ...... ............+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000000 000000111234566788899999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-41 Score=344.11 Aligned_cols=248 Identities=15% Similarity=0.171 Sum_probs=185.7
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCCCcccce-eEEEEcCCeEEEEEeccCCCCH
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSI-RAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l-~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
..+.||+|+||+||+|+. .+|+.||||.+.......++..|+++++.++|+|+|.. .+++...+..++||||+. |++
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l 89 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSL 89 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBH
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cch
Confidence 357899999999999996 56889999998876556678889999999988776655 455567788999999995 566
Q ss_pred HHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEEC---CCCCeEEccCCcccccCC----
Q 006559 415 HSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVD---QLGNACISDIGVHQLFHT---- 487 (640)
Q Consensus 415 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGl~~~~~~---- 487 (640)
.+.+.... ..+++..+..++.|++.||+|||+ .+||||||||+|||++ .+..+||+|||+++.+..
T Consensus 90 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 90 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred hhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 66655432 258999999999999999999995 4599999999999986 456799999999987532
Q ss_pred ---------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHH-HHHHhhcccccc
Q 006559 488 ---------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVK-WVQMMGQDESAW 557 (640)
Q Consensus 488 ---------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~ 557 (640)
...+|..|+|||+. ....++.++|||||||++|||+||+.||......... .......
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~----- 230 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTH-------LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----- 230 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHH-------TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH-----
T ss_pred cceeccccCCcCCCccccCHHHH-------hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc-----
Confidence 23468899999964 3456788999999999999999999999753222111 1111000
Q ss_pred cccchhhccC--hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhcc
Q 006559 558 EVFDFELIMD--KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTK 608 (640)
Q Consensus 558 ~~~d~~~~~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 608 (640)
.....+ ........++.+++..||+.+|++||++.++.+.|+++..+
T Consensus 231 ----~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 ----KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000000 00112234567788889999999999999999999987543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=353.20 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=184.0
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEeccccchHHHHHHHHHHhccCCCcccceeEEEEcC------CeEEEEEeccC
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNIVSIRAYCNGK------DELFLVYDYLP 410 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lV~Ey~~ 410 (640)
.++||+|+||+||+|+.. +|+.||||++.... ....+|++++++++|||||+++++|... ...|||||||+
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~ 102 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence 467999999999999964 68999999997542 2234689999999999999999998543 34799999998
Q ss_pred CCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccCC--
Q 006559 411 HGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHT-- 487 (640)
Q Consensus 411 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~~-- 487 (640)
+|.+..+.+... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++....
T Consensus 103 ~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 103 ETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred CccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 764444332111 12258999999999999999999994 5699999999999999775 899999999987642
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hHHHHHHhhcccc-cc----
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--IVKWVQMMGQDES-AW---- 557 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~-~~---- 557 (640)
...++..|+|||++. ....++.++||||+||++|||++|+.||...... +....+..+.... .+
T Consensus 178 ~~~~~~gt~~y~aPE~~~------~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 178 PNVSYICSRYYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCCSCCSCTTSCCHHHHT------TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccccccccccccChHHhh------cccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 345688999999753 2345788999999999999999999999754321 1111111111000 00
Q ss_pred -cccc---hhhccC----hHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHHhhcc
Q 006559 558 -EVFD---FELIMD----KEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR--MIEDIRTK 608 (640)
Q Consensus 558 -~~~d---~~~~~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~~ 608 (640)
...+ +..... ........++.+++.+||+.||++|||+.|+++ .+++++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 0000 000000 000112234677788899999999999999985 46666543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=346.89 Aligned_cols=248 Identities=17% Similarity=0.210 Sum_probs=180.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc---chHHHHHHHHHHhccCCCcccceeEEEEcCC----eEEEEEecc
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK---KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD----ELFLVYDYL 409 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lV~Ey~ 409 (640)
.+.||+|+||+||+|+. .+|+.||||++.... ..+.+.+|+++|++++||||+++++++.... ..++++||+
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 46899999999999985 578999999997542 2356788999999999999999999997643 234455667
Q ss_pred CCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC--
Q 006559 410 PHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT-- 487 (640)
Q Consensus 410 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~-- 487 (640)
.+|+|.+++... .+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred cCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 799999999753 48899999999999999999995 4599999999999999999999999999876532
Q ss_pred -------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhh-cccccc--
Q 006559 488 -------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG-QDESAW-- 557 (640)
Q Consensus 488 -------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~-- 557 (640)
...++..|+|||++. ....++.++||||+||++|||+||+.||.........+..... ......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTT------TBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccceeeccccccceechHHHhh------cCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 234688999999753 2345678999999999999999999999754322221111100 000000
Q ss_pred -cccch-------hh--ccChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 558 -EVFDF-------EL--IMDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 558 -~~~d~-------~~--~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
..... .. ..... ......++.+++..|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00 00000 0011135778889999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=342.04 Aligned_cols=249 Identities=18% Similarity=0.305 Sum_probs=181.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccc----cchHHHHHHHHHHhccCCCcccceeEEEEc--------CCeEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRER----KKKREVDEWLRVIGGLRHSNIVSIRAYCNG--------KDELFL 404 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~~~~l 404 (640)
.+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|++++++++||||+++++++.. .+..|+
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence 56899999999999996 57899999998644 234668899999999999999999999865 346899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 405 VYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 405 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
||||++++.+..+..... .++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 95 v~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 95 VFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeccCCCccchhhhccc-----ccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeee
Confidence 999999887766554332 47788889999999999999995 4599999999999999999999999999976
Q ss_pred cCC----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-HHHH-HHhhc
Q 006559 485 FHT----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGI-VKWV-QMMGQ 552 (640)
Q Consensus 485 ~~~----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~-~~~~-~~~~~ 552 (640)
... ...+|..|+|||++.. ...++.++||||+||++|||+||+.||.+..... ..-+ +....
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccccccceecCHHHhhHHHHcC------CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 532 2346899999997632 3457789999999999999999999997533211 1111 11111
Q ss_pred c-cccc-cc--------cchhhccChHHHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 553 D-ESAW-EV--------FDFELIMDKEMEE------EMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 553 ~-~~~~-~~--------~d~~~~~~~~~~~------~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
. .... .. ............+ ....+++++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 0000 00 0000000000111 1235677889999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=345.40 Aligned_cols=253 Identities=19% Similarity=0.286 Sum_probs=181.8
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCC------eEEEEE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKD------ELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lV~ 406 (640)
.+.||+|+||+||+|+. .+|+.||||+++... ..+.+.+|+++|++++|||||+++++|...+ ..|+||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 46799999999999995 568999999997542 2345778999999999999999999997654 579999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
||+ +++|..+.+.. .+++..+..++.|++.||+|||+. +||||||||+|||++.++.+|++|||+++...
T Consensus 103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 999 56788777643 489999999999999999999954 59999999999999999999999999998876
Q ss_pred C---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchH--HHHHHhhccc-cccccc
Q 006559 487 T---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIV--KWVQMMGQDE-SAWEVF 560 (640)
Q Consensus 487 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~--~~~~~~~~~~-~~~~~~ 560 (640)
. ...+|..|+|||++.+ ...++.++||||+||++|||++|+.||........ .......... ......
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred CccccccccccccCHHHHcC------CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 4 3456889999997632 23467899999999999999999999975432211 1111111000 000000
Q ss_pred c-----------hhhcc---ChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHHhh
Q 006559 561 D-----------FELIM---DKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRM--IEDIR 606 (640)
Q Consensus 561 d-----------~~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~ 606 (640)
. +.... ..........+.+++.+||..||++|||+.|+++. ++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 00000 00001112346678888999999999999999863 54443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-40 Score=338.03 Aligned_cols=250 Identities=13% Similarity=0.140 Sum_probs=193.5
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccCC-CcccceeEEEEcCCeEEEEEeccCCCCHH
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLRH-SNIVSIRAYCNGKDELFLVYDYLPHGSLH 415 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 415 (640)
.+.||+|+||+||+|+. .+|+.||||.+........+.+|+++++.++| +|++.+++++......++||||+ +|+|.
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~ 88 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE 88 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHH
Confidence 56899999999999995 46889999998766555667788888888876 89999999999999999999999 68999
Q ss_pred HhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECC-----CCCeEEccCCcccccCC---
Q 006559 416 SLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQ-----LGNACISDIGVHQLFHT--- 487 (640)
Q Consensus 416 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~-----~~~~kl~DfGl~~~~~~--- 487 (640)
+++..... .+++.....++.|++.||+||| ..+|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 89 ~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 89 DLLDLCGR----KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp HHHHHTTT----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred HHHHhhcc----chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 99875432 5889999999999999999999 456999999999999974 57899999999987532
Q ss_pred ----------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhccccc
Q 006559 488 ----------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESA 556 (640)
Q Consensus 488 ----------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~ 556 (640)
...+|+.|+|||++ ....++.++|||||||++|||+||+.||...... .....+........
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~-------~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTH-------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHH-------TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccceeecccCceEEchhhcCHHHh-------cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 23468999999964 3456788999999999999999999999743322 22211111110000
Q ss_pred ccccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHHhhccC
Q 006559 557 WEVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHRMIEDIRTKG 609 (640)
Q Consensus 557 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 609 (640)
..... -....+.++.+++..|++.+|++||+++.+.+.|+++..+.
T Consensus 235 ---~~~~~----l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 235 ---TPLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp ---SCHHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---CChHH----hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00000 00112235667777899999999999999999999976543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=337.64 Aligned_cols=248 Identities=17% Similarity=0.263 Sum_probs=187.0
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcCCeEEEEEeccCCC
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 412 (640)
.+.||+|+||+||+|+. .+++.||||+++... ..+.+.+|+.+++.++|||||++++++...+..++|+||+.++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence 46799999999999995 578899999986542 2456789999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHTP---- 488 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~~---- 488 (640)
+|..++...+ .+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||.++.....
T Consensus 87 ~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 87 LKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred cccccccccc-----ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 9988887543 57889999999999999999995 45999999999999999999999999999876432
Q ss_pred --ccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHhh---cc--ccccccc-
Q 006559 489 --FFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMMG---QD--ESAWEVF- 560 (640)
Q Consensus 489 --~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~~---~~--~~~~~~~- 560 (640)
...+..|+|||++. ....++.++||||+||++|||++|+.||..... .....+... .. +..+...
T Consensus 159 ~~~~~~~~~~~pe~~~------~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLF------GAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCGGGCCHHHHT------TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred eeeccccchhhhhHhc------cCCCCCchhhccccchHHHHHhhCCCCCCCCCC-HHHHHHHHHhhcCCCChhhhhhhh
Confidence 23467789999753 223467899999999999999999999754322 122111111 00 0000000
Q ss_pred -----------chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 561 -----------DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 561 -----------d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
................+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000001111234667788899999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.4e-40 Score=337.83 Aligned_cols=246 Identities=15% Similarity=0.225 Sum_probs=184.0
Q ss_pred hhccccccCcceEEEEEe-CCCcEEEEEEeccccchHHHHHHHHHHhccC-CCcccceeEEEEcC--CeEEEEEeccCCC
Q 006559 337 SAELLGKGCVGATYKVVL-DGGDVVVVKRIRERKKKREVDEWLRVIGGLR-HSNIVSIRAYCNGK--DELFLVYDYLPHG 412 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~Ey~~~g 412 (640)
..++||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|++++++++ ||||+++++++... ...++|||||++|
T Consensus 39 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 357899999999999996 56889999998754 3566888999999995 99999999999753 5699999999999
Q ss_pred CHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC-CeEEccCCcccccCC----
Q 006559 413 SLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG-NACISDIGVHQLFHT---- 487 (640)
Q Consensus 413 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGl~~~~~~---- 487 (640)
+|..+.+ .++...+..++.||+.||+|||+. +||||||||+|||++.++ .+||+|||+++....
T Consensus 118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 9987643 478899999999999999999954 599999999999998655 689999999987643
Q ss_pred -CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHHHHHh---------------h
Q 006559 488 -PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKWVQMM---------------G 551 (640)
Q Consensus 488 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~~~~~---------------~ 551 (640)
...+|..|+|||++.+ ...++.++||||+||++|||++|+.||.........+.... .
T Consensus 187 ~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 187 NVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred cccccCccccCcccccC------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2345889999997532 23467899999999999999999999975443322111110 0
Q ss_pred cccc--ccccc-------chhhccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 552 QDES--AWEVF-------DFELIMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 552 ~~~~--~~~~~-------d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... ..... ...............++.+++.+|+..||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000 0000000011112235677888899999999999999865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=339.14 Aligned_cols=240 Identities=20% Similarity=0.248 Sum_probs=183.6
Q ss_pred hhccccccCcceEEEEEe----CCCcEEEEEEeccc------cchHHHHHHHHHHhccCC-CcccceeEEEEcCCeEEEE
Q 006559 337 SAELLGKGCVGATYKVVL----DGGDVVVVKRIRER------KKKREVDEWLRVIGGLRH-SNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~----~~~~~vavK~l~~~------~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lV 405 (640)
..+.||+|+||+||+|+. .+|+.||||.++.. ...+.+.+|++++++++| |||+++++++.+....++|
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence 357899999999999985 24789999998643 234567789999999977 7999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCccccc
Q 006559 406 YDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLF 485 (640)
Q Consensus 406 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~ 485 (640)
|||+.+|+|.+++.... .+.......++.|++.||+|||+. +||||||||+|||++.++.+||+|||+++.+
T Consensus 108 ~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999997654 356778888999999999999954 5999999999999999999999999999875
Q ss_pred CC-------CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc-hHHHHHHhhcccccc
Q 006559 486 HT-------PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG-IVKWVQMMGQDESAW 557 (640)
Q Consensus 486 ~~-------~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~ 557 (640)
.. ...++..|++||.+... ...++.++||||+||+||||+||+.||...... ....+.....
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~-----~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~----- 249 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGG-----DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----- 249 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTC-----C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-----
T ss_pred cccccccccccccccccchhHHhhcC-----CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-----
Confidence 32 23457889999976432 224578999999999999999999999753322 1111111000
Q ss_pred cccchhhccChHHHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006559 558 EVFDFELIMDKEMEEEMRALLQVALLCLAPLPKDRPN-----MSIVHR 600 (640)
Q Consensus 558 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~ 600 (640)
......+.. ...++.+++.+||++||++||| ++|+++
T Consensus 250 ---~~~~~~~~~---~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 ---KSEPPYPQE---MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---HCCCCCCTT---SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---cCCCCCccc---CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001111111 2234666778899999999995 667653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-39 Score=333.33 Aligned_cols=245 Identities=18% Similarity=0.232 Sum_probs=176.3
Q ss_pred hccccccCcceEEEEEeC-CCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEc------CCeEEEEE
Q 006559 338 AELLGKGCVGATYKVVLD-GGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNG------KDELFLVY 406 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lV~ 406 (640)
.++||+|+||+||+|+.. +|+.||||++.... ..+.+.+|+.++++++|||||+++++|.. ....|+||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 468999999999999964 68999999997542 23457789999999999999999999964 36899999
Q ss_pred eccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccC
Q 006559 407 DYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFH 486 (640)
Q Consensus 407 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~ 486 (640)
|||.++.+ +.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||+++...
T Consensus 102 Ey~~~~l~-~~~~~-------~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 102 ELMDANLC-QVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp ECCSEEHH-HHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eccchHHH-Hhhhc-------CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccc
Confidence 99976554 44432 37889999999999999999995 459999999999999999999999999987654
Q ss_pred C-----CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHH--HHHHhhc-------
Q 006559 487 T-----PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVK--WVQMMGQ------- 552 (640)
Q Consensus 487 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~--~~~~~~~------- 552 (640)
. ...+|..|+|||++. ...+++++||||+||++|||++|+.||...+..... .......
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~-------~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVIL-------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp ----------CCTTCCHHHHT-------TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccccccccccccChhhhc-------CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 3 335688999999753 346778999999999999999999999754321110 0000000
Q ss_pred -----------cc-cc-----ccccchhh-c-cChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 553 -----------DE-SA-----WEVFDFEL-I-MDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 553 -----------~~-~~-----~~~~d~~~-~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.. .. ...+.... . ..........++.+++.+|+..||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00 00000000 0 01112334556788999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-39 Score=336.97 Aligned_cols=248 Identities=17% Similarity=0.216 Sum_probs=180.9
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc----chHHHHHHHHHHhccCCCcccceeEEEEcC-----CeEEEEEe
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK----KKREVDEWLRVIGGLRHSNIVSIRAYCNGK-----DELFLVYD 407 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E 407 (640)
.+.||+|+||+||+|+. .+|+.||||++.... ..+.+.+|++++++++|||||++++++... ...++++|
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 56799999999999995 578999999997542 234577899999999999999999998643 34567778
Q ss_pred ccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEEccCCcccccCC
Q 006559 408 YLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACISDIGVHQLFHT 487 (640)
Q Consensus 408 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~~~~~ 487 (640)
|+.+|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++.....
T Consensus 103 ~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp ECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCc
Confidence 88999999999643 48999999999999999999995 4599999999999999999999999999877643
Q ss_pred ---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchHHH--HHHhhcccc-cccccc
Q 006559 488 ---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELGIVKW--VQMMGQDES-AWEVFD 561 (640)
Q Consensus 488 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~~~~~--~~~~~~~~~-~~~~~d 561 (640)
...++..|+|||+.. ....++.++||||+||++|||++|+.||.......... .+....... ......
T Consensus 174 ~~~~~~g~~~y~apE~~~------~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIML------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp GGSSSCHHHHTSCHHHHT------TCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccccccccccccCchhhc------CCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 345578899999753 23345789999999999999999999997543221111 111110000 000000
Q ss_pred --------hhhc--cChH----HHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006559 562 --------FELI--MDKE----MEEEMRALLQVALLCLAPLPKDRPNMSIVHR 600 (640)
Q Consensus 562 --------~~~~--~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 600 (640)
.... .... ......++.+++.+|++.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 0000 0011234677888999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-34 Score=299.53 Aligned_cols=252 Identities=15% Similarity=0.218 Sum_probs=176.5
Q ss_pred hccccccCcceEEEEEe-CCCcEEEEEEecccc-chHHHHHHHHHHhccC-----------CCcccceeEEEEc--CCeE
Q 006559 338 AELLGKGCVGATYKVVL-DGGDVVVVKRIRERK-KKREVDEWLRVIGGLR-----------HSNIVSIRAYCNG--KDEL 402 (640)
Q Consensus 338 ~~~iG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~--~~~~ 402 (640)
.++||+|+||+||+|+. .+|+.||||+++... ..+.+.+|+++++.++ |+||+++++++.. ....
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 97 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence 57899999999999996 578999999998653 3455677888777664 5789999998864 3567
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCC------CeEE
Q 006559 403 FLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLG------NACI 476 (640)
Q Consensus 403 ~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~------~~kl 476 (640)
+++|+++..+.......... ....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++ .+|+
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred eeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeE
Confidence 77777776654333222111 12357888999999999999999996 24699999999999998655 3899
Q ss_pred ccCCcccccCC---CccccccccCCccccCCCCccccCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--------hHH
Q 006559 477 SDIGVHQLFHT---PFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVVLLEILTGKMAKGDGELG--------IVK 545 (640)
Q Consensus 477 ~DfGl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvvl~el~tg~~p~~~~~~~--------~~~ 545 (640)
+|||.+..... ...+|..|+|||++ ....++.++||||+||+++||++|+.||...... ...
T Consensus 174 ~dfg~s~~~~~~~~~~~gt~~y~aPE~~-------~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 174 ADLGNACWYDEHYTNSIQTREYRSPEVL-------LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp CCCTTCEETTBCCCSCCSCGGGCCHHHH-------HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eecccccccccccccccccccccChhhc-------cccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999876543 34568899999965 3456788999999999999999999999743211 111
Q ss_pred HHHHhhccccc------------------ccccchhh--------ccChHHHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006559 546 WVQMMGQDESA------------------WEVFDFEL--------IMDKEMEEEMRALLQVALLCLAPLPKDRPNMSIVH 599 (640)
Q Consensus 546 ~~~~~~~~~~~------------------~~~~d~~~--------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~ 599 (640)
.+...+..... ..+..... ...........++.+++.+|++.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 12221110000 00000000 00001234556788899999999999999999986
Q ss_pred H
Q 006559 600 R 600 (640)
Q Consensus 600 ~ 600 (640)
+
T Consensus 327 ~ 327 (362)
T d1q8ya_ 327 N 327 (362)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=7.2e-31 Score=268.61 Aligned_cols=207 Identities=35% Similarity=0.570 Sum_probs=169.5
Q ss_pred CChhhHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCCCceEecCCC--CcEEEEEeCCCCCCCC---chhccCCCCCCEE
Q 006559 22 SPYSDISTLLSFKASVTGSSDSLSSWVNSTDPCFDSWRGVTCNPST--HRVIKLVLEDLDLTGP---AEVLSRLTQLRLL 96 (640)
Q Consensus 22 ~~~~~~~~ll~~k~~~~~~~~~~~sW~~~~~~c~~~w~gv~C~~~~--~~v~~l~l~~~~l~g~---~~~l~~l~~L~~L 96 (640)
+.+.|++||++||+++.++. .+++|+.++|||.+.|.||+|+..+ .||+.|+|.+++++|. ++.+++|++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 45789999999999997664 4579988888886679999998754 4899999999999984 3789999999999
Q ss_pred eCCC-CcCCCCCC-CCCCCCCCcEEEccccccccc------------------------CCccCCCCCCCCEEEcccCCC
Q 006559 97 SLKN-NLLSSSNL-NLSSWPHLKHLYLSHNRFTGT------------------------FPSGVSSLRHLRRVDLSHNAY 150 (640)
Q Consensus 97 ~Ls~-N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~------------------------~p~~~~~l~~L~~L~Ls~N~l 150 (640)
+|++ |.++|..| .++++++|++|+|++|+|.+. +|..+++++.|+.+++++|.+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 9986 88987654 788899888888888887654 445566677777777777777
Q ss_pred CCCCCch----------------------------------------------------------------------hcC
Q 006559 151 EGEIPMT----------------------------------------------------------------------ELT 160 (640)
Q Consensus 151 ~g~~p~~----------------------------------------------------------------------~~~ 160 (640)
+|.+|.. .+.
T Consensus 162 ~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~ 241 (313)
T d1ogqa_ 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241 (313)
T ss_dssp EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 6655521 234
Q ss_pred CCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcc--cCCCCCCCCCCCcccCCCCCCCCC
Q 006559 161 RLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAW--MSPFGGSSFAGNKNLCGRPLPSDC 230 (640)
Q Consensus 161 ~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~--~~~~~~~~~~gn~~lcg~~~~~~c 230 (640)
.+++|+.|+|++|+|+|.+|..+..+++|+.|+|++|+|+|.||.. +..+....+.||+.+||.|+|. |
T Consensus 242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~-c 312 (313)
T d1ogqa_ 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA-C 312 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSC-C
T ss_pred cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCC-C
Confidence 5678899999999999999999999999999999999999999974 4566777889999999999885 6
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=5.3e-23 Score=193.76 Aligned_cols=165 Identities=16% Similarity=0.141 Sum_probs=115.6
Q ss_pred hhccccccCcceEEEEEeCCCcEEEEEEecccc--------------------chHHHHHHHHHHhccCCCcccceeEEE
Q 006559 337 SAELLGKGCVGATYKVVLDGGDVVVVKRIRERK--------------------KKREVDEWLRVIGGLRHSNIVSIRAYC 396 (640)
Q Consensus 337 ~~~~iG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------------~~~~~~~e~~~l~~l~H~niv~l~~~~ 396 (640)
..+.||+|+||+||+|+..+|+.||||.++... .......|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 357899999999999998889999999875320 012234577788899999999887664
Q ss_pred EcCCeEEEEEeccCCCCHHHhhccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCCeEECCCCCeEE
Q 006559 397 NGKDELFLVYDYLPHGSLHSLLHGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYNKAHLFHGHLSSSNIVVDQLGNACI 476 (640)
Q Consensus 397 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrdlk~~NILl~~~~~~kl 476 (640)
. .++||||++++.+.++ +......++.|++++|+|||. .+|+||||||+|||+++++ ++|
T Consensus 84 ~----~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 84 G----NAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp T----TEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETTE-EEE
T ss_pred C----CEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCCC-EEE
Confidence 2 3799999988665432 222345789999999999995 4599999999999999655 899
Q ss_pred ccCCcccccCCCccccccccCCccccCCCCccccCCCCCccchHHHHHH
Q 006559 477 SDIGVHQLFHTPFFINDAYNAPELKFNNNNNYSQRKFWQRCDVYSFGVV 525 (640)
Q Consensus 477 ~DfGl~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~k~DV~SfGvv 525 (640)
+|||++.....+... .|....+- ....+-.+.|..++||||..--
T Consensus 144 iDFG~a~~~~~~~~~--~~l~rd~~--~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR--EILERDVR--NIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH--HHHHHHHH--HHHHHHHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH--HHHHHHHH--HHHHHHcCCCCCcccHHHHHHH
Confidence 999999776533211 11110000 0000112456678999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=5.8e-17 Score=151.97 Aligned_cols=137 Identities=23% Similarity=0.278 Sum_probs=111.7
Q ss_pred CCCCCCCceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCC-C-CCCCCCCCcEEEcccccccccC
Q 006559 53 PCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSN-L-NLSSWPHLKHLYLSHNRFTGTF 130 (640)
Q Consensus 53 ~c~~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~-~-~~~~l~~L~~L~Ls~N~l~g~~ 130 (640)
.|.|+|..|.|+. ++|+-.+..+ -+++++|+|++|.|++.. . .|..+++|+.|+|++|.+.+..
T Consensus 5 ~C~C~~~~v~Cs~------------~~L~~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~ 70 (192)
T d1w8aa_ 5 MCHCEGTTVDCTG------------RGLKEIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE 70 (192)
T ss_dssp TSEEETTEEECTT------------SCCSSCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBC
T ss_pred CCEEcCCEEEEeC------------CCcCccCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccc
Confidence 3555677777754 4455433333 267899999999998643 3 5788999999999999999988
Q ss_pred CccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 131 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
+..|..+++|+.|+|++|+++. +|+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|.+.+..+
T Consensus 71 ~~~~~~~~~L~~L~Ls~N~l~~-l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 71 PNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp TTTTTTCTTCCEEECCSCCCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccccccccceeeeccccccc-cCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 9999999999999999999985 555788999999999999999999888889899999999999999886554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.3e-15 Score=150.29 Aligned_cols=151 Identities=26% Similarity=0.252 Sum_probs=101.1
Q ss_pred cEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 69 RVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++.|+|++|.+++.. ..|.++++|+.|+|++|.|+..+ .++.+++|++|+|++|++++ +|..+.++++|+.|+|++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~ 109 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSF 109 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCS
T ss_pred CCCEEECcCCcCCCcCHHHhhccccccccccccccccccc-cccccccccccccccccccc-cccccccccccccccccc
Confidence 5778888888887754 56778888888888888876542 35667777777777777764 344556666666666665
Q ss_pred CCCCC-----------------------CCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 148 NAYEG-----------------------EIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 148 N~l~g-----------------------~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
|.+.+ .+|...+..+++|+.|++++|+|++..+..+..+++|+.|+|++|+|+ .+|
T Consensus 110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp 188 (266)
T d1p9ag_ 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (266)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred cccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccC
Confidence 55442 233345566777777777777777777777777778888888888887 677
Q ss_pred cccCCCCC---CCCCCCcccC
Q 006559 205 AWMSPFGG---SSFAGNKNLC 222 (640)
Q Consensus 205 ~~~~~~~~---~~~~gn~~lc 222 (640)
..+..+.. ..+.||+..|
T Consensus 189 ~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 189 KGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTTTTTCCCSEEECCSCCBCC
T ss_pred hhHCCCCCCCEEEecCCCCCC
Confidence 65544332 3345565544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.51 E-value=5.2e-14 Score=131.44 Aligned_cols=125 Identities=18% Similarity=0.228 Sum_probs=105.9
Q ss_pred CEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccC-CccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccC
Q 006559 94 RLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTF-PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLED 172 (640)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~ 172 (640)
+.++.++|.|+..|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+ ..+..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~-~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP-NAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccc-cccccccccceeeecc
Confidence 468999999998876653 68999999999998765 5567999999999999999996555 8899999999999999
Q ss_pred CcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCCC---CCCCCccc
Q 006559 173 NRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGGS---SFAGNKNL 221 (640)
Q Consensus 173 N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~---~~~gn~~l 221 (640)
|+|+...+..|.++++|+.|+|++|+|++..|..+..+... .+.+|+..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 99999999999999999999999999998888777655433 33455443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=5.5e-14 Score=139.85 Aligned_cols=137 Identities=20% Similarity=0.222 Sum_probs=115.4
Q ss_pred hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCC
Q 006559 85 EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP 163 (640)
Q Consensus 85 ~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~ 163 (640)
..+.++++|+.|+|++|.+..... .+..+++|+.+++++|+|++..+..|..+++|+.|+|++|++++ +|...|.+++
T Consensus 99 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-l~~~~f~~l~ 177 (284)
T d1ozna_ 99 ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLH 177 (284)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCT
T ss_pred hhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccc-cchhhhcccc
Confidence 567889999999999999987654 57788899999999999998777888899999999999999985 5547889999
Q ss_pred CCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCC---CCCCCCcccC
Q 006559 164 NLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGG---SSFAGNKNLC 222 (640)
Q Consensus 164 ~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~---~~~~gn~~lc 222 (640)
+|+.|++++|++++..|..+..+++|+.|++++|++++..|..+..... ..+.+|+..|
T Consensus 178 ~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred ccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 9999999999999998999999999999999999999888777665443 3445666554
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.49 E-value=8.4e-15 Score=148.00 Aligned_cols=121 Identities=27% Similarity=0.459 Sum_probs=111.0
Q ss_pred CCCCEEeCCCCcCCCC---CCCCCCCCCCcEEEccc-ccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCc
Q 006559 91 TQLRLLSLKNNLLSSS---NLNLSSWPHLKHLYLSH-NRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLL 166 (640)
Q Consensus 91 ~~L~~L~Ls~N~l~~~---~~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~ 166 (640)
.+++.|+|++|.++|. ++.++++++|++|+|++ |+|+|.+|..|++|++|++|+|++|++.+..| ..+..+++|+
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~-~~~~~~~~L~ 128 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP-DFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC-GGGGGCTTCC
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccccccc-ccccchhhhc
Confidence 3688999999999984 45899999999999997 89999999999999999999999999998776 7789999999
Q ss_pred EEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCCCCC
Q 006559 167 TLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSPFGG 212 (640)
Q Consensus 167 ~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~ 212 (640)
.++++.|.+.+.+|..+..++.|+.+++++|.++|.+|..+..+..
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~ 174 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCT
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccc
Confidence 9999999999999999999999999999999999999988766543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=4.2e-14 Score=121.85 Aligned_cols=103 Identities=30% Similarity=0.412 Sum_probs=80.1
Q ss_pred CEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCC
Q 006559 94 RLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDN 173 (640)
Q Consensus 94 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N 173 (640)
|+|+|++|.++.. +.+..+++|++|+|++|.|+ .+|+.++.+++|+.|+|++|.+++ +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~--~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD--GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG--GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC--ccccccccCeEECCCC
Confidence 5788888888755 35778888888888888887 467778888888888888888874 44 4788888888888888
Q ss_pred cceeccc-CCcCCCCCCcEEEcccCcCcc
Q 006559 174 RFTGTLY-SVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 174 ~l~g~~~-~~~~~~~~L~~l~ls~N~l~g 201 (640)
+++.... ..+..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 8875432 456677888888888888874
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.8e-13 Score=134.62 Aligned_cols=132 Identities=24% Similarity=0.216 Sum_probs=99.3
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.+..|+|++|.+++....+..+++|+.|+|++|.+.+... .+..+.+|+.|++++|.++...+..+..+++|+.|++++
T Consensus 78 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~ 157 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (266)
T ss_dssp TCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cccccccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccc
Confidence 3445555555555554555555566666666555555433 355666777777777777766667788899999999999
Q ss_pred CCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 148 NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 148 N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
|++++ +|...|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+...
T Consensus 158 N~l~~-~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 158 NNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp SCCSC-CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ccccc-cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 99996 45477899999999999999999 7888777899999999999998753
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.2e-13 Score=137.32 Aligned_cols=136 Identities=22% Similarity=0.269 Sum_probs=123.1
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
.++..|+|+++.+.... ..+..+++|+.+++++|.|++.++ .+..+++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 36788899998887644 567889999999999999998866 5788999999999999999988999999999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
++|++++..| ..|..+++|++|++++|.+++..+..+..+.+|++|+|++|.+.+.-+
T Consensus 185 ~~N~l~~i~~-~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 185 HQNRVAHVHP-HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CSSCCCEECT-TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhccccccCh-hHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 9999997666 889999999999999999999998899999999999999999997655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=9.9e-14 Score=119.45 Aligned_cols=118 Identities=25% Similarity=0.268 Sum_probs=96.2
Q ss_pred EEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCC
Q 006559 72 KLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYE 151 (640)
Q Consensus 72 ~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 151 (640)
.|+|++++++... .+..+++|++|+|++|.|+..++.++.+++|+.|++++|.|++ +| .+.++++|+.|++++|+++
T Consensus 2 ~L~Ls~n~l~~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~ 78 (124)
T d1dcea3 2 VLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQ 78 (124)
T ss_dssp EEECTTSCCSSCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCC
T ss_pred EEEcCCCCCCCCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccC
Confidence 4789999998654 5899999999999999999887789999999999999999985 44 5899999999999999998
Q ss_pred CCCCchhcCCCCCCcEEEccCCcceecc---cCCcCCCCCCcEE
Q 006559 152 GEIPMTELTRLPNLLTLRLEDNRFTGTL---YSVNSSSRSILDF 192 (640)
Q Consensus 152 g~~p~~~~~~l~~L~~L~L~~N~l~g~~---~~~~~~~~~L~~l 192 (640)
..-....+..+++|++|++++|+++... ......+++|+.+
T Consensus 79 ~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 79 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 5333356889999999999999998532 1122335555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1e-13 Score=125.42 Aligned_cols=111 Identities=18% Similarity=0.167 Sum_probs=64.3
Q ss_pred ccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCc
Q 006559 87 LSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLL 166 (640)
Q Consensus 87 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~ 166 (640)
+.+..+|+.|+|++|.|+..+.-+..+++|+.|||++|.++. ++ .|..+++|+.|+|++|+++. +|...+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccC-CCccccccccccc
Confidence 445556666666666666554333556666666666666653 22 35666666666666666653 4423345566666
Q ss_pred EEEccCCcceeccc-CCcCCCCCCcEEEcccCcCc
Q 006559 167 TLRLEDNRFTGTLY-SVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 167 ~L~L~~N~l~g~~~-~~~~~~~~L~~l~ls~N~l~ 200 (640)
.|+|++|+++.... ..+..+++|+.|++++|.++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCccc
Confidence 66666666654221 23455666666666666664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=2.2e-13 Score=123.15 Aligned_cols=125 Identities=18% Similarity=0.132 Sum_probs=104.6
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|.++.++.....+..+++|+.|+|++|.|+.. +.+..+++|++|+|++|+++...+..+..+++|+.|+|++
T Consensus 18 ~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~ 96 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 96 (162)
T ss_dssp TSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred CcCcEEECCCCCCCccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence 367889999999998766678899999999999999875 4688999999999999999976666677899999999999
Q ss_pred CCCCCCCCc-hhcCCCCCCcEEEccCCcceecc---cCCcCCCCCCcEEEc
Q 006559 148 NAYEGEIPM-TELTRLPNLLTLRLEDNRFTGTL---YSVNSSSRSILDFNV 194 (640)
Q Consensus 148 N~l~g~~p~-~~~~~l~~L~~L~L~~N~l~g~~---~~~~~~~~~L~~l~l 194 (640)
|+++. ++. ..+..+++|++|++++|.++... +..+..+++|+.||-
T Consensus 97 N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 97 NSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred ccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 99984 432 45788999999999999997543 124566889998874
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.39 E-value=1.5e-12 Score=130.49 Aligned_cols=152 Identities=22% Similarity=0.296 Sum_probs=110.7
Q ss_pred CCCCCCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEc
Q 006559 53 PCFDSWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYL 121 (640)
Q Consensus 53 ~c~~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L 121 (640)
.|.|.|++|.|+.. ...++.|+|++|.++... ..|.++++|+.|++++|.+...++ .+..+++|++|++
T Consensus 7 ~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp TCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 46679999999753 245788999999998766 478999999999999999998765 5889999999999
Q ss_pred ccccccccCC------------------------------------------------ccCCCCCCCCEEEcccCCCCCC
Q 006559 122 SHNRFTGTFP------------------------------------------------SGVSSLRHLRRVDLSHNAYEGE 153 (640)
Q Consensus 122 s~N~l~g~~p------------------------------------------------~~~~~l~~L~~L~Ls~N~l~g~ 153 (640)
++|+++. +| ..+..+++|+.+++++|.++ .
T Consensus 87 ~~n~l~~-l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~ 164 (305)
T d1xkua_ 87 SKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 164 (305)
T ss_dssp CSSCCSB-CCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred cCCccCc-CccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-c
Confidence 9988763 22 12344556666666666665 3
Q ss_pred CCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCCcccCC
Q 006559 154 IPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIPAWMSP 209 (640)
Q Consensus 154 ~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~ 209 (640)
+|. ..+++|+.|++++|..++..+..+..+..++.|++++|.+++..|.++..
T Consensus 165 l~~---~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~ 217 (305)
T d1xkua_ 165 IPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217 (305)
T ss_dssp CCS---SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cCc---ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccc
Confidence 441 23466777777777777777777777777777777777777666655543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.3e-12 Score=117.13 Aligned_cols=110 Identities=23% Similarity=0.308 Sum_probs=72.8
Q ss_pred CCCCCCCceEecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCC-cCCCCCC-CCCCCCCCcEEEcccccccccC
Q 006559 53 PCFDSWRGVTCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNN-LLSSSNL-NLSSWPHLKHLYLSHNRFTGTF 130 (640)
Q Consensus 53 ~c~~~w~gv~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N-~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~ 130 (640)
|||+.+.+|+|... ++...+..+..+++|+.|+|++| .|+..++ .|.++++|+.|+|++|+|+...
T Consensus 5 C~c~~~~~l~c~~~------------~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~ 72 (156)
T d2ifga3 5 CCPHGSSGLRCTRD------------GALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72 (156)
T ss_dssp SCCSSSSCEECCSS------------CCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred CCcCCCCeEEecCC------------CCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcc
Confidence 44456788888653 23233344566777788888655 4666544 4777777777777777777766
Q ss_pred CccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcce
Q 006559 131 PSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFT 176 (640)
Q Consensus 131 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~ 176 (640)
|..|..+++|++|+|++|+|+ .+|...+..+ +|+.|+|++|.|.
T Consensus 73 ~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 73 PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp TTGGGSCSCCCEEECCSSCCS-CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred cccccccccccceeccCCCCc-ccChhhhccc-cccccccCCCccc
Confidence 777777777777777777777 5664444433 5777777777664
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.29 E-value=1.1e-11 Score=116.09 Aligned_cols=124 Identities=24% Similarity=0.348 Sum_probs=67.9
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
++..|+|+++.+++..+ ++.+++|+.|++++|.+...+ .+..++.|+.|++++|.+... ..+..+++|+.|++++|
T Consensus 63 nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n 138 (199)
T d2omxa2 63 NLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSN 138 (199)
T ss_dssp TCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSS
T ss_pred CcCcCccccccccCccc-ccCCccccccccccccccccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhh
Confidence 45555555555555432 555566666666665554432 355555666666665555432 23455666666666666
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
++.. +| .+..+++|+.|++++|++++.. .+..+++|+.|++++|+++.
T Consensus 139 ~l~~-~~--~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 139 TISD-IS--ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCCC-CG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred hhcc-cc--cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence 6552 22 3555666666666666665432 24455666666666666653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.28 E-value=1e-11 Score=116.16 Aligned_cols=125 Identities=23% Similarity=0.323 Sum_probs=106.7
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
+++.|++.+++++.. +.+..+++|++|+|++|.+++.++ +..+++|++|++++|.+.. +| .+.++++|+.|++++|
T Consensus 41 ~l~~L~l~~~~i~~l-~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~ 116 (199)
T d2omxa2 41 QVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNN 116 (199)
T ss_dssp TCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSS
T ss_pred CCCEEECCCCCCCCc-cccccCCCcCcCccccccccCccc-ccCCccccccccccccccc-cc-cccccccccccccccc
Confidence 577899998887753 458889999999999999998754 8999999999999999874 44 4889999999999999
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
.+... ..+..+++|+.|++++|++... +.+..+++|+.|++++|++++.
T Consensus 117 ~~~~~---~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l 165 (199)
T d2omxa2 117 QITDI---DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL 165 (199)
T ss_dssp CCCCC---GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC
T ss_pred ccccc---cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC
Confidence 99853 3478899999999999999753 3467799999999999999864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=1.1e-11 Score=111.01 Aligned_cols=108 Identities=17% Similarity=0.163 Sum_probs=92.2
Q ss_pred CCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccc-cccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEE
Q 006559 91 TQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHN-RFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLR 169 (640)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~ 169 (640)
...+.++.+++.+...+..+..+++|+.|+|++| .++..-+..|.++++|+.|+|++|+|+. |++..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~-i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF-VAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE-ECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC-ccccccccccccccee
Confidence 3456688999999888778889999999999876 4887667789999999999999999995 6557899999999999
Q ss_pred ccCCcceecccCCcCCCCCCcEEEcccCcCc
Q 006559 170 LEDNRFTGTLYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 170 L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
|++|+|+...+..+.. .+|+.|+|++|.|.
T Consensus 87 Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhcc-ccccccccCCCccc
Confidence 9999999655556654 47999999999986
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.23 E-value=2.5e-11 Score=114.53 Aligned_cols=124 Identities=31% Similarity=0.378 Sum_probs=85.5
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
++..|+|+++.+++.. .++.+++|+.|+|++|.+++.+ .+..+++|+.|++++|.+.. ...+..+++|+.+++++|
T Consensus 69 ~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n 144 (210)
T d1h6ta2 69 NVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNN 144 (210)
T ss_dssp TCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSS
T ss_pred CCCEEeCCCccccCcc-ccccCccccccccccccccccc-cccccccccccccccccccc--cccccccccccccccccc
Confidence 5677777777777644 3567777777777777776543 46677777777777777653 234667777777777777
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
.+++. ..+..+++|+.+++++|++++..+ +.++++|+.|+|++|+|+.
T Consensus 145 ~l~~~---~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 145 KITDI---TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CCCCC---GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred ccccc---cccccccccccccccccccccccc--ccCCCCCCEEECCCCCCCC
Confidence 77642 235667778888888887776432 5567778888888887763
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=3.3e-11 Score=113.64 Aligned_cols=126 Identities=24% Similarity=0.391 Sum_probs=107.0
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
.++.|++.++.++... .+..+++|+.|+|++|.+++.+ .+..+++|++|++++|++++ +| .+.++++|+.|++++|
T Consensus 47 ~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~ 122 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHN 122 (210)
T ss_dssp TCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTS
T ss_pred CccEEECcCCCCCCch-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccc-cc-cccccccccccccccc
Confidence 4778888888887654 4788999999999999999865 47889999999999999986 44 5889999999999999
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccC
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~i 203 (640)
.+.. ++ .+..+++|+.+++++|.+++.. ....+++|+.+++++|++++..
T Consensus 123 ~~~~-~~--~l~~l~~l~~l~~~~n~l~~~~--~~~~l~~L~~l~l~~n~l~~i~ 172 (210)
T d1h6ta2 123 GISD-IN--GLVHLPQLESLYLGNNKITDIT--VLSRLTKLDTLSLEDNQISDIV 172 (210)
T ss_dssp CCCC-CG--GGGGCTTCCEEECCSSCCCCCG--GGGGCTTCSEEECCSSCCCCCG
T ss_pred cccc-cc--cccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 9873 43 5788999999999999998643 4556899999999999998643
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.20 E-value=3.5e-11 Score=120.30 Aligned_cols=130 Identities=19% Similarity=0.258 Sum_probs=106.6
Q ss_pred cEEEEEeCCCCCCC---CchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEc
Q 006559 69 RVIKLVLEDLDLTG---PAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDL 145 (640)
Q Consensus 69 ~v~~l~l~~~~l~g---~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 145 (640)
....++...+.... ....+..+++|+.+++++|.+...+.. .+++|+.|++++|.+++..+..|.+++.++.|++
T Consensus 125 ~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~ 202 (305)
T d1xkua_ 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202 (305)
T ss_dssp TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred cccccccccccccccCCCccccccccccCccccccCCccccCcc--cCCccCEEECCCCcCCCCChhHhhcccccccccc
Confidence 34455555543322 235678899999999999998876433 3689999999999999999999999999999999
Q ss_pred ccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCccc
Q 006559 146 SHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 146 s~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
++|.+++..| ..+.++++|++|+|++|.|+ .+|..+..+++|+.|+|++|+|+..
T Consensus 203 s~n~l~~~~~-~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 203 SFNSISAVDN-GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257 (305)
T ss_dssp CSSCCCEECT-TTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred cccccccccc-ccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCcc
Confidence 9999996444 78899999999999999998 4677888899999999999999843
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.18 E-value=3.6e-11 Score=123.94 Aligned_cols=130 Identities=26% Similarity=0.313 Sum_probs=85.4
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCC----------------
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFP---------------- 131 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p---------------- 131 (640)
..+..+++.++.++.. +.+..+++|+.|++++|.+++.+ .+..+++|+.|++++|.+++..|
T Consensus 219 ~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~ 296 (384)
T d2omza2 219 TNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296 (384)
T ss_dssp TTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSC
T ss_pred CCCCEEECCCCCCCCc-chhhcccccchhccccCccCCCC-cccccccCCEeeccCcccCCCCccccccccccccccccc
Confidence 3566777777777654 35677788888888888877654 36667777777777777765322
Q ss_pred ----ccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcccCC
Q 006559 132 ----SGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 132 ----~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
..+..+++++.|+|++|++++. + .+..+++|+.|+|++|+|++ ++ .+..+++|+.|++++|+|++.+|
T Consensus 297 l~~~~~~~~~~~l~~L~ls~n~l~~l-~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 297 LEDISPISNLKNLTYLTLYFNNISDI-S--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CSCCGGGGGCTTCSEEECCSSCCSCC-G--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred cccccccchhcccCeEECCCCCCCCC-c--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 2244556666777777777643 2 25666777777777777765 22 35566777777777777776544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=4.1e-11 Score=115.51 Aligned_cols=100 Identities=19% Similarity=0.217 Sum_probs=78.4
Q ss_pred CCCCCCCceEecCC---------CCcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCCcCCCCCC--CCCCCCCCcEEE
Q 006559 53 PCFDSWRGVTCNPS---------THRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNNLLSSSNL--NLSSWPHLKHLY 120 (640)
Q Consensus 53 ~c~~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~ 120 (640)
.|.|+++.|.|... ...++.|+|+++.++... ..|.++++|++|+|++|.+...++ .+..++++++|+
T Consensus 5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred cCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence 46678999999642 135889999999998754 568999999999999999876432 467788888888
Q ss_pred ccc-ccccccCCccCCCCCCCCEEEcccCCCCC
Q 006559 121 LSH-NRFTGTFPSGVSSLRHLRRVDLSHNAYEG 152 (640)
Q Consensus 121 Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 152 (640)
+.. |++....+..|.++++|+.|++++|.+..
T Consensus 85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp EECCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred ccccccccccccccccccccccccccchhhhcc
Confidence 764 67777777778888888888888888763
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.11 E-value=1e-10 Score=120.46 Aligned_cols=121 Identities=25% Similarity=0.278 Sum_probs=99.1
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC---------------------CCCCCCCCcEEEccccccc
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL---------------------NLSSWPHLKHLYLSHNRFT 127 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~---------------------~~~~l~~L~~L~Ls~N~l~ 127 (640)
.+..+++.++.+++.. .+..+++|+.|++++|.+++.++ .+..+++++.|+|++|+++
T Consensus 242 ~L~~L~l~~n~l~~~~-~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~ 320 (384)
T d2omza2 242 NLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNIS 320 (384)
T ss_dssp TCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCS
T ss_pred ccchhccccCccCCCC-cccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCC
Confidence 5677888888887754 36777888888888887765321 2455679999999999999
Q ss_pred ccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccC
Q 006559 128 GTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNN 197 (640)
Q Consensus 128 g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N 197 (640)
+.. .+..+++|+.|+|++|++++ +| .+.++++|++|+|++|++++.+| +.++++|+.|+|++|
T Consensus 321 ~l~--~l~~l~~L~~L~L~~n~l~~-l~--~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 321 DIS--PVSSLTKLQRLFFANNKVSD-VS--SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCG--GGGGCTTCCEEECCSSCCCC-CG--GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCc--ccccCCCCCEEECCCCCCCC-Ch--hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 753 38899999999999999985 54 58899999999999999998765 678999999999998
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.11 E-value=2.1e-10 Score=109.32 Aligned_cols=126 Identities=27% Similarity=0.382 Sum_probs=78.0
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCC-----------------
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFP----------------- 131 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p----------------- 131 (640)
++..|+++++.+++.. .+..+++|+.|++++|.++.. +.+..+++|+.|++++|...+..+
T Consensus 64 ~L~~L~ls~n~i~~~~-~l~~l~~l~~l~~~~n~~~~i-~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~ 141 (227)
T d1h6ua2 64 NLIGLELKDNQITDLA-PLKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQI 141 (227)
T ss_dssp TCCEEECCSSCCCCCG-GGTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred CCcEeecCCceeeccc-ccccccccccccccccccccc-ccccccccccccccccccccccchhccccchhhhhchhhhh
Confidence 5667777777766543 366677777777777766543 345566666666666666543211
Q ss_pred ---ccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 132 ---SGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 132 ---~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
..+.++++|+.|++++|.+++. ..+.++++|+.|+|++|++++.. .+..+++|+.|+|++|+|++
T Consensus 142 ~~~~~~~~~~~L~~L~l~~n~~~~~---~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 142 TNISPLAGLTNLQYLSIGNAQVSDL---TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISD 209 (227)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCCC---GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCB
T ss_pred chhhhhccccccccccccccccccc---hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCC
Confidence 1234556667777777766532 23566777777777777776532 25556777777777777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.09 E-value=1e-12 Score=122.84 Aligned_cols=116 Identities=21% Similarity=0.207 Sum_probs=97.2
Q ss_pred chhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCC
Q 006559 84 AEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLP 163 (640)
Q Consensus 84 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~ 163 (640)
...+..|++|+.|+|++|.|+.. +.+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+++. ++ .+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~--~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS--GIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH--HHHHHH
T ss_pred hhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccc-cccccccccccccccccccccccc-cc--cccccc
Confidence 35688999999999999999875 46889999999999999997 567666667789999999999984 43 477889
Q ss_pred CCcEEEccCCcceeccc-CCcCCCCCCcEEEcccCcCcccCC
Q 006559 164 NLLTLRLEDNRFTGTLY-SVNSSSRSILDFNVSNNQLSGQIP 204 (640)
Q Consensus 164 ~L~~L~L~~N~l~g~~~-~~~~~~~~L~~l~ls~N~l~g~ip 204 (640)
+|+.|+|++|+++.... ..+..+++|+.|+|++|.+....+
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 99999999999986432 456789999999999999876544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.01 E-value=1e-09 Score=104.47 Aligned_cols=127 Identities=20% Similarity=0.282 Sum_probs=101.2
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
.++.|++.+++++.. +.+..+++|+.|+|++|.+.+.. .+..+++|++|++++|.++. ++ .+.++++|+.|++++|
T Consensus 42 ~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~~~-~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~ 117 (227)
T d1h6ua2 42 GITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLA-PLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTST 117 (227)
T ss_dssp TCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCG-GGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTS
T ss_pred CcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeeccc-cccccccccccccccccccc-cc-cccccccccccccccc
Confidence 588899999988864 56899999999999999998764 48899999999999999873 43 5789999999999999
Q ss_pred CCCCCCCc-------------------hhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcCcc
Q 006559 149 AYEGEIPM-------------------TELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQLSG 201 (640)
Q Consensus 149 ~l~g~~p~-------------------~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g 201 (640)
...+..+. ..+..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++
T Consensus 118 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD 187 (227)
T ss_dssp CCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred cccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchh--hcccccceecccCCCccCC
Confidence 87653221 124556778888888888775433 5668888888888888875
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.99 E-value=2.1e-12 Score=120.72 Aligned_cols=122 Identities=23% Similarity=0.269 Sum_probs=98.8
Q ss_pred CcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEccc
Q 006559 68 HRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSH 147 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 147 (640)
.++..|+|+++.++.. +.+..+++|+.|+|++|.|+..+.....+++|+.|++++|.++.. +.+..+++|+.|+|++
T Consensus 48 ~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~ 124 (198)
T d1m9la_ 48 KACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSN 124 (198)
T ss_dssp TTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSEEEESE
T ss_pred cccceeECcccCCCCc-ccccCCccccChhhccccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence 3688999999988854 468899999999999999987654344567899999999999853 3478899999999999
Q ss_pred CCCCCCCC-chhcCCCCCCcEEEccCCcceecccCC----------cCCCCCCcEEE
Q 006559 148 NAYEGEIP-MTELTRLPNLLTLRLEDNRFTGTLYSV----------NSSSRSILDFN 193 (640)
Q Consensus 148 N~l~g~~p-~~~~~~l~~L~~L~L~~N~l~g~~~~~----------~~~~~~L~~l~ 193 (640)
|+++. ++ ...+..+++|+.|+|++|.++...+.. +..+++|+.||
T Consensus 125 N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 125 NKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp EECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred chhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99985 33 246899999999999999998765543 34577888876
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.69 E-value=2.4e-08 Score=95.44 Aligned_cols=135 Identities=19% Similarity=0.157 Sum_probs=89.5
Q ss_pred EecCCCCcEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccccccccCC-ccCCCCCC
Q 006559 62 TCNPSTHRVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHNRFTGTFP-SGVSSLRH 139 (640)
Q Consensus 62 ~C~~~~~~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~ 139 (640)
.|+.. +++ ++..+.+++-.++.+ .++++.|+|++|.|+..++ .|.++++|++|+|++|.+...+| ..|.+++.
T Consensus 5 ~C~C~-~~~--i~c~~~~l~~iP~~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~ 79 (242)
T d1xwdc1 5 ICHCS-NRV--FLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79 (242)
T ss_dssp SEEEC-SSE--EEEESCSCSSCCSCS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTT
T ss_pred cCCCc-CCE--EEEeCCCCCCcCCCC--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccc
Confidence 34443 344 444555565433322 2478888998888887665 57888888889988888876554 35778888
Q ss_pred CCEEEccc-CCCCCCCCchhcCCCCCCcEEEccCCcceecccC-CcCCCCCCcEEEcccCcCccc
Q 006559 140 LRRVDLSH-NAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYS-VNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 140 L~~L~Ls~-N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~-~~~~~~~L~~l~ls~N~l~g~ 202 (640)
++.|++.. |++.. ++...|..+++|++|++++|.++...+. ....+..+..+..+++.+...
T Consensus 80 l~~l~~~~~n~l~~-~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 80 LHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp CCEEEEECCTTCCE-ECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE
T ss_pred cccccccccccccc-cccccccccccccccccchhhhcccccccccccccccccccccccccccc
Confidence 88888764 66664 4436778888888888888888754332 233445555566666666543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.53 E-value=3.2e-07 Score=92.06 Aligned_cols=114 Identities=24% Similarity=0.234 Sum_probs=79.3
Q ss_pred cEEEEEeCCCCCCCCchhccCCCCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccC
Q 006559 69 RVIKLVLEDLDLTGPAEVLSRLTQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHN 148 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 148 (640)
++..|+|++++++..++ .+++|+.|+|++|+|+..+.. +.+|+.|++++|+++. ++.. .+.|++|+|++|
T Consensus 39 ~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~~n 108 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPE---LPPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNN 108 (353)
T ss_dssp TCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSS
T ss_pred CCCEEEeCCCCCCCCCC---CCCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccch-hhhh---cccccccccccc
Confidence 46678888888876553 357888999999998866433 4578888999988873 3321 145889999999
Q ss_pred CCCCCCCchhcCCCCCCcEEEccCCcceecccCCcCCCCCCcEEEcccCcC
Q 006559 149 AYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYSVNSSSRSILDFNVSNNQL 199 (640)
Q Consensus 149 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~~~~~~~~L~~l~ls~N~l 199 (640)
.+. .+| .++.+++|+.|++++|.++..... ...+..+.+.++..
T Consensus 109 ~l~-~lp--~~~~l~~L~~L~l~~~~~~~~~~~----~~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 109 QLE-KLP--ELQNSSFLKIIDVDNNSLKKLPDL----PPSLEFIAAGNNQL 152 (353)
T ss_dssp CCS-SCC--CCTTCTTCCEEECCSSCCSCCCCC----CTTCCEEECCSSCC
T ss_pred ccc-ccc--chhhhccceeeccccccccccccc----cccccchhhccccc
Confidence 887 566 257788999999988888754321 23444555544443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.52 E-value=2.3e-07 Score=93.25 Aligned_cols=99 Identities=28% Similarity=0.262 Sum_probs=80.4
Q ss_pred CCCCEEeCCCCcCCCCCCCCCCCCCCcEEEcccccccccCCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEc
Q 006559 91 TQLRLLSLKNNLLSSSNLNLSSWPHLKHLYLSHNRFTGTFPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRL 170 (640)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L 170 (640)
.+|+.|||++|.|+..|. .+++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++ . + .+.|++|+|
T Consensus 38 ~~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~-~-l--p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPE---LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALS-D-L--PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCC-S-C--CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCCCCC---CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhh-h-h--ccccccccc
Confidence 478999999999987653 3578999999999998 67865 457999999999998 455 2 1 247999999
Q ss_pred cCCcceecccCCcCCCCCCcEEEcccCcCcccC
Q 006559 171 EDNRFTGTLYSVNSSSRSILDFNVSNNQLSGQI 203 (640)
Q Consensus 171 ~~N~l~g~~~~~~~~~~~L~~l~ls~N~l~g~i 203 (640)
++|.++. +|. +..+++|+.|++++|.++...
T Consensus 106 ~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~ 136 (353)
T d1jl5a_ 106 SNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLP 136 (353)
T ss_dssp CSSCCSS-CCC-CTTCTTCCEEECCSSCCSCCC
T ss_pred ccccccc-ccc-hhhhccceeeccccccccccc
Confidence 9999985 454 467899999999999987543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=4.3e-08 Score=96.33 Aligned_cols=80 Identities=28% Similarity=0.277 Sum_probs=51.3
Q ss_pred cEEEEEeCCCCCCCC--chhccCCCCCCEEeCCCCcCCCCCC-CCCCCCCCcEEEcccc-ccccc-CCccCCCCCCCCEE
Q 006559 69 RVIKLVLEDLDLTGP--AEVLSRLTQLRLLSLKNNLLSSSNL-NLSSWPHLKHLYLSHN-RFTGT-FPSGVSSLRHLRRV 143 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~--~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~~l~~L~~L 143 (640)
++..|+|+++.++.. ...+..+++|++|+|+++.+++... .+..+++|++|+|+++ .++.. +...+.++++|+.|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence 567777777665542 2456777888888888887765322 4566778888888774 45421 22223456777777
Q ss_pred EcccC
Q 006559 144 DLSHN 148 (640)
Q Consensus 144 ~Ls~N 148 (640)
+|+++
T Consensus 127 ~ls~c 131 (284)
T d2astb2 127 NLSWC 131 (284)
T ss_dssp ECCCC
T ss_pred ccccc
Confidence 77763
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.17 E-value=1.8e-07 Score=91.76 Aligned_cols=143 Identities=23% Similarity=0.257 Sum_probs=90.8
Q ss_pred CcEEEEEeCCCCCCCCc-hhccCCCCCCEEeCCCC-cCCCCCC--CCCCCCCCcEEEcccc-ccccc-CCccCC-CCCCC
Q 006559 68 HRVIKLVLEDLDLTGPA-EVLSRLTQLRLLSLKNN-LLSSSNL--NLSSWPHLKHLYLSHN-RFTGT-FPSGVS-SLRHL 140 (640)
Q Consensus 68 ~~v~~l~l~~~~l~g~~-~~l~~l~~L~~L~Ls~N-~l~~~~~--~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~-~l~~L 140 (640)
.++..|+|.++.++... ..+..+++|+.|+|+++ .++.... -..++++|++|+|+++ .++.. ++..+. ..++|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 36788889888776543 56788899999999884 5653211 1346788999999884 44321 222222 24678
Q ss_pred CEEEcccC--CCCCCCCchhcCCCCCCcEEEccCC-cceecccCCcCCCCCCcEEEccc-CcCcccCCcccCCC
Q 006559 141 RRVDLSHN--AYEGEIPMTELTRLPNLLTLRLEDN-RFTGTLYSVNSSSRSILDFNVSN-NQLSGQIPAWMSPF 210 (640)
Q Consensus 141 ~~L~Ls~N--~l~g~~p~~~~~~l~~L~~L~L~~N-~l~g~~~~~~~~~~~L~~l~ls~-N~l~g~ip~~~~~~ 210 (640)
+.|+|++. .++..--...+.++++|++|+|++| .+++.....+..+++|+.|+|++ +.+++.....++..
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~ 224 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGC
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcC
Confidence 88888753 3332111122345778888888775 47766666677778888888887 46665544444433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.16 E-value=1e-08 Score=91.82 Aligned_cols=39 Identities=33% Similarity=0.345 Sum_probs=17.0
Q ss_pred CCCCCCEEeCCCCcCCCCCC---CCCCCCCCcEEEccccccc
Q 006559 89 RLTQLRLLSLKNNLLSSSNL---NLSSWPHLKHLYLSHNRFT 127 (640)
Q Consensus 89 ~l~~L~~L~Ls~N~l~~~~~---~~~~l~~L~~L~Ls~N~l~ 127 (640)
.+++|++|+|++|+|+...+ .+..+++|+.|+|++|.++
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 34455555555555544321 1233444444444444444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.09 E-value=7.6e-08 Score=100.44 Aligned_cols=58 Identities=26% Similarity=0.328 Sum_probs=26.5
Q ss_pred cEEEEEeCCCCCCCC--chhccCCCCCCEEeCCCCcCCCCC-----CCCCCCCCCcEEEcccccc
Q 006559 69 RVIKLVLEDLDLTGP--AEVLSRLTQLRLLSLKNNLLSSSN-----LNLSSWPHLKHLYLSHNRF 126 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~--~~~l~~l~~L~~L~Ls~N~l~~~~-----~~~~~l~~L~~L~Ls~N~l 126 (640)
.+..||++++++++. ...+..+++|+.|+|++|.++... ..+..+++|++|||++|.|
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i 67 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL 67 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCC
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcC
Confidence 345555555555543 133444455555555555444210 0123444455555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.08 E-value=3.4e-07 Score=92.21 Aligned_cols=132 Identities=18% Similarity=0.229 Sum_probs=77.6
Q ss_pred cEEEEEeCCCCCCCC--------c------hhccCCCCCCEEeCCCCcCCCCCC-----CCCCCCCCcEEEccccccccc
Q 006559 69 RVIKLVLEDLDLTGP--------A------EVLSRLTQLRLLSLKNNLLSSSNL-----NLSSWPHLKHLYLSHNRFTGT 129 (640)
Q Consensus 69 ~v~~l~l~~~~l~g~--------~------~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~g~ 129 (640)
.+..|+++++.++.. . ......+.|+.|++++|.++.... .+..++.|+.|+|++|.++..
T Consensus 122 ~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 201 (344)
T d2ca6a1 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201 (344)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH
T ss_pred cchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccccccc
Confidence 567778877766321 0 112355677777777777654211 134456777777777776531
Q ss_pred -----CCccCCCCCCCCEEEcccCCCCCC----CCchhcCCCCCCcEEEccCCcceecccC----CcC--CCCCCcEEEc
Q 006559 130 -----FPSGVSSLRHLRRVDLSHNAYEGE----IPMTELTRLPNLLTLRLEDNRFTGTLYS----VNS--SSRSILDFNV 194 (640)
Q Consensus 130 -----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~~l~~L~~L~L~~N~l~g~~~~----~~~--~~~~L~~l~l 194 (640)
+...+..+++|+.|+|++|.++.. +. ..+..+++|++|+|++|.+++.-.. .+. ....|+.|++
T Consensus 202 g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~-~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l 280 (344)
T d2ca6a1 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA-IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280 (344)
T ss_dssp HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH-HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred ccccchhhhhcchhhhccccccccccccccccccc-ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence 233456677777777777776421 11 2355667777777777777653111 111 2355777777
Q ss_pred ccCcCcc
Q 006559 195 SNNQLSG 201 (640)
Q Consensus 195 s~N~l~g 201 (640)
++|+|+.
T Consensus 281 s~N~i~~ 287 (344)
T d2ca6a1 281 QYNEIEL 287 (344)
T ss_dssp CSSCCBH
T ss_pred CCCcCCh
Confidence 7777753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.98 E-value=4.3e-07 Score=80.86 Aligned_cols=87 Identities=23% Similarity=0.289 Sum_probs=66.3
Q ss_pred CCCCCCcEEEccccccccc--CCccCCCCCCCCEEEcccCCCCCCCCchhcCCCCCCcEEEccCCcceecccC-------
Q 006559 111 SSWPHLKHLYLSHNRFTGT--FPSGVSSLRHLRRVDLSHNAYEGEIPMTELTRLPNLLTLRLEDNRFTGTLYS------- 181 (640)
Q Consensus 111 ~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~l~~L~~L~L~~N~l~g~~~~------- 181 (640)
..+++|++|+|++|+++.. ++..+..+++|+.|||++|.++. ++.-.+.....|+.|+|++|.++.....
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 4688999999999999864 34556789999999999999984 4433344456799999999999875542
Q ss_pred CcCCCCCCcEEEcccCcCc
Q 006559 182 VNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 182 ~~~~~~~L~~l~ls~N~l~ 200 (640)
.+..+++|+.|| ++.+.
T Consensus 141 i~~~~P~L~~LD--g~~v~ 157 (162)
T d1koha1 141 IRERFPKLLRLD--GHELP 157 (162)
T ss_dssp HHTTSTTCCEET--TEECC
T ss_pred HHHHCCCCCEEC--cCCCc
Confidence 255688999875 55543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.97 E-value=3.6e-07 Score=92.07 Aligned_cols=41 Identities=27% Similarity=0.277 Sum_probs=18.5
Q ss_pred CCCCCCcEEEccCCcceec----ccCCcCCCCCCcEEEcccCcCc
Q 006559 160 TRLPNLLTLRLEDNRFTGT----LYSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 160 ~~l~~L~~L~L~~N~l~g~----~~~~~~~~~~L~~l~ls~N~l~ 200 (640)
..+++|+.|+|++|.|+.. +...+..+++|+.|+|++|.|+
T Consensus 212 ~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 212 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred cchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 3344555555555554321 2222333445555555555544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.90 E-value=7.1e-07 Score=92.79 Aligned_cols=111 Identities=18% Similarity=0.208 Sum_probs=85.2
Q ss_pred CCCCEEeCCCCcCCCCC--CCCCCCCCCcEEEcccccccc----cCCccCCCCCCCCEEEcccCCCCCC----CCchhcC
Q 006559 91 TQLRLLSLKNNLLSSSN--LNLSSWPHLKHLYLSHNRFTG----TFPSGVSSLRHLRRVDLSHNAYEGE----IPMTELT 160 (640)
Q Consensus 91 ~~L~~L~Ls~N~l~~~~--~~~~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~ 160 (640)
.+|+.||+++|++++.. .-+..+++|+.|+|++|.++- .++..+..+++|+.|||++|.++.. +. ..+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~-~~l~ 80 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL-QGLQ 80 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHH-HTTC
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHH-HHHh
Confidence 36899999999998742 125668899999999999873 3455677899999999999998521 11 1122
Q ss_pred -CCCCCcEEEccCCcceec----ccCCcCCCCCCcEEEcccCcCccc
Q 006559 161 -RLPNLLTLRLEDNRFTGT----LYSVNSSSRSILDFNVSNNQLSGQ 202 (640)
Q Consensus 161 -~l~~L~~L~L~~N~l~g~----~~~~~~~~~~L~~l~ls~N~l~g~ 202 (640)
..++|+.|+|++|+++.. ++..+..+++|+.|+|++|.++..
T Consensus 81 ~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~ 127 (460)
T d1z7xw1 81 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA 127 (460)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred cCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhh
Confidence 235899999999999864 455667789999999999998753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.89 E-value=3.6e-05 Score=73.54 Aligned_cols=130 Identities=16% Similarity=0.145 Sum_probs=83.9
Q ss_pred ccC-cceEEEEEeCCCcEEEEEEeccc--cchHHHHHHHHHHhccC-CCcccceeEEEEcCCeEEEEEeccCCCCHHHhh
Q 006559 343 KGC-VGATYKVVLDGGDVVVVKRIRER--KKKREVDEWLRVIGGLR-HSNIVSIRAYCNGKDELFLVYDYLPHGSLHSLL 418 (640)
Q Consensus 343 ~G~-fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l 418 (640)
+|+ .+.||+.... +..+++|+.... .....+.+|...+..+. +--+.++++++...+..++|||++++..+.+..
T Consensus 23 ~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 23 EGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 344 3579988654 455667776543 22334566766665543 333567788888888999999999998876544
Q ss_pred ccCCCCCCCCcCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------------
Q 006559 419 HGSRGPGRMPVDWNKRLKLASDSAKGLAFLHGYN---------------------------------------------- 452 (640)
Q Consensus 419 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------- 452 (640)
.... . ...++.++++.++.||...
T Consensus 102 ~~~~-------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 102 EDEQ-------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp TTCS-------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred cccc-------c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 3211 1 1223444555555555211
Q ss_pred ----------CCCceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 453 ----------KAHLFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 453 ----------~~~ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
...++|+|+.+.|||+++++.+-|.||+.+.
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1227899999999999987767799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=2.1e-05 Score=74.87 Aligned_cols=73 Identities=16% Similarity=0.212 Sum_probs=51.0
Q ss_pred ccccCc-ceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCC--CcccceeEEEEcCCeEEEEEeccCCCCH
Q 006559 341 LGKGCV-GATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRH--SNIVSIRAYCNGKDELFLVYDYLPHGSL 414 (640)
Q Consensus 341 iG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL 414 (640)
+..|.. +.||+...+++..+++|.-.... ...+..|.+.++.+.. -.+.+++++..+.+..++||||+++.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT-TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC-HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444543 57899998888888889765442 3345666666665533 2356678888888899999999987654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.32 E-value=1.7e-05 Score=70.46 Aligned_cols=112 Identities=13% Similarity=0.195 Sum_probs=63.8
Q ss_pred cCCCCCCEEeCCCC-cCCCCC-----CCCCCCCCCcEEEccccccccc----CCccCCCCCCCCEEEcccCCCCCCCC--
Q 006559 88 SRLTQLRLLSLKNN-LLSSSN-----LNLSSWPHLKHLYLSHNRFTGT----FPSGVSSLRHLRRVDLSHNAYEGEIP-- 155 (640)
Q Consensus 88 ~~l~~L~~L~Ls~N-~l~~~~-----~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p-- 155 (640)
.+.++|+.|+|+++ .++... ..+...+.|++|+|++|.+... +...+...+.|+.|+|++|.++..--
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34567777777763 454321 1245556777777777777532 11233445677778887777763200
Q ss_pred -chhcCCCCCCcEEEccCCcceec-------ccCCcCCCCCCcEEEcccCcC
Q 006559 156 -MTELTRLPNLLTLRLEDNRFTGT-------LYSVNSSSRSILDFNVSNNQL 199 (640)
Q Consensus 156 -~~~~~~l~~L~~L~L~~N~l~g~-------~~~~~~~~~~L~~l~ls~N~l 199 (640)
...+...++|++|+|++|.+... +...+...++|+.|+++.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 01345556778888877754421 233344456777777766543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.80 E-value=0.0022 Score=64.72 Aligned_cols=73 Identities=8% Similarity=0.028 Sum_probs=43.4
Q ss_pred ccccccCcceEEEEEeCC-CcEEEEEEeccc-----c----chHHHHHHHHHHhcc---CCCcccceeEEEEcCCeEEEE
Q 006559 339 ELLGKGCVGATYKVVLDG-GDVVVVKRIRER-----K----KKREVDEWLRVIGGL---RHSNIVSIRAYCNGKDELFLV 405 (640)
Q Consensus 339 ~~iG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~----~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lV 405 (640)
+.||.|....||++...+ ++.++||.-... . .......|.+.++.+ -...+.+++.+. ++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 458999999999998654 667888865321 0 111233455555433 223455566553 4556899
Q ss_pred EeccCCCC
Q 006559 406 YDYLPHGS 413 (640)
Q Consensus 406 ~Ey~~~gs 413 (640)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.80 E-value=0.00024 Score=62.75 Aligned_cols=89 Identities=20% Similarity=0.315 Sum_probs=64.5
Q ss_pred CCCCCcEEEcccc-ccccc----CCccCCCCCCCCEEEcccCCCCCC--CC-chhcCCCCCCcEEEccCCcceec----c
Q 006559 112 SWPHLKHLYLSHN-RFTGT----FPSGVSSLRHLRRVDLSHNAYEGE--IP-MTELTRLPNLLTLRLEDNRFTGT----L 179 (640)
Q Consensus 112 ~l~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~--~p-~~~~~~l~~L~~L~L~~N~l~g~----~ 179 (640)
+.++|+.|+|+++ .++.. +-..+...++|+.|+|++|.+... .. ...+...+.|+.|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4678999999974 56432 233466778999999999998631 11 02344568899999999999854 2
Q ss_pred cCCcCCCCCCcEEEcccCcCc
Q 006559 180 YSVNSSSRSILDFNVSNNQLS 200 (640)
Q Consensus 180 ~~~~~~~~~L~~l~ls~N~l~ 200 (640)
...+...++|+.|++++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 334566788999999999765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.73 E-value=0.0037 Score=61.18 Aligned_cols=136 Identities=15% Similarity=0.089 Sum_probs=77.4
Q ss_pred ceEEEEEeCCCcEEEEEEeccc-cchHHHHHHHHHHhccCCCcc-----cce--eEEEEcCCeEEEEEeccCCCCHH---
Q 006559 347 GATYKVVLDGGDVVVVKRIRER-KKKREVDEWLRVIGGLRHSNI-----VSI--RAYCNGKDELFLVYDYLPHGSLH--- 415 (640)
Q Consensus 347 g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~e~~~l~~l~H~ni-----v~l--~~~~~~~~~~~lV~Ey~~~gsL~--- 415 (640)
-.||++..++|..+++|+.+.. ...+++.+|.+.+..|....+ +.. -..+...+..+.+++|+++..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 3799999999999999998765 356677888877766643222 111 11223456788999999763321
Q ss_pred ---------------HhhccCCCCCCCCcCHHH----------------------HHHHHHHHHHHHHH-hhcCCCCCce
Q 006559 416 ---------------SLLHGSRGPGRMPVDWNK----------------------RLKLASDSAKGLAF-LHGYNKAHLF 457 (640)
Q Consensus 416 ---------------~~l~~~~~~~~~~l~~~~----------------------~~~i~~~ia~gL~y-LH~~~~~~iv 457 (640)
..........+...++.. ....+.++...+.- ........+|
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 111111111122222211 11122222222221 1122245689
Q ss_pred ecCCCCCCeEECCCCCeEEccCCcccc
Q 006559 458 HGHLSSSNIVVDQLGNACISDIGVHQL 484 (640)
Q Consensus 458 Hrdlk~~NILl~~~~~~kl~DfGl~~~ 484 (640)
|+|+.+.|||++++ ..+.||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999753 45899987653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.31 E-value=0.00015 Score=63.97 Aligned_cols=112 Identities=15% Similarity=0.213 Sum_probs=65.5
Q ss_pred cCCCCCCEEeCCC-CcCCCCCC-----CCCCCCCCcEEEccccccccc----CCccCCCCCCCCEEEcccCCCCCCCC--
Q 006559 88 SRLTQLRLLSLKN-NLLSSSNL-----NLSSWPHLKHLYLSHNRFTGT----FPSGVSSLRHLRRVDLSHNAYEGEIP-- 155 (640)
Q Consensus 88 ~~l~~L~~L~Ls~-N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p-- 155 (640)
.+.++|+.|+|++ |.++.... .+...++|++|+|++|.++.. +-..+...++|+.|++++|.+...--
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4557777787776 44543211 244567778888888777543 22234456778888888877753210
Q ss_pred -chhcCCCCCCcEEEc--cCCccee----cccCCcCCCCCCcEEEcccCcC
Q 006559 156 -MTELTRLPNLLTLRL--EDNRFTG----TLYSVNSSSRSILDFNVSNNQL 199 (640)
Q Consensus 156 -~~~~~~l~~L~~L~L--~~N~l~g----~~~~~~~~~~~L~~l~ls~N~l 199 (640)
...+...++|+.++| ++|.+.. .+...+...++|+.|+++.|+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 023455667776555 4566643 2333344567788888776654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.99 E-value=0.0087 Score=60.11 Aligned_cols=71 Identities=11% Similarity=0.136 Sum_probs=45.1
Q ss_pred cccccCcceEEEEEeCCC--------cEEEEEEeccccchHHHHHHHHHHhccCCCcc-cceeEEEEcCCeEEEEEeccC
Q 006559 340 LLGKGCVGATYKVVLDGG--------DVVVVKRIRERKKKREVDEWLRVIGGLRHSNI-VSIRAYCNGKDELFLVYDYLP 410 (640)
Q Consensus 340 ~iG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~ 410 (640)
.|+.|-.-.+|++...++ ..|+++..-.........+|.++++.+.-.++ .++++++.+ .+||||++
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~ 124 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIP 124 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEec
Confidence 466677778999987543 34666655433333445567777776643344 467777743 68999998
Q ss_pred CCCH
Q 006559 411 HGSL 414 (640)
Q Consensus 411 ~gsL 414 (640)
+..+
T Consensus 125 g~~l 128 (395)
T d1nw1a_ 125 SRPL 128 (395)
T ss_dssp EEEC
T ss_pred cccC
Confidence 6443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.16 E-value=0.00095 Score=58.54 Aligned_cols=108 Identities=18% Similarity=0.208 Sum_probs=76.0
Q ss_pred CcEEEEEeCCC-CCCCC-----chhccCCCCCCEEeCCCCcCCCCCC-----CCCCCCCCcEEEccccccccc----CCc
Q 006559 68 HRVIKLVLEDL-DLTGP-----AEVLSRLTQLRLLSLKNNLLSSSNL-----NLSSWPHLKHLYLSHNRFTGT----FPS 132 (640)
Q Consensus 68 ~~v~~l~l~~~-~l~g~-----~~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~Ls~N~l~g~----~p~ 132 (640)
..++.|+|+++ .++.. ...+...++|+.|+|++|.++.... .+...+.|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 36788888874 45432 2456788999999999999875321 245678899999999998643 334
Q ss_pred cCCCCCCCCEEEc--ccCCCCCC----CCchhcCCCCCCcEEEccCCcce
Q 006559 133 GVSSLRHLRRVDL--SHNAYEGE----IPMTELTRLPNLLTLRLEDNRFT 176 (640)
Q Consensus 133 ~~~~l~~L~~L~L--s~N~l~g~----~p~~~~~~l~~L~~L~L~~N~l~ 176 (640)
.+...++|+.++| ++|.+... +. ..+...++|+.|+++.|...
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La-~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIA-NMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHH-HHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHH-HHHHhCCCcCEEeCcCCCCc
Confidence 5677889987665 56777521 11 23557789999999888654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.88 E-value=0.095 Score=50.17 Aligned_cols=142 Identities=13% Similarity=0.081 Sum_probs=71.3
Q ss_pred ccccCcceEEEEEeCCCcEEEEEEeccccchHHHHHHHHHHhccCCCcc-----cce-eE--EEEcCCeEEEEEeccCCC
Q 006559 341 LGKGCVGATYKVVLDGGDVVVVKRIRERKKKREVDEWLRVIGGLRHSNI-----VSI-RA--YCNGKDELFLVYDYLPHG 412 (640)
Q Consensus 341 iG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~e~~~l~~l~H~ni-----v~l-~~--~~~~~~~~~lV~Ey~~~g 412 (640)
|..|---+.|+.+..+|+ +++|+.......+++..|++++..|.+.++ +.. -| +..-......++.+..+.
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~ 104 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGM 104 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCB
T ss_pred CCCCcccCeEEEEECCCc-EEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecccc
Confidence 455666788999887765 778887654444556666666665543322 111 00 112244566777777654
Q ss_pred CHHH--------------hhc----cCCCCC--CCCcCHHH----------------HHHHHHHHHHHHHHhhc-CCCCC
Q 006559 413 SLHS--------------LLH----GSRGPG--RMPVDWNK----------------RLKLASDSAKGLAFLHG-YNKAH 455 (640)
Q Consensus 413 sL~~--------------~l~----~~~~~~--~~~l~~~~----------------~~~i~~~ia~gL~yLH~-~~~~~ 455 (640)
.... .++ ...... .....|.. ....+......+.-.+. .-+.+
T Consensus 105 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~g 184 (316)
T d2ppqa1 105 WLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAG 184 (316)
T ss_dssp CCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEE
T ss_pred cccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccccc
Confidence 3211 000 000000 00000100 11112222222222221 12456
Q ss_pred ceecCCCCCCeEECCCCCeEEccCCccc
Q 006559 456 LFHGHLSSSNIVVDQLGNACISDIGVHQ 483 (640)
Q Consensus 456 ivHrdlk~~NILl~~~~~~kl~DfGl~~ 483 (640)
+||+|+.+.||+++.+...-|.||+.+.
T Consensus 185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcchhhhhcccccceeEecccccc
Confidence 9999999999999988877899998864
|